data_2lqw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lqw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 98' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -114.73 25.32 11.06 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.361 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 46.2 p90 -69.47 140.49 54.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 165.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.45 118.69 18.59 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.582 -178.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.665 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 17.0 m -90.52 78.73 6.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.85 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -176.39 -53.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.068 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 12' ' ' SER . 34.8 t70 -78.18 127.75 32.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.311 0.577 . . . . 0.0 111.562 -170.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.417 ' C ' ' H ' ' A' ' 13' ' ' ALA . 1.1 mpp_? -51.82 -37.68 52.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.674 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.45 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 3.2 m -73.87 23.97 0.08 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.875 0.369 . . . . 0.0 111.929 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 11' ' ' ARG . . . -118.59 -47.19 2.54 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.883 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.402 ' HD1' ' HB2' ' A' ' 13' ' ' ALA . 28.3 p-90 -132.21 -22.39 2.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -166.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -86.86 119.71 27.38 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.942 -171.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 55.6 mtt -117.09 5.78 12.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.908 0.385 . . . . 0.0 111.143 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 49.91 -114.4 2.4 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.247 -0.888 . . . . 0.0 114.73 174.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 15.3 Cg_exo -69.01 95.96 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.916 2.411 . . . . 0.0 112.608 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.822 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 95.3 t -128.88 -71.53 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.117 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.84 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 54.1 m 78.52 170.01 0.2 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.196 0.598 . . . . 0.0 110.439 172.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -49.05 -43.61 40.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.435 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 1.5 pt20 -46.57 -58.57 3.69 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.956 0.785 . . . . 0.0 112.81 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.522 ' HB2' HG11 ' A' ' 19' ' ' VAL . 23.5 mm-40 -85.65 -43.46 13.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.118 0.485 . . . . 0.0 110.467 -172.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.76 -37.41 63.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.765 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -72.25 -35.97 68.95 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.554 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 23' ' ' GLU . 10.8 t -79.8 -32.62 40.79 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.192 -174.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -84.65 -15.06 46.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.082 0.468 . . . . 0.0 111.173 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.483 HD11 ' HG ' ' A' ' 37' ' ' LEU . 78.3 mt -117.11 30.44 7.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.298 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -113.73 139.69 48.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.238 0.542 . . . . 0.0 111.671 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.09 -47.85 3.93 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.648 ' O ' ' HG3' ' A' ' 32' ' ' ARG . 77.9 mt-30 -131.91 80.47 1.92 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 118.875 1.338 . . . . 0.0 111.801 -168.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.874 ' HA ' ' HE1' ' A' ' 35' ' ' MET . 0.0 OUTLIER -169.22 146.07 3.49 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.523 -176.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.98 104.91 1.93 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 166.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.44 -3.67 69.09 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.566 -173.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.874 ' HE1' ' HA ' ' A' ' 32' ' ' ARG . 57.7 mtm -85.61 138.07 32.42 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.932 0.396 . . . . 0.0 110.511 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -144.27 174.33 10.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.743 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.483 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.2 pp -160.45 143.37 13.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.747 172.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.05 135.88 45.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.84 ' HD2' ' H ' ' A' ' 20' ' ' SER . 22.5 ptt-85 -139.64 155.26 47.52 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.397 -173.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.417 ' OD1' ' HA2' ' A' ' 17' ' ' GLY . 2.2 m-20 -66.18 118.25 9.63 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 168.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.524 ' HB2' HG21 ' A' ' 49' ' ' VAL . 21.4 t -84.44 170.06 13.91 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.993 0.425 . . . . 0.0 110.263 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t -112.23 7.13 19.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.484 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -53.68 27.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 47.4 t -170.62 121.74 0.55 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.414 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -40.41 104.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.464 2.776 . . . . 0.0 112.465 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.11 -21.73 2.62 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.209 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -103.25 145.36 30.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.076 0.465 . . . . 0.0 109.773 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.548 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 24.8 m-85 -126.42 160.19 31.18 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' A' ' 41' ' ' SER . 44.0 t -128.16 103.46 10.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.471 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 tp -79.66 98.38 6.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.399 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 m -96.0 120.1 35.68 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.279 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.602 HG23 HD12 ' A' ' 93' ' ' LEU . 54.5 t -116.83 134.24 61.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.28 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.791 ' HG ' ' HB2' ' A' ' 32' ' ' ARG . 31.8 t -103.58 111.63 24.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.209 0.528 . . . . 0.0 111.78 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.538 ' HG3' ' HB ' ' A' ' 96' ' ' THR . 3.2 mm-40 -150.01 152.71 35.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.071 173.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 56.74 28.12 13.79 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.501 0.501 . . . . 0.0 110.877 -171.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.9 m 60.31 28.38 17.99 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.281 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 53' ' ' SER . 12.0 ptt-85 -124.53 158.29 33.29 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 t -110.56 95.21 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 t -81.22 118.8 22.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -100.63 99.91 10.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.675 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.802 ' HE1' HD13 ' A' ' 153' ' ' ILE . 63.1 m-85 -98.09 113.7 25.66 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.74 0.305 . . . . 0.0 111.205 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 68.5 mt -82.3 131.52 33.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.427 0.632 . . . . 0.0 112.448 -174.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 4.3 mp -98.25 122.55 50.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.176 174.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -111.4 132.53 54.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -77.78 110.35 12.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.449 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.722 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 93.1 mt -77.93 170.85 14.32 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.722 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 23.5 Cg_endo -61.69 56.37 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.007 2.472 . . . . 0.0 114.412 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 t30 79.92 4.99 1.94 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.34 0.656 . . . . 0.0 111.964 161.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -97.6 -51.26 4.18 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.836 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.659 ' HB3' ' HA ' ' A' ' 79' ' ' ASP . 5.8 ptp180 -156.32 -171.69 3.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.865 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -109.72 157.92 18.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.595 0.236 . . . . 0.0 110.476 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.754 ' HE3' ' HA ' ' A' ' 75' ' ' ASP . 55.9 tttp -129.27 96.54 4.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.675 0.274 . . . . 0.0 110.278 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.494 ' HB ' HG13 ' A' ' 63' ' ' ILE . 3.1 tt -97.1 94.12 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.496 0.665 . . . . 0.0 109.869 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.94 57.38 7.84 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.277 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.754 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 25.1 t0 76.74 -50.21 0.57 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.16 0.584 . . . . 0.0 111.487 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -61.5 123.2 17.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.888 0.375 . . . . 0.0 110.057 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.2 130.33 54.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.723 0.773 . . . . 0.0 111.809 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 7.8 m-85 -127.74 150.28 49.86 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.659 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 9.9 m-20 -62.43 -26.05 68.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -170.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -161.95 172.78 15.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.029 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.549 HD23 HD21 ' A' ' 84' ' ' LEU . 11.6 mt -56.55 -51.45 81.1 Favored Pre-proline 0 CA--C 1.537 0.455 0 O-C-N 123.373 0.42 . . . . 0.0 111.868 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.665 ' HB3' ' O ' ' A' ' 8' ' ' SER . 60.3 Cg_exo -57.35 -11.34 8.15 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.661 2.24 . . . . 0.0 114.095 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.95 -36.11 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.236 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.549 HD21 HD23 ' A' ' 81' ' ' LEU . 3.9 pp -76.33 -26.97 56.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.071 0.462 . . . . 0.0 110.557 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.81 -15.68 62.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.784 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -86.16 -37.46 18.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.886 0.374 . . . . 0.0 110.566 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -63.84 -37.7 88.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.28 0.562 . . . . 0.0 110.49 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.536 ' CG ' HD21 ' A' ' 93' ' ' LEU . 38.8 m-85 -81.77 -1.16 46.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.545 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.428 ' O ' HG22 ' A' ' 97' ' ' THR . 7.7 tmtm? -76.26 -24.89 54.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.106 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -115.57 -12.67 11.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.478 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.515 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 12.3 t-160 -72.44 -41.56 66.01 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.995 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.529 ' HA ' HG21 ' A' ' 97' ' ' THR . 83.6 m-85 72.8 108.9 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.379 1.049 . . . . 0.0 109.548 -167.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.73 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 4.9 mt -82.53 14.14 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 95' ' ' THR . 27.2 t70 172.55 -140.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 156' ' ' PRO . 12.8 t -78.12 -7.12 56.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.305 0.574 . . . . 0.0 109.685 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.538 ' HB ' ' HG3' ' A' ' 54' ' ' GLU . 20.7 m -136.44 158.73 43.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.692 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 92' ' ' TYR . 56.7 p -96.63 -169.12 1.83 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.59 ' O ' ' HB1' ' A' ' 4' ' ' ALA . 74.3 mt -67.53 125.76 27.18 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 167.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.56 -68.67 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.896 0.379 . . . . 0.0 110.415 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' A' ' 35' ' ' MET . 61.8 mm-40 -144.02 149.4 45.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.053 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.38 162.86 37.51 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.754 2.302 . . . . 0.0 113.718 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -78.62 171.59 12.1 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.488 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 74.1 Cg_exo -55.8 177.58 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.581 2.854 . . . . 0.0 114.524 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.699 -178.765 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 1.081 HD23 HG21 ' A' ' 152' ' ' ILE . 10.6 mp . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 122.246 1.022 . . . . 0.0 113.007 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 17.0 tp10 -167.59 -74.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.715 -175.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -107.1 110.39 22.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.187 0.517 . . . . 0.0 111.11 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.518 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 70.3 t -127.84 132.04 69.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.687 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HB3' HD11 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -112.57 145.0 41.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.87 0.367 . . . . 0.0 110.66 -178.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.879 HG21 HG12 ' A' ' 178' ' ' VAL . 42.1 p -93.29 129.07 39.5 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.332 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 21.2 mt -104.14 -32.98 8.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.717 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.602 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 34.1 t80 -86.12 -36.08 19.8 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -170.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.659 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 2.0 t70 79.65 129.3 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.557 0.535 . . . . 0.0 110.728 -175.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 91.5 t80 -151.39 100.64 2.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -89.1 65.88 2.6 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.595 2.197 . . . . 0.0 113.006 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.95 -29.82 73.81 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.774 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.522 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 47.3 m-80 50.22 73.32 0.27 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.87 0.868 . . . . 0.0 113.313 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -171.14 -176.28 1.89 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.09 -10.13 51.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.535 0.684 . . . . 0.0 109.168 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -94.09 -32.75 13.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.304 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.79 104.78 9.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.733 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.663 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 46.2 tp -71.9 117.81 61.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 55.2 Cg_endo -76.59 111.38 3.24 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.062 1.842 . . . . 0.0 111.728 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.628 ' CG ' HG22 ' A' ' 130' ' ' THR . 12.5 p90 -125.91 163.69 22.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.143 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.659 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 20.8 pttm -122.15 -168.51 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.739 -173.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.4 OUTLIER -80.94 67.15 6.74 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -178.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.9 42.95 0.11 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.413 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.597 ' HG2' ' HG2' ' A' ' 145' ' ' LYS . 5.3 mm-40 -99.2 145.09 27.6 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.535 -0.391 . . . . 0.0 110.073 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 129' ' ' ARG . 46.5 mm -98.41 124.35 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 175.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 165' ' ' ASN . 34.2 mt -120.43 158.7 26.64 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 90.4 t -119.0 126.05 75.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 1.081 HG21 HD23 ' A' ' 125' ' ' LEU . 48.6 mm -75.76 87.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 122.355 1.074 . . . . 0.0 108.913 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.802 HD13 ' HE1' ' A' ' 61' ' ' TYR . 6.7 tt -82.77 -37.36 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.832 -170.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.787 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 20.7 mt-10 -136.0 143.44 44.79 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -131.8 90.54 35.94 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 121.593 -0.692 . . . . 0.0 111.41 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 6.7 Cg_exo -74.05 -52.14 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.401 2.067 . . . . 0.0 111.957 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -115.19 -179.12 3.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.434 ' O ' HG21 ' A' ' 175' ' ' VAL . 42.1 mt-10 -102.48 -25.48 13.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.831 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.422 ' O ' HG22 ' A' ' 175' ' ' VAL . 7.6 tt0 -85.45 -27.78 25.48 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.237 0.541 . . . . 0.0 110.404 175.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.561 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 45.4 m95 -128.86 124.19 34.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.634 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.556 ' O ' HG13 ' A' ' 173' ' ' ILE . 52.6 m0 -111.3 148.32 33.18 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.787 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 33.3 m -95.63 101.01 12.67 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.534 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -108.93 153.96 22.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.573 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.9 ptt180 -96.2 133.4 40.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.663 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 64.2 t30 -74.27 -177.5 3.04 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.777 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.411 ' H ' ' CG ' ' A' ' 165' ' ' ASN . 38.6 ttmt -62.44 -26.21 68.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.04 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.642 ' OD1' ' HB3' ' A' ' 165' ' ' ASN . 54.0 p-10 -90.56 3.7 53.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.335 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.04 -1.08 87.8 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.804 -0.635 . . . . 0.0 113.131 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 25.7 ttm-85 -64.67 129.22 38.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.698 0.285 . . . . 0.0 111.021 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.97 111.68 29.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.038 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.39 165.65 26.32 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 175.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.561 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 21.0 mtp -79.92 138.47 37.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.13 0.465 . . . . 0.0 110.229 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.559 HD11 HG13 ' A' ' 178' ' ' VAL . 2.8 pp -133.7 145.61 56.87 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.023 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.476 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 4.6 Cg_exo -77.3 131.97 12.13 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.809 2.339 . . . . 0.0 112.371 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.559 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 57.2 t -62.05 -43.27 85.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 18.3 Cg_endo -61.37 -11.6 20.23 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.899 1.732 . . . . 0.0 112.903 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -92.17 -12.34 33.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.53 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.879 HG12 HG21 ' A' ' 130' ' ' THR . 32.7 m -126.6 162.17 31.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.228 0.537 . . . . 0.0 112.376 -169.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -133.98 134.77 42.89 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.931 176.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.416 ' HG2' HG22 ' A' ' 128' ' ' VAL . 45.9 mtmt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.753 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.529 ' HB ' HG11 ' A' ' 266' ' ' VAL . 22.0 t . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -114.73 115.27 26.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.275 0.559 . . . . 0.0 110.941 -175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.575 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -136.55 127.6 27.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.889 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.761 ' HB3' HD13 ' A' ' 263' ' ' ILE . 22.3 pttm -93.06 140.51 29.41 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.271 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.53 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -72.4 110.52 6.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.613 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.469 HG13 ' HG3' ' A' ' 244' ' ' GLN . 26.6 pt -69.1 -32.69 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 111.04 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.469 ' HG3' HG13 ' A' ' 243' ' ' ILE . 23.6 mt-30 -118.41 166.2 12.95 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.459 ' HB3' HG11 ' A' ' 260' ' ' VAL . 9.3 ptpp? -94.81 146.16 24.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.42 0.628 . . . . 0.0 111.099 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.698 ' HB2' HH11 ' A' ' 246' ' ' ARG . 0.0 OUTLIER -128.28 110.85 12.77 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.35 173.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--N 1.316 -0.853 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.689 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -84.55 113.39 21.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.687 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.582 HD23 ' HB ' ' A' ' 279' ' ' VAL . 1.3 tt -88.86 117.3 27.76 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.68 120.74 14.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 245' ' ' LYS . 95.0 mt -128.12 116.26 19.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.174 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -86.55 158.37 19.54 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.053 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.459 HG11 ' HB3' ' A' ' 245' ' ' LYS . 9.6 m -62.1 110.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.509 0.671 . . . . 0.0 111.864 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.99 -1.44 57.79 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.96 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -79.32 138.55 37.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.841 0.321 . . . . 0.0 110.665 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.761 HD13 ' HB3' ' A' ' 241' ' ' LYS . 46.2 mm -84.1 116.64 28.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.04 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.415 HG21 HD23 ' A' ' 258' ' ' LEU . 40.4 t -89.31 114.09 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.307 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -86.26 88.7 7.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.529 HG11 ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -91.85 117.34 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.515 0.674 . . . . 0.0 110.714 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.06 -22.85 13.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.504 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.591 ' HB2' ' HG2' ' A' ' 276' ' ' GLU . 55.6 mtp180 -123.32 126.09 46.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.412 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 53.1 mtt -122.95 127.2 48.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.422 ' HB2' ' HG3' ' A' ' 274' ' ' GLN . 40.3 m-80 -91.68 139.79 30.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 25.9 pt -70.66 -8.29 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.903 0.383 . . . . 0.0 111.858 -173.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -69.1 -30.46 68.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.952 0.406 . . . . 0.0 110.774 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.3 -5.06 13.43 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.572 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.422 ' HG3' ' HB2' ' A' ' 270' ' ' ASN . 7.8 pt20 -94.69 115.0 27.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 175.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.476 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 36.5 m0 -110.42 145.58 37.35 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.146 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.591 ' HG2' ' HB2' ' A' ' 268' ' ' ARG . 1.4 pm0 -112.61 115.38 28.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.556 0.694 . . . . 0.0 110.383 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -118.22 164.21 12.87 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.112 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -102.02 110.79 22.84 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.582 ' HB ' HD23 ' A' ' 256' ' ' LEU . 98.7 t -122.76 117.87 53.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.204 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.36 -81.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.369 -175.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -147.32 3.63 0.9 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.364 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.8 mtp-105 -108.31 144.54 35.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.845 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -120.44 121.57 38.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.847 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -144.95 169.24 26.75 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.404 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 95.5 mt -93.56 113.99 26.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.975 0.417 . . . . 0.0 110.225 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -115.51 143.17 30.0 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.565 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.64 149.89 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.256 1.97 . . . . 0.0 112.205 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -65.17 -16.64 63.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.274 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -5.65 56.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.023 0.44 . . . . 0.0 111.597 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 246' ' ' ARG . 63.4 t60 -96.73 -18.76 19.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.01 0.433 . . . . 0.0 110.662 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 242' ' ' ALA . 31.3 m -128.03 170.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.419 -176.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -131.1 126.4 35.69 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.575 HD12 ' HB2' ' A' ' 240' ' ' ALA . 41.5 mm -70.83 130.72 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -133.24 161.26 34.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.033 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 28.2 t0 . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.69 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.27 0.557 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -150.38 92.93 1.92 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.773 0.797 . . . . 0.0 110.652 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -138.88 162.8 33.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.18 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -78.24 93.19 4.58 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 4.5 p -77.26 65.15 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.304 0.573 . . . . 0.0 110.434 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.4 t -175.48 -41.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.079 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.36 104.46 0.5 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.489 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 9.1 mtm-85 -70.51 -14.39 62.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.554 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -85.31 -1.94 57.52 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.1 -47.79 5.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.722 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 30.2 p-90 -114.95 -29.99 6.53 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.43 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 47.9 t80 -75.42 111.21 10.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.628 ' HB3' HG23 ' A' ' 19' ' ' VAL . 10.7 tpp -100.58 1.53 40.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.367 -172.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.6 -114.71 3.23 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.013 -0.994 . . . . 0.0 114.225 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.58 104.3 1.85 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.429 2.086 . . . . 0.0 112.383 -176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.818 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 93.2 t -132.88 -76.35 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 119.256 -0.402 . . . . 0.0 112.037 -174.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.718 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 73.3 m 74.47 167.99 0.29 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -53.36 -32.79 50.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -44.46 -54.72 5.68 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.884 0.74 . . . . 0.0 112.111 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.603 ' HB2' HG12 ' A' ' 19' ' ' VAL . 47.3 mt-10 -95.6 -45.21 7.14 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.262 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.55 -46.65 28.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.28 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.672 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 20.7 mt-30 -64.71 -56.4 13.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.668 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -66.2 -23.44 66.44 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -171.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -86.24 -15.75 39.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.898 0.38 . . . . 0.0 110.692 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.601 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 68.7 mt -121.63 17.89 11.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.593 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 54.8 mm-40 -76.3 70.02 2.87 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.08 -20.04 52.38 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.677 171.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -61.79 123.11 17.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.244 0.522 . . . . 0.0 111.477 -175.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.48 ' HB2' ' HE1' ' A' ' 35' ' ' MET . 34.8 mtm180 55.58 -51.56 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.111 1.764 . . . . 0.0 115.19 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 32.0 m170 74.19 134.01 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.571 0.748 . . . . 0.0 109.143 -170.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.15 -3.24 44.13 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -172.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.746 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 76.1 mtm -96.62 147.72 23.6 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.41 ' CD1' HD23 ' A' ' 98' ' ' LEU . 45.8 p90 -146.68 165.94 28.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.613 0.244 . . . . 0.0 110.935 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.3 pp -152.8 136.04 15.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.94 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.8 t -103.86 122.8 57.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.49 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.818 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 9.6 ptt180 -121.63 165.63 15.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.507 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.402 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 3.9 p30 -85.57 138.8 31.93 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.508 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 8.5 t -74.45 135.73 42.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.212 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.1 t -78.13 -10.32 59.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.639 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -78.39 -48.34 15.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.581 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 41' ' ' SER . 48.4 t -159.03 135.98 6.79 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.37 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.42 5.08 2.1 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.303 2.002 . . . . 0.0 112.728 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.34 8.26 58.69 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.523 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -144.7 160.84 40.55 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.402 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 22.1 m-85 -124.78 164.05 20.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.955 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.503 HG22 HG12 ' A' ' 62' ' ' ILE . 18.6 t -127.56 99.13 5.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 0.0 110.569 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.403 ' CB ' HD12 ' A' ' 63' ' ' ILE . 22.2 tp -78.17 101.31 6.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.134 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 59' ' ' SER . 58.4 m -96.75 131.98 42.91 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.385 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.601 HG23 HD12 ' A' ' 93' ' ' LEU . 47.2 t -119.36 151.82 21.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.835 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.601 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 14.1 t -102.59 119.02 38.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.999 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 1.067 ' HG2' ' HB3' ' A' ' 57' ' ' ARG . 7.1 pm0 -145.61 175.25 10.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 169.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 6.0 p30 -36.2 89.51 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.391 1.076 . . . . 0.0 113.865 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m 39.8 62.55 1.2 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.912 0.863 . . . . 0.0 110.023 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 1.067 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -162.14 50.57 0.2 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.027 -154.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 38.2 t -76.62 95.63 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.562 ' OG ' ' HB ' ' A' ' 52' ' ' VAL . 12.5 p -77.88 119.35 21.22 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.281 -172.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -101.11 88.13 3.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.081 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.64 ' CE2' HD23 ' A' ' 93' ' ' LEU . 71.4 m-85 -93.12 112.12 23.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.516 0.327 . . . . 0.0 111.713 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.503 HG12 HG22 ' A' ' 49' ' ' VAL . 43.9 mt -82.17 140.56 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.1 mp -124.2 121.04 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.629 0.771 . . . . 0.0 110.603 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -85.39 135.57 33.82 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.7 t -80.86 103.23 10.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' A' ' 72' ' ' LYS . 83.3 mt -85.6 132.13 45.5 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.877 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.46 -5.84 12.3 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.019 2.48 . . . . 0.0 112.28 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -87.85 14.76 8.12 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.81 31.29 14.2 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.518 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -121.14 176.04 5.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.881 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 58.9 m-85 -139.13 129.24 25.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.105 0.478 . . . . 0.0 110.692 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HB2' HD12 ' A' ' 66' ' ' LEU . 39.7 ttmt -115.94 108.01 15.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.73 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.563 HD12 HD11 ' A' ' 84' ' ' LEU . 15.9 tt -87.5 78.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.642 0.734 . . . . 0.0 110.17 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.68 81.37 0.09 OUTLIER Glycine 0 C--O 1.226 -0.4 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.89 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.8 t70 75.94 -48.09 0.58 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.962 0.505 . . . . 0.0 112.158 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -66.93 125.01 24.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.632 0.73 . . . . 0.0 111.744 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -84.47 131.79 34.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.129 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -139.53 173.77 11.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.998 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -77.04 -42.95 36.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.974 0.416 . . . . 0.0 110.454 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.496 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 6.8 p80 -172.49 -174.48 1.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.159 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.555 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 13.0 mt -54.4 -60.74 6.88 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.629 ' HB3' ' O ' ' A' ' 8' ' ' SER . 51.5 Cg_exo -58.43 -9.69 7.36 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.411 2.074 . . . . 0.0 113.795 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.48 -35.62 12.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.759 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 73' ' ' ILE . 4.1 pp -76.19 -29.7 57.75 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.323 0.582 . . . . 0.0 109.431 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.17 -30.64 70.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.794 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.402 ' HA ' ' CD ' ' A' ' 89' ' ' LYS . 33.9 tt0 -76.43 -7.98 56.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.37 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -97.23 -37.17 10.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.499 0.666 . . . . 0.0 109.445 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.637 ' CG ' HD21 ' A' ' 93' ' ' LEU . 38.8 m-85 -81.0 -10.32 59.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.466 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.402 ' CD ' ' HA ' ' A' ' 86' ' ' GLU . 22.4 ptmt -81.31 -7.34 59.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.225 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.6 pt -123.74 3.67 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 121.262 0.553 . . . . 0.0 110.619 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 4.5 t-160 -97.13 -40.27 8.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.435 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.707 ' CD2' HG21 ' A' ' 97' ' ' THR . 95.7 m-85 75.17 88.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.416 1.073 . . . . 0.0 110.472 -172.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.64 HD23 ' CE2' ' A' ' 61' ' ' TYR . 2.0 mt -66.51 97.88 0.46 Allowed 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.737 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 9.4 t70 56.33 73.13 0.46 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.021 -175.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 27.2 m 75.32 -39.32 0.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -107.75 139.9 41.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.176 0.512 . . . . 0.0 111.047 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.707 HG21 ' CD2' ' A' ' 92' ' ' TYR . 2.9 p -83.62 177.14 8.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.789 0.328 . . . . 0.0 110.527 176.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.41 HD23 ' CD1' ' A' ' 36' ' ' PHE . 81.5 mt -70.05 98.44 1.31 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 172.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 50.8 mm -84.47 -55.73 6.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.808 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.746 ' O ' ' HA ' ' A' ' 35' ' ' MET . 36.7 tt0 -167.02 141.59 3.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.061 -175.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.12 157.74 28.59 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.556 2.171 . . . . 0.0 112.734 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.43 144.49 57.5 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.818 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.402 ' HD3' ' SD ' ' A' ' 35' ' ' MET . 33.5 Cg_exo -60.42 131.68 39.65 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.569 2.179 . . . . 0.0 111.594 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.457 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 26.3 ptt180 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.748 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.579 HD11 HG22 ' A' ' 152' ' ' ILE . 2.2 mm? . . . . . 0 N--CA 1.467 0.41 0 CA-C-O 121.293 0.568 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 5.2 tp10 -165.86 -76.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.413 -171.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 180' ' ' LYS . 28.5 m-85 -106.01 124.4 49.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.753 -171.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.789 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 22.3 t -133.22 151.36 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.112 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG2' ' HB3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -131.02 142.11 50.29 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.681 162.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.465 HG23 HG13 ' A' ' 178' ' ' VAL . 1.8 p -97.94 140.22 32.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.914 0.387 . . . . 0.0 111.949 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 61.8 mt -108.55 -22.63 12.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.14 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 57.0 t80 -92.33 -35.04 13.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -167.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.532 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 7.0 t70 76.01 113.19 0.07 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.337 0.589 . . . . 0.0 110.395 -174.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 71.4 t80 -147.19 109.51 3.96 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.068 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.692 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 20.9 Cg_endo -92.91 102.28 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.53 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.694 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -95.12 4.27 67.47 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.365 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.7 m120 57.54 20.63 6.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.331 0.653 . . . . 0.0 112.547 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.471 ' N ' ' HD3' ' A' ' 143' ' ' PRO . 1.9 p30 52.2 -175.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 173.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 69.09 7.2 6.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.494 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -169.39 -45.7 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.241 -1.345 . . . . 0.0 108.361 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.694 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 24.2 m-20 -140.85 116.04 9.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.759 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.672 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 25.2 tp -67.53 120.57 74.03 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.617 0.246 . . . . 0.0 110.937 -174.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.692 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 43.6 Cg_endo -75.13 95.59 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.031 1.821 . . . . 0.0 111.346 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.429 ' HB2' ' HG1' ' A' ' 130' ' ' THR . 10.0 p90 -104.6 172.58 6.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.567 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.42 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 8.7 ttmm -122.52 -178.14 3.82 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.941 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.6 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -84.02 75.18 10.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.458 0.647 . . . . 0.0 109.604 177.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.9 33.83 0.54 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.171 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 6.7 mm-40 -94.62 154.95 17.1 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 129' ' ' ARG . 40.0 mm -103.85 125.84 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 165' ' ' ASN . 32.9 mt -118.82 156.77 28.85 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 59.8 t -124.83 129.79 73.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.579 HG22 HD11 ' A' ' 125' ' ' LEU . 30.6 mm -74.55 86.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.384 1.088 . . . . 0.0 109.073 -176.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.485 HG12 ' HE1' ' A' ' 61' ' ' TYR . 10.4 tt -75.18 -26.42 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.341 -174.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.767 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 44.5 mt-10 -146.69 143.91 29.08 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -125.34 87.44 55.64 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 121.46 -0.775 . . . . 0.0 111.026 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.509 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 16.8 Cg_exo -70.62 -62.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.387 2.058 . . . . 0.0 112.542 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -109.63 -174.8 2.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.845 0.355 . . . . 0.0 111.748 -171.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -95.81 -29.15 14.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.324 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -96.18 -22.53 17.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.155 0.502 . . . . 0.0 110.82 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.614 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 42.5 m95 -128.93 124.55 35.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.67 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -107.42 164.87 11.83 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.767 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 29.3 m -113.13 106.66 14.92 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.926 -0.484 . . . . 0.0 109.748 174.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -115.95 158.92 22.3 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.388 -176.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.2 ptt180 -95.48 132.43 40.58 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.355 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.672 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 63.0 t30 -72.0 171.35 12.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.522 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -59.31 -29.79 67.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.45 -43.43 94.28 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.02 67.43 0.7 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.866 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -143.73 160.01 41.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.414 HG22 HD11 ' A' ' 153' ' ' ILE . 37.5 t -101.75 125.57 55.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.307 0.575 . . . . 0.0 111.986 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.6 161.9 30.44 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.614 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 25.6 mtp -81.07 144.25 31.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.179 0.489 . . . . 0.0 110.271 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.494 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.7 pp -139.66 143.4 35.02 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.875 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.488 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 3.0 Cg_exo -76.3 132.65 13.94 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.897 2.398 . . . . 0.0 112.561 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.579 ' O ' HG21 ' A' ' 178' ' ' VAL . 60.3 t -62.8 -43.03 81.87 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 23.2 Cg_endo -62.57 -4.39 5.56 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.953 1.769 . . . . 0.0 113.302 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -99.64 -8.57 24.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.592 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.579 HG21 ' O ' ' A' ' 175' ' ' VAL . 10.5 m -107.24 -178.33 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 122.265 1.031 . . . . 0.0 113.576 -168.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.717 ' HB3' ' HG2' ' A' ' 129' ' ' ARG . 23.6 tt0 -154.46 42.13 0.49 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.098 -1.865 . . . . 0.0 109.221 -165.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.789 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.626 0 O-C-N 120.432 -1.418 . . . . 0.0 108.817 -167.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.764 ' N ' HG12 ' A' ' 266' ' ' VAL . 88.8 t . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.991 ' HB2' ' HA ' ' A' ' 265' ' ' LYS . 0.0 OUTLIER -69.21 130.61 43.12 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.333 1.063 . . . . 0.0 111.996 -160.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.545 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -148.63 159.41 44.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.802 -168.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -91.3 135.78 33.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.556 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -77.56 126.5 30.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 31.9 pt -101.75 -6.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.439 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.32 155.63 43.25 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.583 ' HB3' HG22 ' A' ' 260' ' ' VAL . 18.4 pttp -113.88 137.02 52.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.749 0.309 . . . . 0.0 110.777 174.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.535 ' HG3' ' HE1' ' A' ' 290' ' ' HIS . 0.0 OUTLIER -174.72 137.61 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 257' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.629 0 CA-C-O 119.248 -0.406 . . . . 0.0 112.041 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 121.405 0.621 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -89.64 147.77 23.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.577 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.39 110.15 22.29 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 247' ' ' VAL . . . -56.75 105.48 0.22 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.514 0.509 . . . . 0.0 110.588 177.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.601 HD21 HG23 ' A' ' 279' ' ' VAL . 90.8 mt -118.38 130.59 56.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.018 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -111.79 173.7 6.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.038 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.583 HG22 ' HB3' ' A' ' 245' ' ' LYS . 57.7 t -75.58 124.57 33.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 112.109 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 88.25 25.31 31.52 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.383 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.28 150.84 36.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.135 0.468 . . . . 0.0 110.389 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 30.7 mm -86.52 123.19 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.317 0.579 . . . . 0.0 111.639 -175.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.705 ' HA ' HG22 ' A' ' 279' ' ' VAL . 44.7 t -101.07 103.2 14.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.772 177.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.991 ' HA ' ' HB2' ' A' ' 239' ' ' PHE . 18.0 ttpp -86.03 86.5 7.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.006 0.432 . . . . 0.0 110.667 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.764 HG12 ' N ' ' A' ' 238' ' ' VAL . 13.7 p -105.29 136.46 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 15.3 t -124.55 -14.41 6.85 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -167.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -135.78 98.64 3.96 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 120.921 1.691 . . . . 0.0 111.744 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.717 ' HE2' HG21 ' A' ' 238' ' ' VAL . 34.1 ttm -79.1 140.29 37.88 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -162.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -98.3 137.0 37.67 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.734 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.6 tt -75.93 -8.35 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.267 0.556 . . . . 0.0 110.623 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -69.21 -28.51 66.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.945 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 109.48 -17.79 30.68 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.696 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.1 118.82 29.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.437 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 47.3 m0 -98.85 145.03 27.4 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.051 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 266' ' ' VAL . 38.7 tt0 -117.93 97.41 5.81 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.275 0.56 . . . . 0.0 109.741 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -107.61 150.73 16.9 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.153 -168.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -104.65 109.83 21.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 264' ' ' VAL . 60.4 t -114.39 91.27 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.083 0.468 . . . . 0.0 110.453 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 54.37 55.89 7.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.814 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 97.71 -28.33 14.86 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.512 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.1 mtm105 -104.39 118.48 36.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.945 0.373 . . . . 0.0 110.377 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 47.9 pttt -121.31 142.44 49.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.084 0.468 . . . . 0.0 111.882 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -171.07 -174.48 38.91 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.484 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 87.0 mt -93.38 144.75 25.04 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.583 0.706 . . . . 0.0 111.905 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.486 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 36.1 p90 -149.77 151.41 32.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.999 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.442 ' HG2' ' HB2' ' A' ' 290' ' ' HIS . 60.8 Cg_endo -74.34 151.71 43.39 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.261 1.974 . . . . 0.0 112.26 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -64.25 -21.34 66.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.636 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.2 m -77.22 -8.53 57.73 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.229 0.538 . . . . 0.0 110.992 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.535 ' HE1' ' HG3' ' A' ' 246' ' ' ARG . 16.5 t60 -86.03 -22.01 27.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.157 0.503 . . . . 0.0 110.631 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' A' ' 242' ' ' ALA . 35.0 m -128.31 178.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.501 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -141.29 136.91 32.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.524 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.545 HD12 ' HB2' ' A' ' 240' ' ' ALA . 47.2 mm -81.68 102.82 7.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -100.23 14.44 30.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.825 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.348 177.351 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.34 0 CA-C-O 120.777 0.323 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -113.9 -68.07 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 5.4 m-85 62.96 165.28 0.11 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -109.53 -39.35 5.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.818 161.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.2 m 64.68 147.56 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.037 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.0 p 61.15 -49.65 0.12 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.988 1.315 . . . . 0.0 113.875 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -57.31 107.01 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 111.586 -172.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.587 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -61.97 -22.81 65.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.479 -178.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.2 t -79.32 -15.96 57.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.641 0.258 . . . . 0.0 110.862 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.93 -49.03 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.168 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -110.83 -22.81 11.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.587 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 56.2 t80 -85.57 113.13 21.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.708 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 9.6 tpp -97.42 -1.16 44.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.555 -172.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.44 -115.43 3.75 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.159 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.1 Cg_exo -74.75 103.61 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.842 2.361 . . . . 0.0 112.187 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.639 ' HB ' ' CB ' ' A' ' 39' ' ' ARG . 88.3 t -137.36 -74.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 60.0 m 76.02 172.12 0.25 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.467 ' HD2' ' HB2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -51.95 -43.69 63.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -174.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -60.37 -38.04 82.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -92.35 -44.79 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.385 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . -55.84 -37.56 68.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.882 0.372 . . . . 0.0 111.121 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 64.9 tt0 -67.37 -52.83 35.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.908 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -72.71 -14.25 61.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 0.0 111.425 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -78.65 -44.07 24.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.565 0.697 . . . . 0.0 110.055 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 16.1 mt -104.25 12.07 34.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.491 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 20.8 tt0 -76.87 104.45 7.37 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.618 0.723 . . . . 0.0 110.573 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' H ' ' NE2' ' A' ' 31' ' ' GLN . . . 118.02 -20.82 10.53 Favored Glycine 0 CA--C 1.499 -0.917 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.909 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER 40.11 111.02 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 112.592 -1.804 . . . . 0.0 115.185 172.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 39.6 ttp180 -68.84 -10.22 55.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.959 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.425 ' HD2' ' HB2' ' A' ' 31' ' ' GLN . 32.3 m170 74.26 122.5 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.113 176.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.54 19.99 49.83 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.059 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 35.8 mtm -115.49 147.58 40.48 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.454 ' HB2' HD13 ' A' ' 50' ' ' LEU . 40.0 p90 -147.44 158.85 44.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.129 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.4 pp -150.95 135.35 16.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.218 0.533 . . . . 0.0 110.507 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.11 115.58 44.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.113 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.639 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.68 -173.44 2.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.05 0.452 . . . . 0.0 112.048 -176.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.451 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 7.3 p-10 -71.23 138.06 49.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.874 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -100.42 89.14 3.86 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 168.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 p -71.75 11.82 0.46 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.449 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 t -100.19 -8.51 23.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 50.3 t -164.76 110.0 0.84 Allowed Pre-proline 0 CA--C 1.528 0.121 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.079 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.04 115.83 2.83 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.966 2.444 . . . . 0.0 112.466 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.48 -41.94 1.78 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.049 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.64 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 3.3 m-20 -74.3 158.66 33.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.723 0.297 . . . . 0.0 110.483 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -134.68 173.91 11.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.695 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.622 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 58.4 t -137.94 109.38 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 111.007 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.454 HD13 ' HB2' ' A' ' 36' ' ' PHE . 26.2 tp -81.03 104.55 11.6 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.536 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 m -95.46 120.95 36.6 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.856 0.36 . . . . 0.0 110.34 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 22.1 t -120.4 142.55 35.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.909 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 89.2 p -121.99 133.56 54.82 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.531 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' CB ' ' HB3' ' A' ' 94' ' ' ASP . 1.9 tm-20 -147.94 178.15 8.75 Favored 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -16.94 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.461 ' HA ' ' CD ' ' A' ' 31' ' ' GLN . 36.3 m 35.91 72.13 0.11 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.706 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.88 ' HD2' ' HB3' ' A' ' 155' ' ' LYS . 9.8 ttp85 -168.51 52.93 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.743 -158.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 25.3 t -77.68 101.62 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 122.07 0.938 . . . . 0.0 109.651 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 m -93.21 121.22 34.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.323 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -94.25 89.45 5.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.283 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.444 ' HB3' HD11 ' A' ' 73' ' ' ILE . 88.0 m-85 -84.81 115.07 22.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.725 0.41 . . . . 0.0 110.786 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.1 mt -81.3 140.0 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -174.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.619 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.6 mp -115.75 121.19 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.597 0.759 . . . . 0.0 110.568 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.64 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 8.3 m120 -85.74 146.28 26.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.916 0.487 . . . . 0.0 111.566 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.0 t -93.18 99.18 11.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.924 174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.4 mt -84.22 142.91 41.44 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.48 -28.78 46.31 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.617 2.878 . . . . 0.0 114.115 -172.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -91.63 20.15 5.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.412 -0.18 . . . . 0.0 111.383 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.533 ' HD2' ' HB3' ' A' ' 280' ' ' ASN . 0.0 OUTLIER 67.43 40.21 2.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.139 0.495 . . . . 0.0 111.045 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -113.61 148.24 36.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.49 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 58.7 m-85 -114.71 115.77 27.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.936 0.398 . . . . 0.0 111.297 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 39.5 ttpt -110.77 105.94 14.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.538 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.619 ' HB ' HG13 ' A' ' 63' ' ' ILE . 10.2 tt -81.74 76.99 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.842 0.83 . . . . 0.0 110.175 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 60.73 95.15 0.01 OUTLIER Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.547 178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 15.9 t70 74.93 -49.51 0.66 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.849 0.357 . . . . 0.0 111.498 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -85.15 113.25 21.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 11.6 pt-20 -101.7 134.96 44.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.317 0.579 . . . . 0.0 110.816 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 80.1 m-85 -121.73 174.14 7.02 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.956 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.27 -46.89 85.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.026 0.441 . . . . 0.0 110.885 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -166.47 -178.07 4.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.427 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.498 HD23 HD21 ' A' ' 84' ' ' LEU . 16.4 mt -55.19 -57.49 19.78 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.51 25.46 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.062 1.841 . . . . 0.0 112.831 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 81' ' ' LEU . . . -119.81 -34.86 3.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.951 175.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.498 HD21 HD23 ' A' ' 81' ' ' LEU . 3.7 pp -76.68 -30.82 56.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.214 0.531 . . . . 0.0 109.968 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.6 mt -64.57 -41.48 96.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.403 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.618 ' HA ' ' HD2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -69.5 -4.08 17.31 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.562 178.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -96.21 -37.69 10.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.812 0.815 . . . . 0.0 109.637 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.475 ' CD1' HD22 ' A' ' 93' ' ' LEU . 46.7 m-85 -77.37 -2.92 37.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.506 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.618 ' HD2' ' HA ' ' A' ' 86' ' ' GLU . 16.5 ptmt -78.86 -11.11 59.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.607 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.99 -12.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 120.936 0.398 . . . . 0.0 110.88 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -75.46 -29.68 59.71 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.827 ' HA ' HG21 ' A' ' 97' ' ' THR . 23.0 m-85 59.14 55.21 4.48 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.7 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.556 ' HA ' ' OE1' ' A' ' 154' ' ' GLU . 3.4 pp -60.9 123.27 17.08 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 118.463 -1.295 . . . . 0.0 107.518 169.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 1.9 m-20 81.6 -2.5 1.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.28 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.786 ' OG1' ' HB3' ' A' ' 156' ' ' PRO . 33.6 m 55.99 75.55 0.33 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 122.054 0.93 . . . . 0.0 110.665 -172.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.431 ' O ' HD13 ' A' ' 99' ' ' ILE . 1.8 m 179.06 -34.32 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.211 177.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.827 HG21 ' HA ' ' A' ' 92' ' ' TYR . 4.8 p 73.38 -172.17 0.13 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.641 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 35.0 mt -85.65 94.13 9.0 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.478 173.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 96' ' ' THR . 49.7 mm -68.79 -56.87 10.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.549 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 11.2 pt-20 -157.5 163.56 24.42 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.497 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 100' ' ' GLU . 40.4 Cg_endo -67.32 153.09 78.06 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.129 1.886 . . . . 0.0 113.026 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -71.98 143.34 86.36 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.467 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 24.0 Cg_exo -64.57 155.94 63.74 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.548 2.165 . . . . 0.0 112.066 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.708 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 14.1 mtm180 . . . . . 0 C--N 1.324 -0.508 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.598 HD11 HG23 ' A' ' 152' ' ' ILE . 3.5 mm? . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -170.14 -81.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.878 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -104.66 124.63 49.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.207 0.527 . . . . 0.0 110.655 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.68 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 61.4 t -133.53 137.15 53.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.407 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.599 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 2.3 ptp180 -114.31 146.67 40.19 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.066 167.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.559 HG23 HG13 ' A' ' 178' ' ' VAL . 2.1 p -103.58 135.28 45.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.017 0.436 . . . . 0.0 111.577 -176.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.574 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 78.3 mt -101.46 -40.1 7.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.421 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 23.1 t80 -74.28 -35.12 63.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -168.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.56 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.1 t70 73.47 107.34 0.07 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.247 0.546 . . . . 0.0 110.095 -177.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 77.3 t80 -140.92 103.25 6.26 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.764 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 33.7 Cg_endo -90.08 93.06 0.3 Allowed 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.378 2.052 . . . . 0.0 112.11 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -83.31 -21.16 59.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.014 174.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.9 m120 48.22 47.58 19.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.492 -0.854 . . . . 0.0 111.967 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.653 ' HB3' ' HB2' ' A' ' 141' ' ' ASP . 20.1 t70 -141.14 161.04 38.8 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.55 -7.12 53.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.271 0.558 . . . . 0.0 110.98 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.674 ' O ' ' HB2' ' A' ' 172' ' ' MET . 1.4 mp0 -125.62 15.51 8.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.695 172.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.653 ' HB2' ' HB3' ' A' ' 138' ' ' ASP . 20.4 m-20 -146.61 87.75 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.561 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 27.1 tp -69.76 119.96 74.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.49 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.764 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 59.2 Cg_endo -73.99 90.97 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.221 1.948 . . . . 0.0 111.434 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 11.4 p90 -99.6 158.74 15.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.56 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 72.9 mmtt -98.94 178.75 4.85 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.278 0.561 . . . . 0.0 111.322 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.76 18.21 2.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.596 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.64 29.87 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.35 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 145' ' ' LYS . 24.0 tt0 -99.81 156.64 17.0 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 129' ' ' ARG . 50.4 mm -99.02 133.52 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 57.4 mt -120.54 157.04 30.32 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.14 132.47 70.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 125' ' ' LEU . 35.5 mm -75.09 88.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 122.184 0.992 . . . . 0.0 109.633 -176.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.436 HG22 HG21 ' A' ' 170' ' ' VAL . 21.5 tt -76.96 -31.32 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.189 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.99 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 65.5 mt-10 -132.63 141.46 48.66 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 171.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.88 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 1.9 tptm -129.8 84.14 61.95 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 122.305 1.05 . . . . 0.0 109.357 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.786 ' HB3' ' OG1' ' A' ' 95' ' ' THR . 19.3 Cg_exo -77.73 -66.78 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.413 2.742 . . . . 0.0 113.308 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -94.55 175.93 6.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.956 -172.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.78 -10.26 20.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -123.46 -3.34 8.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.272 0.558 . . . . 0.0 110.602 173.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.653 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 58.4 m95 -129.75 125.74 36.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.395 173.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.752 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.4 m0 -122.22 135.68 54.79 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.31 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.99 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.6 m -90.28 92.8 9.08 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.192 0.52 . . . . 0.0 109.632 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.54 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -94.22 163.27 13.51 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.939 0.4 . . . . 0.0 110.657 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.3 ptt180 -100.78 132.3 46.25 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.44 0.638 . . . . 0.0 110.583 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.561 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -50.3 139.06 15.65 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.467 172.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 166' ' ' LYS . 12.4 tmtt? -56.85 -27.0 59.7 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -99.93 9.6 42.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.583 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.5 83.11 1.63 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.21 -0.995 . . . . 0.0 115.279 166.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 169' ' ' ARG . 2.5 ptp180 -173.04 157.63 3.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.508 0.194 . . . . 0.0 110.488 162.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.436 HG21 HG22 ' A' ' 153' ' ' ILE . 48.0 t -98.32 129.91 47.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 142' ' ' LEU . . . -154.44 152.79 24.31 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.102 172.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.674 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -73.45 138.44 45.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.652 0.263 . . . . 0.0 110.461 177.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -136.71 144.65 47.84 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.74 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.933 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 23.7 Cg_exo -68.22 139.12 45.19 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.28 2.653 . . . . 0.0 112.989 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.645 ' O ' HG23 ' A' ' 178' ' ' VAL . 88.0 t -76.34 -47.61 3.35 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.7 Cg_endo -66.08 6.43 0.49 Allowed 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.994 1.796 . . . . 0.0 111.909 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.933 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 1.2 m-85 -105.76 -1.64 24.16 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.439 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 175' ' ' VAL . 12.9 m -116.75 -167.04 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -169.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.599 ' HB3' ' HG3' ' A' ' 129' ' ' ARG . 7.7 tp10 -157.97 41.31 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.705 -1.588 . . . . 0.0 108.791 -163.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 O-C-N 120.987 -1.07 . . . . 0.0 111.466 -167.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.507 ' HB ' HG11 ' A' ' 266' ' ' VAL . 26.1 t . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.695 0.283 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.48 118.92 37.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.579 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -120.28 128.07 52.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.093 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -82.75 126.18 32.09 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -78.72 92.29 4.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.97 -15.99 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.133 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -130.18 129.87 43.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -69.77 172.92 6.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.397 0.618 . . . . 0.0 111.64 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 25.3 tpt180 -147.0 103.26 3.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.158 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 54.2 t . . . . . 0 C--N 1.32 -0.703 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.553 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.002 0.429 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -66.01 125.68 26.2 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.159 0.504 . . . . 0.0 110.622 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.485 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.9 OUTLIER -79.08 115.68 18.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.869 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -70.11 115.15 8.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.917 0.389 . . . . 0.0 110.44 177.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.514 HD21 HG22 ' A' ' 279' ' ' VAL . 93.0 mt -118.62 154.82 32.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.617 -176.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.75 159.15 38.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.954 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.44 122.96 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.557 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.61 3.3 30.62 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.668 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.418 ' CG ' HH11 ' A' ' 69' ' ' ARG . 41.7 t0 -107.51 161.97 14.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.519 0.659 . . . . 0.0 110.204 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 27.2 mm -102.91 121.91 54.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.243 0.545 . . . . 0.0 111.362 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.412 ' HA ' HG21 ' A' ' 279' ' ' VAL . 21.5 t -91.01 112.1 24.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.589 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.624 ' HZ3' ' HB2' ' A' ' 265' ' ' LYS . 10.2 mtmp? -88.98 94.36 9.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.507 HG11 ' HB ' ' A' ' 238' ' ' VAL . 2.9 p -86.07 123.68 39.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.428 0.632 . . . . 0.0 110.69 -173.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.9 t -110.81 -17.83 13.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.514 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.788 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 24.9 ttm-85 -131.87 97.35 4.16 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.02 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 54.9 mtt -94.83 134.01 37.91 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.59 ' OD1' ' HB3' ' A' ' 272' ' ' ASN . 7.5 p30 -131.26 167.74 18.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.976 -172.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.58 6.8 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.312 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.59 ' HB3' ' OD1' ' A' ' 270' ' ' ASN . 3.7 t30 -87.39 -30.68 20.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.869 0.366 . . . . 0.0 110.93 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 125.42 -64.43 0.57 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.304 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -73.71 124.54 26.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.535 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 11.1 m0 -93.65 168.29 11.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.56 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 35.8 tt0 -104.38 113.29 26.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.21 162.95 18.16 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.811 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.52 116.81 30.15 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.854 HG11 ' H ' ' A' ' 280' ' ' ASN . 15.2 t -125.82 -172.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.854 ' H ' HG11 ' A' ' 279' ' ' VAL . 9.2 p30 -55.06 -32.08 61.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.026 0.376 . . . . 0.0 111.874 -176.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.28 -68.39 1.6 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.071 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.485 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -179.71 -169.87 0.14 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 60.7 mttm -85.2 129.11 34.87 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -161.54 176.88 38.01 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 80.0 mt -84.32 134.52 34.51 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.985 0.421 . . . . 0.0 111.103 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -137.45 140.93 31.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.211 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.22 139.03 16.5 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.478 2.118 . . . . 0.0 112.239 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -73.72 6.79 2.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.87 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.2 p -95.67 -15.97 22.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.764 0.316 . . . . 0.0 111.35 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -98.74 -13.12 20.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.234 0.54 . . . . 0.0 110.059 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.1 160.89 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.287 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -127.78 120.21 27.38 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.076 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.71 109.05 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.172 171.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -103.92 11.58 35.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.21 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.464 0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.353 -178.237 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 121.118 0.485 . . . . 0.0 112.145 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -137.69 105.29 5.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.049 0.452 . . . . 0.0 110.496 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -155.89 157.86 37.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.545 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.36 111.79 14.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.908 0.385 . . . . 0.0 110.21 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 t -87.93 64.91 8.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.169 0.509 . . . . 0.0 110.397 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.0 t -173.47 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.915 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.46 111.44 1.39 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.742 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -56.0 -33.16 64.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.097 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 m -79.89 3.15 20.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.891 0.377 . . . . 0.0 111.595 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.85 -47.87 5.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.174 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -124.39 -22.67 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -87.68 117.33 26.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.745 0.307 . . . . 0.0 110.633 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.749 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 2.0 mpp? -109.57 7.23 24.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.722 0.296 . . . . 0.0 111.445 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.85 -114.6 3.27 Favored Glycine 0 C--O 1.225 -0.457 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.875 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 13.6 Cg_exo -69.73 101.08 0.86 Allowed 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.448 2.099 . . . . 0.0 112.137 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.601 ' HB ' ' CB ' ' A' ' 39' ' ' ARG . 86.0 t -129.11 -76.48 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.597 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 2.2 p 88.4 170.87 0.04 OUTLIER 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 169.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.7 mtp85 -53.35 -35.83 60.69 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.793 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -61.37 -51.91 66.81 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.458 0.474 . . . . 0.0 111.801 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.78 -43.6 12.4 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.16 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . -50.57 -41.12 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.825 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.519 ' HA ' HG12 ' A' ' 58' ' ' VAL . 11.1 tt0 -81.88 -33.48 30.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.984 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.2 t -79.8 -18.33 51.19 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.02 0.438 . . . . 0.0 111.339 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -88.86 -27.93 20.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.017 0.436 . . . . 0.0 110.792 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.634 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 78.0 mt -111.22 25.69 11.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.38 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.59 29.76 0.07 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -172.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.65 -1.45 39.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.908 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -50.24 -59.24 4.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.951 0.405 . . . . 0.0 110.936 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.578 ' HB2' ' HE1' ' A' ' 35' ' ' MET . 51.9 mtm180 -132.09 111.46 11.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 172.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -68.98 114.87 7.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.46 -18.46 6.42 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.781 -173.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.753 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.6 mtm -74.65 144.71 43.71 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 120.674 0.273 . . . . 0.0 110.327 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.445 ' CG ' HD23 ' A' ' 98' ' ' LEU . 33.4 p90 -144.34 164.59 30.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.139 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.6 pp -153.85 138.79 17.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.043 0.449 . . . . 0.0 110.464 174.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.5 121.49 54.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.601 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -124.82 168.97 12.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -178.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.546 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 2.1 m-20 -72.23 134.13 45.45 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 168.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.532 ' HA ' HG21 ' A' ' 49' ' ' VAL . 24.3 t -37.01 -86.69 0.0 OUTLIER 'General case' 0 C--O 1.236 0.376 0 O-C-N 124.585 1.178 . . . . 0.0 112.875 -168.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.9 m -172.58 -61.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.4 t -98.3 -26.96 14.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.671 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.2 m -102.43 108.62 58.1 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.158 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.03 107.84 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.231 2.621 . . . . 0.0 111.686 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.99 -47.97 0.89 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.406 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 11.4 m-20 -78.24 151.75 32.94 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 168.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -124.3 172.9 8.74 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 121.387 -0.125 . . . . 0.0 110.731 -172.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.666 HG22 HG13 ' A' ' 62' ' ' ILE . 42.8 t -145.48 104.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 175.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.31 105.37 4.04 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.329 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.7 m -96.63 139.26 32.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.977 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.594 HG23 HD12 ' A' ' 93' ' ' LEU . 40.6 t -129.09 150.45 34.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.876 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.634 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 31.1 t -98.73 121.1 40.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.322 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 1.3 mt-10 -143.11 173.96 11.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 56.7 m-80 -40.24 87.39 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.857 0.863 . . . . 0.0 112.917 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m 42.13 58.35 2.97 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.278 1.037 . . . . 0.0 109.25 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.694 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -161.01 53.87 0.29 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.239 -153.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 8.9 t -75.94 94.33 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 t -87.03 121.27 29.25 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.332 -172.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -100.77 98.55 9.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.383 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.483 ' CE2' HD23 ' A' ' 93' ' ' LEU . 50.2 m-85 -97.83 115.74 28.65 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.486 0.315 . . . . 0.0 111.371 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.666 HG13 HG22 ' A' ' 49' ' ' VAL . 7.1 tt -72.44 150.02 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.2 mp -128.37 117.74 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.184 0.594 . . . . 0.0 109.549 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.406 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 9.6 m120 -87.41 138.39 31.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.37 -173.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.3 t -83.23 100.28 10.5 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 171.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -78.17 157.87 77.79 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.8 62.48 2.36 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.586 2.191 . . . . 0.0 112.426 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 84.3 0.72 0.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.806 0.842 . . . . 0.0 110.61 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -72.32 -78.64 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.244 173.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.719 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 3.2 mpt_? -153.95 -171.01 3.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.358 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.423 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 27.4 m-85 -112.98 115.18 27.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -101.53 109.61 21.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.564 -171.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.3 tt -97.46 85.22 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.658 0.742 . . . . 0.0 110.72 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.02 81.38 0.09 OUTLIER Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.635 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.4 t70 72.6 -43.99 0.58 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.062 0.545 . . . . 0.0 111.315 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -74.81 126.16 30.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.826 0.346 . . . . 0.0 110.184 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -108.01 124.77 50.66 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.562 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.719 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 81.7 m-85 -124.19 148.6 47.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.568 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 10.7 m-20 -62.7 -29.82 70.94 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -170.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 6.5 p80 -160.35 171.63 18.76 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.254 -0.179 . . . . 0.0 110.871 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.523 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.9 mt -55.91 -56.62 28.45 Favored Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.34 0.4 . . . . 0.0 111.84 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 32.3 Cg_exo -61.6 -9.2 12.82 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.215 1.943 . . . . 0.0 113.538 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.34 -36.19 16.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.515 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -76.17 -30.03 57.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 98' ' ' LEU . 92.2 mt -65.17 -38.74 91.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.495 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.815 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 40.3 mt-10 -75.86 -20.94 57.7 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -74.49 -38.8 62.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.295 0.569 . . . . 0.0 110.128 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.486 ' CG ' HD21 ' A' ' 93' ' ' LEU . 47.8 m-85 -79.28 -6.77 57.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.104 0.478 . . . . 0.0 110.703 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.815 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 25.5 mtpp -71.78 -17.21 62.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.496 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.77 7.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 121.042 0.448 . . . . 0.0 111.162 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 20.2 t-160 -102.07 -32.29 10.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.299 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.523 ' CD1' HG21 ' A' ' 97' ' ' THR . 98.8 m-85 70.43 101.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.741 0.651 . . . . 0.0 110.513 -175.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.638 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 9.4 mt -70.98 -20.61 62.41 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.856 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.588 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 30.9 t70 -172.75 82.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.715 171.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 66.7 -24.39 0.11 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.57 0.748 . . . . 0.0 111.874 -178.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 94' ' ' ASP . 13.9 t -124.3 157.94 33.76 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.523 HG21 ' CD1' ' A' ' 92' ' ' TYR . 19.1 p -100.04 -172.84 2.3 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.655 0.264 . . . . 0.0 111.088 -177.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.445 HD23 ' CG ' ' A' ' 36' ' ' PHE . 86.5 mt -70.96 93.54 1.0 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 35.9 mm -85.03 -59.32 2.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.138 -173.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.753 ' O ' ' HA ' ' A' ' 35' ' ' MET . 4.9 pt-20 -149.33 147.55 23.76 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.652 -174.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.43 149.54 27.58 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.5 2.134 . . . . 0.0 112.471 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.552 ' HB3' HD23 ' A' ' 28' ' ' LEU . . . -70.58 146.49 93.86 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.999 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.97 140.83 92.22 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.879 2.386 . . . . 0.0 112.16 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.749 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 52.4 mtm180 . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.984 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 1.002 HD13 HG13 ' A' ' 152' ' ' ILE . 4.3 mm? . . . . . 0 N--CA 1.461 0.119 0 CA-C-O 121.83 0.824 . . . . 0.0 112.721 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -151.53 -88.45 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.533 -172.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.527 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 79.0 m-85 -109.95 119.9 40.78 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.921 0.867 . . . . 0.0 112.035 -175.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.727 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 68.5 t -132.99 130.97 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.367 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.852 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 8.4 ptp85 -110.58 155.94 21.63 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 118.415 -1.314 . . . . 0.0 109.431 172.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.415 HG22 HG11 ' A' ' 178' ' ' VAL . 3.9 p -111.72 141.03 45.85 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.495 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 76.4 mt -103.44 -39.35 6.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.211 -175.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.3 t80 -73.82 -31.68 63.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -167.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.643 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 17.3 t70 67.82 91.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.443 0.639 . . . . 0.0 109.892 -172.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 88.1 t80 -124.85 113.24 26.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.349 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 58.0 Cg_endo -87.88 95.1 0.42 Allowed 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.15 1.9 . . . . 0.0 112.573 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.89 -10.27 84.28 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.586 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.412 HD21 ' HA ' ' A' ' 137' ' ' ASN . 10.8 m120 62.96 25.62 15.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.033 0.533 . . . . 0.0 111.524 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.756 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 3.8 p30 46.83 -168.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 73.66 1.27 3.89 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.155 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -178.59 -35.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.125 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -134.41 110.38 9.39 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.492 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.6 HD13 ' HD2' ' A' ' 143' ' ' PRO . 31.4 tp -68.04 127.47 93.31 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 120.829 0.347 . . . . 0.0 111.72 -172.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 138' ' ' ASP . 60.0 Cg_endo -78.8 105.28 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.292 1.995 . . . . 0.0 110.943 171.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 9.0 p90 -112.7 157.87 20.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.647 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.643 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 3.4 mptp? -102.91 178.79 4.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.817 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -66.45 -9.3 32.82 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.862 -177.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.493 ' N ' ' HD2' ' A' ' 146' ' ' LYS . . . -164.16 45.8 0.31 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.678 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -102.3 147.18 27.0 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.631 HD11 ' HB3' ' A' ' 129' ' ' ARG . 33.8 mm -93.23 132.52 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.548 HD22 ' HA ' ' A' ' 165' ' ' ASN . 18.7 mt -118.8 154.85 32.18 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.66 129.86 74.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 172.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 1.002 HG13 HD13 ' A' ' 125' ' ' LEU . 46.3 mm -75.67 86.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.783 HG21 ' HG2' ' A' ' 154' ' ' GLU . 17.0 tt -67.95 -26.8 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.128 -176.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.783 ' HG2' HG21 ' A' ' 153' ' ' ILE . 0.5 OUTLIER -155.85 140.95 17.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.934 0.397 . . . . 0.0 111.2 173.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.453 ' HD2' ' CD2' ' A' ' 125' ' ' LEU . 32.2 tttm -120.89 95.84 48.82 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-O 121.249 0.547 . . . . 0.0 110.482 172.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.446 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 3.1 Cg_exo -77.16 -59.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.81 2.34 . . . . 0.0 112.062 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -104.87 -170.37 1.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.052 -174.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -100.27 -42.72 6.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.897 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -80.31 -25.3 39.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.768 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.514 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 39.1 m95 -129.01 128.17 43.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.005 0.431 . . . . 0.0 110.759 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.642 ' O ' HG13 ' A' ' 173' ' ' ILE . 53.6 m0 -114.18 135.68 53.78 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.059 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.667 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 17.6 m -87.58 103.14 15.28 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.257 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.537 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -112.35 173.68 6.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.987 0.422 . . . . 0.0 111.13 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.4 ptt180 -119.88 137.56 53.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.0 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.548 ' HA ' HD22 ' A' ' 150' ' ' LEU . 0.1 OUTLIER -78.59 -168.1 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.505 -177.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -60.45 -34.8 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.799 0.333 . . . . 0.0 110.422 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.52 ' HB2' HD22 ' A' ' 165' ' ' ASN . 44.8 m-20 -70.63 -21.27 62.65 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.042 0.449 . . . . 0.0 110.655 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.469 ' H ' HD21 ' A' ' 165' ' ' ASN . . . 97.62 5.26 57.82 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.701 -0.761 . . . . 0.0 114.449 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.756 ' HD3' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -86.77 151.15 23.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.998 0.899 . . . . 0.0 111.45 -177.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.478 HG23 HG23 ' A' ' 153' ' ' ILE . 39.5 t -98.91 140.74 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.567 -166.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -168.1 158.14 30.75 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 169.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 31.5 mtp -76.12 139.48 41.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.366 0.583 . . . . 0.0 110.089 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.642 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -133.77 148.69 69.45 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.678 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.514 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 3.5 Cg_exo -77.48 132.6 12.39 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.168 2.579 . . . . 0.0 112.674 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.636 ' O ' HG22 ' A' ' 178' ' ' VAL . 24.1 t -58.62 -46.33 99.59 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.363 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.0 Cg_exo -63.27 -2.1 3.62 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.375 2.05 . . . . 0.0 113.786 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.58 -5.66 26.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.415 -0.178 . . . . 0.0 111.327 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.0 m -107.41 -172.19 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -166.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.852 ' HB3' ' HG3' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -159.66 42.21 0.21 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.609 -163.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.727 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.754 0 O-C-N 121.219 -0.926 . . . . 0.0 109.25 -168.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.548 ' HB ' HG11 ' A' ' 266' ' ' VAL . 20.7 t . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.928 0.394 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.11 132.56 56.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.382 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.505 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -121.17 155.27 34.9 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.669 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -119.5 119.08 32.8 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 259' ' ' GLU . . . -70.45 119.06 14.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.686 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 22.9 pt -91.01 -4.25 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.053 -172.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -142.48 160.87 39.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.587 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.872 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 20.9 ttmm -93.51 123.05 36.55 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.853 HH11 ' HB3' ' A' ' 246' ' ' ARG . 0.7 OUTLIER -139.44 114.31 9.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--N 1.32 -0.689 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.323 -179.418 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 68.6 p . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -98.95 107.03 19.36 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.072 0.463 . . . . 0.0 110.964 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -73.18 113.62 10.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -58.71 108.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.538 0.524 . . . . 0.0 110.811 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.712 HD21 HG21 ' A' ' 279' ' ' VAL . 95.8 mt -130.25 127.03 38.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.264 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.872 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 11.7 pt-20 -119.61 -177.12 3.31 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.538 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 30.7 m -61.36 135.31 26.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.22 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 68.12 28.86 73.21 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.984 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -108.2 140.02 42.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.972 0.386 . . . . 0.0 110.146 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.0 mm -88.28 123.23 40.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.34 0.591 . . . . 0.0 111.523 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.469 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 23.2 t -104.71 107.89 23.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.078 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -82.44 87.68 6.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.717 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.548 HG11 ' HB ' ' A' ' 238' ' ' VAL . 4.9 p -88.55 116.92 31.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.622 0.725 . . . . 0.0 110.584 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.414 ' O ' ' HD2' ' A' ' 268' ' ' ARG . 3.1 m -110.6 -19.15 12.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.694 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.437 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 13.8 mmm180 -122.34 109.96 15.07 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.5 mtt -107.6 118.3 36.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.154 0.502 . . . . 0.0 111.572 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -90.76 158.92 16.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.023 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.57 -14.7 9.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.455 0.645 . . . . 0.0 110.493 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -80.81 -1.8 44.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.893 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.82 -61.65 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.918 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.569 ' HG3' HD13 ' A' ' 285' ' ' LEU . 0.0 OUTLIER -77.71 131.21 37.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.93 0.395 . . . . 0.0 110.628 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.507 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 15.8 m0 -107.08 168.64 9.07 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.237 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 14.0 mt-10 -110.51 122.53 47.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.096 0.474 . . . . 0.0 110.299 174.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -130.26 145.14 16.41 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.511 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -94.41 109.11 20.99 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.712 HG21 HD21 ' A' ' 258' ' ' LEU . 20.8 t -113.43 167.76 6.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.404 ' N ' HG13 ' A' ' 279' ' ' VAL . 16.2 m120 -60.13 -16.66 34.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -81.28 -45.08 7.66 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.863 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.625 ' HG2' HH11 ' A' ' 282' ' ' ARG . 1.0 OUTLIER 173.16 178.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 16.5 pttp -103.75 139.43 39.0 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 166.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -172.33 -170.24 35.95 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.7 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.569 HD13 ' HG3' ' A' ' 274' ' ' GLN . 97.9 mt -91.1 143.42 26.71 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.242 0.544 . . . . 0.0 110.803 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 41.6 p90 -147.97 137.16 11.9 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.561 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 7.3 Cg_exo -72.89 136.34 24.97 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.43 2.086 . . . . 0.0 111.309 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -63.51 -20.64 65.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.926 0.393 . . . . 0.0 110.956 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 m -69.81 -13.11 62.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.315 0.579 . . . . 0.0 110.828 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -97.39 -14.35 21.28 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.079 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 240' ' ' ALA . 27.6 m -124.61 165.82 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.527 0.68 . . . . 0.0 112.14 -173.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -114.43 116.33 28.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.517 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 240' ' ' ALA . 21.3 mm -89.02 117.12 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.13 0.49 . . . . 0.0 110.643 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -141.52 148.32 39.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.699 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 35.1 t0 . . . . . 0 C--N 1.316 -0.855 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.02 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -119.1 -8.01 10.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.837 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.722 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 27.6 p90 -94.11 162.37 13.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.58 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.28 123.84 48.9 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 m -79.96 21.83 0.54 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.723 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -111.41 -37.16 5.33 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.651 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 12' ' ' SER . 34.4 t70 -87.94 108.35 19.15 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.055 -174.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -65.49 -20.04 66.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.426 -179.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.406 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 23.9 m -74.03 -5.41 41.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.803 0.335 . . . . 0.0 110.669 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.76 -47.88 5.42 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -115.62 -21.26 9.79 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -171.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 49.3 t80 -81.52 118.55 22.83 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.202 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.797 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 6.9 tpp -95.14 -7.94 37.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.359 -172.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.08 -115.45 3.6 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.254 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 6.4 Cg_exo -73.65 95.02 0.86 Allowed 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.974 2.449 . . . . 0.0 112.529 -174.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.873 HG13 ' H ' ' A' ' 20' ' ' SER . 14.1 t -136.86 -152.97 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.873 ' H ' HG13 ' A' ' 19' ' ' VAL . 82.4 p 176.32 178.56 0.21 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -166.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -69.31 -39.89 78.0 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.121 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -63.34 -59.54 4.57 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.395 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 8.3 tp10 -59.9 -47.23 86.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.124 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.31 -35.87 70.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.51 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.458 HE21 ' HB3' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -64.65 -40.95 96.33 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.647 -179.372 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -80.17 -6.51 57.9 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.126 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 20.6 mmt85 -87.57 -35.32 18.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.714 0.769 . . . . 0.0 109.03 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.909 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 39.2 mt -100.08 27.4 5.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.331 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -51.35 97.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.478 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.2 -4.63 31.62 Favored Glycine 0 CA--C 1.49 -1.503 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 167.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 1.057 HE21 ' HA ' ' A' ' 56' ' ' SER . 1.6 mp0 57.14 85.59 0.08 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 113.814 -1.193 . . . . 0.0 110.768 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -70.33 -19.95 63.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.61 ' NE2' ' HA ' ' A' ' 55' ' ' ASN . 41.2 m170 78.63 118.93 0.06 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.297 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.95 9.08 59.95 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.972 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.643 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 29.3 mtm -106.75 137.07 45.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.498 -0.413 . . . . 0.0 110.176 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' A' ' 50' ' ' LEU . 43.3 p90 -133.98 162.34 32.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.247 -175.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.4 pp -151.0 135.03 16.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.52 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.0 t -102.49 108.31 23.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.74 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 23.6 ptt-85 -110.82 168.62 9.34 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.134 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.431 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 27.2 t70 -85.81 92.99 8.78 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.468 ' HA ' HG21 ' A' ' 49' ' ' VAL . 37.7 m 33.81 -149.22 0.0 OUTLIER 'General case' 0 C--O 1.238 0.5 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 41' ' ' SER . 63.8 m -157.29 -15.67 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.105 171.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 m -121.37 -44.87 2.35 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.038 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 40.9 t -115.65 99.87 52.96 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.11 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 22.6 Cg_endo -61.87 129.26 26.89 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.716 2.277 . . . . 0.0 111.84 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.32 -33.36 4.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.37 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.42 166.45 12.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.431 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 25.4 m-85 -125.73 166.22 17.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.778 0.323 . . . . 0.0 111.123 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 41' ' ' SER . 45.0 t -144.13 106.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.846 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.7 ' HB2' HD12 ' A' ' 63' ' ' ILE . 63.8 tp -70.09 101.34 1.81 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.408 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.9 m -94.82 118.85 32.44 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.08 0.467 . . . . 0.0 109.99 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.556 HG22 HD12 ' A' ' 93' ' ' LEU . 46.5 t -119.2 134.19 63.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.192 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.909 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 84.1 p -93.39 132.85 37.25 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.776 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 5.1 mm-40 -143.95 176.24 9.43 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.61 ' HA ' ' NE2' ' A' ' 33' ' ' HIS . 55.5 m-80 -31.34 82.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -168.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 1.057 ' HA ' HE21 ' A' ' 31' ' ' GLN . 3.9 m 44.89 57.18 4.79 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.948 0.88 . . . . 0.0 109.765 -177.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.952 HH21 ' HB2' ' A' ' 94' ' ' ASP . 35.8 ttp85 -167.17 55.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.366 -151.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 61.8 t -74.93 102.49 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.245 -0.91 . . . . 0.0 109.598 -173.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 t -86.4 121.3 28.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.724 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -93.3 88.2 5.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.624 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.585 ' HH ' ' HB3' ' A' ' 93' ' ' LEU . 77.8 m-85 -78.86 116.01 18.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.651 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 18.5 tt -79.64 145.55 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -171.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.7 HD12 ' HB2' ' A' ' 50' ' ' LEU . 14.9 mt -138.31 116.35 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 9.3 m120 -87.21 142.34 27.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 122.314 0.246 . . . . 0.0 110.735 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.6 t -87.53 100.68 12.95 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 72' ' ' LYS . 87.9 mt -90.01 142.77 29.08 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.385 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 17.2 Cg_exo -67.49 -8.15 21.34 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.244 2.629 . . . . 0.0 113.071 -176.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.703 ' HB2' ' HG2' ' A' ' 70' ' ' ARG . 9.4 m120 -83.69 9.49 11.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.719 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 2.3 tpm_? 63.46 26.45 14.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.611 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.703 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 5.9 ptp180 -112.78 172.4 6.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.989 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.463 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 96.0 m-85 -131.66 127.2 36.47 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.204 0.526 . . . . 0.0 110.948 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 18.5 ttmm -97.16 100.06 11.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.926 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 10.9 tt -93.44 86.38 2.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.838 0.828 . . . . 0.0 110.227 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 76' ' ' GLN . . . 71.32 60.34 4.46 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.087 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t0 74.44 -16.27 0.55 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.935 0.494 . . . . 0.0 111.38 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.457 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -78.83 126.86 31.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.876 0.369 . . . . 0.0 111.109 177.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -98.45 100.1 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.457 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 76' ' ' GLN . 97.6 m-85 -103.46 168.85 8.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.839 0.352 . . . . 0.0 110.59 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.17 -53.56 53.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.461 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.457 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 1.2 p80 -164.81 -174.11 3.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.264 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.1 mt -55.23 -57.84 18.08 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.543 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 39.1 Cg_exo -59.8 -10.74 12.69 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.327 2.018 . . . . 0.0 113.214 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.22 -30.74 13.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.389 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.463 HD11 HD12 ' A' ' 73' ' ' ILE . 4.1 pp -76.19 -26.27 56.02 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.5 mt -70.56 -25.85 63.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.913 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 52.1 mt-10 -73.5 -20.64 60.62 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.768 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -84.84 -35.59 22.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.054 0.454 . . . . 0.0 110.77 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.452 ' CG ' HD21 ' A' ' 93' ' ' LEU . 49.6 m-85 -86.59 1.07 53.05 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.999 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 13.0 ptmt -74.02 -21.99 59.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 171.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.439 HG23 ' HG3' ' A' ' 89' ' ' LYS . 23.6 pt -120.85 9.14 6.2 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -96.55 -38.78 9.84 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.206 -0.309 . . . . 0.0 111.233 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.538 ' CD1' HG23 ' A' ' 97' ' ' THR . 76.9 m-85 70.39 102.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.894 0.746 . . . . 0.0 109.716 -171.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.719 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 6.4 mt -74.23 -19.76 60.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.53 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.952 ' HB2' HH21 ' A' ' 57' ' ' ARG . 33.6 t70 -173.78 70.96 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 170.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 76.91 -29.81 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.22 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.51 HG23 HD13 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -107.43 157.58 17.88 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.538 HG23 ' CD1' ' A' ' 92' ' ' TYR . 18.1 p -105.26 -169.25 1.57 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.761 0.315 . . . . 0.0 110.178 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.437 HD23 ' CD1' ' A' ' 36' ' ' PHE . 97.6 mt -77.47 99.97 5.85 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 1.8 mp -96.91 -55.37 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.643 ' O ' ' HA ' ' A' ' 35' ' ' MET . 8.1 mm-40 -143.96 151.61 53.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.735 0.302 . . . . 0.0 111.293 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.722 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 24.7 Cg_endo -88.83 156.58 6.05 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.807 2.338 . . . . 0.0 111.893 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.466 ' O ' ' HE1' ' A' ' 16' ' ' MET . . . -79.48 139.63 55.4 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.947 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.43 135.57 46.74 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.479 2.119 . . . . 0.0 112.16 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.797 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 39.9 ptt180 . . . . . 0 C--N 1.327 -0.393 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 1.049 HD23 HG21 ' A' ' 152' ' ' ILE . 7.9 mp . . . . . 0 CA--C 1.508 -0.668 0 CA-C-O 121.527 0.679 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 16.8 pt-20 -165.77 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.193 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.46 130.92 54.51 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.908 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.971 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 72.8 t -142.41 157.57 19.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 179' ' ' GLU . 0.7 OUTLIER -136.05 150.8 49.32 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.092 161.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.46 HG21 HG13 ' A' ' 178' ' ' VAL . 6.0 p -105.67 140.46 38.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.052 0.453 . . . . 0.0 111.994 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.524 HD11 ' HG2' ' A' ' 179' ' ' GLU . 67.2 mt -110.83 -25.58 9.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.726 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.522 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 41.5 t80 -86.38 -32.6 20.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -168.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.641 ' HB2' ' HD3' ' A' ' 146' ' ' LYS . 6.6 t70 73.38 111.59 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.133 0.492 . . . . 0.0 110.617 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -141.65 89.1 9.31 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 35.4 Cg_endo -94.87 84.16 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 122.799 2.333 . . . . 0.0 112.871 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.516 ' HA3' ' OD2' ' A' ' 141' ' ' ASP . . . -94.1 -24.34 19.91 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.206 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 52.0 m-80 68.05 83.22 0.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.484 0.714 . . . . 0.0 112.715 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -173.42 -171.96 0.74 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 173.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.28 -16.89 28.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.314 1.054 . . . . 0.0 108.334 171.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 172' ' ' MET . 41.4 tt0 -73.57 -28.88 62.09 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.978 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 172' ' ' MET . 8.0 p-10 -157.17 117.04 3.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.369 174.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 13.6 tp -69.62 121.39 82.27 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.964 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 41.6 Cg_endo -67.87 98.16 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.293 1.996 . . . . 0.0 111.324 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -112.73 162.25 15.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.485 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 1.6 mptm? -112.6 -167.79 1.23 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.291 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.641 ' HD3' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -91.25 19.6 5.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.921 176.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.4 30.86 0.52 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.606 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.485 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 23.2 mm-40 -104.71 144.14 32.13 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.887 -0.184 . . . . 0.0 110.73 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 129' ' ' ARG . 46.7 mm -98.65 135.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 165' ' ' ASN . 18.5 mt -118.95 155.24 31.68 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 93.4 t -120.32 125.42 74.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 174.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 1.049 HG21 HD23 ' A' ' 125' ' ' LEU . 47.1 mm -76.05 83.8 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 122.761 1.267 . . . . 0.0 108.674 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.717 HG21 HG21 ' A' ' 170' ' ' VAL . 15.1 tt -79.3 -26.97 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.195 -174.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.84 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 14.9 mt-10 -144.41 142.23 30.19 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.505 0.503 . . . . 0.0 109.975 173.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.867 ' HB3' ' HZ3' ' A' ' 155' ' ' LYS . 3.8 ttpm? -134.58 89.74 25.55 Favored Pre-proline 0 C--O 1.236 0.371 0 O-C-N 121.842 -0.536 . . . . 0.0 111.172 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.405 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 16.9 Cg_exo -71.94 -55.31 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.549 2.166 . . . . 0.0 112.76 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -106.52 172.51 6.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.521 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.424 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 2.7 mm-40 -113.76 70.15 0.72 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.551 0.691 . . . . 0.0 110.505 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.513 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 13.9 pt20 175.58 -34.37 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.601 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.513 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 53.1 m95 -122.96 129.34 51.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.767 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.651 ' O ' HG13 ' A' ' 173' ' ' ILE . 51.0 m0 -120.21 137.26 54.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.35 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.84 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.5 m -88.29 92.72 9.27 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.439 0.638 . . . . 0.0 109.899 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.482 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -108.62 161.24 15.26 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.813 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.8 ptt180 -104.27 136.76 43.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.809 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.557 ' HA ' HD22 ' A' ' 150' ' ' LEU . 16.3 p-10 -81.63 -173.1 4.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 110.993 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -59.13 -27.5 65.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.773 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.81 -18.93 38.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.734 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.16 29.06 7.77 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.134 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.813 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 19.6 ttm-85 -104.02 136.07 44.35 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.568 -0.372 . . . . 0.0 110.857 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.717 HG21 HG21 ' A' ' 153' ' ' ILE . 59.0 t -99.88 119.81 48.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.99 0.424 . . . . 0.0 111.167 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.2 160.22 28.22 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -68.81 131.37 45.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.027 0.441 . . . . 0.0 111.023 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -130.22 145.45 57.38 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.261 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.459 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 4.5 Cg_exo -78.71 131.66 10.4 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.062 2.508 . . . . 0.0 112.633 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.611 ' O ' HG22 ' A' ' 178' ' ' VAL . 41.4 t -59.68 -44.19 96.92 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -65.13 5.49 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.225 1.95 . . . . 0.0 113.6 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -108.43 -6.14 16.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.093 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.1 m -107.52 -171.08 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -165.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 0.2 OUTLIER -156.09 41.21 0.38 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 112.821 -1.991 . . . . 0.0 106.91 -163.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.971 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 16.3 pttm . . . . . 0 N--CA 1.446 -0.637 0 CA-C-O 121.891 0.853 . . . . 0.0 110.435 -162.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.479 ' HB ' HG11 ' A' ' 266' ' ' VAL . 22.8 t . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.501 ' HD1' HG21 ' A' ' 263' ' ' ILE . 96.2 m-85 -109.6 123.91 50.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.0 111.001 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.551 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -142.02 122.04 13.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.033 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.96 144.68 31.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.068 0.461 . . . . 0.0 110.505 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -88.78 94.67 10.0 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.049 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.4 pp -94.48 19.45 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.687 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.61 173.39 11.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.331 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -95.34 133.67 38.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.553 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -147.77 113.55 5.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.096 0.474 . . . . 0.0 111.382 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.755 174.674 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 121.049 0.452 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -104.58 99.61 9.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.119 0.485 . . . . 0.0 110.442 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.582 HD23 ' HB ' ' A' ' 279' ' ' VAL . 0.7 OUTLIER -78.37 121.5 24.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.919 -177.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -83.45 136.92 34.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.056 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.74 119.5 20.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.998 0.427 . . . . 0.0 110.313 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -100.01 149.83 23.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.514 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 15.6 t -58.02 123.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.839 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 157.46 -68.1 0.28 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.815 -1.183 . . . . 0.0 114.952 174.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 263' ' ' ILE . 5.0 t70 -116.96 -169.33 1.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.473 0.637 . . . . 0.0 112.496 -159.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.501 HG21 ' HD1' ' A' ' 239' ' ' PHE . 40.6 mm -91.72 135.6 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.238 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.47 110.16 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.735 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.438 ' HB3' ' HZ2' ' A' ' 265' ' ' LYS . 9.6 mtpm? -80.58 87.81 5.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 110.862 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.479 HG11 ' HB ' ' A' ' 238' ' ' VAL . 6.8 p -90.21 130.62 39.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.038 0.447 . . . . 0.0 110.911 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.405 HG22 ' HG3' ' A' ' 268' ' ' ARG . 9.0 t -113.07 -20.83 11.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.405 ' HG3' HG22 ' A' ' 267' ' ' THR . 98.2 mtt180 -117.92 98.92 6.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 0.0 110.107 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 34.8 ttm -101.18 109.68 21.59 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.168 0.509 . . . . 0.0 110.804 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -83.31 162.31 21.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.932 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.1 tt -97.38 -13.72 7.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.129 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -67.24 -53.7 27.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.227 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 164.77 -37.81 0.29 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.791 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.89 134.92 44.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.057 0.456 . . . . 0.0 110.24 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.511 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 20.9 m0 -107.89 165.1 11.7 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.167 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -121.53 116.85 25.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.136 0.494 . . . . 0.0 110.253 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -129.56 169.98 20.59 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.514 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 74.8 mt-10 -108.39 108.35 19.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.906 0.384 . . . . 0.0 110.767 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.582 ' HB ' HD23 ' A' ' 256' ' ' LEU . 47.2 t -128.28 139.08 52.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 279' ' ' VAL . 15.4 m120 70.96 8.02 6.39 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.631 0.373 . . . . 0.0 110.76 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 86.46 13.46 67.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.975 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 282' ' ' ARG . 1.7 ptm180 -132.03 137.98 48.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.86 0.362 . . . . 0.0 110.525 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 3.3 ptpp? -97.79 134.3 41.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.693 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -152.39 173.94 31.39 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.566 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 91.7 mt -90.14 140.59 29.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.015 0.436 . . . . 0.0 111.504 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.469 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 33.5 p90 -145.64 134.73 11.21 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.521 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 5.0 Cg_exo -74.54 148.82 38.11 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.857 2.371 . . . . 0.0 112.811 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.435 ' C ' ' H ' ' A' ' 290' ' ' HIS . 36.7 p90 -64.32 -25.27 67.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.286 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.8 m -76.0 37.45 0.15 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.45 0.643 . . . . 0.0 110.928 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.435 ' H ' ' C ' ' A' ' 288' ' ' PHE . 8.5 m-70 -141.6 -61.02 0.47 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.384 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 23.2 m -90.92 150.38 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.797 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -109.35 117.04 33.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.86 0.362 . . . . 0.0 110.785 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' A' ' 240' ' ' ALA . 36.8 mm -69.94 125.49 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.837 175.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -122.3 -179.31 4.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.465 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.133 0.492 . . . . 0.0 110.017 178.319 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -163.11 105.15 1.01 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.114 0.483 . . . . 0.0 110.319 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CB ' ' HD3' ' A' ' 101' ' ' PRO . 25.4 p90 -132.28 -180.0 5.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.985 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -89.36 91.03 8.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.122 0.487 . . . . 0.0 110.699 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.746 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 40.8 m -67.65 150.56 48.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.894 177.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 8' ' ' SER . 49.7 m 78.28 -39.35 0.26 Allowed 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.799 0.687 . . . . 0.0 112.31 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.96 101.85 0.17 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.049 0.452 . . . . 0.0 110.295 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -56.96 -46.2 82.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.033 -170.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m -77.27 7.87 4.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.34 -40.27 11.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.572 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.3 p-90 -127.76 -27.81 2.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.0 t80 -79.77 123.67 27.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.896 0.317 . . . . 0.0 110.355 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.426 ' HB2' HG23 ' A' ' 19' ' ' VAL . 22.3 mmt -110.52 -1.33 17.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.844 -173.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.435 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.46 -114.27 2.88 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.007 -0.542 . . . . 0.0 113.709 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.435 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 10.3 Cg_exo -70.33 103.59 1.28 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.008 2.472 . . . . 0.0 112.175 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.781 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 85.9 t -136.57 -70.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.815 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 30.1 t 81.36 165.59 0.15 Allowed 'General case' 0 C--N 1.347 0.477 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -55.83 -38.96 70.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.746 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -59.63 -40.99 89.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.069 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.98 -44.97 8.58 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.235 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . -53.92 -41.31 67.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.811 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 47.8 tt0 -72.3 -46.27 56.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.413 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.3 t -68.39 -23.42 64.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.988 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -83.39 -29.31 28.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.2 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.719 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 38.4 mt -103.43 -0.05 30.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.027 0.441 . . . . 0.0 110.757 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 25.7 tt0 -70.15 113.53 7.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.6 -174.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.89 33.82 84.96 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.573 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -102.47 -168.48 1.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.665 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 17.8 ttp180 -62.85 113.19 2.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.627 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.66 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 42.7 m170 -62.26 118.5 7.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.929 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.91 -8.33 6.81 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.569 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.665 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 20.1 mtp -87.17 140.11 29.88 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 122.52 0.328 . . . . 0.0 110.442 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.739 ' HB2' HG21 ' A' ' 52' ' ' VAL . 28.8 p90 -142.52 164.52 29.89 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.643 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.98 136.67 14.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.221 0.534 . . . . 0.0 111.056 175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 15' ' ' TYR . 93.2 t -101.42 112.7 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.815 ' HD2' ' H ' ' A' ' 20' ' ' SER . 20.9 ptt-85 -107.59 176.47 5.14 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.685 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -81.5 138.97 35.41 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.409 ' HA ' HG21 ' A' ' 49' ' ' VAL . 83.3 p -55.6 -19.87 11.75 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.086 0.241 . . . . 0.0 111.596 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m 69.41 17.63 8.07 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.507 0.67 . . . . 0.0 109.794 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 p -140.42 -45.05 0.41 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.733 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 66.3 m -134.27 127.13 18.79 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.765 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 24.2 Cg_exo -64.48 -14.37 43.95 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.863 2.375 . . . . 0.0 112.578 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.57 29.2 13.03 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.862 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.31 134.74 18.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -124.76 162.34 24.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.512 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.71 HG22 HG12 ' A' ' 62' ' ' ILE . 21.2 t -131.51 99.88 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.125 0.488 . . . . 0.0 111.189 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.2 tp -76.28 96.34 3.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.141 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.9 m -97.35 135.41 39.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.971 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.739 HG21 ' HB2' ' A' ' 36' ' ' PHE . 86.7 t -128.87 137.18 57.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.114 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.719 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 31.3 t -83.5 99.38 10.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.704 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.66 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 15.8 pt-20 -172.81 173.87 3.74 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.995 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.731 ' HB2' ' CG ' ' A' ' 94' ' ' ASP . 27.7 t-20 71.67 -56.3 0.64 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.734 1.254 . . . . 0.0 109.499 -164.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.448 ' H ' ' C ' ' A' ' 54' ' ' GLU . 29.8 t -162.32 -40.63 0.04 OUTLIER 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.068 -1.878 . . . . 0.0 106.88 -176.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.719 HH21 ' HB3' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -165.35 -39.51 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.689 ' CG2' ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -144.2 110.97 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 120.822 1.646 . . . . 0.0 114.899 -173.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.625 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 16.0 m -95.85 108.29 20.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 163.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -100.34 99.0 9.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -170.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.666 ' CE2' HD23 ' A' ' 93' ' ' LEU . 44.0 m-85 -116.97 114.31 23.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.71 HG12 HG22 ' A' ' 49' ' ' VAL . 19.9 mt -81.07 138.59 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.744 HG13 ' HB ' ' A' ' 73' ' ' ILE . 5.3 mp -114.2 115.25 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.205 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -85.0 143.15 29.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.692 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.7 t -93.56 98.69 11.33 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.607 HD12 ' HB2' ' A' ' 72' ' ' LYS . 23.0 mt -78.58 124.94 85.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 14.1 Cg_exo -68.12 -33.58 24.73 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.313 2.009 . . . . 0.0 113.44 -174.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -67.53 -18.85 65.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -172.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.641 ' HG2' ' N ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -176.65 -53.55 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.641 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 2.3 ptm180 -136.85 -172.18 3.11 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -160.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -102.36 157.81 16.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.539 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.607 ' HB2' HD12 ' A' ' 66' ' ' LEU . 24.7 ttmm -138.82 104.67 5.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.744 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.7 tt -90.88 78.78 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.785 0.802 . . . . 0.0 110.006 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 65.52 86.49 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.742 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 10.8 t70 75.1 -61.68 0.48 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.475 0.31 . . . . 0.0 111.472 176.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.28 124.04 23.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.023 0.44 . . . . 0.0 109.987 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.3 138.5 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.282 0.563 . . . . 0.0 110.489 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.48 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 44.5 m-85 -127.18 166.59 17.42 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.54 -50.42 71.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -149.38 175.78 11.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.452 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.644 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 15.4 mt -54.85 -55.22 40.97 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.746 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 41.4 Cg_exo -59.96 -10.42 12.31 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.277 1.985 . . . . 0.0 113.797 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.74 -34.92 16.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.348 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -76.32 -28.75 57.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.394 0.616 . . . . 0.0 109.385 176.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.42 ' O ' HD12 ' A' ' 98' ' ' LEU . 74.0 mt -66.35 -23.4 66.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.009 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.561 ' O ' ' HB3' ' A' ' 89' ' ' LYS . 38.0 tt0 -85.46 -29.27 24.45 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.237 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -69.37 -38.7 78.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.238 0.542 . . . . 0.0 110.063 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.509 ' CG ' HD21 ' A' ' 93' ' ' LEU . 59.2 m-85 -80.83 -2.61 47.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.54 0.686 . . . . 0.0 110.467 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 47.5 tttm -78.77 -14.82 59.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.035 174.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -128.73 -1.77 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 111.474 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 22.6 t-160 -98.75 -28.51 13.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.127 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 83.0 m-85 70.1 132.23 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 O-C-N 124.079 0.862 . . . . 0.0 109.376 -169.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.666 HD23 ' CE2' ' A' ' 61' ' ' TYR . 9.2 mt -92.31 -26.63 18.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.731 ' CG ' ' HB2' ' A' ' 55' ' ' ASN . 10.3 t0 -173.83 83.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.777 168.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 71.66 -19.18 0.27 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.925 0.89 . . . . 0.0 112.064 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 94' ' ' ASP . 31.7 m -120.43 158.0 28.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.0 p -106.16 172.57 6.73 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.445 HD23 ' CD2' ' A' ' 36' ' ' PHE . 95.5 mt -64.71 93.69 0.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.032 0.444 . . . . 0.0 110.104 175.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.582 HG22 ' HG3' ' A' ' 100' ' ' GLU . 47.1 mm -81.34 -62.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.254 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.582 ' HG3' HG22 ' A' ' 99' ' ' ILE . 43.5 mt-10 -147.65 157.16 44.8 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.562 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.468 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 11.9 Cg_exo -70.46 156.98 60.36 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.097 1.865 . . . . 0.0 111.19 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.24 138.74 71.83 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.473 ' HD2' ' HE2' ' A' ' 35' ' ' MET . 69.4 Cg_exo -52.14 126.19 19.59 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.232 1.954 . . . . 0.0 111.808 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.057 179.87 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.485 HD13 HG13 ' A' ' 152' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.517 -0.297 0 CA-C-O 122.04 0.924 . . . . 0.0 111.488 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -172.07 -33.75 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.895 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -123.7 109.77 14.13 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.655 0.741 . . . . 0.0 111.352 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 179' ' ' GLU . 25.4 t -124.38 153.05 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.372 -175.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -135.06 150.37 50.25 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.066 174.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.678 HG21 HG12 ' A' ' 178' ' ' VAL . 51.4 p -95.46 133.95 38.85 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.823 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.4 mt -106.96 -37.52 6.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.664 -173.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.589 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 47.5 t80 -90.45 -31.62 16.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -168.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 6.5 t70 77.67 123.91 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.214 0.53 . . . . 0.0 111.113 -172.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 84.8 t80 -156.77 106.3 1.96 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.733 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -91.98 95.22 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.879 2.386 . . . . 0.0 113.123 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -97.41 0.6 59.97 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.794 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.48 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 66.96 5.33 4.0 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.301 0.641 . . . . 0.0 112.223 -178.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.843 ' HB2' ' HD3' ' A' ' 143' ' ' PRO . 18.5 t0 52.47 -146.51 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.869 0.867 . . . . 0.0 112.94 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.461 ' H ' ' CG ' ' A' ' 138' ' ' ASP . . . 69.51 11.83 8.08 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.499 1.12 . . . . 0.0 108.828 -165.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 139' ' ' ALA . 23.2 tt0 171.81 -39.67 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.139 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 172' ' ' MET . 21.8 m-20 -133.33 97.73 4.05 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.78 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.594 ' HB3' HG21 ' A' ' 173' ' ' ILE . 23.7 tp -54.67 129.86 63.91 Favored Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 122.971 0.509 . . . . 0.0 111.931 -174.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.843 ' HD3' ' HB2' ' A' ' 138' ' ' ASP . 73.1 Cg_endo -81.54 117.5 3.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.513 2.142 . . . . 0.0 111.355 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.582 ' CB ' HG22 ' A' ' 130' ' ' THR . 21.3 p90 -123.04 165.51 16.66 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.986 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.51 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 42.4 mttp -115.05 -165.88 1.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.272 0.558 . . . . 0.0 111.904 -174.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.447 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -93.98 26.98 2.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.089 179.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.43 25.92 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 119.625 -1.274 . . . . 0.0 114.388 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -108.12 161.6 14.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.93 0.865 . . . . 0.0 109.331 174.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.0 mm -119.36 146.9 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.757 -167.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 15.9 mt -122.77 166.38 15.05 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -173.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.41 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 97.6 t -123.53 125.76 72.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.491 HD13 ' HB3' ' A' ' 163' ' ' ALA . 21.6 mm -77.0 97.54 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 CA-C-O 122.475 1.131 . . . . 0.0 108.747 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.62 ' CD1' ' HE1' ' A' ' 61' ' ' TYR . 1.7 tt -97.52 -49.01 12.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 112.472 -2.149 . . . . 0.0 109.024 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.036 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 15.7 mt-10 -116.16 142.85 46.27 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.593 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 15.8 ttpp -140.23 72.04 32.96 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 121.466 -0.771 . . . . 0.0 109.901 170.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.466 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 24.5 Cg_exo -62.12 -43.89 22.13 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.453 2.102 . . . . 0.0 111.885 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -113.73 -174.07 2.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.05 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -107.14 -40.0 5.55 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.525 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -84.08 -11.55 56.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.174 0.512 . . . . 0.0 110.324 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.632 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 68.0 m95 -129.2 118.58 22.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.407 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.601 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.7 m0 -108.76 139.08 44.07 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 1.036 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 11.3 t -101.72 91.08 4.25 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.39 0.614 . . . . 0.0 109.639 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.509 ' HB1' ' HB3' ' A' ' 150' ' ' LEU . . . -109.52 161.53 15.25 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.197 -172.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 19.5 ptt-85 -97.54 136.21 38.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.846 HD22 ' HB3' ' A' ' 167' ' ' ASP . 12.9 p-10 -85.76 175.57 8.62 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.619 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -79.9 4.28 17.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.37 0.605 . . . . 0.0 110.975 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.846 ' HB3' HD22 ' A' ' 165' ' ' ASN . 33.6 t70 -104.03 -1.28 27.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.245 0.545 . . . . 0.0 109.535 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 85.47 72.09 1.3 Allowed Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.81 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 38.4 ttm-85 -164.46 129.04 2.65 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.78 -0.247 . . . . 0.0 110.364 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' A' ' 164' ' ' ARG . 39.0 t -105.48 109.56 28.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.373 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.489 ' HA3' ' OD1' ' A' ' 138' ' ' ASP . . . -146.23 170.09 27.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.095 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.632 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 22.5 mtp -82.49 137.11 34.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.038 0.447 . . . . 0.0 111.211 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -133.9 146.04 58.4 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.699 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.432 ' HD2' ' CE2' ' A' ' 144' ' ' PHE . 7.3 Cg_exo -72.23 128.35 13.72 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.064 2.509 . . . . 0.0 112.41 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.589 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 47.8 t -67.4 -36.67 10.86 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.278 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 26.8 Cg_endo -63.49 10.4 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.646 1.564 . . . . 0.0 113.177 173.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.504 ' H ' ' C ' ' A' ' 175' ' ' VAL . 4.6 m-85 -118.38 -19.83 8.73 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.554 0.342 . . . . 0.0 111.322 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.678 HG12 HG21 ' A' ' 130' ' ' THR . 3.8 m -146.2 155.97 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.674 -166.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.503 ' C ' ' HD3' ' A' ' 180' ' ' LYS . 11.7 mt-10 -150.46 -56.35 0.17 Allowed 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 115.939 -2.305 . . . . 0.0 115.652 155.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.729 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.349 0 C-N-CA 115.619 -2.432 . . . . 0.0 116.04 -160.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 38.4 t . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.19 122.01 46.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.88 0.371 . . . . 0.0 110.818 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.437 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -120.28 142.91 48.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.25 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -95.37 123.75 39.06 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -75.81 111.24 10.96 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.121 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.404 HG21 ' HE3' ' A' ' 292' ' ' LYS . 35.6 pt -94.58 -9.98 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -138.92 144.04 38.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.6 ' HG2' ' HA ' ' A' ' 259' ' ' GLU . 84.1 mttt -82.3 121.94 27.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.932 0.396 . . . . 0.0 111.093 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.701 ' HD2' ' CE1' ' A' ' 290' ' ' HIS . 54.1 ttt85 -93.16 102.47 14.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 C--N 1.318 -0.765 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.196 -179.246 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.267 0.556 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -92.59 111.01 22.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.929 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.514 HD23 ' HB ' ' A' ' 279' ' ' VAL . 1.4 tt -90.11 113.3 25.01 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -64.68 123.82 20.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.016 0.436 . . . . 0.0 110.909 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.3 mt -128.03 165.18 20.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.848 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.6 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 14.3 pt-20 -146.36 166.27 26.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.535 177.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 42.9 t -70.56 124.01 25.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.022 0.439 . . . . 0.0 111.071 -174.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.35 4.43 50.08 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.805 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -100.3 155.08 17.98 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.977 0.389 . . . . 0.0 109.992 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.8 mm -94.74 113.04 28.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.169 0.509 . . . . 0.0 110.99 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 t -87.05 95.4 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.285 0.565 . . . . 0.0 109.592 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -81.52 98.58 8.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.057 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 275' ' ' TRP . 4.0 p -89.11 120.96 38.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.392 0.615 . . . . 0.0 111.27 -176.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 26.4 m -93.99 -30.91 14.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.506 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.989 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 13.0 tpt180 -115.54 97.34 6.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.441 -177.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 2.2 tpt -81.53 106.16 13.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.167 0.508 . . . . 0.0 109.659 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -86.39 166.17 15.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.192 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 40.1 mm -76.91 83.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.418 -175.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.6 t30 83.65 82.42 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.752 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 114.35 -77.16 0.25 Allowed Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 119.69 -1.243 . . . . 0.0 114.066 154.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -72.52 88.57 1.24 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.825 0.345 . . . . 0.0 110.718 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.497 ' HB3' HG22 ' A' ' 266' ' ' VAL . 9.9 m0 -92.88 161.47 14.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.033 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.989 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 27.5 tt0 -109.98 116.09 30.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.086 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.36 155.71 18.24 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.368 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.3 108.37 19.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.514 ' HB ' HD23 ' A' ' 256' ' ' LEU . 61.0 t -128.98 140.12 50.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 13.7 m120 66.68 -71.05 0.1 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.831 0.707 . . . . 0.0 110.882 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -173.98 31.51 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -151.17 143.59 24.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.733 -0.233 . . . . 0.0 110.577 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 98.3 mttt -96.52 131.39 43.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 171.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.71 171.23 30.52 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.98 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 37.2 mt -92.83 145.09 24.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.093 0.473 . . . . 0.0 110.668 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.657 ' HB2' ' HE2' ' A' ' 290' ' ' HIS . 31.5 p90 -148.22 124.93 5.46 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.16 177.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.4 ' HB2' HG21 ' A' ' 289' ' ' THR . 44.4 Cg_endo -71.6 157.48 55.84 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.271 1.981 . . . . 0.0 111.772 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -81.55 15.21 2.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.1 0.476 . . . . 0.0 111.5 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.4 HG21 ' HB2' ' A' ' 287' ' ' PRO . 8.8 t -89.81 1.56 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.576 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.701 ' CE1' ' HD2' ' A' ' 246' ' ' ARG . 1.2 p-80 -137.39 3.77 2.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 176.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.651 HG12 ' HD2' ' A' ' 290' ' ' HIS . 18.4 m -129.54 157.35 42.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.404 ' HE3' HG21 ' A' ' 243' ' ' ILE . 16.8 ptpt -129.9 135.66 48.62 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.516 176.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 240' ' ' ALA . 46.5 mm -83.47 103.4 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.252 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -93.69 167.56 11.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.194 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--N 1.321 -0.651 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.859 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.622 ' HB3' ' HG2' ' A' ' 89' ' ' LYS . . . . . . . . 0 C--O 1.234 0.271 0 N-CA-C 110.637 -0.134 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.96 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.619 0.575 . . . . 0.0 109.487 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.658 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 3.5 p90 38.4 -122.56 0.28 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 124.288 0.992 . . . . 0.0 111.14 -174.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -139.99 81.59 1.83 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 172.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -71.84 62.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.943 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -179.19 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.12 100.07 4.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.576 -174.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -64.41 -24.62 67.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.761 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.6 m -67.41 -7.6 26.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.353 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.49 -47.99 4.49 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -112.15 -20.6 11.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -82.08 110.34 17.22 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.796 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 11.3 tpp -96.34 0.6 50.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.168 -171.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.428 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.49 -113.36 2.29 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.181 -0.918 . . . . 0.0 114.152 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 3.0 Cg_exo -79.33 100.24 1.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.823 2.348 . . . . 0.0 112.127 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.594 ' HB ' ' HG2' ' A' ' 39' ' ' ARG . 85.1 t -130.34 -76.63 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 48.8 m 82.65 162.92 0.13 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -51.65 -42.3 61.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -55.86 -39.46 71.52 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.423 0.452 . . . . 0.0 112.104 -177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 34.2 mt-10 -95.75 -44.91 7.22 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.254 -177.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.86 51.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.336 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -81.67 -32.88 31.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.759 -173.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.474 ' HA ' ' HB2' ' A' ' 29' ' ' GLN . 10.6 t -78.0 -27.74 49.05 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 110.682 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 21.2 mmt85 -64.62 -33.9 77.01 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.855 0.836 . . . . 0.0 109.755 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.979 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 80.7 mt -113.89 23.29 13.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.077 -176.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 26' ' ' THR . 24.4 tt0 -72.71 72.13 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.227 0.537 . . . . 0.0 110.536 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.14 15.96 59.32 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.296 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -62.98 -28.37 70.04 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 20.0 ttm180 -156.24 -36.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.476 172.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.622 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 28.9 m170 77.08 132.0 0.05 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.129 0.893 . . . . 0.0 109.52 -173.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.31 -10.86 67.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.567 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 55.4 mtm -87.36 153.75 21.21 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.407 ' HB2' HD13 ' A' ' 50' ' ' LEU . 39.0 p90 -141.63 162.16 36.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.331 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.5 pp -150.81 135.98 17.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.024 0.44 . . . . 0.0 110.337 172.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.7 t -105.54 116.26 48.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.425 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.6 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -119.85 163.72 17.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.893 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.2 131.81 45.51 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.517 ' OG ' HG22 ' A' ' 43' ' ' THR . 26.8 t -79.4 158.62 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.57 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.0 t -117.92 4.4 12.15 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.176 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.517 HG22 ' OG ' ' A' ' 41' ' ' SER . 14.7 t -93.52 -26.2 17.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.893 0.378 . . . . 0.0 110.345 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.666 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 62.8 m -141.98 144.67 33.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.07 -48.92 15.9 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.819 2.346 . . . . 0.0 112.568 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.92 71.59 0.21 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.577 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.666 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 34.3 t70 -151.3 150.98 31.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -173.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -130.35 172.1 12.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.617 HG21 HG12 ' A' ' 62' ' ' ILE . 54.2 t -144.47 108.29 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 111.543 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 36' ' ' PHE . 42.9 tp -81.37 105.36 12.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.214 173.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -96.96 128.56 44.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.304 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.631 HG21 HD12 ' A' ' 93' ' ' LEU . 86.9 t -125.7 134.62 66.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.04 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.979 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 65.6 p -106.93 124.65 49.92 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.622 ' HG2' ' HB3' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -154.84 153.64 31.48 Favored 'General case' 0 C--O 1.212 -0.888 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 163.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 57.72 19.98 6.02 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.0 m 54.46 61.27 3.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 123.018 1.39 . . . . 0.0 108.259 -170.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 39.6 ttp85 -162.3 57.75 0.23 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.121 -2.309 . . . . 0.0 107.286 -159.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.2 t -76.97 100.24 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.723 -172.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 p -79.69 120.99 24.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.924 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -95.41 98.7 10.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.105 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.644 ' HE1' HG13 ' A' ' 153' ' ' ILE . 26.0 m-85 -93.9 115.83 28.23 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.617 HG12 HG21 ' A' ' 49' ' ' VAL . 7.1 mt -76.43 139.63 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.581 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 2.7 mp -124.81 118.41 53.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.696 0.798 . . . . 0.0 109.895 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 11.0 m120 -84.99 131.66 34.44 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 -172.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -79.77 99.45 7.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.2 mt -90.63 132.48 34.95 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.429 -176.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.07 -3.81 6.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.902 2.402 . . . . 0.0 112.699 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -93.82 22.18 5.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.152 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.626 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.8 mmp_? 63.36 26.83 15.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.394 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.7 164.41 15.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.663 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.581 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 62.5 m-85 -133.69 114.9 13.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.72 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.464 ' NZ ' ' HG3' ' A' ' 77' ' ' GLU . 21.8 ttmm -100.73 107.18 18.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.817 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.0 tt -94.7 78.42 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.858 0.837 . . . . 0.0 109.742 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.42 89.31 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.226 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.93 -57.69 0.63 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.464 0.706 . . . . 0.0 111.193 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -69.19 121.53 16.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.995 0.426 . . . . 0.0 110.965 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.464 ' HG3' ' NZ ' ' A' ' 72' ' ' LYS . 20.4 mt-10 -97.59 125.56 42.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.966 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 74.3 m-85 -115.38 152.45 32.82 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.84 -11.19 60.81 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -175.17 176.32 2.09 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.628 0.195 . . . . 0.0 110.757 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.493 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 5.9 mt -56.44 -55.56 41.27 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 123.278 0.361 . . . . 0.0 111.833 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.38 -3.86 5.82 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.123 1.882 . . . . 0.0 113.638 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.13 -35.04 16.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.76 0.314 . . . . 0.0 110.55 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -76.15 -31.92 58.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.5 mt -68.24 -24.35 64.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.713 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.18 -19.12 40.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.828 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -88.38 -39.14 14.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.177 0.513 . . . . 0.0 110.199 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.479 ' CG ' HD21 ' A' ' 93' ' ' LEU . 52.8 m-85 -78.28 -3.5 43.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.518 0.675 . . . . 0.0 109.78 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.622 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 1.4 tmtp? -64.71 -35.09 79.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.869 170.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.7 pt -113.69 -6.39 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.629 -0.428 . . . . 0.0 112.072 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 6.2 t-160 -73.18 -43.21 61.77 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.806 -0.179 . . . . 0.0 110.886 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.607 ' CD1' HG23 ' A' ' 97' ' ' THR . 94.5 m-85 68.03 100.04 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.257 0.973 . . . . 0.0 108.867 -165.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.709 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 4.2 mt -69.64 -98.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.513 ' O ' HG21 ' A' ' 95' ' ' THR . 17.5 t0 -89.84 76.86 7.09 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 121.368 -0.832 . . . . 0.0 109.325 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.513 HG21 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 68.15 -34.07 0.24 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.538 1.135 . . . . 0.0 112.409 -177.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 94' ' ' ASP . 39.5 m -107.87 146.06 32.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.607 HG23 ' CD1' ' A' ' 92' ' ' TYR . 3.1 p -81.76 -178.5 7.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 0.0 110.704 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.1 mt -77.18 91.76 3.76 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.1 mm -74.93 -60.83 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.424 -175.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.658 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 9.4 pt-20 -162.35 156.09 17.9 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.407 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.2 158.15 49.32 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.621 2.214 . . . . 0.0 113.36 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HB3' HD23 ' A' ' 28' ' ' LEU . . . -72.49 154.38 91.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.842 176.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.25 124.4 15.55 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.054 2.503 . . . . 0.0 112.673 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.796 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 75.8 ttt180 . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.072 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.65 ' CD1' HG22 ' A' ' 152' ' ' ILE . 1.3 mm? . . . . . 0 C--O 1.234 0.289 0 CA-C-O 121.77 0.795 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.598 ' CD ' ' H ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -154.77 -76.73 0.1 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.608 -171.112 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.598 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 48.9 m-85 -104.98 108.52 20.07 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.612 0.72 . . . . 0.0 111.392 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.889 HG23 ' HB3' ' A' ' 180' ' ' LYS . 74.3 t -122.81 132.25 71.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.516 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.962 ' HB2' ' HB3' ' A' ' 179' ' ' GLU . 26.1 mtt180 -107.7 160.29 15.82 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.548 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.759 ' HG1' ' HB2' ' A' ' 144' ' ' PHE . 12.5 p -117.08 134.43 54.77 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.547 176.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.627 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 81.0 mt -104.42 -32.22 9.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.692 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.534 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 47.6 t80 -78.13 -36.85 47.32 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -169.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.584 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 7.4 t70 74.5 105.22 0.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.336 0.589 . . . . 0.0 109.813 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -141.1 100.15 6.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 51.9 Cg_endo -88.52 87.7 0.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.273 1.982 . . . . 0.0 112.492 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.665 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -83.3 -12.83 78.04 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.931 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 1.01 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 4.6 p30 35.71 66.74 0.33 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.431 1.092 . . . . 0.0 113.888 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -159.39 -178.88 7.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.57 -7.33 57.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.577 0.703 . . . . 0.0 109.763 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.4 pt-20 -116.85 4.07 12.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.451 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.665 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 10.3 m-20 -146.79 97.3 2.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.378 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.678 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 49.1 tp -75.16 120.55 82.17 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 1.01 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 12.1 Cg_endo -80.84 92.94 1.04 Allowed 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.106 1.871 . . . . 0.0 111.178 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.759 ' HB2' ' HG1' ' A' ' 130' ' ' THR . 10.3 p90 -100.9 164.61 11.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.685 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.584 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 9.2 mtpt -119.46 -178.83 3.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.576 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -77.28 63.56 2.51 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.089 0.947 . . . . 0.0 111.544 -175.259 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.97 35.54 0.27 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.722 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 5.3 mm-40 -96.7 141.0 30.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.982 0.42 . . . . 0.0 110.224 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.06 128.37 43.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.573 HD22 ' HA ' ' A' ' 165' ' ' ASN . 40.1 mt -121.03 157.23 30.46 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 58.0 t -116.08 128.41 73.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.65 HG22 ' CD1' ' A' ' 125' ' ' LEU . 42.5 mm -75.16 97.38 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.809 0.814 . . . . 0.0 109.204 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.711 HG22 ' HG2' ' A' ' 154' ' ' GLU . 8.7 tt -85.11 -42.81 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.868 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.954 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 0.8 OUTLIER -122.23 140.23 52.85 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.569 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 45.6 tttt -131.24 88.72 43.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 O-C-N 121.673 -0.642 . . . . 0.0 110.915 171.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.571 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 16.2 Cg_exo -74.3 -51.83 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.66 2.24 . . . . 0.0 113.083 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -110.91 -171.38 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.233 -0.292 . . . . 0.0 110.82 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.65 -25.7 9.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.774 0.321 . . . . 0.0 110.411 174.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -84.72 -28.0 26.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.277 0.56 . . . . 0.0 110.416 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.669 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 43.3 m95 -128.36 130.39 47.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.122 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.699 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.7 m0 -122.52 142.83 50.17 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.064 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.954 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.2 m -98.82 94.59 6.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.438 0.637 . . . . 0.0 110.391 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.533 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -100.1 164.23 12.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.217 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.684 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.2 ptt180 -104.35 134.52 47.43 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.775 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.678 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 64.7 t30 -75.12 -179.32 4.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.568 -177.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -58.78 -21.12 55.17 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 172.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.5 -36.78 81.73 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.469 0.652 . . . . 0.0 109.36 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.25 -6.78 42.94 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.808 -168.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.684 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 13.0 ttm-85 -69.72 140.08 53.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.463 -0.868 . . . . 0.0 111.606 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.632 HG21 HG21 ' A' ' 153' ' ' ILE . 44.4 t -98.89 125.42 52.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.953 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 142' ' ' LEU . . . -150.1 163.2 29.41 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.59 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.669 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -79.65 136.18 36.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.622 0.249 . . . . 0.0 110.609 179.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.699 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -136.09 145.39 52.14 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.378 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.487 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 6.1 Cg_exo -80.45 133.65 9.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.037 2.491 . . . . 0.0 112.903 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.669 ' O ' HG22 ' A' ' 178' ' ' VAL . 92.6 t -62.84 -41.74 73.61 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.1 Cg_endo -63.42 0.73 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.012 1.808 . . . . 0.0 113.304 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -106.74 -3.48 20.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.645 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 175' ' ' VAL . 11.4 m -107.2 -178.85 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -165.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.962 ' HB3' ' HB2' ' A' ' 129' ' ' ARG . 1.0 OUTLIER -149.25 39.98 0.85 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 112.702 -2.045 . . . . 0.0 108.498 -165.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.889 ' HB3' HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.686 0 O-C-N 121.109 -0.995 . . . . 0.0 110.913 -169.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.795 ' O ' HG12 ' A' ' 266' ' ' VAL . 21.4 t . . . . . 0 N--CA 1.524 3.226 0 CA-C-O 117.968 -1.015 . . . . 0.0 108.342 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -65.26 119.59 11.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.621 1.101 . . . . 0.0 111.315 -163.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.588 ' HB2' HD11 ' A' ' 293' ' ' ILE . . . -132.96 156.98 46.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.583 -168.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -96.65 122.59 39.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.336 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.47 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -73.39 115.09 12.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.12 -0.22 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -172.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 245' ' ' LYS . 7.2 tt0 -140.94 147.89 39.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.869 0.366 . . . . 0.0 110.507 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.806 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 51.6 mtmt -79.24 140.23 37.69 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.297 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -140.39 104.91 4.88 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.998 0.428 . . . . 0.0 110.462 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.692 -179.369 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 121.049 0.452 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.95 103.5 14.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.064 0.459 . . . . 0.0 111.444 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.471 HD23 ' HB ' ' A' ' 279' ' ' VAL . 1.0 OUTLIER -74.27 114.06 12.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.817 177.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -70.95 132.44 45.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.524 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.446 HD21 HG21 ' A' ' 279' ' ' VAL . 96.7 mt -136.35 -177.96 4.95 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.337 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.806 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 7.5 pt-20 -154.55 -165.66 2.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.181 176.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.727 HG21 ' HG3' ' A' ' 245' ' ' LYS . 39.2 t -108.23 130.43 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 111.802 -173.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.21 15.87 12.05 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.586 -0.816 . . . . 0.0 114.497 168.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.3 179.78 6.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.87 0.835 . . . . 0.0 111.212 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.9 mm -105.82 119.43 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.816 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.687 ' O ' HG13 ' A' ' 266' ' ' VAL . 65.7 t -76.38 125.15 35.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.488 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 89.5 mttt -68.34 88.63 0.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.808 0.813 . . . . 0.0 109.5 173.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' ' 238' ' ' VAL . 2.1 p -127.56 126.19 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.556 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.404 ' N ' ' N ' ' A' ' 238' ' ' VAL . 5.1 m -137.87 -26.18 0.96 Allowed 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.618 HH12 ' HB3' ' A' ' 276' ' ' GLU . 5.9 tmm_? -136.05 93.07 2.87 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.115 0.966 . . . . 0.0 110.46 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.567 ' HE1' ' HB ' ' A' ' 238' ' ' VAL . 4.0 ptp -87.37 141.36 28.69 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.205 -0.934 . . . . 0.0 113.255 -174.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -75.03 157.4 34.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.372 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.2 tp -92.54 -3.47 10.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.531 0.681 . . . . 0.0 110.253 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -73.27 -10.01 59.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.104 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 100.18 -29.35 12.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.932 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.946 ' HA ' HE21 ' A' ' 274' ' ' GLN . 0.0 OUTLIER -89.5 113.38 24.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.181 0.515 . . . . 0.0 109.654 175.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 55.0 m0 -92.8 162.76 13.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.564 -173.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.618 ' HB3' HH12 ' A' ' 268' ' ' ARG . 2.8 tm-20 -128.6 89.63 2.92 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 120.209 -0.597 . . . . 0.0 109.814 -168.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -117.96 158.35 14.72 Favored Glycine 0 C--O 1.226 -0.389 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.995 -174.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 265' ' ' LYS . 18.0 tt0 -116.79 111.08 19.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.246 0.523 . . . . 0.0 110.572 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.471 ' HB ' HD23 ' A' ' 256' ' ' LEU . 97.9 t -109.93 122.22 64.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.682 0.277 . . . . 0.0 110.64 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 48.15 32.22 2.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.58 1.152 . . . . 0.0 112.41 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 97.3 -3.03 61.45 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.198 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -107.92 114.96 29.27 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.1 OUTLIER -106.61 141.56 37.68 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.875 178.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -171.18 -170.29 35.14 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.649 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 80.5 mt -99.56 135.01 41.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.064 0.459 . . . . 0.0 110.188 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.466 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 50.7 p90 -136.79 140.87 33.12 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.16 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 2.8 Cg_exo -76.65 152.37 33.22 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.989 2.459 . . . . 0.0 112.661 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.48 ' HB3' ' CH2' ' A' ' 275' ' ' TRP . 7.6 p90 -69.71 -2.51 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.399 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.7 p -90.45 4.33 51.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.058 0.456 . . . . 0.0 111.47 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -117.44 -15.37 10.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.778 0.323 . . . . 0.0 111.441 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.6 160.85 38.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.266 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -121.54 119.0 30.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.73 0.3 . . . . 0.0 110.535 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.588 HD11 ' HB2' ' A' ' 240' ' ' ALA . 49.5 mm -73.36 123.22 27.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.604 175.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -126.16 174.26 8.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.394 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 121.486 0.66 . . . . 0.0 112.438 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -122.59 -57.55 1.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.107 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 62.58 176.27 0.14 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 172.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.08 73.7 0.76 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.624 -2.08 . . . . 0.0 106.08 164.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.2 m -63.44 154.84 30.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.0 -167.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.6 m 75.84 -45.9 0.54 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.321 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.38 110.21 0.92 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.525 0.679 . . . . 0.0 111.048 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -57.72 -32.14 67.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.941 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 t -81.38 -1.66 46.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.3 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.2 -46.94 7.49 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.367 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -117.76 -26.22 6.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -173.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -84.33 125.38 32.23 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.025 -0.422 . . . . 0.0 110.866 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.504 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.2 mmt -108.53 -3.47 18.04 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.189 -175.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.434 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 52.17 -112.18 1.88 Allowed Glycine 0 CA--C 1.522 0.53 0 O-C-N 123.66 0.6 . . . . 0.0 113.953 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.6 Cg_exo -66.63 88.35 0.28 Allowed 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.411 2.741 . . . . 0.0 113.499 -176.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.907 HG13 ' H ' ' A' ' 20' ' ' SER . 16.4 t -131.96 -162.88 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.907 ' H ' HG13 ' A' ' 19' ' ' VAL . 47.5 p -173.77 178.27 2.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.701 1.137 . . . . 0.0 109.167 -169.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 20.1 tpt180 -55.43 -54.45 43.62 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.288 0.367 . . . . 0.0 110.034 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -58.28 -59.6 5.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.717 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 56.5 mm-40 -61.05 -46.53 90.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.02 -174.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.85 77.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 18.3 pt20 -70.06 -33.32 71.79 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.954 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.6 m -64.5 -34.41 78.15 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.43 0.633 . . . . 0.0 111.082 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 22.8 mmt85 -64.23 -41.41 97.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.843 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 1.064 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 14.5 mt -112.19 6.97 19.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -168.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 29' ' ' GLN . 4.1 pt20 -74.65 100.41 3.94 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.454 0.645 . . . . 0.0 111.721 -176.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.67 4.96 90.23 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.313 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -88.19 -171.69 3.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.574 0.226 . . . . 0.0 110.691 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.523 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 6.0 mtp180 -48.78 126.47 12.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.934 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.425 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 30.5 m170 -85.59 155.17 21.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.929 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.7 -2.06 79.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.322 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.533 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 39.5 mtm -93.1 153.25 18.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.0 110.335 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.596 ' CD1' HD23 ' A' ' 98' ' ' LEU . 49.3 p90 -150.13 166.53 29.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.434 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.504 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -155.27 138.33 15.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.641 174.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t -105.41 125.12 60.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.605 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.748 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 32.7 ptt-85 -124.44 174.37 7.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.291 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -72.55 131.76 42.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.627 ' HA ' HG23 ' A' ' 49' ' ' VAL . 15.4 t -56.05 146.64 22.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.633 0.73 . . . . 0.0 112.443 -170.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -92.22 -7.93 46.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.213 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.6 m -110.34 -47.87 3.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.335 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 41' ' ' SER . 56.2 m -125.09 119.0 25.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.714 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.9 112.79 1.75 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.527 2.151 . . . . 0.0 111.572 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.04 -21.88 11.85 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.437 ' C ' ' HB2' ' A' ' 41' ' ' SER . 26.4 t70 -82.85 171.94 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.518 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 27.1 m-85 -130.37 160.91 32.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.458 0.572 . . . . 0.0 111.205 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.627 HG23 ' HA ' ' A' ' 41' ' ' SER . 39.5 t -136.77 105.4 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.213 0.53 . . . . 0.0 111.218 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.475 ' CB ' HD12 ' A' ' 63' ' ' ILE . 33.6 tp -82.27 102.7 11.34 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.226 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.7 m -95.36 119.43 33.86 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 48.9 t -117.89 136.33 55.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.113 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 1.064 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 89.6 p -104.89 135.12 46.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.694 0.759 . . . . 0.0 111.806 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.538 ' OE1' ' HB3' ' A' ' 94' ' ' ASP . 18.9 mt-10 -144.79 176.29 9.55 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 170.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.469 ' N ' HD21 ' A' ' 55' ' ' ASN . 0.0 OUTLIER -29.23 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 m 34.14 70.95 0.11 Allowed 'General case' 0 C--N 1.349 0.582 0 CA-C-O 121.983 0.897 . . . . 0.0 110.882 -171.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.924 HH12 ' HA ' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -162.31 45.46 0.15 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.088 -157.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.6 t -81.83 90.6 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.561 0.696 . . . . 0.0 109.667 -177.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.5 m -86.1 122.13 29.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.477 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -93.72 95.89 9.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.685 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.577 ' CE2' HD23 ' A' ' 93' ' ' LEU . 78.4 m-85 -87.51 117.31 26.22 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 123.15 0.58 . . . . 0.0 111.657 -175.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.4 HG12 HG21 ' A' ' 49' ' ' VAL . 5.6 mt -80.49 133.38 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.7 mp -115.49 118.63 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.197 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -83.77 134.53 34.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.813 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -87.77 105.77 17.62 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 82.9 mt -88.26 145.79 36.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.415 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 34.6 Cg_exo -62.19 -23.11 75.17 Favored 'Trans proline' 0 N--CA 1.473 0.315 0 C-N-CA 123.363 2.708 . . . . 0.0 112.962 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -89.03 18.1 5.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.186 0.517 . . . . 0.0 110.183 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.811 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 1.2 mmp_? 64.41 31.95 12.3 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.275 173.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -113.18 165.41 12.42 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.487 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 60.1 m-85 -127.22 117.45 22.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.441 0.639 . . . . 0.0 111.509 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -106.57 98.76 8.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.511 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 8.7 tt -79.6 85.16 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.545 0.688 . . . . 0.0 110.476 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.69 73.2 0.52 Allowed Glycine 0 C--O 1.227 -0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.117 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.6 t0 75.7 -38.39 0.35 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.101 0.56 . . . . 0.0 111.023 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.522 ' HA ' HE21 ' A' ' 76' ' ' GLN . 0.0 OUTLIER -59.26 114.66 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.46 0.304 . . . . 0.0 110.902 174.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.82 115.43 27.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.794 0.33 . . . . 0.0 111.345 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' A' ' 76' ' ' GLN . 84.4 m-85 -126.05 168.02 14.54 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -86.22 -34.71 20.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.708 0.29 . . . . 0.0 111.524 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 2.6 p80 -152.63 168.54 25.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.677 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.652 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 12.4 mt -57.04 -55.26 45.84 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.29 -3.8 8.13 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.789 1.659 . . . . 0.0 113.014 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.81 -32.62 17.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.736 0.303 . . . . 0.0 110.558 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.2 pp -76.74 -32.35 57.72 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.1 mt -66.03 -26.98 67.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.731 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -74.57 -35.11 63.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.823 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -75.36 -38.02 60.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 111.301 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.414 ' CG ' HD21 ' A' ' 93' ' ' LEU . 44.5 m-85 -72.79 1.94 7.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.954 0.407 . . . . 0.0 111.34 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.524 ' HZ3' ' HB2' ' A' ' 89' ' ' LYS . 4.1 ttmp? -64.91 -36.66 85.1 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.322 172.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 mt -104.13 -7.39 9.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.177 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -82.69 -37.09 25.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.875 -171.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.721 ' HA ' HG22 ' A' ' 97' ' ' THR . 81.2 m-85 66.27 95.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.993 0.808 . . . . 0.0 110.203 -169.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.704 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 23.6 mt -62.71 -23.52 67.2 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.404 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.538 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 23.7 t70 -139.11 -77.89 0.34 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 164.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.653 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 5.8 t -146.95 10.44 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.585 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.502 HG23 ' CD1' ' A' ' 99' ' ' ILE . 4.3 m -124.19 -39.23 2.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.721 HG22 ' HA ' ' A' ' 92' ' ' TYR . 17.6 p 82.9 -173.3 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.422 1.489 . . . . 0.0 111.011 -174.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.596 HD23 ' CD1' ' A' ' 36' ' ' PHE . 93.7 mt -88.25 106.11 17.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.857 176.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 1.9 mp -89.08 -53.82 8.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.56 ' HG2' HG21 ' A' ' 99' ' ' ILE . 9.9 pt-20 -163.54 149.39 9.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.74 159.56 47.9 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.328 2.019 . . . . 0.0 112.413 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.57 124.48 89.33 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.89 76.48 0.61 Allowed 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.908 2.405 . . . . 0.0 113.678 -171.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.446 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 3.7 tpm_? . . . . . 0 N--CA 1.469 0.504 0 C-N-CA 124.142 0.977 . . . . 0.0 111.772 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 1.024 ' HG ' ' HD3' ' A' ' 155' ' ' LYS . 4.3 mm? . . . . . 0 N--CA 1.461 0.092 0 CA-C-O 121.687 0.756 . . . . 0.0 112.339 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 45.0 tt0 -144.93 -66.09 0.33 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.647 -172.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -117.39 118.37 32.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.806 0.812 . . . . 0.0 111.457 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.759 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 71.8 t -133.3 135.31 56.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.746 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 1.026 ' HB2' ' HB3' ' A' ' 179' ' ' GLU . 23.0 mtt180 -107.7 158.25 17.43 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.055 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.442 HG22 ' CD2' ' A' ' 144' ' ' PHE . 6.3 p -116.22 138.8 50.98 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.801 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.542 HD21 ' CG ' ' A' ' 179' ' ' GLU . 12.3 mt -112.87 -37.03 4.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.636 -172.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -69.79 -35.98 75.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.994 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.8 t70 70.69 92.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.456 0.646 . . . . 0.0 109.262 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 79.1 t80 -127.59 116.89 21.14 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.917 -176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 48.8 Cg_endo -92.47 96.38 0.18 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 122.37 2.047 . . . . 0.0 113.067 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.84 -17.49 80.13 Favored Glycine 0 CA--C 1.507 -0.466 0 CA-C-O 121.795 0.664 . . . . 0.0 111.483 173.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.477 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 17.4 m120 55.57 29.99 14.48 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.024 -1.088 . . . . 0.0 112.804 -171.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.517 ' HB2' ' HD3' ' A' ' 169' ' ' ARG . 34.4 t0 82.63 168.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 157.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 89.06 -35.39 0.02 OUTLIER 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.832 1.653 . . . . 0.0 112.409 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -143.76 -14.61 0.64 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.945 0.403 . . . . 0.0 110.253 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -147.53 120.48 8.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.446 0.641 . . . . 0.0 110.511 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.616 HD12 ' HG2' ' A' ' 169' ' ' ARG . 41.7 tp -75.71 124.32 88.7 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.019 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 55.5 Cg_endo -77.61 96.2 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.42 2.08 . . . . 0.0 110.808 172.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.53 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 6.9 p90 -105.23 163.4 12.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.716 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.846 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 8.4 mmpt? -103.75 -176.39 3.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.303 0.573 . . . . 0.0 111.233 -175.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 13.73 2.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.52 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.75 39.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.719 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.846 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 29.9 mm-40 -98.54 155.74 17.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.77 HD13 ' HG2' ' A' ' 129' ' ' ARG . 15.7 mm -97.27 134.57 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.596 HD22 ' HA ' ' A' ' 165' ' ' ASN . 22.5 mt -117.32 156.61 27.53 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.558 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 62.1 t -116.87 127.01 74.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.559 HD13 ' HB3' ' A' ' 163' ' ' ALA . 45.9 mm -76.06 82.52 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.221 1.01 . . . . 0.0 108.889 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.728 HG22 HG23 ' A' ' 170' ' ' VAL . 14.7 tt -77.44 -27.43 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.913 -175.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.924 ' HA ' HH12 ' A' ' 57' ' ' ARG . 4.4 mt-10 -139.97 139.74 36.14 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 173.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 1.024 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 5.7 ttpm? -133.86 86.47 38.18 Favored Pre-proline 0 C--O 1.237 0.412 0 O-C-N 121.755 -0.59 . . . . 0.0 111.036 174.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.653 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 53.6 Cg_endo -79.01 -46.07 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.285 1.99 . . . . 0.0 112.786 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -109.11 179.88 4.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.252 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -103.37 -29.43 11.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.842 0.353 . . . . 0.0 110.962 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -93.44 -21.44 19.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.618 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.498 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 35.9 m95 -129.06 126.02 38.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.1 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.64 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.1 m0 -116.1 137.79 51.81 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.09 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.848 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.5 m -89.33 89.72 8.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.129 0.49 . . . . 0.0 110.071 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.559 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -101.22 154.84 18.42 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.962 -0.461 . . . . 0.0 111.354 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.724 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.2 ptt180 -98.54 128.9 45.05 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.533 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.596 ' HA ' HD22 ' A' ' 150' ' ' LEU . 64.5 t30 -63.58 160.73 16.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.12 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -59.46 -25.01 64.04 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.451 ' HB3' HD21 ' A' ' 165' ' ' ASN . 11.1 t70 -75.69 -24.33 56.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.797 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.9 74.84 1.11 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.293 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.724 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -159.07 133.12 7.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.819 -0.191 . . . . 0.0 110.979 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.728 HG23 HG22 ' A' ' 153' ' ' ILE . 83.9 t -103.35 120.39 53.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.192 0.52 . . . . 0.0 111.892 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.97 159.89 28.29 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 170.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.548 ' HE3' ' HG2' ' A' ' 156' ' ' PRO . 21.6 mtp -71.21 138.95 49.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.254 0.527 . . . . 0.0 110.0 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -134.96 145.85 56.21 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.291 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 5.5 Cg_exo -75.94 129.04 11.19 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 123.299 2.666 . . . . 0.0 112.702 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.657 ' O ' HG21 ' A' ' 178' ' ' VAL . 92.3 t -58.77 -45.66 99.61 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 47.4 Cg_exo -59.5 -6.92 4.72 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.329 2.019 . . . . 0.0 113.86 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -98.15 -1.29 42.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.657 HG21 ' O ' ' A' ' 175' ' ' VAL . 5.9 m -109.41 178.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -164.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 1.026 ' HB3' ' HB2' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -138.9 40.38 2.15 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 111.267 -2.697 . . . . 0.0 107.983 -168.187 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.759 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 20.0 pttm . . . . . 0 C--N 1.322 -0.625 0 O-C-N 121.669 -0.644 . . . . 0.0 110.038 -165.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -91.94 118.47 30.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.412 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.94 150.67 40.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.027 176.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -111.13 130.79 55.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.897 0.379 . . . . 0.0 110.244 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.551 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -74.31 122.36 22.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.414 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 290' ' ' HIS . 27.1 pt -104.03 6.15 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -169.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.406 HE21 ' HB3' ' A' ' 244' ' ' GLN . 0.4 OUTLIER -156.12 149.11 24.22 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.581 -176.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 11.2 tptm -79.45 116.44 19.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.427 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.63 ' HB3' ' CE1' ' A' ' 290' ' ' HIS . 6.4 ttt-85 -151.32 107.64 3.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.143 0.497 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.891 178.495 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.452 -0.375 0 CA-C-O 120.647 0.261 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -89.06 116.74 27.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.867 0.365 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.563 HD23 ' HB ' ' A' ' 279' ' ' VAL . 1.1 tt -77.96 125.0 28.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -70.83 108.11 4.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.907 0.384 . . . . 0.0 110.581 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.6 mt -136.15 123.26 21.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.294 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 7.5 pt-20 -100.08 -134.87 0.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.782 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.86 130.2 68.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.53 . . . . 0.0 111.736 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 85.66 21.92 52.04 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.666 173.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -109.71 159.41 17.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.429 0.614 . . . . 0.0 110.019 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.47 127.09 56.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 110.94 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.646 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 39.9 t -107.03 122.03 60.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.496 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -90.94 101.23 14.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.63 HG11 ' CZ3' ' A' ' 275' ' ' TRP . 4.8 p -126.34 147.83 31.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.424 -170.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -112.64 -54.22 2.64 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 275' ' ' TRP . 45.4 mtt180 -90.48 128.22 36.46 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 122.365 -0.21 . . . . 0.0 110.633 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.887 ' C ' ' HA3' ' A' ' 273' ' ' GLY . 0.2 OUTLIER -117.25 113.48 22.25 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.932 ' HB2' ' HD2' ' A' ' 288' ' ' PHE . 0.9 OUTLIER -20.67 176.59 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 129.849 3.26 . . . . 0.0 117.643 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.427 HG13 ' CE2' ' A' ' 288' ' ' PHE . 43.6 mt 63.8 70.41 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 113.315 -1.766 . . . . 0.0 107.14 -160.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.6 13.42 9.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.048 -164.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.887 ' HA3' ' C ' ' A' ' 269' ' ' MET . . . -91.59 -35.47 6.89 Favored Glycine 0 N--CA 1.427 -1.924 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.558 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.903 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 8.9 pt20 23.44 121.71 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 125.638 1.434 . . . . 0.0 113.716 -161.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.833 ' CE2' ' HB3' ' A' ' 288' ' ' PHE . 7.6 m0 -83.81 132.57 34.81 Favored 'General case' 0 CA--C 1.48 -1.726 0 C-N-CA 118.015 -1.474 . . . . 0.0 111.18 -161.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.5 94.53 4.83 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 111.593 -2.549 . . . . 0.0 110.281 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.95 137.7 10.6 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.419 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.66 ' HG3' ' HB3' ' A' ' 283' ' ' LYS . 23.8 mp0 -101.88 109.52 21.29 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.563 ' HB ' HD23 ' A' ' 256' ' ' LEU . 58.7 t -123.17 121.74 63.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.743 0.306 . . . . 0.0 111.438 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 5.9 t30 66.24 -72.68 0.08 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.541 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -113.56 -43.47 0.82 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.244 -174.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.54 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 5.5 ppt_? -158.11 174.26 15.47 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.66 ' HB3' ' HG3' ' A' ' 278' ' ' GLU . 60.0 pttt -95.77 143.83 26.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.873 -175.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.39 161.44 29.75 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.514 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.89 HD21 ' HB2' ' A' ' 274' ' ' GLN . 21.1 mt -87.53 137.48 32.3 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.718 0.771 . . . . 0.0 111.558 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.646 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 21.4 p90 -149.54 142.9 16.28 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.096 174.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.611 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 13.8 Cg_exo -69.64 144.69 55.48 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.005 1.803 . . . . 0.0 110.76 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.932 ' HD2' ' HB2' ' A' ' 270' ' ' ASN . 26.5 p90 -69.1 6.02 1.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.5 m -88.14 -12.48 43.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.358 0.599 . . . . 0.0 109.685 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.63 ' CE1' ' HB3' ' A' ' 246' ' ' ARG . 69.1 t60 -83.41 -20.92 33.27 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.135 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 242' ' ' ALA . 23.6 m -127.02 176.99 6.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.694 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -136.87 134.89 37.37 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.133 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.407 HD11 ' HH2' ' A' ' 275' ' ' TRP . 44.5 mm -82.75 102.96 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -93.43 176.2 6.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.878 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--N 1.332 -0.189 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.662 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.644 0.259 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -154.85 93.42 1.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.207 0.527 . . . . 0.0 110.622 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.56 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 45.7 p90 -145.02 154.88 42.99 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.58 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -71.99 97.77 1.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.63 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.7 m -77.17 59.0 1.67 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.191 0.52 . . . . 0.0 110.51 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 t 179.42 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.603 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -69.66 102.02 1.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.34 0.59 . . . . 0.0 110.759 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 11.6 mmt180 -61.73 -29.25 69.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.525 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.3 m -79.09 0.38 28.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.607 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.12 -47.34 5.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -116.42 -21.32 9.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 44.4 t80 -85.7 118.5 25.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.809 0.338 . . . . 0.0 111.28 -173.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.592 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 19.1 mmt -104.15 -2.11 26.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 110.963 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.07 -115.86 4.47 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.485 -0.779 . . . . 0.0 114.022 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.1 94.61 0.73 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.265 1.977 . . . . 0.0 113.534 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.87 HG12 ' H ' ' A' ' 20' ' ' SER . 19.0 t -139.93 -175.56 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.87 ' H ' HG12 ' A' ' 19' ' ' VAL . 93.9 p -151.45 176.64 11.09 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.254 0.934 . . . . 0.0 108.554 -170.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -53.79 -66.03 0.46 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.39 -43.24 91.25 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.21 -45.8 90.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.471 0.176 . . . . 0.0 111.369 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -56.31 -48.37 76.83 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.063 0.459 . . . . 0.0 111.27 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -73.53 -30.04 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.004 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.679 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 95.7 m -62.1 -34.78 76.96 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.272 0.558 . . . . 0.0 110.466 174.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -75.43 -14.29 60.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.121 0.486 . . . . 0.0 110.417 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.547 ' O ' ' HB3' ' A' ' 31' ' ' GLN . 20.4 mt -115.75 17.7 16.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.406 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.679 ' HG2' ' O ' ' A' ' 26' ' ' THR . 12.5 pt20 -88.08 116.0 25.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.399 0.619 . . . . 0.0 110.675 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.74 26.55 24.46 Favored Glycine 0 CA--C 1.499 -0.916 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.823 ' HB2' ' HG ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -50.59 177.7 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 111.187 -2.506 . . . . 0.0 115.141 -175.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -86.19 -9.31 56.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.558 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.598 ' HD2' ' HG2' ' A' ' 31' ' ' GLN . 61.7 m170 66.03 92.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.445 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.41 28.89 3.61 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -170.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 52.4 ttp -124.19 134.19 53.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.55 ' CD1' HD23 ' A' ' 98' ' ' LEU . 43.8 p90 -135.6 164.13 28.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -173.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.497 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -150.62 144.02 24.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.364 171.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.422 HG22 HD11 ' A' ' 50' ' ' LEU . 61.2 t -109.24 119.17 58.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.551 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -123.01 168.47 12.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.708 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.475 ' OD2' ' HA ' ' A' ' 45' ' ' PRO . 34.6 t70 -66.11 125.93 27.05 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.02 -0.734 . . . . 0.0 109.02 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.63 ' HA ' HG22 ' A' ' 49' ' ' VAL . 31.9 p -53.63 120.02 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.518 0.675 . . . . 0.0 112.104 -172.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.691 ' HB3' ' HA ' ' A' ' 20' ' ' SER . 3.4 p -74.58 73.62 1.97 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.922 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.0 t 174.72 -36.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.327 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 66.5 m -147.43 93.85 4.57 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.253 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HA ' ' OD2' ' A' ' 40' ' ' ASP . 54.5 Cg_exo -52.21 116.18 2.65 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.524 2.149 . . . . 0.0 112.253 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.57 -47.83 0.9 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.523 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 1.2 m-20 -78.62 -172.05 2.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.457 ' CE1' ' HE1' ' A' ' 15' ' ' TYR . 25.9 m-85 -138.46 169.4 17.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.255 0.55 . . . . 0.0 112.132 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.63 HG22 ' HA ' ' A' ' 41' ' ' SER . 44.1 t -146.94 111.42 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.525 175.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.579 ' HB2' HD13 ' A' ' 63' ' ' ILE . 62.5 tp -82.04 104.27 12.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.133 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.9 m -94.99 109.32 21.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.271 0.558 . . . . 0.0 109.829 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.623 HG12 ' OE2' ' A' ' 54' ' ' GLU . 29.0 t -111.2 138.16 40.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.126 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.823 ' HG ' ' HB2' ' A' ' 31' ' ' GLN . 81.8 p -118.22 137.37 53.06 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.7 ' HB2' ' HE ' ' A' ' 57' ' ' ARG . 13.9 mp0 -143.58 179.44 7.12 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.428 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 23.6 m-20 -21.15 81.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 124.846 1.341 . . . . 0.0 114.194 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m 42.68 62.8 1.63 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.671 0.788 . . . . 0.0 111.787 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.7 ' HE ' ' HB2' ' A' ' 54' ' ' GLU . 1.4 ptm85 -167.52 57.45 0.07 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -163.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 19.2 t -76.58 103.79 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.34 -0.85 . . . . 0.0 109.54 -176.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.48 ' HG ' ' NH2' ' A' ' 57' ' ' ARG . 54.8 m -92.1 121.47 33.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.185 -172.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -92.58 88.26 6.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.768 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.74 ' HH ' ' HB3' ' A' ' 93' ' ' LEU . 90.3 m-85 -78.89 117.25 19.81 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.077 0.551 . . . . 0.0 110.924 -176.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 8.4 tp -71.4 135.96 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.579 HD13 ' HB2' ' A' ' 50' ' ' LEU . 4.0 mp -122.23 117.76 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.964 0.411 . . . . 0.0 110.769 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.523 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 5.5 m120 -85.61 136.07 33.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.936 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 t -92.73 98.43 11.41 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.498 HD22 ' HD2' ' A' ' 72' ' ' LYS . 55.0 mt -72.89 168.36 25.23 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.107 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.427 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 36.6 Cg_exo -63.17 68.3 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.998 2.465 . . . . 0.0 112.803 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 70.79 14.89 6.99 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.369 1.468 . . . . 0.0 112.176 164.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 66.4 mtt180 -93.75 -72.75 0.6 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.707 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.698 ' HB2' ' O ' ' A' ' 78' ' ' PHE . 3.2 ptp180 -156.79 -169.62 3.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.596 -172.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.553 ' HB3' HG21 ' A' ' 63' ' ' ILE . 97.4 m-85 -118.31 127.92 54.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.959 0.409 . . . . 0.0 111.053 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.663 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 52.9 mttm -98.22 101.09 12.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.842 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 10.7 tt -87.41 81.94 2.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 122.127 0.965 . . . . 0.0 110.202 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.27 81.63 0.38 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.161 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.5 t0 72.59 -58.0 0.61 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.778 0.431 . . . . 0.0 111.376 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -79.03 140.02 38.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.406 0.622 . . . . 0.0 110.726 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.663 ' HB3' ' HG2' ' A' ' 72' ' ' LYS . 10.5 pt-20 -110.8 141.72 43.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.321 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.698 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 71.9 m-85 -122.68 151.08 41.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -58.94 -24.89 62.99 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -169.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -163.75 172.32 14.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.332 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.7 mt -55.09 -56.49 27.61 Favored Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 34.6 Cg_exo -61.15 -9.48 12.62 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.125 1.884 . . . . 0.0 113.23 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.481 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . . . -88.7 -25.58 22.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.66 0.267 . . . . 0.0 110.991 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.571 HD11 HD12 ' A' ' 73' ' ' ILE . 3.9 pp -79.49 -31.52 42.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.26 -35.48 79.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.756 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.481 ' HG2' ' HA ' ' A' ' 83' ' ' ALA . 7.6 pt-20 -80.56 -6.16 57.83 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -87.65 -37.58 16.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.372 0.606 . . . . 0.0 109.592 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.592 ' CG ' HD21 ' A' ' 93' ' ' LEU . 41.9 m-85 -81.85 -6.88 59.47 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.565 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.523 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 14.2 ptmm? -83.62 -3.73 57.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.527 171.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.4 pt -123.21 -22.16 2.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 121.021 0.439 . . . . 0.0 110.522 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 10.6 t-160 -68.9 -41.96 77.55 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.946 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.559 ' CD2' HG21 ' A' ' 97' ' ' THR . 91.3 m-85 71.81 108.39 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 O-C-N 124.554 1.159 . . . . 0.0 108.93 -165.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.74 ' HB3' ' HH ' ' A' ' 61' ' ' TYR . 4.8 mt -78.86 1.38 23.66 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.669 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 28.4 t70 -168.53 -134.19 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.525 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 10.6 t -83.07 -8.05 59.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.516 0.674 . . . . 0.0 109.372 172.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.9 t -125.92 169.46 12.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.912 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.559 HG21 ' CD2' ' A' ' 92' ' ' TYR . 9.1 p -109.14 -176.66 3.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.555 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.55 HD23 ' CD1' ' A' ' 36' ' ' PHE . 92.6 mt -69.13 98.8 1.04 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.681 HG23 ' HG3' ' A' ' 100' ' ' GLU . 51.3 mm -90.68 -58.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.929 -176.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.681 ' HG3' HG23 ' A' ' 99' ' ' ILE . 45.3 mt-10 -141.01 158.12 65.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.712 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 93.6 Cg_endo -83.27 157.37 14.83 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.611 2.208 . . . . 0.0 112.04 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.45 158.33 83.59 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.386 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.74 129.43 27.67 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.258 1.972 . . . . 0.0 111.812 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.592 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 35.3 ttt180 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.371 0.605 . . . . 0.0 110.266 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.513 HD12 ' CE2' ' A' ' 161' ' ' TRP . 0.5 OUTLIER . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.642 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 8.5 mt-10 169.08 -54.42 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 O-C-N 125.703 1.877 . . . . 0.0 109.988 171.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.675 ' O ' ' HA ' ' A' ' 180' ' ' LYS . 12.9 m-85 -61.28 107.42 0.76 Allowed 'General case' 0 C--O 1.208 -1.12 0 CA-C-N 119.18 0.9 . . . . 0.0 110.805 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 179' ' ' GLU . 2.0 t -131.23 132.66 63.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.807 172.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.807 HH21 HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -126.31 135.43 51.5 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.601 173.29 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.954 HG21 HG12 ' A' ' 178' ' ' VAL . 70.9 p -94.06 132.86 38.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -173.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.542 HD11 ' HG3' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -112.38 -0.32 15.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.801 -175.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -105.93 -44.36 4.63 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -168.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.3 t70 81.16 102.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.273 0.629 . . . . 0.0 110.35 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 87.3 t80 -142.61 110.82 5.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -91.89 90.42 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.619 2.213 . . . . 0.0 112.615 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.598 ' HA3' ' OD1' ' A' ' 141' ' ' ASP . . . -79.93 -2.42 88.56 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.257 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.452 HD21 ' HA ' ' A' ' 137' ' ' ASN . 7.4 m120 56.95 25.84 11.08 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.642 0.377 . . . . 0.0 111.974 -174.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.781 ' HA ' ' O ' ' A' ' 141' ' ' ASP . 3.0 p30 53.35 -166.61 0.07 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 168.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 90.6 -47.49 0.02 OUTLIER 'General case' 0 C--N 1.347 0.46 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.875 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -142.37 14.01 1.99 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.781 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 11.5 t70 -153.53 173.55 15.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 112.756 -2.02 . . . . 0.0 105.824 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.587 HD13 ' HD2' ' A' ' 143' ' ' PRO . 54.8 tp -134.61 128.81 19.19 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 119.16 0.891 . . . . 0.0 110.477 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.587 ' HD2' HD13 ' A' ' 142' ' ' LEU . 12.6 Cg_endo -85.09 98.77 0.67 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.449 2.099 . . . . 0.0 111.194 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.683 ' HB2' ' HG1' ' A' ' 130' ' ' THR . 10.9 p90 -111.77 167.96 9.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.556 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.589 ' H ' ' HB2' ' A' ' 148' ' ' GLU . 24.5 mtpp -126.1 -174.05 3.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -173.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.413 ' O ' ' HE2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -69.79 66.47 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.52 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 121.0 49.34 0.28 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.263 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.589 ' HB2' ' H ' ' A' ' 145' ' ' LYS . 5.8 tp10 -99.34 154.52 18.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.807 HD11 HH21 ' A' ' 129' ' ' ARG . 1.0 OUTLIER -112.32 134.2 55.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.69 -173.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.638 HD21 ' O ' ' A' ' 149' ' ' ILE . 21.0 mt -143.14 155.8 44.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.899 0.857 . . . . 0.0 110.913 -170.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 39.3 t -126.32 126.41 69.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.614 173.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 161' ' ' TRP . 36.2 mm -74.53 86.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 122.156 0.979 . . . . 0.0 110.412 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.951 HG23 HG21 ' A' ' 170' ' ' VAL . 9.1 tt -82.51 -28.28 8.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.726 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.94 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 28.0 mt-10 -130.73 141.66 50.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -136.23 77.43 48.33 Favored Pre-proline 0 C--O 1.24 0.566 0 O-C-N 121.472 -0.768 . . . . 0.0 111.566 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.412 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 16.6 Cg_exo -66.16 -54.62 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.256 1.971 . . . . 0.0 111.342 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -106.82 175.06 5.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.62 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -98.89 -23.33 15.39 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.33 -27.64 21.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.273 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.639 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 44.2 m95 -124.41 122.47 37.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.642 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.696 ' HB3' HD11 ' A' ' 152' ' ' ILE . 45.7 m0 -112.18 137.72 49.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.53 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.94 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.7 m -94.82 109.54 21.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.564 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -116.79 159.32 22.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -173.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 9.7 ptt180 -94.0 118.86 32.09 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.996 173.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.605 ' HA ' ' CD2' ' A' ' 150' ' ' LEU . 0.2 OUTLIER -69.16 179.11 2.03 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.664 0.269 . . . . 0.0 111.452 -178.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -61.41 -30.37 70.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.987 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -93.65 4.1 54.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.636 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.23 74.82 1.22 Allowed Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.785 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.671 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -150.92 138.41 19.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 177.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.951 HG21 HG23 ' A' ' 153' ' ' ILE . 95.1 t -103.78 126.03 58.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.201 0.524 . . . . 0.0 111.973 -175.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.669 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . -157.42 167.45 34.01 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 171.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.639 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 22.7 mtp -79.96 139.44 37.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.178 0.489 . . . . 0.0 110.7 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.682 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -138.24 148.3 59.14 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.75 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.24 131.77 10.98 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.65 2.233 . . . . 0.0 112.435 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 61.1 t -59.34 -45.07 99.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 31.9 Cg_endo -65.29 -1.62 4.8 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.22 1.947 . . . . 0.0 113.452 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -99.7 -7.94 24.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.783 0.325 . . . . 0.0 111.066 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.954 HG12 HG21 ' A' ' 130' ' ' THR . 2.9 m -144.2 176.56 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.662 -166.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.684 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 6.6 pt-20 -153.64 -55.65 0.11 Allowed 'General case' 0 C--O 1.2 -1.533 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 144.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-N 122.538 2.426 . . . . 0.0 115.686 -171.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 28.3 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.592 0.234 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.469 ' CE1' ' HE2' ' A' ' 265' ' ' LYS . 54.1 m-85 -81.28 126.64 31.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.17 0.509 . . . . 0.0 111.272 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.564 ' HB2' HD11 ' A' ' 293' ' ' ILE . . . -135.32 130.9 35.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.097 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -97.47 126.66 42.87 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -73.48 111.69 8.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.434 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.461 HD13 ' HG3' ' A' ' 244' ' ' GLN . 1.9 pp -87.81 -10.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.691 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.461 ' HG3' HD13 ' A' ' 243' ' ' ILE . 28.8 mt-30 -120.23 167.19 12.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 258' ' ' LEU . 21.2 pttp -118.79 137.48 53.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.302 0.573 . . . . 0.0 111.058 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.517 ' NH1' ' HD2' ' A' ' 287' ' ' PRO . 40.8 ttp-105 -139.41 117.55 11.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.845 -176.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.973 179.725 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 N--CA 1.468 0.452 0 CA-C-O 121.28 0.562 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -91.35 103.95 16.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.695 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.416 HD23 ' HB ' ' A' ' 279' ' ' VAL . 1.5 tt -67.23 131.38 45.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.632 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -75.21 120.38 20.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.618 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 245' ' ' LYS . 81.7 mt -138.0 113.02 9.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.593 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.63 172.45 7.7 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 43.9 t -69.56 106.91 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.02 0.438 . . . . 0.0 110.443 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 123.4 -8.56 8.92 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.415 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.03 130.9 44.35 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.836 0.35 . . . . 0.0 110.867 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 45.9 mm -89.02 108.73 19.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.378 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 36.1 t -85.81 106.54 15.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.27 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.469 ' HE2' ' CE1' ' A' ' 239' ' ' PHE . 28.5 mmtt -84.24 92.74 8.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.685 HG13 ' HE1' ' A' ' 269' ' ' MET . 7.6 p -87.31 125.66 41.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.972 0.415 . . . . 0.0 110.044 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 4.9 p -100.34 -32.86 10.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.59 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 24.8 tpp180 -125.88 99.36 5.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.976 0.417 . . . . 0.0 110.165 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.685 ' HE1' HG13 ' A' ' 266' ' ' VAL . 25.2 mtt -85.32 107.65 17.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.511 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -63.63 125.28 23.78 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.4 mt -75.79 68.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.899 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.425 HD21 ' N ' ' A' ' 273' ' ' GLY . 3.1 t30 -177.26 -69.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.147 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.569 ' O ' ' HG2' ' A' ' 274' ' ' GLN . . . 179.11 143.26 5.28 Favored Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -166.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 273' ' ' GLY . 0.6 OUTLIER 64.31 119.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 125.418 1.487 . . . . 0.0 110.189 -172.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 286' ' ' PHE . 15.2 m0 -114.02 167.73 10.42 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.985 -174.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -122.67 115.02 21.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.364 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -141.03 158.01 26.17 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 1.064 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 16.5 mt-10 -103.17 108.98 20.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.34 0.57 . . . . 0.0 110.275 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.416 ' HB ' HD23 ' A' ' 256' ' ' LEU . 41.1 t -133.09 139.45 49.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.828 -175.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 26.6 p30 43.52 32.38 0.52 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.757 1.223 . . . . 0.0 113.695 172.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.61 -59.86 0.43 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.858 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.54 176.11 12.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.654 -0.321 . . . . 0.0 111.681 -174.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 1.064 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 13.1 pttm -87.14 141.1 28.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.123 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.87 173.93 32.46 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.76 127.83 37.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.078 0.466 . . . . 0.0 110.258 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 275' ' ' TRP . 43.4 p90 -126.13 131.16 23.87 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.688 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.517 ' HD2' ' NH1' ' A' ' 246' ' ' ARG . 48.2 Cg_exo -58.0 138.69 87.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.615 2.21 . . . . 0.0 111.593 172.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -72.22 -18.39 61.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.401 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 13.8 p -79.43 -0.54 33.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.3 0.572 . . . . 0.0 111.081 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -95.59 -18.69 20.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.586 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 31.7 m -127.83 164.17 29.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.456 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -127.42 122.54 33.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.728 0.299 . . . . 0.0 110.393 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 240' ' ' ALA . 48.8 mm -71.0 122.09 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.152 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -135.54 147.64 48.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.826 0.346 . . . . 0.0 110.272 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.307 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -142.06 91.51 2.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.331 0.586 . . . . 0.0 111.079 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -147.17 148.38 31.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.496 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -79.82 96.88 6.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.991 0.424 . . . . 0.0 110.259 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 m -69.78 74.48 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.133 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 t -176.53 -43.33 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.915 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.85 107.49 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.183 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -32.54 67.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.17 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.0 t -69.78 -9.22 53.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.278 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.26 -46.76 7.56 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.761 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -118.4 -19.93 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -170.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -82.03 123.42 28.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.798 0.333 . . . . 0.0 110.649 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.549 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 16.6 mmt -101.72 -9.55 20.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.557 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.4 -113.23 2.18 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.49 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.17 91.06 0.32 Allowed 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.063 2.509 . . . . 0.0 113.38 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.941 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 14.3 t -137.43 -157.12 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.867 ' H ' HG13 ' A' ' 19' ' ' VAL . 12.5 t 178.93 174.96 0.66 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.8 1.182 . . . . 0.0 108.661 -169.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.544 HH11 ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -44.49 -66.84 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.885 0.741 . . . . 0.0 112.046 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -63.79 -54.34 36.63 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.443 0.464 . . . . 0.0 111.991 -173.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -54.7 -46.82 74.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.41 -42.9 83.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.459 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -80.39 -33.39 37.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.663 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 t -74.19 -18.77 60.72 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.886 -0.325 . . . . 0.0 111.429 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -97.8 -10.38 24.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 110.727 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.658 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 73.2 mt -111.45 0.86 16.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.657 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.14 108.88 3.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.878 0.847 . . . . 0.0 110.679 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.78 -76.69 0.92 Allowed Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.915 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.665 ' HB2' ' HG ' ' A' ' 53' ' ' SER . 17.2 mm-40 45.28 -159.38 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.169 0.57 . . . . 0.0 111.737 -175.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.548 HH21 ' HB2' ' A' ' 100' ' ' GLU . 33.0 ptt180 -101.13 5.94 43.0 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.521 176.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 53' ' ' SER . 27.3 m170 68.29 123.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.478 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.75 16.53 21.63 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.542 ' HE3' ' HA ' ' A' ' 102' ' ' ALA . 73.2 mmm -106.0 134.94 48.33 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CB ' HG23 ' A' ' 52' ' ' VAL . 43.3 p90 -139.58 162.93 33.88 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.621 -174.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.549 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -155.73 141.9 18.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.56 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.31 129.19 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.941 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 32.0 ptt-85 -129.43 173.2 10.77 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.59 133.77 34.04 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 170.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.464 ' HB2' HG23 ' A' ' 43' ' ' THR . 93.9 p -80.45 147.97 30.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.212 0.529 . . . . 0.0 111.162 -173.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.0 t -99.28 34.42 2.17 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 41' ' ' SER . 9.0 t -135.47 -27.55 1.18 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.206 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 91.2 m -147.36 118.25 4.53 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.786 0.327 . . . . 0.0 110.622 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.21 117.98 4.81 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.776 2.317 . . . . 0.0 112.144 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.66 -22.81 34.55 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.713 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 20.0 m-20 -89.84 152.03 21.48 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -119.85 174.97 6.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.557 0.218 . . . . 0.0 111.3 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 41' ' ' SER . 24.1 t -142.63 109.83 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.31 . . . . 0.0 110.861 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.41 HD13 ' HB2' ' A' ' 36' ' ' PHE . 32.1 tp -85.29 100.63 11.92 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.972 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.7 m -96.54 127.41 42.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.97 177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.927 HG21 HD12 ' A' ' 93' ' ' LEU . 48.4 t -123.61 137.17 57.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.453 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.665 ' HG ' ' HB2' ' A' ' 31' ' ' GLN . 90.1 p -97.28 123.8 41.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.647 0.26 . . . . 0.0 111.367 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.683 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 26.7 mt-10 -145.14 175.95 9.88 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.644 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 2.6 p30 -37.04 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -163.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.5 m 37.55 56.87 1.44 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.109 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.884 HH21 ' HB2' ' A' ' 94' ' ' ASP . 7.0 ttp85 -167.67 53.72 0.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.79 -159.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 37.2 t -77.18 98.52 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.909 0.861 . . . . 0.0 109.193 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -87.47 121.17 29.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.839 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -94.71 99.4 11.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.19 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.425 ' HE1' ' CG1' ' A' ' 153' ' ' ILE . 58.6 m-85 -96.07 116.15 28.52 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.367 0.267 . . . . 0.0 111.529 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 64.5 mt -80.31 134.2 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.698 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.0 mp -109.45 119.5 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 123.16 0.584 . . . . 0.0 110.347 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.503 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 13.2 m120 -84.98 137.68 32.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.789 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.7 t -87.41 102.0 14.12 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.663 HD12 ' HB2' ' A' ' 72' ' ' LYS . 91.4 mt -83.44 140.27 41.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.993 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.75 -23.07 69.48 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.221 2.614 . . . . 0.0 112.958 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -85.23 17.71 2.93 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.014 0.435 . . . . 0.0 110.287 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.868 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.8 OUTLIER 61.97 57.84 2.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.957 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.756 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 62.0 mtt180 -138.59 171.41 14.4 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.124 175.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.508 ' HB3' HG23 ' A' ' 63' ' ' ILE . 53.8 m-85 -130.63 114.99 16.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.404 0.621 . . . . 0.0 110.493 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.663 ' HB2' HD12 ' A' ' 66' ' ' LEU . 87.5 tttt -105.62 99.79 9.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.981 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.698 ' HB ' HG13 ' A' ' 63' ' ' ILE . 8.6 tt -83.63 78.63 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 122.024 0.916 . . . . 0.0 111.063 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.07 -15.99 40.64 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.119 -0.946 . . . . 0.0 114.645 171.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 19.1 t70 176.92 -63.3 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.809 0.804 . . . . 0.0 111.275 -176.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -66.42 129.14 38.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.59 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -87.47 108.41 19.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.378 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.459 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 67.0 m-85 -105.51 149.46 26.21 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.756 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 22.6 m-20 -73.55 -25.05 60.21 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -173.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 6.1 p80 -160.04 168.73 24.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.707 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.1 mt -56.27 -56.27 33.22 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.51 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 32.4 Cg_exo -63.15 -3.0 4.32 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.261 1.974 . . . . 0.0 113.681 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.86 -33.72 17.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.019 0.438 . . . . 0.0 110.284 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.4 pp -79.38 -26.73 41.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.289 0.566 . . . . 0.0 109.6 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 82' ' ' PRO . 79.3 mt -67.89 -29.52 68.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.616 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 82' ' ' PRO . 16.6 mm-40 -83.52 -14.66 51.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.995 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -84.23 -39.02 19.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.267 0.556 . . . . 0.0 109.831 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.591 ' CG ' HD21 ' A' ' 93' ' ' LEU . 66.8 m-85 -81.59 0.81 36.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.36 0.6 . . . . 0.0 110.572 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -74.12 -22.43 59.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.827 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.4 pt -122.72 -19.64 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.597 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.405 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 5.5 t-160 -84.29 -19.95 32.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.343 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 80.6 m-85 72.41 162.24 0.25 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.832 0.707 . . . . 0.0 109.54 -170.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.927 HD12 HG21 ' A' ' 52' ' ' VAL . 11.5 mt -114.55 -11.01 12.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.174 0.511 . . . . 0.0 110.087 168.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.884 ' HB2' HH21 ' A' ' 57' ' ' ARG . 9.6 t70 -157.57 -80.28 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.636 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.462 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 7.0 t -132.49 -16.0 2.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.073 0.463 . . . . 0.0 110.077 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.465 HG21 ' OE1' ' A' ' 54' ' ' GLU . 4.6 t -121.76 -177.83 3.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.5 p -114.88 178.77 4.16 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.155 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.413 HD23 ' CD1' ' A' ' 36' ' ' PHE . 87.7 mt -64.37 97.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.1 mm -85.56 -64.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.673 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.548 ' HB2' HH21 ' A' ' 32' ' ' ARG . 43.2 mt-10 -150.27 153.36 34.86 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.889 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.69 154.65 72.72 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.793 2.329 . . . . 0.0 112.444 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.542 ' HA ' ' HE3' ' A' ' 35' ' ' MET . . . -76.46 157.6 82.34 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.227 176.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.28 135.68 20.9 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.366 2.044 . . . . 0.0 111.819 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.486 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 88.9 mtm180 . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.921 HD13 HG13 ' A' ' 152' ' ' ILE . 1.3 mm? . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.695 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 32.6 tt0 -155.94 -72.74 0.11 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.003 -177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -93.1 109.19 20.67 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.156 -168.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.907 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 90.6 t -134.25 129.17 53.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.011 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.95 ' HG2' ' HB3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -109.79 154.71 22.58 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 118.584 -1.247 . . . . 0.0 108.54 172.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.871 ' HG1' ' HB2' ' A' ' 144' ' ' PHE . 18.9 p -112.21 141.34 46.03 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.714 HD21 ' HG3' ' A' ' 179' ' ' GLU . 58.3 mt -111.82 -41.4 4.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.222 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 51.5 t80 -72.22 -27.88 62.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -168.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.633 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 30.1 t70 69.51 96.36 0.07 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.626 0.727 . . . . 0.0 110.994 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -122.72 96.32 45.54 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.839 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.72 88.92 0.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.44 2.093 . . . . 0.0 112.139 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -87.65 -23.76 38.22 Favored Glycine 0 C--O 1.228 -0.227 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.324 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 47.02 80.33 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.593 0.757 . . . . 0.0 112.57 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -162.64 173.39 13.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.19 -3.29 58.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.155 0.502 . . . . 0.0 110.588 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.26 -11.29 10.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.378 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -129.78 105.43 8.02 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.688 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 36.5 tp -76.52 117.57 65.42 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.674 0.273 . . . . 0.0 110.62 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.16 106.27 1.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.109 1.873 . . . . 0.0 111.244 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.871 ' HB2' ' HG1' ' A' ' 130' ' ' THR . 9.6 p90 -113.64 164.45 13.66 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.216 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.633 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -106.13 -169.56 1.59 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.105 -168.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.567 ' HD2' ' HB2' ' A' ' 133' ' ' ASP . 13.7 mptt -78.37 -5.15 51.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.176 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.72 56.53 0.16 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.361 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.449 ' HB2' ' HD3' ' A' ' 145' ' ' LYS . 7.8 tp10 -105.54 150.74 25.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.587 HD11 ' HB3' ' A' ' 129' ' ' ARG . 45.9 mm -96.66 129.72 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.562 HD22 ' HA ' ' A' ' 165' ' ' ASN . 44.0 mt -123.03 160.48 26.24 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.315 0.579 . . . . 0.0 109.5 -178.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 87.2 t -124.77 128.03 73.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.921 HG13 HD13 ' A' ' 125' ' ' LEU . 36.7 mm -74.33 87.84 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 122.244 1.021 . . . . 0.0 109.529 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.635 HG21 ' HG3' ' A' ' 154' ' ' GLU . 18.0 tt -78.49 -26.38 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.32 -174.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.951 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 15.5 mt-10 -142.04 143.99 33.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.663 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 48.4 tttm -137.05 90.52 15.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 O-C-N 121.237 -0.915 . . . . 0.0 111.399 171.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.462 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 52.8 Cg_endo -81.0 -44.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.064 1.843 . . . . 0.0 112.497 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -109.43 178.52 4.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.331 -172.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -98.77 -33.09 11.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.353 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 159' ' ' GLN . 14.2 mm-40 -100.0 -11.36 20.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.927 0.394 . . . . 0.0 110.762 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.519 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 71.9 m95 -126.38 118.57 25.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.748 ' CZ3' HD11 ' A' ' 125' ' ' LEU . 48.5 m0 -112.28 136.71 51.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.951 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 10.6 t -92.05 92.97 8.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.346 0.593 . . . . 0.0 109.418 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -103.26 158.09 16.57 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 122.022 -0.424 . . . . 0.0 111.477 -174.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.731 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.7 ptt180 -98.22 128.71 44.83 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.812 176.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.688 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 64.5 t30 -70.75 164.64 24.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.556 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -71.96 -10.6 60.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.49 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.481 ' OD1' ' HB3' ' A' ' 165' ' ' ASN . 2.4 p-10 -87.0 -10.58 52.79 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.64 57.14 1.36 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.926 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.731 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 19.1 ttm-85 -136.21 141.9 44.04 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 122.85 -0.206 . . . . 0.0 110.968 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.524 HG22 HG23 ' A' ' 153' ' ' ILE . 49.6 t -103.28 118.46 50.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.609 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -151.15 158.31 27.63 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.411 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.519 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 22.5 mtp -79.18 140.03 37.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.894 0.378 . . . . 0.0 110.431 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.607 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -135.54 145.57 53.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.342 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.432 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 4.3 Cg_exo -76.53 133.06 13.98 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.32 2.68 . . . . 0.0 113.111 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.639 ' O ' HG22 ' A' ' 178' ' ' VAL . 88.3 t -60.4 -44.58 96.24 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.439 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 23.9 Cg_exo -65.27 3.92 0.89 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.219 1.946 . . . . 0.0 113.345 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.432 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.5 m-85 -107.89 -4.81 17.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.282 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.8 m -106.89 -169.07 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -165.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.95 ' HB3' ' HG2' ' A' ' 129' ' ' ARG . 0.4 OUTLIER -160.13 41.51 0.19 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.82 -161.164 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.907 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 25.2 pttm . . . . . 0 C--N 1.321 -0.64 0 O-C-N 120.456 -1.403 . . . . 0.0 109.58 -162.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.474 HG11 HD13 ' A' ' 293' ' ' ILE . 21.6 t . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 121.026 0.441 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.1 116.9 32.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.685 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -120.29 128.16 53.04 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.46 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.59 ' HG3' ' CE1' ' A' ' 294' ' ' PHE . 28.5 mtpp -78.75 125.25 29.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.548 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -75.59 91.42 2.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.888 0.375 . . . . 0.0 110.136 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 24.6 pt -73.24 9.59 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.847 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 242' ' ' ALA . 4.9 tt0 -148.91 152.87 37.17 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -95.85 144.96 25.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.618 ' HB3' ' CE1' ' A' ' 290' ' ' HIS . 0.5 OUTLIER -171.02 125.69 0.67 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.638 0.256 . . . . 0.0 110.756 178.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.812 172.86 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.104 0.478 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -79.56 107.42 12.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.931 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.34 101.67 5.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -68.66 124.2 22.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.912 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 82.3 mt -128.7 143.68 50.99 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.605 0.566 . . . . 0.0 111.275 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.83 170.93 9.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.359 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.3 p -89.34 113.25 25.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.485 0.66 . . . . 0.0 110.485 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 110.3 -6.49 30.33 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.999 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -76.88 161.2 28.61 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.662 0.268 . . . . 0.0 110.646 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 35.0 mm -104.02 111.17 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.296 0.57 . . . . 0.0 111.13 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.409 ' HA ' HG21 ' A' ' 279' ' ' VAL . 38.8 t -88.55 109.19 19.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.532 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.62 ' HB3' ' HZ2' ' A' ' 265' ' ' LYS . 9.6 mtpm? -85.16 88.13 7.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.766 175.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.88 131.86 35.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.553 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -114.79 -22.5 9.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.817 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.687 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 26.4 mmm180 -125.25 123.69 40.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.245 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 51.4 mtt -112.46 102.73 10.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.226 0.536 . . . . 0.0 110.41 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -81.25 139.42 35.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.034 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.0 pt -67.92 -8.99 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.261 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -63.07 -38.65 92.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.529 176.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 121.47 -9.97 9.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.71 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -114.28 119.31 36.56 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.453 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 47.2 m0 -93.63 159.77 15.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.829 0.347 . . . . 0.0 111.073 -174.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.687 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 41.5 mt-10 -107.27 117.77 34.95 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.089 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -142.31 154.01 24.78 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 283' ' ' LYS . 37.7 tt0 -111.73 109.82 19.88 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.52 HG13 HD21 ' A' ' 280' ' ' ASN . 57.6 t -112.55 122.15 66.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.033 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.52 HD21 HG13 ' A' ' 279' ' ' VAL . 31.5 m-80 65.48 -70.21 0.1 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.049 0.843 . . . . 0.0 111.793 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -159.65 26.99 0.35 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.588 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -150.82 128.66 11.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.711 0.255 . . . . 0.0 110.444 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 278' ' ' GLU . 53.4 pttt -102.57 139.33 38.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.969 0.414 . . . . 0.0 110.338 174.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -167.38 -169.96 31.59 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.713 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 93.6 mt -100.13 146.3 26.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.934 0.397 . . . . 0.0 110.692 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 41.1 p90 -148.82 145.54 19.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.609 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 11.8 Cg_exo -72.37 149.22 50.27 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.628 2.218 . . . . 0.0 111.99 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -76.38 -17.68 59.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.837 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.0 t -82.08 3.82 25.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.727 0.775 . . . . 0.0 109.934 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.618 ' CE1' ' HB3' ' A' ' 246' ' ' ARG . 52.8 t60 -96.27 -24.17 16.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.557 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 242' ' ' ALA . 29.1 m -125.02 175.41 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.798 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -138.57 125.36 20.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.557 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.474 HD13 HG11 ' A' ' 238' ' ' VAL . 49.8 mm -73.95 102.7 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.59 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 21.4 p90 -100.19 167.61 10.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.433 -174.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.498 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.234 0.272 0 CA-C-O 121.071 0.462 . . . . 0.0 112.133 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -140.63 88.44 2.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.625 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -168.96 165.82 11.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.932 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -99.63 115.58 29.76 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -69.25 -11.46 60.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.001 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 p -101.65 -23.38 14.26 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.82 102.19 1.2 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.899 -0.501 . . . . 0.0 110.778 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -58.51 -42.3 87.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.239 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.7 m -74.6 10.75 1.23 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.916 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.22 -47.5 4.5 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.828 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -118.02 -21.54 8.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -85.6 115.15 23.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.862 0.363 . . . . 0.0 110.356 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 37' ' ' LEU . 18.0 mmt -102.09 -1.92 30.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 -174.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.7 -114.32 3.01 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.057 -0.974 . . . . 0.0 114.19 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.6 82.68 0.9 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.961 2.44 . . . . 0.0 113.676 -174.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.908 HG11 ' H ' ' A' ' 20' ' ' SER . 16.4 t -121.02 -160.6 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.908 ' H ' HG11 ' A' ' 19' ' ' VAL . 50.8 p -165.84 172.96 11.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 119.751 1.16 . . . . 0.0 109.706 -168.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -52.73 -59.54 4.36 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.158 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -64.32 -52.63 57.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.081 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.6 -44.5 96.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.987 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.58 69.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 110.988 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -46.04 80.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.934 0.397 . . . . 0.0 110.471 175.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.0 m -61.91 -27.45 68.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.177 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -91.99 -14.26 29.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.952 -176.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 1.009 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 67.1 mt -114.96 -17.11 11.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.574 -0.45 . . . . 0.0 112.082 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 11.65 -97.29 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.284 1.433 . . . . 0.0 114.565 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.29 33.22 1.82 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' HB3' ' CE ' ' A' ' 35' ' ' MET . 9.4 tt0 -73.41 -154.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.361 -0.92 . . . . 0.0 109.43 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.424 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -53.65 110.21 0.55 Allowed 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.117 179.13 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -73.04 104.33 4.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.72 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.632 ' HA3' HD11 ' A' ' 99' ' ' ILE . . . 141.93 -3.5 2.01 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.303 -171.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.666 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 38.4 mtm -83.36 144.91 29.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.95 157.26 45.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.585 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.6 pp -150.11 137.47 19.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.575 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.8 t -105.77 128.71 59.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.244 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.822 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 34.9 ptt-85 -129.94 161.6 30.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.828 -175.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.97 133.1 46.91 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 48.9 m -64.48 131.93 48.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.148 0.499 . . . . 0.0 111.441 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.0 t -76.98 43.68 0.36 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.987 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 t -165.87 -37.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.033 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 41' ' ' SER . 65.4 m -134.77 121.6 14.99 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 14.5 Cg_exo -69.36 -19.0 38.63 Favored 'Trans proline' 0 CA--C 1.527 0.163 0 C-N-CA 122.723 2.282 . . . . 0.0 112.724 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.15 -52.82 3.31 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.792 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.6 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 5.7 m-20 -77.38 157.84 30.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.594 0.235 . . . . 0.0 110.987 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -123.73 177.42 5.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.932 0.396 . . . . 0.0 111.328 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.57 HG21 HD12 ' A' ' 62' ' ' ILE . 22.8 t -139.27 112.58 6.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.8 tp -83.05 100.07 10.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.952 0.406 . . . . 0.0 109.933 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.5 m -97.4 118.02 32.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.114 0.483 . . . . 0.0 111.202 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.742 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 41.1 t -111.18 157.28 12.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.377 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 1.009 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 88.1 p -123.65 135.04 53.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.302 0.955 . . . . 0.0 112.7 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.664 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 1.7 pm0 -146.05 176.24 9.86 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.513 175.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -25.51 80.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 -173.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.7 m 39.61 65.32 0.72 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.781 0.8 . . . . 0.0 110.121 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.664 ' HG3' ' HG2' ' A' ' 54' ' ' GLU . 28.5 tpt85 -168.11 52.58 0.06 Allowed 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.689 -149.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.537 HG13 ' HE2' ' A' ' 60' ' ' HIS . 2.2 p -76.65 114.19 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.024 -1.047 . . . . 0.0 111.834 -170.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.766 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 53.5 m -73.62 90.4 1.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.002 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.537 ' HE2' HG13 ' A' ' 58' ' ' VAL . 58.6 m-70 -87.05 87.9 7.57 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.208 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.766 ' CE2' ' HB3' ' A' ' 59' ' ' SER . 71.2 m-85 -92.52 117.76 30.28 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.57 HD12 HG21 ' A' ' 49' ' ' VAL . 30.7 mm -69.95 139.69 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.792 0.33 . . . . 0.0 111.188 176.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 2.7 mp -125.08 118.2 52.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.288 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.6 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 7.8 m120 -73.42 128.89 36.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.943 0.402 . . . . 0.0 110.964 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.6 t -86.85 113.66 22.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.304 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.0 mt -93.72 135.62 24.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.757 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.2 -16.21 32.66 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.144 2.562 . . . . 0.0 113.053 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -85.5 15.57 4.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.0 110.537 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 4.9 mmt85 68.6 22.91 7.41 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.18 176.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -113.38 162.95 15.47 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.54 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 91.9 m-85 -135.55 116.31 14.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.457 0.646 . . . . 0.0 112.169 -172.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 31.3 ttpt -98.17 98.83 10.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.587 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 12.0 tt -80.72 77.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 122.077 0.942 . . . . 0.0 111.469 -175.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.07 -30.17 2.1 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.737 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.15 -77.01 0.24 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.256 0.55 . . . . 0.0 111.434 -169.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -95.05 148.53 22.25 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.437 -169.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -82.14 124.88 30.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.682 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -112.4 144.4 41.91 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.02 -25.37 63.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.788 -170.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -164.8 168.5 17.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.238 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.429 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 8.4 mt -55.21 -55.81 35.4 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.0 Cg_exo -59.27 -8.98 7.45 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.548 2.165 . . . . 0.0 114.002 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.04 -33.51 18.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.792 0.329 . . . . 0.0 111.139 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -79.55 -27.41 41.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.286 0.565 . . . . 0.0 109.675 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.439 ' O ' HD12 ' A' ' 98' ' ' LEU . 79.4 mt -67.87 -33.94 75.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.616 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.644 ' HA ' ' HE3' ' A' ' 89' ' ' LYS . 11.1 pt-20 -90.9 -3.71 57.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.329 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -91.01 -37.06 13.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.377 0.608 . . . . 0.0 110.01 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.518 ' CG ' HD21 ' A' ' 93' ' ' LEU . 20.5 m-85 -83.39 1.5 41.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.884 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' A' ' 86' ' ' GLU . 17.8 ptpt -86.36 14.97 5.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.442 HD13 ' N ' ' A' ' 91' ' ' HIS . 1.7 pp -165.33 -30.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.787 0.804 . . . . 0.0 108.845 -170.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.442 ' N ' HD13 ' A' ' 90' ' ' ILE . 9.0 t60 -65.73 -28.2 68.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.414 172.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.639 ' CD1' HG22 ' A' ' 97' ' ' THR . 70.3 m-85 64.0 110.81 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 124.569 1.168 . . . . 0.0 109.538 -168.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.544 HD11 HD21 ' A' ' 98' ' ' LEU . 20.0 mt -56.2 -42.34 77.04 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 1.006 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 0.1 OUTLIER -138.59 -80.67 0.33 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.378 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.744 HG23 ' HB3' ' A' ' 156' ' ' PRO . 11.0 m -136.94 -6.17 1.88 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.493 1.14 . . . . 0.0 108.546 166.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -106.53 138.69 42.25 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.931 172.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.639 HG22 ' CD1' ' A' ' 92' ' ' TYR . 11.9 p -98.55 -175.46 3.09 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.949 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.544 HD21 HD11 ' A' ' 93' ' ' LEU . 87.6 mt -88.77 88.76 7.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.632 HD11 ' HA3' ' A' ' 34' ' ' GLY . 3.6 mp -75.1 -54.96 13.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.725 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.666 ' O ' ' HA ' ' A' ' 35' ' ' MET . 15.2 pt-20 -154.07 161.34 29.5 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.725 -176.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.94 155.78 61.43 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.536 2.157 . . . . 0.0 112.341 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -77.95 168.22 29.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.527 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 21.8 Cg_endo -62.08 148.01 93.99 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.328 2.019 . . . . 0.0 112.116 175.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.113 0.483 . . . . 0.0 110.218 -179.046 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 152' ' ' ILE . 1.3 mm? . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.731 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 3.9 mm-40 -159.82 -68.67 0.08 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.908 -173.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.62 110.86 23.17 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.328 1.061 . . . . 0.0 111.791 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 1.035 HG22 ' HB3' ' A' ' 180' ' ' LYS . 70.1 t -115.08 150.1 17.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.918 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.963 ' HG2' ' HG3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -124.58 153.24 42.45 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.72 165.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.934 HG21 HG11 ' A' ' 178' ' ' VAL . 21.7 p -112.81 141.18 46.91 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.541 ' HG ' ' OE1' ' A' ' 179' ' ' GLU . 0.3 OUTLIER -99.13 -45.05 6.05 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.946 0.403 . . . . 0.0 111.368 -177.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 35.1 t80 -70.62 -38.63 73.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -163.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.535 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 13.5 t70 75.63 100.71 0.07 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -172.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 77.2 t80 -139.14 107.54 7.38 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.112 -175.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 27.1 Cg_endo -92.31 85.73 0.23 Allowed 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.783 2.322 . . . . 0.0 112.356 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.714 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -71.74 -11.88 73.75 Favored Glycine 0 CA--C 1.506 -0.499 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 172.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 138' ' ' ASP . 17.7 m120 51.46 59.53 4.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.603 -1.299 . . . . 0.0 113.312 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 21.0 t70 81.36 163.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 155.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 88.79 -47.52 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.638 1.575 . . . . 0.0 111.704 169.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -160.35 6.08 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.324 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.714 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 39.0 m-20 -139.64 97.14 3.2 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.709 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 21.9 tp -70.13 128.02 91.86 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 120.832 0.348 . . . . 0.0 110.792 -174.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 56.4 Cg_endo -79.28 101.62 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.212 1.941 . . . . 0.0 111.736 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.578 ' HB2' ' HG1' ' A' ' 130' ' ' THR . 15.1 p90 -109.94 157.09 19.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.366 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.535 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 35.4 mtmm -112.02 175.62 5.35 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.056 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.718 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -76.58 71.89 3.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.621 0.724 . . . . 0.0 110.443 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 131.21 30.39 0.57 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.244 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -95.32 155.13 16.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.822 HD11 ' HB3' ' A' ' 129' ' ' ARG . 47.1 mm -105.34 132.55 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.554 HD22 ' HA ' ' A' ' 165' ' ' ASN . 29.9 mt -122.03 156.97 32.38 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.731 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 39.0 t -114.47 127.87 71.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 171.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.586 HG21 HD11 ' A' ' 125' ' ' LEU . 23.4 mm -75.03 114.04 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.481 1.134 . . . . 0.0 110.491 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.878 HG22 HG13 ' A' ' 170' ' ' VAL . 2.5 tp -92.89 -24.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.37 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.006 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 6.8 tp10 -155.51 147.58 23.52 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 121.553 -0.717 . . . . 0.0 111.774 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -129.83 84.13 61.9 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.094 168.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.744 ' HB3' HG23 ' A' ' 95' ' ' THR . 57.2 Cg_endo -91.61 -58.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.092 1.861 . . . . 0.0 111.334 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.448 ' OE1' ' HG2' ' A' ' 156' ' ' PRO . 1.3 mp0 -82.63 175.02 10.49 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.476 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -112.86 -5.64 13.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 159' ' ' GLN . 6.3 tp60 -104.44 -24.23 13.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.675 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.757 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 34.9 m95 -129.0 138.23 51.82 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.811 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.651 ' O ' HG13 ' A' ' 173' ' ' ILE . 36.1 m0 -123.74 137.63 54.66 Favored 'General case' 0 C--O 1.213 -0.818 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.859 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 12.9 m -88.34 123.66 33.13 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.531 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -130.76 155.11 47.22 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.361 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 26.9 ptt-85 -97.75 136.89 37.45 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 171.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.709 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 65.5 t30 -71.33 168.22 17.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.24 -173.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.431 ' HE3' ' H ' ' A' ' 149' ' ' ILE . 10.2 ttpp -66.01 -17.55 64.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.544 ' HB3' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -74.4 -33.81 63.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.61 172.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 137.82 -36.37 1.94 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.215 -0.993 . . . . 0.0 115.4 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.537 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -90.8 160.82 15.56 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.492 1.146 . . . . 0.0 113.463 -163.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.878 HG13 HG22 ' A' ' 153' ' ' ILE . 78.1 t -89.65 136.27 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.363 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.91 156.42 28.15 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.565 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.757 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -72.85 136.15 45.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -135.44 147.92 63.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.771 0.319 . . . . 0.0 110.859 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 1.063 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 16.2 Cg_exo -70.71 139.13 36.29 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.943 2.429 . . . . 0.0 113.128 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.544 ' O ' HG22 ' A' ' 178' ' ' VAL . 21.9 t -78.31 -44.95 2.15 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.4 Cg_endo -66.92 0.51 3.64 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.888 1.725 . . . . 0.0 111.684 173.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 1.063 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 0.9 OUTLIER -100.92 -4.99 26.62 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.139 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.934 HG11 HG21 ' A' ' 130' ' ' THR . 26.8 m -123.5 170.89 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 122.543 1.163 . . . . 0.0 113.645 -171.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.963 ' HG3' ' HG2' ' A' ' 129' ' ' ARG . 8.2 pt-20 -133.6 48.57 2.36 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.677 -2.056 . . . . 0.0 110.232 -170.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 1.035 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 -166.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.887 HG12 HG12 ' A' ' 266' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 120.996 0.427 . . . . 0.0 111.107 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -114.23 126.26 54.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.527 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.513 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -133.56 129.23 36.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.077 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -94.81 129.4 41.78 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.619 -0.432 . . . . 0.0 109.979 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.645 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -74.71 115.56 14.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.288 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.753 HD11 ' HG2' ' A' ' 292' ' ' LYS . 0.2 OUTLIER -102.14 -16.06 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.268 0.556 . . . . 0.0 110.387 179.01 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.29 120.45 23.2 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -58.65 155.58 12.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.175 0.988 . . . . 0.0 112.812 -168.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 25.6 tpt180 -131.0 97.71 4.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.637 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.315 -0.915 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.256 -174.57 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 121.602 0.715 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -86.85 142.23 28.21 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.452 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.45 ' HB2' ' HA3' ' A' ' 284' ' ' GLY . 1.3 tt -98.72 115.84 29.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.99 115.38 7.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.2 0.524 . . . . 0.0 110.929 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.546 HD21 HG22 ' A' ' 279' ' ' VAL . 72.8 mt -129.7 153.6 48.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.912 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -133.93 172.13 13.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 170.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 2.1 p -67.94 114.11 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.575 0.703 . . . . 0.0 111.071 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 121.44 -0.16 11.29 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.628 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -96.55 142.06 29.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.904 0.383 . . . . 0.0 110.939 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.7 mm -94.76 114.36 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.741 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.471 ' HA ' HG21 ' A' ' 279' ' ' VAL . 20.1 t -94.96 115.81 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.064 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -98.3 98.84 10.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.887 HG12 HG12 ' A' ' 238' ' ' VAL . 7.2 p -88.74 132.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.107 0.48 . . . . 0.0 110.878 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 2.5 p -108.57 -30.99 7.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.561 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -127.68 112.29 14.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.131 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.758 ' HE1' HG11 ' A' ' 238' ' ' VAL . 31.8 mtt -92.86 106.16 18.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.36 0.6 . . . . 0.0 111.216 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 92.9 m-20 -80.08 117.93 21.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.637 176.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.39 -17.26 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.715 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.401 ' OD1' ' HB3' ' A' ' 270' ' ' ASN . 3.4 p-10 -75.27 -7.58 54.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 134.41 -66.46 0.57 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.806 -1.188 . . . . 0.0 113.628 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.715 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp0 -81.72 120.58 25.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.841 0.32 . . . . 0.0 110.571 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -93.76 164.54 13.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.659 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -102.93 102.97 13.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.358 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -126.38 168.21 18.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 282' ' ' ARG . 0.9 OUTLIER -122.64 144.05 49.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.451 . . . . 0.0 109.844 178.045 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.546 HG22 HD21 ' A' ' 258' ' ' LEU . 95.6 t -135.42 100.76 2.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.204 174.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 68.66 28.82 5.58 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.6 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 101.11 14.02 32.1 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.988 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 20.2 mtp-105 -125.71 120.02 29.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.89 0.345 . . . . 0.0 110.823 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 283' ' ' LYS . 30.4 mtpt -96.07 141.83 28.99 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.45 ' HA3' ' HB2' ' A' ' 256' ' ' LEU . . . -165.6 164.17 37.13 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.262 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 85.5 mt -86.85 110.57 20.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.464 0.649 . . . . 0.0 110.87 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 24.2 p90 -115.94 128.53 25.91 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.174 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 10.7 Cg_exo -72.98 143.78 37.04 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.646 2.231 . . . . 0.0 111.076 173.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -66.01 -7.63 18.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.16 -11.96 60.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.041 0.448 . . . . 0.0 111.462 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -103.63 -11.94 17.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 111.029 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.9 163.76 30.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.031 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.753 ' HG2' HD11 ' A' ' 243' ' ' ILE . 32.5 mmmt -124.9 122.3 36.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.569 176.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.513 HD12 ' HB2' ' A' ' 240' ' ' ALA . 45.1 mm -71.06 102.84 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.89 170.9 8.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.248 0.547 . . . . 0.0 111.698 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.755 175.357 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 121.13 0.49 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -109.15 20.03 18.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.696 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.482 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 50.7 p90 -91.34 156.27 17.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.08 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.36 135.27 36.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 m -110.84 10.9 22.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -121.52 -37.82 2.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.511 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -72.25 116.34 12.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.219 0.533 . . . . 0.0 110.715 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -56.87 -30.17 63.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.995 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.5 t -80.88 -2.71 48.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -175.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.76 -46.9 6.4 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.815 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 31.7 p-90 -120.4 -21.38 6.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -172.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -78.94 118.27 20.79 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.944 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.688 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 7.8 tpp -97.38 -4.48 38.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.201 0.524 . . . . 0.0 110.455 -172.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.66 -115.81 3.72 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.951 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.43 103.49 1.75 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.455 2.103 . . . . 0.0 112.338 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.818 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 80.8 t -132.66 -83.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.255 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.712 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 66.9 m 87.73 152.38 0.06 Allowed 'General case' 0 C--N 1.348 0.543 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -59.06 -35.67 73.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -164.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -25.94 66.97 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.019 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.425 ' O ' HG21 ' A' ' 26' ' ' THR . 23.7 tp10 -87.29 -45.24 10.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.7 -44.24 77.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.838 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -76.92 -32.74 57.59 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 23' ' ' GLU . 6.9 t -72.54 -22.07 61.07 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.591 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -88.42 -24.64 22.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.399 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.791 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 95.2 mt -107.86 20.35 18.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.532 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -66.58 90.99 0.17 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.527 0.68 . . . . 0.0 109.217 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.41 -70.1 2.68 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.579 ' HG3' ' H ' ' A' ' 32' ' ' ARG . 4.6 tp-100 48.74 -167.39 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.795 0.838 . . . . 0.0 110.894 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.579 ' H ' ' HG3' ' A' ' 31' ' ' GLN . 74.1 mtm-85 -80.04 112.09 17.01 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 170.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.464 ' NE2' ' HA ' ' A' ' 55' ' ' ASN . 32.8 m170 -57.88 117.75 4.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.115 0.483 . . . . 0.0 110.053 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.05 14.36 7.22 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -168.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.502 ' HE3' ' HA ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -95.82 145.95 24.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.53 ' HB2' HG23 ' A' ' 52' ' ' VAL . 31.1 p90 -150.34 166.97 28.42 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.45 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.1 pp -156.45 135.57 12.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.511 173.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG21 HD11 ' A' ' 50' ' ' LEU . 51.4 t -101.74 111.28 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.818 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 13.4 ptt-85 -110.7 173.95 6.09 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.868 0.366 . . . . 0.0 110.791 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -82.22 137.37 34.92 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.6 p -59.44 -28.58 67.09 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.582 -174.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.2 t 61.29 19.98 10.63 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.942 0.877 . . . . 0.0 108.787 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.5 m -116.41 -49.86 2.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.045 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 44.7 t -145.83 124.45 6.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.614 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.62 87.11 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.411 2.074 . . . . 0.0 111.344 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.43 -11.27 0.13 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.774 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -126.34 145.88 50.26 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.36 -0.494 . . . . 0.0 109.763 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.43 164.42 13.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.363 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.29 99.42 4.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.213 0.53 . . . . 0.0 110.619 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.498 HD11 HG21 ' A' ' 38' ' ' VAL . 41.9 tp -78.67 99.53 6.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.894 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.4 m -96.3 121.51 38.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.135 0.493 . . . . 0.0 109.992 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.833 HG21 HD12 ' A' ' 93' ' ' LEU . 84.2 t -116.5 134.3 60.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.955 -177.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.791 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 95.5 p -105.78 134.54 48.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.563 0.697 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.499 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 7.2 mt-10 -144.56 175.81 9.87 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.464 ' HA ' ' NE2' ' A' ' 33' ' ' HIS . 0.3 OUTLIER -38.45 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -173.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m 50.57 59.79 4.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.444 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 55' ' ' ASN . 21.0 mmm180 -160.33 49.46 0.27 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.177 -157.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 36.4 t -80.96 90.9 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.967 0.889 . . . . 0.0 109.351 -175.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 51.1 m -80.4 120.81 24.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.172 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -97.81 99.02 10.33 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.366 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.585 ' CE2' HD23 ' A' ' 93' ' ' LEU . 64.0 m-85 -103.17 116.03 31.71 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.6 mt -81.69 139.27 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.522 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.8 mp -127.05 118.04 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 122.877 0.471 . . . . 0.0 110.422 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -84.35 139.41 32.29 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.464 -0.148 . . . . 0.0 110.822 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.9 t -84.52 107.77 16.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -83.84 149.66 57.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.007 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.71 -23.9 73.49 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.129 2.553 . . . . 0.0 112.911 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -79.66 6.13 11.49 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.013 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 66.11 36.07 5.87 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.676 0.751 . . . . 0.0 110.234 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 92.7 mtt180 -113.97 172.99 6.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.604 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.522 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 60.0 m-85 -135.92 115.72 13.04 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.12 0.486 . . . . 0.0 111.291 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -98.39 108.4 21.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.745 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.539 HD12 HD11 ' A' ' 84' ' ' LEU . 9.5 tt -97.8 78.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.842 0.829 . . . . 0.0 110.043 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.74 95.62 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.283 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 t0 71.81 -56.96 0.63 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.033 0.533 . . . . 0.0 111.736 173.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -78.61 140.53 38.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.738 0.304 . . . . 0.0 110.665 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -112.7 128.64 56.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.627 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 74.6 m-85 -116.77 164.6 14.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.273 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 70' ' ' ARG . 3.6 m-20 -72.97 -29.66 63.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -176.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.602 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -164.06 167.06 20.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.974 -178.291 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.557 HD23 HD21 ' A' ' 84' ' ' LEU . 10.6 mt -53.58 -51.79 72.96 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 32.2 Cg_exo -59.96 -11.92 17.01 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.956 1.77 . . . . 0.0 112.955 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.512 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . . . -91.73 -32.21 15.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.111 -175.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.557 HD21 HD23 ' A' ' 81' ' ' LEU . 3.9 pp -77.46 -31.95 54.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.67 -38.3 90.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.354 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 13.9 pt-20 -78.25 -18.17 55.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.196 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -79.07 -39.01 34.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.191 0.519 . . . . 0.0 109.961 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.479 ' CG ' HD21 ' A' ' 93' ' ' LEU . 32.4 m-85 -77.85 -15.95 58.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.599 -177.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 22.0 pttm -67.48 -20.27 65.44 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.316 -0.254 . . . . 0.0 110.316 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.418 HG22 ' HG3' ' A' ' 89' ' ' LYS . 18.9 pt -121.91 22.48 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.991 -0.443 . . . . 0.0 111.529 174.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 22.3 t-160 -113.56 -32.47 6.18 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.078 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.583 ' HA ' HG23 ' A' ' 97' ' ' THR . 76.1 m-85 73.32 107.75 0.07 Allowed 'General case' 0 C--O 1.22 -0.452 0 O-C-N 124.072 0.858 . . . . 0.0 109.966 -172.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.833 HD12 HG21 ' A' ' 52' ' ' VAL . 12.2 mt -79.87 -12.2 59.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.76 0.79 . . . . 0.0 109.173 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.499 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 24.9 t70 -149.04 -71.83 0.19 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.238 160.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.553 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.7 t -149.22 2.33 0.56 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.424 HG22 ' CD ' ' A' ' 54' ' ' GLU . 1.9 t -132.08 -12.54 3.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.409 -0.807 . . . . 0.0 112.795 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.583 HG23 ' HA ' ' A' ' 92' ' ' TYR . 8.4 p 74.08 -166.06 0.1 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.301 1.041 . . . . 0.0 111.696 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.5 mt -81.72 108.56 15.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.311 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.7 mm -98.45 -48.57 12.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.556 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 9.8 pt-20 -167.56 158.14 9.67 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.916 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.447 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 1.5 Cg_endo -83.28 162.82 15.15 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.801 2.334 . . . . 0.0 112.726 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.502 ' HA ' ' HE3' ' A' ' 35' ' ' MET . . . -84.18 154.08 63.26 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.096 177.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.71 139.31 62.6 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.629 2.22 . . . . 0.0 112.119 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.688 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 68.1 mtm180 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.049 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.586 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 47.9 tp10 -161.14 -78.72 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.092 -175.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.89 116.49 32.04 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.9 0.857 . . . . 0.0 112.039 -171.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 86.6 t -134.36 125.89 48.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.573 -173.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.635 ' CG ' ' HB3' ' A' ' 179' ' ' GLU . 7.2 ptp85 -111.49 135.01 52.65 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 118.127 -1.429 . . . . 0.0 110.817 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.402 ' C ' HD12 ' A' ' 131' ' ' LEU . 7.4 p -97.48 140.66 31.59 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.094 0.473 . . . . 0.0 112.081 -174.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 1.045 HD21 ' HB2' ' A' ' 179' ' ' GLU . 0.1 OUTLIER -117.44 -38.33 3.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.448 -171.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 29.9 t80 -64.32 -32.56 74.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.886 -170.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 12.5 t70 72.44 105.84 0.07 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.737 0.648 . . . . 0.0 110.04 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 71.3 t80 -144.08 108.72 5.0 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.095 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 66.1 Cg_endo -87.92 99.6 0.44 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.325 2.017 . . . . 0.0 112.661 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.65 -3.71 90.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.99 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.1 m120 57.92 24.66 11.2 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.133 0.573 . . . . 0.0 111.777 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.668 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 2.0 p30 50.45 -176.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.038 1.335 . . . . 0.0 114.457 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 71.89 9.17 6.14 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.432 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -175.38 -46.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.069 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -137.07 124.26 21.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.828 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.616 HD13 ' HD2' ' A' ' 143' ' ' PRO . 46.7 tp -69.86 132.28 88.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-O 120.693 0.282 . . . . 0.0 110.662 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 6.4 Cg_endo -85.25 89.23 0.83 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.374 2.049 . . . . 0.0 110.636 176.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 14.2 p90 -99.5 158.02 16.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.472 -177.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.562 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 82.9 mttt -112.15 -172.44 2.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.469 -172.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.22 18.46 1.4 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.742 -175.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.94 36.06 0.08 OUTLIER Glycine 0 C--N 1.33 0.218 0 C-N-CA 119.813 -1.185 . . . . 0.0 113.916 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.562 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 21.9 mm-40 -98.84 157.41 16.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 129' ' ' ARG . 9.4 tp -103.52 138.83 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 172.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.545 HD22 ' HA ' ' A' ' 165' ' ' ASN . 26.5 mt -120.61 155.7 33.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 19.2 t -119.74 130.89 73.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.632 HG21 HD13 ' A' ' 125' ' ' LEU . 39.6 mm -74.3 96.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.552 HG21 ' HG2' ' A' ' 154' ' ' GLU . 16.3 tt -79.02 -31.2 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.77 -175.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.552 ' HG2' HG21 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -146.9 141.0 26.09 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.934 171.172 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.599 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 1.6 ttpm? -119.06 87.13 33.54 Favored Pre-proline 0 C--N 1.328 -0.367 0 O-C-N 121.331 -0.856 . . . . 0.0 110.877 173.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.553 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 11.4 Cg_exo -72.92 -58.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.584 2.19 . . . . 0.0 112.35 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -107.83 177.44 4.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.23 -20.18 14.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.757 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -85.47 -34.76 21.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.15 0.5 . . . . 0.0 110.122 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.431 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 31.7 m95 -128.3 129.73 46.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.206 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -108.97 156.17 20.02 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.484 ' HG ' ' HG3' ' A' ' 154' ' ' GLU . 22.7 t -111.58 101.96 10.33 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.351 0.596 . . . . 0.0 110.056 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.471 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -113.71 163.19 15.34 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.169 -176.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 168' ' ' GLY . 29.8 ptt-85 -108.23 140.55 41.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.328 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 150' ' ' LEU . 57.1 t30 -70.56 178.61 2.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.587 -175.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -58.67 -32.02 68.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -60.6 -42.14 96.15 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.105 170.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 164' ' ' ARG . . . 115.86 -9.33 18.81 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.689 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.668 ' HD3' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -76.73 152.69 35.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.541 0.671 . . . . 0.0 110.811 -176.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.446 ' CG2' HD11 ' A' ' 153' ' ' ILE . 26.2 t -99.73 143.59 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.287 0.565 . . . . 0.0 112.413 -168.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -171.98 162.98 35.29 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.757 169.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.431 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 22.9 mtp -81.7 147.31 29.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.3 0.55 . . . . 0.0 110.822 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.8 pp -141.32 145.83 39.9 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.386 -174.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 7.8 Cg_exo -73.29 133.17 18.88 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.185 2.59 . . . . 0.0 112.699 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 178' ' ' VAL . 58.0 t -61.7 -47.3 92.69 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 23.3 Cg_endo -61.4 -13.44 29.0 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.169 1.913 . . . . 0.0 113.294 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -86.35 -4.21 59.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.888 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 175' ' ' VAL . 4.1 m -110.61 159.04 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -166.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 1.045 ' HB2' HD21 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -117.75 45.19 2.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 111.493 -2.594 . . . . 0.0 109.242 -178.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.806 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.586 0 O-C-N 120.963 -1.085 . . . . 0.0 109.398 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.615 HG11 HD13 ' A' ' 293' ' ' ILE . 45.8 t . . . . . 0 C--O 1.234 0.26 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -115.14 135.12 54.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.851 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.538 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -122.29 142.56 50.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.2 174.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.733 ' HA ' ' O ' ' A' ' 262' ' ' ASP . 56.3 mttm -84.52 119.6 25.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.088 0.47 . . . . 0.0 110.233 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 1.102 ' HB1' ' HA ' ' A' ' 259' ' ' GLU . . . -89.39 114.91 26.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.217 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.422 HD11 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -130.7 -10.26 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -165.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.659 ' HB3' ' OE2' ' A' ' 259' ' ' GLU . 7.7 tt0 -113.57 -89.05 0.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.059 -0.657 . . . . 0.0 112.752 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.44 ' N ' ' HB3' ' A' ' 259' ' ' GLU . 85.8 tttt -173.81 118.74 0.27 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -173.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.925 ' HG2' ' HG3' ' A' ' 259' ' ' GLU . 19.8 mmm180 -131.34 98.74 4.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.61 167.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.106 179.168 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 121.384 0.612 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -94.37 118.43 31.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.507 . . . . 0.0 111.183 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 tt -91.17 126.28 36.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.367 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -81.82 110.66 17.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.188 0.518 . . . . 0.0 110.931 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.549 HD23 HG23 ' A' ' 264' ' ' VAL . 1.3 pp -164.86 -141.82 0.05 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.115 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 1.102 ' HA ' ' HB1' ' A' ' 242' ' ' ALA . 0.0 OUTLIER 80.82 1.18 1.78 Allowed 'General case' 0 C--O 1.222 -0.367 0 O-C-N 123.899 0.75 . . . . 0.0 111.566 177.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.32 90.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -178.8 -83.35 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.823 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.733 ' O ' ' HA ' ' A' ' 241' ' ' LYS . 29.2 t0 179.04 -79.06 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 121.056 0.455 . . . . 0.0 111.68 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 263' ' ' ILE . 36.9 mm -100.65 119.81 49.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -170.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.549 HG23 HD23 ' A' ' 258' ' ' LEU . 99.2 t -107.11 121.79 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.472 168.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.661 ' HZ3' ' HB2' ' A' ' 265' ' ' LYS . 9.7 mtmp? -94.09 116.25 28.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.163 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 275' ' ' TRP . 2.7 p -111.68 117.27 54.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.306 0.574 . . . . 0.0 110.692 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.2 p -107.57 -15.44 14.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.753 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.459 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 38.2 mmt-85 -124.01 100.38 6.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.043 0.449 . . . . 0.0 111.211 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.415 ' HE3' HG12 ' A' ' 238' ' ' VAL . 46.8 mtt -101.85 140.31 36.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.332 176.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.619 ' OD1' ' HB3' ' A' ' 272' ' ' ASN . 9.0 p30 -135.49 176.66 8.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.461 -176.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 13.7 pt -87.1 4.58 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -172.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.619 ' HB3' ' OD1' ' A' ' 270' ' ' ASN . 7.4 t-20 -74.77 -44.59 48.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.26 0.552 . . . . 0.0 109.578 175.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.73 -39.21 2.55 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.408 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 44.3 mt-30 -79.35 116.54 19.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 13.6 m0 -93.04 155.85 17.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.977 -173.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 40.2 mt-10 -101.26 107.62 19.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.994 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.99 148.74 17.89 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 282' ' ' ARG . 0.0 OUTLIER -110.09 109.63 20.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.372 0.606 . . . . 0.0 110.33 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.473 HG23 HG13 ' A' ' 264' ' ' VAL . 21.6 t -127.6 -79.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.755 -176.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -82.26 67.04 8.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.268 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.07 16.92 60.49 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.85 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 40.5 ttm180 -155.32 146.63 22.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.139 0.469 . . . . 0.0 111.095 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 278' ' ' GLU . 39.4 tttm -102.48 113.98 27.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.118 170.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -146.67 178.21 24.48 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.074 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 96.5 mt -84.86 140.43 31.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 0.0 111.681 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -142.86 129.5 10.69 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.22 170.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.28 137.08 25.31 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.58 2.187 . . . . 0.0 112.536 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -71.51 -10.74 60.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.844 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.7 m -84.65 -2.57 57.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.451 0.643 . . . . 0.0 110.411 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.459 ' HB3' ' OE2' ' A' ' 259' ' ' GLU . 3.1 m-70 -101.12 -54.65 2.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.395 174.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 35.0 m -85.03 159.61 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.798 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.496 ' HB2' ' HZ1' ' A' ' 292' ' ' LYS . 0.2 OUTLIER -110.42 107.16 16.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.229 0.538 . . . . 0.0 110.3 178.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.615 HD13 HG11 ' A' ' 238' ' ' VAL . 5.0 tp -70.1 131.66 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.461 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 18.3 p90 -134.63 160.64 37.48 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.624 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.1 t0 . . . . . 0 C--N 1.316 -0.888 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.178 177.277 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.652 ' NE ' ' HA ' ' A' ' 5' ' ' ARG . 5.0 mmp_? -113.71 15.14 18.84 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -86.59 171.13 11.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 8' ' ' SER . 24.4 t70 -82.52 -133.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.505 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 9.6 t -173.71 43.19 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.9 t -164.51 -11.02 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.968 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' A' ' 7' ' ' ASP . 7.9 p-10 -75.44 81.0 2.49 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.809 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -70.5 -16.85 62.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.479 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 t -75.77 -7.96 55.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.659 174.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.3 -47.08 3.59 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.8 p-90 -107.63 -20.46 13.22 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -172.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -81.92 122.71 28.11 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 122.027 -0.421 . . . . 0.0 110.672 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.658 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 24.7 mmt -103.36 -13.55 16.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.479 -176.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.05 -113.42 2.18 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.658 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.6 84.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.199 2.599 . . . . 0.0 113.327 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.569 HG13 ' H ' ' A' ' 20' ' ' SER . 84.1 t -137.03 172.8 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.569 ' H ' HG13 ' A' ' 19' ' ' VAL . 43.8 p -145.41 172.28 13.42 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -168.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -63.02 -37.15 86.04 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.873 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -56.74 11.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.688 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -61.55 -50.25 73.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.25 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . -56.73 -37.23 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.353 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -64.33 -43.94 93.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.128 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.2 t -78.92 -21.27 47.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.871 0.367 . . . . 0.0 111.409 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 51.1 mtp180 -82.43 -10.43 59.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.892 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 53' ' ' SER . 26.9 mt -126.97 12.06 7.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.097 0.475 . . . . 0.0 111.018 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.49 98.25 2.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.377 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.69 -1.92 70.52 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.344 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.415 HE21 ' HB3' ' A' ' 31' ' ' GLN . 4.7 mm100 -60.37 168.15 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.853 0.461 . . . . 0.0 111.689 -175.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.514 ' HB3' ' HE1' ' A' ' 35' ' ' MET . 20.8 ttp180 -47.63 118.98 2.49 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.551 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.595 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 36.3 m170 -63.6 117.16 6.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.337 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.8 -13.55 6.1 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.997 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.683 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 64.3 mtt -69.19 153.58 43.46 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.511 0.196 . . . . 0.0 110.518 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -155.62 159.23 39.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.658 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.6 pp -153.52 140.41 19.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.001 0.429 . . . . 0.0 110.851 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.3 t -110.39 116.47 52.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.861 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.447 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 25.4 ptt-85 -117.77 176.05 5.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.97 -177.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.41 134.46 40.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.133 0.492 . . . . 0.0 110.645 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 t -87.36 107.97 18.77 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.5 t -73.96 8.09 2.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.563 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.5 p -94.6 -25.56 16.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.803 0.335 . . . . 0.0 110.659 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 76.7 m -152.36 115.23 2.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.879 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.45 103.05 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.799 2.333 . . . . 0.0 112.436 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.54 -24.73 4.1 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.659 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -88.37 165.87 14.66 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.412 ' CD2' HD11 ' A' ' 81' ' ' LEU . 58.0 m-85 -134.52 -177.87 4.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.758 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 62' ' ' ILE . 6.2 t -143.96 113.85 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.62 177.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.8 tp -80.83 97.09 7.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 172.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.1 m -94.05 118.12 31.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.329 0.585 . . . . 0.0 109.666 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 58.7 t -110.68 142.66 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.639 -174.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 40.7 t -91.68 103.89 16.41 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.595 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 7.0 tp10 -167.11 166.43 15.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.898 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.537 HD21 ' CG ' ' A' ' 94' ' ' ASP . 0.7 OUTLIER 76.82 -64.5 0.33 Allowed 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 123.58 1.657 . . . . 0.0 108.546 -168.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.5 m -160.86 -27.64 0.06 Allowed 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 111.314 -2.675 . . . . 0.0 106.133 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.794 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.363 0.0 OUTLIER -163.08 -48.34 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.084 1 N-CA-C 123.333 4.568 . . . . 0.0 123.333 179.624 . . . . . . . . 5 4 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.794 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -147.98 107.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 121.785 2.084 . . . . 0.0 114.096 -166.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.53 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -98.03 112.6 24.49 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 171.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -101.53 86.48 2.97 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -169.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.752 ' CE1' HD13 ' A' ' 153' ' ' ILE . 55.5 m-85 -102.01 110.27 22.2 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 118.626 0.648 . . . . 0.0 112.248 -174.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -75.38 139.49 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.295 0.569 . . . . 0.0 112.39 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.568 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.3 mp -110.33 108.8 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.587 175.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -82.82 141.93 31.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.177 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.7 t -85.75 118.46 25.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.104 0.478 . . . . 0.0 110.352 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.498 HD22 ' HE2' ' A' ' 72' ' ' LYS . 95.3 mt -95.15 142.54 24.74 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.058 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.54 -8.66 21.61 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.864 2.376 . . . . 0.0 112.386 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.48 10.12 5.1 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.64 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 67.32 25.9 8.64 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.087 -179.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 71.0 mtt180 -115.2 -176.1 2.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.199 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.512 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 61.5 m-85 -138.85 124.69 19.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.718 0.294 . . . . 0.0 110.934 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.815 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 25.7 ttpt -113.62 109.65 18.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 111.466 -177.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.568 ' HB ' HG13 ' A' ' 63' ' ' ILE . 14.0 tt -95.91 81.29 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.723 0.773 . . . . 0.0 110.052 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.76 82.59 0.27 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.79 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.2 t0 71.46 -47.09 0.65 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.963 0.905 . . . . 0.0 111.48 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -74.75 101.34 4.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.889 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.815 ' HB3' ' HD3' ' A' ' 72' ' ' LYS . 8.2 pt-20 -95.55 118.26 31.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.662 0.744 . . . . 0.0 110.934 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.571 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 76.3 m-85 -100.22 174.71 6.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.83 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 31.9 t70 -73.06 -25.14 60.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.317 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.648 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 1.7 p80 -172.01 172.17 4.79 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.662 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.593 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.5 mt -51.4 -54.41 39.05 Favored Pre-proline 0 N--CA 1.472 0.633 0 O-C-N 123.301 0.376 . . . . 0.0 111.95 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 59.6 Cg_endo -70.4 16.99 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.284 1.99 . . . . 0.0 113.292 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 81' ' ' LEU . . . -107.5 -35.4 6.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 174.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.8 pp -76.88 -31.74 56.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.175 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.68 -30.35 71.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.619 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.55 ' HG3' ' HD2' ' A' ' 89' ' ' LYS . 3.6 tt0 -91.36 -12.61 34.41 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.104 0.478 . . . . 0.0 111.107 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.403 ' CE2' ' ND1' ' A' ' 91' ' ' HIS . 72.4 t80 -86.01 -30.62 22.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.98 0.895 . . . . 0.0 108.957 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.516 ' CG ' HD21 ' A' ' 93' ' ' LEU . 40.7 m-85 -82.71 2.38 33.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.252 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.55 ' HD2' ' HG3' ' A' ' 86' ' ' GLU . 98.3 mttt -76.39 -3.96 39.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.875 173.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.34 -2.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.032 0.444 . . . . 0.0 110.726 177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.403 ' ND1' ' CE2' ' A' ' 87' ' ' PHE . 5.0 t60 -81.36 -31.83 33.2 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.383 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 96' ' ' THR . 75.7 m-85 62.77 67.0 0.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.125 -173.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.672 HD13 ' O ' ' A' ' 93' ' ' LEU . 2.0 pp -71.62 117.58 13.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.79 174.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.871 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 7.6 t70 97.81 -48.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.973 1.709 . . . . 0.0 108.278 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.732 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 6.0 t 167.23 22.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.615 -1.629 . . . . 0.0 106.652 168.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.536 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 2.2 t -149.2 150.64 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.445 -173.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.7 p -91.44 157.55 17.0 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.51 99.66 0.22 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.883 0.373 . . . . 0.0 110.18 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.4 mm -80.83 -57.81 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.765 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.683 ' O ' ' HA ' ' A' ' 35' ' ' MET . 29.8 tt0 -165.16 136.93 3.32 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 -174.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.31 155.68 44.99 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.652 2.235 . . . . 0.0 112.956 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.75 157.84 85.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.697 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.31 122.5 11.91 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.34 2.027 . . . . 0.0 111.823 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 . . . . . 0 CA--C 1.519 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.591 -179.333 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.528 HD13 HG22 ' A' ' 152' ' ' ILE . 3.8 mm? . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.512 0.672 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.697 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 11.1 tp10 -165.1 -61.4 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.13 -173.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -113.49 112.34 23.43 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.271 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 1.028 HG23 ' HG3' ' A' ' 180' ' ' LYS . 2.4 t -117.19 153.39 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.654 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.4 ptp180 -129.15 148.35 51.08 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 117.947 -1.501 . . . . 0.0 108.059 157.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.502 HG22 HD12 ' A' ' 150' ' ' LEU . 43.6 p -100.58 133.54 44.87 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.695 0.759 . . . . 0.0 110.874 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.495 HD21 ' HG2' ' A' ' 179' ' ' GLU . 8.0 mt -107.56 2.25 23.91 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.555 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 16.3 t80 -102.41 -45.02 5.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.039 -173.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.623 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.9 t70 78.74 103.74 0.07 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.166 0.508 . . . . 0.0 110.679 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 68.9 t80 -132.93 91.08 29.99 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.585 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 98.3 Cg_endo -87.45 70.33 3.43 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.219 1.946 . . . . 0.0 112.763 -175.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.62 -33.88 82.22 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.737 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.479 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 26.5 m-80 61.97 66.49 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.133 -0.533 . . . . 0.0 111.825 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.66 172.63 12.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.271 176.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.46 -9.55 49.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.051 0.929 . . . . 0.0 108.795 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.649 ' O ' ' HB2' ' A' ' 172' ' ' MET . 28.5 mt-10 -106.63 -15.58 14.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.807 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -137.89 106.82 5.97 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.331 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.788 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 20.1 tp -75.53 126.91 86.93 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.767 0.317 . . . . 0.0 110.989 -175.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.585 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 73.9 Cg_endo -78.12 97.18 1.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.845 1.697 . . . . 0.0 111.687 173.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.66 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 15.3 p90 -105.95 156.71 18.1 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.623 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 62.5 mttp -113.07 173.34 6.44 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -173.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.53 ' N ' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -71.72 57.88 0.3 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.209 178.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 134.41 38.25 0.21 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.784 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.697 ' CD ' ' HG ' ' A' ' 150' ' ' LEU . 1.7 pp20? -91.04 169.06 11.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.17 127.66 73.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.779 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 78.1 mt -117.21 156.33 27.89 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -173.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 89.4 t -120.45 122.13 67.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 171.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.528 HG22 HD13 ' A' ' 125' ' ' LEU . 46.4 mm -78.0 78.82 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 122.793 1.282 . . . . 0.0 108.325 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.752 HD13 ' CE1' ' A' ' 61' ' ' TYR . 5.4 tt -70.89 -28.91 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 112.577 -2.101 . . . . 0.0 109.478 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.871 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -134.89 143.14 46.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.165 176.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.51 ' CD ' ' HG ' ' A' ' 125' ' ' LEU . 67.0 tttt -141.61 83.76 12.87 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.732 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 21.8 Cg_exo -68.14 -49.69 0.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.432 2.088 . . . . 0.0 112.199 174.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -119.35 175.73 5.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.658 -171.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -101.96 -4.93 25.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.276 0.56 . . . . 0.0 110.164 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -93.64 -36.55 12.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.516 0.674 . . . . 0.0 109.853 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.448 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 41.0 m95 -129.8 145.04 51.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.925 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.745 ' O ' HG13 ' A' ' 173' ' ' ILE . 48.5 m0 -124.31 138.88 54.34 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 122.761 0.424 . . . . 0.0 110.184 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.653 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 2.9 m -98.55 98.36 9.54 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -174.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.557 ' HB1' ' HB3' ' A' ' 150' ' ' LEU . . . -114.77 155.83 25.99 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -170.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.909 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 31.7 ptt-85 -94.86 128.11 41.38 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.858 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.788 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 65.8 t30 -59.21 178.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.106 -1.406 . . . . 0.0 112.21 -169.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -51.01 -28.34 9.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.182 164.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -70.57 -44.33 67.63 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.492 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.572 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 113.87 9.58 15.99 Favored Glycine 0 C--O 1.223 -0.533 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.966 -169.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.909 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 16.4 ttm-85 -76.09 136.54 39.87 Favored 'General case' 0 C--O 1.212 -0.892 0 C-N-CA 123.409 0.683 . . . . 0.0 112.319 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 153' ' ' ILE . 56.2 t -84.07 120.2 34.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.15 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -156.12 155.89 26.65 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.476 -0.649 . . . . 0.0 111.476 172.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.649 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -76.02 138.8 41.12 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 117.354 0.577 . . . . 0.0 111.277 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.745 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -139.16 141.48 29.77 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.187 -176.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 21.4 Cg_exo -65.58 131.77 28.86 Favored 'Trans proline' 0 CA--C 1.527 0.146 0 C-N-CA 122.464 2.109 . . . . 0.0 112.936 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 178' ' ' VAL . 66.6 t -61.42 -44.54 92.86 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 22.7 Cg_exo -64.61 2.17 1.38 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.188 1.925 . . . . 0.0 113.162 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.7 m-30 -100.99 -11.65 19.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.231 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 175' ' ' VAL . 3.6 m -105.63 -177.03 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -164.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.654 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.8 tp10 -151.82 51.59 0.81 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 111.947 -2.388 . . . . 0.0 112.332 -155.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 1.028 ' HG3' HG23 ' A' ' 128' ' ' VAL . 1.8 mppt? . . . . . 0 N--CA 1.463 0.221 0 O-C-N 120.056 -1.652 . . . . 0.0 109.96 -161.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.486 ' HB ' HG11 ' A' ' 266' ' ' VAL . 17.8 t . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -105.44 129.0 53.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.55 137.19 53.99 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.421 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.423 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 44.6 tptt -81.19 118.58 22.69 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -72.84 108.92 6.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 28.1 pt -102.36 12.88 6.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.016 0.436 . . . . 0.0 111.099 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -157.83 149.0 21.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.07 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.623 ' HG2' ' HG3' ' A' ' 259' ' ' GLU . 26.4 mtpp -68.27 101.56 1.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.064 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -89.73 83.52 6.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.313 178.859 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 47.9 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.306 0.574 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.06 119.71 25.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.513 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 246' ' ' ARG . 1.2 tt -78.4 134.67 37.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -82.54 110.27 17.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.075 0.464 . . . . 0.0 110.961 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 77.5 mt -122.09 172.76 8.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.383 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.623 ' HG3' ' HG2' ' A' ' 245' ' ' LYS . 31.6 tt0 -147.7 149.86 33.24 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 2.4 p -60.35 122.14 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 110.61 8.19 24.96 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.195 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -105.02 149.92 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.4 mm -103.9 109.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.358 0.599 . . . . 0.0 110.453 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 43.7 t -89.38 109.65 20.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.855 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 265' ' ' LYS . 13.2 ptmm? -88.48 99.88 12.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.417 0.627 . . . . 0.0 109.944 174.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.486 HG11 ' HB ' ' A' ' 238' ' ' VAL . 2.4 p -89.2 119.55 36.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.349 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 m -96.84 -18.9 19.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.947 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.551 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 48.3 ttt180 -132.18 122.35 25.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.762 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.417 ' HE2' ' CE3' ' A' ' 275' ' ' TRP . 29.9 mtt -118.53 141.05 48.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.286 0.565 . . . . 0.0 111.551 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -125.25 178.95 5.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.004 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.0 tp -96.61 -5.81 9.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.47 . . . . 0.0 111.329 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -94.14 14.81 18.87 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.94 -0.475 . . . . 0.0 111.99 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 98.59 -61.53 0.85 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.705 -0.759 . . . . 0.0 114.218 169.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 2.2 mp0 -77.15 110.82 12.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.899 0.349 . . . . 0.0 110.724 -176.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.528 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 11.2 m0 -93.34 168.05 11.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.741 -176.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 27.7 tt0 -108.9 108.22 18.91 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.31 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -124.16 154.99 17.9 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.127 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -108.32 108.48 19.5 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.402 ' HB ' ' H ' ' A' ' 280' ' ' ASN . 15.5 t -130.53 -91.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.102 -175.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.402 ' H ' ' HB ' ' A' ' 279' ' ' VAL . 93.1 m-20 -88.27 77.96 8.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.746 -170.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 67.67 -0.74 9.0 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.227 175.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 282' ' ' ARG . 46.4 mtp180 -147.92 153.61 39.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -174.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 55.0 pttt -120.06 134.57 55.21 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -161.26 -170.16 25.53 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.263 -175.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 71.4 mt -94.22 117.5 30.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.351 0.595 . . . . 0.0 110.966 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 43.6 p90 -115.62 138.26 23.72 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.525 176.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 5.7 Cg_exo -77.9 133.43 12.51 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.734 2.289 . . . . 0.0 111.169 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -61.05 -14.21 22.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.816 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.5 p -75.56 -14.33 60.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.799 0.333 . . . . 0.0 111.578 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -98.83 -9.03 24.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.854 0.359 . . . . 0.0 110.675 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.4 m -128.58 179.11 4.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.343 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.438 ' HB2' ' NZ ' ' A' ' 292' ' ' LYS . 2.4 ttmp? -141.11 131.24 24.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.53 174.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 28.5 mm -79.91 124.42 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.523 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.1 p90 -149.49 -174.72 4.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.886 -174.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 C--N 1.323 -0.581 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.763 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 120.819 0.343 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 5' ' ' ARG . 4.5 ptp180 -79.79 -2.03 41.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.019 0.438 . . . . 0.0 110.764 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -74.76 161.58 29.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.047 0.451 . . . . 0.0 111.017 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -98.65 117.32 32.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.78 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -83.69 1.81 40.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.39 -173.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.4 m -105.11 -31.23 9.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.774 0.321 . . . . 0.0 111.137 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.86 106.09 3.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.077 0.465 . . . . 0.0 110.727 -176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -58.76 -38.24 78.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.141 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.9 m -74.35 -0.94 18.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.693 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.47 -34.86 13.93 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.408 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -130.42 -24.66 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -173.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -79.16 123.56 27.5 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.026 -0.421 . . . . 0.0 110.692 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.481 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.1 mmt -109.06 -4.62 16.48 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.208 -175.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.82 -113.74 2.67 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.67 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.19 106.54 1.39 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.606 2.204 . . . . 0.0 112.635 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.717 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 79.7 t -137.81 -78.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.532 -177.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.79 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 8.1 t 89.79 156.99 0.05 OUTLIER 'General case' 0 C--N 1.349 0.557 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -62.58 -31.73 72.6 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.589 -169.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -55.04 -45.92 75.28 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.389 0.431 . . . . 0.0 111.153 175.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -84.03 -44.64 13.92 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.126 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.46 -34.9 51.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.286 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.538 ' HA ' HG22 ' A' ' 58' ' ' VAL . 7.9 tt0 -67.36 -47.23 71.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -76.85 -11.5 59.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -173.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -98.79 -14.98 19.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.651 0.263 . . . . 0.0 111.134 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 58.8 mt -127.29 23.78 6.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.254 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -84.7 63.48 7.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.264 0.554 . . . . 0.0 112.027 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.54 4.38 80.11 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.865 -0.683 . . . . 0.0 114.164 171.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.46 -51.23 70.74 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 117.187 0.494 . . . . 0.0 111.478 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.665 ' HB3' ' HE2' ' A' ' 35' ' ' MET . 30.8 ttm180 -142.1 148.15 37.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -92.87 112.36 24.29 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.757 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . 116.99 -7.61 16.84 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.213 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.767 ' HG3' ' HB3' ' A' ' 53' ' ' SER . 6.5 ptp -79.69 134.24 36.4 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.036 177.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.456 ' CD1' HD23 ' A' ' 98' ' ' LEU . 47.1 p90 -142.32 167.79 21.26 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.861 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.54 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.2 pp -155.76 137.21 14.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.185 0.517 . . . . 0.0 110.933 175.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.1 t -102.26 124.05 55.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.79 ' HD2' ' H ' ' A' ' 20' ' ' SER . 14.7 ptt-85 -123.52 167.17 14.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.019 -173.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.56 115.95 18.61 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 28.5 t -63.75 122.49 16.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.494 -173.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 p -74.69 -29.69 61.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.331 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 p -85.63 -18.57 32.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.061 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 41' ' ' SER . 34.4 m -137.25 85.63 21.5 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.98 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.95 107.12 0.42 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.896 2.397 . . . . 0.0 112.518 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.04 -6.84 23.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.206 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -111.04 179.28 4.09 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -126.83 158.92 35.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.921 0.391 . . . . 0.0 111.301 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.632 HG22 HG12 ' A' ' 62' ' ' ILE . 46.1 t -131.21 113.04 22.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.338 174.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.1 tp -85.15 100.45 11.74 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.884 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 59' ' ' SER . 73.5 m -96.12 132.46 41.49 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.731 174.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.652 HG21 HD12 ' A' ' 93' ' ' LEU . 95.1 t -127.76 137.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.912 -172.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.767 ' HB3' ' HG3' ' A' ' 35' ' ' MET . 29.5 t -93.57 97.57 10.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.48 0.657 . . . . 0.0 109.484 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.717 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -135.97 136.26 40.23 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.332 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 55.5 16.98 2.03 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.24 0.337 . . . . 0.0 111.361 -169.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m 69.21 25.78 5.61 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.371 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 1.9 ppt_? -124.93 144.24 50.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.538 HG22 ' HA ' ' A' ' 25' ' ' GLN . 14.6 t -85.51 96.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.27 0.557 . . . . 0.0 110.962 -173.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 51' ' ' SER . 2.4 m -67.7 113.17 5.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.993 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -101.65 88.41 3.4 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.241 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.595 ' CE2' HD23 ' A' ' 93' ' ' LEU . 40.6 m-85 -102.77 114.71 29.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.49 0.186 . . . . 0.0 111.015 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.632 HG12 HG22 ' A' ' 49' ' ' VAL . 51.7 mt -81.28 126.52 39.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.778 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.4 mp -106.55 119.0 55.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 170.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 72' ' ' LYS . 35.3 p-10 -105.26 151.69 23.81 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.249 -174.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t -86.56 91.96 8.73 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.677 -176.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 97.4 mt -63.82 128.62 93.08 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -48.03 -64.4 0.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.118 2.546 . . . . 0.0 114.629 -172.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -113.92 34.12 4.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.8 -164.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.504 ' HG3' ' HB3' ' A' ' 66' ' ' LEU . 8.7 ptt180 -154.28 -85.02 0.06 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.523 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 4.3 ptm180 -156.36 -171.44 3.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -161.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.541 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 56.9 m-85 -107.41 121.96 45.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.641 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.408 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 17.9 ttmm -109.17 114.0 27.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.735 0.302 . . . . 0.0 110.703 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.778 ' HB ' HG13 ' A' ' 63' ' ' ILE . 8.9 tt -93.43 77.61 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 110.002 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.93 96.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.165 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t70 72.89 -61.46 0.5 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.378 0.271 . . . . 0.0 111.168 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.734 ' HA ' HE21 ' A' ' 76' ' ' GLN . 0.0 OUTLIER -75.62 111.08 10.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -175.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 10.0 pt-20 -94.59 130.05 41.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.198 0.523 . . . . 0.0 110.563 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.521 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 89.4 m-85 -116.36 168.24 10.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.128 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.68 -46.16 86.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.806 0.336 . . . . 0.0 111.399 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -154.54 176.16 12.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.38 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.625 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.5 mt -57.59 -56.41 34.51 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 40.0 Cg_exo -59.68 -8.25 7.08 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.202 1.935 . . . . 0.0 113.504 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.56 -29.4 20.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.786 0.327 . . . . 0.0 110.525 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.7 pp -83.64 -30.4 26.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.2 mt -65.17 -40.98 95.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.501 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -79.68 -4.39 51.55 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.46 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -91.39 -39.32 12.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.343 0.592 . . . . 0.0 109.559 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.515 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 50.9 m-85 -74.28 -10.59 59.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.25 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -57.16 -37.94 72.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.118 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 pp -111.32 7.79 8.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 O-C-N 121.65 -0.657 . . . . 0.0 111.784 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 8.3 t-160 -94.41 -35.71 12.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -177.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.753 ' HA ' HG22 ' A' ' 97' ' ' THR . 79.2 m-85 70.86 99.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 124.066 0.854 . . . . 0.0 109.96 -170.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.694 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 25.2 mt -64.79 -21.24 66.73 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.717 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 1.5 m-20 -145.63 -74.65 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.791 165.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.5 t -144.14 -11.17 0.65 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.527 HG22 ' CD ' ' A' ' 54' ' ' GLU . 5.8 t -124.7 -12.74 7.11 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.752 -0.592 . . . . 0.0 112.034 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.753 HG22 ' HA ' ' A' ' 92' ' ' TYR . 6.6 p 74.18 -169.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.34 1.056 . . . . 0.0 111.599 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.456 HD23 ' CD1' ' A' ' 36' ' ' PHE . 81.0 mt -75.88 106.47 7.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.791 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.757 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 31.2 mm -99.78 -56.4 5.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.105 -172.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.683 ' O ' ' HA ' ' A' ' 35' ' ' MET . 28.3 tt0 -166.62 124.79 1.05 Allowed Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -174.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.03 162.31 11.65 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.551 2.834 . . . . 0.0 113.719 -171.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.29 151.02 94.38 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.054 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.3 141.81 36.23 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.301 2.001 . . . . 0.0 113.402 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.238 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.696 HD13 HG23 ' A' ' 152' ' ' ILE . 4.6 mm? . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 121.545 0.688 . . . . 0.0 111.555 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.622 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 36.6 tt0 -171.25 -56.76 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.261 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.62 ' HB3' HH12 ' A' ' 129' ' ' ARG . 36.3 m-85 -105.2 107.97 19.24 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.33 -175.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.546 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 93.8 t -132.9 147.42 31.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.171 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.62 HH12 ' HB3' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -129.49 145.11 51.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.814 0.34 . . . . 0.0 110.346 176.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.955 HG21 HG12 ' A' ' 178' ' ' VAL . 16.5 p -100.56 139.44 36.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.591 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.499 ' CD1' ' HG3' ' A' ' 179' ' ' GLU . 3.8 mp -119.25 -4.96 10.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.308 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -98.59 -39.76 8.55 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.558 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 74.21 120.81 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.865 0.84 . . . . 0.0 110.747 -175.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.475 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 62.1 t80 -153.78 116.53 2.65 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.91 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 4.0 Cg_endo -87.27 102.53 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.726 2.284 . . . . 0.0 112.347 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -82.37 -9.42 84.97 Favored Glycine 0 CA--C 1.511 -0.208 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.174 176.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.2 m120 51.5 24.52 2.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.229 0.612 . . . . 0.0 112.618 -173.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.52 ' HB2' ' HD3' ' A' ' 169' ' ' ARG . 19.0 t0 73.1 157.89 0.2 Allowed 'General case' 0 C--O 1.232 0.14 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 165.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 70.63 18.46 6.39 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.091 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.9 tp10 -168.23 -50.53 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.466 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 49.6 m-20 -142.39 148.03 37.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.055 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.525 ' HB3' ' CG2' ' A' ' 173' ' ' ILE . 34.1 tp -90.44 125.37 60.0 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.258 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 7.9 Cg_exo -70.16 108.34 2.13 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.284 1.989 . . . . 0.0 111.231 170.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.471 ' CG ' HG22 ' A' ' 130' ' ' THR . 6.6 p90 -126.06 163.52 22.88 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 42.0 mttp -100.18 -175.2 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 110.41 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.757 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -90.88 8.47 34.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.441 179.158 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.8 34.55 0.8 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -93.52 144.42 25.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.745 -0.227 . . . . 0.0 110.62 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.9 mm -98.3 135.6 32.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 165' ' ' ASN . 49.2 mt -128.56 158.5 38.26 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -175.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 43.3 t -119.47 129.25 75.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.696 HG23 HD13 ' A' ' 125' ' ' LEU . 37.5 mm -75.05 87.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.617 HG21 HG22 ' A' ' 170' ' ' VAL . 16.0 tt -74.45 -32.74 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.313 -173.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.694 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 29.2 mt-10 -144.7 140.76 28.81 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.417 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 32.4 tttp -127.67 91.43 45.51 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 121.664 -0.648 . . . . 0.0 111.948 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.559 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 15.6 Cg_exo -72.39 -52.2 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.248 1.966 . . . . 0.0 112.865 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -113.5 -172.85 2.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -170.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -99.1 -42.91 6.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.914 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -93.09 -10.09 37.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.392 . . . . 0.0 111.212 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.646 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 58.0 m95 -128.89 125.78 38.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.905 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.651 ' O ' HG13 ' A' ' 173' ' ' ILE . 54.9 m0 -121.73 144.87 48.54 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.097 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.2 m -95.64 94.82 7.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.3 0.572 . . . . 0.0 110.279 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.484 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -101.29 161.81 13.35 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.172 -0.33 . . . . 0.0 110.549 -177.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.717 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 20.6 ptt-85 -104.98 133.95 48.9 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.612 ' C ' HD21 ' A' ' 165' ' ' ASN . 0.2 OUTLIER -78.31 -176.69 4.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.685 -175.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -49.48 -31.64 10.45 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.204 0.94 . . . . 0.0 111.926 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.519 ' HB2' HD22 ' A' ' 165' ' ' ASN . 8.0 m-20 -72.33 -58.93 3.01 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 172.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.553 ' H ' ' ND2' ' A' ' 165' ' ' ASN . . . 139.84 3.28 1.54 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.407 -172.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.717 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -73.66 152.69 40.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.584 0.692 . . . . 0.0 110.866 -177.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.617 HG22 HG21 ' A' ' 153' ' ' ILE . 26.0 t -103.65 121.37 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.133 0.492 . . . . 0.0 111.077 -176.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.64 157.78 27.38 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.646 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.3 OUTLIER -73.8 140.06 45.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.001 0.429 . . . . 0.0 111.165 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -137.95 143.68 40.78 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.153 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.472 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 5.6 Cg_exo -80.87 135.73 10.18 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 123.226 2.617 . . . . 0.0 112.923 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.54 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 99.8 t -58.33 -44.83 99.57 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.6 Cg_endo -64.48 -0.95 3.35 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.036 1.824 . . . . 0.0 113.502 177.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.88 -6.36 21.42 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.746 0.308 . . . . 0.0 111.185 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.955 HG12 HG21 ' A' ' 130' ' ' THR . 17.3 m -128.58 156.07 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -168.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.499 ' HG3' ' CD1' ' A' ' 131' ' ' LEU . 21.8 mt-10 -119.7 125.64 49.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.008 166.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 28.2 mttp . . . . . 0 C--N 1.313 -1.017 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.458 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.46 ' HB ' HG12 ' A' ' 266' ' ' VAL . 20.3 t . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -100.08 112.88 25.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.907 0.384 . . . . 0.0 111.348 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -120.68 122.01 39.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.124 175.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.98 122.3 28.12 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -72.04 112.88 8.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.21 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.515 HG13 ' HG3' ' A' ' 244' ' ' GLN . 33.2 pt -89.28 -9.04 10.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.229 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.558 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 19.4 mt-30 -134.86 149.16 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -79.08 141.96 36.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.429 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 1.023 ' HD2' ' HE1' ' A' ' 290' ' ' HIS . 58.1 ttt85 -135.8 138.82 42.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.347 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.433 177.767 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 285' ' ' LEU . 2.6 m . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 121.377 0.608 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -76.85 115.54 16.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.749 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.579 HD23 ' HB ' ' A' ' 279' ' ' VAL . 1.6 tt -84.67 129.43 34.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.035 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -72.09 121.83 19.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.863 0.363 . . . . 0.0 110.597 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.442 HD23 HG22 ' A' ' 264' ' ' VAL . 96.0 mt -129.89 145.04 51.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.717 ' HB2' ' HB2' ' A' ' 262' ' ' ASP . 8.7 mm-40 -101.0 161.4 13.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.141 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.26 119.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.3 64.26 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.511 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.717 ' HB2' ' HB2' ' A' ' 259' ' ' GLU . 24.7 t70 -85.81 146.18 26.88 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.673 0.273 . . . . 0.0 110.436 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.411 ' HA ' HD11 ' A' ' 263' ' ' ILE . 50.4 mm -92.69 106.51 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.758 -178.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.442 HG22 HD23 ' A' ' 258' ' ' LEU . 16.3 t -83.97 107.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.501 177.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -87.96 92.43 9.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.45 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.601 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 3.8 p -88.29 134.35 28.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.889 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 58.9 p -103.79 -45.11 4.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -111.47 116.98 31.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.524 ' HE1' HG11 ' A' ' 266' ' ' VAL . 32.9 mtt -106.72 116.65 32.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.915 0.388 . . . . 0.0 111.121 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -82.92 152.13 25.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.25 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 8.6 mm -95.61 29.39 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.559 0.695 . . . . 0.0 110.259 -172.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.454 HD22 ' HG2' ' A' ' 274' ' ' GLN . 30.4 p-10 -113.35 -25.43 8.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.146 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 136.3 -23.6 3.3 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.142 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.454 ' HG2' HD22 ' A' ' 272' ' ' ASN . 14.3 pt20 -107.25 130.24 54.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.038 0.419 . . . . 0.0 110.263 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.446 ' HE3' ' CE2' ' A' ' 286' ' ' PHE . 5.8 m0 -118.75 169.64 9.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.245 -174.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -111.28 110.66 21.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.337 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -116.31 155.88 15.97 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 176.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 283' ' ' LYS . 35.3 tt0 -108.0 109.46 20.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.384 0.592 . . . . 0.0 110.539 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.579 ' HB ' HD23 ' A' ' 256' ' ' LEU . 71.7 t -131.34 129.36 62.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 14.2 m120 65.83 30.4 10.03 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.43 0.456 . . . . 0.0 110.982 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.53 9.29 86.12 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.825 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -118.71 123.02 43.86 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.705 -0.291 . . . . 0.0 110.779 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 83.4 mttt -94.13 111.64 23.39 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -132.81 168.72 22.74 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.817 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.431 ' H ' HG22 ' A' ' 254' ' ' THR . 87.8 mt -86.62 132.2 33.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.245 0.545 . . . . 0.0 110.82 -178.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.711 ' HB2' ' HE2' ' A' ' 290' ' ' HIS . 36.1 p90 -132.5 126.57 20.22 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.595 175.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.21 161.29 23.54 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 123.04 2.493 . . . . 0.0 113.185 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -68.18 -33.73 74.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.183 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.3 p -81.7 17.88 1.37 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 1.023 ' HE1' ' HD2' ' A' ' 246' ' ' ARG . 0.6 OUTLIER -143.45 8.35 1.56 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.071 -0.651 . . . . 0.0 112.097 176.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.32 161.09 37.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -139.9 119.93 13.63 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.752 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.64 117.89 16.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -115.35 143.73 44.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.424 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 C--N 1.32 -0.705 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.234 0.263 0 CA-C-O 120.745 0.307 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -138.31 89.16 2.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.03 0.443 . . . . 0.0 110.959 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -161.93 163.06 29.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' A' ' 9' ' ' SER . 32.7 m-20 -82.3 -17.87 44.32 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.382 -173.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 70.28 -32.88 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.547 0.739 . . . . 0.0 111.48 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 7' ' ' ASP . 17.6 m -93.06 -23.27 18.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.95 100.74 4.22 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.431 -173.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.63 -26.36 68.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 104' ' ' ARG . 68.5 m -70.81 -4.78 25.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.488 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.22 -47.3 4.77 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 40.0 p-90 -111.54 -20.19 12.27 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -76.41 116.71 17.36 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.971 -0.455 . . . . 0.0 110.894 -173.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.598 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.5 mmt -98.14 -12.08 22.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.396 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.94 -113.0 1.89 Allowed Glycine 0 CA--C 1.521 0.45 0 O-C-N 123.852 0.72 . . . . 0.0 113.828 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.92 84.33 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.041 2.494 . . . . 0.0 113.281 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.958 HG12 ' H ' ' A' ' 20' ' ' SER . 61.0 t -135.92 -162.16 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.958 ' H ' HG12 ' A' ' 19' ' ' VAL . 87.2 p -170.88 165.12 7.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -168.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.625 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 8.1 ptm85 -68.01 -31.71 71.59 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 118.872 -1.131 . . . . 0.0 110.851 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -59.16 -58.57 8.07 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.092 0.472 . . . . 0.0 110.387 176.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.619 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 35.7 mt-10 -64.95 -46.22 82.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.353 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -56.08 -43.75 78.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.833 -177.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 18.2 mt-30 -69.5 -34.45 74.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.79 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 23' ' ' GLU . 11.5 t -78.65 -7.97 58.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.947 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.619 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 41.6 mtp180 -97.12 -10.54 25.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.048 0.452 . . . . 0.0 109.828 176.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.515 HD22 ' HB2' ' A' ' 53' ' ' SER . 45.7 mt -114.27 -11.64 12.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.414 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.588 HE22 ' HB3' ' A' ' 57' ' ' ARG . 7.0 tp-100 -70.88 125.97 28.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.441 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.93 15.07 71.32 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.197 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.52 ' HA ' HE21 ' A' ' 31' ' ' GLN . 0.1 OUTLIER -101.29 164.6 11.7 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -178.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 32' ' ' ARG . 19.4 ptt85 -61.21 130.87 48.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.212 0.529 . . . . 0.0 110.642 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 53' ' ' SER . 32.2 m170 -67.79 132.59 47.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.953 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.54 -20.29 7.4 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.682 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.734 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.9 mtm -75.01 136.85 41.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -139.16 168.21 20.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.294 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.598 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -156.07 141.3 17.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.921 0.391 . . . . 0.0 110.755 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.429 ' HB ' ' CE3' ' A' ' 14' ' ' TRP . 61.6 t -114.07 124.93 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.554 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 19.2 ptt-85 -125.46 167.91 14.35 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.909 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.87 129.98 38.62 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.411 ' HB3' ' OG1' ' A' ' 43' ' ' THR . 61.8 m -68.78 147.22 52.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.559 0.695 . . . . 0.0 112.5 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.2 t -76.71 -14.29 59.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.426 175.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 41' ' ' SER . 0.2 OUTLIER -76.3 -62.1 1.73 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.646 176.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.2 m -149.75 141.41 14.92 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.391 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -59.35 -23.04 68.4 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.963 2.442 . . . . 0.0 112.258 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.25 37.38 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.647 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -156.86 148.32 22.33 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -129.5 171.65 12.35 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 t -137.05 112.9 11.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.543 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.6 tp -82.22 92.44 6.91 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.79 171.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.2 m -95.59 120.59 36.11 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.629 HG13 ' HG3' ' A' ' 54' ' ' GLU . 88.2 t -112.76 141.78 27.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.552 -174.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.515 ' HB2' HD22 ' A' ' 28' ' ' LEU . 29.5 t -82.02 100.26 9.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.629 ' HG3' HG13 ' A' ' 52' ' ' VAL . 29.6 mt-10 -155.58 149.99 25.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.457 . . . . 0.0 112.142 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.656 HD22 ' HB3' ' A' ' 155' ' ' LYS . 1.7 m-20 60.13 59.37 2.39 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.416 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t 70.98 -24.52 0.17 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.751 -174.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.705 ' CD ' ' H ' ' A' ' 58' ' ' VAL 0.405 0.0 OUTLIER -160.0 -53.39 0.06 Allowed 'General case' 0 C--N 1.363 1.156 1 N-CA-C 124.47 4.989 . . . . 0.0 124.47 -178.551 . . . . . . . . 5 4 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.705 ' H ' ' CD ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -154.24 116.84 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 121.671 2.032 . . . . 0.0 113.3 -171.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.561 ' OG ' ' HB2' ' A' ' 54' ' ' GLU . 6.0 m -97.8 110.54 23.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 164.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -94.01 110.13 21.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.537 ' CE2' HD23 ' A' ' 93' ' ' LEU . 69.1 m-85 -120.1 102.5 8.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.019 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.82 148.67 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.534 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.8 mp -129.67 86.47 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.07 131.94 47.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.881 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.8 t -77.45 125.26 29.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.265 0.555 . . . . 0.0 110.799 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 1.097 HD13 ' HB2' ' A' ' 69' ' ' ARG . 94.1 mt -76.0 147.57 80.56 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.12 169.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.469 ' HD2' ' NH2' ' A' ' 69' ' ' ARG . 35.8 Cg_exo -64.25 61.99 0.25 Allowed 'Trans proline' 0 C--O 1.218 -0.479 0 C-N-CA 122.762 2.308 . . . . 0.0 110.458 165.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 1.015 HD21 ' N ' ' A' ' 69' ' ' ARG 0.268 0.2 OUTLIER 103.66 -50.88 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 128.67 2.788 . . . . 0.0 109.467 -179.688 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 1.097 ' HB2' HD13 ' A' ' 66' ' ' LEU . 73.1 mtm180 -34.45 -53.94 0.52 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 125.093 1.496 . . . . 0.0 112.137 -149.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.809 ' HD2' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -169.85 -167.11 0.62 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.184 1.794 . . . . 0.0 106.572 167.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.15 114.18 26.31 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.378 166.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -102.51 104.78 15.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 111.339 -171.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.534 ' HB ' HG13 ' A' ' 63' ' ' ILE . 6.5 tt -92.49 77.53 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.773 0.797 . . . . 0.0 109.463 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.98 89.1 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.947 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.4 t0 75.48 -52.03 0.65 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.705 0.402 . . . . 0.0 110.877 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -83.16 114.84 21.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.643 0.258 . . . . 0.0 110.472 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -93.38 133.03 37.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.386 0.612 . . . . 0.0 110.613 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.752 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 64.1 m-85 -121.0 158.23 28.22 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.809 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 4.3 m-20 -44.15 -41.23 5.54 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.405 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 3.4 p80 -170.46 -173.13 1.37 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.549 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 11.6 mt -57.83 -55.23 47.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 123.047 0.217 . . . . 0.0 111.339 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 32.1 Cg_exo -63.56 5.68 0.32 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.774 2.316 . . . . 0.0 114.005 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.54 -32.19 7.8 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.26 -0.275 . . . . 0.0 110.952 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.537 HD21 HD23 ' A' ' 81' ' ' LEU . 4.4 pp -76.15 -30.14 58.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.211 0.529 . . . . 0.0 109.739 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.437 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 53.5 mt -63.02 -32.41 73.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.943 176.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.612 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 24.3 tp10 -72.07 -26.8 62.31 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.544 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -73.3 -29.3 62.61 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.053 0.93 . . . . 0.0 108.932 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.773 ' CD1' HD21 ' A' ' 93' ' ' LEU . 42.0 m-85 -92.39 2.67 56.52 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.338 -175.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.612 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 52.0 mtpt -85.65 -15.52 42.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.639 172.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.2 pt -122.74 -1.85 7.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 121.309 0.576 . . . . 0.0 110.091 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.493 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.4 t-160 -86.88 -43.78 12.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.841 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.448 ' CD2' HG23 ' A' ' 97' ' ' THR . 66.1 m-85 63.74 94.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -162.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.773 HD21 ' CD1' ' A' ' 88' ' ' TYR . 16.5 mt -51.53 -97.21 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 123.712 0.633 . . . . 0.0 110.564 176.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.59 ' OD2' ' HB2' ' A' ' 55' ' ' ASN . 3.2 t0 -68.04 -65.26 0.72 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.512 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 9.8 t -157.31 13.06 0.23 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.915 0.864 . . . . 0.0 110.228 175.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.457 HG21 ' OE1' ' A' ' 54' ' ' GLU . 6.5 t -140.65 171.72 13.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 169.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.448 HG23 ' CD2' ' A' ' 92' ' ' TYR . 17.8 p -98.02 171.55 8.19 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.042 -0.411 . . . . 0.0 110.619 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.4 94.26 0.72 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.1 mm -76.17 -53.78 14.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.802 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.734 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.9 pt-20 -167.92 154.57 7.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.632 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 42.3 Cg_endo -66.88 154.56 74.16 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.297 1.998 . . . . 0.0 112.737 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.404 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -72.61 161.05 81.15 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.323 175.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.404 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 9.6 Cg_endo -51.64 126.43 19.63 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.154 1.902 . . . . 0.0 110.971 176.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 12' ' ' SER . 40.7 ttt180 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.295 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.559 HD11 ' HD2' ' A' ' 155' ' ' LYS . 3.6 mm? . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 121.523 0.678 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.0 tp10 -177.57 -68.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.648 -172.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -112.92 106.96 15.36 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.332 0.587 . . . . 0.0 110.293 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.782 HG21 ' CG ' ' A' ' 180' ' ' LYS . 99.4 t -120.49 133.88 65.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.287 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.705 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 7.4 ptp180 -110.35 144.42 39.13 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.855 -1.938 . . . . 0.0 108.724 170.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.402 ' HG1' ' HB2' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -101.28 132.15 46.95 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.514 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.538 HD21 ' HG2' ' A' ' 179' ' ' GLU . 14.9 mt -107.4 -15.13 14.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.973 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -82.06 -40.97 21.23 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -173.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.619 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 11.3 t70 71.52 96.43 0.07 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.459 0.647 . . . . 0.0 110.603 -175.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -127.81 88.25 53.77 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 91.3 Cg_endo -84.85 79.02 2.51 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.075 1.85 . . . . 0.0 113.158 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.29 -23.94 77.51 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.381 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.855 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 67.38 50.8 0.92 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.452 0.701 . . . . 0.0 111.639 177.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -144.5 178.96 7.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.387 . . . . 0.0 110.969 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.503 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -99.96 -9.41 22.78 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 171.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 172' ' ' MET . 4.8 mm-40 -80.87 -38.25 28.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.432 174.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 172' ' ' MET . 24.1 m-20 -133.88 108.67 8.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.945 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.737 ' CD2' HD22 ' A' ' 150' ' ' LEU . 35.4 tp -63.95 129.78 94.1 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.855 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 10.2 Cg_endo -81.21 87.53 1.47 Allowed 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 121.627 1.551 . . . . 0.0 111.088 175.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.536 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 10.2 p90 -100.63 159.83 14.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.527 -173.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.619 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 40.5 mttp -104.22 -172.44 2.11 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -174.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.896 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -85.23 8.55 17.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.334 -172.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.95 41.19 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.405 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -105.1 148.25 27.04 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.706 -177.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.64 132.84 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.331 0.586 . . . . 0.0 109.817 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.737 HD22 ' CD2' ' A' ' 142' ' ' LEU . 24.4 mt -125.85 162.31 25.43 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -176.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.578 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 99.0 t -125.44 122.08 61.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 175.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.501 HG21 ' CD1' ' A' ' 125' ' ' LEU . 34.0 mm -77.01 78.68 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.465 HD13 ' CE1' ' A' ' 61' ' ' TYR . 10.5 tt -78.34 -39.26 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.727 -176.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.651 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 63.1 mt-10 -116.54 140.27 49.57 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 171.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.656 ' HB3' HD22 ' A' ' 55' ' ' ASN . 78.4 tttt -136.71 86.93 21.18 Favored Pre-proline 0 C--N 1.316 -0.863 0 O-C-N 121.49 -0.756 . . . . 0.0 110.149 175.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.681 ' HG2' ' SD ' ' A' ' 172' ' ' MET . 4.3 Cg_exo -67.32 -55.53 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.614 2.209 . . . . 0.0 111.592 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 160' ' ' TRP . 17.4 mm-40 -107.17 167.94 9.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.814 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.6 mm-40 -94.47 -16.35 23.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.153 0.502 . . . . 0.0 109.714 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.441 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 2.0 pt20 -94.21 -21.23 19.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.547 173.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.542 ' CB ' ' HE1' ' A' ' 172' ' ' MET . 52.4 m95 -131.22 127.71 38.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.555 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.768 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.2 m0 -117.88 136.85 53.19 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.357 -176.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.674 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 74.5 m -100.46 90.38 4.28 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 150' ' ' LEU . . . -102.44 149.4 24.41 Favored 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.48 -171.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.836 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 23.5 ptt-85 -86.75 119.35 26.89 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.718 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 6.0 t30 -46.59 166.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 112.374 -2.194 . . . . 0.0 111.213 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -68.57 10.71 0.23 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.64 0.733 . . . . 0.0 110.505 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 165' ' ' ASN . 18.5 m-20 -114.38 -6.68 12.91 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.798 172.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.37 67.87 1.54 Allowed Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.257 -172.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.836 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 8.7 ttm-85 -139.48 126.31 20.81 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.481 HG12 ' CD ' ' A' ' 154' ' ' GLU . 12.1 t -86.65 116.27 28.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.073 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -144.09 149.16 21.18 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.681 ' SD ' ' HG2' ' A' ' 156' ' ' PRO . 7.4 mtp -74.93 134.89 41.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.223 0.511 . . . . 0.0 110.583 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.768 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.5 pp -137.11 142.74 39.23 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.341 -176.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.59 ' HG2' ' CG ' ' A' ' 177' ' ' TYR . 9.7 Cg_endo -62.85 130.4 29.23 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.989 2.459 . . . . 0.0 113.152 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.563 ' O ' HG21 ' A' ' 178' ' ' VAL . 99.2 t -64.67 -44.91 75.35 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.167 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.504 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 48.6 Cg_exo -58.25 1.44 0.25 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.429 2.086 . . . . 0.0 114.104 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.59 ' CG ' ' HG2' ' A' ' 174' ' ' PRO . 3.2 m-85 -104.77 -10.53 17.36 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.34 0.256 . . . . 0.0 111.589 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.63 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.4 m -106.39 -171.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -165.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.705 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.1 tp10 -159.34 47.51 0.3 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.327 -1.761 . . . . 0.0 111.497 -154.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.782 ' CG ' HG21 ' A' ' 128' ' ' VAL . 1.9 mptt . . . . . 0 C--N 1.33 -0.24 0 O-C-N 119.297 -2.127 . . . . 0.0 110.469 -162.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.45 HG12 ' HE1' ' A' ' 269' ' ' MET . 7.6 t . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 121.052 0.453 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.68 125.98 52.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.172 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.418 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -124.57 139.07 54.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.708 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.96 130.72 46.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.107 176.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -75.41 104.56 6.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.896 0.379 . . . . 0.0 110.18 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 21.0 pt -75.24 -13.0 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.415 HE21 ' HB2' ' A' ' 244' ' ' GLN . 0.7 OUTLIER -146.94 157.82 43.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.308 178.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -73.27 158.71 34.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.429 0.633 . . . . 0.0 111.082 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.677 ' HD3' HD11 ' A' ' 258' ' ' LEU . 58.9 mtp85 -132.21 115.66 15.97 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.84 175.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.317 -0.829 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 172.204 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 120.784 0.325 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.0 116.83 23.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.48 133.64 49.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.938 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -95.77 135.48 37.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.675 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.677 HD11 ' HD3' ' A' ' 246' ' ' ARG . 96.7 mt -134.75 151.91 51.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 0.0 111.851 -169.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -97.67 172.98 7.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.392 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.69 122.53 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.893 0.378 . . . . 0.0 110.669 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.48 22.22 62.83 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.373 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -89.63 169.12 11.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.6 mm -106.58 116.0 49.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.325 0.584 . . . . 0.0 110.635 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.502 ' HA ' HG21 ' A' ' 279' ' ' VAL . 21.9 t -102.4 109.86 27.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.268 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.479 ' HB2' ' HE3' ' A' ' 265' ' ' LYS . 33.3 mtmt -87.2 99.73 12.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.013 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.418 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 5.8 p -90.15 116.48 31.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.593 0.711 . . . . 0.0 109.833 175.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 19.6 p -93.43 -36.31 12.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.321 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.539 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 56.5 ttt180 -121.56 96.9 5.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.832 175.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.527 ' HE3' ' CH2' ' A' ' 275' ' ' TRP . 45.7 ttm -81.81 111.54 18.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.059 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 91.6 m-20 -86.74 144.95 26.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.996 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 16.3 tt -79.46 -12.95 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.109 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -75.81 -25.47 56.36 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.725 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.19 -40.05 1.89 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.608 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 34.6 mt-30 -75.7 108.85 8.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.527 ' CH2' ' HE3' ' A' ' 269' ' ' MET . 52.8 m0 -93.39 145.43 24.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.857 0.361 . . . . 0.0 111.315 -176.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 9.0 tp10 -91.99 107.35 19.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.183 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -140.03 157.11 25.29 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.534 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -124.13 123.99 41.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.232 0.539 . . . . 0.0 110.043 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.51 HG22 HD21 ' A' ' 258' ' ' LEU . 28.7 t -124.81 160.96 29.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.078 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -54.82 85.64 0.0 OUTLIER 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.559 0.695 . . . . 0.0 110.889 174.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 156.3 -39.69 0.58 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.375 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 179.69 152.89 0.45 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.1 0.476 . . . . 0.0 111.233 -176.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -101.25 127.64 47.75 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.5 -169.41 35.84 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.68 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 97.4 mt -93.87 145.8 24.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.706 0.288 . . . . 0.0 110.376 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -141.73 127.48 10.91 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 121.083 0.468 . . . . 0.0 111.092 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.499 ' HD2' ' CZ ' ' A' ' 246' ' ' ARG . 72.4 Cg_exo -55.39 126.37 22.29 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 123.269 2.646 . . . . 0.0 112.449 169.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -64.75 -14.76 60.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.454 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 13.8 p -71.8 -2.43 17.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -113.79 0.19 14.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.175 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.28 168.99 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.011 0.434 . . . . 0.0 111.164 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -129.33 129.38 44.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.37 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.423 HD13 HG11 ' A' ' 238' ' ' VAL . 32.9 mm -81.16 126.25 39.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.259 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.23 157.05 40.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.947 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 121.431 0.634 . . . . 0.0 110.008 175.142 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 98' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 121.04 0.448 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -148.93 -53.02 0.17 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.686 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 p90 37.46 -162.35 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.632 1.208 . . . . 0.0 113.09 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.99 -44.91 19.37 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.046 -0.409 . . . . 0.0 110.861 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 t 72.5 -53.7 0.69 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.971 0.795 . . . . 0.0 111.87 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 m -84.47 -25.38 28.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.109 0.481 . . . . 0.0 110.946 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -86.74 116.91 25.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.063 0.459 . . . . 0.0 111.119 -171.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -63.54 -31.74 72.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.521 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.8 t -69.28 -8.28 44.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.23 -47.69 7.09 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.913 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -117.78 -23.38 7.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -170.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -73.65 116.01 13.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.624 ' HB3' HG23 ' A' ' 19' ' ' VAL . 12.4 tpp -100.71 -1.66 34.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.347 -172.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.429 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.96 -115.9 3.95 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.252 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.1 Cg_exo -72.4 103.28 1.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.9 2.4 . . . . 0.0 112.036 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.829 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 64.4 t -136.17 -83.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -176.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.817 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 11.7 t 83.6 176.47 0.06 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 168.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 7.8 tpt180 -42.16 -62.68 0.88 Allowed 'General case' 0 C--N 1.314 -0.944 0 O-C-N 124.112 0.883 . . . . 0.0 112.276 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -62.12 -28.53 69.7 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.05 -168.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -95.75 -45.55 6.95 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.561 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -55.54 32.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.504 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 12.3 pt20 -68.69 -31.26 70.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.829 -174.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.2 m -65.48 -42.95 91.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.42 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -71.22 -28.83 64.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.962 0.411 . . . . 0.0 111.239 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 1.055 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 17.4 mt -107.24 25.88 10.87 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.233 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -75.56 76.22 2.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.54 0.686 . . . . 0.0 109.9 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.41 -64.47 3.98 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.258 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 11.99 -108.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.208 1.403 . . . . 0.0 113.796 -172.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 18.7 ttp180 -111.06 143.88 41.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 53' ' ' SER . 36.5 m170 -94.6 140.99 29.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.73 23.21 12.26 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -173.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.562 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 41.7 mtm -115.58 143.34 45.47 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.758 0.313 . . . . 0.0 110.373 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.525 ' CG ' HD23 ' A' ' 98' ' ' LEU . 29.6 p90 -144.79 161.13 40.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.472 -176.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.1 pp -150.92 133.99 15.99 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.051 0.453 . . . . 0.0 110.415 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.51 113.78 38.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.829 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 12.1 ptt180 -114.29 168.83 9.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.08 128.21 33.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.495 ' HB2' HG21 ' A' ' 49' ' ' VAL . 21.3 t -85.0 163.1 19.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.27 0.557 . . . . 0.0 111.573 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 p -105.84 13.57 29.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.659 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.7 p -78.34 -52.71 8.2 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.128 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.445 ' HG ' ' HB2' ' A' ' 47' ' ' ASP . 24.3 p -165.22 139.31 3.97 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.563 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.57 113.41 1.36 Allowed 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.918 2.412 . . . . 0.0 112.437 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.26 -20.34 8.46 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.528 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.488 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 32.4 t70 -86.37 152.14 22.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -131.04 162.06 30.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.705 0.288 . . . . 0.0 110.991 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 41' ' ' SER . 56.6 t -137.67 112.02 9.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.017 0.436 . . . . 0.0 111.227 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 36' ' ' PHE . 30.9 tp -85.85 100.67 12.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.189 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 59' ' ' SER . 61.2 m -96.72 134.23 40.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.053 0.454 . . . . 0.0 110.44 175.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.741 HG21 HD12 ' A' ' 93' ' ' LEU . 96.4 t -123.59 149.5 27.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.102 -174.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 1.055 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 33.5 t -123.0 98.21 5.79 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 0.9 OUTLIER -133.9 139.93 46.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.025 172.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 55.39 29.32 12.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.695 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.4 m 64.94 31.46 11.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.702 0.763 . . . . 0.0 111.1 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -124.18 120.71 33.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.668 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 19.2 t -88.31 93.98 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.199 0.523 . . . . 0.0 110.215 -178.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 38.6 m -74.39 118.24 17.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.787 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -102.16 94.38 5.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.467 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 59' ' ' SER . 27.6 m-85 -101.97 115.27 30.18 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.566 0.222 . . . . 0.0 111.355 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 69.0 mt -80.55 133.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.706 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.4 mp -108.23 120.97 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.488 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 5.4 t-20 -107.29 133.17 52.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -165.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.7 t -77.64 97.32 5.07 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.06 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' A' ' 69' ' ' ARG . 91.5 mt -66.82 151.55 96.66 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.91 73.57 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.298 1.999 . . . . 0.0 112.339 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 85.71 1.39 0.67 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.985 165.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HB2' HD13 ' A' ' 66' ' ' LEU . 4.4 mmp_? -80.65 -85.17 0.09 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.737 177.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.52 ' HD2' ' HG3' ' A' ' 77' ' ' GLU . 8.4 ptp85 -158.41 -168.32 2.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.169 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.418 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 47.8 m-85 -104.3 115.51 30.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.151 0.501 . . . . 0.0 110.56 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -103.65 107.95 19.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.769 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.706 ' HB ' HG13 ' A' ' 63' ' ' ILE . 5.8 tt -96.69 88.68 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.603 0.716 . . . . 0.0 110.627 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.99 79.28 0.13 Allowed Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.346 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.2 t70 73.36 -44.37 0.58 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.93 0.492 . . . . 0.0 112.016 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -66.39 148.49 51.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.059 0.457 . . . . 0.0 111.234 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.52 ' HG3' ' HD2' ' A' ' 70' ' ' ARG . 3.4 tp10 -110.42 116.81 32.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.166 -171.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 93.0 m-85 -131.73 141.99 49.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -76.46 -16.95 59.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.902 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 15.6 p80 -167.63 167.97 13.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.94 -0.118 . . . . 0.0 110.738 173.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.521 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 9.8 mt -52.46 -57.78 14.28 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 23.5 Cg_exo -67.53 13.66 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.35 2.033 . . . . 0.0 113.838 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -36.95 8.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.144 0.497 . . . . 0.0 109.981 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.5 pp -76.74 -27.84 55.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.657 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.73 -30.15 70.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.106 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.478 ' CD ' ' HZ3' ' A' ' 89' ' ' LYS . 29.8 mm-40 -83.1 -31.26 27.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.564 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -69.07 -39.52 79.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.939 0.4 . . . . 0.0 110.705 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.476 ' CG ' HD21 ' A' ' 93' ' ' LEU . 43.9 m-85 -77.7 -15.37 59.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.205 0.526 . . . . 0.0 110.598 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.478 ' HZ3' ' CD ' ' A' ' 86' ' ' GLU . 40.0 ttmt -66.81 -21.58 66.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.932 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.1 pt -116.42 18.43 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.937 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -111.24 -37.54 5.28 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.598 ' CD1' HG22 ' A' ' 97' ' ' THR . 54.7 m-85 71.11 102.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.786 0.679 . . . . 0.0 110.183 -173.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.741 HD12 HG21 ' A' ' 52' ' ' VAL . 2.9 mt -78.67 -19.32 52.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 110.728 -177.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.647 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 23.2 t70 -167.55 75.38 0.14 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.723 170.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 68.18 -22.69 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.133 0.973 . . . . 0.0 112.018 -176.545 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.568 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 18.9 m -117.39 154.29 31.59 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.598 HG22 ' CD1' ' A' ' 92' ' ' TYR . 14.1 p -95.21 -178.73 4.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.173 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.525 HD23 ' CG ' ' A' ' 36' ' ' PHE . 97.7 mt -69.98 88.54 0.58 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.452 HG21 ' HG3' ' A' ' 100' ' ' GLU . 33.2 mm -74.07 -65.04 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.237 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 35' ' ' MET . 46.1 mt-10 -144.32 153.79 56.33 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.202 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.3 151.87 80.09 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.18 1.92 . . . . 0.0 111.358 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -69.36 147.79 97.14 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.362 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 38.9 Cg_exo -61.32 116.92 3.71 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.628 2.219 . . . . 0.0 112.154 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.2 ttm180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.107 178.179 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.591 HD11 HG23 ' A' ' 152' ' ' ILE . 3.2 mm? . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.272 0.558 . . . . 0.0 111.98 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 7.3 tp10 62.45 -87.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.59 176.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -103.22 106.93 17.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.3 1.048 . . . . 0.0 112.253 -175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.586 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 55.9 t -119.6 162.25 18.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.779 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.568 HH11 ' HG2' ' A' ' 129' ' ' ARG . 0.8 OUTLIER -149.82 126.18 10.8 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.072 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.896 HG21 HG11 ' A' ' 178' ' ' VAL . 3.0 p -87.42 140.45 29.52 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -169.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 90.7 mt -110.63 -29.69 7.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.022 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -78.64 -30.48 46.42 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -170.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.527 ' HB2' ' HD3' ' A' ' 146' ' ' LYS . 14.1 t70 68.82 103.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.246 0.546 . . . . 0.0 110.185 -174.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 66.9 t80 -140.6 96.88 7.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.826 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 10.3 Cg_endo -92.29 100.79 0.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.048 2.499 . . . . 0.0 113.18 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 137' ' ' ASN . . . -96.41 2.59 63.07 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.855 174.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.527 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 73.81 -7.91 1.5 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.815 0.846 . . . . 0.0 111.552 -178.105 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.886 ' HB2' ' HD3' ' A' ' 143' ' ' PRO . 32.5 t0 62.85 162.88 0.1 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.403 ' H ' ' CG ' ' A' ' 138' ' ' ASP . . . 158.87 -34.44 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 111.625 -2.534 . . . . 0.0 104.382 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.33 31.24 0.06 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.629 -2.078 . . . . 0.0 107.694 166.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 172' ' ' MET . 9.4 p-10 -163.1 85.59 0.52 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.79 -175.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.711 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 33.7 tp -64.96 132.85 95.6 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.931 -168.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.886 ' HD3' ' HB2' ' A' ' 138' ' ' ASP . 68.1 Cg_endo -80.6 86.71 1.6 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.487 2.791 . . . . 0.0 111.906 175.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.523 ' CG ' HG22 ' A' ' 130' ' ' THR . 10.0 p90 -97.3 156.78 16.29 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.786 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.704 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 2.8 mptp? -105.89 -171.0 1.82 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.001 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.527 ' HD3' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -88.42 9.03 24.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.542 -177.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.99 27.12 0.63 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.312 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.704 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 5.9 mm-40 -98.5 150.78 21.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.83 0.315 . . . . 0.0 110.231 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.71 134.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.562 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 52.7 mt -119.68 155.8 31.7 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 42.5 t -122.0 126.48 74.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.591 HG23 HD11 ' A' ' 125' ' ' LEU . 32.9 mm -74.99 81.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.663 HG21 ' HG2' ' A' ' 154' ' ' GLU . 8.2 tt -69.01 -34.11 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.607 -173.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.663 ' HG2' HG21 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -131.49 139.66 49.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.532 ' HD2' HD12 ' A' ' 125' ' ' LEU . 74.3 tttt -119.7 86.0 34.34 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.021 0.438 . . . . 0.0 110.453 172.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.421 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 3.1 Cg_exo -77.26 -54.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.674 2.25 . . . . 0.0 111.682 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -109.17 -178.53 3.59 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -109.98 -22.58 11.77 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.115 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.574 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 24.3 pt20 -88.6 -21.72 23.88 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.101 0.476 . . . . 0.0 110.251 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.574 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 48.7 m95 -129.09 123.57 32.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.785 178.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.647 ' O ' HG13 ' A' ' 173' ' ' ILE . 38.2 m0 -112.53 133.58 54.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.319 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 54.0 m -86.26 99.71 11.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.26 0.553 . . . . 0.0 110.311 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.456 ' CB ' HD13 ' A' ' 152' ' ' ILE . . . -109.29 158.62 17.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.697 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 16.0 ptt-85 -104.61 135.42 46.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.039 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.711 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 55.5 t30 -73.87 -173.96 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.998 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -68.89 -13.88 62.7 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 170.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -81.99 -13.76 56.96 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.071 170.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.6 1.54 90.19 Favored Glycine 0 C--O 1.229 -0.182 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.502 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.723 ' HG2' ' OD2' ' A' ' 138' ' ' ASP . 38.5 ttm-85 -66.0 132.58 48.91 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.371 0.668 . . . . 0.0 110.069 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.444 HG21 HD12 ' A' ' 153' ' ' ILE . 59.5 t -104.62 106.4 20.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -173.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.613 ' HA3' ' OD1' ' A' ' 138' ' ' ASP . . . -140.98 168.34 25.35 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.266 175.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.53 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 26.0 mtp -81.35 136.85 35.76 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.647 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -132.68 149.96 74.46 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.15 132.3 13.8 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.106 2.537 . . . . 0.0 112.577 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.673 ' O ' HG22 ' A' ' 178' ' ' VAL . 41.0 t -61.12 -45.59 95.97 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 30.8 Cg_endo -64.47 -1.09 3.49 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.027 1.818 . . . . 0.0 113.774 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.02 -4.48 29.87 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.744 0.307 . . . . 0.0 111.287 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.896 HG11 HG21 ' A' ' 130' ' ' THR . 6.1 m -120.57 163.46 18.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -167.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 160.73 21.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.521 172.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp . . . . . 0 C--N 1.321 -0.66 0 CA-C-O 120.679 0.276 . . . . 0.0 110.582 -173.302 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.522 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 35.3 t . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.86 115.26 27.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.165 0.507 . . . . 0.0 111.162 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 293' ' ' ILE . . . -119.89 129.69 54.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.058 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -89.06 119.3 29.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.039 0.447 . . . . 0.0 110.498 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.979 ' HB2' ' HA ' ' A' ' 259' ' ' GLU . . . -78.42 119.56 21.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.675 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.428 HD11 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -109.5 -26.61 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -170.028 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.662 ' HG2' ' HG2' ' A' ' 245' ' ' LYS . 13.9 tt0 -93.92 -98.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.278 0.49 . . . . 0.0 111.339 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.662 ' HG2' ' HG2' ' A' ' 244' ' ' GLN . 24.4 pttm -175.45 107.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -177.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.584 ' H ' ' HB2' ' A' ' 259' ' ' GLU . 15.3 tpt180 -110.55 101.81 10.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.882 0.372 . . . . 0.0 111.491 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.879 173.634 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 121.125 0.488 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -88.46 127.94 35.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.038 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -81.01 120.8 25.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.899 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.35 117.24 5.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.113 0.482 . . . . 0.0 110.45 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 86.5 mt -143.46 -169.67 3.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.714 0.768 . . . . 0.0 111.333 -172.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.979 ' HA ' ' HB2' ' A' ' 242' ' ' ALA . 26.4 mt-10 79.62 -179.36 0.09 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 113.683 -1.599 . . . . 0.0 114.265 164.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 t 67.12 32.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.91 -172.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.05 38.89 2.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.126 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.72 137.6 44.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.298 . . . . 0.0 110.94 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.2 mm -89.64 106.95 17.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.143 0.497 . . . . 0.0 109.93 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 40.0 t -88.47 118.29 33.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.699 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -90.06 97.44 11.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.516 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.522 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 7.5 p -91.66 129.19 42.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 110.5 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.1 p -106.11 -38.17 6.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.536 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.585 ' NE ' ' HA ' ' A' ' 268' ' ' ARG . 2.2 mmp_? -124.46 114.09 19.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 111.084 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 50.1 mtt -95.41 113.88 25.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.196 0.522 . . . . 0.0 110.312 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -85.21 164.25 18.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.431 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.4 pt -88.72 7.37 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.185 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -88.25 -4.72 58.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.533 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 94.64 -47.02 2.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.554 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 43.3 mt-30 -81.05 124.93 29.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.247 0.546 . . . . 0.0 110.207 173.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -94.18 158.49 15.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.349 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.433 ' HG3' ' HB2' ' A' ' 268' ' ' ARG . 9.4 pt-20 -115.27 125.34 53.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.59 0.709 . . . . 0.0 110.486 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -134.1 170.6 22.48 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.925 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.3 108.49 11.76 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.449 HG13 ' ND2' ' A' ' 280' ' ' ASN . 26.9 t -126.41 138.38 54.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.122 -175.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.449 ' ND2' HG13 ' A' ' 279' ' ' VAL . 52.8 m-80 71.82 -55.37 0.66 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.829 0.851 . . . . 0.0 110.669 -177.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 164.75 30.69 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -141.86 147.65 37.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -105.24 126.91 52.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.35 167.65 32.98 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.731 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 87.1 mt -95.38 142.04 28.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.687 0.279 . . . . 0.0 110.722 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 53.8 p90 -138.3 136.87 19.7 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.973 176.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 12.1 Cg_exo -71.9 141.7 37.5 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.737 2.292 . . . . 0.0 111.941 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -61.67 -15.82 43.39 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.284 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.2 t -86.22 -3.33 58.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 111.563 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -104.44 -11.15 17.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.774 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 240' ' ' ALA . 26.9 m -128.04 158.44 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.956 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -121.09 120.15 34.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.607 178.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 240' ' ' ALA . 47.3 mm -76.91 111.86 14.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.587 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -121.11 163.88 17.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.491 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 11.6 t0 . . . . . 0 C--N 1.325 -0.48 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.286 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . . . . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.888 0.375 . . . . 0.0 110.419 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.468 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 22.5 mmt180 -105.9 6.81 31.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.528 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.757 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 51.9 p90 -79.35 148.59 31.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 175.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -88.79 101.75 14.33 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.567 0.699 . . . . 0.0 110.635 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.58 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 50.6 m -63.82 169.9 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.567 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 8' ' ' SER . 43.0 t 76.73 -50.84 0.57 Allowed 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.593 0.558 . . . . 0.0 111.397 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.79 101.45 1.71 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.467 0.651 . . . . 0.0 110.342 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 75.6 mtt-85 -72.45 -17.28 61.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.568 -171.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -76.36 0.52 19.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.799 0.333 . . . . 0.0 110.836 173.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.58 -46.45 5.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.4 p-90 -115.39 -20.94 10.07 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -171.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 84.1 t80 -86.4 128.94 35.0 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.023 -0.423 . . . . 0.0 110.61 -176.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.528 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 20.1 mmt -109.43 -9.3 14.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 110.909 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.48 -116.6 4.87 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.629 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.86 105.44 0.55 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.558 2.172 . . . . 0.0 112.508 -175.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.674 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 79.2 t -139.02 -77.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.606 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.7 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 17.2 t 86.2 170.34 0.06 Allowed 'General case' 0 C--N 1.347 0.469 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -59.63 -39.4 84.19 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.512 -171.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.36 -38.62 91.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.559 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.575 ' HB3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -85.72 -47.31 9.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.175 0.512 . . . . 0.0 110.775 -177.331 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.92 -40.56 76.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.656 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 52.0 tp60 -70.27 -39.61 74.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.0 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -78.87 -15.13 58.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.641 0.258 . . . . 0.0 111.43 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 90.8 mtt180 -83.57 -50.8 7.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.674 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.492 HD22 ' HB2' ' A' ' 53' ' ' SER . 39.9 mt -94.22 13.36 23.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.052 -173.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 36.6 tt0 -71.08 87.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.103 0.478 . . . . 0.0 110.615 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.33 36.43 8.16 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.334 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' CG ' ' HA ' ' A' ' 28' ' ' LEU . 71.4 mm-40 -91.4 170.66 9.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 111.59 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.614 ' HB3' ' HE1' ' A' ' 35' ' ' MET . 38.4 ttm180 -52.81 139.14 27.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.722 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.466 ' HB3' HG23 ' A' ' 96' ' ' THR . 39.1 m170 -70.03 116.41 10.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.949 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.45 -11.99 7.52 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.256 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.614 ' HE1' ' HB3' ' A' ' 32' ' ' ARG . 57.6 mtt -74.17 149.18 41.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.853 0.327 . . . . 0.0 110.562 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.567 ' HB2' HG22 ' A' ' 52' ' ' VAL . 23.2 p90 -157.16 166.48 33.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.319 177.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -158.04 138.91 13.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.73 175.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.96 125.96 57.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.7 ' HD2' ' H ' ' A' ' 20' ' ' SER . 12.8 ptt-85 -123.12 162.16 23.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.77 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.401 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 24.5 t70 -81.29 127.58 32.88 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 172.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.657 ' HB2' HG21 ' A' ' 49' ' ' VAL . 18.8 t -101.34 154.27 18.94 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.188 0.518 . . . . 0.0 110.779 -174.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 p -91.69 -5.36 53.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.807 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -44.77 94.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.595 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.758 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 69.4 m -152.05 150.67 26.31 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.806 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.36 109.13 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.525 2.15 . . . . 0.0 111.658 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.96 0.26 55.02 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.455 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.758 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 13.4 t70 -85.92 151.38 23.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.799 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 35.0 m-85 -132.6 171.59 13.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.635 0.255 . . . . 0.0 110.964 -176.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.657 HG21 ' HB2' ' A' ' 41' ' ' SER . 78.1 t -145.24 112.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.107 0.48 . . . . 0.0 110.515 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.55 ' HB2' HD13 ' A' ' 63' ' ' ILE . 42.6 tp -83.42 102.26 11.93 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.044 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' SER . 69.5 m -96.95 125.77 41.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.078 0.466 . . . . 0.0 110.391 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.585 HG23 HD12 ' A' ' 93' ' ' LEU . 70.2 t -125.25 138.59 53.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.675 -172.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.492 ' HB2' HD22 ' A' ' 28' ' ' LEU . 33.3 t -102.89 98.51 8.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.207 0.527 . . . . 0.0 110.947 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 35.5 mt-10 -138.32 148.48 44.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.526 ' HB2' ' CG ' ' A' ' 94' ' ' ASP . 1.8 t-20 63.94 11.16 5.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.666 0.387 . . . . 0.0 111.111 -176.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.2 m 70.2 26.41 4.4 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.523 0.678 . . . . 0.0 110.367 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.834 ' NH2' ' HA ' ' A' ' 154' ' ' GLU . 43.8 ptt85 -124.34 151.58 44.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.9 t -93.37 97.49 7.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.037 0.446 . . . . 0.0 110.102 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 51' ' ' SER . 19.3 m -73.18 118.13 15.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.317 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -101.19 115.02 29.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.406 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.663 ' CE2' HD23 ' A' ' 93' ' ' LEU . 52.5 m-85 -121.93 108.01 12.93 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.407 HG12 HG22 ' A' ' 49' ' ' VAL . 58.8 mt -70.21 132.0 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.799 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.2 mp -104.72 123.86 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.352 1.061 . . . . 0.0 109.848 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -106.59 142.59 36.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -78.72 108.95 12.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.153 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 96.3 mt -85.82 170.91 11.63 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 26.2 Cg_exo -63.76 62.34 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.972 2.448 . . . . 0.0 114.263 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 13.2 m120 93.13 -43.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.986 0.914 . . . . 0.0 112.718 161.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.563 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.53 -29.4 33.56 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -169.413 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 1.017 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 81.6 mtt180 -148.07 177.65 9.2 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -169.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -129.7 120.69 25.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.522 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -98.31 112.59 24.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.463 ' O ' HG21 ' A' ' 73' ' ' ILE . 19.6 tt -77.48 78.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 122.158 0.98 . . . . 0.0 109.723 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.95 -55.8 4.54 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.085 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -146.8 -48.02 0.19 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.91 0.385 . . . . 0.0 110.581 -170.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -77.22 129.15 35.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.008 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.459 ' HG2' ' HD3' ' A' ' 70' ' ' ARG . 38.1 tt0 -99.45 130.15 45.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.026 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -128.53 160.79 31.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 1.017 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 36.5 m-20 -64.78 -45.47 86.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -153.27 177.12 11.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.504 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.637 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.2 mt -57.79 -57.87 22.5 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.58 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 30.5 Cg_exo -63.88 -6.71 11.51 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.012 1.808 . . . . 0.0 112.82 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.12 -31.73 17.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.645 0.26 . . . . 0.0 110.797 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.61 -30.32 56.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 82' ' ' PRO . 48.8 mt -68.04 -28.79 67.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.03 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.16 -23.94 63.07 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.049 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -86.67 -38.64 16.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.318 0.58 . . . . 0.0 110.435 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.55 ' CG ' HD21 ' A' ' 93' ' ' LEU . 45.1 m-85 -75.95 -7.75 55.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.878 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.467 ' HB3' ' HE2' ' A' ' 89' ' ' LYS . 30.7 ttpt -63.96 -33.1 74.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.573 173.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mt -110.32 -17.74 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.994 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 19.6 t-160 -69.79 -35.95 75.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.512 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.795 ' HA ' HG22 ' A' ' 97' ' ' THR . 97.2 m-85 71.61 101.61 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 124.083 0.865 . . . . 0.0 109.752 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.663 HD23 ' CE2' ' A' ' 61' ' ' TYR . 13.0 mt -70.83 -13.96 62.23 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.311 0.577 . . . . 0.0 109.649 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.699 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 21.5 t70 -152.56 -64.01 0.16 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.873 169.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 11.9 t -165.9 3.43 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 33' ' ' HIS . 13.0 t -133.38 -13.57 2.66 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.567 -0.708 . . . . 0.0 112.162 176.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.795 HG22 ' HA ' ' A' ' 92' ' ' TYR . 16.7 p 71.13 -179.49 0.23 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.379 1.072 . . . . 0.0 112.131 178.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.8 mt -71.34 109.26 5.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.267 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.424 HD13 ' O ' ' A' ' 96' ' ' THR . 49.3 mm -101.19 -52.39 8.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.059 -177.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.757 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 17.1 pt-20 -154.84 164.16 21.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.619 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 98.4 Cg_endo -82.81 151.13 14.48 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.919 1.746 . . . . 0.0 112.119 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.15 153.16 86.35 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.91 175.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.63 120.36 7.72 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.5 2.133 . . . . 0.0 111.349 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 110.989 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.928 ' HG ' ' HD3' ' A' ' 155' ' ' LYS . 4.3 mm? . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 30.1 tt0 -165.65 -66.72 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -110.94 118.04 35.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.616 0.722 . . . . 0.0 112.006 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.483 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 55.5 t -130.92 159.57 42.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.701 -175.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -131.6 145.29 51.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.94 HG22 HG12 ' A' ' 178' ' ' VAL . 12.3 p -102.51 136.4 42.4 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.724 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' A' ' 179' ' ' GLU . 5.3 mt -107.68 -27.67 10.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.901 -174.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.47 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 44.6 t80 -86.4 -37.27 18.55 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -170.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.511 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 14.4 t70 70.8 108.04 0.06 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.529 0.681 . . . . 0.0 109.844 -170.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 70.3 t80 -147.06 113.19 4.17 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.401 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.74 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 30.2 Cg_endo -92.16 100.41 0.19 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.711 2.274 . . . . 0.0 112.422 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -85.31 14.4 50.47 Favored Glycine 0 CA--C 1.516 0.095 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.174 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.2 m120 50.23 24.16 1.39 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.116 0.566 . . . . 0.0 112.447 -172.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.53 ' HB3' ' HD3' ' A' ' 143' ' ' PRO . 2.3 p30 46.86 -170.07 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.909 1.284 . . . . 0.0 114.157 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 75.76 -26.72 0.19 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.856 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.5 pt-20 -142.1 -30.56 0.57 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.07 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.445 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 5.6 m-20 -141.36 117.65 10.73 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.62 ' CD1' ' HD2' ' A' ' 169' ' ' ARG . 36.3 tp -67.81 136.25 92.38 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-O 120.718 0.294 . . . . 0.0 111.487 -173.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.74 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 1.0 OUTLIER -84.94 102.46 0.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.835 2.357 . . . . 0.0 110.661 172.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.677 ' CG ' HG23 ' A' ' 130' ' ' THR . 6.6 p90 -111.76 158.91 18.79 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.186 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.511 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -99.23 -179.43 4.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.756 -172.463 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -4.71 39.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -171.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.93 42.71 0.2 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.643 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -98.83 165.74 11.63 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.9 mm -99.9 138.38 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 165' ' ' ASN . 29.4 mt -120.26 155.62 32.86 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 25.9 t -118.81 125.15 74.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.897 HG21 HD12 ' A' ' 125' ' ' LEU . 41.7 mm -75.13 95.84 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.265 1.031 . . . . 0.0 108.62 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.837 HG23 ' HG3' ' A' ' 154' ' ' GLU . 19.8 tt -89.71 -27.21 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.003 -171.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.908 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 27.0 mt-10 -142.75 144.47 32.65 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.928 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 7.1 ttpm? -135.62 81.01 42.83 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 121.424 -0.798 . . . . 0.0 111.26 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.597 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 19.9 Cg_exo -68.23 -46.07 2.4 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.787 2.325 . . . . 0.0 112.298 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -117.99 -175.22 2.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.541 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.56 -28.53 9.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.041 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.503 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 4.2 pt20 -93.84 -13.2 27.53 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.197 0.522 . . . . 0.0 110.515 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.746 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 51.6 m95 -129.28 127.81 41.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.733 175.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.673 ' O ' HG13 ' A' ' 173' ' ' ILE . 48.9 m0 -118.16 140.62 49.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.43 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.908 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 7.6 t -96.15 99.38 11.12 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.433 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -114.05 156.33 24.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.869 0.366 . . . . 0.0 111.464 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.463 ' HD3' HD13 ' A' ' 153' ' ' ILE . 26.7 ptt-85 -100.41 131.56 46.26 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.574 ' HA ' HD22 ' A' ' 150' ' ' LEU . 0.1 OUTLIER -79.58 171.38 15.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.871 -179.017 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -72.37 -12.21 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.161 0.505 . . . . 0.0 110.314 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -80.13 -19.34 47.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.931 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.14 7.2 12.83 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 116.696 1.438 . . . . 0.0 116.696 169.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.62 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -123.52 155.79 36.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.511 1.655 . . . . 0.0 111.903 -177.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.92 143.8 11.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.106 -175.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -166.23 161.43 35.07 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.746 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.2 OUTLIER -74.23 137.95 43.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.845 0.355 . . . . 0.0 110.968 179.263 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.673 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -135.24 143.73 46.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.371 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.01 134.04 14.21 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.7 2.267 . . . . 0.0 112.096 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.553 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 17.8 t -62.85 -43.45 82.84 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.078 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 34.5 Cg_endo -65.9 7.44 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 122.283 1.989 . . . . 0.0 113.651 175.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.09 -6.56 15.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.697 0.284 . . . . 0.0 111.097 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.94 HG12 HG22 ' A' ' 130' ' ' THR . 26.3 m -127.62 166.46 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -168.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.623 ' HB2' HD22 ' A' ' 131' ' ' LEU . 4.1 mm-40 -125.41 163.75 21.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.577 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.62 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.05 125.71 53.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.139 0.495 . . . . 0.0 110.804 -174.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.552 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -127.59 131.78 49.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.883 176.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -86.99 125.43 34.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.587 ' HA ' HG13 ' A' ' 291' ' ' VAL . . . -78.2 104.1 8.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.228 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.585 HG13 ' HG3' ' A' ' 244' ' ' GLN . 29.1 pt -83.14 -11.89 12.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.072 0.463 . . . . 0.0 111.229 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.585 ' HG3' HG13 ' A' ' 243' ' ' ILE . 24.7 mt-30 -124.68 165.27 18.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.448 ' HB3' HG13 ' A' ' 260' ' ' VAL . 24.4 pttm -128.72 144.4 51.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.129 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.86 150.51 4.69 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.744 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 CA--C 1.535 0.383 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.822 -172.122 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 122.819 1.295 . . . . 0.0 107.943 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 285' ' ' LEU . . . -8.62 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 111.311 -2.677 . . . . 0.0 113.262 152.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.573 ' O ' ' HG ' ' A' ' 258' ' ' LEU . 1.7 tt -75.12 118.79 18.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.482 ' H ' ' NH1' ' A' ' 282' ' ' ARG . . . -55.97 121.42 9.28 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 123.477 0.485 . . . . 0.0 110.527 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 256' ' ' LEU . 96.2 mt -136.18 136.54 40.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.785 -175.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -98.89 -176.68 3.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.316 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 245' ' ' LYS . 17.5 m -86.79 132.64 31.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.956 0.408 . . . . 0.0 110.683 176.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 86.06 0.7 87.06 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.518 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.55 152.99 25.75 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.738 0.304 . . . . 0.0 110.724 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.7 mm -97.79 114.7 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.15 107.63 20.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.626 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -93.56 114.53 26.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.716 HG13 ' HE1' ' A' ' 269' ' ' MET . 11.6 p -88.37 143.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.969 0.414 . . . . 0.0 110.677 -177.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 30.0 m -98.74 -49.02 4.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.89 0.376 . . . . 0.0 110.266 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.49 ' HD2' ' OE1' ' A' ' 276' ' ' GLU . 3.3 ptp180 -132.45 118.84 19.83 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.096 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.716 ' HE1' HG13 ' A' ' 266' ' ' VAL . 47.1 mtt -89.62 110.8 21.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.128 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -131.62 139.7 49.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.415 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 52.3 mt 56.81 84.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.84 168.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 60.37 -29.14 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 166.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.609 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 165.24 -7.55 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.624 -1.274 . . . . 0.0 114.038 -177.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -85.78 77.05 9.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.558 0.679 . . . . 0.0 109.634 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 23.3 m0 -93.25 158.77 15.58 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.273 -170.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.49 ' OE1' ' HD2' ' A' ' 268' ' ' ARG . 40.9 tt0 -113.87 116.09 28.75 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.45 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.05 170.96 16.29 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.491 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.02 109.17 13.19 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.48 -86.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.531 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.12 66.98 8.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.188 0.518 . . . . 0.0 111.771 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 72.8 -2.49 32.51 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.456 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.482 ' NH1' ' H ' ' A' ' 257' ' ' ALA . 2.5 ptm180 -142.44 153.71 43.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.874 0.368 . . . . 0.0 110.983 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 20.3 pttp -104.48 142.01 35.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.766 173.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -160.19 -178.9 34.6 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.56 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.602 ' O ' ' HA ' ' A' ' 255' ' ' ALA . 91.3 mt -95.98 140.31 30.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.615 0.245 . . . . 0.0 110.961 -177.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 40.1 p90 -140.38 140.33 22.74 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 4.1 Cg_exo -79.85 142.79 16.02 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.702 2.268 . . . . 0.0 111.505 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.609 ' CD1' ' HA3' ' A' ' 273' ' ' GLY . 21.1 p90 -65.97 -15.43 62.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.9 m -77.54 -16.15 58.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.391 0.615 . . . . 0.0 110.541 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -86.81 -24.09 25.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.379 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.587 HG13 ' HA ' ' A' ' 242' ' ' ALA . 30.4 m -127.7 178.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.663 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -140.56 119.42 12.58 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' A' ' 240' ' ' ALA . 39.3 mm -60.43 122.36 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.812 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -145.83 179.71 7.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.843 -173.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.35 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.642 ' HB3' ' HE3' ' A' ' 89' ' ' LYS . . . . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.772 0.32 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -123.66 94.7 4.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.998 -177.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -156.56 154.08 29.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.235 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -75.44 91.88 2.8 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.987 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 14.4 t -74.86 68.71 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.204 0.526 . . . . 0.0 110.068 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 t -179.62 -44.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.445 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -59.34 105.64 0.37 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.007 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 7.6 tpp180 -60.29 -32.35 71.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.549 -174.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.4 m -82.57 -1.36 50.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.644 0.259 . . . . 0.0 111.57 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.49 -45.61 8.05 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.326 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -117.94 -29.4 5.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 65.0 t80 -79.62 113.04 17.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.133 0.492 . . . . 0.0 110.696 -176.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.485 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 23.1 mmt -94.66 -2.86 50.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.051 -175.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.07 -114.21 3.09 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.663 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.63 96.75 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.015 2.477 . . . . 0.0 113.042 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.867 HG12 ' H ' ' A' ' 20' ' ' SER . 7.4 t -142.62 -161.15 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.867 ' H ' HG12 ' A' ' 19' ' ' VAL . 23.2 t 178.32 177.46 0.43 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -170.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.0 mtp85 -54.58 -61.6 2.2 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.75 -44.54 95.93 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.279 0.362 . . . . 0.0 111.336 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HA ' HG21 ' A' ' 26' ' ' THR . 40.3 mt-10 -62.17 -47.51 84.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.345 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.85 -34.45 69.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 0.0 111.281 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.674 ' HG3' HG21 ' A' ' 58' ' ' VAL . 5.4 tt0 -81.88 -34.66 29.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.051 -175.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.443 HG21 ' HA ' ' A' ' 23' ' ' GLU . 11.3 t -82.46 -14.7 54.63 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -104.39 -18.6 14.36 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.773 0.797 . . . . 0.0 110.878 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -132.54 33.01 3.83 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 123.647 1.689 . . . . 0.0 108.095 -174.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -58.18 177.52 0.12 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.229 173.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.445 ' HA2' ' OG ' ' A' ' 53' ' ' SER . . . -73.58 53.02 1.96 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.813 -176.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -78.31 -38.17 42.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.415 0.626 . . . . 0.0 109.893 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.508 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 22.7 ttp180 -144.67 128.46 17.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.56 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 63.9 m170 -83.84 132.54 34.8 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.903 0.382 . . . . 0.0 110.607 -176.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.34 10.93 22.9 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.695 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.67 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.0 mtm -97.96 147.36 24.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.46 ' CD2' HD23 ' A' ' 98' ' ' LEU . 41.7 p90 -143.53 163.04 34.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.025 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.538 HD22 ' CB ' ' A' ' 28' ' ' LEU . 4.1 pp -150.36 134.3 16.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.968 0.413 . . . . 0.0 110.175 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.6 t -102.27 123.33 55.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.865 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 22.6 ptt-85 -126.57 153.42 45.27 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.571 -172.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.424 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 38.2 t70 -75.89 107.95 8.43 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 170.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.509 ' HB2' HG21 ' A' ' 49' ' ' VAL . 13.3 t -79.42 178.22 8.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.679 -168.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.8 m -125.12 17.55 8.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.951 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.46 -47.94 14.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.25 0.547 . . . . 0.0 109.584 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.3 m -144.18 152.93 55.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.296 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.69 87.19 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.139 1.893 . . . . 0.0 111.674 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.52 15.57 2.97 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.967 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.98 155.09 19.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.289 0.544 . . . . 0.0 109.802 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.424 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 44.8 m-85 -127.2 159.91 32.86 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.772 HG22 HG12 ' A' ' 62' ' ' ILE . 40.6 t -135.03 108.69 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.117 175.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.63 103.15 7.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.478 173.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 59' ' ' SER . 70.9 m -95.67 135.37 37.45 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.136 177.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.581 HG22 HD12 ' A' ' 93' ' ' LEU . 92.8 t -127.73 134.38 65.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.579 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.445 ' OG ' ' HA2' ' A' ' 30' ' ' GLY . 29.2 t -100.28 112.42 24.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.744 0.307 . . . . 0.0 111.327 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.56 ' OE1' ' HB3' ' A' ' 33' ' ' HIS . 10.6 tp10 -157.34 140.76 15.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.176 175.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.504 ' ND2' ' HZ1' ' A' ' 155' ' ' LYS . 30.2 m-80 48.3 39.38 12.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.469 0.707 . . . . 0.0 112.899 -176.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.9 m 66.98 18.44 10.58 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.1 173.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 57' ' ' ARG . 14.6 ptt180 -124.51 133.19 53.4 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.674 HG21 ' HG3' ' A' ' 25' ' ' GLN . 46.0 t -93.69 97.23 6.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.747 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 25.3 m -68.99 117.66 10.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.328 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -101.26 92.56 5.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.95 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.63 ' CE2' HD23 ' A' ' 93' ' ' LEU . 37.4 m-85 -97.15 114.85 26.59 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.951 0.157 . . . . 0.0 111.056 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.772 HG12 HG22 ' A' ' 49' ' ' VAL . 28.8 mt -81.99 135.98 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -175.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.726 HG13 ' HB ' ' A' ' 73' ' ' ILE . 5.3 mp -117.38 123.81 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.292 1.037 . . . . 0.0 109.692 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -106.25 135.49 47.63 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.06 -0.4 . . . . 0.0 110.263 -173.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.0 t -80.29 108.63 14.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.006 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.6 mt -80.62 142.91 53.9 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.22 -17.97 49.27 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.728 2.286 . . . . 0.0 112.014 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.52 10.36 7.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.06 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 67.96 29.55 6.45 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.609 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -116.95 159.68 22.08 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.411 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 46.7 m-85 -118.84 115.55 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.188 0.518 . . . . 0.0 111.612 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -104.15 109.02 20.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.027 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.726 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.6 tt -96.47 87.52 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.75 0.786 . . . . 0.0 110.557 177.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.98 75.74 0.43 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.901 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 t0 76.25 -52.69 0.61 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.111 0.564 . . . . 0.0 111.507 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -70.56 111.8 6.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.45 0.643 . . . . 0.0 110.41 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -95.68 128.91 42.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.938 -178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.532 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 89.3 m-85 -119.19 175.08 5.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.683 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.28 -51.05 63.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.18 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -156.2 -177.57 6.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.486 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.6 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.6 mt -56.62 -54.56 52.4 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.466 ' HB3' ' O ' ' A' ' 8' ' ' SER . 52.9 Cg_exo -58.77 -10.38 9.4 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.132 1.888 . . . . 0.0 113.614 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.21 -34.93 16.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.677 0.275 . . . . 0.0 110.919 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.8 pp -76.24 -27.03 56.61 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.3 mt -67.89 -24.23 65.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.821 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 48.8 mt-10 -91.02 -9.41 46.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.762 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.681 ' HE1' ' CZ ' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -97.8 -29.66 13.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 176.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.681 ' CZ ' ' HE1' ' A' ' 87' ' ' PHE . 26.7 m-85 -78.03 -13.28 59.93 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.787 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.642 ' HE3' ' HB3' ' A' ' 4' ' ' ALA . 21.7 ptmt -74.01 -16.68 61.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.588 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.415 HD13 ' H ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -116.77 25.35 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.937 169.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -114.06 -41.62 3.5 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.248 -0.282 . . . . 0.0 111.662 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.593 ' CD1' HG22 ' A' ' 97' ' ' THR . 93.4 m-85 73.16 96.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.96 0.788 . . . . 0.0 110.624 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.63 HD23 ' CE2' ' A' ' 61' ' ' TYR . 2.2 mt -74.57 -13.89 60.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.062 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 96' ' ' THR . 20.0 t70 -172.45 63.02 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.581 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER 74.05 -25.15 0.2 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.114 -175.198 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.461 ' H ' ' C ' ' A' ' 94' ' ' ASP . 41.7 m -114.52 146.18 41.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.593 HG22 ' CD1' ' A' ' 92' ' ' TYR . 16.7 p -90.97 -176.03 4.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.408 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.518 ' HG ' HD11 ' A' ' 93' ' ' LEU . 82.2 mt -69.61 96.39 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 38.5 mm -84.39 -55.08 7.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.031 0.443 . . . . 0.0 110.525 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 35' ' ' MET . 45.6 tt0 -162.32 141.75 7.24 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.454 -177.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.66 153.23 37.17 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.738 2.292 . . . . 0.0 112.914 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.526 ' HB3' HD13 ' A' ' 28' ' ' LEU . . . -73.58 153.84 89.64 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.598 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.24 115.22 2.42 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.448 2.098 . . . . 0.0 112.22 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.206 177.646 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.747 HD13 HG23 ' A' ' 152' ' ' ILE . 3.4 mm? . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.708 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 12.7 pt-20 -170.09 -59.14 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.073 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.465 ' H ' ' HG3' ' A' ' 126' ' ' GLU . 15.1 m-85 -102.01 108.76 20.29 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.704 0.764 . . . . 0.0 111.666 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.462 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 65.0 t -130.18 154.98 41.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.057 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -135.74 137.6 41.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.848 0.356 . . . . 0.0 110.108 175.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.913 HG21 HG12 ' A' ' 178' ' ' VAL . 31.4 p -90.28 137.32 32.45 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.236 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.9 mt -113.19 -24.59 9.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.508 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 44.4 t80 -89.3 -34.77 16.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.508 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 27.1 t70 76.62 122.35 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.89 0.744 . . . . 0.0 111.171 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 80.9 t80 -156.98 107.59 1.93 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.781 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -87.52 97.55 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.594 2.196 . . . . 0.0 112.651 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -87.57 -6.51 77.03 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.077 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.84 22.76 12.8 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.998 0.519 . . . . 0.0 111.932 -175.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.652 ' CB ' ' HD3' ' A' ' 169' ' ' ARG . 2.4 p30 54.94 -173.37 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 168.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 77.48 -34.93 0.21 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 113.341 -1.754 . . . . 0.0 109.785 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.625 ' O ' ' HB2' ' A' ' 172' ' ' MET . 33.9 tt0 -133.69 -29.47 1.33 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.139 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.543 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 22.4 m-20 -138.26 111.39 7.89 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.665 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 25.9 tp -66.22 119.6 63.26 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 120.562 0.22 . . . . 0.0 110.612 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.53 ' HD2' ' HD2' ' A' ' 169' ' ' ARG . 29.2 Cg_endo -71.98 105.03 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.895 1.73 . . . . 0.0 111.335 174.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.622 ' CG ' HG22 ' A' ' 130' ' ' THR . 7.8 p90 -115.23 163.85 15.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 -177.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -97.2 -170.51 2.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.14 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.72 11.18 29.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.193 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.71 39.84 0.2 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.476 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -105.23 155.11 19.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.747 0.273 . . . . 0.0 110.453 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.39 137.43 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.579 HD22 ' HA ' ' A' ' 165' ' ' ASN . 43.4 mt -125.42 160.71 28.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.708 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 22.0 t -122.83 131.67 72.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.747 HG23 HD13 ' A' ' 125' ' ' LEU . 32.7 mm -74.02 91.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.984 0.897 . . . . 0.0 109.433 -175.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.739 HG22 ' HG2' ' A' ' 154' ' ' GLU . 0.6 OUTLIER -74.61 -45.39 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.891 -176.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.739 ' HG2' HG22 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -129.81 139.94 51.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 174.11 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.687 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 0.7 OUTLIER -126.86 86.81 57.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.989 174.766 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.581 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 7.3 Cg_exo -77.4 -61.61 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.063 2.509 . . . . 0.0 113.64 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -97.05 -175.36 3.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 0.0 111.867 -169.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -90.32 -52.53 4.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.67 -178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.1 0.18 51.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.966 0.412 . . . . 0.0 110.915 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.651 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 57.0 m95 -129.53 124.71 34.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.159 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.68 ' O ' HG13 ' A' ' 173' ' ' ILE . 51.5 m0 -121.91 145.47 48.06 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.5 m -100.24 99.72 10.44 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.144 0.497 . . . . 0.0 109.742 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -105.45 160.9 14.79 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.131 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.736 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 22.3 ptt-85 -101.32 128.95 47.25 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.501 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.665 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 66.7 t30 -65.52 164.14 14.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.097 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 15.3 tptp -67.86 -11.47 58.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.454 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.99 -4.53 46.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.939 0.4 . . . . 0.0 110.448 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.28 75.28 1.28 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.393 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.736 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 5.4 ttm-85 -155.36 135.07 12.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.359 0.123 . . . . 0.0 111.117 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.572 HG21 HG21 ' A' ' 153' ' ' ILE . 66.5 t -103.3 117.82 49.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.792 0.33 . . . . 0.0 111.361 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.44 166.92 30.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.866 173.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.651 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -79.72 138.35 37.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.702 0.287 . . . . 0.0 110.829 179.498 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.68 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -137.71 145.44 48.7 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.458 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 6.3 Cg_exo -80.28 136.81 11.56 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.95 2.433 . . . . 0.0 112.873 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.523 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 98.8 t -64.08 -42.62 70.22 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.436 177.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 37.4 Cg_endo -67.49 10.75 0.25 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.015 1.81 . . . . 0.0 113.06 175.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 175' ' ' VAL . 3.3 m-85 -113.65 -5.93 13.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.716 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.913 HG12 HG21 ' A' ' 130' ' ' THR . 20.2 m -132.18 163.84 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.425 0.631 . . . . 0.0 112.614 -167.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -128.47 161.35 29.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.815 172.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.514 ' N ' ' HD3' ' A' ' 180' ' ' LYS . 3.2 mppt? . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.266 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.55 ' HB ' ' HE1' ' A' ' 269' ' ' MET . 21.6 t . . . . . 0 CA--C 1.512 -0.511 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.944 ' HE1' HG23 ' A' ' 263' ' ' ILE . 0.1 OUTLIER -118.29 123.04 44.41 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.087 -171.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.505 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -124.62 158.69 32.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.098 0.475 . . . . 0.0 112.082 -170.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.722 ' HE3' ' HA2' ' A' ' 261' ' ' GLY . 54.4 tttp -102.23 130.85 49.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.477 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -75.44 104.68 6.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.551 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.855 HD12 ' HG3' ' A' ' 244' ' ' GLN . 2.7 pp -82.45 -15.44 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.226 0.536 . . . . 0.0 110.833 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.855 ' HG3' HD12 ' A' ' 243' ' ' ILE . 23.5 mt-30 -123.98 -172.05 2.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.229 172.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -124.5 169.42 11.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.521 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 57.6 mtp85 -148.78 125.85 11.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.342 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.487 173.432 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -81.2 128.4 33.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.654 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.58 127.28 31.96 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 172.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -83.33 117.84 23.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.083 0.468 . . . . 0.0 109.96 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.645 HD21 HG21 ' A' ' 279' ' ' VAL . 58.2 mt -131.81 160.18 36.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.915 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 262' ' ' ASP . 48.6 mt-10 -132.8 167.88 19.38 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.01 131.11 31.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.331 0.586 . . . . 0.0 111.291 -175.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.722 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 92.17 3.88 67.17 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.205 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 0.7 OUTLIER -85.38 160.01 19.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.943 0.401 . . . . 0.0 110.722 -175.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.944 HG23 ' HE1' ' A' ' 239' ' ' PHE . 18.5 mm -95.61 123.36 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.494 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.51 96.72 4.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.131 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -79.71 87.28 5.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.529 HG23 ' HB3' ' A' ' 275' ' ' TRP . 2.4 p -87.01 118.12 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.871 0.843 . . . . 0.0 111.133 -175.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.5 m -103.09 -18.44 14.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.761 -171.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.745 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 36.2 ttm-85 -129.97 103.52 6.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.772 0.32 . . . . 0.0 110.915 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.55 ' HE1' ' HB ' ' A' ' 238' ' ' VAL . 58.5 mtt -102.98 118.68 37.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.875 0.369 . . . . 0.0 110.412 178.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -86.51 1.57 51.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 75.1 mt 74.51 -39.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.398 0.679 . . . . 0.0 112.581 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -63.16 -16.3 59.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 129.96 -27.4 4.08 Favored Glycine 0 CA--C 1.506 -0.501 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.647 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -85.02 113.45 21.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.04 0.447 . . . . 0.0 109.959 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.529 ' HB3' HG23 ' A' ' 266' ' ' VAL . 51.2 m0 -109.42 145.07 36.76 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.084 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 41.9 tt0 -100.97 114.92 29.26 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.96 149.58 18.16 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.297 -176.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -121.52 108.99 14.27 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.645 HG21 HD21 ' A' ' 258' ' ' LEU . 42.1 t -115.82 -98.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.245 -175.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -99.81 82.89 2.66 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.655 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.7 5.81 32.9 Favored Glycine 0 CA--C 1.517 0.167 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.202 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -128.06 129.08 46.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.852 0.358 . . . . 0.0 110.977 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 28.6 ttpp -115.32 111.2 20.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.223 174.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -143.48 -174.66 15.93 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.052 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.14 144.59 27.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.144 0.497 . . . . 0.0 111.5 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.573 ' HE2' HG21 ' A' ' 291' ' ' VAL . 44.3 p90 -148.64 142.57 16.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.683 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 3.2 Cg_exo -77.2 145.21 24.12 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.539 2.16 . . . . 0.0 111.632 176.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -62.96 -14.73 50.89 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.577 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.3 p -72.24 -8.66 56.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -107.56 -8.36 16.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.482 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.573 HG21 ' HE2' ' A' ' 286' ' ' PHE . 34.9 m -128.62 164.29 31.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.796 ' HG2' HG12 ' A' ' 243' ' ' ILE . 31.4 mmtp -137.29 139.68 41.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 174.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 240' ' ' ALA . 47.1 mm -78.81 118.19 25.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.476 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 13.3 p90 -121.06 163.83 17.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.84 0.352 . . . . 0.0 110.324 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.987 -178.928 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.012 0.434 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 5' ' ' ARG . 48.1 mtm105 -121.9 81.44 1.82 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.749 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.483 ' CE1' ' HD3' ' A' ' 89' ' ' LYS . 31.3 p90 -113.55 161.18 17.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.433 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 8' ' ' SER . 10.0 m-20 -61.44 -45.31 94.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -173.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.608 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 63.1 m 67.72 157.61 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.762 0.664 . . . . 0.0 109.999 -169.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.6 t 72.64 -49.94 0.7 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.989 0.516 . . . . 0.0 111.491 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -50.98 101.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.34 0.59 . . . . 0.0 111.591 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -40.22 73.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.249 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -78.62 8.97 4.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.667 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.91 -47.62 4.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.708 0.29 . . . . 0.0 111.022 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -121.03 -25.87 5.25 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -86.46 115.46 23.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.93 0.395 . . . . 0.0 110.692 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.1 mtt -113.13 6.59 17.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.107 0.48 . . . . 0.0 110.779 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.0 -115.23 3.36 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.006 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 25.5 Cg_exo -63.95 103.75 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.697 2.265 . . . . 0.0 111.914 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.585 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 54.4 t -135.58 -75.26 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.732 -176.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.774 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 55.9 m 84.99 176.02 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 122.743 0.417 . . . . 0.0 110.141 166.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.56 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 26.6 mmm180 -40.65 -61.76 0.89 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.054 0.846 . . . . 0.0 111.782 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -55.17 -56.84 15.41 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.941 0.776 . . . . 0.0 112.007 -173.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.6 -42.92 60.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.253 -169.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.26 -52.8 63.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.197 -176.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.562 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 12.9 pt20 -70.89 -32.81 69.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.151 -176.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.596 ' HA ' ' OE1' ' A' ' 29' ' ' GLN . 39.5 m -66.73 -34.3 77.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 111.354 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -63.22 -35.39 80.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.82 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 1.063 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 23.6 mt -99.61 13.0 35.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.045 -173.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.596 ' OE1' ' HA ' ' A' ' 26' ' ' THR . 27.3 mt-30 -73.65 96.71 2.52 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.88 5.07 89.7 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.738 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -82.43 -162.26 0.55 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.946 0.373 . . . . 0.0 110.15 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.51 ' HG3' ' HE1' ' A' ' 35' ' ' MET . 14.5 mtm180 -62.78 131.51 49.1 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.185 0.517 . . . . 0.0 111.352 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -73.72 114.66 12.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.474 173.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.08 -16.86 4.4 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.124 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 62.2 mtt -67.7 142.71 56.24 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.711 0.291 . . . . 0.0 111.544 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.489 ' CB ' HG22 ' A' ' 52' ' ' VAL . 40.2 p90 -140.24 160.04 40.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.016 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -151.1 141.74 22.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.967 0.413 . . . . 0.0 110.627 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.51 124.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.461 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.774 ' HD2' ' H ' ' A' ' 20' ' ' SER . 9.2 ptt180 -122.17 161.7 22.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.189 -173.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.3 113.17 18.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.454 ' HB2' HG21 ' A' ' 49' ' ' VAL . 21.1 t -73.51 140.5 46.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.703 -171.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 t -78.96 -13.46 59.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.351 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.0 p -68.03 -48.5 65.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.107 0.479 . . . . 0.0 109.983 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.4 m -146.95 103.45 3.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.163 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.7 116.58 3.09 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.59 2.193 . . . . 0.0 111.216 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.38 -30.89 5.26 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -172.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.534 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 3.2 m-20 -86.18 168.87 13.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 171.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.757 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 32.0 m-85 -135.52 174.02 11.07 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.684 -171.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 41' ' ' SER . 58.5 t -143.27 112.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.175 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.596 ' HB2' HD13 ' A' ' 63' ' ' ILE . 46.0 tp -83.54 99.84 10.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.254 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 59' ' ' SER . 68.4 m -97.11 135.14 39.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.528 177.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.588 HG23 HD12 ' A' ' 93' ' ' LEU . 81.9 t -132.09 142.39 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.553 -173.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 1.063 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 42.3 t -102.01 113.86 27.46 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.882 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.685 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 18.0 pt-20 -156.86 145.99 20.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.0 p30 43.3 31.39 0.38 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.732 0.813 . . . . 0.0 112.714 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.8 m 63.71 63.82 0.82 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.534 0.683 . . . . 0.0 111.234 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.685 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 29.3 ptt180 -160.3 166.34 29.66 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 34.3 t -119.45 90.85 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.081 0.467 . . . . 0.0 109.941 175.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 51' ' ' SER . 3.6 m -63.14 116.28 5.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.597 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -102.86 97.04 7.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.683 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.42 ' CE2' HD23 ' A' ' 93' ' ' LEU . 82.7 m-85 -105.38 113.06 26.42 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.904 -0.134 . . . . 0.0 111.097 177.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.56 ' O ' HG13 ' A' ' 73' ' ' ILE . 19.0 tt -77.53 139.34 18.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.757 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.5 mp -109.4 122.74 64.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.789 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.534 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 11.2 m120 -110.16 126.31 53.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.911 0.386 . . . . 0.0 110.211 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 p -80.67 100.89 8.91 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.02 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.86 HD11 ' HG2' ' A' ' 70' ' ' ARG . 96.3 mt -66.34 130.06 94.2 Favored Pre-proline 0 CA--C 1.51 -0.595 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -40.26 -68.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.166 2.577 . . . . 0.0 113.658 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -123.25 31.77 5.87 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.001 0.905 . . . . 0.0 108.605 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.751 HH21 HD21 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -131.24 -91.33 0.43 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.596 -173.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.86 ' HG2' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -157.81 -170.4 3.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.051 -167.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -97.62 130.22 44.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.339 0.59 . . . . 0.0 110.323 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.601 ' HD2' HD12 ' A' ' 66' ' ' LEU . 44.9 tttm -123.48 103.33 8.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.309 -173.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 62' ' ' ILE . 15.0 tt -74.13 86.23 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.842 0.829 . . . . 0.0 111.049 -173.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.04 -34.73 1.47 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.784 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -168.08 -51.29 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.648 0.261 . . . . 0.0 110.46 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -80.87 121.28 25.78 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.436 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.8 pt-20 -94.86 143.28 26.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.289 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.515 ' HE1' ' CG2' ' A' ' 73' ' ' ILE . 91.2 m-85 -115.4 -77.37 0.57 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.688 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD2' ' HD2' ' A' ' 80' ' ' HIS . 11.7 t70 -177.11 -54.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.458 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.482 ' HD2' ' OD2' ' A' ' 79' ' ' ASP . 10.8 p80 -147.77 177.64 9.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.486 176.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 11.6 mt -58.84 -59.11 14.8 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.608 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 44.6 Cg_exo -60.05 -7.38 6.26 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.279 1.986 . . . . 0.0 113.427 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.88 -23.01 24.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.94 0.4 . . . . 0.0 110.963 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -88.09 -28.76 21.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.472 ' O ' HD12 ' A' ' 98' ' ' LEU . 77.7 mt -68.21 -25.76 65.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.849 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.638 ' HA ' ' HE2' ' A' ' 89' ' ' LYS . 10.1 pt-20 -85.78 -15.58 41.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -79.8 -37.69 34.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.512 0.672 . . . . 0.0 110.116 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.466 ' CG ' HD21 ' A' ' 93' ' ' LEU . 60.3 m-85 -78.88 2.79 18.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.082 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.638 ' HE2' ' HA ' ' A' ' 86' ' ' GLU . 52.2 mtmt -86.37 -5.79 59.09 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.793 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 -27.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.087 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -79.39 -19.59 49.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.235 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.598 ' CD2' HG21 ' A' ' 97' ' ' THR . 54.5 m-85 67.28 174.32 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -168.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.588 HD12 HG23 ' A' ' 52' ' ' VAL . 4.2 mt -114.27 2.04 14.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 165.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 15.7 t70 -178.07 -121.76 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.502 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.526 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.1 t -94.01 -3.96 50.46 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.1 m -120.3 141.68 49.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.52 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.598 HG21 ' CD2' ' A' ' 92' ' ' TYR . 18.6 p -94.8 178.92 5.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 174.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 93' ' ' LEU . 83.0 mt -69.48 101.85 1.67 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 51.1 mm -86.02 -65.07 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.79 -176.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 35' ' ' MET . 5.7 pm0 -150.37 155.96 36.88 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.221 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.71 145.79 70.69 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.43 2.087 . . . . 0.0 111.726 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 35' ' ' MET . . . -69.62 147.4 96.56 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.426 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.507 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 25.0 Cg_exo -63.66 127.76 20.55 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.356 2.037 . . . . 0.0 111.184 175.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.431 0.634 . . . . 0.0 109.79 178.897 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.55 HD11 HG22 ' A' ' 152' ' ' ILE . 4.1 mm? . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 121.415 0.626 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 -164.72 -81.31 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.38 -173.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -104.97 114.63 28.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.339 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.563 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 53.7 t -128.73 133.47 66.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.128 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -111.29 141.28 45.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.132 0.491 . . . . 0.0 110.922 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.873 HG22 HG11 ' A' ' 178' ' ' VAL . 7.3 p -93.49 139.61 30.53 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.426 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.436 HD13 ' CG ' ' A' ' 179' ' ' GLU . 16.7 mt -110.32 -27.46 9.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.464 -173.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.467 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 53.3 t80 -83.09 -37.47 23.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -171.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.67 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 17.7 t70 75.13 107.92 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.697 0.623 . . . . 0.0 110.33 -174.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 83.6 t80 -139.82 100.7 7.29 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 8.2 Cg_endo -89.03 78.37 1.09 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.018 2.478 . . . . 0.0 112.502 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.64 -22.41 66.93 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.162 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.4 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 53.3 m-80 49.53 55.01 10.02 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.47 -0.865 . . . . 0.0 112.815 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -153.48 171.39 18.77 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.675 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -79.86 -16.07 56.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.147 0.498 . . . . 0.0 110.929 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.43 -10.19 17.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.604 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -135.73 92.14 2.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.599 ' HB3' ' CG2' ' A' ' 173' ' ' ILE . 46.8 tp -67.91 122.66 84.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.807 0.337 . . . . 0.0 110.793 -175.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.552 ' HD2' HD13 ' A' ' 142' ' ' LEU . 66.2 Cg_endo -71.62 99.68 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.403 2.069 . . . . 0.0 111.066 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.578 ' CG ' HG23 ' A' ' 130' ' ' THR . 6.3 p90 -116.49 155.67 28.22 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.85 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.67 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 52.8 mttp -101.7 176.17 5.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.15 -174.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.874 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -83.65 69.5 10.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.956 0.884 . . . . 0.0 109.421 176.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.5 23.43 0.73 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.591 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 145' ' ' LYS . 8.1 tp10 -92.93 153.53 18.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.1 mm -104.61 128.21 58.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 165' ' ' ASN . 18.2 mt -122.65 159.02 28.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.544 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 42.1 t -117.01 129.02 74.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.55 HG22 HD11 ' A' ' 125' ' ' LEU . 38.3 mm -75.81 93.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.815 0.817 . . . . 0.0 109.641 -175.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.711 HG21 HG21 ' A' ' 170' ' ' VAL . 8.6 tp -91.04 -33.56 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.001 -172.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.024 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 19.3 mt-10 -132.02 143.63 50.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -145.32 75.06 13.91 Favored Pre-proline 0 C--N 1.323 -0.585 0 O-C-N 121.66 -0.65 . . . . 0.0 111.093 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.526 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 14.0 Cg_exo -68.28 -40.11 8.97 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.716 2.277 . . . . 0.0 111.678 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -112.26 -178.51 3.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.098 -175.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -110.27 -18.19 13.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.31 0.576 . . . . 0.0 109.599 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -88.88 -30.35 18.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.96 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.729 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 36.8 m95 -128.97 134.53 48.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.473 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.756 ' O ' HG13 ' A' ' 173' ' ' ILE . 41.5 m0 -124.82 135.21 52.73 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.906 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 1.024 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.6 m -85.62 101.74 12.97 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.511 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -106.59 161.74 14.36 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 122.058 -0.401 . . . . 0.0 110.404 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.544 ' HG2' ' HB ' ' A' ' 151' ' ' VAL . 15.2 ptt180 -105.32 133.57 49.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.82 0.343 . . . . 0.0 110.317 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.519 ' HA ' HD22 ' A' ' 150' ' ' LEU . 60.2 t30 -64.71 170.41 4.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.905 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.406 ' HG3' ' OE1' ' A' ' 148' ' ' GLU . 8.9 mtmm -61.79 -16.34 48.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.11 0.481 . . . . 0.0 110.515 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.55 -1.8 58.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.283 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.42 -8.37 79.92 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.343 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 7.0 ttp-105 -68.59 129.24 39.36 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.803 -0.234 . . . . 0.0 111.103 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.711 HG21 HG21 ' A' ' 153' ' ' ILE . 73.5 t -89.73 128.53 41.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.675 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -153.17 149.02 20.51 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.025 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.729 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -69.5 130.62 42.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.755 0.312 . . . . 0.0 110.432 178.396 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.756 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -133.29 146.78 62.32 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.364 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.431 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 4.0 Cg_exo -77.39 134.54 14.11 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.724 2.283 . . . . 0.0 112.28 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.578 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 66.9 t -65.47 -40.83 45.54 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 27.4 Cg_endo -63.61 -4.56 7.16 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.824 1.683 . . . . 0.0 112.973 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-85 -96.69 -6.05 37.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.407 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.873 HG11 HG22 ' A' ' 130' ' ' THR . 15.5 m -126.6 163.92 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -168.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.436 ' CG ' HD13 ' A' ' 131' ' ' LEU . 4.7 mm-40 -139.87 163.94 31.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.587 170.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.535 ' N ' ' HD3' ' A' ' 180' ' ' LYS . 2.8 mppt? . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 120.573 0.225 . . . . 0.0 110.908 -172.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.555 ' HB ' HG13 ' A' ' 266' ' ' VAL . 21.7 t . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.47 134.95 52.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.02 0.438 . . . . 0.0 110.922 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -138.93 131.87 29.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.372 175.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.409 ' HG3' ' CE1' ' A' ' 294' ' ' PHE . 92.3 mttt -84.46 124.02 30.89 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.565 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -76.94 100.42 5.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.018 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 36.0 pt -88.79 -15.69 8.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.266 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 244' ' ' GLN . 0.7 OUTLIER -140.3 135.69 32.49 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.402 ' HG3' HG21 ' A' ' 260' ' ' VAL . 27.4 mtpp -50.68 137.19 20.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 112.547 -175.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.714 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -111.86 91.64 3.73 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 120.781 0.324 . . . . 0.0 111.306 -175.593 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.851 0.358 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -95.03 107.04 19.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.312 -174.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.49 120.0 27.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.714 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -75.98 111.25 11.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.143 0.497 . . . . 0.0 110.586 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.0 mt -114.52 144.14 43.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.315 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.99 167.41 9.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.371 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.402 HG21 ' HG3' ' A' ' 245' ' ' LYS . 58.3 t -77.41 121.31 29.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.976 0.417 . . . . 0.0 110.489 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 100.32 9.95 46.25 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.87 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -92.1 148.77 21.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 16.4 mm -99.35 111.65 29.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 0.0 110.186 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.44 HG23 HG13 ' A' ' 291' ' ' VAL . 35.7 t -87.51 115.21 27.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.179 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.625 ' HZ1' ' HG2' ' A' ' 278' ' ' GLU . 9.5 ttpp -96.91 98.95 10.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.555 HG13 ' HB ' ' A' ' 238' ' ' VAL . 6.5 p -94.85 124.72 47.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.264 0.554 . . . . 0.0 110.585 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 88.2 m -116.75 -35.19 4.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.052 176.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -91.36 92.29 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.224 0.535 . . . . 0.0 110.07 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.783 ' HA ' ' HB3' ' A' ' 275' ' ' TRP . 29.9 mtt -97.58 139.61 33.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.879 0.371 . . . . 0.0 110.886 177.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -93.57 -175.01 3.65 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.3 tt -73.52 71.87 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.796 0.808 . . . . 0.0 110.976 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 73.65 -37.99 0.39 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.903 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 274' ' ' GLN . . . -91.43 78.59 1.34 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.159 -1.019 . . . . 0.0 113.02 -169.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.461 ' HG2' ' HA ' ' A' ' 287' ' ' PRO . 46.5 mt-30 75.67 128.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.894 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.783 ' HB3' ' HA ' ' A' ' 269' ' ' MET . 0.6 OUTLIER -124.62 169.57 11.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.36 -169.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 38.8 mt-10 -107.54 108.45 19.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.607 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.31 133.3 11.58 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.168 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.625 ' HG2' ' HZ1' ' A' ' 265' ' ' LYS . 1.4 pm0 -95.04 108.81 20.9 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.291 0.567 . . . . 0.0 109.489 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 27.1 t -115.74 -87.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.143 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -92.04 72.67 5.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.08 0.467 . . . . 0.0 111.059 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.89 4.89 78.41 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.729 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -159.97 162.6 34.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.207 0.503 . . . . 0.0 111.426 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 278' ' ' GLU . 10.1 ptmm? -116.88 138.79 51.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -154.35 175.8 32.4 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.146 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.49 127.17 34.84 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.094 0.473 . . . . 0.0 110.792 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -127.43 125.76 23.97 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.023 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 17.0 Cg_exo -68.31 139.61 46.21 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.636 2.224 . . . . 0.0 111.409 176.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -75.66 26.26 0.11 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 287' ' ' PRO . 8.7 t -115.48 -9.82 12.03 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.961 0.41 . . . . 0.0 109.953 171.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -90.34 -30.34 17.51 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 242' ' ' ALA . 18.0 m -124.25 161.53 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.51 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -130.75 133.16 45.78 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.02 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 240' ' ' ALA . 43.6 mm -70.76 111.98 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.723 178.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.409 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 34.8 p90 -111.12 142.08 43.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.901 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.473 -179.049 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.6 0.238 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -134.38 84.96 2.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.847 0.355 . . . . 0.0 111.0 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.421 ' HE1' ' O ' ' A' ' 98' ' ' LEU . 41.7 p90 -161.22 164.22 30.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.863 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 12.8 t70 -90.02 120.24 31.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 40.5 m -70.13 -16.53 63.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.856 -172.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -103.46 -11.79 17.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.89 0.376 . . . . 0.0 111.505 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 11.1 t0 -75.62 94.47 3.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.174 0.512 . . . . 0.0 110.879 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.3 mtm-85 -65.84 -25.19 67.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.311 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -73.88 1.83 9.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.849 0.357 . . . . 0.0 110.781 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.84 -47.43 3.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.718 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -114.05 -20.34 11.03 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -76.21 120.32 21.33 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.104 -0.372 . . . . 0.0 110.999 -172.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.628 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.6 mmt -102.12 -16.18 16.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.963 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.461 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.88 -112.57 1.71 Allowed Glycine 0 CA--C 1.525 0.667 0 O-C-N 123.431 0.457 . . . . 0.0 113.543 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.461 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 16.8 Cg_exo -66.55 83.06 0.3 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.217 2.611 . . . . 0.0 113.518 -176.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.974 HG13 ' H ' ' A' ' 20' ' ' SER . 57.5 t -135.33 -164.66 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.974 ' H ' HG13 ' A' ' 19' ' ' VAL . 45.7 p -172.68 174.32 3.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -168.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -53.07 60.9 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.092 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -57.12 -61.9 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.495 0.497 . . . . 0.0 111.532 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -57.72 -47.16 83.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.654 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . -57.54 -49.87 74.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.055 0.455 . . . . 0.0 111.641 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -61.56 -44.34 97.22 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.801 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m -57.85 -38.33 75.47 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -81.31 -9.52 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 80.1 mt -122.41 -12.98 8.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.902 HE21 ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -74.36 117.26 15.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.971 0.415 . . . . 0.0 111.272 -174.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.97 3.05 63.19 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.75 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -80.75 -171.42 3.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.654 0.264 . . . . 0.0 110.453 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.469 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 17.2 mtm180 -60.79 152.71 26.3 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.417 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 62.3 m170 -98.54 142.08 30.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.11 -9.04 54.3 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -172.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.63 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 73.8 mtp -76.75 138.25 39.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.38 -0.41 . . . . 0.0 109.895 176.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.441 ' HB2' HG23 ' A' ' 52' ' ' VAL . 27.3 p90 -144.02 167.47 22.29 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.628 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -158.94 146.93 17.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.5 116.11 50.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.677 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.402 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 36.1 ptt-85 -114.17 -179.31 3.6 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.601 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -86.46 138.04 32.07 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -89.23 177.77 6.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.398 0.618 . . . . 0.0 111.433 -174.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 m -110.4 -4.94 15.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.21 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 p -73.98 -65.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.822 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 26.6 m -133.37 143.29 47.49 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.639 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.93 88.64 0.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.239 1.959 . . . . 0.0 111.334 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 145.72 -21.63 1.82 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -77.52 150.99 34.76 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -130.43 173.78 10.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.538 HG21 HG12 ' A' ' 62' ' ' ILE . 9.5 t -138.93 109.67 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.122 0.487 . . . . 0.0 111.722 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.6 tp -83.29 97.61 8.99 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.322 175.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.9 m -95.75 117.09 29.86 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.685 0.278 . . . . 0.0 110.254 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.51 HG21 HD12 ' A' ' 93' ' ' LEU . 60.4 t -113.23 133.62 58.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.405 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.568 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 48.1 t -102.05 118.05 36.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.705 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 10.7 tp10 -151.18 153.22 34.55 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.502 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 63.4 m-80 57.41 21.85 7.31 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.323 0.389 . . . . 0.0 111.822 -177.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 m 57.6 51.51 9.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.253 1.025 . . . . 0.0 108.996 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 1.026 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.29 0.0 OUTLIER -166.81 70.03 0.11 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.376 -155.784 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 22.5 t -71.93 110.86 5.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.883 -168.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.3 m -76.64 120.46 21.86 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.282 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -97.71 89.9 4.79 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.859 ' HE1' HD13 ' A' ' 153' ' ' ILE . 75.5 m-85 -89.05 106.76 18.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.538 HG12 HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -80.51 136.41 23.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.209 0.528 . . . . 0.0 111.97 -178.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.525 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.6 mp -117.88 106.57 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.534 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -83.58 148.67 27.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.735 0.302 . . . . 0.0 110.548 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.9 t -85.49 109.32 18.4 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 72' ' ' LYS . 98.2 mt -79.41 147.43 68.28 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.544 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.8 -13.47 37.22 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.695 2.263 . . . . 0.0 110.547 170.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -75.39 -0.72 20.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.366 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.575 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.1 mmp_? 64.71 28.51 13.04 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.972 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 70' ' ' ARG . 59.1 mtt85 -124.8 157.37 35.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.537 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.525 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 25.7 m-85 -105.6 114.93 29.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.888 0.375 . . . . 0.0 110.519 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.543 ' HB2' HD12 ' A' ' 66' ' ' LEU . 38.6 ttpt -103.53 111.96 24.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.546 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.602 HD13 ' HB3' ' A' ' 61' ' ' TYR . 7.9 tt -93.23 75.26 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 122.179 0.99 . . . . 0.0 109.124 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.07 97.78 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.979 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.4 t0 75.49 -51.5 0.64 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.649 0.379 . . . . 0.0 111.381 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -94.05 119.27 32.69 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.8 pt-20 -100.24 135.77 41.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.319 0.58 . . . . 0.0 110.796 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.457 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 94.2 m-85 -115.86 177.12 4.79 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.473 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.43 -49.68 74.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.903 0.382 . . . . 0.0 111.167 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -164.52 -175.43 3.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 15.2 mt -53.22 -58.82 10.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HB3' ' O ' ' A' ' 8' ' ' SER . 30.6 Cg_endo -64.89 -4.75 9.31 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.206 1.937 . . . . 0.0 113.433 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.87 -36.63 15.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.813 0.339 . . . . 0.0 110.425 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -77.11 -37.03 55.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.16 -38.8 84.27 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.832 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 1.9 tp10 -66.26 -43.84 85.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.725 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -64.91 -28.3 69.44 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.432 0.634 . . . . 0.0 110.968 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.68 ' CG ' HD21 ' A' ' 93' ' ' LEU . 20.6 m-85 -92.03 1.73 57.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.324 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 56.8 mtpt -85.02 3.54 38.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 175.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.3 pt -140.53 -8.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-O 121.252 0.549 . . . . 0.0 109.706 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 4.4 t60 -86.17 -36.68 19.36 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.973 -174.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 93.8 m-85 70.13 91.69 0.09 Allowed 'General case' 0 C--O 1.225 -0.205 0 O-C-N 124.277 0.986 . . . . 0.0 109.033 -166.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.68 HD21 ' CG ' ' A' ' 88' ' ' TYR . 25.1 mt -58.67 -44.76 90.27 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.351 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.946 ' HA ' ' HG2' ' A' ' 154' ' ' GLU . 28.3 p-10 -150.51 48.82 0.88 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.627 -166.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.8 OUTLIER 70.63 -5.73 1.37 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.413 1.885 . . . . 0.0 111.635 -169.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.578 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -126.13 151.64 46.99 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.424 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.0 p -96.72 167.05 11.35 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.421 ' O ' ' HE1' ' A' ' 6' ' ' PHE . 72.6 mt -65.38 99.66 0.42 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 97' ' ' THR . 48.0 mm -87.4 -64.06 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.343 -172.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 35' ' ' MET . 42.0 tt0 -156.86 126.01 3.09 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.201 -174.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.68 153.71 47.66 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.023 2.482 . . . . 0.0 113.127 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.62 154.23 94.98 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.514 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.61 115.78 2.76 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 121.904 1.736 . . . . 0.0 111.672 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.483 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 54.3 ttp180 . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.439 0.638 . . . . 0.0 109.7 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.568 ' HG ' ' HD2' ' A' ' 155' ' ' LYS . 3.3 mm? . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 121.66 0.743 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 44.3 tt0 -175.59 -54.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.207 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -118.5 107.5 13.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.909 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.627 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 4.2 t -116.26 140.02 40.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.709 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 4.9 ptp180 -115.24 138.61 50.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 116.71 -1.996 . . . . 0.0 108.682 164.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.557 ' HB ' ' CD2' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -100.67 125.5 47.1 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.738 -178.036 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.49 HD12 ' HB2' ' A' ' 179' ' ' GLU . 17.2 mt -99.22 -26.32 14.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.243 -173.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.533 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 34.7 t80 -73.48 -41.98 62.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -172.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.542 ' HB2' ' C ' ' A' ' 145' ' ' LYS . 6.0 t70 75.24 100.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.699 0.761 . . . . 0.0 110.832 -174.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 53.5 t80 -128.7 86.78 56.66 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 89.6 Cg_endo -83.6 86.72 1.33 Allowed 'Trans proline' 0 N--CA 1.441 -1.611 0 C-N-CA 121.147 1.231 . . . . 0.0 112.368 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.67 -24.47 60.35 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.557 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.6 m120 61.6 50.83 4.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.709 -1.246 . . . . 0.0 112.22 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -136.67 176.25 8.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.273 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.82 -13.83 35.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 122.11 0.957 . . . . 0.0 108.496 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.558 ' O ' ' HB2' ' A' ' 172' ' ' MET . 19.6 mm-40 -88.02 -31.4 19.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.244 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -135.2 105.76 6.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.939 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.723 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 26.5 tp -66.94 128.79 94.0 Favored Pre-proline 0 CA--C 1.51 -0.563 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.989 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 92.4 Cg_endo -79.34 98.08 1.14 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 121.384 1.389 . . . . 0.0 111.306 173.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.564 ' CE1' ' HB ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -89.32 -165.1 1.26 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.542 ' C ' ' HB2' ' A' ' 133' ' ' ASP . 56.2 mtpt -139.49 -176.02 4.39 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.408 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.91 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -82.99 50.41 1.72 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.665 0.745 . . . . 0.0 110.665 -174.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.99 35.28 0.17 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.647 ' OE1' ' HB2' ' A' ' 166' ' ' LYS . 5.1 tp10 -84.34 151.8 24.5 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.983 -173.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.3 122.82 64.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.549 0.69 . . . . 0.0 109.157 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.675 HD22 ' CD2' ' A' ' 142' ' ' LEU . 65.4 mt -123.67 157.57 33.53 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.008 -171.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.532 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 66.1 t -117.3 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 161' ' ' TRP . 45.6 mm -76.86 95.48 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-O 122.177 0.989 . . . . 0.0 109.508 -175.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.859 HD13 ' HE1' ' A' ' 61' ' ' TYR . 19.3 tt -81.64 -28.07 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.602 -175.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.026 ' HA ' HH21 ' A' ' 57' ' ' ARG . 4.0 mt-10 -136.37 144.39 44.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.144 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.613 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 86.8 tttt -124.31 76.53 61.28 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 164.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.54 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 23.2 Cg_exo -67.2 -51.17 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.768 2.312 . . . . 0.0 111.778 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -113.8 177.54 4.6 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.619 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -100.18 -16.98 17.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.976 0.417 . . . . 0.0 110.3 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -99.8 -19.79 16.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.574 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 39.7 m95 -129.74 141.95 50.79 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.741 ' O ' HG13 ' A' ' 173' ' ' ILE . 46.5 m0 -124.92 137.86 54.26 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 6.1 m -97.7 109.88 22.55 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 150' ' ' LEU . . . -121.29 152.1 39.3 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.244 -176.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.761 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 27.1 ptt-85 -87.65 127.69 35.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 173.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.723 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 56.3 t30 -61.75 178.01 0.37 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.133 -172.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.647 ' HB2' ' OE1' ' A' ' 148' ' ' GLU . 3.6 ttmp? -54.19 -26.03 25.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.303 166.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -74.98 -38.45 61.66 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.03 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 164' ' ' ARG . . . 115.32 -11.85 19.37 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.458 -175.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.761 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -59.12 138.18 57.66 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.26 0.624 . . . . 0.0 112.051 177.434 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 74.0 t -88.76 121.07 38.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.542 177.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -153.73 156.2 26.64 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.438 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.574 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -77.55 143.68 38.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.805 0.303 . . . . 0.0 111.295 178.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -142.07 142.0 23.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.526 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 20.4 Cg_exo -65.95 129.46 22.02 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.715 2.277 . . . . 0.0 112.879 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 44.9 t -62.72 -40.1 60.68 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 17.5 Cg_endo -59.39 -11.28 13.11 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.023 1.815 . . . . 0.0 112.627 175.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -93.29 -10.53 35.16 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.604 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.494 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 2.1 m -105.98 -177.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -166.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.709 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 3.4 tp10 -159.43 44.82 0.25 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 112.467 -2.151 . . . . 0.0 110.833 -154.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.706 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.449 0 O-C-N 119.174 -2.204 . . . . 0.0 112.87 -162.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.7 t . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 121.043 0.449 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -93.77 123.45 37.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.173 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.494 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -119.81 143.34 47.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.175 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 45.0 tttp -90.89 119.08 30.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.15 0.5 . . . . 0.0 109.752 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 1.004 ' HB1' ' HG2' ' A' ' 259' ' ' GLU . . . -84.23 127.22 33.81 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.781 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 46.2 pt -128.12 -30.1 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -168.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -82.62 -75.9 0.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.298 -169.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.764 ' HA ' ' CB ' ' A' ' 259' ' ' GLU . 1.0 OUTLIER 153.85 131.25 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.391 1.476 . . . . 0.0 108.183 168.495 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.524 ' H ' ' HB2' ' A' ' 259' ' ' GLU . 19.2 mmm180 -124.2 100.61 6.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.917 0.389 . . . . 0.0 110.968 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.453 178.165 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -93.0 126.76 38.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.456 HD13 HD21 ' A' ' 258' ' ' LEU . 0.6 OUTLIER -85.08 122.12 28.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.952 0.406 . . . . 0.0 110.524 -176.252 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -84.06 109.89 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.779 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 259' ' ' GLU . 0.4 OUTLIER -157.05 -156.25 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.166 176.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 1.004 ' HG2' ' HB1' ' A' ' 242' ' ' ALA . 3.7 mt-10 88.12 139.92 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 24.9 t 82.56 83.16 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 112.695 -2.048 . . . . 0.0 111.114 -172.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 89.98 14.38 59.33 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.417 -0.81 . . . . 0.0 113.48 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -105.36 145.99 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.974 0.416 . . . . 0.0 111.163 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 32.2 mm -98.45 111.4 28.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.495 HG22 HD23 ' A' ' 258' ' ' LEU . 43.5 t -92.83 117.25 35.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 -175.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -96.39 105.67 17.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.102 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 275' ' ' TRP . 2.4 p -94.67 118.01 39.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.999 0.428 . . . . 0.0 110.304 176.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -93.8 -24.37 17.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.173 0.511 . . . . 0.0 110.763 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.47 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 88.8 mtt180 -121.56 98.27 5.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.801 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.555 ' HE3' ' CZ2' ' A' ' 275' ' ' TRP . 1.2 mtt -91.39 112.93 25.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.321 0.581 . . . . 0.0 111.373 -176.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -92.13 158.79 15.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.173 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.5 tt -91.28 -14.98 8.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.347 0.594 . . . . 0.0 109.851 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.99 23.02 1.57 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.8 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 91.04 -55.63 3.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.136 -0.554 . . . . 0.0 114.077 168.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -77.81 114.84 17.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.346 0.593 . . . . 0.0 110.526 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.555 ' CZ2' ' HE3' ' A' ' 269' ' ' MET . 42.9 m0 -94.74 155.65 16.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.457 -175.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 0.2 OUTLIER -107.58 113.29 26.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.425 -179.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -141.73 168.35 25.61 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.288 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -118.25 110.16 17.21 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.529 ' HB ' HD22 ' A' ' 258' ' ' LEU . 43.9 t -139.93 146.72 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 63.61 24.51 14.0 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.094 0.473 . . . . 0.0 111.02 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 82.16 3.37 90.58 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.238 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -134.24 149.58 50.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.943 0.402 . . . . 0.0 110.767 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -103.6 143.26 32.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.274 178.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -172.18 170.74 43.72 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.477 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 95.3 mt -90.34 133.5 34.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.119 0.485 . . . . 0.0 111.122 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -134.62 147.85 64.93 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.184 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -87.77 139.29 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.685 2.257 . . . . 0.0 112.752 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -70.53 -11.52 60.98 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.063 0.459 . . . . 0.0 111.016 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.5 p -78.23 4.84 11.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.236 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -116.94 -49.11 2.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.657 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 242' ' ' ALA . 27.5 m -85.98 152.52 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.216 -175.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -109.29 124.34 50.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.797 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 240' ' ' ALA . 20.8 mm -79.77 127.62 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.473 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 2.6 p90 -146.08 173.19 12.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.166 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 . . . . . 0 C--N 1.315 -0.91 0 CA-C-O 121.373 0.606 . . . . 0.0 111.049 179.147 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtt . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.424 ' CB ' ' HE ' ' A' ' 5' ' ' ARG . 12.7 m 61.72 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.646 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.3 m 66.49 -51.14 0.44 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.326 0.65 . . . . 0.0 110.331 -168.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 98' ' ' LEU . . . -130.98 92.69 3.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.244 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.424 ' HE ' ' CB ' ' A' ' 2' ' ' SER . 5.3 ptp180 -114.73 25.32 11.06 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.361 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 46.2 p90 -69.47 140.49 54.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 165.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.45 118.69 18.59 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.582 -178.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.665 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 17.0 m -90.52 78.73 6.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.85 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -176.39 -53.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.068 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 12' ' ' SER . 34.8 t70 -78.18 127.75 32.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.311 0.577 . . . . 0.0 111.562 -170.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.417 ' C ' ' H ' ' A' ' 13' ' ' ALA . 1.1 mpp_? -51.82 -37.68 52.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.674 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 108' ' ' PRO . 3.2 m -73.87 23.97 0.08 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.875 0.369 . . . . 0.0 111.929 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 11' ' ' ARG . . . -118.59 -47.19 2.54 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.883 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.402 ' HD1' ' HB2' ' A' ' 13' ' ' ALA . 28.3 p-90 -132.21 -22.39 2.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -166.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -86.86 119.71 27.38 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.942 -171.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.836 ' HG2' ' HG3' ' A' ' 109' ' ' PRO . 55.6 mtt -117.09 5.78 12.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.908 0.385 . . . . 0.0 111.143 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 49.91 -114.4 2.4 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.247 -0.888 . . . . 0.0 114.73 174.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 15.3 Cg_exo -69.01 95.96 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.916 2.411 . . . . 0.0 112.608 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.822 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 95.3 t -128.88 -71.53 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.117 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.84 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 54.1 m 78.52 170.01 0.2 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.196 0.598 . . . . 0.0 110.439 172.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -49.05 -43.61 40.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.435 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 1.5 pt20 -46.57 -58.57 3.69 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.956 0.785 . . . . 0.0 112.81 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.522 ' HB2' HG11 ' A' ' 19' ' ' VAL . 23.5 mm-40 -85.65 -43.46 13.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.118 0.485 . . . . 0.0 110.467 -172.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.76 -37.41 63.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.765 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -72.25 -35.97 68.95 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.554 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 23' ' ' GLU . 10.8 t -79.8 -32.62 40.79 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.192 -174.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -84.65 -15.06 46.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.082 0.468 . . . . 0.0 111.173 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.483 HD11 ' HG ' ' A' ' 37' ' ' LEU . 78.3 mt -117.11 30.44 7.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.298 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -113.73 139.69 48.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.238 0.542 . . . . 0.0 111.671 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.09 -47.85 3.93 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.648 ' O ' ' HG3' ' A' ' 32' ' ' ARG . 77.9 mt-30 -131.91 80.47 1.92 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 118.875 1.338 . . . . 0.0 111.801 -168.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.874 ' HA ' ' HE1' ' A' ' 35' ' ' MET . 0.0 OUTLIER -169.22 146.07 3.49 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.523 -176.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.98 104.91 1.93 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 166.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.44 -3.67 69.09 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.566 -173.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.874 ' HE1' ' HA ' ' A' ' 32' ' ' ARG . 57.7 mtm -85.61 138.07 32.42 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.932 0.396 . . . . 0.0 110.511 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -144.27 174.33 10.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.743 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.483 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.2 pp -160.45 143.37 13.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.747 172.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.05 135.88 45.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.84 ' HD2' ' H ' ' A' ' 20' ' ' SER . 22.5 ptt-85 -139.64 155.26 47.52 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.397 -173.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.417 ' OD1' ' HA2' ' A' ' 17' ' ' GLY . 2.2 m-20 -66.18 118.25 9.63 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 168.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.524 ' HB2' HG21 ' A' ' 49' ' ' VAL . 21.4 t -84.44 170.06 13.91 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.993 0.425 . . . . 0.0 110.263 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t -112.23 7.13 19.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.484 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -53.68 27.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 47.4 t -170.62 121.74 0.55 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.414 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -40.41 104.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.464 2.776 . . . . 0.0 112.465 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.11 -21.73 2.62 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.209 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -103.25 145.36 30.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.076 0.465 . . . . 0.0 109.773 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.548 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 24.8 m-85 -126.42 160.19 31.18 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' A' ' 41' ' ' SER . 44.0 t -128.16 103.46 10.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.471 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 tp -79.66 98.38 6.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.399 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 m -96.0 120.1 35.68 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.279 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.602 HG23 HD12 ' A' ' 93' ' ' LEU . 54.5 t -116.83 134.24 61.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.28 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.791 ' HG ' ' HB2' ' A' ' 32' ' ' ARG . 31.8 t -103.58 111.63 24.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.209 0.528 . . . . 0.0 111.78 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.538 ' HG3' ' HB ' ' A' ' 96' ' ' THR . 3.2 mm-40 -150.01 152.71 35.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.071 173.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 56.74 28.12 13.79 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.501 0.501 . . . . 0.0 110.877 -171.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.9 m 60.31 28.38 17.99 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.281 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 53' ' ' SER . 12.0 ptt-85 -124.53 158.29 33.29 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 t -110.56 95.21 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 t -81.22 118.8 22.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -100.63 99.91 10.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.675 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.802 ' HE1' HD13 ' A' ' 153' ' ' ILE . 63.1 m-85 -98.09 113.7 25.66 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.74 0.305 . . . . 0.0 111.205 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.468 ' HB ' ' CD ' ' A' ' 209' ' ' GLN . 68.5 mt -82.3 131.52 33.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.427 0.632 . . . . 0.0 112.448 -174.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 4.3 mp -98.25 122.55 50.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.176 174.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -111.4 132.53 54.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -77.78 110.35 12.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.449 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.722 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 93.1 mt -77.93 170.85 14.32 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.722 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 23.5 Cg_endo -61.69 56.37 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.007 2.472 . . . . 0.0 114.412 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 t30 79.92 4.99 1.94 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.34 0.656 . . . . 0.0 111.964 161.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -97.6 -51.26 4.18 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.836 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.659 ' HB3' ' HA ' ' A' ' 79' ' ' ASP . 5.8 ptp180 -156.32 -171.69 3.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.865 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -109.72 157.92 18.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.595 0.236 . . . . 0.0 110.476 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.754 ' HE3' ' HA ' ' A' ' 75' ' ' ASP . 55.9 tttp -129.27 96.54 4.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.675 0.274 . . . . 0.0 110.278 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.494 ' HB ' HG13 ' A' ' 63' ' ' ILE . 3.1 tt -97.1 94.12 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.496 0.665 . . . . 0.0 109.869 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.94 57.38 7.84 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.277 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.754 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 25.1 t0 76.74 -50.21 0.57 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.16 0.584 . . . . 0.0 111.487 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -61.5 123.2 17.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.888 0.375 . . . . 0.0 110.057 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.2 130.33 54.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.723 0.773 . . . . 0.0 111.809 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 7.8 m-85 -127.74 150.28 49.86 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.659 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 9.9 m-20 -62.43 -26.05 68.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -170.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -161.95 172.78 15.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.029 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.549 HD23 HD21 ' A' ' 84' ' ' LEU . 11.6 mt -56.55 -51.45 81.1 Favored Pre-proline 0 CA--C 1.537 0.455 0 O-C-N 123.373 0.42 . . . . 0.0 111.868 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.665 ' HB3' ' O ' ' A' ' 8' ' ' SER . 60.3 Cg_exo -57.35 -11.34 8.15 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.661 2.24 . . . . 0.0 114.095 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.95 -36.11 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.236 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.549 HD21 HD23 ' A' ' 81' ' ' LEU . 3.9 pp -76.33 -26.97 56.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.071 0.462 . . . . 0.0 110.557 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.81 -15.68 62.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.784 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -86.16 -37.46 18.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.886 0.374 . . . . 0.0 110.566 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -63.84 -37.7 88.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.28 0.562 . . . . 0.0 110.49 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.536 ' CG ' HD21 ' A' ' 93' ' ' LEU . 38.8 m-85 -81.77 -1.16 46.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.545 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.428 ' O ' HG22 ' A' ' 97' ' ' THR . 7.7 tmtm? -76.26 -24.89 54.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.106 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -115.57 -12.67 11.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.478 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.515 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 12.3 t-160 -72.44 -41.56 66.01 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.995 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.529 ' HA ' HG21 ' A' ' 97' ' ' THR . 83.6 m-85 72.8 108.9 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.379 1.049 . . . . 0.0 109.548 -167.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.73 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 4.9 mt -82.53 14.14 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 95' ' ' THR . 27.2 t70 172.55 -140.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 156' ' ' PRO . 12.8 t -78.12 -7.12 56.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.305 0.574 . . . . 0.0 109.685 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.538 ' HB ' ' HG3' ' A' ' 54' ' ' GLU . 20.7 m -136.44 158.73 43.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.692 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 92' ' ' TYR . 56.7 p -96.63 -169.12 1.83 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.59 ' O ' ' HB1' ' A' ' 4' ' ' ALA . 74.3 mt -67.53 125.76 27.18 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 167.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.56 -68.67 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.896 0.379 . . . . 0.0 110.415 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' A' ' 35' ' ' MET . 61.8 mm-40 -144.02 149.4 45.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.053 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.38 162.86 37.51 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.754 2.302 . . . . 0.0 113.718 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -78.62 171.59 12.1 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.488 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 74.1 Cg_exo -55.8 177.58 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.581 2.854 . . . . 0.0 114.524 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.694 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 2.8 ttp180 -98.75 156.14 16.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.699 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 1.011 ' HB3' ' HD3' ' A' ' 106' ' ' PRO . 45.8 t80 -159.19 -69.3 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.366 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 1.011 ' HD3' ' HB3' ' A' ' 105' ' ' TYR . 9.2 Cg_endo -94.36 -87.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.789 2.326 . . . . 0.0 112.464 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.643 ' O ' ' HD3' ' A' ' 109' ' ' PRO . 13.1 t -76.65 141.53 69.08 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.514 ' HA ' ' HD3' ' A' ' 104' ' ' ARG . 43.3 Cg_endo -68.8 108.06 1.81 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.051 2.5 . . . . 0.0 114.754 -172.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.836 ' HG3' ' HG2' ' A' ' 16' ' ' MET . 90.7 Cg_endo -102.16 -150.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 124.079 3.186 . . . . 0.0 111.149 170.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.419 ' H ' ' HB2' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -57.38 -60.4 3.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.05 0.453 . . . . 0.0 110.636 -178.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.23 80.28 1.36 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.879 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 103' ' ' PRO . 39.3 m -114.42 149.18 36.61 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.0 t -82.23 -38.05 15.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.069 0.462 . . . . 0.0 110.256 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.3 m -149.81 159.45 44.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.727 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -118.41 138.43 25.72 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.813 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 14.6 Cg_exo -70.28 -19.69 33.33 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.291 2.661 . . . . 0.0 112.976 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -83.32 87.2 6.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.938 0.399 . . . . 0.0 111.96 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.558 HD12 ' HD2' ' A' ' 119' ' ' PRO . 50.3 tp -80.96 118.54 72.84 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 170.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.558 ' HD2' HD12 ' A' ' 118' ' ' LEU . 72.2 Cg_endo -76.87 -179.38 5.34 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.462 2.108 . . . . 0.0 113.237 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.8 t -144.53 137.26 26.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.243 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 66.9 166.95 0.22 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.796 0.685 . . . . 0.0 112.707 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.41 176.6 11.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.268 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -157.64 177.26 11.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.34 -96.06 0.21 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 1.081 HD23 HG21 ' A' ' 152' ' ' ILE . 10.6 mp 62.93 123.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.246 1.022 . . . . 0.0 113.007 174.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 17.0 tp10 -167.59 -74.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.715 -175.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -107.1 110.39 22.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.187 0.517 . . . . 0.0 111.11 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.518 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 70.3 t -127.84 132.04 69.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.687 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.501 ' NH2' ' HB2' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -112.57 145.0 41.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.87 0.367 . . . . 0.0 110.66 -178.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.879 HG21 HG12 ' A' ' 178' ' ' VAL . 42.1 p -93.29 129.07 39.5 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.332 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 21.2 mt -104.14 -32.98 8.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.717 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.602 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 34.1 t80 -86.12 -36.08 19.8 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -170.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.659 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 2.0 t70 79.65 129.3 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.557 0.535 . . . . 0.0 110.728 -175.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 91.5 t80 -151.39 100.64 2.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -89.1 65.88 2.6 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.595 2.197 . . . . 0.0 113.006 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.95 -29.82 73.81 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.774 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.522 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 47.3 m-80 50.22 73.32 0.27 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.87 0.868 . . . . 0.0 113.313 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -171.14 -176.28 1.89 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.09 -10.13 51.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.535 0.684 . . . . 0.0 109.168 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -94.09 -32.75 13.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.304 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.79 104.78 9.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.733 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.663 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 46.2 tp -71.9 117.81 61.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 55.2 Cg_endo -76.59 111.38 3.24 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.062 1.842 . . . . 0.0 111.728 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.628 ' CG ' HG22 ' A' ' 130' ' ' THR . 12.5 p90 -125.91 163.69 22.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.143 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.659 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 20.8 pttm -122.15 -168.51 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.739 -173.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.4 OUTLIER -80.94 67.15 6.74 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -178.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.9 42.95 0.11 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.413 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.597 ' HG2' ' HG2' ' A' ' 145' ' ' LYS . 5.3 mm-40 -99.2 145.09 27.6 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.535 -0.391 . . . . 0.0 110.073 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 129' ' ' ARG . 46.5 mm -98.41 124.35 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 175.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 165' ' ' ASN . 34.2 mt -120.43 158.7 26.64 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 90.4 t -119.0 126.05 75.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 1.081 HG21 HD23 ' A' ' 125' ' ' LEU . 48.6 mm -75.76 87.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 122.355 1.074 . . . . 0.0 108.913 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.802 HD13 ' HE1' ' A' ' 61' ' ' TYR . 6.7 tt -82.77 -37.36 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.832 -170.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.787 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 20.7 mt-10 -136.0 143.44 44.79 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -131.8 90.54 35.94 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 121.593 -0.692 . . . . 0.0 111.41 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 6.7 Cg_exo -74.05 -52.14 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.401 2.067 . . . . 0.0 111.957 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -115.19 -179.12 3.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.434 ' O ' HG21 ' A' ' 175' ' ' VAL . 42.1 mt-10 -102.48 -25.48 13.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.831 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.422 ' O ' HG22 ' A' ' 175' ' ' VAL . 7.6 tt0 -85.45 -27.78 25.48 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.237 0.541 . . . . 0.0 110.404 175.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.561 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 45.4 m95 -128.86 124.19 34.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.634 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.556 ' O ' HG13 ' A' ' 173' ' ' ILE . 52.6 m0 -111.3 148.32 33.18 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.787 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 33.3 m -95.63 101.01 12.67 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.534 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -108.93 153.96 22.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.573 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.9 ptt180 -96.2 133.4 40.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.663 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 64.2 t30 -74.27 -177.5 3.04 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.777 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.411 ' H ' ' CG ' ' A' ' 165' ' ' ASN . 38.6 ttmt -62.44 -26.21 68.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.04 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.642 ' OD1' ' HB3' ' A' ' 165' ' ' ASN . 54.0 p-10 -90.56 3.7 53.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.335 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 210' ' ' PRO . . . 86.04 -1.08 87.8 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.804 -0.635 . . . . 0.0 113.131 172.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 25.7 ttm-85 -64.67 129.22 38.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.698 0.285 . . . . 0.0 111.021 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.97 111.68 29.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.038 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.39 165.65 26.32 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 175.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.561 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 21.0 mtp -79.92 138.47 37.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.13 0.465 . . . . 0.0 110.229 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.559 HD11 HG13 ' A' ' 178' ' ' VAL . 2.8 pp -133.7 145.61 56.87 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.023 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.476 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 4.6 Cg_exo -77.3 131.97 12.13 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.809 2.339 . . . . 0.0 112.371 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.559 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 57.2 t -62.05 -43.27 85.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 18.3 Cg_endo -61.37 -11.6 20.23 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.899 1.732 . . . . 0.0 112.903 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -92.17 -12.34 33.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.53 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.879 HG12 HG21 ' A' ' 130' ' ' THR . 32.7 m -126.6 162.17 31.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.228 0.537 . . . . 0.0 112.376 -169.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -133.98 134.77 42.89 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.931 176.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.42 ' HE2' ' HE ' ' A' ' 183' ' ' ARG . 45.9 mtmt -81.93 148.56 28.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.753 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.501 ' HB2' ' NH2' ' A' ' 129' ' ' ARG . 26.2 tp -76.92 -32.28 57.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 171.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 19.6 t -85.93 69.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.662 171.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.447 ' O ' ' HG2' ' A' ' 183' ' ' ARG . 15.9 ttm180 -177.95 32.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.993 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.1 t -66.28 102.34 0.84 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.035 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.2 p -156.92 161.9 28.65 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.313 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.84 105.99 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.895 2.397 . . . . 0.0 112.731 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -103.82 -74.82 0.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -121.72 51.54 0.78 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 67.95 97.79 0.06 Allowed 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.586 0.754 . . . . 0.0 110.58 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -92.97 7.03 45.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.291 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.48 -24.16 63.51 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.452 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -75.33 -9.8 58.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.94 0.37 . . . . 0.0 110.198 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 64.78 -93.36 0.04 OUTLIER 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.793 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 60.1 t30 56.02 29.78 15.02 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.766 0.666 . . . . 0.0 111.129 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.5 m -74.01 -30.2 62.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.872 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.456 ' C ' ' HG ' ' A' ' 197' ' ' SER . 7.7 t30 -71.66 -42.05 67.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.887 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.456 ' HG ' ' C ' ' A' ' 196' ' ' ASN . 56.1 p 50.37 -94.98 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.093 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -153.33 123.81 7.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 159.02 166.13 17.4 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.382 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.484 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 30.1 pt -92.5 139.57 23.84 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.852 0.358 . . . . 0.0 110.501 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 6.3 Cg_exo -74.43 85.11 1.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.773 2.315 . . . . 0.0 112.432 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -127.93 96.39 32.08 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.822 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.97 82.05 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.893 2.395 . . . . 0.0 112.022 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -103.62 158.07 16.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.613 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -92.76 95.11 9.35 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.24 3.94 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.531 -170.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.424 ' HB3' ' H ' ' A' ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.487 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -100.38 2.37 42.31 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.468 ' CD ' ' HB ' ' A' ' 62' ' ' ILE . 7.1 tp60 -53.11 121.53 24.65 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.076 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.461 ' HA ' ' HD2' ' A' ' 164' ' ' ARG . 52.3 Cg_exo -55.58 100.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.219 1.946 . . . . 0.0 110.788 171.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -71.05 92.93 0.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.698 -173.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.493 ' HG1' ' HB2' ' A' ' 75' ' ' ASP . 16.8 m -49.87 -47.27 51.99 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.709 0.631 . . . . 0.0 111.544 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 19.6 m 57.36 76.0 0.34 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.421 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 12.7 m -64.93 112.92 9.16 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.864 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.12 35.65 0.58 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.546 2.83 . . . . 0.0 112.204 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 94.4 mt 64.96 105.09 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.287 0 O-C-N 123.819 0.7 . . . . 0.0 111.066 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.462 ' HB2' ' HB2' ' A' ' 220' ' ' SER . 55.4 Cg_endo -72.9 111.23 3.22 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.324 2.016 . . . . 0.0 112.049 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -80.61 -34.6 35.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.156 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.34 91.83 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.739 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 217' ' ' PRO . 28.9 t -128.14 91.76 3.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.54 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -129.85 144.9 16.06 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.311 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.9 p -67.74 138.57 93.25 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 122.398 0.279 . . . . 0.0 110.852 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.3 106.95 0.9 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.498 2.132 . . . . 0.0 112.098 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -91.89 120.34 6.03 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.283 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 73.24 -43.85 0.57 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.653 0.781 . . . . 0.0 112.705 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 60.24 42.5 15.09 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.228 0.537 . . . . 0.0 110.53 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 2.4 pp -80.21 -5.94 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.645 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 26.2 m -76.27 130.51 77.33 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.27 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.27 -41.56 65.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.012 2.475 . . . . 0.0 112.945 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 48.8 tp -120.75 88.34 43.65 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.792 0.33 . . . . 0.0 110.401 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -95.02 10.37 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.389 2.726 . . . . 0.0 112.457 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 20.6 m -123.83 169.52 11.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.063 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 41.1 p -87.43 156.76 19.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.687 0.279 . . . . 0.0 110.796 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -66.17 98.16 0.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.832 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -98.11 -33.79 11.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.415 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.9 -135.18 1.9 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.761 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.25 160.26 39.54 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.749 2.3 . . . . 0.0 112.023 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.529 ' HB ' HG11 ' A' ' 266' ' ' VAL . 22.0 t -99.65 145.12 11.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -114.73 115.27 26.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.275 0.559 . . . . 0.0 110.941 -175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.575 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -136.55 127.6 27.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.889 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.761 ' HB3' HD13 ' A' ' 263' ' ' ILE . 22.3 pttm -93.06 140.51 29.41 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.271 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.53 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -72.4 110.52 6.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.613 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.469 HG13 ' HG3' ' A' ' 244' ' ' GLN . 26.6 pt -69.1 -32.69 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 111.04 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.469 ' HG3' HG13 ' A' ' 243' ' ' ILE . 23.6 mt-30 -118.41 166.2 12.95 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.459 ' HB3' HG11 ' A' ' 260' ' ' VAL . 9.3 ptpp? -94.81 146.16 24.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.42 0.628 . . . . 0.0 111.099 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.698 ' HB2' HH11 ' A' ' 246' ' ' ARG . 0.0 OUTLIER -128.28 110.85 12.77 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.35 173.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.829 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 33.7 m -82.21 173.3 7.82 Favored Pre-proline 0 C--N 1.316 -0.853 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.829 ' HD2' ' HB ' ' A' ' 247' ' ' VAL . 46.2 Cg_endo -69.1 52.88 0.81 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.615 2.21 . . . . 0.0 112.864 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 15.8 t -100.28 -146.71 0.34 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 61.11 19.06 9.63 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.306 0.575 . . . . 0.0 109.995 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 60.33 31.32 20.37 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.32 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 69.65 14.83 8.18 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.141 168.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -81.41 89.42 6.12 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.554 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.7 p 50.84 31.85 6.56 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.489 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -84.55 113.39 21.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.687 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.582 HD23 ' HB ' ' A' ' 279' ' ' VAL . 1.3 tt -88.86 117.3 27.76 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.68 120.74 14.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 245' ' ' LYS . 95.0 mt -128.12 116.26 19.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.174 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -86.55 158.37 19.54 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.053 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.459 HG11 ' HB3' ' A' ' 245' ' ' LYS . 9.6 m -62.1 110.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.509 0.671 . . . . 0.0 111.864 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.99 -1.44 57.79 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.96 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -79.32 138.55 37.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.841 0.321 . . . . 0.0 110.665 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.761 HD13 ' HB3' ' A' ' 241' ' ' LYS . 46.2 mm -84.1 116.64 28.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.04 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.415 HG21 HD23 ' A' ' 258' ' ' LEU . 40.4 t -89.31 114.09 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.307 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -86.26 88.7 7.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.529 HG11 ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -91.85 117.34 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.515 0.674 . . . . 0.0 110.714 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.06 -22.85 13.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.504 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.591 ' HB2' ' HG2' ' A' ' 276' ' ' GLU . 55.6 mtp180 -123.32 126.09 46.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.412 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 53.1 mtt -122.95 127.2 48.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.422 ' HB2' ' HG3' ' A' ' 274' ' ' GLN . 40.3 m-80 -91.68 139.79 30.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 25.9 pt -70.66 -8.29 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.903 0.383 . . . . 0.0 111.858 -173.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -69.1 -30.46 68.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.952 0.406 . . . . 0.0 110.774 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.3 -5.06 13.43 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.572 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.422 ' HG3' ' HB2' ' A' ' 270' ' ' ASN . 7.8 pt20 -94.69 115.0 27.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 175.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.476 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 36.5 m0 -110.42 145.58 37.35 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.146 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.591 ' HG2' ' HB2' ' A' ' 268' ' ' ARG . 1.4 pm0 -112.61 115.38 28.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.556 0.694 . . . . 0.0 110.383 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -118.22 164.21 12.87 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.112 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -102.02 110.79 22.84 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.582 ' HB ' HD23 ' A' ' 256' ' ' LEU . 98.7 t -122.76 117.87 53.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.204 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.36 -81.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.369 -175.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -147.32 3.63 0.9 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.364 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.8 mtp-105 -108.31 144.54 35.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.845 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -120.44 121.57 38.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.847 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -144.95 169.24 26.75 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.404 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 95.5 mt -93.56 113.99 26.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.975 0.417 . . . . 0.0 110.225 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -115.51 143.17 30.0 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.565 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.64 149.89 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.256 1.97 . . . . 0.0 112.205 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -65.17 -16.64 63.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.274 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -5.65 56.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.023 0.44 . . . . 0.0 111.597 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 246' ' ' ARG . 63.4 t60 -96.73 -18.76 19.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.01 0.433 . . . . 0.0 110.662 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 242' ' ' ALA . 31.3 m -128.03 170.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.419 -176.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -131.1 126.4 35.69 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.575 HD12 ' HB2' ' A' ' 240' ' ' ALA . 41.5 mm -70.83 130.72 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -133.24 161.26 34.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.033 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -67.76 115.41 27.35 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.27 -25.25 64.66 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.754 2.303 . . . . 0.0 111.991 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -101.87 86.95 3.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.077 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -90.46 113.32 57.19 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.04 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.67 -13.24 22.24 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.359 2.04 . . . . 0.0 111.781 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.22 146.27 26.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.541 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 71.51 -75.4 0.08 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.996 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 303' ' ' GLU . 6.3 t30 -109.19 91.95 3.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -172.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 302' ' ' ASN . 10.7 tp10 . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.523 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.644 0.259 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.8 m -78.45 110.1 13.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.244 0.545 . . . . 0.0 110.667 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 t -142.94 147.86 35.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.258 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -73.6 85.3 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.27 0.557 . . . . 0.0 110.67 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -150.38 92.93 1.92 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.773 0.797 . . . . 0.0 110.652 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -138.88 162.8 33.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.18 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -78.24 93.19 4.58 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 4.5 p -77.26 65.15 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.304 0.573 . . . . 0.0 110.434 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.4 t -175.48 -41.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.079 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.36 104.46 0.5 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.489 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 9.1 mtm-85 -70.51 -14.39 62.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.554 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -85.31 -1.94 57.52 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.1 -47.79 5.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.722 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 30.2 p-90 -114.95 -29.99 6.53 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.43 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 47.9 t80 -75.42 111.21 10.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.628 ' HB3' HG23 ' A' ' 19' ' ' VAL . 10.7 tpp -100.58 1.53 40.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.367 -172.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.6 -114.71 3.23 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.013 -0.994 . . . . 0.0 114.225 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.58 104.3 1.85 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.429 2.086 . . . . 0.0 112.383 -176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.818 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 93.2 t -132.88 -76.35 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 119.256 -0.402 . . . . 0.0 112.037 -174.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.718 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 73.3 m 74.47 167.99 0.29 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -53.36 -32.79 50.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -44.46 -54.72 5.68 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.884 0.74 . . . . 0.0 112.111 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.603 ' HB2' HG12 ' A' ' 19' ' ' VAL . 47.3 mt-10 -95.6 -45.21 7.14 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.262 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.55 -46.65 28.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.28 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.672 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 20.7 mt-30 -64.71 -56.4 13.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.668 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -66.2 -23.44 66.44 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -171.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -86.24 -15.75 39.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.898 0.38 . . . . 0.0 110.692 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.601 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 68.7 mt -121.63 17.89 11.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.593 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 54.8 mm-40 -76.3 70.02 2.87 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.08 -20.04 52.38 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.677 171.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.781 ' HG2' ' HB3' ' A' ' 108' ' ' PRO . 26.1 mp0 -61.79 123.11 17.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.244 0.522 . . . . 0.0 111.477 -175.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.48 ' HB2' ' HE1' ' A' ' 35' ' ' MET . 34.8 mtm180 55.58 -51.56 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.111 1.764 . . . . 0.0 115.19 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 32.0 m170 74.19 134.01 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.571 0.748 . . . . 0.0 109.143 -170.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.15 -3.24 44.13 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -172.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.746 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 76.1 mtm -96.62 147.72 23.6 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.41 ' CD1' HD23 ' A' ' 98' ' ' LEU . 45.8 p90 -146.68 165.94 28.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.613 0.244 . . . . 0.0 110.935 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.45 ' O ' HD13 ' A' ' 37' ' ' LEU . 4.3 pp -152.8 136.04 15.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.94 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.8 t -103.86 122.8 57.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.49 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.818 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 9.6 ptt180 -121.63 165.63 15.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.507 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.402 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 3.9 p30 -85.57 138.8 31.93 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.508 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 8.5 t -74.45 135.73 42.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.212 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.1 t -78.13 -10.32 59.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.639 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -78.39 -48.34 15.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.581 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 41' ' ' SER . 48.4 t -159.03 135.98 6.79 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.37 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.42 5.08 2.1 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.303 2.002 . . . . 0.0 112.728 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.34 8.26 58.69 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.523 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -144.7 160.84 40.55 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.402 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 22.1 m-85 -124.78 164.05 20.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.955 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.503 HG22 HG12 ' A' ' 62' ' ' ILE . 18.6 t -127.56 99.13 5.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 0.0 110.569 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.403 ' CB ' HD12 ' A' ' 63' ' ' ILE . 22.2 tp -78.17 101.31 6.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.134 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 59' ' ' SER . 58.4 m -96.75 131.98 42.91 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.385 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.601 HG23 HD12 ' A' ' 93' ' ' LEU . 47.2 t -119.36 151.82 21.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.835 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.601 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 14.1 t -102.59 119.02 38.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.999 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 1.067 ' HG2' ' HB3' ' A' ' 57' ' ' ARG . 7.1 pm0 -145.61 175.25 10.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 169.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.472 ' HB2' ' C ' ' A' ' 117' ' ' ASN . 6.0 p30 -36.2 89.51 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.391 1.076 . . . . 0.0 113.865 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.631 ' CB ' ' HA ' ' A' ' 116' ' ' PRO . 1.4 m 39.8 62.55 1.2 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.912 0.863 . . . . 0.0 110.023 -173.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 1.067 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -162.14 50.57 0.2 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.027 -154.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 38.2 t -76.62 95.63 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.562 ' OG ' ' HB ' ' A' ' 52' ' ' VAL . 12.5 p -77.88 119.35 21.22 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.281 -172.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -101.11 88.13 3.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.081 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.64 ' CE2' HD23 ' A' ' 93' ' ' LEU . 71.4 m-85 -93.12 112.12 23.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.516 0.327 . . . . 0.0 111.713 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.503 HG12 HG22 ' A' ' 49' ' ' VAL . 43.9 mt -82.17 140.56 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.1 mp -124.2 121.04 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.629 0.771 . . . . 0.0 110.603 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -85.39 135.57 33.82 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.7 t -80.86 103.23 10.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' A' ' 72' ' ' LYS . 83.3 mt -85.6 132.13 45.5 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.877 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.46 -5.84 12.3 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.019 2.48 . . . . 0.0 112.28 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -87.85 14.76 8.12 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.81 31.29 14.2 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.518 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -121.14 176.04 5.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.881 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 58.9 m-85 -139.13 129.24 25.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.105 0.478 . . . . 0.0 110.692 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HB2' HD12 ' A' ' 66' ' ' LEU . 39.7 ttmt -115.94 108.01 15.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.73 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.563 HD12 HD11 ' A' ' 84' ' ' LEU . 15.9 tt -87.5 78.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.642 0.734 . . . . 0.0 110.17 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.551 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 61.68 81.37 0.09 OUTLIER Glycine 0 C--O 1.226 -0.4 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.89 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.812 ' HB2' ' HB2' ' A' ' 211' ' ' GLN . 37.8 t70 75.94 -48.09 0.58 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.962 0.505 . . . . 0.0 112.158 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -66.93 125.01 24.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.632 0.73 . . . . 0.0 111.744 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -84.47 131.79 34.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.129 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -139.53 173.77 11.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.998 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -77.04 -42.95 36.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.974 0.416 . . . . 0.0 110.454 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.496 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 6.8 p80 -172.49 -174.48 1.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.159 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.555 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 13.0 mt -54.4 -60.74 6.88 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.629 ' HB3' ' O ' ' A' ' 8' ' ' SER . 51.5 Cg_exo -58.43 -9.69 7.36 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.411 2.074 . . . . 0.0 113.795 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.48 -35.62 12.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.759 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 73' ' ' ILE . 4.1 pp -76.19 -29.7 57.75 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.323 0.582 . . . . 0.0 109.431 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.17 -30.64 70.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.794 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.402 ' HA ' ' CD ' ' A' ' 89' ' ' LYS . 33.9 tt0 -76.43 -7.98 56.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.37 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -97.23 -37.17 10.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.499 0.666 . . . . 0.0 109.445 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.637 ' CG ' HD21 ' A' ' 93' ' ' LEU . 38.8 m-85 -81.0 -10.32 59.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.466 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.402 ' CD ' ' HA ' ' A' ' 86' ' ' GLU . 22.4 ptmt -81.31 -7.34 59.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.225 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.6 pt -123.74 3.67 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 121.262 0.553 . . . . 0.0 110.619 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 4.5 t-160 -97.13 -40.27 8.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.435 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.707 ' CD2' HG21 ' A' ' 97' ' ' THR . 95.7 m-85 75.17 88.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.416 1.073 . . . . 0.0 110.472 -172.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.64 HD23 ' CE2' ' A' ' 61' ' ' TYR . 2.0 mt -66.51 97.88 0.46 Allowed 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.737 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 9.4 t70 56.33 73.13 0.46 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.021 -175.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 27.2 m 75.32 -39.32 0.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -107.75 139.9 41.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.176 0.512 . . . . 0.0 111.047 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.707 HG21 ' CD2' ' A' ' 92' ' ' TYR . 2.9 p -83.62 177.14 8.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.789 0.328 . . . . 0.0 110.527 176.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.41 HD23 ' CD1' ' A' ' 36' ' ' PHE . 81.5 mt -70.05 98.44 1.31 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 172.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 50.8 mm -84.47 -55.73 6.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.808 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.746 ' O ' ' HA ' ' A' ' 35' ' ' MET . 36.7 tt0 -167.02 141.59 3.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.061 -175.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.12 157.74 28.59 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.556 2.171 . . . . 0.0 112.734 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.43 144.49 57.5 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.818 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.402 ' HD3' ' SD ' ' A' ' 35' ' ' MET . 33.5 Cg_exo -60.42 131.68 39.65 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.569 2.179 . . . . 0.0 111.594 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.457 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 26.3 ptt180 -80.51 30.95 0.29 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.748 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -131.36 135.19 26.66 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.44 53.92 3.22 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.175 2.584 . . . . 0.0 113.131 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.65 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 11.2 t -84.61 -43.94 0.71 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.781 ' HB3' ' HG2' ' A' ' 31' ' ' GLN . 10.1 Cg_endo -52.76 134.88 55.73 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.468 2.112 . . . . 0.0 112.955 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.87 155.78 23.59 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.676 2.251 . . . . 0.0 112.413 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 50.8 ttm -83.99 106.69 15.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.602 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.01 111.77 4.47 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.895 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m -83.84 75.13 10.12 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.834 -0.215 . . . . 0.0 111.477 -176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.607 ' HA ' ' HB2' ' A' ' 121' ' ' ALA . 7.1 p 35.53 84.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.454 1.102 . . . . 0.0 113.966 173.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 m -97.03 -57.52 2.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.292 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.621 ' HB1' ' HG2' ' A' ' 119' ' ' PRO . . . -172.54 144.8 1.35 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.762 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.631 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 6.3 Cg_exo -79.81 168.08 19.69 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.964 2.442 . . . . 0.0 112.512 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.591 ' H ' ' HB2' ' A' ' 56' ' ' SER . 10.6 m120 73.03 8.5 5.4 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 173.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.903 ' HB3' ' HD3' ' A' ' 119' ' ' PRO . 1.0 OUTLIER -169.64 -68.35 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.167 169.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.903 ' HD3' ' HB3' ' A' ' 118' ' ' LEU . 37.3 Cg_exo -61.74 -76.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 122.478 2.119 . . . . 0.0 114.034 -173.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.622 ' N ' ' HG ' ' A' ' 56' ' ' SER . 13.5 t -172.19 169.22 5.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.528 -173.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' A' ' 113' ' ' VAL . . . 80.84 144.99 0.08 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.486 1.114 . . . . 0.0 112.917 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.428 ' OE2' ' HB ' ' A' ' 58' ' ' VAL . 54.9 mt-10 -94.9 119.19 33.04 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.312 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.41 ' HB3' ' HG3' ' A' ' 116' ' ' PRO . 26.4 t70 -152.78 -77.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.411 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 1.9 t-20 -82.65 168.66 17.06 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.579 HD11 HG22 ' A' ' 152' ' ' ILE . 2.2 mm? 65.88 94.05 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.635 0.584 . . . . 0.0 109.887 -175.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 5.2 tp10 -165.86 -76.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.413 -171.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 180' ' ' LYS . 28.5 m-85 -106.01 124.4 49.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.753 -171.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.789 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 22.3 t -133.22 151.36 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.112 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG2' ' HB3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -131.02 142.11 50.29 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.681 162.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.465 HG23 HG13 ' A' ' 178' ' ' VAL . 1.8 p -97.94 140.22 32.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.914 0.387 . . . . 0.0 111.949 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 61.8 mt -108.55 -22.63 12.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.14 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 57.0 t80 -92.33 -35.04 13.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -167.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.532 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 7.0 t70 76.01 113.19 0.07 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.337 0.589 . . . . 0.0 110.395 -174.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 71.4 t80 -147.19 109.51 3.96 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.068 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.692 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 20.9 Cg_endo -92.91 102.28 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.53 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.694 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -95.12 4.27 67.47 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.365 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.7 m120 57.54 20.63 6.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.331 0.653 . . . . 0.0 112.547 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.471 ' N ' ' HD3' ' A' ' 143' ' ' PRO . 1.9 p30 52.2 -175.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 173.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 69.09 7.2 6.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.494 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -169.39 -45.7 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.241 -1.345 . . . . 0.0 108.361 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.694 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 24.2 m-20 -140.85 116.04 9.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.759 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.672 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 25.2 tp -67.53 120.57 74.03 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.617 0.246 . . . . 0.0 110.937 -174.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.692 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 43.6 Cg_endo -75.13 95.59 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.031 1.821 . . . . 0.0 111.346 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.429 ' HB2' ' HG1' ' A' ' 130' ' ' THR . 10.0 p90 -104.6 172.58 6.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.567 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.42 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 8.7 ttmm -122.52 -178.14 3.82 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.941 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.6 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -84.02 75.18 10.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.458 0.647 . . . . 0.0 109.604 177.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.9 33.83 0.54 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.171 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 6.7 mm-40 -94.62 154.95 17.1 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 129' ' ' ARG . 40.0 mm -103.85 125.84 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 165' ' ' ASN . 32.9 mt -118.82 156.77 28.85 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 59.8 t -124.83 129.79 73.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.579 HG22 HD11 ' A' ' 125' ' ' LEU . 30.6 mm -74.55 86.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.384 1.088 . . . . 0.0 109.073 -176.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 210' ' ' PRO . 10.4 tt -75.18 -26.42 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.341 -174.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.767 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 44.5 mt-10 -146.69 143.91 29.08 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -125.34 87.44 55.64 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 121.46 -0.775 . . . . 0.0 111.026 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.509 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 16.8 Cg_exo -70.62 -62.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.387 2.058 . . . . 0.0 112.542 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -109.63 -174.8 2.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.845 0.355 . . . . 0.0 111.748 -171.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -95.81 -29.15 14.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.324 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -96.18 -22.53 17.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.155 0.502 . . . . 0.0 110.82 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.614 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 42.5 m95 -128.93 124.55 35.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.67 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -107.42 164.87 11.83 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.767 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 29.3 m -113.13 106.66 14.92 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.926 -0.484 . . . . 0.0 109.748 174.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -115.95 158.92 22.3 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.388 -176.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.675 HH12 ' HA ' ' A' ' 208' ' ' ALA . 13.2 ptt180 -95.48 132.43 40.58 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.355 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.672 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 63.0 t30 -72.0 171.35 12.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.522 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -59.31 -29.79 67.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.45 -43.43 94.28 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.753 ' HA3' ' HA ' ' A' ' 211' ' ' GLN . . . 105.02 67.43 0.7 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.866 -176.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -143.73 160.01 41.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.414 HG22 HD11 ' A' ' 153' ' ' ILE . 37.5 t -101.75 125.57 55.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.307 0.575 . . . . 0.0 111.986 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.6 161.9 30.44 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.614 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 25.6 mtp -81.07 144.25 31.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.179 0.489 . . . . 0.0 110.271 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.494 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.7 pp -139.66 143.4 35.02 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.875 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.488 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 3.0 Cg_exo -76.3 132.65 13.94 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.897 2.398 . . . . 0.0 112.561 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.579 ' O ' HG21 ' A' ' 178' ' ' VAL . 60.3 t -62.8 -43.03 81.87 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 23.2 Cg_endo -62.57 -4.39 5.56 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.953 1.769 . . . . 0.0 113.302 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -99.64 -8.57 24.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.592 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.579 HG21 ' O ' ' A' ' 175' ' ' VAL . 10.5 m -107.24 -178.33 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 122.265 1.031 . . . . 0.0 113.576 -168.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.717 ' HB3' ' HG2' ' A' ' 129' ' ' ARG . 23.6 tt0 -154.46 42.13 0.49 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.098 -1.865 . . . . 0.0 109.221 -165.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.951 ' HE3' ' HB2' ' A' ' 183' ' ' ARG . 0.1 OUTLIER -77.69 137.74 38.68 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 120.432 -1.418 . . . . 0.0 108.817 -167.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -30.51 -76.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 113.303 -1.771 . . . . 0.0 114.085 -157.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.8 t -118.88 110.49 30.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.415 -175.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.951 ' HB2' ' HE3' ' A' ' 180' ' ' LYS . 18.2 ttt180 -170.07 99.53 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 173.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.5 t -134.83 97.72 3.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.262 0.553 . . . . 0.0 110.194 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.421 ' HB3' ' HE1' ' A' ' 187' ' ' HIS . 8.3 t -88.53 136.43 31.37 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.65 127.28 22.13 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.589 2.193 . . . . 0.0 112.363 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 190' ' ' HIS . 80.3 m80 -139.35 170.62 15.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -58.92 -59.19 11.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.457 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -125.79 59.2 1.3 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.96 0.409 . . . . 0.0 110.434 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 187' ' ' HIS . 51.0 t60 -161.5 118.25 2.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.697 173.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -172.45 -158.64 17.17 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.886 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -142.98 143.49 31.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.726 0.298 . . . . 0.0 110.327 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -84.76 -40.43 17.26 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -156.46 140.76 16.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.98 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 51.8 m -143.4 114.74 7.96 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -143.75 113.63 7.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.365 0.602 . . . . 0.0 110.779 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.49 ' HB3' HD13 ' A' ' 200' ' ' ILE . 38.8 m -149.19 83.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.847 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -94.73 -36.49 11.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.795 -174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -88.94 32.68 4.5 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.538 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.628 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 2.6 mp -114.1 -54.14 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 119.751 -0.166 . . . . 0.0 111.225 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 16.2 Cg_exo -68.59 106.94 1.53 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.155 1.903 . . . . 0.0 112.711 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -118.27 109.38 40.68 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.457 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.46 94.8 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.688 2.259 . . . . 0.0 111.838 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -96.2 -51.11 4.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.488 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -152.61 93.2 1.75 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.789 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -76.85 90.23 3.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.233 0.539 . . . . 0.0 111.658 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.675 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -91.39 39.38 1.0 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.399 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.483 ' HG2' ' HB ' ' A' ' 62' ' ' ILE . 39.5 mt-30 -61.29 146.01 89.51 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.551 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 52.8 Cg_exo -57.15 -51.44 8.69 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 121.936 1.757 . . . . 0.0 110.76 172.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.812 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 50.2 tt0 -85.09 111.06 19.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.524 ' HB ' ' HE ' ' A' ' 164' ' ' ARG . 15.2 t -62.08 -39.92 94.06 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.185 -0.206 . . . . 0.0 110.715 -176.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 25.2 m 68.83 -63.01 0.37 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.929 0.492 . . . . 0.0 111.774 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 4.7 m 62.63 78.18 0.31 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.78 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.74 128.81 5.37 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.885 2.39 . . . . 0.0 111.262 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.733 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 6.3 mp -103.78 -58.24 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.618 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.733 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 27.9 Cg_exo -63.28 -19.83 69.25 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.286 1.991 . . . . 0.0 112.539 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -86.0 21.12 2.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.661 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.558 HG21 ' H ' ' A' ' 221' ' ' GLY . 11.5 p -89.25 132.48 33.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.056 0.455 . . . . 0.0 110.276 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 11.0 p -91.72 -12.91 32.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.959 0.409 . . . . 0.0 110.923 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.558 ' H ' HG21 ' A' ' 219' ' ' VAL . . . 88.53 -116.32 4.59 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 9.5 t 69.37 100.71 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.059 0.544 . . . . 0.0 111.615 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.93 167.75 25.52 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.505 2.137 . . . . 0.0 111.919 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -81.43 70.27 3.13 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.379 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.53 -35.09 17.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.628 0.251 . . . . 0.0 110.666 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 57.14 -171.58 0.09 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.863 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.2 tt -89.32 -38.48 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.215 0.531 . . . . 0.0 109.575 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.7 p -134.31 112.63 12.07 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.992 177.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.94 -32.05 92.11 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.712 2.275 . . . . 0.0 112.178 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -146.46 108.82 4.17 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.02 116.96 3.67 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 111.987 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 12.3 t -84.18 124.83 31.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.003 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 12.5 p -102.43 154.93 18.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.127 0.489 . . . . 0.0 111.44 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.402 ' HB2' ' HZ2' ' A' ' 283' ' ' LYS . 18.0 pt20 -130.38 27.3 5.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.554 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.675 HD21 ' N ' ' A' ' 235' ' ' ASN . 0.0 OUTLIER -171.49 119.44 0.46 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.118 -164.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.822 ' HA3' ' HB3' ' A' ' 276' ' ' GLU . . . -133.64 -175.92 14.15 Favored Glycine 0 C--O 1.19 -2.639 0 CA-C-O 118.474 -1.181 . . . . 0.0 111.498 177.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 1.041 ' HB3' ' HE3' ' A' ' 269' ' ' MET . 0.0 OUTLIER -14.42 -134.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.519 3.017 2 C-N-CA 130.787 7.658 . . . . 0.0 124.952 -168.747 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.764 ' N ' HG12 ' A' ' 266' ' ' VAL . 88.8 t -131.52 131.84 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.965 -1.085 . . . . 0.0 111.988 -165.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.991 ' HB2' ' HA ' ' A' ' 265' ' ' LYS . 0.0 OUTLIER -69.21 130.61 43.12 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.333 1.063 . . . . 0.0 111.996 -160.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.545 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -148.63 159.41 44.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.802 -168.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -91.3 135.78 33.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.556 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -77.56 126.5 30.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 31.9 pt -101.75 -6.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.439 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.32 155.63 43.25 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.583 ' HB3' HG22 ' A' ' 260' ' ' VAL . 18.4 pttp -113.88 137.02 52.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.749 0.309 . . . . 0.0 110.777 174.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.535 ' HG3' ' HE1' ' A' ' 290' ' ' HIS . 0.0 OUTLIER -174.72 137.61 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 1.066 HG13 ' HD3' ' A' ' 248' ' ' PRO . 0.2 OUTLIER -95.61 -52.33 0.23 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 119.248 -0.406 . . . . 0.0 112.041 178.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 1.066 ' HD3' HG13 ' A' ' 247' ' ' VAL . 33.6 Cg_endo -95.53 143.8 1.22 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.119 1.88 . . . . 0.0 111.997 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 45.7 t -84.76 58.94 5.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 65.9 -66.21 0.16 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.798 0.839 . . . . 0.0 111.453 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -102.53 -11.01 18.84 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.199 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 31.4 t70 67.32 106.76 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.917 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -135.68 86.39 2.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.765 174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.7 p 51.4 57.6 6.42 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.987 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -89.64 147.77 23.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.577 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.39 110.15 22.29 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 247' ' ' VAL . . . -56.75 105.48 0.22 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.514 0.509 . . . . 0.0 110.588 177.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.601 HD21 HG23 ' A' ' 279' ' ' VAL . 90.8 mt -118.38 130.59 56.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.018 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -111.79 173.7 6.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.038 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.583 HG22 ' HB3' ' A' ' 245' ' ' LYS . 57.7 t -75.58 124.57 33.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 112.109 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 88.25 25.31 31.52 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.383 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.28 150.84 36.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.135 0.468 . . . . 0.0 110.389 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 30.7 mm -86.52 123.19 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.317 0.579 . . . . 0.0 111.639 -175.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.705 ' HA ' HG22 ' A' ' 279' ' ' VAL . 44.7 t -101.07 103.2 14.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.772 177.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.991 ' HA ' ' HB2' ' A' ' 239' ' ' PHE . 18.0 ttpp -86.03 86.5 7.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.006 0.432 . . . . 0.0 110.667 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.764 HG12 ' N ' ' A' ' 238' ' ' VAL . 13.7 p -105.29 136.46 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 236' ' ' GLY . 15.3 t -124.55 -14.41 6.85 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -167.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.536 ' H ' ' C ' ' A' ' 236' ' ' GLY . 35.1 ttt180 -135.78 98.64 3.96 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 120.921 1.691 . . . . 0.0 111.744 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 1.041 ' HE3' ' HB3' ' A' ' 237' ' ' PRO . 34.1 ttm -79.1 140.29 37.88 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -162.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.572 ' H ' ' HG3' ' A' ' 237' ' ' PRO . 83.2 m-20 -98.3 137.0 37.67 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.734 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.6 tt -75.93 -8.35 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.267 0.556 . . . . 0.0 110.623 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -69.21 -28.51 66.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.945 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 109.48 -17.79 30.68 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.696 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.1 118.82 29.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.864 ' HA ' ' HG2' ' A' ' 237' ' ' PRO . 47.3 m0 -98.85 145.03 27.4 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.051 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.953 ' H ' ' HD2' ' A' ' 237' ' ' PRO . 38.7 tt0 -117.93 97.41 5.81 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.275 0.56 . . . . 0.0 109.741 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -107.61 150.73 16.9 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.153 -168.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -104.65 109.83 21.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 264' ' ' VAL . 60.4 t -114.39 91.27 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.083 0.468 . . . . 0.0 110.453 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 54.37 55.89 7.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.814 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 97.71 -28.33 14.86 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.512 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.1 mtm105 -104.39 118.48 36.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.945 0.373 . . . . 0.0 110.377 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 47.9 pttt -121.31 142.44 49.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.084 0.468 . . . . 0.0 111.882 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -171.07 -174.48 38.91 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.484 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 87.0 mt -93.38 144.75 25.04 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.583 0.706 . . . . 0.0 111.905 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.486 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 36.1 p90 -149.77 151.41 32.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.999 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.442 ' HG2' ' HB2' ' A' ' 290' ' ' HIS . 60.8 Cg_endo -74.34 151.71 43.39 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.261 1.974 . . . . 0.0 112.26 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -64.25 -21.34 66.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.636 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.2 m -77.22 -8.53 57.73 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.229 0.538 . . . . 0.0 110.992 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.535 ' HE1' ' HG3' ' A' ' 246' ' ' ARG . 16.5 t60 -86.03 -22.01 27.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.157 0.503 . . . . 0.0 110.631 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' A' ' 242' ' ' ALA . 35.0 m -128.31 178.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.501 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -141.29 136.91 32.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.524 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.545 HD12 ' HB2' ' A' ' 240' ' ' ALA . 47.2 mm -81.68 102.82 7.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -100.23 14.44 30.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.825 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 53.58 70.72 1.64 Allowed Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.348 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.76 -22.34 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.119 2.546 . . . . 0.0 113.634 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -140.63 19.84 2.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.03 0.443 . . . . 0.0 110.864 -176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -140.14 115.56 7.82 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.339 0.59 . . . . 0.0 110.625 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -86.69 41.61 0.8 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.161 2.574 . . . . 0.0 111.881 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -114.42 127.31 55.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.503 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -87.52 -0.9 57.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.999 170.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.579 ' ND2' ' HG2' ' A' ' 303' ' ' GLU . 0.2 OUTLIER 64.45 -95.56 0.04 OUTLIER 'General case' 0 C--O 1.23 0.067 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.839 -178.029 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . 0.579 ' HG2' ' ND2' ' A' ' 302' ' ' ASN . 6.0 pt-20 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 117.622 -1.18 . . . . 0.0 109.573 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.714 ' HG3' ' HE2' ' A' ' 89' ' ' LYS . 25.8 mmt . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.859 0.362 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.8 p -87.39 -57.43 2.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.99 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -128.74 100.61 5.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.977 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -179.65 135.72 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.445 0.466 . . . . 0.0 111.054 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -113.9 -68.07 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 5.4 m-85 62.96 165.28 0.11 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -109.53 -39.35 5.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.818 161.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.2 m 64.68 147.56 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.037 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.0 p 61.15 -49.65 0.12 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.988 1.315 . . . . 0.0 113.875 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -57.31 107.01 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 111.586 -172.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.587 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -61.97 -22.81 65.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.479 -178.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.2 t -79.32 -15.96 57.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.641 0.258 . . . . 0.0 110.862 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.93 -49.03 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.168 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -110.83 -22.81 11.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.587 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 56.2 t80 -85.57 113.13 21.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.708 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 9.6 tpp -97.42 -1.16 44.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.555 -172.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.44 -115.43 3.75 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.159 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.1 Cg_exo -74.75 103.61 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.842 2.361 . . . . 0.0 112.187 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.639 ' HB ' ' CB ' ' A' ' 39' ' ' ARG . 88.3 t -137.36 -74.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 60.0 m 76.02 172.12 0.25 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.467 ' HD2' ' HB2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -51.95 -43.69 63.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -174.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -60.37 -38.04 82.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -92.35 -44.79 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.385 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . -55.84 -37.56 68.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.882 0.372 . . . . 0.0 111.121 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 64.9 tt0 -67.37 -52.83 35.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.908 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -72.71 -14.25 61.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 0.0 111.425 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -78.65 -44.07 24.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.565 0.697 . . . . 0.0 110.055 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 16.1 mt -104.25 12.07 34.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.491 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 20.8 tt0 -76.87 104.45 7.37 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.618 0.723 . . . . 0.0 110.573 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' H ' ' NE2' ' A' ' 31' ' ' GLN . . . 118.02 -20.82 10.53 Favored Glycine 0 CA--C 1.499 -0.917 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.909 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER 40.11 111.02 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 112.592 -1.804 . . . . 0.0 115.185 172.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.719 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 39.6 ttp180 -68.84 -10.22 55.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.959 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.549 ' HE1' ' HG3' ' A' ' 119' ' ' PRO . 32.3 m170 74.26 122.5 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.113 176.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.54 19.99 49.83 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.059 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 35.8 mtm -115.49 147.58 40.48 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.454 ' HB2' HD13 ' A' ' 50' ' ' LEU . 40.0 p90 -147.44 158.85 44.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.129 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.4 pp -150.95 135.35 16.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.218 0.533 . . . . 0.0 110.507 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.11 115.58 44.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.113 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.639 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.68 -173.44 2.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.05 0.452 . . . . 0.0 112.048 -176.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 7.3 p-10 -71.23 138.06 49.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.874 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -100.42 89.14 3.86 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 168.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 p -71.75 11.82 0.46 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.449 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 t -100.19 -8.51 23.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 50.3 t -164.76 110.0 0.84 Allowed Pre-proline 0 CA--C 1.528 0.121 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.079 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.04 115.83 2.83 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.966 2.444 . . . . 0.0 112.466 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.48 -41.94 1.78 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.049 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.64 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 3.3 m-20 -74.3 158.66 33.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.723 0.297 . . . . 0.0 110.483 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -134.68 173.91 11.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.695 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.622 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 58.4 t -137.94 109.38 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 111.007 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.454 HD13 ' HB2' ' A' ' 36' ' ' PHE . 26.2 tp -81.03 104.55 11.6 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.536 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 m -95.46 120.95 36.6 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.856 0.36 . . . . 0.0 110.34 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 22.1 t -120.4 142.55 35.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.909 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 89.2 p -121.99 133.56 54.82 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.531 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' CB ' ' HB3' ' A' ' 94' ' ' ASP . 1.9 tm-20 -147.94 178.15 8.75 Favored 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -16.94 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.461 ' HA ' ' CD ' ' A' ' 31' ' ' GLN . 36.3 m 35.91 72.13 0.11 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.706 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.88 ' HD2' ' HB3' ' A' ' 155' ' ' LYS . 9.8 ttp85 -168.51 52.93 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.743 -158.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 25.3 t -77.68 101.62 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 122.07 0.938 . . . . 0.0 109.651 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 m -93.21 121.22 34.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.323 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -94.25 89.45 5.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.283 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.444 ' HB3' HD11 ' A' ' 73' ' ' ILE . 88.0 m-85 -84.81 115.07 22.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.725 0.41 . . . . 0.0 110.786 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.599 HD13 ' HG2' ' A' ' 209' ' ' GLN . 63.1 mt -81.3 140.0 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -174.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.619 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.6 mp -115.75 121.19 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.597 0.759 . . . . 0.0 110.568 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.64 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 8.3 m120 -85.74 146.28 26.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.916 0.487 . . . . 0.0 111.566 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.0 t -93.18 99.18 11.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.924 174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.4 mt -84.22 142.91 41.44 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.48 -28.78 46.31 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.617 2.878 . . . . 0.0 114.115 -172.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -91.63 20.15 5.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.412 -0.18 . . . . 0.0 111.383 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.533 ' HD2' ' HB3' ' A' ' 280' ' ' ASN . 0.0 OUTLIER 67.43 40.21 2.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.139 0.495 . . . . 0.0 111.045 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -113.61 148.24 36.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.49 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 58.7 m-85 -114.71 115.77 27.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.936 0.398 . . . . 0.0 111.297 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 39.5 ttpt -110.77 105.94 14.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.538 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.619 ' HB ' HG13 ' A' ' 63' ' ' ILE . 10.2 tt -81.74 76.99 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.842 0.83 . . . . 0.0 110.175 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.837 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 60.73 95.15 0.01 OUTLIER Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.547 178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.637 ' HB2' ' HG1' ' A' ' 212' ' ' THR . 15.9 t70 74.93 -49.51 0.66 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.849 0.357 . . . . 0.0 111.498 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -85.15 113.25 21.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 11.6 pt-20 -101.7 134.96 44.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.317 0.579 . . . . 0.0 110.816 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 80.1 m-85 -121.73 174.14 7.02 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.956 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.27 -46.89 85.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.026 0.441 . . . . 0.0 110.885 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -166.47 -178.07 4.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.427 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.498 HD23 HD21 ' A' ' 84' ' ' LEU . 16.4 mt -55.19 -57.49 19.78 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.51 25.46 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.062 1.841 . . . . 0.0 112.831 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 81' ' ' LEU . . . -119.81 -34.86 3.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.951 175.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.498 HD21 HD23 ' A' ' 81' ' ' LEU . 3.7 pp -76.68 -30.82 56.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.214 0.531 . . . . 0.0 109.968 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.6 mt -64.57 -41.48 96.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.403 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.618 ' HA ' ' HD2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -69.5 -4.08 17.31 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.562 178.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -96.21 -37.69 10.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.812 0.815 . . . . 0.0 109.637 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.475 ' CD1' HD22 ' A' ' 93' ' ' LEU . 46.7 m-85 -77.37 -2.92 37.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.506 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.714 ' HE2' ' HG3' ' A' ' 1' ' ' MET . 16.5 ptmt -78.86 -11.11 59.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.607 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.99 -12.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 120.936 0.398 . . . . 0.0 110.88 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -75.46 -29.68 59.71 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.827 ' HA ' HG21 ' A' ' 97' ' ' THR . 23.0 m-85 59.14 55.21 4.48 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.7 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.556 ' HA ' ' OE1' ' A' ' 154' ' ' GLU . 3.4 pp -60.9 123.27 17.08 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 118.463 -1.295 . . . . 0.0 107.518 169.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 1.9 m-20 81.6 -2.5 1.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.28 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.786 ' OG1' ' HB3' ' A' ' 156' ' ' PRO . 33.6 m 55.99 75.55 0.33 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 122.054 0.93 . . . . 0.0 110.665 -172.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.431 ' O ' HD13 ' A' ' 99' ' ' ILE . 1.8 m 179.06 -34.32 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.211 177.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.827 HG21 ' HA ' ' A' ' 92' ' ' TYR . 4.8 p 73.38 -172.17 0.13 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.641 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 35.0 mt -85.65 94.13 9.0 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.478 173.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 96' ' ' THR . 49.7 mm -68.79 -56.87 10.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.549 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 11.2 pt-20 -157.5 163.56 24.42 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.497 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 100' ' ' GLU . 40.4 Cg_endo -67.32 153.09 78.06 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.129 1.886 . . . . 0.0 113.026 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -71.98 143.34 86.36 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.467 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 24.0 Cg_exo -64.57 155.94 63.74 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.548 2.165 . . . . 0.0 112.066 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.708 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 14.1 mtm180 -93.94 -79.93 0.4 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 65.0 120.6 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 124.043 0.839 . . . . 0.0 112.881 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.67 -11.6 22.14 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.516 2.144 . . . . 0.0 111.385 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.7 t -140.25 129.17 13.23 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.023 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.88 111.98 2.34 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.828 2.352 . . . . 0.0 111.91 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.58 -31.09 1.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.45 2.1 . . . . 0.0 112.763 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 97.1 mmm 62.4 175.28 0.14 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.781 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.17 118.73 1.05 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.742 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.3 m -155.25 85.2 1.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.93 -27.06 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.722 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 p -103.32 87.49 2.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.117 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.475 ' CB ' ' HG3' ' A' ' 32' ' ' ARG . . . -169.49 143.54 2.3 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.428 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.409 ' HD2' ' O ' ' A' ' 32' ' ' ARG . 1.3 Cg_endo -86.03 30.81 0.48 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 123.849 3.032 . . . . 0.0 111.999 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.719 ' OD1' ' HA ' ' A' ' 32' ' ' ARG . 5.0 m-20 -50.52 142.37 10.82 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.697 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.1 mt 49.2 74.21 0.85 Allowed Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.807 174.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.549 ' HG3' ' HE1' ' A' ' 33' ' ' HIS . 72.8 Cg_endo -93.41 -36.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.571 2.18 . . . . 0.0 111.859 168.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.404 ' H ' ' CD ' ' A' ' 119' ' ' PRO . 90.5 m -160.85 145.86 14.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.32 103.97 16.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -93.96 118.37 31.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.229 -172.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -136.12 -11.94 1.93 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.582 0.706 . . . . 0.0 109.818 176.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.694 ' HA ' HG11 ' A' ' 182' ' ' VAL . 0.9 OUTLIER -79.47 -12.2 59.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.028 -178.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.598 HD11 HG23 ' A' ' 152' ' ' ILE . 3.5 mm? -100.49 107.07 18.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.244 -173.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -170.14 -81.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.878 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -104.66 124.63 49.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.207 0.527 . . . . 0.0 110.655 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.68 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 61.4 t -133.53 137.15 53.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.407 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.599 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 2.3 ptp180 -114.31 146.67 40.19 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.066 167.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.559 HG23 HG13 ' A' ' 178' ' ' VAL . 2.1 p -103.58 135.28 45.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.017 0.436 . . . . 0.0 111.577 -176.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.574 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 78.3 mt -101.46 -40.1 7.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.421 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 23.1 t80 -74.28 -35.12 63.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -168.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.56 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.1 t70 73.47 107.34 0.07 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.247 0.546 . . . . 0.0 110.095 -177.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 77.3 t80 -140.92 103.25 6.26 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.764 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 33.7 Cg_endo -90.08 93.06 0.3 Allowed 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.378 2.052 . . . . 0.0 112.11 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -83.31 -21.16 59.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.014 174.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.9 m120 48.22 47.58 19.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.492 -0.854 . . . . 0.0 111.967 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.653 ' HB3' ' HB2' ' A' ' 141' ' ' ASP . 20.1 t70 -141.14 161.04 38.8 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.55 -7.12 53.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.271 0.558 . . . . 0.0 110.98 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.674 ' O ' ' HB2' ' A' ' 172' ' ' MET . 1.4 mp0 -125.62 15.51 8.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.695 172.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.653 ' HB2' ' HB3' ' A' ' 138' ' ' ASP . 20.4 m-20 -146.61 87.75 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.561 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 27.1 tp -69.76 119.96 74.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.49 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.764 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 59.2 Cg_endo -73.99 90.97 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.221 1.948 . . . . 0.0 111.434 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 11.4 p90 -99.6 158.74 15.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.56 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 72.9 mmtt -98.94 178.75 4.85 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.278 0.561 . . . . 0.0 111.322 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.76 18.21 2.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.596 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.64 29.87 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.35 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 145' ' ' LYS . 24.0 tt0 -99.81 156.64 17.0 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 129' ' ' ARG . 50.4 mm -99.02 133.52 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 57.4 mt -120.54 157.04 30.32 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.14 132.47 70.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 125' ' ' LEU . 35.5 mm -75.09 88.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 122.184 0.992 . . . . 0.0 109.633 -176.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.436 HG22 HG21 ' A' ' 170' ' ' VAL . 21.5 tt -76.96 -31.32 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.189 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.99 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 65.5 mt-10 -132.63 141.46 48.66 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 171.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.88 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 1.9 tptm -129.8 84.14 61.95 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 122.305 1.05 . . . . 0.0 109.357 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.786 ' HB3' ' OG1' ' A' ' 95' ' ' THR . 19.3 Cg_exo -77.73 -66.78 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.413 2.742 . . . . 0.0 113.308 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -94.55 175.93 6.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.956 -172.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.78 -10.26 20.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -123.46 -3.34 8.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.272 0.558 . . . . 0.0 110.602 173.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.653 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 58.4 m95 -129.75 125.74 36.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.395 173.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.752 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.4 m0 -122.22 135.68 54.79 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.31 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.99 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.6 m -90.28 92.8 9.08 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.192 0.52 . . . . 0.0 109.632 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.54 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -94.22 163.27 13.51 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.939 0.4 . . . . 0.0 110.657 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.585 HH12 ' HA ' ' A' ' 208' ' ' ALA . 13.3 ptt180 -100.78 132.3 46.25 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.44 0.638 . . . . 0.0 110.583 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.561 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -50.3 139.06 15.65 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.467 172.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 166' ' ' LYS . 12.4 tmtt? -56.85 -27.0 59.7 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 215' ' ' PRO . 67.1 m-20 -99.93 9.6 42.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.583 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.644 ' HA3' HG23 ' A' ' 212' ' ' THR . . . 95.5 83.11 1.63 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.21 -0.995 . . . . 0.0 115.279 166.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 169' ' ' ARG . 2.5 ptp180 -173.04 157.63 3.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.508 0.194 . . . . 0.0 110.488 162.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.436 HG21 HG22 ' A' ' 153' ' ' ILE . 48.0 t -98.32 129.91 47.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 142' ' ' LEU . . . -154.44 152.79 24.31 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.102 172.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.674 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -73.45 138.44 45.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.652 0.263 . . . . 0.0 110.461 177.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -136.71 144.65 47.84 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.74 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.933 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 23.7 Cg_exo -68.22 139.12 45.19 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.28 2.653 . . . . 0.0 112.989 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.645 ' O ' HG23 ' A' ' 178' ' ' VAL . 88.0 t -76.34 -47.61 3.35 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.7 Cg_endo -66.08 6.43 0.49 Allowed 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.994 1.796 . . . . 0.0 111.909 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.933 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 1.2 m-85 -105.76 -1.64 24.16 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.439 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 175' ' ' VAL . 12.9 m -116.75 -167.04 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -169.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.599 ' HB3' ' HG3' ' A' ' 129' ' ' ARG . 7.7 tp10 -157.97 41.31 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.705 -1.588 . . . . 0.0 108.791 -163.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -79.61 137.98 37.29 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.987 -1.07 . . . . 0.0 111.466 -167.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.4 mt -55.32 -44.56 75.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.782 -1.554 . . . . 0.0 114.05 -165.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.694 HG11 ' HA ' ' A' ' 124' ' ' ASN . 35.8 t -56.77 -37.86 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -168.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.447 ' HD2' ' HE2' ' A' ' 180' ' ' LYS . 79.2 mtt180 -92.03 18.87 7.36 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.89 -0.506 . . . . 0.0 111.337 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.6 t -152.6 58.91 0.81 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.254 0.549 . . . . 0.0 109.819 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.484 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 67.6 m -140.24 148.65 55.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.108 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 190' ' ' HIS . 9.3 Cg_endo -53.08 -59.08 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.079 2.519 . . . . 0.0 112.791 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.484 ' CE1' ' HB2' ' A' ' 185' ' ' SER . 42.1 m80 67.95 -70.05 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.069 0.548 . . . . 0.0 111.356 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.49 -68.75 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.236 -0.507 . . . . 0.0 111.909 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.23 -30.38 38.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.72 0.295 . . . . 0.0 111.125 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 186' ' ' PRO . 83.1 t60 -79.94 60.34 3.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.486 0.66 . . . . 0.0 110.791 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 93.87 40.85 4.53 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.783 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.429 ' HA ' HH21 ' A' ' 193' ' ' ARG . 84.6 m-20 62.15 -163.28 0.27 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.797 0.332 . . . . 0.0 110.725 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.429 HH21 ' HA ' ' A' ' 192' ' ' ASN . 0.1 OUTLIER -99.74 -74.86 0.58 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 63.2 -76.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.028 0.83 . . . . 0.0 112.102 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.2 t -75.02 104.78 5.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.96 0.41 . . . . 0.0 110.051 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -146.63 69.25 1.18 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.625 0.726 . . . . 0.0 109.663 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 21.5 t -115.63 110.57 19.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.005 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -87.13 -45.58 10.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.947 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 59.06 -119.53 18.44 Favored Glycine 0 N--CA 1.453 -0.187 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.364 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 9.4 tt -140.03 92.75 9.58 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 121.64 0.733 . . . . 0.0 110.359 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.712 ' HB2' ' HB3' ' A' ' 204' ' ' ALA . 71.6 Cg_endo -81.57 112.83 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.703 2.269 . . . . 0.0 112.205 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.583 ' HB2' ' HD3' ' A' ' 203' ' ' PRO . 33.4 mt-10 -71.77 -53.55 7.07 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.24 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' A' ' 202' ' ' GLU . 3.3 Cg_exo -81.38 19.42 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.416 2.078 . . . . 0.0 112.899 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.712 ' HB3' ' HB2' ' A' ' 201' ' ' PRO . . . -80.85 8.05 9.12 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -64.41 113.4 3.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.951 0.405 . . . . 0.0 110.202 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.66 80.04 7.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 111.855 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.505 ' HE2' HG12 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.585 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -103.32 25.58 9.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.191 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.599 ' HG2' HD13 ' A' ' 62' ' ' ILE . 4.0 pp0? -71.89 142.43 85.51 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.837 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 73.0 Cg_exo -53.45 -14.33 4.58 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 C-N-CA 123.724 2.95 . . . . 0.0 114.807 -172.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 75.01 86.88 0.09 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.646 0.591 . . . . 0.0 112.374 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.644 HG23 ' HA3' ' A' ' 168' ' ' GLY . 0.7 OUTLIER -134.05 86.67 2.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.855 174.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 11.8 m -112.41 -58.05 2.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.038 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.2 m -148.01 100.55 3.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.018 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.439 ' HA ' ' OD1' ' A' ' 167' ' ' ASP . 8.2 Cg_exo -73.57 150.08 45.06 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 123.037 2.491 . . . . 0.0 112.294 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.502 ' CD1' ' HZ2' ' A' ' 166' ' ' LYS . 10.1 mp -66.71 -49.06 51.59 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.821 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 216' ' ' LEU . 64.1 Cg_endo -72.45 13.54 0.55 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.251 1.967 . . . . 0.0 112.954 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -113.67 112.62 23.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.086 0.469 . . . . 0.0 110.657 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.7 m -105.34 -13.86 9.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.228 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.4 m 65.23 169.66 0.2 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.61 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -90.15 175.08 41.04 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.4 t 64.44 84.22 0.18 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.036 0.446 . . . . 0.0 110.116 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.64 -5.69 17.59 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.201 2.601 . . . . 0.0 112.33 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -84.39 140.24 18.84 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.123 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.44 -8.49 47.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.205 0.526 . . . . 0.0 110.372 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -101.82 88.58 3.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.119 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 69.5 mt -99.13 108.17 21.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 13.6 m -59.49 117.86 26.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.016 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 228' ' ' THR . 6.3 Cg_exo -79.2 64.69 8.87 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.263 2.642 . . . . 0.0 111.149 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.691 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 46.5 tp -78.11 -53.54 1.38 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.863 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.691 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 16.4 Cg_exo -68.69 -22.22 37.84 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.915 1.743 . . . . 0.0 111.733 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 16.6 m -74.35 105.76 5.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.492 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 6.2 p -126.91 120.92 30.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.622 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -87.49 76.33 9.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.748 0.785 . . . . 0.0 109.663 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -108.78 -21.98 12.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.564 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 82.75 82.26 0.91 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.157 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.51 134.25 43.72 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.373 2.049 . . . . 0.0 111.372 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.507 ' HB ' HG11 ' A' ' 266' ' ' VAL . 26.1 t -72.09 137.34 23.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.242 -177.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.48 118.92 37.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.579 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -120.28 128.07 52.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.093 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -82.75 126.18 32.09 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -78.72 92.29 4.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.97 -15.99 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.133 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -130.18 129.87 43.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -69.77 172.92 6.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.397 0.618 . . . . 0.0 111.64 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 25.3 tpt180 -147.0 103.26 3.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.158 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.99 126.82 54.08 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.52 146.43 92.86 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.683 2.255 . . . . 0.0 112.456 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.87 160.06 18.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.1 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.99 -34.0 71.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.703 0.287 . . . . 0.0 111.138 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.39 9.85 27.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.013 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.4 t70 74.65 -69.18 0.19 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.262 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 62.76 21.76 12.96 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.543 0.527 . . . . 0.0 112.387 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.1 m 66.02 14.28 9.52 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.002 0.429 . . . . 0.0 110.984 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -66.01 125.68 26.2 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.159 0.504 . . . . 0.0 110.622 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.485 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.9 OUTLIER -79.08 115.68 18.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.869 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -70.11 115.15 8.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.917 0.389 . . . . 0.0 110.44 177.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.514 HD21 HG22 ' A' ' 279' ' ' VAL . 93.0 mt -118.62 154.82 32.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.617 -176.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.75 159.15 38.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.954 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.44 122.96 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.557 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.61 3.3 30.62 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.668 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.418 ' CG ' HH11 ' A' ' 69' ' ' ARG . 41.7 t0 -107.51 161.97 14.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.519 0.659 . . . . 0.0 110.204 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 27.2 mm -102.91 121.91 54.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.243 0.545 . . . . 0.0 111.362 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.412 ' HA ' HG21 ' A' ' 279' ' ' VAL . 21.5 t -91.01 112.1 24.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.589 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.624 ' HZ3' ' HB2' ' A' ' 265' ' ' LYS . 10.2 mtmp? -88.98 94.36 9.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.507 HG11 ' HB ' ' A' ' 238' ' ' VAL . 2.9 p -86.07 123.68 39.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.428 0.632 . . . . 0.0 110.69 -173.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.9 t -110.81 -17.83 13.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.514 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.788 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 24.9 ttm-85 -131.87 97.35 4.16 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.02 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 54.9 mtt -94.83 134.01 37.91 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.59 ' OD1' ' HB3' ' A' ' 272' ' ' ASN . 7.5 p30 -131.26 167.74 18.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.976 -172.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.58 6.8 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.312 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.59 ' HB3' ' OD1' ' A' ' 270' ' ' ASN . 3.7 t30 -87.39 -30.68 20.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.869 0.366 . . . . 0.0 110.93 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 125.42 -64.43 0.57 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.304 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -73.71 124.54 26.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.535 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 11.1 m0 -93.65 168.29 11.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.56 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 35.8 tt0 -104.38 113.29 26.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.21 162.95 18.16 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.811 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.52 116.81 30.15 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.854 HG11 ' H ' ' A' ' 280' ' ' ASN . 15.2 t -125.82 -172.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.854 ' H ' HG11 ' A' ' 279' ' ' VAL . 9.2 p30 -55.06 -32.08 61.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.026 0.376 . . . . 0.0 111.874 -176.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.28 -68.39 1.6 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.071 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.485 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -179.71 -169.87 0.14 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 60.7 mttm -85.2 129.11 34.87 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -161.54 176.88 38.01 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 80.0 mt -84.32 134.52 34.51 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.985 0.421 . . . . 0.0 111.103 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -137.45 140.93 31.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.211 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.22 139.03 16.5 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.478 2.118 . . . . 0.0 112.239 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -73.72 6.79 2.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.87 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.2 p -95.67 -15.97 22.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.764 0.316 . . . . 0.0 111.35 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -98.74 -13.12 20.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.234 0.54 . . . . 0.0 110.059 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.1 160.89 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.287 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -127.78 120.21 27.38 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.076 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.71 109.05 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.172 171.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -103.92 11.58 35.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.21 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 54.37 80.1 0.31 Allowed Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.353 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.07 -53.24 6.67 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.401 2.734 . . . . 0.0 113.091 -173.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -145.32 18.95 1.55 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.622 0.725 . . . . 0.0 109.599 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -153.81 92.05 3.16 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.193 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.05 58.82 5.68 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.731 2.287 . . . . 0.0 110.996 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.02 143.2 50.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.968 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.22 54.15 2.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.842 0.829 . . . . 0.0 109.71 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -79.48 120.76 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.227 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.742 -0.647 . . . . 0.0 109.982 177.916 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtm . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.428 0.156 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m 59.98 47.98 9.23 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.643 0.59 . . . . 0.0 111.405 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 t -156.02 104.67 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.587 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 62.29 95.0 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.743 0.652 . . . . 0.0 112.145 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -137.69 105.29 5.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.049 0.452 . . . . 0.0 110.496 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -155.89 157.86 37.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.545 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.36 111.79 14.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.908 0.385 . . . . 0.0 110.21 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 t -87.93 64.91 8.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.169 0.509 . . . . 0.0 110.397 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.0 t -173.47 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.915 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.46 111.44 1.39 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.742 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -56.0 -33.16 64.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.097 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 m -79.89 3.15 20.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.891 0.377 . . . . 0.0 111.595 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.85 -47.87 5.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.174 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -124.39 -22.67 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -87.68 117.33 26.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.745 0.307 . . . . 0.0 110.633 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.749 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 2.0 mpp? -109.57 7.23 24.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.722 0.296 . . . . 0.0 111.445 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.85 -114.6 3.27 Favored Glycine 0 C--O 1.225 -0.457 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.875 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 13.6 Cg_exo -69.73 101.08 0.86 Allowed 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.448 2.099 . . . . 0.0 112.137 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.601 ' HB ' ' CB ' ' A' ' 39' ' ' ARG . 86.0 t -129.11 -76.48 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.597 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 2.2 p 88.4 170.87 0.04 OUTLIER 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 169.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.7 mtp85 -53.35 -35.83 60.69 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.793 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -61.37 -51.91 66.81 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.458 0.474 . . . . 0.0 111.801 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.78 -43.6 12.4 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.16 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . -50.57 -41.12 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.825 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.519 ' HA ' HG12 ' A' ' 58' ' ' VAL . 11.1 tt0 -81.88 -33.48 30.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.984 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.2 t -79.8 -18.33 51.19 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.02 0.438 . . . . 0.0 111.339 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -88.86 -27.93 20.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.017 0.436 . . . . 0.0 110.792 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.634 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 78.0 mt -111.22 25.69 11.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.38 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.59 29.76 0.07 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -172.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.65 -1.45 39.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.908 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -50.24 -59.24 4.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.951 0.405 . . . . 0.0 110.936 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.578 ' HB2' ' HE1' ' A' ' 35' ' ' MET . 51.9 mtm180 -132.09 111.46 11.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 172.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -68.98 114.87 7.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.46 -18.46 6.42 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.781 -173.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.753 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.6 mtm -74.65 144.71 43.71 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 120.674 0.273 . . . . 0.0 110.327 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.445 ' CG ' HD23 ' A' ' 98' ' ' LEU . 33.4 p90 -144.34 164.59 30.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.139 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.6 pp -153.85 138.79 17.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.043 0.449 . . . . 0.0 110.464 174.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.5 121.49 54.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.601 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -124.82 168.97 12.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -178.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.546 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 2.1 m-20 -72.23 134.13 45.45 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 168.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.532 ' HA ' HG21 ' A' ' 49' ' ' VAL . 24.3 t -37.01 -86.69 0.0 OUTLIER 'General case' 0 C--O 1.236 0.376 0 O-C-N 124.585 1.178 . . . . 0.0 112.875 -168.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.9 m -172.58 -61.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.4 t -98.3 -26.96 14.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.671 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.2 m -102.43 108.62 58.1 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.158 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.03 107.84 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.231 2.621 . . . . 0.0 111.686 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.99 -47.97 0.89 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.406 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 11.4 m-20 -78.24 151.75 32.94 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 168.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -124.3 172.9 8.74 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 121.387 -0.125 . . . . 0.0 110.731 -172.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.666 HG22 HG13 ' A' ' 62' ' ' ILE . 42.8 t -145.48 104.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 175.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.31 105.37 4.04 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.329 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.7 m -96.63 139.26 32.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.977 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.594 HG23 HD12 ' A' ' 93' ' ' LEU . 40.6 t -129.09 150.45 34.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.876 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.634 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 31.1 t -98.73 121.1 40.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.322 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 1.3 mt-10 -143.11 173.96 11.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 56.7 m-80 -40.24 87.39 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.857 0.863 . . . . 0.0 112.917 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m 42.13 58.35 2.97 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.278 1.037 . . . . 0.0 109.25 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.694 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -161.01 53.87 0.29 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.239 -153.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 8.9 t -75.94 94.33 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 t -87.03 121.27 29.25 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.332 -172.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.401 ' H ' ' HB1' ' A' ' 208' ' ' ALA . 45.5 m-70 -100.77 98.55 9.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.383 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.483 ' CE2' HD23 ' A' ' 93' ' ' LEU . 50.2 m-85 -97.83 115.74 28.65 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.486 0.315 . . . . 0.0 111.371 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.666 HG13 HG22 ' A' ' 49' ' ' VAL . 7.1 tt -72.44 150.02 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.2 mp -128.37 117.74 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.184 0.594 . . . . 0.0 109.549 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.406 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 9.6 m120 -87.41 138.39 31.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.37 -173.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.3 t -83.23 100.28 10.5 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 171.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -78.17 157.87 77.79 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.8 62.48 2.36 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.586 2.191 . . . . 0.0 112.426 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 84.3 0.72 0.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.806 0.842 . . . . 0.0 110.61 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -72.32 -78.64 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.244 173.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.719 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 3.2 mpt_? -153.95 -171.01 3.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.358 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.423 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 27.4 m-85 -112.98 115.18 27.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -101.53 109.61 21.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.564 -171.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.3 tt -97.46 85.22 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.658 0.742 . . . . 0.0 110.72 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 210' ' ' PRO . . . 62.02 81.38 0.09 OUTLIER Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.635 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.4 t70 72.6 -43.99 0.58 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.062 0.545 . . . . 0.0 111.315 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -74.81 126.16 30.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.826 0.346 . . . . 0.0 110.184 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -108.01 124.77 50.66 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.562 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.719 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 81.7 m-85 -124.19 148.6 47.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.568 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 10.7 m-20 -62.7 -29.82 70.94 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -170.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 6.5 p80 -160.35 171.63 18.76 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.254 -0.179 . . . . 0.0 110.871 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.523 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.9 mt -55.91 -56.62 28.45 Favored Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.34 0.4 . . . . 0.0 111.84 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 32.3 Cg_exo -61.6 -9.2 12.82 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.215 1.943 . . . . 0.0 113.538 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.34 -36.19 16.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.515 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -76.17 -30.03 57.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 98' ' ' LEU . 92.2 mt -65.17 -38.74 91.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.495 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.815 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 40.3 mt-10 -75.86 -20.94 57.7 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -74.49 -38.8 62.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.295 0.569 . . . . 0.0 110.128 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.486 ' CG ' HD21 ' A' ' 93' ' ' LEU . 47.8 m-85 -79.28 -6.77 57.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.104 0.478 . . . . 0.0 110.703 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.815 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 25.5 mtpp -71.78 -17.21 62.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.496 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.77 7.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 121.042 0.448 . . . . 0.0 111.162 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 20.2 t-160 -102.07 -32.29 10.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.299 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.523 ' CD1' HG21 ' A' ' 97' ' ' THR . 98.8 m-85 70.43 101.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.741 0.651 . . . . 0.0 110.513 -175.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.638 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 9.4 mt -70.98 -20.61 62.41 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.856 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.588 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 30.9 t70 -172.75 82.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.715 171.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 66.7 -24.39 0.11 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.57 0.748 . . . . 0.0 111.874 -178.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 94' ' ' ASP . 13.9 t -124.3 157.94 33.76 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.523 HG21 ' CD1' ' A' ' 92' ' ' TYR . 19.1 p -100.04 -172.84 2.3 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.655 0.264 . . . . 0.0 111.088 -177.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.445 HD23 ' CG ' ' A' ' 36' ' ' PHE . 86.5 mt -70.96 93.54 1.0 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 35.9 mm -85.03 -59.32 2.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.138 -173.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.753 ' O ' ' HA ' ' A' ' 35' ' ' MET . 4.9 pt-20 -149.33 147.55 23.76 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.652 -174.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.43 149.54 27.58 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.5 2.134 . . . . 0.0 112.471 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.552 ' HB3' HD23 ' A' ' 28' ' ' LEU . . . -70.58 146.49 93.86 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.999 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.97 140.83 92.22 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.879 2.386 . . . . 0.0 112.16 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.749 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 52.4 mtm180 -81.07 -179.52 7.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.984 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.4 t80 72.42 133.43 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.411 0 O-C-N 123.961 0.788 . . . . 0.0 110.449 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.28 116.21 2.14 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.193 2.595 . . . . 0.0 112.427 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.2 p -91.9 147.23 34.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.519 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.41 118.2 5.05 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.593 2.195 . . . . 0.0 111.498 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.8 106.47 1.12 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.697 2.265 . . . . 0.0 112.324 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 55.9 ttp -103.83 -65.21 1.03 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.48 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.68 65.98 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.04 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.1 m -109.34 109.17 19.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.828 0.347 . . . . 0.0 110.819 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.547 HG11 ' H ' ' A' ' 114' ' ' SER . 2.7 p -96.55 -59.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.487 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.547 ' H ' HG11 ' A' ' 113' ' ' VAL . 61.0 m -165.91 -174.37 3.0 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.477 ' N ' ' HD2' ' A' ' 116' ' ' PRO . . . -67.49 -52.01 29.73 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 115' ' ' ALA . 20.7 Cg_endo -61.25 152.2 73.79 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.995 1.797 . . . . 0.0 112.158 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.577 HD21 ' HG ' ' A' ' 118' ' ' LEU . 1.1 p-10 -79.46 -177.96 6.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.891 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.577 ' HG ' HD21 ' A' ' 117' ' ' ASN . 87.9 mt 68.51 88.51 0.1 Allowed Pre-proline 0 N--CA 1.464 0.275 0 O-C-N 123.966 0.791 . . . . 0.0 110.797 -175.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.66 160.25 31.48 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.933 2.422 . . . . 0.0 111.505 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.4 m -79.29 63.36 3.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.63 0.729 . . . . 0.0 110.545 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -176.62 105.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.236 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 60.73 77.71 0.31 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.653 0.596 . . . . 0.0 111.553 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.558 ' HB2' ' HB3' ' A' ' 183' ' ' ARG . 4.4 m-20 -75.35 87.15 2.54 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -87.16 83.89 7.36 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.006 -173.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 1.002 HD13 HG13 ' A' ' 152' ' ' ILE . 4.3 mm? 72.71 120.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.721 169.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -151.53 -88.45 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.533 -172.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.527 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 79.0 m-85 -109.95 119.9 40.78 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.921 0.867 . . . . 0.0 112.035 -175.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.727 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 68.5 t -132.99 130.97 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.367 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.852 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 8.4 ptp85 -110.58 155.94 21.63 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 118.415 -1.314 . . . . 0.0 109.431 172.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.415 HG22 HG11 ' A' ' 178' ' ' VAL . 3.9 p -111.72 141.03 45.85 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.495 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 76.4 mt -103.44 -39.35 6.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.211 -175.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.3 t80 -73.82 -31.68 63.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -167.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.643 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 17.3 t70 67.82 91.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.443 0.639 . . . . 0.0 109.892 -172.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 88.1 t80 -124.85 113.24 26.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.349 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 58.0 Cg_endo -87.88 95.1 0.42 Allowed 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.15 1.9 . . . . 0.0 112.573 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.89 -10.27 84.28 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.586 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.412 HD21 ' HA ' ' A' ' 137' ' ' ASN . 10.8 m120 62.96 25.62 15.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.033 0.533 . . . . 0.0 111.524 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.756 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 3.8 p30 46.83 -168.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 73.66 1.27 3.89 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.155 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -178.59 -35.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.125 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -134.41 110.38 9.39 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.492 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.6 HD13 ' HD2' ' A' ' 143' ' ' PRO . 31.4 tp -68.04 127.47 93.31 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 120.829 0.347 . . . . 0.0 111.72 -172.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 138' ' ' ASP . 60.0 Cg_endo -78.8 105.28 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.292 1.995 . . . . 0.0 110.943 171.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 9.0 p90 -112.7 157.87 20.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.647 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.643 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 3.4 mptp? -102.91 178.79 4.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.817 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -66.45 -9.3 32.82 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.862 -177.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.493 ' N ' ' HD2' ' A' ' 146' ' ' LYS . . . -164.16 45.8 0.31 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.678 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -102.3 147.18 27.0 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.631 HD11 ' HB3' ' A' ' 129' ' ' ARG . 33.8 mm -93.23 132.52 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.548 HD22 ' HA ' ' A' ' 165' ' ' ASN . 18.7 mt -118.8 154.85 32.18 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.66 129.86 74.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 172.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 1.002 HG13 HD13 ' A' ' 125' ' ' LEU . 46.3 mm -75.67 86.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.783 HG21 ' HG2' ' A' ' 154' ' ' GLU . 17.0 tt -67.95 -26.8 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.128 -176.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.783 ' HG2' HG21 ' A' ' 153' ' ' ILE . 0.5 OUTLIER -155.85 140.95 17.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.934 0.397 . . . . 0.0 111.2 173.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.453 ' HD2' ' CD2' ' A' ' 125' ' ' LEU . 32.2 tttm -120.89 95.84 48.82 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-O 121.249 0.547 . . . . 0.0 110.482 172.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.446 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 3.1 Cg_exo -77.16 -59.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.81 2.34 . . . . 0.0 112.062 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -104.87 -170.37 1.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.052 -174.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -100.27 -42.72 6.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.897 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -80.31 -25.3 39.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.768 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.514 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 39.1 m95 -129.01 128.17 43.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.005 0.431 . . . . 0.0 110.759 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.642 ' O ' HG13 ' A' ' 173' ' ' ILE . 53.6 m0 -114.18 135.68 53.78 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.059 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.667 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 17.6 m -87.58 103.14 15.28 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.257 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.537 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -112.35 173.68 6.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.987 0.422 . . . . 0.0 111.13 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.4 ptt180 -119.88 137.56 53.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.0 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.548 ' HA ' HD22 ' A' ' 150' ' ' LEU . 0.1 OUTLIER -78.59 -168.1 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.505 -177.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -60.45 -34.8 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.799 0.333 . . . . 0.0 110.422 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.52 ' HB2' HD22 ' A' ' 165' ' ' ASN . 44.8 m-20 -70.63 -21.27 62.65 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.042 0.449 . . . . 0.0 110.655 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.469 ' H ' HD21 ' A' ' 165' ' ' ASN . . . 97.62 5.26 57.82 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.701 -0.761 . . . . 0.0 114.449 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.756 ' HD3' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -86.77 151.15 23.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.998 0.899 . . . . 0.0 111.45 -177.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.478 HG23 HG23 ' A' ' 153' ' ' ILE . 39.5 t -98.91 140.74 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.567 -166.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -168.1 158.14 30.75 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 169.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 31.5 mtp -76.12 139.48 41.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.366 0.583 . . . . 0.0 110.089 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.642 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -133.77 148.69 69.45 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.678 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.514 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 3.5 Cg_exo -77.48 132.6 12.39 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.168 2.579 . . . . 0.0 112.674 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.636 ' O ' HG22 ' A' ' 178' ' ' VAL . 24.1 t -58.62 -46.33 99.59 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.363 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.0 Cg_exo -63.27 -2.1 3.62 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.375 2.05 . . . . 0.0 113.786 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.58 -5.66 26.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.415 -0.178 . . . . 0.0 111.327 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.0 m -107.41 -172.19 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -166.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.852 ' HB3' ' HG3' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -159.66 42.21 0.21 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.609 -163.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.727 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -75.32 139.08 42.23 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 121.219 -0.926 . . . . 0.0 109.25 -168.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.603 ' O ' ' HB ' ' A' ' 182' ' ' VAL . 4.2 mm? -37.5 -60.9 0.65 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 124.802 1.314 . . . . 0.0 112.438 -170.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 181' ' ' LEU . 8.9 p 160.74 -9.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 123.921 0.763 . . . . 0.0 111.11 -175.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.558 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 95.7 mtt180 69.88 -80.46 0.04 OUTLIER 'General case' 0 C--N 1.343 0.318 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -169.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.1 t 177.48 121.59 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.687 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 15.3 m -60.92 128.93 89.78 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 77.3 Cg_exo -53.61 -9.08 0.93 Allowed 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.96 3.107 . . . . 0.0 115.132 -172.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.687 ' CE1' ' HB2' ' A' ' 185' ' ' SER . 0.0 OUTLIER -65.96 127.77 33.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.949 0.404 . . . . 0.0 110.525 175.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -65.5 -25.05 71.28 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.195 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 189' ' ' LYS . 12.3 mptt -91.45 104.27 16.8 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.423 0.63 . . . . 0.0 110.078 177.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -144.21 114.93 7.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.544 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -141.35 104.99 0.4 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.457 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -69.11 112.68 5.87 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 66.7 mtm180 -73.01 102.2 3.44 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.9 m120 70.44 165.73 0.28 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.887 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.6 p -79.31 18.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.695 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -71.64 -55.34 7.92 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 109.739 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.7 m -88.27 78.94 7.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.005 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -95.52 105.07 17.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.681 0.753 . . . . 0.0 111.399 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -100.97 13.68 58.89 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.7 tt -140.72 119.6 8.36 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.568 -176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -93.38 -161.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.111 2.54 . . . . 0.0 111.164 174.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 1.5 pm0 -80.39 112.08 27.98 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.948 0.404 . . . . 0.0 109.913 174.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 16.8 Cg_exo -67.78 -24.96 40.02 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.194 2.596 . . . . 0.0 112.58 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 73.05 -50.84 0.71 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.554 0.742 . . . . 0.0 111.761 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -117.85 110.22 17.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.778 0.323 . . . . 0.0 110.173 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -83.47 66.52 8.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.483 . . . . 0.0 110.96 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.401 ' HB1' ' H ' ' A' ' 60' ' ' HIS . . . -103.7 18.76 21.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -62.8 146.22 95.09 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.684 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.504 ' HB2' ' HA3' ' A' ' 74' ' ' GLY . 36.6 Cg_exo -59.49 145.28 98.45 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.751 1.634 . . . . 0.0 110.402 172.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -81.54 -174.09 4.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.302 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 21.1 m -108.07 123.84 49.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.351 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 167' ' ' ASP . 73.1 m -57.67 130.83 48.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.089 172.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 3.7 t -125.99 99.89 31.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.638 0.732 . . . . 0.0 111.256 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.36 116.1 3.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.954 2.436 . . . . 0.0 111.037 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.1 tt -141.94 95.56 6.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -93.21 -76.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.211 2.607 . . . . 0.0 112.047 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -159.49 131.48 6.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.508 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.57 111.74 26.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.676 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 24.3 m 68.55 113.89 0.04 OUTLIER 'General case' 0 C--O 1.234 0.262 0 O-C-N 123.825 0.703 . . . . 0.0 111.746 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -129.28 -125.66 2.76 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.018 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 10.3 m -126.82 143.85 48.05 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 11.7 Cg_exo -71.66 146.48 49.02 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.803 2.336 . . . . 0.0 111.214 172.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.847 ' HA3' ' HD3' ' A' ' 229' ' ' PRO . . . -84.82 54.01 4.88 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.732 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 61.83 -85.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.3 0.64 . . . . 0.0 111.006 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.37 104.03 14.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.631 HG12 ' H ' ' A' ' 228' ' ' THR . 0.1 OUTLIER 40.43 -92.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 124.276 0.985 . . . . 0.0 112.662 -171.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.631 ' H ' HG12 ' A' ' 227' ' ' ILE . 8.8 t -133.25 149.73 73.36 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.847 ' HD3' ' HA3' ' A' ' 224' ' ' GLY . 13.8 Cg_endo -58.57 99.63 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.158 1.906 . . . . 0.0 111.099 174.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 96.8 mt -75.21 118.43 70.59 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.182 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 5.8 Cg_exo -79.69 66.63 8.77 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.142 2.562 . . . . 0.0 111.255 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 8.6 p -73.17 -71.18 0.32 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.502 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 12.5 p -95.34 -27.48 15.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.724 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 72.64 0.95 3.82 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.928 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 13.3 m120 68.29 -67.43 0.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.62 0.768 . . . . 0.0 111.582 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 111.32 -137.94 14.63 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.59 114.14 3.9 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.796 2.331 . . . . 0.0 111.384 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.548 ' HB ' HG11 ' A' ' 266' ' ' VAL . 20.7 t -94.21 145.06 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.928 0.394 . . . . 0.0 110.229 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.11 132.56 56.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.382 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.505 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -121.17 155.27 34.9 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.669 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -119.5 119.08 32.8 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 259' ' ' GLU . . . -70.45 119.06 14.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.686 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 22.9 pt -91.01 -4.25 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.053 -172.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -142.48 160.87 39.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.587 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.872 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 20.9 ttmm -93.51 123.05 36.55 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.853 HH11 ' HB3' ' A' ' 246' ' ' ARG . 0.7 OUTLIER -139.44 114.31 9.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.505 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 35.9 m -97.16 159.87 30.32 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.323 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.786 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 85.6 Cg_endo -79.04 178.6 7.33 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.607 2.205 . . . . 0.0 112.273 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.571 ' HB3' ' CG ' ' A' ' 253' ' ' LYS . 47.2 t -103.39 96.37 6.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.307 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 66.06 -74.29 0.06 Allowed 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 124.245 0.965 . . . . 0.0 112.589 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.44 ' O ' ' HB3' ' A' ' 252' ' ' ASP . 0.0 OUTLIER -88.08 -46.74 9.06 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -177.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.527 ' HA ' ' HB2' ' A' ' 248' ' ' PRO . 7.5 p-10 167.84 -57.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.617 -174.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.571 ' CG ' ' HB3' ' A' ' 249' ' ' CYS . 13.7 mmmm 55.87 41.8 29.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.749 0.309 . . . . 0.0 110.278 -173.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 68.6 p 57.74 15.04 2.72 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.426 1.091 . . . . 0.0 112.251 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 248' ' ' PRO . . . -98.95 107.03 19.36 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.072 0.463 . . . . 0.0 110.964 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -73.18 113.62 10.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.786 ' HB1' ' HD3' ' A' ' 248' ' ' PRO . . . -58.71 108.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.538 0.524 . . . . 0.0 110.811 177.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.712 HD21 HG21 ' A' ' 279' ' ' VAL . 95.8 mt -130.25 127.03 38.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.264 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.872 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 11.7 pt-20 -119.61 -177.12 3.31 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.538 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 30.7 m -61.36 135.31 26.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.22 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 68.12 28.86 73.21 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.984 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -108.2 140.02 42.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.972 0.386 . . . . 0.0 110.146 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.0 mm -88.28 123.23 40.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.34 0.591 . . . . 0.0 111.523 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.469 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 23.2 t -104.71 107.89 23.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.078 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -82.44 87.68 6.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.717 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.548 HG11 ' HB ' ' A' ' 238' ' ' VAL . 4.9 p -88.55 116.92 31.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.622 0.725 . . . . 0.0 110.584 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.414 ' O ' ' HD2' ' A' ' 268' ' ' ARG . 3.1 m -110.6 -19.15 12.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.694 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.437 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 13.8 mmm180 -122.34 109.96 15.07 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.5 mtt -107.6 118.3 36.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.154 0.502 . . . . 0.0 111.572 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -90.76 158.92 16.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.023 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.57 -14.7 9.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.455 0.645 . . . . 0.0 110.493 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -80.81 -1.8 44.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.893 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.82 -61.65 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.918 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.569 ' HG3' HD13 ' A' ' 285' ' ' LEU . 0.0 OUTLIER -77.71 131.21 37.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.93 0.395 . . . . 0.0 110.628 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.507 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 15.8 m0 -107.08 168.64 9.07 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.237 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 14.0 mt-10 -110.51 122.53 47.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.096 0.474 . . . . 0.0 110.299 174.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -130.26 145.14 16.41 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.511 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -94.41 109.11 20.99 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.712 HG21 HD21 ' A' ' 258' ' ' LEU . 20.8 t -113.43 167.76 6.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.404 ' N ' HG13 ' A' ' 279' ' ' VAL . 16.2 m120 -60.13 -16.66 34.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -81.28 -45.08 7.66 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.863 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.625 ' HG2' HH11 ' A' ' 282' ' ' ARG . 1.0 OUTLIER 173.16 178.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 16.5 pttp -103.75 139.43 39.0 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 166.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -172.33 -170.24 35.95 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.7 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.569 HD13 ' HG3' ' A' ' 274' ' ' GLN . 97.9 mt -91.1 143.42 26.71 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.242 0.544 . . . . 0.0 110.803 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 41.6 p90 -147.97 137.16 11.9 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.561 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 7.3 Cg_exo -72.89 136.34 24.97 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.43 2.086 . . . . 0.0 111.309 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -63.51 -20.64 65.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.926 0.393 . . . . 0.0 110.956 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 m -69.81 -13.11 62.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.315 0.579 . . . . 0.0 110.828 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -97.39 -14.35 21.28 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.079 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 240' ' ' ALA . 27.6 m -124.61 165.82 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.527 0.68 . . . . 0.0 112.14 -173.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -114.43 116.33 28.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.517 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 240' ' ' ALA . 21.3 mm -89.02 117.12 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.13 0.49 . . . . 0.0 110.643 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.422 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 25.3 p90 -141.52 148.32 39.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.699 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.594 ' OD2' ' HA ' ' A' ' 298' ' ' ASN . 35.1 t0 -92.97 105.89 16.89 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 26.8 Cg_exo -61.88 -50.43 5.19 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.033 2.489 . . . . 0.0 112.675 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -111.94 -15.49 13.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.008 -172.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.594 ' HA ' ' OD2' ' A' ' 295' ' ' ASP . 3.6 t-20 55.23 72.8 0.98 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 123.656 0.782 . . . . 0.0 112.446 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -90.08 0.47 5.5 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.751 2.301 . . . . 0.0 111.012 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.12 82.23 1.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.797 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -172.96 -65.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.833 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -100.23 90.45 4.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.628 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.36 -0.828 . . . . 0.0 109.782 178.135 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 m -103.55 17.29 24.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.126 0.489 . . . . 0.0 110.168 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 m -79.25 93.12 5.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.458 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 73.48 130.41 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.072 0.858 . . . . 0.0 112.659 173.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -119.1 -8.01 10.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.837 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.722 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 27.6 p90 -94.11 162.37 13.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.58 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.28 123.84 48.9 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 m -79.96 21.83 0.54 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.723 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -111.41 -37.16 5.33 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.651 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 12' ' ' SER . 34.4 t70 -87.94 108.35 19.15 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.055 -174.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -65.49 -20.04 66.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.426 -179.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.406 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 23.9 m -74.03 -5.41 41.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.803 0.335 . . . . 0.0 110.669 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.76 -47.88 5.42 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -115.62 -21.26 9.79 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -171.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 49.3 t80 -81.52 118.55 22.83 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.202 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.797 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 6.9 tpp -95.14 -7.94 37.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.359 -172.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.08 -115.45 3.6 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.254 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 6.4 Cg_exo -73.65 95.02 0.86 Allowed 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.974 2.449 . . . . 0.0 112.529 -174.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.873 HG13 ' H ' ' A' ' 20' ' ' SER . 14.1 t -136.86 -152.97 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.873 ' H ' HG13 ' A' ' 19' ' ' VAL . 82.4 p 176.32 178.56 0.21 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -166.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -69.31 -39.89 78.0 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.121 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -63.34 -59.54 4.57 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.395 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 8.3 tp10 -59.9 -47.23 86.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.124 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.31 -35.87 70.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.51 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.458 HE21 ' HB3' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -64.65 -40.95 96.33 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.647 -179.372 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -80.17 -6.51 57.9 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.126 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 20.6 mmt85 -87.57 -35.32 18.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.714 0.769 . . . . 0.0 109.03 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.909 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 39.2 mt -100.08 27.4 5.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.331 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -51.35 97.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.478 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.2 -4.63 31.62 Favored Glycine 0 CA--C 1.49 -1.503 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 167.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 1.057 HE21 ' HA ' ' A' ' 56' ' ' SER . 1.6 mp0 57.14 85.59 0.08 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 113.814 -1.193 . . . . 0.0 110.768 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.696 ' HA ' ' HB3' ' A' ' 116' ' ' PRO . 14.7 ttm180 -70.33 -19.95 63.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.61 ' NE2' ' HA ' ' A' ' 55' ' ' ASN . 41.2 m170 78.63 118.93 0.06 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.297 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.95 9.08 59.95 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.972 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.643 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 29.3 mtm -106.75 137.07 45.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.498 -0.413 . . . . 0.0 110.176 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' A' ' 50' ' ' LEU . 43.3 p90 -133.98 162.34 32.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.247 -175.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.4 pp -151.0 135.03 16.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.52 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.0 t -102.49 108.31 23.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.74 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 23.6 ptt-85 -110.82 168.62 9.34 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.134 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 27.2 t70 -85.81 92.99 8.78 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.468 ' HA ' HG21 ' A' ' 49' ' ' VAL . 37.7 m 33.81 -149.22 0.0 OUTLIER 'General case' 0 C--O 1.238 0.5 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.918 ' HB2' ' O1P' ' A' ' 207' ' ' PTR . 63.8 m -157.29 -15.67 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.105 171.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.607 ' OG1' ' O3P' ' A' ' 207' ' ' PTR . 19.5 m -121.37 -44.87 2.35 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.038 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 40.9 t -115.65 99.87 52.96 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.11 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 22.6 Cg_endo -61.87 129.26 26.89 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.716 2.277 . . . . 0.0 111.84 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.32 -33.36 4.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.37 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.42 166.45 12.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.431 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 25.4 m-85 -125.73 166.22 17.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.778 0.323 . . . . 0.0 111.123 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 41' ' ' SER . 45.0 t -144.13 106.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.846 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.7 ' HB2' HD12 ' A' ' 63' ' ' ILE . 63.8 tp -70.09 101.34 1.81 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.408 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.9 m -94.82 118.85 32.44 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.08 0.467 . . . . 0.0 109.99 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.556 HG22 HD12 ' A' ' 93' ' ' LEU . 46.5 t -119.2 134.19 63.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.192 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.909 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 84.1 p -93.39 132.85 37.25 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.776 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 5.1 mm-40 -143.95 176.24 9.43 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.61 ' HA ' ' NE2' ' A' ' 33' ' ' HIS . 55.5 m-80 -31.34 82.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -168.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 1.057 ' HA ' HE21 ' A' ' 31' ' ' GLN . 3.9 m 44.89 57.18 4.79 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.948 0.88 . . . . 0.0 109.765 -177.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.952 HH21 ' HB2' ' A' ' 94' ' ' ASP . 35.8 ttp85 -167.17 55.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.366 -151.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 61.8 t -74.93 102.49 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.245 -0.91 . . . . 0.0 109.598 -173.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 t -86.4 121.3 28.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.724 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -93.3 88.2 5.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.624 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.585 ' HH ' ' HB3' ' A' ' 93' ' ' LEU . 77.8 m-85 -78.86 116.01 18.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.651 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 18.5 tt -79.64 145.55 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -171.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.7 HD12 ' HB2' ' A' ' 50' ' ' LEU . 14.9 mt -138.31 116.35 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 9.3 m120 -87.21 142.34 27.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 122.314 0.246 . . . . 0.0 110.735 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.6 t -87.53 100.68 12.95 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 72' ' ' LYS . 87.9 mt -90.01 142.77 29.08 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.385 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 17.2 Cg_exo -67.49 -8.15 21.34 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.244 2.629 . . . . 0.0 113.071 -176.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.703 ' HB2' ' HG2' ' A' ' 70' ' ' ARG . 9.4 m120 -83.69 9.49 11.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.719 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 2.3 tpm_? 63.46 26.45 14.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.611 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.703 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 5.9 ptp180 -112.78 172.4 6.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.989 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.463 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 96.0 m-85 -131.66 127.2 36.47 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.204 0.526 . . . . 0.0 110.948 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 18.5 ttmm -97.16 100.06 11.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.926 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 10.9 tt -93.44 86.38 2.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.838 0.828 . . . . 0.0 110.227 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.61 ' HA3' ' HA ' ' A' ' 209' ' ' GLN . . . 71.32 60.34 4.46 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.087 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t0 74.44 -16.27 0.55 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.935 0.494 . . . . 0.0 111.38 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 211' ' ' GLN . 0.1 OUTLIER -78.83 126.86 31.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.876 0.369 . . . . 0.0 111.109 177.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -98.45 100.1 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.457 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 76' ' ' GLN . 97.6 m-85 -103.46 168.85 8.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.839 0.352 . . . . 0.0 110.59 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.17 -53.56 53.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.461 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.457 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 1.2 p80 -164.81 -174.11 3.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.264 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.1 mt -55.23 -57.84 18.08 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.543 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 39.1 Cg_exo -59.8 -10.74 12.69 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.327 2.018 . . . . 0.0 113.214 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.22 -30.74 13.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.389 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.463 HD11 HD12 ' A' ' 73' ' ' ILE . 4.1 pp -76.19 -26.27 56.02 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.5 mt -70.56 -25.85 63.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.913 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 52.1 mt-10 -73.5 -20.64 60.62 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.768 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.743 ' HZ ' HG21 ' A' ' 212' ' ' THR . 34.7 t80 -84.84 -35.59 22.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.054 0.454 . . . . 0.0 110.77 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.452 ' CG ' HD21 ' A' ' 93' ' ' LEU . 49.6 m-85 -86.59 1.07 53.05 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.999 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 13.0 ptmt -74.02 -21.99 59.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 171.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.439 HG23 ' HG3' ' A' ' 89' ' ' LYS . 23.6 pt -120.85 9.14 6.2 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -96.55 -38.78 9.84 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.206 -0.309 . . . . 0.0 111.233 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.538 ' CD1' HG23 ' A' ' 97' ' ' THR . 76.9 m-85 70.39 102.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.894 0.746 . . . . 0.0 109.716 -171.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.719 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 6.4 mt -74.23 -19.76 60.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.53 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.952 ' HB2' HH21 ' A' ' 57' ' ' ARG . 33.6 t70 -173.78 70.96 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 170.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 76.91 -29.81 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.22 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.51 HG23 HD13 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -107.43 157.58 17.88 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.538 HG23 ' CD1' ' A' ' 92' ' ' TYR . 18.1 p -105.26 -169.25 1.57 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.761 0.315 . . . . 0.0 110.178 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.437 HD23 ' CD1' ' A' ' 36' ' ' PHE . 97.6 mt -77.47 99.97 5.85 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 1.8 mp -96.91 -55.37 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.643 ' O ' ' HA ' ' A' ' 35' ' ' MET . 8.1 mm-40 -143.96 151.61 53.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.735 0.302 . . . . 0.0 111.293 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.722 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 24.7 Cg_endo -88.83 156.58 6.05 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.807 2.338 . . . . 0.0 111.893 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.466 ' O ' ' HE1' ' A' ' 16' ' ' MET . . . -79.48 139.63 55.4 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.947 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.526 ' CG ' ' HA ' ' A' ' 107' ' ' SER . 27.7 Cg_endo -64.43 135.57 46.74 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.479 2.119 . . . . 0.0 112.16 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.797 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 39.9 ptt180 -78.8 -23.52 45.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.674 ' HB3' ' HD3' ' A' ' 106' ' ' PRO . 26.1 t80 -135.59 -58.09 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 120.651 -0.42 . . . . 0.0 112.084 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' A' ' 105' ' ' TYR . 47.0 Cg_exo -55.92 -72.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.134 1.89 . . . . 0.0 112.435 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.526 ' HA ' ' CG ' ' A' ' 103' ' ' PRO . 23.4 m 70.54 135.9 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 123.761 0.663 . . . . 0.0 112.056 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 107' ' ' SER . 14.0 Cg_exo -69.54 112.95 3.18 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.686 2.257 . . . . 0.0 111.274 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.94 113.71 2.12 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.818 2.346 . . . . 0.0 112.18 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.3 mmt 55.82 40.28 30.68 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.456 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.89 66.82 2.75 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.78 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 p -133.96 -171.73 2.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.593 0.235 . . . . 0.0 110.931 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t 67.61 -94.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.408 0.683 . . . . 0.0 111.327 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 p -103.73 9.18 37.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.085 0.469 . . . . 0.0 111.342 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.434 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -75.48 -47.75 4.17 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.689 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.696 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 98.8 Cg_endo -81.76 -158.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.835 1.69 . . . . 0.0 111.596 172.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -79.77 -5.59 55.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 51.0 tp 56.68 85.66 0.18 Allowed Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.49 -174.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.545 ' HB3' ' HE1' ' A' ' 33' ' ' HIS . 36.8 Cg_endo -67.27 128.96 19.34 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.506 2.137 . . . . 0.0 112.933 -176.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 p -91.52 -26.79 18.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.999 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.66 74.38 9.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.647 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.65 90.91 8.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.488 ' OD1' ' HB2' ' A' ' 125' ' ' LEU . 2.9 p30 -98.08 179.26 4.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.391 0.615 . . . . 0.0 111.35 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.38 45.73 2.76 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 1.049 HD23 HG21 ' A' ' 152' ' ' ILE . 7.9 mp -76.89 123.44 26.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.158 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 16.8 pt-20 -165.77 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.193 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.46 130.92 54.51 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.908 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.971 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 72.8 t -142.41 157.57 19.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 179' ' ' GLU . 0.7 OUTLIER -136.05 150.8 49.32 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.092 161.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.46 HG21 HG13 ' A' ' 178' ' ' VAL . 6.0 p -105.67 140.46 38.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.052 0.453 . . . . 0.0 111.994 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.524 HD11 ' HG2' ' A' ' 179' ' ' GLU . 67.2 mt -110.83 -25.58 9.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.726 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.522 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 41.5 t80 -86.38 -32.6 20.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -168.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.641 ' HB2' ' HD3' ' A' ' 146' ' ' LYS . 6.6 t70 73.38 111.59 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.133 0.492 . . . . 0.0 110.617 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -141.65 89.1 9.31 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 35.4 Cg_endo -94.87 84.16 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 122.799 2.333 . . . . 0.0 112.871 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.516 ' HA3' ' OD2' ' A' ' 141' ' ' ASP . . . -94.1 -24.34 19.91 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.206 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 52.0 m-80 68.05 83.22 0.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.484 0.714 . . . . 0.0 112.715 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -173.42 -171.96 0.74 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 173.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.28 -16.89 28.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.314 1.054 . . . . 0.0 108.334 171.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 172' ' ' MET . 41.4 tt0 -73.57 -28.88 62.09 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.978 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 172' ' ' MET . 8.0 p-10 -157.17 117.04 3.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.369 174.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 13.6 tp -69.62 121.39 82.27 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.964 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 41.6 Cg_endo -67.87 98.16 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.293 1.996 . . . . 0.0 111.324 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -112.73 162.25 15.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.485 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 1.6 mptm? -112.6 -167.79 1.23 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.291 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.641 ' HD3' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -91.25 19.6 5.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.921 176.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.4 30.86 0.52 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.606 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.485 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 23.2 mm-40 -104.71 144.14 32.13 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.887 -0.184 . . . . 0.0 110.73 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 129' ' ' ARG . 46.7 mm -98.65 135.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 165' ' ' ASN . 18.5 mt -118.95 155.24 31.68 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 93.4 t -120.32 125.42 74.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 174.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 1.049 HG21 HD23 ' A' ' 125' ' ' LEU . 47.1 mm -76.05 83.8 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 122.761 1.267 . . . . 0.0 108.674 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.717 HG21 HG21 ' A' ' 170' ' ' VAL . 15.1 tt -79.3 -26.97 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.195 -174.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.84 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 14.9 mt-10 -144.41 142.23 30.19 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.505 0.503 . . . . 0.0 109.975 173.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.867 ' HB3' ' HZ3' ' A' ' 155' ' ' LYS . 3.8 ttpm? -134.58 89.74 25.55 Favored Pre-proline 0 C--O 1.236 0.371 0 O-C-N 121.842 -0.536 . . . . 0.0 111.172 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.405 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 16.9 Cg_exo -71.94 -55.31 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.549 2.166 . . . . 0.0 112.76 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -106.52 172.51 6.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.521 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.424 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 2.7 mm-40 -113.76 70.15 0.72 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.551 0.691 . . . . 0.0 110.505 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.513 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 13.9 pt20 175.58 -34.37 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.601 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.513 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 53.1 m95 -122.96 129.34 51.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.767 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.651 ' O ' HG13 ' A' ' 173' ' ' ILE . 51.0 m0 -120.21 137.26 54.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.35 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.84 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.5 m -88.29 92.72 9.27 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.439 0.638 . . . . 0.0 109.899 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.482 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -108.62 161.24 15.26 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.813 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.8 ptt180 -104.27 136.76 43.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.809 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.557 ' HA ' HD22 ' A' ' 150' ' ' LEU . 16.3 p-10 -81.63 -173.1 4.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 110.993 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -59.13 -27.5 65.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.773 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.81 -18.93 38.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.734 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.16 29.06 7.77 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.134 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.813 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 19.6 ttm-85 -104.02 136.07 44.35 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.568 -0.372 . . . . 0.0 110.857 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.731 HG23 ' HA ' ' A' ' 210' ' ' PRO . 59.0 t -99.88 119.81 48.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.99 0.424 . . . . 0.0 111.167 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.2 160.22 28.22 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -68.81 131.37 45.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.027 0.441 . . . . 0.0 111.023 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -130.22 145.45 57.38 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.261 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.459 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 4.5 Cg_exo -78.71 131.66 10.4 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.062 2.508 . . . . 0.0 112.633 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.611 ' O ' HG22 ' A' ' 178' ' ' VAL . 41.4 t -59.68 -44.19 96.92 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -65.13 5.49 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.225 1.95 . . . . 0.0 113.6 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -108.43 -6.14 16.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.093 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.1 m -107.52 -171.08 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -165.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 0.2 OUTLIER -156.09 41.21 0.38 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 112.821 -1.991 . . . . 0.0 106.91 -163.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.971 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 16.3 pttm -77.45 150.94 34.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.891 0.853 . . . . 0.0 110.435 -162.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.1 tp -68.65 150.66 47.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.469 -173.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.623 HG23 ' H ' ' A' ' 183' ' ' ARG . 3.1 m -66.76 -69.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -169.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.623 ' H ' HG23 ' A' ' 182' ' ' VAL . 0.1 OUTLIER -161.92 164.6 28.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.151 -0.343 . . . . 0.0 110.46 -173.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.6 t -102.32 158.66 16.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 5.4 p -69.0 144.02 95.14 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-O 120.546 0.212 . . . . 0.0 110.772 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.17 -58.83 1.39 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.645 2.897 . . . . 0.0 113.852 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 56.4 m80 64.37 -78.01 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.525 0.515 . . . . 0.0 110.814 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -166.82 -61.45 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -90.2 76.0 6.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.994 0.426 . . . . 0.0 110.065 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.37 -46.06 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.615 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -169.0 60.04 0.2 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.495 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 67.56 -171.93 0.19 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.815 0.446 . . . . 0.0 111.057 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -131.87 139.81 48.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.558 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -139.92 -40.25 0.44 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.807 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 55.3 m -115.6 -17.94 11.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.791 0.329 . . . . 0.0 110.602 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 66.94 -89.22 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.382 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 4.5 p -96.84 132.25 42.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.267 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -101.16 -21.08 15.04 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.685 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 113.8 25.02 4.39 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.341 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 30.3 pt -129.32 162.38 52.94 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.42 107.16 2.34 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.376 2.051 . . . . 0.0 112.083 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.485 ' N ' ' HD2' ' A' ' 203' ' ' PRO . 2.8 mp0 -63.29 -47.64 84.21 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.388 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 202' ' ' GLU . 56.5 Cg_endo -71.2 64.18 2.69 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.187 1.925 . . . . 0.0 111.758 172.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.34 179.22 4.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.423 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -82.58 31.63 0.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.582 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.19 79.46 3.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.332 0.587 . . . . 0.0 110.806 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.918 ' O1P' ' HB2' ' A' ' 42' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.748 ' HA ' ' NH1' ' A' ' 164' ' ' ARG . . . -124.97 113.45 17.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.61 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 3.8 pt20 -107.38 101.49 39.26 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.241 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.731 ' HA ' HG23 ' A' ' 170' ' ' VAL . 15.0 Cg_endo -99.11 83.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.648 2.899 . . . . 0.0 114.215 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.643 ' HB3' ' HA ' ' A' ' 169' ' ' ARG . 4.2 tp-100 -57.58 -49.64 75.73 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.743 HG21 ' HZ ' ' A' ' 87' ' ' PHE . 51.6 m 73.89 -45.15 0.59 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 172.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.431 ' OG1' ' HD3' ' A' ' 169' ' ' ARG . 3.2 m 81.13 83.89 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.581 0.753 . . . . 0.0 109.475 -172.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 7.2 p -88.86 126.18 60.26 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.229 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.04 -15.07 11.91 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.52 2.147 . . . . 0.0 112.444 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.3 tt 59.01 82.52 0.23 Allowed Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.091 -177.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.45 109.0 2.7 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.857 2.372 . . . . 0.0 112.408 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -94.13 93.4 7.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.746 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.25 135.9 24.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.968 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 41.2 m -87.36 135.35 33.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.561 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -108.29 109.02 2.79 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.758 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.417 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 32.5 p -81.36 122.29 80.96 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 24.6 Cg_exo -63.12 134.7 47.13 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.6 2.2 . . . . 0.0 112.218 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -69.65 156.65 53.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.794 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.87 137.32 41.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.849 0.356 . . . . 0.0 111.012 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -82.67 95.0 7.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.053 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.3 pt -62.94 -48.05 89.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.974 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 11.6 t -166.43 134.8 2.3 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 228' ' ' THR . 36.7 Cg_endo -89.22 96.22 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.808 2.339 . . . . 0.0 112.522 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.665 ' H ' HD23 ' A' ' 230' ' ' LEU . 1.7 pt? -99.93 100.09 10.56 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.75 109.44 2.86 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.568 2.179 . . . . 0.0 112.407 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 48.8 m -73.82 149.54 41.57 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 12.0 p -71.84 90.54 1.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.712 0.768 . . . . 0.0 111.176 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.422 ' HG2' ' HB ' ' A' ' 267' ' ' THR . 67.5 mt-30 -75.9 75.74 2.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.445 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -68.22 -36.88 80.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.719 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -142.85 78.01 0.28 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.858 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.69 133.13 21.48 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.414 2.076 . . . . 0.0 112.295 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.479 ' HB ' HG11 ' A' ' 266' ' ' VAL . 22.8 t -94.43 144.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.501 ' HD1' HG21 ' A' ' 263' ' ' ILE . 96.2 m-85 -109.6 123.91 50.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.0 111.001 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.551 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -142.02 122.04 13.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.033 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.96 144.68 31.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.068 0.461 . . . . 0.0 110.505 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -88.78 94.67 10.0 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.049 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.4 pp -94.48 19.45 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.687 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.61 173.39 11.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.331 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -95.34 133.67 38.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.553 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -147.77 113.55 5.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.096 0.474 . . . . 0.0 111.382 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.62 158.62 33.36 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.755 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -94.57 -172.31 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.946 2.431 . . . . 0.0 112.68 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 252' ' ' ASP . 42.4 t -80.01 149.62 30.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.25 -48.04 74.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.706 0.289 . . . . 0.0 111.672 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.53 ' HE1' ' HB2' ' A' ' 253' ' ' LYS . 19.2 p90 -92.1 -7.22 49.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.85 0.357 . . . . 0.0 110.651 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 249' ' ' CYS . 15.1 t70 63.9 106.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.751 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.53 ' HB2' ' HE1' ' A' ' 251' ' ' TYR . 1.7 tmtp? -113.04 84.5 2.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 34.7 p 48.25 36.25 6.57 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.665 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -104.58 99.61 9.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.119 0.485 . . . . 0.0 110.442 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.582 HD23 ' HB ' ' A' ' 279' ' ' VAL . 0.7 OUTLIER -78.37 121.5 24.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.919 -177.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -83.45 136.92 34.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.056 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.74 119.5 20.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.998 0.427 . . . . 0.0 110.313 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -100.01 149.83 23.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.514 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 15.6 t -58.02 123.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.839 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 157.46 -68.1 0.28 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.815 -1.183 . . . . 0.0 114.952 174.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 263' ' ' ILE . 5.0 t70 -116.96 -169.33 1.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.473 0.637 . . . . 0.0 112.496 -159.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.501 HG21 ' HD1' ' A' ' 239' ' ' PHE . 40.6 mm -91.72 135.6 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.238 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.47 110.16 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.735 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.438 ' HB3' ' HZ2' ' A' ' 265' ' ' LYS . 9.6 mtpm? -80.58 87.81 5.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 110.862 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.479 HG11 ' HB ' ' A' ' 238' ' ' VAL . 6.8 p -90.21 130.62 39.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.038 0.447 . . . . 0.0 110.911 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.422 ' HB ' ' HG2' ' A' ' 234' ' ' GLN . 9.0 t -113.07 -20.83 11.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.405 ' HG3' HG22 ' A' ' 267' ' ' THR . 98.2 mtt180 -117.92 98.92 6.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 0.0 110.107 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 34.8 ttm -101.18 109.68 21.59 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.168 0.509 . . . . 0.0 110.804 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -83.31 162.31 21.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.932 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.1 tt -97.38 -13.72 7.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.129 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -67.24 -53.7 27.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.227 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 164.77 -37.81 0.29 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.791 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.89 134.92 44.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.057 0.456 . . . . 0.0 110.24 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.511 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 20.9 m0 -107.89 165.1 11.7 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.167 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -121.53 116.85 25.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.136 0.494 . . . . 0.0 110.253 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -129.56 169.98 20.59 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.514 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 74.8 mt-10 -108.39 108.35 19.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.906 0.384 . . . . 0.0 110.767 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.582 ' HB ' HD23 ' A' ' 256' ' ' LEU . 47.2 t -128.28 139.08 52.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 279' ' ' VAL . 15.4 m120 70.96 8.02 6.39 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.631 0.373 . . . . 0.0 110.76 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 86.46 13.46 67.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.975 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 282' ' ' ARG . 1.7 ptm180 -132.03 137.98 48.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.86 0.362 . . . . 0.0 110.525 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 3.3 ptpp? -97.79 134.3 41.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.693 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -152.39 173.94 31.39 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.566 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 91.7 mt -90.14 140.59 29.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.015 0.436 . . . . 0.0 111.504 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.469 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 33.5 p90 -145.64 134.73 11.21 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.521 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 5.0 Cg_exo -74.54 148.82 38.11 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.857 2.371 . . . . 0.0 112.811 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.435 ' C ' ' H ' ' A' ' 290' ' ' HIS . 36.7 p90 -64.32 -25.27 67.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.286 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.8 m -76.0 37.45 0.15 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.45 0.643 . . . . 0.0 110.928 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.435 ' H ' ' C ' ' A' ' 288' ' ' PHE . 8.5 m-70 -141.6 -61.02 0.47 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.384 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 23.2 m -90.92 150.38 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.797 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -109.35 117.04 33.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.86 0.362 . . . . 0.0 110.785 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' A' ' 240' ' ' ALA . 36.8 mm -69.94 125.49 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.837 175.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -122.3 -179.31 4.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.465 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 296' ' ' PRO . 14.7 m-20 -78.82 114.86 47.55 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.133 0.492 . . . . 0.0 110.017 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 295' ' ' ASP . 21.5 Cg_endo -94.5 43.55 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.513 2.809 . . . . 0.0 113.126 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.488 ' NE2' HD21 ' A' ' 298' ' ' ASN . 5.6 pm0 -73.29 -14.88 61.39 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.488 HD21 ' NE2' ' A' ' 297' ' ' GLN . 4.3 p30 -96.07 98.73 4.27 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.779 171.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 297' ' ' GLN . 74.3 Cg_endo -95.24 21.14 0.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.946 2.431 . . . . 0.0 113.285 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 44.3 t0 65.08 97.08 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.703 0.627 . . . . 0.0 110.402 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.45 -49.67 70.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.738 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -76.52 101.73 5.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.165 0.507 . . . . 0.0 111.493 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.396 -0.812 . . . . 0.0 109.543 177.117 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.677 0.275 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 p -111.5 28.51 8.67 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 m -65.88 -44.39 85.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.599 0.714 . . . . 0.0 109.315 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -91.94 117.3 29.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.144 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -163.11 105.15 1.01 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.114 0.483 . . . . 0.0 110.319 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CB ' ' HD3' ' A' ' 101' ' ' PRO . 25.4 p90 -132.28 -180.0 5.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.985 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -89.36 91.03 8.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.122 0.487 . . . . 0.0 110.699 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.746 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 40.8 m -67.65 150.56 48.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.894 177.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 8' ' ' SER . 49.7 m 78.28 -39.35 0.26 Allowed 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.799 0.687 . . . . 0.0 112.31 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.96 101.85 0.17 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.049 0.452 . . . . 0.0 110.295 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -56.96 -46.2 82.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.033 -170.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m -77.27 7.87 4.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.34 -40.27 11.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.572 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.3 p-90 -127.76 -27.81 2.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.0 t80 -79.77 123.67 27.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.896 0.317 . . . . 0.0 110.355 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.426 ' HB2' HG23 ' A' ' 19' ' ' VAL . 22.3 mmt -110.52 -1.33 17.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.844 -173.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.46 -114.27 2.88 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.007 -0.542 . . . . 0.0 113.709 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.435 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 10.3 Cg_exo -70.33 103.59 1.28 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.008 2.472 . . . . 0.0 112.175 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.781 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 85.9 t -136.57 -70.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.815 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 30.1 t 81.36 165.59 0.15 Allowed 'General case' 0 C--N 1.347 0.477 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -55.83 -38.96 70.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.746 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -59.63 -40.99 89.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.069 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.98 -44.97 8.58 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.235 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . -53.92 -41.31 67.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.811 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 47.8 tt0 -72.3 -46.27 56.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.413 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.3 t -68.39 -23.42 64.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.988 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -83.39 -29.31 28.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.2 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.719 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 38.4 mt -103.43 -0.05 30.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.027 0.441 . . . . 0.0 110.757 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 25.7 tt0 -70.15 113.53 7.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.6 -174.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.89 33.82 84.96 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.573 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -102.47 -168.48 1.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.665 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 17.8 ttp180 -62.85 113.19 2.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.627 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.66 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 42.7 m170 -62.26 118.5 7.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.929 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.91 -8.33 6.81 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.569 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.665 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 20.1 mtp -87.17 140.11 29.88 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 122.52 0.328 . . . . 0.0 110.442 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.739 ' HB2' HG21 ' A' ' 52' ' ' VAL . 28.8 p90 -142.52 164.52 29.89 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.643 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.98 136.67 14.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.221 0.534 . . . . 0.0 111.056 175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 15' ' ' TYR . 93.2 t -101.42 112.7 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.815 ' HD2' ' H ' ' A' ' 20' ' ' SER . 20.9 ptt-85 -107.59 176.47 5.14 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.685 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -81.5 138.97 35.41 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.409 ' HA ' HG21 ' A' ' 49' ' ' VAL . 83.3 p -55.6 -19.87 11.75 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.086 0.241 . . . . 0.0 111.596 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m 69.41 17.63 8.07 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.507 0.67 . . . . 0.0 109.794 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 p -140.42 -45.05 0.41 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.733 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 66.3 m -134.27 127.13 18.79 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.765 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 24.2 Cg_exo -64.48 -14.37 43.95 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.863 2.375 . . . . 0.0 112.578 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.57 29.2 13.03 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.862 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.31 134.74 18.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -124.76 162.34 24.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.512 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.712 HG12 ' HE2' ' A' ' 207' ' ' PTR . 21.2 t -131.51 99.88 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.125 0.488 . . . . 0.0 111.189 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.2 tp -76.28 96.34 3.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.141 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.9 m -97.35 135.41 39.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.971 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.739 HG21 ' HB2' ' A' ' 36' ' ' PHE . 86.7 t -128.87 137.18 57.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.114 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.719 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 31.3 t -83.5 99.38 10.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.704 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.66 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 15.8 pt-20 -172.81 173.87 3.74 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.995 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.731 ' HB2' ' CG ' ' A' ' 94' ' ' ASP . 27.7 t-20 71.67 -56.3 0.64 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.734 1.254 . . . . 0.0 109.499 -164.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.448 ' H ' ' C ' ' A' ' 54' ' ' GLU . 29.8 t -162.32 -40.63 0.04 OUTLIER 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.068 -1.878 . . . . 0.0 106.88 -176.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.719 HH21 ' HB3' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -165.35 -39.51 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.689 ' CG2' ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -144.2 110.97 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 120.822 1.646 . . . . 0.0 114.899 -173.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.625 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 16.0 m -95.85 108.29 20.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 163.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -100.34 99.0 9.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -170.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.666 ' CE2' HD23 ' A' ' 93' ' ' LEU . 44.0 m-85 -116.97 114.31 23.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.71 HG12 HG22 ' A' ' 49' ' ' VAL . 19.9 mt -81.07 138.59 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.744 HG13 ' HB ' ' A' ' 73' ' ' ILE . 5.3 mp -114.2 115.25 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.205 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -85.0 143.15 29.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.692 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.7 t -93.56 98.69 11.33 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.607 HD12 ' HB2' ' A' ' 72' ' ' LYS . 23.0 mt -78.58 124.94 85.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 14.1 Cg_exo -68.12 -33.58 24.73 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.313 2.009 . . . . 0.0 113.44 -174.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -67.53 -18.85 65.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -172.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.641 ' HG2' ' N ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -176.65 -53.55 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.641 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 2.3 ptm180 -136.85 -172.18 3.11 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -160.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -102.36 157.81 16.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.539 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.607 ' HB2' HD12 ' A' ' 66' ' ' LEU . 24.7 ttmm -138.82 104.67 5.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.744 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.7 tt -90.88 78.78 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.785 0.802 . . . . 0.0 110.006 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.748 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 65.52 86.49 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.742 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.712 ' HB2' ' HG1' ' A' ' 212' ' ' THR . 10.8 t70 75.1 -61.68 0.48 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.475 0.31 . . . . 0.0 111.472 176.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.28 124.04 23.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.023 0.44 . . . . 0.0 109.987 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.3 138.5 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.282 0.563 . . . . 0.0 110.489 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.48 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 44.5 m-85 -127.18 166.59 17.42 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.54 -50.42 71.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -149.38 175.78 11.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.452 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.644 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 15.4 mt -54.85 -55.22 40.97 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.746 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 41.4 Cg_exo -59.96 -10.42 12.31 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.277 1.985 . . . . 0.0 113.797 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.74 -34.92 16.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.348 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -76.32 -28.75 57.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.394 0.616 . . . . 0.0 109.385 176.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.42 ' O ' HD12 ' A' ' 98' ' ' LEU . 74.0 mt -66.35 -23.4 66.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.009 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.561 ' O ' ' HB3' ' A' ' 89' ' ' LYS . 38.0 tt0 -85.46 -29.27 24.45 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.237 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -69.37 -38.7 78.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.238 0.542 . . . . 0.0 110.063 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.509 ' CG ' HD21 ' A' ' 93' ' ' LEU . 59.2 m-85 -80.83 -2.61 47.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.54 0.686 . . . . 0.0 110.467 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 47.5 tttm -78.77 -14.82 59.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.035 174.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -128.73 -1.77 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 111.474 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 22.6 t-160 -98.75 -28.51 13.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.127 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 83.0 m-85 70.1 132.23 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 O-C-N 124.079 0.862 . . . . 0.0 109.376 -169.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.666 HD23 ' CE2' ' A' ' 61' ' ' TYR . 9.2 mt -92.31 -26.63 18.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.731 ' CG ' ' HB2' ' A' ' 55' ' ' ASN . 10.3 t0 -173.83 83.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.777 168.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 71.66 -19.18 0.27 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.925 0.89 . . . . 0.0 112.064 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 94' ' ' ASP . 31.7 m -120.43 158.0 28.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.0 p -106.16 172.57 6.73 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.445 HD23 ' CD2' ' A' ' 36' ' ' PHE . 95.5 mt -64.71 93.69 0.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.032 0.444 . . . . 0.0 110.104 175.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.582 HG22 ' HG3' ' A' ' 100' ' ' GLU . 47.1 mm -81.34 -62.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.254 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.582 ' HG3' HG22 ' A' ' 99' ' ' ILE . 43.5 mt-10 -147.65 157.16 44.8 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.562 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.468 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 11.9 Cg_exo -70.46 156.98 60.36 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.097 1.865 . . . . 0.0 111.19 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.24 138.74 71.83 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.569 ' HG2' ' HB2' ' A' ' 107' ' ' SER . 69.4 Cg_exo -52.14 126.19 19.59 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.232 1.954 . . . . 0.0 111.808 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -60.62 -31.48 70.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.057 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -108.45 138.17 20.15 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.214 174.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -44.97 119.29 2.33 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.549 2.833 . . . . 0.0 113.496 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.597 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 23.3 t -72.47 -49.74 8.61 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.756 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 107' ' ' SER . 8.0 Cg_exo -34.6 -54.88 0.55 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 124.025 3.15 . . . . 0.0 115.604 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.47 -0.81 7.2 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 122.006 1.804 . . . . 0.0 113.701 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 22.4 ptm -147.84 25.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.22 165.23 24.74 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.195 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.3 m -107.57 106.95 17.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.846 0.355 . . . . 0.0 110.402 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.4 t -81.85 82.31 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.585 0.707 . . . . 0.0 110.124 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.1 m -151.54 -42.93 0.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.338 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.468 ' N ' ' HD2' ' A' ' 116' ' ' PRO . . . -62.42 -48.78 86.17 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.355 174.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.493 ' HB3' ' HB2' ' A' ' 32' ' ' ARG . 38.1 Cg_endo -67.59 104.34 0.93 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.5 1.467 . . . . 0.0 111.715 172.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -76.18 140.37 41.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.799 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 53.3 tp -120.82 83.65 36.81 Favored Pre-proline 0 C--N 1.32 -0.686 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.766 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -88.97 115.82 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.305 2.67 . . . . 0.0 110.188 167.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 t -116.83 157.32 25.79 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.668 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.08 -153.9 0.5 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.221 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.77 -178.63 1.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.326 0.584 . . . . 0.0 110.724 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -86.35 -7.96 58.06 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -86.83 -151.83 0.17 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.152 -1.386 . . . . 0.0 109.386 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.485 HD13 HG13 ' A' ' 152' ' ' ILE . 1.0 OUTLIER 63.19 86.08 0.12 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 122.04 0.924 . . . . 0.0 111.488 177.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -172.07 -33.75 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.895 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.669 ' HB3' HH21 ' A' ' 183' ' ' ARG . 19.2 m-85 -123.7 109.77 14.13 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.655 0.741 . . . . 0.0 111.352 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 179' ' ' GLU . 25.4 t -124.38 153.05 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.372 -175.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -135.06 150.37 50.25 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.066 174.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.678 HG21 HG12 ' A' ' 178' ' ' VAL . 51.4 p -95.46 133.95 38.85 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.823 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.4 mt -106.96 -37.52 6.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.664 -173.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.589 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 47.5 t80 -90.45 -31.62 16.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -168.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 6.5 t70 77.67 123.91 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.214 0.53 . . . . 0.0 111.113 -172.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 84.8 t80 -156.77 106.3 1.96 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.733 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -91.98 95.22 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.879 2.386 . . . . 0.0 113.123 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -97.41 0.6 59.97 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.794 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.48 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 66.96 5.33 4.0 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.301 0.641 . . . . 0.0 112.223 -178.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.843 ' HB2' ' HD3' ' A' ' 143' ' ' PRO . 18.5 t0 52.47 -146.51 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.869 0.867 . . . . 0.0 112.94 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.461 ' H ' ' CG ' ' A' ' 138' ' ' ASP . . . 69.51 11.83 8.08 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.499 1.12 . . . . 0.0 108.828 -165.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 139' ' ' ALA . 23.2 tt0 171.81 -39.67 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.139 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 172' ' ' MET . 21.8 m-20 -133.33 97.73 4.05 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.78 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.594 ' HB3' HG21 ' A' ' 173' ' ' ILE . 23.7 tp -54.67 129.86 63.91 Favored Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 122.971 0.509 . . . . 0.0 111.931 -174.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.843 ' HD3' ' HB2' ' A' ' 138' ' ' ASP . 73.1 Cg_endo -81.54 117.5 3.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.513 2.142 . . . . 0.0 111.355 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.582 ' CB ' HG22 ' A' ' 130' ' ' THR . 21.3 p90 -123.04 165.51 16.66 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.986 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.51 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 42.4 mttp -115.05 -165.88 1.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.272 0.558 . . . . 0.0 111.904 -174.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.447 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -93.98 26.98 2.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.089 179.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.43 25.92 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 119.625 -1.274 . . . . 0.0 114.388 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -108.12 161.6 14.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.93 0.865 . . . . 0.0 109.331 174.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.599 HG21 HD23 ' A' ' 181' ' ' LEU . 7.0 mm -119.36 146.9 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.757 -167.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 15.9 mt -122.77 166.38 15.05 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -173.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.41 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 97.6 t -123.53 125.76 72.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.491 HD13 ' HB3' ' A' ' 163' ' ' ALA . 21.6 mm -77.0 97.54 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 CA-C-O 122.475 1.131 . . . . 0.0 108.747 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.62 ' CD1' ' HE1' ' A' ' 61' ' ' TYR . 1.7 tt -97.52 -49.01 12.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 112.472 -2.149 . . . . 0.0 109.024 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.036 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 15.7 mt-10 -116.16 142.85 46.27 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.593 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 15.8 ttpp -140.23 72.04 32.96 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 121.466 -0.771 . . . . 0.0 109.901 170.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.466 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 24.5 Cg_exo -62.12 -43.89 22.13 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.453 2.102 . . . . 0.0 111.885 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -113.73 -174.07 2.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.05 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -107.14 -40.0 5.55 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.525 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -84.08 -11.55 56.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.174 0.512 . . . . 0.0 110.324 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.632 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 68.0 m95 -129.2 118.58 22.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.407 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.601 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.7 m0 -108.76 139.08 44.07 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 1.036 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 11.3 t -101.72 91.08 4.25 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.39 0.614 . . . . 0.0 109.639 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.509 ' HB1' ' HB3' ' A' ' 150' ' ' LEU . . . -109.52 161.53 15.25 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.197 -172.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.804 HH12 ' HA ' ' A' ' 208' ' ' ALA . 19.5 ptt-85 -97.54 136.21 38.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.846 HD22 ' HB3' ' A' ' 167' ' ' ASP . 12.9 p-10 -85.76 175.57 8.62 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.619 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -79.9 4.28 17.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.37 0.605 . . . . 0.0 110.975 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.846 ' HB3' HD22 ' A' ' 165' ' ' ASN . 33.6 t70 -104.03 -1.28 27.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.245 0.545 . . . . 0.0 109.535 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.772 ' HA3' ' HA ' ' A' ' 212' ' ' THR . . . 85.47 72.09 1.3 Allowed Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.81 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 38.4 ttm-85 -164.46 129.04 2.65 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.78 -0.247 . . . . 0.0 110.364 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' A' ' 164' ' ' ARG . 39.0 t -105.48 109.56 28.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.373 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.489 ' HA3' ' OD1' ' A' ' 138' ' ' ASP . . . -146.23 170.09 27.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.095 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.632 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 22.5 mtp -82.49 137.11 34.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.038 0.447 . . . . 0.0 111.211 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -133.9 146.04 58.4 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.699 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.432 ' HD2' ' CE2' ' A' ' 144' ' ' PHE . 7.3 Cg_exo -72.23 128.35 13.72 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.064 2.509 . . . . 0.0 112.41 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.589 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 47.8 t -67.4 -36.67 10.86 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.278 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 26.8 Cg_endo -63.49 10.4 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.646 1.564 . . . . 0.0 113.177 173.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.504 ' H ' ' C ' ' A' ' 175' ' ' VAL . 4.6 m-85 -118.38 -19.83 8.73 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.554 0.342 . . . . 0.0 111.322 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.678 HG12 HG21 ' A' ' 130' ' ' THR . 3.8 m -146.2 155.97 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.674 -166.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.503 ' C ' ' HD3' ' A' ' 180' ' ' LYS . 11.7 mt-10 -150.46 -56.35 0.17 Allowed 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 115.939 -2.305 . . . . 0.0 115.652 155.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.729 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -144.35 150.0 37.07 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 115.619 -2.432 . . . . 0.0 116.04 -160.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.599 HD23 HG21 ' A' ' 149' ' ' ILE . 37.0 tp -147.08 110.42 4.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.242 163.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.74 -26.98 21.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 O-C-N 123.837 0.71 . . . . 0.0 111.241 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.669 HH21 ' HB3' ' A' ' 127' ' ' TYR . 0.2 OUTLIER 83.15 -42.11 0.1 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.64 169.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.2 t -67.98 91.79 0.35 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.377 0.608 . . . . 0.0 110.451 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.4 p -144.6 139.1 15.14 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.182 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.81 -41.92 72.44 Favored 'Trans proline' 0 N--CA 1.471 0.191 0 C-N-CA 123.287 2.658 . . . . 0.0 113.479 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.411 ' HB3' ' H ' ' A' ' 188' ' ' GLY . 71.4 m80 60.61 -155.52 0.36 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 187' ' ' HIS . . . -76.42 -52.55 6.01 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.227 173.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -138.51 18.45 2.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 110.27 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 66.13 10.08 6.78 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.59 0.71 . . . . 0.0 110.51 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -149.88 -138.35 2.89 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -157.74 161.9 38.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -128.73 132.27 47.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.129 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 195' ' ' SER . 10.8 t30 -136.91 -81.67 0.37 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.145 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 194' ' ' ASN . 15.7 t 174.33 116.69 0.02 OUTLIER 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 60.17 -165.57 0.2 Allowed 'General case' 0 C--O 1.235 0.316 0 O-C-N 123.803 0.689 . . . . 0.0 110.311 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 32.2 t 66.03 19.37 11.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.673 0.389 . . . . 0.0 111.15 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -79.91 105.73 11.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.262 0.554 . . . . 0.0 110.693 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -169.88 63.27 0.18 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.579 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 203' ' ' PRO . 14.2 pt -98.08 116.2 65.65 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 121.283 0.564 . . . . 0.0 111.335 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -87.57 101.11 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.891 2.394 . . . . 0.0 112.086 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 60.85 81.65 0.24 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.665 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.512 ' HB3' HD13 ' A' ' 200' ' ' ILE . 74.4 Cg_endo -76.73 19.93 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.877 2.385 . . . . 0.0 113.249 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -78.75 -58.76 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.343 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -120.93 -21.6 6.49 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.419 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 59.79 -156.07 0.35 Allowed 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.498 0.498 . . . . 0.0 111.098 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.712 ' HE2' HG12 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.804 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -92.57 5.65 50.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.64 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -59.91 145.82 83.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.676 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.748 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 21.4 Cg_exo -65.81 85.82 0.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.221 1.948 . . . . 0.0 111.465 175.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.797 ' HA ' HE21 ' A' ' 211' ' ' GLN . 0.0 OUTLIER -72.98 112.05 8.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 -178.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.772 ' HA ' ' HA3' ' A' ' 168' ' ' GLY . 2.9 m -67.13 -38.83 86.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.449 -176.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 25.3 m 72.87 -68.1 0.24 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.953 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 212' ' ' THR . 11.3 p -105.96 150.45 39.27 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.826 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.49 147.32 86.75 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.531 2.154 . . . . 0.0 112.152 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.694 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 98.7 mt -57.81 -53.47 65.4 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.694 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 13.6 Cg_exo -70.77 132.86 22.52 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.071 1.847 . . . . 0.0 111.926 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -67.6 -29.24 68.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.208 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 47.2 t -67.22 106.6 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.322 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 32.7 t -127.91 97.74 4.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.295 0.569 . . . . 0.0 110.696 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -132.92 -49.78 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 66.4 m -157.94 110.11 1.76 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -51.74 -48.78 19.77 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.764 2.309 . . . . 0.0 112.166 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 179.47 100.69 0.14 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.867 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.35 -32.13 72.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.236 0.541 . . . . 0.0 109.571 176.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -106.79 142.02 37.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.295 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 60.8 mt -95.0 100.58 11.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.042 0.449 . . . . 0.0 110.902 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 63.8 m -106.59 112.39 63.67 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.797 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.416 ' HB2' HD23 ' A' ' 230' ' ' LEU . 17.1 Cg_exo -66.32 -78.79 0.01 OUTLIER 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.866 2.377 . . . . 0.0 112.889 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 229' ' ' PRO . 2.7 pt? -168.31 151.67 5.58 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.94 129.46 8.01 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.381 2.054 . . . . 0.0 111.718 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 39.6 p -99.75 2.22 43.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.118 0.485 . . . . 0.0 110.391 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 43.7 p -105.0 -172.75 2.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.866 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -94.26 9.93 36.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.215 0.531 . . . . 0.0 110.131 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -82.36 113.67 20.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.501 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -177.3 -139.76 3.42 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.037 -0.601 . . . . 0.0 111.632 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.92 160.4 33.82 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.548 2.165 . . . . 0.0 111.948 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 38.4 t -103.21 145.16 12.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.19 122.01 46.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.88 0.371 . . . . 0.0 110.818 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.437 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -120.28 142.91 48.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.25 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -95.37 123.75 39.06 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -75.81 111.24 10.96 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.121 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.404 HG21 ' HE3' ' A' ' 292' ' ' LYS . 35.6 pt -94.58 -9.98 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -138.92 144.04 38.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.6 ' HG2' ' HA ' ' A' ' 259' ' ' GLU . 84.1 mttt -82.3 121.94 27.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.932 0.396 . . . . 0.0 111.093 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.701 ' HD2' ' CE1' ' A' ' 290' ' ' HIS . 54.1 ttt85 -93.16 102.47 14.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 45.7 t -80.59 136.97 51.52 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.196 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.02 141.48 79.02 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.994 2.463 . . . . 0.0 112.75 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.93 165.5 25.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.234 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.75 -23.66 67.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.949 0.404 . . . . 0.0 111.108 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -125.33 30.32 5.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.945 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.459 ' HB2' ' HB2' ' A' ' 255' ' ' ALA . 9.9 p-10 -43.63 103.84 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.971 0.891 . . . . 0.0 112.277 -169.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -111.97 -33.8 6.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.904 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 7.4 p -129.96 16.18 5.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.307 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 252' ' ' ASP . . . -92.59 111.01 22.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.929 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.514 HD23 ' HB ' ' A' ' 279' ' ' VAL . 1.4 tt -90.11 113.3 25.01 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -64.68 123.82 20.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.016 0.436 . . . . 0.0 110.909 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.3 mt -128.03 165.18 20.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.848 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.6 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 14.3 pt-20 -146.36 166.27 26.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.535 177.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 42.9 t -70.56 124.01 25.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.022 0.439 . . . . 0.0 111.071 -174.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.35 4.43 50.08 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.805 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -100.3 155.08 17.98 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.977 0.389 . . . . 0.0 109.992 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.43 HD12 ' OD1' ' A' ' 302' ' ' ASN . 22.8 mm -94.74 113.04 28.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.169 0.509 . . . . 0.0 110.99 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 t -87.05 95.4 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.285 0.565 . . . . 0.0 109.592 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -81.52 98.58 8.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.057 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 275' ' ' TRP . 4.0 p -89.11 120.96 38.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.392 0.615 . . . . 0.0 111.27 -176.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 26.4 m -93.99 -30.91 14.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.506 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.989 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 13.0 tpt180 -115.54 97.34 6.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.441 -177.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 2.2 tpt -81.53 106.16 13.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.167 0.508 . . . . 0.0 109.659 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -86.39 166.17 15.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.192 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 40.1 mm -76.91 83.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.418 -175.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.6 t30 83.65 82.42 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.752 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 114.35 -77.16 0.25 Allowed Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 119.69 -1.243 . . . . 0.0 114.066 154.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -72.52 88.57 1.24 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.825 0.345 . . . . 0.0 110.718 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.497 ' HB3' HG22 ' A' ' 266' ' ' VAL . 9.9 m0 -92.88 161.47 14.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.033 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.989 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 27.5 tt0 -109.98 116.09 30.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.086 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.36 155.71 18.24 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.368 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.3 108.37 19.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.514 ' HB ' HD23 ' A' ' 256' ' ' LEU . 61.0 t -128.98 140.12 50.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 13.7 m120 66.68 -71.05 0.1 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.831 0.707 . . . . 0.0 110.882 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -173.98 31.51 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -151.17 143.59 24.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.733 -0.233 . . . . 0.0 110.577 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 98.3 mttt -96.52 131.39 43.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 171.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.71 171.23 30.52 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.98 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 37.2 mt -92.83 145.09 24.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.093 0.473 . . . . 0.0 110.668 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.657 ' HB2' ' HE2' ' A' ' 290' ' ' HIS . 31.5 p90 -148.22 124.93 5.46 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.16 177.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.4 ' HB2' HG21 ' A' ' 289' ' ' THR . 44.4 Cg_endo -71.6 157.48 55.84 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.271 1.981 . . . . 0.0 111.772 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -81.55 15.21 2.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.1 0.476 . . . . 0.0 111.5 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.4 HG21 ' HB2' ' A' ' 287' ' ' PRO . 8.8 t -89.81 1.56 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.576 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.701 ' CE1' ' HD2' ' A' ' 246' ' ' ARG . 1.2 p-80 -137.39 3.77 2.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 176.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.651 HG12 ' HD2' ' A' ' 290' ' ' HIS . 18.4 m -129.54 157.35 42.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.404 ' HE3' HG21 ' A' ' 243' ' ' ILE . 16.8 ptpt -129.9 135.66 48.62 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.516 176.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 240' ' ' ALA . 46.5 mm -83.47 103.4 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.252 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -93.69 167.56 11.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.194 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.1 134.72 59.16 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.89 -20.06 27.89 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.158 2.572 . . . . 0.0 113.359 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -86.58 86.28 7.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.182 0.515 . . . . 0.0 110.005 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 17.0 m120 -83.06 135.93 44.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.962 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 16.5 Cg_exo -69.24 -32.69 20.2 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.698 2.265 . . . . 0.0 110.518 171.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -96.86 -173.37 2.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.222 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -121.2 14.9 11.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.027 0.441 . . . . 0.0 110.154 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.43 ' OD1' HD12 ' A' ' 263' ' ' ILE . 0.7 OUTLIER 66.26 3.32 2.7 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.632 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 . . . . . 0 C--O 1.244 0.771 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.294 173.162 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 ttp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -117.07 88.39 2.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.178 0.513 . . . . 0.0 110.226 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -95.27 -37.48 10.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.709 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.622 ' HB3' ' HG2' ' A' ' 89' ' ' LYS . . . -179.5 143.24 0.19 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.637 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.96 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.619 0.575 . . . . 0.0 109.487 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.658 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 3.5 p90 38.4 -122.56 0.28 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 124.288 0.992 . . . . 0.0 111.14 -174.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -139.99 81.59 1.83 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 172.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -71.84 62.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.943 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -179.19 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.12 100.07 4.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.576 -174.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -64.41 -24.62 67.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.761 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.6 m -67.41 -7.6 26.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.353 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.49 -47.99 4.49 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -112.15 -20.6 11.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -82.08 110.34 17.22 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.796 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 11.3 tpp -96.34 0.6 50.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.168 -171.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.428 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.49 -113.36 2.29 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.181 -0.918 . . . . 0.0 114.152 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 3.0 Cg_exo -79.33 100.24 1.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.823 2.348 . . . . 0.0 112.127 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.594 ' HB ' ' HG2' ' A' ' 39' ' ' ARG . 85.1 t -130.34 -76.63 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 48.8 m 82.65 162.92 0.13 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.795 ' HG3' ' O2P' ' A' ' 207' ' ' PTR . 44.4 mtp85 -51.65 -42.3 61.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -55.86 -39.46 71.52 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.423 0.452 . . . . 0.0 112.104 -177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 34.2 mt-10 -95.75 -44.91 7.22 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.254 -177.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.86 51.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.336 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -81.67 -32.88 31.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.759 -173.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.474 ' HA ' ' HB2' ' A' ' 29' ' ' GLN . 10.6 t -78.0 -27.74 49.05 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 110.682 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 21.2 mmt85 -64.62 -33.9 77.01 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.855 0.836 . . . . 0.0 109.755 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.979 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 80.7 mt -113.89 23.29 13.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.077 -176.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 26' ' ' THR . 24.4 tt0 -72.71 72.13 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.227 0.537 . . . . 0.0 110.536 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.14 15.96 59.32 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.296 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -62.98 -28.37 70.04 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 20.0 ttm180 -156.24 -36.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.476 172.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.622 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 28.9 m170 77.08 132.0 0.05 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.129 0.893 . . . . 0.0 109.52 -173.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.31 -10.86 67.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.567 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 55.4 mtm -87.36 153.75 21.21 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.407 ' HB2' HD13 ' A' ' 50' ' ' LEU . 39.0 p90 -141.63 162.16 36.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.331 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 37' ' ' LEU . 4.5 pp -150.81 135.98 17.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.024 0.44 . . . . 0.0 110.337 172.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.7 t -105.54 116.26 48.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.425 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.6 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -119.85 163.72 17.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.893 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.2 131.81 45.51 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.517 ' OG ' HG22 ' A' ' 43' ' ' THR . 26.8 t -79.4 158.62 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.57 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.643 ' HB3' ' O1P' ' A' ' 207' ' ' PTR . 40.0 t -117.92 4.4 12.15 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.176 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.517 HG22 ' OG ' ' A' ' 41' ' ' SER . 14.7 t -93.52 -26.2 17.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.893 0.378 . . . . 0.0 110.345 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.666 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 62.8 m -141.98 144.67 33.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.07 -48.92 15.9 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.819 2.346 . . . . 0.0 112.568 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.92 71.59 0.21 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.577 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.666 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 34.3 t70 -151.3 150.98 31.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -173.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -130.35 172.1 12.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.617 HG21 HG12 ' A' ' 62' ' ' ILE . 54.2 t -144.47 108.29 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 111.543 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 36' ' ' PHE . 42.9 tp -81.37 105.36 12.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.214 173.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -96.96 128.56 44.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.304 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.631 HG21 HD12 ' A' ' 93' ' ' LEU . 86.9 t -125.7 134.62 66.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.04 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.979 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 65.6 p -106.93 124.65 49.92 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.622 ' HG2' ' HB3' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -154.84 153.64 31.48 Favored 'General case' 0 C--O 1.212 -0.888 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 163.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 57.72 19.98 6.02 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.0 m 54.46 61.27 3.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 123.018 1.39 . . . . 0.0 108.259 -170.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 39.6 ttp85 -162.3 57.75 0.23 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.121 -2.309 . . . . 0.0 107.286 -159.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.2 t -76.97 100.24 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.723 -172.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 p -79.69 120.99 24.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.924 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -95.41 98.7 10.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.105 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.644 ' HE1' HG13 ' A' ' 153' ' ' ILE . 26.0 m-85 -93.9 115.83 28.23 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.846 ' HB ' ' HB3' ' A' ' 209' ' ' GLN . 7.1 mt -76.43 139.63 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.581 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 2.7 mp -124.81 118.41 53.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.696 0.798 . . . . 0.0 109.895 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 11.0 m120 -84.99 131.66 34.44 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 -172.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -79.77 99.45 7.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.2 mt -90.63 132.48 34.95 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.429 -176.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.07 -3.81 6.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.902 2.402 . . . . 0.0 112.699 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -93.82 22.18 5.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.152 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.626 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 2.8 mmp_? 63.36 26.83 15.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.394 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.7 164.41 15.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.663 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.581 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 62.5 m-85 -133.69 114.9 13.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.72 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.464 ' NZ ' ' HG3' ' A' ' 77' ' ' GLU . 21.8 ttmm -100.73 107.18 18.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.817 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.0 tt -94.7 78.42 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.858 0.837 . . . . 0.0 109.742 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.42 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 67.42 89.31 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.226 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.93 -57.69 0.63 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.464 0.706 . . . . 0.0 111.193 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -69.19 121.53 16.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.995 0.426 . . . . 0.0 110.965 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.464 ' HG3' ' NZ ' ' A' ' 72' ' ' LYS . 20.4 mt-10 -97.59 125.56 42.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.966 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 74.3 m-85 -115.38 152.45 32.82 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.84 -11.19 60.81 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -175.17 176.32 2.09 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.628 0.195 . . . . 0.0 110.757 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.493 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 5.9 mt -56.44 -55.56 41.27 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 123.278 0.361 . . . . 0.0 111.833 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.38 -3.86 5.82 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.123 1.882 . . . . 0.0 113.638 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.13 -35.04 16.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.76 0.314 . . . . 0.0 110.55 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -76.15 -31.92 58.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.5 mt -68.24 -24.35 64.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.713 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.18 -19.12 40.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.828 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -88.38 -39.14 14.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.177 0.513 . . . . 0.0 110.199 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.479 ' CG ' HD21 ' A' ' 93' ' ' LEU . 52.8 m-85 -78.28 -3.5 43.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.518 0.675 . . . . 0.0 109.78 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.622 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 1.4 tmtp? -64.71 -35.09 79.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.869 170.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.7 pt -113.69 -6.39 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.629 -0.428 . . . . 0.0 112.072 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 6.2 t-160 -73.18 -43.21 61.77 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.806 -0.179 . . . . 0.0 110.886 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.607 ' CD1' HG23 ' A' ' 97' ' ' THR . 94.5 m-85 68.03 100.04 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.257 0.973 . . . . 0.0 108.867 -165.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.709 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 4.2 mt -69.64 -98.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.513 ' O ' HG21 ' A' ' 95' ' ' THR . 17.5 t0 -89.84 76.86 7.09 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 121.368 -0.832 . . . . 0.0 109.325 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.513 HG21 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 68.15 -34.07 0.24 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.538 1.135 . . . . 0.0 112.409 -177.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 94' ' ' ASP . 39.5 m -107.87 146.06 32.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.607 HG23 ' CD1' ' A' ' 92' ' ' TYR . 3.1 p -81.76 -178.5 7.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 0.0 110.704 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.1 mt -77.18 91.76 3.76 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.1 mm -74.93 -60.83 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.424 -175.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.658 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 9.4 pt-20 -162.35 156.09 17.9 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.407 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.2 158.15 49.32 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.621 2.214 . . . . 0.0 113.36 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HB3' HD23 ' A' ' 28' ' ' LEU . . . -72.49 154.38 91.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.842 176.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.25 124.4 15.55 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.054 2.503 . . . . 0.0 112.673 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.796 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 75.8 ttt180 -67.58 -46.96 71.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.072 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -129.78 118.97 18.89 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.045 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.82 98.08 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.714 2.276 . . . . 0.0 111.262 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.0 m -70.94 125.45 92.01 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.511 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.431 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 79.8 Cg_exo -48.75 -46.52 24.15 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.099 2.532 . . . . 0.0 113.253 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 108' ' ' PRO . 18.3 Cg_endo -62.21 105.07 0.38 Allowed 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 121.455 1.437 . . . . 0.0 110.936 169.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -76.14 120.07 20.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.281 0.562 . . . . 0.0 111.437 -174.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.99 0.11 27.08 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.752 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.8 t -162.88 114.27 1.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 110.457 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.8 m -121.07 -19.51 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.803 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.8 m -96.5 112.39 24.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.892 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.632 ' H ' ' HD2' ' A' ' 116' ' ' PRO . . . -165.58 -49.48 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.809 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.632 ' HD2' ' H ' ' A' ' 115' ' ' ALA . 40.8 Cg_endo -68.51 126.04 13.62 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 121.994 1.796 . . . . 0.0 112.78 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -81.76 -28.42 33.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.504 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.6 mt -145.86 95.99 4.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.391 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -82.2 -6.26 12.03 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.013 2.475 . . . . 0.0 111.567 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.7 p -70.54 129.33 38.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.685 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.59 133.77 55.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.009 0.433 . . . . 0.0 111.823 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -151.44 109.7 3.75 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.1 106.07 0.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.49 0.493 . . . . 0.0 111.87 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.443 ' HA ' ' CD ' ' A' ' 183' ' ' ARG . 45.1 m-80 -143.89 171.93 13.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.434 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.65 ' CD1' HG22 ' A' ' 152' ' ' ILE . 1.3 mm? 66.51 85.94 0.14 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.77 0.795 . . . . 0.0 111.147 174.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.598 ' CD ' ' H ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -154.77 -76.73 0.1 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.608 -171.112 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.598 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 48.9 m-85 -104.98 108.52 20.07 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.612 0.72 . . . . 0.0 111.392 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.889 HG23 ' HB3' ' A' ' 180' ' ' LYS . 74.3 t -122.81 132.25 71.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.516 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.962 ' HB2' ' HB3' ' A' ' 179' ' ' GLU . 26.1 mtt180 -107.7 160.29 15.82 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.548 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.759 ' HG1' ' HB2' ' A' ' 144' ' ' PHE . 12.5 p -117.08 134.43 54.77 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.547 176.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.627 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 81.0 mt -104.42 -32.22 9.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.692 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.534 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 47.6 t80 -78.13 -36.85 47.32 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -169.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.584 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 7.4 t70 74.5 105.22 0.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.336 0.589 . . . . 0.0 109.813 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -141.1 100.15 6.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 51.9 Cg_endo -88.52 87.7 0.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.273 1.982 . . . . 0.0 112.492 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.665 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -83.3 -12.83 78.04 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.931 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 1.01 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 4.6 p30 35.71 66.74 0.33 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.431 1.092 . . . . 0.0 113.888 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -159.39 -178.88 7.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.57 -7.33 57.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.577 0.703 . . . . 0.0 109.763 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.4 pt-20 -116.85 4.07 12.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.451 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.665 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 10.3 m-20 -146.79 97.3 2.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.378 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.678 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 49.1 tp -75.16 120.55 82.17 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 1.01 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 12.1 Cg_endo -80.84 92.94 1.04 Allowed 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.106 1.871 . . . . 0.0 111.178 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.759 ' HB2' ' HG1' ' A' ' 130' ' ' THR . 10.3 p90 -100.9 164.61 11.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.685 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.584 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 9.2 mtpt -119.46 -178.83 3.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.576 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -77.28 63.56 2.51 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.089 0.947 . . . . 0.0 111.544 -175.259 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.97 35.54 0.27 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.722 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 5.3 mm-40 -96.7 141.0 30.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.982 0.42 . . . . 0.0 110.224 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.06 128.37 43.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.573 HD22 ' HA ' ' A' ' 165' ' ' ASN . 40.1 mt -121.03 157.23 30.46 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 58.0 t -116.08 128.41 73.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.65 HG22 ' CD1' ' A' ' 125' ' ' LEU . 42.5 mm -75.16 97.38 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.809 0.814 . . . . 0.0 109.204 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.711 HG22 ' HG2' ' A' ' 154' ' ' GLU . 8.7 tt -85.11 -42.81 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.868 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.954 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 0.8 OUTLIER -122.23 140.23 52.85 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.569 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 45.6 tttt -131.24 88.72 43.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 O-C-N 121.673 -0.642 . . . . 0.0 110.915 171.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.571 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 16.2 Cg_exo -74.3 -51.83 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.66 2.24 . . . . 0.0 113.083 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -110.91 -171.38 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.233 -0.292 . . . . 0.0 110.82 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.65 -25.7 9.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.774 0.321 . . . . 0.0 110.411 174.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -84.72 -28.0 26.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.277 0.56 . . . . 0.0 110.416 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.669 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 43.3 m95 -128.36 130.39 47.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.122 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.699 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.7 m0 -122.52 142.83 50.17 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.064 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.954 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.2 m -98.82 94.59 6.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.438 0.637 . . . . 0.0 110.391 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.533 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -100.1 164.23 12.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.217 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.684 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.2 ptt180 -104.35 134.52 47.43 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.775 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.678 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 64.7 t30 -75.12 -179.32 4.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.568 -177.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.6 ' O ' ' HB ' ' A' ' 213' ' ' THR . 4.4 tppp? -58.78 -21.12 55.17 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.5 -36.78 81.73 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.469 0.652 . . . . 0.0 109.36 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.25 -6.78 42.94 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.808 -168.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.684 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 13.0 ttm-85 -69.72 140.08 53.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.463 -0.868 . . . . 0.0 111.606 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.632 HG21 HG21 ' A' ' 153' ' ' ILE . 44.4 t -98.89 125.42 52.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.953 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 142' ' ' LEU . . . -150.1 163.2 29.41 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.59 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.669 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -79.65 136.18 36.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.622 0.249 . . . . 0.0 110.609 179.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.699 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -136.09 145.39 52.14 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.378 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.487 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 6.1 Cg_exo -80.45 133.65 9.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.037 2.491 . . . . 0.0 112.903 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.669 ' O ' HG22 ' A' ' 178' ' ' VAL . 92.6 t -62.84 -41.74 73.61 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.1 Cg_endo -63.42 0.73 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.012 1.808 . . . . 0.0 113.304 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -106.74 -3.48 20.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.645 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 175' ' ' VAL . 11.4 m -107.2 -178.85 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -165.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.962 ' HB3' ' HB2' ' A' ' 129' ' ' ARG . 1.0 OUTLIER -149.25 39.98 0.85 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 112.702 -2.045 . . . . 0.0 108.498 -165.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.889 ' HB3' HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -77.41 150.77 35.0 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.109 -0.995 . . . . 0.0 110.913 -169.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.539 HD23 ' NH2' ' A' ' 129' ' ' ARG . 48.7 mt -63.66 179.7 0.46 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.35 -170.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.95 -22.23 4.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.78 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.443 ' CD ' ' HA ' ' A' ' 124' ' ' ASN . 22.4 mtm-85 63.31 84.68 0.14 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.57 0.7 . . . . 0.0 110.698 -175.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.3 p -84.41 -178.34 6.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.921 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.455 ' HB2' ' HD3' ' A' ' 186' ' ' PRO . 69.1 m -147.72 -44.53 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.455 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 25.3 Cg_exo -64.4 93.06 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.214 1.276 . . . . 0.0 110.288 168.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.413 ' HB3' ' HA3' ' A' ' 191' ' ' GLY . 32.8 m-70 -101.37 -56.18 2.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.265 -172.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 65.07 -112.92 5.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.33 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -86.25 -3.21 58.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.19 0.519 . . . . 0.0 110.583 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -103.99 48.53 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.373 0.606 . . . . 0.0 109.482 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 187' ' ' HIS . . . -171.85 -149.57 6.7 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.626 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -134.92 145.8 48.54 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -71.05 135.54 47.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.953 0.406 . . . . 0.0 110.407 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.403 ' HB2' ' CD ' ' A' ' 202' ' ' GLU . 4.3 p-10 -73.91 170.55 15.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.543 -176.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 4.8 m -74.58 139.22 43.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.323 -175.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 62.95 -88.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.043 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 14.1 p -159.88 -62.88 0.07 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.784 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -85.57 96.07 9.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.956 0.407 . . . . 0.0 110.462 -178.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.464 ' HA3' ' OE2' ' A' ' 202' ' ' GLU . . . -157.43 107.11 0.31 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.784 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 42.5 mm -102.88 -59.57 0.08 OUTLIER Pre-proline 0 C--N 1.322 -0.601 0 O-C-N 122.859 -0.201 . . . . 0.0 111.186 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.784 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 69.2 Cg_endo -89.45 40.19 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.168 1.912 . . . . 0.0 113.086 -177.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.464 ' OE2' ' HA3' ' A' ' 199' ' ' GLY . 8.7 pt-20 -111.13 111.4 55.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.198 0.523 . . . . 0.0 110.836 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.18 -24.87 14.23 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.293 1.995 . . . . 0.0 111.322 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 55.49 -97.8 0.08 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.584 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 64.16 162.85 0.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.995 0.809 . . . . 0.0 111.764 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.0 174.26 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.556 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.795 ' O2P' ' HG3' ' A' ' 21' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -87.68 39.89 0.91 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.541 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.846 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 8.0 pt20 -67.07 146.2 98.99 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 47.1 Cg_exo -57.43 -27.11 74.54 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.471 2.114 . . . . 0.0 112.045 176.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 68.53 -173.46 0.19 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.332 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 26.1 m -146.43 97.24 2.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.833 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 166' ' ' LYS . 24.2 m -120.05 92.81 3.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.219 0.533 . . . . 0.0 110.956 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.9 t -132.65 104.63 13.09 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.034 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.478 ' HB2' HD21 ' A' ' 216' ' ' LEU . 37.8 Cg_endo -67.03 -41.01 10.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.795 2.33 . . . . 0.0 112.733 -176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 215' ' ' PRO . 3.0 mm? -129.77 138.79 33.88 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.23 106.91 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.452 2.101 . . . . 0.0 110.951 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -66.52 108.07 2.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.201 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.83 110.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.557 0.694 . . . . 0.0 110.899 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.6 p -166.22 170.71 12.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.67 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 85.34 -102.53 2.63 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.832 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.758 ' HB2' ' HD3' ' A' ' 223' ' ' PRO . 16.0 m -68.6 -53.16 17.22 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 116.501 0.15 . . . . 0.0 111.134 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.758 ' HD3' ' HB2' ' A' ' 222' ' ' SER . 56.6 Cg_endo -93.76 115.66 0.26 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.209 1.939 . . . . 0.0 112.056 174.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 131.35 -0.43 5.16 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.689 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 72.87 -42.62 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.609 0.764 . . . . 0.0 112.435 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -70.23 99.53 1.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.958 0.408 . . . . 0.0 110.538 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 37.5 pt -91.33 156.66 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.498 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.5 p -132.46 164.14 45.6 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.344 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.14 -61.26 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.659 2.239 . . . . 0.0 112.143 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 37.2 tp -173.42 101.45 0.32 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.452 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.81 33.97 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.795 2.33 . . . . 0.0 111.333 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 24.4 m 70.46 170.59 0.31 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.991 -171.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 18.6 p -87.23 -76.43 0.37 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.153 -0.219 . . . . 0.0 110.413 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.509 ' HA ' ' HB ' ' A' ' 267' ' ' THR . 7.6 tt0 51.22 50.25 19.38 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.284 0.564 . . . . 0.0 110.503 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.761 ' HB3' ' HB3' ' A' ' 265' ' ' LYS . 52.1 m-80 -66.69 -18.11 65.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.562 -174.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.837 ' C ' ' H ' ' A' ' 267' ' ' THR . . . -172.77 -132.58 1.53 Allowed Glycine 0 C--O 1.211 -1.287 0 CA-C-O 118.877 -0.957 . . . . 0.0 112.362 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 1.06 ' HG3' ' H ' ' A' ' 276' ' ' GLU . 4.5 Cg_exo -87.0 -36.99 0.09 OUTLIER 'Trans proline' 1 CA--C 1.622 4.915 2 N-CA-C 126.178 5.415 . . . . 0.0 126.178 167.597 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 237' ' ' PRO . 21.4 t 169.21 127.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 C-N-CA 127.902 2.481 . . . . 0.0 108.342 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -65.26 119.59 11.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.621 1.101 . . . . 0.0 111.315 -163.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.588 ' HB2' HD11 ' A' ' 293' ' ' ILE . . . -132.96 156.98 46.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.583 -168.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -96.65 122.59 39.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.336 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.47 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -73.39 115.09 12.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.12 -0.22 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -172.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 245' ' ' LYS . 7.2 tt0 -140.94 147.89 39.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.869 0.366 . . . . 0.0 110.507 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.806 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 51.6 mtmt -79.24 140.23 37.69 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.297 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -140.39 104.91 4.88 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.998 0.428 . . . . 0.0 110.462 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.4 m -105.57 140.95 21.68 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.692 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 51.7 Cg_endo -70.54 126.57 12.94 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.429 2.086 . . . . 0.0 111.838 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.439 ' C ' ' H ' ' A' ' 251' ' ' TYR . 23.8 t -88.54 178.69 6.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.533 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -71.24 10.17 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.139 0.495 . . . . 0.0 111.557 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 249' ' ' CYS . 27.5 m-85 -121.44 19.86 11.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.748 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.68 132.18 51.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.259 0.552 . . . . 0.0 111.376 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -130.27 -49.47 1.09 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.121 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.9 p -138.98 30.07 2.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.988 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.95 103.5 14.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.064 0.459 . . . . 0.0 111.444 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.471 HD23 ' HB ' ' A' ' 279' ' ' VAL . 1.0 OUTLIER -74.27 114.06 12.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.817 177.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.632 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -70.95 132.44 45.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.524 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.446 HD21 HG21 ' A' ' 279' ' ' VAL . 96.7 mt -136.35 -177.96 4.95 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.337 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.806 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 7.5 pt-20 -154.55 -165.66 2.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.181 176.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.727 HG21 ' HG3' ' A' ' 245' ' ' LYS . 39.2 t -108.23 130.43 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 111.802 -173.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.21 15.87 12.05 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.586 -0.816 . . . . 0.0 114.497 168.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.3 179.78 6.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.87 0.835 . . . . 0.0 111.212 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.9 mm -105.82 119.43 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.816 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.687 ' O ' HG13 ' A' ' 266' ' ' VAL . 65.7 t -76.38 125.15 35.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.488 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.761 ' HB3' ' HB3' ' A' ' 235' ' ' ASN . 89.5 mttt -68.34 88.63 0.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.808 0.813 . . . . 0.0 109.5 173.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.815 ' CG2' ' HD2' ' A' ' 237' ' ' PRO . 2.1 p -127.56 126.19 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.556 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.837 ' H ' ' C ' ' A' ' 236' ' ' GLY . 5.1 m -137.87 -26.18 0.96 Allowed 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.927 ' C ' ' HA ' ' A' ' 237' ' ' PRO . 5.9 tmm_? -136.05 93.07 2.87 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.115 0.966 . . . . 0.0 110.46 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.805 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 4.0 ptp -87.37 141.36 28.69 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.205 -0.934 . . . . 0.0 113.255 -174.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -75.03 157.4 34.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.372 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.2 tp -92.54 -3.47 10.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.531 0.681 . . . . 0.0 110.253 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -73.27 -10.01 59.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.104 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 100.18 -29.35 12.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.932 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.946 HE21 ' HA ' ' A' ' 274' ' ' GLN . 0.0 OUTLIER -89.5 113.38 24.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.181 0.515 . . . . 0.0 109.654 175.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.852 ' HB3' ' CG ' ' A' ' 237' ' ' PRO . 55.0 m0 -92.8 162.76 13.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.564 -173.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 1.06 ' H ' ' HG3' ' A' ' 237' ' ' PRO . 2.8 tm-20 -128.6 89.63 2.92 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 120.209 -0.597 . . . . 0.0 109.814 -168.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.551 ' CA ' ' HD3' ' A' ' 237' ' ' PRO . . . -117.96 158.35 14.72 Favored Glycine 0 C--O 1.226 -0.389 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.995 -174.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 265' ' ' LYS . 18.0 tt0 -116.79 111.08 19.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.246 0.523 . . . . 0.0 110.572 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.471 ' HB ' HD23 ' A' ' 256' ' ' LEU . 97.9 t -109.93 122.22 64.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.682 0.277 . . . . 0.0 110.64 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 48.15 32.22 2.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.58 1.152 . . . . 0.0 112.41 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 97.3 -3.03 61.45 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.198 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -107.92 114.96 29.27 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.1 OUTLIER -106.61 141.56 37.68 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.875 178.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -171.18 -170.29 35.14 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.649 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 80.5 mt -99.56 135.01 41.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.064 0.459 . . . . 0.0 110.188 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.466 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 50.7 p90 -136.79 140.87 33.12 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.16 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 2.8 Cg_exo -76.65 152.37 33.22 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.989 2.459 . . . . 0.0 112.661 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.48 ' HB3' ' CH2' ' A' ' 275' ' ' TRP . 7.6 p90 -69.71 -2.51 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.399 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.7 p -90.45 4.33 51.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.058 0.456 . . . . 0.0 111.47 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -117.44 -15.37 10.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.778 0.323 . . . . 0.0 111.441 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.6 160.85 38.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.266 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -121.54 119.0 30.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.73 0.3 . . . . 0.0 110.535 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.588 HD11 ' HB2' ' A' ' 240' ' ' ALA . 49.5 mm -73.36 123.22 27.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.604 175.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.445 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 8.8 p90 -126.16 174.26 8.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.394 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -102.64 90.15 2.11 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 57.6 Cg_endo -71.54 -32.87 11.52 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.359 2.039 . . . . 0.0 112.68 -173.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -137.36 68.75 1.41 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.206 0.527 . . . . 0.0 110.116 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 5.5 p30 -76.33 115.35 46.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.362 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 8.9 Cg_exo -72.29 -35.12 6.99 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.802 2.335 . . . . 0.0 111.361 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -136.0 -167.52 2.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.432 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 62.29 33.16 16.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.4 0.619 . . . . 0.0 110.335 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -80.57 1.21 30.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.552 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.021 -179.325 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.757 0.313 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -148.42 154.04 39.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.314 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.2 m -126.63 26.97 6.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.862 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 75.58 147.39 0.09 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.438 175.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -122.59 -57.55 1.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.107 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 62.58 176.27 0.14 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 172.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.08 73.7 0.76 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.624 -2.08 . . . . 0.0 106.08 164.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.2 m -63.44 154.84 30.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.0 -167.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.6 m 75.84 -45.9 0.54 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.321 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.38 110.21 0.92 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.525 0.679 . . . . 0.0 111.048 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -57.72 -32.14 67.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.941 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 t -81.38 -1.66 46.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.3 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.2 -46.94 7.49 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.367 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -117.76 -26.22 6.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -173.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -84.33 125.38 32.23 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.025 -0.422 . . . . 0.0 110.866 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.504 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.2 mmt -108.53 -3.47 18.04 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.189 -175.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.434 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 52.17 -112.18 1.88 Allowed Glycine 0 CA--C 1.522 0.53 0 O-C-N 123.66 0.6 . . . . 0.0 113.953 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.6 Cg_exo -66.63 88.35 0.28 Allowed 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.411 2.741 . . . . 0.0 113.499 -176.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.907 HG13 ' H ' ' A' ' 20' ' ' SER . 16.4 t -131.96 -162.88 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.907 ' H ' HG13 ' A' ' 19' ' ' VAL . 47.5 p -173.77 178.27 2.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.701 1.137 . . . . 0.0 109.167 -169.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 20.1 tpt180 -55.43 -54.45 43.62 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.288 0.367 . . . . 0.0 110.034 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -58.28 -59.6 5.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.717 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 56.5 mm-40 -61.05 -46.53 90.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.02 -174.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.85 77.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 18.3 pt20 -70.06 -33.32 71.79 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.954 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.6 m -64.5 -34.41 78.15 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.43 0.633 . . . . 0.0 111.082 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 22.8 mmt85 -64.23 -41.41 97.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.843 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 1.064 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 14.5 mt -112.19 6.97 19.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -168.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 29' ' ' GLN . 4.1 pt20 -74.65 100.41 3.94 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.454 0.645 . . . . 0.0 111.721 -176.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.67 4.96 90.23 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.313 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -88.19 -171.69 3.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.574 0.226 . . . . 0.0 110.691 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.523 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 6.0 mtp180 -48.78 126.47 12.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.934 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.425 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 30.5 m170 -85.59 155.17 21.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.929 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.7 -2.06 79.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.322 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.533 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 39.5 mtm -93.1 153.25 18.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.0 110.335 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.596 ' CD1' HD23 ' A' ' 98' ' ' LEU . 49.3 p90 -150.13 166.53 29.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.434 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.504 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -155.27 138.33 15.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.641 174.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t -105.41 125.12 60.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.605 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.748 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 32.7 ptt-85 -124.44 174.37 7.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.291 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -72.55 131.76 42.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.627 ' HA ' HG23 ' A' ' 49' ' ' VAL . 15.4 t -56.05 146.64 22.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.633 0.73 . . . . 0.0 112.443 -170.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -92.22 -7.93 46.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.213 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.6 m -110.34 -47.87 3.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.335 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 41' ' ' SER . 56.2 m -125.09 119.0 25.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.714 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.9 112.79 1.75 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.527 2.151 . . . . 0.0 111.572 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.04 -21.88 11.85 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.437 ' C ' ' HB2' ' A' ' 41' ' ' SER . 26.4 t70 -82.85 171.94 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.518 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 27.1 m-85 -130.37 160.91 32.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.458 0.572 . . . . 0.0 111.205 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.627 HG23 ' HA ' ' A' ' 41' ' ' SER . 39.5 t -136.77 105.4 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.213 0.53 . . . . 0.0 111.218 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.475 ' CB ' HD12 ' A' ' 63' ' ' ILE . 33.6 tp -82.27 102.7 11.34 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.226 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.7 m -95.36 119.43 33.86 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 48.9 t -117.89 136.33 55.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.113 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 1.064 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 89.6 p -104.89 135.12 46.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.694 0.759 . . . . 0.0 111.806 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.538 ' OE1' ' HB3' ' A' ' 94' ' ' ASP . 18.9 mt-10 -144.79 176.29 9.55 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 170.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.469 HD21 ' N ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -29.23 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 m 34.14 70.95 0.11 Allowed 'General case' 0 C--N 1.349 0.582 0 CA-C-O 121.983 0.897 . . . . 0.0 110.882 -171.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.924 HH12 ' HA ' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -162.31 45.46 0.15 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.088 -157.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.6 t -81.83 90.6 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.561 0.696 . . . . 0.0 109.667 -177.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.5 m -86.1 122.13 29.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.477 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.49 ' O ' ' HB3' ' A' ' 207' ' ' PTR . 14.3 m-70 -93.72 95.89 9.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.685 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.909 ' HA ' ' HB2' ' A' ' 208' ' ' ALA . 78.4 m-85 -87.51 117.31 26.22 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 123.15 0.58 . . . . 0.0 111.657 -175.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.4 HG12 HG21 ' A' ' 49' ' ' VAL . 5.6 mt -80.49 133.38 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.7 mp -115.49 118.63 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.197 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -83.77 134.53 34.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.813 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -87.77 105.77 17.62 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 82.9 mt -88.26 145.79 36.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.415 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 34.6 Cg_exo -62.19 -23.11 75.17 Favored 'Trans proline' 0 N--CA 1.473 0.315 0 C-N-CA 123.363 2.708 . . . . 0.0 112.962 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -89.03 18.1 5.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.186 0.517 . . . . 0.0 110.183 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.811 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 1.2 mmp_? 64.41 31.95 12.3 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.275 173.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -113.18 165.41 12.42 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.487 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 60.1 m-85 -127.22 117.45 22.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.441 0.639 . . . . 0.0 111.509 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -106.57 98.76 8.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.511 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 8.7 tt -79.6 85.16 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.545 0.688 . . . . 0.0 110.476 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.478 ' O ' ' HD2' ' A' ' 210' ' ' PRO . . . 60.69 73.2 0.52 Allowed Glycine 0 C--O 1.227 -0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.117 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.6 t0 75.7 -38.39 0.35 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.101 0.56 . . . . 0.0 111.023 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.522 ' HA ' HE21 ' A' ' 76' ' ' GLN . 0.0 OUTLIER -59.26 114.66 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.46 0.304 . . . . 0.0 110.902 174.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.82 115.43 27.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.794 0.33 . . . . 0.0 111.345 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' A' ' 76' ' ' GLN . 84.4 m-85 -126.05 168.02 14.54 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -86.22 -34.71 20.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.708 0.29 . . . . 0.0 111.524 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 2.6 p80 -152.63 168.54 25.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.677 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.652 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 12.4 mt -57.04 -55.26 45.84 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.29 -3.8 8.13 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.789 1.659 . . . . 0.0 113.014 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.81 -32.62 17.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.736 0.303 . . . . 0.0 110.558 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.2 pp -76.74 -32.35 57.72 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.1 mt -66.03 -26.98 67.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.731 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -74.57 -35.11 63.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.823 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -75.36 -38.02 60.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 111.301 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.473 ' OH ' ' HG2' ' A' ' 210' ' ' PRO . 44.5 m-85 -72.79 1.94 7.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.954 0.407 . . . . 0.0 111.34 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.524 ' HZ3' ' HB2' ' A' ' 89' ' ' LYS . 4.1 ttmp? -64.91 -36.66 85.1 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.322 172.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 mt -104.13 -7.39 9.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.177 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -82.69 -37.09 25.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.875 -171.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.721 ' HA ' HG22 ' A' ' 97' ' ' THR . 81.2 m-85 66.27 95.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.993 0.808 . . . . 0.0 110.203 -169.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.704 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 23.6 mt -62.71 -23.52 67.2 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.404 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.538 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 23.7 t70 -139.11 -77.89 0.34 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 164.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.653 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 5.8 t -146.95 10.44 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.585 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.502 HG23 ' CD1' ' A' ' 99' ' ' ILE . 4.3 m -124.19 -39.23 2.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.721 HG22 ' HA ' ' A' ' 92' ' ' TYR . 17.6 p 82.9 -173.3 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.422 1.489 . . . . 0.0 111.011 -174.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.596 HD23 ' CD1' ' A' ' 36' ' ' PHE . 93.7 mt -88.25 106.11 17.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.857 176.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 1.9 mp -89.08 -53.82 8.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.56 ' HG2' HG21 ' A' ' 99' ' ' ILE . 9.9 pt-20 -163.54 149.39 9.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.74 159.56 47.9 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.328 2.019 . . . . 0.0 112.413 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.57 124.48 89.33 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.89 76.48 0.61 Allowed 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.908 2.405 . . . . 0.0 113.678 -171.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.446 ' HE ' ' HA ' ' A' ' 104' ' ' ARG . 3.7 tpm_? 70.33 -58.52 0.54 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.142 0.977 . . . . 0.0 111.772 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.633 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 3.3 p90 -124.05 167.22 15.96 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.633 ' HD2' ' HB2' ' A' ' 105' ' ' TYR . 73.3 Cg_endo -73.53 25.67 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.906 2.404 . . . . 0.0 114.326 -172.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.6 p 49.36 94.86 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.802 0.841 . . . . 0.0 112.538 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.566 ' HD3' ' HD2' ' A' ' 105' ' ' TYR . 21.2 Cg_exo -65.63 162.9 32.31 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.177 2.585 . . . . 0.0 111.888 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.66 93.66 0.17 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.688 2.259 . . . . 0.0 112.23 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.1 ttt -108.2 -31.02 8.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.791 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.1 -25.4 3.51 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.831 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.6 m -81.33 112.66 18.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -92.25 -17.69 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.831 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 m 68.89 176.7 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.685 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.551 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -71.65 -52.69 8.05 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.4 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 115' ' ' ALA . 2.8 Cg_exo -76.64 41.86 0.97 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.698 2.266 . . . . 0.0 112.935 -176.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.487 ' O ' HD21 ' A' ' 118' ' ' LEU . 46.0 t30 -78.06 110.82 13.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.702 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.487 HD21 ' O ' ' A' ' 117' ' ' ASN . 1.3 mm? -155.48 82.97 3.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.02 -71.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.782 2.322 . . . . 0.0 113.419 -172.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.0 p -90.92 104.05 16.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.374 0.607 . . . . 0.0 112.449 -172.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.56 110.43 12.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.589 ' HG2' ' HA2' ' A' ' 188' ' ' GLY . 3.8 mp0 -62.78 -75.29 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.869 ' HA ' ' HA ' ' A' ' 185' ' ' SER . 3.3 t70 48.14 -151.48 0.12 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.006 0.816 . . . . 0.0 111.539 174.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 173.87 -80.41 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 1.024 ' HG ' ' HD3' ' A' ' 155' ' ' LYS . 4.3 mm? 46.99 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.092 0 O-C-N 124.251 0.969 . . . . 0.0 112.339 173.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 45.0 tt0 -144.93 -66.09 0.33 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.647 -172.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -117.39 118.37 32.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.806 0.812 . . . . 0.0 111.457 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.759 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 71.8 t -133.3 135.31 56.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.746 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 1.026 ' HB2' ' HB3' ' A' ' 179' ' ' GLU . 23.0 mtt180 -107.7 158.25 17.43 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.055 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.442 HG22 ' CD2' ' A' ' 144' ' ' PHE . 6.3 p -116.22 138.8 50.98 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.801 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.542 HD21 ' CG ' ' A' ' 179' ' ' GLU . 12.3 mt -112.87 -37.03 4.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.636 -172.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -69.79 -35.98 75.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.994 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.8 t70 70.69 92.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.456 0.646 . . . . 0.0 109.262 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 79.1 t80 -127.59 116.89 21.14 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.917 -176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 48.8 Cg_endo -92.47 96.38 0.18 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 122.37 2.047 . . . . 0.0 113.067 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.84 -17.49 80.13 Favored Glycine 0 CA--C 1.507 -0.466 0 CA-C-O 121.795 0.664 . . . . 0.0 111.483 173.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.477 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 17.4 m120 55.57 29.99 14.48 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.024 -1.088 . . . . 0.0 112.804 -171.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.517 ' HB2' ' HD3' ' A' ' 169' ' ' ARG . 34.4 t0 82.63 168.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 157.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.795 ' HA ' ' NE2' ' A' ' 211' ' ' GLN . . . 89.06 -35.39 0.02 OUTLIER 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.832 1.653 . . . . 0.0 112.409 173.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -143.76 -14.61 0.64 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.945 0.403 . . . . 0.0 110.253 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -147.53 120.48 8.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.446 0.641 . . . . 0.0 110.511 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.616 HD12 ' HG2' ' A' ' 169' ' ' ARG . 41.7 tp -75.71 124.32 88.7 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.019 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 55.5 Cg_endo -77.61 96.2 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.42 2.08 . . . . 0.0 110.808 172.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.53 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 6.9 p90 -105.23 163.4 12.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.716 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.846 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 8.4 mmpt? -103.75 -176.39 3.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.303 0.573 . . . . 0.0 111.233 -175.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 13.73 2.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.52 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.75 39.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.719 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.846 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 29.9 mm-40 -98.54 155.74 17.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.77 HD13 ' HG2' ' A' ' 129' ' ' ARG . 15.7 mm -97.27 134.57 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.596 HD22 ' HA ' ' A' ' 165' ' ' ASN . 22.5 mt -117.32 156.61 27.53 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.558 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 62.1 t -116.87 127.01 74.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.559 HD13 ' HB3' ' A' ' 163' ' ' ALA . 45.9 mm -76.06 82.52 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.221 1.01 . . . . 0.0 108.889 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.728 HG22 HG23 ' A' ' 170' ' ' VAL . 14.7 tt -77.44 -27.43 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.913 -175.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.924 ' HA ' HH12 ' A' ' 57' ' ' ARG . 4.4 mt-10 -139.97 139.74 36.14 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 173.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 1.024 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 5.7 ttpm? -133.86 86.47 38.18 Favored Pre-proline 0 C--O 1.237 0.412 0 O-C-N 121.755 -0.59 . . . . 0.0 111.036 174.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.653 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 53.6 Cg_endo -79.01 -46.07 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.285 1.99 . . . . 0.0 112.786 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -109.11 179.88 4.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.252 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -103.37 -29.43 11.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.842 0.353 . . . . 0.0 110.962 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -93.44 -21.44 19.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.618 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.498 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 35.9 m95 -129.06 126.02 38.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.1 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.64 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.1 m0 -116.1 137.79 51.81 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.09 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.848 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.5 m -89.33 89.72 8.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.129 0.49 . . . . 0.0 110.071 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.559 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -101.22 154.84 18.42 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.962 -0.461 . . . . 0.0 111.354 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.724 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.2 ptt180 -98.54 128.9 45.05 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.533 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.596 ' HA ' HD22 ' A' ' 150' ' ' LEU . 64.5 t30 -63.58 160.73 16.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.12 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -59.46 -25.01 64.04 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.451 ' HB3' HD21 ' A' ' 165' ' ' ASN . 11.1 t70 -75.69 -24.33 56.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.797 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.9 74.84 1.11 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.293 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.724 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -159.07 133.12 7.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.819 -0.191 . . . . 0.0 110.979 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.728 HG23 HG22 ' A' ' 153' ' ' ILE . 83.9 t -103.35 120.39 53.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.192 0.52 . . . . 0.0 111.892 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.97 159.89 28.29 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 170.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.548 ' HE3' ' HG2' ' A' ' 156' ' ' PRO . 21.6 mtp -71.21 138.95 49.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.254 0.527 . . . . 0.0 110.0 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -134.96 145.85 56.21 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.291 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 5.5 Cg_exo -75.94 129.04 11.19 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 123.299 2.666 . . . . 0.0 112.702 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.657 ' O ' HG21 ' A' ' 178' ' ' VAL . 92.3 t -58.77 -45.66 99.61 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 47.4 Cg_exo -59.5 -6.92 4.72 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.329 2.019 . . . . 0.0 113.86 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -98.15 -1.29 42.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.657 HG21 ' O ' ' A' ' 175' ' ' VAL . 5.9 m -109.41 178.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -164.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 1.026 ' HB3' ' HB2' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -138.9 40.38 2.15 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 111.267 -2.697 . . . . 0.0 107.983 -168.187 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.759 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 20.0 pttm -77.75 144.14 37.44 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.669 -0.644 . . . . 0.0 110.038 -165.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.0 mt -69.36 -58.36 4.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.24 -169.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.11 147.59 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.024 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.42 ' HD3' ' HH2' ' A' ' 161' ' ' TRP . 15.6 tpt180 -153.02 116.27 4.64 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.029 177.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.4 t -160.5 77.93 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.869 ' HA ' ' HA ' ' A' ' 123' ' ' ASP . 0.3 OUTLIER -64.84 -57.85 14.88 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.283 -176.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.66 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 32.4 Cg_endo -97.05 -135.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.602 2.201 . . . . 0.0 110.57 169.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.593 ' CE1' ' HD2' ' A' ' 186' ' ' PRO . 0.0 OUTLIER 43.38 65.33 1.0 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.34 0.656 . . . . 0.0 111.481 -177.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.589 ' HA2' ' HG2' ' A' ' 122' ' ' GLU . . . -60.04 -24.18 60.36 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.919 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -69.1 -19.08 64.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -99.47 -3.03 34.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.33 0.586 . . . . 0.0 110.177 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -93.1 95.41 1.99 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.466 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 193' ' ' ARG . 88.0 m-20 -71.53 -25.47 62.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 192' ' ' ASN . 55.0 ttt180 72.65 136.16 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.755 0.659 . . . . 0.0 111.581 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 34.6 m-80 -108.95 141.19 41.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.963 177.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 30.7 p -107.8 -18.01 13.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.979 0.419 . . . . 0.0 110.048 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -109.09 24.57 12.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.469 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.526 ' O ' HG12 ' A' ' 200' ' ' ILE . 5.6 p -66.16 -26.93 67.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.315 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -82.8 4.81 23.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.167 0.508 . . . . 0.0 110.546 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -93.12 -6.39 63.19 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.589 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 197' ' ' SER . 38.1 pt -80.31 130.37 65.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.402 . . . . 0.0 110.583 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.525 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 1.2 Cg_endo -83.89 135.86 6.84 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.162 2.575 . . . . 0.0 112.609 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.714 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . 14.7 tp10 -132.16 112.41 14.46 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.35 117.05 3.64 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.101 2.534 . . . . 0.0 112.22 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 59.56 40.8 19.91 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.737 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.714 ' HB3' ' HB3' ' A' ' 202' ' ' GLU . 1.4 p80 -62.77 103.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.562 0.696 . . . . 0.0 110.9 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.0 147.33 36.88 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.978 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.49 ' HB3' ' O ' ' A' ' 60' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.909 ' HB2' ' HA ' ' A' ' 61' ' ' TYR . . . -161.28 173.37 15.11 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.638 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.448 HE21 ' HB2' ' A' ' 209' ' ' GLN . 6.5 tt0 174.89 101.84 0.08 OUTLIER Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.674 ' HA ' HG22 ' A' ' 170' ' ' VAL . 7.6 Cg_exo -75.66 -126.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 123.905 3.07 . . . . 0.0 113.549 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.795 ' NE2' ' HA ' ' A' ' 139' ' ' ALA . 27.6 mt-30 -98.5 -172.95 2.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.432 0.634 . . . . 0.0 112.21 -172.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 82.5 p -93.0 -176.3 4.14 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.248 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.402 ' O ' ' HD3' ' A' ' 215' ' ' PRO . 4.5 m -72.87 92.2 1.59 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.608 HG23 ' HB1' ' A' ' 139' ' ' ALA . 3.4 m -111.38 100.17 46.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.431 -174.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 213' ' ' THR . 6.9 Cg_endo -87.61 93.47 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.9 2.4 . . . . 0.0 111.54 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 62.4 tp -114.9 106.27 52.0 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.972 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.616 ' HA ' HD12 ' A' ' 230' ' ' LEU . 59.6 Cg_endo -75.15 67.4 6.06 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.8 2.333 . . . . 0.0 112.071 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -148.29 -42.98 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.32 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 14.6 m -80.48 49.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.172 0.51 . . . . 0.0 112.313 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 13.8 p -164.65 -77.46 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.456 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 156.37 34.3 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.736 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 22.7 m -135.68 112.44 10.71 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.07 -23.73 39.69 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.921 2.414 . . . . 0.0 111.966 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 92.15 36.87 6.14 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.734 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.22 66.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.922 0.392 . . . . 0.0 110.901 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -165.26 -61.29 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.805 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.6 mt -90.79 136.64 23.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.625 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.1 t -162.88 135.35 4.16 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-O 120.761 0.315 . . . . 0.0 110.664 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.49 -9.32 21.41 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.768 2.312 . . . . 0.0 112.409 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.616 HD12 ' HA ' ' A' ' 217' ' ' PRO . 2.9 pp -139.25 146.78 50.37 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.514 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 14.3 Cg_exo -69.83 170.94 15.49 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.677 2.251 . . . . 0.0 112.08 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.6 m -98.16 158.82 15.33 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 10.7 t -60.22 142.17 54.89 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.046 0.451 . . . . 0.0 111.022 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -139.96 -44.32 0.43 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.65 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.3 p30 46.03 -91.73 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.075 0.95 . . . . 0.0 112.868 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -164.88 179.91 39.26 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.022 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.61 116.62 4.35 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.853 2.368 . . . . 0.0 111.852 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 21.1 t -87.72 145.98 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.509 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -91.94 118.47 30.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.412 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.94 150.67 40.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.027 176.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -111.13 130.79 55.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.897 0.379 . . . . 0.0 110.244 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.551 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -74.31 122.36 22.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.414 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 290' ' ' HIS . 27.1 pt -104.03 6.15 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -169.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.406 HE21 ' HB3' ' A' ' 244' ' ' GLN . 0.4 OUTLIER -156.12 149.11 24.22 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.581 -176.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 11.2 tptm -79.45 116.44 19.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.427 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.63 ' HB3' ' CE1' ' A' ' 290' ' ' HIS . 6.4 ttt-85 -151.32 107.64 3.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.143 0.497 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.52 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 34.6 m -92.6 174.48 4.04 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.891 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.663 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 39.3 Cg_exo -60.87 122.38 11.13 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.417 2.078 . . . . 0.0 112.119 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.864 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 52.7 t -71.19 159.03 35.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.374 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.07 -42.93 66.33 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -105.45 11.18 32.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.811 0.339 . . . . 0.0 111.197 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.864 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.5 m-20 -111.3 92.42 4.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.174 0.512 . . . . 0.0 111.21 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -77.53 -27.76 51.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.689 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.5 p -89.2 15.03 9.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.608 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -89.06 116.74 27.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.867 0.365 . . . . 0.0 110.924 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.563 HD23 ' HB ' ' A' ' 279' ' ' VAL . 1.1 tt -77.96 125.0 28.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.663 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -70.83 108.11 4.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.907 0.384 . . . . 0.0 110.581 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.6 mt -136.15 123.26 21.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.294 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 7.5 pt-20 -100.08 -134.87 0.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.782 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.86 130.2 68.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.53 . . . . 0.0 111.736 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 85.66 21.92 52.04 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.666 173.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -109.71 159.41 17.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.429 0.614 . . . . 0.0 110.019 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.47 127.09 56.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 110.94 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.646 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 39.9 t -107.03 122.03 60.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.496 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -90.94 101.23 14.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.63 HG11 ' CZ3' ' A' ' 275' ' ' TRP . 4.8 p -126.34 147.83 31.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.424 -170.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -112.64 -54.22 2.64 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 275' ' ' TRP . 45.4 mtt180 -90.48 128.22 36.46 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 122.365 -0.21 . . . . 0.0 110.633 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.887 ' C ' ' HA3' ' A' ' 273' ' ' GLY . 0.2 OUTLIER -117.25 113.48 22.25 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.932 ' HB2' ' HD2' ' A' ' 288' ' ' PHE . 0.9 OUTLIER -20.67 176.59 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 129.849 3.26 . . . . 0.0 117.643 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.427 HG13 ' CE2' ' A' ' 288' ' ' PHE . 43.6 mt 63.8 70.41 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 113.315 -1.766 . . . . 0.0 107.14 -160.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.6 13.42 9.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.048 -164.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.887 ' HA3' ' C ' ' A' ' 269' ' ' MET . . . -91.59 -35.47 6.89 Favored Glycine 0 N--CA 1.427 -1.924 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.558 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.903 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 8.9 pt20 23.44 121.71 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 125.638 1.434 . . . . 0.0 113.716 -161.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.833 ' CE2' ' HB3' ' A' ' 288' ' ' PHE . 7.6 m0 -83.81 132.57 34.81 Favored 'General case' 0 CA--C 1.48 -1.726 0 C-N-CA 118.015 -1.474 . . . . 0.0 111.18 -161.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.5 94.53 4.83 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 111.593 -2.549 . . . . 0.0 110.281 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.95 137.7 10.6 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.419 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.66 ' HG3' ' HB3' ' A' ' 283' ' ' LYS . 23.8 mp0 -101.88 109.52 21.29 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.563 ' HB ' HD23 ' A' ' 256' ' ' LEU . 58.7 t -123.17 121.74 63.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.743 0.306 . . . . 0.0 111.438 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 5.9 t30 66.24 -72.68 0.08 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.541 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -113.56 -43.47 0.82 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.244 -174.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.54 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 5.5 ppt_? -158.11 174.26 15.47 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.66 ' HB3' ' HG3' ' A' ' 278' ' ' GLU . 60.0 pttt -95.77 143.83 26.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.873 -175.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.39 161.44 29.75 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.514 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.89 HD21 ' HB2' ' A' ' 274' ' ' GLN . 21.1 mt -87.53 137.48 32.3 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.718 0.771 . . . . 0.0 111.558 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.646 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 21.4 p90 -149.54 142.9 16.28 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.096 174.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.611 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 13.8 Cg_exo -69.64 144.69 55.48 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.005 1.803 . . . . 0.0 110.76 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.932 ' HD2' ' HB2' ' A' ' 270' ' ' ASN . 26.5 p90 -69.1 6.02 1.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.5 m -88.14 -12.48 43.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.358 0.599 . . . . 0.0 109.685 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.63 ' CE1' ' HB3' ' A' ' 246' ' ' ARG . 69.1 t60 -83.41 -20.92 33.27 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.135 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 242' ' ' ALA . 23.6 m -127.02 176.99 6.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.694 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -136.87 134.89 37.37 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.133 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.407 HD11 ' HH2' ' A' ' 275' ' ' TRP . 44.5 mm -82.75 102.96 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -93.43 176.2 6.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.878 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 296' ' ' PRO . 10.1 m-20 -59.92 109.58 2.1 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 295' ' ' ASP . 7.1 Cg_exo -73.29 -25.04 16.05 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.904 2.403 . . . . 0.0 112.711 -173.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -85.31 93.55 8.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.167 0.508 . . . . 0.0 110.836 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.445 HD21 ' N ' ' A' ' 298' ' ' ASN . 0.9 OUTLIER -106.26 102.9 42.86 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.23 73.84 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.074 2.516 . . . . 0.0 113.257 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -111.12 -44.41 3.58 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.698 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.17 -14.0 23.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.044 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -71.69 126.28 29.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.399 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.891 -0.576 . . . . 0.0 110.5 -179.637 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 t -76.94 97.55 4.65 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 p -79.64 162.94 24.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.259 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.93 127.88 34.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.37 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -154.85 93.42 1.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.207 0.527 . . . . 0.0 110.622 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.56 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 45.7 p90 -145.02 154.88 42.99 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.58 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -71.99 97.77 1.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.63 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.7 m -77.17 59.0 1.67 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.191 0.52 . . . . 0.0 110.51 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 t 179.42 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.603 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -69.66 102.02 1.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.34 0.59 . . . . 0.0 110.759 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 11.6 mmt180 -61.73 -29.25 69.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.525 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.3 m -79.09 0.38 28.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.607 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.12 -47.34 5.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -116.42 -21.32 9.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 44.4 t80 -85.7 118.5 25.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.809 0.338 . . . . 0.0 111.28 -173.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.592 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 19.1 mmt -104.15 -2.11 26.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 110.963 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.07 -115.86 4.47 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.485 -0.779 . . . . 0.0 114.022 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.1 94.61 0.73 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.265 1.977 . . . . 0.0 113.534 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.87 HG12 ' H ' ' A' ' 20' ' ' SER . 19.0 t -139.93 -175.56 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.87 ' H ' HG12 ' A' ' 19' ' ' VAL . 93.9 p -151.45 176.64 11.09 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.254 0.934 . . . . 0.0 108.554 -170.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.674 ' HG3' ' O3P' ' A' ' 207' ' ' PTR . 46.0 mtp85 -53.79 -66.03 0.46 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.39 -43.24 91.25 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.21 -45.8 90.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.471 0.176 . . . . 0.0 111.369 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -56.31 -48.37 76.83 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.063 0.459 . . . . 0.0 111.27 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -73.53 -30.04 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.004 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.679 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 95.7 m -62.1 -34.78 76.96 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.272 0.558 . . . . 0.0 110.466 174.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -75.43 -14.29 60.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.121 0.486 . . . . 0.0 110.417 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.547 ' O ' ' HB3' ' A' ' 31' ' ' GLN . 20.4 mt -115.75 17.7 16.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.406 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.679 ' HG2' ' O ' ' A' ' 26' ' ' THR . 12.5 pt20 -88.08 116.0 25.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.399 0.619 . . . . 0.0 110.675 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.74 26.55 24.46 Favored Glycine 0 CA--C 1.499 -0.916 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.823 ' HB2' ' HG ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -50.59 177.7 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 111.187 -2.506 . . . . 0.0 115.141 -175.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -86.19 -9.31 56.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.558 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.598 ' HD2' ' HG2' ' A' ' 31' ' ' GLN . 61.7 m170 66.03 92.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.445 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.41 28.89 3.61 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -170.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 52.4 ttp -124.19 134.19 53.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.55 ' CD1' HD23 ' A' ' 98' ' ' LEU . 43.8 p90 -135.6 164.13 28.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -173.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.497 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -150.62 144.02 24.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.364 171.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.422 HG22 HD11 ' A' ' 50' ' ' LEU . 61.2 t -109.24 119.17 58.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.551 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -123.01 168.47 12.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.708 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.475 ' OD2' ' HA ' ' A' ' 45' ' ' PRO . 34.6 t70 -66.11 125.93 27.05 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.02 -0.734 . . . . 0.0 109.02 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.63 ' HA ' HG22 ' A' ' 49' ' ' VAL . 31.9 p -53.63 120.02 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.518 0.675 . . . . 0.0 112.104 -172.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.691 ' HB3' ' HA ' ' A' ' 20' ' ' SER . 3.4 p -74.58 73.62 1.97 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.922 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.733 ' HB ' ' O1P' ' A' ' 207' ' ' PTR . 10.0 t 174.72 -36.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.327 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 66.5 m -147.43 93.85 4.57 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.253 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HA ' ' OD2' ' A' ' 40' ' ' ASP . 54.5 Cg_exo -52.21 116.18 2.65 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.524 2.149 . . . . 0.0 112.253 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.57 -47.83 0.9 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.523 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 1.2 m-20 -78.62 -172.05 2.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.457 ' CE1' ' HE1' ' A' ' 15' ' ' TYR . 25.9 m-85 -138.46 169.4 17.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.255 0.55 . . . . 0.0 112.132 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.63 HG22 ' HA ' ' A' ' 41' ' ' SER . 44.1 t -146.94 111.42 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.525 175.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.579 ' HB2' HD13 ' A' ' 63' ' ' ILE . 62.5 tp -82.04 104.27 12.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.133 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.9 m -94.99 109.32 21.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.271 0.558 . . . . 0.0 109.829 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.623 HG12 ' OE2' ' A' ' 54' ' ' GLU . 29.0 t -111.2 138.16 40.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.126 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.823 ' HG ' ' HB2' ' A' ' 31' ' ' GLN . 81.8 p -118.22 137.37 53.06 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.7 ' HB2' ' HE ' ' A' ' 57' ' ' ARG . 13.9 mp0 -143.58 179.44 7.12 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.428 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 23.6 m-20 -21.15 81.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 124.846 1.341 . . . . 0.0 114.194 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m 42.68 62.8 1.63 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.671 0.788 . . . . 0.0 111.787 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.7 ' HE ' ' HB2' ' A' ' 54' ' ' GLU . 1.4 ptm85 -167.52 57.45 0.07 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -163.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 19.2 t -76.58 103.79 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.34 -0.85 . . . . 0.0 109.54 -176.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.48 ' HG ' ' NH2' ' A' ' 57' ' ' ARG . 54.8 m -92.1 121.47 33.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.185 -172.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -92.58 88.26 6.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.768 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.74 ' HH ' ' HB3' ' A' ' 93' ' ' LEU . 90.3 m-85 -78.89 117.25 19.81 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.077 0.551 . . . . 0.0 110.924 -176.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 8.4 tp -71.4 135.96 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.579 HD13 ' HB2' ' A' ' 50' ' ' LEU . 4.0 mp -122.23 117.76 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.964 0.411 . . . . 0.0 110.769 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.523 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 5.5 m120 -85.61 136.07 33.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.936 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 t -92.73 98.43 11.41 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.498 HD22 ' HD2' ' A' ' 72' ' ' LYS . 55.0 mt -72.89 168.36 25.23 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.107 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.427 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 36.6 Cg_exo -63.17 68.3 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.998 2.465 . . . . 0.0 112.803 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 70.79 14.89 6.99 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.369 1.468 . . . . 0.0 112.176 164.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 66.4 mtt180 -93.75 -72.75 0.6 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.707 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.698 ' HB2' ' O ' ' A' ' 78' ' ' PHE . 3.2 ptp180 -156.79 -169.62 3.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.596 -172.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.553 ' HB3' HG21 ' A' ' 63' ' ' ILE . 97.4 m-85 -118.31 127.92 54.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.959 0.409 . . . . 0.0 111.053 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.663 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 52.9 mttm -98.22 101.09 12.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.842 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 10.7 tt -87.41 81.94 2.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 122.127 0.965 . . . . 0.0 110.202 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.465 ' CA ' ' HG3' ' A' ' 209' ' ' GLN . . . 73.27 81.63 0.38 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.161 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.5 t0 72.59 -58.0 0.61 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.778 0.431 . . . . 0.0 111.376 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -79.03 140.02 38.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.406 0.622 . . . . 0.0 110.726 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.663 ' HB3' ' HG2' ' A' ' 72' ' ' LYS . 10.5 pt-20 -110.8 141.72 43.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.321 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.698 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 71.9 m-85 -122.68 151.08 41.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -58.94 -24.89 62.99 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -169.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -163.75 172.32 14.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.332 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.7 mt -55.09 -56.49 27.61 Favored Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 34.6 Cg_exo -61.15 -9.48 12.62 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.125 1.884 . . . . 0.0 113.23 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.481 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . . . -88.7 -25.58 22.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.66 0.267 . . . . 0.0 110.991 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.571 HD11 HD12 ' A' ' 73' ' ' ILE . 3.9 pp -79.49 -31.52 42.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.26 -35.48 79.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.756 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.481 ' HG2' ' HA ' ' A' ' 83' ' ' ALA . 7.6 pt-20 -80.56 -6.16 57.83 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -87.65 -37.58 16.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.372 0.606 . . . . 0.0 109.592 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.592 ' CG ' HD21 ' A' ' 93' ' ' LEU . 41.9 m-85 -81.85 -6.88 59.47 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.565 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.523 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 14.2 ptmm? -83.62 -3.73 57.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.527 171.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.4 pt -123.21 -22.16 2.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 121.021 0.439 . . . . 0.0 110.522 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 10.6 t-160 -68.9 -41.96 77.55 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.946 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.559 ' CD2' HG21 ' A' ' 97' ' ' THR . 91.3 m-85 71.81 108.39 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 O-C-N 124.554 1.159 . . . . 0.0 108.93 -165.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.74 ' HB3' ' HH ' ' A' ' 61' ' ' TYR . 4.8 mt -78.86 1.38 23.66 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.669 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 28.4 t70 -168.53 -134.19 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.525 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 10.6 t -83.07 -8.05 59.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.516 0.674 . . . . 0.0 109.372 172.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.9 t -125.92 169.46 12.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.912 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.559 HG21 ' CD2' ' A' ' 92' ' ' TYR . 9.1 p -109.14 -176.66 3.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.555 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.55 HD23 ' CD1' ' A' ' 36' ' ' PHE . 92.6 mt -69.13 98.8 1.04 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.681 HG23 ' HG3' ' A' ' 100' ' ' GLU . 51.3 mm -90.68 -58.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.929 -176.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.681 ' HG3' HG23 ' A' ' 99' ' ' ILE . 45.3 mt-10 -141.01 158.12 65.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.712 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 93.6 Cg_endo -83.27 157.37 14.83 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.611 2.208 . . . . 0.0 112.04 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.45 158.33 83.59 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.386 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.74 129.43 27.67 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.258 1.972 . . . . 0.0 111.812 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.592 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 35.3 ttt180 -73.33 -2.69 23.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.371 0.605 . . . . 0.0 110.266 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 6.1 m-85 -91.32 130.27 40.31 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.15 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 12.3 Cg_exo -70.72 86.41 0.71 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.642 2.228 . . . . 0.0 112.363 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.0 m -151.63 98.42 3.03 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.165 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.56 147.05 27.9 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.014 2.476 . . . . 0.0 112.46 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.88 147.97 85.66 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.798 2.332 . . . . 0.0 111.7 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.8 mmt -115.33 144.72 43.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.06 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.4 179.9 16.4 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.644 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 64.9 m -71.35 -21.39 62.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.722 0.296 . . . . 0.0 111.154 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.58 -19.3 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.061 0.457 . . . . 0.0 110.638 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.3 m -67.76 97.47 0.64 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.69 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -145.28 128.28 8.3 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.911 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.473 ' HA ' HG22 ' A' ' 58' ' ' VAL . 96.6 Cg_endo -92.28 -162.6 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.312 2.675 . . . . 0.0 110.93 171.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.597 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 61.3 t30 -102.37 152.61 20.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.999 HD11 ' HG ' ' A' ' 185' ' ' SER . 19.9 mt 53.07 52.94 11.19 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.8 0.688 . . . . 0.0 112.819 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 118' ' ' LEU . 3.1 Cg_exo -81.21 -34.16 0.62 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.361 2.041 . . . . 0.0 111.207 176.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 66.2 p -119.71 -176.93 3.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.056 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.55 13.68 33.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.165 0.507 . . . . 0.0 110.217 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.58 148.34 37.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.613 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.637 ' HA ' HH12 ' A' ' 183' ' ' ARG . 21.7 t0 -80.04 102.66 9.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -118.35 -98.09 0.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.315 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.513 HD12 ' CE2' ' A' ' 161' ' ' TRP . 0.5 OUTLIER -127.11 103.44 7.44 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -173.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.971 ' HB2' ' HE ' ' A' ' 183' ' ' ARG . 8.5 mt-10 169.08 -54.42 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 O-C-N 125.703 1.877 . . . . 0.0 109.988 171.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.966 ' CE1' ' HB3' ' A' ' 183' ' ' ARG . 12.9 m-85 -61.28 107.42 0.76 Allowed 'General case' 0 C--O 1.208 -1.12 0 CA-C-N 119.18 0.9 . . . . 0.0 110.805 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 179' ' ' GLU . 2.0 t -131.23 132.66 63.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.807 172.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.807 HH21 HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -126.31 135.43 51.5 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.601 173.29 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.954 HG21 HG12 ' A' ' 178' ' ' VAL . 70.9 p -94.06 132.86 38.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -173.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.542 HD11 ' HG3' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -112.38 -0.32 15.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.801 -175.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -105.93 -44.36 4.63 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -168.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.3 t70 81.16 102.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.273 0.629 . . . . 0.0 110.35 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 87.3 t80 -142.61 110.82 5.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -91.89 90.42 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.619 2.213 . . . . 0.0 112.615 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.598 ' HA3' ' OD1' ' A' ' 141' ' ' ASP . . . -79.93 -2.42 88.56 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.257 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.452 HD21 ' HA ' ' A' ' 137' ' ' ASN . 7.4 m120 56.95 25.84 11.08 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.642 0.377 . . . . 0.0 111.974 -174.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.781 ' HA ' ' O ' ' A' ' 141' ' ' ASP . 3.0 p30 53.35 -166.61 0.07 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 168.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.645 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . 90.6 -47.49 0.02 OUTLIER 'General case' 0 C--N 1.347 0.46 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.875 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -142.37 14.01 1.99 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.781 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 11.5 t70 -153.53 173.55 15.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 112.756 -2.02 . . . . 0.0 105.824 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.587 HD13 ' HD2' ' A' ' 143' ' ' PRO . 54.8 tp -134.61 128.81 19.19 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 119.16 0.891 . . . . 0.0 110.477 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.587 ' HD2' HD13 ' A' ' 142' ' ' LEU . 12.6 Cg_endo -85.09 98.77 0.67 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.449 2.099 . . . . 0.0 111.194 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.683 ' HB2' ' HG1' ' A' ' 130' ' ' THR . 10.9 p90 -111.77 167.96 9.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.556 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.589 ' H ' ' HB2' ' A' ' 148' ' ' GLU . 24.5 mtpp -126.1 -174.05 3.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -173.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.413 ' O ' ' HE2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -69.79 66.47 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.52 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 121.0 49.34 0.28 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.263 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.589 ' HB2' ' H ' ' A' ' 145' ' ' LYS . 5.8 tp10 -99.34 154.52 18.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.807 HD11 HH21 ' A' ' 129' ' ' ARG . 1.0 OUTLIER -112.32 134.2 55.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.69 -173.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.638 HD21 ' O ' ' A' ' 149' ' ' ILE . 21.0 mt -143.14 155.8 44.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.899 0.857 . . . . 0.0 110.913 -170.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 182' ' ' VAL . 39.3 t -126.32 126.41 69.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.614 173.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 161' ' ' TRP . 36.2 mm -74.53 86.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 122.156 0.979 . . . . 0.0 110.412 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.951 HG23 HG21 ' A' ' 170' ' ' VAL . 9.1 tt -82.51 -28.28 8.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.726 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.94 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 28.0 mt-10 -130.73 141.66 50.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -136.23 77.43 48.33 Favored Pre-proline 0 C--O 1.24 0.566 0 O-C-N 121.472 -0.768 . . . . 0.0 111.566 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.412 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 16.6 Cg_exo -66.16 -54.62 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.256 1.971 . . . . 0.0 111.342 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -106.82 175.06 5.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.62 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -98.89 -23.33 15.39 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.33 -27.64 21.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.273 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.639 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 44.2 m95 -124.41 122.47 37.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.642 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.696 ' HB3' HD11 ' A' ' 152' ' ' ILE . 45.7 m0 -112.18 137.72 49.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.53 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.94 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.7 m -94.82 109.54 21.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.564 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -116.79 159.32 22.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -173.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 9.7 ptt180 -94.0 118.86 32.09 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.996 173.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.605 ' HA ' ' CD2' ' A' ' 150' ' ' LEU . 0.2 OUTLIER -69.16 179.11 2.03 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.664 0.269 . . . . 0.0 111.452 -178.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -61.41 -30.37 70.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.987 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -93.65 4.1 54.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.636 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.23 74.82 1.22 Allowed Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.785 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.671 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -150.92 138.41 19.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 177.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.951 HG21 HG23 ' A' ' 153' ' ' ILE . 95.1 t -103.78 126.03 58.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.201 0.524 . . . . 0.0 111.973 -175.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.669 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . -157.42 167.45 34.01 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 171.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.639 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 22.7 mtp -79.96 139.44 37.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.178 0.489 . . . . 0.0 110.7 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.682 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -138.24 148.3 59.14 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.75 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.24 131.77 10.98 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.65 2.233 . . . . 0.0 112.435 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 61.1 t -59.34 -45.07 99.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 31.9 Cg_endo -65.29 -1.62 4.8 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.22 1.947 . . . . 0.0 113.452 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -99.7 -7.94 24.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.783 0.325 . . . . 0.0 111.066 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.954 HG12 HG21 ' A' ' 130' ' ' THR . 2.9 m -144.2 176.56 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.662 -166.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.684 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 6.6 pt-20 -153.64 -55.65 0.11 Allowed 'General case' 0 C--O 1.2 -1.533 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 144.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -147.04 133.97 20.23 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 122.538 2.426 . . . . 0.0 115.686 -171.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.807 ' HB3' HG13 ' A' ' 149' ' ' ILE . 0.1 OUTLIER 161.66 133.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 164.234 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 151' ' ' VAL . 69.7 t 67.51 134.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 124.823 1.249 . . . . 0.0 113.044 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.971 ' HE ' ' HB2' ' A' ' 126' ' ' GLU . 2.6 ttm180 169.54 -23.34 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.93 1.292 . . . . 0.0 109.356 -165.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.0 m -45.12 134.18 6.27 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.91 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.999 ' HG ' HD11 ' A' ' 118' ' ' LEU . 94.5 p -133.91 163.15 53.21 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.704 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.73 ' HD3' ' HB3' ' A' ' 206' ' ' ALA . 31.6 Cg_exo -59.7 135.95 67.41 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.806 2.337 . . . . 0.0 112.091 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -141.07 175.62 9.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.412 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.39 97.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.99 173.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -126.22 113.93 17.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.843 0.354 . . . . 0.0 110.384 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -166.55 -41.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.049 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 90.17 149.48 22.12 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.431 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -102.58 123.53 46.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.764 0.316 . . . . 0.0 110.616 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -138.27 -43.2 0.51 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.273 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 63.94 -98.83 0.07 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.551 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.0 t 179.42 150.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.63 164.22 17.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.9 t 64.43 -159.76 0.29 Allowed 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.546 0.528 . . . . 0.0 109.811 -177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 69.27 120.92 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.443 0.64 . . . . 0.0 111.379 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.24 67.1 3.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.972 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 29.6 pt -130.08 152.52 80.18 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.289 . . . . 0.0 111.11 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.428 ' O ' ' HD3' ' A' ' 203' ' ' PRO . 95.0 Cg_endo -85.21 -169.3 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.047 2.498 . . . . 0.0 111.794 173.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -110.41 96.28 26.3 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.858 0.361 . . . . 0.0 110.43 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 201' ' ' PRO . 11.7 Cg_exo -70.98 -47.01 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.838 2.359 . . . . 0.0 112.197 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.33 -71.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.567 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.463 ' HB3' ' HG3' ' A' ' 186' ' ' PRO . 52.1 t60 179.88 -60.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.737 173.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.73 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . . . -169.13 121.71 0.77 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.036 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.733 ' O1P' ' HB ' ' A' ' 43' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.579 ' HB3' HD13 ' A' ' 153' ' ' ILE . . . -84.65 96.25 9.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.246 0.546 . . . . 0.0 109.918 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.465 ' HG3' ' CA ' ' A' ' 74' ' ' GLY . 60.8 tt0 -101.6 107.11 50.04 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.818 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.867 ' HA ' HG23 ' A' ' 170' ' ' VAL . 1.7 Cg_endo -88.45 -179.09 2.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.868 3.045 . . . . 0.0 112.783 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.469 ' OE1' ' HB2' ' A' ' 169' ' ' ARG . 31.2 tt0 -175.75 127.41 0.24 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.876 0.37 . . . . 0.0 110.913 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 82.7 m -125.3 143.08 51.13 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.448 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.515 ' OG1' ' HB1' ' A' ' 139' ' ' ALA . 13.1 m -50.79 106.92 0.14 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 120.958 0.409 . . . . 0.0 110.706 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.672 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 16.7 m -70.44 -53.35 10.18 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.745 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.672 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 14.5 Cg_exo -69.57 107.0 1.73 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.091 1.861 . . . . 0.0 112.096 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -121.63 102.68 41.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.514 ' HG3' HD23 ' A' ' 230' ' ' LEU . 71.7 Cg_endo -82.09 108.54 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.777 2.318 . . . . 0.0 112.309 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -85.89 -59.52 2.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.852 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 76.9 t -122.76 -42.58 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.703 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 29.9 m -86.21 134.39 33.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.414 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.12 -79.26 0.27 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.6 t -158.75 104.36 1.61 Allowed Pre-proline 0 C--N 1.323 -0.587 0 CA-C-O 120.793 0.33 . . . . 0.0 110.42 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -81.77 21.49 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.055 2.503 . . . . 0.0 111.141 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -158.81 -154.23 7.12 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.16 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 67.88 -73.75 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.152 0.581 . . . . 0.0 111.407 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 69.14 -58.99 0.49 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.663 0.785 . . . . 0.0 111.94 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -38.93 64.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.853 0.359 . . . . 0.0 110.252 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.1 m -79.97 128.46 73.79 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.572 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.59 153.66 73.68 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.789 2.326 . . . . 0.0 112.224 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.514 HD23 ' HG3' ' A' ' 217' ' ' PRO . 7.7 mp -91.23 135.46 28.27 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.791 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 4.6 Cg_exo -73.75 107.07 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.707 2.271 . . . . 0.0 111.384 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 16.2 m -87.45 -32.3 19.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.594 0.712 . . . . 0.0 109.246 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 17.0 p -135.6 148.0 48.88 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.424 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -70.24 -37.74 75.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 269' ' ' MET . 2.2 p30 -94.51 174.39 7.15 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.95 164.04 37.44 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.091 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.665 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 4.7 Cg_exo -74.0 102.0 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.082 2.521 . . . . 0.0 111.357 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 28.3 t -116.51 146.08 21.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.704 -174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.469 ' CE1' ' HE2' ' A' ' 265' ' ' LYS . 54.1 m-85 -81.28 126.64 31.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.17 0.509 . . . . 0.0 111.272 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.564 ' HB2' HD11 ' A' ' 293' ' ' ILE . . . -135.32 130.9 35.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.097 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -97.47 126.66 42.87 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -73.48 111.69 8.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.434 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.461 HD13 ' HG3' ' A' ' 244' ' ' GLN . 1.9 pp -87.81 -10.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.691 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.461 ' HG3' HD13 ' A' ' 243' ' ' ILE . 28.8 mt-30 -120.23 167.19 12.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 258' ' ' LEU . 21.2 pttp -118.79 137.48 53.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.302 0.573 . . . . 0.0 111.058 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.517 ' NH1' ' HD2' ' A' ' 287' ' ' PRO . 40.8 ttp-105 -139.41 117.55 11.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.845 -176.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.84 131.58 24.31 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.973 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.84 127.7 11.76 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.611 2.207 . . . . 0.0 111.861 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 5.7 p -84.24 -178.96 7.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.977 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -67.24 -16.28 64.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.903 0.383 . . . . 0.0 111.683 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -121.43 29.62 7.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.431 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 255' ' ' ALA . 1.8 p-10 -64.31 126.58 28.24 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.668 0.747 . . . . 0.0 110.526 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -98.03 86.68 3.77 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.339 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 44.4 p 60.95 38.15 17.73 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.069 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 252' ' ' ASP . . . -91.35 103.95 16.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.695 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.416 HD23 ' HB ' ' A' ' 279' ' ' VAL . 1.5 tt -67.23 131.38 45.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.632 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -75.21 120.38 20.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.618 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 245' ' ' LYS . 81.7 mt -138.0 113.02 9.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.593 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.63 172.45 7.7 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 43.9 t -69.56 106.91 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.02 0.438 . . . . 0.0 110.443 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 123.4 -8.56 8.92 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.415 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.03 130.9 44.35 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.836 0.35 . . . . 0.0 110.867 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 45.9 mm -89.02 108.73 19.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.378 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 36.1 t -85.81 106.54 15.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.27 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.469 ' HE2' ' CE1' ' A' ' 239' ' ' PHE . 28.5 mmtt -84.24 92.74 8.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.685 HG13 ' HE1' ' A' ' 269' ' ' MET . 7.6 p -87.31 125.66 41.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.972 0.415 . . . . 0.0 110.044 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 4.9 p -100.34 -32.86 10.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.59 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 24.8 tpp180 -125.88 99.36 5.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.976 0.417 . . . . 0.0 110.165 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.685 ' HE1' HG13 ' A' ' 266' ' ' VAL . 25.2 mtt -85.32 107.65 17.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.511 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -63.63 125.28 23.78 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.4 mt -75.79 68.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.899 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.425 HD21 ' N ' ' A' ' 273' ' ' GLY . 3.1 t30 -177.26 -69.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.147 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.569 ' O ' ' HG2' ' A' ' 274' ' ' GLN . . . 179.11 143.26 5.28 Favored Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -166.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 273' ' ' GLY . 0.6 OUTLIER 64.31 119.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 125.418 1.487 . . . . 0.0 110.189 -172.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 286' ' ' PHE . 15.2 m0 -114.02 167.73 10.42 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.985 -174.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -122.67 115.02 21.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.364 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -141.03 158.01 26.17 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 1.064 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 16.5 mt-10 -103.17 108.98 20.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.34 0.57 . . . . 0.0 110.275 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.416 ' HB ' HD23 ' A' ' 256' ' ' LEU . 41.1 t -133.09 139.45 49.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.828 -175.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 26.6 p30 43.52 32.38 0.52 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.757 1.223 . . . . 0.0 113.695 172.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.61 -59.86 0.43 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.858 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.54 176.11 12.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.654 -0.321 . . . . 0.0 111.681 -174.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 1.064 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 13.1 pttm -87.14 141.1 28.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.123 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.87 173.93 32.46 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.76 127.83 37.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.078 0.466 . . . . 0.0 110.258 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 275' ' ' TRP . 43.4 p90 -126.13 131.16 23.87 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.688 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.517 ' HD2' ' NH1' ' A' ' 246' ' ' ARG . 48.2 Cg_exo -58.0 138.69 87.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.615 2.21 . . . . 0.0 111.593 172.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -72.22 -18.39 61.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.401 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 13.8 p -79.43 -0.54 33.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.3 0.572 . . . . 0.0 111.081 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -95.59 -18.69 20.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.586 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 31.7 m -127.83 164.17 29.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.456 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -127.42 122.54 33.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.728 0.299 . . . . 0.0 110.393 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 240' ' ' ALA . 48.8 mm -71.0 122.09 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.152 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -135.54 147.64 48.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.826 0.346 . . . . 0.0 110.272 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.623 ' HB2' ' ND2' ' A' ' 298' ' ' ASN . 6.9 m-20 -72.52 129.43 87.17 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.06 -18.99 31.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.335 2.69 . . . . 0.0 113.324 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -85.79 15.34 4.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.719 0.295 . . . . 0.0 111.322 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.623 ' ND2' ' HB2' ' A' ' 295' ' ' ASP . 41.7 m-80 -115.16 96.59 45.81 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.91 0.386 . . . . 0.0 111.675 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' A' ' 301' ' ' GLU . 96.3 Cg_endo -96.4 19.99 0.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.307 2.672 . . . . 0.0 110.916 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 301' ' ' GLU . 15.7 m-20 73.5 -39.03 0.43 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.484 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 300' ' ' ASP . 41.9 tt0 165.91 -43.06 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 301' ' ' GLU . 7.1 t30 163.02 -52.58 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 113.265 -1.789 . . . . 0.0 108.638 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--O 1.246 0.908 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.372 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.01 0.433 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -111.76 84.29 1.93 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.099 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -74.89 -37.01 62.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.902 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.43 127.83 40.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.542 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -142.06 91.51 2.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.331 0.586 . . . . 0.0 111.079 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -147.17 148.38 31.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.496 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -79.82 96.88 6.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.991 0.424 . . . . 0.0 110.259 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 m -69.78 74.48 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.133 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 t -176.53 -43.33 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.915 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.85 107.49 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.183 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -32.54 67.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.17 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.0 t -69.78 -9.22 53.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.278 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.26 -46.76 7.56 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.761 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -118.4 -19.93 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -170.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -82.03 123.42 28.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.798 0.333 . . . . 0.0 110.649 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.549 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 16.6 mmt -101.72 -9.55 20.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.557 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.4 -113.23 2.18 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.49 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.17 91.06 0.32 Allowed 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.063 2.509 . . . . 0.0 113.38 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.941 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 14.3 t -137.43 -157.12 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.867 ' H ' HG13 ' A' ' 19' ' ' VAL . 12.5 t 178.93 174.96 0.66 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.8 1.182 . . . . 0.0 108.661 -169.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.544 HH11 ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -44.49 -66.84 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.885 0.741 . . . . 0.0 112.046 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -63.79 -54.34 36.63 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.443 0.464 . . . . 0.0 111.991 -173.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -54.7 -46.82 74.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.41 -42.9 83.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.459 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -80.39 -33.39 37.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.663 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 t -74.19 -18.77 60.72 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.886 -0.325 . . . . 0.0 111.429 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -97.8 -10.38 24.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 110.727 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.658 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 73.2 mt -111.45 0.86 16.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.657 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.14 108.88 3.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.878 0.847 . . . . 0.0 110.679 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.78 -76.69 0.92 Allowed Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.915 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.665 ' HB2' ' HG ' ' A' ' 53' ' ' SER . 17.2 mm-40 45.28 -159.38 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.169 0.57 . . . . 0.0 111.737 -175.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.548 HH21 ' HB2' ' A' ' 100' ' ' GLU . 33.0 ptt180 -101.13 5.94 43.0 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.521 176.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 53' ' ' SER . 27.3 m170 68.29 123.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.478 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.75 16.53 21.63 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.542 ' HE3' ' HA ' ' A' ' 102' ' ' ALA . 73.2 mmm -106.0 134.94 48.33 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CB ' HG23 ' A' ' 52' ' ' VAL . 43.3 p90 -139.58 162.93 33.88 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.621 -174.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.549 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -155.73 141.9 18.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.56 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.31 129.19 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.941 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 32.0 ptt-85 -129.43 173.2 10.77 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.59 133.77 34.04 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 170.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.464 ' HB2' HG23 ' A' ' 43' ' ' THR . 93.9 p -80.45 147.97 30.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.212 0.529 . . . . 0.0 111.162 -173.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.0 t -99.28 34.42 2.17 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 41' ' ' SER . 9.0 t -135.47 -27.55 1.18 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.206 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 91.2 m -147.36 118.25 4.53 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.786 0.327 . . . . 0.0 110.622 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.21 117.98 4.81 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.776 2.317 . . . . 0.0 112.144 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.66 -22.81 34.55 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.713 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 20.0 m-20 -89.84 152.03 21.48 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -119.85 174.97 6.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.557 0.218 . . . . 0.0 111.3 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.617 HG11 ' HE2' ' A' ' 207' ' ' PTR . 24.1 t -142.63 109.83 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.31 . . . . 0.0 110.861 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.41 HD13 ' HB2' ' A' ' 36' ' ' PHE . 32.1 tp -85.29 100.63 11.92 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.972 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.7 m -96.54 127.41 42.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.97 177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.927 HG21 HD12 ' A' ' 93' ' ' LEU . 48.4 t -123.61 137.17 57.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.453 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.665 ' HG ' ' HB2' ' A' ' 31' ' ' GLN . 90.1 p -97.28 123.8 41.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.647 0.26 . . . . 0.0 111.367 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.683 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 26.7 mt-10 -145.14 175.95 9.88 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.644 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 2.6 p30 -37.04 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -163.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.5 m 37.55 56.87 1.44 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.109 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.884 HH21 ' HB2' ' A' ' 94' ' ' ASP . 7.0 ttp85 -167.67 53.72 0.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.79 -159.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 37.2 t -77.18 98.52 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.909 0.861 . . . . 0.0 109.193 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -87.47 121.17 29.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.839 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -94.71 99.4 11.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.19 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' HE1' ' CG1' ' A' ' 153' ' ' ILE . 58.6 m-85 -96.07 116.15 28.52 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.367 0.267 . . . . 0.0 111.529 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 64.5 mt -80.31 134.2 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.698 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.0 mp -109.45 119.5 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 123.16 0.584 . . . . 0.0 110.347 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.503 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 13.2 m120 -84.98 137.68 32.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.789 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.7 t -87.41 102.0 14.12 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.663 HD12 ' HB2' ' A' ' 72' ' ' LYS . 91.4 mt -83.44 140.27 41.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.993 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.75 -23.07 69.48 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.221 2.614 . . . . 0.0 112.958 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -85.23 17.71 2.93 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.014 0.435 . . . . 0.0 110.287 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.868 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.8 OUTLIER 61.97 57.84 2.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.957 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.756 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 62.0 mtt180 -138.59 171.41 14.4 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.124 175.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.508 ' HB3' HG23 ' A' ' 63' ' ' ILE . 53.8 m-85 -130.63 114.99 16.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.404 0.621 . . . . 0.0 110.493 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.663 ' HB2' HD12 ' A' ' 66' ' ' LEU . 87.5 tttt -105.62 99.79 9.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.981 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.698 ' HB ' HG13 ' A' ' 63' ' ' ILE . 8.6 tt -83.63 78.63 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 122.024 0.916 . . . . 0.0 111.063 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.952 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 85.07 -15.99 40.64 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.119 -0.946 . . . . 0.0 114.645 171.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 19.1 t70 176.92 -63.3 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.809 0.804 . . . . 0.0 111.275 -176.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -66.42 129.14 38.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.59 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -87.47 108.41 19.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.378 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.459 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 67.0 m-85 -105.51 149.46 26.21 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.756 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 22.6 m-20 -73.55 -25.05 60.21 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -173.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 6.1 p80 -160.04 168.73 24.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.707 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.1 mt -56.27 -56.27 33.22 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.51 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 32.4 Cg_exo -63.15 -3.0 4.32 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.261 1.974 . . . . 0.0 113.681 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.86 -33.72 17.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.019 0.438 . . . . 0.0 110.284 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.4 pp -79.38 -26.73 41.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.289 0.566 . . . . 0.0 109.6 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 82' ' ' PRO . 79.3 mt -67.89 -29.52 68.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.616 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 82' ' ' PRO . 16.6 mm-40 -83.52 -14.66 51.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.995 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -84.23 -39.02 19.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.267 0.556 . . . . 0.0 109.831 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.591 ' CG ' HD21 ' A' ' 93' ' ' LEU . 66.8 m-85 -81.59 0.81 36.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.36 0.6 . . . . 0.0 110.572 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -74.12 -22.43 59.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.827 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.4 pt -122.72 -19.64 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.597 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.405 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 5.5 t-160 -84.29 -19.95 32.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.343 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 80.6 m-85 72.41 162.24 0.25 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.832 0.707 . . . . 0.0 109.54 -170.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.927 HD12 HG21 ' A' ' 52' ' ' VAL . 11.5 mt -114.55 -11.01 12.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.174 0.511 . . . . 0.0 110.087 168.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.884 ' HB2' HH21 ' A' ' 57' ' ' ARG . 9.6 t70 -157.57 -80.28 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.636 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.462 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 7.0 t -132.49 -16.0 2.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.073 0.463 . . . . 0.0 110.077 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.465 HG21 ' OE1' ' A' ' 54' ' ' GLU . 4.6 t -121.76 -177.83 3.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.5 p -114.88 178.77 4.16 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.155 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.413 HD23 ' CD1' ' A' ' 36' ' ' PHE . 87.7 mt -64.37 97.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.1 mm -85.56 -64.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.673 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.548 ' HB2' HH21 ' A' ' 32' ' ' ARG . 43.2 mt-10 -150.27 153.36 34.86 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.889 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.69 154.65 72.72 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.793 2.329 . . . . 0.0 112.444 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.542 ' HA ' ' HE3' ' A' ' 35' ' ' MET . . . -76.46 157.6 82.34 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.227 176.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.28 135.68 20.9 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.366 2.044 . . . . 0.0 111.819 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.486 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 88.9 mtm180 -71.48 123.63 22.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.691 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 32.0 p90 50.43 178.96 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.987 0 O-C-N 124.489 1.118 . . . . 0.0 111.852 -176.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.691 ' HD2' ' HB2' ' A' ' 105' ' ' TYR . 88.7 Cg_exo -50.72 109.42 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.983 1.789 . . . . 0.0 111.71 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.627 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 0.8 OUTLIER -57.89 141.5 80.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.382 -174.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 110' ' ' MET . 52.3 Cg_exo -55.93 148.17 58.84 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.54 2.16 . . . . 0.0 111.723 174.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.37 33.17 0.28 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.127 2.552 . . . . 0.0 113.098 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.424 ' H ' ' C ' ' A' ' 108' ' ' PRO . 70.4 mtm -97.7 -20.52 17.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 160.12 90.21 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.26 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.627 ' HB2' ' HB2' ' A' ' 107' ' ' SER . 40.2 t -112.49 -21.8 11.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.9 t 64.92 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.886 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.3 m -86.1 87.25 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.361 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -143.16 -47.62 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.984 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 115' ' ' ALA . 8.3 Cg_exo -74.48 -137.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.461 2.107 . . . . 0.0 111.551 174.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.53 ' HA ' ' N ' ' A' ' 31' ' ' GLN . 88.0 m-20 63.75 43.07 5.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.14 0.495 . . . . 0.0 110.034 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 87.1 mt -105.97 102.83 41.48 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.137 -174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 117' ' ' ASN . 10.5 Cg_endo -91.03 144.44 3.42 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.272 2.648 . . . . 0.0 111.657 175.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.8 m -126.05 68.9 1.2 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 63.81 98.9 0.04 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.548 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.6 54.03 0.92 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.544 0.687 . . . . 0.0 111.758 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -100.63 94.81 6.3 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 126' ' ' GLU . 4.3 p-10 -87.57 149.29 24.43 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -160.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.921 HD13 HG13 ' A' ' 152' ' ' ILE . 1.3 mm? -52.36 123.56 11.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.591 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.695 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 32.6 tt0 -155.94 -72.74 0.11 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.003 -177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -93.1 109.19 20.67 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.156 -168.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.907 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 90.6 t -134.25 129.17 53.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.011 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.95 ' HG2' ' HB3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -109.79 154.71 22.58 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 118.584 -1.247 . . . . 0.0 108.54 172.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.871 ' HG1' ' HB2' ' A' ' 144' ' ' PHE . 18.9 p -112.21 141.34 46.03 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.714 HD21 ' HG3' ' A' ' 179' ' ' GLU . 58.3 mt -111.82 -41.4 4.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.222 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 51.5 t80 -72.22 -27.88 62.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -168.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.633 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 30.1 t70 69.51 96.36 0.07 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.626 0.727 . . . . 0.0 110.994 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -122.72 96.32 45.54 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.839 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.72 88.92 0.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.44 2.093 . . . . 0.0 112.139 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -87.65 -23.76 38.22 Favored Glycine 0 C--O 1.228 -0.227 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.324 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 47.02 80.33 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.593 0.757 . . . . 0.0 112.57 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -162.64 173.39 13.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.19 -3.29 58.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.155 0.502 . . . . 0.0 110.588 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.26 -11.29 10.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.378 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -129.78 105.43 8.02 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.688 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 36.5 tp -76.52 117.57 65.42 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.674 0.273 . . . . 0.0 110.62 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.16 106.27 1.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.109 1.873 . . . . 0.0 111.244 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.871 ' HB2' ' HG1' ' A' ' 130' ' ' THR . 9.6 p90 -113.64 164.45 13.66 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.216 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.633 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -106.13 -169.56 1.59 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.105 -168.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.567 ' HD2' ' HB2' ' A' ' 133' ' ' ASP . 13.7 mptt -78.37 -5.15 51.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.176 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.72 56.53 0.16 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.361 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.449 ' HB2' ' HD3' ' A' ' 145' ' ' LYS . 7.8 tp10 -105.54 150.74 25.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.587 HD11 ' HB3' ' A' ' 129' ' ' ARG . 45.9 mm -96.66 129.72 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.562 HD22 ' HA ' ' A' ' 165' ' ' ASN . 44.0 mt -123.03 160.48 26.24 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.315 0.579 . . . . 0.0 109.5 -178.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 87.2 t -124.77 128.03 73.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.921 HG13 HD13 ' A' ' 125' ' ' LEU . 36.7 mm -74.33 87.84 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 122.244 1.021 . . . . 0.0 109.529 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.635 HG21 ' HG3' ' A' ' 154' ' ' GLU . 18.0 tt -78.49 -26.38 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.32 -174.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.951 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 15.5 mt-10 -142.04 143.99 33.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.663 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 48.4 tttm -137.05 90.52 15.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 O-C-N 121.237 -0.915 . . . . 0.0 111.399 171.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.462 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 52.8 Cg_endo -81.0 -44.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.064 1.843 . . . . 0.0 112.497 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -109.43 178.52 4.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.331 -172.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -98.77 -33.09 11.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.353 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 159' ' ' GLN . 14.2 mm-40 -100.0 -11.36 20.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.927 0.394 . . . . 0.0 110.762 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.519 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 71.9 m95 -126.38 118.57 25.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.748 ' CZ3' HD11 ' A' ' 125' ' ' LEU . 48.5 m0 -112.28 136.71 51.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.951 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 10.6 t -92.05 92.97 8.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.346 0.593 . . . . 0.0 109.418 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -103.26 158.09 16.57 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 122.022 -0.424 . . . . 0.0 111.477 -174.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.818 HH12 ' HA ' ' A' ' 208' ' ' ALA . 12.7 ptt180 -98.22 128.71 44.83 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.812 176.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.688 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 64.5 t30 -70.75 164.64 24.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.556 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -71.96 -10.6 60.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.49 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.481 ' OD1' ' HB3' ' A' ' 165' ' ' ASN . 2.4 p-10 -87.0 -10.58 52.79 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 210' ' ' PRO . . . 93.64 57.14 1.36 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.926 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.731 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 19.1 ttm-85 -136.21 141.9 44.04 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 122.85 -0.206 . . . . 0.0 110.968 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.524 HG22 HG23 ' A' ' 153' ' ' ILE . 49.6 t -103.28 118.46 50.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.609 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -151.15 158.31 27.63 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.411 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.519 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 22.5 mtp -79.18 140.03 37.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.894 0.378 . . . . 0.0 110.431 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.607 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -135.54 145.57 53.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.342 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.432 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 4.3 Cg_exo -76.53 133.06 13.98 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.32 2.68 . . . . 0.0 113.111 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.639 ' O ' HG22 ' A' ' 178' ' ' VAL . 88.3 t -60.4 -44.58 96.24 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.439 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 23.9 Cg_exo -65.27 3.92 0.89 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.219 1.946 . . . . 0.0 113.345 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.432 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.5 m-85 -107.89 -4.81 17.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.282 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.8 m -106.89 -169.07 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -165.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.95 ' HB3' ' HG2' ' A' ' 129' ' ' ARG . 0.4 OUTLIER -160.13 41.51 0.19 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.82 -161.164 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.907 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 25.2 pttm -73.28 140.42 46.81 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 120.456 -1.403 . . . . 0.0 109.58 -162.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 17.4 tp -75.18 54.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.699 -168.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.4 m 52.34 10.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.785 1.634 . . . . 0.0 113.752 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 57.33 88.64 0.05 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.269 0.557 . . . . 0.0 110.65 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.7 t 61.8 -137.52 0.51 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.211 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.476 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 60.6 p -175.16 167.33 1.89 Allowed Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 40.4 Cg_endo -68.16 -7.32 19.59 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.428 2.085 . . . . 0.0 111.711 172.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 190' ' ' HIS . 51.6 m80 66.25 -161.03 0.25 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.163 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.418 ' H ' ' HB3' ' A' ' 187' ' ' HIS . . . 84.67 -66.74 3.82 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.93 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -101.61 -2.66 29.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.028 0.442 . . . . 0.0 110.77 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 187' ' ' HIS . 50.5 t60 -87.36 105.45 17.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.66 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -103.79 -141.02 10.96 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.222 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -149.62 168.68 22.88 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 53.5 ttp180 -147.15 -84.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.74 0.305 . . . . 0.0 110.626 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 193' ' ' ARG . 27.8 t-20 165.92 150.55 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -173.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.7 m -77.07 -74.24 0.25 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -164.75 30.02 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.217 0.532 . . . . 0.0 110.279 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 24.4 t -137.29 86.91 2.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -76.47 156.39 33.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.885 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 119.06 -32.46 5.1 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -174.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.699 HG23 ' H ' ' A' ' 202' ' ' GLU . 71.2 mt -126.6 132.0 24.14 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 27.4 Cg_exo -63.6 -16.61 55.7 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.691 2.261 . . . . 0.0 112.566 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.699 ' H ' HG23 ' A' ' 200' ' ' ILE . 11.6 pt-20 34.08 80.89 0.25 Allowed Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.376 1.07 . . . . 0.0 112.903 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 205' ' ' HIS . 55.8 Cg_endo -70.87 -11.31 29.2 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.237 1.958 . . . . 0.0 112.421 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 69.02 -28.24 0.16 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.859 0.864 . . . . 0.0 112.861 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.482 ' H ' ' C ' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -78.27 39.04 0.31 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.997 0.519 . . . . 0.0 111.538 -177.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -88.68 84.15 6.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.862 0.363 . . . . 0.0 110.912 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.946 ' O3P' ' HE1' ' A' ' 207' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.818 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -122.59 23.57 9.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.949 -175.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -74.79 149.3 85.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.952 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 50.5 Cg_exo -54.45 -51.54 10.26 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.989 2.459 . . . . 0.0 113.456 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 29.9 tp60 -74.76 123.82 25.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.214 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.7 t -60.07 142.95 53.21 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 170.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 9.2 m -95.77 113.82 25.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.81 0.338 . . . . 0.0 111.778 -173.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 9.2 m -111.69 87.69 8.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -92.27 170.08 2.7 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.04 2.494 . . . . 0.0 112.393 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.2 mp -112.76 103.1 55.47 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.329 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -83.59 -7.21 10.68 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.908 2.406 . . . . 0.0 112.018 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -101.1 116.89 33.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.061 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.06 -19.82 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.232 0.539 . . . . 0.0 110.876 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 21.2 p -92.07 -4.93 53.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 76.05 -85.27 0.9 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.542 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 20.4 m 50.54 67.83 3.98 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.49 -34.61 85.42 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.725 2.283 . . . . 0.0 112.133 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -122.19 51.32 0.8 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 174.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 65.2 -166.96 0.22 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.785 0.434 . . . . 0.0 110.8 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -125.13 -177.94 4.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.38 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 40.5 pt -100.37 -167.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 123.217 0.323 . . . . 0.0 110.384 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.3 p -62.39 131.48 93.86 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.073 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.09 96.06 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.713 2.275 . . . . 0.0 112.276 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.672 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 6.3 tt -101.81 -55.25 0.13 Allowed Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.319 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.672 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 75.3 Cg_exo -51.69 -57.77 1.98 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.258 1.972 . . . . 0.0 112.835 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 50.6 m -158.91 133.78 8.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.971 0.415 . . . . 0.0 111.377 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.5 157.27 19.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 170.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.64 -74.91 0.6 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.023 -174.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 63.83 81.27 0.21 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.78 0.675 . . . . 0.0 110.954 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -132.2 -88.63 0.41 Allowed Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.77 101.76 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.259 1.973 . . . . 0.0 110.148 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.474 HG11 HD13 ' A' ' 293' ' ' ILE . 21.6 t -92.96 145.98 6.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.885 -173.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.1 116.9 32.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.685 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -120.29 128.16 53.04 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.46 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.59 ' HG3' ' CE1' ' A' ' 294' ' ' PHE . 28.5 mtpp -78.75 125.25 29.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.548 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -75.59 91.42 2.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.888 0.375 . . . . 0.0 110.136 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 24.6 pt -73.24 9.59 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.847 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 242' ' ' ALA . 4.9 tt0 -148.91 152.87 37.17 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -95.85 144.96 25.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.618 ' HB3' ' CE1' ' A' ' 290' ' ' HIS . 0.5 OUTLIER -171.02 125.69 0.67 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.638 0.256 . . . . 0.0 110.756 178.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.688 ' HB ' ' HD3' ' A' ' 248' ' ' PRO . 60.3 t -102.18 -55.0 0.13 Allowed Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.812 172.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.688 ' HD3' ' HB ' ' A' ' 247' ' ' VAL . 61.5 Cg_endo -90.0 167.85 4.6 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.427 2.085 . . . . 0.0 113.782 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.511 ' HB3' ' HE ' ' A' ' 246' ' ' ARG . 24.3 p -173.32 89.77 0.08 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.623 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 64.92 -72.68 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.216 1.006 . . . . 0.0 112.971 172.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.535 ' HD1' ' H ' ' A' ' 253' ' ' LYS . 18.3 p90 -91.67 -31.0 16.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.919 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 64.98 -1.33 0.87 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.535 ' H ' ' HD1' ' A' ' 251' ' ' TYR . 57.7 tttp -62.11 -65.31 0.71 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.195 0.521 . . . . 0.0 110.827 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 9.3 p -106.9 40.1 1.72 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.663 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -79.56 107.42 12.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.931 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.34 101.67 5.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -68.66 124.2 22.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.912 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 82.3 mt -128.7 143.68 50.99 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.605 0.566 . . . . 0.0 111.275 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.83 170.93 9.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.359 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.3 p -89.34 113.25 25.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.485 0.66 . . . . 0.0 110.485 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 110.3 -6.49 30.33 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.999 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -76.88 161.2 28.61 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.662 0.268 . . . . 0.0 110.646 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 35.0 mm -104.02 111.17 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.296 0.57 . . . . 0.0 111.13 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.409 ' HA ' HG21 ' A' ' 279' ' ' VAL . 38.8 t -88.55 109.19 19.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.532 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.62 ' HB3' ' HZ2' ' A' ' 265' ' ' LYS . 9.6 mtpm? -85.16 88.13 7.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.766 175.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.88 131.86 35.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.553 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -114.79 -22.5 9.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.817 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.687 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 26.4 mmm180 -125.25 123.69 40.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.245 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 51.4 mtt -112.46 102.73 10.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.226 0.536 . . . . 0.0 110.41 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -81.25 139.42 35.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.034 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.0 pt -67.92 -8.99 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.261 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -63.07 -38.65 92.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.529 176.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 121.47 -9.97 9.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.71 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -114.28 119.31 36.56 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.453 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 47.2 m0 -93.63 159.77 15.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.829 0.347 . . . . 0.0 111.073 -174.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.687 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 41.5 mt-10 -107.27 117.77 34.95 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.089 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -142.31 154.01 24.78 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 283' ' ' LYS . 37.7 tt0 -111.73 109.82 19.88 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.52 HG13 HD21 ' A' ' 280' ' ' ASN . 57.6 t -112.55 122.15 66.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.033 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.52 HD21 HG13 ' A' ' 279' ' ' VAL . 31.5 m-80 65.48 -70.21 0.1 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.049 0.843 . . . . 0.0 111.793 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -159.65 26.99 0.35 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.588 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -150.82 128.66 11.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.711 0.255 . . . . 0.0 110.444 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 278' ' ' GLU . 53.4 pttt -102.57 139.33 38.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.969 0.414 . . . . 0.0 110.338 174.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -167.38 -169.96 31.59 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.713 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 93.6 mt -100.13 146.3 26.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.934 0.397 . . . . 0.0 110.692 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 41.1 p90 -148.82 145.54 19.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.609 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 11.8 Cg_exo -72.37 149.22 50.27 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.628 2.218 . . . . 0.0 111.99 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -76.38 -17.68 59.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.837 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.0 t -82.08 3.82 25.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.727 0.775 . . . . 0.0 109.934 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.618 ' CE1' ' HB3' ' A' ' 246' ' ' ARG . 52.8 t60 -96.27 -24.17 16.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.557 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 242' ' ' ALA . 29.1 m -125.02 175.41 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.798 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -138.57 125.36 20.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.557 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.474 HD13 HG11 ' A' ' 238' ' ' VAL . 49.8 mm -73.95 102.7 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.59 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 21.4 p90 -100.19 167.61 10.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.433 -174.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -107.98 145.43 31.39 Favored Pre-proline 0 CA--C 1.504 -0.814 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.413 ' O ' ' HB3' ' A' ' 297' ' ' GLN . 77.3 Cg_exo -21.73 76.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 1 C-N-CA 125.877 4.385 . . . . 0.0 115.008 -168.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 296' ' ' PRO . 22.9 tm0? 83.09 -48.35 0.15 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.218 175.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.3 t30 64.08 95.85 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.156 0 O-C-N 123.864 0.728 . . . . 0.0 112.248 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.29 -16.37 17.49 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.567 2.178 . . . . 0.0 111.807 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -72.34 120.02 17.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.557 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 77.14 -9.97 1.43 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.122 0.889 . . . . 0.0 110.704 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -80.62 -36.8 32.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.644 178.065 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 tmm? . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m -87.7 88.15 7.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.849 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.1 t -74.32 -13.34 60.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.58 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -48.05 119.44 2.9 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.133 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -140.63 88.44 2.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.625 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -168.96 165.82 11.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.932 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -99.63 115.58 29.76 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -69.25 -11.46 60.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.001 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 p -101.65 -23.38 14.26 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.82 102.19 1.2 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.899 -0.501 . . . . 0.0 110.778 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -58.51 -42.3 87.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.239 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.7 m -74.6 10.75 1.23 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.916 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.22 -47.5 4.5 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.828 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -118.02 -21.54 8.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -85.6 115.15 23.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.862 0.363 . . . . 0.0 110.356 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 37' ' ' LEU . 18.0 mmt -102.09 -1.92 30.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 -174.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.7 -114.32 3.01 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.057 -0.974 . . . . 0.0 114.19 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.6 82.68 0.9 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.961 2.44 . . . . 0.0 113.676 -174.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.908 HG11 ' H ' ' A' ' 20' ' ' SER . 16.4 t -121.02 -160.6 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.908 ' H ' HG11 ' A' ' 19' ' ' VAL . 50.8 p -165.84 172.96 11.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 119.751 1.16 . . . . 0.0 109.706 -168.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -52.73 -59.54 4.36 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.158 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -64.32 -52.63 57.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.081 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.6 -44.5 96.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.987 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.58 69.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 110.988 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.65 ' HG3' ' HA ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -65.63 -46.04 80.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.934 0.397 . . . . 0.0 110.471 175.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.0 m -61.91 -27.45 68.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.177 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.466 ' HG2' ' HA ' ' A' ' 106' ' ' PRO . 39.7 mtp180 -91.99 -14.26 29.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.952 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 1.009 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 67.1 mt -114.96 -17.11 11.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.574 -0.45 . . . . 0.0 112.082 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 11.65 -97.29 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.284 1.433 . . . . 0.0 114.565 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.29 33.22 1.82 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' HB3' ' CE ' ' A' ' 35' ' ' MET . 9.4 tt0 -73.41 -154.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.361 -0.92 . . . . 0.0 109.43 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -53.65 110.21 0.55 Allowed 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.117 179.13 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -73.04 104.33 4.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.72 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.632 ' HA3' HD11 ' A' ' 99' ' ' ILE . . . 141.93 -3.5 2.01 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.303 -171.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.666 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 38.4 mtm -83.36 144.91 29.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.95 157.26 45.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.585 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.6 pp -150.11 137.47 19.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.575 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.8 t -105.77 128.71 59.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.244 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.822 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 34.9 ptt-85 -129.94 161.6 30.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.828 -175.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.97 133.1 46.91 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 48.9 m -64.48 131.93 48.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.148 0.499 . . . . 0.0 111.441 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.576 ' HB3' ' O2P' ' A' ' 207' ' ' PTR . 34.0 t -76.98 43.68 0.36 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.987 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 t -165.87 -37.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.033 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 41' ' ' SER . 65.4 m -134.77 121.6 14.99 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 14.5 Cg_exo -69.36 -19.0 38.63 Favored 'Trans proline' 0 CA--C 1.527 0.163 0 C-N-CA 122.723 2.282 . . . . 0.0 112.724 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.15 -52.82 3.31 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.792 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.6 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 5.7 m-20 -77.38 157.84 30.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.594 0.235 . . . . 0.0 110.987 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -123.73 177.42 5.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.932 0.396 . . . . 0.0 111.328 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.581 HG13 ' HE2' ' A' ' 207' ' ' PTR . 22.8 t -139.27 112.58 6.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.8 tp -83.05 100.07 10.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.952 0.406 . . . . 0.0 109.933 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.5 m -97.4 118.02 32.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.114 0.483 . . . . 0.0 111.202 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.742 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 41.1 t -111.18 157.28 12.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.377 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 1.009 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 88.1 p -123.65 135.04 53.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.302 0.955 . . . . 0.0 112.7 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.664 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 1.7 pm0 -146.05 176.24 9.86 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.513 175.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -25.51 80.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 -173.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.7 m 39.61 65.32 0.72 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.781 0.8 . . . . 0.0 110.121 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.664 ' HG3' ' HG2' ' A' ' 54' ' ' GLU . 28.5 tpt85 -168.11 52.58 0.06 Allowed 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.689 -149.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.537 HG13 ' HE2' ' A' ' 60' ' ' HIS . 2.2 p -76.65 114.19 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.024 -1.047 . . . . 0.0 111.834 -170.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.766 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 53.5 m -73.62 90.4 1.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.002 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.537 ' HE2' HG13 ' A' ' 58' ' ' VAL . 58.6 m-70 -87.05 87.9 7.57 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.208 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.766 ' CE2' ' HB3' ' A' ' 59' ' ' SER . 71.2 m-85 -92.52 117.76 30.28 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.57 HD12 HG21 ' A' ' 49' ' ' VAL . 30.7 mm -69.95 139.69 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.792 0.33 . . . . 0.0 111.188 176.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 2.7 mp -125.08 118.2 52.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.288 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.6 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 7.8 m120 -73.42 128.89 36.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.943 0.402 . . . . 0.0 110.964 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.6 t -86.85 113.66 22.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.304 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.0 mt -93.72 135.62 24.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.757 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.2 -16.21 32.66 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.144 2.562 . . . . 0.0 113.053 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -85.5 15.57 4.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.0 110.537 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 4.9 mmt85 68.6 22.91 7.41 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.18 176.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -113.38 162.95 15.47 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.54 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 91.9 m-85 -135.55 116.31 14.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.457 0.646 . . . . 0.0 112.169 -172.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 31.3 ttpt -98.17 98.83 10.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.587 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 12.0 tt -80.72 77.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 122.077 0.942 . . . . 0.0 111.469 -175.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.632 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 79.07 -30.17 2.1 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.737 172.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.625 ' OD1' ' HB2' ' A' ' 210' ' ' PRO . 0.1 OUTLIER -143.15 -77.01 0.24 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.256 0.55 . . . . 0.0 111.434 -169.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -95.05 148.53 22.25 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.437 -169.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -82.14 124.88 30.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.682 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -112.4 144.4 41.91 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.02 -25.37 63.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.788 -170.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -164.8 168.5 17.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.238 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.429 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 8.4 mt -55.21 -55.81 35.4 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.0 Cg_exo -59.27 -8.98 7.45 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.548 2.165 . . . . 0.0 114.002 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.04 -33.51 18.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.792 0.329 . . . . 0.0 111.139 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -79.55 -27.41 41.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.286 0.565 . . . . 0.0 109.675 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.439 ' O ' HD12 ' A' ' 98' ' ' LEU . 79.4 mt -67.87 -33.94 75.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.616 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.644 ' HA ' ' HE3' ' A' ' 89' ' ' LYS . 11.1 pt-20 -90.9 -3.71 57.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.329 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -91.01 -37.06 13.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.377 0.608 . . . . 0.0 110.01 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.518 ' CG ' HD21 ' A' ' 93' ' ' LEU . 20.5 m-85 -83.39 1.5 41.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.884 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' A' ' 86' ' ' GLU . 17.8 ptpt -86.36 14.97 5.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.442 HD13 ' N ' ' A' ' 91' ' ' HIS . 1.7 pp -165.33 -30.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.787 0.804 . . . . 0.0 108.845 -170.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.442 ' N ' HD13 ' A' ' 90' ' ' ILE . 9.0 t60 -65.73 -28.2 68.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.414 172.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.639 ' CD1' HG22 ' A' ' 97' ' ' THR . 70.3 m-85 64.0 110.81 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 124.569 1.168 . . . . 0.0 109.538 -168.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.544 HD11 HD21 ' A' ' 98' ' ' LEU . 20.0 mt -56.2 -42.34 77.04 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 1.006 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 0.1 OUTLIER -138.59 -80.67 0.33 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.378 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.744 HG23 ' HB3' ' A' ' 156' ' ' PRO . 11.0 m -136.94 -6.17 1.88 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.493 1.14 . . . . 0.0 108.546 166.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -106.53 138.69 42.25 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.931 172.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.639 HG22 ' CD1' ' A' ' 92' ' ' TYR . 11.9 p -98.55 -175.46 3.09 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.949 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.544 HD21 HD11 ' A' ' 93' ' ' LEU . 87.6 mt -88.77 88.76 7.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.632 HD11 ' HA3' ' A' ' 34' ' ' GLY . 3.6 mp -75.1 -54.96 13.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.725 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.666 ' O ' ' HA ' ' A' ' 35' ' ' MET . 15.2 pt-20 -154.07 161.34 29.5 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.725 -176.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.94 155.78 61.43 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.536 2.157 . . . . 0.0 112.341 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -77.95 168.22 29.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.527 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 21.8 Cg_endo -62.08 148.01 93.99 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.328 2.019 . . . . 0.0 112.116 175.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -94.21 11.9 28.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.113 0.483 . . . . 0.0 110.218 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -120.46 135.53 24.62 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.409 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.466 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 31.6 Cg_exo -60.18 108.24 0.49 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.602 2.201 . . . . 0.0 111.935 175.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.0 m -65.93 154.17 89.89 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.785 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.16 136.13 54.44 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.545 2.163 . . . . 0.0 111.587 175.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.97 -39.75 89.17 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.85 2.367 . . . . 0.0 112.112 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 84.9 mtp 70.03 -47.22 0.61 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.914 0.886 . . . . 0.0 112.16 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.05 -15.84 33.24 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.771 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.0 m -58.69 -34.69 71.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 110.904 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.17 139.53 36.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.876 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.5 t -140.25 27.61 2.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.135 0.493 . . . . 0.0 110.019 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 119' ' ' PRO . . . -139.66 109.5 7.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.246 -175.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.65 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 58.6 Cg_endo -73.1 77.66 2.36 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.74 2.293 . . . . 0.0 112.06 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.677 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.4 t30 69.47 161.48 0.21 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.928 0.767 . . . . 0.0 109.08 -173.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.683 ' HA ' ' HG3' ' A' ' 126' ' ' GLU . 0.6 OUTLIER 42.4 81.23 0.25 Allowed Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 121.567 0.699 . . . . 0.0 110.874 -173.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.479 ' HA ' ' CB ' ' A' ' 115' ' ' ALA . 28.0 Cg_exo -60.46 142.27 97.6 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 123.069 2.513 . . . . 0.0 113.557 -169.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.424 ' HA ' ' HG2' ' A' ' 186' ' ' PRO . 3.2 p -79.76 -0.11 32.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.603 175.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' GLU . . . -132.89 102.22 5.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.971 173.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 45.6 mt-10 73.89 136.17 0.05 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.231 0.957 . . . . 0.0 111.473 -173.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.65 -44.85 92.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 66.6 t30 62.53 -106.92 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.289 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 152' ' ' ILE . 1.3 mm? -119.11 89.46 3.13 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.731 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 3.9 mm-40 -159.82 -68.67 0.08 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.908 -173.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.62 110.86 23.17 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.328 1.061 . . . . 0.0 111.791 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 1.035 HG22 ' HB3' ' A' ' 180' ' ' LYS . 70.1 t -115.08 150.1 17.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.918 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.963 ' HG2' ' HG3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -124.58 153.24 42.45 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.72 165.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.934 HG21 HG11 ' A' ' 178' ' ' VAL . 21.7 p -112.81 141.18 46.91 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.541 ' HG ' ' OE1' ' A' ' 179' ' ' GLU . 0.3 OUTLIER -99.13 -45.05 6.05 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.946 0.403 . . . . 0.0 111.368 -177.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 35.1 t80 -70.62 -38.63 73.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -163.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.535 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 13.5 t70 75.63 100.71 0.07 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -172.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 77.2 t80 -139.14 107.54 7.38 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.112 -175.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 27.1 Cg_endo -92.31 85.73 0.23 Allowed 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.783 2.322 . . . . 0.0 112.356 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.714 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -71.74 -11.88 73.75 Favored Glycine 0 CA--C 1.506 -0.499 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 172.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 138' ' ' ASP . 17.7 m120 51.46 59.53 4.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.603 -1.299 . . . . 0.0 113.312 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 21.0 t70 81.36 163.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 155.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 88.79 -47.52 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.638 1.575 . . . . 0.0 111.704 169.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -160.35 6.08 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.324 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.714 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 39.0 m-20 -139.64 97.14 3.2 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.709 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 21.9 tp -70.13 128.02 91.86 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 120.832 0.348 . . . . 0.0 110.792 -174.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 56.4 Cg_endo -79.28 101.62 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.212 1.941 . . . . 0.0 111.736 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.578 ' HB2' ' HG1' ' A' ' 130' ' ' THR . 15.1 p90 -109.94 157.09 19.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.366 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.535 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 35.4 mtmm -112.02 175.62 5.35 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.056 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.718 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -76.58 71.89 3.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.621 0.724 . . . . 0.0 110.443 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 131.21 30.39 0.57 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.244 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -95.32 155.13 16.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.822 HD11 ' HB3' ' A' ' 129' ' ' ARG . 47.1 mm -105.34 132.55 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.554 HD22 ' HA ' ' A' ' 165' ' ' ASN . 29.9 mt -122.03 156.97 32.38 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.731 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 39.0 t -114.47 127.87 71.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 171.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.586 HG21 HD11 ' A' ' 125' ' ' LEU . 23.4 mm -75.03 114.04 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.481 1.134 . . . . 0.0 110.491 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.878 HG22 HG13 ' A' ' 170' ' ' VAL . 2.5 tp -92.89 -24.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.37 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.006 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 6.8 tp10 -155.51 147.58 23.52 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 121.553 -0.717 . . . . 0.0 111.774 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -129.83 84.13 61.9 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.094 168.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.744 ' HB3' HG23 ' A' ' 95' ' ' THR . 57.2 Cg_endo -91.61 -58.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.092 1.861 . . . . 0.0 111.334 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.448 ' OE1' ' HG2' ' A' ' 156' ' ' PRO . 1.3 mp0 -82.63 175.02 10.49 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.476 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -112.86 -5.64 13.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 159' ' ' GLN . 6.3 tp60 -104.44 -24.23 13.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.675 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.757 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 34.9 m95 -129.0 138.23 51.82 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.811 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.651 ' O ' HG13 ' A' ' 173' ' ' ILE . 36.1 m0 -123.74 137.63 54.66 Favored 'General case' 0 C--O 1.213 -0.818 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.859 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 12.9 m -88.34 123.66 33.13 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.531 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -130.76 155.11 47.22 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.361 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 26.9 ptt-85 -97.75 136.89 37.45 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 171.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.709 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 65.5 t30 -71.33 168.22 17.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.24 -173.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.431 ' HE3' ' H ' ' A' ' 149' ' ' ILE . 10.2 ttpp -66.01 -17.55 64.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.544 ' HB3' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -74.4 -33.81 63.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.61 172.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 137.82 -36.37 1.94 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.215 -0.993 . . . . 0.0 115.4 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.537 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -90.8 160.82 15.56 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.492 1.146 . . . . 0.0 113.463 -163.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.878 HG13 HG22 ' A' ' 153' ' ' ILE . 78.1 t -89.65 136.27 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.363 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.91 156.42 28.15 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.565 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.757 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -72.85 136.15 45.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -135.44 147.92 63.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.771 0.319 . . . . 0.0 110.859 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 1.063 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 16.2 Cg_exo -70.71 139.13 36.29 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.943 2.429 . . . . 0.0 113.128 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.544 ' O ' HG22 ' A' ' 178' ' ' VAL . 21.9 t -78.31 -44.95 2.15 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.4 Cg_endo -66.92 0.51 3.64 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.888 1.725 . . . . 0.0 111.684 173.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 1.063 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 0.9 OUTLIER -100.92 -4.99 26.62 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.139 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.934 HG11 HG21 ' A' ' 130' ' ' THR . 26.8 m -123.5 170.89 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 122.543 1.163 . . . . 0.0 113.645 -171.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.963 ' HG3' ' HG2' ' A' ' 129' ' ' ARG . 8.2 pt-20 -133.6 48.57 2.36 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.677 -2.056 . . . . 0.0 110.232 -170.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 1.035 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -71.1 142.47 50.79 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 -166.105 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.513 HD12 ' NH1' ' A' ' 129' ' ' ARG . 9.7 tp -59.58 -37.22 77.91 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.726 HG11 ' HD2' ' A' ' 183' ' ' ARG . 2.3 p 66.8 -48.48 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.729 1.612 . . . . 0.0 115.015 160.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.726 ' HD2' HG11 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -124.74 -86.77 0.63 Allowed 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.213 -0.929 . . . . 0.0 110.271 178.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.509 ' C ' ' HG ' ' A' ' 185' ' ' SER . 8.4 t 49.59 -148.25 0.28 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.828 0.346 . . . . 0.0 110.843 176.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.51 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 12.8 m -155.56 151.94 23.37 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.424 ' HG2' ' HA ' ' A' ' 120' ' ' THR . 22.6 Cg_exo -66.19 114.33 2.98 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.392 2.061 . . . . 0.0 111.262 173.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 185' ' ' SER . 42.0 m80 -125.3 166.13 17.09 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -59.79 -48.06 87.89 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.956 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -91.12 -7.42 51.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 109.834 173.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.469 ' CA ' ' HB2' ' A' ' 187' ' ' HIS . 2.2 t-160 69.3 -51.9 0.6 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.262 1.025 . . . . 0.0 111.494 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 142.66 20.07 0.24 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.424 ' C ' HD21 ' A' ' 192' ' ' ASN . 0.3 OUTLIER -157.02 154.18 29.17 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.974 0.11 . . . . 0.0 110.794 -177.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -126.94 1.76 6.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.522 0.201 . . . . 0.0 110.964 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.478 ' CG ' ' H ' ' A' ' 195' ' ' SER . 63.9 t30 68.36 -169.59 0.19 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.883 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 194' ' ' ASN . 7.4 m -54.18 -45.22 72.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.879 0.371 . . . . 0.0 111.032 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -177.66 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.425 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 36.5 m 66.42 -174.39 0.19 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.782 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -111.11 119.06 37.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.067 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 71.23 -159.72 53.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.097 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.917 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 4.1 mp -110.99 -58.81 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 176.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.917 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 5.2 Cg_exo -78.34 129.45 9.49 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.339 2.026 . . . . 0.0 111.016 173.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 0.3 OUTLIER -96.75 126.57 42.5 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.255 0.55 . . . . 0.0 111.094 -177.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 7.5 Cg_exo -73.86 67.31 4.87 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.631 2.221 . . . . 0.0 110.601 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.22 115.43 3.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.881 -174.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.434 ' O ' ' HD1' ' A' ' 207' ' ' PTR . 19.1 p80 -99.03 -17.13 18.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.693 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 207' ' ' PTR . . . 59.46 -148.82 0.46 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.681 175.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.581 ' HE2' HG13 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -113.57 18.63 17.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.89 -176.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.478 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 10.1 tt0 -58.97 134.08 87.26 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.541 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.632 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 32.1 Cg_exo -58.04 -103.39 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.113 2.542 . . . . 0.0 113.703 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 167' ' ' ASP . 76.7 mt-30 -78.42 -21.45 49.2 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.469 -0.77 . . . . 0.0 111.194 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 211' ' ' GLN . 92.1 m 73.88 -49.53 0.68 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.565 0.541 . . . . 0.0 110.624 -176.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.413 ' C ' ' HG1' ' A' ' 214' ' ' THR . 7.2 m 64.54 -103.64 0.11 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.007 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 57.8 m -164.75 135.99 3.32 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -176.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 3.0 Cg_exo -77.92 -164.48 0.27 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.05 2.5 . . . . 0.0 111.275 171.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 57.2 mt -135.31 110.5 10.64 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.824 0.345 . . . . 0.0 111.478 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.76 -51.51 0.66 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.58 2.187 . . . . 0.0 111.22 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 55.67 -99.57 0.1 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.501 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.1 t -94.25 -58.27 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.536 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.9 m 65.91 19.38 11.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.017 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 112.02 -160.53 13.13 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.039 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 3.1 p -81.57 123.52 80.75 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.93 0.395 . . . . 0.0 110.786 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 3.0 Cg_exo -76.37 45.15 1.51 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.308 2.672 . . . . 0.0 112.383 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -81.98 57.38 4.96 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.571 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -165.49 129.91 2.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -69.63 -31.37 69.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.201 0.524 . . . . 0.0 110.715 177.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.684 HG12 HG21 ' A' ' 228' ' ' THR . 5.7 tt -117.73 111.13 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.595 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.684 HG21 HG12 ' A' ' 227' ' ' ILE . 6.4 t 39.72 87.66 0.11 Allowed Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 124.371 1.069 . . . . 0.0 113.462 177.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.46 105.32 0.41 Allowed 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 122.636 2.224 . . . . 0.0 111.216 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 48.4 tp -115.39 95.77 43.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.033 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -89.82 -1.33 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.799 2.333 . . . . 0.0 111.447 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 18.2 t -90.96 100.67 13.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.98 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 34.2 p -105.86 -41.71 5.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.164 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 234' ' ' GLN . 6.8 tp60 56.37 79.83 0.17 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.899 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -75.23 97.83 3.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.044 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -174.4 -58.9 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.788 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 234' ' ' GLN . 45.4 Cg_exo -58.49 169.59 3.02 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.722 2.282 . . . . 0.0 112.594 174.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.887 HG12 HG12 ' A' ' 266' ' ' VAL . 0.2 OUTLIER -87.18 144.67 8.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.107 -176.04 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -114.23 126.26 54.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.527 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.513 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -133.56 129.23 36.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.077 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -94.81 129.4 41.78 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.619 -0.432 . . . . 0.0 109.979 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.645 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -74.71 115.56 14.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.288 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.753 HD11 ' HG2' ' A' ' 292' ' ' LYS . 0.2 OUTLIER -102.14 -16.06 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.268 0.556 . . . . 0.0 110.387 179.01 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.29 120.45 23.2 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -58.65 155.58 12.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.175 0.988 . . . . 0.0 112.812 -168.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 25.6 tpt180 -131.0 97.71 4.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.637 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.4 m -104.32 155.56 37.09 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.256 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.99 -171.07 0.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.064 2.509 . . . . 0.0 111.583 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.436 ' N ' ' HB3' ' A' ' 252' ' ' ASP . 53.5 t -163.65 166.86 21.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.63 -26.19 61.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.878 0.37 . . . . 0.0 111.22 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -125.08 33.99 5.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.228 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.436 ' HB3' ' N ' ' A' ' 249' ' ' CYS . 0.5 OUTLIER -72.27 135.43 46.0 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.225 0.536 . . . . 0.0 110.16 178.493 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -100.18 85.99 3.13 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.491 174.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.843 HG22 ' HA ' ' A' ' 201' ' ' PRO . 41.0 p 59.87 53.84 4.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.365 -1.288 . . . . 0.0 111.213 174.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -86.85 142.23 28.21 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.452 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.45 ' HB2' ' HA3' ' A' ' 284' ' ' GLY . 1.3 tt -98.72 115.84 29.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.99 115.38 7.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.2 0.524 . . . . 0.0 110.929 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.546 HD21 HG22 ' A' ' 279' ' ' VAL . 72.8 mt -129.7 153.6 48.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.912 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -133.93 172.13 13.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 170.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 2.1 p -67.94 114.11 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.575 0.703 . . . . 0.0 111.071 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 121.44 -0.16 11.29 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.628 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -96.55 142.06 29.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.904 0.383 . . . . 0.0 110.939 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.7 mm -94.76 114.36 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.741 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.471 ' HA ' HG21 ' A' ' 279' ' ' VAL . 20.1 t -94.96 115.81 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.064 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -98.3 98.84 10.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.887 HG12 HG12 ' A' ' 238' ' ' VAL . 7.2 p -88.74 132.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.107 0.48 . . . . 0.0 110.878 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 2.5 p -108.57 -30.99 7.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.561 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -127.68 112.29 14.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.131 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.758 ' HE1' HG11 ' A' ' 238' ' ' VAL . 31.8 mtt -92.86 106.16 18.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.36 0.6 . . . . 0.0 111.216 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 92.9 m-20 -80.08 117.93 21.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.637 176.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.39 -17.26 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.715 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.401 ' OD1' ' HB3' ' A' ' 270' ' ' ASN . 3.4 p-10 -75.27 -7.58 54.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 134.41 -66.46 0.57 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.806 -1.188 . . . . 0.0 113.628 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.715 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp0 -81.72 120.58 25.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.841 0.32 . . . . 0.0 110.571 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -93.76 164.54 13.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.659 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -102.93 102.97 13.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.358 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -126.38 168.21 18.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 282' ' ' ARG . 0.9 OUTLIER -122.64 144.05 49.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.451 . . . . 0.0 109.844 178.045 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.546 HG22 HD21 ' A' ' 258' ' ' LEU . 95.6 t -135.42 100.76 2.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.204 174.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 68.66 28.82 5.58 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.6 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 101.11 14.02 32.1 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.988 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 20.2 mtp-105 -125.71 120.02 29.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.89 0.345 . . . . 0.0 110.823 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 283' ' ' LYS . 30.4 mtpt -96.07 141.83 28.99 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.45 ' HA3' ' HB2' ' A' ' 256' ' ' LEU . . . -165.6 164.17 37.13 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.262 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 85.5 mt -86.85 110.57 20.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.464 0.649 . . . . 0.0 110.87 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 24.2 p90 -115.94 128.53 25.91 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.174 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 10.7 Cg_exo -72.98 143.78 37.04 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.646 2.231 . . . . 0.0 111.076 173.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -66.01 -7.63 18.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.16 -11.96 60.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.041 0.448 . . . . 0.0 111.462 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -103.63 -11.94 17.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 111.029 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.9 163.76 30.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.031 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.753 ' HG2' HD11 ' A' ' 243' ' ' ILE . 32.5 mmmt -124.9 122.3 36.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.569 176.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.513 HD12 ' HB2' ' A' ' 240' ' ' ALA . 45.1 mm -71.06 102.84 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.89 170.9 8.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.248 0.547 . . . . 0.0 111.698 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.415 ' HB2' ' HB2' ' A' ' 298' ' ' ASN . 6.7 p-10 -97.56 127.55 37.41 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.755 175.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 295' ' ' ASP . 24.3 Cg_exo -64.64 -48.4 4.26 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.289 1.993 . . . . 0.0 111.652 176.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -149.3 -5.93 0.37 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.203 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.415 ' HB2' ' HB2' ' A' ' 295' ' ' ASP . 79.6 m-20 -62.26 122.97 76.42 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.392 -174.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.4 -42.53 40.54 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 121.686 1.591 . . . . 0.0 109.749 170.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.6 t70 65.43 -69.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.874 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 58.63 51.31 7.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.493 0.663 . . . . 0.0 110.985 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -75.83 -27.42 57.88 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 167.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 C--O 1.248 1.01 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.313 174.168 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 p -129.29 103.01 6.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.109 0.48 . . . . 0.0 112.137 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.0 t -92.95 -38.25 11.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.698 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 54.49 84.25 0.07 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.837 0.711 . . . . 0.0 111.312 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -109.15 20.03 18.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.696 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.482 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 50.7 p90 -91.34 156.27 17.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.08 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.36 135.27 36.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 m -110.84 10.9 22.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -121.52 -37.82 2.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.511 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -72.25 116.34 12.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.219 0.533 . . . . 0.0 110.715 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -56.87 -30.17 63.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.995 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.5 t -80.88 -2.71 48.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -175.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.76 -46.9 6.4 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.815 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 31.7 p-90 -120.4 -21.38 6.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -172.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -78.94 118.27 20.79 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.944 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.688 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 7.8 tpp -97.38 -4.48 38.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.201 0.524 . . . . 0.0 110.455 -172.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.66 -115.81 3.72 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.951 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.43 103.49 1.75 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.455 2.103 . . . . 0.0 112.338 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.818 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 80.8 t -132.66 -83.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.255 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.712 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 66.9 m 87.73 152.38 0.06 Allowed 'General case' 0 C--N 1.348 0.543 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -59.06 -35.67 73.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -164.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -25.94 66.97 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.019 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' O ' HG21 ' A' ' 26' ' ' THR . 23.7 tp10 -87.29 -45.24 10.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.7 -44.24 77.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.838 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -76.92 -32.74 57.59 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 23' ' ' GLU . 6.9 t -72.54 -22.07 61.07 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.591 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -88.42 -24.64 22.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.399 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.791 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 95.2 mt -107.86 20.35 18.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.532 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -66.58 90.99 0.17 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.527 0.68 . . . . 0.0 109.217 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.41 -70.1 2.68 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.579 ' HG3' ' H ' ' A' ' 32' ' ' ARG . 4.6 tp-100 48.74 -167.39 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.795 0.838 . . . . 0.0 110.894 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.579 ' H ' ' HG3' ' A' ' 31' ' ' GLN . 74.1 mtm-85 -80.04 112.09 17.01 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 170.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.464 ' NE2' ' HA ' ' A' ' 55' ' ' ASN . 32.8 m170 -57.88 117.75 4.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.115 0.483 . . . . 0.0 110.053 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.05 14.36 7.22 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -168.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.502 ' HE3' ' HA ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -95.82 145.95 24.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.53 ' HB2' HG23 ' A' ' 52' ' ' VAL . 31.1 p90 -150.34 166.97 28.42 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.45 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.1 pp -156.45 135.57 12.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.511 173.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG21 HD11 ' A' ' 50' ' ' LEU . 51.4 t -101.74 111.28 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.818 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 13.4 ptt-85 -110.7 173.95 6.09 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.868 0.366 . . . . 0.0 110.791 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -82.22 137.37 34.92 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.6 p -59.44 -28.58 67.09 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.582 -174.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.2 t 61.29 19.98 10.63 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.942 0.877 . . . . 0.0 108.787 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.5 m -116.41 -49.86 2.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.045 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 44.7 t -145.83 124.45 6.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.614 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.494 ' HD2' HG21 ' A' ' 219' ' ' VAL . 28.0 Cg_exo -62.62 87.11 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.411 2.074 . . . . 0.0 111.344 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.43 -11.27 0.13 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.774 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -126.34 145.88 50.26 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.36 -0.494 . . . . 0.0 109.763 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.43 164.42 13.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.363 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.506 HG11 ' HE2' ' A' ' 207' ' ' PTR . 38.6 t -129.29 99.42 4.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.213 0.53 . . . . 0.0 110.619 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.498 HD11 HG21 ' A' ' 38' ' ' VAL . 41.9 tp -78.67 99.53 6.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.894 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.4 m -96.3 121.51 38.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.135 0.493 . . . . 0.0 109.992 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.833 HG21 HD12 ' A' ' 93' ' ' LEU . 84.2 t -116.5 134.3 60.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.955 -177.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.791 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 95.5 p -105.78 134.54 48.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.563 0.697 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.499 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 7.2 mt-10 -144.56 175.81 9.87 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.464 ' HA ' ' NE2' ' A' ' 33' ' ' HIS . 0.3 OUTLIER -38.45 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -173.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m 50.57 59.79 4.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.444 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 55' ' ' ASN . 21.0 mmm180 -160.33 49.46 0.27 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.177 -157.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 36.4 t -80.96 90.9 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.967 0.889 . . . . 0.0 109.351 -175.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 51.1 m -80.4 120.81 24.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.172 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.53 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 88.9 m-70 -97.81 99.02 10.33 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.366 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.585 ' CE2' HD23 ' A' ' 93' ' ' LEU . 64.0 m-85 -103.17 116.03 31.71 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.6 mt -81.69 139.27 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.522 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.8 mp -127.05 118.04 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 122.877 0.471 . . . . 0.0 110.422 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -84.35 139.41 32.29 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.464 -0.148 . . . . 0.0 110.822 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.9 t -84.52 107.77 16.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -83.84 149.66 57.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.007 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.71 -23.9 73.49 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.129 2.553 . . . . 0.0 112.911 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -79.66 6.13 11.49 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.013 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 66.11 36.07 5.87 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.676 0.751 . . . . 0.0 110.234 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 92.7 mtt180 -113.97 172.99 6.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.604 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.522 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 60.0 m-85 -135.92 115.72 13.04 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.12 0.486 . . . . 0.0 111.291 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -98.39 108.4 21.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.745 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.539 HD12 HD11 ' A' ' 84' ' ' LEU . 9.5 tt -97.8 78.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.842 0.829 . . . . 0.0 110.043 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.63 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 69.74 95.62 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.283 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.676 ' HB2' ' HB2' ' A' ' 211' ' ' GLN . 10.6 t0 71.81 -56.96 0.63 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.033 0.533 . . . . 0.0 111.736 173.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -78.61 140.53 38.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.738 0.304 . . . . 0.0 110.665 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -112.7 128.64 56.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.627 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 74.6 m-85 -116.77 164.6 14.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.273 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 70' ' ' ARG . 3.6 m-20 -72.97 -29.66 63.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -176.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.602 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -164.06 167.06 20.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.974 -178.291 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.557 HD23 HD21 ' A' ' 84' ' ' LEU . 10.6 mt -53.58 -51.79 72.96 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 32.2 Cg_exo -59.96 -11.92 17.01 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.956 1.77 . . . . 0.0 112.955 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.512 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . . . -91.73 -32.21 15.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.111 -175.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.557 HD21 HD23 ' A' ' 81' ' ' LEU . 3.9 pp -77.46 -31.95 54.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.67 -38.3 90.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.354 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 13.9 pt-20 -78.25 -18.17 55.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.196 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -79.07 -39.01 34.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.191 0.519 . . . . 0.0 109.961 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.479 ' CG ' HD21 ' A' ' 93' ' ' LEU . 32.4 m-85 -77.85 -15.95 58.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.599 -177.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 22.0 pttm -67.48 -20.27 65.44 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.316 -0.254 . . . . 0.0 110.316 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.418 HG22 ' HG3' ' A' ' 89' ' ' LYS . 18.9 pt -121.91 22.48 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.991 -0.443 . . . . 0.0 111.529 174.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 22.3 t-160 -113.56 -32.47 6.18 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.078 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.583 ' HA ' HG23 ' A' ' 97' ' ' THR . 76.1 m-85 73.32 107.75 0.07 Allowed 'General case' 0 C--O 1.22 -0.452 0 O-C-N 124.072 0.858 . . . . 0.0 109.966 -172.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.833 HD12 HG21 ' A' ' 52' ' ' VAL . 12.2 mt -79.87 -12.2 59.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.76 0.79 . . . . 0.0 109.173 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.499 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 24.9 t70 -149.04 -71.83 0.19 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.238 160.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.553 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.7 t -149.22 2.33 0.56 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.424 HG22 ' CD ' ' A' ' 54' ' ' GLU . 1.9 t -132.08 -12.54 3.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.409 -0.807 . . . . 0.0 112.795 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.583 HG23 ' HA ' ' A' ' 92' ' ' TYR . 8.4 p 74.08 -166.06 0.1 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.301 1.041 . . . . 0.0 111.696 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.5 mt -81.72 108.56 15.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.311 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.7 mm -98.45 -48.57 12.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.556 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 9.8 pt-20 -167.56 158.14 9.67 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.916 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.447 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 1.5 Cg_endo -83.28 162.82 15.15 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.801 2.334 . . . . 0.0 112.726 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.502 ' HA ' ' HE3' ' A' ' 35' ' ' MET . . . -84.18 154.08 63.26 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.096 177.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.727 ' HB2' ' HG3' ' A' ' 106' ' ' PRO . 22.8 Cg_exo -64.71 139.31 62.6 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.629 2.22 . . . . 0.0 112.119 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.688 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 68.1 mtm180 -77.03 -42.56 38.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.049 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -139.61 80.67 21.39 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.562 0.696 . . . . 0.0 110.155 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.727 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 1.4 Cg_endo -82.81 -19.54 5.94 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.671 2.248 . . . . 0.0 112.254 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.8 t 56.18 86.67 0.16 Allowed Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.865 -172.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.434 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 33.6 Cg_exo -56.86 126.59 22.72 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.746 2.298 . . . . 0.0 112.193 -176.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 8.5 Cg_exo -74.54 41.35 0.69 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.383 2.722 . . . . 0.0 112.316 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.401 ' H ' ' C ' ' A' ' 108' ' ' PRO . 92.4 mmm 56.51 45.96 21.49 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.178 177.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.84 -72.97 0.43 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.049 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m -70.08 96.84 1.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.959 0.409 . . . . 0.0 111.257 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.576 HG22 ' HD2' ' A' ' 116' ' ' PRO . 11.1 m -100.82 -22.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.794 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.3 m 58.76 24.83 12.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.345 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.734 ' H ' ' HD2' ' A' ' 116' ' ' PRO . . . -108.42 -50.4 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.734 ' HD2' ' H ' ' A' ' 115' ' ' ALA . 10.2 Cg_endo -53.84 133.68 55.61 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 122.651 2.234 . . . . 0.0 113.21 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -70.06 -46.31 65.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.448 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 91.1 mt -151.77 124.78 4.13 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.239 -174.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 118' ' ' LEU . 4.3 Cg_endo -87.04 26.91 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.388 2.725 . . . . 0.0 111.21 174.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.6 t -69.71 145.14 52.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.563 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.59 26.87 6.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.276 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.39 -57.39 8.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.795 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -81.71 132.1 35.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.332 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -97.37 -74.57 0.57 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.552 174.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? 61.89 101.49 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.912 0.758 . . . . 0.0 111.586 176.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 47.9 tp10 -161.14 -78.72 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.092 -175.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.89 116.49 32.04 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.9 0.857 . . . . 0.0 112.039 -171.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 86.6 t -134.36 125.89 48.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.573 -173.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.635 ' CG ' ' HB3' ' A' ' 179' ' ' GLU . 7.2 ptp85 -111.49 135.01 52.65 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 118.127 -1.429 . . . . 0.0 110.817 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.402 ' C ' HD12 ' A' ' 131' ' ' LEU . 7.4 p -97.48 140.66 31.59 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.094 0.473 . . . . 0.0 112.081 -174.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 1.045 HD21 ' HB2' ' A' ' 179' ' ' GLU . 0.1 OUTLIER -117.44 -38.33 3.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.448 -171.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 29.9 t80 -64.32 -32.56 74.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.886 -170.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 12.5 t70 72.44 105.84 0.07 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.737 0.648 . . . . 0.0 110.04 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 71.3 t80 -144.08 108.72 5.0 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.095 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 66.1 Cg_endo -87.92 99.6 0.44 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.325 2.017 . . . . 0.0 112.661 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.65 -3.71 90.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.99 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.1 m120 57.92 24.66 11.2 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.133 0.573 . . . . 0.0 111.777 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.668 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 2.0 p30 50.45 -176.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.038 1.335 . . . . 0.0 114.457 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 71.89 9.17 6.14 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.432 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -175.38 -46.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.069 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -137.07 124.26 21.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.828 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.616 HD13 ' HD2' ' A' ' 143' ' ' PRO . 46.7 tp -69.86 132.28 88.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-O 120.693 0.282 . . . . 0.0 110.662 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 6.4 Cg_endo -85.25 89.23 0.83 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.374 2.049 . . . . 0.0 110.636 176.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 14.2 p90 -99.5 158.02 16.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.472 -177.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.562 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 82.9 mttt -112.15 -172.44 2.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.469 -172.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.22 18.46 1.4 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.742 -175.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.94 36.06 0.08 OUTLIER Glycine 0 C--N 1.33 0.218 0 C-N-CA 119.813 -1.185 . . . . 0.0 113.916 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.562 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 21.9 mm-40 -98.84 157.41 16.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 129' ' ' ARG . 9.4 tp -103.52 138.83 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 172.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.545 HD22 ' HA ' ' A' ' 165' ' ' ASN . 26.5 mt -120.61 155.7 33.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 19.2 t -119.74 130.89 73.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.632 HG21 HD13 ' A' ' 125' ' ' LEU . 39.6 mm -74.3 96.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.552 HG21 ' HG2' ' A' ' 154' ' ' GLU . 16.3 tt -79.02 -31.2 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.77 -175.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.552 ' HG2' HG21 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -146.9 141.0 26.09 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.934 171.172 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.599 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 1.6 ttpm? -119.06 87.13 33.54 Favored Pre-proline 0 C--N 1.328 -0.367 0 O-C-N 121.331 -0.856 . . . . 0.0 110.877 173.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.553 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 11.4 Cg_exo -72.92 -58.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.584 2.19 . . . . 0.0 112.35 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -107.83 177.44 4.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.23 -20.18 14.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.757 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -85.47 -34.76 21.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.15 0.5 . . . . 0.0 110.122 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.431 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 31.7 m95 -128.3 129.73 46.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.206 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -108.97 156.17 20.02 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.484 ' HG ' ' HG3' ' A' ' 154' ' ' GLU . 22.7 t -111.58 101.96 10.33 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.351 0.596 . . . . 0.0 110.056 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.471 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -113.71 163.19 15.34 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.169 -176.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.458 ' HD2' ' HA ' ' A' ' 210' ' ' PRO . 29.8 ptt-85 -108.23 140.55 41.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.328 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 150' ' ' LEU . 57.1 t30 -70.56 178.61 2.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.587 -175.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -58.67 -32.02 68.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 211' ' ' GLN . 17.9 m-20 -60.6 -42.14 96.15 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.105 170.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.821 ' HA3' ' H ' ' A' ' 211' ' ' GLN . . . 115.86 -9.33 18.81 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.689 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.668 ' HD3' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -76.73 152.69 35.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.541 0.671 . . . . 0.0 110.811 -176.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.446 ' CG2' HD11 ' A' ' 153' ' ' ILE . 26.2 t -99.73 143.59 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.287 0.565 . . . . 0.0 112.413 -168.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -171.98 162.98 35.29 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.757 169.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.431 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 22.9 mtp -81.7 147.31 29.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.3 0.55 . . . . 0.0 110.822 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.8 pp -141.32 145.83 39.9 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.386 -174.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 7.8 Cg_exo -73.29 133.17 18.88 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.185 2.59 . . . . 0.0 112.699 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 178' ' ' VAL . 58.0 t -61.7 -47.3 92.69 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 23.3 Cg_endo -61.4 -13.44 29.0 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.169 1.913 . . . . 0.0 113.294 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -86.35 -4.21 59.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.888 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 175' ' ' VAL . 4.1 m -110.61 159.04 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -166.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 1.045 ' HB2' HD21 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -117.75 45.19 2.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 111.493 -2.594 . . . . 0.0 109.242 -178.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.806 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -74.27 137.77 43.18 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 120.963 -1.085 . . . . 0.0 109.398 -168.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 27.2 tp -60.54 -53.15 60.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.715 -164.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.64 115.91 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.683 0.754 . . . . 0.0 111.565 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -155.11 86.58 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.6 m -74.6 163.27 27.92 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.411 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 1.6 p -78.2 168.18 29.55 Favored Pre-proline 0 C--N 1.318 -0.761 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.77 90.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.852 2.368 . . . . 0.0 114.211 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 1.9 p80 174.22 -176.11 0.08 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.723 1.209 . . . . 0.0 108.566 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -84.3 -162.54 34.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.403 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -74.58 -13.11 60.62 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.146 0.179 . . . . 0.0 110.863 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 14.5 p80 43.04 98.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.742 1.217 . . . . 0.0 113.917 175.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -133.39 156.98 22.51 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.206 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.417 ' N ' HD21 ' A' ' 192' ' ' ASN . 0.9 OUTLIER -62.97 -44.64 95.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.812 0.339 . . . . 0.0 110.389 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -137.56 88.23 2.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 110.149 176.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -93.92 98.87 11.34 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 12.3 p -148.88 -74.28 0.18 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.75 -176.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.41 45.66 1.26 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.544 0.688 . . . . 0.0 109.497 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 24.8 m -103.86 94.66 5.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.399 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.79 169.46 12.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.188 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 91.73 52.12 2.35 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -171.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.687 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 63.7 mt -95.51 -53.6 0.23 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.234 -0.483 . . . . 0.0 111.496 -176.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.687 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 50.6 Cg_exo -55.24 139.26 80.89 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.319 2.012 . . . . 0.0 112.319 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.35 126.46 86.44 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.721 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.61 0.9 9.55 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.476 2.117 . . . . 0.0 111.628 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -159.26 -145.83 0.14 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.467 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 68.84 24.84 6.36 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.469 0.652 . . . . 0.0 110.37 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.1 -60.86 2.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.687 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.53 ' HD2' ' HB3' ' A' ' 60' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -107.07 12.24 28.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.097 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -57.45 136.06 81.86 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.357 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.63 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 26.4 Cg_exo -63.36 145.85 93.01 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.82 1.68 . . . . 0.0 110.167 170.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.821 ' H ' ' HA3' ' A' ' 168' ' ' GLY . 7.4 tp-100 70.62 168.35 0.31 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.974 0.416 . . . . 0.0 109.952 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 4.7 t -114.83 106.7 14.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.588 0.708 . . . . 0.0 110.37 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 27.0 p -87.66 167.09 14.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.004 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 8.7 t -128.95 125.36 22.85 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.894 0.378 . . . . 0.0 110.359 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 8.2 Cg_exo -71.64 110.23 2.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.741 2.294 . . . . 0.0 111.339 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.697 HD22 ' H ' ' A' ' 216' ' ' LEU . 2.4 pt? -86.24 142.9 36.13 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.064 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 7.9 Cg_exo -73.62 -4.15 14.94 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.864 2.376 . . . . 0.0 112.447 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -98.19 115.29 28.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.427 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.494 HG21 ' HD2' ' A' ' 45' ' ' PRO . 3.4 p -71.06 103.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.575 0.702 . . . . 0.0 110.959 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 55.4 m -148.26 127.01 12.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.704 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 146.53 39.14 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.29 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 48.7 m -75.52 118.7 72.8 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 15.0 Cg_exo -68.98 -32.46 21.84 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.935 2.423 . . . . 0.0 112.653 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 79.37 -78.86 1.69 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.746 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -148.64 145.58 27.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.3 116.21 27.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.33 . . . . 0.0 110.605 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.76 127.97 31.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.857 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.4 t -83.02 124.61 76.43 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.537 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -87.04 -161.39 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.67 2.247 . . . . 0.0 112.238 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 231' ' ' PRO . 2.5 pt? -142.44 174.03 4.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 230' ' ' LEU . 50.6 Cg_exo -55.61 -24.19 43.98 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.6 2.2 . . . . 0.0 113.167 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.435 ' H ' ' HG ' ' A' ' 230' ' ' LEU . 8.4 m -79.1 141.25 37.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.342 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 35.3 p -69.86 162.5 27.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.242 0.544 . . . . 0.0 111.606 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -77.4 80.91 3.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.145 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -134.54 2.01 3.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.844 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -130.63 110.03 0.97 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.588 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.66 163.92 18.64 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.313 2.675 . . . . 0.0 111.409 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.615 HG11 HD13 ' A' ' 293' ' ' ILE . 45.8 t -94.9 131.14 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -115.14 135.12 54.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.851 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.538 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -122.29 142.56 50.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.2 174.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.733 ' HA ' ' O ' ' A' ' 262' ' ' ASP . 56.3 mttm -84.52 119.6 25.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.088 0.47 . . . . 0.0 110.233 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 1.102 ' HB1' ' HA ' ' A' ' 259' ' ' GLU . . . -89.39 114.91 26.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.217 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.422 HD11 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -130.7 -10.26 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -165.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.659 ' HB3' ' OE2' ' A' ' 259' ' ' GLU . 7.7 tt0 -113.57 -89.05 0.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.059 -0.657 . . . . 0.0 112.752 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.44 ' N ' ' HB3' ' A' ' 259' ' ' GLU . 85.8 tttt -173.81 118.74 0.27 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -173.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.925 ' HG2' ' HG3' ' A' ' 259' ' ' GLU . 19.8 mmm180 -131.34 98.74 4.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.61 167.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.68 132.75 21.75 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.106 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.57 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 73.3 Cg_endo -81.97 107.69 1.75 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.587 2.192 . . . . 0.0 112.631 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 6.0 t -63.86 161.68 15.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.37 -9.45 3.57 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -67.66 -33.98 76.02 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 46.07 86.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.853 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -121.07 72.83 1.0 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.755 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.9 m 60.18 36.82 20.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.057 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -94.37 118.43 31.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.507 . . . . 0.0 111.183 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 tt -91.17 126.28 36.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.367 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.57 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -81.82 110.66 17.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.188 0.518 . . . . 0.0 110.931 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.549 HD23 HG23 ' A' ' 264' ' ' VAL . 1.3 pp -164.86 -141.82 0.05 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.115 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 1.102 ' HA ' ' HB1' ' A' ' 242' ' ' ALA . 0.0 OUTLIER 80.82 1.18 1.78 Allowed 'General case' 0 C--O 1.222 -0.367 0 O-C-N 123.899 0.75 . . . . 0.0 111.566 177.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.32 90.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -178.8 -83.35 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.823 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.733 ' O ' ' HA ' ' A' ' 241' ' ' LYS . 29.2 t0 179.04 -79.06 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 121.056 0.455 . . . . 0.0 111.68 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 263' ' ' ILE . 36.9 mm -100.65 119.81 49.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -170.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.549 HG23 HD23 ' A' ' 258' ' ' LEU . 99.2 t -107.11 121.79 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.472 168.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.661 ' HZ3' ' HB2' ' A' ' 265' ' ' LYS . 9.7 mtmp? -94.09 116.25 28.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.163 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 275' ' ' TRP . 2.7 p -111.68 117.27 54.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.306 0.574 . . . . 0.0 110.692 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.2 p -107.57 -15.44 14.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.753 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.459 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 38.2 mmt-85 -124.01 100.38 6.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.043 0.449 . . . . 0.0 111.211 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.415 ' HE3' HG12 ' A' ' 238' ' ' VAL . 46.8 mtt -101.85 140.31 36.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.332 176.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.619 ' OD1' ' HB3' ' A' ' 272' ' ' ASN . 9.0 p30 -135.49 176.66 8.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.461 -176.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 13.7 pt -87.1 4.58 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -172.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.619 ' HB3' ' OD1' ' A' ' 270' ' ' ASN . 7.4 t-20 -74.77 -44.59 48.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.26 0.552 . . . . 0.0 109.578 175.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.73 -39.21 2.55 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.408 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 44.3 mt-30 -79.35 116.54 19.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 13.6 m0 -93.04 155.85 17.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.977 -173.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 40.2 mt-10 -101.26 107.62 19.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.994 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.99 148.74 17.89 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 282' ' ' ARG . 0.0 OUTLIER -110.09 109.63 20.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.372 0.606 . . . . 0.0 110.33 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.473 HG23 HG13 ' A' ' 264' ' ' VAL . 21.6 t -127.6 -79.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.755 -176.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -82.26 67.04 8.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.268 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.07 16.92 60.49 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.85 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 40.5 ttm180 -155.32 146.63 22.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.139 0.469 . . . . 0.0 111.095 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 278' ' ' GLU . 39.4 tttm -102.48 113.98 27.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.118 170.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -146.67 178.21 24.48 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.074 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 96.5 mt -84.86 140.43 31.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 0.0 111.681 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -142.86 129.5 10.69 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.22 170.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.28 137.08 25.31 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.58 2.187 . . . . 0.0 112.536 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -71.51 -10.74 60.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.844 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.7 m -84.65 -2.57 57.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.451 0.643 . . . . 0.0 110.411 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.459 ' HB3' ' OE2' ' A' ' 259' ' ' GLU . 3.1 m-70 -101.12 -54.65 2.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.395 174.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 35.0 m -85.03 159.61 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.798 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.496 ' HB2' ' HZ1' ' A' ' 292' ' ' LYS . 0.2 OUTLIER -110.42 107.16 16.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.229 0.538 . . . . 0.0 110.3 178.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.615 HD13 HG11 ' A' ' 238' ' ' VAL . 5.0 tp -70.1 131.66 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.461 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 18.3 p90 -134.63 160.64 37.48 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.624 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -99.31 111.6 61.5 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.178 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.07 39.35 0.83 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.144 2.563 . . . . 0.0 111.603 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 58.85 52.01 6.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.227 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.3 145.59 48.97 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.444 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -94.52 24.88 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.053 2.502 . . . . 0.0 113.617 -175.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -131.3 177.13 7.71 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.419 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 302' ' ' ASN . 7.3 pt-20 59.18 -55.05 0.06 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.033 1.733 . . . . 0.0 114.208 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.459 ' N ' ' HG3' ' A' ' 301' ' ' GLU . 8.6 t30 -78.42 133.32 37.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.193 0.521 . . . . 0.0 111.581 -174.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.236 175.397 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.745 0.307 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.8 m -77.59 141.99 39.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.712 0.291 . . . . 0.0 110.652 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.485 ' HB3' HD12 ' A' ' 99' ' ' ILE . 15.0 m -76.96 -39.74 49.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.034 0.445 . . . . 0.0 109.92 178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.55 94.61 1.32 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.993 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.652 ' HA ' ' NE ' ' A' ' 5' ' ' ARG . 5.0 mmp_? -113.71 15.14 18.84 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -86.59 171.13 11.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 8' ' ' SER . 24.4 t70 -82.52 -133.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.505 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 9.6 t -173.71 43.19 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.9 t -164.51 -11.02 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.968 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' A' ' 7' ' ' ASP . 7.9 p-10 -75.44 81.0 2.49 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.809 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -70.5 -16.85 62.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.479 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 t -75.77 -7.96 55.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.659 174.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.3 -47.08 3.59 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.8 p-90 -107.63 -20.46 13.22 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -172.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -81.92 122.71 28.11 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 122.027 -0.421 . . . . 0.0 110.672 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.658 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 24.7 mmt -103.36 -13.55 16.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.479 -176.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.05 -113.42 2.18 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.658 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.6 84.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.199 2.599 . . . . 0.0 113.327 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.569 HG13 ' H ' ' A' ' 20' ' ' SER . 84.1 t -137.03 172.8 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.569 ' H ' HG13 ' A' ' 19' ' ' VAL . 43.8 p -145.41 172.28 13.42 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -168.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.65 ' HD2' ' O2P' ' A' ' 207' ' ' PTR . 37.4 ttt85 -63.02 -37.15 86.04 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.873 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -56.74 11.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.688 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -61.55 -50.25 73.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.25 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . -56.73 -37.23 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.353 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -64.33 -43.94 93.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.128 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.2 t -78.92 -21.27 47.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.871 0.367 . . . . 0.0 111.409 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 51.1 mtp180 -82.43 -10.43 59.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.892 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 53' ' ' SER . 26.9 mt -126.97 12.06 7.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.097 0.475 . . . . 0.0 111.018 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.49 98.25 2.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.377 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 117' ' ' ASN . . . 78.69 -1.92 70.52 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.344 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.694 ' HA ' ' H ' ' A' ' 117' ' ' ASN . 4.7 mm100 -60.37 168.15 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.853 0.461 . . . . 0.0 111.689 -175.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.514 ' HB3' ' HE1' ' A' ' 35' ' ' MET . 20.8 ttp180 -47.63 118.98 2.49 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.551 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.595 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 36.3 m170 -63.6 117.16 6.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.337 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.8 -13.55 6.1 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.997 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.683 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 64.3 mtt -69.19 153.58 43.46 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.511 0.196 . . . . 0.0 110.518 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -155.62 159.23 39.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.658 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.6 pp -153.52 140.41 19.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.001 0.429 . . . . 0.0 110.851 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.3 t -110.39 116.47 52.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.861 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.447 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 25.4 ptt-85 -117.77 176.05 5.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.97 -177.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.41 134.46 40.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.133 0.492 . . . . 0.0 110.645 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 t -87.36 107.97 18.77 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.5 t -73.96 8.09 2.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.563 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.5 p -94.6 -25.56 16.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.803 0.335 . . . . 0.0 110.659 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 76.7 m -152.36 115.23 2.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.879 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.45 103.05 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.799 2.333 . . . . 0.0 112.436 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.54 -24.73 4.1 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.659 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -88.37 165.87 14.66 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.412 ' CD2' HD11 ' A' ' 81' ' ' LEU . 58.0 m-85 -134.52 -177.87 4.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.758 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 62' ' ' ILE . 6.2 t -143.96 113.85 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.62 177.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.8 tp -80.83 97.09 7.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 172.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.1 m -94.05 118.12 31.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.329 0.585 . . . . 0.0 109.666 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 58.7 t -110.68 142.66 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.639 -174.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 40.7 t -91.68 103.89 16.41 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.595 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 7.0 tp10 -167.11 166.43 15.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.898 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.537 HD21 ' CG ' ' A' ' 94' ' ' ASP . 0.7 OUTLIER 76.82 -64.5 0.33 Allowed 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 123.58 1.657 . . . . 0.0 108.546 -168.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.5 m -160.86 -27.64 0.06 Allowed 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 111.314 -2.675 . . . . 0.0 106.133 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.794 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.363 0.0 OUTLIER -163.08 -48.34 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.084 1 N-CA-C 123.333 4.568 . . . . 0.0 123.333 179.624 . . . . . . . . 5 4 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.794 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -147.98 107.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 121.785 2.084 . . . . 0.0 114.096 -166.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.53 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -98.03 112.6 24.49 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 171.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.4 ' HB2' ' HB1' ' A' ' 208' ' ' ALA . 91.0 m-70 -101.53 86.48 2.97 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -169.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.752 ' CE1' HD13 ' A' ' 153' ' ' ILE . 55.5 m-85 -102.01 110.27 22.2 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 118.626 0.648 . . . . 0.0 112.248 -174.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -75.38 139.49 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.295 0.569 . . . . 0.0 112.39 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.568 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.3 mp -110.33 108.8 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.587 175.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -82.82 141.93 31.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.177 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.7 t -85.75 118.46 25.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.104 0.478 . . . . 0.0 110.352 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.498 HD22 ' HE2' ' A' ' 72' ' ' LYS . 95.3 mt -95.15 142.54 24.74 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.058 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.54 -8.66 21.61 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.864 2.376 . . . . 0.0 112.386 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.48 10.12 5.1 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.64 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 67.32 25.9 8.64 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.087 -179.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 71.0 mtt180 -115.2 -176.1 2.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.199 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.512 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 61.5 m-85 -138.85 124.69 19.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.718 0.294 . . . . 0.0 110.934 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.815 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 25.7 ttpt -113.62 109.65 18.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 111.466 -177.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.568 ' HB ' HG13 ' A' ' 63' ' ' ILE . 14.0 tt -95.91 81.29 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.723 0.773 . . . . 0.0 110.052 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.57 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 71.76 82.59 0.27 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.79 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.76 ' HB2' ' CB ' ' A' ' 211' ' ' GLN . 20.2 t0 71.46 -47.09 0.65 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.963 0.905 . . . . 0.0 111.48 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -74.75 101.34 4.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.889 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.815 ' HB3' ' HD3' ' A' ' 72' ' ' LYS . 8.2 pt-20 -95.55 118.26 31.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.662 0.744 . . . . 0.0 110.934 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.571 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 76.3 m-85 -100.22 174.71 6.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.83 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 31.9 t70 -73.06 -25.14 60.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.317 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.648 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 1.7 p80 -172.01 172.17 4.79 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.662 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.593 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.5 mt -51.4 -54.41 39.05 Favored Pre-proline 0 N--CA 1.472 0.633 0 O-C-N 123.301 0.376 . . . . 0.0 111.95 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 59.6 Cg_endo -70.4 16.99 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.284 1.99 . . . . 0.0 113.292 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 81' ' ' LEU . . . -107.5 -35.4 6.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 174.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.8 pp -76.88 -31.74 56.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.175 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.68 -30.35 71.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.619 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.55 ' HG3' ' HD2' ' A' ' 89' ' ' LYS . 3.6 tt0 -91.36 -12.61 34.41 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.104 0.478 . . . . 0.0 111.107 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.403 ' CE2' ' ND1' ' A' ' 91' ' ' HIS . 72.4 t80 -86.01 -30.62 22.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.98 0.895 . . . . 0.0 108.957 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.516 ' CG ' HD21 ' A' ' 93' ' ' LEU . 40.7 m-85 -82.71 2.38 33.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.252 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.55 ' HD2' ' HG3' ' A' ' 86' ' ' GLU . 98.3 mttt -76.39 -3.96 39.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.875 173.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.34 -2.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.032 0.444 . . . . 0.0 110.726 177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.403 ' ND1' ' CE2' ' A' ' 87' ' ' PHE . 5.0 t60 -81.36 -31.83 33.2 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.383 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 96' ' ' THR . 75.7 m-85 62.77 67.0 0.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.125 -173.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.672 HD13 ' O ' ' A' ' 93' ' ' LEU . 2.0 pp -71.62 117.58 13.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.79 174.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.871 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 7.6 t70 97.81 -48.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.973 1.709 . . . . 0.0 108.278 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.732 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 6.0 t 167.23 22.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.615 -1.629 . . . . 0.0 106.652 168.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.536 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 2.2 t -149.2 150.64 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.445 -173.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.7 p -91.44 157.55 17.0 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.51 99.66 0.22 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.883 0.373 . . . . 0.0 110.18 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 3' ' ' SER . 32.4 mm -80.83 -57.81 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.765 -176.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.683 ' O ' ' HA ' ' A' ' 35' ' ' MET . 29.8 tt0 -165.16 136.93 3.32 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 -174.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.31 155.68 44.99 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.652 2.235 . . . . 0.0 112.956 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.75 157.84 85.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.697 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.31 122.5 11.91 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.34 2.027 . . . . 0.0 111.823 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -69.53 -31.83 70.29 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.591 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -108.62 108.74 61.14 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 174.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.48 -21.11 22.95 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.352 2.034 . . . . 0.0 112.459 -177.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.7 m 69.25 149.59 0.12 Allowed Pre-proline 0 CA--C 1.534 0.349 0 O-C-N 123.837 0.71 . . . . 0.0 110.647 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.737 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 51.5 Cg_exo -53.3 -56.0 3.12 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.435 2.09 . . . . 0.0 113.318 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.737 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 88.8 Cg_endo -93.24 149.65 2.47 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.028 1.818 . . . . 0.0 112.723 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 87.9 mtp -106.1 119.71 39.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.239 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.73 -52.85 3.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.25 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.902 ' HA ' ' HG2' ' A' ' 116' ' ' PRO . 71.7 p 50.76 -153.2 0.17 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.315 0.646 . . . . 0.0 111.871 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 113' ' ' VAL . 11.5 t 64.12 30.67 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.806 0.813 . . . . 0.0 110.508 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.6 m -151.87 -88.9 0.06 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.432 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.617 ' H ' ' HD2' ' A' ' 116' ' ' PRO . . . -101.65 -47.07 0.19 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.33 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.902 ' HG2' ' HA ' ' A' ' 112' ' ' SER . 33.3 Cg_endo -67.01 121.75 8.98 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.454 1.436 . . . . 0.0 112.304 174.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.694 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 56.2 t30 74.86 108.0 0.07 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.0 0.812 . . . . 0.0 111.89 175.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.77 ' HB2' ' HD3' ' A' ' 119' ' ' PRO . 2.3 mm? -119.59 -60.72 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.301 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.77 ' HD3' ' HB2' ' A' ' 118' ' ' LEU . 19.4 Cg_exo -65.66 141.69 67.41 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.602 2.201 . . . . 0.0 112.884 -173.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.5 m -103.31 114.27 28.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.876 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 71.87 128.84 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.95 0.781 . . . . 0.0 111.734 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -83.17 143.29 30.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.868 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.39 -98.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 171.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.524 ' ND2' ' HG3' ' A' ' 183' ' ' ARG . 34.0 m-80 -154.91 -95.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.528 HD13 HG22 ' A' ' 152' ' ' ILE . 3.8 mm? 48.7 90.77 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.006 0.816 . . . . 0.0 111.625 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.697 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 11.1 tp10 -165.1 -61.4 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.13 -173.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -113.49 112.34 23.43 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.271 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 1.028 HG23 ' HG3' ' A' ' 180' ' ' LYS . 2.4 t -117.19 153.39 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.654 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.4 ptp180 -129.15 148.35 51.08 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 117.947 -1.501 . . . . 0.0 108.059 157.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.502 HG22 HD12 ' A' ' 150' ' ' LEU . 43.6 p -100.58 133.54 44.87 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.695 0.759 . . . . 0.0 110.874 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.495 HD21 ' HG2' ' A' ' 179' ' ' GLU . 8.0 mt -107.56 2.25 23.91 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.555 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 16.3 t80 -102.41 -45.02 5.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.039 -173.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.623 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.9 t70 78.74 103.74 0.07 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.166 0.508 . . . . 0.0 110.679 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 68.9 t80 -132.93 91.08 29.99 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.585 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 98.3 Cg_endo -87.45 70.33 3.43 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.219 1.946 . . . . 0.0 112.763 -175.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.62 -33.88 82.22 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.737 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.479 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 26.5 m-80 61.97 66.49 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.133 -0.533 . . . . 0.0 111.825 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.66 172.63 12.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.271 176.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.46 -9.55 49.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.051 0.929 . . . . 0.0 108.795 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.649 ' O ' ' HB2' ' A' ' 172' ' ' MET . 28.5 mt-10 -106.63 -15.58 14.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.807 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -137.89 106.82 5.97 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.331 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.788 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 20.1 tp -75.53 126.91 86.93 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.767 0.317 . . . . 0.0 110.989 -175.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.585 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 73.9 Cg_endo -78.12 97.18 1.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.845 1.697 . . . . 0.0 111.687 173.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.66 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 15.3 p90 -105.95 156.71 18.1 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.623 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 62.5 mttp -113.07 173.34 6.44 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -173.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.53 ' N ' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -71.72 57.88 0.3 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.209 178.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 134.41 38.25 0.21 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.784 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.697 ' CD ' ' HG ' ' A' ' 150' ' ' LEU . 1.7 pp20? -91.04 169.06 11.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.17 127.66 73.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.779 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 78.1 mt -117.21 156.33 27.89 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -173.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 89.4 t -120.45 122.13 67.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 171.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.528 HG22 HD13 ' A' ' 125' ' ' LEU . 46.4 mm -78.0 78.82 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 122.793 1.282 . . . . 0.0 108.325 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.752 HD13 ' CE1' ' A' ' 61' ' ' TYR . 5.4 tt -70.89 -28.91 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 112.577 -2.101 . . . . 0.0 109.478 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.871 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -134.89 143.14 46.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.165 176.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.51 ' CD ' ' HG ' ' A' ' 125' ' ' LEU . 67.0 tttt -141.61 83.76 12.87 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.732 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 21.8 Cg_exo -68.14 -49.69 0.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.432 2.088 . . . . 0.0 112.199 174.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -119.35 175.73 5.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.658 -171.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -101.96 -4.93 25.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.276 0.56 . . . . 0.0 110.164 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -93.64 -36.55 12.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.516 0.674 . . . . 0.0 109.853 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.448 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 41.0 m95 -129.8 145.04 51.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.925 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.745 ' O ' HG13 ' A' ' 173' ' ' ILE . 48.5 m0 -124.31 138.88 54.34 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 122.761 0.424 . . . . 0.0 110.184 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.653 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 2.9 m -98.55 98.36 9.54 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -174.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.557 ' HB1' ' HB3' ' A' ' 150' ' ' LEU . . . -114.77 155.83 25.99 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -170.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.909 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 31.7 ptt-85 -94.86 128.11 41.38 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.858 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.788 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 65.8 t30 -59.21 178.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.106 -1.406 . . . . 0.0 112.21 -169.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -51.01 -28.34 9.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.182 164.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -70.57 -44.33 67.63 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.492 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.572 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 113.87 9.58 15.99 Favored Glycine 0 C--O 1.223 -0.533 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.966 -169.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.909 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 16.4 ttm-85 -76.09 136.54 39.87 Favored 'General case' 0 C--O 1.212 -0.892 0 C-N-CA 123.409 0.683 . . . . 0.0 112.319 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.917 HG21 ' HA ' ' A' ' 210' ' ' PRO . 56.2 t -84.07 120.2 34.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.15 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -156.12 155.89 26.65 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.476 -0.649 . . . . 0.0 111.476 172.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.649 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -76.02 138.8 41.12 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 117.354 0.577 . . . . 0.0 111.277 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.745 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -139.16 141.48 29.77 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.187 -176.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 21.4 Cg_exo -65.58 131.77 28.86 Favored 'Trans proline' 0 CA--C 1.527 0.146 0 C-N-CA 122.464 2.109 . . . . 0.0 112.936 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 178' ' ' VAL . 66.6 t -61.42 -44.54 92.86 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 22.7 Cg_exo -64.61 2.17 1.38 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.188 1.925 . . . . 0.0 113.162 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.7 m-30 -100.99 -11.65 19.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.231 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 175' ' ' VAL . 3.6 m -105.63 -177.03 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -164.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.654 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.8 tp10 -151.82 51.59 0.81 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 111.947 -2.388 . . . . 0.0 112.332 -155.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 1.028 ' HG3' HG23 ' A' ' 128' ' ' VAL . 1.8 mppt? -68.22 135.83 52.62 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 120.056 -1.652 . . . . 0.0 109.96 -161.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.9 tp -84.11 -74.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.872 -165.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 19.0 m -88.04 25.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.23 -175.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.896 ' HD3' ' HE3' ' A' ' 180' ' ' LYS . 28.0 ttt180 -103.12 118.18 36.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.026 0.441 . . . . 0.0 111.525 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 68.7 p -116.21 144.35 44.3 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 9.0 p -57.52 145.11 70.12 Favored Pre-proline 0 C--O 1.238 0.453 0 CA-C-O 120.453 0.168 . . . . 0.0 110.725 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 25.7 Cg_exo -61.67 100.3 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.682 2.255 . . . . 0.0 112.305 -177.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -96.51 177.71 5.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.111 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -83.34 88.24 1.5 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.396 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp 59.85 89.23 0.07 Allowed 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.03 0.532 . . . . 0.0 111.29 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -97.79 -46.79 5.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.831 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 94.44 77.86 1.39 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.142 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -122.2 18.22 10.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.189 0.519 . . . . 0.0 109.761 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' A' ' 193' ' ' ARG . 4.5 mmp_? -88.52 101.42 13.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.013 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 58.8 t30 69.21 99.0 0.06 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.536 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.7 p -111.32 160.99 16.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.922 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -91.62 -174.01 3.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.79 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 22.9 t 72.47 -68.81 0.21 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.248 0.619 . . . . 0.0 110.367 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -87.35 92.77 9.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.162 0.506 . . . . 0.0 110.749 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.73 135.54 6.38 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.553 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 62.6 mt -116.96 109.32 43.02 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.776 0.322 . . . . 0.0 110.339 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.49 124.62 11.81 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.747 2.298 . . . . 0.0 112.316 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 70.31 112.64 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.249 0 O-C-N 123.935 0.772 . . . . 0.0 111.245 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 1.199 ' HG2' ' O1P' ' A' ' 207' ' ' PTR . 37.9 Cg_endo -67.15 120.14 7.2 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.781 2.32 . . . . 0.0 111.998 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.38 173.57 3.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.576 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -70.34 2.53 3.73 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.503 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.52 -65.01 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.27 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 1.199 ' O1P' ' HG2' ' A' ' 203' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.428 ' H ' ' HB3' ' A' ' 207' ' ' PTR . . . -102.05 51.6 0.82 Allowed 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.322 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -65.7 151.25 95.09 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.427 174.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.917 ' HA ' HG21 ' A' ' 170' ' ' VAL . 44.1 Cg_exo -60.76 -9.05 10.6 Favored 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 122.952 2.435 . . . . 0.0 111.848 170.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.76 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 20.7 tp60 -164.52 100.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.67 173.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 88.4 m -53.09 125.5 17.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.187 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 35.5 p -88.61 160.49 17.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.786 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 14.2 m -63.48 118.64 46.15 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.792 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 1.2 Cg_endo -83.74 7.53 5.14 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.103 2.535 . . . . 0.0 112.795 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 216' ' ' LEU . 4.1 mm? -75.86 -50.1 3.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.762 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 216' ' ' LEU . 73.3 Cg_endo -75.67 37.29 0.51 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.16 1.907 . . . . 0.0 112.939 176.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -140.21 158.93 43.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.012 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.08 -22.38 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.399 0.619 . . . . 0.0 110.589 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.8 t -115.89 103.88 11.07 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.807 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -138.07 -178.51 16.18 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.84 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.738 ' HB2' ' HD3' ' A' ' 223' ' ' PRO . 4.6 m -61.76 -54.53 50.51 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.738 ' HD3' ' HB2' ' A' ' 222' ' ' SER . 3.0 Cg_exo -76.67 -32.51 3.55 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.947 1.765 . . . . 0.0 112.122 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 100.6 73.45 1.04 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.48 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -76.61 99.63 5.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.028 0.442 . . . . 0.0 110.993 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -107.21 -40.9 5.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.526 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 9.3 tp -153.93 147.48 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.028 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.2 t -104.04 132.08 21.35 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.791 0.329 . . . . 0.0 110.414 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.35 102.38 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.515 2.144 . . . . 0.0 112.455 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.535 ' H ' ' HD2' ' A' ' 231' ' ' PRO . 57.6 tp -95.83 -45.28 0.26 Allowed Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.889 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.535 ' HD2' ' H ' ' A' ' 230' ' ' LEU . 34.9 Cg_endo -66.1 135.31 40.03 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.509 1.473 . . . . 0.0 112.941 177.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 57.2 m 67.47 18.37 10.06 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.638 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 53.5 p -123.43 143.94 49.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.083 0.468 . . . . 0.0 111.404 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.62 -13.13 37.8 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 170.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 2.3 p30 46.09 -81.3 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.082 1.353 . . . . 0.0 113.478 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -58.43 125.86 40.78 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.122 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.8 155.63 69.14 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.619 2.212 . . . . 0.0 112.313 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.486 ' HB ' HG11 ' A' ' 266' ' ' VAL . 17.8 t -73.07 130.25 35.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.784 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.632 ' HB2' ' HG2' ' A' ' 296' ' ' PRO . 79.4 m-85 -105.44 129.0 53.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.55 137.19 53.99 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.421 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.423 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 44.6 tptt -81.19 118.58 22.69 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -72.84 108.92 6.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 28.1 pt -102.36 12.88 6.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.016 0.436 . . . . 0.0 111.099 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -157.83 149.0 21.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.07 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.623 ' HG2' ' HG3' ' A' ' 259' ' ' GLU . 26.4 mtpp -68.27 101.56 1.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.064 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -89.73 83.52 6.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.04 142.46 28.79 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.313 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.03 154.46 33.14 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.518 2.146 . . . . 0.0 112.023 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.428 ' HB2' ' CB ' ' A' ' 252' ' ' ASP . 1.3 m -108.07 165.14 11.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.625 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.04 -30.22 71.17 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -105.34 15.91 26.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.972 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.428 ' CB ' ' HB2' ' A' ' 249' ' ' CYS . 15.1 t0 -135.83 81.07 1.86 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 175.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -91.96 -15.69 27.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.617 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 47.9 p -85.27 5.78 28.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.306 0.574 . . . . 0.0 109.705 175.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.06 119.71 25.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.513 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 246' ' ' ARG . 1.2 tt -78.4 134.67 37.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -82.54 110.27 17.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.075 0.464 . . . . 0.0 110.961 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 77.5 mt -122.09 172.76 8.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.383 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.623 ' HG3' ' HG2' ' A' ' 245' ' ' LYS . 31.6 tt0 -147.7 149.86 33.24 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 2.4 p -60.35 122.14 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 110.61 8.19 24.96 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.195 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -105.02 149.92 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.4 mm -103.9 109.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.358 0.599 . . . . 0.0 110.453 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 43.7 t -89.38 109.65 20.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.855 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 265' ' ' LYS . 13.2 ptmm? -88.48 99.88 12.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.417 0.627 . . . . 0.0 109.944 174.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.486 HG11 ' HB ' ' A' ' 238' ' ' VAL . 2.4 p -89.2 119.55 36.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.349 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 m -96.84 -18.9 19.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.947 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.551 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 48.3 ttt180 -132.18 122.35 25.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.762 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.417 ' HE2' ' CE3' ' A' ' 275' ' ' TRP . 29.9 mtt -118.53 141.05 48.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.286 0.565 . . . . 0.0 111.551 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -125.25 178.95 5.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.004 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.0 tp -96.61 -5.81 9.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.47 . . . . 0.0 111.329 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -94.14 14.81 18.87 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.94 -0.475 . . . . 0.0 111.99 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 98.59 -61.53 0.85 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.705 -0.759 . . . . 0.0 114.218 169.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 2.2 mp0 -77.15 110.82 12.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.899 0.349 . . . . 0.0 110.724 -176.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.528 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 11.2 m0 -93.34 168.05 11.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.741 -176.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 27.7 tt0 -108.9 108.22 18.91 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.31 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -124.16 154.99 17.9 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.127 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -108.32 108.48 19.5 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.402 ' HB ' ' H ' ' A' ' 280' ' ' ASN . 15.5 t -130.53 -91.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.102 -175.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.402 ' H ' ' HB ' ' A' ' 279' ' ' VAL . 93.1 m-20 -88.27 77.96 8.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.746 -170.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 67.67 -0.74 9.0 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.227 175.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 282' ' ' ARG . 46.4 mtp180 -147.92 153.61 39.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -174.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 55.0 pttt -120.06 134.57 55.21 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -161.26 -170.16 25.53 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.263 -175.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 71.4 mt -94.22 117.5 30.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.351 0.595 . . . . 0.0 110.966 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 43.6 p90 -115.62 138.26 23.72 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.525 176.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 5.7 Cg_exo -77.9 133.43 12.51 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.734 2.289 . . . . 0.0 111.169 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -61.05 -14.21 22.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.816 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.5 p -75.56 -14.33 60.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.799 0.333 . . . . 0.0 111.578 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -98.83 -9.03 24.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.854 0.359 . . . . 0.0 110.675 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.4 m -128.58 179.11 4.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.343 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.438 ' NZ ' ' HB2' ' A' ' 292' ' ' LYS . 2.4 ttmp? -141.11 131.24 24.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.53 174.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 28.5 mm -79.91 124.42 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.523 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.507 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 1.1 p90 -149.49 -174.72 4.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.886 -174.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -96.98 101.08 8.61 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.632 ' HG2' ' HB2' ' A' ' 239' ' ' PHE . 1.8 Cg_endo -82.36 -51.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.705 2.27 . . . . 0.0 112.071 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -102.04 82.76 2.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -72.1 127.44 90.45 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.614 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -89.08 -5.5 5.78 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.872 2.381 . . . . 0.0 109.593 161.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.04 -38.62 70.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 113.864 -1.516 . . . . 0.0 112.293 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.68 13.17 18.58 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.03 0.443 . . . . 0.0 111.115 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -101.48 -31.12 11.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.532 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.441 -178.977 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.767 0.318 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.528 ' O ' HG21 ' A' ' 99' ' ' ILE . 28.6 t -168.77 171.15 8.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -64.44 84.39 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.721 0.638 . . . . 0.0 111.874 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 68.59 38.77 2.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.727 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 5' ' ' ARG . 4.5 ptp180 -79.79 -2.03 41.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.019 0.438 . . . . 0.0 110.764 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -74.76 161.58 29.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.047 0.451 . . . . 0.0 111.017 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -98.65 117.32 32.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.78 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -83.69 1.81 40.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.39 -173.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.4 m -105.11 -31.23 9.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.774 0.321 . . . . 0.0 111.137 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.86 106.09 3.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.077 0.465 . . . . 0.0 110.727 -176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -58.76 -38.24 78.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.141 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.9 m -74.35 -0.94 18.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.693 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.47 -34.86 13.93 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.408 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -130.42 -24.66 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -173.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -79.16 123.56 27.5 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.026 -0.421 . . . . 0.0 110.692 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.481 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.1 mmt -109.06 -4.62 16.48 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.208 -175.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.82 -113.74 2.67 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.67 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.19 106.54 1.39 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.606 2.204 . . . . 0.0 112.635 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.717 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 79.7 t -137.81 -78.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.532 -177.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.79 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 8.1 t 89.79 156.99 0.05 OUTLIER 'General case' 0 C--N 1.349 0.557 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.738 ' CG ' ' O3P' ' A' ' 207' ' ' PTR . 9.3 ptm85 -62.58 -31.73 72.6 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.589 -169.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -55.04 -45.92 75.28 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.389 0.431 . . . . 0.0 111.153 175.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -84.03 -44.64 13.92 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.126 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.46 -34.9 51.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.286 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.538 ' HA ' HG22 ' A' ' 58' ' ' VAL . 7.9 tt0 -67.36 -47.23 71.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -76.85 -11.5 59.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -173.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -98.79 -14.98 19.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.651 0.263 . . . . 0.0 111.134 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 58.8 mt -127.29 23.78 6.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.254 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -84.7 63.48 7.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.264 0.554 . . . . 0.0 112.027 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 117' ' ' ASN . . . 87.54 4.38 80.11 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.865 -0.683 . . . . 0.0 114.164 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.46 -51.23 70.74 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 117.187 0.494 . . . . 0.0 111.478 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.665 ' HB3' ' HE2' ' A' ' 35' ' ' MET . 30.8 ttm180 -142.1 148.15 37.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -92.87 112.36 24.29 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.757 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . 116.99 -7.61 16.84 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.213 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.767 ' HG3' ' HB3' ' A' ' 53' ' ' SER . 6.5 ptp -79.69 134.24 36.4 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.036 177.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' CD1' HD23 ' A' ' 98' ' ' LEU . 47.1 p90 -142.32 167.79 21.26 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.861 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.54 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.2 pp -155.76 137.21 14.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.185 0.517 . . . . 0.0 110.933 175.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.1 t -102.26 124.05 55.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.79 ' HD2' ' H ' ' A' ' 20' ' ' SER . 14.7 ptt-85 -123.52 167.17 14.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.019 -173.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.56 115.95 18.61 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 28.5 t -63.75 122.49 16.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.494 -173.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 p -74.69 -29.69 61.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.331 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.955 HG21 ' O1P' ' A' ' 207' ' ' PTR . 6.4 p -85.63 -18.57 32.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.061 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 41' ' ' SER . 34.4 m -137.25 85.63 21.5 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.98 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.95 107.12 0.42 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.896 2.397 . . . . 0.0 112.518 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.04 -6.84 23.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.206 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -111.04 179.28 4.09 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -126.83 158.92 35.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.921 0.391 . . . . 0.0 111.301 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.632 HG22 HG12 ' A' ' 62' ' ' ILE . 46.1 t -131.21 113.04 22.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.338 174.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.1 tp -85.15 100.45 11.74 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.884 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 59' ' ' SER . 73.5 m -96.12 132.46 41.49 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.731 174.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.652 HG21 HD12 ' A' ' 93' ' ' LEU . 95.1 t -127.76 137.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.912 -172.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.767 ' HB3' ' HG3' ' A' ' 35' ' ' MET . 29.5 t -93.57 97.57 10.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.48 0.657 . . . . 0.0 109.484 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.717 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -135.97 136.26 40.23 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.332 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 55.5 16.98 2.03 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.24 0.337 . . . . 0.0 111.361 -169.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.54 ' HB2' ' OG1' ' A' ' 120' ' ' THR . 20.2 m 69.21 25.78 5.61 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.371 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 1.9 ppt_? -124.93 144.24 50.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.538 HG22 ' HA ' ' A' ' 25' ' ' GLN . 14.6 t -85.51 96.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.27 0.557 . . . . 0.0 110.962 -173.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 51' ' ' SER . 2.4 m -67.7 113.17 5.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.993 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.832 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 96.3 m-70 -101.65 88.41 3.4 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.241 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.595 ' CE2' HD23 ' A' ' 93' ' ' LEU . 40.6 m-85 -102.77 114.71 29.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.49 0.186 . . . . 0.0 111.015 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.632 HG12 HG22 ' A' ' 49' ' ' VAL . 51.7 mt -81.28 126.52 39.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.778 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.4 mp -106.55 119.0 55.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 170.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 72' ' ' LYS . 35.3 p-10 -105.26 151.69 23.81 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.249 -174.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t -86.56 91.96 8.73 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.677 -176.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 97.4 mt -63.82 128.62 93.08 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -48.03 -64.4 0.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.118 2.546 . . . . 0.0 114.629 -172.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -113.92 34.12 4.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.8 -164.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.504 ' HG3' ' HB3' ' A' ' 66' ' ' LEU . 8.7 ptt180 -154.28 -85.02 0.06 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.523 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 4.3 ptm180 -156.36 -171.44 3.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -161.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.541 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 56.9 m-85 -107.41 121.96 45.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.641 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.408 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 17.9 ttmm -109.17 114.0 27.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.735 0.302 . . . . 0.0 110.703 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.778 ' HB ' HG13 ' A' ' 63' ' ' ILE . 8.9 tt -93.43 77.61 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 110.002 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.554 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 61.93 96.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.165 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t70 72.89 -61.46 0.5 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.378 0.271 . . . . 0.0 111.168 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.734 ' HA ' HE21 ' A' ' 76' ' ' GLN . 0.0 OUTLIER -75.62 111.08 10.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -175.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 10.0 pt-20 -94.59 130.05 41.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.198 0.523 . . . . 0.0 110.563 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.521 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 89.4 m-85 -116.36 168.24 10.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.128 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.68 -46.16 86.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.806 0.336 . . . . 0.0 111.399 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -154.54 176.16 12.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.38 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.625 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.5 mt -57.59 -56.41 34.51 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 40.0 Cg_exo -59.68 -8.25 7.08 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.202 1.935 . . . . 0.0 113.504 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.56 -29.4 20.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.786 0.327 . . . . 0.0 110.525 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.7 pp -83.64 -30.4 26.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.2 mt -65.17 -40.98 95.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.501 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -79.68 -4.39 51.55 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.46 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -91.39 -39.32 12.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.343 0.592 . . . . 0.0 109.559 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.515 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 50.9 m-85 -74.28 -10.59 59.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.25 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -57.16 -37.94 72.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.118 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 pp -111.32 7.79 8.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 O-C-N 121.65 -0.657 . . . . 0.0 111.784 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 8.3 t-160 -94.41 -35.71 12.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -177.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.753 ' HA ' HG22 ' A' ' 97' ' ' THR . 79.2 m-85 70.86 99.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 124.066 0.854 . . . . 0.0 109.96 -170.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.694 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 25.2 mt -64.79 -21.24 66.73 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.717 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 1.5 m-20 -145.63 -74.65 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.791 165.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.5 t -144.14 -11.17 0.65 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.527 HG22 ' CD ' ' A' ' 54' ' ' GLU . 5.8 t -124.7 -12.74 7.11 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.752 -0.592 . . . . 0.0 112.034 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.753 HG22 ' HA ' ' A' ' 92' ' ' TYR . 6.6 p 74.18 -169.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.34 1.056 . . . . 0.0 111.599 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.456 HD23 ' CD1' ' A' ' 36' ' ' PHE . 81.0 mt -75.88 106.47 7.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.791 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.757 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 31.2 mm -99.78 -56.4 5.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.105 -172.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.683 ' O ' ' HA ' ' A' ' 35' ' ' MET . 28.3 tt0 -166.62 124.79 1.05 Allowed Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -174.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.03 162.31 11.65 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.551 2.834 . . . . 0.0 113.719 -171.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.29 151.02 94.38 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.054 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.3 141.81 36.23 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.301 2.001 . . . . 0.0 113.402 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.59 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 17.3 mtp180 -89.04 165.2 14.69 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -109.15 95.82 19.22 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.573 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.59 ' HD3' ' O ' ' A' ' 104' ' ' ARG . 69.6 Cg_endo -100.06 26.33 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.707 2.938 . . . . 0.0 111.934 177.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.2 m 63.48 77.5 0.32 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.01 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -85.9 148.81 9.56 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.197 2.598 . . . . 0.0 112.157 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' A' ' 110' ' ' MET . 2.7 Cg_exo -76.51 -80.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.742 2.295 . . . . 0.0 111.565 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' A' ' 109' ' ' PRO . 26.3 mmm -168.53 -170.0 1.15 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.22 0.608 . . . . 0.0 109.426 176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.33 -101.24 2.77 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.564 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.7 m 65.45 -175.96 0.18 Allowed 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 122.835 0.454 . . . . 0.0 110.947 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.5 t -68.4 -72.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.996 0.427 . . . . 0.0 109.913 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 p -171.85 171.27 5.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.471 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -122.42 107.38 34.55 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -59.95 -70.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.541 2.161 . . . . 0.0 111.032 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 58.9 t30 49.46 88.46 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.083 0.865 . . . . 0.0 112.355 172.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -129.27 97.2 26.22 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.689 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.91 134.27 27.26 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.916 2.411 . . . . 0.0 111.981 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 56' ' ' SER . 1.0 OUTLIER -71.05 -32.84 69.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.74 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 64.13 -86.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.969 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -85.88 91.04 8.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.863 0.363 . . . . 0.0 110.377 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -143.78 134.76 25.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.957 0.408 . . . . 0.0 110.595 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.535 ' OD1' ' HG3' ' A' ' 183' ' ' ARG . 15.1 m120 -130.5 26.01 5.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.599 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.696 HD13 HG23 ' A' ' 152' ' ' ILE . 4.6 mm? -77.45 96.89 4.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.545 0.688 . . . . 0.0 111.555 -175.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.622 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 36.6 tt0 -171.25 -56.76 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.261 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.62 ' HB3' HH12 ' A' ' 129' ' ' ARG . 36.3 m-85 -105.2 107.97 19.24 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.33 -175.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.546 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 93.8 t -132.9 147.42 31.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.171 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.62 HH12 ' HB3' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -129.49 145.11 51.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.814 0.34 . . . . 0.0 110.346 176.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.955 HG21 HG12 ' A' ' 178' ' ' VAL . 16.5 p -100.56 139.44 36.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.591 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.499 ' CD1' ' HG3' ' A' ' 179' ' ' GLU . 3.8 mp -119.25 -4.96 10.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.308 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -98.59 -39.76 8.55 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.558 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 74.21 120.81 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.865 0.84 . . . . 0.0 110.747 -175.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.475 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 62.1 t80 -153.78 116.53 2.65 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.91 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 4.0 Cg_endo -87.27 102.53 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.726 2.284 . . . . 0.0 112.347 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -82.37 -9.42 84.97 Favored Glycine 0 CA--C 1.511 -0.208 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.174 176.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.2 m120 51.5 24.52 2.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.229 0.612 . . . . 0.0 112.618 -173.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.52 ' HB2' ' HD3' ' A' ' 169' ' ' ARG . 19.0 t0 73.1 157.89 0.2 Allowed 'General case' 0 C--O 1.232 0.14 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 165.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 70.63 18.46 6.39 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.091 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.9 tp10 -168.23 -50.53 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.466 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 49.6 m-20 -142.39 148.03 37.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.055 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.525 ' HB3' ' CG2' ' A' ' 173' ' ' ILE . 34.1 tp -90.44 125.37 60.0 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.258 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 7.9 Cg_exo -70.16 108.34 2.13 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.284 1.989 . . . . 0.0 111.231 170.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.471 ' CG ' HG22 ' A' ' 130' ' ' THR . 6.6 p90 -126.06 163.52 22.88 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 42.0 mttp -100.18 -175.2 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 110.41 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.757 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -90.88 8.47 34.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.441 179.158 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.8 34.55 0.8 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -93.52 144.42 25.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.745 -0.227 . . . . 0.0 110.62 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.9 mm -98.3 135.6 32.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 165' ' ' ASN . 49.2 mt -128.56 158.5 38.26 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -175.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 43.3 t -119.47 129.25 75.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.696 HG23 HD13 ' A' ' 125' ' ' LEU . 37.5 mm -75.05 87.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.617 HG21 HG22 ' A' ' 170' ' ' VAL . 16.0 tt -74.45 -32.74 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.313 -173.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.694 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 29.2 mt-10 -144.7 140.76 28.81 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.417 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 32.4 tttp -127.67 91.43 45.51 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 121.664 -0.648 . . . . 0.0 111.948 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.559 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 15.6 Cg_exo -72.39 -52.2 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.248 1.966 . . . . 0.0 112.865 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -113.5 -172.85 2.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -170.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -99.1 -42.91 6.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.914 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -93.09 -10.09 37.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.392 . . . . 0.0 111.212 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.646 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 58.0 m95 -128.89 125.78 38.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.905 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.651 ' O ' HG13 ' A' ' 173' ' ' ILE . 54.9 m0 -121.73 144.87 48.54 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.097 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.2 m -95.64 94.82 7.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.3 0.572 . . . . 0.0 110.279 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.484 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -101.29 161.81 13.35 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.172 -0.33 . . . . 0.0 110.549 -177.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.717 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 20.6 ptt-85 -104.98 133.95 48.9 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.612 ' C ' HD21 ' A' ' 165' ' ' ASN . 0.2 OUTLIER -78.31 -176.69 4.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.685 -175.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -49.48 -31.64 10.45 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.204 0.94 . . . . 0.0 111.926 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.649 ' HA ' ' HG3' ' A' ' 215' ' ' PRO . 8.0 m-20 -72.33 -58.93 3.01 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 172.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.553 ' H ' ' ND2' ' A' ' 165' ' ' ASN . . . 139.84 3.28 1.54 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.407 -172.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.717 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -73.66 152.69 40.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.584 0.692 . . . . 0.0 110.866 -177.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.617 HG22 HG21 ' A' ' 153' ' ' ILE . 26.0 t -103.65 121.37 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.133 0.492 . . . . 0.0 111.077 -176.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.64 157.78 27.38 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.646 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.3 OUTLIER -73.8 140.06 45.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.001 0.429 . . . . 0.0 111.165 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -137.95 143.68 40.78 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.153 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.472 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 5.6 Cg_exo -80.87 135.73 10.18 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 123.226 2.617 . . . . 0.0 112.923 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.54 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 99.8 t -58.33 -44.83 99.57 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.6 Cg_endo -64.48 -0.95 3.35 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.036 1.824 . . . . 0.0 113.502 177.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.88 -6.36 21.42 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.746 0.308 . . . . 0.0 111.185 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.955 HG12 HG21 ' A' ' 130' ' ' THR . 17.3 m -128.58 156.07 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -168.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.499 ' HG3' ' CD1' ' A' ' 131' ' ' LEU . 21.8 mt-10 -119.7 125.64 49.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.008 166.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.498 ' HD2' ' HD2' ' A' ' 183' ' ' ARG . 28.2 mttp -72.55 158.17 36.2 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.56 ' HG ' ' CZ ' ' A' ' 129' ' ' ARG . 1.7 mt -65.2 -177.66 0.4 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.532 174.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.3 p -52.63 99.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 121.955 0.883 . . . . 0.0 112.191 -171.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.535 ' HG3' ' OD1' ' A' ' 124' ' ' ASN . 48.3 ttt180 -101.92 112.31 24.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.426 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.409 ' HB3' ' CD2' ' A' ' 190' ' ' HIS . 22.9 t -178.49 168.45 1.81 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.547 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 37.8 p -74.44 165.86 49.96 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.86 94.11 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.992 2.461 . . . . 0.0 113.012 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -108.6 10.18 27.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.752 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 68.34 -122.11 14.53 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.327 -172.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -71.36 101.29 2.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.337 0.589 . . . . 0.0 110.845 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.409 ' CD2' ' HB3' ' A' ' 184' ' ' SER . 18.4 p-80 -146.57 123.17 11.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.309 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 135.72 175.82 14.03 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -175.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -107.25 177.63 4.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.086 0.443 . . . . 0.0 110.857 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -75.67 116.27 16.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.223 0.535 . . . . 0.0 111.393 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -110.9 137.76 48.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.888 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 10.8 t 62.73 28.11 16.39 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.211 0.529 . . . . 0.0 109.975 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 58.41 -90.84 0.03 OUTLIER 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.024 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.8 p -147.8 8.57 0.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.262 0.553 . . . . 0.0 110.449 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -99.13 142.39 30.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.04 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -138.59 85.26 0.23 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.684 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 13.0 tt -105.0 130.93 22.29 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.891 0.376 . . . . 0.0 110.8 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.73 92.35 0.61 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.908 2.405 . . . . 0.0 111.973 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.613 ' H ' ' HD2' ' A' ' 203' ' ' PRO . 5.4 tp10 -113.49 -56.58 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.597 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' A' ' 202' ' ' GLU . 56.4 Cg_endo -70.01 146.05 57.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.908 1.739 . . . . 0.0 112.633 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -78.77 139.29 38.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.246 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -122.78 27.33 7.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.289 0.566 . . . . 0.0 110.582 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.06 92.75 3.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.115 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.955 ' O1P' HG21 ' A' ' 43' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -110.35 18.28 20.01 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.209 -177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.487 ' NE2' HD12 ' A' ' 62' ' ' ILE . 11.0 pt20 -70.46 164.03 57.74 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.768 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.554 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 19.0 Cg_exo -66.82 81.77 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.468 1.446 . . . . 0.0 109.221 165.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -82.88 65.64 8.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.123 -164.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 167' ' ' ASP . 12.7 m -77.09 65.9 2.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.931 0.872 . . . . 0.0 110.919 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 5.6 m -138.92 7.65 2.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.429 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.55 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 9.4 t -107.35 -27.92 0.18 Allowed Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.54 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.649 ' HG3' ' HA ' ' A' ' 167' ' ' ASP . 51.5 Cg_endo -70.08 122.55 9.14 Favored 'Trans proline' 0 C--N 1.362 1.277 0 CA-C-N 121.25 1.482 . . . . 0.0 111.944 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.3 mp -88.82 113.13 54.63 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.25 -25.49 9.92 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.643 2.228 . . . . 0.0 112.905 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 63.69 -86.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.722 0.639 . . . . 0.0 111.113 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.6 160.33 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.5 m -80.75 68.87 7.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.251 0.548 . . . . 0.0 110.572 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.84 -39.36 9.54 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.991 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.8 m -120.9 82.45 35.73 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.491 0.186 . . . . 0.0 111.08 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.77 121.65 8.55 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.672 2.248 . . . . 0.0 111.918 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -152.48 71.05 0.29 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 69.1 -178.59 0.22 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.171 0.588 . . . . 0.0 110.309 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -144.51 114.04 7.12 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.283 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 69.6 mt 68.27 -77.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 124.089 0.868 . . . . 0.0 111.957 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 34.3 p -80.15 155.08 74.92 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.56 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.81 169.55 14.45 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.785 2.323 . . . . 0.0 112.11 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.755 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 59.3 tp -86.28 -55.35 0.38 Allowed Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.294 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 2.7 Cg_exo -76.52 88.03 1.4 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.987 1.792 . . . . 0.0 111.887 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 40.5 t -90.68 121.86 32.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.523 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.1 m -88.18 -13.7 40.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 65.72 91.73 0.08 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.356 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.9 94.12 7.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.419 0.628 . . . . 0.0 110.983 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -179.17 63.81 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -88.91 137.23 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.724 2.282 . . . . 0.0 113.866 -171.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.46 ' HB ' HG12 ' A' ' 266' ' ' VAL . 20.3 t -98.93 145.5 10.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -100.08 112.88 25.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.907 0.384 . . . . 0.0 111.348 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -120.68 122.01 39.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.124 175.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.98 122.3 28.12 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -72.04 112.88 8.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.21 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.515 HG13 ' HG3' ' A' ' 244' ' ' GLN . 33.2 pt -89.28 -9.04 10.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.229 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.558 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 19.4 mt-30 -134.86 149.16 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -79.08 141.96 36.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.429 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 1.023 ' HD2' ' HE1' ' A' ' 290' ' ' HIS . 58.1 ttt85 -135.8 138.82 42.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.347 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 17.7 m -132.7 151.34 77.93 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.433 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.498 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 4.5 Cg_exo -77.96 125.75 7.5 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.958 2.439 . . . . 0.0 111.645 176.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 51.0 t -72.55 175.37 6.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.439 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -63.04 -24.43 67.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.908 0.385 . . . . 0.0 111.452 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -85.37 -6.81 59.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.967 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 30.8 t70 69.91 -72.34 0.11 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.011 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt 61.56 29.32 18.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.234 174.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 285' ' ' LEU . 2.6 m 63.71 19.11 11.56 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.9 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -76.85 115.54 16.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.749 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.579 HD23 ' HB ' ' A' ' 279' ' ' VAL . 1.6 tt -84.67 129.43 34.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.035 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.498 ' HB1' ' HD3' ' A' ' 248' ' ' PRO . . . -72.09 121.83 19.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.863 0.363 . . . . 0.0 110.597 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.442 HD23 HG22 ' A' ' 264' ' ' VAL . 96.0 mt -129.89 145.04 51.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.717 ' HB2' ' HB2' ' A' ' 262' ' ' ASP . 8.7 mm-40 -101.0 161.4 13.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.141 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.26 119.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.3 64.26 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.511 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.717 ' HB2' ' HB2' ' A' ' 259' ' ' GLU . 24.7 t70 -85.81 146.18 26.88 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.673 0.273 . . . . 0.0 110.436 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.411 ' HA ' HD11 ' A' ' 263' ' ' ILE . 50.4 mm -92.69 106.51 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.758 -178.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.442 HG22 HD23 ' A' ' 258' ' ' LEU . 16.3 t -83.97 107.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.501 177.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -87.96 92.43 9.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.45 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.601 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 3.8 p -88.29 134.35 28.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.889 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 58.9 p -103.79 -45.11 4.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -111.47 116.98 31.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.524 ' HE1' HG11 ' A' ' 266' ' ' VAL . 32.9 mtt -106.72 116.65 32.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.915 0.388 . . . . 0.0 111.121 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -82.92 152.13 25.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.25 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 8.6 mm -95.61 29.39 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.559 0.695 . . . . 0.0 110.259 -172.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.454 HD22 ' HG2' ' A' ' 274' ' ' GLN . 30.4 p-10 -113.35 -25.43 8.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.146 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 136.3 -23.6 3.3 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.142 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.454 ' HG2' HD22 ' A' ' 272' ' ' ASN . 14.3 pt20 -107.25 130.24 54.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.038 0.419 . . . . 0.0 110.263 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.446 ' HE3' ' CE2' ' A' ' 286' ' ' PHE . 5.8 m0 -118.75 169.64 9.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.245 -174.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -111.28 110.66 21.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.337 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -116.31 155.88 15.97 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 176.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 283' ' ' LYS . 35.3 tt0 -108.0 109.46 20.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.384 0.592 . . . . 0.0 110.539 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.579 ' HB ' HD23 ' A' ' 256' ' ' LEU . 71.7 t -131.34 129.36 62.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 14.2 m120 65.83 30.4 10.03 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.43 0.456 . . . . 0.0 110.982 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.53 9.29 86.12 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.825 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -118.71 123.02 43.86 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.705 -0.291 . . . . 0.0 110.779 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 83.4 mttt -94.13 111.64 23.39 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -132.81 168.72 22.74 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.817 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.431 ' H ' HG22 ' A' ' 254' ' ' THR . 87.8 mt -86.62 132.2 33.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.245 0.545 . . . . 0.0 110.82 -178.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.711 ' HB2' ' HE2' ' A' ' 290' ' ' HIS . 36.1 p90 -132.5 126.57 20.22 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.595 175.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.21 161.29 23.54 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 123.04 2.493 . . . . 0.0 113.185 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -68.18 -33.73 74.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.183 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.3 p -81.7 17.88 1.37 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 1.023 ' HE1' ' HD2' ' A' ' 246' ' ' ARG . 0.6 OUTLIER -143.45 8.35 1.56 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.071 -0.651 . . . . 0.0 112.097 176.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.32 161.09 37.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -139.9 119.93 13.63 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.752 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.64 117.89 16.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -115.35 143.73 44.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.424 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.76 121.8 83.95 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.8 -14.93 29.37 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.131 2.554 . . . . 0.0 113.234 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -84.14 42.76 0.89 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.49 0.662 . . . . 0.0 110.549 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -126.0 94.62 41.27 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.466 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.19 75.77 4.55 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.991 2.461 . . . . 0.0 111.765 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.5 135.55 48.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.662 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -110.54 -12.56 14.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.856 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -113.29 142.02 46.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.957 -176.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.46 176.895 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.66 0.266 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 m -89.97 -178.14 5.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.648 0.261 . . . . 0.0 111.115 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.508 ' HB2' HD12 ' A' ' 99' ' ' ILE . 5.6 p -82.64 -50.97 8.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.023 0.439 . . . . 0.0 110.133 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -68.66 117.47 10.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.67 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -138.31 89.16 2.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.03 0.443 . . . . 0.0 110.959 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -161.93 163.06 29.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' A' ' 9' ' ' SER . 32.7 m-20 -82.3 -17.87 44.32 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.382 -173.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 70.28 -32.88 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.547 0.739 . . . . 0.0 111.48 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 7' ' ' ASP . 17.6 m -93.06 -23.27 18.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.95 100.74 4.22 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.431 -173.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.63 -26.36 68.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 104' ' ' ARG . 68.5 m -70.81 -4.78 25.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.488 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.22 -47.3 4.77 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 40.0 p-90 -111.54 -20.19 12.27 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -76.41 116.71 17.36 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.971 -0.455 . . . . 0.0 110.894 -173.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.598 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.5 mmt -98.14 -12.08 22.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.396 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.555 ' HA3' HD11 ' A' ' 227' ' ' ILE . . . 50.94 -113.0 1.89 Allowed Glycine 0 CA--C 1.521 0.45 0 O-C-N 123.852 0.72 . . . . 0.0 113.828 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.92 84.33 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.041 2.494 . . . . 0.0 113.281 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.958 HG12 ' H ' ' A' ' 20' ' ' SER . 61.0 t -135.92 -162.16 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.958 ' H ' HG12 ' A' ' 19' ' ' VAL . 87.2 p -170.88 165.12 7.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -168.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.625 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 8.1 ptm85 -68.01 -31.71 71.59 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 118.872 -1.131 . . . . 0.0 110.851 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -59.16 -58.57 8.07 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.092 0.472 . . . . 0.0 110.387 176.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.619 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 35.7 mt-10 -64.95 -46.22 82.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.353 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -56.08 -43.75 78.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.833 -177.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 18.2 mt-30 -69.5 -34.45 74.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.79 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 23' ' ' GLU . 11.5 t -78.65 -7.97 58.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.947 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.619 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 41.6 mtp180 -97.12 -10.54 25.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.048 0.452 . . . . 0.0 109.828 176.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.515 HD22 ' HB2' ' A' ' 53' ' ' SER . 45.7 mt -114.27 -11.64 12.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.414 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.588 HE22 ' HB3' ' A' ' 57' ' ' ARG . 7.0 tp-100 -70.88 125.97 28.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.441 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.93 15.07 71.32 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.197 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.52 HE21 ' HA ' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -101.29 164.6 11.7 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -178.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 32' ' ' ARG . 19.4 ptt85 -61.21 130.87 48.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.212 0.529 . . . . 0.0 110.642 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 53' ' ' SER . 32.2 m170 -67.79 132.59 47.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.953 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.54 -20.29 7.4 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.682 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.734 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.9 mtm -75.01 136.85 41.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -139.16 168.21 20.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.294 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.598 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -156.07 141.3 17.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.921 0.391 . . . . 0.0 110.755 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.429 ' HB ' ' CE3' ' A' ' 14' ' ' TRP . 61.6 t -114.07 124.93 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.554 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 19.2 ptt-85 -125.46 167.91 14.35 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.909 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.87 129.98 38.62 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.411 ' HB3' ' OG1' ' A' ' 43' ' ' THR . 61.8 m -68.78 147.22 52.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.559 0.695 . . . . 0.0 112.5 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.828 ' HB3' ' O1P' ' A' ' 207' ' ' PTR . 37.2 t -76.71 -14.29 59.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.426 175.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.871 ' N ' ' O1P' ' A' ' 207' ' ' PTR . 0.2 OUTLIER -76.3 -62.1 1.73 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.646 176.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.2 m -149.75 141.41 14.92 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.391 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HG3' ' HD3' ' A' ' 223' ' ' PRO . 40.4 Cg_exo -59.35 -23.04 68.4 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.963 2.442 . . . . 0.0 112.258 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.25 37.38 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.647 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -156.86 148.32 22.33 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -129.5 171.65 12.35 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.459 HG21 ' HE2' ' A' ' 207' ' ' PTR . 3.6 t -137.05 112.9 11.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.543 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.6 tp -82.22 92.44 6.91 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.79 171.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.2 m -95.59 120.59 36.11 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.629 HG13 ' HG3' ' A' ' 54' ' ' GLU . 88.2 t -112.76 141.78 27.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.552 -174.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.515 ' HB2' HD22 ' A' ' 28' ' ' LEU . 29.5 t -82.02 100.26 9.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.629 ' HG3' HG13 ' A' ' 52' ' ' VAL . 29.6 mt-10 -155.58 149.99 25.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.457 . . . . 0.0 112.142 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.656 HD22 ' HB3' ' A' ' 155' ' ' LYS . 1.7 m-20 60.13 59.37 2.39 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.416 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t 70.98 -24.52 0.17 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.751 -174.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.775 ' HD3' ' H ' ' A' ' 118' ' ' LEU 0.405 0.0 OUTLIER -160.0 -53.39 0.06 Allowed 'General case' 0 C--N 1.363 1.156 1 N-CA-C 124.47 4.989 . . . . 0.0 124.47 -178.551 . . . . . . . . 5 4 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.705 ' H ' ' CD ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -154.24 116.84 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 121.671 2.032 . . . . 0.0 113.3 -171.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.561 ' OG ' ' HB2' ' A' ' 54' ' ' GLU . 6.0 m -97.8 110.54 23.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 164.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.65 ' O ' ' HB1' ' A' ' 208' ' ' ALA . 91.3 m-70 -94.01 110.13 21.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.537 ' CE2' HD23 ' A' ' 93' ' ' LEU . 69.1 m-85 -120.1 102.5 8.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.019 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.96 HG13 ' HB2' ' A' ' 209' ' ' GLN . 0.1 OUTLIER -77.82 148.67 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.534 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.8 mp -129.67 86.47 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.07 131.94 47.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.881 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.8 t -77.45 125.26 29.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.265 0.555 . . . . 0.0 110.799 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 1.097 HD13 ' HB2' ' A' ' 69' ' ' ARG . 94.1 mt -76.0 147.57 80.56 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.12 169.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.469 ' HD2' ' NH2' ' A' ' 69' ' ' ARG . 35.8 Cg_exo -64.25 61.99 0.25 Allowed 'Trans proline' 0 C--O 1.218 -0.479 0 C-N-CA 122.762 2.308 . . . . 0.0 110.458 165.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 1.015 HD21 ' N ' ' A' ' 69' ' ' ARG 0.268 0.2 OUTLIER 103.66 -50.88 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 128.67 2.788 . . . . 0.0 109.467 -179.688 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 1.097 ' HB2' HD13 ' A' ' 66' ' ' LEU . 73.1 mtm180 -34.45 -53.94 0.52 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 125.093 1.496 . . . . 0.0 112.137 -149.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.809 ' HD2' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -169.85 -167.11 0.62 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.184 1.794 . . . . 0.0 106.572 167.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.15 114.18 26.31 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.378 166.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -102.51 104.78 15.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 111.339 -171.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.534 ' HB ' HG13 ' A' ' 63' ' ' ILE . 6.5 tt -92.49 77.53 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.773 0.797 . . . . 0.0 109.463 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.479 ' HA3' ' HG2' ' A' ' 209' ' ' GLN . . . 66.98 89.1 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.947 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.729 ' HB2' ' HB2' ' A' ' 211' ' ' GLN . 44.4 t0 75.48 -52.03 0.65 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.705 0.402 . . . . 0.0 110.877 173.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -83.16 114.84 21.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.643 0.258 . . . . 0.0 110.472 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -93.38 133.03 37.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.386 0.612 . . . . 0.0 110.613 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.752 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 64.1 m-85 -121.0 158.23 28.22 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.809 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 4.3 m-20 -44.15 -41.23 5.54 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.405 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 3.4 p80 -170.46 -173.13 1.37 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.549 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 11.6 mt -57.83 -55.23 47.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 123.047 0.217 . . . . 0.0 111.339 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 32.1 Cg_exo -63.56 5.68 0.32 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.774 2.316 . . . . 0.0 114.005 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.54 -32.19 7.8 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.26 -0.275 . . . . 0.0 110.952 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.537 HD21 HD23 ' A' ' 81' ' ' LEU . 4.4 pp -76.15 -30.14 58.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.211 0.529 . . . . 0.0 109.739 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.437 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 53.5 mt -63.02 -32.41 73.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.943 176.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.612 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 24.3 tp10 -72.07 -26.8 62.31 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.544 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -73.3 -29.3 62.61 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.053 0.93 . . . . 0.0 108.932 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.773 ' CD1' HD21 ' A' ' 93' ' ' LEU . 42.0 m-85 -92.39 2.67 56.52 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.338 -175.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.612 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 52.0 mtpt -85.65 -15.52 42.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.639 172.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.2 pt -122.74 -1.85 7.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 121.309 0.576 . . . . 0.0 110.091 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.493 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.4 t-160 -86.88 -43.78 12.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.841 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.448 ' CD2' HG23 ' A' ' 97' ' ' THR . 66.1 m-85 63.74 94.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -162.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.773 HD21 ' CD1' ' A' ' 88' ' ' TYR . 16.5 mt -51.53 -97.21 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 123.712 0.633 . . . . 0.0 110.564 176.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.59 ' OD2' ' HB2' ' A' ' 55' ' ' ASN . 3.2 t0 -68.04 -65.26 0.72 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.512 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 9.8 t -157.31 13.06 0.23 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.915 0.864 . . . . 0.0 110.228 175.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.457 HG21 ' OE1' ' A' ' 54' ' ' GLU . 6.5 t -140.65 171.72 13.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 169.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.448 HG23 ' CD2' ' A' ' 92' ' ' TYR . 17.8 p -98.02 171.55 8.19 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.042 -0.411 . . . . 0.0 110.619 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.4 94.26 0.72 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.1 mm -76.17 -53.78 14.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.802 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.734 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.9 pt-20 -167.92 154.57 7.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.632 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 42.3 Cg_endo -66.88 154.56 74.16 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.297 1.998 . . . . 0.0 112.737 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.404 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -72.61 161.05 81.15 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.323 175.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.404 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 9.6 Cg_endo -51.64 126.43 19.63 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.154 1.902 . . . . 0.0 110.971 176.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.517 ' HG2' ' H ' ' A' ' 105' ' ' TYR . 40.7 ttt180 -63.75 175.97 1.01 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.295 -176.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.517 ' H ' ' HG2' ' A' ' 104' ' ' ARG . 4.9 t80 -52.25 -44.52 93.37 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -174.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.6 90.07 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.697 1.598 . . . . 0.0 112.511 173.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.4 t -173.54 132.92 0.6 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.556 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.15 134.49 16.01 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.554 2.169 . . . . 0.0 112.248 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.14 127.02 10.26 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.548 2.165 . . . . 0.0 112.18 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 88.5 mtp -84.91 -45.76 11.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.262 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.98 109.03 0.76 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.2 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.8 t -137.74 152.66 49.44 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.8 142.72 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.992 0.425 . . . . 0.0 110.305 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.3 t -92.96 86.29 5.39 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.79 108.4 61.42 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.455 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.444 ' HA ' ' NE2' ' A' ' 25' ' ' GLN . 5.1 Cg_endo -84.7 97.55 0.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.104 2.536 . . . . 0.0 112.229 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.878 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . 63.5 t30 69.2 110.99 0.05 OUTLIER 'General case' 0 C--N 1.342 0.281 0 O-C-N 123.752 0.657 . . . . 0.0 111.048 177.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.775 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 3.2 mm? 72.73 160.36 0.16 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.922 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 18.2 Cg_endo -60.67 130.54 33.72 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.555 2.17 . . . . 0.0 112.528 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.2 m 73.9 -62.5 0.46 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.321 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.34 175.52 9.95 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.878 ' HG2' ' HB3' ' A' ' 117' ' ' ASN . 26.6 mt-10 -68.17 96.25 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.123 0.487 . . . . 0.0 110.301 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -104.57 -60.74 1.55 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.75 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.653 ' CB ' ' HG3' ' A' ' 183' ' ' ARG . 8.5 p30 -149.2 178.93 8.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.344 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.559 HD11 ' HD2' ' A' ' 155' ' ' LYS . 3.6 mm? 61.03 84.94 0.12 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.523 0.678 . . . . 0.0 110.281 -174.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.0 tp10 -177.57 -68.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.648 -172.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -112.92 106.96 15.36 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.332 0.587 . . . . 0.0 110.293 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.782 HG21 ' CG ' ' A' ' 180' ' ' LYS . 99.4 t -120.49 133.88 65.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.287 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.705 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 7.4 ptp180 -110.35 144.42 39.13 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.855 -1.938 . . . . 0.0 108.724 170.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.402 ' HG1' ' HB2' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -101.28 132.15 46.95 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.514 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.538 HD21 ' HG2' ' A' ' 179' ' ' GLU . 14.9 mt -107.4 -15.13 14.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.973 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -82.06 -40.97 21.23 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -173.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.619 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 11.3 t70 71.52 96.43 0.07 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.459 0.647 . . . . 0.0 110.603 -175.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -127.81 88.25 53.77 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 91.3 Cg_endo -84.85 79.02 2.51 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.075 1.85 . . . . 0.0 113.158 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.29 -23.94 77.51 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.381 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.855 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 67.38 50.8 0.92 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.452 0.701 . . . . 0.0 111.639 177.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -144.5 178.96 7.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.387 . . . . 0.0 110.969 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.503 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -99.96 -9.41 22.78 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 171.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 172' ' ' MET . 4.8 mm-40 -80.87 -38.25 28.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.432 174.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 172' ' ' MET . 24.1 m-20 -133.88 108.67 8.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.945 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.737 ' CD2' HD22 ' A' ' 150' ' ' LEU . 35.4 tp -63.95 129.78 94.1 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.855 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 10.2 Cg_endo -81.21 87.53 1.47 Allowed 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 121.627 1.551 . . . . 0.0 111.088 175.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.536 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 10.2 p90 -100.63 159.83 14.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.527 -173.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.619 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 40.5 mttp -104.22 -172.44 2.11 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -174.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.896 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -85.23 8.55 17.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.334 -172.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.95 41.19 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.405 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -105.1 148.25 27.04 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.706 -177.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.64 132.84 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.331 0.586 . . . . 0.0 109.817 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.737 HD22 ' CD2' ' A' ' 142' ' ' LEU . 24.4 mt -125.85 162.31 25.43 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -176.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.578 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 99.0 t -125.44 122.08 61.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 175.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.501 HG21 ' CD1' ' A' ' 125' ' ' LEU . 34.0 mm -77.01 78.68 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.465 HD13 ' CE1' ' A' ' 61' ' ' TYR . 10.5 tt -78.34 -39.26 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.727 -176.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.651 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 63.1 mt-10 -116.54 140.27 49.57 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 171.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.656 ' HB3' HD22 ' A' ' 55' ' ' ASN . 78.4 tttt -136.71 86.93 21.18 Favored Pre-proline 0 C--N 1.316 -0.863 0 O-C-N 121.49 -0.756 . . . . 0.0 110.149 175.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.681 ' HG2' ' SD ' ' A' ' 172' ' ' MET . 4.3 Cg_exo -67.32 -55.53 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.614 2.209 . . . . 0.0 111.592 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 160' ' ' TRP . 17.4 mm-40 -107.17 167.94 9.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.814 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.6 mm-40 -94.47 -16.35 23.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.153 0.502 . . . . 0.0 109.714 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.441 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 2.0 pt20 -94.21 -21.23 19.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.547 173.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.542 ' CB ' ' HE1' ' A' ' 172' ' ' MET . 52.4 m95 -131.22 127.71 38.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.555 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.768 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.2 m0 -117.88 136.85 53.19 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.357 -176.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.674 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 74.5 m -100.46 90.38 4.28 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 150' ' ' LEU . . . -102.44 149.4 24.41 Favored 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.48 -171.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.836 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 23.5 ptt-85 -86.75 119.35 26.89 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.718 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 6.0 t30 -46.59 166.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 112.374 -2.194 . . . . 0.0 111.213 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -68.57 10.71 0.23 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.64 0.733 . . . . 0.0 110.505 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 165' ' ' ASN . 18.5 m-20 -114.38 -6.68 12.91 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.798 172.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.648 ' HA3' ' HA ' ' A' ' 211' ' ' GLN . . . 79.37 67.87 1.54 Allowed Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.257 -172.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.836 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 8.7 ttm-85 -139.48 126.31 20.81 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.481 HG12 ' CD ' ' A' ' 154' ' ' GLU . 12.1 t -86.65 116.27 28.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.073 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -144.09 149.16 21.18 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.681 ' SD ' ' HG2' ' A' ' 156' ' ' PRO . 7.4 mtp -74.93 134.89 41.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.223 0.511 . . . . 0.0 110.583 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.768 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.5 pp -137.11 142.74 39.23 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.341 -176.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.59 ' HG2' ' CG ' ' A' ' 177' ' ' TYR . 9.7 Cg_endo -62.85 130.4 29.23 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.989 2.459 . . . . 0.0 113.152 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.563 ' O ' HG21 ' A' ' 178' ' ' VAL . 99.2 t -64.67 -44.91 75.35 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.167 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.504 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 48.6 Cg_exo -58.25 1.44 0.25 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.429 2.086 . . . . 0.0 114.104 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.59 ' CG ' ' HG2' ' A' ' 174' ' ' PRO . 3.2 m-85 -104.77 -10.53 17.36 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.34 0.256 . . . . 0.0 111.589 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.63 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.4 m -106.39 -171.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -165.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.705 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.1 tp10 -159.34 47.51 0.3 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.327 -1.761 . . . . 0.0 111.497 -154.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.782 ' CG ' HG21 ' A' ' 128' ' ' VAL . 1.9 mptt -72.35 138.21 47.13 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 119.297 -2.127 . . . . 0.0 110.469 -162.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.426 HD23 ' NH2' ' A' ' 129' ' ' ARG . 24.1 tp -78.3 -71.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.956 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.18 109.44 17.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.509 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.653 ' HG3' ' CB ' ' A' ' 124' ' ' ASN . 35.1 ttt180 -168.27 119.63 0.81 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.9 -177.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.1 m -98.17 68.66 1.96 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.462 0.649 . . . . 0.0 109.844 173.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.427 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 3.1 p -70.78 170.39 11.19 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.38 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 86.7 Cg_exo -49.28 101.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.805 2.337 . . . . 0.0 113.189 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -129.68 -37.77 1.54 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.044 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 190' ' ' HIS . . . 156.54 52.65 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.029 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm 69.47 -14.32 0.34 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.04 0.936 . . . . 0.0 112.421 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.447 ' H ' ' C ' ' A' ' 188' ' ' GLY . 37.5 t-80 70.36 -48.0 0.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.494 0.717 . . . . 0.0 110.898 -175.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 176.22 -131.46 1.88 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -155.27 -167.06 2.43 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -66.35 101.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 0.0 110.655 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -121.66 -37.74 2.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.149 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.0 m -138.08 111.46 8.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.119 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -100.38 -2.48 33.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.552 0.691 . . . . 0.0 109.3 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.5 p -137.54 110.2 7.55 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.271 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 62.91 84.06 0.15 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.72 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -90.94 -33.21 8.4 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.799 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.704 ' HB ' ' HD2' ' A' ' 203' ' ' PRO . 13.9 pt -116.23 91.79 33.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.236 0.541 . . . . 0.0 111.149 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.35 -14.61 11.73 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.949 2.433 . . . . 0.0 112.473 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.787 ' HB3' ' HD3' ' A' ' 203' ' ' PRO . 25.8 tp10 -83.34 -57.51 0.43 Allowed Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.342 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 202' ' ' GLU . 1.1 Cg_endo -83.69 101.46 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.356 2.038 . . . . 0.0 111.836 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.54 125.45 26.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.416 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -110.22 108.32 18.41 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.071 0.462 . . . . 0.0 110.659 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -103.97 -130.43 0.27 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.62 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.871 ' O1P' ' N ' ' A' ' 43' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 60' ' ' HIS . . . -92.42 -75.46 0.49 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.96 ' HB2' HG13 ' A' ' 62' ' ' ILE . 36.7 tt0 67.77 137.64 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.335 0 O-C-N 124.216 0.948 . . . . 0.0 109.547 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.15 -35.26 72.42 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 121.813 1.676 . . . . 0.0 111.547 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.729 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 30.2 tt0 -97.26 148.23 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 171.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.463 ' H ' ' HA3' ' A' ' 168' ' ' GLY . 15.2 t -74.98 142.03 43.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 0.0 110.931 -175.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 18.5 m -64.19 140.69 58.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.648 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.3 p -68.5 148.69 98.14 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.89 -34.4 91.56 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.804 2.336 . . . . 0.0 111.71 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.759 HD22 ' H ' ' A' ' 216' ' ' LEU . 1.6 pt? -87.57 117.15 68.16 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.681 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -93.15 -159.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.237 2.625 . . . . 0.0 112.592 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -139.39 150.39 45.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.227 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.85 161.24 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.72 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.1 m -86.1 160.71 19.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.079 0.466 . . . . 0.0 111.562 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 167.2 78.53 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.617 ' OG ' ' HA ' ' A' ' 42' ' ' SER . 1.4 m -105.09 119.23 53.85 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.415 ' HD3' ' HG3' ' A' ' 45' ' ' PRO . 5.5 Cg_exo -79.69 159.67 24.98 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.068 2.512 . . . . 0.0 111.222 174.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -158.82 -173.3 27.05 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.766 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 65.1 14.24 9.24 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.073 0.549 . . . . 0.0 112.068 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.16 11.17 37.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.889 0.376 . . . . 0.0 111.056 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.555 HD11 ' HA3' ' A' ' 17' ' ' GLY . 61.6 mt -131.26 128.81 62.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.612 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.1 t -83.35 145.42 48.44 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.135 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.07 -76.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.482 2.121 . . . . 0.0 112.844 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 231' ' ' PRO . 2.4 pt? -176.92 170.12 1.08 Allowed Pre-proline 0 C--O 1.235 0.327 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -177.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.406 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 50.3 Cg_exo -55.95 150.82 44.58 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.453 2.102 . . . . 0.0 111.944 172.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 20.3 p -71.93 105.55 3.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.28 0.562 . . . . 0.0 111.591 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 13.7 p -115.67 136.29 53.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.134 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -102.55 -52.04 3.19 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.903 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 66.7 -177.97 0.2 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.784 0.677 . . . . 0.0 111.84 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 82.35 173.3 48.84 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.622 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.92 163.94 23.57 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.898 2.399 . . . . 0.0 111.592 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.45 HG12 ' HE1' ' A' ' 269' ' ' MET . 7.6 t -97.62 136.08 29.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.052 0.453 . . . . 0.0 110.691 -175.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.68 125.98 52.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.172 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.418 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -124.57 139.07 54.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.708 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.96 130.72 46.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.107 176.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -75.41 104.56 6.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.896 0.379 . . . . 0.0 110.18 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 21.0 pt -75.24 -13.0 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.415 HE21 ' HB2' ' A' ' 244' ' ' GLN . 0.7 OUTLIER -146.94 157.82 43.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.308 178.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -73.27 158.71 34.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.429 0.633 . . . . 0.0 111.082 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.677 ' HD3' HD11 ' A' ' 258' ' ' LEU . 58.9 mtp85 -132.21 115.66 15.97 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.84 175.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.452 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 29.5 m -111.71 126.48 28.45 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 172.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 3.0 Cg_exo -80.06 144.08 16.54 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.983 2.455 . . . . 0.0 112.268 -176.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 35.6 t -77.63 171.34 15.07 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.76 87.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.497 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -90.09 6.27 43.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.764 0.316 . . . . 0.0 111.524 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -116.92 64.09 0.72 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.955 0.407 . . . . 0.0 110.234 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -78.44 -13.66 59.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.07 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.0 p -95.39 -1.69 50.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.336 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.0 116.83 23.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.48 133.64 49.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.938 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -95.77 135.48 37.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.675 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.677 HD11 ' HD3' ' A' ' 246' ' ' ARG . 96.7 mt -134.75 151.91 51.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 0.0 111.851 -169.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -97.67 172.98 7.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.392 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.69 122.53 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.893 0.378 . . . . 0.0 110.669 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.48 22.22 62.83 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.373 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -89.63 169.12 11.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.6 mm -106.58 116.0 49.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.325 0.584 . . . . 0.0 110.635 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.502 ' HA ' HG21 ' A' ' 279' ' ' VAL . 21.9 t -102.4 109.86 27.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.268 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.479 ' HB2' ' HE3' ' A' ' 265' ' ' LYS . 33.3 mtmt -87.2 99.73 12.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.013 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.418 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 5.8 p -90.15 116.48 31.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.593 0.711 . . . . 0.0 109.833 175.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 19.6 p -93.43 -36.31 12.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.321 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.539 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 56.5 ttt180 -121.56 96.9 5.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.832 175.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.527 ' HE3' ' CH2' ' A' ' 275' ' ' TRP . 45.7 ttm -81.81 111.54 18.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.059 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 91.6 m-20 -86.74 144.95 26.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.996 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 16.3 tt -79.46 -12.95 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.109 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -75.81 -25.47 56.36 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.725 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.19 -40.05 1.89 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.608 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 34.6 mt-30 -75.7 108.85 8.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.527 ' CH2' ' HE3' ' A' ' 269' ' ' MET . 52.8 m0 -93.39 145.43 24.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.857 0.361 . . . . 0.0 111.315 -176.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 9.0 tp10 -91.99 107.35 19.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.183 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -140.03 157.11 25.29 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.534 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -124.13 123.99 41.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.232 0.539 . . . . 0.0 110.043 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.51 HG22 HD21 ' A' ' 258' ' ' LEU . 28.7 t -124.81 160.96 29.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.078 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -54.82 85.64 0.0 OUTLIER 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.559 0.695 . . . . 0.0 110.889 174.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 156.3 -39.69 0.58 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.375 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 179.69 152.89 0.45 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.1 0.476 . . . . 0.0 111.233 -176.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -101.25 127.64 47.75 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.5 -169.41 35.84 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.68 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 97.4 mt -93.87 145.8 24.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.706 0.288 . . . . 0.0 110.376 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -141.73 127.48 10.91 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 121.083 0.468 . . . . 0.0 111.092 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.499 ' HD2' ' CZ ' ' A' ' 246' ' ' ARG . 72.4 Cg_exo -55.39 126.37 22.29 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 123.269 2.646 . . . . 0.0 112.449 169.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -64.75 -14.76 60.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.454 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 13.8 p -71.8 -2.43 17.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -113.79 0.19 14.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.175 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.28 168.99 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.011 0.434 . . . . 0.0 111.164 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -129.33 129.38 44.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.37 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.423 HD13 HG11 ' A' ' 238' ' ' VAL . 32.9 mm -81.16 126.25 39.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.259 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 296' ' ' PRO . 3.1 p90 -152.23 157.05 40.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.947 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -104.96 99.2 17.99 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 121.431 0.634 . . . . 0.0 110.008 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.406 ' HB3' ' CE2' ' A' ' 294' ' ' PHE . 44.0 Cg_endo -69.33 -25.21 30.83 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.815 2.343 . . . . 0.0 112.805 -175.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 165.47 -34.56 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -171.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 57.68 89.24 0.11 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.694 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.62 5.75 4.98 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.968 2.445 . . . . 0.0 111.098 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -96.35 129.07 43.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.306 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 67.84 0.25 2.25 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.763 0.664 . . . . 0.0 111.037 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -140.0 155.22 47.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.448 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.606 178.801 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 3' ' ' SER . 22.5 t -123.24 13.88 9.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.297 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.445 ' O ' HG23 ' A' ' 99' ' ' ILE . 28.9 t 68.0 -71.34 0.11 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.119 0.568 . . . . 0.0 110.095 -173.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 98' ' ' LEU . . . -133.78 120.61 20.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.04 0.448 . . . . 0.0 110.598 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -148.93 -53.02 0.17 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.686 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 p90 37.46 -162.35 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.632 1.208 . . . . 0.0 113.09 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.99 -44.91 19.37 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.046 -0.409 . . . . 0.0 110.861 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 t 72.5 -53.7 0.69 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.971 0.795 . . . . 0.0 111.87 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 m -84.47 -25.38 28.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.109 0.481 . . . . 0.0 110.946 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -86.74 116.91 25.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.063 0.459 . . . . 0.0 111.119 -171.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -63.54 -31.74 72.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.521 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.8 t -69.28 -8.28 44.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.23 -47.69 7.09 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.913 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -117.78 -23.38 7.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -170.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -73.65 116.01 13.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.624 ' HB3' HG23 ' A' ' 19' ' ' VAL . 12.4 tpp -100.71 -1.66 34.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.347 -172.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.429 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.96 -115.9 3.95 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.252 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.1 Cg_exo -72.4 103.28 1.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.9 2.4 . . . . 0.0 112.036 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.829 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 64.4 t -136.17 -83.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -176.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.817 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 11.7 t 83.6 176.47 0.06 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 168.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 7.8 tpt180 -42.16 -62.68 0.88 Allowed 'General case' 0 C--N 1.314 -0.944 0 O-C-N 124.112 0.883 . . . . 0.0 112.276 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -62.12 -28.53 69.7 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.05 -168.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -95.75 -45.55 6.95 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.561 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -55.54 32.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.504 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 12.3 pt20 -68.69 -31.26 70.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.829 -174.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.2 m -65.48 -42.95 91.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.42 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -71.22 -28.83 64.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.962 0.411 . . . . 0.0 111.239 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 1.055 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 17.4 mt -107.24 25.88 10.87 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.233 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -75.56 76.22 2.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.54 0.686 . . . . 0.0 109.9 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.41 -64.47 3.98 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.258 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 11.99 -108.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.208 1.403 . . . . 0.0 113.796 -172.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 18.7 ttp180 -111.06 143.88 41.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 53' ' ' SER . 36.5 m170 -94.6 140.99 29.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.73 23.21 12.26 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -173.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.562 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 41.7 mtm -115.58 143.34 45.47 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.758 0.313 . . . . 0.0 110.373 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.525 ' CG ' HD23 ' A' ' 98' ' ' LEU . 29.6 p90 -144.79 161.13 40.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.472 -176.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.1 pp -150.92 133.99 15.99 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.051 0.453 . . . . 0.0 110.415 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.51 113.78 38.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.829 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 12.1 ptt180 -114.29 168.83 9.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.08 128.21 33.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.495 ' HB2' HG21 ' A' ' 49' ' ' VAL . 21.3 t -85.0 163.1 19.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.27 0.557 . . . . 0.0 111.573 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.42 ' OG ' ' O1P' ' A' ' 207' ' ' PTR . 3.8 p -105.84 13.57 29.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.659 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.7 p -78.34 -52.71 8.2 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.128 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.445 ' HG ' ' HB2' ' A' ' 47' ' ' ASP . 24.3 p -165.22 139.31 3.97 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.563 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.57 113.41 1.36 Allowed 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.918 2.412 . . . . 0.0 112.437 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.26 -20.34 8.46 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.528 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.488 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 32.4 t70 -86.37 152.14 22.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -131.04 162.06 30.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.705 0.288 . . . . 0.0 110.991 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.59 HG12 ' HE2' ' A' ' 207' ' ' PTR . 56.6 t -137.67 112.02 9.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.017 0.436 . . . . 0.0 111.227 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 36' ' ' PHE . 30.9 tp -85.85 100.67 12.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.189 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 59' ' ' SER . 61.2 m -96.72 134.23 40.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.053 0.454 . . . . 0.0 110.44 175.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.741 HG21 HD12 ' A' ' 93' ' ' LEU . 96.4 t -123.59 149.5 27.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.102 -174.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 1.055 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 33.5 t -123.0 98.21 5.79 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 0.9 OUTLIER -133.9 139.93 46.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.025 172.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 55.39 29.32 12.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.695 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.4 m 64.94 31.46 11.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.702 0.763 . . . . 0.0 111.1 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -124.18 120.71 33.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.668 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 19.2 t -88.31 93.98 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.199 0.523 . . . . 0.0 110.215 -178.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 38.6 m -74.39 118.24 17.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.787 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 82.6 m-70 -102.16 94.38 5.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.467 -175.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 59' ' ' SER . 27.6 m-85 -101.97 115.27 30.18 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.566 0.222 . . . . 0.0 111.355 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 69.0 mt -80.55 133.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.706 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.4 mp -108.23 120.97 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.488 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 5.4 t-20 -107.29 133.17 52.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -165.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.7 t -77.64 97.32 5.07 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.06 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' A' ' 69' ' ' ARG . 91.5 mt -66.82 151.55 96.66 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.91 73.57 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.298 1.999 . . . . 0.0 112.339 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 85.71 1.39 0.67 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.985 165.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HB2' HD13 ' A' ' 66' ' ' LEU . 4.4 mmp_? -80.65 -85.17 0.09 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.737 177.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.52 ' HD2' ' HG3' ' A' ' 77' ' ' GLU . 8.4 ptp85 -158.41 -168.32 2.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.169 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.418 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 47.8 m-85 -104.3 115.51 30.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.151 0.501 . . . . 0.0 110.56 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -103.65 107.95 19.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.769 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.706 ' HB ' HG13 ' A' ' 63' ' ' ILE . 5.8 tt -96.69 88.68 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.603 0.716 . . . . 0.0 110.627 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.646 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 60.99 79.28 0.13 Allowed Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.346 177.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 211' ' ' GLN . 32.2 t70 73.36 -44.37 0.58 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.93 0.492 . . . . 0.0 112.016 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -66.39 148.49 51.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.059 0.457 . . . . 0.0 111.234 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.52 ' HG3' ' HD2' ' A' ' 70' ' ' ARG . 3.4 tp10 -110.42 116.81 32.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.166 -171.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 93.0 m-85 -131.73 141.99 49.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -76.46 -16.95 59.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.902 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 15.6 p80 -167.63 167.97 13.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.94 -0.118 . . . . 0.0 110.738 173.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.521 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 9.8 mt -52.46 -57.78 14.28 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 23.5 Cg_exo -67.53 13.66 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.35 2.033 . . . . 0.0 113.838 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -36.95 8.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.144 0.497 . . . . 0.0 109.981 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.5 pp -76.74 -27.84 55.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.657 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.73 -30.15 70.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.106 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.478 ' CD ' ' HZ3' ' A' ' 89' ' ' LYS . 29.8 mm-40 -83.1 -31.26 27.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.564 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -69.07 -39.52 79.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.939 0.4 . . . . 0.0 110.705 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.476 ' CG ' HD21 ' A' ' 93' ' ' LEU . 43.9 m-85 -77.7 -15.37 59.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.205 0.526 . . . . 0.0 110.598 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.478 ' HZ3' ' CD ' ' A' ' 86' ' ' GLU . 40.0 ttmt -66.81 -21.58 66.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.932 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.1 pt -116.42 18.43 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.937 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -111.24 -37.54 5.28 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.598 ' CD1' HG22 ' A' ' 97' ' ' THR . 54.7 m-85 71.11 102.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.786 0.679 . . . . 0.0 110.183 -173.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.741 HD12 HG21 ' A' ' 52' ' ' VAL . 2.9 mt -78.67 -19.32 52.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 110.728 -177.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.647 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 23.2 t70 -167.55 75.38 0.14 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.723 170.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 68.18 -22.69 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.133 0.973 . . . . 0.0 112.018 -176.545 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.568 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 18.9 m -117.39 154.29 31.59 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.598 HG22 ' CD1' ' A' ' 92' ' ' TYR . 14.1 p -95.21 -178.73 4.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.173 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.525 HD23 ' CG ' ' A' ' 36' ' ' PHE . 97.7 mt -69.98 88.54 0.58 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.452 HG21 ' HG3' ' A' ' 100' ' ' GLU . 33.2 mm -74.07 -65.04 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.237 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 35' ' ' MET . 46.1 mt-10 -144.32 153.79 56.33 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.202 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.3 151.87 80.09 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.18 1.92 . . . . 0.0 111.358 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -69.36 147.79 97.14 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.362 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 38.9 Cg_exo -61.32 116.92 3.71 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.628 2.219 . . . . 0.0 112.154 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.2 ttm180 -66.71 -33.05 74.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.107 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.475 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 28.8 p90 -109.97 125.92 30.11 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.213 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 13.2 Cg_exo -70.8 99.39 0.85 Allowed 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.825 2.35 . . . . 0.0 112.263 178.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 t -93.45 153.77 41.35 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.445 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.54 159.63 4.46 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.828 2.352 . . . . 0.0 112.441 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.07 68.27 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.529 2.82 . . . . 0.0 113.583 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 60.5 mtm -114.74 118.82 34.67 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.51 -51.5 3.98 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.246 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 56.5 m -78.43 5.87 9.72 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.692 -0.299 . . . . 0.0 111.567 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.4 p -84.81 -10.83 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.262 0.553 . . . . 0.0 109.834 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.9 m -66.59 129.77 40.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.814 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.56 111.4 53.83 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.994 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -88.7 -151.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.183 2.589 . . . . 0.0 112.094 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -57.38 106.8 0.36 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.576 ' H ' ' HD2' ' A' ' 119' ' ' PRO . 0.9 OUTLIER -122.68 -52.98 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.496 -176.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.576 ' HD2' ' H ' ' A' ' 118' ' ' LEU . 67.9 Cg_exo -40.51 106.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 123.328 2.686 . . . . 0.0 114.315 -175.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.3 m -140.09 118.25 11.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.675 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.03 -164.23 1.15 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.639 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -83.92 81.55 8.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.937 0.399 . . . . 0.0 112.034 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.421 ' C ' ' HE ' ' A' ' 183' ' ' ARG . 0.0 OUTLIER -102.52 153.53 19.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 167.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -61.89 -76.13 0.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -170.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.591 HD11 HG23 ' A' ' 152' ' ' ILE . 3.2 mm? 62.32 -175.37 0.14 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.742 0.651 . . . . 0.0 111.98 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 7.3 tp10 62.45 -87.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.59 176.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -103.22 106.93 17.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.3 1.048 . . . . 0.0 112.253 -175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.586 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 55.9 t -119.6 162.25 18.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.779 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.568 HH11 ' HG2' ' A' ' 129' ' ' ARG . 0.8 OUTLIER -149.82 126.18 10.8 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.072 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.896 HG21 HG11 ' A' ' 178' ' ' VAL . 3.0 p -87.42 140.45 29.52 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -169.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 90.7 mt -110.63 -29.69 7.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.022 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -78.64 -30.48 46.42 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -170.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.527 ' HB2' ' HD3' ' A' ' 146' ' ' LYS . 14.1 t70 68.82 103.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.246 0.546 . . . . 0.0 110.185 -174.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 66.9 t80 -140.6 96.88 7.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.826 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 10.3 Cg_endo -92.29 100.79 0.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.048 2.499 . . . . 0.0 113.18 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 137' ' ' ASN . . . -96.41 2.59 63.07 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.855 174.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.527 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 73.81 -7.91 1.5 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.815 0.846 . . . . 0.0 111.552 -178.105 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.886 ' HB2' ' HD3' ' A' ' 143' ' ' PRO . 32.5 t0 62.85 162.88 0.1 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.403 ' H ' ' CG ' ' A' ' 138' ' ' ASP . . . 158.87 -34.44 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 111.625 -2.534 . . . . 0.0 104.382 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.33 31.24 0.06 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.629 -2.078 . . . . 0.0 107.694 166.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 172' ' ' MET . 9.4 p-10 -163.1 85.59 0.52 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.79 -175.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.711 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 33.7 tp -64.96 132.85 95.6 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.931 -168.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.886 ' HD3' ' HB2' ' A' ' 138' ' ' ASP . 68.1 Cg_endo -80.6 86.71 1.6 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.487 2.791 . . . . 0.0 111.906 175.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.523 ' CG ' HG22 ' A' ' 130' ' ' THR . 10.0 p90 -97.3 156.78 16.29 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.786 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.704 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 2.8 mptp? -105.89 -171.0 1.82 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.001 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.527 ' HD3' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -88.42 9.03 24.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.542 -177.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.99 27.12 0.63 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.312 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.704 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 5.9 mm-40 -98.5 150.78 21.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.83 0.315 . . . . 0.0 110.231 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.71 134.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.562 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 52.7 mt -119.68 155.8 31.7 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 42.5 t -122.0 126.48 74.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.591 HG23 HD11 ' A' ' 125' ' ' LEU . 32.9 mm -74.99 81.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.663 HG21 ' HG2' ' A' ' 154' ' ' GLU . 8.2 tt -69.01 -34.11 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.607 -173.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.663 ' HG2' HG21 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -131.49 139.66 49.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.532 ' HD2' HD12 ' A' ' 125' ' ' LEU . 74.3 tttt -119.7 86.0 34.34 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.021 0.438 . . . . 0.0 110.453 172.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.421 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 3.1 Cg_exo -77.26 -54.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.674 2.25 . . . . 0.0 111.682 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -109.17 -178.53 3.59 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -109.98 -22.58 11.77 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.115 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.574 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 24.3 pt20 -88.6 -21.72 23.88 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.101 0.476 . . . . 0.0 110.251 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.574 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 48.7 m95 -129.09 123.57 32.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.785 178.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.647 ' O ' HG13 ' A' ' 173' ' ' ILE . 38.2 m0 -112.53 133.58 54.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.319 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 54.0 m -86.26 99.71 11.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.26 0.553 . . . . 0.0 110.311 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.456 ' CB ' HD13 ' A' ' 152' ' ' ILE . . . -109.29 158.62 17.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.989 ' HD2' ' HA ' ' A' ' 210' ' ' PRO . 16.0 ptt-85 -104.61 135.42 46.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.039 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.711 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 55.5 t30 -73.87 -173.96 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.998 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -68.89 -13.88 62.7 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 170.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -81.99 -13.76 56.96 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.071 170.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.6 1.54 90.19 Favored Glycine 0 C--O 1.229 -0.182 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.502 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.723 ' HG2' ' OD2' ' A' ' 138' ' ' ASP . 38.5 ttm-85 -66.0 132.58 48.91 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.371 0.668 . . . . 0.0 110.069 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.444 HG21 HD12 ' A' ' 153' ' ' ILE . 59.5 t -104.62 106.4 20.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -173.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.613 ' HA3' ' OD1' ' A' ' 138' ' ' ASP . . . -140.98 168.34 25.35 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.266 175.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.53 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 26.0 mtp -81.35 136.85 35.76 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.647 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -132.68 149.96 74.46 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.15 132.3 13.8 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.106 2.537 . . . . 0.0 112.577 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.673 ' O ' HG22 ' A' ' 178' ' ' VAL . 41.0 t -61.12 -45.59 95.97 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 30.8 Cg_endo -64.47 -1.09 3.49 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.027 1.818 . . . . 0.0 113.774 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.02 -4.48 29.87 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.744 0.307 . . . . 0.0 111.287 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.896 HG11 HG21 ' A' ' 130' ' ' THR . 6.1 m -120.57 163.46 18.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -167.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 160.73 21.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.521 172.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -118.52 159.36 23.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.679 0.276 . . . . 0.0 110.582 -173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.52 ' HG ' HG23 ' A' ' 182' ' ' VAL . 32.1 tp -75.18 -83.27 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.661 175.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.52 HG23 ' HG ' ' A' ' 181' ' ' LEU . 42.9 t -139.56 -82.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.645 0.259 . . . . 0.0 110.951 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.421 ' HE ' ' C ' ' A' ' 123' ' ' ASP . 2.9 tmm_? 70.07 -30.49 0.2 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.951 0.9 . . . . 0.0 111.841 -177.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 182' ' ' VAL . 16.2 t -61.53 128.71 37.6 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.611 ' HB3' ' HD2' ' A' ' 186' ' ' PRO . 11.2 m -152.84 177.51 1.91 Allowed Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 185' ' ' SER . 86.5 Cg_exo -47.49 -39.92 29.18 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.862 2.375 . . . . 0.0 113.036 172.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.408 ' CD2' ' HB2' ' A' ' 185' ' ' SER . 9.5 p80 -57.6 136.56 56.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.7 -3.17 80.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.407 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt 56.44 73.52 0.44 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.001 0.521 . . . . 0.0 111.491 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -98.3 -46.99 5.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.367 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.19 -169.9 38.46 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.26 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 59.96 70.84 0.61 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.072 0.549 . . . . 0.0 110.978 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -115.18 97.85 6.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -117.0 -63.09 1.49 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 10.6 t -166.73 99.92 0.57 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.168 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -131.12 115.81 16.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.079 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.8 m -100.31 -23.32 14.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.826 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -148.97 141.1 23.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.398 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.22 110.35 2.26 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.462 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 34.5 pt -74.81 131.16 79.83 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.031 0.443 . . . . 0.0 111.51 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 7.2 Cg_exo -73.42 139.45 28.77 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.109 2.54 . . . . 0.0 111.749 176.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.609 ' HB3' ' HD3' ' A' ' 203' ' ' PRO . 6.2 tp10 -65.72 -51.63 48.02 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.663 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.609 ' HD3' ' HB3' ' A' ' 202' ' ' GLU . 7.0 Cg_exo -74.82 30.04 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.5 2.134 . . . . 0.0 112.861 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 202' ' ' GLU . . . -99.54 -34.03 10.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.031 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -87.22 -31.27 20.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.695 0.283 . . . . 0.0 111.377 -176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -116.17 159.83 21.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.509 . . . . 0.0 111.572 -173.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.59 ' HE2' HG12 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -113.89 33.42 5.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.433 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -64.35 133.33 95.62 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.989 ' HA ' ' HD2' ' A' ' 164' ' ' ARG . 94.9 Cg_exo -45.8 -51.71 7.9 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.162 2.575 . . . . 0.0 113.168 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -114.11 172.92 6.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.966 0.412 . . . . 0.0 111.017 179.47 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 8.9 t -128.12 155.14 44.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.401 176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 27.9 m -69.39 117.6 11.22 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 41.3 m 68.97 94.01 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.755 -174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.38 23.46 0.79 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 123.581 2.854 . . . . 0.0 112.588 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.646 ' HB3' ' HD3' ' A' ' 217' ' ' PRO . 64.2 tp -78.4 -53.22 1.33 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.014 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 216' ' ' LEU . 11.3 Cg_exo -72.36 16.5 0.38 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 122.717 2.278 . . . . 0.0 113.573 -176.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -89.09 90.35 8.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.861 0.363 . . . . 0.0 110.113 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.3 m -128.22 160.45 38.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.702 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.8 m -151.38 -158.39 0.9 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.93 -20.38 59.95 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.522 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.6 t 60.06 74.1 0.59 Allowed Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 123.049 0.54 . . . . 0.0 111.697 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.76 126.16 12.37 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.389 2.059 . . . . 0.0 111.495 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 159.83 -151.33 22.03 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -79.97 90.35 5.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.09 0.472 . . . . 0.0 110.65 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -98.85 2.56 46.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.903 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 67.4 mt 72.11 -62.18 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 O-C-N 123.661 0.601 . . . . 0.0 111.062 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.411 ' CG2' ' HD2' ' A' ' 229' ' ' PRO . 5.8 m -118.51 147.02 41.06 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.135 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.411 ' HD2' ' CG2' ' A' ' 228' ' ' THR . 25.6 Cg_endo -64.27 67.55 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.33 2.02 . . . . 0.0 112.136 172.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.687 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 57.3 tp -84.18 -50.15 0.63 Allowed Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.026 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 19.3 Cg_exo -66.92 89.63 0.3 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.909 1.739 . . . . 0.0 110.948 174.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 9.2 p -80.47 -75.42 0.27 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.234 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 43.0 p -132.65 132.28 42.26 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.81 0.338 . . . . 0.0 110.969 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -82.57 -43.54 16.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.931 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 63.7 -166.46 0.23 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.355 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.404 ' HA2' ' HD2' ' A' ' 237' ' ' PRO . . . -102.74 111.92 4.13 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 172.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.404 ' HD2' ' HA2' ' A' ' 236' ' ' GLY . 9.4 Cg_endo -52.16 120.79 7.8 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.247 2.631 . . . . 0.0 112.702 -176.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.522 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 35.3 t -78.51 133.38 30.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.597 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.86 115.26 27.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.165 0.507 . . . . 0.0 111.162 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 293' ' ' ILE . . . -119.89 129.69 54.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.058 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -89.06 119.3 29.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.039 0.447 . . . . 0.0 110.498 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.979 ' HB2' ' HA ' ' A' ' 259' ' ' GLU . . . -78.42 119.56 21.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.675 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.428 HD11 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -109.5 -26.61 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -170.028 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.662 ' HG2' ' HG2' ' A' ' 245' ' ' LYS . 13.9 tt0 -93.92 -98.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.278 0.49 . . . . 0.0 111.339 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.662 ' HG2' ' HG2' ' A' ' 244' ' ' GLN . 24.4 pttm -175.45 107.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -177.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.584 ' H ' ' HB2' ' A' ' 259' ' ' GLU . 15.3 tpt180 -110.55 101.81 10.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.882 0.372 . . . . 0.0 111.491 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.9 m -124.0 117.75 27.05 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.879 173.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.802 ' HB3' ' HB2' ' A' ' 255' ' ' ALA . 30.0 Cg_endo -63.11 134.67 46.97 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.03 2.487 . . . . 0.0 113.212 -175.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 48.5 t -102.52 175.67 5.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.489 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.12 -26.43 62.64 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -70.93 -45.2 64.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.576 ' HB2' ' HB3' ' A' ' 255' ' ' ALA . 0.9 OUTLIER -109.28 81.85 1.5 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.691 -174.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -83.06 -18.99 37.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.412 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.6 p -92.23 13.83 18.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.812 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.802 ' HB2' ' HB3' ' A' ' 248' ' ' PRO . . . -88.46 127.94 35.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.038 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -81.01 120.8 25.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.899 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.35 117.24 5.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.113 0.482 . . . . 0.0 110.45 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 86.5 mt -143.46 -169.67 3.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.714 0.768 . . . . 0.0 111.333 -172.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.979 ' HA ' ' HB2' ' A' ' 242' ' ' ALA . 26.4 mt-10 79.62 -179.36 0.09 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 113.683 -1.599 . . . . 0.0 114.265 164.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 t 67.12 32.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.91 -172.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.05 38.89 2.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.126 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.72 137.6 44.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.298 . . . . 0.0 110.94 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.2 mm -89.64 106.95 17.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.143 0.497 . . . . 0.0 109.93 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 40.0 t -88.47 118.29 33.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.699 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -90.06 97.44 11.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.516 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.522 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 7.5 p -91.66 129.19 42.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 110.5 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.1 p -106.11 -38.17 6.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.536 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.585 ' NE ' ' HA ' ' A' ' 268' ' ' ARG . 2.2 mmp_? -124.46 114.09 19.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 111.084 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 50.1 mtt -95.41 113.88 25.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.196 0.522 . . . . 0.0 110.312 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -85.21 164.25 18.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.431 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.4 pt -88.72 7.37 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.185 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -88.25 -4.72 58.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.533 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 94.64 -47.02 2.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.554 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 43.3 mt-30 -81.05 124.93 29.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.247 0.546 . . . . 0.0 110.207 173.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -94.18 158.49 15.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.349 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.433 ' HG3' ' HB2' ' A' ' 268' ' ' ARG . 9.4 pt-20 -115.27 125.34 53.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.59 0.709 . . . . 0.0 110.486 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -134.1 170.6 22.48 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.925 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.3 108.49 11.76 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.449 HG13 ' ND2' ' A' ' 280' ' ' ASN . 26.9 t -126.41 138.38 54.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.122 -175.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.449 ' ND2' HG13 ' A' ' 279' ' ' VAL . 52.8 m-80 71.82 -55.37 0.66 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.829 0.851 . . . . 0.0 110.669 -177.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 164.75 30.69 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -141.86 147.65 37.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -105.24 126.91 52.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.35 167.65 32.98 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.731 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 87.1 mt -95.38 142.04 28.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.687 0.279 . . . . 0.0 110.722 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 53.8 p90 -138.3 136.87 19.7 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.973 176.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 12.1 Cg_exo -71.9 141.7 37.5 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.737 2.292 . . . . 0.0 111.941 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -61.67 -15.82 43.39 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.284 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.2 t -86.22 -3.33 58.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 111.563 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -104.44 -11.15 17.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.774 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 240' ' ' ALA . 26.9 m -128.04 158.44 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.956 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -121.09 120.15 34.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.607 178.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 240' ' ' ALA . 47.3 mm -76.91 111.86 14.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.587 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -121.11 163.88 17.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.491 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.33 121.7 75.28 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.19 -13.07 36.99 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.708 2.272 . . . . 0.0 113.245 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.546 ' C ' ' HD3' ' A' ' 299' ' ' PRO . 30.4 mm-40 -84.39 93.92 8.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.275 0.56 . . . . 0.0 110.647 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.597 ' N ' ' HD3' ' A' ' 299' ' ' PRO . 1.3 t-20 -125.49 49.42 3.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.915 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.597 ' HD3' ' N ' ' A' ' 298' ' ' ASN . 76.9 Cg_endo -99.66 40.55 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.235 2.624 . . . . 0.0 110.974 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -64.08 -26.82 68.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.233 -173.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -81.42 81.54 7.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.589 0.709 . . . . 0.0 110.017 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -166.81 130.75 1.96 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.066 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.684 -179.577 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.52 0.2 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 p -92.65 129.64 38.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -67.55 -37.33 82.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.914 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . . . -74.83 104.48 5.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.419 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.468 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 22.5 mmt180 -105.9 6.81 31.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.528 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.757 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 51.9 p90 -79.35 148.59 31.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 175.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -88.79 101.75 14.33 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.567 0.699 . . . . 0.0 110.635 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.58 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 50.6 m -63.82 169.9 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.567 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 8' ' ' SER . 43.0 t 76.73 -50.84 0.57 Allowed 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.593 0.558 . . . . 0.0 111.397 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.79 101.45 1.71 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.467 0.651 . . . . 0.0 110.342 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 75.6 mtt-85 -72.45 -17.28 61.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.568 -171.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -76.36 0.52 19.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.799 0.333 . . . . 0.0 110.836 173.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.58 -46.45 5.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.4 p-90 -115.39 -20.94 10.07 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -171.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 84.1 t80 -86.4 128.94 35.0 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.023 -0.423 . . . . 0.0 110.61 -176.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.528 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 20.1 mmt -109.43 -9.3 14.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 110.909 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.48 -116.6 4.87 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.629 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.86 105.44 0.55 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.558 2.172 . . . . 0.0 112.508 -175.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.674 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 79.2 t -139.02 -77.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.606 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.841 ' OG ' ' O3P' ' A' ' 207' ' ' PTR . 17.2 t 86.2 170.34 0.06 Allowed 'General case' 0 C--N 1.347 0.469 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -59.63 -39.4 84.19 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.512 -171.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.36 -38.62 91.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.559 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.575 ' HB3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -85.72 -47.31 9.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.175 0.512 . . . . 0.0 110.775 -177.331 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.92 -40.56 76.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.656 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 52.0 tp60 -70.27 -39.61 74.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.0 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -78.87 -15.13 58.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.641 0.258 . . . . 0.0 111.43 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 90.8 mtt180 -83.57 -50.8 7.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.674 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.492 HD22 ' HB2' ' A' ' 53' ' ' SER . 39.9 mt -94.22 13.36 23.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.052 -173.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 36.6 tt0 -71.08 87.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.103 0.478 . . . . 0.0 110.615 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.33 36.43 8.16 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.334 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' CG ' ' HA ' ' A' ' 28' ' ' LEU . 71.4 mm-40 -91.4 170.66 9.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 111.59 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.614 ' HB3' ' HE1' ' A' ' 35' ' ' MET . 38.4 ttm180 -52.81 139.14 27.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.722 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.466 ' HB3' HG23 ' A' ' 96' ' ' THR . 39.1 m170 -70.03 116.41 10.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.949 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.45 -11.99 7.52 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.256 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.614 ' HE1' ' HB3' ' A' ' 32' ' ' ARG . 57.6 mtt -74.17 149.18 41.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.853 0.327 . . . . 0.0 110.562 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.567 ' HB2' HG22 ' A' ' 52' ' ' VAL . 23.2 p90 -157.16 166.48 33.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.319 177.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -158.04 138.91 13.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.73 175.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.96 125.96 57.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.7 ' HD2' ' H ' ' A' ' 20' ' ' SER . 12.8 ptt-85 -123.12 162.16 23.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.77 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 24.5 t70 -81.29 127.58 32.88 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 172.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.657 ' HB2' HG21 ' A' ' 49' ' ' VAL . 18.8 t -101.34 154.27 18.94 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.188 0.518 . . . . 0.0 110.779 -174.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 p -91.69 -5.36 53.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.807 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -44.77 94.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.595 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.758 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 69.4 m -152.05 150.67 26.31 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.806 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.36 109.13 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.525 2.15 . . . . 0.0 111.658 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.96 0.26 55.02 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.455 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.758 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 13.4 t70 -85.92 151.38 23.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.799 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 35.0 m-85 -132.6 171.59 13.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.635 0.255 . . . . 0.0 110.964 -176.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.657 HG21 ' HB2' ' A' ' 41' ' ' SER . 78.1 t -145.24 112.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.107 0.48 . . . . 0.0 110.515 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.55 ' HB2' HD13 ' A' ' 63' ' ' ILE . 42.6 tp -83.42 102.26 11.93 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.044 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' SER . 69.5 m -96.95 125.77 41.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.078 0.466 . . . . 0.0 110.391 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.585 HG23 HD12 ' A' ' 93' ' ' LEU . 70.2 t -125.25 138.59 53.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.675 -172.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.492 ' HB2' HD22 ' A' ' 28' ' ' LEU . 33.3 t -102.89 98.51 8.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.207 0.527 . . . . 0.0 110.947 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 35.5 mt-10 -138.32 148.48 44.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.526 ' HB2' ' CG ' ' A' ' 94' ' ' ASP . 1.8 t-20 63.94 11.16 5.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.666 0.387 . . . . 0.0 111.111 -176.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.2 m 70.2 26.41 4.4 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.523 0.678 . . . . 0.0 110.367 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.834 ' NH2' ' HA ' ' A' ' 154' ' ' GLU . 43.8 ptt85 -124.34 151.58 44.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.9 t -93.37 97.49 7.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.037 0.446 . . . . 0.0 110.102 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 51' ' ' SER . 19.3 m -73.18 118.13 15.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.317 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.625 ' HB2' ' HB1' ' A' ' 208' ' ' ALA . 92.0 m-70 -101.19 115.02 29.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.406 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.663 ' CE2' HD23 ' A' ' 93' ' ' LEU . 52.5 m-85 -121.93 108.01 12.93 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.407 HG12 HG22 ' A' ' 49' ' ' VAL . 58.8 mt -70.21 132.0 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.799 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.2 mp -104.72 123.86 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.352 1.061 . . . . 0.0 109.848 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -106.59 142.59 36.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -78.72 108.95 12.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.153 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 96.3 mt -85.82 170.91 11.63 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 26.2 Cg_exo -63.76 62.34 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.972 2.448 . . . . 0.0 114.263 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 13.2 m120 93.13 -43.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.986 0.914 . . . . 0.0 112.718 161.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.563 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.53 -29.4 33.56 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -169.413 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 1.017 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 81.6 mtt180 -148.07 177.65 9.2 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -169.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -129.7 120.69 25.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.522 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -98.31 112.59 24.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.463 ' O ' HG21 ' A' ' 73' ' ' ILE . 19.6 tt -77.48 78.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 122.158 0.98 . . . . 0.0 109.723 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.692 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 79.95 -55.8 4.54 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.085 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.418 ' CB ' ' HB2' ' A' ' 210' ' ' PRO . 31.8 t70 -146.8 -48.02 0.19 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.91 0.385 . . . . 0.0 110.581 -170.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -77.22 129.15 35.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.008 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.459 ' HG2' ' HD3' ' A' ' 70' ' ' ARG . 38.1 tt0 -99.45 130.15 45.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.026 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -128.53 160.79 31.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 1.017 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 36.5 m-20 -64.78 -45.47 86.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -153.27 177.12 11.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.504 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.637 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.2 mt -57.79 -57.87 22.5 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.58 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 30.5 Cg_exo -63.88 -6.71 11.51 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.012 1.808 . . . . 0.0 112.82 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.12 -31.73 17.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.645 0.26 . . . . 0.0 110.797 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.61 -30.32 56.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 82' ' ' PRO . 48.8 mt -68.04 -28.79 67.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.03 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.16 -23.94 63.07 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.049 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -86.67 -38.64 16.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.318 0.58 . . . . 0.0 110.435 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.55 ' CG ' HD21 ' A' ' 93' ' ' LEU . 45.1 m-85 -75.95 -7.75 55.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.878 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.467 ' HB3' ' HE2' ' A' ' 89' ' ' LYS . 30.7 ttpt -63.96 -33.1 74.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.573 173.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mt -110.32 -17.74 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.994 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 19.6 t-160 -69.79 -35.95 75.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.512 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.795 ' HA ' HG22 ' A' ' 97' ' ' THR . 97.2 m-85 71.61 101.61 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 124.083 0.865 . . . . 0.0 109.752 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.663 HD23 ' CE2' ' A' ' 61' ' ' TYR . 13.0 mt -70.83 -13.96 62.23 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.311 0.577 . . . . 0.0 109.649 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.699 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 21.5 t70 -152.56 -64.01 0.16 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.873 169.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 11.9 t -165.9 3.43 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 33' ' ' HIS . 13.0 t -133.38 -13.57 2.66 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.567 -0.708 . . . . 0.0 112.162 176.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.795 HG22 ' HA ' ' A' ' 92' ' ' TYR . 16.7 p 71.13 -179.49 0.23 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.379 1.072 . . . . 0.0 112.131 178.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.8 mt -71.34 109.26 5.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.267 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.424 HD13 ' O ' ' A' ' 96' ' ' THR . 49.3 mm -101.19 -52.39 8.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.059 -177.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.757 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 17.1 pt-20 -154.84 164.16 21.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.619 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 98.4 Cg_endo -82.81 151.13 14.48 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.919 1.746 . . . . 0.0 112.119 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.15 153.16 86.35 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.91 175.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.63 120.36 7.72 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.5 2.133 . . . . 0.0 111.349 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.27 4.75 33.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 110.989 -175.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -78.08 150.17 77.39 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.629 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.47 -13.81 36.01 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.202 1.934 . . . . 0.0 111.714 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.7 m -144.14 135.08 12.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.692 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.57 147.42 94.58 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.641 2.228 . . . . 0.0 111.742 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.41 -69.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.691 2.261 . . . . 0.0 111.712 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 87.0 mtp -120.93 -51.08 2.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.166 0.508 . . . . 0.0 109.706 173.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.59 150.81 19.86 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.017 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.9 m -104.21 -7.36 20.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.067 0.461 . . . . 0.0 110.306 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -60.93 115.37 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.658 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.6 m -103.13 -173.94 2.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.29 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.488 ' HB1' ' HD3' ' A' ' 116' ' ' PRO . . . -75.78 -54.79 2.12 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.883 177.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD3' ' HB1' ' A' ' 115' ' ' ALA . 74.1 Cg_endo -75.54 -169.1 0.61 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.841 1.694 . . . . 0.0 111.753 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.7 t30 67.66 80.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.675 0.75 . . . . 0.0 111.567 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 48.6 tp -142.7 103.0 5.36 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.23 125.54 13.73 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.307 2.671 . . . . 0.0 112.894 -175.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.0 m -66.33 -43.42 86.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.15 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -166.17 143.81 5.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.622 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.95 97.98 0.26 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.373 0.42 . . . . 0.0 110.203 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.773 ' HB2' HD23 ' A' ' 125' ' ' LEU . 9.2 p-10 -90.56 137.66 32.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.536 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.486 ' HB2' ' HG3' ' A' ' 183' ' ' ARG . 20.4 m120 -91.98 50.21 1.64 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.362 0.601 . . . . 0.0 110.269 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.928 ' HG ' ' HD3' ' A' ' 155' ' ' LYS . 4.3 mm? -79.29 107.97 12.46 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.506 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 30.1 tt0 -165.65 -66.72 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.52 ' HB3' HD11 ' A' ' 181' ' ' LEU . 58.1 m-85 -110.94 118.04 35.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.616 0.722 . . . . 0.0 112.006 -177.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.483 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 55.5 t -130.92 159.57 42.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.701 -175.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -131.6 145.29 51.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.94 HG22 HG12 ' A' ' 178' ' ' VAL . 12.3 p -102.51 136.4 42.4 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.724 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' A' ' 179' ' ' GLU . 5.3 mt -107.68 -27.67 10.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.901 -174.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.47 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 44.6 t80 -86.4 -37.27 18.55 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -170.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.511 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 14.4 t70 70.8 108.04 0.06 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.529 0.681 . . . . 0.0 109.844 -170.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 70.3 t80 -147.06 113.19 4.17 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.401 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.74 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 30.2 Cg_endo -92.16 100.41 0.19 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.711 2.274 . . . . 0.0 112.422 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -85.31 14.4 50.47 Favored Glycine 0 CA--C 1.516 0.095 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.174 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.2 m120 50.23 24.16 1.39 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.116 0.566 . . . . 0.0 112.447 -172.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.53 ' HB3' ' HD3' ' A' ' 143' ' ' PRO . 2.3 p30 46.86 -170.07 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.909 1.284 . . . . 0.0 114.157 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 75.76 -26.72 0.19 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.856 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.5 pt-20 -142.1 -30.56 0.57 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.07 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.445 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 5.6 m-20 -141.36 117.65 10.73 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.62 ' CD1' ' HD2' ' A' ' 169' ' ' ARG . 36.3 tp -67.81 136.25 92.38 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-O 120.718 0.294 . . . . 0.0 111.487 -173.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.74 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 1.0 OUTLIER -84.94 102.46 0.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.835 2.357 . . . . 0.0 110.661 172.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.677 ' CG ' HG23 ' A' ' 130' ' ' THR . 6.6 p90 -111.76 158.91 18.79 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.186 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.511 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -99.23 -179.43 4.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.756 -172.463 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -4.71 39.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -171.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.93 42.71 0.2 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.643 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -98.83 165.74 11.63 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.9 mm -99.9 138.38 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 165' ' ' ASN . 29.4 mt -120.26 155.62 32.86 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 25.9 t -118.81 125.15 74.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.897 HG21 HD12 ' A' ' 125' ' ' LEU . 41.7 mm -75.13 95.84 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.265 1.031 . . . . 0.0 108.62 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.837 HG23 ' HG3' ' A' ' 154' ' ' GLU . 19.8 tt -89.71 -27.21 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.003 -171.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.908 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 27.0 mt-10 -142.75 144.47 32.65 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.928 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 7.1 ttpm? -135.62 81.01 42.83 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 121.424 -0.798 . . . . 0.0 111.26 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.597 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 19.9 Cg_exo -68.23 -46.07 2.4 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.787 2.325 . . . . 0.0 112.298 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -117.99 -175.22 2.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.541 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.56 -28.53 9.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.041 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.503 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 4.2 pt20 -93.84 -13.2 27.53 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.197 0.522 . . . . 0.0 110.515 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.746 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 51.6 m95 -129.28 127.81 41.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.733 175.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.673 ' O ' HG13 ' A' ' 173' ' ' ILE . 48.9 m0 -118.16 140.62 49.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.43 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.908 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 7.6 t -96.15 99.38 11.12 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.433 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -114.05 156.33 24.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.869 0.366 . . . . 0.0 111.464 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.463 ' HD3' HD13 ' A' ' 153' ' ' ILE . 26.7 ptt-85 -100.41 131.56 46.26 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.574 ' HA ' HD22 ' A' ' 150' ' ' LEU . 0.1 OUTLIER -79.58 171.38 15.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.871 -179.017 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -72.37 -12.21 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.161 0.505 . . . . 0.0 110.314 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -80.13 -19.34 47.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.931 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.735 ' HA2' ' HB2' ' A' ' 211' ' ' GLN . . . 117.14 7.2 12.83 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 116.696 1.438 . . . . 0.0 116.696 169.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.62 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -123.52 155.79 36.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.511 1.655 . . . . 0.0 111.903 -177.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.92 143.8 11.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.106 -175.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -166.23 161.43 35.07 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.746 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.2 OUTLIER -74.23 137.95 43.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.845 0.355 . . . . 0.0 110.968 179.263 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.673 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -135.24 143.73 46.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.371 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.01 134.04 14.21 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.7 2.267 . . . . 0.0 112.096 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.553 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 17.8 t -62.85 -43.45 82.84 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.078 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 34.5 Cg_endo -65.9 7.44 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 122.283 1.989 . . . . 0.0 113.651 175.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.09 -6.56 15.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.697 0.284 . . . . 0.0 111.097 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.94 HG12 HG22 ' A' ' 130' ' ' THR . 26.3 m -127.62 166.46 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -168.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.623 ' HB2' HD22 ' A' ' 131' ' ' LEU . 4.1 mm-40 -125.41 163.75 21.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.577 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -111.21 144.13 40.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 127' ' ' TYR . 4.3 mp -62.81 -75.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 110.439 172.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.1 m -138.78 129.92 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.716 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.486 ' HG3' ' HB2' ' A' ' 124' ' ' ASN . 18.1 ttt-85 -124.03 84.45 2.28 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.0 m -153.16 157.26 40.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.564 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.48 143.88 34.79 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.64 102.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.839 2.36 . . . . 0.0 112.503 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -126.34 -24.96 3.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.147 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.23 -66.02 3.91 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.565 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -86.48 61.84 7.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.241 0.543 . . . . 0.0 110.975 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -86.6 -9.88 55.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.506 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 94.38 25.0 17.21 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.045 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -133.53 163.82 28.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.89 154.04 37.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -71.63 -24.96 61.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -173.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.9 p 54.76 -87.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.917 0.887 . . . . 0.0 111.756 -175.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -68.13 115.82 8.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.606 0.717 . . . . 0.0 109.089 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 6.1 m -97.77 165.21 12.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.27 -172.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -84.95 92.79 8.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -144.79 87.78 0.17 Allowed Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 13.8 pt -117.3 148.78 43.33 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.485 0.183 . . . . 0.0 110.606 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.34 -41.1 52.72 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.054 2.503 . . . . 0.0 112.635 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 8.9 pt-20 -132.63 132.19 22.55 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 6.7 Cg_exo -72.77 81.17 1.64 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.109 2.54 . . . . 0.0 113.369 -173.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -81.21 -12.41 59.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.14 0.495 . . . . 0.0 110.05 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 39.1 m80 69.98 -88.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.662 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 178.24 -62.82 0.01 OUTLIER 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.793 0.683 . . . . 0.0 110.175 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.841 ' O3P' ' OG ' ' A' ' 20' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.625 ' HB1' ' HB2' ' A' ' 60' ' ' HIS . . . -139.53 131.15 27.24 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.4 172.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.28 147.0 6.36 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.692 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 88.4 Cg_exo -48.12 -46.92 20.93 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 121.903 1.735 . . . . 0.0 111.404 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.752 ' HG3' ' H ' ' A' ' 212' ' ' THR . 7.0 tp60 -178.39 -155.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 172.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.752 ' H ' ' HG3' ' A' ' 211' ' ' GLN . 6.3 p -129.07 -173.15 2.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.9 p -60.11 -62.57 1.77 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.821 0.343 . . . . 0.0 111.351 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.943 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 36.5 m -143.77 -58.89 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.967 176.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.943 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 78.2 Cg_endo -98.8 -176.9 0.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.707 2.271 . . . . 0.0 111.13 171.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.844 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 6.5 mp -94.47 -57.23 0.22 Allowed Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.844 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 4.6 Cg_endo -88.79 158.43 6.15 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.448 2.099 . . . . 0.0 111.402 172.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -69.94 152.12 44.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.079 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 219' ' ' VAL . 12.4 t 63.9 13.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.534 0.683 . . . . 0.0 111.616 176.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 19.4 m -96.22 10.84 36.54 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.813 -0.554 . . . . 0.0 111.043 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -135.22 104.56 0.51 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.762 ' HB3' ' HD3' ' A' ' 223' ' ' PRO . 22.9 t -96.28 -61.39 0.14 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.762 ' HD3' ' HB3' ' A' ' 222' ' ' SER . 53.0 Cg_exo -53.48 118.66 5.11 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.445 2.097 . . . . 0.0 112.909 -174.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 113.06 -66.79 0.25 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.84 -39.18 69.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.194 0.521 . . . . 0.0 110.52 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -111.12 112.87 24.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.92 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 9.1 tt -55.29 -39.77 53.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.726 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 17.5 m 58.05 89.76 0.1 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.231 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.87 -6.16 16.27 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.964 2.443 . . . . 0.0 112.94 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.561 ' N ' ' HD3' ' A' ' 231' ' ' PRO . 95.2 mt 61.07 55.41 3.31 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.207 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 230' ' ' LEU . 4.9 Cg_exo -75.76 -57.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.331 2.021 . . . . 0.0 111.215 176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 48.8 m -102.44 102.19 12.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.656 175.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 13.0 p -76.22 97.32 4.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.905 -176.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -101.57 81.04 2.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.457 0.646 . . . . 0.0 110.028 174.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -151.37 171.41 17.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.362 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 139.44 94.02 0.27 Allowed Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.47 86.79 0.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.431 2.087 . . . . 0.0 111.979 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.7 t -93.24 142.83 12.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.612 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.05 125.71 53.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.139 0.495 . . . . 0.0 110.804 -174.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.552 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -127.59 131.78 49.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.883 176.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -86.99 125.43 34.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.587 ' HA ' HG13 ' A' ' 291' ' ' VAL . . . -78.2 104.1 8.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.228 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.585 HG13 ' HG3' ' A' ' 244' ' ' GLN . 29.1 pt -83.14 -11.89 12.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.072 0.463 . . . . 0.0 111.229 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.585 ' HG3' HG13 ' A' ' 243' ' ' ILE . 24.7 mt-30 -124.68 165.27 18.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.448 ' HB3' HG13 ' A' ' 260' ' ' VAL . 24.4 pttm -128.72 144.4 51.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.129 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.86 150.51 4.69 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.744 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 29.4 m -101.67 166.53 12.08 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.822 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.707 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 44.0 Cg_endo -95.31 174.99 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.68 2.92 . . . . 0.0 113.793 -176.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.691 ' HB3' ' HD3' ' A' ' 253' ' ' LYS . 50.6 t -171.04 136.15 1.07 Allowed 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.129 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -44.67 -45.28 9.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.688 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -91.74 58.99 3.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.0 t70 89.72 31.85 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.425 1.583 . . . . 0.0 111.687 162.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.691 ' HD3' ' HB3' ' A' ' 249' ' ' CYS . 2.8 mptp? -114.2 45.63 1.48 Allowed 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 104.354 -2.461 . . . . 0.0 104.354 147.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 7.0 p -53.65 -21.74 7.44 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 122.819 1.295 . . . . 0.0 107.943 169.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 248' ' ' PRO . . . -8.62 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 111.311 -2.677 . . . . 0.0 113.262 152.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.573 ' O ' ' HG ' ' A' ' 258' ' ' LEU . 1.7 tt -75.12 118.79 18.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.707 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -55.97 121.42 9.28 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 123.477 0.485 . . . . 0.0 110.527 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 256' ' ' LEU . 96.2 mt -136.18 136.54 40.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.785 -175.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -98.89 -176.68 3.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.316 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 245' ' ' LYS . 17.5 m -86.79 132.64 31.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.956 0.408 . . . . 0.0 110.683 176.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 86.06 0.7 87.06 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.518 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.55 152.99 25.75 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.738 0.304 . . . . 0.0 110.724 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.7 mm -97.79 114.7 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.15 107.63 20.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.626 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -93.56 114.53 26.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.716 HG13 ' HE1' ' A' ' 269' ' ' MET . 11.6 p -88.37 143.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.969 0.414 . . . . 0.0 110.677 -177.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 30.0 m -98.74 -49.02 4.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.89 0.376 . . . . 0.0 110.266 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.49 ' HD2' ' OE1' ' A' ' 276' ' ' GLU . 3.3 ptp180 -132.45 118.84 19.83 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.096 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.716 ' HE1' HG13 ' A' ' 266' ' ' VAL . 47.1 mtt -89.62 110.8 21.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.128 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -131.62 139.7 49.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.415 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 52.3 mt 56.81 84.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.84 168.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 60.37 -29.14 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 166.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.609 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 165.24 -7.55 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.624 -1.274 . . . . 0.0 114.038 -177.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -85.78 77.05 9.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.558 0.679 . . . . 0.0 109.634 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 23.3 m0 -93.25 158.77 15.58 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.273 -170.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.49 ' OE1' ' HD2' ' A' ' 268' ' ' ARG . 40.9 tt0 -113.87 116.09 28.75 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.45 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.05 170.96 16.29 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.491 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.02 109.17 13.19 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.48 -86.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.531 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.12 66.98 8.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.188 0.518 . . . . 0.0 111.771 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 72.8 -2.49 32.51 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.456 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.482 ' NH1' ' H ' ' A' ' 257' ' ' ALA . 2.5 ptm180 -142.44 153.71 43.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.874 0.368 . . . . 0.0 110.983 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 20.3 pttp -104.48 142.01 35.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.766 173.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -160.19 -178.9 34.6 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.56 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.602 ' O ' ' HA ' ' A' ' 255' ' ' ALA . 91.3 mt -95.98 140.31 30.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.615 0.245 . . . . 0.0 110.961 -177.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 40.1 p90 -140.38 140.33 22.74 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 4.1 Cg_exo -79.85 142.79 16.02 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.702 2.268 . . . . 0.0 111.505 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.609 ' CD1' ' HA3' ' A' ' 273' ' ' GLY . 21.1 p90 -65.97 -15.43 62.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.9 m -77.54 -16.15 58.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.391 0.615 . . . . 0.0 110.541 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -86.81 -24.09 25.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.379 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.587 HG13 ' HA ' ' A' ' 242' ' ' ALA . 30.4 m -127.7 178.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.663 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -140.56 119.42 12.58 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' A' ' 240' ' ' ALA . 39.3 mm -60.43 122.36 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.812 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.753 ' HD2' ' HD2' ' A' ' 296' ' ' PRO . 2.3 p90 -145.83 179.71 7.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.843 -173.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.502 ' HB3' ' HD3' ' A' ' 296' ' ' PRO . 28.5 t70 -110.9 -46.06 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.753 ' HD2' ' HD2' ' A' ' 294' ' ' PHE . 94.0 Cg_exo -49.58 39.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 124.821 3.681 . . . . 0.0 118.735 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.438 HE21 ' HB3' ' A' ' 297' ' ' GLN . 0.9 OUTLIER -97.83 -27.11 14.45 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.584 ' HB2' ' HD3' ' A' ' 299' ' ' PRO . 1.8 m-20 -65.38 -58.22 12.69 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.964 -174.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 298' ' ' ASN . 85.6 Cg_endo -82.27 16.25 1.82 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.13 1.887 . . . . 0.0 113.638 -171.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.22 -21.17 62.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.233 0.54 . . . . 0.0 110.05 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -73.96 -13.06 60.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.646 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -121.44 -179.28 4.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.864 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.354 -0.832 . . . . 0.0 109.814 177.29 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 p -84.94 -10.84 56.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.471 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 m 69.13 -56.25 0.54 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.869 0.73 . . . . 0.0 111.197 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.642 ' HB3' ' HE3' ' A' ' 89' ' ' LYS . . . -77.76 96.47 4.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.179 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -123.66 94.7 4.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.998 -177.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -156.56 154.08 29.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.235 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -75.44 91.88 2.8 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.987 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 14.4 t -74.86 68.71 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.204 0.526 . . . . 0.0 110.068 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 t -179.62 -44.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.445 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -59.34 105.64 0.37 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.007 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 7.6 tpp180 -60.29 -32.35 71.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.549 -174.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.4 m -82.57 -1.36 50.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.644 0.259 . . . . 0.0 111.57 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.49 -45.61 8.05 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.326 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -117.94 -29.4 5.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 65.0 t80 -79.62 113.04 17.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.133 0.492 . . . . 0.0 110.696 -176.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.485 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 23.1 mmt -94.66 -2.86 50.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.051 -175.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.07 -114.21 3.09 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.663 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.63 96.75 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.015 2.477 . . . . 0.0 113.042 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.867 HG12 ' H ' ' A' ' 20' ' ' SER . 7.4 t -142.62 -161.15 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.867 ' H ' HG12 ' A' ' 19' ' ' VAL . 23.2 t 178.32 177.46 0.43 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -170.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.483 ' HG3' ' O2P' ' A' ' 207' ' ' PTR . 36.0 mtp85 -54.58 -61.6 2.2 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.75 -44.54 95.93 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.279 0.362 . . . . 0.0 111.336 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HA ' HG21 ' A' ' 26' ' ' THR . 40.3 mt-10 -62.17 -47.51 84.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.345 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.85 -34.45 69.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 0.0 111.281 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.674 ' HG3' HG21 ' A' ' 58' ' ' VAL . 5.4 tt0 -81.88 -34.66 29.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.051 -175.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.443 HG21 ' HA ' ' A' ' 23' ' ' GLU . 11.3 t -82.46 -14.7 54.63 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -104.39 -18.6 14.36 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.773 0.797 . . . . 0.0 110.878 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -132.54 33.01 3.83 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 123.647 1.689 . . . . 0.0 108.095 -174.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -58.18 177.52 0.12 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.229 173.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.445 ' HA2' ' OG ' ' A' ' 53' ' ' SER . . . -73.58 53.02 1.96 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.813 -176.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -78.31 -38.17 42.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.415 0.626 . . . . 0.0 109.893 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.508 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 22.7 ttp180 -144.67 128.46 17.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.76 ' HE1' ' HB2' ' A' ' 117' ' ' ASN . 63.9 m170 -83.84 132.54 34.8 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.903 0.382 . . . . 0.0 110.607 -176.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.34 10.93 22.9 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.695 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.67 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.0 mtm -97.96 147.36 24.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.46 ' CD2' HD23 ' A' ' 98' ' ' LEU . 41.7 p90 -143.53 163.04 34.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.025 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.538 HD22 ' CB ' ' A' ' 28' ' ' LEU . 4.1 pp -150.36 134.3 16.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.968 0.413 . . . . 0.0 110.175 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.6 t -102.27 123.33 55.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.865 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 22.6 ptt-85 -126.57 153.42 45.27 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.571 -172.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.424 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 38.2 t70 -75.89 107.95 8.43 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 170.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.509 ' HB2' HG21 ' A' ' 49' ' ' VAL . 13.3 t -79.42 178.22 8.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.679 -168.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.8 m -125.12 17.55 8.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.951 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.467 HG21 ' O1P' ' A' ' 207' ' ' PTR . 0.3 OUTLIER -79.46 -47.94 14.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.25 0.547 . . . . 0.0 109.584 177.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.3 m -144.18 152.93 55.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.296 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.69 87.19 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.139 1.893 . . . . 0.0 111.674 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.52 15.57 2.97 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.967 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.98 155.09 19.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.289 0.544 . . . . 0.0 109.802 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.424 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 44.8 m-85 -127.2 159.91 32.86 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.772 HG22 HG12 ' A' ' 62' ' ' ILE . 40.6 t -135.03 108.69 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.117 175.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.63 103.15 7.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.478 173.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 59' ' ' SER . 70.9 m -95.67 135.37 37.45 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.136 177.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.581 HG22 HD12 ' A' ' 93' ' ' LEU . 92.8 t -127.73 134.38 65.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.579 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.445 ' OG ' ' HA2' ' A' ' 30' ' ' GLY . 29.2 t -100.28 112.42 24.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.744 0.307 . . . . 0.0 111.327 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.56 ' OE1' ' HB3' ' A' ' 33' ' ' HIS . 10.6 tp10 -157.34 140.76 15.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.176 175.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.504 ' ND2' ' HZ1' ' A' ' 155' ' ' LYS . 30.2 m-80 48.3 39.38 12.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.469 0.707 . . . . 0.0 112.899 -176.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.9 m 66.98 18.44 10.58 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.1 173.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 57' ' ' ARG . 14.6 ptt180 -124.51 133.19 53.4 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.674 HG21 ' HG3' ' A' ' 25' ' ' GLN . 46.0 t -93.69 97.23 6.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.747 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 25.3 m -68.99 117.66 10.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.328 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 80.1 m-70 -101.26 92.56 5.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.95 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.63 ' CE2' HD23 ' A' ' 93' ' ' LEU . 37.4 m-85 -97.15 114.85 26.59 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.951 0.157 . . . . 0.0 111.056 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.772 HG12 HG22 ' A' ' 49' ' ' VAL . 28.8 mt -81.99 135.98 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -175.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.726 HG13 ' HB ' ' A' ' 73' ' ' ILE . 5.3 mp -117.38 123.81 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.292 1.037 . . . . 0.0 109.692 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -106.25 135.49 47.63 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.06 -0.4 . . . . 0.0 110.263 -173.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.0 t -80.29 108.63 14.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.006 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.6 mt -80.62 142.91 53.9 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.22 -17.97 49.27 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.728 2.286 . . . . 0.0 112.014 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.52 10.36 7.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.06 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 67.96 29.55 6.45 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.609 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -116.95 159.68 22.08 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.411 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 46.7 m-85 -118.84 115.55 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.188 0.518 . . . . 0.0 111.612 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -104.15 109.02 20.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.027 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.726 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.6 tt -96.47 87.52 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.75 0.786 . . . . 0.0 110.557 177.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.98 75.74 0.43 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.901 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' N ' ' HB ' ' A' ' 212' ' ' THR . 25.7 t0 76.25 -52.69 0.61 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.111 0.564 . . . . 0.0 111.507 175.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -70.56 111.8 6.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.45 0.643 . . . . 0.0 110.41 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -95.68 128.91 42.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.938 -178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.532 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 89.3 m-85 -119.19 175.08 5.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.683 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.28 -51.05 63.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.18 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -156.2 -177.57 6.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.486 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.6 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.6 mt -56.62 -54.56 52.4 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.466 ' HB3' ' O ' ' A' ' 8' ' ' SER . 52.9 Cg_exo -58.77 -10.38 9.4 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.132 1.888 . . . . 0.0 113.614 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.21 -34.93 16.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.677 0.275 . . . . 0.0 110.919 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.8 pp -76.24 -27.03 56.61 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.3 mt -67.89 -24.23 65.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.821 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 48.8 mt-10 -91.02 -9.41 46.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.762 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.681 ' HE1' ' CZ ' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -97.8 -29.66 13.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 176.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.681 ' CZ ' ' HE1' ' A' ' 87' ' ' PHE . 26.7 m-85 -78.03 -13.28 59.93 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.787 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.642 ' HE3' ' HB3' ' A' ' 4' ' ' ALA . 21.7 ptmt -74.01 -16.68 61.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.588 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.415 HD13 ' H ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -116.77 25.35 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.937 169.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -114.06 -41.62 3.5 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.248 -0.282 . . . . 0.0 111.662 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.593 ' CD1' HG22 ' A' ' 97' ' ' THR . 93.4 m-85 73.16 96.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.96 0.788 . . . . 0.0 110.624 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.63 HD23 ' CE2' ' A' ' 61' ' ' TYR . 2.2 mt -74.57 -13.89 60.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.062 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 96' ' ' THR . 20.0 t70 -172.45 63.02 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.581 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER 74.05 -25.15 0.2 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.114 -175.198 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.461 ' H ' ' C ' ' A' ' 94' ' ' ASP . 41.7 m -114.52 146.18 41.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.593 HG22 ' CD1' ' A' ' 92' ' ' TYR . 16.7 p -90.97 -176.03 4.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.408 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.518 ' HG ' HD11 ' A' ' 93' ' ' LEU . 82.2 mt -69.61 96.39 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 38.5 mm -84.39 -55.08 7.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.031 0.443 . . . . 0.0 110.525 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 35' ' ' MET . 45.6 tt0 -162.32 141.75 7.24 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.454 -177.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.66 153.23 37.17 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.738 2.292 . . . . 0.0 112.914 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.526 ' HB3' HD13 ' A' ' 28' ' ' LEU . . . -73.58 153.84 89.64 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.598 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.24 115.22 2.42 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.448 2.098 . . . . 0.0 112.22 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -58.1 -32.66 68.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.206 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 83.2 t80 -137.88 126.23 14.35 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 171.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 19.8 Cg_exo -65.75 86.08 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.66 2.24 . . . . 0.0 112.008 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.717 ' HB2' ' HD3' ' A' ' 108' ' ' PRO . 49.4 m -71.49 -53.67 7.42 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.446 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.717 ' HD3' ' HB2' ' A' ' 107' ' ' SER . 59.5 Cg_endo -90.73 155.09 4.16 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.094 1.862 . . . . 0.0 112.212 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.1 174.05 11.23 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.638 2.226 . . . . 0.0 112.036 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -73.31 112.97 9.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.072 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -91.29 175.46 39.45 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.705 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.0 t -111.78 165.38 12.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.781 0.324 . . . . 0.0 110.808 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 t 51.84 50.56 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.962 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.0 t -124.28 18.05 9.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' A' ' 33' ' ' HIS . . . -162.82 112.66 1.07 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.204 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 117' ' ' ASN . 31.9 Cg_exo -62.3 -81.0 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.719 2.28 . . . . 0.0 112.818 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.76 ' HB2' ' HE1' ' A' ' 33' ' ' HIS . 3.6 t-20 60.71 -179.46 0.1 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.147 0.498 . . . . 0.0 111.05 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.566 ' H ' ' ND2' ' A' ' 117' ' ' ASN . 5.9 mp -128.8 80.13 73.24 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 172.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.404 ' HA ' ' OE2' ' A' ' 122' ' ' GLU . 74.4 Cg_endo -75.59 50.78 2.79 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.007 2.471 . . . . 0.0 111.901 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.8 t -133.79 16.15 3.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.941 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.18 -44.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.876 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' A' ' 119' ' ' PRO . 7.0 mm-40 53.86 37.3 26.19 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.503 0.668 . . . . 0.0 109.506 -173.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -70.17 147.22 50.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.941 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -80.16 83.04 6.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.899 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.747 HD13 HG23 ' A' ' 152' ' ' ILE . 3.4 mm? -81.42 91.73 6.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.693 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.708 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 12.7 pt-20 -170.09 -59.14 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.073 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.523 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 15.1 m-85 -102.01 108.76 20.29 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.704 0.764 . . . . 0.0 111.666 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.462 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 65.0 t -130.18 154.98 41.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.057 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.619 ' NH2' HD12 ' A' ' 181' ' ' LEU . 14.1 ptp180 -135.74 137.6 41.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.848 0.356 . . . . 0.0 110.108 175.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.913 HG21 HG12 ' A' ' 178' ' ' VAL . 31.4 p -90.28 137.32 32.45 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.236 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.9 mt -113.19 -24.59 9.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.508 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 44.4 t80 -89.3 -34.77 16.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.508 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 27.1 t70 76.62 122.35 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.89 0.744 . . . . 0.0 111.171 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 80.9 t80 -156.98 107.59 1.93 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.781 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.708 ' HB3' ' HB3' ' A' ' 222' ' ' SER . 57.5 Cg_endo -87.52 97.55 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.594 2.196 . . . . 0.0 112.651 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -87.57 -6.51 77.03 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.077 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.84 22.76 12.8 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.998 0.519 . . . . 0.0 111.932 -175.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.652 ' CB ' ' HD3' ' A' ' 169' ' ' ARG . 2.4 p30 54.94 -173.37 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 168.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 77.48 -34.93 0.21 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 113.341 -1.754 . . . . 0.0 109.785 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.625 ' O ' ' HB2' ' A' ' 172' ' ' MET . 33.9 tt0 -133.69 -29.47 1.33 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.139 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.543 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 22.4 m-20 -138.26 111.39 7.89 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.665 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 25.9 tp -66.22 119.6 63.26 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 120.562 0.22 . . . . 0.0 110.612 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.53 ' HD2' ' HD2' ' A' ' 169' ' ' ARG . 29.2 Cg_endo -71.98 105.03 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.895 1.73 . . . . 0.0 111.335 174.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.622 ' CG ' HG22 ' A' ' 130' ' ' THR . 7.8 p90 -115.23 163.85 15.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 -177.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -97.2 -170.51 2.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.14 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.72 11.18 29.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.193 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.71 39.84 0.2 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.476 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -105.23 155.11 19.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.747 0.273 . . . . 0.0 110.453 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.39 137.43 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.579 HD22 ' HA ' ' A' ' 165' ' ' ASN . 43.4 mt -125.42 160.71 28.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.708 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 22.0 t -122.83 131.67 72.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.747 HG23 HD13 ' A' ' 125' ' ' LEU . 32.7 mm -74.02 91.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.984 0.897 . . . . 0.0 109.433 -175.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.739 HG22 ' HG2' ' A' ' 154' ' ' GLU . 0.6 OUTLIER -74.61 -45.39 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.891 -176.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.739 ' HG2' HG22 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -129.81 139.94 51.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 174.11 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.687 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 0.7 OUTLIER -126.86 86.81 57.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.989 174.766 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.581 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 7.3 Cg_exo -77.4 -61.61 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.063 2.509 . . . . 0.0 113.64 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -97.05 -175.36 3.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 0.0 111.867 -169.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -90.32 -52.53 4.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.67 -178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.1 0.18 51.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.966 0.412 . . . . 0.0 110.915 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.651 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 57.0 m95 -129.53 124.71 34.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.159 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.68 ' O ' HG13 ' A' ' 173' ' ' ILE . 51.5 m0 -121.91 145.47 48.06 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.5 m -100.24 99.72 10.44 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.144 0.497 . . . . 0.0 109.742 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -105.45 160.9 14.79 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.131 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.736 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 22.3 ptt-85 -101.32 128.95 47.25 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.501 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.665 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 66.7 t30 -65.52 164.14 14.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.097 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 15.3 tptp -67.86 -11.47 58.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.454 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.99 -4.53 46.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.939 0.4 . . . . 0.0 110.448 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.28 75.28 1.28 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.393 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.736 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 5.4 ttm-85 -155.36 135.07 12.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.359 0.123 . . . . 0.0 111.117 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.572 HG21 HG21 ' A' ' 153' ' ' ILE . 66.5 t -103.3 117.82 49.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.792 0.33 . . . . 0.0 111.361 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.44 166.92 30.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.866 173.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.651 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -79.72 138.35 37.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.702 0.287 . . . . 0.0 110.829 179.498 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.68 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -137.71 145.44 48.7 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.458 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 6.3 Cg_exo -80.28 136.81 11.56 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.95 2.433 . . . . 0.0 112.873 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.523 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 98.8 t -64.08 -42.62 70.22 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.436 177.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 37.4 Cg_endo -67.49 10.75 0.25 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.015 1.81 . . . . 0.0 113.06 175.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 175' ' ' VAL . 3.3 m-85 -113.65 -5.93 13.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.716 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.913 HG12 HG21 ' A' ' 130' ' ' THR . 20.2 m -132.18 163.84 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.425 0.631 . . . . 0.0 112.614 -167.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -128.47 161.35 29.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.815 172.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.514 ' N ' ' HD3' ' A' ' 180' ' ' LYS . 3.2 mppt? -100.87 137.72 38.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.266 -175.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.619 HD12 ' NH2' ' A' ' 129' ' ' ARG . 65.5 tp -82.06 -41.81 20.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.774 -178.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.42 103.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.841 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -167.36 -92.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.051 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.9 t 173.24 106.66 0.01 OUTLIER 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.006 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 11.0 p -71.23 167.74 27.11 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.72 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.78 97.94 0.1 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.079 1.853 . . . . 0.0 112.177 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -105.67 -44.5 4.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.91 -53.94 4.78 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.209 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -86.26 15.47 5.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.938 0.399 . . . . 0.0 110.539 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -86.96 81.3 8.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.131 0.491 . . . . 0.0 110.202 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -160.02 63.64 0.29 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.398 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.565 ' ND2' ' HB3' ' A' ' 195' ' ' SER . 0.2 OUTLIER -66.74 165.72 14.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.38 109.16 4.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.255 -175.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 72.89 -60.74 0.53 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.846 0.716 . . . . 0.0 112.339 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.565 ' HB3' ' ND2' ' A' ' 192' ' ' ASN . 79.5 p 52.68 -162.45 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.783 0.833 . . . . 0.0 111.255 -173.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.56 160.77 26.33 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 19.9 m -75.33 134.67 40.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.679 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -119.56 158.64 25.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.21 -20.89 1.22 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.96 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 10.7 tt -62.4 120.91 63.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.537 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.32 115.63 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.363 2.042 . . . . 0.0 112.403 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.405 ' O ' ' HD2' ' A' ' 205' ' ' HIS . 1.8 pm0 -79.34 167.02 37.64 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.198 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -62.0 -7.64 10.16 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.245 2.63 . . . . 0.0 113.126 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.6 -27.87 68.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.21 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.405 ' HD2' ' O ' ' A' ' 202' ' ' GLU . 49.3 m-70 -79.52 74.65 6.17 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -76.56 89.27 3.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.649 -174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.483 ' O2P' ' HG3' ' A' ' 21' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -143.37 23.75 1.8 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.119 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.434 ' OE1' HD11 ' A' ' 62' ' ' ILE . 18.2 pt20 -66.63 145.57 98.96 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.867 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 209' ' ' GLN . 24.2 Cg_exo -64.47 -18.98 64.79 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.482 2.121 . . . . 0.0 112.193 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.545 ' HG2' ' H ' ' A' ' 212' ' ' THR . 46.3 tt0 69.06 174.34 0.29 Allowed 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.732 0.645 . . . . 0.0 110.011 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.545 ' H ' ' HG2' ' A' ' 211' ' ' GLN . 8.1 t -169.93 128.18 0.9 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.86 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.2 m 42.98 77.96 0.06 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.394 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.851 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 26.3 m -137.37 -60.75 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.235 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.851 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 7.1 Cg_exo -74.39 -175.79 2.41 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.018 1.812 . . . . 0.0 111.417 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 11.2 mp -69.98 130.22 90.12 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 52.0 Cg_exo -56.24 151.65 42.64 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.033 2.488 . . . . 0.0 112.342 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -75.95 81.59 2.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.15 0.5 . . . . 0.0 110.982 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 47.7 t -86.74 -46.42 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.593 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 2.7 p -103.68 137.83 41.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.109 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 139.07 -132.99 5.95 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.708 ' HB3' ' HB3' ' A' ' 135' ' ' PRO . 39.7 m -125.88 84.12 61.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.937 0.399 . . . . 0.0 110.968 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -96.97 -148.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.74 2.96 . . . . 0.0 112.277 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -137.5 172.94 22.54 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.16 -31.36 64.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.755 0.277 . . . . 0.0 110.715 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 71.69 -53.51 0.68 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.623 0.769 . . . . 0.0 111.922 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 34.5 pt -63.86 146.64 12.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.821 0.343 . . . . 0.0 110.477 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.806 HG23 ' HD2' ' A' ' 231' ' ' PRO . 1.8 m -140.38 63.58 22.61 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 121.091 0.472 . . . . 0.0 110.278 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.19 38.07 0.67 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.21 2.606 . . . . 0.0 113.139 -171.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.927 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 57.5 tp -133.75 -60.88 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.663 178.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.927 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 3.1 Cg_endo -87.93 11.94 3.0 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.522 2.148 . . . . 0.0 111.739 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 8.8 t -149.9 -169.3 3.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -65.21 132.61 49.56 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 123.44 0.462 . . . . 0.0 111.17 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -74.9 -31.72 61.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.771 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 64.36 86.77 0.12 Allowed 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.637 0.585 . . . . 0.0 110.597 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -74.84 151.41 42.66 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.103 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.49 162.07 38.32 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.587 2.191 . . . . 0.0 112.193 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.55 ' HB ' ' HE1' ' A' ' 269' ' ' MET . 21.6 t -89.08 134.03 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.944 ' HE1' HG23 ' A' ' 263' ' ' ILE . 0.1 OUTLIER -118.29 123.04 44.41 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.087 -171.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.505 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -124.62 158.69 32.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.098 0.475 . . . . 0.0 112.082 -170.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.722 ' HE3' ' HA2' ' A' ' 261' ' ' GLY . 54.4 tttp -102.23 130.85 49.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.477 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -75.44 104.68 6.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.551 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.855 HD12 ' HG3' ' A' ' 244' ' ' GLN . 2.7 pp -82.45 -15.44 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.226 0.536 . . . . 0.0 110.833 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.855 ' HG3' HD12 ' A' ' 243' ' ' ILE . 23.5 mt-30 -123.98 -172.05 2.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.229 172.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -124.5 169.42 11.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.521 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 57.6 mtp85 -148.78 125.85 11.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.342 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.445 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 29.3 m -118.33 157.22 49.76 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.487 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 247' ' ' VAL . 28.8 Cg_endo -63.55 108.08 0.81 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.465 2.11 . . . . 0.0 112.932 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.723 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 42.1 t -84.92 171.45 12.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.75 -40.24 75.42 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -104.0 3.78 33.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.162 0.506 . . . . 0.0 110.577 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.738 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 1.0 OUTLIER -104.0 51.08 0.78 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.259 178.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.62 -23.6 64.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.321 0.581 . . . . 0.0 109.787 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 13.9 p -95.65 16.3 17.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.913 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.738 ' HB3' ' HB3' ' A' ' 252' ' ' ASP . . . -81.2 128.4 33.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.654 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.58 127.28 31.96 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 172.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -83.33 117.84 23.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.083 0.468 . . . . 0.0 109.96 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.645 HD21 HG21 ' A' ' 279' ' ' VAL . 58.2 mt -131.81 160.18 36.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.915 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 262' ' ' ASP . 48.6 mt-10 -132.8 167.88 19.38 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.01 131.11 31.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.331 0.586 . . . . 0.0 111.291 -175.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.722 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 92.17 3.88 67.17 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.205 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 0.7 OUTLIER -85.38 160.01 19.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.943 0.401 . . . . 0.0 110.722 -175.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.944 HG23 ' HE1' ' A' ' 239' ' ' PHE . 18.5 mm -95.61 123.36 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.494 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.51 96.72 4.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.131 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -79.71 87.28 5.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.529 HG23 ' HB3' ' A' ' 275' ' ' TRP . 2.4 p -87.01 118.12 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.871 0.843 . . . . 0.0 111.133 -175.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.5 m -103.09 -18.44 14.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.761 -171.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.745 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 36.2 ttm-85 -129.97 103.52 6.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.772 0.32 . . . . 0.0 110.915 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.55 ' HE1' ' HB ' ' A' ' 238' ' ' VAL . 58.5 mtt -102.98 118.68 37.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.875 0.369 . . . . 0.0 110.412 178.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -86.51 1.57 51.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 75.1 mt 74.51 -39.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.398 0.679 . . . . 0.0 112.581 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -63.16 -16.3 59.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 129.96 -27.4 4.08 Favored Glycine 0 CA--C 1.506 -0.501 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.647 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -85.02 113.45 21.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.04 0.447 . . . . 0.0 109.959 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.529 ' HB3' HG23 ' A' ' 266' ' ' VAL . 51.2 m0 -109.42 145.07 36.76 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.084 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 41.9 tt0 -100.97 114.92 29.26 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.96 149.58 18.16 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.297 -176.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -121.52 108.99 14.27 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.645 HG21 HD21 ' A' ' 258' ' ' LEU . 42.1 t -115.82 -98.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.245 -175.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -99.81 82.89 2.66 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.655 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.7 5.81 32.9 Favored Glycine 0 CA--C 1.517 0.167 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.202 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -128.06 129.08 46.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.852 0.358 . . . . 0.0 110.977 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 28.6 ttpp -115.32 111.2 20.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.223 174.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -143.48 -174.66 15.93 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.052 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.14 144.59 27.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.144 0.497 . . . . 0.0 111.5 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.573 ' HE2' HG21 ' A' ' 291' ' ' VAL . 44.3 p90 -148.64 142.57 16.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.683 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 3.2 Cg_exo -77.2 145.21 24.12 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.539 2.16 . . . . 0.0 111.632 176.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -62.96 -14.73 50.89 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.577 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.3 p -72.24 -8.66 56.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -107.56 -8.36 16.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.482 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.573 HG21 ' HE2' ' A' ' 286' ' ' PHE . 34.9 m -128.62 164.29 31.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.796 ' HG2' HG12 ' A' ' 243' ' ' ILE . 31.4 mmtp -137.29 139.68 41.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 174.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 240' ' ' ALA . 47.1 mm -78.81 118.19 25.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.476 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 13.3 p90 -121.06 163.83 17.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.84 0.352 . . . . 0.0 110.324 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.897 ' HB3' ' HB2' ' A' ' 298' ' ' ASN . 4.2 m-20 -93.66 106.75 22.71 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.987 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.766 ' HB3' ' HE2' ' A' ' 239' ' ' PHE . 54.4 Cg_endo -72.56 -50.08 0.24 Allowed 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.422 2.081 . . . . 0.0 113.097 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -141.82 38.08 1.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 122.183 0.992 . . . . 0.0 108.529 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.897 ' HB2' ' HB3' ' A' ' 295' ' ' ASP . 2.6 m-20 -97.18 -54.01 0.21 Allowed Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.554 -172.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' A' ' 298' ' ' ASN . 2.8 Cg_exo -77.04 -5.12 15.59 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.389 2.059 . . . . 0.0 112.763 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -137.68 172.76 12.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -133.49 16.29 4.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.27 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -113.48 112.85 24.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.103 0.478 . . . . 0.0 111.852 -169.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.433 -0.794 . . . . 0.0 109.089 171.453 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.569 ' SD ' ' HB2' ' A' ' 100' ' ' GLU . 58.6 mtt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.907 0.384 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -98.15 -78.78 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.9 t -99.88 80.26 2.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.722 0.296 . . . . 0.0 111.171 -175.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 51.81 46.99 25.67 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.046 174.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 5' ' ' ARG . 48.1 mtm105 -121.9 81.44 1.82 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.749 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.483 ' CE1' ' HD3' ' A' ' 89' ' ' LYS . 31.3 p90 -113.55 161.18 17.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.433 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 8' ' ' SER . 10.0 m-20 -61.44 -45.31 94.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -173.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.608 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 63.1 m 67.72 157.61 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.762 0.664 . . . . 0.0 109.999 -169.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.6 t 72.64 -49.94 0.7 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.989 0.516 . . . . 0.0 111.491 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -50.98 101.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.34 0.59 . . . . 0.0 111.591 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -40.22 73.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.249 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -78.62 8.97 4.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.667 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.91 -47.62 4.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.708 0.29 . . . . 0.0 111.022 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -121.03 -25.87 5.25 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -86.46 115.46 23.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.93 0.395 . . . . 0.0 110.692 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.1 mtt -113.13 6.59 17.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.107 0.48 . . . . 0.0 110.779 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.0 -115.23 3.36 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.006 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 25.5 Cg_exo -63.95 103.75 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.697 2.265 . . . . 0.0 111.914 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.585 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 54.4 t -135.58 -75.26 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.732 -176.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.774 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 55.9 m 84.99 176.02 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 122.743 0.417 . . . . 0.0 110.141 166.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.722 ' HD3' ' O3P' ' A' ' 207' ' ' PTR . 26.6 mmm180 -40.65 -61.76 0.89 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.054 0.846 . . . . 0.0 111.782 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -55.17 -56.84 15.41 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.941 0.776 . . . . 0.0 112.007 -173.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.6 -42.92 60.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.253 -169.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.26 -52.8 63.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.197 -176.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.562 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 12.9 pt20 -70.89 -32.81 69.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.151 -176.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.596 ' HA ' ' OE1' ' A' ' 29' ' ' GLN . 39.5 m -66.73 -34.3 77.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 111.354 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -63.22 -35.39 80.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.82 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 1.063 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 23.6 mt -99.61 13.0 35.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.045 -173.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.596 ' OE1' ' HA ' ' A' ' 26' ' ' THR . 27.3 mt-30 -73.65 96.71 2.52 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.88 5.07 89.7 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.738 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -82.43 -162.26 0.55 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.946 0.373 . . . . 0.0 110.15 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.51 ' HG3' ' HE1' ' A' ' 35' ' ' MET . 14.5 mtm180 -62.78 131.51 49.1 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.185 0.517 . . . . 0.0 111.352 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -73.72 114.66 12.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.474 173.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.08 -16.86 4.4 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.124 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 62.2 mtt -67.7 142.71 56.24 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.711 0.291 . . . . 0.0 111.544 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.489 ' CB ' HG22 ' A' ' 52' ' ' VAL . 40.2 p90 -140.24 160.04 40.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.016 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -151.1 141.74 22.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.967 0.413 . . . . 0.0 110.627 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.51 124.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.461 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.774 ' HD2' ' H ' ' A' ' 20' ' ' SER . 9.2 ptt180 -122.17 161.7 22.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.189 -173.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.3 113.17 18.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.454 ' HB2' HG21 ' A' ' 49' ' ' VAL . 21.1 t -73.51 140.5 46.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.703 -171.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 t -78.96 -13.46 59.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.351 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.0 p -68.03 -48.5 65.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.107 0.479 . . . . 0.0 109.983 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.4 m -146.95 103.45 3.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.163 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.7 116.58 3.09 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.59 2.193 . . . . 0.0 111.216 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.38 -30.89 5.26 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -172.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.534 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 3.2 m-20 -86.18 168.87 13.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 171.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.757 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 32.0 m-85 -135.52 174.02 11.07 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.684 -171.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 41' ' ' SER . 58.5 t -143.27 112.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.175 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.596 ' HB2' HD13 ' A' ' 63' ' ' ILE . 46.0 tp -83.54 99.84 10.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.254 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 59' ' ' SER . 68.4 m -97.11 135.14 39.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.528 177.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.588 HG23 HD12 ' A' ' 93' ' ' LEU . 81.9 t -132.09 142.39 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.553 -173.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 1.063 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 42.3 t -102.01 113.86 27.46 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.882 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.685 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 18.0 pt-20 -156.86 145.99 20.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.0 p30 43.3 31.39 0.38 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.732 0.813 . . . . 0.0 112.714 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.8 m 63.71 63.82 0.82 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.534 0.683 . . . . 0.0 111.234 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.685 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 29.3 ptt180 -160.3 166.34 29.66 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.638 HG22 ' HA ' ' A' ' 117' ' ' ASN . 34.3 t -119.45 90.85 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.081 0.467 . . . . 0.0 109.941 175.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 51' ' ' SER . 3.6 m -63.14 116.28 5.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.597 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.589 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 99.1 m-70 -102.86 97.04 7.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.683 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.42 ' CE2' HD23 ' A' ' 93' ' ' LEU . 82.7 m-85 -105.38 113.06 26.42 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.904 -0.134 . . . . 0.0 111.097 177.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.7 ' HB ' ' CB ' ' A' ' 207' ' ' PTR . 19.0 tt -77.53 139.34 18.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.757 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.5 mp -109.4 122.74 64.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.789 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.534 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 11.2 m120 -110.16 126.31 53.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.911 0.386 . . . . 0.0 110.211 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 p -80.67 100.89 8.91 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.02 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.86 HD11 ' HG2' ' A' ' 70' ' ' ARG . 96.3 mt -66.34 130.06 94.2 Favored Pre-proline 0 CA--C 1.51 -0.595 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -40.26 -68.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.166 2.577 . . . . 0.0 113.658 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -123.25 31.77 5.87 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.001 0.905 . . . . 0.0 108.605 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.751 HH21 HD21 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -131.24 -91.33 0.43 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.596 -173.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.86 ' HG2' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -157.81 -170.4 3.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.051 -167.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -97.62 130.22 44.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.339 0.59 . . . . 0.0 110.323 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.601 ' HD2' HD12 ' A' ' 66' ' ' LEU . 44.9 tttm -123.48 103.33 8.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.309 -173.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 62' ' ' ILE . 15.0 tt -74.13 86.23 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.842 0.829 . . . . 0.0 111.049 -173.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 1.013 ' HA3' ' HA ' ' A' ' 209' ' ' GLN . . . 77.04 -34.73 1.47 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.784 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -168.08 -51.29 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.648 0.261 . . . . 0.0 110.46 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.416 ' NE2' ' HB ' ' A' ' 212' ' ' THR . 64.0 tt0 -80.87 121.28 25.78 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.436 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.8 pt-20 -94.86 143.28 26.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.289 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.515 ' HE1' ' CG2' ' A' ' 73' ' ' ILE . 91.2 m-85 -115.4 -77.37 0.57 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.688 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD2' ' HD2' ' A' ' 80' ' ' HIS . 11.7 t70 -177.11 -54.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.458 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.482 ' HD2' ' OD2' ' A' ' 79' ' ' ASP . 10.8 p80 -147.77 177.64 9.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.486 176.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 11.6 mt -58.84 -59.11 14.8 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.608 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 44.6 Cg_exo -60.05 -7.38 6.26 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.279 1.986 . . . . 0.0 113.427 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.88 -23.01 24.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.94 0.4 . . . . 0.0 110.963 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -88.09 -28.76 21.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.472 ' O ' HD12 ' A' ' 98' ' ' LEU . 77.7 mt -68.21 -25.76 65.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.849 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.638 ' HA ' ' HE2' ' A' ' 89' ' ' LYS . 10.1 pt-20 -85.78 -15.58 41.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -79.8 -37.69 34.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.512 0.672 . . . . 0.0 110.116 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.466 ' CG ' HD21 ' A' ' 93' ' ' LEU . 60.3 m-85 -78.88 2.79 18.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.082 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.638 ' HE2' ' HA ' ' A' ' 86' ' ' GLU . 52.2 mtmt -86.37 -5.79 59.09 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.793 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 -27.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.087 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -79.39 -19.59 49.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.235 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.598 ' CD2' HG21 ' A' ' 97' ' ' THR . 54.5 m-85 67.28 174.32 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -168.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.588 HD12 HG23 ' A' ' 52' ' ' VAL . 4.2 mt -114.27 2.04 14.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 165.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 15.7 t70 -178.07 -121.76 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.502 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.526 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.1 t -94.01 -3.96 50.46 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.1 m -120.3 141.68 49.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.52 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.598 HG21 ' CD2' ' A' ' 92' ' ' TYR . 18.6 p -94.8 178.92 5.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 174.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 93' ' ' LEU . 83.0 mt -69.48 101.85 1.67 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 51.1 mm -86.02 -65.07 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.79 -176.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 35' ' ' MET . 5.7 pm0 -150.37 155.96 36.88 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.221 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.71 145.79 70.69 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.43 2.087 . . . . 0.0 111.726 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 35' ' ' MET . . . -69.62 147.4 96.56 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.426 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.507 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 25.0 Cg_exo -63.66 127.76 20.55 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.356 2.037 . . . . 0.0 111.184 175.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -74.83 78.33 2.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.431 0.634 . . . . 0.0 109.79 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -139.74 115.35 8.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.267 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.81 138.3 37.34 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.854 2.369 . . . . 0.0 111.701 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.5 m 60.55 86.76 0.15 Allowed Pre-proline 0 C--O 1.234 0.249 0 O-C-N 123.713 0.633 . . . . 0.0 111.343 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.99 156.5 54.21 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.067 2.511 . . . . 0.0 112.508 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.54 -25.94 54.86 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.506 2.138 . . . . 0.0 112.369 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 70.6 mtm -130.28 -178.8 4.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.381 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.57 -74.13 2.13 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.386 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.4 m 65.56 -62.3 0.23 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.642 0.777 . . . . 0.0 111.715 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.499 HG21 ' H ' ' A' ' 114' ' ' SER . 0.1 OUTLIER -145.11 -88.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.271 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.499 ' H ' HG21 ' A' ' 113' ' ' VAL . 32.2 m 64.26 -166.34 0.23 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.23 0.538 . . . . 0.0 111.924 171.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 116' ' ' PRO . . . -87.2 -44.31 0.52 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.379 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 115' ' ' ALA . 9.2 Cg_endo -51.32 95.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.522 2.148 . . . . 0.0 113.303 177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.638 ' HA ' HG22 ' A' ' 58' ' ' VAL . 8.6 t-20 -179.37 172.94 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.46 ' HB2' ' H ' ' A' ' 58' ' ' VAL . 34.9 tp -163.18 81.74 1.54 Allowed Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 175.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.651 ' HA ' HH21 ' A' ' 21' ' ' ARG . 3.1 Cg_endo -86.35 -37.67 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.757 2.305 . . . . 0.0 109.501 165.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.529 ' H ' ' HD2' ' A' ' 119' ' ' PRO . 38.1 m -156.52 159.84 38.95 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.717 ' CB ' ' HB2' ' A' ' 126' ' ' GLU . . . -64.94 0.18 1.31 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 121' ' ' ALA . 7.9 tp10 72.24 -64.8 0.38 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.915 0.388 . . . . 0.0 110.754 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -143.41 -43.31 0.29 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.638 -173.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 59.8 t30 -141.85 165.96 26.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.733 -174.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.55 HD11 HG22 ' A' ' 152' ' ' ILE . 4.1 mm? 70.38 73.97 0.21 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.504 0.722 . . . . 0.0 111.397 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.717 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . 4.9 tp10 -164.72 -81.31 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.38 -173.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -104.97 114.63 28.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.339 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.563 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 53.7 t -128.73 133.47 66.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.128 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -111.29 141.28 45.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.132 0.491 . . . . 0.0 110.922 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.873 HG22 HG11 ' A' ' 178' ' ' VAL . 7.3 p -93.49 139.61 30.53 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.426 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.436 HD13 ' CG ' ' A' ' 179' ' ' GLU . 16.7 mt -110.32 -27.46 9.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.464 -173.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.467 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 53.3 t80 -83.09 -37.47 23.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -171.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.67 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 17.7 t70 75.13 107.92 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.697 0.623 . . . . 0.0 110.33 -174.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 83.6 t80 -139.82 100.7 7.29 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 8.2 Cg_endo -89.03 78.37 1.09 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.018 2.478 . . . . 0.0 112.502 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.64 -22.41 66.93 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.162 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.4 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 53.3 m-80 49.53 55.01 10.02 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.47 -0.865 . . . . 0.0 112.815 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -153.48 171.39 18.77 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.675 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -79.86 -16.07 56.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.147 0.498 . . . . 0.0 110.929 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.43 -10.19 17.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.604 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -135.73 92.14 2.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.599 ' HB3' ' CG2' ' A' ' 173' ' ' ILE . 46.8 tp -67.91 122.66 84.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.807 0.337 . . . . 0.0 110.793 -175.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.552 ' HD2' HD13 ' A' ' 142' ' ' LEU . 66.2 Cg_endo -71.62 99.68 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.403 2.069 . . . . 0.0 111.066 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.578 ' CG ' HG23 ' A' ' 130' ' ' THR . 6.3 p90 -116.49 155.67 28.22 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.85 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.67 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 52.8 mttp -101.7 176.17 5.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.15 -174.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.874 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -83.65 69.5 10.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.956 0.884 . . . . 0.0 109.421 176.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.5 23.43 0.73 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.591 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 145' ' ' LYS . 8.1 tp10 -92.93 153.53 18.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.678 HD13 HD22 ' A' ' 181' ' ' LEU . 43.1 mm -104.61 128.21 58.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 165' ' ' ASN . 18.2 mt -122.65 159.02 28.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.544 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 42.1 t -117.01 129.02 74.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.55 HG22 HD11 ' A' ' 125' ' ' LEU . 38.3 mm -75.81 93.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.815 0.817 . . . . 0.0 109.641 -175.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.711 HG21 HG21 ' A' ' 170' ' ' VAL . 8.6 tp -91.04 -33.56 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.001 -172.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.024 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 19.3 mt-10 -132.02 143.63 50.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -145.32 75.06 13.91 Favored Pre-proline 0 C--N 1.323 -0.585 0 O-C-N 121.66 -0.65 . . . . 0.0 111.093 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.526 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 14.0 Cg_exo -68.28 -40.11 8.97 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.716 2.277 . . . . 0.0 111.678 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -112.26 -178.51 3.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.098 -175.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -110.27 -18.19 13.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.31 0.576 . . . . 0.0 109.599 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -88.88 -30.35 18.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.96 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.729 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 36.8 m95 -128.97 134.53 48.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.473 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.756 ' O ' HG13 ' A' ' 173' ' ' ILE . 41.5 m0 -124.82 135.21 52.73 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.906 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 1.024 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.6 m -85.62 101.74 12.97 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.511 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -106.59 161.74 14.36 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 122.058 -0.401 . . . . 0.0 110.404 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.544 ' HG2' ' HB ' ' A' ' 151' ' ' VAL . 15.2 ptt180 -105.32 133.57 49.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.82 0.343 . . . . 0.0 110.317 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.519 ' HA ' HD22 ' A' ' 150' ' ' LEU . 60.2 t30 -64.71 170.41 4.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.905 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.406 ' HG3' ' OE1' ' A' ' 148' ' ' GLU . 8.9 mtmm -61.79 -16.34 48.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.11 0.481 . . . . 0.0 110.515 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.55 -1.8 58.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.283 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.42 -8.37 79.92 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.343 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.767 ' HA ' ' HB3' ' A' ' 211' ' ' GLN . 7.0 ttp-105 -68.59 129.24 39.36 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.803 -0.234 . . . . 0.0 111.103 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.711 HG21 HG21 ' A' ' 153' ' ' ILE . 73.5 t -89.73 128.53 41.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.675 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -153.17 149.02 20.51 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.025 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.729 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -69.5 130.62 42.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.755 0.312 . . . . 0.0 110.432 178.396 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.756 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -133.29 146.78 62.32 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.364 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.431 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 4.0 Cg_exo -77.39 134.54 14.11 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.724 2.283 . . . . 0.0 112.28 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.578 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 66.9 t -65.47 -40.83 45.54 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 27.4 Cg_endo -63.61 -4.56 7.16 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.824 1.683 . . . . 0.0 112.973 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-85 -96.69 -6.05 37.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.407 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.873 HG11 HG22 ' A' ' 130' ' ' THR . 15.5 m -126.6 163.92 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -168.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.436 ' CG ' HD13 ' A' ' 131' ' ' LEU . 4.7 mm-40 -139.87 163.94 31.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.587 170.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.535 ' N ' ' HD3' ' A' ' 180' ' ' LYS . 2.8 mppt? -98.97 137.86 36.91 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.573 0.225 . . . . 0.0 110.908 -172.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.678 HD22 HD13 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -53.85 -80.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.508 HG23 ' H ' ' A' ' 184' ' ' SER . 10.7 m -111.08 -30.6 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -171.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 184' ' ' SER . 3.8 tpt180 66.56 20.05 10.83 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.442 0.464 . . . . 0.0 110.532 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 183' ' ' ARG . 12.1 t 169.87 124.28 0.01 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.07 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 2.6 p -78.37 140.85 60.82 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 43.8 Cg_exo -56.89 108.71 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.146 2.564 . . . . 0.0 112.968 -178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -123.85 -5.98 7.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.308 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.69 -50.96 2.93 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -171.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -84.12 -28.93 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.527 . . . . 0.0 109.789 172.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.456 ' HB3' ' OG ' ' A' ' 184' ' ' SER . 90.4 m-70 -115.88 153.54 31.35 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.566 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 86.38 -100.83 2.56 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -139.53 140.14 37.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -83.52 159.97 21.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.223 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.6 m120 74.78 -30.65 0.2 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.375 0.67 . . . . 0.0 111.979 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 12.6 p -76.0 74.28 2.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.569 0.7 . . . . 0.0 109.613 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -84.44 -5.81 59.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.927 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 19.2 t -138.39 143.38 39.77 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -160.66 -58.16 0.06 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.99 0.424 . . . . 0.0 110.391 -176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -153.16 172.57 32.1 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.952 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.908 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 68.3 mt -128.75 -63.44 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.618 -0.141 . . . . 0.0 110.618 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.908 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 5.3 Cg_exo -78.15 127.7 8.56 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.389 2.059 . . . . 0.0 112.398 -177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -122.49 99.7 42.28 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.417 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.83 48.19 2.76 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 123.473 2.782 . . . . 0.0 112.371 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -161.69 -164.06 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.189 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 73.2 t60 61.75 29.93 18.21 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.566 0.698 . . . . 0.0 110.202 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.64 -175.34 5.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.0 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.73 ' O1P' ' HE1' ' A' ' 207' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.482 ' HA ' ' NH1' ' A' ' 164' ' ' ARG . . . 70.51 -71.53 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.335 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 1.013 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 51.9 mt-30 58.67 63.99 3.68 Favored Pre-proline 0 C--N 1.326 -0.428 0 O-C-N 123.601 0.563 . . . . 0.0 110.374 -171.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 73' ' ' ILE . 8.2 Cg_exo -72.66 145.45 41.59 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.061 2.508 . . . . 0.0 113.013 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.767 ' HB3' ' HA ' ' A' ' 169' ' ' ARG . 31.6 tt0 -133.69 125.9 29.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.05 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.573 HG22 ' H ' ' A' ' 213' ' ' THR . 11.8 m -100.9 176.82 5.15 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.573 ' H ' HG22 ' A' ' 212' ' ' THR . 17.2 m -64.33 92.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.003 0.43 . . . . 0.0 110.836 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 90.7 m -93.61 113.87 61.45 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.308 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.52 115.96 3.5 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.864 2.376 . . . . 0.0 111.979 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 47.9 tp -80.85 112.82 35.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.181 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 12.2 Cg_endo -90.62 21.19 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.385 2.724 . . . . 0.0 112.49 -177.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -144.55 168.3 20.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.025 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 10.8 p -100.98 -32.28 3.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 12.9 t 67.24 -70.05 0.12 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 117.45 152.2 9.47 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.733 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.2 m -151.02 72.83 8.63 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 120.649 0.261 . . . . 0.0 110.869 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.85 -17.1 15.87 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.383 2.055 . . . . 0.0 112.166 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 96.0 -174.64 31.64 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.59 140.15 46.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.748 0.274 . . . . 0.0 110.579 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.05 -44.75 53.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.406 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 20.3 pt -79.24 124.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.54 174.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.9 m -104.9 104.64 47.55 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 227' ' ' ILE . 5.2 Cg_exo -79.77 127.81 7.3 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.252 2.635 . . . . 0.0 112.042 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.519 HD13 HG23 ' A' ' 233' ' ' THR . 1.9 tm? -69.2 119.99 73.83 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.447 ' HB2' ' H ' ' A' ' 232' ' ' SER . 23.3 Cg_exo -64.05 -82.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.611 2.208 . . . . 0.0 112.382 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.447 ' H ' ' HB2' ' A' ' 231' ' ' PRO . 41.3 m -165.73 118.45 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.125 176.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.519 HG23 HD13 ' A' ' 230' ' ' LEU . 12.1 p -80.32 145.95 31.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.531 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.415 HE21 ' HB2' ' A' ' 234' ' ' GLN . 0.0 OUTLIER -81.52 16.04 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.432 -178.032 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.473 ' OD1' ' HB ' ' A' ' 233' ' ' THR . 2.2 m-20 -57.08 -45.95 82.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.764 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 166.14 89.13 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.122 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -89.49 97.61 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.825 2.35 . . . . 0.0 112.209 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.555 ' HB ' HG13 ' A' ' 266' ' ' VAL . 21.7 t -82.71 142.28 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.47 134.95 52.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.02 0.438 . . . . 0.0 110.922 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -138.93 131.87 29.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.372 175.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.409 ' HG3' ' CE1' ' A' ' 294' ' ' PHE . 92.3 mttt -84.46 124.02 30.89 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.565 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -76.94 100.42 5.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.018 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 36.0 pt -88.79 -15.69 8.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.266 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 244' ' ' GLN . 0.7 OUTLIER -140.3 135.69 32.49 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.402 ' HG3' HG21 ' A' ' 260' ' ' VAL . 27.4 mtpp -50.68 137.19 20.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 112.547 -175.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.714 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -111.86 91.64 3.73 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.9 m -86.28 156.16 57.09 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.781 0.324 . . . . 0.0 111.306 -175.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.37 111.59 2.34 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.881 2.387 . . . . 0.0 111.88 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 42.7 t -68.56 165.17 19.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.18 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.93 -27.78 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -171.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -73.84 -21.61 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.536 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 41.82 68.66 0.43 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.601 0.76 . . . . 0.0 112.217 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -148.31 -62.04 0.25 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.056 0.455 . . . . 0.0 110.837 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.7 p -99.34 11.31 39.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.14 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -95.03 107.04 19.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.312 -174.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.49 120.0 27.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.714 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -75.98 111.25 11.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.143 0.497 . . . . 0.0 110.586 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.0 mt -114.52 144.14 43.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.315 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.99 167.41 9.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.371 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.402 HG21 ' HG3' ' A' ' 245' ' ' LYS . 58.3 t -77.41 121.31 29.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.976 0.417 . . . . 0.0 110.489 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 100.32 9.95 46.25 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.87 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -92.1 148.77 21.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 16.4 mm -99.35 111.65 29.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 0.0 110.186 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.44 HG23 HG13 ' A' ' 291' ' ' VAL . 35.7 t -87.51 115.21 27.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.179 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.625 ' HZ1' ' HG2' ' A' ' 278' ' ' GLU . 9.5 ttpp -96.91 98.95 10.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.555 HG13 ' HB ' ' A' ' 238' ' ' VAL . 6.5 p -94.85 124.72 47.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.264 0.554 . . . . 0.0 110.585 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 88.2 m -116.75 -35.19 4.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.052 176.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -91.36 92.29 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.224 0.535 . . . . 0.0 110.07 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.783 ' HA ' ' HB3' ' A' ' 275' ' ' TRP . 29.9 mtt -97.58 139.61 33.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.879 0.371 . . . . 0.0 110.886 177.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -93.57 -175.01 3.65 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.3 tt -73.52 71.87 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.796 0.808 . . . . 0.0 110.976 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 73.65 -37.99 0.39 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.903 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 274' ' ' GLN . . . -91.43 78.59 1.34 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.159 -1.019 . . . . 0.0 113.02 -169.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.461 ' HG2' ' HA ' ' A' ' 287' ' ' PRO . 46.5 mt-30 75.67 128.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.894 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.783 ' HB3' ' HA ' ' A' ' 269' ' ' MET . 0.6 OUTLIER -124.62 169.57 11.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.36 -169.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 38.8 mt-10 -107.54 108.45 19.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.607 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.31 133.3 11.58 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.168 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.625 ' HG2' ' HZ1' ' A' ' 265' ' ' LYS . 1.4 pm0 -95.04 108.81 20.9 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.291 0.567 . . . . 0.0 109.489 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 27.1 t -115.74 -87.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.143 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -92.04 72.67 5.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.08 0.467 . . . . 0.0 111.059 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.89 4.89 78.41 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.729 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -159.97 162.6 34.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.207 0.503 . . . . 0.0 111.426 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 278' ' ' GLU . 10.1 ptmm? -116.88 138.79 51.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -154.35 175.8 32.4 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.146 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.49 127.17 34.84 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.094 0.473 . . . . 0.0 110.792 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -127.43 125.76 23.97 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.023 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 17.0 Cg_exo -68.31 139.61 46.21 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.636 2.224 . . . . 0.0 111.409 176.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -75.66 26.26 0.11 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 287' ' ' PRO . 8.7 t -115.48 -9.82 12.03 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.961 0.41 . . . . 0.0 109.953 171.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -90.34 -30.34 17.51 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 242' ' ' ALA . 18.0 m -124.25 161.53 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.51 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -130.75 133.16 45.78 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.02 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 240' ' ' ALA . 43.6 mm -70.76 111.98 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.723 178.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.409 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 34.8 p90 -111.12 142.08 43.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.901 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' A' ' 298' ' ' ASN . 38.8 t70 -72.11 124.11 90.39 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.473 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 295' ' ' ASP . 39.6 Cg_exo -57.81 -32.41 94.84 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.168 2.579 . . . . 0.0 113.179 -176.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.43 ' HG3' ' OD2' ' A' ' 295' ' ' ASP . 8.3 pt20 -98.07 9.05 43.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.802 0.334 . . . . 0.0 111.205 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.703 ' HB2' ' HB3' ' A' ' 295' ' ' ASP . 64.7 m-20 -129.56 81.86 68.75 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.905 175.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.56 88.03 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.077 2.518 . . . . 0.0 111.677 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 76.64 16.95 1.9 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.872 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . 0.657 ' HB3' ' HB3' ' A' ' 298' ' ' ASN . 10.5 tp10 -85.77 83.31 7.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 170.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -115.19 -75.15 0.59 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.493 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.648 -0.692 . . . . 0.0 110.182 -177.643 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' HB2' ' H ' ' A' ' 2' ' ' SER . 12.4 mmt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' A' ' 1' ' ' MET . 20.0 m -112.92 -55.44 2.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 172.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m 67.23 -59.37 0.4 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.913 0.758 . . . . 0.0 111.071 -176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.37 111.97 11.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.902 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -134.38 84.96 2.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.847 0.355 . . . . 0.0 111.0 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.421 ' HE1' ' O ' ' A' ' 98' ' ' LEU . 41.7 p90 -161.22 164.22 30.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.863 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 12.8 t70 -90.02 120.24 31.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 40.5 m -70.13 -16.53 63.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.856 -172.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -103.46 -11.79 17.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.89 0.376 . . . . 0.0 111.505 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 11.1 t0 -75.62 94.47 3.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.174 0.512 . . . . 0.0 110.879 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.3 mtm-85 -65.84 -25.19 67.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.311 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -73.88 1.83 9.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.849 0.357 . . . . 0.0 110.781 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.84 -47.43 3.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.718 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -114.05 -20.34 11.03 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -76.21 120.32 21.33 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.104 -0.372 . . . . 0.0 110.999 -172.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.628 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.6 mmt -102.12 -16.18 16.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.963 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.461 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.88 -112.57 1.71 Allowed Glycine 0 CA--C 1.525 0.667 0 O-C-N 123.431 0.457 . . . . 0.0 113.543 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.461 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 16.8 Cg_exo -66.55 83.06 0.3 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.217 2.611 . . . . 0.0 113.518 -176.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.974 HG13 ' H ' ' A' ' 20' ' ' SER . 57.5 t -135.33 -164.66 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.974 ' H ' HG13 ' A' ' 19' ' ' VAL . 45.7 p -172.68 174.32 3.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -168.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -53.07 60.9 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.092 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -57.12 -61.9 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.495 0.497 . . . . 0.0 111.532 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -57.72 -47.16 83.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.654 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . -57.54 -49.87 74.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.055 0.455 . . . . 0.0 111.641 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -61.56 -44.34 97.22 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.801 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m -57.85 -38.33 75.47 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -81.31 -9.52 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 80.1 mt -122.41 -12.98 8.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.902 HE21 ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -74.36 117.26 15.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.971 0.415 . . . . 0.0 111.272 -174.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.97 3.05 63.19 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.75 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -80.75 -171.42 3.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.654 0.264 . . . . 0.0 110.453 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.469 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 17.2 mtm180 -60.79 152.71 26.3 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.639 ' HE1' ' HB2' ' A' ' 118' ' ' LEU . 62.3 m170 -98.54 142.08 30.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.11 -9.04 54.3 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -172.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.63 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 73.8 mtp -76.75 138.25 39.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.38 -0.41 . . . . 0.0 109.895 176.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.441 ' HB2' HG23 ' A' ' 52' ' ' VAL . 27.3 p90 -144.02 167.47 22.29 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.628 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -158.94 146.93 17.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.5 116.11 50.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.677 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.48 ' NH2' ' HE2' ' A' ' 207' ' ' PTR . 36.1 ptt-85 -114.17 -179.31 3.6 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.601 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -86.46 138.04 32.07 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -89.23 177.77 6.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.398 0.618 . . . . 0.0 111.433 -174.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 m -110.4 -4.94 15.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.21 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 p -73.98 -65.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.822 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 26.6 m -133.37 143.29 47.49 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.639 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.93 88.64 0.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.239 1.959 . . . . 0.0 111.334 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 145.72 -21.63 1.82 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -77.52 150.99 34.76 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -130.43 173.78 10.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.538 HG21 HG12 ' A' ' 62' ' ' ILE . 9.5 t -138.93 109.67 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.122 0.487 . . . . 0.0 111.722 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.6 tp -83.29 97.61 8.99 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.322 175.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.9 m -95.75 117.09 29.86 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.685 0.278 . . . . 0.0 110.254 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.51 HG21 HD12 ' A' ' 93' ' ' LEU . 60.4 t -113.23 133.62 58.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.405 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.568 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 48.1 t -102.05 118.05 36.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.705 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 10.7 tp10 -151.18 153.22 34.55 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.502 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 63.4 m-80 57.41 21.85 7.31 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.323 0.389 . . . . 0.0 111.822 -177.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 m 57.6 51.51 9.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.253 1.025 . . . . 0.0 108.996 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 1.026 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.29 0.0 OUTLIER -166.81 70.03 0.11 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.376 -155.784 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 22.5 t -71.93 110.86 5.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.883 -168.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.3 m -76.64 120.46 21.86 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.282 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.662 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 91.3 m-70 -97.71 89.9 4.79 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -173.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.859 ' HE1' HD13 ' A' ' 153' ' ' ILE . 75.5 m-85 -89.05 106.76 18.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.538 HG12 HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -80.51 136.41 23.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.209 0.528 . . . . 0.0 111.97 -178.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.525 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.6 mp -117.88 106.57 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.534 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -83.58 148.67 27.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.735 0.302 . . . . 0.0 110.548 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.9 t -85.49 109.32 18.4 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 72' ' ' LYS . 98.2 mt -79.41 147.43 68.28 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.544 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.8 -13.47 37.22 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.695 2.263 . . . . 0.0 110.547 170.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -75.39 -0.72 20.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.366 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.575 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 3.1 mmp_? 64.71 28.51 13.04 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.972 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 70' ' ' ARG . 59.1 mtt85 -124.8 157.37 35.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.537 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.525 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 25.7 m-85 -105.6 114.93 29.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.888 0.375 . . . . 0.0 110.519 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.543 ' HB2' HD12 ' A' ' 66' ' ' LEU . 38.6 ttpt -103.53 111.96 24.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.546 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.602 HD13 ' HB3' ' A' ' 61' ' ' TYR . 7.9 tt -93.23 75.26 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 122.179 0.99 . . . . 0.0 109.124 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.41 ' HA3' ' HG2' ' A' ' 209' ' ' GLN . . . 66.07 97.78 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.979 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.742 ' HA ' HG23 ' A' ' 212' ' ' THR . 42.4 t0 75.49 -51.5 0.64 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.649 0.379 . . . . 0.0 111.381 168.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -94.05 119.27 32.69 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.8 pt-20 -100.24 135.77 41.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.319 0.58 . . . . 0.0 110.796 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.457 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 94.2 m-85 -115.86 177.12 4.79 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.473 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.43 -49.68 74.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.903 0.382 . . . . 0.0 111.167 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -164.52 -175.43 3.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 15.2 mt -53.22 -58.82 10.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HB3' ' O ' ' A' ' 8' ' ' SER . 30.6 Cg_endo -64.89 -4.75 9.31 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.206 1.937 . . . . 0.0 113.433 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.87 -36.63 15.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.813 0.339 . . . . 0.0 110.425 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -77.11 -37.03 55.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.16 -38.8 84.27 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.832 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 1.9 tp10 -66.26 -43.84 85.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.725 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -64.91 -28.3 69.44 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.432 0.634 . . . . 0.0 110.968 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.68 ' CG ' HD21 ' A' ' 93' ' ' LEU . 20.6 m-85 -92.03 1.73 57.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.324 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 56.8 mtpt -85.02 3.54 38.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 175.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.3 pt -140.53 -8.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-O 121.252 0.549 . . . . 0.0 109.706 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 4.4 t60 -86.17 -36.68 19.36 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.973 -174.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 93.8 m-85 70.13 91.69 0.09 Allowed 'General case' 0 C--O 1.225 -0.205 0 O-C-N 124.277 0.986 . . . . 0.0 109.033 -166.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.68 HD21 ' CG ' ' A' ' 88' ' ' TYR . 25.1 mt -58.67 -44.76 90.27 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.351 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.946 ' HA ' ' HG2' ' A' ' 154' ' ' GLU . 28.3 p-10 -150.51 48.82 0.88 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.627 -166.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.8 OUTLIER 70.63 -5.73 1.37 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.413 1.885 . . . . 0.0 111.635 -169.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.578 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -126.13 151.64 46.99 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.424 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.0 p -96.72 167.05 11.35 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.421 ' O ' ' HE1' ' A' ' 6' ' ' PHE . 72.6 mt -65.38 99.66 0.42 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 97' ' ' THR . 48.0 mm -87.4 -64.06 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.343 -172.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 35' ' ' MET . 42.0 tt0 -156.86 126.01 3.09 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.201 -174.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.68 153.71 47.66 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.023 2.482 . . . . 0.0 113.127 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.62 154.23 94.98 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.514 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.61 115.78 2.76 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 121.904 1.736 . . . . 0.0 111.672 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.483 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 54.3 ttp180 -63.19 -27.16 69.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.439 0.638 . . . . 0.0 109.7 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -78.66 155.67 78.26 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.793 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.0 161.7 38.59 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.567 2.178 . . . . 0.0 112.434 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.2 p -112.32 87.31 9.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.49 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 42.0 Cg_exo -57.84 -46.86 23.66 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.935 2.423 . . . . 0.0 113.423 175.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 3.7 Cg_exo -79.05 -153.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.98 1.787 . . . . 0.0 111.636 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -64.77 -30.94 71.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.926 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.81 45.57 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.481 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 m 55.35 47.89 20.33 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.687 0.395 . . . . 0.0 111.397 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.7 t 66.44 97.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.686 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.496 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 3.8 m -86.63 92.47 8.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.274 -178.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.62 93.48 14.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.931 0.396 . . . . 0.0 111.062 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 114' ' ' SER . 84.1 Cg_endo -98.71 118.23 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 123.426 2.751 . . . . 0.0 112.831 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -71.76 90.09 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.639 ' HB2' ' HE1' ' A' ' 33' ' ' HIS . 1.3 tm? -177.85 131.32 0.32 Allowed Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -175.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.45 79.45 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.71 2.274 . . . . 0.0 112.402 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.9 m 63.07 -86.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.231 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 177.19 -73.54 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 123.073 0.549 . . . . 0.0 109.787 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 64.81 22.81 12.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.875 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 124' ' ' ASN . 17.4 m-20 59.73 -145.56 0.51 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.918 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.513 ' HB3' HD21 ' A' ' 125' ' ' LEU . 0.9 OUTLIER 78.04 161.42 0.21 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.749 0.656 . . . . 0.0 111.759 177.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.568 ' HG ' ' HD2' ' A' ' 155' ' ' LYS . 3.3 mm? 65.03 99.21 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.504 175.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 44.3 tt0 -175.59 -54.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.207 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.746 ' HB2' HG22 ' A' ' 182' ' ' VAL . 55.0 m-85 -118.5 107.5 13.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.909 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.627 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 4.2 t -116.26 140.02 40.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.709 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 4.9 ptp180 -115.24 138.61 50.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 116.71 -1.996 . . . . 0.0 108.682 164.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.557 ' HB ' ' CD2' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -100.67 125.5 47.1 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.738 -178.036 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.49 HD12 ' HB2' ' A' ' 179' ' ' GLU . 17.2 mt -99.22 -26.32 14.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.243 -173.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.533 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 34.7 t80 -73.48 -41.98 62.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -172.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.542 ' HB2' ' C ' ' A' ' 145' ' ' LYS . 6.0 t70 75.24 100.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.699 0.761 . . . . 0.0 110.832 -174.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 53.5 t80 -128.7 86.78 56.66 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 89.6 Cg_endo -83.6 86.72 1.33 Allowed 'Trans proline' 0 N--CA 1.441 -1.611 0 C-N-CA 121.147 1.231 . . . . 0.0 112.368 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.67 -24.47 60.35 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.557 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.6 m120 61.6 50.83 4.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.709 -1.246 . . . . 0.0 112.22 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -136.67 176.25 8.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.273 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.82 -13.83 35.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 122.11 0.957 . . . . 0.0 108.496 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.558 ' O ' ' HB2' ' A' ' 172' ' ' MET . 19.6 mm-40 -88.02 -31.4 19.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.244 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -135.2 105.76 6.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.939 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.723 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 26.5 tp -66.94 128.79 94.0 Favored Pre-proline 0 CA--C 1.51 -0.563 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.989 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 92.4 Cg_endo -79.34 98.08 1.14 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 121.384 1.389 . . . . 0.0 111.306 173.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.564 ' CE1' ' HB ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -89.32 -165.1 1.26 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.542 ' C ' ' HB2' ' A' ' 133' ' ' ASP . 56.2 mtpt -139.49 -176.02 4.39 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.408 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.91 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -82.99 50.41 1.72 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.665 0.745 . . . . 0.0 110.665 -174.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.99 35.28 0.17 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.647 ' OE1' ' HB2' ' A' ' 166' ' ' LYS . 5.1 tp10 -84.34 151.8 24.5 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.983 -173.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.3 122.82 64.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.549 0.69 . . . . 0.0 109.157 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.675 HD22 ' CD2' ' A' ' 142' ' ' LEU . 65.4 mt -123.67 157.57 33.53 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.008 -171.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.532 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 66.1 t -117.3 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 161' ' ' TRP . 45.6 mm -76.86 95.48 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-O 122.177 0.989 . . . . 0.0 109.508 -175.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.859 HD13 ' HE1' ' A' ' 61' ' ' TYR . 19.3 tt -81.64 -28.07 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.602 -175.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.026 ' HA ' HH21 ' A' ' 57' ' ' ARG . 4.0 mt-10 -136.37 144.39 44.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.144 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.613 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 86.8 tttt -124.31 76.53 61.28 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 164.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.54 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 23.2 Cg_exo -67.2 -51.17 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.768 2.312 . . . . 0.0 111.778 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -113.8 177.54 4.6 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.619 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -100.18 -16.98 17.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.976 0.417 . . . . 0.0 110.3 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -99.8 -19.79 16.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.574 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 39.7 m95 -129.74 141.95 50.79 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.741 ' O ' HG13 ' A' ' 173' ' ' ILE . 46.5 m0 -124.92 137.86 54.26 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 6.1 m -97.7 109.88 22.55 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 150' ' ' LEU . . . -121.29 152.1 39.3 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.244 -176.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.761 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 27.1 ptt-85 -87.65 127.69 35.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 173.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.723 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 56.3 t30 -61.75 178.01 0.37 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.133 -172.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.665 ' HG2' HG22 ' A' ' 214' ' ' THR . 3.6 ttmp? -54.19 -26.03 25.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.303 166.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 211' ' ' GLN . 24.7 m-20 -74.98 -38.45 61.66 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.03 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 211' ' ' GLN . . . 115.32 -11.85 19.37 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.458 -175.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.761 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -59.12 138.18 57.66 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.26 0.624 . . . . 0.0 112.051 177.434 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 74.0 t -88.76 121.07 38.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.542 177.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -153.73 156.2 26.64 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.438 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.574 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -77.55 143.68 38.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.805 0.303 . . . . 0.0 111.295 178.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -142.07 142.0 23.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.526 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 20.4 Cg_exo -65.95 129.46 22.02 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.715 2.277 . . . . 0.0 112.879 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 44.9 t -62.72 -40.1 60.68 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 17.5 Cg_endo -59.39 -11.28 13.11 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.023 1.815 . . . . 0.0 112.627 175.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -93.29 -10.53 35.16 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.604 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.494 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 2.1 m -105.98 -177.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -166.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.709 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 3.4 tp10 -159.43 44.82 0.25 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 112.467 -2.151 . . . . 0.0 110.833 -154.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.706 ' H ' ' HD2' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -74.02 138.7 44.25 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 119.174 -2.204 . . . . 0.0 112.87 -162.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 22.8 tp -75.77 -70.55 0.43 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 110.773 -2.921 . . . . 0.0 111.386 -168.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.746 HG22 ' HB2' ' A' ' 127' ' ' TYR . 16.5 m -78.2 70.33 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 122.151 0.977 . . . . 0.0 110.329 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.76 -52.75 0.09 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.056 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.3 m 48.63 73.78 0.21 Allowed 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 124.292 0.995 . . . . 0.0 111.02 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 3.7 m -53.56 147.6 20.63 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.108 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.82 104.57 0.1 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.57 2.18 . . . . 0.0 112.589 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.879 ' HB2' ' HB3' ' A' ' 190' ' ' HIS . 40.5 m80 -124.01 -14.91 7.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.35 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.06 -98.96 1.76 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -174.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -71.44 90.91 1.0 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 170.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.879 ' HB3' ' HB2' ' A' ' 187' ' ' HIS . 22.6 p-80 -136.16 136.48 40.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.985 -175.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 80.1 -45.86 3.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.149 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 63.83 14.46 8.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.855 0.462 . . . . 0.0 111.198 176.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 193' ' ' ARG . 3.4 mpt_? 55.48 39.06 31.03 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.733 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -67.71 -29.45 68.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.562 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.1 p -147.92 114.23 5.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.644 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -90.11 -75.03 0.47 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 54.4 p -179.54 148.7 0.35 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.834 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -74.44 -22.45 59.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.532 0.682 . . . . 0.0 109.314 174.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.483 ' O ' ' HB ' ' A' ' 200' ' ' ILE . . . 161.45 69.9 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.29 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 199' ' ' GLY . 2.0 mp 74.06 118.26 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.31 0 CA-C-O 121.113 0.482 . . . . 0.0 110.504 -174.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 7.6 Cg_exo -73.01 144.72 38.54 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.099 2.533 . . . . 0.0 112.085 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -116.57 95.76 46.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.528 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -91.04 -7.64 3.64 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.698 2.265 . . . . 0.0 112.087 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 59.78 81.13 0.18 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.234 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -81.76 87.69 6.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.03 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -88.86 -166.68 1.66 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.243 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' PTR . . . . . 0.662 ' HD2' ' HB3' ' A' ' 60' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.562 ' HB1' ' N ' ' A' ' 60' ' ' HIS . . . -90.32 3.83 52.52 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.307 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.519 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 49.8 tt0 -47.24 129.73 9.7 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.635 173.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 209' ' ' GLN . 15.8 Cg_exo -64.08 102.76 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.809 1.673 . . . . 0.0 109.756 177.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.474 ' HB2' ' HA3' ' A' ' 168' ' ' GLY . 13.4 mm100 -46.96 141.15 4.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.143 0.497 . . . . 0.0 112.131 -171.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.742 HG23 ' HA ' ' A' ' 75' ' ' ASP . 18.0 m -88.14 88.26 7.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.378 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 10.2 m 72.02 157.48 0.18 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.804 0.69 . . . . 0.0 110.24 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.665 HG22 ' HG2' ' A' ' 166' ' ' LYS . 9.6 p -54.37 118.76 17.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.26 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.97 90.3 0.25 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.028 2.485 . . . . 0.0 112.001 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.441 ' N ' ' HD2' ' A' ' 217' ' ' PRO . 91.6 mt -72.84 -53.89 5.05 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.987 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 216' ' ' LEU . 18.6 Cg_endo -61.34 -54.56 1.67 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.802 1.668 . . . . 0.0 112.134 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -167.08 164.34 15.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.621 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.57 -41.11 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.262 0.553 . . . . 0.0 110.248 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 28.6 m -147.49 101.61 3.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.706 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 178.81 -167.94 38.57 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.798 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 23.1 t -147.59 139.18 13.66 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 26.0 Cg_exo -63.96 147.62 91.86 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.865 2.377 . . . . 0.0 112.235 177.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -166.4 150.09 16.83 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.041 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.66 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . . . 59.24 64.37 1.38 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 122.83 0.452 . . . . 0.0 111.745 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -84.73 117.85 24.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.123 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.6 mt 70.55 -64.91 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.714 0.634 . . . . 0.0 110.994 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 83.6 m -151.27 126.75 4.87 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 177.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.66 ' HG3' ' HB3' ' A' ' 225' ' ' ALA . 10.7 Cg_exo -69.28 -92.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.52 2.147 . . . . 0.0 111.735 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.423 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 86.5 mt -151.77 127.37 4.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.902 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.06 171.82 8.3 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.854 2.369 . . . . 0.0 111.674 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 24.2 m -61.53 97.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.812 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 234' ' ' GLN . 3.3 p -92.59 -28.86 16.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.794 -175.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 233' ' ' THR . 59.0 mm-40 67.88 85.1 0.15 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.76 0.662 . . . . 0.0 111.251 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.78 3.25 39.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.532 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 107.02 88.89 2.06 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.25 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 7.5 Cg_exo -73.51 89.1 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.61 2.206 . . . . 0.0 110.831 171.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.7 t -93.43 145.22 8.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.037 -174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -93.77 123.45 37.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.173 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.494 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -119.81 143.34 47.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.175 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.5 ' HZ1' ' CD ' ' A' ' 301' ' ' GLU . 45.0 tttp -90.89 119.08 30.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.15 0.5 . . . . 0.0 109.752 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 1.004 ' HB1' ' HG2' ' A' ' 259' ' ' GLU . . . -84.23 127.22 33.81 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.781 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 46.2 pt -128.12 -30.1 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -168.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -82.62 -75.9 0.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.298 -169.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.764 ' HA ' ' CB ' ' A' ' 259' ' ' GLU . 1.0 OUTLIER 153.85 131.25 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.391 1.476 . . . . 0.0 108.183 168.495 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.524 ' H ' ' HB2' ' A' ' 259' ' ' GLU . 19.2 mmm180 -124.2 100.61 6.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.917 0.389 . . . . 0.0 110.968 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.5 m -117.42 127.0 26.96 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.453 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.486 ' HB2' ' HB2' ' A' ' 252' ' ' ASP . 88.9 Cg_endo -87.8 160.86 7.63 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.029 2.486 . . . . 0.0 112.266 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 11.7 t -94.25 -177.1 4.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.41 -21.88 66.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.918 0.39 . . . . 0.0 111.18 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.09 -22.27 36.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.4 -178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 248' ' ' PRO . 37.7 m-20 -93.48 102.81 15.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.191 -172.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -94.9 -33.9 12.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.171 0.51 . . . . 0.0 109.734 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 19.5 p -93.25 8.18 41.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.737 -176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 248' ' ' PRO . . . -93.0 126.76 38.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.456 HD13 HD21 ' A' ' 258' ' ' LEU . 0.6 OUTLIER -85.08 122.12 28.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.952 0.406 . . . . 0.0 110.524 -176.252 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -84.06 109.89 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.779 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 259' ' ' GLU . 0.4 OUTLIER -157.05 -156.25 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.166 176.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 1.004 ' HG2' ' HB1' ' A' ' 242' ' ' ALA . 3.7 mt-10 88.12 139.92 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 24.9 t 82.56 83.16 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 112.695 -2.048 . . . . 0.0 111.114 -172.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 89.98 14.38 59.33 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.417 -0.81 . . . . 0.0 113.48 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -105.36 145.99 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.974 0.416 . . . . 0.0 111.163 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 32.2 mm -98.45 111.4 28.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.495 HG22 HD23 ' A' ' 258' ' ' LEU . 43.5 t -92.83 117.25 35.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 -175.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -96.39 105.67 17.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.102 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 237' ' ' PRO . 2.4 p -94.67 118.01 39.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.999 0.428 . . . . 0.0 110.304 176.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -93.8 -24.37 17.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.173 0.511 . . . . 0.0 110.763 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.47 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 88.8 mtt180 -121.56 98.27 5.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.801 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.555 ' HE3' ' CZ2' ' A' ' 275' ' ' TRP . 1.2 mtt -91.39 112.93 25.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.321 0.581 . . . . 0.0 111.373 -176.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -92.13 158.79 15.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.173 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.5 tt -91.28 -14.98 8.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.347 0.594 . . . . 0.0 109.851 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.99 23.02 1.57 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.8 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 91.04 -55.63 3.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.136 -0.554 . . . . 0.0 114.077 168.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -77.81 114.84 17.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.346 0.593 . . . . 0.0 110.526 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.555 ' CZ2' ' HE3' ' A' ' 269' ' ' MET . 42.9 m0 -94.74 155.65 16.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.457 -175.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 0.2 OUTLIER -107.58 113.29 26.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.425 -179.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -141.73 168.35 25.61 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.288 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -118.25 110.16 17.21 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.529 ' HB ' HD22 ' A' ' 258' ' ' LEU . 43.9 t -139.93 146.72 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 63.61 24.51 14.0 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.094 0.473 . . . . 0.0 111.02 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 82.16 3.37 90.58 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.238 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -134.24 149.58 50.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.943 0.402 . . . . 0.0 110.767 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -103.6 143.26 32.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.274 178.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -172.18 170.74 43.72 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.477 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 95.3 mt -90.34 133.5 34.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.119 0.485 . . . . 0.0 111.122 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -134.62 147.85 64.93 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.184 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -87.77 139.29 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.685 2.257 . . . . 0.0 112.752 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -70.53 -11.52 60.98 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.063 0.459 . . . . 0.0 111.016 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.5 p -78.23 4.84 11.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.236 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -116.94 -49.11 2.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.657 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 242' ' ' ALA . 27.5 m -85.98 152.52 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.216 -175.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -109.29 124.34 50.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.797 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 240' ' ' ALA . 20.8 mm -79.77 127.62 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.473 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.464 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 2.6 p90 -146.08 173.19 12.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.166 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.596 ' HB2' ' HG2' ' A' ' 297' ' ' GLN . 14.7 p-10 -107.66 98.7 25.6 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-O 121.373 0.606 . . . . 0.0 111.049 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 3.9 Cg_exo -76.69 14.53 1.22 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.759 2.973 . . . . 0.0 111.97 -178.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.596 ' HG2' ' HB2' ' A' ' 295' ' ' ASP . 13.7 pt20 -78.66 -11.39 59.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.877 175.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 45.1 m-80 -93.07 150.53 39.38 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.447 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 5.3 Cg_exo -79.2 12.33 2.34 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 123.175 2.583 . . . . 0.0 112.889 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.26 -46.54 88.34 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . 0.5 ' CD ' ' HZ1' ' A' ' 241' ' ' LYS . 34.7 tt0 -113.52 79.46 1.25 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.493 0.663 . . . . 0.0 110.152 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -144.42 93.64 2.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.119 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.575 -177.358 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 98' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -114.73 25.32 11.06 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.361 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.552 ' CE1' ' HB1' ' A' ' 4' ' ' ALA . 46.2 p90 -69.47 140.49 54.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 165.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.45 118.69 18.59 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.582 -178.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.668 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 17.0 m -90.52 78.73 6.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.85 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -176.39 -53.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.068 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 12' ' ' SER . 34.8 t70 -78.18 127.75 32.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.311 0.577 . . . . 0.0 111.562 -170.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -51.82 -37.68 52.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.674 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.464 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 3.2 m -73.87 23.97 0.08 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.875 0.369 . . . . 0.0 111.929 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.428 ' HB3' ' HD1' ' A' ' 14' ' ' TRP . . . -118.59 -47.19 2.54 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.883 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.428 ' HD1' ' HB3' ' A' ' 13' ' ' ALA . 28.3 p-90 -132.21 -22.39 2.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -166.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -86.86 119.71 27.38 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.942 -171.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 55.6 mtt -117.09 5.78 12.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.908 0.385 . . . . 0.0 111.143 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 49.91 -114.4 2.4 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.247 -0.888 . . . . 0.0 114.73 174.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 15.3 Cg_exo -69.01 95.96 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.916 2.411 . . . . 0.0 112.608 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.859 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 95.3 t -128.88 -71.53 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.117 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.888 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 54.1 m 78.52 170.01 0.2 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.196 0.598 . . . . 0.0 110.439 172.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -49.05 -43.61 40.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 6.9 pt20 -46.57 -58.57 3.69 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.956 0.785 . . . . 0.0 112.81 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.54 ' HB2' HG13 ' A' ' 19' ' ' VAL . 23.5 mm-40 -85.65 -43.46 13.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.118 0.485 . . . . 0.0 110.467 -172.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.76 -37.41 63.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.765 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -72.25 -35.97 68.95 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.554 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 23' ' ' GLU . 10.8 t -79.8 -32.62 40.79 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.192 -174.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -84.65 -15.06 46.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.082 0.468 . . . . 0.0 111.173 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.475 HD11 ' HG ' ' A' ' 37' ' ' LEU . 78.3 mt -117.11 30.44 7.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.298 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -113.73 139.69 48.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.238 0.542 . . . . 0.0 111.671 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.09 -47.85 3.93 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.653 ' O ' ' HG3' ' A' ' 32' ' ' ARG . 77.9 mt-30 -131.91 80.47 1.92 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 118.875 1.338 . . . . 0.0 111.801 -168.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.981 ' HA ' ' HE2' ' A' ' 35' ' ' MET . 0.0 OUTLIER -169.22 146.07 3.49 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.523 -176.564 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.98 104.91 1.93 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 166.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.44 -3.67 69.09 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.566 -173.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.981 ' HE2' ' HA ' ' A' ' 32' ' ' ARG . 57.7 mtm -85.61 138.07 32.42 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.932 0.396 . . . . 0.0 110.511 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -144.27 174.33 10.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.743 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.2 pp -160.45 143.37 13.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.747 172.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.05 135.88 45.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.888 ' HD2' ' H ' ' A' ' 20' ' ' SER . 22.5 ptt-85 -139.64 155.26 47.52 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.397 -173.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.432 ' OD1' ' HA2' ' A' ' 17' ' ' GLY . 2.2 m-20 -66.18 118.25 9.63 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 168.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.525 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.4 t -84.44 170.06 13.91 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.993 0.425 . . . . 0.0 110.263 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t -112.23 7.13 19.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.484 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -53.68 27.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 47.4 t -170.62 121.74 0.55 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.414 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -40.41 104.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.464 2.776 . . . . 0.0 112.465 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.11 -21.73 2.62 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.209 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -103.25 145.36 30.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.076 0.465 . . . . 0.0 109.773 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.565 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 24.8 m-85 -126.42 160.19 31.18 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 41' ' ' SER . 44.0 t -128.16 103.46 10.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.471 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 tp -79.66 98.38 6.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.399 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 m -96.0 120.1 35.68 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.279 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.635 HG21 HD13 ' A' ' 93' ' ' LEU . 54.5 t -116.83 134.24 61.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.28 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 31.8 t -103.58 111.63 24.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.209 0.528 . . . . 0.0 111.78 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.557 ' HG3' ' HB ' ' A' ' 96' ' ' THR . 3.2 mm-40 -150.01 152.71 35.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.071 173.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 56.74 28.12 13.79 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.501 0.501 . . . . 0.0 110.877 -171.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.9 m 60.31 28.38 17.99 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.281 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 53' ' ' SER . 12.0 ptt-85 -124.53 158.29 33.29 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 t -110.56 95.21 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 t -81.22 118.8 22.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -100.63 99.91 10.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.675 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.793 ' HE1' HD11 ' A' ' 153' ' ' ILE . 63.1 m-85 -98.09 113.7 25.66 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.74 0.305 . . . . 0.0 111.205 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 68.5 mt -82.3 131.52 33.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.427 0.632 . . . . 0.0 112.448 -174.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 4.3 mp -98.25 122.55 50.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.176 174.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -111.4 132.53 54.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -77.78 110.35 12.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.449 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.726 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 93.1 mt -77.93 170.85 14.32 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.726 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 23.5 Cg_endo -61.69 56.37 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.007 2.472 . . . . 0.0 114.412 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 t30 79.92 4.99 1.94 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.34 0.656 . . . . 0.0 111.964 161.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -97.6 -51.26 4.18 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.836 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.684 ' HB3' ' HA ' ' A' ' 79' ' ' ASP . 5.8 ptp180 -156.32 -171.69 3.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.865 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.401 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 45.6 m-85 -109.72 157.92 18.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.595 0.236 . . . . 0.0 110.476 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.76 ' HE3' ' HA ' ' A' ' 75' ' ' ASP . 55.9 tttp -129.27 96.54 4.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.675 0.274 . . . . 0.0 110.278 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.547 HD13 ' HE2' ' A' ' 88' ' ' TYR . 3.1 tt -97.1 94.12 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.496 0.665 . . . . 0.0 109.869 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.94 57.38 7.84 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.277 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.76 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 25.1 t0 76.74 -50.21 0.57 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.16 0.584 . . . . 0.0 111.487 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -61.5 123.2 17.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.888 0.375 . . . . 0.0 110.057 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -107.2 130.33 54.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.723 0.773 . . . . 0.0 111.809 -176.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.542 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 7.8 m-85 -127.74 150.28 49.86 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.684 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 9.9 m-20 -62.43 -26.05 68.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -170.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 4.7 p80 -161.95 172.78 15.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.029 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.61 HD23 HD21 ' A' ' 84' ' ' LEU . 11.6 mt -56.55 -51.45 81.1 Favored Pre-proline 0 CA--C 1.537 0.455 0 O-C-N 123.373 0.42 . . . . 0.0 111.868 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.668 ' HB3' ' O ' ' A' ' 8' ' ' SER . 60.3 Cg_exo -57.35 -11.34 8.15 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.661 2.24 . . . . 0.0 114.095 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.95 -36.11 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.236 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.61 HD21 HD23 ' A' ' 81' ' ' LEU . 3.9 pp -76.33 -26.97 56.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.071 0.462 . . . . 0.0 110.557 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.81 -15.68 62.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.784 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -86.16 -37.46 18.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.886 0.374 . . . . 0.0 110.566 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -63.84 -37.7 88.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.28 0.562 . . . . 0.0 110.49 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.547 ' HE2' HD13 ' A' ' 73' ' ' ILE . 38.8 m-85 -81.77 -1.16 46.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.545 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.439 ' O ' HG21 ' A' ' 97' ' ' THR . 7.7 tmtm? -76.26 -24.89 54.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.106 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -115.57 -12.67 11.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.478 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.516 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 12.3 t-160 -72.44 -41.56 66.01 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.995 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.567 ' HA ' HG22 ' A' ' 97' ' ' THR . 83.6 m-85 72.8 108.9 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.379 1.049 . . . . 0.0 109.548 -167.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.736 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 4.9 mt -82.53 14.14 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 95' ' ' THR . 27.2 t70 172.55 -140.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 156' ' ' PRO . 12.8 t -78.12 -7.12 56.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.305 0.574 . . . . 0.0 109.685 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.557 ' HB ' ' HG3' ' A' ' 54' ' ' GLU . 20.7 m -136.44 158.73 43.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.692 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 92' ' ' TYR . 56.7 p -96.63 -169.12 1.83 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.574 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 74.3 mt -67.53 125.76 27.18 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 167.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.56 -68.67 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.896 0.379 . . . . 0.0 110.415 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.642 ' O ' ' HA ' ' A' ' 35' ' ' MET . 61.8 mm-40 -144.02 149.4 45.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.053 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.38 162.86 37.51 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.754 2.302 . . . . 0.0 113.718 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -78.62 171.59 12.1 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.488 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 74.1 Cg_exo -55.8 177.58 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.581 2.854 . . . . 0.0 114.524 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.699 -178.765 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 1.056 HD23 HG21 ' A' ' 152' ' ' ILE . 10.6 mp . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 122.246 1.022 . . . . 0.0 113.007 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 17.0 tp10 -167.59 -74.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.715 -175.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -107.1 110.39 22.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.187 0.517 . . . . 0.0 111.11 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.526 HG22 ' HG2' ' A' ' 180' ' ' LYS . 70.3 t -127.84 132.04 69.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.687 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.467 ' HB3' HD13 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -112.57 145.0 41.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.87 0.367 . . . . 0.0 110.66 -178.795 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.882 HG22 HG12 ' A' ' 178' ' ' VAL . 42.1 p -93.29 129.07 39.5 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.332 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 21.2 mt -104.14 -32.98 8.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.717 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.613 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 34.1 t80 -86.12 -36.08 19.8 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -170.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.673 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 2.0 t70 79.65 129.3 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.557 0.535 . . . . 0.0 110.728 -175.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 91.5 t80 -151.39 100.64 2.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -89.1 65.88 2.6 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.595 2.197 . . . . 0.0 113.006 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.95 -29.82 73.81 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.774 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.517 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 47.3 m-80 50.22 73.32 0.27 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.87 0.868 . . . . 0.0 113.313 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -171.14 -176.28 1.89 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.09 -10.13 51.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.535 0.684 . . . . 0.0 109.168 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -94.09 -32.75 13.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.304 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.79 104.78 9.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.733 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.088 HD11 ' HB2' ' A' ' 165' ' ' ASN . 46.2 tp -71.9 117.81 61.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.566 ' HD2' HD12 ' A' ' 142' ' ' LEU . 55.2 Cg_endo -76.59 111.38 3.24 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.062 1.842 . . . . 0.0 111.728 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.627 ' CG ' HG21 ' A' ' 130' ' ' THR . 12.5 p90 -125.91 163.69 22.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.143 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.673 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 20.8 pttm -122.15 -168.51 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.739 -173.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.542 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.4 OUTLIER -80.94 67.15 6.74 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -178.767 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.9 42.95 0.11 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.413 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.631 ' HG2' ' HG2' ' A' ' 145' ' ' LYS . 5.3 mm-40 -99.2 145.09 27.6 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.535 -0.391 . . . . 0.0 110.073 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.467 HD13 ' HB3' ' A' ' 129' ' ' ARG . 46.5 mm -98.41 124.35 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 175.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.55 HD22 ' HA ' ' A' ' 165' ' ' ASN . 34.2 mt -120.43 158.7 26.64 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 90.4 t -119.0 126.05 75.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.056 HG21 HD23 ' A' ' 125' ' ' LEU . 48.6 mm -75.76 87.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 122.355 1.074 . . . . 0.0 108.913 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.793 HD11 ' HE1' ' A' ' 61' ' ' TYR . 6.7 tt -82.77 -37.36 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.832 -170.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.804 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 20.7 mt-10 -136.0 143.44 44.79 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -131.8 90.54 35.94 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 121.593 -0.692 . . . . 0.0 111.41 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.649 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 6.7 Cg_exo -74.05 -52.14 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.401 2.067 . . . . 0.0 111.957 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -115.19 -179.12 3.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.436 ' O ' HG21 ' A' ' 175' ' ' VAL . 42.1 mt-10 -102.48 -25.48 13.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.831 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 175' ' ' VAL . 7.6 tt0 -85.45 -27.78 25.48 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.237 0.541 . . . . 0.0 110.404 175.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.479 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 45.4 m95 -128.86 124.19 34.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.634 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.563 ' O ' HG13 ' A' ' 173' ' ' ILE . 52.6 m0 -111.3 148.32 33.18 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.804 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 33.3 m -95.63 101.01 12.67 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.756 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.93 153.96 22.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.573 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.9 ptt180 -96.2 133.4 40.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.088 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.2 t30 -74.27 -177.5 3.04 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.777 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 166' ' ' LYS . 38.6 ttmt -62.44 -26.21 68.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.04 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.649 ' OD1' ' HB3' ' A' ' 165' ' ' ASN . 54.0 p-10 -90.56 3.7 53.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.335 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.04 -1.08 87.8 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.804 -0.635 . . . . 0.0 113.131 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 25.7 ttm-85 -64.67 129.22 38.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.698 0.285 . . . . 0.0 111.021 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.409 HG21 HD13 ' A' ' 153' ' ' ILE . 40.4 t -98.97 111.68 29.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.038 178.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.39 165.65 26.32 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 175.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.649 ' HE3' ' HG2' ' A' ' 156' ' ' PRO . 21.0 mtp -79.92 138.47 37.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.13 0.465 . . . . 0.0 110.229 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.592 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -133.7 145.61 56.87 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.023 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.479 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 4.6 Cg_exo -77.3 131.97 12.13 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.809 2.339 . . . . 0.0 112.371 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.569 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 57.2 t -62.05 -43.27 85.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 18.3 Cg_endo -61.37 -11.6 20.23 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.899 1.732 . . . . 0.0 112.903 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -92.17 -12.34 33.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.53 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.882 HG12 HG22 ' A' ' 130' ' ' THR . 32.7 m -126.6 162.17 31.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.228 0.537 . . . . 0.0 112.376 -169.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -133.98 134.77 42.89 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.931 176.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.526 ' HG2' HG22 ' A' ' 128' ' ' VAL . 45.9 mtmt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.753 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.539 ' HB ' HG13 ' A' ' 266' ' ' VAL . 22.0 t . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -114.73 115.27 26.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.275 0.559 . . . . 0.0 110.941 -175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -136.55 127.6 27.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.889 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.789 ' HB3' HD13 ' A' ' 263' ' ' ILE . 22.3 pttm -93.06 140.51 29.41 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.271 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.4 110.52 6.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.613 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.477 HG13 ' HG3' ' A' ' 244' ' ' GLN . 26.6 pt -69.1 -32.69 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 111.04 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.477 ' HG3' HG13 ' A' ' 243' ' ' ILE . 92.7 mt-30 -118.41 166.2 12.95 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.478 ' HB3' HG13 ' A' ' 260' ' ' VAL . 9.3 ptpp? -94.81 146.16 24.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.42 0.628 . . . . 0.0 111.099 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.709 ' HB2' HH11 ' A' ' 246' ' ' ARG . 0.0 OUTLIER -128.28 110.85 12.77 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.35 173.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--N 1.316 -0.853 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.689 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -84.55 113.39 21.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.687 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.638 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.3 tt -88.86 117.3 27.76 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.68 120.74 14.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.586 HD22 HG22 ' A' ' 264' ' ' VAL . 95.0 mt -128.12 116.26 19.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.174 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -86.55 158.37 19.54 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.053 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 245' ' ' LYS . 9.6 m -62.1 110.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.509 0.671 . . . . 0.0 111.864 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.99 -1.44 57.79 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.96 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -79.32 138.55 37.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.841 0.321 . . . . 0.0 110.665 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.789 HD13 ' HB3' ' A' ' 241' ' ' LYS . 46.2 mm -84.1 116.64 28.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.04 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.586 HG22 HD22 ' A' ' 258' ' ' LEU . 40.4 t -89.31 114.09 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.307 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -86.26 88.7 7.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.539 HG13 ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -91.85 117.34 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.515 0.674 . . . . 0.0 110.714 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.06 -22.85 13.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.504 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.621 ' HB2' ' HG2' ' A' ' 276' ' ' GLU . 55.6 mtp180 -123.32 126.09 46.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.412 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 53.1 mtt -122.95 127.2 48.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.448 ' HB2' ' HG3' ' A' ' 274' ' ' GLN . 40.3 m-80 -91.68 139.79 30.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 25.9 pt -70.66 -8.29 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.903 0.383 . . . . 0.0 111.858 -173.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.1 -30.46 68.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.952 0.406 . . . . 0.0 110.774 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.3 -5.06 13.43 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.572 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.448 ' HG3' ' HB2' ' A' ' 270' ' ' ASN . 7.8 pt20 -94.69 115.0 27.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 175.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.483 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 36.5 m0 -110.42 145.58 37.35 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.146 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.621 ' HG2' ' HB2' ' A' ' 268' ' ' ARG . 1.4 pm0 -112.61 115.38 28.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.556 0.694 . . . . 0.0 110.383 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -118.22 164.21 12.87 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.112 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -102.02 110.79 22.84 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.638 ' HB ' HD21 ' A' ' 256' ' ' LEU . 98.7 t -122.76 117.87 53.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.204 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 64.36 -81.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.369 -175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -147.32 3.63 0.9 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.364 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.8 mtp-105 -108.31 144.54 35.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.845 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -120.44 121.57 38.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.847 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.512 ' H ' HD12 ' A' ' 256' ' ' LEU . . . -144.95 169.24 26.75 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.404 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 95.5 mt -93.56 113.99 26.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.975 0.417 . . . . 0.0 110.225 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -115.51 143.17 30.0 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.565 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.64 149.89 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.256 1.97 . . . . 0.0 112.205 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -65.17 -16.64 63.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.274 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -5.65 56.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.023 0.44 . . . . 0.0 111.597 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 246' ' ' ARG . 63.4 t60 -96.73 -18.76 19.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.01 0.433 . . . . 0.0 110.662 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 242' ' ' ALA . 31.3 m -128.03 170.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.419 -176.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -131.1 126.4 35.69 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 240' ' ' ALA . 41.5 mm -70.83 130.72 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -133.24 161.26 34.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.033 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 28.2 t0 . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.69 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.27 0.557 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -150.38 92.93 1.92 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.773 0.797 . . . . 0.0 110.652 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -138.88 162.8 33.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.18 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -78.24 93.19 4.58 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.634 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 4.5 p -77.26 65.15 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.304 0.573 . . . . 0.0 110.434 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.4 t -175.48 -41.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.079 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.36 104.46 0.5 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.489 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 9.1 mtm-85 -70.51 -14.39 62.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.554 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -85.31 -1.94 57.52 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.1 -47.79 5.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.722 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 30.2 p-90 -114.95 -29.99 6.53 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 47.9 t80 -75.42 111.21 10.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.631 ' HB3' HG21 ' A' ' 19' ' ' VAL . 10.7 tpp -100.58 1.53 40.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.367 -172.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.6 -114.71 3.23 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.013 -0.994 . . . . 0.0 114.225 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.58 104.3 1.85 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.429 2.086 . . . . 0.0 112.383 -176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.858 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 93.2 t -132.88 -76.35 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 119.256 -0.402 . . . . 0.0 112.037 -174.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.708 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 73.3 m 74.47 167.99 0.29 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -53.36 -32.79 50.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -44.46 -54.72 5.68 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.884 0.74 . . . . 0.0 112.111 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.617 ' HB2' HG13 ' A' ' 19' ' ' VAL . 47.3 mt-10 -95.6 -45.21 7.14 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.262 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.55 -46.65 28.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.28 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.666 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 20.7 mt-30 -64.71 -56.4 13.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.668 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -66.2 -23.44 66.44 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -171.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -86.24 -15.75 39.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.898 0.38 . . . . 0.0 110.692 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.601 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 68.7 mt -121.63 17.89 11.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.593 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 54.8 mm-40 -76.3 70.02 2.87 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.08 -20.04 52.38 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.677 171.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -61.79 123.11 17.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.244 0.522 . . . . 0.0 111.477 -175.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 34.8 mtm180 55.58 -51.56 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.111 1.764 . . . . 0.0 115.19 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 32.0 m170 74.19 134.01 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.571 0.748 . . . . 0.0 109.143 -170.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.15 -3.24 44.13 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -172.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.759 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 76.1 mtm -96.62 147.72 23.6 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.438 ' CD1' HD22 ' A' ' 98' ' ' LEU . 45.8 p90 -146.68 165.94 28.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.613 0.244 . . . . 0.0 110.935 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.3 pp -152.8 136.04 15.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.94 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.8 t -103.86 122.8 57.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.49 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.858 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 9.6 ptt180 -121.63 165.63 15.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.507 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.423 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 3.9 p30 -85.57 138.8 31.93 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.52 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 8.5 t -74.45 135.73 42.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.212 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.1 t -78.13 -10.32 59.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.639 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -78.39 -48.34 15.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.581 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 41' ' ' SER . 48.4 t -159.03 135.98 6.79 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.37 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.42 5.08 2.1 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.303 2.002 . . . . 0.0 112.728 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.34 8.26 58.69 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.523 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -144.7 160.84 40.55 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.423 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 22.1 m-85 -124.78 164.05 20.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.955 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 62' ' ' ILE . 18.6 t -127.56 99.13 5.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 0.0 110.569 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.41 ' CB ' HD11 ' A' ' 63' ' ' ILE . 22.2 tp -78.17 101.31 6.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.134 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 59' ' ' SER . 58.4 m -96.75 131.98 42.91 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.385 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.617 HG21 HD13 ' A' ' 93' ' ' LEU . 47.2 t -119.36 151.82 21.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.835 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.601 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 14.1 t -102.59 119.02 38.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.999 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 1.101 ' HG2' ' HB3' ' A' ' 57' ' ' ARG . 7.1 pm0 -145.61 175.25 10.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 169.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 6.0 p30 -36.2 89.51 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.391 1.076 . . . . 0.0 113.865 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m 39.8 62.55 1.2 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.912 0.863 . . . . 0.0 110.023 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 1.101 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -162.14 50.57 0.2 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.027 -154.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 38.2 t -76.62 95.63 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.566 ' OG ' ' HB ' ' A' ' 52' ' ' VAL . 12.5 p -77.88 119.35 21.22 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.281 -172.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -101.11 88.13 3.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.081 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.733 ' HB3' HD11 ' A' ' 73' ' ' ILE . 71.4 m-85 -93.12 112.12 23.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.516 0.327 . . . . 0.0 111.713 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.515 HG12 HG22 ' A' ' 49' ' ' VAL . 43.9 mt -82.17 140.56 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.1 mp -124.2 121.04 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.629 0.771 . . . . 0.0 110.603 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -85.39 135.57 33.82 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.7 t -80.86 103.23 10.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 72' ' ' LYS . 83.3 mt -85.6 132.13 45.5 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.877 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.46 -5.84 12.3 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.019 2.48 . . . . 0.0 112.28 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -87.85 14.76 8.12 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.81 31.29 14.2 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.518 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -121.14 176.04 5.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.881 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.446 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 58.9 m-85 -139.13 129.24 25.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.105 0.478 . . . . 0.0 110.692 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HB2' HD11 ' A' ' 66' ' ' LEU . 39.7 ttmt -115.94 108.01 15.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.73 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.733 HD11 ' HB3' ' A' ' 61' ' ' TYR . 15.9 tt -87.5 78.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.642 0.734 . . . . 0.0 110.17 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.68 81.37 0.09 OUTLIER Glycine 0 C--O 1.226 -0.4 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.89 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.8 t70 75.94 -48.09 0.58 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.962 0.505 . . . . 0.0 112.158 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -66.93 125.01 24.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.632 0.73 . . . . 0.0 111.744 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -84.47 131.79 34.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.129 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -139.53 173.77 11.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.998 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -77.04 -42.95 36.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.974 0.416 . . . . 0.0 110.454 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.486 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 6.8 p80 -172.49 -174.48 1.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.159 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 13.0 mt -54.4 -60.74 6.88 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.634 ' HB3' ' O ' ' A' ' 8' ' ' SER . 51.5 Cg_exo -58.43 -9.69 7.36 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.411 2.074 . . . . 0.0 113.795 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.469 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -94.48 -35.62 12.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.759 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.19 -29.7 57.75 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.323 0.582 . . . . 0.0 109.431 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.17 -30.64 70.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.794 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.422 ' HA ' ' CD ' ' A' ' 89' ' ' LYS . 33.9 tt0 -76.43 -7.98 56.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.37 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -97.23 -37.17 10.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.499 0.666 . . . . 0.0 109.445 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.573 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 38.8 m-85 -81.0 -10.32 59.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.466 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.422 ' CD ' ' HA ' ' A' ' 86' ' ' GLU . 22.4 ptmt -81.31 -7.34 59.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.225 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.6 pt -123.74 3.67 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 121.262 0.553 . . . . 0.0 110.619 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.573 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 4.5 t-160 -97.13 -40.27 8.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.435 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.719 ' CD2' HG23 ' A' ' 97' ' ' THR . 95.7 m-85 75.17 88.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.416 1.073 . . . . 0.0 110.472 -172.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.732 HD22 ' CE2' ' A' ' 61' ' ' TYR . 2.0 mt -66.51 97.88 0.46 Allowed 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.743 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 9.4 t70 56.33 73.13 0.46 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.021 -175.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 27.2 m 75.32 -39.32 0.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -107.75 139.9 41.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.176 0.512 . . . . 0.0 111.047 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.719 HG23 ' CD2' ' A' ' 92' ' ' TYR . 2.9 p -83.62 177.14 8.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.789 0.328 . . . . 0.0 110.527 176.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.438 HD22 ' CD1' ' A' ' 36' ' ' PHE . 81.5 mt -70.05 98.44 1.31 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 172.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 50.8 mm -84.47 -55.73 6.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.808 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 35' ' ' MET . 36.7 tt0 -167.02 141.59 3.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.061 -175.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.12 157.74 28.59 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.556 2.171 . . . . 0.0 112.734 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.43 144.49 57.5 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.818 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HD3' ' SD ' ' A' ' 35' ' ' MET . 33.5 Cg_exo -60.42 131.68 39.65 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.569 2.179 . . . . 0.0 111.594 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.471 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 26.3 ptt180 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.748 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.842 HD12 HG21 ' A' ' 152' ' ' ILE . 2.2 mm? . . . . . 0 N--CA 1.467 0.41 0 CA-C-O 121.293 0.568 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 5.2 tp10 -165.86 -76.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.413 -171.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.487 ' O ' ' HB2' ' A' ' 180' ' ' LYS . 28.5 m-85 -106.01 124.4 49.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.753 -171.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 22.3 t -133.22 151.36 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.112 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.727 ' HG2' ' HB3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -131.02 142.11 50.29 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.681 162.287 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.472 HG22 HG12 ' A' ' 178' ' ' VAL . 1.8 p -97.94 140.22 32.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.914 0.387 . . . . 0.0 111.949 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 61.8 mt -108.55 -22.63 12.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.14 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 57.0 t80 -92.33 -35.04 13.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -167.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 7.0 t70 76.01 113.19 0.07 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.337 0.589 . . . . 0.0 110.395 -174.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 71.4 t80 -147.19 109.51 3.96 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.068 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 20.9 Cg_endo -92.91 102.28 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.53 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.737 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -95.12 4.27 67.47 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.365 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 57.54 20.63 6.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.331 0.653 . . . . 0.0 112.547 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 169' ' ' ARG . 1.9 p30 52.2 -175.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 173.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 69.09 7.2 6.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.494 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -169.39 -45.7 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.241 -1.345 . . . . 0.0 108.361 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.737 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 24.2 m-20 -140.85 116.04 9.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.759 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.048 HD11 ' HB2' ' A' ' 165' ' ' ASN . 25.2 tp -67.53 120.57 74.03 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.617 0.246 . . . . 0.0 110.937 -174.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 43.6 Cg_endo -75.13 95.59 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.031 1.821 . . . . 0.0 111.346 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 10.0 p90 -104.6 172.58 6.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.567 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.468 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 8.7 ttmm -122.52 -178.14 3.82 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.941 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.637 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -84.02 75.18 10.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.458 0.647 . . . . 0.0 109.604 177.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.9 33.83 0.54 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.171 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 6.7 mm-40 -94.62 154.95 17.1 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 129' ' ' ARG . 40.0 mm -103.85 125.84 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.559 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 32.9 mt -118.82 156.77 28.85 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 59.8 t -124.83 129.79 73.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.842 HG21 HD12 ' A' ' 125' ' ' LEU . 30.6 mm -74.55 86.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.384 1.088 . . . . 0.0 109.073 -176.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.485 HG12 ' HE1' ' A' ' 61' ' ' TYR . 10.4 tt -75.18 -26.42 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.341 -174.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.785 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 44.5 mt-10 -146.69 143.91 29.08 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.437 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 44.4 tttm -125.34 87.44 55.64 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 121.46 -0.775 . . . . 0.0 111.026 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.597 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 16.8 Cg_exo -70.62 -62.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.387 2.058 . . . . 0.0 112.542 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -109.63 -174.8 2.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.845 0.355 . . . . 0.0 111.748 -171.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -95.81 -29.15 14.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.324 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -96.18 -22.53 17.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.155 0.502 . . . . 0.0 110.82 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.49 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 42.5 m95 -128.93 124.55 35.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.67 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -107.42 164.87 11.83 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.785 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 29.3 m -113.13 106.66 14.92 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.926 -0.484 . . . . 0.0 109.748 174.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.772 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -115.95 158.92 22.3 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.388 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.2 ptt180 -95.48 132.43 40.58 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.355 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.048 ' HB2' HD11 ' A' ' 142' ' ' LEU . 63.0 t30 -72.0 171.35 12.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.522 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -59.31 -29.79 67.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.45 -43.43 94.28 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.02 67.43 0.7 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.866 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.665 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -143.73 160.01 41.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.438 HG22 HD13 ' A' ' 153' ' ' ILE . 37.5 t -101.75 125.57 55.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.307 0.575 . . . . 0.0 111.986 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.6 161.9 30.44 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.597 ' HE3' ' HG2' ' A' ' 156' ' ' PRO . 25.6 mtp -81.07 144.25 31.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.179 0.489 . . . . 0.0 110.271 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.504 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.7 pp -139.66 143.4 35.02 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.875 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.49 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 3.0 Cg_exo -76.3 132.65 13.94 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.897 2.398 . . . . 0.0 112.561 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 178' ' ' VAL . 60.3 t -62.8 -43.03 81.87 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 23.2 Cg_endo -62.57 -4.39 5.56 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.953 1.769 . . . . 0.0 113.302 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -99.64 -8.57 24.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.592 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 175' ' ' VAL . 10.5 m -107.24 -178.33 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 122.265 1.031 . . . . 0.0 113.576 -168.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.727 ' HB3' ' HG2' ' A' ' 129' ' ' ARG . 23.6 tt0 -154.46 42.13 0.49 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.098 -1.865 . . . . 0.0 109.221 -165.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.834 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.626 0 O-C-N 120.432 -1.418 . . . . 0.0 108.817 -167.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.877 ' N ' HG13 ' A' ' 266' ' ' VAL . 88.8 t . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 1.01 ' HB2' ' HA ' ' A' ' 265' ' ' LYS . 0.0 OUTLIER -69.21 130.61 43.12 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.333 1.063 . . . . 0.0 111.996 -160.537 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.535 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -148.63 159.41 44.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.802 -168.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -91.3 135.78 33.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.579 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -77.56 126.5 30.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 31.9 pt -101.75 -6.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.439 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.32 155.63 43.25 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.578 ' HB3' HG23 ' A' ' 260' ' ' VAL . 18.4 pttp -113.88 137.02 52.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.749 0.309 . . . . 0.0 110.777 174.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.549 ' HG3' ' CE1' ' A' ' 290' ' ' HIS . 0.0 OUTLIER -174.72 137.61 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 257' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.629 0 CA-C-O 119.248 -0.406 . . . . 0.0 112.041 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 121.405 0.621 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -89.64 147.77 23.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.577 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.39 110.15 22.29 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 247' ' ' VAL . . . -56.75 105.48 0.22 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.514 0.509 . . . . 0.0 110.588 177.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 279' ' ' VAL . 90.8 mt -118.38 130.59 56.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.018 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -111.79 173.7 6.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.038 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.578 HG23 ' HB3' ' A' ' 245' ' ' LYS . 57.7 t -75.58 124.57 33.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 112.109 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 88.25 25.31 31.52 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.383 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.28 150.84 36.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.135 0.468 . . . . 0.0 110.389 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 30.7 mm -86.52 123.19 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.317 0.579 . . . . 0.0 111.639 -175.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.73 ' HA ' HG22 ' A' ' 279' ' ' VAL . 44.7 t -101.07 103.2 14.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.772 177.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 1.01 ' HA ' ' HB2' ' A' ' 239' ' ' PHE . 18.0 ttpp -86.03 86.5 7.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.006 0.432 . . . . 0.0 110.667 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.877 HG13 ' N ' ' A' ' 238' ' ' VAL . 13.7 p -105.29 136.46 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 15.3 t -124.55 -14.41 6.85 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -167.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -135.78 98.64 3.96 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 120.921 1.691 . . . . 0.0 111.744 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' MET . . . . . 0.732 ' HE3' HG23 ' A' ' 238' ' ' VAL . 34.1 ttm -79.1 140.29 37.88 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -162.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -98.3 137.0 37.67 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.734 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.6 tt -75.93 -8.35 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.267 0.556 . . . . 0.0 110.623 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -69.21 -28.51 66.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.945 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 109.48 -17.79 30.68 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.696 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.1 118.82 29.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.445 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 47.3 m0 -98.85 145.03 27.4 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.051 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.592 ' O ' HG23 ' A' ' 266' ' ' VAL . 38.7 tt0 -117.93 97.41 5.81 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.275 0.56 . . . . 0.0 109.741 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -107.61 150.73 16.9 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.153 -168.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -104.65 109.83 21.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.73 HG22 ' HA ' ' A' ' 264' ' ' VAL . 60.4 t -114.39 91.27 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.083 0.468 . . . . 0.0 110.453 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 54.37 55.89 7.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.814 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 97.71 -28.33 14.86 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.512 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.1 mtm105 -104.39 118.48 36.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.945 0.373 . . . . 0.0 110.377 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 47.9 pttt -121.31 142.44 49.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.084 0.468 . . . . 0.0 111.882 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -171.07 -174.48 38.91 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.484 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 87.0 mt -93.38 144.75 25.04 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.583 0.706 . . . . 0.0 111.905 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.464 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 36.1 p90 -149.77 151.41 32.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.999 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 290' ' ' HIS . 60.8 Cg_endo -74.34 151.71 43.39 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.261 1.974 . . . . 0.0 112.26 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -64.25 -21.34 66.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.636 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.2 m -77.22 -8.53 57.73 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.229 0.538 . . . . 0.0 110.992 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.549 ' CE1' ' HG3' ' A' ' 246' ' ' ARG . 16.5 t60 -86.03 -22.01 27.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.157 0.503 . . . . 0.0 110.631 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.0 m -128.31 178.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.501 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -141.29 136.91 32.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.524 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.535 HD13 ' HB2' ' A' ' 240' ' ' ALA . 47.2 mm -81.68 102.82 7.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -100.23 14.44 30.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.825 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.348 177.351 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.34 0 CA-C-O 120.777 0.323 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 6' ' ' PHE . 4.4 tmt_? -113.9 -68.07 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 5.4 m-85 62.96 165.28 0.11 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -109.53 -39.35 5.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.818 161.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.2 m 64.68 147.56 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.037 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.0 p 61.15 -49.65 0.12 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.988 1.315 . . . . 0.0 113.875 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -57.31 107.01 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 111.586 -172.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.601 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -61.97 -22.81 65.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.479 -178.321 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.2 t -79.32 -15.96 57.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.641 0.258 . . . . 0.0 110.862 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.93 -49.03 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.168 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -110.83 -22.81 11.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.601 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 56.2 t80 -85.57 113.13 21.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.713 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 9.6 tpp -97.42 -1.16 44.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.555 -172.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.444 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.44 -115.43 3.75 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.159 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.1 Cg_exo -74.75 103.61 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.842 2.361 . . . . 0.0 112.187 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.636 ' HB ' ' CB ' ' A' ' 39' ' ' ARG . 88.3 t -137.36 -74.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 60.0 m 76.02 172.12 0.25 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.493 ' HA ' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -51.95 -43.69 63.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -174.571 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -60.37 -38.04 82.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -92.35 -44.79 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.385 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.56 68.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.882 0.372 . . . . 0.0 111.121 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.57 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 64.9 tt0 -67.37 -52.83 35.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.908 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -72.71 -14.25 61.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 0.0 111.425 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -78.65 -44.07 24.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.565 0.697 . . . . 0.0 110.055 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 16.1 mt -104.25 12.07 34.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.491 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 20.8 tt0 -76.87 104.45 7.37 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.618 0.723 . . . . 0.0 110.573 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.499 ' H ' ' NE2' ' A' ' 31' ' ' GLN . . . 118.02 -20.82 10.53 Favored Glycine 0 CA--C 1.499 -0.917 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.922 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER 40.11 111.02 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 112.592 -1.804 . . . . 0.0 115.185 172.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 39.6 ttp180 -68.84 -10.22 55.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.959 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 1.2 m-70 74.26 122.5 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.113 176.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.54 19.99 49.83 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.059 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.456 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 35.8 mtm -115.49 147.58 40.48 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' ' 50' ' ' LEU . 40.0 p90 -147.44 158.85 44.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.129 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 pp -150.95 135.35 16.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.218 0.533 . . . . 0.0 110.507 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.11 115.58 44.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.113 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.636 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.68 -173.44 2.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.05 0.452 . . . . 0.0 112.048 -176.4 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.464 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 7.3 p-10 -71.23 138.06 49.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.874 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -100.42 89.14 3.86 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 168.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 p -71.75 11.82 0.46 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.449 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 t -100.19 -8.51 23.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 50.3 t -164.76 110.0 0.84 Allowed Pre-proline 0 CA--C 1.528 0.121 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.079 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.04 115.83 2.83 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.966 2.444 . . . . 0.0 112.466 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.48 -41.94 1.78 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.049 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.646 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 3.3 m-20 -74.3 158.66 33.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.723 0.297 . . . . 0.0 110.483 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.404 ' CD2' HD11 ' A' ' 81' ' ' LEU . 46.2 m-85 -134.68 173.91 11.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.695 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.634 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 58.4 t -137.94 109.38 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 111.007 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 36' ' ' PHE . 26.2 tp -81.03 104.55 11.6 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.536 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 m -95.46 120.95 36.6 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.856 0.36 . . . . 0.0 110.34 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 22.1 t -120.4 142.55 35.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.922 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 89.2 p -121.99 133.56 54.82 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.531 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.505 ' CB ' ' HB3' ' A' ' 94' ' ' ASP . 1.9 tm-20 -147.94 178.15 8.75 Favored 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.44 ' HA ' ' CE1' ' A' ' 33' ' ' HIS . 5.1 p30 -16.94 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.452 ' HA ' ' CD ' ' A' ' 31' ' ' GLN . 36.3 m 35.91 72.13 0.11 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.706 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.906 ' HD2' ' HB3' ' A' ' 155' ' ' LYS . 9.8 ttp85 -168.51 52.93 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.743 -158.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 25.3 t -77.68 101.62 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 122.07 0.938 . . . . 0.0 109.651 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 m -93.21 121.22 34.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.323 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -94.25 89.45 5.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.283 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.772 ' HB3' HD11 ' A' ' 73' ' ' ILE . 88.0 m-85 -84.81 115.07 22.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.725 0.41 . . . . 0.0 110.786 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.1 mt -81.3 140.0 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -174.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.663 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.6 mp -115.75 121.19 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.597 0.759 . . . . 0.0 110.568 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.646 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 8.3 m120 -85.74 146.28 26.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.916 0.487 . . . . 0.0 111.566 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.0 t -93.18 99.18 11.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.924 174.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.4 mt -84.22 142.91 41.44 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.48 -28.78 46.31 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.617 2.878 . . . . 0.0 114.115 -172.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -91.63 20.15 5.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.412 -0.18 . . . . 0.0 111.383 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.538 ' HD2' ' HB3' ' A' ' 280' ' ' ASN . 0.0 OUTLIER 67.43 40.21 2.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.139 0.495 . . . . 0.0 111.045 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -113.61 148.24 36.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.489 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 58.7 m-85 -114.71 115.77 27.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.936 0.398 . . . . 0.0 111.297 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 39.5 ttpt -110.77 105.94 14.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.538 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.772 HD11 ' HB3' ' A' ' 61' ' ' TYR . 10.2 tt -81.74 76.99 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.842 0.83 . . . . 0.0 110.175 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 60.73 95.15 0.01 OUTLIER Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.547 178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 15.9 t70 74.93 -49.51 0.66 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.849 0.357 . . . . 0.0 111.498 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -85.15 113.25 21.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 11.6 pt-20 -101.7 134.96 44.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.317 0.579 . . . . 0.0 110.816 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 80.1 m-85 -121.73 174.14 7.02 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.956 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.27 -46.89 85.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.026 0.441 . . . . 0.0 110.885 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -166.47 -178.07 4.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.427 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.519 HD23 HD21 ' A' ' 84' ' ' LEU . 16.4 mt -55.19 -57.49 19.78 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.51 25.46 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.062 1.841 . . . . 0.0 112.831 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 81' ' ' LEU . . . -119.81 -34.86 3.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.951 175.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.519 HD21 HD23 ' A' ' 81' ' ' LEU . 3.7 pp -76.68 -30.82 56.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.214 0.531 . . . . 0.0 109.968 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 6' ' ' PHE . 48.6 mt -64.57 -41.48 96.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.403 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.641 ' HA ' ' HD2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -69.5 -4.08 17.31 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.562 178.486 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -96.21 -37.69 10.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.812 0.815 . . . . 0.0 109.637 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.813 ' CD1' HD23 ' A' ' 93' ' ' LEU . 46.7 m-85 -77.37 -2.92 37.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.506 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.641 ' HD2' ' HA ' ' A' ' 86' ' ' GLU . 16.5 ptmt -78.86 -11.11 59.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.607 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.99 -12.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 120.936 0.398 . . . . 0.0 110.88 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -75.46 -29.68 59.71 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.867 ' HA ' HG22 ' A' ' 97' ' ' THR . 23.0 m-85 59.14 55.21 4.48 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.7 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.813 HD23 ' CD1' ' A' ' 88' ' ' TYR . 3.4 pp -60.9 123.27 17.08 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 118.463 -1.295 . . . . 0.0 107.518 169.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 1.9 m-20 81.6 -2.5 1.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.28 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.798 ' OG1' ' HB3' ' A' ' 156' ' ' PRO . 33.6 m 55.99 75.55 0.33 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 122.054 0.93 . . . . 0.0 110.665 -172.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m 179.06 -34.32 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.211 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.867 HG22 ' HA ' ' A' ' 92' ' ' TYR . 4.8 p 73.38 -172.17 0.13 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.641 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 35.0 mt -85.65 94.13 9.0 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.478 173.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.79 -56.87 10.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.557 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 11.2 pt-20 -157.5 163.56 24.42 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.497 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 100' ' ' GLU . 40.4 Cg_endo -67.32 153.09 78.06 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.129 1.886 . . . . 0.0 113.026 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -71.98 143.34 86.36 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.467 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 24.0 Cg_exo -64.57 155.94 63.74 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.548 2.165 . . . . 0.0 112.066 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.713 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 14.1 mtm180 . . . . . 0 C--N 1.324 -0.508 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 1.05 HD12 HG21 ' A' ' 152' ' ' ILE . 3.5 mm? . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -170.14 -81.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.878 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -104.66 124.63 49.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.207 0.527 . . . . 0.0 110.655 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.697 HG22 ' CB ' ' A' ' 180' ' ' LYS . 61.4 t -133.53 137.15 53.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.407 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.613 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 2.3 ptp180 -114.31 146.67 40.19 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.066 167.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.58 HG22 HG12 ' A' ' 178' ' ' VAL . 2.1 p -103.58 135.28 45.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.017 0.436 . . . . 0.0 111.577 -176.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.586 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 78.3 mt -101.46 -40.1 7.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.421 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 23.1 t80 -74.28 -35.12 63.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -168.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.571 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.1 t70 73.47 107.34 0.07 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.247 0.546 . . . . 0.0 110.095 -177.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 77.3 t80 -140.92 103.25 6.26 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.78 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 33.7 Cg_endo -90.08 93.06 0.3 Allowed 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.378 2.052 . . . . 0.0 112.11 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -83.31 -21.16 59.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.014 174.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.9 m120 48.22 47.58 19.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.492 -0.854 . . . . 0.0 111.967 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 141' ' ' ASP . 20.1 t70 -141.14 161.04 38.8 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.55 -7.12 53.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.271 0.558 . . . . 0.0 110.98 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 172' ' ' MET . 1.4 mp0 -125.62 15.51 8.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.695 172.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.67 ' HB2' ' HB3' ' A' ' 138' ' ' ASP . 20.4 m-20 -146.61 87.75 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.788 HD11 ' HB2' ' A' ' 165' ' ' ASN . 27.1 tp -69.76 119.96 74.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.49 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.78 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 59.2 Cg_endo -73.99 90.97 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.221 1.948 . . . . 0.0 111.434 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 11.4 p90 -99.6 158.74 15.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.571 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 72.9 mmtt -98.94 178.75 4.85 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.278 0.561 . . . . 0.0 111.322 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.76 18.21 2.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.596 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.64 29.87 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.35 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 145' ' ' LYS . 24.0 tt0 -99.81 156.64 17.0 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.48 HD13 ' HB3' ' A' ' 129' ' ' ARG . 50.4 mm -99.02 133.52 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.63 HD22 HD21 ' A' ' 142' ' ' LEU . 57.4 mt -120.54 157.04 30.32 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.14 132.47 70.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.05 HG21 HD12 ' A' ' 125' ' ' LEU . 35.5 mm -75.09 88.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 122.184 0.992 . . . . 0.0 109.633 -176.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.468 HG21 HG22 ' A' ' 170' ' ' VAL . 21.5 tt -76.96 -31.32 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.189 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.997 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 65.5 mt-10 -132.63 141.46 48.66 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 171.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.906 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 1.9 tptm -129.8 84.14 61.95 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 122.305 1.05 . . . . 0.0 109.357 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.798 ' HB3' ' OG1' ' A' ' 95' ' ' THR . 19.3 Cg_exo -77.73 -66.78 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.413 2.742 . . . . 0.0 113.308 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -94.55 175.93 6.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.956 -172.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.78 -10.26 20.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -123.46 -3.34 8.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.272 0.558 . . . . 0.0 110.602 173.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.667 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 58.4 m95 -129.75 125.74 36.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.395 173.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.762 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.4 m0 -122.22 135.68 54.79 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.31 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.997 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.6 m -90.28 92.8 9.08 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.192 0.52 . . . . 0.0 109.632 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.69 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -94.22 163.27 13.51 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.939 0.4 . . . . 0.0 110.657 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.3 ptt180 -100.78 132.3 46.25 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.44 0.638 . . . . 0.0 110.583 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.788 ' HB2' HD11 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -50.3 139.06 15.65 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.467 172.484 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 166' ' ' LYS . 12.4 tmtt? -56.85 -27.0 59.7 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -99.93 9.6 42.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.583 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.5 83.11 1.63 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.21 -0.995 . . . . 0.0 115.279 166.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 169' ' ' ARG . 2.5 ptp180 -173.04 157.63 3.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.508 0.194 . . . . 0.0 110.488 162.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 153' ' ' ILE . 48.0 t -98.32 129.91 47.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 142' ' ' LEU . . . -154.44 152.79 24.31 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.102 172.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.69 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -73.45 138.44 45.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.652 0.263 . . . . 0.0 110.461 177.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.762 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -136.71 144.65 47.84 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.74 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.898 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 23.7 Cg_exo -68.22 139.12 45.19 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.28 2.653 . . . . 0.0 112.989 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 178' ' ' VAL . 88.0 t -76.34 -47.61 3.35 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.7 Cg_endo -66.08 6.43 0.49 Allowed 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.994 1.796 . . . . 0.0 111.909 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.898 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 1.2 m-85 -105.76 -1.64 24.16 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.439 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 175' ' ' VAL . 12.9 m -116.75 -167.04 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -169.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.613 ' HB3' ' HG3' ' A' ' 129' ' ' ARG . 7.7 tp10 -157.97 41.31 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.705 -1.588 . . . . 0.0 108.791 -163.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.697 ' CB ' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 O-C-N 120.987 -1.07 . . . . 0.0 111.466 -167.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.537 ' HB ' HG13 ' A' ' 266' ' ' VAL . 26.1 t . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.695 0.283 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.48 118.92 37.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.579 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.467 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.28 128.07 52.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.093 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -82.75 126.18 32.09 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -78.72 92.29 4.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.593 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -82.97 -15.99 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.133 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -130.18 129.87 43.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -69.77 172.92 6.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.397 0.618 . . . . 0.0 111.64 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 25.3 tpt180 -147.0 103.26 3.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.158 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 54.2 t . . . . . 0 C--N 1.32 -0.703 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.553 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.002 0.429 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -66.01 125.68 26.2 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.159 0.504 . . . . 0.0 110.622 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.492 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.9 OUTLIER -79.08 115.68 18.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.869 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -70.11 115.15 8.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.917 0.389 . . . . 0.0 110.44 177.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 279' ' ' VAL . 93.0 mt -118.62 154.82 32.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.617 -176.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.75 159.15 38.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.954 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.44 122.96 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.557 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.61 3.3 30.62 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.668 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.421 ' CG ' HH11 ' A' ' 69' ' ' ARG . 41.7 t0 -107.51 161.97 14.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.519 0.659 . . . . 0.0 110.204 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 27.2 mm -102.91 121.91 54.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.243 0.545 . . . . 0.0 111.362 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.424 ' HA ' HG22 ' A' ' 279' ' ' VAL . 21.5 t -91.01 112.1 24.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.589 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -88.98 94.36 9.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.537 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.9 p -86.07 123.68 39.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.428 0.632 . . . . 0.0 110.69 -173.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.9 t -110.81 -17.83 13.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.514 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.82 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 24.9 ttm-85 -131.87 97.35 4.16 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.02 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 54.9 mtt -94.83 134.01 37.91 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.593 ' OD1' ' HB3' ' A' ' 272' ' ' ASN . 7.5 p30 -131.26 167.74 18.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.976 -172.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.432 ' H ' HG13 ' A' ' 271' ' ' ILE . 2.4 pp -83.58 6.8 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.312 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.593 ' HB3' ' OD1' ' A' ' 270' ' ' ASN . 3.7 t30 -87.39 -30.68 20.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.869 0.366 . . . . 0.0 110.93 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 125.42 -64.43 0.57 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.304 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -73.71 124.54 26.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.547 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 11.1 m0 -93.65 168.29 11.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.56 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.82 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 35.8 tt0 -104.38 113.29 26.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.681 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.21 162.95 18.16 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.811 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.52 116.81 30.15 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.857 HG12 ' H ' ' A' ' 280' ' ' ASN . 15.2 t -125.82 -172.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.857 ' H ' HG12 ' A' ' 279' ' ' VAL . 9.2 p30 -55.06 -32.08 61.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.026 0.376 . . . . 0.0 111.874 -176.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.28 -68.39 1.6 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.071 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.492 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -179.71 -169.87 0.14 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 60.7 mttm -85.2 129.11 34.87 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -161.54 176.88 38.01 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 80.0 mt -84.32 134.52 34.51 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.985 0.421 . . . . 0.0 111.103 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.412 ' HE2' HG21 ' A' ' 291' ' ' VAL . 46.4 p90 -137.45 140.93 31.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.211 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.22 139.03 16.5 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.478 2.118 . . . . 0.0 112.239 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -73.72 6.79 2.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.87 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.2 p -95.67 -15.97 22.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.764 0.316 . . . . 0.0 111.35 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -98.74 -13.12 20.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.234 0.54 . . . . 0.0 110.059 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.412 HG21 ' HE2' ' A' ' 286' ' ' PHE . 34.3 m -120.1 160.89 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.287 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -127.78 120.21 27.38 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.076 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 240' ' ' ALA . 36.4 mm -70.71 109.05 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.172 171.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -103.92 11.58 35.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.21 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.464 0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.353 -178.237 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 121.118 0.485 . . . . 0.0 112.145 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -137.69 105.29 5.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.049 0.452 . . . . 0.0 110.496 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -155.89 157.86 37.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.545 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.36 111.79 14.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.908 0.385 . . . . 0.0 110.21 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 t -87.93 64.91 8.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.169 0.509 . . . . 0.0 110.397 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.0 t -173.47 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.915 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.46 111.44 1.39 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.742 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -56.0 -33.16 64.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.097 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 m -79.89 3.15 20.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.891 0.377 . . . . 0.0 111.595 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.85 -47.87 5.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.174 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -124.39 -22.67 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -87.68 117.33 26.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.745 0.307 . . . . 0.0 110.633 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.754 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 2.0 mpp? -109.57 7.23 24.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.722 0.296 . . . . 0.0 111.445 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.85 -114.6 3.27 Favored Glycine 0 C--O 1.225 -0.457 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.875 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 13.6 Cg_exo -69.73 101.08 0.86 Allowed 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.448 2.099 . . . . 0.0 112.137 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' A' ' 39' ' ' ARG . 86.0 t -129.11 -76.48 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.597 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.467 ' HA ' ' HE ' ' A' ' 39' ' ' ARG . 2.2 p 88.4 170.87 0.04 OUTLIER 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 169.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.7 mtp85 -53.35 -35.83 60.69 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.793 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -61.37 -51.91 66.81 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.458 0.474 . . . . 0.0 111.801 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.78 -43.6 12.4 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.16 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.57 -41.12 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.825 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.535 ' HA ' HG11 ' A' ' 58' ' ' VAL . 11.1 tt0 -81.88 -33.48 30.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.984 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.2 t -79.8 -18.33 51.19 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.02 0.438 . . . . 0.0 111.339 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 27' ' ' ARG . 39.1 ttm180 -88.86 -27.93 20.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.017 0.436 . . . . 0.0 110.792 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' A' ' 102' ' ' ALA . 78.0 mt -111.22 25.69 11.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.38 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.59 29.76 0.07 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -172.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.65 -1.45 39.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.908 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -50.24 -59.24 4.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.951 0.405 . . . . 0.0 110.936 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -132.09 111.46 11.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -68.98 114.87 7.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.46 -18.46 6.42 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.781 -173.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.756 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.6 mtm -74.65 144.71 43.71 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 120.674 0.273 . . . . 0.0 110.327 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.451 ' CG ' HD22 ' A' ' 98' ' ' LEU . 33.4 p90 -144.34 164.59 30.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.139 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.6 pp -153.85 138.79 17.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.043 0.449 . . . . 0.0 110.464 174.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.5 121.49 54.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.599 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -124.82 168.97 12.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -178.255 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.55 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 2.1 m-20 -72.23 134.13 45.45 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 168.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.532 ' HA ' HG23 ' A' ' 49' ' ' VAL . 24.3 t -37.01 -86.69 0.0 OUTLIER 'General case' 0 C--O 1.236 0.376 0 O-C-N 124.585 1.178 . . . . 0.0 112.875 -168.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.9 m -172.58 -61.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.4 t -98.3 -26.96 14.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.671 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.2 m -102.43 108.62 58.1 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.158 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.03 107.84 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.231 2.621 . . . . 0.0 111.686 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.99 -47.97 0.89 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 11.4 m-20 -78.24 151.75 32.94 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 168.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -124.3 172.9 8.74 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 121.387 -0.125 . . . . 0.0 110.731 -172.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.687 HG22 HG13 ' A' ' 62' ' ' ILE . 42.8 t -145.48 104.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 175.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.31 105.37 4.04 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.329 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.7 m -96.63 139.26 32.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.977 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.681 HG21 HD13 ' A' ' 93' ' ' LEU . 40.6 t -129.09 150.45 34.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.876 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.63 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 31.1 t -98.73 121.1 40.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.322 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.725 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 1.3 mt-10 -143.11 173.96 11.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 56.7 m-80 -40.24 87.39 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.857 0.863 . . . . 0.0 112.917 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m 42.13 58.35 2.97 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.278 1.037 . . . . 0.0 109.25 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.725 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -161.01 53.87 0.29 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.239 -153.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 25' ' ' GLN . 8.9 t -75.94 94.33 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 t -87.03 121.27 29.25 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.332 -172.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -100.77 98.55 9.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.383 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.59 ' CE2' HD22 ' A' ' 93' ' ' LEU . 50.2 m-85 -97.83 115.74 28.65 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.486 0.315 . . . . 0.0 111.371 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.687 HG13 HG22 ' A' ' 49' ' ' VAL . 7.1 tt -72.44 150.02 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.615 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.2 mp -128.37 117.74 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.184 0.594 . . . . 0.0 109.549 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.415 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 9.6 m120 -87.41 138.39 31.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.37 -173.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.3 t -83.23 100.28 10.5 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 171.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -78.17 157.87 77.79 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.8 62.48 2.36 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.586 2.191 . . . . 0.0 112.426 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 84.3 0.72 0.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.806 0.842 . . . . 0.0 110.61 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -72.32 -78.64 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.244 173.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.725 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 3.2 mpt_? -153.95 -171.01 3.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.358 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.438 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 27.4 m-85 -112.98 115.18 27.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -101.53 109.61 21.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.564 -171.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.615 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.3 tt -97.46 85.22 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.658 0.742 . . . . 0.0 110.72 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.02 81.38 0.09 OUTLIER Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.635 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.4 t70 72.6 -43.99 0.58 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.062 0.545 . . . . 0.0 111.315 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -74.81 126.16 30.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.826 0.346 . . . . 0.0 110.184 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.401 ' OE1' ' HD3' ' A' ' 70' ' ' ARG . 39.5 tt0 -108.01 124.77 50.66 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.562 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.725 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 81.7 m-85 -124.19 148.6 47.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.582 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 10.7 m-20 -62.7 -29.82 70.94 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -170.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 6.5 p80 -160.35 171.63 18.76 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.254 -0.179 . . . . 0.0 110.871 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.9 mt -55.91 -56.62 28.45 Favored Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.34 0.4 . . . . 0.0 111.84 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 32.3 Cg_exo -61.6 -9.2 12.82 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.215 1.943 . . . . 0.0 113.538 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.34 -36.19 16.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.515 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -76.17 -30.03 57.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 82' ' ' PRO . 92.2 mt -65.17 -38.74 91.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.495 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.817 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 40.3 mt-10 -75.86 -20.94 57.7 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -74.49 -38.8 62.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.295 0.569 . . . . 0.0 110.128 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HE2' HD13 ' A' ' 73' ' ' ILE . 47.8 m-85 -79.28 -6.77 57.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.104 0.478 . . . . 0.0 110.703 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.817 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 25.5 mtpp -71.78 -17.21 62.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.496 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.77 7.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 121.042 0.448 . . . . 0.0 111.162 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 20.2 t-160 -102.07 -32.29 10.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.299 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CD1' HG23 ' A' ' 97' ' ' THR . 98.8 m-85 70.43 101.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.741 0.651 . . . . 0.0 110.513 -175.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.681 HD13 HG21 ' A' ' 52' ' ' VAL . 9.4 mt -70.98 -20.61 62.41 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.856 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.592 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 30.9 t70 -172.75 82.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.715 171.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 66.7 -24.39 0.11 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.57 0.748 . . . . 0.0 111.874 -178.202 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 94' ' ' ASP . 13.9 t -124.3 157.94 33.76 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.539 HG23 ' CD1' ' A' ' 92' ' ' TYR . 19.1 p -100.04 -172.84 2.3 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.655 0.264 . . . . 0.0 111.088 -177.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.451 HD22 ' CG ' ' A' ' 36' ' ' PHE . 86.5 mt -70.96 93.54 1.0 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 35.9 mm -85.03 -59.32 2.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.138 -173.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.756 ' O ' ' HA ' ' A' ' 35' ' ' MET . 4.9 pt-20 -149.33 147.55 23.76 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.652 -174.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.43 149.54 27.58 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.5 2.134 . . . . 0.0 112.471 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -70.58 146.49 93.86 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.999 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.97 140.83 92.22 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.879 2.386 . . . . 0.0 112.16 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.754 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 52.4 mtm180 . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.984 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.969 HD12 HG13 ' A' ' 152' ' ' ILE . 4.3 mm? . . . . . 0 N--CA 1.461 0.119 0 CA-C-O 121.83 0.824 . . . . 0.0 112.721 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -151.53 -88.45 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.533 -172.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.522 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 79.0 m-85 -109.95 119.9 40.78 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.921 0.867 . . . . 0.0 112.035 -175.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.743 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 68.5 t -132.99 130.97 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.367 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.896 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 8.4 ptp85 -110.58 155.94 21.63 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 118.415 -1.314 . . . . 0.0 109.431 172.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.435 HG22 HG12 ' A' ' 178' ' ' VAL . 3.9 p -111.72 141.03 45.85 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.5 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 76.4 mt -103.44 -39.35 6.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.211 -175.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.3 t80 -73.82 -31.68 63.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -167.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.653 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 17.3 t70 67.82 91.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.443 0.639 . . . . 0.0 109.892 -172.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 88.1 t80 -124.85 113.24 26.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.349 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 58.0 Cg_endo -87.88 95.1 0.42 Allowed 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.15 1.9 . . . . 0.0 112.573 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.89 -10.27 84.28 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.586 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 62.96 25.62 15.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.033 0.533 . . . . 0.0 111.524 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.78 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 3.8 p30 46.83 -168.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 73.66 1.27 3.89 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.155 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -178.59 -35.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.125 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -134.41 110.38 9.39 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.492 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.686 HD12 ' HD2' ' A' ' 143' ' ' PRO . 31.4 tp -68.04 127.47 93.31 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 120.829 0.347 . . . . 0.0 111.72 -172.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.686 ' HD2' HD12 ' A' ' 142' ' ' LEU . 60.0 Cg_endo -78.8 105.28 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.292 1.995 . . . . 0.0 110.943 171.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 9.0 p90 -112.7 157.87 20.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.647 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.653 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 3.4 mptp? -102.91 178.79 4.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.817 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -66.45 -9.3 32.82 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.862 -177.494 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.512 ' N ' ' HD2' ' A' ' 146' ' ' LYS . . . -164.16 45.8 0.31 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.678 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -102.3 147.18 27.0 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 129' ' ' ARG . 33.8 mm -93.23 132.52 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.542 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 18.7 mt -118.8 154.85 32.18 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.66 129.86 74.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 172.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.969 HG13 HD12 ' A' ' 125' ' ' LEU . 46.3 mm -75.67 86.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.798 HG23 ' HG2' ' A' ' 154' ' ' GLU . 17.0 tt -67.95 -26.8 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.128 -176.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.798 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.5 OUTLIER -155.85 140.95 17.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.934 0.397 . . . . 0.0 111.2 173.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.475 ' HD2' ' CD2' ' A' ' 125' ' ' LEU . 32.2 tttm -120.89 95.84 48.82 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-O 121.249 0.547 . . . . 0.0 110.482 172.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.16 -59.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.81 2.34 . . . . 0.0 112.062 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -104.87 -170.37 1.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.052 -174.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -100.27 -42.72 6.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.897 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -80.31 -25.3 39.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.768 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.518 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 39.1 m95 -129.01 128.17 43.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.005 0.431 . . . . 0.0 110.759 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.647 ' O ' HG13 ' A' ' 173' ' ' ILE . 53.6 m0 -114.18 135.68 53.78 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.059 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.703 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 17.6 m -87.58 103.14 15.28 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.257 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.711 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -112.35 173.68 6.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.987 0.422 . . . . 0.0 111.13 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.4 ptt180 -119.88 137.56 53.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.0 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.917 ' ND2' ' HE ' ' A' ' 169' ' ' ARG . 51.6 p30 -78.59 -168.1 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.505 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -60.45 -34.8 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.799 0.333 . . . . 0.0 110.422 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -70.63 -21.27 62.65 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.042 0.449 . . . . 0.0 110.655 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.62 5.26 57.82 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.701 -0.761 . . . . 0.0 114.449 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.917 ' HE ' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -86.77 151.15 23.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.998 0.899 . . . . 0.0 111.45 -177.255 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 153' ' ' ILE . 39.5 t -98.91 140.74 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.567 -166.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -168.1 158.14 30.75 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 169.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.526 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 31.5 mtp -76.12 139.48 41.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.366 0.583 . . . . 0.0 110.089 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.647 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -133.77 148.69 69.45 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.678 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.518 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 3.5 Cg_exo -77.48 132.6 12.39 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.168 2.579 . . . . 0.0 112.674 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.647 ' O ' HG22 ' A' ' 178' ' ' VAL . 24.1 t -58.62 -46.33 99.59 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.363 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.48 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.0 Cg_exo -63.27 -2.1 3.62 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.375 2.05 . . . . 0.0 113.786 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.58 -5.66 26.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.415 -0.178 . . . . 0.0 111.327 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.0 m -107.41 -172.19 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -166.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.896 ' HB3' ' HG3' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -159.66 42.21 0.21 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.609 -163.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.743 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.754 0 O-C-N 121.219 -0.926 . . . . 0.0 109.25 -168.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 266' ' ' VAL . 20.7 t . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.928 0.394 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.11 132.56 56.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.382 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.567 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -121.17 155.27 34.9 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.669 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -119.5 119.08 32.8 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.45 119.06 14.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.686 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 22.9 pt -91.01 -4.25 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.053 -172.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -142.48 160.87 39.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.587 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.895 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 20.9 ttmm -93.51 123.05 36.55 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.871 HH11 ' HB3' ' A' ' 246' ' ' ARG . 0.7 OUTLIER -139.44 114.31 9.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.685 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--N 1.32 -0.689 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.323 -179.418 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 68.6 p . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -98.95 107.03 19.36 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.072 0.463 . . . . 0.0 110.964 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -73.18 113.62 10.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -58.71 108.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.538 0.524 . . . . 0.0 110.811 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.689 HD21 HG21 ' A' ' 279' ' ' VAL . 95.8 mt -130.25 127.03 38.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.264 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.895 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 11.7 pt-20 -119.61 -177.12 3.31 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.538 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 30.7 m -61.36 135.31 26.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.22 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 68.12 28.86 73.21 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.984 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -108.2 140.02 42.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.972 0.386 . . . . 0.0 110.146 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.0 mm -88.28 123.23 40.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.34 0.591 . . . . 0.0 111.523 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 240' ' ' ALA . 23.2 t -104.71 107.89 23.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.078 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -82.44 87.68 6.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.717 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' A' ' 238' ' ' VAL . 4.9 p -88.55 116.92 31.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.622 0.725 . . . . 0.0 110.584 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.421 ' O ' ' HD2' ' A' ' 268' ' ' ARG . 3.1 m -110.6 -19.15 12.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.694 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.466 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 13.8 mmm180 -122.34 109.96 15.07 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.5 mtt -107.6 118.3 36.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.154 0.502 . . . . 0.0 111.572 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -90.76 158.92 16.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.023 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.57 -14.7 9.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.455 0.645 . . . . 0.0 110.493 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -80.81 -1.8 44.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.893 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.82 -61.65 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.918 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.596 ' HG3' HD13 ' A' ' 285' ' ' LEU . 5.0 pm0 -77.71 131.21 37.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.93 0.395 . . . . 0.0 110.628 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 15.8 m0 -107.08 168.64 9.07 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.237 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 14.0 mt-10 -110.51 122.53 47.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.096 0.474 . . . . 0.0 110.299 174.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -130.26 145.14 16.41 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.511 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -94.41 109.11 20.99 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.689 HG21 HD21 ' A' ' 258' ' ' LEU . 20.8 t -113.43 167.76 6.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.437 ' N ' HG12 ' A' ' 279' ' ' VAL . 91.3 m-20 -60.13 -16.66 34.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -81.28 -45.08 7.66 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.863 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.64 ' HG2' HH11 ' A' ' 282' ' ' ARG . 1.0 OUTLIER 173.16 178.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.78 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 16.5 pttp -103.75 139.43 39.0 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 166.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -172.33 -170.24 35.95 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.7 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.596 HD13 ' HG3' ' A' ' 274' ' ' GLN . 97.9 mt -91.1 143.42 26.71 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.242 0.544 . . . . 0.0 110.803 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 41.6 p90 -147.97 137.16 11.9 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.561 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 7.3 Cg_exo -72.89 136.34 24.97 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.43 2.086 . . . . 0.0 111.309 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -63.51 -20.64 65.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.926 0.393 . . . . 0.0 110.956 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 m -69.81 -13.11 62.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.315 0.579 . . . . 0.0 110.828 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -97.39 -14.35 21.28 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.079 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.525 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 27.6 m -124.61 165.82 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.527 0.68 . . . . 0.0 112.14 -173.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -114.43 116.33 28.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.517 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' ' 240' ' ' ALA . 21.3 mm -89.02 117.12 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.13 0.49 . . . . 0.0 110.643 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -141.52 148.32 39.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.699 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 35.1 t0 . . . . . 0 C--N 1.316 -0.855 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.02 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -119.1 -8.01 10.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.837 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.741 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 27.6 p90 -94.11 162.37 13.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.58 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.28 123.84 48.9 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 m -79.96 21.83 0.54 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.723 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -111.41 -37.16 5.33 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.651 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' ' 12' ' ' SER . 34.4 t70 -87.94 108.35 19.15 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.055 -174.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -65.49 -20.04 66.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.426 -179.433 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.409 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 23.9 m -74.03 -5.41 41.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.803 0.335 . . . . 0.0 110.669 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.76 -47.88 5.42 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 38.3 p-90 -115.62 -21.26 9.79 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -171.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.439 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 49.3 t80 -81.52 118.55 22.83 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.202 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.794 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 6.9 tpp -95.14 -7.94 37.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.359 -172.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.08 -115.45 3.6 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.254 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 6.4 Cg_exo -73.65 95.02 0.86 Allowed 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.974 2.449 . . . . 0.0 112.529 -174.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.914 HG12 ' H ' ' A' ' 20' ' ' SER . 14.1 t -136.86 -152.97 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.914 ' H ' HG12 ' A' ' 19' ' ' VAL . 82.4 p 176.32 178.56 0.21 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -166.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -69.31 -39.89 78.0 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.121 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -63.34 -59.54 4.57 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.395 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.61 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 8.3 tp10 -59.9 -47.23 86.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.124 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.31 -35.87 70.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.51 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.5 tm0? -64.65 -40.95 96.33 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.647 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -80.17 -6.51 57.9 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.126 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.61 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 20.6 mmt85 -87.57 -35.32 18.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.714 0.769 . . . . 0.0 109.03 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.93 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 39.2 mt -100.08 27.4 5.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.331 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -51.35 97.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.478 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.446 ' H ' ' NE2' ' A' ' 31' ' ' GLN . . . 109.2 -4.63 31.62 Favored Glycine 0 CA--C 1.49 -1.503 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 167.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.586 ' HG3' ' HB2' ' A' ' 53' ' ' SER . 2.1 mp0 57.14 85.59 0.08 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 113.814 -1.193 . . . . 0.0 110.768 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -70.33 -19.95 63.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.846 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 2.8 m-70 78.63 118.93 0.06 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.297 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.95 9.08 59.95 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.972 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.646 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 29.3 mtm -106.75 137.07 45.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.498 -0.413 . . . . 0.0 110.176 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.569 ' HB2' HD11 ' A' ' 50' ' ' LEU . 43.3 p90 -133.98 162.34 32.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.247 -175.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 pp -151.0 135.03 16.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.52 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.0 t -102.49 108.31 23.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.766 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 23.6 ptt-85 -110.82 168.62 9.34 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.134 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.445 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 27.2 t70 -85.81 92.99 8.78 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.505 ' HA ' HG23 ' A' ' 49' ' ' VAL . 37.7 m 33.81 -149.22 0.0 OUTLIER 'General case' 0 C--O 1.238 0.5 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.501 ' H ' ' HB3' ' A' ' 41' ' ' SER . 63.8 m -157.29 -15.67 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.105 171.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 m -121.37 -44.87 2.35 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.038 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 40.9 t -115.65 99.87 52.96 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.11 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 22.6 Cg_endo -61.87 129.26 26.89 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.716 2.277 . . . . 0.0 111.84 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.32 -33.36 4.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.37 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.42 166.45 12.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.445 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 25.4 m-85 -125.73 166.22 17.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.778 0.323 . . . . 0.0 111.123 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.505 HG23 ' HA ' ' A' ' 41' ' ' SER . 45.0 t -144.13 106.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.846 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.72 ' HB2' HD11 ' A' ' 63' ' ' ILE . 63.8 tp -70.09 101.34 1.81 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.408 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.9 m -94.82 118.85 32.44 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.08 0.467 . . . . 0.0 109.99 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG21 HD13 ' A' ' 93' ' ' LEU . 46.5 t -119.2 134.19 63.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.192 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.93 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 84.1 p -93.39 132.85 37.25 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.776 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.664 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 5.1 mm-40 -143.95 176.24 9.43 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.846 ' HA ' ' CE1' ' A' ' 33' ' ' HIS . 55.5 m-80 -31.34 82.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -168.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.57 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 3.9 m 44.89 57.18 4.79 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.948 0.88 . . . . 0.0 109.765 -177.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.989 HH21 ' HB2' ' A' ' 94' ' ' ASP . 35.8 ttp85 -167.17 55.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.366 -151.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 61.8 t -74.93 102.49 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.245 -0.91 . . . . 0.0 109.598 -173.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 t -86.4 121.3 28.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.724 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -93.3 88.2 5.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.624 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.446 ' CE2' HD22 ' A' ' 93' ' ' LEU . 77.8 m-85 -78.86 116.01 18.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 18.5 tt -79.64 145.55 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -171.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.72 HD11 ' HB2' ' A' ' 50' ' ' LEU . 14.9 mt -138.31 116.35 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.602 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 9.3 m120 -87.21 142.34 27.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 122.314 0.246 . . . . 0.0 110.735 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.6 t -87.53 100.68 12.95 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 72' ' ' LYS . 87.9 mt -90.01 142.77 29.08 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.385 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 17.2 Cg_exo -67.49 -8.15 21.34 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.244 2.629 . . . . 0.0 113.071 -176.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.731 ' HB2' ' HG2' ' A' ' 70' ' ' ARG . 9.4 m120 -83.69 9.49 11.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.745 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 2.3 tpm_? 63.46 26.45 14.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.611 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.731 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 5.9 ptp180 -112.78 172.4 6.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.989 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.472 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 96.0 m-85 -131.66 127.2 36.47 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.204 0.526 . . . . 0.0 110.948 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.602 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 18.5 ttmm -97.16 100.06 11.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.926 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 10.9 tt -93.44 86.38 2.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.838 0.828 . . . . 0.0 110.227 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.32 60.34 4.46 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.087 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t0 74.44 -16.27 0.55 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.935 0.494 . . . . 0.0 111.38 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.461 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -78.83 126.86 31.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.876 0.369 . . . . 0.0 111.109 177.112 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -98.45 100.1 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.457 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.461 ' CE2' ' HB3' ' A' ' 76' ' ' GLN . 97.6 m-85 -103.46 168.85 8.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.839 0.352 . . . . 0.0 110.59 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.17 -53.56 53.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.461 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.449 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 1.2 p80 -164.81 -174.11 3.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.264 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.1 mt -55.23 -57.84 18.08 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.55 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 39.1 Cg_exo -59.8 -10.74 12.69 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.327 2.018 . . . . 0.0 113.214 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.447 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -95.22 -30.74 13.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.389 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.19 -26.27 56.02 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.5 mt -70.56 -25.85 63.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.913 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 52.1 mt-10 -73.5 -20.64 60.62 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.768 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -84.84 -35.59 22.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.054 0.454 . . . . 0.0 110.77 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.523 ' HE2' HD13 ' A' ' 73' ' ' ILE . 49.6 m-85 -86.59 1.07 53.05 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.999 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 13.0 ptmt -74.02 -21.99 59.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 171.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.448 HG23 ' HG3' ' A' ' 89' ' ' LYS . 23.6 pt -120.85 9.14 6.2 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -96.55 -38.78 9.84 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.206 -0.309 . . . . 0.0 111.233 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.543 ' CD1' HG23 ' A' ' 97' ' ' THR . 76.9 m-85 70.39 102.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.894 0.746 . . . . 0.0 109.716 -171.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.729 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 6.4 mt -74.23 -19.76 60.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.53 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.989 ' HB2' HH21 ' A' ' 57' ' ' ARG . 33.6 t70 -173.78 70.96 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 170.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 76.91 -29.81 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.22 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.408 HG22 HD13 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -107.43 157.58 17.88 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.676 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.543 HG23 ' CD1' ' A' ' 92' ' ' TYR . 18.1 p -105.26 -169.25 1.57 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.761 0.315 . . . . 0.0 110.178 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.464 HD22 ' CD1' ' A' ' 36' ' ' PHE . 97.6 mt -77.47 99.97 5.85 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 1.8 mp -96.91 -55.37 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.646 ' O ' ' HA ' ' A' ' 35' ' ' MET . 8.1 mm-40 -143.96 151.61 53.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.735 0.302 . . . . 0.0 111.293 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 24.7 Cg_endo -88.83 156.58 6.05 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.807 2.338 . . . . 0.0 111.893 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.48 139.63 55.4 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.947 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.43 135.57 46.74 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.479 2.119 . . . . 0.0 112.16 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.794 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 39.9 ptt180 . . . . . 0 C--N 1.327 -0.393 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 1.017 HD23 HG21 ' A' ' 152' ' ' ILE . 7.9 mp . . . . . 0 CA--C 1.508 -0.668 0 CA-C-O 121.527 0.679 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 16.8 pt-20 -165.77 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.193 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.46 130.92 54.51 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.908 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.976 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 72.8 t -142.41 157.57 19.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 179' ' ' GLU . 0.7 OUTLIER -136.05 150.8 49.32 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.092 161.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.483 HG22 HG12 ' A' ' 178' ' ' VAL . 6.0 p -105.67 140.46 38.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.052 0.453 . . . . 0.0 111.994 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.518 HD11 ' HG2' ' A' ' 179' ' ' GLU . 67.2 mt -110.83 -25.58 9.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.726 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.528 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 41.5 t80 -86.38 -32.6 20.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -168.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.67 ' HB2' ' HD3' ' A' ' 146' ' ' LYS . 6.6 t70 73.38 111.59 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.133 0.492 . . . . 0.0 110.617 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -141.65 89.1 9.31 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 35.4 Cg_endo -94.87 84.16 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 122.799 2.333 . . . . 0.0 112.871 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.508 ' HA3' ' OD2' ' A' ' 141' ' ' ASP . . . -94.1 -24.34 19.91 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.206 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.428 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 52.0 m-80 68.05 83.22 0.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.484 0.714 . . . . 0.0 112.715 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -173.42 -171.96 0.74 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 173.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.28 -16.89 28.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.314 1.054 . . . . 0.0 108.334 171.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 172' ' ' MET . 41.4 tt0 -73.57 -28.88 62.09 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.978 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.6 ' HA ' ' O ' ' A' ' 172' ' ' MET . 8.0 p-10 -157.17 117.04 3.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.369 174.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 165' ' ' ASN . 13.6 tp -69.62 121.39 82.27 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.964 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 41.6 Cg_endo -67.87 98.16 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.293 1.996 . . . . 0.0 111.324 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -112.73 162.25 15.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.522 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 1.6 mptm? -112.6 -167.79 1.23 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.291 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.67 ' HD3' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -91.25 19.6 5.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.921 176.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.4 30.86 0.52 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.606 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 23.2 mm-40 -104.71 144.14 32.13 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.887 -0.184 . . . . 0.0 110.73 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.502 HD13 ' HB3' ' A' ' 129' ' ' ARG . 46.7 mm -98.65 135.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.555 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 18.5 mt -118.95 155.24 31.68 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 93.4 t -120.32 125.42 74.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 174.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.017 HG21 HD23 ' A' ' 125' ' ' LEU . 47.1 mm -76.05 83.8 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 122.761 1.267 . . . . 0.0 108.674 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.759 HG21 HG22 ' A' ' 170' ' ' VAL . 15.1 tt -79.3 -26.97 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.195 -174.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 14.9 mt-10 -144.41 142.23 30.19 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.505 0.503 . . . . 0.0 109.975 173.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.601 ' HD3' HD22 ' A' ' 125' ' ' LEU . 3.8 ttpm? -134.58 89.74 25.55 Favored Pre-proline 0 C--O 1.236 0.371 0 O-C-N 121.842 -0.536 . . . . 0.0 111.172 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.465 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 16.9 Cg_exo -71.94 -55.31 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.549 2.166 . . . . 0.0 112.76 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -106.52 172.51 6.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.521 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 2.7 mm-40 -113.76 70.15 0.72 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.551 0.691 . . . . 0.0 110.505 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.503 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 13.9 pt20 175.58 -34.37 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.601 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.503 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 53.1 m95 -122.96 129.34 51.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.767 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.661 ' O ' HG13 ' A' ' 173' ' ' ILE . 51.0 m0 -120.21 137.26 54.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.35 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.868 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.5 m -88.29 92.72 9.27 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.439 0.638 . . . . 0.0 109.899 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.72 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.62 161.24 15.26 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.822 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.8 ptt180 -104.27 136.76 43.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.809 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 142' ' ' LEU . 16.3 p-10 -81.63 -173.1 4.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 110.993 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -59.13 -27.5 65.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.773 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.81 -18.93 38.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.734 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.16 29.06 7.77 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.134 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.822 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 19.6 ttm-85 -104.02 136.07 44.35 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.568 -0.372 . . . . 0.0 110.857 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.759 HG22 HG21 ' A' ' 153' ' ' ILE . 59.0 t -99.88 119.81 48.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.99 0.424 . . . . 0.0 111.167 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.2 160.22 28.22 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.6 ' O ' ' HA ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -68.81 131.37 45.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.027 0.441 . . . . 0.0 111.023 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.661 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -130.22 145.45 57.38 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.261 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.46 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 4.5 Cg_exo -78.71 131.66 10.4 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.062 2.508 . . . . 0.0 112.633 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.62 ' O ' HG22 ' A' ' 178' ' ' VAL . 41.4 t -59.68 -44.19 96.92 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.401 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 27.2 Cg_exo -65.13 5.49 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.225 1.95 . . . . 0.0 113.6 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -108.43 -6.14 16.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.093 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.1 m -107.52 -171.08 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -165.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 0.2 OUTLIER -156.09 41.21 0.38 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 112.821 -1.991 . . . . 0.0 106.91 -163.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.976 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 16.3 pttm . . . . . 0 N--CA 1.446 -0.637 0 CA-C-O 121.891 0.853 . . . . 0.0 110.435 -162.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.497 ' HB ' HG13 ' A' ' 266' ' ' VAL . 22.8 t . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.502 ' HD1' HG21 ' A' ' 263' ' ' ILE . 96.2 m-85 -109.6 123.91 50.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.0 111.001 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.692 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -142.02 122.04 13.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.033 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.476 ' CD ' ' H ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -80.96 144.68 31.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.068 0.461 . . . . 0.0 110.505 -178.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -88.78 94.67 10.0 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.049 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.447 ' H ' HG13 ' A' ' 243' ' ' ILE . 2.4 pp -94.48 19.45 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.687 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.61 173.39 11.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.331 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.435 ' H ' ' HG2' ' A' ' 245' ' ' LYS . 20.8 pttm -95.34 133.67 38.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.553 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -147.77 113.55 5.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.096 0.474 . . . . 0.0 111.382 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.755 174.674 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 121.049 0.452 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -104.58 99.61 9.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.119 0.485 . . . . 0.0 110.442 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.507 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.7 OUTLIER -78.37 121.5 24.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.919 -177.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -83.45 136.92 34.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.056 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.74 119.5 20.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.998 0.427 . . . . 0.0 110.313 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -100.01 149.83 23.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.514 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 15.6 t -58.02 123.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.839 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 157.46 -68.1 0.28 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.815 -1.183 . . . . 0.0 114.952 174.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 263' ' ' ILE . 5.0 t70 -116.96 -169.33 1.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.473 0.637 . . . . 0.0 112.496 -159.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.502 HG21 ' HD1' ' A' ' 239' ' ' PHE . 40.6 mm -91.72 135.6 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.238 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.47 110.16 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.735 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -80.58 87.81 5.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 110.862 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.497 HG13 ' HB ' ' A' ' 238' ' ' VAL . 6.8 p -90.21 130.62 39.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.038 0.447 . . . . 0.0 110.911 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.426 HG23 ' HG3' ' A' ' 268' ' ' ARG . 9.0 t -113.07 -20.83 11.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.426 ' HG3' HG23 ' A' ' 267' ' ' THR . 98.2 mtt180 -117.92 98.92 6.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 0.0 110.107 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 34.8 ttm -101.18 109.68 21.59 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.168 0.509 . . . . 0.0 110.804 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -83.31 162.31 21.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.932 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.1 tt -97.38 -13.72 7.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.129 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -67.24 -53.7 27.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.227 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 164.77 -37.81 0.29 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.791 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.421 ' HG3' HD13 ' A' ' 285' ' ' LEU . 0.5 OUTLIER -101.89 134.92 44.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.057 0.456 . . . . 0.0 110.24 178.437 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.519 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 20.9 m0 -107.89 165.1 11.7 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.167 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 43.7 tt0 -121.53 116.85 25.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.136 0.494 . . . . 0.0 110.253 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -129.56 169.98 20.59 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.54 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 74.8 mt-10 -108.39 108.35 19.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.906 0.384 . . . . 0.0 110.767 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.507 ' HB ' HD21 ' A' ' 256' ' ' LEU . 47.2 t -128.28 139.08 52.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 279' ' ' VAL . 88.1 m-20 70.96 8.02 6.39 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.631 0.373 . . . . 0.0 110.76 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 86.46 13.46 67.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.975 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 282' ' ' ARG . 1.7 ptm180 -132.03 137.98 48.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.86 0.362 . . . . 0.0 110.525 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 3.3 ptpp? -97.79 134.3 41.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.693 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -152.39 173.94 31.39 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.566 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 91.7 mt -90.14 140.59 29.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.015 0.436 . . . . 0.0 111.504 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 33.5 p90 -145.64 134.73 11.21 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.521 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 5.0 Cg_exo -74.54 148.82 38.11 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.857 2.371 . . . . 0.0 112.811 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.406 ' C ' ' H ' ' A' ' 290' ' ' HIS . 36.7 p90 -64.32 -25.27 67.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.286 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.8 m -76.0 37.45 0.15 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.45 0.643 . . . . 0.0 110.928 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.406 ' H ' ' C ' ' A' ' 288' ' ' PHE . 8.5 m-70 -141.6 -61.02 0.47 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.384 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.461 HG21 ' HE2' ' A' ' 286' ' ' PHE . 23.2 m -90.92 150.38 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.797 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -109.35 117.04 33.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.86 0.362 . . . . 0.0 110.785 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.692 HD13 ' HB2' ' A' ' 240' ' ' ALA . 36.8 mm -69.94 125.49 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.837 175.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -122.3 -179.31 4.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.465 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.133 0.492 . . . . 0.0 110.017 178.319 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 98' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 5' ' ' ARG . 17.4 ttp180 -163.11 105.15 1.01 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.114 0.483 . . . . 0.0 110.319 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.477 ' CB ' ' HD3' ' A' ' 101' ' ' PRO . 25.4 p90 -132.28 -180.0 5.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.985 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -89.36 91.03 8.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.122 0.487 . . . . 0.0 110.699 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.766 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 40.8 m -67.65 150.56 48.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.894 177.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m 78.28 -39.35 0.26 Allowed 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.799 0.687 . . . . 0.0 112.31 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.96 101.85 0.17 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.049 0.452 . . . . 0.0 110.295 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -56.96 -46.2 82.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.033 -170.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m -77.27 7.87 4.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.34 -40.27 11.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.572 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.3 p-90 -127.76 -27.81 2.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.0 t80 -79.77 123.67 27.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.896 0.317 . . . . 0.0 110.355 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.441 ' HB2' HG21 ' A' ' 19' ' ' VAL . 22.3 mmt -110.52 -1.33 17.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.844 -173.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.46 -114.27 2.88 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.007 -0.542 . . . . 0.0 113.709 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 10.3 Cg_exo -70.33 103.59 1.28 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.008 2.472 . . . . 0.0 112.175 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.816 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 85.9 t -136.57 -70.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.794 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 30.1 t 81.36 165.59 0.15 Allowed 'General case' 0 C--N 1.347 0.477 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -55.83 -38.96 70.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.746 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -59.63 -40.99 89.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.069 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -91.98 -44.97 8.58 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.235 -175.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.92 -41.31 67.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.811 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 47.8 tt0 -72.3 -46.27 56.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.413 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.3 t -68.39 -23.42 64.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.988 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -83.39 -29.31 28.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.2 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.713 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 38.4 mt -103.43 -0.05 30.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.027 0.441 . . . . 0.0 110.757 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 25.7 tt0 -70.15 113.53 7.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.6 -174.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.89 33.82 84.96 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.573 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -102.47 -168.48 1.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.678 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 17.8 ttp180 -62.85 113.19 2.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.627 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.478 ' ND1' ' HA ' ' A' ' 54' ' ' GLU . 4.2 m-70 -62.26 118.5 7.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.929 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.91 -8.33 6.81 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.569 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.678 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 20.1 mtp -87.17 140.11 29.88 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 122.52 0.328 . . . . 0.0 110.442 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.778 ' HB2' HG22 ' A' ' 52' ' ' VAL . 28.8 p90 -142.52 164.52 29.89 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.643 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.402 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.2 pp -154.98 136.67 14.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.221 0.534 . . . . 0.0 111.056 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 15' ' ' TYR . 93.2 t -101.42 112.7 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.816 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 20.9 ptt-85 -107.59 176.47 5.14 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.685 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -81.5 138.97 35.41 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.415 ' HA ' HG23 ' A' ' 49' ' ' VAL . 83.3 p -55.6 -19.87 11.75 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.086 0.241 . . . . 0.0 111.596 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m 69.41 17.63 8.07 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.507 0.67 . . . . 0.0 109.794 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 p -140.42 -45.05 0.41 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.733 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 66.3 m -134.27 127.13 18.79 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.765 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 24.2 Cg_exo -64.48 -14.37 43.95 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.863 2.375 . . . . 0.0 112.578 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.57 29.2 13.03 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.862 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.31 134.74 18.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -124.76 162.34 24.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.512 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.715 HG22 HG12 ' A' ' 62' ' ' ILE . 21.2 t -131.51 99.88 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.125 0.488 . . . . 0.0 111.189 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.2 tp -76.28 96.34 3.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.141 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.9 m -97.35 135.41 39.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.971 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.778 HG22 ' HB2' ' A' ' 36' ' ' PHE . 86.7 t -128.87 137.18 57.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.114 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.713 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 31.3 t -83.5 99.38 10.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.704 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' OE2' ' HB2' ' A' ' 93' ' ' LEU . 15.8 pt-20 -172.81 173.87 3.74 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.995 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.748 ' HB3' HH21 ' A' ' 57' ' ' ARG . 27.7 t-20 71.67 -56.3 0.64 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.734 1.254 . . . . 0.0 109.499 -164.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.401 ' C ' ' HG3' ' A' ' 57' ' ' ARG . 29.8 t -162.32 -40.63 0.04 OUTLIER 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.068 -1.878 . . . . 0.0 106.88 -176.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.748 HH21 ' HB3' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -165.35 -39.51 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.705 ' CG2' ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -144.2 110.97 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 120.822 1.646 . . . . 0.0 114.899 -173.285 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.652 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 16.0 m -95.85 108.29 20.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 163.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -100.34 99.0 9.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -170.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.729 ' CE2' HD22 ' A' ' 93' ' ' LEU . 44.0 m-85 -116.97 114.31 23.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.715 HG12 HG22 ' A' ' 49' ' ' VAL . 19.9 mt -81.07 138.59 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.787 HG13 ' HB ' ' A' ' 73' ' ' ILE . 5.3 mp -114.2 115.25 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.205 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -85.0 143.15 29.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.692 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.7 t -93.56 98.69 11.33 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' A' ' 72' ' ' LYS . 23.0 mt -78.58 124.94 85.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 14.1 Cg_exo -68.12 -33.58 24.73 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.313 2.009 . . . . 0.0 113.44 -174.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -67.53 -18.85 65.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -172.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.641 ' HG2' ' N ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -176.65 -53.55 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.641 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 2.3 ptm180 -136.85 -172.18 3.11 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -160.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -102.36 157.81 16.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.539 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.659 ' HB2' HD11 ' A' ' 66' ' ' LEU . 24.7 ttmm -138.82 104.67 5.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.787 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.7 tt -90.88 78.78 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.785 0.802 . . . . 0.0 110.006 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 65.52 86.49 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.742 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 10.8 t70 75.1 -61.68 0.48 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.475 0.31 . . . . 0.0 111.472 176.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.28 124.04 23.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.023 0.44 . . . . 0.0 109.987 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 11.1 pt-20 -107.3 138.5 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.282 0.563 . . . . 0.0 110.489 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.495 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 44.5 m-85 -127.18 166.59 17.42 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.54 -50.42 71.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -149.38 175.78 11.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.452 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.653 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 15.4 mt -54.85 -55.22 40.97 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.766 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 41.4 Cg_exo -59.96 -10.42 12.31 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.277 1.985 . . . . 0.0 113.797 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.74 -34.92 16.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.348 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -76.32 -28.75 57.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.394 0.616 . . . . 0.0 109.385 176.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 82' ' ' PRO . 74.0 mt -66.35 -23.4 66.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.009 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' A' ' 89' ' ' LYS . 38.0 tt0 -85.46 -29.27 24.45 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.237 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -69.37 -38.7 78.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.238 0.542 . . . . 0.0 110.063 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HE2' HD13 ' A' ' 73' ' ' ILE . 59.2 m-85 -80.83 -2.61 47.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.54 0.686 . . . . 0.0 110.467 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 47.5 tttm -78.77 -14.82 59.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.035 174.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -128.73 -1.77 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 111.474 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 22.6 t-160 -98.75 -28.51 13.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.127 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 70.1 132.23 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 O-C-N 124.079 0.862 . . . . 0.0 109.376 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 61' ' ' TYR . 9.2 mt -92.31 -26.63 18.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.734 ' CG ' ' HB2' ' A' ' 55' ' ' ASN . 10.3 t0 -173.83 83.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.777 168.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 71.66 -19.18 0.27 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.925 0.89 . . . . 0.0 112.064 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.7 m -120.43 158.0 28.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.0 p -106.16 172.57 6.73 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.458 ' O ' ' HB1' ' A' ' 4' ' ' ALA . 95.5 mt -64.71 93.69 0.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.032 0.444 . . . . 0.0 110.104 175.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.598 HG22 ' HG3' ' A' ' 100' ' ' GLU . 47.1 mm -81.34 -62.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.254 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.598 ' HG3' HG22 ' A' ' 99' ' ' ILE . 43.5 mt-10 -147.65 157.16 44.8 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.562 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 11.9 Cg_exo -70.46 156.98 60.36 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.097 1.865 . . . . 0.0 111.19 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.24 138.74 71.83 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -52.14 126.19 19.59 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.232 1.954 . . . . 0.0 111.808 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.057 179.87 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.597 HD12 HG21 ' A' ' 152' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.517 -0.297 0 CA-C-O 122.04 0.924 . . . . 0.0 111.488 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -172.07 -33.75 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.895 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -123.7 109.77 14.13 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.655 0.741 . . . . 0.0 111.352 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 179' ' ' GLU . 25.4 t -124.38 153.05 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.372 -175.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.732 ' HG2' ' O ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -135.06 150.37 50.25 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.066 174.646 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.649 HG22 ' CG1' ' A' ' 178' ' ' VAL . 51.4 p -95.46 133.95 38.85 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.823 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 178' ' ' VAL . 6.4 mt -106.96 -37.52 6.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.664 -173.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.599 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 47.5 t80 -90.45 -31.62 16.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -168.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.599 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 6.5 t70 77.67 123.91 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.214 0.53 . . . . 0.0 111.113 -172.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 84.8 t80 -156.77 106.3 1.96 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.733 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -91.98 95.22 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.879 2.386 . . . . 0.0 113.123 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -97.41 0.6 59.97 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.794 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.557 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 4.8 m-20 66.96 5.33 4.0 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.301 0.641 . . . . 0.0 112.223 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.883 ' HB2' ' HD3' ' A' ' 143' ' ' PRO . 18.5 t0 52.47 -146.51 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.869 0.867 . . . . 0.0 112.94 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 140' ' ' GLU . . . 69.51 11.83 8.08 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.499 1.12 . . . . 0.0 108.828 -165.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 139' ' ' ALA . 23.2 tt0 171.81 -39.67 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.139 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.506 ' C ' ' HA ' ' A' ' 138' ' ' ASP . 21.8 m-20 -133.33 97.73 4.05 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.78 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.819 HD12 ' HD2' ' A' ' 143' ' ' PRO . 23.7 tp -54.67 129.86 63.91 Favored Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 122.971 0.509 . . . . 0.0 111.931 -174.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.883 ' HD3' ' HB2' ' A' ' 138' ' ' ASP . 73.1 Cg_endo -81.54 117.5 3.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.513 2.142 . . . . 0.0 111.355 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.615 ' CB ' HG21 ' A' ' 130' ' ' THR . 21.3 p90 -123.04 165.51 16.66 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.986 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.521 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 42.4 mttp -115.05 -165.88 1.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.272 0.558 . . . . 0.0 111.904 -174.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.531 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -93.98 26.98 2.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.089 179.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.43 25.92 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 119.625 -1.274 . . . . 0.0 114.388 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.541 ' OE1' ' HB2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -108.12 161.6 14.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.93 0.865 . . . . 0.0 109.331 174.116 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.0 mm -119.36 146.9 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.757 -167.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 165' ' ' ASN . 15.9 mt -122.77 166.38 15.05 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -173.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.44 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 97.6 t -123.53 125.76 72.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.712 HD13 ' HB2' ' A' ' 163' ' ' ALA . 21.6 mm -77.0 97.54 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 CA-C-O 122.475 1.131 . . . . 0.0 108.747 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.615 ' CD1' ' HE1' ' A' ' 61' ' ' TYR . 1.7 tt -97.52 -49.01 12.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 112.472 -2.149 . . . . 0.0 109.024 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.044 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 15.7 mt-10 -116.16 142.85 46.27 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.573 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 15.8 ttpp -140.23 72.04 32.96 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 121.466 -0.771 . . . . 0.0 109.901 170.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.474 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 24.5 Cg_exo -62.12 -43.89 22.13 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.453 2.102 . . . . 0.0 111.885 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -113.73 -174.07 2.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.05 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 4.2 tp10 -107.14 -40.0 5.55 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.525 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -84.08 -11.55 56.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.174 0.512 . . . . 0.0 110.324 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.427 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 68.0 m95 -129.2 118.58 22.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.407 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.604 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.7 m0 -108.76 139.08 44.07 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . 1.044 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 11.3 t -101.72 91.08 4.25 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.39 0.614 . . . . 0.0 109.639 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.712 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.52 161.53 15.25 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.197 -172.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.699 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 19.5 ptt-85 -97.54 136.21 38.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.796 ' HB3' HD11 ' A' ' 142' ' ' LEU . 0.1 OUTLIER -85.76 175.57 8.62 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.619 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -79.9 4.28 17.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.37 0.605 . . . . 0.0 110.975 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.513 ' HB3' ' OD1' ' A' ' 165' ' ' ASN . 33.6 t70 -104.03 -1.28 27.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.245 0.545 . . . . 0.0 109.535 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 85.47 72.09 1.3 Allowed Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.81 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 38.4 ttm-85 -164.46 129.04 2.65 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.78 -0.247 . . . . 0.0 110.364 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.689 HG22 ' HB3' ' A' ' 164' ' ' ARG . 39.0 t -105.48 109.56 28.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.373 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.505 ' HA3' ' OD1' ' A' ' 138' ' ' ASP . . . -146.23 170.09 27.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.095 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.587 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 22.5 mtp -82.49 137.11 34.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.038 0.447 . . . . 0.0 111.211 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.613 HG23 ' HB3' ' A' ' 142' ' ' LEU . 2.7 pp -133.9 146.04 58.4 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.699 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.461 ' HD2' ' CE2' ' A' ' 144' ' ' PHE . 7.3 Cg_exo -72.23 128.35 13.72 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.064 2.509 . . . . 0.0 112.41 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 47.8 t -67.4 -36.67 10.86 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.278 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 26.8 Cg_endo -63.49 10.4 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.646 1.564 . . . . 0.0 113.177 173.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 175' ' ' VAL . 4.6 m-85 -118.38 -19.83 8.73 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.554 0.342 . . . . 0.0 111.322 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.649 ' CG1' HG22 ' A' ' 130' ' ' THR . 3.8 m -146.2 155.97 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.674 -166.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.5 ' C ' ' HD3' ' A' ' 180' ' ' LYS . 11.7 mt-10 -150.46 -56.35 0.17 Allowed 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 115.939 -2.305 . . . . 0.0 115.652 155.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.732 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.349 0 C-N-CA 115.619 -2.432 . . . . 0.0 116.04 -160.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.442 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 38.4 t . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.19 122.01 46.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.88 0.371 . . . . 0.0 110.818 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.492 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.28 142.91 48.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.25 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -95.37 123.75 39.06 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -75.81 111.24 10.96 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.121 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.417 HG21 ' HE3' ' A' ' 292' ' ' LYS . 35.6 pt -94.58 -9.98 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.431 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 62.3 tt0 -138.92 144.04 38.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.607 ' HG2' ' HA ' ' A' ' 259' ' ' GLU . 84.1 mttt -82.3 121.94 27.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.932 0.396 . . . . 0.0 111.093 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.596 ' HD2' ' HE2' ' A' ' 290' ' ' HIS . 54.1 ttt85 -93.16 102.47 14.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 C--N 1.318 -0.765 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.196 -179.246 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.267 0.556 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -92.59 111.01 22.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.929 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.475 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.4 tt -90.11 113.3 25.01 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -64.68 123.82 20.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.016 0.436 . . . . 0.0 110.909 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.3 mt -128.03 165.18 20.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.848 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.607 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 14.3 pt-20 -146.36 166.27 26.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.535 177.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 42.9 t -70.56 124.01 25.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.022 0.439 . . . . 0.0 111.071 -174.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.35 4.43 50.08 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.805 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -100.3 155.08 17.98 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.977 0.389 . . . . 0.0 109.992 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.8 mm -94.74 113.04 28.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.169 0.509 . . . . 0.0 110.99 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 t -87.05 95.4 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.285 0.565 . . . . 0.0 109.592 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -81.52 98.58 8.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.057 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 275' ' ' TRP . 4.0 p -89.11 120.96 38.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.392 0.615 . . . . 0.0 111.27 -176.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 26.4 m -93.99 -30.91 14.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.506 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 1.001 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 13.0 tpt180 -115.54 97.34 6.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.441 -177.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 2.2 tpt -81.53 106.16 13.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.167 0.508 . . . . 0.0 109.659 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -86.39 166.17 15.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.192 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 40.1 mm -76.91 83.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.418 -175.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.6 t30 83.65 82.42 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.752 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.407 ' HA2' ' HD1' ' A' ' 288' ' ' PHE . . . 114.35 -77.16 0.25 Allowed Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 119.69 -1.243 . . . . 0.0 114.066 154.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -72.52 88.57 1.24 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.825 0.345 . . . . 0.0 110.718 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.514 ' HB3' HG21 ' A' ' 266' ' ' VAL . 9.9 m0 -92.88 161.47 14.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.033 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 1.001 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 27.5 tt0 -109.98 116.09 30.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.086 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.36 155.71 18.24 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.368 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.3 108.37 19.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.475 ' HB ' HD21 ' A' ' 256' ' ' LEU . 61.0 t -128.98 140.12 50.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 66.68 -71.05 0.1 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.831 0.707 . . . . 0.0 110.882 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -173.98 31.51 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -151.17 143.59 24.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.733 -0.233 . . . . 0.0 110.577 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 98.3 mttt -96.52 131.39 43.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 171.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.71 171.23 30.52 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.98 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 37.2 mt -92.83 145.09 24.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.093 0.473 . . . . 0.0 110.668 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.871 ' HB2' ' HE1' ' A' ' 290' ' ' HIS . 31.5 p90 -148.22 124.93 5.46 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.16 177.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.416 ' HB2' HG22 ' A' ' 289' ' ' THR . 44.4 Cg_endo -71.6 157.48 55.84 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.271 1.981 . . . . 0.0 111.772 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.407 ' HD1' ' HA2' ' A' ' 273' ' ' GLY . 22.8 p90 -81.55 15.21 2.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.1 0.476 . . . . 0.0 111.5 -176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.416 HG22 ' HB2' ' A' ' 287' ' ' PRO . 8.8 t -89.81 1.56 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.576 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.871 ' HE1' ' HB2' ' A' ' 286' ' ' PHE . 0.3 OUTLIER -137.39 3.77 2.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 176.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.463 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 18.4 m -129.54 157.35 42.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.417 ' HE3' HG21 ' A' ' 243' ' ' ILE . 16.8 ptpt -129.9 135.66 48.62 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.516 176.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.492 HD13 ' HB2' ' A' ' 240' ' ' ALA . 46.5 mm -83.47 103.4 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.252 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -93.69 167.56 11.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.194 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--N 1.321 -0.651 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.859 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.629 ' HB3' ' HG2' ' A' ' 89' ' ' LYS . . . . . . . . 0 C--O 1.234 0.271 0 N-CA-C 110.637 -0.134 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.96 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.619 0.575 . . . . 0.0 109.487 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.684 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 3.5 p90 38.4 -122.56 0.28 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 124.288 0.992 . . . . 0.0 111.14 -174.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -139.99 81.59 1.83 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 172.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -71.84 62.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.943 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -179.19 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.12 100.07 4.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.576 -174.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -64.41 -24.62 67.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.761 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.6 m -67.41 -7.6 26.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.353 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.49 -47.99 4.49 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -112.15 -20.6 11.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -82.08 110.34 17.22 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.811 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 11.3 tpp -96.34 0.6 50.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.168 -171.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.433 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.49 -113.36 2.29 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.181 -0.918 . . . . 0.0 114.152 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 3.0 Cg_exo -79.33 100.24 1.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.823 2.348 . . . . 0.0 112.127 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.598 ' HB ' ' HG2' ' A' ' 39' ' ' ARG . 85.1 t -130.34 -76.63 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 48.8 m 82.65 162.92 0.13 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -51.65 -42.3 61.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -55.86 -39.46 71.52 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.423 0.452 . . . . 0.0 112.104 -177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 34.2 mt-10 -95.75 -44.91 7.22 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.254 -177.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.86 51.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.336 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -81.67 -32.88 31.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.759 -173.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.493 ' HA ' ' HB2' ' A' ' 29' ' ' GLN . 10.6 t -78.0 -27.74 49.05 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 110.682 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 21.2 mmt85 -64.62 -33.9 77.01 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.855 0.836 . . . . 0.0 109.755 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.987 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 80.7 mt -113.89 23.29 13.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.077 -176.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.493 ' HB2' ' HA ' ' A' ' 26' ' ' THR . 24.4 tt0 -72.71 72.13 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.227 0.537 . . . . 0.0 110.536 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.14 15.96 59.32 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.296 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -62.98 -28.37 70.04 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 20.0 ttm180 -156.24 -36.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.476 172.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.623 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 28.9 m170 77.08 132.0 0.05 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.129 0.893 . . . . 0.0 109.52 -173.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.31 -10.86 67.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.567 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 55.4 mtm -87.36 153.75 21.21 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 50' ' ' LEU . 39.0 p90 -141.63 162.16 36.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.331 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.5 pp -150.81 135.98 17.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.024 0.44 . . . . 0.0 110.337 172.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.7 t -105.54 116.26 48.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.425 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.618 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -119.85 163.72 17.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.893 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.2 131.81 45.51 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.527 ' OG ' HG22 ' A' ' 43' ' ' THR . 26.8 t -79.4 158.62 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.57 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.0 t -117.92 4.4 12.15 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.176 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.527 HG22 ' OG ' ' A' ' 41' ' ' SER . 14.7 t -93.52 -26.2 17.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.893 0.378 . . . . 0.0 110.345 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.696 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 62.8 m -141.98 144.67 33.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.07 -48.92 15.9 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.819 2.346 . . . . 0.0 112.568 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.92 71.59 0.21 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.577 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.696 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 34.3 t70 -151.3 150.98 31.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -173.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -130.35 172.1 12.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.647 HG22 HG12 ' A' ' 62' ' ' ILE . 54.2 t -144.47 108.29 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 111.543 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' A' ' 36' ' ' PHE . 42.9 tp -81.37 105.36 12.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.214 173.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -96.96 128.56 44.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.304 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.596 HG21 HD13 ' A' ' 93' ' ' LEU . 86.9 t -125.7 134.62 66.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.04 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.987 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 65.6 p -106.93 124.65 49.92 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.623 ' HG2' ' HB3' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -154.84 153.64 31.48 Favored 'General case' 0 C--O 1.212 -0.888 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 163.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 57.72 19.98 6.02 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.0 m 54.46 61.27 3.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 123.018 1.39 . . . . 0.0 108.259 -170.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 39.6 ttp85 -162.3 57.75 0.23 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.121 -2.309 . . . . 0.0 107.286 -159.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.2 t -76.97 100.24 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.723 -172.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 p -79.69 120.99 24.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.924 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -95.41 98.7 10.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.105 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.678 ' CE2' HD22 ' A' ' 93' ' ' LEU . 26.0 m-85 -93.9 115.83 28.23 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.647 HG12 HG22 ' A' ' 49' ' ' VAL . 7.1 mt -76.43 139.63 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.585 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 2.7 mp -124.81 118.41 53.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.696 0.798 . . . . 0.0 109.895 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 11.0 m120 -84.99 131.66 34.44 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 -172.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -79.77 99.45 7.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 72' ' ' LYS . 61.2 mt -90.63 132.48 34.95 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.429 -176.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 25.1 Cg_exo -64.07 -3.81 6.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.902 2.402 . . . . 0.0 112.699 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -93.82 22.18 5.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.152 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.655 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.8 mmp_? 63.36 26.83 15.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.394 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.7 164.41 15.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.663 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.585 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 62.5 m-85 -133.69 114.9 13.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.72 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.47 ' NZ ' ' HG3' ' A' ' 77' ' ' GLU . 21.8 ttmm -100.73 107.18 18.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.817 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.0 tt -94.7 78.42 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.858 0.837 . . . . 0.0 109.742 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.42 89.31 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.226 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.93 -57.69 0.63 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.464 0.706 . . . . 0.0 111.193 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -69.19 121.53 16.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.995 0.426 . . . . 0.0 110.965 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.47 ' HG3' ' NZ ' ' A' ' 72' ' ' LYS . 20.4 mt-10 -97.59 125.56 42.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.966 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 74.3 m-85 -115.38 152.45 32.82 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.84 -11.19 60.81 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -175.17 176.32 2.09 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.628 0.195 . . . . 0.0 110.757 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.5 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 5.9 mt -56.44 -55.56 41.27 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 123.278 0.361 . . . . 0.0 111.833 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.418 ' HA ' HD12 ' A' ' 85' ' ' LEU . 37.8 Cg_exo -63.38 -3.86 5.82 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.123 1.882 . . . . 0.0 113.638 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.13 -35.04 16.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.76 0.314 . . . . 0.0 110.55 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -76.15 -31.92 58.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 82' ' ' PRO . 55.5 mt -68.24 -24.35 64.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.713 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.18 -19.12 40.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.828 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -88.38 -39.14 14.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.177 0.513 . . . . 0.0 110.199 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.519 ' HE2' HD13 ' A' ' 73' ' ' ILE . 52.8 m-85 -78.28 -3.5 43.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.518 0.675 . . . . 0.0 109.78 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.629 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 1.4 tmtp? -64.71 -35.09 79.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.869 170.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.7 pt -113.69 -6.39 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.629 -0.428 . . . . 0.0 112.072 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 6.2 t-160 -73.18 -43.21 61.77 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.806 -0.179 . . . . 0.0 110.886 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.62 ' CD1' HG23 ' A' ' 97' ' ' THR . 94.5 m-85 68.03 100.04 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.257 0.973 . . . . 0.0 108.867 -165.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.717 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 4.2 mt -69.64 -98.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.527 ' OD2' ' HB3' ' A' ' 54' ' ' GLU . 17.5 t0 -89.84 76.86 7.09 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 121.368 -0.832 . . . . 0.0 109.325 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 68.15 -34.07 0.24 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.538 1.135 . . . . 0.0 112.409 -177.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.404 ' H ' ' C ' ' A' ' 94' ' ' ASP . 39.5 m -107.87 146.06 32.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.62 HG23 ' CD1' ' A' ' 92' ' ' TYR . 3.1 p -81.76 -178.5 7.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 0.0 110.704 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.401 HD22 ' CD2' ' A' ' 36' ' ' PHE . 95.1 mt -77.18 91.76 3.76 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.1 mm -74.93 -60.83 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.424 -175.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.684 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 9.4 pt-20 -162.35 156.09 17.9 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.407 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.2 158.15 49.32 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.621 2.214 . . . . 0.0 113.36 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -72.49 154.38 91.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.842 176.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.25 124.4 15.55 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.054 2.503 . . . . 0.0 112.673 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.811 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 75.8 ttt180 . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.072 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.969 HD12 HG21 ' A' ' 152' ' ' ILE . 1.3 mm? . . . . . 0 C--O 1.234 0.289 0 CA-C-O 121.77 0.795 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -154.77 -76.73 0.1 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.608 -171.112 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.578 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 48.9 m-85 -104.98 108.52 20.07 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.612 0.72 . . . . 0.0 111.392 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.944 HG22 ' HB3' ' A' ' 180' ' ' LYS . 74.3 t -122.81 132.25 71.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.516 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.975 ' HB2' ' HB3' ' A' ' 179' ' ' GLU . 26.1 mtt180 -107.7 160.29 15.82 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.548 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.452 HG21 ' CG ' ' A' ' 144' ' ' PHE . 12.5 p -117.08 134.43 54.77 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.547 176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.634 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 81.0 mt -104.42 -32.22 9.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.692 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.54 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 47.6 t80 -78.13 -36.85 47.32 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -169.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.601 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 7.4 t70 74.5 105.22 0.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.336 0.589 . . . . 0.0 109.813 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -141.1 100.15 6.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 51.9 Cg_endo -88.52 87.7 0.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.273 1.982 . . . . 0.0 112.492 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.682 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -83.3 -12.83 78.04 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.931 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 1.026 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 4.6 p30 35.71 66.74 0.33 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.431 1.092 . . . . 0.0 113.888 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -159.39 -178.88 7.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.57 -7.33 57.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.577 0.703 . . . . 0.0 109.763 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.4 pt-20 -116.85 4.07 12.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.451 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.682 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 10.3 m-20 -146.79 97.3 2.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.378 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.099 HD11 ' HB2' ' A' ' 165' ' ' ASN . 49.1 tp -75.16 120.55 82.17 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 1.026 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 12.1 Cg_endo -80.84 92.94 1.04 Allowed 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.106 1.871 . . . . 0.0 111.178 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.452 ' CG ' HG21 ' A' ' 130' ' ' THR . 10.3 p90 -100.9 164.61 11.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.685 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.601 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 9.2 mtpt -119.46 -178.83 3.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.654 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -77.28 63.56 2.51 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.089 0.947 . . . . 0.0 111.544 -175.259 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.97 35.54 0.27 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.722 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.486 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 5.3 mm-40 -96.7 141.0 30.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.982 0.42 . . . . 0.0 110.224 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.06 128.37 43.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 165' ' ' ASN . 40.1 mt -121.03 157.23 30.46 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 58.0 t -116.08 128.41 73.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.969 HG21 HD12 ' A' ' 125' ' ' LEU . 42.5 mm -75.16 97.38 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.809 0.814 . . . . 0.0 109.204 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.735 HG23 ' HG2' ' A' ' 154' ' ' GLU . 8.7 tt -85.11 -42.81 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.868 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.984 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 0.8 OUTLIER -122.23 140.23 52.85 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.567 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 45.6 tttt -131.24 88.72 43.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 O-C-N 121.673 -0.642 . . . . 0.0 110.915 171.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.478 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 16.2 Cg_exo -74.3 -51.83 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.66 2.24 . . . . 0.0 113.083 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -110.91 -171.38 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.233 -0.292 . . . . 0.0 110.82 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.42 ' HA ' ' HE1' ' A' ' 161' ' ' TRP . 0.2 OUTLIER -110.65 -25.7 9.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.774 0.321 . . . . 0.0 110.411 174.014 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -84.72 -28.0 26.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.277 0.56 . . . . 0.0 110.416 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.682 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 43.3 m95 -128.36 130.39 47.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.122 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.704 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.7 m0 -122.52 142.83 50.17 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.064 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.984 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.2 m -98.82 94.59 6.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.438 0.637 . . . . 0.0 110.391 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.71 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -100.1 164.23 12.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.217 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.703 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.2 ptt180 -104.35 134.52 47.43 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.775 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.099 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.7 t30 -75.12 -179.32 4.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.568 -177.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -58.78 -21.12 55.17 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 172.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.5 -36.78 81.73 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.469 0.652 . . . . 0.0 109.36 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.25 -6.78 42.94 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.808 -168.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.703 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 13.0 ttm-85 -69.72 140.08 53.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.463 -0.868 . . . . 0.0 111.606 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.644 HG22 HG21 ' A' ' 153' ' ' ILE . 44.4 t -98.89 125.42 52.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.953 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.418 ' CA ' ' HB2' ' A' ' 142' ' ' LEU . . . -150.1 163.2 29.41 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.59 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.682 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -79.65 136.18 36.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.622 0.249 . . . . 0.0 110.609 179.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.704 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -136.09 145.39 52.14 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.378 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.488 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 6.1 Cg_exo -80.45 133.65 9.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.037 2.491 . . . . 0.0 112.903 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.677 ' O ' HG22 ' A' ' 178' ' ' VAL . 92.6 t -62.84 -41.74 73.61 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.1 Cg_endo -63.42 0.73 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.012 1.808 . . . . 0.0 113.304 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -106.74 -3.48 20.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.645 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 175' ' ' VAL . 11.4 m -107.2 -178.85 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -165.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.975 ' HB3' ' HB2' ' A' ' 129' ' ' ARG . 1.0 OUTLIER -149.25 39.98 0.85 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 112.702 -2.045 . . . . 0.0 108.498 -165.171 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.944 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.686 0 O-C-N 121.109 -0.995 . . . . 0.0 110.913 -169.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 1.054 ' N ' HG22 ' A' ' 266' ' ' VAL . 21.4 t . . . . . 0 N--CA 1.524 3.226 0 CA-C-O 117.968 -1.015 . . . . 0.0 108.342 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.448 ' HA ' HG13 ' A' ' 266' ' ' VAL . 60.1 m-85 -65.26 119.59 11.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.621 1.101 . . . . 0.0 111.315 -163.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -132.96 156.98 46.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.583 -168.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -96.65 122.59 39.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.336 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.465 ' HB2' HG23 ' A' ' 264' ' ' VAL . . . -73.39 115.09 12.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.12 -0.22 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -172.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 245' ' ' LYS . 7.2 tt0 -140.94 147.89 39.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.869 0.366 . . . . 0.0 110.507 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.822 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 51.6 mtmt -79.24 140.23 37.69 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.297 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -140.39 104.91 4.88 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.998 0.428 . . . . 0.0 110.462 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.692 -179.369 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 121.049 0.452 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.95 103.5 14.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.064 0.459 . . . . 0.0 111.444 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.455 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.0 OUTLIER -74.27 114.06 12.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.817 177.538 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -70.95 132.44 45.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.524 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.429 HD21 HG21 ' A' ' 279' ' ' VAL . 96.7 mt -136.35 -177.96 4.95 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.337 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.822 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 7.5 pt-20 -154.55 -165.66 2.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.181 176.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.76 HG23 ' HG3' ' A' ' 245' ' ' LYS . 39.2 t -108.23 130.43 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 111.802 -173.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.21 15.87 12.05 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.586 -0.816 . . . . 0.0 114.497 168.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.3 179.78 6.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.87 0.835 . . . . 0.0 111.212 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.9 mm -105.82 119.43 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.816 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 266' ' ' VAL . 65.7 t -76.38 125.15 35.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.488 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 89.5 mttt -68.34 88.63 0.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.808 0.813 . . . . 0.0 109.5 173.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 1.054 HG22 ' N ' ' A' ' 238' ' ' VAL . 2.1 p -127.56 126.19 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.556 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.404 ' N ' ' N ' ' A' ' 238' ' ' VAL . 5.1 m -137.87 -26.18 0.96 Allowed 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.64 HH12 ' HB3' ' A' ' 276' ' ' GLU . 5.9 tmm_? -136.05 93.07 2.87 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.115 0.966 . . . . 0.0 110.46 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' MET . . . . . 0.551 ' CE ' ' HB ' ' A' ' 238' ' ' VAL . 4.0 ptp -87.37 141.36 28.69 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.205 -0.934 . . . . 0.0 113.255 -174.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -75.03 157.4 34.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.372 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.2 tp -92.54 -3.47 10.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.531 0.681 . . . . 0.0 110.253 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -73.27 -10.01 59.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.104 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 100.18 -29.35 12.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.932 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.444 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 16.4 mm-40 -89.5 113.38 24.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.181 0.515 . . . . 0.0 109.654 175.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.568 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 55.0 m0 -92.8 162.76 13.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.564 -173.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.64 ' HB3' HH12 ' A' ' 268' ' ' ARG . 2.8 tm-20 -128.6 89.63 2.92 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 120.209 -0.597 . . . . 0.0 109.814 -168.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -117.96 158.35 14.72 Favored Glycine 0 C--O 1.226 -0.389 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.995 -174.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 265' ' ' LYS . 18.0 tt0 -116.79 111.08 19.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.246 0.523 . . . . 0.0 110.572 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.455 ' HB ' HD21 ' A' ' 256' ' ' LEU . 97.9 t -109.93 122.22 64.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.682 0.277 . . . . 0.0 110.64 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 48.15 32.22 2.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.58 1.152 . . . . 0.0 112.41 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 97.3 -3.03 61.45 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.198 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -107.92 114.96 29.27 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.1 OUTLIER -106.61 141.56 37.68 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.875 178.036 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -171.18 -170.29 35.14 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.649 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 80.5 mt -99.56 135.01 41.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.064 0.459 . . . . 0.0 110.188 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 50.7 p90 -136.79 140.87 33.12 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.16 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 2.8 Cg_exo -76.65 152.37 33.22 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.989 2.459 . . . . 0.0 112.661 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.502 ' HB3' ' CH2' ' A' ' 275' ' ' TRP . 7.6 p90 -69.71 -2.51 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.399 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.7 p -90.45 4.33 51.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.058 0.456 . . . . 0.0 111.47 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -117.44 -15.37 10.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.778 0.323 . . . . 0.0 111.441 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.418 HG21 ' HE2' ' A' ' 286' ' ' PHE . 33.1 m -128.6 160.85 38.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.266 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -121.54 119.0 30.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.73 0.3 . . . . 0.0 110.535 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.653 HD13 ' HB2' ' A' ' 240' ' ' ALA . 49.5 mm -73.36 123.22 27.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.604 175.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -126.16 174.26 8.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.394 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 121.486 0.66 . . . . 0.0 112.438 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -122.59 -57.55 1.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.107 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 62.58 176.27 0.14 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 172.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.08 73.7 0.76 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.624 -2.08 . . . . 0.0 106.08 164.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.2 m -63.44 154.84 30.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.0 -167.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.474 ' H ' ' HB3' ' A' ' 82' ' ' PRO . 24.6 m 75.84 -45.9 0.54 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.321 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.38 110.21 0.92 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.525 0.679 . . . . 0.0 111.048 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -57.72 -32.14 67.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.941 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 t -81.38 -1.66 46.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.3 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.2 -46.94 7.49 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.367 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -117.76 -26.22 6.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -173.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -84.33 125.38 32.23 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.025 -0.422 . . . . 0.0 110.866 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.519 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.2 mmt -108.53 -3.47 18.04 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.189 -175.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 52.17 -112.18 1.88 Allowed Glycine 0 CA--C 1.522 0.53 0 O-C-N 123.66 0.6 . . . . 0.0 113.953 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.6 Cg_exo -66.63 88.35 0.28 Allowed 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.411 2.741 . . . . 0.0 113.499 -176.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.882 HG12 ' H ' ' A' ' 20' ' ' SER . 16.4 t -131.96 -162.88 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.882 ' H ' HG12 ' A' ' 19' ' ' VAL . 47.5 p -173.77 178.27 2.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.701 1.137 . . . . 0.0 109.167 -169.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 20.1 tpt180 -55.43 -54.45 43.62 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.288 0.367 . . . . 0.0 110.034 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -58.28 -59.6 5.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.717 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 56.5 mm-40 -61.05 -46.53 90.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.02 -174.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.85 77.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 18.3 pt20 -70.06 -33.32 71.79 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.954 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.6 m -64.5 -34.41 78.15 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.43 0.633 . . . . 0.0 111.082 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 22.8 mmt85 -64.23 -41.41 97.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.843 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 14.5 mt -112.19 6.97 19.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -168.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 29' ' ' GLN . 4.1 pt20 -74.65 100.41 3.94 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.454 0.645 . . . . 0.0 111.721 -176.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.67 4.96 90.23 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.313 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -88.19 -171.69 3.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.574 0.226 . . . . 0.0 110.691 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.538 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 6.0 mtp180 -48.78 126.47 12.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.934 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -85.59 155.17 21.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.929 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.7 -2.06 79.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.322 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 39.5 mtm -93.1 153.25 18.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.0 110.335 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.634 ' CD1' HD22 ' A' ' 98' ' ' LEU . 49.3 p90 -150.13 166.53 29.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.434 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.519 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -155.27 138.33 15.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.641 174.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t -105.41 125.12 60.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.605 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.793 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 32.7 ptt-85 -124.44 174.37 7.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.291 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -72.55 131.76 42.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.634 ' HA ' HG23 ' A' ' 49' ' ' VAL . 15.4 t -56.05 146.64 22.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.633 0.73 . . . . 0.0 112.443 -170.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -92.22 -7.93 46.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.213 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.6 m -110.34 -47.87 3.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.335 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 41' ' ' SER . 56.2 m -125.09 119.0 25.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.714 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.9 112.79 1.75 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.527 2.151 . . . . 0.0 111.572 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.04 -21.88 11.85 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.459 ' C ' ' HB2' ' A' ' 41' ' ' SER . 26.4 t70 -82.85 171.94 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 27.1 m-85 -130.37 160.91 32.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.458 0.572 . . . . 0.0 111.205 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 41' ' ' SER . 39.5 t -136.77 105.4 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.213 0.53 . . . . 0.0 111.218 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.485 ' CB ' HD11 ' A' ' 63' ' ' ILE . 33.6 tp -82.27 102.7 11.34 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.226 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.7 m -95.36 119.43 33.86 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.55 HG21 HD13 ' A' ' 93' ' ' LEU . 48.9 t -117.89 136.33 55.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.113 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 1.079 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 89.6 p -104.89 135.12 46.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.694 0.759 . . . . 0.0 111.806 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.554 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 18.9 mt-10 -144.79 176.29 9.55 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 170.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -29.23 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 m 34.14 70.95 0.11 Allowed 'General case' 0 C--N 1.349 0.582 0 CA-C-O 121.983 0.897 . . . . 0.0 110.882 -171.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.933 HH12 ' HA ' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -162.31 45.46 0.15 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.088 -157.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.6 t -81.83 90.6 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.561 0.696 . . . . 0.0 109.667 -177.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.5 m -86.1 122.13 29.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.477 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -93.72 95.89 9.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.685 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.608 ' CE2' HD22 ' A' ' 93' ' ' LEU . 78.4 m-85 -87.51 117.31 26.22 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 123.15 0.58 . . . . 0.0 111.657 -175.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 49' ' ' VAL . 5.6 mt -80.49 133.38 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.7 mp -115.49 118.63 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.197 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -83.77 134.53 34.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.813 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -87.77 105.77 17.62 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 82.9 mt -88.26 145.79 36.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.415 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 34.6 Cg_exo -62.19 -23.11 75.17 Favored 'Trans proline' 0 N--CA 1.473 0.315 0 C-N-CA 123.363 2.708 . . . . 0.0 112.962 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -89.03 18.1 5.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.186 0.517 . . . . 0.0 110.183 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.837 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 1.2 mmp_? 64.41 31.95 12.3 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.275 173.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -113.18 165.41 12.42 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.487 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 60.1 m-85 -127.22 117.45 22.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.441 0.639 . . . . 0.0 111.509 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -106.57 98.76 8.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.511 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.593 HD11 ' HB3' ' A' ' 61' ' ' TYR . 8.7 tt -79.6 85.16 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.545 0.688 . . . . 0.0 110.476 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.69 73.2 0.52 Allowed Glycine 0 C--O 1.227 -0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.117 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.6 t0 75.7 -38.39 0.35 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.101 0.56 . . . . 0.0 111.023 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.519 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 21.5 mm-40 -59.26 114.66 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.46 0.304 . . . . 0.0 110.902 174.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.82 115.43 27.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.794 0.33 . . . . 0.0 111.345 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 76' ' ' GLN . 84.4 m-85 -126.05 168.02 14.54 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -86.22 -34.71 20.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.708 0.29 . . . . 0.0 111.524 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 2.6 p80 -152.63 168.54 25.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.677 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.659 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 12.4 mt -57.04 -55.26 45.84 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.601 ' HA ' HD12 ' A' ' 85' ' ' LEU . 32.8 Cg_endo -65.29 -3.8 8.13 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.789 1.659 . . . . 0.0 113.014 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.81 -32.62 17.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.736 0.303 . . . . 0.0 110.558 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.2 pp -76.74 -32.35 57.72 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.601 HD12 ' HA ' ' A' ' 82' ' ' PRO . 51.1 mt -66.03 -26.98 67.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.731 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -74.57 -35.11 63.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.823 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -75.36 -38.02 60.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 111.301 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.463 ' HE2' HD13 ' A' ' 73' ' ' ILE . 44.5 m-85 -72.79 1.94 7.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.954 0.407 . . . . 0.0 111.34 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -64.91 -36.66 85.1 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.322 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 mt -104.13 -7.39 9.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.177 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -82.69 -37.09 25.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.875 -171.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.755 ' HA ' HG22 ' A' ' 97' ' ' THR . 81.2 m-85 66.27 95.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.993 0.808 . . . . 0.0 110.203 -169.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.712 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 23.6 mt -62.71 -23.52 67.2 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.404 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.554 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 23.7 t70 -139.11 -77.89 0.34 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 164.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.686 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 5.8 t -146.95 10.44 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.585 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 99' ' ' ILE . 4.3 m -124.19 -39.23 2.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.755 HG22 ' HA ' ' A' ' 92' ' ' TYR . 17.6 p 82.9 -173.3 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.422 1.489 . . . . 0.0 111.011 -174.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.634 HD22 ' CD1' ' A' ' 36' ' ' PHE . 93.7 mt -88.25 106.11 17.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.857 176.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 1.9 mp -89.08 -53.82 8.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.574 ' HG2' HG22 ' A' ' 99' ' ' ILE . 9.9 pt-20 -163.54 149.39 9.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.74 159.56 47.9 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.328 2.019 . . . . 0.0 112.413 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.57 124.48 89.33 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.89 76.48 0.61 Allowed 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.908 2.405 . . . . 0.0 113.678 -171.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.469 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 3.7 tpm_? . . . . . 0 N--CA 1.469 0.504 0 C-N-CA 124.142 0.977 . . . . 0.0 111.772 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 1.045 ' HG ' ' HD3' ' A' ' 155' ' ' LYS . 4.3 mm? . . . . . 0 N--CA 1.461 0.092 0 CA-C-O 121.687 0.756 . . . . 0.0 112.339 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 45.0 tt0 -144.93 -66.09 0.33 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.647 -172.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -117.39 118.37 32.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.806 0.812 . . . . 0.0 111.457 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.763 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 71.8 t -133.3 135.31 56.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.746 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 1.032 ' HB2' ' HB3' ' A' ' 179' ' ' GLU . 23.0 mtt180 -107.7 158.25 17.43 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.055 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.449 HG21 ' CD2' ' A' ' 144' ' ' PHE . 6.3 p -116.22 138.8 50.98 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.801 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.547 HD21 ' CG ' ' A' ' 179' ' ' GLU . 12.3 mt -112.87 -37.03 4.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.636 -172.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -69.79 -35.98 75.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.994 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.8 t70 70.69 92.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.456 0.646 . . . . 0.0 109.262 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 79.1 t80 -127.59 116.89 21.14 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.917 -176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.627 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 48.8 Cg_endo -92.47 96.38 0.18 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 122.37 2.047 . . . . 0.0 113.067 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.84 -17.49 80.13 Favored Glycine 0 CA--C 1.507 -0.466 0 CA-C-O 121.795 0.664 . . . . 0.0 111.483 173.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.526 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 17.4 m120 55.57 29.99 14.48 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.024 -1.088 . . . . 0.0 112.804 -171.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.545 ' HB2' ' HD3' ' A' ' 169' ' ' ARG . 34.4 t0 82.63 168.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 157.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 89.06 -35.39 0.02 OUTLIER 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.832 1.653 . . . . 0.0 112.409 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -143.76 -14.61 0.64 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.945 0.403 . . . . 0.0 110.253 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -147.53 120.48 8.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.446 0.641 . . . . 0.0 110.511 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.04 HD11 ' HB2' ' A' ' 165' ' ' ASN . 41.7 tp -75.71 124.32 88.7 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.019 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.627 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 55.5 Cg_endo -77.61 96.2 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.42 2.08 . . . . 0.0 110.808 172.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 6.9 p90 -105.23 163.4 12.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.716 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.879 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 8.4 mmpt? -103.75 -176.39 3.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.303 0.573 . . . . 0.0 111.233 -175.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 13.73 2.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.52 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.75 39.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.719 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.879 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 29.9 mm-40 -98.54 155.74 17.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.744 HD12 ' HG2' ' A' ' 129' ' ' ARG . 15.7 mm -97.27 134.57 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 165' ' ' ASN . 22.5 mt -117.32 156.61 27.53 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.589 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 62.1 t -116.87 127.01 74.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.668 HD13 ' HB2' ' A' ' 163' ' ' ALA . 45.9 mm -76.06 82.52 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.221 1.01 . . . . 0.0 108.889 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.759 HG21 HG22 ' A' ' 170' ' ' VAL . 14.7 tt -77.44 -27.43 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.913 -175.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.933 ' HA ' HH12 ' A' ' 57' ' ' ARG . 4.4 mt-10 -139.97 139.74 36.14 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 173.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 1.045 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 5.7 ttpm? -133.86 86.47 38.18 Favored Pre-proline 0 C--O 1.237 0.412 0 O-C-N 121.755 -0.59 . . . . 0.0 111.036 174.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.686 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 53.6 Cg_endo -79.01 -46.07 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.285 1.99 . . . . 0.0 112.786 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -109.11 179.88 4.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.252 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -103.37 -29.43 11.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.842 0.353 . . . . 0.0 110.962 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -93.44 -21.44 19.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.618 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.625 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 35.9 m95 -129.06 126.02 38.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.1 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.648 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.1 m0 -116.1 137.79 51.81 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.09 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.863 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.5 m -89.33 89.72 8.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.129 0.49 . . . . 0.0 110.071 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.668 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -101.22 154.84 18.42 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.962 -0.461 . . . . 0.0 111.354 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.2 ptt180 -98.54 128.9 45.05 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.533 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.04 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.5 t30 -63.58 160.73 16.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.12 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -59.46 -25.01 64.04 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.48 ' HB3' HD22 ' A' ' 165' ' ' ASN . 11.1 t70 -75.69 -24.33 56.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.797 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.9 74.84 1.11 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.293 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.735 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -159.07 133.12 7.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.819 -0.191 . . . . 0.0 110.979 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.759 HG22 HG21 ' A' ' 153' ' ' ILE . 83.9 t -103.35 120.39 53.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.192 0.52 . . . . 0.0 111.892 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.97 159.89 28.29 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 170.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.625 ' HE2' ' HB3' ' A' ' 160' ' ' TRP . 21.6 mtp -71.21 138.95 49.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.254 0.527 . . . . 0.0 110.0 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.648 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -134.96 145.85 56.21 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.291 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 5.5 Cg_exo -75.94 129.04 11.19 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 123.299 2.666 . . . . 0.0 112.702 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.671 ' O ' HG22 ' A' ' 178' ' ' VAL . 92.3 t -58.77 -45.66 99.61 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 47.4 Cg_exo -59.5 -6.92 4.72 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.329 2.019 . . . . 0.0 113.86 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -98.15 -1.29 42.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 175' ' ' VAL . 5.9 m -109.41 178.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -164.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 1.032 ' HB3' ' HB2' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -138.9 40.38 2.15 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 111.267 -2.697 . . . . 0.0 107.983 -168.187 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.763 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 20.0 pttm . . . . . 0 C--N 1.322 -0.625 0 O-C-N 121.669 -0.644 . . . . 0.0 110.038 -165.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -91.94 118.47 30.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.412 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.94 150.67 40.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.027 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -111.13 130.79 55.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.897 0.379 . . . . 0.0 110.244 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.581 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -74.31 122.36 22.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.414 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 290' ' ' HIS . 27.1 pt -104.03 6.15 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -169.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? -156.12 149.11 24.22 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.581 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 11.2 tptm -79.45 116.44 19.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.427 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.644 ' HB3' ' CE1' ' A' ' 290' ' ' HIS . 6.4 ttt-85 -151.32 107.64 3.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.143 0.497 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.891 178.495 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.452 -0.375 0 CA-C-O 120.647 0.261 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -89.06 116.74 27.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.867 0.365 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.544 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 1.1 tt -77.96 125.0 28.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -70.83 108.11 4.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.907 0.384 . . . . 0.0 110.581 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.6 mt -136.15 123.26 21.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.294 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 7.5 pt-20 -100.08 -134.87 0.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.782 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.86 130.2 68.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.53 . . . . 0.0 111.736 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 85.66 21.92 52.04 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.666 173.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -109.71 159.41 17.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.429 0.614 . . . . 0.0 110.019 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.47 127.09 56.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 110.94 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.638 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 39.9 t -107.03 122.03 60.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.496 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.495 ' HB2' ' HE3' ' A' ' 265' ' ' LYS . 34.7 ttmt -90.94 101.23 14.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.636 HG11 ' CZ3' ' A' ' 275' ' ' TRP . 4.8 p -126.34 147.83 31.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.424 -170.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -112.64 -54.22 2.64 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 275' ' ' TRP . 45.4 mtt180 -90.48 128.22 36.46 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 122.365 -0.21 . . . . 0.0 110.633 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' MET . . . . . 0.882 ' C ' ' HA3' ' A' ' 273' ' ' GLY . 0.2 OUTLIER -117.25 113.48 22.25 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.396 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.921 ' HB2' ' HD2' ' A' ' 288' ' ' PHE . 3.9 m-20 -20.67 176.59 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 129.849 3.26 . . . . 0.0 117.643 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.428 HG13 ' CE2' ' A' ' 288' ' ' PHE . 43.6 mt 63.8 70.41 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 113.315 -1.766 . . . . 0.0 107.14 -160.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 66.6 13.42 9.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.048 -164.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.882 ' HA3' ' C ' ' A' ' 269' ' ' MET . . . -91.59 -35.47 6.89 Favored Glycine 0 N--CA 1.427 -1.924 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.558 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.748 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 8.9 pt20 23.44 121.71 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 125.638 1.434 . . . . 0.0 113.716 -161.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.845 ' CE2' ' HB3' ' A' ' 288' ' ' PHE . 7.6 m0 -83.81 132.57 34.81 Favored 'General case' 0 CA--C 1.48 -1.726 0 C-N-CA 118.015 -1.474 . . . . 0.0 111.18 -161.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.5 94.53 4.83 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 111.593 -2.549 . . . . 0.0 110.281 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.95 137.7 10.6 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.419 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.675 ' HG3' ' HB3' ' A' ' 283' ' ' LYS . 23.8 mp0 -101.88 109.52 21.29 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 256' ' ' LEU . 58.7 t -123.17 121.74 63.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.743 0.306 . . . . 0.0 111.438 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 5.9 t30 66.24 -72.68 0.08 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.541 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -113.56 -43.47 0.82 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.244 -174.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.544 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 5.5 ppt_? -158.11 174.26 15.47 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.675 ' HB3' ' HG3' ' A' ' 278' ' ' GLU . 60.0 pttt -95.77 143.83 26.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.873 -175.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.39 161.44 29.75 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.514 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 275' ' ' TRP . 21.1 mt -87.53 137.48 32.3 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.718 0.771 . . . . 0.0 111.558 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.638 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 21.4 p90 -149.54 142.9 16.28 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.096 174.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.76 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 13.8 Cg_exo -69.64 144.69 55.48 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.005 1.803 . . . . 0.0 110.76 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.921 ' HD2' ' HB2' ' A' ' 270' ' ' ASN . 26.5 p90 -69.1 6.02 1.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.5 m -88.14 -12.48 43.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.358 0.599 . . . . 0.0 109.685 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.644 ' CE1' ' HB3' ' A' ' 246' ' ' ARG . 69.1 t60 -83.41 -20.92 33.27 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.135 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.581 HG12 ' HA ' ' A' ' 242' ' ' ALA . 23.6 m -127.02 176.99 6.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.694 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -136.87 134.89 37.37 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.133 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 240' ' ' ALA . 44.5 mm -82.75 102.96 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -93.43 176.2 6.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.878 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--N 1.332 -0.189 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.662 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.644 0.259 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -154.85 93.42 1.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.207 0.527 . . . . 0.0 110.622 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.587 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 45.7 p90 -145.02 154.88 42.99 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.58 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -71.99 97.77 1.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.63 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.7 m -77.17 59.0 1.67 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.191 0.52 . . . . 0.0 110.51 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 t 179.42 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.603 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -69.66 102.02 1.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.34 0.59 . . . . 0.0 110.759 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.498 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 11.6 mmt180 -61.73 -29.25 69.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.525 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.3 m -79.09 0.38 28.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.607 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.12 -47.34 5.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -116.42 -21.32 9.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.498 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 44.4 t80 -85.7 118.5 25.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.809 0.338 . . . . 0.0 111.28 -173.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.602 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 19.1 mmt -104.15 -2.11 26.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 110.963 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.07 -115.86 4.47 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.485 -0.779 . . . . 0.0 114.022 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.1 94.61 0.73 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.265 1.977 . . . . 0.0 113.534 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.86 HG12 ' H ' ' A' ' 20' ' ' SER . 19.0 t -139.93 -175.56 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.86 ' H ' HG12 ' A' ' 19' ' ' VAL . 93.9 p -151.45 176.64 11.09 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.254 0.934 . . . . 0.0 108.554 -170.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -53.79 -66.03 0.46 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -65.39 -43.24 91.25 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.21 -45.8 90.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.471 0.176 . . . . 0.0 111.369 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.37 76.83 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.063 0.459 . . . . 0.0 111.27 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -73.53 -30.04 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.004 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.69 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 95.7 m -62.1 -34.78 76.96 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.272 0.558 . . . . 0.0 110.466 174.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -75.43 -14.29 60.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.121 0.486 . . . . 0.0 110.417 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.552 ' O ' ' HB3' ' A' ' 31' ' ' GLN . 20.4 mt -115.75 17.7 16.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.406 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 26' ' ' THR . 12.5 pt20 -88.08 116.0 25.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.399 0.619 . . . . 0.0 110.675 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.74 26.55 24.46 Favored Glycine 0 CA--C 1.499 -0.916 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.552 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -50.59 177.7 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 111.187 -2.506 . . . . 0.0 115.141 -175.255 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -86.19 -9.31 56.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.558 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.562 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 4.6 m-70 66.03 92.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.445 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.41 28.89 3.61 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -170.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 52.4 ttp -124.19 134.19 53.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.56 ' CD1' HD22 ' A' ' 98' ' ' LEU . 43.8 p90 -135.6 164.13 28.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -173.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.48 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -150.62 144.02 24.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.364 171.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.403 HG22 HD13 ' A' ' 50' ' ' LEU . 61.2 t -109.24 119.17 58.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.545 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -123.01 168.47 12.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.708 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.455 ' OD2' ' HA ' ' A' ' 45' ' ' PRO . 34.6 t70 -66.11 125.93 27.05 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.02 -0.734 . . . . 0.0 109.02 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.624 ' HA ' HG23 ' A' ' 49' ' ' VAL . 31.9 p -53.63 120.02 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.518 0.675 . . . . 0.0 112.104 -172.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.719 ' HB3' ' HA ' ' A' ' 20' ' ' SER . 3.4 p -74.58 73.62 1.97 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.922 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.0 t 174.72 -36.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.327 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 66.5 m -147.43 93.85 4.57 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.253 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.455 ' HA ' ' OD2' ' A' ' 40' ' ' ASP . 54.5 Cg_exo -52.21 116.18 2.65 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.524 2.149 . . . . 0.0 112.253 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.57 -47.83 0.9 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.529 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 1.2 m-20 -78.62 -172.05 2.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.46 ' CE1' ' HE1' ' A' ' 15' ' ' TYR . 25.9 m-85 -138.46 169.4 17.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.255 0.55 . . . . 0.0 112.132 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 41' ' ' SER . 44.1 t -146.94 111.42 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.525 175.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.482 ' HG ' HG23 ' A' ' 52' ' ' VAL . 62.5 tp -82.04 104.27 12.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.133 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.9 m -94.99 109.32 21.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.271 0.558 . . . . 0.0 109.829 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.556 HG12 ' OE2' ' A' ' 54' ' ' GLU . 29.0 t -111.2 138.16 40.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.126 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 81.8 p -118.22 137.37 53.06 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.724 ' HB2' ' HE ' ' A' ' 57' ' ' ARG . 13.9 mp0 -143.58 179.44 7.12 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.562 ' HA ' ' CE1' ' A' ' 33' ' ' HIS . 23.6 m-20 -21.15 81.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 124.846 1.341 . . . . 0.0 114.194 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m 42.68 62.8 1.63 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.671 0.788 . . . . 0.0 111.787 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.724 ' HE ' ' HB2' ' A' ' 54' ' ' GLU . 1.4 ptm85 -167.52 57.45 0.07 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -163.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 19.2 t -76.58 103.79 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.34 -0.85 . . . . 0.0 109.54 -176.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.8 m -92.1 121.47 33.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.185 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -92.58 88.26 6.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.768 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.531 ' CE2' HD22 ' A' ' 93' ' ' LEU . 90.3 m-85 -78.89 117.25 19.81 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.077 0.551 . . . . 0.0 110.924 -176.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 8.4 tp -71.4 135.96 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.561 HG23 ' HB3' ' A' ' 71' ' ' PHE . 4.0 mp -122.23 117.76 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.964 0.411 . . . . 0.0 110.769 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.529 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 70.4 m-20 -85.61 136.07 33.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.936 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 47' ' ' ASP . 10.8 t -92.73 98.43 11.41 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 174.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.572 HD11 ' HG3' ' A' ' 72' ' ' LYS . 55.0 mt -72.89 168.36 25.23 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.107 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 36.6 Cg_exo -63.17 68.3 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.998 2.465 . . . . 0.0 112.803 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 70.79 14.89 6.99 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.369 1.468 . . . . 0.0 112.176 164.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 66.4 mtt180 -93.75 -72.75 0.6 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.707 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.711 ' HB2' ' O ' ' A' ' 78' ' ' PHE . 3.2 ptp180 -156.79 -169.62 3.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.596 -172.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.561 ' HB3' HG23 ' A' ' 63' ' ' ILE . 97.4 m-85 -118.31 127.92 54.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.959 0.409 . . . . 0.0 111.053 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.693 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 52.9 mttm -98.22 101.09 12.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.842 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.675 HD13 ' HE2' ' A' ' 88' ' ' TYR . 10.7 tt -87.41 81.94 2.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 122.127 0.965 . . . . 0.0 110.202 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.27 81.63 0.38 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.161 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.5 t0 72.59 -58.0 0.61 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.778 0.431 . . . . 0.0 111.376 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -79.03 140.02 38.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.406 0.622 . . . . 0.0 110.726 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.693 ' HB3' ' HG2' ' A' ' 72' ' ' LYS . 10.5 pt-20 -110.8 141.72 43.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.321 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.711 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 71.9 m-85 -122.68 151.08 41.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -58.94 -24.89 62.99 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -169.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -163.75 172.32 14.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.332 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.574 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.7 mt -55.09 -56.49 27.61 Favored Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 34.6 Cg_exo -61.15 -9.48 12.62 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.125 1.884 . . . . 0.0 113.23 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . . . -88.7 -25.58 22.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.66 0.267 . . . . 0.0 110.991 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -79.49 -31.52 42.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.26 -35.48 79.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.756 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.502 ' HG2' ' HA ' ' A' ' 83' ' ' ALA . 7.6 pt-20 -80.56 -6.16 57.83 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -87.65 -37.58 16.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.372 0.606 . . . . 0.0 109.592 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.675 ' HE2' HD13 ' A' ' 73' ' ' ILE . 41.9 m-85 -81.85 -6.88 59.47 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.565 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.538 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 14.2 ptmm? -83.62 -3.73 57.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.527 171.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.4 pt -123.21 -22.16 2.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 121.021 0.439 . . . . 0.0 110.522 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 10.6 t-160 -68.9 -41.96 77.55 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.946 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.567 ' CD2' HG23 ' A' ' 97' ' ' THR . 91.3 m-85 71.81 108.39 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 O-C-N 124.554 1.159 . . . . 0.0 108.93 -165.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.659 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 4.8 mt -78.86 1.38 23.66 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.687 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 28.4 t70 -168.53 -134.19 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.467 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 10.6 t -83.07 -8.05 59.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.516 0.674 . . . . 0.0 109.372 172.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.9 t -125.92 169.46 12.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.912 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.567 HG23 ' CD2' ' A' ' 92' ' ' TYR . 9.1 p -109.14 -176.66 3.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.555 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.56 HD22 ' CD1' ' A' ' 36' ' ' PHE . 92.6 mt -69.13 98.8 1.04 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.697 HG22 ' HG3' ' A' ' 100' ' ' GLU . 51.3 mm -90.68 -58.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.929 -176.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.697 ' HG3' HG22 ' A' ' 99' ' ' ILE . 45.3 mt-10 -141.01 158.12 65.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.712 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 93.6 Cg_endo -83.27 157.37 14.83 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.611 2.208 . . . . 0.0 112.04 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.45 158.33 83.59 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.386 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.74 129.43 27.67 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.258 1.972 . . . . 0.0 111.812 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.602 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 35.3 ttt180 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.371 0.605 . . . . 0.0 110.266 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.492 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 0.5 OUTLIER . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.625 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 8.5 mt-10 169.08 -54.42 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 O-C-N 125.703 1.877 . . . . 0.0 109.988 171.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.651 ' O ' ' HA ' ' A' ' 180' ' ' LYS . 12.9 m-85 -61.28 107.42 0.76 Allowed 'General case' 0 C--O 1.208 -1.12 0 CA-C-N 119.18 0.9 . . . . 0.0 110.805 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.787 HG21 HD11 ' A' ' 152' ' ' ILE . 2.0 t -131.23 132.66 63.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.807 172.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.811 HH21 HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -126.31 135.43 51.5 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.601 173.29 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.952 HG22 HG12 ' A' ' 178' ' ' VAL . 70.9 p -94.06 132.86 38.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -173.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -112.38 -0.32 15.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.801 -175.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -105.93 -44.36 4.63 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -168.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.3 t70 81.16 102.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.273 0.629 . . . . 0.0 110.35 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 87.3 t80 -142.61 110.82 5.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 57.6 Cg_endo -91.89 90.42 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.619 2.213 . . . . 0.0 112.615 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.605 ' HA3' ' OD1' ' A' ' 141' ' ' ASP . . . -79.93 -2.42 88.56 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.257 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 56.95 25.84 11.08 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.642 0.377 . . . . 0.0 111.974 -174.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.794 ' HA ' ' O ' ' A' ' 141' ' ' ASP . 3.0 p30 53.35 -166.61 0.07 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 168.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 138' ' ' ASP . . . 90.6 -47.49 0.02 OUTLIER 'General case' 0 C--N 1.347 0.46 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.875 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -142.37 14.01 1.99 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.794 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 11.5 t70 -153.53 173.55 15.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 112.756 -2.02 . . . . 0.0 105.824 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.752 HD11 ' HB3' ' A' ' 165' ' ' ASN . 54.8 tp -134.61 128.81 19.19 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 119.16 0.891 . . . . 0.0 110.477 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.651 ' HD2' HD12 ' A' ' 142' ' ' LEU . 12.6 Cg_endo -85.09 98.77 0.67 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.449 2.099 . . . . 0.0 111.194 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.666 ' CG ' HG21 ' A' ' 130' ' ' THR . 10.9 p90 -111.77 167.96 9.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.556 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.656 ' H ' ' HB2' ' A' ' 148' ' ' GLU . 24.5 mtpp -126.1 -174.05 3.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -173.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -69.79 66.47 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.52 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 121.0 49.34 0.28 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.263 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.656 ' HB2' ' H ' ' A' ' 145' ' ' LYS . 5.8 tp10 -99.34 154.52 18.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.811 HD11 HH21 ' A' ' 129' ' ' ARG . 1.0 OUTLIER -112.32 134.2 55.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.69 -173.108 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.719 HD22 HD21 ' A' ' 142' ' ' LEU . 21.0 mt -143.14 155.8 44.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.899 0.857 . . . . 0.0 110.913 -170.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.691 HG21 ' HE ' ' A' ' 164' ' ' ARG . 39.3 t -126.32 126.41 69.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.614 173.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.793 HD13 ' HB2' ' A' ' 163' ' ' ALA . 36.2 mm -74.53 86.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 122.156 0.979 . . . . 0.0 110.412 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.852 HG21 HG22 ' A' ' 170' ' ' VAL . 9.1 tt -82.51 -28.28 8.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.726 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.958 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 28.0 mt-10 -130.73 141.66 50.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -136.23 77.43 48.33 Favored Pre-proline 0 C--O 1.24 0.566 0 O-C-N 121.472 -0.768 . . . . 0.0 111.566 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 16.6 Cg_exo -66.16 -54.62 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.256 1.971 . . . . 0.0 111.342 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -106.82 175.06 5.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.62 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -98.89 -23.33 15.39 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.33 -27.64 21.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.273 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.404 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 44.2 m95 -124.41 122.47 37.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.642 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.756 ' HB3' HD12 ' A' ' 152' ' ' ILE . 45.7 m0 -112.18 137.72 49.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.53 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.958 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.7 m -94.82 109.54 21.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.793 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -116.79 159.32 22.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -173.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.691 ' HE ' HG21 ' A' ' 151' ' ' VAL . 9.7 ptt180 -94.0 118.86 32.09 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.996 173.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.752 ' HB3' HD11 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -69.16 179.11 2.03 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.664 0.269 . . . . 0.0 111.452 -178.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -61.41 -30.37 70.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.987 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -93.65 4.1 54.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.636 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.41 ' H ' HD22 ' A' ' 165' ' ' ASN . . . 84.23 74.82 1.22 Allowed Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.785 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -150.92 138.41 19.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 177.022 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.852 HG22 HG21 ' A' ' 153' ' ' ILE . 95.1 t -103.78 126.03 58.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.201 0.524 . . . . 0.0 111.973 -175.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . -157.42 167.45 34.01 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 171.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 22.7 mtp -79.96 139.44 37.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.178 0.489 . . . . 0.0 110.7 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.766 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -138.24 148.3 59.14 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.75 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 5.7 Cg_exo -78.24 131.77 10.98 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.65 2.233 . . . . 0.0 112.435 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.547 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 61.1 t -59.34 -45.07 99.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 31.9 Cg_endo -65.29 -1.62 4.8 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.22 1.947 . . . . 0.0 113.452 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 2.6 m-85 -99.7 -7.94 24.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.783 0.325 . . . . 0.0 111.066 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.952 HG12 HG22 ' A' ' 130' ' ' THR . 2.9 m -144.2 176.56 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.662 -166.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.695 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 6.6 pt-20 -153.64 -55.65 0.11 Allowed 'General case' 0 C--O 1.2 -1.533 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 144.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-N 122.538 2.426 . . . . 0.0 115.686 -171.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.405 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 28.3 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.592 0.234 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.472 ' CE1' ' HE2' ' A' ' 265' ' ' LYS . 54.1 m-85 -81.28 126.64 31.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.17 0.509 . . . . 0.0 111.272 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.685 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -135.32 130.9 35.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.097 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -97.47 126.66 42.87 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -73.48 111.69 8.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.434 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.455 HD12 ' HG3' ' A' ' 244' ' ' GLN . 1.9 pp -87.81 -10.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.691 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.455 ' HG3' HD12 ' A' ' 243' ' ' ILE . 79.0 mt-30 -120.23 167.19 12.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 258' ' ' LEU . 21.2 pttp -118.79 137.48 53.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.302 0.573 . . . . 0.0 111.058 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.539 ' NH1' ' HD2' ' A' ' 287' ' ' PRO . 40.8 ttp-105 -139.41 117.55 11.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.845 -176.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.973 179.725 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 N--CA 1.468 0.452 0 CA-C-O 121.28 0.562 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -91.35 103.95 16.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.695 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 257' ' ' ALA . 1.5 tt -67.23 131.38 45.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.632 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.437 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -75.21 120.38 20.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.618 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 245' ' ' LYS . 81.7 mt -138.0 113.02 9.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.593 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.63 172.45 7.7 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 43.9 t -69.56 106.91 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.02 0.438 . . . . 0.0 110.443 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 123.4 -8.56 8.92 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.415 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.03 130.9 44.35 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.836 0.35 . . . . 0.0 110.867 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 45.9 mm -89.02 108.73 19.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.378 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.416 HG21 HG11 ' A' ' 291' ' ' VAL . 36.1 t -85.81 106.54 15.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.27 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.472 ' HE2' ' CE1' ' A' ' 239' ' ' PHE . 28.5 mmtt -84.24 92.74 8.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.567 ' HA ' ' HA3' ' A' ' 277' ' ' GLY . 7.6 p -87.31 125.66 41.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.972 0.415 . . . . 0.0 110.044 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 4.9 p -100.34 -32.86 10.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.59 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 24.8 tpp180 -125.88 99.36 5.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.976 0.417 . . . . 0.0 110.165 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' MET . . . . . 0.405 ' HE3' ' HB ' ' A' ' 238' ' ' VAL . 25.2 mtt -85.32 107.65 17.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.511 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -63.63 125.28 23.78 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.4 mt -75.79 68.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.899 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -177.26 -69.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.147 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.576 ' O ' ' HG2' ' A' ' 274' ' ' GLN . . . 179.11 143.26 5.28 Favored Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -166.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.576 ' HG2' ' O ' ' A' ' 273' ' ' GLY . 9.3 pt20 64.31 119.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 125.418 1.487 . . . . 0.0 110.189 -172.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 286' ' ' PHE . 15.2 m0 -114.02 167.73 10.42 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.985 -174.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -122.67 115.02 21.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.364 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -141.03 158.01 26.17 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 1.07 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 16.5 mt-10 -103.17 108.98 20.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.34 0.57 . . . . 0.0 110.275 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 41.1 t -133.09 139.45 49.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.828 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 26.6 p30 43.52 32.38 0.52 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.757 1.223 . . . . 0.0 113.695 172.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.61 -59.86 0.43 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.858 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.54 176.11 12.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.654 -0.321 . . . . 0.0 111.681 -174.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 1.07 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 13.1 pttm -87.14 141.1 28.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.123 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.87 173.93 32.46 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.76 127.83 37.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.078 0.466 . . . . 0.0 110.258 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 275' ' ' TRP . 43.4 p90 -126.13 131.16 23.87 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.688 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.539 ' HD2' ' NH1' ' A' ' 246' ' ' ARG . 48.2 Cg_exo -58.0 138.69 87.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.615 2.21 . . . . 0.0 111.593 172.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -72.22 -18.39 61.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.401 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 13.8 p -79.43 -0.54 33.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.3 0.572 . . . . 0.0 111.081 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -95.59 -18.69 20.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.586 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.416 HG11 HG21 ' A' ' 264' ' ' VAL . 31.7 m -127.83 164.17 29.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.456 -175.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.426 ' HG2' HG12 ' A' ' 243' ' ' ILE . 30.9 mmmt -127.42 122.54 33.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.728 0.299 . . . . 0.0 110.393 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.685 HD13 ' HB2' ' A' ' 240' ' ' ALA . 48.8 mm -71.0 122.09 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.152 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -135.54 147.64 48.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.826 0.346 . . . . 0.0 110.272 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.307 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -142.06 91.51 2.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.331 0.586 . . . . 0.0 111.079 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -147.17 148.38 31.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.496 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -79.82 96.88 6.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.991 0.424 . . . . 0.0 110.259 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 m -69.78 74.48 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.133 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 t -176.53 -43.33 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.915 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.85 107.49 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.183 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -32.54 67.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.17 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.0 t -69.78 -9.22 53.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.278 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.26 -46.76 7.56 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.761 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -118.4 -19.93 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -170.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -82.03 123.42 28.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.798 0.333 . . . . 0.0 110.649 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.562 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 16.6 mmt -101.72 -9.55 20.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.557 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.4 -113.23 2.18 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.49 -177.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 16.9 Cg_exo -67.17 91.06 0.32 Allowed 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.063 2.509 . . . . 0.0 113.38 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.994 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 14.3 t -137.43 -157.12 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.891 ' H ' HG12 ' A' ' 19' ' ' VAL . 12.5 t 178.93 174.96 0.66 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.8 1.182 . . . . 0.0 108.661 -169.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.541 HH11 ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -44.49 -66.84 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.885 0.741 . . . . 0.0 112.046 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -63.79 -54.34 36.63 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.443 0.464 . . . . 0.0 111.991 -173.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -54.7 -46.82 74.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.41 -42.9 83.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.459 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -80.39 -33.39 37.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.663 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 t -74.19 -18.77 60.72 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.886 -0.325 . . . . 0.0 111.429 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -97.8 -10.38 24.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 110.727 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.68 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 73.2 mt -111.45 0.86 16.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.657 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.14 108.88 3.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.878 0.847 . . . . 0.0 110.679 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.78 -76.69 0.92 Allowed Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.915 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.417 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 17.2 mm-40 45.28 -159.38 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.169 0.57 . . . . 0.0 111.737 -175.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.565 HH21 ' HB2' ' A' ' 100' ' ' GLU . 33.0 ptt180 -101.13 5.94 43.0 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.521 176.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 53' ' ' SER . 27.3 m170 68.29 123.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.478 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.75 16.53 21.63 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.416 ' HG3' ' HB3' ' A' ' 31' ' ' GLN . 73.2 mmm -106.0 134.94 48.33 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.472 ' CB ' HG22 ' A' ' 52' ' ' VAL . 43.3 p90 -139.58 162.93 33.88 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.621 -174.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.562 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -155.73 141.9 18.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.56 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.31 129.19 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.994 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 32.0 ptt-85 -129.43 173.2 10.77 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.59 133.77 34.04 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 170.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.462 ' HB2' HG22 ' A' ' 43' ' ' THR . 93.9 p -80.45 147.97 30.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.212 0.529 . . . . 0.0 111.162 -173.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.0 t -99.28 34.42 2.17 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 41' ' ' SER . 9.0 t -135.47 -27.55 1.18 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.206 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 91.2 m -147.36 118.25 4.53 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.786 0.327 . . . . 0.0 110.622 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.21 117.98 4.81 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.776 2.317 . . . . 0.0 112.144 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.66 -22.81 34.55 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.713 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 20.0 m-20 -89.84 152.03 21.48 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -119.85 174.97 6.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.557 0.218 . . . . 0.0 111.3 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.436 HG23 ' HB3' ' A' ' 41' ' ' SER . 24.1 t -142.63 109.83 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.31 . . . . 0.0 110.861 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 36' ' ' PHE . 32.1 tp -85.29 100.63 11.92 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.972 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.7 m -96.54 127.41 42.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.97 177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.835 HG21 HD13 ' A' ' 93' ' ' LEU . 48.4 t -123.61 137.17 57.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.453 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.68 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 90.1 p -97.28 123.8 41.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.647 0.26 . . . . 0.0 111.367 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.696 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 26.7 mt-10 -145.14 175.95 9.88 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.653 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 2.6 p30 -37.04 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -163.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.5 m 37.55 56.87 1.44 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.109 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.876 HH21 ' HB2' ' A' ' 94' ' ' ASP . 7.0 ttp85 -167.67 53.72 0.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.79 -159.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.2 t -77.18 98.52 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.909 0.861 . . . . 0.0 109.193 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -87.47 121.17 29.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.839 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -94.71 99.4 11.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.19 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.608 ' CE2' HD22 ' A' ' 93' ' ' LEU . 58.6 m-85 -96.07 116.15 28.52 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.367 0.267 . . . . 0.0 111.529 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 64.5 mt -80.31 134.2 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.739 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.0 mp -109.45 119.5 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 123.16 0.584 . . . . 0.0 110.347 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.51 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 91.6 m-20 -84.98 137.68 32.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.789 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.7 t -87.41 102.0 14.12 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.68 HD11 ' HB2' ' A' ' 72' ' ' LYS . 91.4 mt -83.44 140.27 41.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.993 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.75 -23.07 69.48 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.221 2.614 . . . . 0.0 112.958 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -85.23 17.71 2.93 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.014 0.435 . . . . 0.0 110.287 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.893 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.8 OUTLIER 61.97 57.84 2.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.957 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.773 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 62.0 mtt180 -138.59 171.41 14.4 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.124 175.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.513 ' HB3' HG23 ' A' ' 63' ' ' ILE . 53.8 m-85 -130.63 114.99 16.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.404 0.621 . . . . 0.0 110.493 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.68 ' HB2' HD11 ' A' ' 66' ' ' LEU . 87.5 tttt -105.62 99.79 9.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.981 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.739 ' HB ' HG13 ' A' ' 63' ' ' ILE . 8.6 tt -83.63 78.63 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 122.024 0.916 . . . . 0.0 111.063 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.07 -15.99 40.64 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.119 -0.946 . . . . 0.0 114.645 171.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.564 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 19.1 t70 176.92 -63.3 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.809 0.804 . . . . 0.0 111.275 -176.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -66.42 129.14 38.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.59 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -87.47 108.41 19.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.378 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.471 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 67.0 m-85 -105.51 149.46 26.21 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.773 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 22.6 m-20 -73.55 -25.05 60.21 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -173.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 6.1 p80 -160.04 168.73 24.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.707 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.59 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.1 mt -56.27 -56.27 33.22 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.612 ' HA ' HD12 ' A' ' 85' ' ' LEU . 32.4 Cg_exo -63.15 -3.0 4.32 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.261 1.974 . . . . 0.0 113.681 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.86 -33.72 17.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.019 0.438 . . . . 0.0 110.284 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.4 pp -79.38 -26.73 41.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.289 0.566 . . . . 0.0 109.6 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.612 HD12 ' HA ' ' A' ' 82' ' ' PRO . 79.3 mt -67.89 -29.52 68.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.616 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 82' ' ' PRO . 16.6 mm-40 -83.52 -14.66 51.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.995 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -84.23 -39.02 19.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.267 0.556 . . . . 0.0 109.831 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -81.59 0.81 36.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.36 0.6 . . . . 0.0 110.572 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -74.12 -22.43 59.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.827 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.4 pt -122.72 -19.64 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.597 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -84.29 -19.95 32.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.343 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 72.41 162.24 0.25 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.832 0.707 . . . . 0.0 109.54 -170.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.835 HD13 HG21 ' A' ' 52' ' ' VAL . 11.5 mt -114.55 -11.01 12.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.174 0.511 . . . . 0.0 110.087 168.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.876 ' HB2' HH21 ' A' ' 57' ' ' ARG . 9.6 t70 -157.57 -80.28 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.636 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 7.0 t -132.49 -16.0 2.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.073 0.463 . . . . 0.0 110.077 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.472 HG22 ' OE1' ' A' ' 54' ' ' GLU . 4.6 t -121.76 -177.83 3.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.5 p -114.88 178.77 4.16 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.155 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.449 HD22 ' CD1' ' A' ' 36' ' ' PHE . 87.7 mt -64.37 97.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.1 mm -85.56 -64.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.673 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.565 ' HB2' HH21 ' A' ' 32' ' ' ARG . 43.2 mt-10 -150.27 153.36 34.86 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.889 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.69 154.65 72.72 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.793 2.329 . . . . 0.0 112.444 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.46 157.6 82.34 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.227 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.28 135.68 20.9 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.366 2.044 . . . . 0.0 111.819 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.507 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 88.9 mtm180 . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.899 HD12 HG13 ' A' ' 152' ' ' ILE . 1.3 mm? . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.687 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 32.6 tt0 -155.94 -72.74 0.11 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.003 -177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -93.1 109.19 20.67 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.156 -168.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.919 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 90.6 t -134.25 129.17 53.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.011 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.976 ' HG2' ' HB3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -109.79 154.71 22.58 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 118.584 -1.247 . . . . 0.0 108.54 172.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 178' ' ' VAL . 18.9 p -112.21 141.34 46.03 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.755 HD21 ' HG3' ' A' ' 179' ' ' GLU . 58.3 mt -111.82 -41.4 4.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.222 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 51.5 t80 -72.22 -27.88 62.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -168.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.646 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 30.1 t70 69.51 96.36 0.07 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.626 0.727 . . . . 0.0 110.994 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -122.72 96.32 45.54 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.839 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.72 88.92 0.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.44 2.093 . . . . 0.0 112.139 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -87.65 -23.76 38.22 Favored Glycine 0 C--O 1.228 -0.227 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.324 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 47.02 80.33 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.593 0.757 . . . . 0.0 112.57 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -162.64 173.39 13.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.19 -3.29 58.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.155 0.502 . . . . 0.0 110.588 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.26 -11.29 10.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.378 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -129.78 105.43 8.02 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.021 HD11 ' HB2' ' A' ' 165' ' ' ASN . 36.5 tp -76.52 117.57 65.42 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.674 0.273 . . . . 0.0 110.62 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.467 ' HD2' HD12 ' A' ' 142' ' ' LEU . 45.8 Cg_endo -71.16 106.27 1.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.109 1.873 . . . . 0.0 111.244 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -113.64 164.45 13.66 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.216 -177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.646 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -106.13 -169.56 1.59 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.105 -168.541 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.557 ' HD2' ' HB2' ' A' ' 133' ' ' ASP . 13.7 mptt -78.37 -5.15 51.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.176 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.72 56.53 0.16 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.361 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.462 ' HB2' ' HD3' ' A' ' 145' ' ' LYS . 7.8 tp10 -105.54 150.74 25.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.615 HD13 ' HB3' ' A' ' 129' ' ' ARG . 45.9 mm -96.66 129.72 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' A' ' 165' ' ' ASN . 44.0 mt -123.03 160.48 26.24 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.315 0.579 . . . . 0.0 109.5 -178.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 87.2 t -124.77 128.03 73.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.899 HG13 HD12 ' A' ' 125' ' ' LEU . 36.7 mm -74.33 87.84 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 122.244 1.021 . . . . 0.0 109.529 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.656 HG23 ' HG3' ' A' ' 154' ' ' GLU . 18.0 tt -78.49 -26.38 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.32 -174.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.961 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 15.5 mt-10 -142.04 143.99 33.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.697 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 48.4 tttm -137.05 90.52 15.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 O-C-N 121.237 -0.915 . . . . 0.0 111.399 171.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 52.8 Cg_endo -81.0 -44.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.064 1.843 . . . . 0.0 112.497 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -109.43 178.52 4.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.331 -172.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -98.77 -33.09 11.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.353 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.484 ' OE1' ' HA ' ' A' ' 159' ' ' GLN . 14.2 mm-40 -100.0 -11.36 20.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.927 0.394 . . . . 0.0 110.762 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.436 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 71.9 m95 -126.38 118.57 25.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.719 ' CZ3' HD11 ' A' ' 125' ' ' LEU . 48.5 m0 -112.28 136.71 51.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.961 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 10.6 t -92.05 92.97 8.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.346 0.593 . . . . 0.0 109.418 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -103.26 158.09 16.57 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 122.022 -0.424 . . . . 0.0 111.477 -174.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.739 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.7 ptt180 -98.22 128.71 44.83 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.812 176.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.021 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.5 t30 -70.75 164.64 24.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.556 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -71.96 -10.6 60.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.49 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 165' ' ' ASN . 2.4 p-10 -87.0 -10.58 52.79 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.64 57.14 1.36 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.926 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.739 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 19.1 ttm-85 -136.21 141.9 44.04 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 122.85 -0.206 . . . . 0.0 110.968 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.538 HG22 HG21 ' A' ' 153' ' ' ILE . 49.6 t -103.28 118.46 50.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.609 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -151.15 158.31 27.63 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.411 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 22.5 mtp -79.18 140.03 37.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.894 0.378 . . . . 0.0 110.431 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -135.54 145.57 53.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.342 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.455 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 4.3 Cg_exo -76.53 133.06 13.98 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.32 2.68 . . . . 0.0 113.111 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.648 ' O ' HG22 ' A' ' 178' ' ' VAL . 88.3 t -60.4 -44.58 96.24 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 23.9 Cg_exo -65.27 3.92 0.89 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.219 1.946 . . . . 0.0 113.345 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.5 m-85 -107.89 -4.81 17.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.282 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.8 m -106.89 -169.07 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -165.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.976 ' HB3' ' HG2' ' A' ' 129' ' ' ARG . 0.4 OUTLIER -160.13 41.51 0.19 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.82 -161.164 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.919 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 25.2 pttm . . . . . 0 C--N 1.321 -0.64 0 O-C-N 120.456 -1.403 . . . . 0.0 109.58 -162.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.458 HG11 HD12 ' A' ' 293' ' ' ILE . 21.6 t . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 121.026 0.441 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.1 116.9 32.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.685 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.51 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.29 128.16 53.04 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.46 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.601 ' HG3' ' CE1' ' A' ' 294' ' ' PHE . 28.5 mtpp -78.75 125.25 29.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.567 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -75.59 91.42 2.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.888 0.375 . . . . 0.0 110.136 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 24.6 pt -73.24 9.59 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.847 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -148.91 152.87 37.17 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -95.85 144.96 25.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.422 ' HB3' ' NE2' ' A' ' 290' ' ' HIS . 0.5 OUTLIER -171.02 125.69 0.67 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.638 0.256 . . . . 0.0 110.756 178.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.812 172.86 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.104 0.478 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -79.56 107.42 12.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.931 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.55 HD23 HH11 ' A' ' 282' ' ' ARG . 1.0 OUTLIER -76.34 101.67 5.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.381 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -68.66 124.2 22.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.912 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 82.3 mt -128.7 143.68 50.99 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.605 0.566 . . . . 0.0 111.275 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.83 170.93 9.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.359 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.3 p -89.34 113.25 25.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.485 0.66 . . . . 0.0 110.485 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 110.3 -6.49 30.33 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.999 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -76.88 161.2 28.61 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.662 0.268 . . . . 0.0 110.646 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 35.0 mm -104.02 111.17 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.296 0.57 . . . . 0.0 111.13 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.44 ' HA ' HG22 ' A' ' 279' ' ' VAL . 38.8 t -88.55 109.19 19.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.532 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -85.16 88.13 7.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.766 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.88 131.86 35.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.553 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -114.79 -22.5 9.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.817 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.71 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 26.4 mmm180 -125.25 123.69 40.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.245 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 51.4 mtt -112.46 102.73 10.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.226 0.536 . . . . 0.0 110.41 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -81.25 139.42 35.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.034 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.0 pt -67.92 -8.99 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.261 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -63.07 -38.65 92.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.529 176.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 121.47 -9.97 9.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.71 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -114.28 119.31 36.56 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.463 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 47.2 m0 -93.63 159.77 15.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.829 0.347 . . . . 0.0 111.073 -174.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 41.5 mt-10 -107.27 117.77 34.95 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.089 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -142.31 154.01 24.78 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 283' ' ' LYS . 37.7 tt0 -111.73 109.82 19.88 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 264' ' ' VAL . 57.6 t -112.55 122.15 66.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.033 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.8 m120 65.48 -70.21 0.1 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.049 0.843 . . . . 0.0 111.793 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -159.65 26.99 0.35 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.588 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.55 HH11 HD23 ' A' ' 256' ' ' LEU . 17.2 ttm180 -150.82 128.66 11.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.711 0.255 . . . . 0.0 110.444 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 278' ' ' GLU . 53.4 pttt -102.57 139.33 38.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.969 0.414 . . . . 0.0 110.338 174.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -167.38 -169.96 31.59 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.713 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 93.6 mt -100.13 146.3 26.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.934 0.397 . . . . 0.0 110.692 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.463 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 41.1 p90 -148.82 145.54 19.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.609 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 11.8 Cg_exo -72.37 149.22 50.27 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.628 2.218 . . . . 0.0 111.99 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -76.38 -17.68 59.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.837 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.0 t -82.08 3.82 25.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.727 0.775 . . . . 0.0 109.934 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.422 ' NE2' ' HB3' ' A' ' 246' ' ' ARG . 49.6 t-80 -96.27 -24.17 16.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.557 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 242' ' ' ALA . 29.1 m -125.02 175.41 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.798 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -138.57 125.36 20.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.557 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.51 HD13 ' HB2' ' A' ' 240' ' ' ALA . 49.8 mm -73.95 102.7 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.601 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 21.4 p90 -100.19 167.61 10.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.433 -174.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.498 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.234 0.272 0 CA-C-O 121.071 0.462 . . . . 0.0 112.133 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -140.63 88.44 2.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.625 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -168.96 165.82 11.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.932 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -99.63 115.58 29.76 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -69.25 -11.46 60.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.001 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 p -101.65 -23.38 14.26 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.82 102.19 1.2 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.899 -0.501 . . . . 0.0 110.778 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 11' ' ' ARG . 11.4 mmt180 -58.51 -42.3 87.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.239 -176.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.7 m -74.6 10.75 1.23 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.916 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.22 -47.5 4.5 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.828 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -118.02 -21.54 8.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -173.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -85.6 115.15 23.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.862 0.363 . . . . 0.0 110.356 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.461 ' HG2' ' HB2' ' A' ' 37' ' ' LEU . 18.0 mmt -102.09 -1.92 30.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 -174.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.7 -114.32 3.01 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.057 -0.974 . . . . 0.0 114.19 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 14.4 Cg_exo -70.6 82.68 0.9 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.961 2.44 . . . . 0.0 113.676 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.931 HG12 ' H ' ' A' ' 20' ' ' SER . 16.4 t -121.02 -160.6 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.931 ' H ' HG12 ' A' ' 19' ' ' VAL . 50.8 p -165.84 172.96 11.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 119.751 1.16 . . . . 0.0 109.706 -168.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -52.73 -59.54 4.36 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.158 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -64.32 -52.63 57.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.081 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.6 -44.5 96.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.987 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.58 69.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 110.988 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -65.63 -46.04 80.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.934 0.397 . . . . 0.0 110.471 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.0 m -61.91 -27.45 68.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.177 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -91.99 -14.26 29.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.952 -176.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.027 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 67.1 mt -114.96 -17.11 11.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.574 -0.45 . . . . 0.0 112.082 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 11.65 -97.29 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.284 1.433 . . . . 0.0 114.565 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.29 33.22 1.82 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.516 ' HB3' ' CE ' ' A' ' 35' ' ' MET . 2.7 tt0 -73.41 -154.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.361 -0.92 . . . . 0.0 109.43 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.484 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -53.65 110.21 0.55 Allowed 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.117 179.13 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -73.04 104.33 4.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.72 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' A' ' 99' ' ' ILE . . . 141.93 -3.5 2.01 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.303 -171.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.667 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 38.4 mtm -83.36 144.91 29.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.95 157.26 45.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.585 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.461 ' HB2' ' HG2' ' A' ' 16' ' ' MET . 4.6 pp -150.11 137.47 19.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.575 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.8 t -105.77 128.71 59.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.244 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.877 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 34.9 ptt-85 -129.94 161.6 30.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.828 -175.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.97 133.1 46.91 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 48.9 m -64.48 131.93 48.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.148 0.499 . . . . 0.0 111.441 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.0 t -76.98 43.68 0.36 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.987 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 t -165.87 -37.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.033 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 41' ' ' SER . 65.4 m -134.77 121.6 14.99 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 14.5 Cg_exo -69.36 -19.0 38.63 Favored 'Trans proline' 0 CA--C 1.527 0.163 0 C-N-CA 122.723 2.282 . . . . 0.0 112.724 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.15 -52.82 3.31 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.792 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.604 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 5.7 m-20 -77.38 157.84 30.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.594 0.235 . . . . 0.0 110.987 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -123.73 177.42 5.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.932 0.396 . . . . 0.0 111.328 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.635 HG22 HD13 ' A' ' 62' ' ' ILE . 22.8 t -139.27 112.58 6.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.8 tp -83.05 100.07 10.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.952 0.406 . . . . 0.0 109.933 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 59' ' ' SER . 59.5 m -97.4 118.02 32.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.114 0.483 . . . . 0.0 111.202 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.737 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 41.1 t -111.18 157.28 12.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.377 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 1.027 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 88.1 p -123.65 135.04 53.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.302 0.955 . . . . 0.0 112.7 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.69 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 1.7 pm0 -146.05 176.24 9.86 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.513 175.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -25.51 80.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 -173.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.7 m 39.61 65.32 0.72 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.781 0.8 . . . . 0.0 110.121 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.69 ' HG3' ' HG2' ' A' ' 54' ' ' GLU . 28.5 tpt85 -168.11 52.58 0.06 Allowed 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.689 -149.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 52' ' ' VAL . 2.2 p -76.65 114.19 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.024 -1.047 . . . . 0.0 111.834 -170.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.774 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 53.5 m -73.62 90.4 1.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.002 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.475 ' CD2' HG22 ' A' ' 58' ' ' VAL . 58.6 m-70 -87.05 87.9 7.57 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.208 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.774 ' CE2' ' HB3' ' A' ' 59' ' ' SER . 71.2 m-85 -92.52 117.76 30.28 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.635 HD13 HG22 ' A' ' 49' ' ' VAL . 30.7 mm -69.95 139.69 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.792 0.33 . . . . 0.0 111.188 176.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 2.7 mp -125.08 118.2 52.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.288 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.604 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 7.8 m120 -73.42 128.89 36.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.943 0.402 . . . . 0.0 110.964 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.6 t -86.85 113.66 22.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.304 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.0 mt -93.72 135.62 24.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.757 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.2 -16.21 32.66 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.144 2.562 . . . . 0.0 113.053 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -85.5 15.57 4.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.0 110.537 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 68.6 22.91 7.41 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.18 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -113.38 162.95 15.47 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.544 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 91.9 m-85 -135.55 116.31 14.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.457 0.646 . . . . 0.0 112.169 -172.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 31.3 ttpt -98.17 98.83 10.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.587 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 12.0 tt -80.72 77.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 122.077 0.942 . . . . 0.0 111.469 -175.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.07 -30.17 2.1 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.737 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.15 -77.01 0.24 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.256 0.55 . . . . 0.0 111.434 -169.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.434 ' H ' ' HG2' ' A' ' 76' ' ' GLN . 12.9 pt20 -95.05 148.53 22.25 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.437 -169.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -82.14 124.88 30.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.682 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.408 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 77.5 m-85 -112.4 144.4 41.91 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 169.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.02 -25.37 63.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.788 -170.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -164.8 168.5 17.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.238 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.458 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 8.4 mt -55.21 -55.81 35.4 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.0 Cg_exo -59.27 -8.98 7.45 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.548 2.165 . . . . 0.0 114.002 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.04 -33.51 18.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.792 0.329 . . . . 0.0 111.139 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -79.55 -27.41 41.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.286 0.565 . . . . 0.0 109.675 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 82' ' ' PRO . 79.4 mt -67.87 -33.94 75.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.616 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.66 ' HA ' ' HE3' ' A' ' 89' ' ' LYS . 11.1 pt-20 -90.9 -3.71 57.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.329 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -91.01 -37.06 13.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.377 0.608 . . . . 0.0 110.01 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -83.39 1.5 41.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.884 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.66 ' HE3' ' HA ' ' A' ' 86' ' ' GLU . 17.8 ptpt -86.36 14.97 5.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 91' ' ' HIS . 1.7 pp -165.33 -30.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.787 0.804 . . . . 0.0 108.845 -170.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.45 ' N ' HD12 ' A' ' 90' ' ' ILE . 9.0 t60 -65.73 -28.2 68.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.414 172.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.649 ' CD1' HG23 ' A' ' 97' ' ' THR . 70.3 m-85 64.0 110.81 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 124.569 1.168 . . . . 0.0 109.538 -168.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.503 HD11 HD21 ' A' ' 98' ' ' LEU . 20.0 mt -56.2 -42.34 77.04 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 1.034 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 0.1 OUTLIER -138.59 -80.67 0.33 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.378 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.768 HG21 ' HB3' ' A' ' 156' ' ' PRO . 11.0 m -136.94 -6.17 1.88 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.493 1.14 . . . . 0.0 108.546 166.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -106.53 138.69 42.25 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.931 172.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.649 HG23 ' CD1' ' A' ' 92' ' ' TYR . 11.9 p -98.55 -175.46 3.09 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.949 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.503 HD21 HD11 ' A' ' 93' ' ' LEU . 87.6 mt -88.77 88.76 7.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.621 HD13 ' HA3' ' A' ' 34' ' ' GLY . 3.6 mp -75.1 -54.96 13.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.725 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 35' ' ' MET . 15.2 pt-20 -154.07 161.34 29.5 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.725 -176.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.94 155.78 61.43 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.536 2.157 . . . . 0.0 112.341 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -77.95 168.22 29.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.527 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 21.8 Cg_endo -62.08 148.01 93.99 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.328 2.019 . . . . 0.0 112.116 175.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 81.4 mtp180 . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.113 0.483 . . . . 0.0 110.218 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.85 HD12 HG21 ' A' ' 152' ' ' ILE . 1.3 mm? . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.722 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 3.9 mm-40 -159.82 -68.67 0.08 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.908 -173.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.62 110.86 23.17 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.328 1.061 . . . . 0.0 111.791 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.991 HG22 ' HB3' ' A' ' 180' ' ' LYS . 70.1 t -115.08 150.1 17.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.918 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.96 ' HG2' ' HG3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -124.58 153.24 42.45 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.72 165.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.975 HG22 HG12 ' A' ' 178' ' ' VAL . 21.7 p -112.81 141.18 46.91 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 131' ' ' LEU . 0.3 OUTLIER -99.13 -45.05 6.05 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.946 0.403 . . . . 0.0 111.368 -177.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 35.1 t80 -70.62 -38.63 73.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -163.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 13.5 t70 75.63 100.71 0.07 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -172.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 77.2 t80 -139.14 107.54 7.38 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.112 -175.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 27.1 Cg_endo -92.31 85.73 0.23 Allowed 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.783 2.322 . . . . 0.0 112.356 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.751 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -71.74 -11.88 73.75 Favored Glycine 0 CA--C 1.506 -0.499 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 172.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 138' ' ' ASP . 17.7 m120 51.46 59.53 4.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.603 -1.299 . . . . 0.0 113.312 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.471 ' H ' ' HD3' ' A' ' 143' ' ' PRO . 21.0 t70 81.36 163.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 155.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 88.79 -47.52 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.638 1.575 . . . . 0.0 111.704 169.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -160.35 6.08 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.324 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.751 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 39.0 m-20 -139.64 97.14 3.2 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.075 HD11 ' HB2' ' A' ' 165' ' ' ASN . 21.9 tp -70.13 128.02 91.86 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 120.832 0.348 . . . . 0.0 110.792 -174.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 56.4 Cg_endo -79.28 101.62 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.212 1.941 . . . . 0.0 111.736 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 15.1 p90 -109.94 157.09 19.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.366 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.549 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 35.4 mtmm -112.02 175.62 5.35 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.056 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.786 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -76.58 71.89 3.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.621 0.724 . . . . 0.0 110.443 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 131.21 30.39 0.57 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.244 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -95.32 155.13 16.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.84 HD13 ' HB3' ' A' ' 129' ' ' ARG . 47.1 mm -105.34 132.55 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.521 HD22 ' HA ' ' A' ' 165' ' ' ASN . 29.9 mt -122.03 156.97 32.38 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.722 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 39.0 t -114.47 127.87 71.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 171.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.85 HG21 HD12 ' A' ' 125' ' ' LEU . 23.4 mm -75.03 114.04 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.481 1.134 . . . . 0.0 110.491 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.885 HG21 HG13 ' A' ' 170' ' ' VAL . 2.5 tp -92.89 -24.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.37 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.034 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 6.8 tp10 -155.51 147.58 23.52 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 121.553 -0.717 . . . . 0.0 111.774 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -129.83 84.13 61.9 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.094 168.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.768 ' HB3' HG21 ' A' ' 95' ' ' THR . 57.2 Cg_endo -91.61 -58.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.092 1.861 . . . . 0.0 111.334 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.451 ' OE1' ' HG2' ' A' ' 156' ' ' PRO . 1.3 mp0 -82.63 175.02 10.49 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.476 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -112.86 -5.64 13.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 159' ' ' GLN . 6.3 tp60 -104.44 -24.23 13.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.675 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.774 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 34.9 m95 -129.0 138.23 51.82 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.811 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.649 ' O ' HG13 ' A' ' 173' ' ' ILE . 36.1 m0 -123.74 137.63 54.66 Favored 'General case' 0 C--O 1.213 -0.818 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.868 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 12.9 m -88.34 123.66 33.13 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.794 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -130.76 155.11 47.22 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.361 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 26.9 ptt-85 -97.75 136.89 37.45 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 171.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.075 ' HB2' HD11 ' A' ' 142' ' ' LEU . 65.5 t30 -71.33 168.22 17.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.24 -173.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.519 ' HE3' ' H ' ' A' ' 149' ' ' ILE . 10.2 ttpp -66.01 -17.55 64.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.545 ' HB3' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -74.4 -33.81 63.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.61 172.695 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 137.82 -36.37 1.94 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.215 -0.993 . . . . 0.0 115.4 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.565 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -90.8 160.82 15.56 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.492 1.146 . . . . 0.0 113.463 -163.182 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.885 HG13 HG21 ' A' ' 153' ' ' ILE . 78.1 t -89.65 136.27 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.363 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.91 156.42 28.15 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.565 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.774 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -72.85 136.15 45.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.649 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -135.44 147.92 63.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.771 0.319 . . . . 0.0 110.859 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 1.03 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 16.2 Cg_exo -70.71 139.13 36.29 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.943 2.429 . . . . 0.0 113.128 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.54 ' O ' HG22 ' A' ' 178' ' ' VAL . 21.9 t -78.31 -44.95 2.15 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.4 Cg_endo -66.92 0.51 3.64 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.888 1.725 . . . . 0.0 111.684 173.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 1.03 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 0.9 OUTLIER -100.92 -4.99 26.62 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.139 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.975 HG12 HG22 ' A' ' 130' ' ' THR . 26.8 m -123.5 170.89 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 122.543 1.163 . . . . 0.0 113.645 -171.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.96 ' HG3' ' HG2' ' A' ' 129' ' ' ARG . 8.2 pt-20 -133.6 48.57 2.36 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.677 -2.056 . . . . 0.0 110.232 -170.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.991 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 -166.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 1.003 HG13 HG13 ' A' ' 266' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 120.996 0.427 . . . . 0.0 111.107 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -114.23 126.26 54.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.527 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.647 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -133.56 129.23 36.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.077 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -94.81 129.4 41.78 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.619 -0.432 . . . . 0.0 109.979 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.653 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -74.71 115.56 14.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.288 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.844 HD12 ' HG2' ' A' ' 292' ' ' LYS . 0.2 OUTLIER -102.14 -16.06 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.268 0.556 . . . . 0.0 110.387 179.01 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.29 120.45 23.2 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -58.65 155.58 12.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.175 0.988 . . . . 0.0 112.812 -168.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 25.6 tpt180 -131.0 97.71 4.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.637 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.315 -0.915 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.256 -174.57 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 121.602 0.715 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -86.85 142.23 28.21 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.452 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.443 ' HB2' ' HA3' ' A' ' 284' ' ' GLY . 1.3 tt -98.72 115.84 29.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.99 115.38 7.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.2 0.524 . . . . 0.0 110.929 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.55 HD21 HG21 ' A' ' 279' ' ' VAL . 72.8 mt -129.7 153.6 48.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.912 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -133.93 172.13 13.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 170.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 2.1 p -67.94 114.11 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.575 0.703 . . . . 0.0 111.071 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 121.44 -0.16 11.29 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.628 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -96.55 142.06 29.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.904 0.383 . . . . 0.0 110.939 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.7 mm -94.76 114.36 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.741 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.495 ' HA ' HG22 ' A' ' 279' ' ' VAL . 20.1 t -94.96 115.81 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.064 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -98.3 98.84 10.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 1.003 HG13 HG13 ' A' ' 238' ' ' VAL . 7.2 p -88.74 132.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.107 0.48 . . . . 0.0 110.878 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 2.5 p -108.57 -30.99 7.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.561 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 40.7 ttm180 -127.68 112.29 14.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.131 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' MET . . . . . 0.559 ' HE3' HG11 ' A' ' 238' ' ' VAL . 31.8 mtt -92.86 106.16 18.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.36 0.6 . . . . 0.0 111.216 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 92.9 m-20 -80.08 117.93 21.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.637 176.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.39 -17.26 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.715 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.416 ' OD1' ' HB3' ' A' ' 270' ' ' ASN . 3.4 p-10 -75.27 -7.58 54.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 134.41 -66.46 0.57 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.806 -1.188 . . . . 0.0 113.628 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 24.3 mp0 -81.72 120.58 25.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.841 0.32 . . . . 0.0 110.571 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.472 ' CZ3' ' HE2' ' A' ' 269' ' ' MET . 28.8 m0 -93.76 164.54 13.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.659 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 46.7 mt-10 -102.93 102.97 13.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.358 175.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -126.38 168.21 18.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 282' ' ' ARG . 0.9 OUTLIER -122.64 144.05 49.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.451 . . . . 0.0 109.844 178.045 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.55 HG21 HD21 ' A' ' 258' ' ' LEU . 95.6 t -135.42 100.76 2.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.204 174.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 68.66 28.82 5.58 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.6 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 101.11 14.02 32.1 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.988 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 20.2 mtp-105 -125.71 120.02 29.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.89 0.345 . . . . 0.0 110.823 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 283' ' ' LYS . 30.4 mtpt -96.07 141.83 28.99 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 256' ' ' LEU . . . -165.6 164.17 37.13 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.262 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.727 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 85.5 mt -86.85 110.57 20.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.464 0.649 . . . . 0.0 110.87 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 24.2 p90 -115.94 128.53 25.91 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.174 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 10.7 Cg_exo -72.98 143.78 37.04 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.646 2.231 . . . . 0.0 111.076 173.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -66.01 -7.63 18.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.16 -11.96 60.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.041 0.448 . . . . 0.0 111.462 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -103.63 -11.94 17.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 111.029 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.417 HG21 ' HE2' ' A' ' 286' ' ' PHE . 27.3 m -127.9 163.76 30.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.031 -175.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.844 ' HG2' HD12 ' A' ' 243' ' ' ILE . 32.5 mmmt -124.9 122.3 36.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.569 176.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.647 HD13 ' HB2' ' A' ' 240' ' ' ALA . 45.1 mm -71.06 102.84 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.89 170.9 8.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.248 0.547 . . . . 0.0 111.698 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.755 175.357 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 121.13 0.49 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -109.15 20.03 18.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.696 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.499 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 50.7 p90 -91.34 156.27 17.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.08 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.36 135.27 36.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 m -110.84 10.9 22.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -121.52 -37.82 2.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.511 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -72.25 116.34 12.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.219 0.533 . . . . 0.0 110.715 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HG2' ' H ' ' A' ' 11' ' ' ARG . 16.5 mmt180 -56.87 -30.17 63.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.995 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.5 t -80.88 -2.71 48.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -175.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.76 -46.9 6.4 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.815 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 31.7 p-90 -120.4 -21.38 6.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -172.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -78.94 118.27 20.79 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.944 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.692 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 7.8 tpp -97.38 -4.48 38.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.201 0.524 . . . . 0.0 110.455 -172.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.66 -115.81 3.72 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.951 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.43 103.49 1.75 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.455 2.103 . . . . 0.0 112.338 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.861 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 80.8 t -132.66 -83.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.255 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.691 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 66.9 m 87.73 152.38 0.06 Allowed 'General case' 0 C--N 1.348 0.543 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -59.06 -35.67 73.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -164.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -25.94 66.97 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.019 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' HG22 ' A' ' 26' ' ' THR . 23.7 tp10 -87.29 -45.24 10.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.7 -44.24 77.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.838 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -76.92 -32.74 57.59 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 23' ' ' GLU . 6.9 t -72.54 -22.07 61.07 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.591 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -88.42 -24.64 22.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.399 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.813 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 95.2 mt -107.86 20.35 18.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.532 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -66.58 90.99 0.17 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.527 0.68 . . . . 0.0 109.217 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.41 -70.1 2.68 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.576 ' HG3' ' H ' ' A' ' 32' ' ' ARG . 4.6 tp-100 48.74 -167.39 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.795 0.838 . . . . 0.0 110.894 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.576 ' H ' ' HG3' ' A' ' 31' ' ' GLN . 74.1 mtm-85 -80.04 112.09 17.01 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 170.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.478 ' NE2' ' HA ' ' A' ' 55' ' ' ASN . 32.8 m170 -57.88 117.75 4.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.115 0.483 . . . . 0.0 110.053 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.05 14.36 7.22 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -168.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -95.82 145.95 24.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.506 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.557 ' HB2' HG22 ' A' ' 52' ' ' VAL . 31.1 p90 -150.34 166.97 28.42 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.45 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.1 pp -156.45 135.57 12.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.511 173.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.52 HG22 HD13 ' A' ' 50' ' ' LEU . 51.4 t -101.74 111.28 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.861 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 13.4 ptt-85 -110.7 173.95 6.09 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.868 0.366 . . . . 0.0 110.791 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -82.22 137.37 34.92 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.6 p -59.44 -28.58 67.09 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.582 -174.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.2 t 61.29 19.98 10.63 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.942 0.877 . . . . 0.0 108.787 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.5 m -116.41 -49.86 2.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.045 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 44.7 t -145.83 124.45 6.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.614 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.62 87.11 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.411 2.074 . . . . 0.0 111.344 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.43 -11.27 0.13 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.774 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -126.34 145.88 50.26 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.36 -0.494 . . . . 0.0 109.763 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.43 164.42 13.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.363 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.29 99.42 4.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.213 0.53 . . . . 0.0 110.619 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.52 HD13 HG22 ' A' ' 38' ' ' VAL . 41.9 tp -78.67 99.53 6.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.894 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.4 m -96.3 121.51 38.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.135 0.493 . . . . 0.0 109.992 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.863 HG21 HD13 ' A' ' 93' ' ' LEU . 84.2 t -116.5 134.3 60.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.955 -177.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.813 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 95.5 p -105.78 134.54 48.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.563 0.697 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.515 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 7.2 mt-10 -144.56 175.81 9.87 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.478 ' HA ' ' NE2' ' A' ' 33' ' ' HIS . 0.3 OUTLIER -38.45 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -173.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m 50.57 59.79 4.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.444 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 55' ' ' ASN . 21.0 mmm180 -160.33 49.46 0.27 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.177 -157.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 36.4 t -80.96 90.9 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.967 0.889 . . . . 0.0 109.351 -175.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 51.1 m -80.4 120.81 24.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.172 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -97.81 99.02 10.33 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.366 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.647 ' CE2' HD22 ' A' ' 93' ' ' LEU . 64.0 m-85 -103.17 116.03 31.71 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.6 mt -81.69 139.27 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.524 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.8 mp -127.05 118.04 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 122.877 0.471 . . . . 0.0 110.422 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -84.35 139.41 32.29 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.464 -0.148 . . . . 0.0 110.822 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.9 t -84.52 107.77 16.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -83.84 149.66 57.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.007 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.71 -23.9 73.49 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.129 2.553 . . . . 0.0 112.911 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -79.66 6.13 11.49 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.013 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 66.11 36.07 5.87 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.676 0.751 . . . . 0.0 110.234 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 92.7 mtt180 -113.97 172.99 6.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.604 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.524 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 60.0 m-85 -135.92 115.72 13.04 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.12 0.486 . . . . 0.0 111.291 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -98.39 108.4 21.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.745 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.548 HD13 ' HE2' ' A' ' 88' ' ' TYR . 9.5 tt -97.8 78.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.842 0.829 . . . . 0.0 110.043 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.74 95.62 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.283 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 t0 71.81 -56.96 0.63 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.033 0.533 . . . . 0.0 111.736 173.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -78.61 140.53 38.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.738 0.304 . . . . 0.0 110.665 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -112.7 128.64 56.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.627 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.485 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 74.6 m-85 -116.77 164.6 14.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.273 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' ARG . 3.6 m-20 -72.97 -29.66 63.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -176.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.623 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -164.06 167.06 20.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.974 -178.291 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.659 HD23 HD21 ' A' ' 84' ' ' LEU . 10.6 mt -53.58 -51.79 72.96 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.623 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 32.2 Cg_exo -59.96 -11.92 17.01 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.956 1.77 . . . . 0.0 112.955 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . . . -91.73 -32.21 15.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.111 -175.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.659 HD21 HD23 ' A' ' 81' ' ' LEU . 3.9 pp -77.46 -31.95 54.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.67 -38.3 90.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.354 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.645 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 13.9 pt-20 -78.25 -18.17 55.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.196 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -79.07 -39.01 34.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.191 0.519 . . . . 0.0 109.961 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.548 ' HE2' HD13 ' A' ' 73' ' ' ILE . 32.4 m-85 -77.85 -15.95 58.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.599 -177.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 22.0 pttm -67.48 -20.27 65.44 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.316 -0.254 . . . . 0.0 110.316 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.441 HG23 ' HG3' ' A' ' 89' ' ' LYS . 18.9 pt -121.91 22.48 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.991 -0.443 . . . . 0.0 111.529 174.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 22.3 t-160 -113.56 -32.47 6.18 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.078 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.584 ' HA ' HG22 ' A' ' 97' ' ' THR . 76.1 m-85 73.32 107.75 0.07 Allowed 'General case' 0 C--O 1.22 -0.452 0 O-C-N 124.072 0.858 . . . . 0.0 109.966 -172.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.863 HD13 HG21 ' A' ' 52' ' ' VAL . 12.2 mt -79.87 -12.2 59.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.76 0.79 . . . . 0.0 109.173 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.515 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 24.9 t70 -149.04 -71.83 0.19 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.238 160.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.607 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.7 t -149.22 2.33 0.56 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.433 HG22 ' CD ' ' A' ' 54' ' ' GLU . 1.9 t -132.08 -12.54 3.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.409 -0.807 . . . . 0.0 112.795 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 92' ' ' TYR . 8.4 p 74.08 -166.06 0.1 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.301 1.041 . . . . 0.0 111.696 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.414 HD22 ' CD1' ' A' ' 36' ' ' PHE . 63.5 mt -81.72 108.56 15.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.311 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.7 mm -98.45 -48.57 12.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.556 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 9.8 pt-20 -167.56 158.14 9.67 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.916 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 1.5 Cg_endo -83.28 162.82 15.15 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.801 2.334 . . . . 0.0 112.726 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.18 154.08 63.26 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.096 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.71 139.31 62.6 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.629 2.22 . . . . 0.0 112.119 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.692 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 68.1 mtm180 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.049 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.661 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.586 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 47.9 tp10 -161.14 -78.72 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.092 -175.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.89 116.49 32.04 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.9 0.857 . . . . 0.0 112.039 -171.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.826 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 86.6 t -134.36 125.89 48.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.573 -173.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.672 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 7.2 ptp85 -111.49 135.01 52.65 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 118.127 -1.429 . . . . 0.0 110.817 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.413 HG22 HG12 ' A' ' 178' ' ' VAL . 7.4 p -97.48 140.66 31.59 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.094 0.473 . . . . 0.0 112.081 -174.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.054 HD21 ' HB2' ' A' ' 179' ' ' GLU . 0.1 OUTLIER -117.44 -38.33 3.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.448 -171.626 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 29.9 t80 -64.32 -32.56 74.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.886 -170.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 12.5 t70 72.44 105.84 0.07 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.737 0.648 . . . . 0.0 110.04 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 71.3 t80 -144.08 108.72 5.0 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.095 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 66.1 Cg_endo -87.92 99.6 0.44 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.325 2.017 . . . . 0.0 112.661 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -81.65 -3.71 90.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.99 175.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 57.92 24.66 11.2 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.133 0.573 . . . . 0.0 111.777 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.704 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 2.0 p30 50.45 -176.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.038 1.335 . . . . 0.0 114.457 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 71.89 9.17 6.14 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.432 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -175.38 -46.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.069 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.411 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 17.5 m-20 -137.07 124.26 21.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.828 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.936 HD11 ' HB2' ' A' ' 165' ' ' ASN . 46.7 tp -69.86 132.28 88.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-O 120.693 0.282 . . . . 0.0 110.662 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 6.4 Cg_endo -85.25 89.23 0.83 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.374 2.049 . . . . 0.0 110.636 176.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 14.2 p90 -99.5 158.02 16.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.472 -177.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.58 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 82.9 mttt -112.15 -172.44 2.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.469 -172.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.22 18.46 1.4 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.742 -175.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.94 36.06 0.08 OUTLIER Glycine 0 C--N 1.33 0.218 0 C-N-CA 119.813 -1.185 . . . . 0.0 113.916 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.58 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 21.9 mm-40 -98.84 157.41 16.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.4 tp -103.52 138.83 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.563 HD22 ' HA ' ' A' ' 165' ' ' ASN . 26.5 mt -120.61 155.7 33.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 19.2 t -119.74 130.89 73.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 163' ' ' ALA . 39.6 mm -74.3 96.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.557 HG23 ' HG2' ' A' ' 154' ' ' GLU . 16.3 tt -79.02 -31.2 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.77 -175.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.557 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -146.9 141.0 26.09 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.934 171.172 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.623 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 1.6 ttpm? -119.06 87.13 33.54 Favored Pre-proline 0 C--N 1.328 -0.367 0 O-C-N 121.331 -0.856 . . . . 0.0 110.877 173.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.607 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 11.4 Cg_exo -72.92 -58.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.584 2.19 . . . . 0.0 112.35 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -107.83 177.44 4.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.23 -20.18 14.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.757 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -85.47 -34.76 21.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.15 0.5 . . . . 0.0 110.122 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -128.3 129.73 46.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.206 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -108.97 156.17 20.02 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 22.7 t -111.58 101.96 10.33 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.351 0.596 . . . . 0.0 110.056 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -113.71 163.19 15.34 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.169 -176.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 168' ' ' GLY . 29.8 ptt-85 -108.23 140.55 41.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.328 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.936 ' HB2' HD11 ' A' ' 142' ' ' LEU . 57.1 t30 -70.56 178.61 2.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.587 -175.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -58.67 -32.02 68.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -60.6 -42.14 96.15 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.105 170.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 164' ' ' ARG . . . 115.86 -9.33 18.81 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.689 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.704 ' HD3' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -76.73 152.69 35.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.541 0.671 . . . . 0.0 110.811 -176.363 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.464 ' CG2' HD13 ' A' ' 153' ' ' ILE . 26.2 t -99.73 143.59 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.287 0.565 . . . . 0.0 112.413 -168.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -171.98 162.98 35.29 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.757 169.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.421 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 22.9 mtp -81.7 147.31 29.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.3 0.55 . . . . 0.0 110.822 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.8 pp -141.32 145.83 39.9 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.386 -174.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 7.8 Cg_exo -73.29 133.17 18.88 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.185 2.59 . . . . 0.0 112.699 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.62 ' O ' HG22 ' A' ' 178' ' ' VAL . 58.0 t -61.7 -47.3 92.69 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 23.3 Cg_endo -61.4 -13.44 29.0 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.169 1.913 . . . . 0.0 113.294 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -86.35 -4.21 59.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.888 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 175' ' ' VAL . 4.1 m -110.61 159.04 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -166.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 1.054 ' HB2' HD21 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -117.75 45.19 2.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 111.493 -2.594 . . . . 0.0 109.242 -178.725 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.826 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.586 0 O-C-N 120.963 -1.085 . . . . 0.0 109.398 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.704 HG12 HD11 ' A' ' 293' ' ' ILE . 45.8 t . . . . . 0 C--O 1.234 0.26 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -115.14 135.12 54.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.851 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -122.29 142.56 50.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.2 174.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.741 ' HA ' ' O ' ' A' ' 262' ' ' ASP . 56.3 mttm -84.52 119.6 25.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.088 0.47 . . . . 0.0 110.233 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 1.091 ' HB1' ' HA ' ' A' ' 259' ' ' GLU . . . -89.39 114.91 26.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.217 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -130.7 -10.26 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -165.718 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.667 ' HB3' ' OE2' ' A' ' 259' ' ' GLU . 57.7 tt0 -113.57 -89.05 0.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.059 -0.657 . . . . 0.0 112.752 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.445 ' N ' ' HB3' ' A' ' 259' ' ' GLU . 85.8 tttt -173.81 118.74 0.27 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -173.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.954 ' HG2' ' HG3' ' A' ' 259' ' ' GLU . 19.8 mmm180 -131.34 98.74 4.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.61 167.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.106 179.168 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 121.384 0.612 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -94.37 118.43 31.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.507 . . . . 0.0 111.183 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 tt -91.17 126.28 36.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.367 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -81.82 110.66 17.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.188 0.518 . . . . 0.0 110.931 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.59 HD22 HG22 ' A' ' 264' ' ' VAL . 1.3 pp -164.86 -141.82 0.05 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.115 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 1.091 ' HA ' ' HB1' ' A' ' 242' ' ' ALA . 0.0 OUTLIER 80.82 1.18 1.78 Allowed 'General case' 0 C--O 1.222 -0.367 0 O-C-N 123.899 0.75 . . . . 0.0 111.566 177.432 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.32 90.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -178.8 -83.35 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.823 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.741 ' O ' ' HA ' ' A' ' 241' ' ' LYS . 29.2 t0 179.04 -79.06 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 121.056 0.455 . . . . 0.0 111.68 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 36.9 mm -100.65 119.81 49.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -170.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.59 HG22 HD22 ' A' ' 258' ' ' LEU . 99.2 t -107.11 121.79 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.472 168.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -94.09 116.25 28.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.163 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 275' ' ' TRP . 2.7 p -111.68 117.27 54.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.306 0.574 . . . . 0.0 110.692 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.2 p -107.57 -15.44 14.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.753 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.499 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 38.2 mmt-85 -124.01 100.38 6.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.043 0.449 . . . . 0.0 111.211 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 46.8 mtt -101.85 140.31 36.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.332 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.632 ' OD1' ' HB3' ' A' ' 272' ' ' ASN . 9.0 p30 -135.49 176.66 8.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.461 -176.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 271' ' ' ILE . 13.7 pt -87.1 4.58 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -172.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.632 ' HB3' ' OD1' ' A' ' 270' ' ' ASN . 7.4 t-20 -74.77 -44.59 48.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.26 0.552 . . . . 0.0 109.578 175.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.73 -39.21 2.55 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 44.3 mt-30 -79.35 116.54 19.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.578 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 13.6 m0 -93.04 155.85 17.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.977 -173.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 40.2 mt-10 -101.26 107.62 19.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.994 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.99 148.74 17.89 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 282' ' ' ARG . 0.0 OUTLIER -110.09 109.63 20.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.372 0.606 . . . . 0.0 110.33 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.487 HG21 HG13 ' A' ' 264' ' ' VAL . 21.6 t -127.6 -79.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.755 -176.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -82.26 67.04 8.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.268 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.07 16.92 60.49 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.85 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 40.5 ttm180 -155.32 146.63 22.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.139 0.469 . . . . 0.0 111.095 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 278' ' ' GLU . 39.4 tttm -102.48 113.98 27.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.118 170.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -146.67 178.21 24.48 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.074 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 96.5 mt -84.86 140.43 31.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 0.0 111.681 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.412 ' HE2' HG21 ' A' ' 291' ' ' VAL . 34.8 p90 -142.86 129.5 10.69 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.22 170.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.28 137.08 25.31 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.58 2.187 . . . . 0.0 112.536 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -71.51 -10.74 60.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.844 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.7 m -84.65 -2.57 57.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.451 0.643 . . . . 0.0 110.411 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.455 ' HB3' ' OE2' ' A' ' 259' ' ' GLU . 3.1 m-70 -101.12 -54.65 2.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.395 174.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.412 HG21 ' HE2' ' A' ' 286' ' ' PHE . 35.0 m -85.03 159.61 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.798 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.42 107.16 16.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.229 0.538 . . . . 0.0 110.3 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' A' ' 240' ' ' ALA . 5.0 tp -70.1 131.66 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.472 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 18.3 p90 -134.63 160.64 37.48 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.624 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.1 t0 . . . . . 0 C--N 1.316 -0.888 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.178 177.277 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.657 ' HA ' ' NE ' ' A' ' 5' ' ' ARG . 5.0 mmp_? -113.71 15.14 18.84 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -86.59 171.13 11.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.456 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 24.4 t70 -82.52 -133.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.444 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 9.6 t -173.71 43.19 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.406 ' H ' ' H ' ' A' ' 10' ' ' ASP . 9.9 t -164.51 -11.02 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.968 174.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.456 ' OD1' ' HB3' ' A' ' 7' ' ' ASP . 7.9 p-10 -75.44 81.0 2.49 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.809 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 48.0 mtt-85 -70.5 -16.85 62.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.479 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 t -75.77 -7.96 55.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.659 174.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.3 -47.08 3.59 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.8 p-90 -107.63 -20.46 13.22 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -172.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 22.8 t80 -81.92 122.71 28.11 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 122.027 -0.421 . . . . 0.0 110.672 -174.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.694 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 24.7 mmt -103.36 -13.55 16.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.479 -176.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.05 -113.42 2.18 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.658 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.6 84.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.199 2.599 . . . . 0.0 113.327 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.523 HG21 ' HB3' ' A' ' 16' ' ' MET . 84.1 t -137.03 172.8 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 19' ' ' VAL . 43.8 p -145.41 172.28 13.42 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -168.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -63.02 -37.15 86.04 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.873 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -56.74 11.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.688 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -61.55 -50.25 73.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.25 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.73 -37.23 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.353 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -64.33 -43.94 93.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.128 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.2 t -78.92 -21.27 47.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.871 0.367 . . . . 0.0 111.409 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.415 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 51.1 mtp180 -82.43 -10.43 59.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.892 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.611 HD22 ' HB2' ' A' ' 53' ' ' SER . 26.9 mt -126.97 12.06 7.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.097 0.475 . . . . 0.0 111.018 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.49 98.25 2.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.377 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.69 -1.92 70.52 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.344 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 37.4 mm-40 -60.37 168.15 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.853 0.461 . . . . 0.0 111.689 -175.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -47.63 118.98 2.49 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.551 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.601 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 36.3 m170 -63.6 117.16 6.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.337 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.8 -13.55 6.1 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.997 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.691 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 64.3 mtt -69.19 153.58 43.46 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.511 0.196 . . . . 0.0 110.518 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.418 ' CB ' HG22 ' A' ' 52' ' ' VAL . 28.7 p90 -155.62 159.23 39.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.694 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.6 pp -153.52 140.41 19.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.001 0.429 . . . . 0.0 110.851 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.3 t -110.39 116.47 52.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.861 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.499 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 25.4 ptt-85 -117.77 176.05 5.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.97 -177.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.41 134.46 40.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.133 0.492 . . . . 0.0 110.645 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 t -87.36 107.97 18.77 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.5 t -73.96 8.09 2.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.563 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.5 p -94.6 -25.56 16.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.803 0.335 . . . . 0.0 110.659 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 76.7 m -152.36 115.23 2.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.879 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 28.0 Cg_endo -62.45 103.05 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.799 2.333 . . . . 0.0 112.436 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.54 -24.73 4.1 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.659 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -88.37 165.87 14.66 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.422 ' CD2' HD11 ' A' ' 81' ' ' LEU . 58.0 m-85 -134.52 -177.87 4.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.758 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.556 HG22 HG12 ' A' ' 62' ' ' ILE . 6.2 t -143.96 113.85 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.62 177.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.452 ' HB2' HD11 ' A' ' 63' ' ' ILE . 62.8 tp -80.83 97.09 7.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.1 m -94.05 118.12 31.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.329 0.585 . . . . 0.0 109.666 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 58.7 t -110.68 142.66 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.639 -174.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 40.7 t -91.68 103.89 16.41 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.601 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 7.0 tp10 -167.11 166.43 15.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.898 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.574 HD22 ' CG ' ' A' ' 94' ' ' ASP . 0.7 OUTLIER 76.82 -64.5 0.33 Allowed 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 123.58 1.657 . . . . 0.0 108.546 -168.41 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.5 m -160.86 -27.64 0.06 Allowed 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 111.314 -2.675 . . . . 0.0 106.133 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.82 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.363 0.0 OUTLIER -163.08 -48.34 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.084 1 N-CA-C 123.333 4.568 . . . . 0.0 123.333 179.624 . . . . . . . . 5 4 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.82 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -147.98 107.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 121.785 2.084 . . . . 0.0 114.096 -166.922 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.522 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -98.03 112.6 24.49 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 171.135 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -101.53 86.48 2.97 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -169.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.759 ' CE1' HD11 ' A' ' 153' ' ' ILE . 55.5 m-85 -102.01 110.27 22.2 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 118.626 0.648 . . . . 0.0 112.248 -174.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.556 HG12 HG22 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -75.38 139.49 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.295 0.569 . . . . 0.0 112.39 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.616 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.3 mp -110.33 108.8 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.587 175.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -82.82 141.93 31.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.177 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.7 t -85.75 118.46 25.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.104 0.478 . . . . 0.0 110.352 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.512 HD21 ' HE2' ' A' ' 72' ' ' LYS . 95.3 mt -95.15 142.54 24.74 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.058 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 19.9 Cg_exo -66.54 -8.66 21.61 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.864 2.376 . . . . 0.0 112.386 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.48 10.12 5.1 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.658 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 67.32 25.9 8.64 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.087 -179.497 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 71.0 mtt180 -115.2 -176.1 2.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.199 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.516 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 61.5 m-85 -138.85 124.69 19.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.718 0.294 . . . . 0.0 110.934 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.801 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 25.7 ttpt -113.62 109.65 18.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 111.466 -177.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.616 ' HB ' HG13 ' A' ' 63' ' ' ILE . 14.0 tt -95.91 81.29 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.723 0.773 . . . . 0.0 110.052 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.76 82.59 0.27 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.79 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.2 t0 71.46 -47.09 0.65 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.963 0.905 . . . . 0.0 111.48 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -74.75 101.34 4.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.889 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.801 ' HB3' ' HD3' ' A' ' 72' ' ' LYS . 8.2 pt-20 -95.55 118.26 31.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.662 0.744 . . . . 0.0 110.934 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.583 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 76.3 m-85 -100.22 174.71 6.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.83 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 31.9 t70 -73.06 -25.14 60.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.317 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.649 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 1.7 p80 -172.01 172.17 4.79 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.662 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.6 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.5 mt -51.4 -54.41 39.05 Favored Pre-proline 0 N--CA 1.472 0.633 0 O-C-N 123.301 0.376 . . . . 0.0 111.95 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.649 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 59.6 Cg_endo -70.4 16.99 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.284 1.99 . . . . 0.0 113.292 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.5 -35.4 6.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 174.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.8 pp -76.88 -31.74 56.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.175 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.68 -30.35 71.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.619 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 89' ' ' LYS . 3.6 tt0 -91.36 -12.61 34.41 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.104 0.478 . . . . 0.0 111.107 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.403 ' CE2' ' ND1' ' A' ' 91' ' ' HIS . 72.4 t80 -86.01 -30.62 22.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.98 0.895 . . . . 0.0 108.957 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.791 ' CD1' HD23 ' A' ' 93' ' ' LEU . 40.7 m-85 -82.71 2.38 33.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.252 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.552 ' HD2' ' HG3' ' A' ' 86' ' ' GLU . 98.3 mttt -76.39 -3.96 39.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.875 173.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.34 -2.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.032 0.444 . . . . 0.0 110.726 177.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.403 ' ND1' ' CE2' ' A' ' 87' ' ' PHE . 5.0 t60 -81.36 -31.83 33.2 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.383 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 96' ' ' THR . 75.7 m-85 62.77 67.0 0.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.125 -173.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.791 HD23 ' CD1' ' A' ' 88' ' ' TYR . 2.0 pp -71.62 117.58 13.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.79 174.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.82 ' CA ' ' HB3' ' A' ' 154' ' ' GLU . 7.6 t70 97.81 -48.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.973 1.709 . . . . 0.0 108.278 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.704 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 6.0 t 167.23 22.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.615 -1.629 . . . . 0.0 106.652 168.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.535 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 2.2 t -149.2 150.64 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.445 -173.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.7 p -91.44 157.55 17.0 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.51 99.66 0.22 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.883 0.373 . . . . 0.0 110.18 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.4 mm -80.83 -57.81 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.765 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.691 ' O ' ' HA ' ' A' ' 35' ' ' MET . 29.8 tt0 -165.16 136.93 3.32 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 -174.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.31 155.68 44.99 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.652 2.235 . . . . 0.0 112.956 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.75 157.84 85.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.697 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.31 122.5 11.91 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.34 2.027 . . . . 0.0 111.823 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 . . . . . 0 CA--C 1.519 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.591 -179.333 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.962 HD12 HG21 ' A' ' 152' ' ' ILE . 3.8 mm? . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.512 0.672 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 11.1 tp10 -165.1 -61.4 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.13 -173.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -113.49 112.34 23.43 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.271 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 1.034 HG22 ' HG3' ' A' ' 180' ' ' LYS . 2.4 t -117.19 153.39 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.669 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.4 ptp180 -129.15 148.35 51.08 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 117.947 -1.501 . . . . 0.0 108.059 157.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.529 HG22 HG12 ' A' ' 178' ' ' VAL . 43.6 p -100.58 133.54 44.87 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.695 0.759 . . . . 0.0 110.874 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.498 HD21 ' HG2' ' A' ' 179' ' ' GLU . 8.0 mt -107.56 2.25 23.91 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.555 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.48 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 16.3 t80 -102.41 -45.02 5.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.039 -173.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.622 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.9 t70 78.74 103.74 0.07 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.166 0.508 . . . . 0.0 110.679 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 68.9 t80 -132.93 91.08 29.99 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 98.3 Cg_endo -87.45 70.33 3.43 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.219 1.946 . . . . 0.0 112.763 -175.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.62 -33.88 82.22 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.737 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.469 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 26.5 m-80 61.97 66.49 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.133 -0.533 . . . . 0.0 111.825 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -143.66 172.63 12.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.271 176.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.46 -9.55 49.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.051 0.929 . . . . 0.0 108.795 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' A' ' 172' ' ' MET . 28.5 mt-10 -106.63 -15.58 14.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.807 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -137.89 106.82 5.97 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.331 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.973 HD11 ' HB2' ' A' ' 165' ' ' ASN . 20.1 tp -75.53 126.91 86.93 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.767 0.317 . . . . 0.0 110.989 -175.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 73.9 Cg_endo -78.12 97.18 1.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.845 1.697 . . . . 0.0 111.687 173.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.617 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 15.3 p90 -105.95 156.71 18.1 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.622 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 62.5 mttp -113.07 173.34 6.44 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -173.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.529 ' N ' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -71.72 57.88 0.3 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.209 178.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 134.41 38.25 0.21 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.784 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.667 ' CD ' ' HG ' ' A' ' 150' ' ' LEU . 1.7 pp20? -91.04 169.06 11.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.17 127.66 73.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.803 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 78.1 mt -117.21 156.33 27.89 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -173.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 89.4 t -120.45 122.13 67.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 171.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.074 HD13 ' HB2' ' A' ' 163' ' ' ALA . 46.4 mm -78.0 78.82 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 122.793 1.282 . . . . 0.0 108.325 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.759 HD11 ' CE1' ' A' ' 61' ' ' TYR . 5.4 tt -70.89 -28.91 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 112.577 -2.101 . . . . 0.0 109.478 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.82 ' HB3' ' CA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -134.89 143.14 46.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.165 176.077 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.523 ' H ' HD21 ' A' ' 55' ' ' ASN . 67.0 tttt -141.61 83.76 12.87 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.704 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 21.8 Cg_exo -68.14 -49.69 0.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.432 2.088 . . . . 0.0 112.199 174.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -119.35 175.73 5.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.658 -171.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -101.96 -4.93 25.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.276 0.56 . . . . 0.0 110.164 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -93.64 -36.55 12.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.516 0.674 . . . . 0.0 109.853 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.47 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 41.0 m95 -129.8 145.04 51.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.925 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.758 ' O ' HG13 ' A' ' 173' ' ' ILE . 48.5 m0 -124.31 138.88 54.34 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 122.761 0.424 . . . . 0.0 110.184 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.678 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 2.9 m -98.55 98.36 9.54 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -174.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.074 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -114.77 155.83 25.99 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -170.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.922 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 31.7 ptt-85 -94.86 128.11 41.38 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.858 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.973 ' HB2' HD11 ' A' ' 142' ' ' LEU . 65.8 t30 -59.21 178.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.106 -1.406 . . . . 0.0 112.21 -169.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -51.01 -28.34 9.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.182 164.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -70.57 -44.33 67.63 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.492 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.587 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 113.87 9.58 15.99 Favored Glycine 0 C--O 1.223 -0.533 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.966 -169.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.922 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 16.4 ttm-85 -76.09 136.54 39.87 Favored 'General case' 0 C--O 1.212 -0.892 0 C-N-CA 123.409 0.683 . . . . 0.0 112.319 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.57 HG22 HG21 ' A' ' 153' ' ' ILE . 56.2 t -84.07 120.2 34.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.15 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.402 ' CA ' ' HB2' ' A' ' 142' ' ' LEU . . . -156.12 155.89 26.65 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.476 -0.649 . . . . 0.0 111.476 172.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.657 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -76.02 138.8 41.12 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 117.354 0.577 . . . . 0.0 111.277 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.758 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -139.16 141.48 29.77 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.187 -176.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 21.4 Cg_exo -65.58 131.77 28.86 Favored 'Trans proline' 0 CA--C 1.527 0.146 0 C-N-CA 122.464 2.109 . . . . 0.0 112.936 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.519 ' O ' HG22 ' A' ' 178' ' ' VAL . 66.6 t -61.42 -44.54 92.86 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.438 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 22.7 Cg_exo -64.61 2.17 1.38 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.188 1.925 . . . . 0.0 113.162 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.7 m-30 -100.99 -11.65 19.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.231 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.73 ' HB ' HG13 ' A' ' 128' ' ' VAL . 3.6 m -105.63 -177.03 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -164.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.669 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.8 tp10 -151.82 51.59 0.81 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 111.947 -2.388 . . . . 0.0 112.332 -155.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 1.034 ' HG3' HG22 ' A' ' 128' ' ' VAL . 1.8 mppt? . . . . . 0 N--CA 1.463 0.221 0 O-C-N 120.056 -1.652 . . . . 0.0 109.96 -161.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.505 ' HB ' HG13 ' A' ' 266' ' ' VAL . 17.8 t . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -105.44 129.0 53.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.55 137.19 53.99 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.421 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 44.6 tptt -81.19 118.58 22.69 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -72.84 108.92 6.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 28.1 pt -102.36 12.88 6.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.016 0.436 . . . . 0.0 111.099 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -157.83 149.0 21.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.07 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.645 ' HG2' ' HG3' ' A' ' 259' ' ' GLU . 26.4 mtpp -68.27 101.56 1.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.064 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -89.73 83.52 6.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.313 178.859 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 47.9 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.306 0.574 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.06 119.71 25.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.513 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 246' ' ' ARG . 1.2 tt -78.4 134.67 37.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.425 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -82.54 110.27 17.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.075 0.464 . . . . 0.0 110.961 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 77.5 mt -122.09 172.76 8.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.383 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.645 ' HG3' ' HG2' ' A' ' 245' ' ' LYS . 31.6 tt0 -147.7 149.86 33.24 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 2.4 p -60.35 122.14 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 110.61 8.19 24.96 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.195 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -105.02 149.92 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.4 mm -103.9 109.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.358 0.599 . . . . 0.0 110.453 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 43.7 t -89.38 109.65 20.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.855 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 265' ' ' LYS . 13.2 ptmm? -88.48 99.88 12.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.417 0.627 . . . . 0.0 109.944 174.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.505 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.4 p -89.2 119.55 36.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.349 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 m -96.84 -18.9 19.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.947 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.561 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 48.3 ttt180 -132.18 122.35 25.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.762 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 29.9 mtt -118.53 141.05 48.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.286 0.565 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -125.25 178.95 5.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.004 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.0 tp -96.61 -5.81 9.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.47 . . . . 0.0 111.329 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -94.14 14.81 18.87 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.94 -0.475 . . . . 0.0 111.99 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 98.59 -61.53 0.85 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.705 -0.759 . . . . 0.0 114.218 169.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 28.8 mp0 -77.15 110.82 12.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.899 0.349 . . . . 0.0 110.724 -176.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.54 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 11.2 m0 -93.34 168.05 11.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.741 -176.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 27.7 tt0 -108.9 108.22 18.91 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.31 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -124.16 154.99 17.9 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.127 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -108.32 108.48 19.5 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 15.5 t -130.53 -91.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.102 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -88.27 77.96 8.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.746 -170.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 67.67 -0.74 9.0 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.227 175.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 282' ' ' ARG . 46.4 mtp180 -147.92 153.61 39.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -174.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 55.0 pttt -120.06 134.57 55.21 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -161.26 -170.16 25.53 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.263 -175.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 71.4 mt -94.22 117.5 30.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.351 0.595 . . . . 0.0 110.966 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -115.62 138.26 23.72 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.525 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.9 133.43 12.51 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.734 2.289 . . . . 0.0 111.169 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -61.05 -14.21 22.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.816 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.5 p -75.56 -14.33 60.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.799 0.333 . . . . 0.0 111.578 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -98.83 -9.03 24.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.854 0.359 . . . . 0.0 110.675 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.4 m -128.58 179.11 4.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.343 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.437 ' NZ ' ' HB2' ' A' ' 292' ' ' LYS . 2.4 ttmp? -141.11 131.24 24.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.53 174.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 293' ' ' ILE . 28.5 mm -79.91 124.42 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.523 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.433 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.1 p90 -149.49 -174.72 4.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.886 -174.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 C--N 1.323 -0.581 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.763 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 120.819 0.343 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 5' ' ' ARG . 4.5 ptp180 -79.79 -2.03 41.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.019 0.438 . . . . 0.0 110.764 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -74.76 161.58 29.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.047 0.451 . . . . 0.0 111.017 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -98.65 117.32 32.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.78 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -83.69 1.81 40.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.39 -173.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.4 m -105.11 -31.23 9.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.774 0.321 . . . . 0.0 111.137 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.86 106.09 3.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.077 0.465 . . . . 0.0 110.727 -176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -58.76 -38.24 78.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.141 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.9 m -74.35 -0.94 18.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.693 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.47 -34.86 13.93 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.408 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -130.42 -24.66 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -173.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -79.16 123.56 27.5 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.026 -0.421 . . . . 0.0 110.692 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.496 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.1 mmt -109.06 -4.62 16.48 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.208 -175.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.82 -113.74 2.67 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.67 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.19 106.54 1.39 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.606 2.204 . . . . 0.0 112.635 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.75 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 79.7 t -137.81 -78.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.532 -177.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.837 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 8.1 t 89.79 156.99 0.05 OUTLIER 'General case' 0 C--N 1.349 0.557 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -62.58 -31.73 72.6 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.589 -169.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -55.04 -45.92 75.28 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.389 0.431 . . . . 0.0 111.153 175.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -84.03 -44.64 13.92 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.126 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.46 -34.9 51.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.286 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.576 ' HA ' HG21 ' A' ' 58' ' ' VAL . 46.6 tt0 -67.36 -47.23 71.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -76.85 -11.5 59.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -173.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -98.79 -14.98 19.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.651 0.263 . . . . 0.0 111.134 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 58.8 mt -127.29 23.78 6.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.254 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -84.7 63.48 7.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.264 0.554 . . . . 0.0 112.027 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.54 4.38 80.11 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.865 -0.683 . . . . 0.0 114.164 171.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -58.46 -51.23 70.74 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 117.187 0.494 . . . . 0.0 111.478 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 35' ' ' MET . 30.8 ttm180 -142.1 148.15 37.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -92.87 112.36 24.29 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.76 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . 116.99 -7.61 16.84 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.213 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.802 ' HG3' ' HB3' ' A' ' 53' ' ' SER . 6.5 ptp -79.69 134.24 36.4 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.036 177.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.502 ' H ' ' HA ' ' A' ' 101' ' ' PRO . 47.1 p90 -142.32 167.79 21.26 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.861 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.551 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.2 pp -155.76 137.21 14.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.185 0.517 . . . . 0.0 110.933 175.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.1 t -102.26 124.05 55.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.837 ' HD2' ' H ' ' A' ' 20' ' ' SER . 14.7 ptt-85 -123.52 167.17 14.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.019 -173.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.56 115.95 18.61 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 28.5 t -63.75 122.49 16.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.494 -173.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 p -74.69 -29.69 61.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.331 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 p -85.63 -18.57 32.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.061 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' SER . 34.4 m -137.25 85.63 21.5 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.98 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.95 107.12 0.42 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.896 2.397 . . . . 0.0 112.518 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.04 -6.84 23.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.206 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -111.04 179.28 4.09 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -126.83 158.92 35.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.921 0.391 . . . . 0.0 111.301 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 62' ' ' ILE . 46.1 t -131.21 113.04 22.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.338 174.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.1 tp -85.15 100.45 11.74 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.884 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 59' ' ' SER . 73.5 m -96.12 132.46 41.49 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.731 174.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.598 HG21 HD13 ' A' ' 93' ' ' LEU . 95.1 t -127.76 137.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.912 -172.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.802 ' HB3' ' HG3' ' A' ' 35' ' ' MET . 29.5 t -93.57 97.57 10.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.48 0.657 . . . . 0.0 109.484 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -135.97 136.26 40.23 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.332 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 55.5 16.98 2.03 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.24 0.337 . . . . 0.0 111.361 -169.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m 69.21 25.78 5.61 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.371 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 1.9 ppt_? -124.93 144.24 50.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 25' ' ' GLN . 14.6 t -85.51 96.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.27 0.557 . . . . 0.0 110.962 -173.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 51' ' ' SER . 2.4 m -67.7 113.17 5.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.993 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -101.65 88.41 3.4 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.241 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.694 ' CE2' HD22 ' A' ' 93' ' ' LEU . 40.6 m-85 -102.77 114.71 29.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.49 0.186 . . . . 0.0 111.015 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.664 HG12 HG22 ' A' ' 49' ' ' VAL . 51.7 mt -81.28 126.52 39.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.818 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.4 mp -106.55 119.0 55.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 170.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' A' ' 72' ' ' LYS . 35.3 p-10 -105.26 151.69 23.81 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.249 -174.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t -86.56 91.96 8.73 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.677 -176.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.529 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 97.4 mt -63.82 128.62 93.08 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -48.03 -64.4 0.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.118 2.546 . . . . 0.0 114.629 -172.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -113.92 34.12 4.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.8 -164.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.529 ' HG3' ' HB3' ' A' ' 66' ' ' LEU . 8.7 ptt180 -154.28 -85.02 0.06 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.524 ' HG2' HD12 ' A' ' 66' ' ' LEU . 4.3 ptm180 -156.36 -171.44 3.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -161.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.545 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 56.9 m-85 -107.41 121.96 45.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.641 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 17.9 ttmm -109.17 114.0 27.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.735 0.302 . . . . 0.0 110.703 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.818 ' HB ' HG13 ' A' ' 63' ' ' ILE . 8.9 tt -93.43 77.61 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 110.002 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.93 96.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.165 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t70 72.89 -61.46 0.5 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.378 0.271 . . . . 0.0 111.168 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -75.62 111.08 10.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 10.0 pt-20 -94.59 130.05 41.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.198 0.523 . . . . 0.0 110.563 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.52 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 89.4 m-85 -116.36 168.24 10.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.128 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.68 -46.16 86.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.806 0.336 . . . . 0.0 111.399 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -154.54 176.16 12.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.38 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.632 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.5 mt -57.59 -56.41 34.51 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 40.0 Cg_exo -59.68 -8.25 7.08 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.202 1.935 . . . . 0.0 113.504 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.56 -29.4 20.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.786 0.327 . . . . 0.0 110.525 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.7 pp -83.64 -30.4 26.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 82' ' ' PRO . 89.2 mt -65.17 -40.98 95.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.501 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -79.68 -4.39 51.55 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.46 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -91.39 -39.32 12.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.343 0.592 . . . . 0.0 109.559 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.551 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 50.9 m-85 -74.28 -10.59 59.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.25 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -57.16 -37.94 72.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.118 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 pp -111.32 7.79 8.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 O-C-N 121.65 -0.657 . . . . 0.0 111.784 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.551 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 8.3 t-160 -94.41 -35.71 12.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -177.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.785 ' HA ' HG22 ' A' ' 97' ' ' THR . 79.2 m-85 70.86 99.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 124.066 0.854 . . . . 0.0 109.96 -170.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.694 HD22 ' CE2' ' A' ' 61' ' ' TYR . 25.2 mt -64.79 -21.24 66.73 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.693 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 1.5 m-20 -145.63 -74.65 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.791 165.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.5 t -144.14 -11.17 0.65 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.531 HG22 ' CD ' ' A' ' 54' ' ' GLU . 5.8 t -124.7 -12.74 7.11 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.752 -0.592 . . . . 0.0 112.034 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 92' ' ' TYR . 6.6 p 74.18 -169.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.34 1.056 . . . . 0.0 111.599 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.476 HD22 ' CD1' ' A' ' 36' ' ' PHE . 81.0 mt -75.88 106.47 7.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.791 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.76 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 31.2 mm -99.78 -56.4 5.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.105 -172.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.705 ' O ' ' HA ' ' A' ' 35' ' ' MET . 28.3 tt0 -166.62 124.79 1.05 Allowed Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -174.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.502 ' HA ' ' H ' ' A' ' 36' ' ' PHE . 18.0 Cg_endo -58.03 162.31 11.65 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.551 2.834 . . . . 0.0 113.719 -171.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.29 151.02 94.38 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.054 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.3 141.81 36.23 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.301 2.001 . . . . 0.0 113.402 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.238 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.725 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 121.545 0.688 . . . . 0.0 111.555 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.621 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 36.6 tt0 -171.25 -56.76 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.261 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.644 ' HB3' HH12 ' A' ' 129' ' ' ARG . 36.3 m-85 -105.2 107.97 19.24 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.33 -175.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 93.8 t -132.9 147.42 31.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.171 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.644 HH12 ' HB3' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -129.49 145.11 51.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.814 0.34 . . . . 0.0 110.346 176.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.97 HG22 HG12 ' A' ' 178' ' ' VAL . 16.5 p -100.56 139.44 36.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.591 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.493 ' CD1' ' HG3' ' A' ' 179' ' ' GLU . 3.8 mp -119.25 -4.96 10.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.308 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -98.59 -39.76 8.55 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.558 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.444 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 74.21 120.81 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.865 0.84 . . . . 0.0 110.747 -175.255 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.477 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 62.1 t80 -153.78 116.53 2.65 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.91 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 4.0 Cg_endo -87.27 102.53 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.726 2.284 . . . . 0.0 112.347 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -82.37 -9.42 84.97 Favored Glycine 0 CA--C 1.511 -0.208 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.174 176.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 51.5 24.52 2.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.229 0.612 . . . . 0.0 112.618 -173.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.531 ' HB2' ' HD3' ' A' ' 169' ' ' ARG . 19.0 t0 73.1 157.89 0.2 Allowed 'General case' 0 C--O 1.232 0.14 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 165.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 70.63 18.46 6.39 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.091 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.9 tp10 -168.23 -50.53 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.528 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 49.6 m-20 -142.39 148.03 37.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.055 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' A' ' 165' ' ' ASN . 34.1 tp -90.44 125.37 60.0 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.258 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 7.9 Cg_exo -70.16 108.34 2.13 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.284 1.989 . . . . 0.0 111.231 170.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.478 ' CG ' HG21 ' A' ' 130' ' ' THR . 6.6 p90 -126.06 163.52 22.88 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.494 ' H ' ' HB2' ' A' ' 148' ' ' GLU . 42.0 mttp -100.18 -175.2 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 110.41 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.842 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -90.88 8.47 34.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.441 179.158 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.8 34.55 0.8 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.494 ' HB2' ' H ' ' A' ' 145' ' ' LYS . 4.5 tp10 -93.52 144.42 25.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.745 -0.227 . . . . 0.0 110.62 -175.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.9 mm -98.3 135.6 32.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 165' ' ' ASN . 49.2 mt -128.56 158.5 38.26 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -175.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 43.3 t -119.47 129.25 75.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.725 HG21 HD12 ' A' ' 125' ' ' LEU . 37.5 mm -75.05 87.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.645 HG21 HG22 ' A' ' 170' ' ' VAL . 16.0 tt -74.45 -32.74 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.313 -173.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.692 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 29.2 mt-10 -144.7 140.76 28.81 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.428 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 32.4 tttp -127.67 91.43 45.51 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 121.664 -0.648 . . . . 0.0 111.948 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.45 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 15.6 Cg_exo -72.39 -52.2 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.248 1.966 . . . . 0.0 112.865 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -113.5 -172.85 2.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -170.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -99.1 -42.91 6.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.914 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -93.09 -10.09 37.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.392 . . . . 0.0 111.212 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.659 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 58.0 m95 -128.89 125.78 38.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.905 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.656 ' O ' HG13 ' A' ' 173' ' ' ILE . 54.9 m0 -121.73 144.87 48.54 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.097 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 20.2 m -95.64 94.82 7.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.3 0.572 . . . . 0.0 110.279 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -101.29 161.81 13.35 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.172 -0.33 . . . . 0.0 110.549 -177.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.736 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 20.6 ptt-85 -104.98 133.95 48.9 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.861 ' ND2' ' HE ' ' A' ' 169' ' ' ARG . 44.7 p30 -78.31 -176.69 4.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.685 -175.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -49.48 -31.64 10.45 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.204 0.94 . . . . 0.0 111.926 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.33 -58.93 3.01 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 139.84 3.28 1.54 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.407 -172.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.861 ' HE ' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -73.66 152.69 40.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.584 0.692 . . . . 0.0 110.866 -177.27 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.645 HG22 HG21 ' A' ' 153' ' ' ILE . 26.0 t -103.65 121.37 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.133 0.492 . . . . 0.0 111.077 -176.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.64 157.78 27.38 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.659 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.3 OUTLIER -73.8 140.06 45.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.001 0.429 . . . . 0.0 111.165 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.675 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -137.95 143.68 40.78 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.153 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.472 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 5.6 Cg_exo -80.87 135.73 10.18 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 123.226 2.617 . . . . 0.0 112.923 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.551 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 99.8 t -58.33 -44.83 99.57 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.6 Cg_endo -64.48 -0.95 3.35 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.036 1.824 . . . . 0.0 113.502 177.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.88 -6.36 21.42 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.746 0.308 . . . . 0.0 111.185 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.97 HG12 HG22 ' A' ' 130' ' ' THR . 17.3 m -128.58 156.07 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -168.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.493 ' HG3' ' CD1' ' A' ' 131' ' ' LEU . 21.8 mt-10 -119.7 125.64 49.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.008 166.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.411 ' HE3' ' HH2' ' A' ' 161' ' ' TRP . 28.2 mttp . . . . . 0 C--N 1.313 -1.017 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.47 ' HB ' HG13 ' A' ' 266' ' ' VAL . 20.3 t . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -100.08 112.88 25.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.907 0.384 . . . . 0.0 111.348 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -120.68 122.01 39.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.124 175.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.98 122.3 28.12 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -72.04 112.88 8.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.21 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.533 HG13 ' HG3' ' A' ' 244' ' ' GLN . 33.2 pt -89.28 -9.04 10.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.229 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 75.5 mt-30 -134.86 149.16 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -79.08 141.96 36.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.429 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.611 ' HD2' ' NE2' ' A' ' 290' ' ' HIS . 58.1 ttt85 -135.8 138.82 42.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.347 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.433 177.767 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 285' ' ' LEU . 2.6 m . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 121.377 0.608 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -76.85 115.54 16.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.749 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.615 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.6 tt -84.67 129.43 34.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.035 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -72.09 121.83 19.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.863 0.363 . . . . 0.0 110.597 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.538 HD22 HG22 ' A' ' 264' ' ' VAL . 96.0 mt -129.89 145.04 51.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 262' ' ' ASP . 8.7 mm-40 -101.0 161.4 13.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.141 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.26 119.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.3 64.26 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.511 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.739 ' HB2' ' HB2' ' A' ' 259' ' ' GLU . 24.7 t70 -85.81 146.18 26.88 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.673 0.273 . . . . 0.0 110.436 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.4 mm -92.69 106.51 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.758 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.538 HG22 HD22 ' A' ' 258' ' ' LEU . 16.3 t -83.97 107.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.501 177.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -87.96 92.43 9.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.45 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.63 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 3.8 p -88.29 134.35 28.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.889 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 58.9 p -103.79 -45.11 4.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -111.47 116.98 31.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 32.9 mtt -106.72 116.65 32.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.915 0.388 . . . . 0.0 111.121 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -82.92 152.13 25.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.25 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 8.6 mm -95.61 29.39 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.559 0.695 . . . . 0.0 110.259 -172.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.47 HD21 ' HG2' ' A' ' 274' ' ' GLN . 30.4 p-10 -113.35 -25.43 8.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.146 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 136.3 -23.6 3.3 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.142 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.47 ' HG2' HD21 ' A' ' 272' ' ' ASN . 14.3 pt20 -107.25 130.24 54.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.038 0.419 . . . . 0.0 110.263 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.443 ' HE3' ' CE2' ' A' ' 286' ' ' PHE . 5.8 m0 -118.75 169.64 9.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.245 -174.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -111.28 110.66 21.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.337 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -116.31 155.88 15.97 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 176.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.465 ' HB2' ' HE2' ' A' ' 283' ' ' LYS . 35.3 tt0 -108.0 109.46 20.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.384 0.592 . . . . 0.0 110.539 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.615 ' HB ' HD21 ' A' ' 256' ' ' LEU . 71.7 t -131.34 129.36 62.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 65.83 30.4 10.03 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.43 0.456 . . . . 0.0 110.982 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.53 9.29 86.12 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.825 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -118.71 123.02 43.86 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.705 -0.291 . . . . 0.0 110.779 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 83.4 mttt -94.13 111.64 23.39 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -132.81 168.72 22.74 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.817 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.43 ' H ' HG22 ' A' ' 254' ' ' THR . 87.8 mt -86.62 132.2 33.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.245 0.545 . . . . 0.0 110.82 -178.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.944 ' HB2' ' HE1' ' A' ' 290' ' ' HIS . 36.1 p90 -132.5 126.57 20.22 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.595 175.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.527 ' HD2' ' CE1' ' A' ' 290' ' ' HIS . 31.6 Cg_exo -61.21 161.29 23.54 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 123.04 2.493 . . . . 0.0 113.185 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -68.18 -33.73 74.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.183 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.3 p -81.7 17.88 1.37 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.944 ' HE1' ' HB2' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -143.45 8.35 1.56 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.071 -0.651 . . . . 0.0 112.097 176.271 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.32 161.09 37.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -139.9 119.93 13.63 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.752 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 240' ' ' ALA . 1.4 mp -72.64 117.89 16.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -115.35 143.73 44.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.424 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 C--N 1.32 -0.705 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.976 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.234 0.263 0 CA-C-O 120.745 0.307 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -138.31 89.16 2.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.03 0.443 . . . . 0.0 110.959 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -161.93 163.06 29.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 9' ' ' SER . 32.7 m-20 -82.3 -17.87 44.32 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.382 -173.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 70.28 -32.88 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.547 0.739 . . . . 0.0 111.48 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 7' ' ' ASP . 17.6 m -93.06 -23.27 18.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.95 100.74 4.22 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.431 -173.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.63 -26.36 68.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 104' ' ' ARG . 68.5 m -70.81 -4.78 25.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.488 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.22 -47.3 4.77 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 40.0 p-90 -111.54 -20.19 12.27 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -76.41 116.71 17.36 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.971 -0.455 . . . . 0.0 110.894 -173.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.612 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.5 mmt -98.14 -12.08 22.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.396 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.94 -113.0 1.89 Allowed Glycine 0 CA--C 1.521 0.45 0 O-C-N 123.852 0.72 . . . . 0.0 113.828 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.4 Cg_exo -69.92 84.33 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.041 2.494 . . . . 0.0 113.281 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.013 HG12 ' H ' ' A' ' 20' ' ' SER . 61.0 t -135.92 -162.16 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.013 ' H ' HG12 ' A' ' 19' ' ' VAL . 87.2 p -170.88 165.12 7.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -168.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.623 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 8.1 ptm85 -68.01 -31.71 71.59 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 118.872 -1.131 . . . . 0.0 110.851 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -59.16 -58.57 8.07 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.092 0.472 . . . . 0.0 110.387 176.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.63 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 35.7 mt-10 -64.95 -46.22 82.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.353 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.08 -43.75 78.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.833 -177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 67.8 mt-30 -69.5 -34.45 74.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.79 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 23' ' ' GLU . 11.5 t -78.65 -7.97 58.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.947 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.63 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 41.6 mtp180 -97.12 -10.54 25.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.048 0.452 . . . . 0.0 109.828 176.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 45.7 mt -114.27 -11.64 12.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.414 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -70.88 125.97 28.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.441 -178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.93 15.07 71.32 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.197 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HB3' ' CE ' ' A' ' 35' ' ' MET . 27.5 mm-40 -101.29 164.6 11.7 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 32' ' ' ARG . 19.4 ptt85 -61.21 130.87 48.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.212 0.529 . . . . 0.0 110.642 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.409 ' HA ' ' O ' ' A' ' 53' ' ' SER . 32.2 m170 -67.79 132.59 47.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.953 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.54 -20.29 7.4 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.682 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.738 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.9 mtm -75.01 136.85 41.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.412 ' CB ' HG22 ' A' ' 52' ' ' VAL . 50.0 p90 -139.16 168.21 20.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.294 -176.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.612 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -156.07 141.3 17.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.921 0.391 . . . . 0.0 110.755 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.436 ' HB ' ' CE3' ' A' ' 14' ' ' TRP . 61.6 t -114.07 124.93 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.617 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 19.2 ptt-85 -125.46 167.91 14.35 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.909 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.87 129.98 38.62 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.429 ' HB3' ' OG1' ' A' ' 43' ' ' THR . 61.8 m -68.78 147.22 52.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.559 0.695 . . . . 0.0 112.5 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.2 t -76.71 -14.29 59.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.426 175.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.429 ' OG1' ' HB3' ' A' ' 41' ' ' SER . 0.2 OUTLIER -76.3 -62.1 1.73 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.646 176.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 73.2 m -149.75 141.41 14.92 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.391 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 40.4 Cg_exo -59.35 -23.04 68.4 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.963 2.442 . . . . 0.0 112.258 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.25 37.38 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.647 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -156.86 148.32 22.33 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.419 ' CD2' HD11 ' A' ' 81' ' ' LEU . 29.0 m-85 -129.5 171.65 12.35 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 t -137.05 112.9 11.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.543 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.414 ' HB2' HD11 ' A' ' 63' ' ' ILE . 63.6 tp -82.22 92.44 6.91 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.79 171.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.2 m -95.59 120.59 36.11 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.627 HG12 ' HG3' ' A' ' 54' ' ' GLU . 88.2 t -112.76 141.78 27.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.552 -174.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 29.5 t -82.02 100.26 9.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.627 ' HG3' HG12 ' A' ' 52' ' ' VAL . 29.6 mt-10 -155.58 149.99 25.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.457 . . . . 0.0 112.142 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.598 ' HB2' ' OD2' ' A' ' 94' ' ' ASP . 0.1 OUTLIER 60.13 59.37 2.39 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.416 179.734 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 55' ' ' ASN . 32.8 t 70.98 -24.52 0.17 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.751 -174.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.711 ' CD ' ' H ' ' A' ' 58' ' ' VAL 0.405 0.0 OUTLIER -160.0 -53.39 0.06 Allowed 'General case' 0 C--N 1.363 1.156 1 N-CA-C 124.47 4.989 . . . . 0.0 124.47 -178.551 . . . . . . . . 5 4 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.711 ' H ' ' CD ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -154.24 116.84 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 121.671 2.032 . . . . 0.0 113.3 -171.741 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.576 ' OG ' ' HB2' ' A' ' 54' ' ' GLU . 6.0 m -97.8 110.54 23.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 164.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -94.01 110.13 21.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.946 ' HB3' HD11 ' A' ' 73' ' ' ILE . 69.1 m-85 -120.1 102.5 8.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.019 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.82 148.67 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.6 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.8 mp -129.67 86.47 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.07 131.94 47.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.881 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.8 t -77.45 125.26 29.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.265 0.555 . . . . 0.0 110.799 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.999 HD13 ' HB2' ' A' ' 69' ' ' ARG . 94.1 mt -76.0 147.57 80.56 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.12 169.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.505 ' HD2' HH21 ' A' ' 69' ' ' ARG . 35.8 Cg_exo -64.25 61.99 0.25 Allowed 'Trans proline' 0 C--O 1.218 -0.479 0 C-N-CA 122.762 2.308 . . . . 0.0 110.458 165.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.484 ' OD1' ' N ' ' A' ' 69' ' ' ARG 0.268 30.1 p30 103.66 -50.88 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 128.67 2.788 . . . . 0.0 109.467 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.999 ' HB2' HD13 ' A' ' 66' ' ' LEU . 73.1 mtm180 -34.45 -53.94 0.52 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 125.093 1.496 . . . . 0.0 112.137 -149.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.841 ' H ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -169.85 -167.11 0.62 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.184 1.794 . . . . 0.0 106.572 167.015 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.15 114.18 26.31 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.378 166.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 23.2 ttmm -102.51 104.78 15.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 111.339 -171.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.946 HD11 ' HB3' ' A' ' 61' ' ' TYR . 6.5 tt -92.49 77.53 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.773 0.797 . . . . 0.0 109.463 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.98 89.1 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.947 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.4 t0 75.48 -52.03 0.65 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.705 0.402 . . . . 0.0 110.877 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -83.16 114.84 21.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.643 0.258 . . . . 0.0 110.472 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.5 pm0 -93.38 133.03 37.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.386 0.612 . . . . 0.0 110.613 174.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.755 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 64.1 m-85 -121.0 158.23 28.22 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.837 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 4.3 m-20 -44.15 -41.23 5.54 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.514 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 3.4 p80 -170.46 -173.13 1.37 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 11.6 mt -57.83 -55.23 47.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 123.047 0.217 . . . . 0.0 111.339 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 32.1 Cg_exo -63.56 5.68 0.32 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.774 2.316 . . . . 0.0 114.005 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -107.54 -32.19 7.8 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.26 -0.275 . . . . 0.0 110.952 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.57 HD21 HD23 ' A' ' 81' ' ' LEU . 4.4 pp -76.15 -30.14 58.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.211 0.529 . . . . 0.0 109.739 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 53.5 mt -63.02 -32.41 73.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.943 176.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.639 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 24.3 tp10 -72.07 -26.8 62.31 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.544 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 91' ' ' HIS . 14.1 t80 -73.3 -29.3 62.61 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.053 0.93 . . . . 0.0 108.932 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.533 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 42.0 m-85 -92.39 2.67 56.52 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.338 -175.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.639 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 52.0 mtpt -85.65 -15.52 42.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.639 172.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.2 pt -122.74 -1.85 7.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 121.309 0.576 . . . . 0.0 110.091 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.4 t-160 -86.88 -43.78 12.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.841 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.459 ' CD2' HG23 ' A' ' 97' ' ' THR . 66.1 m-85 63.74 94.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -162.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.728 HD22 ' CE2' ' A' ' 61' ' ' TYR . 16.5 mt -51.53 -97.21 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 123.712 0.633 . . . . 0.0 110.564 176.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.598 ' OD2' ' HB2' ' A' ' 55' ' ' ASN . 3.2 t0 -68.04 -65.26 0.72 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.546 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 9.8 t -157.31 13.06 0.23 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.915 0.864 . . . . 0.0 110.228 175.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.49 HG22 ' OE1' ' A' ' 54' ' ' GLU . 6.5 t -140.65 171.72 13.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 169.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.459 HG23 ' CD2' ' A' ' 92' ' ' TYR . 17.8 p -98.02 171.55 8.19 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.042 -0.411 . . . . 0.0 110.619 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.4 94.26 0.72 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.1 mm -76.17 -53.78 14.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.802 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.738 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.9 pt-20 -167.92 154.57 7.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.632 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 42.3 Cg_endo -66.88 154.56 74.16 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.297 1.998 . . . . 0.0 112.737 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -72.61 161.05 81.15 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.323 175.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 9.6 Cg_endo -51.64 126.43 19.63 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.154 1.902 . . . . 0.0 110.971 176.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 12' ' ' SER . 40.7 ttt180 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.295 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.538 HD12 HG21 ' A' ' 152' ' ' ILE . 3.6 mm? . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 121.523 0.678 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.0 tp10 -177.57 -68.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.648 -172.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -112.92 106.96 15.36 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.332 0.587 . . . . 0.0 110.293 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.74 HG22 ' CG ' ' A' ' 180' ' ' LYS . 99.4 t -120.49 133.88 65.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.287 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.714 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 7.4 ptp180 -110.35 144.42 39.13 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.855 -1.938 . . . . 0.0 108.724 170.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.541 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -101.28 132.15 46.95 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.514 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.554 HD21 ' HG2' ' A' ' 179' ' ' GLU . 14.9 mt -107.4 -15.13 14.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.973 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.405 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 19.1 t80 -82.06 -40.97 21.23 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -173.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.635 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 11.3 t70 71.52 96.43 0.07 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.459 0.647 . . . . 0.0 110.603 -175.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -127.81 88.25 53.77 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 91.3 Cg_endo -84.85 79.02 2.51 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.075 1.85 . . . . 0.0 113.158 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.29 -23.94 77.51 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.381 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.856 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 4.3 m-20 67.38 50.8 0.92 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.452 0.701 . . . . 0.0 111.639 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.419 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 19.7 m-20 -144.5 178.96 7.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.387 . . . . 0.0 110.969 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.519 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -99.96 -9.41 22.78 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 171.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 172' ' ' MET . 4.8 mm-40 -80.87 -38.25 28.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.432 174.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 172' ' ' MET . 24.1 m-20 -133.88 108.67 8.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.945 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.054 HD11 ' HB2' ' A' ' 165' ' ' ASN . 35.4 tp -63.95 129.78 94.1 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.856 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 10.2 Cg_endo -81.21 87.53 1.47 Allowed 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 121.627 1.551 . . . . 0.0 111.088 175.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.49 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 10.2 p90 -100.63 159.83 14.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.527 -173.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.635 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 40.5 mttp -104.22 -172.44 2.11 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -174.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.954 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -85.23 8.55 17.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.334 -172.877 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.95 41.19 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.405 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -105.1 148.25 27.04 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.706 -177.431 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.64 132.84 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.331 0.586 . . . . 0.0 109.817 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.752 HD22 ' CD2' ' A' ' 142' ' ' LEU . 24.4 mt -125.85 162.31 25.43 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -176.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.631 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 99.0 t -125.44 122.08 61.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 175.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.073 HD13 ' HB2' ' A' ' 163' ' ' ALA . 34.0 mm -77.01 78.68 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.445 HG21 HG22 ' A' ' 170' ' ' VAL . 10.5 tt -78.34 -39.26 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.727 -176.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.654 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 63.1 mt-10 -116.54 140.27 49.57 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 171.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.531 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 78.4 tttt -136.71 86.93 21.18 Favored Pre-proline 0 C--N 1.316 -0.863 0 O-C-N 121.49 -0.756 . . . . 0.0 110.149 175.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.693 ' HG2' ' SD ' ' A' ' 172' ' ' MET . 4.3 Cg_exo -67.32 -55.53 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.614 2.209 . . . . 0.0 111.592 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 160' ' ' TRP . 17.4 mm-40 -107.17 167.94 9.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.814 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.431 ' O ' HG21 ' A' ' 175' ' ' VAL . 1.6 mm-40 -94.47 -16.35 23.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.153 0.502 . . . . 0.0 109.714 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.419 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 11.7 pt20 -94.21 -21.23 19.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.547 173.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.721 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 52.4 m95 -131.22 127.71 38.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.555 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.852 ' HB3' HD12 ' A' ' 152' ' ' ILE . 47.2 m0 -117.88 136.85 53.19 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.357 -176.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.683 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 74.5 m -100.46 90.38 4.28 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.073 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -102.44 149.4 24.41 Favored 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.48 -171.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.825 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 23.5 ptt-85 -86.75 119.35 26.89 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.054 ' HB2' HD11 ' A' ' 142' ' ' LEU . 6.0 t30 -46.59 166.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 112.374 -2.194 . . . . 0.0 111.213 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -68.57 10.71 0.23 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.64 0.733 . . . . 0.0 110.505 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 165' ' ' ASN . 18.5 m-20 -114.38 -6.68 12.91 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.798 172.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.37 67.87 1.54 Allowed Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.257 -172.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.825 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 8.7 ttm-85 -139.48 126.31 20.81 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.494 HG11 ' CD ' ' A' ' 154' ' ' GLU . 12.1 t -86.65 116.27 28.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.073 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -144.09 149.16 21.18 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.721 ' HE2' ' HB3' ' A' ' 160' ' ' TRP . 7.4 mtp -74.93 134.89 41.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.223 0.511 . . . . 0.0 110.583 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.779 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.5 pp -137.11 142.74 39.23 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.341 -176.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.602 ' HG2' ' CG ' ' A' ' 177' ' ' TYR . 9.7 Cg_endo -62.85 130.4 29.23 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.989 2.459 . . . . 0.0 113.152 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 178' ' ' VAL . 99.2 t -64.67 -44.91 75.35 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.167 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.524 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 48.6 Cg_exo -58.25 1.44 0.25 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.429 2.086 . . . . 0.0 114.104 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.602 ' CG ' ' HG2' ' A' ' 174' ' ' PRO . 3.2 m-85 -104.77 -10.53 17.36 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.34 0.256 . . . . 0.0 111.589 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.642 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.4 m -106.39 -171.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -165.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.714 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.1 tp10 -159.34 47.51 0.3 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.327 -1.761 . . . . 0.0 111.497 -154.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.74 ' CG ' HG22 ' A' ' 128' ' ' VAL . 1.9 mptt . . . . . 0 C--N 1.33 -0.24 0 O-C-N 119.297 -2.127 . . . . 0.0 110.469 -162.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.56 ' CG1' HD12 ' A' ' 293' ' ' ILE . 7.6 t . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 121.052 0.453 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.68 125.98 52.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.172 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.484 ' HB1' ' HB ' ' A' ' 291' ' ' VAL . . . -124.57 139.07 54.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.708 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.96 130.72 46.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.107 176.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -75.41 104.56 6.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.896 0.379 . . . . 0.0 110.18 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 21.0 pt -75.24 -13.0 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -146.94 157.82 43.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.308 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -73.27 158.71 34.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.429 0.633 . . . . 0.0 111.082 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.645 ' HD3' HD12 ' A' ' 258' ' ' LEU . 58.9 mtp85 -132.21 115.66 15.97 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.84 175.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.317 -0.829 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 172.204 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 120.784 0.325 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.0 116.83 23.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.48 133.64 49.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.938 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -95.77 135.48 37.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.675 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.645 HD12 ' HD3' ' A' ' 246' ' ' ARG . 96.7 mt -134.75 151.91 51.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 0.0 111.851 -169.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -97.67 172.98 7.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.392 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.69 122.53 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.893 0.378 . . . . 0.0 110.669 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.48 22.22 62.83 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.373 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -89.63 169.12 11.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.6 mm -106.58 116.0 49.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.325 0.584 . . . . 0.0 110.635 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.531 ' HA ' HG22 ' A' ' 279' ' ' VAL . 21.9 t -102.4 109.86 27.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.268 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.481 ' HB2' ' HE3' ' A' ' 265' ' ' LYS . 33.3 mtmt -87.2 99.73 12.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.013 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 5.8 p -90.15 116.48 31.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.593 0.711 . . . . 0.0 109.833 175.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 19.6 p -93.43 -36.31 12.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.321 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.563 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 56.5 ttt180 -121.56 96.9 5.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.832 175.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' MET . . . . . 0.45 ' HG3' ' NE1' ' A' ' 275' ' ' TRP . 45.7 ttm -81.81 111.54 18.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.059 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 91.6 m-20 -86.74 144.95 26.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.996 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 16.3 tt -79.46 -12.95 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.109 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -75.81 -25.47 56.36 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.725 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.19 -40.05 1.89 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.608 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 34.6 mt-30 -75.7 108.85 8.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.45 ' NE1' ' HG3' ' A' ' 269' ' ' MET . 52.8 m0 -93.39 145.43 24.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.857 0.361 . . . . 0.0 111.315 -176.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 9.0 tp10 -91.99 107.35 19.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.183 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -140.03 157.11 25.29 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.534 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -124.13 123.99 41.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.232 0.539 . . . . 0.0 110.043 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 264' ' ' VAL . 28.7 t -124.81 160.96 29.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.078 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -54.82 85.64 0.0 OUTLIER 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.559 0.695 . . . . 0.0 110.889 174.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 156.3 -39.69 0.58 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.375 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 282' ' ' ARG . 34.5 ttm180 179.69 152.89 0.45 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.1 0.476 . . . . 0.0 111.233 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -101.25 127.64 47.75 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.5 -169.41 35.84 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.68 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 97.4 mt -93.87 145.8 24.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.706 0.288 . . . . 0.0 110.376 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -141.73 127.48 10.91 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 121.083 0.468 . . . . 0.0 111.092 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.508 ' HD2' ' CZ ' ' A' ' 246' ' ' ARG . 72.4 Cg_exo -55.39 126.37 22.29 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 123.269 2.646 . . . . 0.0 112.449 169.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -64.75 -14.76 60.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.454 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 13.8 p -71.8 -2.43 17.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -113.79 0.19 14.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.175 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.484 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 28.5 m -128.28 168.99 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.011 0.434 . . . . 0.0 111.164 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -129.33 129.38 44.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.37 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.56 HD12 ' CG1' ' A' ' 238' ' ' VAL . 32.9 mm -81.16 126.25 39.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.259 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.23 157.05 40.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.947 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 121.431 0.634 . . . . 0.0 110.008 175.142 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 121.04 0.448 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -148.93 -53.02 0.17 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.686 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 p90 37.46 -162.35 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.632 1.208 . . . . 0.0 113.09 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.99 -44.91 19.37 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.046 -0.409 . . . . 0.0 110.861 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 t 72.5 -53.7 0.69 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.971 0.795 . . . . 0.0 111.87 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 m -84.47 -25.38 28.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.109 0.481 . . . . 0.0 110.946 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -86.74 116.91 25.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.063 0.459 . . . . 0.0 111.119 -171.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -63.54 -31.74 72.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.521 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.8 t -69.28 -8.28 44.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.23 -47.69 7.09 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.913 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -117.78 -23.38 7.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -170.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -73.65 116.01 13.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.619 ' HB3' HG21 ' A' ' 19' ' ' VAL . 12.4 tpp -100.71 -1.66 34.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.347 -172.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.96 -115.9 3.95 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.252 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.1 Cg_exo -72.4 103.28 1.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.9 2.4 . . . . 0.0 112.036 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.853 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 64.4 t -136.17 -83.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -176.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.796 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 11.7 t 83.6 176.47 0.06 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 168.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 7.8 tpt180 -42.16 -62.68 0.88 Allowed 'General case' 0 C--N 1.314 -0.944 0 O-C-N 124.112 0.883 . . . . 0.0 112.276 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -62.12 -28.53 69.7 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.05 -168.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -95.75 -45.55 6.95 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.561 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -55.54 32.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.504 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 12.3 pt20 -68.69 -31.26 70.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.829 -174.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.2 m -65.48 -42.95 91.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.42 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -71.22 -28.83 64.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.962 0.411 . . . . 0.0 111.239 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.079 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 17.4 mt -107.24 25.88 10.87 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.233 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -75.56 76.22 2.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.54 0.686 . . . . 0.0 109.9 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.41 -64.47 3.98 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.258 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 11.99 -108.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.208 1.403 . . . . 0.0 113.796 -172.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.415 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 18.7 ttp180 -111.06 143.88 41.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 53' ' ' SER . 36.5 m170 -94.6 140.99 29.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.73 23.21 12.26 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -173.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.569 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 41.7 mtm -115.58 143.34 45.47 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.758 0.313 . . . . 0.0 110.373 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.536 ' CG ' HD22 ' A' ' 98' ' ' LEU . 29.6 p90 -144.79 161.13 40.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.472 -176.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.1 pp -150.92 133.99 15.99 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.051 0.453 . . . . 0.0 110.415 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.51 113.78 38.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.853 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 12.1 ptt180 -114.29 168.83 9.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.08 128.21 33.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.3 t -85.0 163.1 19.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.27 0.557 . . . . 0.0 111.573 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 p -105.84 13.57 29.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.659 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.7 p -78.34 -52.71 8.2 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.128 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 47' ' ' ASP . 24.3 p -165.22 139.31 3.97 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.563 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.57 113.41 1.36 Allowed 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.918 2.412 . . . . 0.0 112.437 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 65' ' ' SER . . . 121.26 -20.34 8.46 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.528 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.5 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 32.4 t70 -86.37 152.14 22.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.411 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 35.7 m-85 -131.04 162.06 30.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.705 0.288 . . . . 0.0 110.991 -176.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.49 HG23 ' HB2' ' A' ' 41' ' ' SER . 56.6 t -137.67 112.02 9.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.017 0.436 . . . . 0.0 111.227 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 36' ' ' PHE . 30.9 tp -85.85 100.67 12.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.189 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 59' ' ' SER . 61.2 m -96.72 134.23 40.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.053 0.454 . . . . 0.0 110.44 175.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.734 HG21 HD13 ' A' ' 93' ' ' LEU . 96.4 t -123.59 149.5 27.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.102 -174.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 1.079 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 33.5 t -123.0 98.21 5.79 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.681 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 0.9 OUTLIER -133.9 139.93 46.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.025 172.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 55.39 29.32 12.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.695 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.4 m 64.94 31.46 11.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.702 0.763 . . . . 0.0 111.1 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -124.18 120.71 33.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.668 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 25' ' ' GLN . 19.2 t -88.31 93.98 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.199 0.523 . . . . 0.0 110.215 -178.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 38.6 m -74.39 118.24 17.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.787 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -102.16 94.38 5.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.467 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.698 ' CE2' HD22 ' A' ' 93' ' ' LEU . 27.6 m-85 -101.97 115.27 30.18 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.566 0.222 . . . . 0.0 111.355 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 69.0 mt -80.55 133.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.73 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.4 mp -108.23 120.97 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 5.4 t-20 -107.29 133.17 52.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -165.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 25.7 t -77.64 97.32 5.07 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.06 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.5 mt -66.82 151.55 96.66 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 17.2 Cg_exo -66.91 73.57 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.298 1.999 . . . . 0.0 112.339 177.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 67' ' ' PRO . 28.6 t-20 85.71 1.39 0.67 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.985 165.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -80.65 -85.17 0.09 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.737 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.546 ' HD2' ' HG3' ' A' ' 77' ' ' GLU . 8.4 ptp85 -158.41 -168.32 2.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.169 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.417 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 47.8 m-85 -104.3 115.51 30.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.151 0.501 . . . . 0.0 110.56 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' A' ' 75' ' ' ASP . 87.6 tttt -103.65 107.95 19.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.769 -176.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.73 ' HB ' HG13 ' A' ' 63' ' ' ILE . 5.8 tt -96.69 88.68 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.603 0.716 . . . . 0.0 110.627 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.99 79.28 0.13 Allowed Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.346 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.406 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 32.2 t70 73.36 -44.37 0.58 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.93 0.492 . . . . 0.0 112.016 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -66.39 148.49 51.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.059 0.457 . . . . 0.0 111.234 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.546 ' HG3' ' HD2' ' A' ' 70' ' ' ARG . 3.4 tp10 -110.42 116.81 32.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.166 -171.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 93.0 m-85 -131.73 141.99 49.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -76.46 -16.95 59.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.902 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 15.6 p80 -167.63 167.97 13.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.94 -0.118 . . . . 0.0 110.738 173.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.539 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 9.8 mt -52.46 -57.78 14.28 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 23.5 Cg_exo -67.53 13.66 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.35 2.033 . . . . 0.0 113.838 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -36.95 8.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.144 0.497 . . . . 0.0 109.981 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.5 pp -76.74 -27.84 55.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.657 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.73 -30.15 70.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.106 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.498 ' CD ' ' HZ2' ' A' ' 89' ' ' LYS . 29.8 mm-40 -83.1 -31.26 27.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.564 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -69.07 -39.52 79.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.939 0.4 . . . . 0.0 110.705 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.425 ' HE2' HD13 ' A' ' 73' ' ' ILE . 43.9 m-85 -77.7 -15.37 59.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.205 0.526 . . . . 0.0 110.598 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.498 ' HZ2' ' CD ' ' A' ' 86' ' ' GLU . 40.0 ttmt -66.81 -21.58 66.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.932 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.1 pt -116.42 18.43 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.937 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -111.24 -37.54 5.28 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.606 ' CD1' HG23 ' A' ' 97' ' ' THR . 54.7 m-85 71.11 102.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.786 0.679 . . . . 0.0 110.183 -173.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.734 HD13 HG21 ' A' ' 52' ' ' VAL . 2.9 mt -78.67 -19.32 52.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 110.728 -177.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.681 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 23.2 t70 -167.55 75.38 0.14 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.723 170.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 68.18 -22.69 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.133 0.973 . . . . 0.0 112.018 -176.545 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.563 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 18.9 m -117.39 154.29 31.59 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.606 HG23 ' CD1' ' A' ' 92' ' ' TYR . 14.1 p -95.21 -178.73 4.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.173 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.536 HD22 ' CG ' ' A' ' 36' ' ' PHE . 97.7 mt -69.98 88.54 0.58 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.468 HG22 ' HG3' ' A' ' 100' ' ' GLU . 33.2 mm -74.07 -65.04 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.237 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 35' ' ' MET . 46.1 mt-10 -144.32 153.79 56.33 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.202 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.3 151.87 80.09 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.18 1.92 . . . . 0.0 111.358 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -69.36 147.79 97.14 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.362 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 38.9 Cg_exo -61.32 116.92 3.71 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.628 2.219 . . . . 0.0 112.154 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.2 ttm180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.107 178.179 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.638 HD12 HG21 ' A' ' 152' ' ' ILE . 3.2 mm? . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.272 0.558 . . . . 0.0 111.98 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 7.3 tp10 62.45 -87.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.59 176.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -103.22 106.93 17.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.3 1.048 . . . . 0.0 112.253 -175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.581 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 55.9 t -119.6 162.25 18.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.779 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.576 HH11 ' HG2' ' A' ' 129' ' ' ARG . 0.8 OUTLIER -149.82 126.18 10.8 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.072 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.904 HG22 HG12 ' A' ' 178' ' ' VAL . 3.0 p -87.42 140.45 29.52 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -169.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 90.7 mt -110.63 -29.69 7.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.022 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 40.5 t80 -78.64 -30.48 46.42 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -170.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.543 ' HB2' ' HD3' ' A' ' 146' ' ' LYS . 14.1 t70 68.82 103.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.246 0.546 . . . . 0.0 110.185 -174.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 66.9 t80 -140.6 96.88 7.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.819 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 10.3 Cg_endo -92.29 100.79 0.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.048 2.499 . . . . 0.0 113.18 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 137' ' ' ASN . . . -96.41 2.59 63.07 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.855 174.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.61 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 3.7 m-20 73.81 -7.91 1.5 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.815 0.846 . . . . 0.0 111.552 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.917 ' HB2' ' HD3' ' A' ' 143' ' ' PRO . 32.5 t0 62.85 162.88 0.1 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 158.87 -34.44 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 111.625 -2.534 . . . . 0.0 104.382 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.33 31.24 0.06 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.629 -2.078 . . . . 0.0 107.694 166.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 172' ' ' MET . 9.4 p-10 -163.1 85.59 0.52 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.79 -175.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.066 HD11 ' HB2' ' A' ' 165' ' ' ASN . 33.7 tp -64.96 132.85 95.6 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.931 -168.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 1.013 ' HD2' HD12 ' A' ' 142' ' ' LEU . 68.1 Cg_endo -80.6 86.71 1.6 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.487 2.791 . . . . 0.0 111.906 175.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.526 ' CG ' HG21 ' A' ' 130' ' ' THR . 10.0 p90 -97.3 156.78 16.29 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.786 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.729 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 2.8 mptp? -105.89 -171.0 1.82 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.001 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.543 ' HD3' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -88.42 9.03 24.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.542 -177.776 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.99 27.12 0.63 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.312 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.729 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 5.9 mm-40 -98.5 150.78 21.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.83 0.315 . . . . 0.0 110.231 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.71 134.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.644 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 52.7 mt -119.68 155.8 31.7 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 42.5 t -122.0 126.48 74.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.84 HD13 ' HB2' ' A' ' 163' ' ' ALA . 32.9 mm -74.99 81.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.695 HG23 ' HG2' ' A' ' 154' ' ' GLU . 8.2 tt -69.01 -34.11 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.607 -173.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.695 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -131.49 139.66 49.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.214 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.546 ' HD2' HD11 ' A' ' 125' ' ' LEU . 74.3 tttt -119.7 86.0 34.34 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.021 0.438 . . . . 0.0 110.453 172.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 3.1 Cg_exo -77.26 -54.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.674 2.25 . . . . 0.0 111.682 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -109.17 -178.53 3.59 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -109.98 -22.58 11.77 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.115 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.561 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 24.3 pt20 -88.6 -21.72 23.88 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.101 0.476 . . . . 0.0 110.251 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.561 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 48.7 m95 -129.09 123.57 32.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.785 178.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.652 ' O ' HG13 ' A' ' 173' ' ' ILE . 38.2 m0 -112.53 133.58 54.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.319 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 54.0 m -86.26 99.71 11.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.26 0.553 . . . . 0.0 110.311 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.84 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.29 158.62 17.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.716 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 16.0 ptt-85 -104.61 135.42 46.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.039 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.066 ' HB2' HD11 ' A' ' 142' ' ' LEU . 55.5 t30 -73.87 -173.96 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.998 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -68.89 -13.88 62.7 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 170.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -81.99 -13.76 56.96 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.071 170.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.6 1.54 90.19 Favored Glycine 0 C--O 1.229 -0.182 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.502 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.718 ' HG2' ' OD2' ' A' ' 138' ' ' ASP . 38.5 ttm-85 -66.0 132.58 48.91 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.371 0.668 . . . . 0.0 110.069 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.48 HG21 HD13 ' A' ' 153' ' ' ILE . 59.5 t -104.62 106.4 20.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -173.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.627 ' HA3' ' OD1' ' A' ' 138' ' ' ASP . . . -140.98 168.34 25.35 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.266 175.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 26.0 mtp -81.35 136.85 35.76 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -132.68 149.96 74.46 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 2.9 Cg_exo -76.15 132.3 13.8 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.106 2.537 . . . . 0.0 112.577 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.679 ' O ' HG22 ' A' ' 178' ' ' VAL . 41.0 t -61.12 -45.59 95.97 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 30.8 Cg_endo -64.47 -1.09 3.49 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.027 1.818 . . . . 0.0 113.774 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.02 -4.48 29.87 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.744 0.307 . . . . 0.0 111.287 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.904 HG12 HG22 ' A' ' 130' ' ' THR . 6.1 m -120.57 163.46 18.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -167.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 160.73 21.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.521 172.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp . . . . . 0 C--N 1.321 -0.66 0 CA-C-O 120.679 0.276 . . . . 0.0 110.582 -173.302 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.532 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 35.3 t . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.86 115.26 27.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.165 0.507 . . . . 0.0 111.162 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.627 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.89 129.69 54.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.058 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -89.06 119.3 29.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.039 0.447 . . . . 0.0 110.498 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.917 ' HB1' ' HG2' ' A' ' 259' ' ' GLU . . . -78.42 119.56 21.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.675 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.635 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -109.5 -26.61 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -170.028 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.685 ' HG2' ' HG2' ' A' ' 245' ' ' LYS . 13.9 tt0 -93.92 -98.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.278 0.49 . . . . 0.0 111.339 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.685 ' HG2' ' HG2' ' A' ' 244' ' ' GLN . 24.4 pttm -175.45 107.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -177.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.567 ' H ' ' HB2' ' A' ' 259' ' ' GLU . 15.3 tpt180 -110.55 101.81 10.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.882 0.372 . . . . 0.0 111.491 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.879 173.634 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 121.125 0.488 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -88.46 127.94 35.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.038 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -81.01 120.8 25.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.899 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.35 117.24 5.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.113 0.482 . . . . 0.0 110.45 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.438 ' H ' ' HB3' ' A' ' 246' ' ' ARG . 86.5 mt -143.46 -169.67 3.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.714 0.768 . . . . 0.0 111.333 -172.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.917 ' HG2' ' HB1' ' A' ' 242' ' ' ALA . 26.4 mt-10 79.62 -179.36 0.09 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 113.683 -1.599 . . . . 0.0 114.265 164.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 t 67.12 32.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.91 -172.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.05 38.89 2.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.126 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.72 137.6 44.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.298 . . . . 0.0 110.94 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.2 mm -89.64 106.95 17.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.143 0.497 . . . . 0.0 109.93 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.425 HG22 HD22 ' A' ' 258' ' ' LEU . 40.0 t -88.47 118.29 33.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.699 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -90.06 97.44 11.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.516 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 7.5 p -91.66 129.19 42.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 110.5 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.1 p -106.11 -38.17 6.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.536 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.587 ' NE ' ' HA ' ' A' ' 268' ' ' ARG . 2.2 mmp_? -124.46 114.09 19.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 111.084 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 50.1 mtt -95.41 113.88 25.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.196 0.522 . . . . 0.0 110.312 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -85.21 164.25 18.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.431 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.4 pt -88.72 7.37 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.185 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -88.25 -4.72 58.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.533 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 94.64 -47.02 2.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.554 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.513 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 43.3 mt-30 -81.05 124.93 29.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.247 0.546 . . . . 0.0 110.207 173.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -94.18 158.49 15.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.349 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 268' ' ' ARG . 9.4 pt-20 -115.27 125.34 53.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.59 0.709 . . . . 0.0 110.486 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -134.1 170.6 22.48 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.925 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.3 108.49 11.76 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 26.9 t -126.41 138.38 54.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.122 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 23.2 m120 71.82 -55.37 0.66 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.829 0.851 . . . . 0.0 110.669 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 164.75 30.69 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -141.86 147.65 37.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -105.24 126.91 52.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.35 167.65 32.98 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.731 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 87.1 mt -95.38 142.04 28.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.687 0.279 . . . . 0.0 110.722 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 53.8 p90 -138.3 136.87 19.7 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.973 176.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 12.1 Cg_exo -71.9 141.7 37.5 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.737 2.292 . . . . 0.0 111.941 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -61.67 -15.82 43.39 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.284 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.2 t -86.22 -3.33 58.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 111.563 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -104.44 -11.15 17.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.774 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.488 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 26.9 m -128.04 158.44 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.956 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -121.09 120.15 34.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.607 178.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.627 HD13 ' HB2' ' A' ' 240' ' ' ALA . 47.3 mm -76.91 111.86 14.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.587 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -121.11 163.88 17.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.491 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 11.6 t0 . . . . . 0 C--N 1.325 -0.48 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.286 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.888 0.375 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.475 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 22.5 mmt180 -105.9 6.81 31.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.528 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.772 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 51.9 p90 -79.35 148.59 31.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 175.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -88.79 101.75 14.33 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.567 0.699 . . . . 0.0 110.635 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 50.6 m -63.82 169.9 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.567 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 8' ' ' SER . 43.0 t 76.73 -50.84 0.57 Allowed 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.593 0.558 . . . . 0.0 111.397 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.79 101.45 1.71 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.467 0.651 . . . . 0.0 110.342 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 75.6 mtt-85 -72.45 -17.28 61.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.568 -171.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -76.36 0.52 19.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.799 0.333 . . . . 0.0 110.836 173.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.58 -46.45 5.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.4 p-90 -115.39 -20.94 10.07 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -171.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 84.1 t80 -86.4 128.94 35.0 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.023 -0.423 . . . . 0.0 110.61 -176.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.541 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 20.1 mmt -109.43 -9.3 14.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 110.909 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.48 -116.6 4.87 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.629 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.86 105.44 0.55 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.558 2.172 . . . . 0.0 112.508 -175.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.696 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 79.2 t -139.02 -77.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.606 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.66 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 17.2 t 86.2 170.34 0.06 Allowed 'General case' 0 C--N 1.347 0.469 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -59.63 -39.4 84.19 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.512 -171.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.36 -38.62 91.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.559 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.618 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -85.72 -47.31 9.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.175 0.512 . . . . 0.0 110.775 -177.331 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.92 -40.56 76.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.656 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 52.0 tp60 -70.27 -39.61 74.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.0 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -78.87 -15.13 58.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.641 0.258 . . . . 0.0 111.43 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 90.8 mtt180 -83.57 -50.8 7.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.674 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.51 ' HA ' ' CG ' ' A' ' 31' ' ' GLN . 39.9 mt -94.22 13.36 23.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.052 -173.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 36.6 tt0 -71.08 87.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.103 0.478 . . . . 0.0 110.615 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.33 36.43 8.16 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.334 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.51 ' CG ' ' HA ' ' A' ' 28' ' ' LEU . 71.4 mm-40 -91.4 170.66 9.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 111.59 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -52.81 139.14 27.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.722 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.475 ' HB3' HG21 ' A' ' 96' ' ' THR . 39.1 m170 -70.03 116.41 10.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.949 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.45 -11.99 7.52 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.256 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 57.6 mtt -74.17 149.18 41.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.853 0.327 . . . . 0.0 110.562 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.611 ' HB2' HG22 ' A' ' 52' ' ' VAL . 23.2 p90 -157.16 166.48 33.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.319 177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.541 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -158.04 138.91 13.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.73 175.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.96 125.96 57.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.696 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 12.8 ptt-85 -123.12 162.16 23.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.77 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.29 127.58 32.88 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 172.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.659 ' HB2' HG23 ' A' ' 49' ' ' VAL . 18.8 t -101.34 154.27 18.94 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.188 0.518 . . . . 0.0 110.779 -174.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 p -91.69 -5.36 53.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.807 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -44.77 94.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.595 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.784 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 69.4 m -152.05 150.67 26.31 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.806 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.36 109.13 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.525 2.15 . . . . 0.0 111.658 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.96 0.26 55.02 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.455 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.784 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 13.4 t70 -85.92 151.38 23.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.813 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 35.0 m-85 -132.6 171.59 13.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.635 0.255 . . . . 0.0 110.964 -176.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 41' ' ' SER . 78.1 t -145.24 112.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.107 0.48 . . . . 0.0 110.515 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.417 ' HB2' HD11 ' A' ' 63' ' ' ILE . 42.6 tp -83.42 102.26 11.93 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.044 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 59' ' ' SER . 69.5 m -96.95 125.77 41.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.078 0.466 . . . . 0.0 110.391 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.611 HG22 ' HB2' ' A' ' 36' ' ' PHE . 70.2 t -125.25 138.59 53.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.675 -172.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 28' ' ' LEU . 33.3 t -102.89 98.51 8.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.207 0.527 . . . . 0.0 110.947 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.726 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 35.5 mt-10 -138.32 148.48 44.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.532 ' HB2' ' CG ' ' A' ' 94' ' ' ASP . 1.8 t-20 63.94 11.16 5.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.666 0.387 . . . . 0.0 111.111 -176.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.2 m 70.2 26.41 4.4 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.523 0.678 . . . . 0.0 110.367 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.846 ' NH2' ' HA ' ' A' ' 154' ' ' GLU . 43.8 ptt85 -124.34 151.58 44.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.9 t -93.37 97.49 7.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.037 0.446 . . . . 0.0 110.102 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 51' ' ' SER . 19.3 m -73.18 118.13 15.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.317 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -101.19 115.02 29.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.406 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.756 ' CE2' HD22 ' A' ' 93' ' ' LEU . 52.5 m-85 -121.93 108.01 12.93 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.433 HG12 HG22 ' A' ' 49' ' ' VAL . 58.8 mt -70.21 132.0 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.813 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.2 mp -104.72 123.86 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.352 1.061 . . . . 0.0 109.848 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -106.59 142.59 36.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -78.72 108.95 12.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.153 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 96.3 mt -85.82 170.91 11.63 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 26.2 Cg_exo -63.76 62.34 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.972 2.448 . . . . 0.0 114.263 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 13.2 m120 93.13 -43.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.986 0.914 . . . . 0.0 112.718 161.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.644 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.53 -29.4 33.56 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -169.413 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 1.052 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 81.6 mtt180 -148.07 177.65 9.2 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -169.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -129.7 120.69 25.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.522 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HB2' HD11 ' A' ' 66' ' ' LEU . 24.9 ttpp -98.31 112.59 24.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 61' ' ' TYR . 19.6 tt -77.48 78.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 122.158 0.98 . . . . 0.0 109.723 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.95 -55.8 4.54 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.085 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -146.8 -48.02 0.19 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.91 0.385 . . . . 0.0 110.581 -170.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -77.22 129.15 35.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.008 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.491 ' HG2' ' HD3' ' A' ' 70' ' ' ARG . 38.1 tt0 -99.45 130.15 45.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.026 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -128.53 160.79 31.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 1.052 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 36.5 m-20 -64.78 -45.47 86.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.455 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 6.0 p80 -153.27 177.12 11.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.504 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.645 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.2 mt -57.79 -57.87 22.5 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.645 ' HA ' HD12 ' A' ' 85' ' ' LEU . 30.5 Cg_exo -63.88 -6.71 11.51 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.012 1.808 . . . . 0.0 112.82 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.455 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -89.12 -31.73 17.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.645 0.26 . . . . 0.0 110.797 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.61 -30.32 56.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 82' ' ' PRO . 48.8 mt -68.04 -28.79 67.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.03 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.16 -23.94 63.07 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.049 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -86.67 -38.64 16.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.318 0.58 . . . . 0.0 110.435 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.502 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 45.1 m-85 -75.95 -7.75 55.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.878 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.466 ' HB3' ' HE2' ' A' ' 89' ' ' LYS . 30.7 ttpt -63.96 -33.1 74.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.573 173.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mt -110.32 -17.74 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.994 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 19.6 t-160 -69.79 -35.95 75.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.512 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.849 ' HA ' HG22 ' A' ' 97' ' ' THR . 97.2 m-85 71.61 101.61 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 124.083 0.865 . . . . 0.0 109.752 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.756 HD22 ' CE2' ' A' ' 61' ' ' TYR . 13.0 mt -70.83 -13.96 62.23 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.311 0.577 . . . . 0.0 109.649 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.726 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 21.5 t70 -152.56 -64.01 0.16 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.873 169.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.588 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 11.9 t -165.9 3.43 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 33' ' ' HIS . 13.0 t -133.38 -13.57 2.66 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.567 -0.708 . . . . 0.0 112.162 176.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.849 HG22 ' HA ' ' A' ' 92' ' ' TYR . 16.7 p 71.13 -179.49 0.23 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.379 1.072 . . . . 0.0 112.131 178.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.42 HD22 ' CD2' ' A' ' 36' ' ' PHE . 65.8 mt -71.34 109.26 5.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.267 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.3 mm -101.19 -52.39 8.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.059 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.772 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 17.1 pt-20 -154.84 164.16 21.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.619 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.591 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 98.4 Cg_endo -82.81 151.13 14.48 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.919 1.746 . . . . 0.0 112.119 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.425 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -75.15 153.16 86.35 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.91 175.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.63 120.36 7.72 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.5 2.133 . . . . 0.0 111.349 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 110.989 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.946 HD12 HG21 ' A' ' 152' ' ' ILE . 4.3 mm? . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 30.1 tt0 -165.65 -66.72 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -110.94 118.04 35.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.616 0.722 . . . . 0.0 112.006 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.487 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 55.5 t -130.92 159.57 42.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.701 -175.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 129' ' ' ARG . 19.6 mtt180 -131.6 145.29 51.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.866 HG22 HG12 ' A' ' 178' ' ' VAL . 12.3 p -102.51 136.4 42.4 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.724 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 179' ' ' GLU . 5.3 mt -107.68 -27.67 10.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.901 -174.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.479 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 44.6 t80 -86.4 -37.27 18.55 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -170.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.527 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 14.4 t70 70.8 108.04 0.06 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.529 0.681 . . . . 0.0 109.844 -170.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 70.3 t80 -147.06 113.19 4.17 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.401 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.734 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 30.2 Cg_endo -92.16 100.41 0.19 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.711 2.274 . . . . 0.0 112.422 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -85.31 14.4 50.47 Favored Glycine 0 CA--C 1.516 0.095 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.174 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 50.23 24.16 1.39 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.116 0.566 . . . . 0.0 112.447 -172.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.563 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 2.3 p30 46.86 -170.07 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.909 1.284 . . . . 0.0 114.157 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 75.76 -26.72 0.19 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.856 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.5 pt-20 -142.1 -30.56 0.57 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.07 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.488 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 5.6 m-20 -141.36 117.65 10.73 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.837 HD11 ' HB3' ' A' ' 165' ' ' ASN . 36.3 tp -67.81 136.25 92.38 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-O 120.718 0.294 . . . . 0.0 111.487 -173.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.734 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 1.0 OUTLIER -84.94 102.46 0.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.835 2.357 . . . . 0.0 110.661 172.646 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.673 ' CG ' HG21 ' A' ' 130' ' ' THR . 6.6 p90 -111.76 158.91 18.79 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.186 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.527 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -99.23 -179.43 4.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.756 -172.463 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -4.71 39.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -171.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.93 42.71 0.2 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.643 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -98.83 165.74 11.63 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.408 HD12 ' HE ' ' A' ' 129' ' ' ARG . 34.9 mm -99.9 138.38 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.521 HD22 ' HA ' ' A' ' 165' ' ' ASN . 29.4 mt -120.26 155.62 32.86 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 25.9 t -118.81 125.15 74.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.946 HG21 HD12 ' A' ' 125' ' ' LEU . 41.7 mm -75.13 95.84 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.265 1.031 . . . . 0.0 108.62 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.849 HG23 ' HG3' ' A' ' 154' ' ' GLU . 19.8 tt -89.71 -27.21 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.003 -171.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.919 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 27.0 mt-10 -142.75 144.47 32.65 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.945 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 7.1 ttpm? -135.62 81.01 42.83 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 121.424 -0.798 . . . . 0.0 111.26 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.588 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 19.9 Cg_exo -68.23 -46.07 2.4 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.787 2.325 . . . . 0.0 112.298 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -117.99 -175.22 2.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.541 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.56 -28.53 9.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.041 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.515 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 30.0 pt20 -93.84 -13.2 27.53 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.197 0.522 . . . . 0.0 110.515 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.76 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 51.6 m95 -129.28 127.81 41.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.733 175.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.687 ' O ' HG13 ' A' ' 173' ' ' ILE . 48.9 m0 -118.16 140.62 49.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.43 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.919 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 7.6 t -96.15 99.38 11.12 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.77 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -114.05 156.33 24.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.869 0.366 . . . . 0.0 111.464 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.486 ' HD3' HD12 ' A' ' 153' ' ' ILE . 26.7 ptt-85 -100.41 131.56 46.26 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.837 ' HB3' HD11 ' A' ' 142' ' ' LEU . 11.3 p-10 -79.58 171.38 15.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.871 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -72.37 -12.21 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.161 0.505 . . . . 0.0 110.314 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.533 ' HB3' HD22 ' A' ' 165' ' ' ASN . 5.6 t70 -80.13 -19.34 47.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.931 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.14 7.2 12.83 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 116.696 1.438 . . . . 0.0 116.696 169.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.645 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -123.52 155.79 36.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.511 1.655 . . . . 0.0 111.903 -177.785 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.92 143.8 11.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.106 -175.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -166.23 161.43 35.07 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.76 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.2 OUTLIER -74.23 137.95 43.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.845 0.355 . . . . 0.0 110.968 179.263 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -135.24 143.73 46.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.371 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 3.9 Cg_exo -77.01 134.04 14.21 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.7 2.267 . . . . 0.0 112.096 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.564 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 17.8 t -62.85 -43.45 82.84 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.078 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 34.5 Cg_endo -65.9 7.44 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 122.283 1.989 . . . . 0.0 113.651 175.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.0 m-85 -109.09 -6.56 15.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.697 0.284 . . . . 0.0 111.097 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.866 HG12 HG22 ' A' ' 130' ' ' THR . 26.3 m -127.62 166.46 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -168.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.681 ' HB2' HD21 ' A' ' 131' ' ' LEU . 4.1 mm-40 -125.41 163.75 21.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.577 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.62 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.05 125.71 53.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.139 0.495 . . . . 0.0 110.804 -174.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.748 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -127.59 131.78 49.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.883 176.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -86.99 125.43 34.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.574 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -78.2 104.1 8.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.228 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.606 HG13 ' HG3' ' A' ' 244' ' ' GLN . 29.1 pt -83.14 -11.89 12.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.072 0.463 . . . . 0.0 111.229 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.606 ' HG3' HG13 ' A' ' 243' ' ' ILE . 70.9 mt-30 -124.68 165.27 18.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.463 ' HB3' HG13 ' A' ' 260' ' ' VAL . 24.4 pttm -128.72 144.4 51.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.129 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.86 150.51 4.69 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.744 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 CA--C 1.535 0.383 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.822 -172.122 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 122.819 1.295 . . . . 0.0 107.943 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 285' ' ' LEU . . . -8.62 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 111.311 -2.677 . . . . 0.0 113.262 152.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.58 ' O ' ' HG ' ' A' ' 258' ' ' LEU . 1.7 tt -75.12 118.79 18.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.53 ' H ' ' NH1' ' A' ' 282' ' ' ARG . . . -55.97 121.42 9.28 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 123.477 0.485 . . . . 0.0 110.527 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 256' ' ' LEU . 96.2 mt -136.18 136.54 40.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.785 -175.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -98.89 -176.68 3.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.316 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' A' ' 245' ' ' LYS . 17.5 m -86.79 132.64 31.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.956 0.408 . . . . 0.0 110.683 176.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 86.06 0.7 87.06 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.518 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.55 152.99 25.75 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.738 0.304 . . . . 0.0 110.724 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.7 mm -97.79 114.7 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.461 HG22 HD22 ' A' ' 258' ' ' LEU . 21.2 t -97.15 107.63 20.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.626 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -93.56 114.53 26.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 11.6 p -88.37 143.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.969 0.414 . . . . 0.0 110.677 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 30.0 m -98.74 -49.02 4.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.89 0.376 . . . . 0.0 110.266 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.515 ' HG3' ' HB3' ' A' ' 276' ' ' GLU . 3.3 ptp180 -132.45 118.84 19.83 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.096 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 47.1 mtt -89.62 110.8 21.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.128 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -131.62 139.7 49.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.415 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 52.3 mt 56.81 84.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.84 168.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 60.37 -29.14 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 166.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.626 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 165.24 -7.55 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.624 -1.274 . . . . 0.0 114.038 -177.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -85.78 77.05 9.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.558 0.679 . . . . 0.0 109.634 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.458 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 23.3 m0 -93.25 158.77 15.58 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.273 -170.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.515 ' HB3' ' HG3' ' A' ' 268' ' ' ARG . 40.9 tt0 -113.87 116.09 28.75 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.45 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.05 170.96 16.29 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.491 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.02 109.17 13.19 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.48 -86.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.531 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.12 66.98 8.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.188 0.518 . . . . 0.0 111.771 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 72.8 -2.49 32.51 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.456 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.53 ' NH1' ' H ' ' A' ' 257' ' ' ALA . 2.5 ptm180 -142.44 153.71 43.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.874 0.368 . . . . 0.0 110.983 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 20.3 pttp -104.48 142.01 35.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.766 173.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -160.19 -178.9 34.6 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.56 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.661 ' O ' ' HA ' ' A' ' 255' ' ' ALA . 91.3 mt -95.98 140.31 30.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.615 0.245 . . . . 0.0 110.961 -177.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 40.1 p90 -140.38 140.33 22.74 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 4.1 Cg_exo -79.85 142.79 16.02 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.702 2.268 . . . . 0.0 111.505 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.626 ' CD1' ' HA3' ' A' ' 273' ' ' GLY . 21.1 p90 -65.97 -15.43 62.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.9 m -77.54 -16.15 58.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.391 0.615 . . . . 0.0 110.541 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -86.81 -24.09 25.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.379 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 242' ' ' ALA . 30.4 m -127.7 178.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.663 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -140.56 119.42 12.58 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.748 HD13 ' HB2' ' A' ' 240' ' ' ALA . 39.3 mm -60.43 122.36 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.812 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -145.83 179.71 7.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.843 -173.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.35 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.646 ' HB3' ' HE3' ' A' ' 89' ' ' LYS . . . . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.772 0.32 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -123.66 94.7 4.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.998 -177.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -156.56 154.08 29.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.235 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -75.44 91.88 2.8 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.987 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 14.4 t -74.86 68.71 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.204 0.526 . . . . 0.0 110.068 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 t -179.62 -44.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.445 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -59.34 105.64 0.37 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.007 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 7.6 tpp180 -60.29 -32.35 71.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.549 -174.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.4 m -82.57 -1.36 50.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.644 0.259 . . . . 0.0 111.57 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.49 -45.61 8.05 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.326 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -117.94 -29.4 5.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.458 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 65.0 t80 -79.62 113.04 17.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.133 0.492 . . . . 0.0 110.696 -176.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.514 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 23.1 mmt -94.66 -2.86 50.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.051 -175.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.07 -114.21 3.09 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.663 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.63 96.75 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.015 2.477 . . . . 0.0 113.042 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.921 HG12 ' H ' ' A' ' 20' ' ' SER . 7.4 t -142.62 -161.15 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.921 ' H ' HG12 ' A' ' 19' ' ' VAL . 23.2 t 178.32 177.46 0.43 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -170.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.0 mtp85 -54.58 -61.6 2.2 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.75 -44.54 95.93 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.279 0.362 . . . . 0.0 111.336 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.465 ' HA ' HG22 ' A' ' 26' ' ' THR . 40.3 mt-10 -62.17 -47.51 84.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.345 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.85 -34.45 69.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 0.0 111.281 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.679 ' HG3' HG21 ' A' ' 58' ' ' VAL . 5.4 tt0 -81.88 -34.66 29.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.051 -175.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 23' ' ' GLU . 11.3 t -82.46 -14.7 54.63 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -104.39 -18.6 14.36 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.773 0.797 . . . . 0.0 110.878 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.788 HD13 ' HB2' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -132.54 33.01 3.83 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 123.647 1.689 . . . . 0.0 108.095 -174.281 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -58.18 177.52 0.12 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.229 173.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.454 ' HA2' ' OG ' ' A' ' 53' ' ' SER . . . -73.58 53.02 1.96 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.813 -176.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -78.31 -38.17 42.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.415 0.626 . . . . 0.0 109.893 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 22.7 ttp180 -144.67 128.46 17.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.57 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 63.9 m170 -83.84 132.54 34.8 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.903 0.382 . . . . 0.0 110.607 -176.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.34 10.93 22.9 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.695 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.681 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.0 mtm -97.96 147.36 24.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.45 ' CD2' HD22 ' A' ' 98' ' ' LEU . 41.7 p90 -143.53 163.04 34.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.025 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.575 HD23 ' CB ' ' A' ' 28' ' ' LEU . 4.1 pp -150.36 134.3 16.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.968 0.413 . . . . 0.0 110.175 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.6 t -102.27 123.33 55.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.879 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 22.6 ptt-85 -126.57 153.42 45.27 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.571 -172.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 38.2 t70 -75.89 107.95 8.43 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 170.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.519 ' HB2' HG23 ' A' ' 49' ' ' VAL . 13.3 t -79.42 178.22 8.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.679 -168.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.8 m -125.12 17.55 8.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.951 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.46 -47.94 14.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.25 0.547 . . . . 0.0 109.584 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.3 m -144.18 152.93 55.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.296 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.69 87.19 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.139 1.893 . . . . 0.0 111.674 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.52 15.57 2.97 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.967 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.98 155.09 19.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.289 0.544 . . . . 0.0 109.802 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.419 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 44.8 m-85 -127.2 159.91 32.86 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 62' ' ' ILE . 40.6 t -135.03 108.69 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.117 175.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.63 103.15 7.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.478 173.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 59' ' ' SER . 70.9 m -95.67 135.37 37.45 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.136 177.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 93' ' ' LEU . 92.8 t -127.73 134.38 65.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.579 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.454 ' OG ' ' HA2' ' A' ' 30' ' ' GLY . 29.2 t -100.28 112.42 24.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.744 0.307 . . . . 0.0 111.327 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.57 ' OE1' ' HB3' ' A' ' 33' ' ' HIS . 10.6 tp10 -157.34 140.76 15.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.176 175.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.1 m120 48.3 39.38 12.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.469 0.707 . . . . 0.0 112.899 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.9 m 66.98 18.44 10.58 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.1 173.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 57' ' ' ARG . 14.6 ptt180 -124.51 133.19 53.4 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.679 HG21 ' HG3' ' A' ' 25' ' ' GLN . 46.0 t -93.69 97.23 6.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.747 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 25.3 m -68.99 117.66 10.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.328 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -101.26 92.56 5.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.95 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.695 ' CE2' HD22 ' A' ' 93' ' ' LEU . 37.4 m-85 -97.15 114.85 26.59 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.951 0.157 . . . . 0.0 111.056 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.779 HG12 HG22 ' A' ' 49' ' ' VAL . 28.8 mt -81.99 135.98 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -175.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.764 HG13 ' HB ' ' A' ' 73' ' ' ILE . 5.3 mp -117.38 123.81 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.292 1.037 . . . . 0.0 109.692 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -106.25 135.49 47.63 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.06 -0.4 . . . . 0.0 110.263 -173.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.0 t -80.29 108.63 14.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.006 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.6 mt -80.62 142.91 53.9 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.22 -17.97 49.27 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.728 2.286 . . . . 0.0 112.014 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -82.52 10.36 7.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.06 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 67.96 29.55 6.45 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.609 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -116.95 159.68 22.08 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.409 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 46.7 m-85 -118.84 115.55 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.188 0.518 . . . . 0.0 111.612 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 21.5 ttmm -104.15 109.02 20.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.027 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.764 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.6 tt -96.47 87.52 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.75 0.786 . . . . 0.0 110.557 177.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.98 75.74 0.43 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.901 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 t0 76.25 -52.69 0.61 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.111 0.564 . . . . 0.0 111.507 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -70.56 111.8 6.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.45 0.643 . . . . 0.0 110.41 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 8.6 pt-20 -95.68 128.91 42.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.938 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.547 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 89.3 m-85 -119.19 175.08 5.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.683 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.28 -51.05 63.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.18 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -156.2 -177.57 6.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.486 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.6 mt -56.62 -54.56 52.4 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.546 ' HA ' HD12 ' A' ' 85' ' ' LEU . 52.9 Cg_exo -58.77 -10.38 9.4 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.132 1.888 . . . . 0.0 113.614 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.21 -34.93 16.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.677 0.275 . . . . 0.0 110.919 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.8 pp -76.24 -27.03 56.61 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 82' ' ' PRO . 61.3 mt -67.89 -24.23 65.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.821 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 48.8 mt-10 -91.02 -9.41 46.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.762 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.682 ' HE1' ' CZ ' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -97.8 -29.66 13.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 176.025 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.682 ' CZ ' ' HE1' ' A' ' 87' ' ' PHE . 26.7 m-85 -78.03 -13.28 59.93 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.787 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.646 ' HE3' ' HB3' ' A' ' 4' ' ' ALA . 21.7 ptmt -74.01 -16.68 61.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.588 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.503 HD13 ' H ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -116.77 25.35 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.937 169.385 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -114.06 -41.62 3.5 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.248 -0.282 . . . . 0.0 111.662 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.599 ' CD1' HG23 ' A' ' 97' ' ' THR . 93.4 m-85 73.16 96.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.96 0.788 . . . . 0.0 110.624 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.695 HD22 ' CE2' ' A' ' 61' ' ' TYR . 2.2 mt -74.57 -13.89 60.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.062 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 95' ' ' THR . 20.0 t70 -172.45 63.02 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.609 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER 74.05 -25.15 0.2 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.114 -175.198 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 94' ' ' ASP . 41.7 m -114.52 146.18 41.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.599 HG23 ' CD1' ' A' ' 92' ' ' TYR . 16.7 p -90.97 -176.03 4.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.408 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.45 HD22 ' CD2' ' A' ' 36' ' ' PHE . 82.2 mt -69.61 96.39 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 38.5 mm -84.39 -55.08 7.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.031 0.443 . . . . 0.0 110.525 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.681 ' O ' ' HA ' ' A' ' 35' ' ' MET . 45.6 tt0 -162.32 141.75 7.24 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.454 -177.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.415 ' HD2' ' HG3' ' A' ' 100' ' ' GLU . 12.1 Cg_endo -56.66 153.23 37.17 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.738 2.292 . . . . 0.0 112.914 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.788 ' HB2' HD13 ' A' ' 28' ' ' LEU . . . -73.58 153.84 89.64 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.598 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.24 115.22 2.42 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.448 2.098 . . . . 0.0 112.22 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.206 177.646 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.803 HD12 HG21 ' A' ' 152' ' ' ILE . 3.4 mm? . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 12.7 pt-20 -170.09 -59.14 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.073 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.482 ' H ' ' HG3' ' A' ' 126' ' ' GLU . 15.1 m-85 -102.01 108.76 20.29 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.704 0.764 . . . . 0.0 111.666 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 65.0 t -130.18 154.98 41.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.057 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -135.74 137.6 41.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.848 0.356 . . . . 0.0 110.108 175.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.956 HG22 HG12 ' A' ' 178' ' ' VAL . 31.4 p -90.28 137.32 32.45 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.236 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.9 mt -113.19 -24.59 9.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.519 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 44.4 t80 -89.3 -34.77 16.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 27.1 t70 76.62 122.35 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.89 0.744 . . . . 0.0 111.171 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 80.9 t80 -156.98 107.59 1.93 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.781 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 57.5 Cg_endo -87.52 97.55 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.594 2.196 . . . . 0.0 112.651 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.581 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -87.57 -6.51 77.03 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.077 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.84 22.76 12.8 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.998 0.519 . . . . 0.0 111.932 -175.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.674 ' CB ' ' HD3' ' A' ' 169' ' ' ARG . 2.4 p30 54.94 -173.37 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 168.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 77.48 -34.93 0.21 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 113.341 -1.754 . . . . 0.0 109.785 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 172' ' ' MET . 33.9 tt0 -133.69 -29.47 1.33 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.139 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.581 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 22.4 m-20 -138.26 111.39 7.89 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.049 HD11 ' HB2' ' A' ' 165' ' ' ASN . 25.9 tp -66.22 119.6 63.26 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 120.562 0.22 . . . . 0.0 110.612 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.561 ' HD2' ' HD2' ' A' ' 169' ' ' ARG . 29.2 Cg_endo -71.98 105.03 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.895 1.73 . . . . 0.0 111.335 174.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.629 ' CG ' HG21 ' A' ' 130' ' ' THR . 7.8 p90 -115.23 163.85 15.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 -177.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -97.2 -170.51 2.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.14 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.72 11.18 29.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.193 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.71 39.84 0.2 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.476 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -105.23 155.11 19.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.747 0.273 . . . . 0.0 110.453 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.39 137.43 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 165' ' ' ASN . 43.4 mt -125.42 160.71 28.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 22.0 t -122.83 131.67 72.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.803 HG21 HD12 ' A' ' 125' ' ' LEU . 32.7 mm -74.02 91.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.984 0.897 . . . . 0.0 109.433 -175.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.778 HG23 ' HG2' ' A' ' 154' ' ' GLU . 0.6 OUTLIER -74.61 -45.39 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.891 -176.256 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.778 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -129.81 139.94 51.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 174.11 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.712 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 0.7 OUTLIER -126.86 86.81 57.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.989 174.766 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.609 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 7.3 Cg_exo -77.4 -61.61 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.063 2.509 . . . . 0.0 113.64 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -97.05 -175.36 3.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 0.0 111.867 -169.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -90.32 -52.53 4.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.67 -178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -96.1 0.18 51.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.966 0.412 . . . . 0.0 110.915 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.664 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 57.0 m95 -129.53 124.71 34.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.159 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.687 ' O ' HG13 ' A' ' 173' ' ' ILE . 51.5 m0 -121.91 145.47 48.06 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.5 m -100.24 99.72 10.44 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.144 0.497 . . . . 0.0 109.742 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.618 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -105.45 160.9 14.79 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.131 -176.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.751 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 22.3 ptt-85 -101.32 128.95 47.25 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.501 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.049 ' HB2' HD11 ' A' ' 142' ' ' LEU . 66.7 t30 -65.52 164.14 14.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.097 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 15.3 tptp -67.86 -11.47 58.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.454 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.99 -4.53 46.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.939 0.4 . . . . 0.0 110.448 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.28 75.28 1.28 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.393 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.751 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 5.4 ttm-85 -155.36 135.07 12.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.359 0.123 . . . . 0.0 111.117 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.55 HG22 HG21 ' A' ' 153' ' ' ILE . 66.5 t -103.3 117.82 49.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.792 0.33 . . . . 0.0 111.361 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.44 166.92 30.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.866 173.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.664 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -79.72 138.35 37.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.702 0.287 . . . . 0.0 110.829 179.498 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -137.71 145.44 48.7 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.461 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 6.3 Cg_exo -80.28 136.81 11.56 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.95 2.433 . . . . 0.0 112.873 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.54 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 98.8 t -64.08 -42.62 70.22 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.436 177.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 37.4 Cg_endo -67.49 10.75 0.25 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.015 1.81 . . . . 0.0 113.06 175.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' A' ' 175' ' ' VAL . 3.3 m-85 -113.65 -5.93 13.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.716 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.956 HG12 HG22 ' A' ' 130' ' ' THR . 20.2 m -132.18 163.84 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.425 0.631 . . . . 0.0 112.614 -167.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -128.47 161.35 29.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.815 172.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 180' ' ' LYS . 3.2 mppt? . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.266 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.411 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 21.6 t . . . . . 0 CA--C 1.512 -0.511 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.739 ' HE1' HG23 ' A' ' 263' ' ' ILE . 0.1 OUTLIER -118.29 123.04 44.41 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.087 -171.127 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.585 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -124.62 158.69 32.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.098 0.475 . . . . 0.0 112.082 -170.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.735 ' HE3' ' HA2' ' A' ' 261' ' ' GLY . 54.4 tttp -102.23 130.85 49.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.498 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -75.44 104.68 6.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.551 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.864 HD12 ' HG3' ' A' ' 244' ' ' GLN . 2.7 pp -82.45 -15.44 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.226 0.536 . . . . 0.0 110.833 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.864 ' HG3' HD12 ' A' ' 243' ' ' ILE . 73.4 mt-30 -123.98 -172.05 2.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.229 172.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -124.5 169.42 11.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.521 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 57.6 mtp85 -148.78 125.85 11.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.342 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.487 173.432 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -81.2 128.4 33.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.654 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.58 127.28 31.96 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 172.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -83.33 117.84 23.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.083 0.468 . . . . 0.0 109.96 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.594 HD21 HG21 ' A' ' 279' ' ' VAL . 58.2 mt -131.81 160.18 36.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.915 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 262' ' ' ASP . 48.6 mt-10 -132.8 167.88 19.38 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.01 131.11 31.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.331 0.586 . . . . 0.0 111.291 -175.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.735 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 92.17 3.88 67.17 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.205 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 0.7 OUTLIER -85.38 160.01 19.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.943 0.401 . . . . 0.0 110.722 -175.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.739 HG23 ' HE1' ' A' ' 239' ' ' PHE . 18.5 mm -95.61 123.36 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.494 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.51 96.72 4.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.131 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -79.71 87.28 5.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 275' ' ' TRP . 2.4 p -87.01 118.12 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.871 0.843 . . . . 0.0 111.133 -175.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.5 m -103.09 -18.44 14.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.761 -171.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.779 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 36.2 ttm-85 -129.97 103.52 6.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.772 0.32 . . . . 0.0 110.915 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' MET . . . . . 0.411 ' HE3' ' HB ' ' A' ' 238' ' ' VAL . 58.5 mtt -102.98 118.68 37.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.875 0.369 . . . . 0.0 110.412 178.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -86.51 1.57 51.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 75.1 mt 74.51 -39.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.398 0.679 . . . . 0.0 112.581 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -63.16 -16.3 59.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 129.96 -27.4 4.08 Favored Glycine 0 CA--C 1.506 -0.501 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.647 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -85.02 113.45 21.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.04 0.447 . . . . 0.0 109.959 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.571 ' HB3' HG21 ' A' ' 266' ' ' VAL . 51.2 m0 -109.42 145.07 36.76 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.084 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.779 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 41.9 tt0 -100.97 114.92 29.26 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.96 149.58 18.16 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.297 -176.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -121.52 108.99 14.27 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.594 HG21 HD21 ' A' ' 258' ' ' LEU . 42.1 t -115.82 -98.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.245 -175.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -99.81 82.89 2.66 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.655 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.7 5.81 32.9 Favored Glycine 0 CA--C 1.517 0.167 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.202 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.404 ' NH1' ' H ' ' A' ' 257' ' ' ALA . 56.4 mtp180 -128.06 129.08 46.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.852 0.358 . . . . 0.0 110.977 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 28.6 ttpp -115.32 111.2 20.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.223 174.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -143.48 -174.66 15.93 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.052 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.14 144.59 27.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.144 0.497 . . . . 0.0 111.5 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.558 ' HE2' HG21 ' A' ' 291' ' ' VAL . 44.3 p90 -148.64 142.57 16.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.683 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 3.2 Cg_exo -77.2 145.21 24.12 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.539 2.16 . . . . 0.0 111.632 176.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -62.96 -14.73 50.89 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.577 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.3 p -72.24 -8.66 56.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -107.56 -8.36 16.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.482 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.558 HG21 ' HE2' ' A' ' 286' ' ' PHE . 34.9 m -128.62 164.29 31.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.832 ' HG2' HG12 ' A' ' 243' ' ' ILE . 31.4 mmtp -137.29 139.68 41.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 174.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 240' ' ' ALA . 47.1 mm -78.81 118.19 25.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 13.3 p90 -121.06 163.83 17.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.84 0.352 . . . . 0.0 110.324 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.987 -178.928 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.012 0.434 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 5' ' ' ARG . 48.1 mtm105 -121.9 81.44 1.82 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.749 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.491 ' CE1' ' HD3' ' A' ' 89' ' ' LYS . 31.3 p90 -113.55 161.18 17.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.433 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.44 -45.31 94.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.631 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 63.1 m 67.72 157.61 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.762 0.664 . . . . 0.0 109.999 -169.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.6 t 72.64 -49.94 0.7 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.989 0.516 . . . . 0.0 111.491 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -50.98 101.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.34 0.59 . . . . 0.0 111.591 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -40.22 73.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.249 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -78.62 8.97 4.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.667 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.91 -47.62 4.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.708 0.29 . . . . 0.0 111.022 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -121.03 -25.87 5.25 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -86.46 115.46 23.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.93 0.395 . . . . 0.0 110.692 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.1 mtt -113.13 6.59 17.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.107 0.48 . . . . 0.0 110.779 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.0 -115.23 3.36 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.006 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 25.5 Cg_exo -63.95 103.75 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.697 2.265 . . . . 0.0 111.914 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.605 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 54.4 t -135.58 -75.26 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.732 -176.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.745 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 55.9 m 84.99 176.02 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 122.743 0.417 . . . . 0.0 110.141 166.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 26.6 mmm180 -40.65 -61.76 0.89 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.054 0.846 . . . . 0.0 111.782 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -55.17 -56.84 15.41 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.941 0.776 . . . . 0.0 112.007 -173.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.6 -42.92 60.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.253 -169.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.26 -52.8 63.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.197 -176.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.581 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 12.9 pt20 -70.89 -32.81 69.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.151 -176.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.598 ' HA ' ' OE1' ' A' ' 29' ' ' GLN . 39.5 m -66.73 -34.3 77.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 111.354 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.514 ' HD2' ' O ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -63.22 -35.39 80.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.82 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.052 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 23.6 mt -99.61 13.0 35.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.045 -173.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.598 ' OE1' ' HA ' ' A' ' 26' ' ' THR . 27.3 mt-30 -73.65 96.71 2.52 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.88 5.07 89.7 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.738 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -82.43 -162.26 0.55 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.946 0.373 . . . . 0.0 110.15 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.491 HH21 ' CD ' ' A' ' 100' ' ' GLU . 14.5 mtm180 -62.78 131.51 49.1 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.185 0.517 . . . . 0.0 111.352 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -73.72 114.66 12.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.474 173.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.08 -16.86 4.4 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.124 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.608 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 62.2 mtt -67.7 142.71 56.24 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.711 0.291 . . . . 0.0 111.544 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.498 ' CB ' HG22 ' A' ' 52' ' ' VAL . 40.2 p90 -140.24 160.04 40.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.016 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -151.1 141.74 22.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.967 0.413 . . . . 0.0 110.627 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.51 124.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.461 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.745 ' HD2' ' H ' ' A' ' 20' ' ' SER . 9.2 ptt180 -122.17 161.7 22.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.189 -173.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.3 113.17 18.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.449 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.1 t -73.51 140.5 46.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.703 -171.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 t -78.96 -13.46 59.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.351 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.0 p -68.03 -48.5 65.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.107 0.479 . . . . 0.0 109.983 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.4 m -146.95 103.45 3.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.163 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.7 116.58 3.09 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.59 2.193 . . . . 0.0 111.216 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.38 -30.89 5.26 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -172.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 3.2 m-20 -86.18 168.87 13.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 171.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.768 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 32.0 m-85 -135.52 174.02 11.07 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.684 -171.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.449 HG23 ' HB2' ' A' ' 41' ' ' SER . 58.5 t -143.27 112.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.175 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.509 ' HB2' HD11 ' A' ' 63' ' ' ILE . 46.0 tp -83.54 99.84 10.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.254 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' SER . 68.4 m -97.11 135.14 39.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.528 177.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 93' ' ' LEU . 81.9 t -132.09 142.39 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.553 -173.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 1.052 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 42.3 t -102.01 113.86 27.46 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.882 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.692 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 18.0 pt-20 -156.86 145.99 20.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.0 p30 43.3 31.39 0.38 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.732 0.813 . . . . 0.0 112.714 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.8 m 63.71 63.82 0.82 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.534 0.683 . . . . 0.0 111.234 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 29.3 ptt180 -160.3 166.34 29.66 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 34.3 t -119.45 90.85 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.081 0.467 . . . . 0.0 109.941 175.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.581 ' O ' ' HA ' ' A' ' 51' ' ' SER . 3.6 m -63.14 116.28 5.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.597 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -102.86 97.04 7.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.683 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.628 ' HB3' HD11 ' A' ' 73' ' ' ILE . 82.7 m-85 -105.38 113.06 26.42 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.904 -0.134 . . . . 0.0 111.097 177.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.578 ' O ' HG13 ' A' ' 73' ' ' ILE . 19.0 tt -77.53 139.34 18.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.768 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.5 mp -109.4 122.74 64.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.789 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.549 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 11.2 m120 -110.16 126.31 53.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.911 0.386 . . . . 0.0 110.211 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 p -80.67 100.89 8.91 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.02 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.848 HD12 ' HG2' ' A' ' 70' ' ' ARG . 96.3 mt -66.34 130.06 94.2 Favored Pre-proline 0 CA--C 1.51 -0.595 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -40.26 -68.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.166 2.577 . . . . 0.0 113.658 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -123.25 31.77 5.87 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.001 0.905 . . . . 0.0 108.605 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.775 HH21 HD22 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -131.24 -91.33 0.43 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.596 -173.457 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.848 ' HG2' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -157.81 -170.4 3.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.051 -167.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -97.62 130.22 44.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.339 0.59 . . . . 0.0 110.323 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.624 ' HD3' HD21 ' A' ' 66' ' ' LEU . 44.9 tttm -123.48 103.33 8.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.309 -173.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.628 HD11 ' HB3' ' A' ' 61' ' ' TYR . 15.0 tt -74.13 86.23 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.842 0.829 . . . . 0.0 111.049 -173.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.04 -34.73 1.47 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.784 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -168.08 -51.29 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.648 0.261 . . . . 0.0 110.46 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -80.87 121.28 25.78 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.436 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.8 pt-20 -94.86 143.28 26.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.289 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.515 ' HE1' ' CG2' ' A' ' 73' ' ' ILE . 91.2 m-85 -115.4 -77.37 0.57 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.688 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD2' ' HD2' ' A' ' 80' ' ' HIS . 11.7 t70 -177.11 -54.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.458 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.482 ' HD2' ' OD2' ' A' ' 79' ' ' ASP . 10.8 p80 -147.77 177.64 9.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.486 176.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 11.6 mt -58.84 -59.11 14.8 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.631 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 44.6 Cg_exo -60.05 -7.38 6.26 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.279 1.986 . . . . 0.0 113.427 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.414 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -87.88 -23.01 24.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.94 0.4 . . . . 0.0 110.963 -177.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -88.09 -28.76 21.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 82' ' ' PRO . 77.7 mt -68.21 -25.76 65.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.849 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.663 ' HA ' ' HE2' ' A' ' 89' ' ' LYS . 10.1 pt-20 -85.78 -15.58 41.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -79.8 -37.69 34.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.512 0.672 . . . . 0.0 110.116 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.463 ' HE2' HD13 ' A' ' 73' ' ' ILE . 60.3 m-85 -78.88 2.79 18.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.082 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.663 ' HE2' ' HA ' ' A' ' 86' ' ' GLU . 52.2 mtmt -86.37 -5.79 59.09 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.793 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 -27.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.087 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -79.39 -19.59 49.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.235 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.615 ' CD2' HG23 ' A' ' 97' ' ' THR . 54.5 m-85 67.28 174.32 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -168.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 52' ' ' VAL . 4.2 mt -114.27 2.04 14.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 165.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.418 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 15.7 t70 -178.07 -121.76 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.502 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.539 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.1 t -94.01 -3.96 50.46 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.1 m -120.3 141.68 49.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.52 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.615 HG23 ' CD2' ' A' ' 92' ' ' TYR . 18.6 p -94.8 178.92 5.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 174.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.512 ' CD2' HD11 ' A' ' 93' ' ' LEU . 83.0 mt -69.48 101.85 1.67 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 51.1 mm -86.02 -65.07 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.79 -176.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 35' ' ' MET . 5.7 pm0 -150.37 155.96 36.88 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.221 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.71 145.79 70.69 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.43 2.087 . . . . 0.0 111.726 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -69.62 147.4 96.56 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.426 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.514 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 25.0 Cg_exo -63.66 127.76 20.55 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.356 2.037 . . . . 0.0 111.184 175.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.431 0.634 . . . . 0.0 109.79 178.897 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.592 HD12 HG21 ' A' ' 152' ' ' ILE . 4.1 mm? . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 121.415 0.626 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 -164.72 -81.31 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.38 -173.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -104.97 114.63 28.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.339 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.563 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 53.7 t -128.73 133.47 66.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.128 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.413 HH21 HD11 ' A' ' 149' ' ' ILE . 1.1 ptp180 -111.29 141.28 45.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.132 0.491 . . . . 0.0 110.922 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.829 HG22 HG12 ' A' ' 178' ' ' VAL . 7.3 p -93.49 139.61 30.53 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.426 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.429 HD11 ' CG ' ' A' ' 179' ' ' GLU . 16.7 mt -110.32 -27.46 9.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.464 -173.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 53.3 t80 -83.09 -37.47 23.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -171.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.676 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 17.7 t70 75.13 107.92 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.697 0.623 . . . . 0.0 110.33 -174.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 83.6 t80 -139.82 100.7 7.29 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 8.2 Cg_endo -89.03 78.37 1.09 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.018 2.478 . . . . 0.0 112.502 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -78.64 -22.41 66.93 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.162 176.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 49.53 55.01 10.02 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.47 -0.865 . . . . 0.0 112.815 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -153.48 171.39 18.77 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.687 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -79.86 -16.07 56.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.147 0.498 . . . . 0.0 110.929 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.43 -10.19 17.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.604 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.419 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 66.9 m-20 -135.73 92.14 2.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.847 HD11 ' HB2' ' A' ' 165' ' ' ASN . 46.8 tp -67.91 122.66 84.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.807 0.337 . . . . 0.0 110.793 -175.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.682 ' HD2' HD12 ' A' ' 142' ' ' LEU . 66.2 Cg_endo -71.62 99.68 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.403 2.069 . . . . 0.0 111.066 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.585 ' CG ' HG21 ' A' ' 130' ' ' THR . 6.3 p90 -116.49 155.67 28.22 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.85 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.676 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 52.8 mttp -101.7 176.17 5.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.15 -174.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.945 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -83.65 69.5 10.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.956 0.884 . . . . 0.0 109.421 176.137 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.5 23.43 0.73 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.591 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 145' ' ' LYS . 8.1 tp10 -92.93 153.53 18.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.413 HD11 HH21 ' A' ' 129' ' ' ARG . 43.1 mm -104.61 128.21 58.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.487 HD13 HD23 ' A' ' 142' ' ' LEU . 18.2 mt -122.65 159.02 28.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 42.1 t -117.01 129.02 74.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.728 HD13 ' HB2' ' A' ' 163' ' ' ALA . 38.3 mm -75.81 93.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.815 0.817 . . . . 0.0 109.641 -175.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.705 HG21 HG22 ' A' ' 170' ' ' VAL . 8.6 tp -91.04 -33.56 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.001 -172.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.061 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 19.3 mt-10 -132.02 143.63 50.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -145.32 75.06 13.91 Favored Pre-proline 0 C--N 1.323 -0.585 0 O-C-N 121.66 -0.65 . . . . 0.0 111.093 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.539 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 14.0 Cg_exo -68.28 -40.11 8.97 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.716 2.277 . . . . 0.0 111.678 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -112.26 -178.51 3.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.098 -175.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -110.27 -18.19 13.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.31 0.576 . . . . 0.0 109.599 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -88.88 -30.35 18.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.96 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.741 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 36.8 m95 -128.97 134.53 48.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.473 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.762 ' O ' HG13 ' A' ' 173' ' ' ILE . 41.5 m0 -124.82 135.21 52.73 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.906 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' SER . . . . . 1.061 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.6 m -85.62 101.74 12.97 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.728 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -106.59 161.74 14.36 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 122.058 -0.401 . . . . 0.0 110.404 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.568 ' HG2' ' HB ' ' A' ' 151' ' ' VAL . 15.2 ptt180 -105.32 133.57 49.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.82 0.343 . . . . 0.0 110.317 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.847 ' HB2' HD11 ' A' ' 142' ' ' LEU . 60.2 t30 -64.71 170.41 4.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.905 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.408 ' HG3' ' OE1' ' A' ' 148' ' ' GLU . 8.9 mtmm -61.79 -16.34 48.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.11 0.481 . . . . 0.0 110.515 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.55 -1.8 58.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.283 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.42 -8.37 79.92 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.343 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 7.0 ttp-105 -68.59 129.24 39.36 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.803 -0.234 . . . . 0.0 111.103 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.705 HG22 HG21 ' A' ' 153' ' ' ILE . 73.5 t -89.73 128.53 41.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -153.17 149.02 20.51 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.025 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.741 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -69.5 130.62 42.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.755 0.312 . . . . 0.0 110.432 178.396 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.762 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -133.29 146.78 62.32 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.364 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 4.0 Cg_exo -77.39 134.54 14.11 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.724 2.283 . . . . 0.0 112.28 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 66.9 t -65.47 -40.83 45.54 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 27.4 Cg_endo -63.61 -4.56 7.16 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.824 1.683 . . . . 0.0 112.973 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-85 -96.69 -6.05 37.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.407 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.829 HG12 HG22 ' A' ' 130' ' ' THR . 15.5 m -126.6 163.92 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -168.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.429 ' CG ' HD11 ' A' ' 131' ' ' LEU . 4.7 mm-40 -139.87 163.94 31.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.587 170.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.525 ' N ' ' HD3' ' A' ' 180' ' ' LYS . 2.8 mppt? . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 120.573 0.225 . . . . 0.0 110.908 -172.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.588 ' HB ' HG13 ' A' ' 266' ' ' VAL . 21.7 t . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.47 134.95 52.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.02 0.438 . . . . 0.0 110.922 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.581 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -138.93 131.87 29.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.372 175.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.417 ' HG3' ' CE1' ' A' ' 294' ' ' PHE . 92.3 mttt -84.46 124.02 30.89 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.613 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -76.94 100.42 5.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.018 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 36.0 pt -88.79 -15.69 8.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.266 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -140.3 135.69 32.49 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.43 ' HG3' HG23 ' A' ' 260' ' ' VAL . 27.4 mtpp -50.68 137.19 20.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 112.547 -175.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.728 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -111.86 91.64 3.73 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.589 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 120.781 0.324 . . . . 0.0 111.306 -175.593 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.851 0.358 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -95.03 107.04 19.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.312 -174.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.49 120.0 27.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.728 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -75.98 111.25 11.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.143 0.497 . . . . 0.0 110.586 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.0 mt -114.52 144.14 43.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.315 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.99 167.41 9.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.371 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.43 HG23 ' HG3' ' A' ' 245' ' ' LYS . 58.3 t -77.41 121.31 29.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.976 0.417 . . . . 0.0 110.489 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 100.32 9.95 46.25 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.87 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -92.1 148.77 21.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 16.4 mm -99.35 111.65 29.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 0.0 110.186 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.502 HG21 HG11 ' A' ' 291' ' ' VAL . 35.7 t -87.51 115.21 27.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.179 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.5 ttpp -96.91 98.95 10.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.588 HG13 ' HB ' ' A' ' 238' ' ' VAL . 6.5 p -94.85 124.72 47.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.264 0.554 . . . . 0.0 110.585 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 88.2 m -116.75 -35.19 4.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.052 176.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -91.36 92.29 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.224 0.535 . . . . 0.0 110.07 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' MET . . . . . 0.789 ' HA ' ' HB3' ' A' ' 275' ' ' TRP . 29.9 mtt -97.58 139.61 33.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.879 0.371 . . . . 0.0 110.886 177.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -93.57 -175.01 3.65 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.3 tt -73.52 71.87 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.796 0.808 . . . . 0.0 110.976 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 41.3 t30 73.65 -37.99 0.39 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.903 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 274' ' ' GLN . . . -91.43 78.59 1.34 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.159 -1.019 . . . . 0.0 113.02 -169.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 287' ' ' PRO . 46.5 mt-30 75.67 128.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.894 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.789 ' HB3' ' HA ' ' A' ' 269' ' ' MET . 0.6 OUTLIER -124.62 169.57 11.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.36 -169.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 38.8 mt-10 -107.54 108.45 19.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.607 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.31 133.3 11.58 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.168 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 283' ' ' LYS . 1.4 pm0 -95.04 108.81 20.9 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.291 0.567 . . . . 0.0 109.489 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 27.1 t -115.74 -87.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.143 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -92.04 72.67 5.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.08 0.467 . . . . 0.0 111.059 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.89 4.89 78.41 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.729 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 282' ' ' ARG . 14.3 ptt180 -159.97 162.6 34.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.207 0.503 . . . . 0.0 111.426 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.59 ' HB3' ' HB3' ' A' ' 278' ' ' GLU . 10.1 ptmm? -116.88 138.79 51.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -154.35 175.8 32.4 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.146 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.49 127.17 34.84 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.094 0.473 . . . . 0.0 110.792 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -127.43 125.76 23.97 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.023 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 17.0 Cg_exo -68.31 139.61 46.21 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.636 2.224 . . . . 0.0 111.409 176.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -75.66 26.26 0.11 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.7 t -115.48 -9.82 12.03 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.961 0.41 . . . . 0.0 109.953 171.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -90.34 -30.34 17.51 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.613 HG12 ' HA ' ' A' ' 242' ' ' ALA . 18.0 m -124.25 161.53 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.51 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -130.75 133.16 45.78 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.02 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 240' ' ' ALA . 43.6 mm -70.76 111.98 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.723 178.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.417 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 34.8 p90 -111.12 142.08 43.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.901 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.473 -179.049 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.427 ' HB1' ' HE3' ' A' ' 89' ' ' LYS . . . . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.6 0.238 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -134.38 84.96 2.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.847 0.355 . . . . 0.0 111.0 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.418 ' HE1' ' O ' ' A' ' 98' ' ' LEU . 41.7 p90 -161.22 164.22 30.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.863 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 12.8 t70 -90.02 120.24 31.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 40.5 m -70.13 -16.53 63.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.856 -172.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -103.46 -11.79 17.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.89 0.376 . . . . 0.0 111.505 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 11.1 t0 -75.62 94.47 3.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.174 0.512 . . . . 0.0 110.879 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.3 mtm-85 -65.84 -25.19 67.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.311 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -73.88 1.83 9.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.849 0.357 . . . . 0.0 110.781 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.84 -47.43 3.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.718 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -114.05 -20.34 11.03 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -76.21 120.32 21.33 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.104 -0.372 . . . . 0.0 110.999 -172.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.642 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.6 mmt -102.12 -16.18 16.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.963 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.473 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.88 -112.57 1.71 Allowed Glycine 0 CA--C 1.525 0.667 0 O-C-N 123.431 0.457 . . . . 0.0 113.543 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.473 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 16.8 Cg_exo -66.55 83.06 0.3 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.217 2.611 . . . . 0.0 113.518 -176.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.966 HG12 ' H ' ' A' ' 20' ' ' SER . 57.5 t -135.33 -164.66 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.966 ' H ' HG12 ' A' ' 19' ' ' VAL . 45.7 p -172.68 174.32 3.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -168.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -53.07 60.9 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.092 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -57.12 -61.9 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.495 0.497 . . . . 0.0 111.532 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -57.72 -47.16 83.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.654 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.87 74.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.055 0.455 . . . . 0.0 111.641 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -61.56 -44.34 97.22 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.801 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m -57.85 -38.33 75.47 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -81.31 -9.52 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 80.1 mt -122.41 -12.98 8.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -74.36 117.26 15.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.971 0.415 . . . . 0.0 111.272 -174.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.97 3.05 63.19 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.75 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -80.75 -171.42 3.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.654 0.264 . . . . 0.0 110.453 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.462 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 17.2 mtm180 -60.79 152.71 26.3 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.434 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 62.3 m170 -98.54 142.08 30.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.11 -9.04 54.3 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -172.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.64 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 73.8 mtp -76.75 138.25 39.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.38 -0.41 . . . . 0.0 109.895 176.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' HB2' HG22 ' A' ' 52' ' ' VAL . 27.3 p90 -144.02 167.47 22.29 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.642 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -158.94 146.93 17.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.5 116.11 50.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.677 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.463 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 36.1 ptt-85 -114.17 -179.31 3.6 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.601 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -86.46 138.04 32.07 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -89.23 177.77 6.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.398 0.618 . . . . 0.0 111.433 -174.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 m -110.4 -4.94 15.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.21 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 p -73.98 -65.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.822 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 26.6 m -133.37 143.29 47.49 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.639 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.93 88.64 0.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.239 1.959 . . . . 0.0 111.334 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 145.72 -21.63 1.82 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -77.52 150.99 34.76 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -130.43 173.78 10.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG22 HG12 ' A' ' 62' ' ' ILE . 9.5 t -138.93 109.67 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.122 0.487 . . . . 0.0 111.722 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.404 ' HB2' HD11 ' A' ' 63' ' ' ILE . 51.6 tp -83.29 97.61 8.99 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.322 175.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.9 m -95.75 117.09 29.86 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.685 0.278 . . . . 0.0 110.254 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.651 HG21 HD13 ' A' ' 93' ' ' LEU . 60.4 t -113.23 133.62 58.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.405 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 48.1 t -102.05 118.05 36.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.712 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 10.7 tp10 -151.18 153.22 34.55 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.465 ' HB2' ' CG ' ' A' ' 57' ' ' ARG . 30.3 m120 57.41 21.85 7.31 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.323 0.389 . . . . 0.0 111.822 -177.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 m 57.6 51.51 9.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.253 1.025 . . . . 0.0 108.996 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 1.022 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.29 0.0 OUTLIER -166.81 70.03 0.11 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.376 -155.784 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 22.5 t -71.93 110.86 5.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.883 -168.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.3 m -76.64 120.46 21.86 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.282 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -97.71 89.9 4.79 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.875 ' HE1' HD11 ' A' ' 153' ' ' ILE . 75.5 m-85 -89.05 106.76 18.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -80.51 136.41 23.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.209 0.528 . . . . 0.0 111.97 -178.652 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.6 mp -117.88 106.57 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.534 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -83.58 148.67 27.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.735 0.302 . . . . 0.0 110.548 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.9 t -85.49 109.32 18.4 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 72' ' ' LYS . 98.2 mt -79.41 147.43 68.28 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.544 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.8 -13.47 37.22 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.695 2.263 . . . . 0.0 110.547 170.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -75.39 -0.72 20.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.366 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.588 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.1 mmp_? 64.71 28.51 13.04 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.972 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 70' ' ' ARG . 59.1 mtt85 -124.8 157.37 35.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.537 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.526 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 25.7 m-85 -105.6 114.93 29.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.888 0.375 . . . . 0.0 110.519 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.63 ' HB2' HD11 ' A' ' 66' ' ' LEU . 38.6 ttpt -103.53 111.96 24.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.546 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.714 HD11 ' HB3' ' A' ' 61' ' ' TYR . 7.9 tt -93.23 75.26 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 122.179 0.99 . . . . 0.0 109.124 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.07 97.78 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.979 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.4 t0 75.49 -51.5 0.64 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.649 0.379 . . . . 0.0 111.381 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -94.05 119.27 32.69 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.8 pt-20 -100.24 135.77 41.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.319 0.58 . . . . 0.0 110.796 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 94.2 m-85 -115.86 177.12 4.79 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.473 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.43 -49.68 74.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.903 0.382 . . . . 0.0 111.167 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -164.52 -175.43 3.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 15.2 mt -53.22 -58.82 10.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' A' ' 8' ' ' SER . 30.6 Cg_endo -64.89 -4.75 9.31 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.206 1.937 . . . . 0.0 113.433 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.87 -36.63 15.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.813 0.339 . . . . 0.0 110.425 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -77.11 -37.03 55.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.16 -38.8 84.27 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.832 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.599 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 1.9 tp10 -66.26 -43.84 85.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.725 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -64.91 -28.3 69.44 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.432 0.634 . . . . 0.0 110.968 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.494 ' CG ' HD21 ' A' ' 93' ' ' LEU . 20.6 m-85 -92.03 1.73 57.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.324 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.599 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 56.8 mtpt -85.02 3.54 38.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 175.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.3 pt -140.53 -8.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-O 121.252 0.549 . . . . 0.0 109.706 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 4.4 t60 -86.17 -36.68 19.36 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.973 -174.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 93.8 m-85 70.13 91.69 0.09 Allowed 'General case' 0 C--O 1.225 -0.205 0 O-C-N 124.277 0.986 . . . . 0.0 109.033 -166.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.651 HD13 HG21 ' A' ' 52' ' ' VAL . 25.1 mt -58.67 -44.76 90.27 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.351 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.964 ' HA ' ' HG2' ' A' ' 154' ' ' GLU . 28.3 p-10 -150.51 48.82 0.88 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.627 -166.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.8 OUTLIER 70.63 -5.73 1.37 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.413 1.885 . . . . 0.0 111.635 -169.744 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.58 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -126.13 151.64 46.99 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.0 p -96.72 167.05 11.35 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.418 ' O ' ' HE1' ' A' ' 6' ' ' PHE . 72.6 mt -65.38 99.66 0.42 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 97' ' ' THR . 48.0 mm -87.4 -64.06 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.343 -172.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 35' ' ' MET . 42.0 tt0 -156.86 126.01 3.09 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.201 -174.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.68 153.71 47.66 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.023 2.482 . . . . 0.0 113.127 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.439 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -69.62 154.23 94.98 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.514 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.61 115.78 2.76 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 121.904 1.736 . . . . 0.0 111.672 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.498 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 54.3 ttp180 . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.439 0.638 . . . . 0.0 109.7 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.881 HD12 HG21 ' A' ' 152' ' ' ILE . 3.3 mm? . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 121.66 0.743 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 44.3 tt0 -175.59 -54.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.207 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -118.5 107.5 13.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.909 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.67 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 4.2 t -116.26 140.02 40.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.719 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 4.9 ptp180 -115.24 138.61 50.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 116.71 -1.996 . . . . 0.0 108.682 164.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.634 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -100.67 125.5 47.1 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.738 -178.036 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.462 HD21 ' HG2' ' A' ' 179' ' ' GLU . 17.2 mt -99.22 -26.32 14.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.243 -173.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 34.7 t80 -73.48 -41.98 62.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -172.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.548 ' HB2' ' N ' ' A' ' 146' ' ' LYS . 6.0 t70 75.24 100.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.699 0.761 . . . . 0.0 110.832 -174.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 53.5 t80 -128.7 86.78 56.66 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.594 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 89.6 Cg_endo -83.6 86.72 1.33 Allowed 'Trans proline' 0 N--CA 1.441 -1.611 0 C-N-CA 121.147 1.231 . . . . 0.0 112.368 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.67 -24.47 60.35 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.541 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.6 m120 61.6 50.83 4.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.709 -1.246 . . . . 0.0 112.22 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.422 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 4.8 m-20 -136.67 176.25 8.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.273 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.82 -13.83 35.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 122.11 0.957 . . . . 0.0 108.496 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 172' ' ' MET . 19.6 mm-40 -88.02 -31.4 19.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.244 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -135.2 105.76 6.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.939 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.037 HD11 ' HB2' ' A' ' 165' ' ' ASN . 26.5 tp -66.94 128.79 94.0 Favored Pre-proline 0 CA--C 1.51 -0.563 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.989 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.621 ' HD2' HD12 ' A' ' 142' ' ' LEU . 92.4 Cg_endo -79.34 98.08 1.14 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 121.384 1.389 . . . . 0.0 111.306 173.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.562 ' CD2' ' HB ' ' A' ' 130' ' ' THR . 0.5 OUTLIER -89.32 -165.1 1.26 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.574 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.54 ' C ' ' HB2' ' A' ' 133' ' ' ASP . 56.2 mtpt -139.49 -176.02 4.39 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.408 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.946 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -82.99 50.41 1.72 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.665 0.745 . . . . 0.0 110.665 -174.653 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.99 35.28 0.17 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.663 ' OE1' ' HB2' ' A' ' 166' ' ' LYS . 5.1 tp10 -84.34 151.8 24.5 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.983 -173.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.3 122.82 64.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.549 0.69 . . . . 0.0 109.157 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.734 HD22 ' CD2' ' A' ' 142' ' ' LEU . 65.4 mt -123.67 157.57 33.53 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.008 -171.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 66.1 t -117.3 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.075 HD13 ' HB2' ' A' ' 163' ' ' ALA . 45.6 mm -76.86 95.48 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-O 122.177 0.989 . . . . 0.0 109.508 -175.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.875 HD11 ' HE1' ' A' ' 61' ' ' TYR . 19.3 tt -81.64 -28.07 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.602 -175.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.022 ' HA ' HH21 ' A' ' 57' ' ' ARG . 4.0 mt-10 -136.37 144.39 44.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.144 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.642 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 86.8 tttt -124.31 76.53 61.28 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 164.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.563 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 23.2 Cg_exo -67.2 -51.17 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.768 2.312 . . . . 0.0 111.778 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -113.8 177.54 4.6 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.619 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -100.18 -16.98 17.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.976 0.417 . . . . 0.0 110.3 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -99.8 -19.79 16.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.593 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 39.7 m95 -129.74 141.95 50.79 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.752 ' O ' HG13 ' A' ' 173' ' ' ILE . 46.5 m0 -124.92 137.86 54.26 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 6.1 m -97.7 109.88 22.55 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.075 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -121.29 152.1 39.3 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.244 -176.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.775 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 27.1 ptt-85 -87.65 127.69 35.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 173.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.037 ' HB2' HD11 ' A' ' 142' ' ' LEU . 56.3 t30 -61.75 178.01 0.37 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.133 -172.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.663 ' HB2' ' OE1' ' A' ' 148' ' ' GLU . 3.6 ttmp? -54.19 -26.03 25.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.303 166.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -74.98 -38.45 61.66 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.03 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 164' ' ' ARG . . . 115.32 -11.85 19.37 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.458 -175.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.775 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -59.12 138.18 57.66 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.26 0.624 . . . . 0.0 112.051 177.434 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 74.0 t -88.76 121.07 38.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.542 177.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -153.73 156.2 26.64 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.438 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.593 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -77.55 143.68 38.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.805 0.303 . . . . 0.0 111.295 178.714 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -142.07 142.0 23.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.526 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 20.4 Cg_exo -65.95 129.46 22.02 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.715 2.277 . . . . 0.0 112.879 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.614 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 44.9 t -62.72 -40.1 60.68 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 17.5 Cg_endo -59.39 -11.28 13.11 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.023 1.815 . . . . 0.0 112.627 175.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -93.29 -10.53 35.16 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.604 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.634 HG12 HG22 ' A' ' 130' ' ' THR . 2.1 m -105.98 -177.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -166.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.719 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 3.4 tp10 -159.43 44.82 0.25 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 112.467 -2.151 . . . . 0.0 110.833 -154.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.77 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.449 0 O-C-N 119.174 -2.204 . . . . 0.0 112.87 -162.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.617 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 27.7 t . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 121.043 0.449 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -93.77 123.45 37.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.173 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.81 143.34 47.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.175 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 45.0 tttp -90.89 119.08 30.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.15 0.5 . . . . 0.0 109.752 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.94 ' HB1' ' HG2' ' A' ' 259' ' ' GLU . . . -84.23 127.22 33.81 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.781 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 46.2 pt -128.12 -30.1 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -168.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 19.7 tm0? -82.62 -75.9 0.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.298 -169.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.692 ' HA ' ' CB ' ' A' ' 259' ' ' GLU . 1.0 OUTLIER 153.85 131.25 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.391 1.476 . . . . 0.0 108.183 168.495 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 19.2 mmm180 -124.2 100.61 6.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.917 0.389 . . . . 0.0 110.968 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.453 178.165 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -93.0 126.76 38.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.532 HD13 HD21 ' A' ' 258' ' ' LEU . 0.6 OUTLIER -85.08 122.12 28.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.952 0.406 . . . . 0.0 110.524 -176.252 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -84.06 109.89 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.779 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.571 HD23 ' HB ' ' A' ' 279' ' ' VAL . 0.4 OUTLIER -157.05 -156.25 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.166 176.269 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.94 ' HG2' ' HB1' ' A' ' 242' ' ' ALA . 3.7 mt-10 88.12 139.92 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 24.9 t 82.56 83.16 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 112.695 -2.048 . . . . 0.0 111.114 -172.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 89.98 14.38 59.33 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.417 -0.81 . . . . 0.0 113.48 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -105.36 145.99 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.974 0.416 . . . . 0.0 111.163 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 32.2 mm -98.45 111.4 28.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.534 HG22 HD22 ' A' ' 258' ' ' LEU . 43.5 t -92.83 117.25 35.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 -175.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -96.39 105.67 17.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.102 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.52 HG21 ' HB3' ' A' ' 275' ' ' TRP . 2.4 p -94.67 118.01 39.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.999 0.428 . . . . 0.0 110.304 176.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -93.8 -24.37 17.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.173 0.511 . . . . 0.0 110.763 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 88.8 mtt180 -121.56 98.27 5.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.801 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' MET . . . . . 0.617 ' HE3' ' HB ' ' A' ' 238' ' ' VAL . 1.2 mtt -91.39 112.93 25.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.321 0.581 . . . . 0.0 111.373 -176.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -92.13 158.79 15.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.173 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.5 tt -91.28 -14.98 8.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.347 0.594 . . . . 0.0 109.851 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.99 23.02 1.57 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.8 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 91.04 -55.63 3.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.136 -0.554 . . . . 0.0 114.077 168.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.458 ' H ' ' HG2' ' A' ' 274' ' ' GLN . 6.1 pt20 -77.81 114.84 17.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.346 0.593 . . . . 0.0 110.526 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.52 ' HB3' HG21 ' A' ' 266' ' ' VAL . 42.9 m0 -94.74 155.65 16.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.457 -175.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 0.2 OUTLIER -107.58 113.29 26.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.425 -179.844 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -141.73 168.35 25.61 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.288 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -118.25 110.16 17.21 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.571 ' HB ' HD23 ' A' ' 258' ' ' LEU . 43.9 t -139.93 146.72 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 63.61 24.51 14.0 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.094 0.473 . . . . 0.0 111.02 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 82.16 3.37 90.58 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.238 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -134.24 149.58 50.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.943 0.402 . . . . 0.0 110.767 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -103.6 143.26 32.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.274 178.508 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -172.18 170.74 43.72 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.477 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 95.3 mt -90.34 133.5 34.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.119 0.485 . . . . 0.0 111.122 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -134.62 147.85 64.93 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.184 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -87.77 139.29 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.685 2.257 . . . . 0.0 112.752 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -70.53 -11.52 60.98 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.063 0.459 . . . . 0.0 111.016 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.5 p -78.23 4.84 11.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.236 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -116.94 -49.11 2.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.657 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 242' ' ' ALA . 27.5 m -85.98 152.52 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.216 -175.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -109.29 124.34 50.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.797 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 240' ' ' ALA . 20.8 mm -79.77 127.62 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.473 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 2.6 p90 -146.08 173.19 12.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.166 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 . . . . . 0 C--N 1.315 -0.91 0 CA-C-O 121.373 0.606 . . . . 0.0 111.049 179.147 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtt . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.451 ' CB ' ' HE ' ' A' ' 5' ' ' ARG . 12.7 m 61.72 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.646 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.3 m 66.49 -51.14 0.44 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.326 0.65 . . . . 0.0 110.331 -168.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 98' ' ' LEU . . . -130.98 92.69 3.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.244 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.451 ' HE ' ' CB ' ' A' ' 2' ' ' SER . 5.3 ptp180 -114.73 25.32 11.06 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.361 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.552 ' CE1' ' HB1' ' A' ' 4' ' ' ALA . 46.2 p90 -69.47 140.49 54.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 165.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.45 118.69 18.59 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.582 -178.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.668 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 17.0 m -90.52 78.73 6.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.85 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -176.39 -53.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.068 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 12' ' ' SER . 34.8 t70 -78.18 127.75 32.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.311 0.577 . . . . 0.0 111.562 -170.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -51.82 -37.68 52.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.674 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 108' ' ' PRO . 3.2 m -73.87 23.97 0.08 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.875 0.369 . . . . 0.0 111.929 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.428 ' HB3' ' HD1' ' A' ' 14' ' ' TRP . . . -118.59 -47.19 2.54 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.883 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.428 ' HD1' ' HB3' ' A' ' 13' ' ' ALA . 28.3 p-90 -132.21 -22.39 2.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -166.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -86.86 119.71 27.38 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.942 -171.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.835 ' HG2' ' HG3' ' A' ' 109' ' ' PRO . 55.6 mtt -117.09 5.78 12.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.908 0.385 . . . . 0.0 111.143 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 49.91 -114.4 2.4 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.247 -0.888 . . . . 0.0 114.73 174.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 15.3 Cg_exo -69.01 95.96 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.916 2.411 . . . . 0.0 112.608 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.859 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 95.3 t -128.88 -71.53 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.117 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.888 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 54.1 m 78.52 170.01 0.2 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.196 0.598 . . . . 0.0 110.439 172.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -49.05 -43.61 40.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 6.9 pt20 -46.57 -58.57 3.69 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.956 0.785 . . . . 0.0 112.81 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.54 ' HB2' HG13 ' A' ' 19' ' ' VAL . 23.5 mm-40 -85.65 -43.46 13.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.118 0.485 . . . . 0.0 110.467 -172.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.76 -37.41 63.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.765 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -72.25 -35.97 68.95 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.554 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 23' ' ' GLU . 10.8 t -79.8 -32.62 40.79 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.192 -174.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -84.65 -15.06 46.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.082 0.468 . . . . 0.0 111.173 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.475 HD11 ' HG ' ' A' ' 37' ' ' LEU . 78.3 mt -117.11 30.44 7.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.298 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -113.73 139.69 48.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.238 0.542 . . . . 0.0 111.671 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.09 -47.85 3.93 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.653 ' O ' ' HG3' ' A' ' 32' ' ' ARG . 77.9 mt-30 -131.91 80.47 1.92 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 118.875 1.338 . . . . 0.0 111.801 -168.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.981 ' HA ' ' HE2' ' A' ' 35' ' ' MET . 0.0 OUTLIER -169.22 146.07 3.49 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.523 -176.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.98 104.91 1.93 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 166.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.44 -3.67 69.09 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.566 -173.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.981 ' HE2' ' HA ' ' A' ' 32' ' ' ARG . 57.7 mtm -85.61 138.07 32.42 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.932 0.396 . . . . 0.0 110.511 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -144.27 174.33 10.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.743 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.2 pp -160.45 143.37 13.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.747 172.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.05 135.88 45.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.888 ' HD2' ' H ' ' A' ' 20' ' ' SER . 22.5 ptt-85 -139.64 155.26 47.52 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.397 -173.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' OD1' ' HA2' ' A' ' 17' ' ' GLY . 2.2 m-20 -66.18 118.25 9.63 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 168.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.525 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.4 t -84.44 170.06 13.91 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.993 0.425 . . . . 0.0 110.263 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t -112.23 7.13 19.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.484 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -53.68 27.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 47.4 t -170.62 121.74 0.55 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.414 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -40.41 104.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.464 2.776 . . . . 0.0 112.465 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.11 -21.73 2.62 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.209 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -103.25 145.36 30.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.076 0.465 . . . . 0.0 109.773 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.565 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 24.8 m-85 -126.42 160.19 31.18 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 41' ' ' SER . 44.0 t -128.16 103.46 10.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.471 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 tp -79.66 98.38 6.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.399 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 m -96.0 120.1 35.68 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.279 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.635 HG21 HD13 ' A' ' 93' ' ' LEU . 54.5 t -116.83 134.24 61.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.28 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 31.8 t -103.58 111.63 24.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.209 0.528 . . . . 0.0 111.78 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.557 ' HG3' ' HB ' ' A' ' 96' ' ' THR . 3.2 mm-40 -150.01 152.71 35.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.071 173.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 56.74 28.12 13.79 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.501 0.501 . . . . 0.0 110.877 -171.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.9 m 60.31 28.38 17.99 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.281 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 53' ' ' SER . 12.0 ptt-85 -124.53 158.29 33.29 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 t -110.56 95.21 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 t -81.22 118.8 22.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -100.63 99.91 10.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.675 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.793 ' HE1' HD11 ' A' ' 153' ' ' ILE . 63.1 m-85 -98.09 113.7 25.66 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.74 0.305 . . . . 0.0 111.205 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.477 ' HB ' ' CD ' ' A' ' 209' ' ' GLN . 68.5 mt -82.3 131.52 33.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.427 0.632 . . . . 0.0 112.448 -174.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 4.3 mp -98.25 122.55 50.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.176 174.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -111.4 132.53 54.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -77.78 110.35 12.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.449 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.726 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 93.1 mt -77.93 170.85 14.32 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.726 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 23.5 Cg_endo -61.69 56.37 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.007 2.472 . . . . 0.0 114.412 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 t30 79.92 4.99 1.94 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.34 0.656 . . . . 0.0 111.964 161.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -97.6 -51.26 4.18 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.836 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.684 ' HB3' ' HA ' ' A' ' 79' ' ' ASP . 5.8 ptp180 -156.32 -171.69 3.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.865 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.401 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 45.6 m-85 -109.72 157.92 18.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.595 0.236 . . . . 0.0 110.476 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.76 ' HE3' ' HA ' ' A' ' 75' ' ' ASP . 55.9 tttp -129.27 96.54 4.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.675 0.274 . . . . 0.0 110.278 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.547 HD13 ' HE2' ' A' ' 88' ' ' TYR . 3.1 tt -97.1 94.12 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.496 0.665 . . . . 0.0 109.869 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.94 57.38 7.84 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.277 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.76 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 25.1 t0 76.74 -50.21 0.57 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.16 0.584 . . . . 0.0 111.487 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -61.5 123.2 17.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.888 0.375 . . . . 0.0 110.057 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -107.2 130.33 54.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.723 0.773 . . . . 0.0 111.809 -176.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.542 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 7.8 m-85 -127.74 150.28 49.86 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.684 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 9.9 m-20 -62.43 -26.05 68.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -170.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 4.7 p80 -161.95 172.78 15.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.029 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.61 HD23 HD21 ' A' ' 84' ' ' LEU . 11.6 mt -56.55 -51.45 81.1 Favored Pre-proline 0 CA--C 1.537 0.455 0 O-C-N 123.373 0.42 . . . . 0.0 111.868 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.668 ' HB3' ' O ' ' A' ' 8' ' ' SER . 60.3 Cg_exo -57.35 -11.34 8.15 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.661 2.24 . . . . 0.0 114.095 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.95 -36.11 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.236 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.61 HD21 HD23 ' A' ' 81' ' ' LEU . 3.9 pp -76.33 -26.97 56.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.071 0.462 . . . . 0.0 110.557 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.81 -15.68 62.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.784 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -86.16 -37.46 18.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.886 0.374 . . . . 0.0 110.566 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -63.84 -37.7 88.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.28 0.562 . . . . 0.0 110.49 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.547 ' HE2' HD13 ' A' ' 73' ' ' ILE . 38.8 m-85 -81.77 -1.16 46.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.545 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.439 ' O ' HG21 ' A' ' 97' ' ' THR . 7.7 tmtm? -76.26 -24.89 54.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.106 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -115.57 -12.67 11.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.478 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.516 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 12.3 t-160 -72.44 -41.56 66.01 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.995 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.567 ' HA ' HG22 ' A' ' 97' ' ' THR . 83.6 m-85 72.8 108.9 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.379 1.049 . . . . 0.0 109.548 -167.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.736 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 4.9 mt -82.53 14.14 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 95' ' ' THR . 27.2 t70 172.55 -140.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 156' ' ' PRO . 12.8 t -78.12 -7.12 56.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.305 0.574 . . . . 0.0 109.685 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.557 ' HB ' ' HG3' ' A' ' 54' ' ' GLU . 20.7 m -136.44 158.73 43.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.692 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 92' ' ' TYR . 56.7 p -96.63 -169.12 1.83 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.574 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 74.3 mt -67.53 125.76 27.18 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 167.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.56 -68.67 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.896 0.379 . . . . 0.0 110.415 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.642 ' O ' ' HA ' ' A' ' 35' ' ' MET . 61.8 mm-40 -144.02 149.4 45.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.053 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.38 162.86 37.51 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.754 2.302 . . . . 0.0 113.718 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -78.62 171.59 12.1 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.488 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 74.1 Cg_exo -55.8 177.58 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.581 2.854 . . . . 0.0 114.524 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.702 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 2.8 ttp180 -98.75 156.14 16.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.699 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 1.014 ' HB3' ' HD3' ' A' ' 106' ' ' PRO . 45.8 t80 -159.19 -69.3 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.366 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 1.014 ' HD3' ' HB3' ' A' ' 105' ' ' TYR . 9.2 Cg_endo -94.36 -87.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.789 2.326 . . . . 0.0 112.464 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.631 ' O ' ' HD3' ' A' ' 109' ' ' PRO . 13.1 t -76.65 141.53 69.08 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.507 ' O ' ' HA ' ' A' ' 12' ' ' SER . 43.3 Cg_endo -68.8 108.06 1.81 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.051 2.5 . . . . 0.0 114.754 -172.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.835 ' HG3' ' HG2' ' A' ' 16' ' ' MET . 90.7 Cg_endo -102.16 -150.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 124.079 3.186 . . . . 0.0 111.149 170.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -60.4 3.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.05 0.453 . . . . 0.0 110.636 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.23 80.28 1.36 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.879 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.453 ' H ' ' HA ' ' A' ' 103' ' ' PRO . 39.3 m -114.42 149.18 36.61 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.0 t -82.23 -38.05 15.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.069 0.462 . . . . 0.0 110.256 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.3 m -149.81 159.45 44.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.727 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -118.41 138.43 25.72 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.813 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 14.6 Cg_exo -70.28 -19.69 33.33 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.291 2.661 . . . . 0.0 112.976 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -83.32 87.2 6.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.938 0.399 . . . . 0.0 111.96 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.586 HD12 ' HD2' ' A' ' 119' ' ' PRO . 50.3 tp -80.96 118.54 72.84 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 170.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.586 ' HD2' HD12 ' A' ' 118' ' ' LEU . 72.2 Cg_endo -76.87 -179.38 5.34 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.462 2.108 . . . . 0.0 113.237 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.8 t -144.53 137.26 26.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.243 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 66.9 166.95 0.22 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.796 0.685 . . . . 0.0 112.707 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.41 176.6 11.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.268 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -157.64 177.26 11.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -97.34 -96.06 0.21 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 1.056 HD23 HG21 ' A' ' 152' ' ' ILE . 10.6 mp 62.93 123.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.246 1.022 . . . . 0.0 113.007 174.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 17.0 tp10 -167.59 -74.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.715 -175.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -107.1 110.39 22.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.187 0.517 . . . . 0.0 111.11 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.526 HG22 ' HG2' ' A' ' 180' ' ' LYS . 70.3 t -127.84 132.04 69.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.687 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.526 HH22 ' HB2' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -112.57 145.0 41.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.87 0.367 . . . . 0.0 110.66 -178.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.882 HG22 HG12 ' A' ' 178' ' ' VAL . 42.1 p -93.29 129.07 39.5 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.332 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 21.2 mt -104.14 -32.98 8.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.717 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.613 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 34.1 t80 -86.12 -36.08 19.8 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -170.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.673 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 2.0 t70 79.65 129.3 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.557 0.535 . . . . 0.0 110.728 -175.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 91.5 t80 -151.39 100.64 2.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -89.1 65.88 2.6 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.595 2.197 . . . . 0.0 113.006 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.95 -29.82 73.81 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.774 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.517 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 47.3 m-80 50.22 73.32 0.27 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.87 0.868 . . . . 0.0 113.313 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -171.14 -176.28 1.89 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.09 -10.13 51.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.535 0.684 . . . . 0.0 109.168 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -94.09 -32.75 13.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.304 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.79 104.78 9.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.733 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.088 HD11 ' HB2' ' A' ' 165' ' ' ASN . 46.2 tp -71.9 117.81 61.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.566 ' HD2' HD12 ' A' ' 142' ' ' LEU . 55.2 Cg_endo -76.59 111.38 3.24 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.062 1.842 . . . . 0.0 111.728 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.627 ' CG ' HG21 ' A' ' 130' ' ' THR . 12.5 p90 -125.91 163.69 22.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.143 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.673 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 20.8 pttm -122.15 -168.51 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.739 -173.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.542 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.4 OUTLIER -80.94 67.15 6.74 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -178.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.9 42.95 0.11 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.413 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.631 ' HG2' ' HG2' ' A' ' 145' ' ' LYS . 5.3 mm-40 -99.2 145.09 27.6 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.535 -0.391 . . . . 0.0 110.073 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.467 HD13 ' HB3' ' A' ' 129' ' ' ARG . 46.5 mm -98.41 124.35 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 175.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.55 HD22 ' HA ' ' A' ' 165' ' ' ASN . 34.2 mt -120.43 158.7 26.64 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 90.4 t -119.0 126.05 75.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.056 HG21 HD23 ' A' ' 125' ' ' LEU . 48.6 mm -75.76 87.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 122.355 1.074 . . . . 0.0 108.913 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.793 HD11 ' HE1' ' A' ' 61' ' ' TYR . 6.7 tt -82.77 -37.36 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.832 -170.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.804 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 20.7 mt-10 -136.0 143.44 44.79 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -131.8 90.54 35.94 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 121.593 -0.692 . . . . 0.0 111.41 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.649 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 6.7 Cg_exo -74.05 -52.14 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.401 2.067 . . . . 0.0 111.957 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -115.19 -179.12 3.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.436 ' O ' HG21 ' A' ' 175' ' ' VAL . 42.1 mt-10 -102.48 -25.48 13.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.831 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 175' ' ' VAL . 7.6 tt0 -85.45 -27.78 25.48 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.237 0.541 . . . . 0.0 110.404 175.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.479 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 45.4 m95 -128.86 124.19 34.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.634 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.563 ' O ' HG13 ' A' ' 173' ' ' ILE . 52.6 m0 -111.3 148.32 33.18 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.804 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 33.3 m -95.63 101.01 12.67 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.756 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.93 153.96 22.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.573 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.9 ptt180 -96.2 133.4 40.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.088 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.2 t30 -74.27 -177.5 3.04 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.777 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 166' ' ' LYS . 38.6 ttmt -62.44 -26.21 68.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.04 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.649 ' OD1' ' HB3' ' A' ' 165' ' ' ASN . 54.0 p-10 -90.56 3.7 53.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.335 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 210' ' ' PRO . . . 86.04 -1.08 87.8 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.804 -0.635 . . . . 0.0 113.131 172.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 25.7 ttm-85 -64.67 129.22 38.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.698 0.285 . . . . 0.0 111.021 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.409 HG21 HD13 ' A' ' 153' ' ' ILE . 40.4 t -98.97 111.68 29.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.038 178.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.39 165.65 26.32 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 175.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.649 ' HE3' ' HG2' ' A' ' 156' ' ' PRO . 21.0 mtp -79.92 138.47 37.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.13 0.465 . . . . 0.0 110.229 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.592 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -133.7 145.61 56.87 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.023 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.479 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 4.6 Cg_exo -77.3 131.97 12.13 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.809 2.339 . . . . 0.0 112.371 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.569 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 57.2 t -62.05 -43.27 85.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 18.3 Cg_endo -61.37 -11.6 20.23 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.899 1.732 . . . . 0.0 112.903 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -92.17 -12.34 33.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.53 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.882 HG12 HG22 ' A' ' 130' ' ' THR . 32.7 m -126.6 162.17 31.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.228 0.537 . . . . 0.0 112.376 -169.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -133.98 134.77 42.89 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.931 176.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.526 ' HG2' HG22 ' A' ' 128' ' ' VAL . 45.9 mtmt -81.93 148.56 28.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.753 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.526 ' HB2' HH22 ' A' ' 129' ' ' ARG . 26.2 tp -76.92 -32.28 57.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 171.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 19.6 t -85.93 69.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.662 171.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.51 ' HE ' ' HE2' ' A' ' 180' ' ' LYS . 15.9 ttm180 -177.95 32.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.993 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.1 t -66.28 102.34 0.84 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.035 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.2 p -156.92 161.9 28.65 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.313 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.84 105.99 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.895 2.397 . . . . 0.0 112.731 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -103.82 -74.82 0.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -121.72 51.54 0.78 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 67.95 97.79 0.06 Allowed 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.586 0.754 . . . . 0.0 110.58 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -92.97 7.03 45.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.291 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.48 -24.16 63.51 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.452 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -75.33 -9.8 58.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.94 0.37 . . . . 0.0 110.198 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 64.78 -93.36 0.04 OUTLIER 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.793 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 60.1 t30 56.02 29.78 15.02 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.766 0.666 . . . . 0.0 111.129 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.5 m -74.01 -30.2 62.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.872 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -71.66 -42.05 67.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.887 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 56.1 p 50.37 -94.98 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.093 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -153.33 123.81 7.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 159.02 166.13 17.4 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.382 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 30.1 pt -92.5 139.57 23.84 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.852 0.358 . . . . 0.0 110.501 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 6.3 Cg_exo -74.43 85.11 1.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.773 2.315 . . . . 0.0 112.432 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -127.93 96.39 32.08 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.822 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.97 82.05 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.893 2.395 . . . . 0.0 112.022 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -103.62 158.07 16.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.613 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -92.76 95.11 9.35 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.24 3.94 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.531 -170.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.422 ' CD1' HD11 ' A' ' 62' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.479 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -100.38 2.37 42.31 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.477 ' CD ' ' HB ' ' A' ' 62' ' ' ILE . 7.1 tp60 -53.11 121.53 24.65 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.076 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.521 ' HA ' ' HD2' ' A' ' 164' ' ' ARG . 52.3 Cg_exo -55.58 100.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.219 1.946 . . . . 0.0 110.788 171.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -71.05 92.93 0.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.698 -173.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 16.8 m -49.87 -47.27 51.99 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.709 0.631 . . . . 0.0 111.544 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 19.6 m 57.36 76.0 0.34 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.421 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 12.7 m -64.93 112.92 9.16 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.864 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 1.7 Cg_endo -83.12 35.65 0.58 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.546 2.83 . . . . 0.0 112.204 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 94.4 mt 64.96 105.09 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.287 0 O-C-N 123.819 0.7 . . . . 0.0 111.066 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 220' ' ' SER . 55.4 Cg_endo -72.9 111.23 3.22 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.324 2.016 . . . . 0.0 112.049 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -80.61 -34.6 35.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.156 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.34 91.83 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.739 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 217' ' ' PRO . 28.9 t -128.14 91.76 3.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.54 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -129.85 144.9 16.06 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.311 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.9 p -67.74 138.57 93.25 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 122.398 0.279 . . . . 0.0 110.852 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.3 106.95 0.9 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.498 2.132 . . . . 0.0 112.098 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -91.89 120.34 6.03 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.283 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 73.24 -43.85 0.57 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.653 0.781 . . . . 0.0 112.705 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 60.24 42.5 15.09 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.228 0.537 . . . . 0.0 110.53 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.466 ' H ' HG13 ' A' ' 227' ' ' ILE . 2.4 pp -80.21 -5.94 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.645 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 26.2 m -76.27 130.51 77.33 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.27 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.27 -41.56 65.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.012 2.475 . . . . 0.0 112.945 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 48.8 tp -120.75 88.34 43.65 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.792 0.33 . . . . 0.0 110.401 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -95.02 10.37 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.389 2.726 . . . . 0.0 112.457 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 20.6 m -123.83 169.52 11.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.063 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 41.1 p -87.43 156.76 19.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.687 0.279 . . . . 0.0 110.796 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -66.17 98.16 0.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.832 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -98.11 -33.79 11.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.415 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.9 -135.18 1.9 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.761 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.25 160.26 39.54 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.749 2.3 . . . . 0.0 112.023 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.539 ' HB ' HG13 ' A' ' 266' ' ' VAL . 22.0 t -99.65 145.12 11.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -114.73 115.27 26.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.275 0.559 . . . . 0.0 110.941 -175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -136.55 127.6 27.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.889 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.789 ' HB3' HD13 ' A' ' 263' ' ' ILE . 22.3 pttm -93.06 140.51 29.41 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.271 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.4 110.52 6.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.613 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.477 HG13 ' HG3' ' A' ' 244' ' ' GLN . 26.6 pt -69.1 -32.69 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 111.04 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.477 ' HG3' HG13 ' A' ' 243' ' ' ILE . 92.7 mt-30 -118.41 166.2 12.95 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.478 ' HB3' HG13 ' A' ' 260' ' ' VAL . 9.3 ptpp? -94.81 146.16 24.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.42 0.628 . . . . 0.0 111.099 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.709 ' HB2' HH11 ' A' ' 246' ' ' ARG . 0.0 OUTLIER -128.28 110.85 12.77 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.35 173.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.839 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 33.7 m -82.21 173.3 7.82 Favored Pre-proline 0 C--N 1.316 -0.853 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.839 ' HD2' ' HB ' ' A' ' 247' ' ' VAL . 46.2 Cg_endo -69.1 52.88 0.81 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.615 2.21 . . . . 0.0 112.864 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 15.8 t -100.28 -146.71 0.34 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 61.11 19.06 9.63 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.306 0.575 . . . . 0.0 109.995 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 60.33 31.32 20.37 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.32 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 69.65 14.83 8.18 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.141 168.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -81.41 89.42 6.12 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.554 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.7 p 50.84 31.85 6.56 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.489 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -84.55 113.39 21.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.687 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.638 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.3 tt -88.86 117.3 27.76 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.68 120.74 14.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.586 HD22 HG22 ' A' ' 264' ' ' VAL . 95.0 mt -128.12 116.26 19.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.174 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -86.55 158.37 19.54 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.053 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 245' ' ' LYS . 9.6 m -62.1 110.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.509 0.671 . . . . 0.0 111.864 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.99 -1.44 57.79 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.96 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -79.32 138.55 37.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.841 0.321 . . . . 0.0 110.665 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.789 HD13 ' HB3' ' A' ' 241' ' ' LYS . 46.2 mm -84.1 116.64 28.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.04 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.586 HG22 HD22 ' A' ' 258' ' ' LEU . 40.4 t -89.31 114.09 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.307 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -86.26 88.7 7.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.539 HG13 ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -91.85 117.34 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.515 0.674 . . . . 0.0 110.714 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.06 -22.85 13.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.504 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.621 ' HB2' ' HG2' ' A' ' 276' ' ' GLU . 55.6 mtp180 -123.32 126.09 46.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.412 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 53.1 mtt -122.95 127.2 48.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.448 ' HB2' ' HG3' ' A' ' 274' ' ' GLN . 40.3 m-80 -91.68 139.79 30.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 25.9 pt -70.66 -8.29 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.903 0.383 . . . . 0.0 111.858 -173.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.1 -30.46 68.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.952 0.406 . . . . 0.0 110.774 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.3 -5.06 13.43 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.572 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.448 ' HG3' ' HB2' ' A' ' 270' ' ' ASN . 7.8 pt20 -94.69 115.0 27.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 175.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.483 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 36.5 m0 -110.42 145.58 37.35 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.146 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.621 ' HG2' ' HB2' ' A' ' 268' ' ' ARG . 1.4 pm0 -112.61 115.38 28.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.556 0.694 . . . . 0.0 110.383 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -118.22 164.21 12.87 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.112 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -102.02 110.79 22.84 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.638 ' HB ' HD21 ' A' ' 256' ' ' LEU . 98.7 t -122.76 117.87 53.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.204 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 64.36 -81.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.369 -175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -147.32 3.63 0.9 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.364 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.8 mtp-105 -108.31 144.54 35.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.845 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -120.44 121.57 38.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.847 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.512 ' H ' HD12 ' A' ' 256' ' ' LEU . . . -144.95 169.24 26.75 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.404 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 95.5 mt -93.56 113.99 26.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.975 0.417 . . . . 0.0 110.225 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -115.51 143.17 30.0 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.565 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.64 149.89 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.256 1.97 . . . . 0.0 112.205 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -65.17 -16.64 63.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.274 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -5.65 56.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.023 0.44 . . . . 0.0 111.597 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 246' ' ' ARG . 63.4 t60 -96.73 -18.76 19.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.01 0.433 . . . . 0.0 110.662 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 242' ' ' ALA . 31.3 m -128.03 170.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.419 -176.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -131.1 126.4 35.69 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 240' ' ' ALA . 41.5 mm -70.83 130.72 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -133.24 161.26 34.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.033 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -67.76 115.41 27.35 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.27 -25.25 64.66 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.754 2.303 . . . . 0.0 111.991 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -101.87 86.95 3.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.077 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -90.46 113.32 57.19 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.04 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.67 -13.24 22.24 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.359 2.04 . . . . 0.0 111.781 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.22 146.27 26.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.541 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 71.51 -75.4 0.08 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.996 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 303' ' ' GLU . 6.3 t30 -109.19 91.95 3.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -172.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 302' ' ' ASN . 10.7 tp10 . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.523 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.644 0.259 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.8 m -78.45 110.1 13.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.244 0.545 . . . . 0.0 110.667 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 t -142.94 147.86 35.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.258 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -73.6 85.3 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.27 0.557 . . . . 0.0 110.67 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -150.38 92.93 1.92 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.773 0.797 . . . . 0.0 110.652 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -138.88 162.8 33.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.18 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -78.24 93.19 4.58 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.634 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 4.5 p -77.26 65.15 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.304 0.573 . . . . 0.0 110.434 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.4 t -175.48 -41.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.079 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.36 104.46 0.5 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.489 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 9.1 mtm-85 -70.51 -14.39 62.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.554 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -85.31 -1.94 57.52 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.1 -47.79 5.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.722 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 30.2 p-90 -114.95 -29.99 6.53 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 47.9 t80 -75.42 111.21 10.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.631 ' HB3' HG21 ' A' ' 19' ' ' VAL . 10.7 tpp -100.58 1.53 40.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.367 -172.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.6 -114.71 3.23 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.013 -0.994 . . . . 0.0 114.225 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.58 104.3 1.85 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.429 2.086 . . . . 0.0 112.383 -176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.858 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 93.2 t -132.88 -76.35 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 119.256 -0.402 . . . . 0.0 112.037 -174.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.708 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 73.3 m 74.47 167.99 0.29 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -53.36 -32.79 50.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -44.46 -54.72 5.68 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.884 0.74 . . . . 0.0 112.111 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.617 ' HB2' HG13 ' A' ' 19' ' ' VAL . 47.3 mt-10 -95.6 -45.21 7.14 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.262 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.55 -46.65 28.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.28 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.666 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 20.7 mt-30 -64.71 -56.4 13.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.668 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -66.2 -23.44 66.44 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -171.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -86.24 -15.75 39.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.898 0.38 . . . . 0.0 110.692 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.601 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 68.7 mt -121.63 17.89 11.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.593 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 54.8 mm-40 -76.3 70.02 2.87 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.08 -20.04 52.38 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.677 171.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.788 ' HG2' ' HB3' ' A' ' 108' ' ' PRO . 26.1 mp0 -61.79 123.11 17.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.244 0.522 . . . . 0.0 111.477 -175.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 34.8 mtm180 55.58 -51.56 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.111 1.764 . . . . 0.0 115.19 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 32.0 m170 74.19 134.01 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.571 0.748 . . . . 0.0 109.143 -170.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.15 -3.24 44.13 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -172.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.759 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 76.1 mtm -96.62 147.72 23.6 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.438 ' CD1' HD22 ' A' ' 98' ' ' LEU . 45.8 p90 -146.68 165.94 28.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.613 0.244 . . . . 0.0 110.935 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.3 pp -152.8 136.04 15.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.94 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.8 t -103.86 122.8 57.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.49 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.858 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 9.6 ptt180 -121.63 165.63 15.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.507 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.423 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 3.9 p30 -85.57 138.8 31.93 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.52 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 8.5 t -74.45 135.73 42.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.212 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.1 t -78.13 -10.32 59.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.639 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -78.39 -48.34 15.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.581 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 41' ' ' SER . 48.4 t -159.03 135.98 6.79 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.37 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.42 5.08 2.1 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.303 2.002 . . . . 0.0 112.728 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.34 8.26 58.69 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.523 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -144.7 160.84 40.55 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.423 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 22.1 m-85 -124.78 164.05 20.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.955 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 62' ' ' ILE . 18.6 t -127.56 99.13 5.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 0.0 110.569 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.41 ' CB ' HD11 ' A' ' 63' ' ' ILE . 22.2 tp -78.17 101.31 6.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.134 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 59' ' ' SER . 58.4 m -96.75 131.98 42.91 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.385 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.617 HG21 HD13 ' A' ' 93' ' ' LEU . 47.2 t -119.36 151.82 21.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.835 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.601 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 14.1 t -102.59 119.02 38.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.999 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 1.101 ' HG2' ' HB3' ' A' ' 57' ' ' ARG . 7.1 pm0 -145.61 175.25 10.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 169.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.475 ' HB2' ' C ' ' A' ' 117' ' ' ASN . 6.0 p30 -36.2 89.51 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.391 1.076 . . . . 0.0 113.865 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.671 ' CB ' ' HA ' ' A' ' 116' ' ' PRO . 1.4 m 39.8 62.55 1.2 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.912 0.863 . . . . 0.0 110.023 -173.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.101 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -162.14 50.57 0.2 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.027 -154.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 38.2 t -76.62 95.63 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.566 ' OG ' ' HB ' ' A' ' 52' ' ' VAL . 12.5 p -77.88 119.35 21.22 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.281 -172.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 84.4 m-70 -101.11 88.13 3.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.081 -176.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.733 ' HB3' HD11 ' A' ' 73' ' ' ILE . 71.4 m-85 -93.12 112.12 23.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.516 0.327 . . . . 0.0 111.713 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.515 HG12 HG22 ' A' ' 49' ' ' VAL . 43.9 mt -82.17 140.56 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.1 mp -124.2 121.04 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.629 0.771 . . . . 0.0 110.603 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -85.39 135.57 33.82 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.7 t -80.86 103.23 10.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 72' ' ' LYS . 83.3 mt -85.6 132.13 45.5 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.877 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.46 -5.84 12.3 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.019 2.48 . . . . 0.0 112.28 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -87.85 14.76 8.12 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.81 31.29 14.2 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.518 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -121.14 176.04 5.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.881 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.446 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 58.9 m-85 -139.13 129.24 25.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.105 0.478 . . . . 0.0 110.692 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HB2' HD11 ' A' ' 66' ' ' LEU . 39.7 ttmt -115.94 108.01 15.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.73 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.733 HD11 ' HB3' ' A' ' 61' ' ' TYR . 15.9 tt -87.5 78.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.642 0.734 . . . . 0.0 110.17 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.545 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 61.68 81.37 0.09 OUTLIER Glycine 0 C--O 1.226 -0.4 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.89 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.847 ' HB2' ' HB2' ' A' ' 211' ' ' GLN . 37.8 t70 75.94 -48.09 0.58 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.962 0.505 . . . . 0.0 112.158 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -66.93 125.01 24.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.632 0.73 . . . . 0.0 111.744 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -84.47 131.79 34.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.129 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -139.53 173.77 11.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.998 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -77.04 -42.95 36.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.974 0.416 . . . . 0.0 110.454 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.486 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 6.8 p80 -172.49 -174.48 1.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.159 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 13.0 mt -54.4 -60.74 6.88 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.634 ' HB3' ' O ' ' A' ' 8' ' ' SER . 51.5 Cg_exo -58.43 -9.69 7.36 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.411 2.074 . . . . 0.0 113.795 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.469 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -94.48 -35.62 12.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.759 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.19 -29.7 57.75 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.323 0.582 . . . . 0.0 109.431 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.17 -30.64 70.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.794 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.422 ' HA ' ' CD ' ' A' ' 89' ' ' LYS . 33.9 tt0 -76.43 -7.98 56.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.37 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -97.23 -37.17 10.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.499 0.666 . . . . 0.0 109.445 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.573 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 38.8 m-85 -81.0 -10.32 59.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.466 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.422 ' CD ' ' HA ' ' A' ' 86' ' ' GLU . 22.4 ptmt -81.31 -7.34 59.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.225 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.6 pt -123.74 3.67 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 121.262 0.553 . . . . 0.0 110.619 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.573 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 4.5 t-160 -97.13 -40.27 8.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.435 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.719 ' CD2' HG23 ' A' ' 97' ' ' THR . 95.7 m-85 75.17 88.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.416 1.073 . . . . 0.0 110.472 -172.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.732 HD22 ' CE2' ' A' ' 61' ' ' TYR . 2.0 mt -66.51 97.88 0.46 Allowed 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.743 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 9.4 t70 56.33 73.13 0.46 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.021 -175.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 27.2 m 75.32 -39.32 0.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -107.75 139.9 41.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.176 0.512 . . . . 0.0 111.047 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.719 HG23 ' CD2' ' A' ' 92' ' ' TYR . 2.9 p -83.62 177.14 8.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.789 0.328 . . . . 0.0 110.527 176.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.438 HD22 ' CD1' ' A' ' 36' ' ' PHE . 81.5 mt -70.05 98.44 1.31 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 172.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 50.8 mm -84.47 -55.73 6.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.808 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 35' ' ' MET . 36.7 tt0 -167.02 141.59 3.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.061 -175.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.12 157.74 28.59 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.556 2.171 . . . . 0.0 112.734 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.43 144.49 57.5 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.818 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HD3' ' SD ' ' A' ' 35' ' ' MET . 33.5 Cg_exo -60.42 131.68 39.65 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.569 2.179 . . . . 0.0 111.594 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.471 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 26.3 ptt180 -80.51 30.95 0.29 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.748 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -131.36 135.19 26.66 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.44 53.92 3.22 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.175 2.584 . . . . 0.0 113.131 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.653 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 11.2 t -84.61 -43.94 0.71 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.788 ' HB3' ' HG2' ' A' ' 31' ' ' GLN . 10.1 Cg_endo -52.76 134.88 55.73 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.468 2.112 . . . . 0.0 112.955 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.87 155.78 23.59 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.676 2.251 . . . . 0.0 112.413 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 50.8 ttm -83.99 106.69 15.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.602 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.01 111.77 4.47 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.895 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m -83.84 75.13 10.12 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.834 -0.215 . . . . 0.0 111.477 -176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.58 ' HA ' ' HB2' ' A' ' 121' ' ' ALA . 7.1 p 35.53 84.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.454 1.102 . . . . 0.0 113.966 173.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 m -97.03 -57.52 2.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.292 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.628 ' HB3' ' HG2' ' A' ' 119' ' ' PRO . . . -172.54 144.8 1.35 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.762 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.671 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 6.3 Cg_exo -79.81 168.08 19.69 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.964 2.442 . . . . 0.0 112.512 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.549 ' H ' ' HB2' ' A' ' 56' ' ' SER . 84.8 m-20 73.03 8.5 5.4 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 173.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.903 ' HB3' ' HD3' ' A' ' 119' ' ' PRO . 1.0 OUTLIER -169.64 -68.35 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.167 169.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.903 ' HD3' ' HB3' ' A' ' 118' ' ' LEU . 37.3 Cg_exo -61.74 -76.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 122.478 2.119 . . . . 0.0 114.034 -173.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.5 t -172.19 169.22 5.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.528 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.58 ' HB2' ' HA ' ' A' ' 113' ' ' VAL . . . 80.84 144.99 0.08 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.486 1.114 . . . . 0.0 112.917 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.436 ' OE2' ' HB ' ' A' ' 58' ' ' VAL . 54.9 mt-10 -94.9 119.19 33.04 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.312 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.435 ' HB3' ' HG3' ' A' ' 116' ' ' PRO . 26.4 t70 -152.78 -77.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.454 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 1.9 t-20 -82.65 168.66 17.06 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.842 HD12 HG21 ' A' ' 152' ' ' ILE . 2.2 mm? 65.88 94.05 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.635 0.584 . . . . 0.0 109.887 -175.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 5.2 tp10 -165.86 -76.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.413 -171.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.487 ' O ' ' HB2' ' A' ' 180' ' ' LYS . 28.5 m-85 -106.01 124.4 49.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.753 -171.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 22.3 t -133.22 151.36 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.112 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.727 ' HG2' ' HB3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -131.02 142.11 50.29 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.681 162.287 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.472 HG22 HG12 ' A' ' 178' ' ' VAL . 1.8 p -97.94 140.22 32.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.914 0.387 . . . . 0.0 111.949 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 61.8 mt -108.55 -22.63 12.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.14 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 57.0 t80 -92.33 -35.04 13.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -167.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 7.0 t70 76.01 113.19 0.07 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.337 0.589 . . . . 0.0 110.395 -174.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 71.4 t80 -147.19 109.51 3.96 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.068 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 20.9 Cg_endo -92.91 102.28 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.53 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.737 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -95.12 4.27 67.47 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.365 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 57.54 20.63 6.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.331 0.653 . . . . 0.0 112.547 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 169' ' ' ARG . 1.9 p30 52.2 -175.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 173.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 69.09 7.2 6.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.494 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -169.39 -45.7 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.241 -1.345 . . . . 0.0 108.361 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.737 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 24.2 m-20 -140.85 116.04 9.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.759 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.048 HD11 ' HB2' ' A' ' 165' ' ' ASN . 25.2 tp -67.53 120.57 74.03 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.617 0.246 . . . . 0.0 110.937 -174.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 43.6 Cg_endo -75.13 95.59 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.031 1.821 . . . . 0.0 111.346 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 10.0 p90 -104.6 172.58 6.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.567 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.468 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 8.7 ttmm -122.52 -178.14 3.82 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.941 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.637 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -84.02 75.18 10.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.458 0.647 . . . . 0.0 109.604 177.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.9 33.83 0.54 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.171 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 6.7 mm-40 -94.62 154.95 17.1 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 129' ' ' ARG . 40.0 mm -103.85 125.84 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.559 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 32.9 mt -118.82 156.77 28.85 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 59.8 t -124.83 129.79 73.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.842 HG21 HD12 ' A' ' 125' ' ' LEU . 30.6 mm -74.55 86.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.384 1.088 . . . . 0.0 109.073 -176.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 210' ' ' PRO . 10.4 tt -75.18 -26.42 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.341 -174.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.785 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 44.5 mt-10 -146.69 143.91 29.08 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.437 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 44.4 tttm -125.34 87.44 55.64 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 121.46 -0.775 . . . . 0.0 111.026 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.597 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 16.8 Cg_exo -70.62 -62.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.387 2.058 . . . . 0.0 112.542 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -109.63 -174.8 2.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.845 0.355 . . . . 0.0 111.748 -171.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -95.81 -29.15 14.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.324 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -96.18 -22.53 17.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.155 0.502 . . . . 0.0 110.82 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.49 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 42.5 m95 -128.93 124.55 35.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.67 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -107.42 164.87 11.83 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.785 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 29.3 m -113.13 106.66 14.92 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.926 -0.484 . . . . 0.0 109.748 174.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.772 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -115.95 158.92 22.3 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.388 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.708 HH12 ' HA ' ' A' ' 208' ' ' ALA . 13.2 ptt180 -95.48 132.43 40.58 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.355 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.048 ' HB2' HD11 ' A' ' 142' ' ' LEU . 63.0 t30 -72.0 171.35 12.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.522 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -59.31 -29.79 67.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.45 -43.43 94.28 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.783 ' HA3' ' HA ' ' A' ' 211' ' ' GLN . . . 105.02 67.43 0.7 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.866 -176.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.665 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -143.73 160.01 41.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.438 HG22 HD13 ' A' ' 153' ' ' ILE . 37.5 t -101.75 125.57 55.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.307 0.575 . . . . 0.0 111.986 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.6 161.9 30.44 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.597 ' HE3' ' HG2' ' A' ' 156' ' ' PRO . 25.6 mtp -81.07 144.25 31.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.179 0.489 . . . . 0.0 110.271 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.504 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.7 pp -139.66 143.4 35.02 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.875 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.49 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 3.0 Cg_exo -76.3 132.65 13.94 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.897 2.398 . . . . 0.0 112.561 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 178' ' ' VAL . 60.3 t -62.8 -43.03 81.87 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 23.2 Cg_endo -62.57 -4.39 5.56 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.953 1.769 . . . . 0.0 113.302 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -99.64 -8.57 24.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.592 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 175' ' ' VAL . 10.5 m -107.24 -178.33 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 122.265 1.031 . . . . 0.0 113.576 -168.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.727 ' HB3' ' HG2' ' A' ' 129' ' ' ARG . 23.6 tt0 -154.46 42.13 0.49 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.098 -1.865 . . . . 0.0 109.221 -165.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.955 ' HE3' ' HB2' ' A' ' 183' ' ' ARG . 0.1 OUTLIER -77.69 137.74 38.68 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 120.432 -1.418 . . . . 0.0 108.817 -167.282 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.421 HD23 ' HB3' ' A' ' 127' ' ' TYR . 4.6 mm? -30.51 -76.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 113.303 -1.771 . . . . 0.0 114.085 -157.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.8 t -118.88 110.49 30.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.415 -175.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.955 ' HB2' ' HE3' ' A' ' 180' ' ' LYS . 18.2 ttt180 -170.07 99.53 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 173.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.5 t -134.83 97.72 3.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.262 0.553 . . . . 0.0 110.194 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.425 ' HB3' ' HE1' ' A' ' 187' ' ' HIS . 8.3 t -88.53 136.43 31.37 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.65 127.28 22.13 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.589 2.193 . . . . 0.0 112.363 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 190' ' ' HIS . 80.3 m80 -139.35 170.62 15.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -58.92 -59.19 11.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.457 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -125.79 59.2 1.3 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.96 0.409 . . . . 0.0 110.434 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 187' ' ' HIS . 51.0 t60 -161.5 118.25 2.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.697 173.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -172.45 -158.64 17.17 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.886 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -142.98 143.49 31.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.726 0.298 . . . . 0.0 110.327 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -84.76 -40.43 17.26 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -156.46 140.76 16.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.98 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 51.8 m -143.4 114.74 7.96 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -143.75 113.63 7.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.365 0.602 . . . . 0.0 110.779 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.498 ' HB3' HD13 ' A' ' 200' ' ' ILE . 38.8 m -149.19 83.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.847 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -94.73 -36.49 11.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.795 -174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -88.94 32.68 4.5 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.538 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.642 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 2.6 mp -114.1 -54.14 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 119.751 -0.166 . . . . 0.0 111.225 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 16.2 Cg_exo -68.59 106.94 1.53 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.155 1.903 . . . . 0.0 112.711 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -118.27 109.38 40.68 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.457 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.46 94.8 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.688 2.259 . . . . 0.0 111.838 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -96.2 -51.11 4.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.488 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -152.61 93.2 1.75 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.789 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -76.85 90.23 3.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.233 0.539 . . . . 0.0 111.658 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.411 ' HD2' ' HB3' ' A' ' 60' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.708 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -91.39 39.38 1.0 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.399 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.481 ' HG2' ' HB ' ' A' ' 62' ' ' ILE . 39.5 mt-30 -61.29 146.01 89.51 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.545 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 52.8 Cg_exo -57.15 -51.44 8.69 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 121.936 1.757 . . . . 0.0 110.76 172.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.847 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 50.2 tt0 -85.09 111.06 19.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.523 ' HB ' ' HE ' ' A' ' 164' ' ' ARG . 15.2 t -62.08 -39.92 94.06 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.185 -0.206 . . . . 0.0 110.715 -176.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 25.2 m 68.83 -63.01 0.37 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.929 0.492 . . . . 0.0 111.774 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 4.7 m 62.63 78.18 0.31 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.78 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.74 128.81 5.37 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.885 2.39 . . . . 0.0 111.262 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.75 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 6.3 mp -103.78 -58.24 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.618 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.75 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 27.9 Cg_exo -63.28 -19.83 69.25 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.286 1.991 . . . . 0.0 112.539 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -86.0 21.12 2.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.661 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.623 HG22 ' H ' ' A' ' 221' ' ' GLY . 11.5 p -89.25 132.48 33.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.056 0.455 . . . . 0.0 110.276 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 11.0 p -91.72 -12.91 32.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.959 0.409 . . . . 0.0 110.923 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.623 ' H ' HG22 ' A' ' 219' ' ' VAL . . . 88.53 -116.32 4.59 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 9.5 t 69.37 100.71 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.059 0.544 . . . . 0.0 111.615 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.93 167.75 25.52 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.505 2.137 . . . . 0.0 111.919 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -81.43 70.27 3.13 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.379 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.53 -35.09 17.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.628 0.251 . . . . 0.0 110.666 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 57.14 -171.58 0.09 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.863 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.2 tt -89.32 -38.48 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.215 0.531 . . . . 0.0 109.575 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 229' ' ' PRO . 4.7 p -134.31 112.63 12.07 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.992 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 228' ' ' THR . 17.8 Cg_endo -60.94 -32.05 92.11 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.712 2.275 . . . . 0.0 112.178 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -146.46 108.82 4.17 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.02 116.96 3.67 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 111.987 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 12.3 t -84.18 124.83 31.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.003 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 12.5 p -102.43 154.93 18.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.127 0.489 . . . . 0.0 111.44 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -130.38 27.3 5.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.554 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -171.49 119.44 0.46 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.118 -164.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.836 ' HA3' ' HB3' ' A' ' 276' ' ' GLU . . . -133.64 -175.92 14.15 Favored Glycine 0 C--O 1.19 -2.639 0 CA-C-O 118.474 -1.181 . . . . 0.0 111.498 177.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.944 ' HD2' ' H ' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -14.42 -134.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.519 3.017 2 C-N-CA 130.787 7.658 . . . . 0.0 124.952 -168.747 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.877 ' N ' HG13 ' A' ' 266' ' ' VAL . 88.8 t -131.52 131.84 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.965 -1.085 . . . . 0.0 111.988 -165.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 1.01 ' HB2' ' HA ' ' A' ' 265' ' ' LYS . 0.0 OUTLIER -69.21 130.61 43.12 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.333 1.063 . . . . 0.0 111.996 -160.537 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.535 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -148.63 159.41 44.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.802 -168.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -91.3 135.78 33.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.579 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -77.56 126.5 30.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 31.9 pt -101.75 -6.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.439 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.32 155.63 43.25 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.578 ' HB3' HG23 ' A' ' 260' ' ' VAL . 18.4 pttp -113.88 137.02 52.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.749 0.309 . . . . 0.0 110.777 174.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.549 ' HG3' ' CE1' ' A' ' 290' ' ' HIS . 0.0 OUTLIER -174.72 137.61 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 1.058 HG13 ' HD3' ' A' ' 248' ' ' PRO . 0.2 OUTLIER -95.61 -52.33 0.23 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 119.248 -0.406 . . . . 0.0 112.041 178.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 1.058 ' HD3' HG13 ' A' ' 247' ' ' VAL . 33.6 Cg_endo -95.53 143.8 1.22 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.119 1.88 . . . . 0.0 111.997 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 45.7 t -84.76 58.94 5.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 65.9 -66.21 0.16 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.798 0.839 . . . . 0.0 111.453 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -102.53 -11.01 18.84 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.199 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 31.4 t70 67.32 106.76 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.917 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -135.68 86.39 2.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.765 174.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.7 p 51.4 57.6 6.42 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.987 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -89.64 147.77 23.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.577 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.39 110.15 22.29 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 247' ' ' VAL . . . -56.75 105.48 0.22 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.514 0.509 . . . . 0.0 110.588 177.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 279' ' ' VAL . 90.8 mt -118.38 130.59 56.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.018 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -111.79 173.7 6.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.038 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.578 HG23 ' HB3' ' A' ' 245' ' ' LYS . 57.7 t -75.58 124.57 33.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 112.109 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 88.25 25.31 31.52 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.383 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.28 150.84 36.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.135 0.468 . . . . 0.0 110.389 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 30.7 mm -86.52 123.19 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.317 0.579 . . . . 0.0 111.639 -175.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.73 ' HA ' HG22 ' A' ' 279' ' ' VAL . 44.7 t -101.07 103.2 14.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.772 177.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 1.01 ' HA ' ' HB2' ' A' ' 239' ' ' PHE . 18.0 ttpp -86.03 86.5 7.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.006 0.432 . . . . 0.0 110.667 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.877 HG13 ' N ' ' A' ' 238' ' ' VAL . 13.7 p -105.29 136.46 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 236' ' ' GLY . 15.3 t -124.55 -14.41 6.85 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -167.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 236' ' ' GLY . 35.1 ttt180 -135.78 98.64 3.96 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 120.921 1.691 . . . . 0.0 111.744 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' MET . . . . . 0.891 ' CA ' ' HA ' ' A' ' 237' ' ' PRO . 34.1 ttm -79.1 140.29 37.88 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -162.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.561 ' H ' ' HG3' ' A' ' 237' ' ' PRO . 83.2 m-20 -98.3 137.0 37.67 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.734 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.6 tt -75.93 -8.35 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.267 0.556 . . . . 0.0 110.623 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -69.21 -28.51 66.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.945 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 109.48 -17.79 30.68 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.696 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.1 118.82 29.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.879 ' HA ' ' HG2' ' A' ' 237' ' ' PRO . 47.3 m0 -98.85 145.03 27.4 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.051 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.944 ' H ' ' HD2' ' A' ' 237' ' ' PRO . 38.7 tt0 -117.93 97.41 5.81 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.275 0.56 . . . . 0.0 109.741 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -107.61 150.73 16.9 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.153 -168.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -104.65 109.83 21.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.73 HG22 ' HA ' ' A' ' 264' ' ' VAL . 60.4 t -114.39 91.27 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.083 0.468 . . . . 0.0 110.453 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 54.37 55.89 7.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.814 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 97.71 -28.33 14.86 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.512 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.1 mtm105 -104.39 118.48 36.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.945 0.373 . . . . 0.0 110.377 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 47.9 pttt -121.31 142.44 49.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.084 0.468 . . . . 0.0 111.882 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -171.07 -174.48 38.91 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.484 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 87.0 mt -93.38 144.75 25.04 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.583 0.706 . . . . 0.0 111.905 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.464 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 36.1 p90 -149.77 151.41 32.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.999 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 290' ' ' HIS . 60.8 Cg_endo -74.34 151.71 43.39 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.261 1.974 . . . . 0.0 112.26 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -64.25 -21.34 66.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.636 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.2 m -77.22 -8.53 57.73 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.229 0.538 . . . . 0.0 110.992 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.549 ' CE1' ' HG3' ' A' ' 246' ' ' ARG . 16.5 t60 -86.03 -22.01 27.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.157 0.503 . . . . 0.0 110.631 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.0 m -128.31 178.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.501 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -141.29 136.91 32.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.524 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.535 HD13 ' HB2' ' A' ' 240' ' ' ALA . 47.2 mm -81.68 102.82 7.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -100.23 14.44 30.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.825 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 53.58 70.72 1.64 Allowed Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.348 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.76 -22.34 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.119 2.546 . . . . 0.0 113.634 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -140.63 19.84 2.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.03 0.443 . . . . 0.0 110.864 -176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -140.14 115.56 7.82 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.339 0.59 . . . . 0.0 110.625 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -86.69 41.61 0.8 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.161 2.574 . . . . 0.0 111.881 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -114.42 127.31 55.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.503 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -87.52 -0.9 57.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.999 170.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.426 ' OD1' ' HG2' ' A' ' 303' ' ' GLU . 22.4 t-20 64.45 -95.56 0.04 OUTLIER 'General case' 0 C--O 1.23 0.067 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.839 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' GLU . . . . . 0.426 ' HG2' ' OD1' ' A' ' 302' ' ' ASN . 6.0 pt-20 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 117.622 -1.18 . . . . 0.0 109.573 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.713 ' HG3' ' HE2' ' A' ' 89' ' ' LYS . 25.8 mmt . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.859 0.362 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.8 p -87.39 -57.43 2.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.99 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -128.74 100.61 5.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.977 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -179.65 135.72 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.445 0.466 . . . . 0.0 111.054 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 6' ' ' PHE . 4.4 tmt_? -113.9 -68.07 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 5.4 m-85 62.96 165.28 0.11 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -109.53 -39.35 5.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.818 161.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.2 m 64.68 147.56 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.037 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.0 p 61.15 -49.65 0.12 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.988 1.315 . . . . 0.0 113.875 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -57.31 107.01 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 111.586 -172.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.601 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -61.97 -22.81 65.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.479 -178.321 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.2 t -79.32 -15.96 57.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.641 0.258 . . . . 0.0 110.862 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.93 -49.03 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.168 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -110.83 -22.81 11.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.601 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 56.2 t80 -85.57 113.13 21.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.713 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 9.6 tpp -97.42 -1.16 44.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.555 -172.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.444 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.44 -115.43 3.75 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.159 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.1 Cg_exo -74.75 103.61 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.842 2.361 . . . . 0.0 112.187 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.636 ' HB ' ' CB ' ' A' ' 39' ' ' ARG . 88.3 t -137.36 -74.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 60.0 m 76.02 172.12 0.25 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.493 ' HA ' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -51.95 -43.69 63.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -174.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -60.37 -38.04 82.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -92.35 -44.79 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.385 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.56 68.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.882 0.372 . . . . 0.0 111.121 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.57 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 64.9 tt0 -67.37 -52.83 35.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.908 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -72.71 -14.25 61.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 0.0 111.425 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -78.65 -44.07 24.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.565 0.697 . . . . 0.0 110.055 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 16.1 mt -104.25 12.07 34.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.491 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 20.8 tt0 -76.87 104.45 7.37 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.618 0.723 . . . . 0.0 110.573 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.499 ' H ' ' NE2' ' A' ' 31' ' ' GLN . . . 118.02 -20.82 10.53 Favored Glycine 0 CA--C 1.499 -0.917 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.922 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER 40.11 111.02 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 112.592 -1.804 . . . . 0.0 115.185 172.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.734 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 39.6 ttp180 -68.84 -10.22 55.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.959 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 1.2 m-70 74.26 122.5 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.113 176.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.54 19.99 49.83 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.059 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.456 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 35.8 mtm -115.49 147.58 40.48 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' ' 50' ' ' LEU . 40.0 p90 -147.44 158.85 44.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.129 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 pp -150.95 135.35 16.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.218 0.533 . . . . 0.0 110.507 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.11 115.58 44.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.113 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.636 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.68 -173.44 2.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.05 0.452 . . . . 0.0 112.048 -176.4 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 7.3 p-10 -71.23 138.06 49.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.874 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -100.42 89.14 3.86 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 168.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 p -71.75 11.82 0.46 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.449 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 t -100.19 -8.51 23.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 50.3 t -164.76 110.0 0.84 Allowed Pre-proline 0 CA--C 1.528 0.121 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.079 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.04 115.83 2.83 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.966 2.444 . . . . 0.0 112.466 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.48 -41.94 1.78 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.049 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.646 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 3.3 m-20 -74.3 158.66 33.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.723 0.297 . . . . 0.0 110.483 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.404 ' CD2' HD11 ' A' ' 81' ' ' LEU . 46.2 m-85 -134.68 173.91 11.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.695 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.634 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 58.4 t -137.94 109.38 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 111.007 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 36' ' ' PHE . 26.2 tp -81.03 104.55 11.6 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.536 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 m -95.46 120.95 36.6 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.856 0.36 . . . . 0.0 110.34 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 22.1 t -120.4 142.55 35.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.922 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 89.2 p -121.99 133.56 54.82 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.531 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.505 ' CB ' ' HB3' ' A' ' 94' ' ' ASP . 1.9 tm-20 -147.94 178.15 8.75 Favored 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.44 ' HA ' ' CE1' ' A' ' 33' ' ' HIS . 5.1 p30 -16.94 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.455 ' HB2' ' H ' ' A' ' 122' ' ' GLU . 36.3 m 35.91 72.13 0.11 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.706 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.906 ' HD2' ' HB3' ' A' ' 155' ' ' LYS . 9.8 ttp85 -168.51 52.93 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.743 -158.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 25.3 t -77.68 101.62 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 122.07 0.938 . . . . 0.0 109.651 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 m -93.21 121.22 34.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.323 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -94.25 89.45 5.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.283 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.772 ' HB3' HD11 ' A' ' 73' ' ' ILE . 88.0 m-85 -84.81 115.07 22.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.725 0.41 . . . . 0.0 110.786 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.632 HD12 ' HG2' ' A' ' 209' ' ' GLN . 63.1 mt -81.3 140.0 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -174.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.663 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.6 mp -115.75 121.19 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.597 0.759 . . . . 0.0 110.568 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.646 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 8.3 m120 -85.74 146.28 26.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.916 0.487 . . . . 0.0 111.566 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.0 t -93.18 99.18 11.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.924 174.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.4 mt -84.22 142.91 41.44 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.48 -28.78 46.31 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.617 2.878 . . . . 0.0 114.115 -172.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -91.63 20.15 5.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.412 -0.18 . . . . 0.0 111.383 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.538 ' HD2' ' HB3' ' A' ' 280' ' ' ASN . 0.0 OUTLIER 67.43 40.21 2.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.139 0.495 . . . . 0.0 111.045 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -113.61 148.24 36.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.489 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 58.7 m-85 -114.71 115.77 27.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.936 0.398 . . . . 0.0 111.297 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 39.5 ttpt -110.77 105.94 14.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.538 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.772 HD11 ' HB3' ' A' ' 61' ' ' TYR . 10.2 tt -81.74 76.99 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.842 0.83 . . . . 0.0 110.175 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.845 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 60.73 95.15 0.01 OUTLIER Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.547 178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 15.9 t70 74.93 -49.51 0.66 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.849 0.357 . . . . 0.0 111.498 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -85.15 113.25 21.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 11.6 pt-20 -101.7 134.96 44.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.317 0.579 . . . . 0.0 110.816 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 80.1 m-85 -121.73 174.14 7.02 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.956 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.27 -46.89 85.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.026 0.441 . . . . 0.0 110.885 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -166.47 -178.07 4.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.427 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.519 HD23 HD21 ' A' ' 84' ' ' LEU . 16.4 mt -55.19 -57.49 19.78 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.51 25.46 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.062 1.841 . . . . 0.0 112.831 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 81' ' ' LEU . . . -119.81 -34.86 3.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.951 175.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.519 HD21 HD23 ' A' ' 81' ' ' LEU . 3.7 pp -76.68 -30.82 56.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.214 0.531 . . . . 0.0 109.968 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 6' ' ' PHE . 48.6 mt -64.57 -41.48 96.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.403 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.641 ' HA ' ' HD2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -69.5 -4.08 17.31 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.562 178.486 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -96.21 -37.69 10.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.812 0.815 . . . . 0.0 109.637 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.813 ' CD1' HD23 ' A' ' 93' ' ' LEU . 46.7 m-85 -77.37 -2.92 37.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.506 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.713 ' HE2' ' HG3' ' A' ' 1' ' ' MET . 16.5 ptmt -78.86 -11.11 59.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.607 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.99 -12.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 120.936 0.398 . . . . 0.0 110.88 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -75.46 -29.68 59.71 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.867 ' HA ' HG22 ' A' ' 97' ' ' THR . 23.0 m-85 59.14 55.21 4.48 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.7 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.813 HD23 ' CD1' ' A' ' 88' ' ' TYR . 3.4 pp -60.9 123.27 17.08 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 118.463 -1.295 . . . . 0.0 107.518 169.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 1.9 m-20 81.6 -2.5 1.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.28 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.798 ' OG1' ' HB3' ' A' ' 156' ' ' PRO . 33.6 m 55.99 75.55 0.33 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 122.054 0.93 . . . . 0.0 110.665 -172.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m 179.06 -34.32 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.211 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.867 HG22 ' HA ' ' A' ' 92' ' ' TYR . 4.8 p 73.38 -172.17 0.13 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.641 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 35.0 mt -85.65 94.13 9.0 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.478 173.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.79 -56.87 10.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.557 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 11.2 pt-20 -157.5 163.56 24.42 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.497 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 100' ' ' GLU . 40.4 Cg_endo -67.32 153.09 78.06 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.129 1.886 . . . . 0.0 113.026 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -71.98 143.34 86.36 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.467 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 24.0 Cg_exo -64.57 155.94 63.74 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.548 2.165 . . . . 0.0 112.066 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.713 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 14.1 mtm180 -93.94 -79.93 0.4 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 65.0 120.6 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 124.043 0.839 . . . . 0.0 112.881 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.67 -11.6 22.14 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.516 2.144 . . . . 0.0 111.385 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.486 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 47.7 t -140.25 129.17 13.23 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.023 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 107' ' ' SER . 16.7 Cg_exo -66.88 111.98 2.34 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.828 2.352 . . . . 0.0 111.91 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.58 -31.09 1.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.45 2.1 . . . . 0.0 112.763 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 97.1 mmm 62.4 175.28 0.14 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.781 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.17 118.73 1.05 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.742 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.3 m -155.25 85.2 1.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.93 -27.06 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.722 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 p -103.32 87.49 2.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.117 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.486 ' CB ' ' HG3' ' A' ' 32' ' ' ARG . . . -169.49 143.54 2.3 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.428 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 32' ' ' ARG . 1.3 Cg_endo -86.03 30.81 0.48 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 123.849 3.032 . . . . 0.0 111.999 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.734 ' OD1' ' HA ' ' A' ' 32' ' ' ARG . 5.0 m-20 -50.52 142.37 10.82 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.697 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.1 mt 49.2 74.21 0.85 Allowed Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.807 174.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -93.41 -36.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.571 2.18 . . . . 0.0 111.859 168.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 90.5 m -160.85 145.86 14.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.32 103.97 16.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.455 ' H ' ' HB2' ' A' ' 56' ' ' SER . 4.3 tp10 -93.96 118.37 31.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.229 -172.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -136.12 -11.94 1.93 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.582 0.706 . . . . 0.0 109.818 176.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.716 ' HA ' HG11 ' A' ' 182' ' ' VAL . 0.9 OUTLIER -79.47 -12.2 59.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.028 -178.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 1.05 HD12 HG21 ' A' ' 152' ' ' ILE . 3.5 mm? -100.49 107.07 18.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.244 -173.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -170.14 -81.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.878 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -104.66 124.63 49.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.207 0.527 . . . . 0.0 110.655 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.697 HG22 ' CB ' ' A' ' 180' ' ' LYS . 61.4 t -133.53 137.15 53.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.407 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.613 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 2.3 ptp180 -114.31 146.67 40.19 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.066 167.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.58 HG22 HG12 ' A' ' 178' ' ' VAL . 2.1 p -103.58 135.28 45.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.017 0.436 . . . . 0.0 111.577 -176.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.586 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 78.3 mt -101.46 -40.1 7.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.421 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 23.1 t80 -74.28 -35.12 63.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -168.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.571 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.1 t70 73.47 107.34 0.07 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.247 0.546 . . . . 0.0 110.095 -177.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 77.3 t80 -140.92 103.25 6.26 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.78 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 33.7 Cg_endo -90.08 93.06 0.3 Allowed 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.378 2.052 . . . . 0.0 112.11 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -83.31 -21.16 59.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.014 174.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.9 m120 48.22 47.58 19.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.492 -0.854 . . . . 0.0 111.967 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 141' ' ' ASP . 20.1 t70 -141.14 161.04 38.8 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.55 -7.12 53.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.271 0.558 . . . . 0.0 110.98 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 172' ' ' MET . 1.4 mp0 -125.62 15.51 8.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.695 172.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.67 ' HB2' ' HB3' ' A' ' 138' ' ' ASP . 20.4 m-20 -146.61 87.75 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.788 HD11 ' HB2' ' A' ' 165' ' ' ASN . 27.1 tp -69.76 119.96 74.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.49 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.78 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 59.2 Cg_endo -73.99 90.97 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.221 1.948 . . . . 0.0 111.434 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 11.4 p90 -99.6 158.74 15.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.571 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 72.9 mmtt -98.94 178.75 4.85 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.278 0.561 . . . . 0.0 111.322 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.76 18.21 2.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.596 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.64 29.87 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.35 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 145' ' ' LYS . 24.0 tt0 -99.81 156.64 17.0 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.48 HD13 ' HB3' ' A' ' 129' ' ' ARG . 50.4 mm -99.02 133.52 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.63 HD22 HD21 ' A' ' 142' ' ' LEU . 57.4 mt -120.54 157.04 30.32 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.14 132.47 70.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.05 HG21 HD12 ' A' ' 125' ' ' LEU . 35.5 mm -75.09 88.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 122.184 0.992 . . . . 0.0 109.633 -176.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.468 HG21 HG22 ' A' ' 170' ' ' VAL . 21.5 tt -76.96 -31.32 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.189 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.997 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 65.5 mt-10 -132.63 141.46 48.66 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 171.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.906 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 1.9 tptm -129.8 84.14 61.95 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 122.305 1.05 . . . . 0.0 109.357 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.798 ' HB3' ' OG1' ' A' ' 95' ' ' THR . 19.3 Cg_exo -77.73 -66.78 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.413 2.742 . . . . 0.0 113.308 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -94.55 175.93 6.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.956 -172.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.78 -10.26 20.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -123.46 -3.34 8.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.272 0.558 . . . . 0.0 110.602 173.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.667 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 58.4 m95 -129.75 125.74 36.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.395 173.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.762 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.4 m0 -122.22 135.68 54.79 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.31 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.997 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.6 m -90.28 92.8 9.08 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.192 0.52 . . . . 0.0 109.632 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.69 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -94.22 163.27 13.51 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.939 0.4 . . . . 0.0 110.657 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.609 HH12 ' HA ' ' A' ' 208' ' ' ALA . 13.3 ptt180 -100.78 132.3 46.25 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.44 0.638 . . . . 0.0 110.583 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.788 ' HB2' HD11 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -50.3 139.06 15.65 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.467 172.484 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 166' ' ' LYS . 12.4 tmtt? -56.85 -27.0 59.7 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.453 ' OD1' ' HA ' ' A' ' 215' ' ' PRO . 67.1 m-20 -99.93 9.6 42.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.583 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.64 ' HA3' HG23 ' A' ' 212' ' ' THR . . . 95.5 83.11 1.63 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.21 -0.995 . . . . 0.0 115.279 166.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 169' ' ' ARG . 2.5 ptp180 -173.04 157.63 3.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.508 0.194 . . . . 0.0 110.488 162.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 153' ' ' ILE . 48.0 t -98.32 129.91 47.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 142' ' ' LEU . . . -154.44 152.79 24.31 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.102 172.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.69 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -73.45 138.44 45.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.652 0.263 . . . . 0.0 110.461 177.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.762 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -136.71 144.65 47.84 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.74 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.898 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 23.7 Cg_exo -68.22 139.12 45.19 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.28 2.653 . . . . 0.0 112.989 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 178' ' ' VAL . 88.0 t -76.34 -47.61 3.35 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.7 Cg_endo -66.08 6.43 0.49 Allowed 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.994 1.796 . . . . 0.0 111.909 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.898 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 1.2 m-85 -105.76 -1.64 24.16 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.439 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 175' ' ' VAL . 12.9 m -116.75 -167.04 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -169.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.613 ' HB3' ' HG3' ' A' ' 129' ' ' ARG . 7.7 tp10 -157.97 41.31 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.705 -1.588 . . . . 0.0 108.791 -163.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.697 ' CB ' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -79.61 137.98 37.29 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.987 -1.07 . . . . 0.0 111.466 -167.36 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.4 mt -55.32 -44.56 75.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.782 -1.554 . . . . 0.0 114.05 -165.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.716 HG11 ' HA ' ' A' ' 124' ' ' ASN . 35.8 t -56.77 -37.86 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -168.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.457 ' HD2' ' HE2' ' A' ' 180' ' ' LYS . 79.2 mtt180 -92.03 18.87 7.36 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.89 -0.506 . . . . 0.0 111.337 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.6 t -152.6 58.91 0.81 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.254 0.549 . . . . 0.0 109.819 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.6 m -140.24 148.65 55.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.108 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 190' ' ' HIS . 9.3 Cg_endo -53.08 -59.08 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.079 2.519 . . . . 0.0 112.791 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 67.95 -70.05 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.069 0.548 . . . . 0.0 111.356 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.49 -68.75 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.236 -0.507 . . . . 0.0 111.909 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.23 -30.38 38.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.72 0.295 . . . . 0.0 111.125 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.535 ' O ' ' HA ' ' A' ' 186' ' ' PRO . 36.4 t-80 -79.94 60.34 3.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.486 0.66 . . . . 0.0 110.791 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 93.87 40.85 4.53 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.783 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.452 ' HA ' HH21 ' A' ' 193' ' ' ARG . 84.6 m-20 62.15 -163.28 0.27 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.797 0.332 . . . . 0.0 110.725 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.452 HH21 ' HA ' ' A' ' 192' ' ' ASN . 0.1 OUTLIER -99.74 -74.86 0.58 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.079 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 63.2 -76.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.028 0.83 . . . . 0.0 112.102 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.2 t -75.02 104.78 5.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.96 0.41 . . . . 0.0 110.051 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -146.63 69.25 1.18 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.625 0.726 . . . . 0.0 109.663 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 21.5 t -115.63 110.57 19.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.005 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -87.13 -45.58 10.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.947 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 59.06 -119.53 18.44 Favored Glycine 0 N--CA 1.453 -0.187 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.364 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 9.4 tt -140.03 92.75 9.58 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 121.64 0.733 . . . . 0.0 110.359 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.71 ' HB2' ' HB2' ' A' ' 204' ' ' ALA . 71.6 Cg_endo -81.57 112.83 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.703 2.269 . . . . 0.0 112.205 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.567 ' HB2' ' HD3' ' A' ' 203' ' ' PRO . 33.4 mt-10 -71.77 -53.55 7.07 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.24 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 202' ' ' GLU . 3.3 Cg_exo -81.38 19.42 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.416 2.078 . . . . 0.0 112.899 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 201' ' ' PRO . . . -80.85 8.05 9.12 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -64.41 113.4 3.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.951 0.405 . . . . 0.0 110.202 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.66 80.04 7.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 111.855 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.526 ' HE2' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.609 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -103.32 25.58 9.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.191 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.632 ' HG2' HD12 ' A' ' 62' ' ' ILE . 4.0 pp0? -71.89 142.43 85.51 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.845 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 73.0 Cg_exo -53.45 -14.33 4.58 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 C-N-CA 123.724 2.95 . . . . 0.0 114.807 -172.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 75.01 86.88 0.09 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.646 0.591 . . . . 0.0 112.374 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.64 HG23 ' HA3' ' A' ' 168' ' ' GLY . 0.7 OUTLIER -134.05 86.67 2.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.855 174.28 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 11.8 m -112.41 -58.05 2.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.038 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.2 m -148.01 100.55 3.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.018 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.453 ' HA ' ' OD1' ' A' ' 167' ' ' ASP . 8.2 Cg_exo -73.57 150.08 45.06 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 123.037 2.491 . . . . 0.0 112.294 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 217' ' ' PRO . 10.1 mp -66.71 -49.06 51.59 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.821 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 216' ' ' LEU . 64.1 Cg_endo -72.45 13.54 0.55 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.251 1.967 . . . . 0.0 112.954 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -113.67 112.62 23.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.086 0.469 . . . . 0.0 110.657 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.7 m -105.34 -13.86 9.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.228 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.4 m 65.23 169.66 0.2 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.61 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -90.15 175.08 41.04 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.4 t 64.44 84.22 0.18 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.036 0.446 . . . . 0.0 110.116 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.64 -5.69 17.59 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.201 2.601 . . . . 0.0 112.33 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -84.39 140.24 18.84 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.123 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.44 -8.49 47.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.205 0.526 . . . . 0.0 110.372 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -101.82 88.58 3.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.119 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 69.5 mt -99.13 108.17 21.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 13.6 m -59.49 117.86 26.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.016 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 228' ' ' THR . 6.3 Cg_exo -79.2 64.69 8.87 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.263 2.642 . . . . 0.0 111.149 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.696 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 46.5 tp -78.11 -53.54 1.38 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.863 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 16.4 Cg_exo -68.69 -22.22 37.84 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.915 1.743 . . . . 0.0 111.733 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 16.6 m -74.35 105.76 5.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.492 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 6.2 p -126.91 120.92 30.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.622 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -87.49 76.33 9.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.748 0.785 . . . . 0.0 109.663 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -108.78 -21.98 12.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.564 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 82.75 82.26 0.91 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.157 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.51 134.25 43.72 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.373 2.049 . . . . 0.0 111.372 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.537 ' HB ' HG13 ' A' ' 266' ' ' VAL . 26.1 t -72.09 137.34 23.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.242 -177.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.48 118.92 37.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.579 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.467 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.28 128.07 52.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.093 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -82.75 126.18 32.09 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -78.72 92.29 4.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.593 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -82.97 -15.99 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.133 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -130.18 129.87 43.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -69.77 172.92 6.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.397 0.618 . . . . 0.0 111.64 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 25.3 tpt180 -147.0 103.26 3.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.158 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.99 126.82 54.08 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 32.1 Cg_endo -63.52 146.43 92.86 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.683 2.255 . . . . 0.0 112.456 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.87 160.06 18.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.1 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.99 -34.0 71.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.703 0.287 . . . . 0.0 111.138 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.39 9.85 27.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.013 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.4 t70 74.65 -69.18 0.19 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.262 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 62.76 21.76 12.96 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.543 0.527 . . . . 0.0 112.387 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.1 m 66.02 14.28 9.52 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.002 0.429 . . . . 0.0 110.984 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -66.01 125.68 26.2 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.159 0.504 . . . . 0.0 110.622 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.492 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.9 OUTLIER -79.08 115.68 18.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.869 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -70.11 115.15 8.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.917 0.389 . . . . 0.0 110.44 177.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 279' ' ' VAL . 93.0 mt -118.62 154.82 32.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.617 -176.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.75 159.15 38.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.954 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.44 122.96 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.557 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.61 3.3 30.62 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.668 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.421 ' CG ' HH11 ' A' ' 69' ' ' ARG . 41.7 t0 -107.51 161.97 14.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.519 0.659 . . . . 0.0 110.204 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 27.2 mm -102.91 121.91 54.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.243 0.545 . . . . 0.0 111.362 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.424 ' HA ' HG22 ' A' ' 279' ' ' VAL . 21.5 t -91.01 112.1 24.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.589 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -88.98 94.36 9.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.537 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.9 p -86.07 123.68 39.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.428 0.632 . . . . 0.0 110.69 -173.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.9 t -110.81 -17.83 13.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.514 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.82 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 24.9 ttm-85 -131.87 97.35 4.16 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.02 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 54.9 mtt -94.83 134.01 37.91 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.593 ' OD1' ' HB3' ' A' ' 272' ' ' ASN . 7.5 p30 -131.26 167.74 18.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.976 -172.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.432 ' H ' HG13 ' A' ' 271' ' ' ILE . 2.4 pp -83.58 6.8 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.312 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.593 ' HB3' ' OD1' ' A' ' 270' ' ' ASN . 3.7 t30 -87.39 -30.68 20.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.869 0.366 . . . . 0.0 110.93 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 125.42 -64.43 0.57 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.304 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -73.71 124.54 26.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.547 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 11.1 m0 -93.65 168.29 11.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.56 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.82 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 35.8 tt0 -104.38 113.29 26.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.681 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.21 162.95 18.16 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.811 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.52 116.81 30.15 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.857 HG12 ' H ' ' A' ' 280' ' ' ASN . 15.2 t -125.82 -172.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.857 ' H ' HG12 ' A' ' 279' ' ' VAL . 9.2 p30 -55.06 -32.08 61.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.026 0.376 . . . . 0.0 111.874 -176.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.28 -68.39 1.6 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.071 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.492 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -179.71 -169.87 0.14 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 60.7 mttm -85.2 129.11 34.87 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -161.54 176.88 38.01 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 80.0 mt -84.32 134.52 34.51 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.985 0.421 . . . . 0.0 111.103 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.412 ' HE2' HG21 ' A' ' 291' ' ' VAL . 46.4 p90 -137.45 140.93 31.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.211 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.22 139.03 16.5 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.478 2.118 . . . . 0.0 112.239 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -73.72 6.79 2.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.87 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.2 p -95.67 -15.97 22.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.764 0.316 . . . . 0.0 111.35 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -98.74 -13.12 20.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.234 0.54 . . . . 0.0 110.059 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.412 HG21 ' HE2' ' A' ' 286' ' ' PHE . 34.3 m -120.1 160.89 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.287 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -127.78 120.21 27.38 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.076 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 240' ' ' ALA . 36.4 mm -70.71 109.05 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.172 171.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -103.92 11.58 35.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.21 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 54.37 80.1 0.31 Allowed Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.353 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.07 -53.24 6.67 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.401 2.734 . . . . 0.0 113.091 -173.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -145.32 18.95 1.55 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.622 0.725 . . . . 0.0 109.599 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -153.81 92.05 3.16 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.193 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.05 58.82 5.68 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.731 2.287 . . . . 0.0 110.996 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.02 143.2 50.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.968 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.22 54.15 2.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.842 0.829 . . . . 0.0 109.71 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -79.48 120.76 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.227 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.742 -0.647 . . . . 0.0 109.982 177.916 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtm . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.428 0.156 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m 59.98 47.98 9.23 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.643 0.59 . . . . 0.0 111.405 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 t -156.02 104.67 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.587 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 62.29 95.0 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.743 0.652 . . . . 0.0 112.145 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -137.69 105.29 5.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.049 0.452 . . . . 0.0 110.496 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -155.89 157.86 37.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.545 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.36 111.79 14.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.908 0.385 . . . . 0.0 110.21 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 t -87.93 64.91 8.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.169 0.509 . . . . 0.0 110.397 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.0 t -173.47 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.915 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.46 111.44 1.39 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.742 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -56.0 -33.16 64.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.097 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 m -79.89 3.15 20.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.891 0.377 . . . . 0.0 111.595 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.85 -47.87 5.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.174 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -124.39 -22.67 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -87.68 117.33 26.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.745 0.307 . . . . 0.0 110.633 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.754 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 2.0 mpp? -109.57 7.23 24.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.722 0.296 . . . . 0.0 111.445 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.85 -114.6 3.27 Favored Glycine 0 C--O 1.225 -0.457 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.875 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 13.6 Cg_exo -69.73 101.08 0.86 Allowed 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.448 2.099 . . . . 0.0 112.137 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' A' ' 39' ' ' ARG . 86.0 t -129.11 -76.48 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.597 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.467 ' HA ' ' HE ' ' A' ' 39' ' ' ARG . 2.2 p 88.4 170.87 0.04 OUTLIER 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 169.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.7 mtp85 -53.35 -35.83 60.69 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.793 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -61.37 -51.91 66.81 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.458 0.474 . . . . 0.0 111.801 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.78 -43.6 12.4 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.16 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.57 -41.12 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.825 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.535 ' HA ' HG11 ' A' ' 58' ' ' VAL . 11.1 tt0 -81.88 -33.48 30.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.984 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.2 t -79.8 -18.33 51.19 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.02 0.438 . . . . 0.0 111.339 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 27' ' ' ARG . 39.1 ttm180 -88.86 -27.93 20.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.017 0.436 . . . . 0.0 110.792 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' A' ' 102' ' ' ALA . 78.0 mt -111.22 25.69 11.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.38 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.59 29.76 0.07 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -172.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.65 -1.45 39.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.908 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -50.24 -59.24 4.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.951 0.405 . . . . 0.0 110.936 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -132.09 111.46 11.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -68.98 114.87 7.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.46 -18.46 6.42 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.781 -173.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.756 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.6 mtm -74.65 144.71 43.71 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 120.674 0.273 . . . . 0.0 110.327 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.451 ' CG ' HD22 ' A' ' 98' ' ' LEU . 33.4 p90 -144.34 164.59 30.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.139 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.6 pp -153.85 138.79 17.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.043 0.449 . . . . 0.0 110.464 174.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.5 121.49 54.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.599 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -124.82 168.97 12.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -178.255 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.55 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 2.1 m-20 -72.23 134.13 45.45 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 168.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.532 ' HA ' HG23 ' A' ' 49' ' ' VAL . 24.3 t -37.01 -86.69 0.0 OUTLIER 'General case' 0 C--O 1.236 0.376 0 O-C-N 124.585 1.178 . . . . 0.0 112.875 -168.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.9 m -172.58 -61.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.4 t -98.3 -26.96 14.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.671 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.2 m -102.43 108.62 58.1 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.158 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.03 107.84 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.231 2.621 . . . . 0.0 111.686 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.99 -47.97 0.89 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 11.4 m-20 -78.24 151.75 32.94 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 168.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -124.3 172.9 8.74 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 121.387 -0.125 . . . . 0.0 110.731 -172.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.687 HG22 HG13 ' A' ' 62' ' ' ILE . 42.8 t -145.48 104.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 175.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.31 105.37 4.04 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.329 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.7 m -96.63 139.26 32.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.977 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.681 HG21 HD13 ' A' ' 93' ' ' LEU . 40.6 t -129.09 150.45 34.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.876 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.63 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 31.1 t -98.73 121.1 40.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.322 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.725 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 1.3 mt-10 -143.11 173.96 11.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 56.7 m-80 -40.24 87.39 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.857 0.863 . . . . 0.0 112.917 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m 42.13 58.35 2.97 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.278 1.037 . . . . 0.0 109.25 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.725 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -161.01 53.87 0.29 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.239 -153.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 25' ' ' GLN . 8.9 t -75.94 94.33 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 t -87.03 121.27 29.25 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.332 -172.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -100.77 98.55 9.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.383 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.59 ' CE2' HD22 ' A' ' 93' ' ' LEU . 50.2 m-85 -97.83 115.74 28.65 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.486 0.315 . . . . 0.0 111.371 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.687 HG13 HG22 ' A' ' 49' ' ' VAL . 7.1 tt -72.44 150.02 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.615 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.2 mp -128.37 117.74 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.184 0.594 . . . . 0.0 109.549 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.415 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 9.6 m120 -87.41 138.39 31.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.37 -173.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.3 t -83.23 100.28 10.5 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 171.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -78.17 157.87 77.79 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.8 62.48 2.36 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.586 2.191 . . . . 0.0 112.426 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 84.3 0.72 0.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.806 0.842 . . . . 0.0 110.61 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -72.32 -78.64 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.244 173.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.725 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 3.2 mpt_? -153.95 -171.01 3.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.358 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.438 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 27.4 m-85 -112.98 115.18 27.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -101.53 109.61 21.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.564 -171.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.615 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.3 tt -97.46 85.22 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.658 0.742 . . . . 0.0 110.72 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 210' ' ' PRO . . . 62.02 81.38 0.09 OUTLIER Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.635 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.4 t70 72.6 -43.99 0.58 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.062 0.545 . . . . 0.0 111.315 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -74.81 126.16 30.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.826 0.346 . . . . 0.0 110.184 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.401 ' OE1' ' HD3' ' A' ' 70' ' ' ARG . 39.5 tt0 -108.01 124.77 50.66 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.562 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.725 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 81.7 m-85 -124.19 148.6 47.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.582 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 10.7 m-20 -62.7 -29.82 70.94 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -170.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 6.5 p80 -160.35 171.63 18.76 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.254 -0.179 . . . . 0.0 110.871 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.9 mt -55.91 -56.62 28.45 Favored Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.34 0.4 . . . . 0.0 111.84 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 32.3 Cg_exo -61.6 -9.2 12.82 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.215 1.943 . . . . 0.0 113.538 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.34 -36.19 16.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.515 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -76.17 -30.03 57.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 82' ' ' PRO . 92.2 mt -65.17 -38.74 91.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.495 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.817 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 40.3 mt-10 -75.86 -20.94 57.7 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -74.49 -38.8 62.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.295 0.569 . . . . 0.0 110.128 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HE2' HD13 ' A' ' 73' ' ' ILE . 47.8 m-85 -79.28 -6.77 57.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.104 0.478 . . . . 0.0 110.703 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.817 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 25.5 mtpp -71.78 -17.21 62.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.496 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.77 7.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 121.042 0.448 . . . . 0.0 111.162 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 20.2 t-160 -102.07 -32.29 10.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.299 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CD1' HG23 ' A' ' 97' ' ' THR . 98.8 m-85 70.43 101.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.741 0.651 . . . . 0.0 110.513 -175.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.681 HD13 HG21 ' A' ' 52' ' ' VAL . 9.4 mt -70.98 -20.61 62.41 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.856 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.592 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 30.9 t70 -172.75 82.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.715 171.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 66.7 -24.39 0.11 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.57 0.748 . . . . 0.0 111.874 -178.202 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 94' ' ' ASP . 13.9 t -124.3 157.94 33.76 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.539 HG23 ' CD1' ' A' ' 92' ' ' TYR . 19.1 p -100.04 -172.84 2.3 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.655 0.264 . . . . 0.0 111.088 -177.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.451 HD22 ' CG ' ' A' ' 36' ' ' PHE . 86.5 mt -70.96 93.54 1.0 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 35.9 mm -85.03 -59.32 2.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.138 -173.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.756 ' O ' ' HA ' ' A' ' 35' ' ' MET . 4.9 pt-20 -149.33 147.55 23.76 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.652 -174.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.43 149.54 27.58 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.5 2.134 . . . . 0.0 112.471 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -70.58 146.49 93.86 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.999 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.97 140.83 92.22 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.879 2.386 . . . . 0.0 112.16 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.754 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 52.4 mtm180 -81.07 -179.52 7.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.984 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.4 t80 72.42 133.43 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.411 0 O-C-N 123.961 0.788 . . . . 0.0 110.449 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.28 116.21 2.14 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.193 2.595 . . . . 0.0 112.427 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 11.2 p -91.9 147.23 34.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.519 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 107' ' ' SER . 31.2 Cg_exo -59.41 118.2 5.05 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.593 2.195 . . . . 0.0 111.498 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.8 106.47 1.12 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.697 2.265 . . . . 0.0 112.324 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 55.9 ttp -103.83 -65.21 1.03 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.48 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.68 65.98 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.04 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.1 m -109.34 109.17 19.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.828 0.347 . . . . 0.0 110.819 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.57 HG13 ' H ' ' A' ' 114' ' ' SER . 2.7 p -96.55 -59.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.487 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.57 ' H ' HG13 ' A' ' 113' ' ' VAL . 61.0 m -165.91 -174.37 3.0 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.484 ' N ' ' HD2' ' A' ' 116' ' ' PRO . . . -67.49 -52.01 29.73 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 115' ' ' ALA . 20.7 Cg_endo -61.25 152.2 73.79 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.995 1.797 . . . . 0.0 112.158 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.633 HD22 ' HG ' ' A' ' 118' ' ' LEU . 1.1 p-10 -79.46 -177.96 6.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.891 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.633 ' HG ' HD22 ' A' ' 117' ' ' ASN . 87.9 mt 68.51 88.51 0.1 Allowed Pre-proline 0 N--CA 1.464 0.275 0 O-C-N 123.966 0.791 . . . . 0.0 110.797 -175.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.66 160.25 31.48 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.933 2.422 . . . . 0.0 111.505 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.4 m -79.29 63.36 3.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.63 0.729 . . . . 0.0 110.545 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -176.62 105.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.236 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 60.73 77.71 0.31 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.653 0.596 . . . . 0.0 111.553 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.6 ' HB2' ' HB3' ' A' ' 183' ' ' ARG . 4.4 m-20 -75.35 87.15 2.54 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -87.16 83.89 7.36 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.006 -173.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.969 HD12 HG13 ' A' ' 152' ' ' ILE . 4.3 mm? 72.71 120.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.721 169.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -151.53 -88.45 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.533 -172.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.522 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 79.0 m-85 -109.95 119.9 40.78 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.921 0.867 . . . . 0.0 112.035 -175.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.743 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 68.5 t -132.99 130.97 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.367 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.896 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 8.4 ptp85 -110.58 155.94 21.63 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 118.415 -1.314 . . . . 0.0 109.431 172.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.435 HG22 HG12 ' A' ' 178' ' ' VAL . 3.9 p -111.72 141.03 45.85 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.5 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 76.4 mt -103.44 -39.35 6.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.211 -175.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.3 t80 -73.82 -31.68 63.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -167.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.653 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 17.3 t70 67.82 91.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.443 0.639 . . . . 0.0 109.892 -172.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 88.1 t80 -124.85 113.24 26.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.349 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 58.0 Cg_endo -87.88 95.1 0.42 Allowed 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.15 1.9 . . . . 0.0 112.573 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.89 -10.27 84.28 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.586 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 62.96 25.62 15.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.033 0.533 . . . . 0.0 111.524 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.78 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 3.8 p30 46.83 -168.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 73.66 1.27 3.89 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.155 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -178.59 -35.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.125 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -134.41 110.38 9.39 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.492 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.686 HD12 ' HD2' ' A' ' 143' ' ' PRO . 31.4 tp -68.04 127.47 93.31 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 120.829 0.347 . . . . 0.0 111.72 -172.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.686 ' HD2' HD12 ' A' ' 142' ' ' LEU . 60.0 Cg_endo -78.8 105.28 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.292 1.995 . . . . 0.0 110.943 171.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 9.0 p90 -112.7 157.87 20.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.647 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.653 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 3.4 mptp? -102.91 178.79 4.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.817 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -66.45 -9.3 32.82 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.862 -177.494 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.512 ' N ' ' HD2' ' A' ' 146' ' ' LYS . . . -164.16 45.8 0.31 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.678 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -102.3 147.18 27.0 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 129' ' ' ARG . 33.8 mm -93.23 132.52 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.542 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 18.7 mt -118.8 154.85 32.18 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.66 129.86 74.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 172.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.969 HG13 HD12 ' A' ' 125' ' ' LEU . 46.3 mm -75.67 86.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.798 HG23 ' HG2' ' A' ' 154' ' ' GLU . 17.0 tt -67.95 -26.8 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.128 -176.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.798 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.5 OUTLIER -155.85 140.95 17.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.934 0.397 . . . . 0.0 111.2 173.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.475 ' HD2' ' CD2' ' A' ' 125' ' ' LEU . 32.2 tttm -120.89 95.84 48.82 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-O 121.249 0.547 . . . . 0.0 110.482 172.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.16 -59.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.81 2.34 . . . . 0.0 112.062 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -104.87 -170.37 1.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.052 -174.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -100.27 -42.72 6.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.897 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -80.31 -25.3 39.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.768 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.518 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 39.1 m95 -129.01 128.17 43.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.005 0.431 . . . . 0.0 110.759 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.647 ' O ' HG13 ' A' ' 173' ' ' ILE . 53.6 m0 -114.18 135.68 53.78 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.059 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.703 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 17.6 m -87.58 103.14 15.28 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.257 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.711 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -112.35 173.68 6.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.987 0.422 . . . . 0.0 111.13 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.4 ptt180 -119.88 137.56 53.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.0 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.917 ' ND2' ' HE ' ' A' ' 169' ' ' ARG . 51.6 p30 -78.59 -168.1 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.505 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -60.45 -34.8 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.799 0.333 . . . . 0.0 110.422 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 213' ' ' THR . 44.8 m-20 -70.63 -21.27 62.65 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.042 0.449 . . . . 0.0 110.655 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.62 5.26 57.82 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.701 -0.761 . . . . 0.0 114.449 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.917 ' HE ' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -86.77 151.15 23.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.998 0.899 . . . . 0.0 111.45 -177.255 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 153' ' ' ILE . 39.5 t -98.91 140.74 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.567 -166.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -168.1 158.14 30.75 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 169.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.526 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 31.5 mtp -76.12 139.48 41.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.366 0.583 . . . . 0.0 110.089 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.647 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -133.77 148.69 69.45 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.678 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.518 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 3.5 Cg_exo -77.48 132.6 12.39 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.168 2.579 . . . . 0.0 112.674 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.647 ' O ' HG22 ' A' ' 178' ' ' VAL . 24.1 t -58.62 -46.33 99.59 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.363 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.48 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.0 Cg_exo -63.27 -2.1 3.62 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.375 2.05 . . . . 0.0 113.786 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.58 -5.66 26.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.415 -0.178 . . . . 0.0 111.327 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.0 m -107.41 -172.19 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -166.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.896 ' HB3' ' HG3' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -159.66 42.21 0.21 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.609 -163.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.743 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -75.32 139.08 42.23 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 121.219 -0.926 . . . . 0.0 109.25 -168.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.61 ' O ' ' HB ' ' A' ' 182' ' ' VAL . 4.2 mm? -37.5 -60.9 0.65 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 124.802 1.314 . . . . 0.0 112.438 -170.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 181' ' ' LEU . 8.9 p 160.74 -9.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 123.921 0.763 . . . . 0.0 111.11 -175.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.6 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 95.7 mtt180 69.88 -80.46 0.04 OUTLIER 'General case' 0 C--N 1.343 0.318 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -169.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.1 t 177.48 121.59 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.699 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 15.3 m -60.92 128.93 89.78 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 77.3 Cg_exo -53.61 -9.08 0.93 Allowed 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.96 3.107 . . . . 0.0 115.132 -172.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.699 ' CE1' ' HB2' ' A' ' 185' ' ' SER . 0.0 OUTLIER -65.96 127.77 33.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.949 0.404 . . . . 0.0 110.525 175.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -65.5 -25.05 71.28 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.195 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 189' ' ' LYS . 12.3 mptt -91.45 104.27 16.8 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.423 0.63 . . . . 0.0 110.078 177.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -144.21 114.93 7.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.544 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -141.35 104.99 0.4 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.457 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -69.11 112.68 5.87 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 66.7 mtm180 -73.01 102.2 3.44 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.9 m120 70.44 165.73 0.28 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.887 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.6 p -79.31 18.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.695 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -71.64 -55.34 7.92 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 109.739 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.7 m -88.27 78.94 7.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.005 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -95.52 105.07 17.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.681 0.753 . . . . 0.0 111.399 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -100.97 13.68 58.89 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.7 tt -140.72 119.6 8.36 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.568 -176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -93.38 -161.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.111 2.54 . . . . 0.0 111.164 174.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' A' ' 202' ' ' GLU . 1.5 pm0 -80.39 112.08 27.98 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.948 0.404 . . . . 0.0 109.913 174.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 16.8 Cg_exo -67.78 -24.96 40.02 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.194 2.596 . . . . 0.0 112.58 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 73.05 -50.84 0.71 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.554 0.742 . . . . 0.0 111.761 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -117.85 110.22 17.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.778 0.323 . . . . 0.0 110.173 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -83.47 66.52 8.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.483 . . . . 0.0 110.96 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -103.7 18.76 21.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -62.8 146.22 95.09 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.684 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.492 ' HB2' ' HA3' ' A' ' 74' ' ' GLY . 36.6 Cg_exo -59.49 145.28 98.45 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.751 1.634 . . . . 0.0 110.402 172.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -81.54 -174.09 4.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.302 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 21.1 m -108.07 123.84 49.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.351 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 167' ' ' ASP . 73.1 m -57.67 130.83 48.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.089 172.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 3.7 t -125.99 99.89 31.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.638 0.732 . . . . 0.0 111.256 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.36 116.1 3.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.954 2.436 . . . . 0.0 111.037 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.1 tt -141.94 95.56 6.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -93.21 -76.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.211 2.607 . . . . 0.0 112.047 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -159.49 131.48 6.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.508 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.57 111.74 26.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.676 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 24.3 m 68.55 113.89 0.04 OUTLIER 'General case' 0 C--O 1.234 0.262 0 O-C-N 123.825 0.703 . . . . 0.0 111.746 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -129.28 -125.66 2.76 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.018 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.464 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 10.3 m -126.82 143.85 48.05 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 11.7 Cg_exo -71.66 146.48 49.02 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.803 2.336 . . . . 0.0 111.214 172.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.88 ' HA3' ' HD3' ' A' ' 229' ' ' PRO . . . -84.82 54.01 4.88 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.732 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 61.83 -85.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.3 0.64 . . . . 0.0 111.006 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.37 104.03 14.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.631 HG12 ' H ' ' A' ' 228' ' ' THR . 0.1 OUTLIER 40.43 -92.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 124.276 0.985 . . . . 0.0 112.662 -171.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.631 ' H ' HG12 ' A' ' 227' ' ' ILE . 8.8 t -133.25 149.73 73.36 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.88 ' HD3' ' HA3' ' A' ' 224' ' ' GLY . 13.8 Cg_endo -58.57 99.63 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.158 1.906 . . . . 0.0 111.099 174.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 96.8 mt -75.21 118.43 70.59 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.182 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 5.8 Cg_exo -79.69 66.63 8.77 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.142 2.562 . . . . 0.0 111.255 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 8.6 p -73.17 -71.18 0.32 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.502 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 12.5 p -95.34 -27.48 15.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.724 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 72.64 0.95 3.82 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.928 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 13.3 m120 68.29 -67.43 0.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.62 0.768 . . . . 0.0 111.582 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 111.32 -137.94 14.63 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.59 114.14 3.9 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.796 2.331 . . . . 0.0 111.384 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 266' ' ' VAL . 20.7 t -94.21 145.06 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.928 0.394 . . . . 0.0 110.229 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.11 132.56 56.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.382 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.567 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -121.17 155.27 34.9 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.669 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -119.5 119.08 32.8 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.45 119.06 14.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.686 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 22.9 pt -91.01 -4.25 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.053 -172.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -142.48 160.87 39.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.587 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.895 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 20.9 ttmm -93.51 123.05 36.55 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.871 HH11 ' HB3' ' A' ' 246' ' ' ARG . 0.7 OUTLIER -139.44 114.31 9.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.519 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 35.9 m -97.16 159.87 30.32 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.323 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.845 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 85.6 Cg_endo -79.04 178.6 7.33 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.607 2.205 . . . . 0.0 112.273 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.578 ' HB3' ' HG3' ' A' ' 253' ' ' LYS . 47.2 t -103.39 96.37 6.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.307 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 66.06 -74.29 0.06 Allowed 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 124.245 0.965 . . . . 0.0 112.589 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 252' ' ' ASP . 0.0 OUTLIER -88.08 -46.74 9.06 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -177.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.554 ' HA ' ' HB2' ' A' ' 248' ' ' PRO . 7.5 p-10 167.84 -57.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.617 -174.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.578 ' HG3' ' HB3' ' A' ' 249' ' ' CYS . 13.7 mmmm 55.87 41.8 29.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.749 0.309 . . . . 0.0 110.278 -173.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 68.6 p 57.74 15.04 2.72 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.426 1.091 . . . . 0.0 112.251 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 248' ' ' PRO . . . -98.95 107.03 19.36 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.072 0.463 . . . . 0.0 110.964 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -73.18 113.62 10.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.845 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -58.71 108.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.538 0.524 . . . . 0.0 110.811 177.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.689 HD21 HG21 ' A' ' 279' ' ' VAL . 95.8 mt -130.25 127.03 38.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.264 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.895 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 11.7 pt-20 -119.61 -177.12 3.31 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.538 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 30.7 m -61.36 135.31 26.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.22 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 68.12 28.86 73.21 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.984 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -108.2 140.02 42.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.972 0.386 . . . . 0.0 110.146 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.0 mm -88.28 123.23 40.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.34 0.591 . . . . 0.0 111.523 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 240' ' ' ALA . 23.2 t -104.71 107.89 23.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.078 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -82.44 87.68 6.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.717 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' A' ' 238' ' ' VAL . 4.9 p -88.55 116.92 31.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.622 0.725 . . . . 0.0 110.584 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.421 ' O ' ' HD2' ' A' ' 268' ' ' ARG . 3.1 m -110.6 -19.15 12.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.694 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.466 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 13.8 mmm180 -122.34 109.96 15.07 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.5 mtt -107.6 118.3 36.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.154 0.502 . . . . 0.0 111.572 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -90.76 158.92 16.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.023 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.57 -14.7 9.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.455 0.645 . . . . 0.0 110.493 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -80.81 -1.8 44.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.893 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.82 -61.65 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.918 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.596 ' HG3' HD13 ' A' ' 285' ' ' LEU . 5.0 pm0 -77.71 131.21 37.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.93 0.395 . . . . 0.0 110.628 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 15.8 m0 -107.08 168.64 9.07 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.237 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 14.0 mt-10 -110.51 122.53 47.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.096 0.474 . . . . 0.0 110.299 174.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -130.26 145.14 16.41 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.511 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -94.41 109.11 20.99 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.689 HG21 HD21 ' A' ' 258' ' ' LEU . 20.8 t -113.43 167.76 6.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.437 ' N ' HG12 ' A' ' 279' ' ' VAL . 91.3 m-20 -60.13 -16.66 34.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -81.28 -45.08 7.66 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.863 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.64 ' HG2' HH11 ' A' ' 282' ' ' ARG . 1.0 OUTLIER 173.16 178.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 16.5 pttp -103.75 139.43 39.0 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 166.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -172.33 -170.24 35.95 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.7 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.596 HD13 ' HG3' ' A' ' 274' ' ' GLN . 97.9 mt -91.1 143.42 26.71 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.242 0.544 . . . . 0.0 110.803 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 41.6 p90 -147.97 137.16 11.9 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.561 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 7.3 Cg_exo -72.89 136.34 24.97 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.43 2.086 . . . . 0.0 111.309 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -63.51 -20.64 65.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.926 0.393 . . . . 0.0 110.956 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 m -69.81 -13.11 62.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.315 0.579 . . . . 0.0 110.828 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -97.39 -14.35 21.28 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.079 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.525 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 27.6 m -124.61 165.82 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.527 0.68 . . . . 0.0 112.14 -173.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -114.43 116.33 28.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.517 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' ' 240' ' ' ALA . 21.3 mm -89.02 117.12 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.13 0.49 . . . . 0.0 110.643 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.417 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 25.3 p90 -141.52 148.32 39.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.699 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.603 ' OD2' ' HA ' ' A' ' 298' ' ' ASN . 35.1 t0 -92.97 105.89 16.89 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 26.8 Cg_exo -61.88 -50.43 5.19 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.033 2.489 . . . . 0.0 112.675 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -111.94 -15.49 13.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.008 -172.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.603 ' HA ' ' OD2' ' A' ' 295' ' ' ASP . 3.6 t-20 55.23 72.8 0.98 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 123.656 0.782 . . . . 0.0 112.446 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -90.08 0.47 5.5 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.751 2.301 . . . . 0.0 111.012 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.12 82.23 1.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.797 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -172.96 -65.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.833 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -100.23 90.45 4.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.628 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.36 -0.828 . . . . 0.0 109.782 178.135 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 m -103.55 17.29 24.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.126 0.489 . . . . 0.0 110.168 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 m -79.25 93.12 5.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.458 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 73.48 130.41 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.072 0.858 . . . . 0.0 112.659 173.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -119.1 -8.01 10.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.837 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.741 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 27.6 p90 -94.11 162.37 13.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.58 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.28 123.84 48.9 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 m -79.96 21.83 0.54 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.723 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -111.41 -37.16 5.33 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.651 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' ' 12' ' ' SER . 34.4 t70 -87.94 108.35 19.15 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.055 -174.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -65.49 -20.04 66.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.426 -179.433 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.409 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 23.9 m -74.03 -5.41 41.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.803 0.335 . . . . 0.0 110.669 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.76 -47.88 5.42 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 38.3 p-90 -115.62 -21.26 9.79 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -171.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.439 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 49.3 t80 -81.52 118.55 22.83 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.202 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.794 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 6.9 tpp -95.14 -7.94 37.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.359 -172.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.08 -115.45 3.6 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.254 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 6.4 Cg_exo -73.65 95.02 0.86 Allowed 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.974 2.449 . . . . 0.0 112.529 -174.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.914 HG12 ' H ' ' A' ' 20' ' ' SER . 14.1 t -136.86 -152.97 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.914 ' H ' HG12 ' A' ' 19' ' ' VAL . 82.4 p 176.32 178.56 0.21 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -166.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -69.31 -39.89 78.0 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.121 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -63.34 -59.54 4.57 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.395 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.61 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 8.3 tp10 -59.9 -47.23 86.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.124 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.31 -35.87 70.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.51 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.447 HE21 ' HB3' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -64.65 -40.95 96.33 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.647 -179.372 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -80.17 -6.51 57.9 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.126 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.61 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 20.6 mmt85 -87.57 -35.32 18.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.714 0.769 . . . . 0.0 109.03 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.93 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 39.2 mt -100.08 27.4 5.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.331 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -51.35 97.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.478 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' H ' ' NE2' ' A' ' 31' ' ' GLN . . . 109.2 -4.63 31.62 Favored Glycine 0 CA--C 1.49 -1.503 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 167.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.586 ' HG3' ' HB2' ' A' ' 53' ' ' SER . 2.1 mp0 57.14 85.59 0.08 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 113.814 -1.193 . . . . 0.0 110.768 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.735 ' HA ' ' HB3' ' A' ' 116' ' ' PRO . 14.7 ttm180 -70.33 -19.95 63.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.846 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 2.8 m-70 78.63 118.93 0.06 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.297 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.95 9.08 59.95 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.972 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.646 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 29.3 mtm -106.75 137.07 45.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.498 -0.413 . . . . 0.0 110.176 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.569 ' HB2' HD11 ' A' ' 50' ' ' LEU . 43.3 p90 -133.98 162.34 32.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.247 -175.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 pp -151.0 135.03 16.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.52 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.0 t -102.49 108.31 23.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.766 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 23.6 ptt-85 -110.82 168.62 9.34 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.134 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.445 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 27.2 t70 -85.81 92.99 8.78 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.505 ' HA ' HG23 ' A' ' 49' ' ' VAL . 37.7 m 33.81 -149.22 0.0 OUTLIER 'General case' 0 C--O 1.238 0.5 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.944 ' HB2' ' O1P' ' A' ' 207' ' ' PTR . 63.8 m -157.29 -15.67 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.105 171.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.601 ' OG1' ' O3P' ' A' ' 207' ' ' PTR . 19.5 m -121.37 -44.87 2.35 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.038 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 40.9 t -115.65 99.87 52.96 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.11 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 22.6 Cg_endo -61.87 129.26 26.89 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.716 2.277 . . . . 0.0 111.84 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.32 -33.36 4.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.37 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.42 166.45 12.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.445 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 25.4 m-85 -125.73 166.22 17.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.778 0.323 . . . . 0.0 111.123 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.505 HG23 ' HA ' ' A' ' 41' ' ' SER . 45.0 t -144.13 106.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.846 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.72 ' HB2' HD11 ' A' ' 63' ' ' ILE . 63.8 tp -70.09 101.34 1.81 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.408 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.9 m -94.82 118.85 32.44 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.08 0.467 . . . . 0.0 109.99 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG21 HD13 ' A' ' 93' ' ' LEU . 46.5 t -119.2 134.19 63.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.192 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.93 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 84.1 p -93.39 132.85 37.25 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.776 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.664 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 5.1 mm-40 -143.95 176.24 9.43 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.846 ' HA ' ' CE1' ' A' ' 33' ' ' HIS . 55.5 m-80 -31.34 82.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -168.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.57 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 3.9 m 44.89 57.18 4.79 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.948 0.88 . . . . 0.0 109.765 -177.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.989 HH21 ' HB2' ' A' ' 94' ' ' ASP . 35.8 ttp85 -167.17 55.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.366 -151.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 61.8 t -74.93 102.49 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.245 -0.91 . . . . 0.0 109.598 -173.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 t -86.4 121.3 28.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.724 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -93.3 88.2 5.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.624 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.446 ' CE2' HD22 ' A' ' 93' ' ' LEU . 77.8 m-85 -78.86 116.01 18.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 18.5 tt -79.64 145.55 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -171.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.72 HD11 ' HB2' ' A' ' 50' ' ' LEU . 14.9 mt -138.31 116.35 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.602 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 9.3 m120 -87.21 142.34 27.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 122.314 0.246 . . . . 0.0 110.735 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.6 t -87.53 100.68 12.95 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 72' ' ' LYS . 87.9 mt -90.01 142.77 29.08 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.385 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 17.2 Cg_exo -67.49 -8.15 21.34 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.244 2.629 . . . . 0.0 113.071 -176.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.731 ' HB2' ' HG2' ' A' ' 70' ' ' ARG . 9.4 m120 -83.69 9.49 11.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.745 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 2.3 tpm_? 63.46 26.45 14.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.611 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.731 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 5.9 ptp180 -112.78 172.4 6.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.989 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.472 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 96.0 m-85 -131.66 127.2 36.47 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.204 0.526 . . . . 0.0 110.948 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.602 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 18.5 ttmm -97.16 100.06 11.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.926 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 10.9 tt -93.44 86.38 2.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.838 0.828 . . . . 0.0 110.227 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' A' ' 209' ' ' GLN . . . 71.32 60.34 4.46 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.087 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t0 74.44 -16.27 0.55 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.935 0.494 . . . . 0.0 111.38 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 211' ' ' GLN . 0.1 OUTLIER -78.83 126.86 31.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.876 0.369 . . . . 0.0 111.109 177.112 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -98.45 100.1 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.457 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.461 ' CE2' ' HB3' ' A' ' 76' ' ' GLN . 97.6 m-85 -103.46 168.85 8.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.839 0.352 . . . . 0.0 110.59 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.17 -53.56 53.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.461 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.449 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 1.2 p80 -164.81 -174.11 3.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.264 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.1 mt -55.23 -57.84 18.08 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.55 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 39.1 Cg_exo -59.8 -10.74 12.69 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.327 2.018 . . . . 0.0 113.214 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.447 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -95.22 -30.74 13.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.389 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.19 -26.27 56.02 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.5 mt -70.56 -25.85 63.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.913 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 52.1 mt-10 -73.5 -20.64 60.62 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.768 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.751 ' HZ ' HG21 ' A' ' 212' ' ' THR . 34.7 t80 -84.84 -35.59 22.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.054 0.454 . . . . 0.0 110.77 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.523 ' HE2' HD13 ' A' ' 73' ' ' ILE . 49.6 m-85 -86.59 1.07 53.05 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.999 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 13.0 ptmt -74.02 -21.99 59.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 171.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.448 HG23 ' HG3' ' A' ' 89' ' ' LYS . 23.6 pt -120.85 9.14 6.2 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -96.55 -38.78 9.84 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.206 -0.309 . . . . 0.0 111.233 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.543 ' CD1' HG23 ' A' ' 97' ' ' THR . 76.9 m-85 70.39 102.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.894 0.746 . . . . 0.0 109.716 -171.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.729 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 6.4 mt -74.23 -19.76 60.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.53 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.989 ' HB2' HH21 ' A' ' 57' ' ' ARG . 33.6 t70 -173.78 70.96 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 170.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 76.91 -29.81 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.22 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.408 HG22 HD13 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -107.43 157.58 17.88 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.543 HG23 ' CD1' ' A' ' 92' ' ' TYR . 18.1 p -105.26 -169.25 1.57 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.761 0.315 . . . . 0.0 110.178 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.464 HD22 ' CD1' ' A' ' 36' ' ' PHE . 97.6 mt -77.47 99.97 5.85 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 1.8 mp -96.91 -55.37 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.646 ' O ' ' HA ' ' A' ' 35' ' ' MET . 8.1 mm-40 -143.96 151.61 53.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.735 0.302 . . . . 0.0 111.293 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 24.7 Cg_endo -88.83 156.58 6.05 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.807 2.338 . . . . 0.0 111.893 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.48 139.63 55.4 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.947 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.529 ' CG ' ' HA ' ' A' ' 107' ' ' SER . 27.7 Cg_endo -64.43 135.57 46.74 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.479 2.119 . . . . 0.0 112.16 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.794 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 39.9 ptt180 -78.8 -23.52 45.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.681 ' HB3' ' HD3' ' A' ' 106' ' ' PRO . 26.1 t80 -135.59 -58.09 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 120.651 -0.42 . . . . 0.0 112.084 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 105' ' ' TYR . 47.0 Cg_exo -55.92 -72.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.134 1.89 . . . . 0.0 112.435 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.529 ' HA ' ' CG ' ' A' ' 103' ' ' PRO . 23.4 m 70.54 135.9 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 123.761 0.663 . . . . 0.0 112.056 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.446 ' HD3' ' HG3' ' A' ' 103' ' ' PRO . 14.0 Cg_exo -69.54 112.95 3.18 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.686 2.257 . . . . 0.0 111.274 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.94 113.71 2.12 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.818 2.346 . . . . 0.0 112.18 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.3 mmt 55.82 40.28 30.68 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.456 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.89 66.82 2.75 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.78 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 p -133.96 -171.73 2.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.593 0.235 . . . . 0.0 110.931 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t 67.61 -94.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.408 0.683 . . . . 0.0 111.327 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 p -103.73 9.18 37.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.085 0.469 . . . . 0.0 111.342 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.447 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -75.48 -47.75 4.17 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.689 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.735 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 98.8 Cg_endo -81.76 -158.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.835 1.69 . . . . 0.0 111.596 172.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -79.77 -5.59 55.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 51.0 tp 56.68 85.66 0.18 Allowed Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.49 -174.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.27 128.96 19.34 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.506 2.137 . . . . 0.0 112.933 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 p -91.52 -26.79 18.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.999 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.66 74.38 9.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.647 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.65 90.91 8.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.51 ' HB2' HD13 ' A' ' 125' ' ' LEU . 2.9 p30 -98.08 179.26 4.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.391 0.615 . . . . 0.0 111.35 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.402 HD22 ' C ' ' A' ' 124' ' ' ASN . 0.2 OUTLIER -131.38 45.73 2.76 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.253 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 1.017 HD23 HG21 ' A' ' 152' ' ' ILE . 7.9 mp -76.89 123.44 26.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.158 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 16.8 pt-20 -165.77 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.193 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.46 130.92 54.51 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.908 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.976 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 72.8 t -142.41 157.57 19.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 179' ' ' GLU . 0.7 OUTLIER -136.05 150.8 49.32 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.092 161.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.483 HG22 HG12 ' A' ' 178' ' ' VAL . 6.0 p -105.67 140.46 38.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.052 0.453 . . . . 0.0 111.994 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.518 HD11 ' HG2' ' A' ' 179' ' ' GLU . 67.2 mt -110.83 -25.58 9.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.726 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.528 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 41.5 t80 -86.38 -32.6 20.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -168.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.67 ' HB2' ' HD3' ' A' ' 146' ' ' LYS . 6.6 t70 73.38 111.59 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.133 0.492 . . . . 0.0 110.617 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -141.65 89.1 9.31 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 35.4 Cg_endo -94.87 84.16 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 122.799 2.333 . . . . 0.0 112.871 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.508 ' HA3' ' OD2' ' A' ' 141' ' ' ASP . . . -94.1 -24.34 19.91 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.206 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.428 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 52.0 m-80 68.05 83.22 0.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.484 0.714 . . . . 0.0 112.715 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -173.42 -171.96 0.74 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 173.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.28 -16.89 28.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.314 1.054 . . . . 0.0 108.334 171.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 172' ' ' MET . 41.4 tt0 -73.57 -28.88 62.09 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.978 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.6 ' HA ' ' O ' ' A' ' 172' ' ' MET . 8.0 p-10 -157.17 117.04 3.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.369 174.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 165' ' ' ASN . 13.6 tp -69.62 121.39 82.27 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.964 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 41.6 Cg_endo -67.87 98.16 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.293 1.996 . . . . 0.0 111.324 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -112.73 162.25 15.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.522 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 1.6 mptm? -112.6 -167.79 1.23 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.291 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.67 ' HD3' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -91.25 19.6 5.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.921 176.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.4 30.86 0.52 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.606 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 23.2 mm-40 -104.71 144.14 32.13 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.887 -0.184 . . . . 0.0 110.73 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.502 HD13 ' HB3' ' A' ' 129' ' ' ARG . 46.7 mm -98.65 135.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.555 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 18.5 mt -118.95 155.24 31.68 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 93.4 t -120.32 125.42 74.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 174.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.017 HG21 HD23 ' A' ' 125' ' ' LEU . 47.1 mm -76.05 83.8 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 122.761 1.267 . . . . 0.0 108.674 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.759 HG21 HG22 ' A' ' 170' ' ' VAL . 15.1 tt -79.3 -26.97 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.195 -174.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 14.9 mt-10 -144.41 142.23 30.19 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.505 0.503 . . . . 0.0 109.975 173.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.601 ' HD3' HD22 ' A' ' 125' ' ' LEU . 3.8 ttpm? -134.58 89.74 25.55 Favored Pre-proline 0 C--O 1.236 0.371 0 O-C-N 121.842 -0.536 . . . . 0.0 111.172 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.465 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 16.9 Cg_exo -71.94 -55.31 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.549 2.166 . . . . 0.0 112.76 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -106.52 172.51 6.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.521 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 2.7 mm-40 -113.76 70.15 0.72 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.551 0.691 . . . . 0.0 110.505 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.503 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 13.9 pt20 175.58 -34.37 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.601 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.503 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 53.1 m95 -122.96 129.34 51.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.767 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.661 ' O ' HG13 ' A' ' 173' ' ' ILE . 51.0 m0 -120.21 137.26 54.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.35 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.868 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.5 m -88.29 92.72 9.27 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.439 0.638 . . . . 0.0 109.899 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.72 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.62 161.24 15.26 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.822 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.8 ptt180 -104.27 136.76 43.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.809 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 142' ' ' LEU . 16.3 p-10 -81.63 -173.1 4.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 110.993 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -59.13 -27.5 65.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.773 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.81 -18.93 38.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.734 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.16 29.06 7.77 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.134 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.822 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 19.6 ttm-85 -104.02 136.07 44.35 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.568 -0.372 . . . . 0.0 110.857 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.759 HG22 HG21 ' A' ' 153' ' ' ILE . 59.0 t -99.88 119.81 48.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.99 0.424 . . . . 0.0 111.167 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.2 160.22 28.22 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.6 ' O ' ' HA ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -68.81 131.37 45.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.027 0.441 . . . . 0.0 111.023 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.661 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -130.22 145.45 57.38 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.261 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.46 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 4.5 Cg_exo -78.71 131.66 10.4 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.062 2.508 . . . . 0.0 112.633 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.62 ' O ' HG22 ' A' ' 178' ' ' VAL . 41.4 t -59.68 -44.19 96.92 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.401 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 27.2 Cg_exo -65.13 5.49 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.225 1.95 . . . . 0.0 113.6 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -108.43 -6.14 16.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.093 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.1 m -107.52 -171.08 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -165.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 0.2 OUTLIER -156.09 41.21 0.38 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 112.821 -1.991 . . . . 0.0 106.91 -163.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.976 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 16.3 pttm -77.45 150.94 34.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.891 0.853 . . . . 0.0 110.435 -162.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 181' ' ' LEU . 4.1 tp -68.65 150.66 47.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.469 -173.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.611 HG23 ' H ' ' A' ' 183' ' ' ARG . 3.1 m -66.76 -69.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -169.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.611 ' H ' HG23 ' A' ' 182' ' ' VAL . 0.1 OUTLIER -161.92 164.6 28.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.151 -0.343 . . . . 0.0 110.46 -173.588 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.6 t -102.32 158.66 16.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 5.4 p -69.0 144.02 95.14 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-O 120.546 0.212 . . . . 0.0 110.772 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.17 -58.83 1.39 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.645 2.897 . . . . 0.0 113.852 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 56.4 m80 64.37 -78.01 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.525 0.515 . . . . 0.0 110.814 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -166.82 -61.45 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -90.2 76.0 6.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.994 0.426 . . . . 0.0 110.065 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.37 -46.06 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.615 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -169.0 60.04 0.2 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.495 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 67.56 -171.93 0.19 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.815 0.446 . . . . 0.0 111.057 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.402 ' HB2' ' OD1' ' A' ' 196' ' ' ASN . 14.3 ptm180 -131.87 139.81 48.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.558 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -139.92 -40.25 0.44 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.807 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 55.3 m -115.6 -17.94 11.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.791 0.329 . . . . 0.0 110.602 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 193' ' ' ARG . 62.7 m-20 66.94 -89.22 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.382 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 4.5 p -96.84 132.25 42.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.267 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -101.16 -21.08 15.04 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.685 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 113.8 25.02 4.39 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.341 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 30.3 pt -129.32 162.38 52.94 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.42 107.16 2.34 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.376 2.051 . . . . 0.0 112.083 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.491 ' N ' ' HD2' ' A' ' 203' ' ' PRO . 2.8 mp0 -63.29 -47.64 84.21 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.388 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 202' ' ' GLU . 56.5 Cg_endo -71.2 64.18 2.69 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.187 1.925 . . . . 0.0 111.758 172.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.34 179.22 4.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.423 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -82.58 31.63 0.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.582 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.19 79.46 3.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.332 0.587 . . . . 0.0 110.806 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.944 ' O1P' ' HB2' ' A' ' 42' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.758 ' HA ' ' NH1' ' A' ' 164' ' ' ARG . . . -124.97 113.45 17.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.651 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 27.1 pt20 -107.38 101.49 39.26 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.241 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.723 ' HA ' HG23 ' A' ' 170' ' ' VAL . 15.0 Cg_endo -99.11 83.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.648 2.899 . . . . 0.0 114.215 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.65 ' HB3' ' HA ' ' A' ' 169' ' ' ARG . 4.2 tp-100 -57.58 -49.64 75.73 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.751 HG21 ' HZ ' ' A' ' 87' ' ' PHE . 51.6 m 73.89 -45.15 0.59 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 172.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.43 ' OG1' ' HD3' ' A' ' 169' ' ' ARG . 3.2 m 81.13 83.89 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.581 0.753 . . . . 0.0 109.475 -172.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 7.2 p -88.86 126.18 60.26 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.229 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.04 -15.07 11.91 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.52 2.147 . . . . 0.0 112.444 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.3 tt 59.01 82.52 0.23 Allowed Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.091 -177.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.45 109.0 2.7 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.857 2.372 . . . . 0.0 112.408 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -94.13 93.4 7.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.746 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.25 135.9 24.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.968 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 41.2 m -87.36 135.35 33.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.561 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -108.29 109.02 2.79 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.758 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 32.5 p -81.36 122.29 80.96 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 24.6 Cg_exo -63.12 134.7 47.13 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.6 2.2 . . . . 0.0 112.218 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -69.65 156.65 53.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.794 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.87 137.32 41.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.849 0.356 . . . . 0.0 111.012 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -82.67 95.0 7.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.053 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 228' ' ' THR . 16.3 pt -62.94 -48.05 89.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.974 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.468 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 11.6 t -166.43 134.8 2.3 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 228' ' ' THR . 36.7 Cg_endo -89.22 96.22 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.808 2.339 . . . . 0.0 112.522 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.724 ' H ' HD23 ' A' ' 230' ' ' LEU . 1.7 pt? -99.93 100.09 10.56 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.75 109.44 2.86 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.568 2.179 . . . . 0.0 112.407 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 48.8 m -73.82 149.54 41.57 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 12.0 p -71.84 90.54 1.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.712 0.768 . . . . 0.0 111.176 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.417 ' HG2' ' HB ' ' A' ' 267' ' ' THR . 67.5 mt-30 -75.9 75.74 2.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.445 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -68.22 -36.88 80.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.719 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -142.85 78.01 0.28 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.858 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.69 133.13 21.48 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.414 2.076 . . . . 0.0 112.295 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.497 ' HB ' HG13 ' A' ' 266' ' ' VAL . 22.8 t -94.43 144.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.502 ' HD1' HG21 ' A' ' 263' ' ' ILE . 96.2 m-85 -109.6 123.91 50.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.0 111.001 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.692 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -142.02 122.04 13.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.033 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.476 ' CD ' ' H ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -80.96 144.68 31.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.068 0.461 . . . . 0.0 110.505 -178.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -88.78 94.67 10.0 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.049 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.447 ' H ' HG13 ' A' ' 243' ' ' ILE . 2.4 pp -94.48 19.45 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.687 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.61 173.39 11.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.331 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.435 ' H ' ' HG2' ' A' ' 245' ' ' LYS . 20.8 pttm -95.34 133.67 38.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.553 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -147.77 113.55 5.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.096 0.474 . . . . 0.0 111.382 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.62 158.62 33.36 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.755 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -94.57 -172.31 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.946 2.431 . . . . 0.0 112.68 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 252' ' ' ASP . 42.4 t -80.01 149.62 30.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.25 -48.04 74.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.706 0.289 . . . . 0.0 111.672 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.53 ' HE1' ' HB2' ' A' ' 253' ' ' LYS . 19.2 p90 -92.1 -7.22 49.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.85 0.357 . . . . 0.0 110.651 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' ' 249' ' ' CYS . 15.1 t70 63.9 106.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.751 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.53 ' HB2' ' HE1' ' A' ' 251' ' ' TYR . 1.7 tmtp? -113.04 84.5 2.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 34.7 p 48.25 36.25 6.57 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.665 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -104.58 99.61 9.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.119 0.485 . . . . 0.0 110.442 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.507 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.7 OUTLIER -78.37 121.5 24.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.919 -177.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -83.45 136.92 34.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.056 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.74 119.5 20.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.998 0.427 . . . . 0.0 110.313 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -100.01 149.83 23.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.514 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 15.6 t -58.02 123.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.839 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 157.46 -68.1 0.28 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.815 -1.183 . . . . 0.0 114.952 174.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 263' ' ' ILE . 5.0 t70 -116.96 -169.33 1.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.473 0.637 . . . . 0.0 112.496 -159.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.502 HG21 ' HD1' ' A' ' 239' ' ' PHE . 40.6 mm -91.72 135.6 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.238 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.47 110.16 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.735 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -80.58 87.81 5.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 110.862 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.497 HG13 ' HB ' ' A' ' 238' ' ' VAL . 6.8 p -90.21 130.62 39.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.038 0.447 . . . . 0.0 110.911 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.426 HG23 ' HG3' ' A' ' 268' ' ' ARG . 9.0 t -113.07 -20.83 11.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.426 ' HG3' HG23 ' A' ' 267' ' ' THR . 98.2 mtt180 -117.92 98.92 6.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 0.0 110.107 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 34.8 ttm -101.18 109.68 21.59 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.168 0.509 . . . . 0.0 110.804 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -83.31 162.31 21.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.932 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.1 tt -97.38 -13.72 7.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.129 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -67.24 -53.7 27.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.227 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 164.77 -37.81 0.29 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.791 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.421 ' HG3' HD13 ' A' ' 285' ' ' LEU . 0.5 OUTLIER -101.89 134.92 44.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.057 0.456 . . . . 0.0 110.24 178.437 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.519 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 20.9 m0 -107.89 165.1 11.7 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.167 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 43.7 tt0 -121.53 116.85 25.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.136 0.494 . . . . 0.0 110.253 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -129.56 169.98 20.59 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.54 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 74.8 mt-10 -108.39 108.35 19.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.906 0.384 . . . . 0.0 110.767 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.507 ' HB ' HD21 ' A' ' 256' ' ' LEU . 47.2 t -128.28 139.08 52.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 279' ' ' VAL . 88.1 m-20 70.96 8.02 6.39 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.631 0.373 . . . . 0.0 110.76 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 86.46 13.46 67.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.975 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 282' ' ' ARG . 1.7 ptm180 -132.03 137.98 48.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.86 0.362 . . . . 0.0 110.525 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 3.3 ptpp? -97.79 134.3 41.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.693 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -152.39 173.94 31.39 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.566 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 91.7 mt -90.14 140.59 29.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.015 0.436 . . . . 0.0 111.504 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 33.5 p90 -145.64 134.73 11.21 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.521 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 5.0 Cg_exo -74.54 148.82 38.11 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.857 2.371 . . . . 0.0 112.811 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.406 ' C ' ' H ' ' A' ' 290' ' ' HIS . 36.7 p90 -64.32 -25.27 67.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.286 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.8 m -76.0 37.45 0.15 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.45 0.643 . . . . 0.0 110.928 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.406 ' H ' ' C ' ' A' ' 288' ' ' PHE . 8.5 m-70 -141.6 -61.02 0.47 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.384 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.461 HG21 ' HE2' ' A' ' 286' ' ' PHE . 23.2 m -90.92 150.38 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.797 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -109.35 117.04 33.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.86 0.362 . . . . 0.0 110.785 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.692 HD13 ' HB2' ' A' ' 240' ' ' ALA . 36.8 mm -69.94 125.49 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.837 175.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -122.3 -179.31 4.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.465 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 296' ' ' PRO . 14.7 m-20 -78.82 114.86 47.55 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.133 0.492 . . . . 0.0 110.017 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 295' ' ' ASP . 21.5 Cg_endo -94.5 43.55 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.513 2.809 . . . . 0.0 113.126 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.465 ' O ' ' HD3' ' A' ' 299' ' ' PRO . 5.6 pm0 -73.29 -14.88 61.39 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -96.07 98.73 4.27 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.779 171.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 297' ' ' GLN . 74.3 Cg_endo -95.24 21.14 0.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.946 2.431 . . . . 0.0 113.285 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 44.3 t0 65.08 97.08 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.703 0.627 . . . . 0.0 110.402 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.45 -49.67 70.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.738 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -76.52 101.73 5.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.165 0.507 . . . . 0.0 111.493 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.396 -0.812 . . . . 0.0 109.543 177.117 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.677 0.275 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 p -111.5 28.51 8.67 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 m -65.88 -44.39 85.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.599 0.714 . . . . 0.0 109.315 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 98' ' ' LEU . . . -91.94 117.3 29.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.144 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 5' ' ' ARG . 17.4 ttp180 -163.11 105.15 1.01 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.114 0.483 . . . . 0.0 110.319 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.477 ' CB ' ' HD3' ' A' ' 101' ' ' PRO . 25.4 p90 -132.28 -180.0 5.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.985 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -89.36 91.03 8.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.122 0.487 . . . . 0.0 110.699 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.766 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 40.8 m -67.65 150.56 48.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.894 177.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m 78.28 -39.35 0.26 Allowed 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.799 0.687 . . . . 0.0 112.31 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.96 101.85 0.17 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.049 0.452 . . . . 0.0 110.295 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -56.96 -46.2 82.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.033 -170.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m -77.27 7.87 4.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.34 -40.27 11.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.572 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.3 p-90 -127.76 -27.81 2.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.0 t80 -79.77 123.67 27.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.896 0.317 . . . . 0.0 110.355 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.441 ' HB2' HG21 ' A' ' 19' ' ' VAL . 22.3 mmt -110.52 -1.33 17.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.844 -173.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.46 -114.27 2.88 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.007 -0.542 . . . . 0.0 113.709 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 10.3 Cg_exo -70.33 103.59 1.28 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.008 2.472 . . . . 0.0 112.175 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.816 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 85.9 t -136.57 -70.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.794 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 30.1 t 81.36 165.59 0.15 Allowed 'General case' 0 C--N 1.347 0.477 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -55.83 -38.96 70.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.746 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -59.63 -40.99 89.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.069 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -91.98 -44.97 8.58 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.235 -175.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.92 -41.31 67.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.811 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 47.8 tt0 -72.3 -46.27 56.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.413 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.3 t -68.39 -23.42 64.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.988 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -83.39 -29.31 28.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.2 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.713 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 38.4 mt -103.43 -0.05 30.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.027 0.441 . . . . 0.0 110.757 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 25.7 tt0 -70.15 113.53 7.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.6 -174.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.89 33.82 84.96 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.573 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -102.47 -168.48 1.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.678 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 17.8 ttp180 -62.85 113.19 2.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.627 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.478 ' ND1' ' HA ' ' A' ' 54' ' ' GLU . 4.2 m-70 -62.26 118.5 7.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.929 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.91 -8.33 6.81 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.569 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.678 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 20.1 mtp -87.17 140.11 29.88 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 122.52 0.328 . . . . 0.0 110.442 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.778 ' HB2' HG22 ' A' ' 52' ' ' VAL . 28.8 p90 -142.52 164.52 29.89 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.643 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.402 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.2 pp -154.98 136.67 14.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.221 0.534 . . . . 0.0 111.056 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 15' ' ' TYR . 93.2 t -101.42 112.7 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.816 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 20.9 ptt-85 -107.59 176.47 5.14 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.685 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -81.5 138.97 35.41 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.415 ' HA ' HG23 ' A' ' 49' ' ' VAL . 83.3 p -55.6 -19.87 11.75 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.086 0.241 . . . . 0.0 111.596 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m 69.41 17.63 8.07 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.507 0.67 . . . . 0.0 109.794 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 p -140.42 -45.05 0.41 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.733 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 66.3 m -134.27 127.13 18.79 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.765 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 24.2 Cg_exo -64.48 -14.37 43.95 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.863 2.375 . . . . 0.0 112.578 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.57 29.2 13.03 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.862 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.31 134.74 18.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -124.76 162.34 24.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.512 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.72 HG11 ' HE2' ' A' ' 207' ' ' PTR . 21.2 t -131.51 99.88 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.125 0.488 . . . . 0.0 111.189 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.2 tp -76.28 96.34 3.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.141 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.9 m -97.35 135.41 39.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.971 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.778 HG22 ' HB2' ' A' ' 36' ' ' PHE . 86.7 t -128.87 137.18 57.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.114 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.713 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 31.3 t -83.5 99.38 10.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.704 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' OE2' ' HB2' ' A' ' 93' ' ' LEU . 15.8 pt-20 -172.81 173.87 3.74 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.995 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.748 ' HB3' HH21 ' A' ' 57' ' ' ARG . 27.7 t-20 71.67 -56.3 0.64 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.734 1.254 . . . . 0.0 109.499 -164.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.401 ' C ' ' HG3' ' A' ' 57' ' ' ARG . 29.8 t -162.32 -40.63 0.04 OUTLIER 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.068 -1.878 . . . . 0.0 106.88 -176.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.748 HH21 ' HB3' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -165.35 -39.51 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.705 ' CG2' ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -144.2 110.97 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 120.822 1.646 . . . . 0.0 114.899 -173.285 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.652 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 16.0 m -95.85 108.29 20.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 163.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -100.34 99.0 9.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -170.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.729 ' CE2' HD22 ' A' ' 93' ' ' LEU . 44.0 m-85 -116.97 114.31 23.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.715 HG12 HG22 ' A' ' 49' ' ' VAL . 19.9 mt -81.07 138.59 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.787 HG13 ' HB ' ' A' ' 73' ' ' ILE . 5.3 mp -114.2 115.25 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.205 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -85.0 143.15 29.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.692 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.7 t -93.56 98.69 11.33 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' A' ' 72' ' ' LYS . 23.0 mt -78.58 124.94 85.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 14.1 Cg_exo -68.12 -33.58 24.73 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.313 2.009 . . . . 0.0 113.44 -174.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -67.53 -18.85 65.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -172.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.641 ' HG2' ' N ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -176.65 -53.55 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.641 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 2.3 ptm180 -136.85 -172.18 3.11 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -160.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -102.36 157.81 16.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.539 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.659 ' HB2' HD11 ' A' ' 66' ' ' LEU . 24.7 ttmm -138.82 104.67 5.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.787 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.7 tt -90.88 78.78 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.785 0.802 . . . . 0.0 110.006 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.749 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 65.52 86.49 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.742 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 10.8 t70 75.1 -61.68 0.48 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.475 0.31 . . . . 0.0 111.472 176.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.28 124.04 23.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.023 0.44 . . . . 0.0 109.987 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 11.1 pt-20 -107.3 138.5 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.282 0.563 . . . . 0.0 110.489 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.495 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 44.5 m-85 -127.18 166.59 17.42 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.54 -50.42 71.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -149.38 175.78 11.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.452 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.653 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 15.4 mt -54.85 -55.22 40.97 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.766 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 41.4 Cg_exo -59.96 -10.42 12.31 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.277 1.985 . . . . 0.0 113.797 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.74 -34.92 16.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.348 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -76.32 -28.75 57.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.394 0.616 . . . . 0.0 109.385 176.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 82' ' ' PRO . 74.0 mt -66.35 -23.4 66.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.009 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' A' ' 89' ' ' LYS . 38.0 tt0 -85.46 -29.27 24.45 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.237 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -69.37 -38.7 78.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.238 0.542 . . . . 0.0 110.063 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HE2' HD13 ' A' ' 73' ' ' ILE . 59.2 m-85 -80.83 -2.61 47.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.54 0.686 . . . . 0.0 110.467 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 47.5 tttm -78.77 -14.82 59.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.035 174.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -128.73 -1.77 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 111.474 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 22.6 t-160 -98.75 -28.51 13.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.127 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 70.1 132.23 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 O-C-N 124.079 0.862 . . . . 0.0 109.376 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 61' ' ' TYR . 9.2 mt -92.31 -26.63 18.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.734 ' CG ' ' HB2' ' A' ' 55' ' ' ASN . 10.3 t0 -173.83 83.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.777 168.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 71.66 -19.18 0.27 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.925 0.89 . . . . 0.0 112.064 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.7 m -120.43 158.0 28.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.0 p -106.16 172.57 6.73 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.458 ' O ' ' HB1' ' A' ' 4' ' ' ALA . 95.5 mt -64.71 93.69 0.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.032 0.444 . . . . 0.0 110.104 175.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.598 HG22 ' HG3' ' A' ' 100' ' ' GLU . 47.1 mm -81.34 -62.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.254 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.598 ' HG3' HG22 ' A' ' 99' ' ' ILE . 43.5 mt-10 -147.65 157.16 44.8 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.562 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 11.9 Cg_exo -70.46 156.98 60.36 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.097 1.865 . . . . 0.0 111.19 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.24 138.74 71.83 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.584 ' HG2' ' HB2' ' A' ' 107' ' ' SER . 69.4 Cg_exo -52.14 126.19 19.59 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.232 1.954 . . . . 0.0 111.808 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -60.62 -31.48 70.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.057 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -108.45 138.17 20.15 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.214 174.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -44.97 119.29 2.33 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.549 2.833 . . . . 0.0 113.496 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.603 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 23.3 t -72.47 -49.74 8.61 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.756 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 107' ' ' SER . 8.0 Cg_exo -34.6 -54.88 0.55 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 124.025 3.15 . . . . 0.0 115.604 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.47 -0.81 7.2 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 122.006 1.804 . . . . 0.0 113.701 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 22.4 ptm -147.84 25.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.22 165.23 24.74 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.195 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.3 m -107.57 106.95 17.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.846 0.355 . . . . 0.0 110.402 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.4 t -81.85 82.31 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.585 0.707 . . . . 0.0 110.124 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.414 ' H ' ' HD2' ' A' ' 116' ' ' PRO . 70.1 m -151.54 -42.93 0.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.338 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.478 ' N ' ' HD2' ' A' ' 116' ' ' PRO . . . -62.42 -48.78 86.17 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.355 174.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HB3' ' HB2' ' A' ' 32' ' ' ARG . 38.1 Cg_endo -67.59 104.34 0.93 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.5 1.467 . . . . 0.0 111.715 172.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -76.18 140.37 41.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.799 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 53.3 tp -120.82 83.65 36.81 Favored Pre-proline 0 C--N 1.32 -0.686 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.766 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -88.97 115.82 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.305 2.67 . . . . 0.0 110.188 167.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 t -116.83 157.32 25.79 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.668 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.08 -153.9 0.5 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.221 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.77 -178.63 1.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.326 0.584 . . . . 0.0 110.724 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -86.35 -7.96 58.06 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -86.83 -151.83 0.17 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.152 -1.386 . . . . 0.0 109.386 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.597 HD12 HG21 ' A' ' 152' ' ' ILE . 1.0 OUTLIER 63.19 86.08 0.12 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 122.04 0.924 . . . . 0.0 111.488 177.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -172.07 -33.75 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.895 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.678 ' HB3' HH21 ' A' ' 183' ' ' ARG . 19.2 m-85 -123.7 109.77 14.13 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.655 0.741 . . . . 0.0 111.352 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 179' ' ' GLU . 25.4 t -124.38 153.05 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.372 -175.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.732 ' HG2' ' O ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -135.06 150.37 50.25 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.066 174.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.649 HG22 ' CG1' ' A' ' 178' ' ' VAL . 51.4 p -95.46 133.95 38.85 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.823 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 178' ' ' VAL . 6.4 mt -106.96 -37.52 6.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.664 -173.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.599 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 47.5 t80 -90.45 -31.62 16.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -168.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.599 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 6.5 t70 77.67 123.91 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.214 0.53 . . . . 0.0 111.113 -172.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 84.8 t80 -156.77 106.3 1.96 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.733 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -91.98 95.22 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.879 2.386 . . . . 0.0 113.123 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -97.41 0.6 59.97 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.794 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.557 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 4.8 m-20 66.96 5.33 4.0 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.301 0.641 . . . . 0.0 112.223 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.883 ' HB2' ' HD3' ' A' ' 143' ' ' PRO . 18.5 t0 52.47 -146.51 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.869 0.867 . . . . 0.0 112.94 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 140' ' ' GLU . . . 69.51 11.83 8.08 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.499 1.12 . . . . 0.0 108.828 -165.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 139' ' ' ALA . 23.2 tt0 171.81 -39.67 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.139 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.506 ' C ' ' HA ' ' A' ' 138' ' ' ASP . 21.8 m-20 -133.33 97.73 4.05 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.78 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.819 HD12 ' HD2' ' A' ' 143' ' ' PRO . 23.7 tp -54.67 129.86 63.91 Favored Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 122.971 0.509 . . . . 0.0 111.931 -174.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.883 ' HD3' ' HB2' ' A' ' 138' ' ' ASP . 73.1 Cg_endo -81.54 117.5 3.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.513 2.142 . . . . 0.0 111.355 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.615 ' CB ' HG21 ' A' ' 130' ' ' THR . 21.3 p90 -123.04 165.51 16.66 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.986 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.521 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 42.4 mttp -115.05 -165.88 1.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.272 0.558 . . . . 0.0 111.904 -174.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.531 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -93.98 26.98 2.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.089 179.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.43 25.92 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 119.625 -1.274 . . . . 0.0 114.388 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.541 ' OE1' ' HB2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -108.12 161.6 14.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.93 0.865 . . . . 0.0 109.331 174.116 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.602 HG21 HD23 ' A' ' 181' ' ' LEU . 7.0 mm -119.36 146.9 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.757 -167.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 165' ' ' ASN . 15.9 mt -122.77 166.38 15.05 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -173.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.44 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 97.6 t -123.53 125.76 72.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.712 HD13 ' HB2' ' A' ' 163' ' ' ALA . 21.6 mm -77.0 97.54 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 CA-C-O 122.475 1.131 . . . . 0.0 108.747 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.615 ' CD1' ' HE1' ' A' ' 61' ' ' TYR . 1.7 tt -97.52 -49.01 12.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 112.472 -2.149 . . . . 0.0 109.024 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.044 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 15.7 mt-10 -116.16 142.85 46.27 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.573 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 15.8 ttpp -140.23 72.04 32.96 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 121.466 -0.771 . . . . 0.0 109.901 170.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.474 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 24.5 Cg_exo -62.12 -43.89 22.13 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.453 2.102 . . . . 0.0 111.885 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -113.73 -174.07 2.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.05 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 4.2 tp10 -107.14 -40.0 5.55 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.525 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -84.08 -11.55 56.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.174 0.512 . . . . 0.0 110.324 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.427 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 68.0 m95 -129.2 118.58 22.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.407 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.604 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.7 m0 -108.76 139.08 44.07 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . 1.044 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 11.3 t -101.72 91.08 4.25 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.39 0.614 . . . . 0.0 109.639 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.712 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.52 161.53 15.25 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.197 -172.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.837 HH12 ' HA ' ' A' ' 208' ' ' ALA . 19.5 ptt-85 -97.54 136.21 38.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.796 ' HB3' HD11 ' A' ' 142' ' ' LEU . 0.1 OUTLIER -85.76 175.57 8.62 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.619 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -79.9 4.28 17.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.37 0.605 . . . . 0.0 110.975 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.513 ' HB3' ' OD1' ' A' ' 165' ' ' ASN . 33.6 t70 -104.03 -1.28 27.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.245 0.545 . . . . 0.0 109.535 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.798 ' HA3' ' HA ' ' A' ' 212' ' ' THR . . . 85.47 72.09 1.3 Allowed Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.81 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 38.4 ttm-85 -164.46 129.04 2.65 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.78 -0.247 . . . . 0.0 110.364 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.689 HG22 ' HB3' ' A' ' 164' ' ' ARG . 39.0 t -105.48 109.56 28.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.373 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.505 ' HA3' ' OD1' ' A' ' 138' ' ' ASP . . . -146.23 170.09 27.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.095 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.587 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 22.5 mtp -82.49 137.11 34.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.038 0.447 . . . . 0.0 111.211 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.613 HG23 ' HB3' ' A' ' 142' ' ' LEU . 2.7 pp -133.9 146.04 58.4 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.699 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.461 ' HD2' ' CE2' ' A' ' 144' ' ' PHE . 7.3 Cg_exo -72.23 128.35 13.72 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.064 2.509 . . . . 0.0 112.41 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 47.8 t -67.4 -36.67 10.86 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.278 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 26.8 Cg_endo -63.49 10.4 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.646 1.564 . . . . 0.0 113.177 173.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 175' ' ' VAL . 4.6 m-85 -118.38 -19.83 8.73 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.554 0.342 . . . . 0.0 111.322 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.649 ' CG1' HG22 ' A' ' 130' ' ' THR . 3.8 m -146.2 155.97 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.674 -166.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.5 ' C ' ' HD3' ' A' ' 180' ' ' LYS . 11.7 mt-10 -150.46 -56.35 0.17 Allowed 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 115.939 -2.305 . . . . 0.0 115.652 155.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.732 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -144.35 150.0 37.07 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 115.619 -2.432 . . . . 0.0 116.04 -160.04 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.602 HD23 HG21 ' A' ' 149' ' ' ILE . 37.0 tp -147.08 110.42 4.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.242 163.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.74 -26.98 21.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 O-C-N 123.837 0.71 . . . . 0.0 111.241 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.678 HH21 ' HB3' ' A' ' 127' ' ' TYR . 0.2 OUTLIER 83.15 -42.11 0.1 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.64 169.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.2 t -67.98 91.79 0.35 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.377 0.608 . . . . 0.0 110.451 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 4.4 p -144.6 139.1 15.14 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.182 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 52.7 Cg_exo -55.81 -41.92 72.44 Favored 'Trans proline' 0 N--CA 1.471 0.191 0 C-N-CA 123.287 2.658 . . . . 0.0 113.479 -174.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 71.4 m80 60.61 -155.52 0.36 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -76.42 -52.55 6.01 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.227 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -138.51 18.45 2.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 110.27 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 66.13 10.08 6.78 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.59 0.71 . . . . 0.0 110.51 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -149.88 -138.35 2.89 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -157.74 161.9 38.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -128.73 132.27 47.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.129 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 195' ' ' SER . 10.8 t30 -136.91 -81.67 0.37 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.145 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 194' ' ' ASN . 15.7 t 174.33 116.69 0.02 OUTLIER 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 60.17 -165.57 0.2 Allowed 'General case' 0 C--O 1.235 0.316 0 O-C-N 123.803 0.689 . . . . 0.0 110.311 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 32.2 t 66.03 19.37 11.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.673 0.389 . . . . 0.0 111.15 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -79.91 105.73 11.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.262 0.554 . . . . 0.0 110.693 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -169.88 63.27 0.18 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.579 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 203' ' ' PRO . 14.2 pt -98.08 116.2 65.65 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 121.283 0.564 . . . . 0.0 111.335 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -87.57 101.11 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.891 2.394 . . . . 0.0 112.086 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 60.85 81.65 0.24 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.665 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.545 ' HB3' HD12 ' A' ' 200' ' ' ILE . 74.4 Cg_endo -76.73 19.93 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.877 2.385 . . . . 0.0 113.249 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -78.75 -58.76 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.343 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -120.93 -21.6 6.49 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.419 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 59.79 -156.07 0.35 Allowed 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.498 0.498 . . . . 0.0 111.098 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.72 ' HE2' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.837 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -92.57 5.65 50.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.64 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.406 ' HB3' ' H ' ' A' ' 62' ' ' ILE . 19.4 pt20 -59.91 145.82 83.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.676 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.749 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 21.4 Cg_exo -65.81 85.82 0.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.221 1.948 . . . . 0.0 111.465 175.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -72.98 112.05 8.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.798 ' HA ' ' HA3' ' A' ' 168' ' ' GLY . 2.9 m -67.13 -38.83 86.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.449 -176.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 25.3 m 72.87 -68.1 0.24 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.953 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 212' ' ' THR . 11.3 p -105.96 150.45 39.27 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.826 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.49 147.32 86.75 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.531 2.154 . . . . 0.0 112.152 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.691 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 98.7 mt -57.81 -53.47 65.4 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 13.6 Cg_exo -70.77 132.86 22.52 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.071 1.847 . . . . 0.0 111.926 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -67.6 -29.24 68.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.208 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 47.2 t -67.22 106.6 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.322 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 32.7 t -127.91 97.74 4.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.295 0.569 . . . . 0.0 110.696 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -132.92 -49.78 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 66.4 m -157.94 110.11 1.76 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -51.74 -48.78 19.77 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.764 2.309 . . . . 0.0 112.166 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 179.47 100.69 0.14 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.867 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.35 -32.13 72.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.236 0.541 . . . . 0.0 109.571 176.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -106.79 142.02 37.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.295 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 60.8 mt -95.0 100.58 11.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.042 0.449 . . . . 0.0 110.902 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.473 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 63.8 m -106.59 112.39 63.67 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.797 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 228' ' ' THR . 17.1 Cg_exo -66.32 -78.79 0.01 OUTLIER 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.866 2.377 . . . . 0.0 112.889 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 229' ' ' PRO . 2.7 pt? -168.31 151.67 5.58 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.94 129.46 8.01 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.381 2.054 . . . . 0.0 111.718 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 39.6 p -99.75 2.22 43.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.118 0.485 . . . . 0.0 110.391 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 43.7 p -105.0 -172.75 2.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.866 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -94.26 9.93 36.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.215 0.531 . . . . 0.0 110.131 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -82.36 113.67 20.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.501 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -177.3 -139.76 3.42 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.037 -0.601 . . . . 0.0 111.632 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.92 160.4 33.82 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.548 2.165 . . . . 0.0 111.948 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.442 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 38.4 t -103.21 145.16 12.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.19 122.01 46.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.88 0.371 . . . . 0.0 110.818 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.492 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.28 142.91 48.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.25 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -95.37 123.75 39.06 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -75.81 111.24 10.96 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.121 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.417 HG21 ' HE3' ' A' ' 292' ' ' LYS . 35.6 pt -94.58 -9.98 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.431 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 62.3 tt0 -138.92 144.04 38.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.607 ' HG2' ' HA ' ' A' ' 259' ' ' GLU . 84.1 mttt -82.3 121.94 27.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.932 0.396 . . . . 0.0 111.093 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.596 ' HD2' ' HE2' ' A' ' 290' ' ' HIS . 54.1 ttt85 -93.16 102.47 14.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 45.7 t -80.59 136.97 51.52 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.196 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 11.6 Cg_endo -55.02 141.48 79.02 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.994 2.463 . . . . 0.0 112.75 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.93 165.5 25.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.234 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.75 -23.66 67.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.949 0.404 . . . . 0.0 111.108 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -125.33 30.32 5.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.945 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.487 ' HB2' ' HB3' ' A' ' 255' ' ' ALA . 9.9 p-10 -43.63 103.84 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.971 0.891 . . . . 0.0 112.277 -169.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -111.97 -33.8 6.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.904 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 7.4 p -129.96 16.18 5.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.307 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . . . -92.59 111.01 22.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.929 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.475 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.4 tt -90.11 113.3 25.01 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -64.68 123.82 20.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.016 0.436 . . . . 0.0 110.909 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.3 mt -128.03 165.18 20.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.848 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.607 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 14.3 pt-20 -146.36 166.27 26.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.535 177.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 42.9 t -70.56 124.01 25.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.022 0.439 . . . . 0.0 111.071 -174.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.35 4.43 50.08 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.805 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -100.3 155.08 17.98 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.977 0.389 . . . . 0.0 109.992 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.447 HD11 ' OD1' ' A' ' 302' ' ' ASN . 22.8 mm -94.74 113.04 28.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.169 0.509 . . . . 0.0 110.99 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 t -87.05 95.4 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.285 0.565 . . . . 0.0 109.592 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -81.52 98.58 8.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.057 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 275' ' ' TRP . 4.0 p -89.11 120.96 38.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.392 0.615 . . . . 0.0 111.27 -176.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 26.4 m -93.99 -30.91 14.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.506 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 1.001 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 13.0 tpt180 -115.54 97.34 6.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.441 -177.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 2.2 tpt -81.53 106.16 13.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.167 0.508 . . . . 0.0 109.659 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -86.39 166.17 15.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.192 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 40.1 mm -76.91 83.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.418 -175.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.6 t30 83.65 82.42 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.752 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.407 ' HA2' ' HD1' ' A' ' 288' ' ' PHE . . . 114.35 -77.16 0.25 Allowed Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 119.69 -1.243 . . . . 0.0 114.066 154.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -72.52 88.57 1.24 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.825 0.345 . . . . 0.0 110.718 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.514 ' HB3' HG21 ' A' ' 266' ' ' VAL . 9.9 m0 -92.88 161.47 14.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.033 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 1.001 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 27.5 tt0 -109.98 116.09 30.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.086 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.36 155.71 18.24 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.368 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.3 108.37 19.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.475 ' HB ' HD21 ' A' ' 256' ' ' LEU . 61.0 t -128.98 140.12 50.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 66.68 -71.05 0.1 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.831 0.707 . . . . 0.0 110.882 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -173.98 31.51 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -151.17 143.59 24.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.733 -0.233 . . . . 0.0 110.577 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 98.3 mttt -96.52 131.39 43.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 171.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.71 171.23 30.52 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.98 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 37.2 mt -92.83 145.09 24.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.093 0.473 . . . . 0.0 110.668 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.871 ' HB2' ' HE1' ' A' ' 290' ' ' HIS . 31.5 p90 -148.22 124.93 5.46 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.16 177.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.416 ' HB2' HG22 ' A' ' 289' ' ' THR . 44.4 Cg_endo -71.6 157.48 55.84 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.271 1.981 . . . . 0.0 111.772 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.407 ' HD1' ' HA2' ' A' ' 273' ' ' GLY . 22.8 p90 -81.55 15.21 2.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.1 0.476 . . . . 0.0 111.5 -176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.416 HG22 ' HB2' ' A' ' 287' ' ' PRO . 8.8 t -89.81 1.56 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.576 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.871 ' HE1' ' HB2' ' A' ' 286' ' ' PHE . 0.3 OUTLIER -137.39 3.77 2.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 176.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.463 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 18.4 m -129.54 157.35 42.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.417 ' HE3' HG21 ' A' ' 243' ' ' ILE . 16.8 ptpt -129.9 135.66 48.62 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.516 176.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.492 HD13 ' HB2' ' A' ' 240' ' ' ALA . 46.5 mm -83.47 103.4 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.252 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -93.69 167.56 11.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.194 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.1 134.72 59.16 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.89 -20.06 27.89 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.158 2.572 . . . . 0.0 113.359 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -86.58 86.28 7.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.182 0.515 . . . . 0.0 110.005 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 17.0 m120 -83.06 135.93 44.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.962 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 16.5 Cg_exo -69.24 -32.69 20.2 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.698 2.265 . . . . 0.0 110.518 171.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -96.86 -173.37 2.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.222 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -121.2 14.9 11.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.027 0.441 . . . . 0.0 110.154 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.447 ' OD1' HD11 ' A' ' 263' ' ' ILE . 0.7 OUTLIER 66.26 3.32 2.7 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.632 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 . . . . . 0 C--O 1.244 0.771 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.294 173.162 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 ttp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -117.07 88.39 2.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.178 0.513 . . . . 0.0 110.226 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -95.27 -37.48 10.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.709 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.629 ' HB3' ' HG2' ' A' ' 89' ' ' LYS . . . -179.5 143.24 0.19 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.637 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.96 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.619 0.575 . . . . 0.0 109.487 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.684 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 3.5 p90 38.4 -122.56 0.28 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 124.288 0.992 . . . . 0.0 111.14 -174.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -139.99 81.59 1.83 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 172.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -71.84 62.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.943 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -179.19 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.12 100.07 4.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.576 -174.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -64.41 -24.62 67.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.761 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.6 m -67.41 -7.6 26.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.353 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.49 -47.99 4.49 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -112.15 -20.6 11.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -82.08 110.34 17.22 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.811 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 11.3 tpp -96.34 0.6 50.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.168 -171.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.433 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.49 -113.36 2.29 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.181 -0.918 . . . . 0.0 114.152 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 3.0 Cg_exo -79.33 100.24 1.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.823 2.348 . . . . 0.0 112.127 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.598 ' HB ' ' HG2' ' A' ' 39' ' ' ARG . 85.1 t -130.34 -76.63 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 48.8 m 82.65 162.92 0.13 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.803 ' HG3' ' O2P' ' A' ' 207' ' ' PTR . 44.4 mtp85 -51.65 -42.3 61.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -55.86 -39.46 71.52 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.423 0.452 . . . . 0.0 112.104 -177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 34.2 mt-10 -95.75 -44.91 7.22 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.254 -177.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.86 51.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.336 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -81.67 -32.88 31.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.759 -173.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.493 ' HA ' ' HB2' ' A' ' 29' ' ' GLN . 10.6 t -78.0 -27.74 49.05 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 110.682 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 21.2 mmt85 -64.62 -33.9 77.01 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.855 0.836 . . . . 0.0 109.755 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.987 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 80.7 mt -113.89 23.29 13.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.077 -176.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.493 ' HB2' ' HA ' ' A' ' 26' ' ' THR . 24.4 tt0 -72.71 72.13 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.227 0.537 . . . . 0.0 110.536 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.14 15.96 59.32 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.296 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -62.98 -28.37 70.04 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 20.0 ttm180 -156.24 -36.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.476 172.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.623 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 28.9 m170 77.08 132.0 0.05 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.129 0.893 . . . . 0.0 109.52 -173.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.31 -10.86 67.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.567 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 55.4 mtm -87.36 153.75 21.21 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 50' ' ' LEU . 39.0 p90 -141.63 162.16 36.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.331 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.5 pp -150.81 135.98 17.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.024 0.44 . . . . 0.0 110.337 172.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.7 t -105.54 116.26 48.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.425 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.618 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -119.85 163.72 17.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.893 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.2 131.81 45.51 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.527 ' OG ' HG22 ' A' ' 43' ' ' THR . 26.8 t -79.4 158.62 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.57 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.656 ' HB3' ' O1P' ' A' ' 207' ' ' PTR . 40.0 t -117.92 4.4 12.15 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.176 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.527 HG22 ' OG ' ' A' ' 41' ' ' SER . 14.7 t -93.52 -26.2 17.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.893 0.378 . . . . 0.0 110.345 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.696 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 62.8 m -141.98 144.67 33.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.07 -48.92 15.9 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.819 2.346 . . . . 0.0 112.568 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.92 71.59 0.21 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.577 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.696 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 34.3 t70 -151.3 150.98 31.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -173.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -130.35 172.1 12.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.647 HG22 HG12 ' A' ' 62' ' ' ILE . 54.2 t -144.47 108.29 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 111.543 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' A' ' 36' ' ' PHE . 42.9 tp -81.37 105.36 12.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.214 173.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -96.96 128.56 44.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.304 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.596 HG21 HD13 ' A' ' 93' ' ' LEU . 86.9 t -125.7 134.62 66.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.04 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.987 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 65.6 p -106.93 124.65 49.92 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.623 ' HG2' ' HB3' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -154.84 153.64 31.48 Favored 'General case' 0 C--O 1.212 -0.888 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 163.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 57.72 19.98 6.02 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.0 m 54.46 61.27 3.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 123.018 1.39 . . . . 0.0 108.259 -170.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 39.6 ttp85 -162.3 57.75 0.23 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.121 -2.309 . . . . 0.0 107.286 -159.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.2 t -76.97 100.24 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.723 -172.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 p -79.69 120.99 24.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.924 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -95.41 98.7 10.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.105 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.678 ' CE2' HD22 ' A' ' 93' ' ' LEU . 26.0 m-85 -93.9 115.83 28.23 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.864 ' HB ' ' HB3' ' A' ' 209' ' ' GLN . 7.1 mt -76.43 139.63 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.585 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 2.7 mp -124.81 118.41 53.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.696 0.798 . . . . 0.0 109.895 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 11.0 m120 -84.99 131.66 34.44 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 -172.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -79.77 99.45 7.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 72' ' ' LYS . 61.2 mt -90.63 132.48 34.95 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.429 -176.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 25.1 Cg_exo -64.07 -3.81 6.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.902 2.402 . . . . 0.0 112.699 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -93.82 22.18 5.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.152 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.655 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 2.8 mmp_? 63.36 26.83 15.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.394 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.7 164.41 15.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.663 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.585 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 62.5 m-85 -133.69 114.9 13.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.72 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.47 ' NZ ' ' HG3' ' A' ' 77' ' ' GLU . 21.8 ttmm -100.73 107.18 18.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.817 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.0 tt -94.7 78.42 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.858 0.837 . . . . 0.0 109.742 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.406 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 67.42 89.31 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.226 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.93 -57.69 0.63 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.464 0.706 . . . . 0.0 111.193 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -69.19 121.53 16.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.995 0.426 . . . . 0.0 110.965 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.47 ' HG3' ' NZ ' ' A' ' 72' ' ' LYS . 20.4 mt-10 -97.59 125.56 42.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.966 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 74.3 m-85 -115.38 152.45 32.82 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.84 -11.19 60.81 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -175.17 176.32 2.09 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.628 0.195 . . . . 0.0 110.757 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.5 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 5.9 mt -56.44 -55.56 41.27 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 123.278 0.361 . . . . 0.0 111.833 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.418 ' HA ' HD12 ' A' ' 85' ' ' LEU . 37.8 Cg_exo -63.38 -3.86 5.82 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.123 1.882 . . . . 0.0 113.638 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.13 -35.04 16.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.76 0.314 . . . . 0.0 110.55 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -76.15 -31.92 58.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 82' ' ' PRO . 55.5 mt -68.24 -24.35 64.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.713 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.18 -19.12 40.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.828 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -88.38 -39.14 14.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.177 0.513 . . . . 0.0 110.199 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.519 ' HE2' HD13 ' A' ' 73' ' ' ILE . 52.8 m-85 -78.28 -3.5 43.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.518 0.675 . . . . 0.0 109.78 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.629 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 1.4 tmtp? -64.71 -35.09 79.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.869 170.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.7 pt -113.69 -6.39 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.629 -0.428 . . . . 0.0 112.072 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 6.2 t-160 -73.18 -43.21 61.77 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.806 -0.179 . . . . 0.0 110.886 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.62 ' CD1' HG23 ' A' ' 97' ' ' THR . 94.5 m-85 68.03 100.04 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.257 0.973 . . . . 0.0 108.867 -165.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.717 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 4.2 mt -69.64 -98.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.527 ' OD2' ' HB3' ' A' ' 54' ' ' GLU . 17.5 t0 -89.84 76.86 7.09 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 121.368 -0.832 . . . . 0.0 109.325 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 68.15 -34.07 0.24 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.538 1.135 . . . . 0.0 112.409 -177.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.404 ' H ' ' C ' ' A' ' 94' ' ' ASP . 39.5 m -107.87 146.06 32.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.62 HG23 ' CD1' ' A' ' 92' ' ' TYR . 3.1 p -81.76 -178.5 7.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 0.0 110.704 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.401 HD22 ' CD2' ' A' ' 36' ' ' PHE . 95.1 mt -77.18 91.76 3.76 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.1 mm -74.93 -60.83 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.424 -175.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.684 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 9.4 pt-20 -162.35 156.09 17.9 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.407 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.2 158.15 49.32 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.621 2.214 . . . . 0.0 113.36 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -72.49 154.38 91.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.842 176.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.25 124.4 15.55 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.054 2.503 . . . . 0.0 112.673 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.811 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 75.8 ttt180 -67.58 -46.96 71.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.072 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 78.5 t80 -129.78 118.97 18.89 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.045 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 12.7 Cg_exo -70.82 98.08 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.714 2.276 . . . . 0.0 111.262 175.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.0 m -70.94 125.45 92.01 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.511 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.437 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 79.8 Cg_exo -48.75 -46.52 24.15 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.099 2.532 . . . . 0.0 113.253 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 108' ' ' PRO . 18.3 Cg_endo -62.21 105.07 0.38 Allowed 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 121.455 1.437 . . . . 0.0 110.936 169.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -76.14 120.07 20.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.281 0.562 . . . . 0.0 111.437 -174.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.99 0.11 27.08 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.752 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.8 t -162.88 114.27 1.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 110.457 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.8 m -121.07 -19.51 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.803 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.8 m -96.5 112.39 24.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.892 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.705 ' H ' ' HD2' ' A' ' 116' ' ' PRO . . . -165.58 -49.48 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.809 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.705 ' HD2' ' H ' ' A' ' 115' ' ' ALA . 40.8 Cg_endo -68.51 126.04 13.62 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 121.994 1.796 . . . . 0.0 112.78 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -81.76 -28.42 33.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.504 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.6 mt -145.86 95.99 4.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.391 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -82.2 -6.26 12.03 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.013 2.475 . . . . 0.0 111.567 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.7 p -70.54 129.33 38.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.685 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.59 133.77 55.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.009 0.433 . . . . 0.0 111.823 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -151.44 109.7 3.75 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.1 106.07 0.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.49 0.493 . . . . 0.0 111.87 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.454 ' HA ' ' CD ' ' A' ' 183' ' ' ARG . 45.1 m-80 -143.89 171.93 13.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.434 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.969 HD12 HG21 ' A' ' 152' ' ' ILE . 1.3 mm? 66.51 85.94 0.14 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.77 0.795 . . . . 0.0 111.147 174.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -154.77 -76.73 0.1 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.608 -171.112 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.578 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 48.9 m-85 -104.98 108.52 20.07 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.612 0.72 . . . . 0.0 111.392 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.944 HG22 ' HB3' ' A' ' 180' ' ' LYS . 74.3 t -122.81 132.25 71.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.516 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.975 ' HB2' ' HB3' ' A' ' 179' ' ' GLU . 26.1 mtt180 -107.7 160.29 15.82 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.548 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.452 HG21 ' CG ' ' A' ' 144' ' ' PHE . 12.5 p -117.08 134.43 54.77 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.547 176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.634 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 81.0 mt -104.42 -32.22 9.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.692 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.54 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 47.6 t80 -78.13 -36.85 47.32 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -169.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.601 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 7.4 t70 74.5 105.22 0.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.336 0.589 . . . . 0.0 109.813 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -141.1 100.15 6.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 51.9 Cg_endo -88.52 87.7 0.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.273 1.982 . . . . 0.0 112.492 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.682 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -83.3 -12.83 78.04 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.931 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 1.026 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 4.6 p30 35.71 66.74 0.33 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.431 1.092 . . . . 0.0 113.888 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -159.39 -178.88 7.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.57 -7.33 57.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.577 0.703 . . . . 0.0 109.763 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.4 pt-20 -116.85 4.07 12.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.451 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.682 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 10.3 m-20 -146.79 97.3 2.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.378 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.099 HD11 ' HB2' ' A' ' 165' ' ' ASN . 49.1 tp -75.16 120.55 82.17 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 1.026 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 12.1 Cg_endo -80.84 92.94 1.04 Allowed 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.106 1.871 . . . . 0.0 111.178 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.452 ' CG ' HG21 ' A' ' 130' ' ' THR . 10.3 p90 -100.9 164.61 11.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.685 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.601 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 9.2 mtpt -119.46 -178.83 3.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.654 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -77.28 63.56 2.51 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.089 0.947 . . . . 0.0 111.544 -175.259 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.97 35.54 0.27 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.722 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.486 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 5.3 mm-40 -96.7 141.0 30.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.982 0.42 . . . . 0.0 110.224 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.06 128.37 43.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 165' ' ' ASN . 40.1 mt -121.03 157.23 30.46 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 58.0 t -116.08 128.41 73.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.969 HG21 HD12 ' A' ' 125' ' ' LEU . 42.5 mm -75.16 97.38 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.809 0.814 . . . . 0.0 109.204 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.735 HG23 ' HG2' ' A' ' 154' ' ' GLU . 8.7 tt -85.11 -42.81 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.868 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.984 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 0.8 OUTLIER -122.23 140.23 52.85 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.567 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 45.6 tttt -131.24 88.72 43.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 O-C-N 121.673 -0.642 . . . . 0.0 110.915 171.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.478 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 16.2 Cg_exo -74.3 -51.83 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.66 2.24 . . . . 0.0 113.083 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -110.91 -171.38 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.233 -0.292 . . . . 0.0 110.82 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.42 ' HA ' ' HE1' ' A' ' 161' ' ' TRP . 0.2 OUTLIER -110.65 -25.7 9.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.774 0.321 . . . . 0.0 110.411 174.014 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -84.72 -28.0 26.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.277 0.56 . . . . 0.0 110.416 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.682 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 43.3 m95 -128.36 130.39 47.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.122 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.704 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.7 m0 -122.52 142.83 50.17 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.064 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.984 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.2 m -98.82 94.59 6.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.438 0.637 . . . . 0.0 110.391 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.71 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -100.1 164.23 12.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.217 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.703 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.2 ptt180 -104.35 134.52 47.43 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.775 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.099 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.7 t30 -75.12 -179.32 4.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.568 -177.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.604 ' O ' ' HB ' ' A' ' 213' ' ' THR . 4.4 tppp? -58.78 -21.12 55.17 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.5 -36.78 81.73 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.469 0.652 . . . . 0.0 109.36 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.25 -6.78 42.94 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.808 -168.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.703 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 13.0 ttm-85 -69.72 140.08 53.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.463 -0.868 . . . . 0.0 111.606 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.644 HG22 HG21 ' A' ' 153' ' ' ILE . 44.4 t -98.89 125.42 52.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.953 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.418 ' CA ' ' HB2' ' A' ' 142' ' ' LEU . . . -150.1 163.2 29.41 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.59 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.682 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -79.65 136.18 36.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.622 0.249 . . . . 0.0 110.609 179.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.704 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -136.09 145.39 52.14 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.378 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.488 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 6.1 Cg_exo -80.45 133.65 9.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.037 2.491 . . . . 0.0 112.903 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.677 ' O ' HG22 ' A' ' 178' ' ' VAL . 92.6 t -62.84 -41.74 73.61 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.1 Cg_endo -63.42 0.73 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.012 1.808 . . . . 0.0 113.304 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -106.74 -3.48 20.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.645 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 175' ' ' VAL . 11.4 m -107.2 -178.85 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -165.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.975 ' HB3' ' HB2' ' A' ' 129' ' ' ARG . 1.0 OUTLIER -149.25 39.98 0.85 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 112.702 -2.045 . . . . 0.0 108.498 -165.171 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.944 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -77.41 150.77 35.0 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.109 -0.995 . . . . 0.0 110.913 -169.132 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.586 HD21 ' NH2' ' A' ' 129' ' ' ARG . 48.7 mt -63.66 179.7 0.46 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.35 -170.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.95 -22.23 4.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.78 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.454 ' CD ' ' HA ' ' A' ' 124' ' ' ASN . 22.4 mtm-85 63.31 84.68 0.14 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.57 0.7 . . . . 0.0 110.698 -175.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.3 p -84.41 -178.34 6.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.921 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.477 ' H ' ' HD2' ' A' ' 186' ' ' PRO . 69.1 m -147.72 -44.53 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.477 ' HD2' ' H ' ' A' ' 185' ' ' SER . 25.3 Cg_exo -64.4 93.06 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.214 1.276 . . . . 0.0 110.288 168.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.423 ' HB3' ' HA3' ' A' ' 191' ' ' GLY . 32.8 m-70 -101.37 -56.18 2.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.265 -172.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 65.07 -112.92 5.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.33 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -86.25 -3.21 58.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.19 0.519 . . . . 0.0 110.583 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -103.99 48.53 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.373 0.606 . . . . 0.0 109.482 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' A' ' 187' ' ' HIS . . . -171.85 -149.57 6.7 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.626 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -134.92 145.8 48.54 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -71.05 135.54 47.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.953 0.406 . . . . 0.0 110.407 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.416 ' HB2' ' CD ' ' A' ' 202' ' ' GLU . 4.3 p-10 -73.91 170.55 15.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.543 -176.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 4.8 m -74.58 139.22 43.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.323 -175.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 62.95 -88.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.043 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 14.1 p -159.88 -62.88 0.07 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.784 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -85.57 96.07 9.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.956 0.407 . . . . 0.0 110.462 -178.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.48 ' HA3' ' OE2' ' A' ' 202' ' ' GLU . . . -157.43 107.11 0.31 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.792 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 42.5 mm -102.88 -59.57 0.08 OUTLIER Pre-proline 0 C--N 1.322 -0.601 0 O-C-N 122.859 -0.201 . . . . 0.0 111.186 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.792 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 69.2 Cg_endo -89.45 40.19 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.168 1.912 . . . . 0.0 113.086 -177.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.48 ' OE2' ' HA3' ' A' ' 199' ' ' GLY . 8.7 pt-20 -111.13 111.4 55.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.198 0.523 . . . . 0.0 110.836 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.18 -24.87 14.23 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.293 1.995 . . . . 0.0 111.322 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 55.49 -97.8 0.08 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.584 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 64.16 162.85 0.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.995 0.809 . . . . 0.0 111.764 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.0 174.26 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.556 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.803 ' O2P' ' HG3' ' A' ' 21' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -87.68 39.89 0.91 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.541 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.864 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 8.0 pt20 -67.07 146.2 98.99 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.406 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 47.1 Cg_exo -57.43 -27.11 74.54 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.471 2.114 . . . . 0.0 112.045 176.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 68.53 -173.46 0.19 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.332 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 26.1 m -146.43 97.24 2.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.833 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' A' ' 166' ' ' LYS . 24.2 m -120.05 92.81 3.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.219 0.533 . . . . 0.0 110.956 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.9 t -132.65 104.63 13.09 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.034 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.483 ' HB2' HD22 ' A' ' 216' ' ' LEU . 37.8 Cg_endo -67.03 -41.01 10.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.795 2.33 . . . . 0.0 112.733 -176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' A' ' 215' ' ' PRO . 3.0 mm? -129.77 138.79 33.88 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.23 106.91 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.452 2.101 . . . . 0.0 110.951 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -66.52 108.07 2.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.201 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.83 110.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.557 0.694 . . . . 0.0 110.899 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.6 p -166.22 170.71 12.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.67 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 85.34 -102.53 2.63 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.832 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.759 ' HB2' ' HD3' ' A' ' 223' ' ' PRO . 16.0 m -68.6 -53.16 17.22 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 116.501 0.15 . . . . 0.0 111.134 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.759 ' HD3' ' HB2' ' A' ' 222' ' ' SER . 56.6 Cg_endo -93.76 115.66 0.26 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.209 1.939 . . . . 0.0 112.056 174.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 131.35 -0.43 5.16 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.689 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 72.87 -42.62 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.609 0.764 . . . . 0.0 112.435 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -70.23 99.53 1.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.958 0.408 . . . . 0.0 110.538 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 37.5 pt -91.33 156.66 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.498 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.5 p -132.46 164.14 45.6 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.344 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.14 -61.26 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.659 2.239 . . . . 0.0 112.143 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 37.2 tp -173.42 101.45 0.32 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.452 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.81 33.97 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.795 2.33 . . . . 0.0 111.333 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 24.4 m 70.46 170.59 0.31 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.991 -171.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 18.6 p -87.23 -76.43 0.37 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.153 -0.219 . . . . 0.0 110.413 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.523 ' HA ' ' HB ' ' A' ' 267' ' ' THR . 7.6 tt0 51.22 50.25 19.38 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.284 0.564 . . . . 0.0 110.503 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.793 ' HB3' ' HB3' ' A' ' 265' ' ' LYS . 24.0 m120 -66.69 -18.11 65.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.562 -174.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.891 ' C ' ' H ' ' A' ' 267' ' ' THR . . . -172.77 -132.58 1.53 Allowed Glycine 0 C--O 1.211 -1.287 0 CA-C-O 118.877 -0.957 . . . . 0.0 112.362 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.964 ' CD ' HG23 ' A' ' 266' ' ' VAL . 4.5 Cg_exo -87.0 -36.99 0.09 OUTLIER 'Trans proline' 1 CA--C 1.622 4.915 2 N-CA-C 126.178 5.415 . . . . 0.0 126.178 167.597 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 1.054 ' N ' HG22 ' A' ' 266' ' ' VAL . 21.4 t 169.21 127.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 C-N-CA 127.902 2.481 . . . . 0.0 108.342 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.448 ' HA ' HG13 ' A' ' 266' ' ' VAL . 60.1 m-85 -65.26 119.59 11.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.621 1.101 . . . . 0.0 111.315 -163.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -132.96 156.98 46.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.583 -168.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -96.65 122.59 39.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.336 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.465 ' HB2' HG23 ' A' ' 264' ' ' VAL . . . -73.39 115.09 12.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.12 -0.22 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -172.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 245' ' ' LYS . 7.2 tt0 -140.94 147.89 39.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.869 0.366 . . . . 0.0 110.507 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.822 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 51.6 mtmt -79.24 140.23 37.69 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.297 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -140.39 104.91 4.88 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.998 0.428 . . . . 0.0 110.462 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.4 m -105.57 140.95 21.68 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.692 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 51.7 Cg_endo -70.54 126.57 12.94 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.429 2.086 . . . . 0.0 111.838 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.421 ' C ' ' H ' ' A' ' 251' ' ' TYR . 23.8 t -88.54 178.69 6.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.533 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -71.24 10.17 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.139 0.495 . . . . 0.0 111.557 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 249' ' ' CYS . 27.5 m-85 -121.44 19.86 11.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.748 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.68 132.18 51.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.259 0.552 . . . . 0.0 111.376 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -130.27 -49.47 1.09 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.121 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.9 p -138.98 30.07 2.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.988 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.95 103.5 14.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.064 0.459 . . . . 0.0 111.444 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.455 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.0 OUTLIER -74.27 114.06 12.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.817 177.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.642 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -70.95 132.44 45.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.524 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.429 HD21 HG21 ' A' ' 279' ' ' VAL . 96.7 mt -136.35 -177.96 4.95 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.337 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.822 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 7.5 pt-20 -154.55 -165.66 2.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.181 176.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.76 HG23 ' HG3' ' A' ' 245' ' ' LYS . 39.2 t -108.23 130.43 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 111.802 -173.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.21 15.87 12.05 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.586 -0.816 . . . . 0.0 114.497 168.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.3 179.78 6.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.87 0.835 . . . . 0.0 111.212 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.9 mm -105.82 119.43 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.816 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 266' ' ' VAL . 65.7 t -76.38 125.15 35.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.488 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.793 ' HB3' ' HB3' ' A' ' 235' ' ' ASN . 89.5 mttt -68.34 88.63 0.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.808 0.813 . . . . 0.0 109.5 173.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 1.054 HG22 ' N ' ' A' ' 238' ' ' VAL . 2.1 p -127.56 126.19 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.556 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.891 ' H ' ' C ' ' A' ' 236' ' ' GLY . 5.1 m -137.87 -26.18 0.96 Allowed 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.929 ' C ' ' HA ' ' A' ' 237' ' ' PRO . 5.9 tmm_? -136.05 93.07 2.87 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.115 0.966 . . . . 0.0 110.46 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' MET . . . . . 0.778 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 4.0 ptp -87.37 141.36 28.69 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.205 -0.934 . . . . 0.0 113.255 -174.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -75.03 157.4 34.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.372 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.2 tp -92.54 -3.47 10.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.531 0.681 . . . . 0.0 110.253 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -73.27 -10.01 59.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.104 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 100.18 -29.35 12.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.932 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 274' ' ' GLN . 16.4 mm-40 -89.5 113.38 24.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.181 0.515 . . . . 0.0 109.654 175.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.872 ' HB3' ' CG ' ' A' ' 237' ' ' PRO . 55.0 m0 -92.8 162.76 13.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.564 -173.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.952 ' H ' ' HG3' ' A' ' 237' ' ' PRO . 2.8 tm-20 -128.6 89.63 2.92 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 120.209 -0.597 . . . . 0.0 109.814 -168.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.575 ' CA ' ' HD3' ' A' ' 237' ' ' PRO . . . -117.96 158.35 14.72 Favored Glycine 0 C--O 1.226 -0.389 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.995 -174.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 265' ' ' LYS . 18.0 tt0 -116.79 111.08 19.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.246 0.523 . . . . 0.0 110.572 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.455 ' HB ' HD21 ' A' ' 256' ' ' LEU . 97.9 t -109.93 122.22 64.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.682 0.277 . . . . 0.0 110.64 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 48.15 32.22 2.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.58 1.152 . . . . 0.0 112.41 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 97.3 -3.03 61.45 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.198 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -107.92 114.96 29.27 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.1 OUTLIER -106.61 141.56 37.68 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.875 178.036 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -171.18 -170.29 35.14 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.649 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 80.5 mt -99.56 135.01 41.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.064 0.459 . . . . 0.0 110.188 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 50.7 p90 -136.79 140.87 33.12 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.16 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 2.8 Cg_exo -76.65 152.37 33.22 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.989 2.459 . . . . 0.0 112.661 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.502 ' HB3' ' CH2' ' A' ' 275' ' ' TRP . 7.6 p90 -69.71 -2.51 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.399 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.7 p -90.45 4.33 51.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.058 0.456 . . . . 0.0 111.47 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -117.44 -15.37 10.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.778 0.323 . . . . 0.0 111.441 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.418 HG21 ' HE2' ' A' ' 286' ' ' PHE . 33.1 m -128.6 160.85 38.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.266 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -121.54 119.0 30.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.73 0.3 . . . . 0.0 110.535 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.653 HD13 ' HB2' ' A' ' 240' ' ' ALA . 49.5 mm -73.36 123.22 27.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.604 175.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.471 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 8.8 p90 -126.16 174.26 8.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.394 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -102.64 90.15 2.11 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 57.6 Cg_endo -71.54 -32.87 11.52 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.359 2.039 . . . . 0.0 112.68 -173.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -137.36 68.75 1.41 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.206 0.527 . . . . 0.0 110.116 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 5.5 p30 -76.33 115.35 46.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.362 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 8.9 Cg_exo -72.29 -35.12 6.99 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.802 2.335 . . . . 0.0 111.361 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -136.0 -167.52 2.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.432 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 62.29 33.16 16.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.4 0.619 . . . . 0.0 110.335 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -80.57 1.21 30.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.552 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.021 -179.325 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.757 0.313 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -148.42 154.04 39.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.314 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.2 m -126.63 26.97 6.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.862 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 75.58 147.39 0.09 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.438 175.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -122.59 -57.55 1.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.107 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 62.58 176.27 0.14 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 172.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.08 73.7 0.76 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.624 -2.08 . . . . 0.0 106.08 164.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.2 m -63.44 154.84 30.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.0 -167.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.474 ' H ' ' HB3' ' A' ' 82' ' ' PRO . 24.6 m 75.84 -45.9 0.54 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.321 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.38 110.21 0.92 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.525 0.679 . . . . 0.0 111.048 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -57.72 -32.14 67.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.941 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 t -81.38 -1.66 46.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.3 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.2 -46.94 7.49 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.367 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -117.76 -26.22 6.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -173.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -84.33 125.38 32.23 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.025 -0.422 . . . . 0.0 110.866 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.519 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.2 mmt -108.53 -3.47 18.04 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.189 -175.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 52.17 -112.18 1.88 Allowed Glycine 0 CA--C 1.522 0.53 0 O-C-N 123.66 0.6 . . . . 0.0 113.953 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.6 Cg_exo -66.63 88.35 0.28 Allowed 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.411 2.741 . . . . 0.0 113.499 -176.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.882 HG12 ' H ' ' A' ' 20' ' ' SER . 16.4 t -131.96 -162.88 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.882 ' H ' HG12 ' A' ' 19' ' ' VAL . 47.5 p -173.77 178.27 2.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.701 1.137 . . . . 0.0 109.167 -169.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 20.1 tpt180 -55.43 -54.45 43.62 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.288 0.367 . . . . 0.0 110.034 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -58.28 -59.6 5.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.717 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 56.5 mm-40 -61.05 -46.53 90.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.02 -174.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.85 77.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 18.3 pt20 -70.06 -33.32 71.79 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.954 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.6 m -64.5 -34.41 78.15 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.43 0.633 . . . . 0.0 111.082 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 22.8 mmt85 -64.23 -41.41 97.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.843 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 14.5 mt -112.19 6.97 19.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -168.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 29' ' ' GLN . 4.1 pt20 -74.65 100.41 3.94 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.454 0.645 . . . . 0.0 111.721 -176.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.67 4.96 90.23 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.313 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -88.19 -171.69 3.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.574 0.226 . . . . 0.0 110.691 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.538 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 6.0 mtp180 -48.78 126.47 12.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.934 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.439 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 26.3 m-70 -85.59 155.17 21.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.929 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.7 -2.06 79.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.322 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 39.5 mtm -93.1 153.25 18.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.0 110.335 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.634 ' CD1' HD22 ' A' ' 98' ' ' LEU . 49.3 p90 -150.13 166.53 29.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.434 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.519 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -155.27 138.33 15.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.641 174.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t -105.41 125.12 60.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.605 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.793 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 32.7 ptt-85 -124.44 174.37 7.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.291 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -72.55 131.76 42.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.634 ' HA ' HG23 ' A' ' 49' ' ' VAL . 15.4 t -56.05 146.64 22.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.633 0.73 . . . . 0.0 112.443 -170.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.407 ' HB2' ' OH ' ' A' ' 207' ' ' PTR . 12.8 m -92.22 -7.93 46.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.213 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.6 m -110.34 -47.87 3.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.335 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 41' ' ' SER . 56.2 m -125.09 119.0 25.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.714 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.9 112.79 1.75 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.527 2.151 . . . . 0.0 111.572 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.04 -21.88 11.85 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.459 ' C ' ' HB2' ' A' ' 41' ' ' SER . 26.4 t70 -82.85 171.94 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 27.1 m-85 -130.37 160.91 32.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.458 0.572 . . . . 0.0 111.205 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 41' ' ' SER . 39.5 t -136.77 105.4 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.213 0.53 . . . . 0.0 111.218 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.485 ' CB ' HD11 ' A' ' 63' ' ' ILE . 33.6 tp -82.27 102.7 11.34 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.226 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.7 m -95.36 119.43 33.86 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.55 HG21 HD13 ' A' ' 93' ' ' LEU . 48.9 t -117.89 136.33 55.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.113 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 1.079 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 89.6 p -104.89 135.12 46.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.694 0.759 . . . . 0.0 111.806 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.554 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 18.9 mt-10 -144.79 176.29 9.55 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 170.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -29.23 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 m 34.14 70.95 0.11 Allowed 'General case' 0 C--N 1.349 0.582 0 CA-C-O 121.983 0.897 . . . . 0.0 110.882 -171.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.933 HH12 ' HA ' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -162.31 45.46 0.15 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.088 -157.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.6 t -81.83 90.6 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.561 0.696 . . . . 0.0 109.667 -177.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.5 m -86.1 122.13 29.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.477 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.501 ' O ' ' HB2' ' A' ' 207' ' ' PTR . 14.3 m-70 -93.72 95.89 9.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.685 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.922 ' HA ' ' HB3' ' A' ' 208' ' ' ALA . 78.4 m-85 -87.51 117.31 26.22 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 123.15 0.58 . . . . 0.0 111.657 -175.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 49' ' ' VAL . 5.6 mt -80.49 133.38 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.7 mp -115.49 118.63 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.197 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -83.77 134.53 34.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.813 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -87.77 105.77 17.62 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 82.9 mt -88.26 145.79 36.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.415 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 34.6 Cg_exo -62.19 -23.11 75.17 Favored 'Trans proline' 0 N--CA 1.473 0.315 0 C-N-CA 123.363 2.708 . . . . 0.0 112.962 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -89.03 18.1 5.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.186 0.517 . . . . 0.0 110.183 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.837 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 1.2 mmp_? 64.41 31.95 12.3 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.275 173.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -113.18 165.41 12.42 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.487 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 60.1 m-85 -127.22 117.45 22.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.441 0.639 . . . . 0.0 111.509 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -106.57 98.76 8.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.511 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.593 HD11 ' HB3' ' A' ' 61' ' ' TYR . 8.7 tt -79.6 85.16 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.545 0.688 . . . . 0.0 110.476 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.493 ' O ' ' HD2' ' A' ' 210' ' ' PRO . . . 60.69 73.2 0.52 Allowed Glycine 0 C--O 1.227 -0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.117 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' OD2' HG22 ' A' ' 212' ' ' THR . 45.6 t0 75.7 -38.39 0.35 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.101 0.56 . . . . 0.0 111.023 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.519 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 21.5 mm-40 -59.26 114.66 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.46 0.304 . . . . 0.0 110.902 174.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.82 115.43 27.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.794 0.33 . . . . 0.0 111.345 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 76' ' ' GLN . 84.4 m-85 -126.05 168.02 14.54 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -86.22 -34.71 20.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.708 0.29 . . . . 0.0 111.524 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 2.6 p80 -152.63 168.54 25.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.677 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.659 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 12.4 mt -57.04 -55.26 45.84 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.601 ' HA ' HD12 ' A' ' 85' ' ' LEU . 32.8 Cg_endo -65.29 -3.8 8.13 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.789 1.659 . . . . 0.0 113.014 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.81 -32.62 17.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.736 0.303 . . . . 0.0 110.558 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.2 pp -76.74 -32.35 57.72 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.601 HD12 ' HA ' ' A' ' 82' ' ' PRO . 51.1 mt -66.03 -26.98 67.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.731 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -74.57 -35.11 63.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.823 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -75.36 -38.02 60.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 111.301 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.493 ' OH ' ' HG2' ' A' ' 210' ' ' PRO . 44.5 m-85 -72.79 1.94 7.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.954 0.407 . . . . 0.0 111.34 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -64.91 -36.66 85.1 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.322 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 mt -104.13 -7.39 9.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.177 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -82.69 -37.09 25.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.875 -171.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.755 ' HA ' HG22 ' A' ' 97' ' ' THR . 81.2 m-85 66.27 95.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.993 0.808 . . . . 0.0 110.203 -169.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.712 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 23.6 mt -62.71 -23.52 67.2 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.404 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.554 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 23.7 t70 -139.11 -77.89 0.34 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 164.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.686 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 5.8 t -146.95 10.44 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.585 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 99' ' ' ILE . 4.3 m -124.19 -39.23 2.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.755 HG22 ' HA ' ' A' ' 92' ' ' TYR . 17.6 p 82.9 -173.3 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.422 1.489 . . . . 0.0 111.011 -174.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.634 HD22 ' CD1' ' A' ' 36' ' ' PHE . 93.7 mt -88.25 106.11 17.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.857 176.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 1.9 mp -89.08 -53.82 8.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.574 ' HG2' HG22 ' A' ' 99' ' ' ILE . 9.9 pt-20 -163.54 149.39 9.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.74 159.56 47.9 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.328 2.019 . . . . 0.0 112.413 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.57 124.48 89.33 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.89 76.48 0.61 Allowed 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.908 2.405 . . . . 0.0 113.678 -171.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.469 ' HE ' ' HA ' ' A' ' 104' ' ' ARG . 3.7 tpm_? 70.33 -58.52 0.54 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.142 0.977 . . . . 0.0 111.772 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.657 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 3.3 p90 -124.05 167.22 15.96 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' A' ' 105' ' ' TYR . 73.3 Cg_endo -73.53 25.67 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.906 2.404 . . . . 0.0 114.326 -172.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.6 p 49.36 94.86 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.802 0.841 . . . . 0.0 112.538 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.59 ' HD3' ' HD2' ' A' ' 105' ' ' TYR . 21.2 Cg_exo -65.63 162.9 32.31 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.177 2.585 . . . . 0.0 111.888 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.66 93.66 0.17 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.688 2.259 . . . . 0.0 112.23 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.1 ttt -108.2 -31.02 8.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.791 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.1 -25.4 3.51 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.831 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.6 m -81.33 112.66 18.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -92.25 -17.69 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.831 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 m 68.89 176.7 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.685 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.547 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -71.65 -52.69 8.05 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.4 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 115' ' ' ALA . 2.8 Cg_exo -76.64 41.86 0.97 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.698 2.266 . . . . 0.0 112.935 -176.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.49 ' O ' HD22 ' A' ' 118' ' ' LEU . 46.0 t30 -78.06 110.82 13.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.702 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.49 HD22 ' O ' ' A' ' 117' ' ' ASN . 1.3 mm? -155.48 82.97 3.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.02 -71.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.782 2.322 . . . . 0.0 113.419 -172.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.0 p -90.92 104.05 16.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.374 0.607 . . . . 0.0 112.449 -172.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.56 110.43 12.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.618 ' HG2' ' HA2' ' A' ' 188' ' ' GLY . 3.8 mp0 -62.78 -75.29 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.863 ' HA ' ' HA ' ' A' ' 185' ' ' SER . 3.3 t70 48.14 -151.48 0.12 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.006 0.816 . . . . 0.0 111.539 174.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 173.87 -80.41 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 1.045 ' HG ' ' HD3' ' A' ' 155' ' ' LYS . 4.3 mm? 46.99 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.092 0 O-C-N 124.251 0.969 . . . . 0.0 112.339 173.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 45.0 tt0 -144.93 -66.09 0.33 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.647 -172.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -117.39 118.37 32.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.806 0.812 . . . . 0.0 111.457 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.763 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 71.8 t -133.3 135.31 56.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.746 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 1.032 ' HB2' ' HB3' ' A' ' 179' ' ' GLU . 23.0 mtt180 -107.7 158.25 17.43 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.055 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.449 HG21 ' CD2' ' A' ' 144' ' ' PHE . 6.3 p -116.22 138.8 50.98 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.801 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.547 HD21 ' CG ' ' A' ' 179' ' ' GLU . 12.3 mt -112.87 -37.03 4.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.636 -172.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -69.79 -35.98 75.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.994 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.8 t70 70.69 92.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.456 0.646 . . . . 0.0 109.262 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 79.1 t80 -127.59 116.89 21.14 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.917 -176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.627 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 48.8 Cg_endo -92.47 96.38 0.18 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 122.37 2.047 . . . . 0.0 113.067 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.84 -17.49 80.13 Favored Glycine 0 CA--C 1.507 -0.466 0 CA-C-O 121.795 0.664 . . . . 0.0 111.483 173.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.526 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 17.4 m120 55.57 29.99 14.48 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.024 -1.088 . . . . 0.0 112.804 -171.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.545 ' HB2' ' HD3' ' A' ' 169' ' ' ARG . 34.4 t0 82.63 168.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 157.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.805 ' HA ' ' NE2' ' A' ' 211' ' ' GLN . . . 89.06 -35.39 0.02 OUTLIER 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.832 1.653 . . . . 0.0 112.409 173.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -143.76 -14.61 0.64 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.945 0.403 . . . . 0.0 110.253 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -147.53 120.48 8.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.446 0.641 . . . . 0.0 110.511 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.04 HD11 ' HB2' ' A' ' 165' ' ' ASN . 41.7 tp -75.71 124.32 88.7 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.019 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.627 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 55.5 Cg_endo -77.61 96.2 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.42 2.08 . . . . 0.0 110.808 172.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 6.9 p90 -105.23 163.4 12.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.716 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.879 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 8.4 mmpt? -103.75 -176.39 3.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.303 0.573 . . . . 0.0 111.233 -175.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 13.73 2.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.52 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.75 39.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.719 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.879 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 29.9 mm-40 -98.54 155.74 17.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.744 HD12 ' HG2' ' A' ' 129' ' ' ARG . 15.7 mm -97.27 134.57 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 165' ' ' ASN . 22.5 mt -117.32 156.61 27.53 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.589 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 62.1 t -116.87 127.01 74.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.668 HD13 ' HB2' ' A' ' 163' ' ' ALA . 45.9 mm -76.06 82.52 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.221 1.01 . . . . 0.0 108.889 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.759 HG21 HG22 ' A' ' 170' ' ' VAL . 14.7 tt -77.44 -27.43 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.913 -175.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.933 ' HA ' HH12 ' A' ' 57' ' ' ARG . 4.4 mt-10 -139.97 139.74 36.14 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 173.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 1.045 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 5.7 ttpm? -133.86 86.47 38.18 Favored Pre-proline 0 C--O 1.237 0.412 0 O-C-N 121.755 -0.59 . . . . 0.0 111.036 174.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.686 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 53.6 Cg_endo -79.01 -46.07 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.285 1.99 . . . . 0.0 112.786 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -109.11 179.88 4.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.252 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -103.37 -29.43 11.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.842 0.353 . . . . 0.0 110.962 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -93.44 -21.44 19.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.618 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.625 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 35.9 m95 -129.06 126.02 38.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.1 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.648 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.1 m0 -116.1 137.79 51.81 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.09 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.863 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.5 m -89.33 89.72 8.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.129 0.49 . . . . 0.0 110.071 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.668 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -101.22 154.84 18.42 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.962 -0.461 . . . . 0.0 111.354 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.2 ptt180 -98.54 128.9 45.05 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.533 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.04 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.5 t30 -63.58 160.73 16.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.12 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -59.46 -25.01 64.04 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.48 ' HB3' HD22 ' A' ' 165' ' ' ASN . 11.1 t70 -75.69 -24.33 56.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.797 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.9 74.84 1.11 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.293 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.735 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -159.07 133.12 7.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.819 -0.191 . . . . 0.0 110.979 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.759 HG22 HG21 ' A' ' 153' ' ' ILE . 83.9 t -103.35 120.39 53.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.192 0.52 . . . . 0.0 111.892 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.97 159.89 28.29 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 170.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.625 ' HE2' ' HB3' ' A' ' 160' ' ' TRP . 21.6 mtp -71.21 138.95 49.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.254 0.527 . . . . 0.0 110.0 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.648 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -134.96 145.85 56.21 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.291 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 5.5 Cg_exo -75.94 129.04 11.19 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 123.299 2.666 . . . . 0.0 112.702 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.671 ' O ' HG22 ' A' ' 178' ' ' VAL . 92.3 t -58.77 -45.66 99.61 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 47.4 Cg_exo -59.5 -6.92 4.72 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.329 2.019 . . . . 0.0 113.86 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -98.15 -1.29 42.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 175' ' ' VAL . 5.9 m -109.41 178.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -164.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 1.032 ' HB3' ' HB2' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -138.9 40.38 2.15 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 111.267 -2.697 . . . . 0.0 107.983 -168.187 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.763 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 20.0 pttm -77.75 144.14 37.44 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.669 -0.644 . . . . 0.0 110.038 -165.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 181' ' ' LEU . 4.0 mt -69.36 -58.36 4.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.24 -169.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.11 147.59 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.024 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.437 ' HD3' ' HH2' ' A' ' 161' ' ' TRP . 15.6 tpt180 -153.02 116.27 4.64 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.029 177.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.4 t -160.5 77.93 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.863 ' HA ' ' HA ' ' A' ' 123' ' ' ASP . 0.3 OUTLIER -64.84 -57.85 14.88 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.283 -176.113 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 32.4 Cg_endo -97.05 -135.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.602 2.201 . . . . 0.0 110.57 169.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.605 ' CE1' ' HD2' ' A' ' 186' ' ' PRO . 0.0 OUTLIER 43.38 65.33 1.0 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.34 0.656 . . . . 0.0 111.481 -177.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.618 ' HA2' ' HG2' ' A' ' 122' ' ' GLU . . . -60.04 -24.18 60.36 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.919 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -69.1 -19.08 64.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -99.47 -3.03 34.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.33 0.586 . . . . 0.0 110.177 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -93.1 95.41 1.99 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.466 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 193' ' ' ARG . 88.0 m-20 -71.53 -25.47 62.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.421 ' HB3' ' O ' ' A' ' 192' ' ' ASN . 55.0 ttt180 72.65 136.16 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.755 0.659 . . . . 0.0 111.581 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 34.6 m-80 -108.95 141.19 41.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.963 177.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 30.7 p -107.8 -18.01 13.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.979 0.419 . . . . 0.0 110.048 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -109.09 24.57 12.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.469 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.53 ' O ' HG12 ' A' ' 200' ' ' ILE . 5.6 p -66.16 -26.93 67.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.315 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -82.8 4.81 23.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.167 0.508 . . . . 0.0 110.546 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -93.12 -6.39 63.19 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.589 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 197' ' ' SER . 38.1 pt -80.31 130.37 65.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.402 . . . . 0.0 110.583 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 1.2 Cg_endo -83.89 135.86 6.84 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.162 2.575 . . . . 0.0 112.609 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . 14.7 tp10 -132.16 112.41 14.46 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.35 117.05 3.64 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.101 2.534 . . . . 0.0 112.22 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 59.56 40.8 19.91 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.737 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.715 ' HB3' ' HB3' ' A' ' 202' ' ' GLU . 1.4 p80 -62.77 103.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.562 0.696 . . . . 0.0 110.9 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.0 147.33 36.88 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.978 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.501 ' HB2' ' O ' ' A' ' 60' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.922 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . . . -161.28 173.37 15.11 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.638 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 174.89 101.84 0.08 OUTLIER Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.754 ' HA ' HG23 ' A' ' 170' ' ' VAL . 7.6 Cg_exo -75.66 -126.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 123.905 3.07 . . . . 0.0 113.549 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.805 ' NE2' ' HA ' ' A' ' 139' ' ' ALA . 27.6 mt-30 -98.5 -172.95 2.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.432 0.634 . . . . 0.0 112.21 -172.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.405 HG22 ' OD2' ' A' ' 75' ' ' ASP . 82.5 p -93.0 -176.3 4.14 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.248 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 215' ' ' PRO . 4.5 m -72.87 92.2 1.59 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.687 HG21 ' HB2' ' A' ' 139' ' ' ALA . 3.4 m -111.38 100.17 46.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.431 -174.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 213' ' ' THR . 6.9 Cg_endo -87.61 93.47 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.9 2.4 . . . . 0.0 111.54 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 62.4 tp -114.9 106.27 52.0 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.972 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.571 ' HA ' HD11 ' A' ' 230' ' ' LEU . 59.6 Cg_endo -75.15 67.4 6.06 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.8 2.333 . . . . 0.0 112.071 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -148.29 -42.98 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.32 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 14.6 m -80.48 49.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.172 0.51 . . . . 0.0 112.313 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 13.8 p -164.65 -77.46 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.456 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 156.37 34.3 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.736 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 22.7 m -135.68 112.44 10.71 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.07 -23.73 39.69 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.921 2.414 . . . . 0.0 111.966 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 92.15 36.87 6.14 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.734 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.22 66.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.922 0.392 . . . . 0.0 110.901 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -165.26 -61.29 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.805 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.6 mt -90.79 136.64 23.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.625 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.1 t -162.88 135.35 4.16 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-O 120.761 0.315 . . . . 0.0 110.664 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.49 -9.32 21.41 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.768 2.312 . . . . 0.0 112.409 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' A' ' 217' ' ' PRO . 2.9 pp -139.25 146.78 50.37 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.514 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 14.3 Cg_exo -69.83 170.94 15.49 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.677 2.251 . . . . 0.0 112.08 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.6 m -98.16 158.82 15.33 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.405 ' HA ' ' HG2' ' A' ' 215' ' ' PRO . 10.7 t -60.22 142.17 54.89 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.046 0.451 . . . . 0.0 111.022 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -139.96 -44.32 0.43 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.65 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.3 p30 46.03 -91.73 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.075 0.95 . . . . 0.0 112.868 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -164.88 179.91 39.26 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.022 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.61 116.62 4.35 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.853 2.368 . . . . 0.0 111.852 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 21.1 t -87.72 145.98 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.509 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -91.94 118.47 30.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.412 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.94 150.67 40.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.027 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -111.13 130.79 55.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.897 0.379 . . . . 0.0 110.244 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.581 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -74.31 122.36 22.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.414 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 290' ' ' HIS . 27.1 pt -104.03 6.15 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -169.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? -156.12 149.11 24.22 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.581 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 11.2 tptm -79.45 116.44 19.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.427 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.644 ' HB3' ' CE1' ' A' ' 290' ' ' HIS . 6.4 ttt-85 -151.32 107.64 3.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.143 0.497 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.554 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 34.6 m -92.6 174.48 4.04 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.891 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 247' ' ' VAL . 39.3 Cg_exo -60.87 122.38 11.13 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.417 2.078 . . . . 0.0 112.119 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.876 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 52.7 t -71.19 159.03 35.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.374 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.07 -42.93 66.33 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -105.45 11.18 32.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.811 0.339 . . . . 0.0 111.197 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.876 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.5 m-20 -111.3 92.42 4.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.174 0.512 . . . . 0.0 111.21 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -77.53 -27.76 51.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.689 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.5 p -89.2 15.03 9.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.608 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -89.06 116.74 27.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.867 0.365 . . . . 0.0 110.924 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.544 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 1.1 tt -77.96 125.0 28.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.465 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -70.83 108.11 4.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.907 0.384 . . . . 0.0 110.581 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.6 mt -136.15 123.26 21.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.294 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 7.5 pt-20 -100.08 -134.87 0.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.782 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.86 130.2 68.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.53 . . . . 0.0 111.736 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 85.66 21.92 52.04 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.666 173.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -109.71 159.41 17.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.429 0.614 . . . . 0.0 110.019 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.47 127.09 56.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 110.94 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.638 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 39.9 t -107.03 122.03 60.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.496 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.495 ' HB2' ' HE3' ' A' ' 265' ' ' LYS . 34.7 ttmt -90.94 101.23 14.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.636 HG11 ' CZ3' ' A' ' 275' ' ' TRP . 4.8 p -126.34 147.83 31.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.424 -170.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -112.64 -54.22 2.64 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 275' ' ' TRP . 45.4 mtt180 -90.48 128.22 36.46 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 122.365 -0.21 . . . . 0.0 110.633 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' MET . . . . . 0.882 ' C ' ' HA3' ' A' ' 273' ' ' GLY . 0.2 OUTLIER -117.25 113.48 22.25 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.396 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.921 ' HB2' ' HD2' ' A' ' 288' ' ' PHE . 3.9 m-20 -20.67 176.59 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 129.849 3.26 . . . . 0.0 117.643 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.428 HG13 ' CE2' ' A' ' 288' ' ' PHE . 43.6 mt 63.8 70.41 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 113.315 -1.766 . . . . 0.0 107.14 -160.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 66.6 13.42 9.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.048 -164.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.882 ' HA3' ' C ' ' A' ' 269' ' ' MET . . . -91.59 -35.47 6.89 Favored Glycine 0 N--CA 1.427 -1.924 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.558 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.748 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 8.9 pt20 23.44 121.71 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 125.638 1.434 . . . . 0.0 113.716 -161.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.845 ' CE2' ' HB3' ' A' ' 288' ' ' PHE . 7.6 m0 -83.81 132.57 34.81 Favored 'General case' 0 CA--C 1.48 -1.726 0 C-N-CA 118.015 -1.474 . . . . 0.0 111.18 -161.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.5 94.53 4.83 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 111.593 -2.549 . . . . 0.0 110.281 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.95 137.7 10.6 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.419 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.675 ' HG3' ' HB3' ' A' ' 283' ' ' LYS . 23.8 mp0 -101.88 109.52 21.29 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 256' ' ' LEU . 58.7 t -123.17 121.74 63.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.743 0.306 . . . . 0.0 111.438 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 5.9 t30 66.24 -72.68 0.08 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.541 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -113.56 -43.47 0.82 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.244 -174.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.544 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 5.5 ppt_? -158.11 174.26 15.47 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.675 ' HB3' ' HG3' ' A' ' 278' ' ' GLU . 60.0 pttt -95.77 143.83 26.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.873 -175.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.39 161.44 29.75 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.514 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 275' ' ' TRP . 21.1 mt -87.53 137.48 32.3 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.718 0.771 . . . . 0.0 111.558 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.638 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 21.4 p90 -149.54 142.9 16.28 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.096 174.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.76 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 13.8 Cg_exo -69.64 144.69 55.48 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.005 1.803 . . . . 0.0 110.76 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.921 ' HD2' ' HB2' ' A' ' 270' ' ' ASN . 26.5 p90 -69.1 6.02 1.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.5 m -88.14 -12.48 43.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.358 0.599 . . . . 0.0 109.685 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.644 ' CE1' ' HB3' ' A' ' 246' ' ' ARG . 69.1 t60 -83.41 -20.92 33.27 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.135 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.581 HG12 ' HA ' ' A' ' 242' ' ' ALA . 23.6 m -127.02 176.99 6.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.694 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -136.87 134.89 37.37 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.133 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 240' ' ' ALA . 44.5 mm -82.75 102.96 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -93.43 176.2 6.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.878 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 296' ' ' PRO . 10.1 m-20 -59.92 109.58 2.1 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 295' ' ' ASP . 7.1 Cg_exo -73.29 -25.04 16.05 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.904 2.403 . . . . 0.0 112.711 -173.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -85.31 93.55 8.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.167 0.508 . . . . 0.0 110.836 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -106.26 102.9 42.86 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.23 73.84 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.074 2.516 . . . . 0.0 113.257 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -111.12 -44.41 3.58 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.698 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 301' ' ' GLU . 0.1 OUTLIER -96.17 -14.0 23.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.044 178.188 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -71.69 126.28 29.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.399 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.891 -0.576 . . . . 0.0 110.5 -179.637 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 t -76.94 97.55 4.65 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 p -79.64 162.94 24.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.259 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.93 127.88 34.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.37 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -154.85 93.42 1.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.207 0.527 . . . . 0.0 110.622 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.587 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 45.7 p90 -145.02 154.88 42.99 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.58 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -71.99 97.77 1.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.63 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.7 m -77.17 59.0 1.67 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.191 0.52 . . . . 0.0 110.51 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 t 179.42 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.603 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -69.66 102.02 1.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.34 0.59 . . . . 0.0 110.759 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.498 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 11.6 mmt180 -61.73 -29.25 69.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.525 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.3 m -79.09 0.38 28.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.607 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.12 -47.34 5.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -116.42 -21.32 9.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.498 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 44.4 t80 -85.7 118.5 25.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.809 0.338 . . . . 0.0 111.28 -173.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.602 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 19.1 mmt -104.15 -2.11 26.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 110.963 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.07 -115.86 4.47 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.485 -0.779 . . . . 0.0 114.022 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.1 94.61 0.73 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.265 1.977 . . . . 0.0 113.534 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.86 HG12 ' H ' ' A' ' 20' ' ' SER . 19.0 t -139.93 -175.56 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.86 ' H ' HG12 ' A' ' 19' ' ' VAL . 93.9 p -151.45 176.64 11.09 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.254 0.934 . . . . 0.0 108.554 -170.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.678 ' HG3' ' O3P' ' A' ' 207' ' ' PTR . 46.0 mtp85 -53.79 -66.03 0.46 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.39 -43.24 91.25 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.21 -45.8 90.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.471 0.176 . . . . 0.0 111.369 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.37 76.83 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.063 0.459 . . . . 0.0 111.27 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -73.53 -30.04 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.004 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.69 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 95.7 m -62.1 -34.78 76.96 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.272 0.558 . . . . 0.0 110.466 174.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -75.43 -14.29 60.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.121 0.486 . . . . 0.0 110.417 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.552 ' O ' ' HB3' ' A' ' 31' ' ' GLN . 20.4 mt -115.75 17.7 16.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.406 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 26' ' ' THR . 12.5 pt20 -88.08 116.0 25.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.399 0.619 . . . . 0.0 110.675 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.74 26.55 24.46 Favored Glycine 0 CA--C 1.499 -0.916 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.552 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -50.59 177.7 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 111.187 -2.506 . . . . 0.0 115.141 -175.255 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -86.19 -9.31 56.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.558 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.562 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 4.6 m-70 66.03 92.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.445 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.41 28.89 3.61 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -170.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 52.4 ttp -124.19 134.19 53.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.56 ' CD1' HD22 ' A' ' 98' ' ' LEU . 43.8 p90 -135.6 164.13 28.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -173.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.48 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -150.62 144.02 24.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.364 171.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.403 HG22 HD13 ' A' ' 50' ' ' LEU . 61.2 t -109.24 119.17 58.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.545 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -123.01 168.47 12.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.708 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.455 ' OD2' ' HA ' ' A' ' 45' ' ' PRO . 34.6 t70 -66.11 125.93 27.05 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.02 -0.734 . . . . 0.0 109.02 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.624 ' HA ' HG23 ' A' ' 49' ' ' VAL . 31.9 p -53.63 120.02 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.518 0.675 . . . . 0.0 112.104 -172.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.719 ' HB3' ' HA ' ' A' ' 20' ' ' SER . 3.4 p -74.58 73.62 1.97 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.922 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.753 ' HB ' ' O1P' ' A' ' 207' ' ' PTR . 10.0 t 174.72 -36.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.327 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 66.5 m -147.43 93.85 4.57 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.253 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.455 ' HA ' ' OD2' ' A' ' 40' ' ' ASP . 54.5 Cg_exo -52.21 116.18 2.65 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.524 2.149 . . . . 0.0 112.253 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.57 -47.83 0.9 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.529 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 1.2 m-20 -78.62 -172.05 2.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.46 ' CE1' ' HE1' ' A' ' 15' ' ' TYR . 25.9 m-85 -138.46 169.4 17.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.255 0.55 . . . . 0.0 112.132 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 41' ' ' SER . 44.1 t -146.94 111.42 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.525 175.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.482 ' HG ' HG23 ' A' ' 52' ' ' VAL . 62.5 tp -82.04 104.27 12.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.133 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.9 m -94.99 109.32 21.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.271 0.558 . . . . 0.0 109.829 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.556 HG12 ' OE2' ' A' ' 54' ' ' GLU . 29.0 t -111.2 138.16 40.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.126 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 81.8 p -118.22 137.37 53.06 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.724 ' HB2' ' HE ' ' A' ' 57' ' ' ARG . 13.9 mp0 -143.58 179.44 7.12 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.562 ' HA ' ' CE1' ' A' ' 33' ' ' HIS . 23.6 m-20 -21.15 81.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 124.846 1.341 . . . . 0.0 114.194 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m 42.68 62.8 1.63 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.671 0.788 . . . . 0.0 111.787 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.724 ' HE ' ' HB2' ' A' ' 54' ' ' GLU . 1.4 ptm85 -167.52 57.45 0.07 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -163.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 19.2 t -76.58 103.79 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.34 -0.85 . . . . 0.0 109.54 -176.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.8 m -92.1 121.47 33.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.185 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -92.58 88.26 6.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.768 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.531 ' CE2' HD22 ' A' ' 93' ' ' LEU . 90.3 m-85 -78.89 117.25 19.81 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.077 0.551 . . . . 0.0 110.924 -176.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 8.4 tp -71.4 135.96 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.561 HG23 ' HB3' ' A' ' 71' ' ' PHE . 4.0 mp -122.23 117.76 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.964 0.411 . . . . 0.0 110.769 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.529 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 70.4 m-20 -85.61 136.07 33.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.936 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 47' ' ' ASP . 10.8 t -92.73 98.43 11.41 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 174.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.572 HD11 ' HG3' ' A' ' 72' ' ' LYS . 55.0 mt -72.89 168.36 25.23 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.107 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 36.6 Cg_exo -63.17 68.3 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.998 2.465 . . . . 0.0 112.803 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 70.79 14.89 6.99 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.369 1.468 . . . . 0.0 112.176 164.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 66.4 mtt180 -93.75 -72.75 0.6 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.707 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.711 ' HB2' ' O ' ' A' ' 78' ' ' PHE . 3.2 ptp180 -156.79 -169.62 3.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.596 -172.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.561 ' HB3' HG23 ' A' ' 63' ' ' ILE . 97.4 m-85 -118.31 127.92 54.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.959 0.409 . . . . 0.0 111.053 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.693 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 52.9 mttm -98.22 101.09 12.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.842 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.675 HD13 ' HE2' ' A' ' 88' ' ' TYR . 10.7 tt -87.41 81.94 2.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 122.127 0.965 . . . . 0.0 110.202 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.474 ' CA ' ' HG3' ' A' ' 209' ' ' GLN . . . 73.27 81.63 0.38 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.161 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.5 t0 72.59 -58.0 0.61 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.778 0.431 . . . . 0.0 111.376 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -79.03 140.02 38.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.406 0.622 . . . . 0.0 110.726 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.693 ' HB3' ' HG2' ' A' ' 72' ' ' LYS . 10.5 pt-20 -110.8 141.72 43.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.321 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.711 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 71.9 m-85 -122.68 151.08 41.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -58.94 -24.89 62.99 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -169.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -163.75 172.32 14.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.332 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.574 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.7 mt -55.09 -56.49 27.61 Favored Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 34.6 Cg_exo -61.15 -9.48 12.62 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.125 1.884 . . . . 0.0 113.23 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . . . -88.7 -25.58 22.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.66 0.267 . . . . 0.0 110.991 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -79.49 -31.52 42.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.26 -35.48 79.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.756 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.502 ' HG2' ' HA ' ' A' ' 83' ' ' ALA . 7.6 pt-20 -80.56 -6.16 57.83 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -87.65 -37.58 16.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.372 0.606 . . . . 0.0 109.592 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.675 ' HE2' HD13 ' A' ' 73' ' ' ILE . 41.9 m-85 -81.85 -6.88 59.47 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.565 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.538 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 14.2 ptmm? -83.62 -3.73 57.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.527 171.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.4 pt -123.21 -22.16 2.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 121.021 0.439 . . . . 0.0 110.522 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 10.6 t-160 -68.9 -41.96 77.55 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.946 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.567 ' CD2' HG23 ' A' ' 97' ' ' THR . 91.3 m-85 71.81 108.39 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 O-C-N 124.554 1.159 . . . . 0.0 108.93 -165.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.659 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 4.8 mt -78.86 1.38 23.66 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.687 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 28.4 t70 -168.53 -134.19 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.467 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 10.6 t -83.07 -8.05 59.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.516 0.674 . . . . 0.0 109.372 172.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.9 t -125.92 169.46 12.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.912 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.567 HG23 ' CD2' ' A' ' 92' ' ' TYR . 9.1 p -109.14 -176.66 3.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.555 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.56 HD22 ' CD1' ' A' ' 36' ' ' PHE . 92.6 mt -69.13 98.8 1.04 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.697 HG22 ' HG3' ' A' ' 100' ' ' GLU . 51.3 mm -90.68 -58.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.929 -176.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.697 ' HG3' HG22 ' A' ' 99' ' ' ILE . 45.3 mt-10 -141.01 158.12 65.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.712 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 93.6 Cg_endo -83.27 157.37 14.83 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.611 2.208 . . . . 0.0 112.04 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.45 158.33 83.59 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.386 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.74 129.43 27.67 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.258 1.972 . . . . 0.0 111.812 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.602 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 35.3 ttt180 -73.33 -2.69 23.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.371 0.605 . . . . 0.0 110.266 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 6.1 m-85 -91.32 130.27 40.31 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.15 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 12.3 Cg_exo -70.72 86.41 0.71 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.642 2.228 . . . . 0.0 112.363 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.0 m -151.63 98.42 3.03 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.165 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 3.0 Cg_exo -76.56 147.05 27.9 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.014 2.476 . . . . 0.0 112.46 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 22.6 Cg_exo -65.88 147.97 85.66 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.798 2.332 . . . . 0.0 111.7 175.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.8 mmt -115.33 144.72 43.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.06 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.4 179.9 16.4 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.644 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 64.9 m -71.35 -21.39 62.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.722 0.296 . . . . 0.0 111.154 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.58 -19.3 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.061 0.457 . . . . 0.0 110.638 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.3 m -67.76 97.47 0.64 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.69 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -145.28 128.28 8.3 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.911 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.528 ' HA ' HG23 ' A' ' 58' ' ' VAL . 96.6 Cg_endo -92.28 -162.6 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.312 2.675 . . . . 0.0 110.93 171.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.566 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 61.3 t30 -102.37 152.61 20.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.596 ' N ' ' HD3' ' A' ' 119' ' ' PRO . 19.9 mt 53.07 52.94 11.19 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.8 0.688 . . . . 0.0 112.819 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 118' ' ' LEU . 3.1 Cg_exo -81.21 -34.16 0.62 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.361 2.041 . . . . 0.0 111.207 176.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 66.2 p -119.71 -176.93 3.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.056 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.55 13.68 33.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.165 0.507 . . . . 0.0 110.217 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.58 148.34 37.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.613 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.671 ' HA ' HH12 ' A' ' 183' ' ' ARG . 21.7 t0 -80.04 102.66 9.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -118.35 -98.09 0.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.315 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.492 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 0.5 OUTLIER -127.11 103.44 7.44 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -173.159 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.994 ' HB2' ' HE ' ' A' ' 183' ' ' ARG . 8.5 mt-10 169.08 -54.42 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 O-C-N 125.703 1.877 . . . . 0.0 109.988 171.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.977 ' CE1' ' HB3' ' A' ' 183' ' ' ARG . 12.9 m-85 -61.28 107.42 0.76 Allowed 'General case' 0 C--O 1.208 -1.12 0 CA-C-N 119.18 0.9 . . . . 0.0 110.805 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.787 HG21 HD11 ' A' ' 152' ' ' ILE . 2.0 t -131.23 132.66 63.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.807 172.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.811 HH21 HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -126.31 135.43 51.5 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.601 173.29 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.952 HG22 HG12 ' A' ' 178' ' ' VAL . 70.9 p -94.06 132.86 38.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -173.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -112.38 -0.32 15.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.801 -175.172 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -105.93 -44.36 4.63 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -168.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.3 t70 81.16 102.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.273 0.629 . . . . 0.0 110.35 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 87.3 t80 -142.61 110.82 5.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 57.6 Cg_endo -91.89 90.42 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.619 2.213 . . . . 0.0 112.615 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.605 ' HA3' ' OD1' ' A' ' 141' ' ' ASP . . . -79.93 -2.42 88.56 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.257 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 56.95 25.84 11.08 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.642 0.377 . . . . 0.0 111.974 -174.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.794 ' HA ' ' O ' ' A' ' 141' ' ' ASP . 3.0 p30 53.35 -166.61 0.07 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 168.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . 90.6 -47.49 0.02 OUTLIER 'General case' 0 C--N 1.347 0.46 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.875 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -142.37 14.01 1.99 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.794 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 11.5 t70 -153.53 173.55 15.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 112.756 -2.02 . . . . 0.0 105.824 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.752 HD11 ' HB3' ' A' ' 165' ' ' ASN . 54.8 tp -134.61 128.81 19.19 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 119.16 0.891 . . . . 0.0 110.477 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.651 ' HD2' HD12 ' A' ' 142' ' ' LEU . 12.6 Cg_endo -85.09 98.77 0.67 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.449 2.099 . . . . 0.0 111.194 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.666 ' CG ' HG21 ' A' ' 130' ' ' THR . 10.9 p90 -111.77 167.96 9.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.556 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.656 ' H ' ' HB2' ' A' ' 148' ' ' GLU . 24.5 mtpp -126.1 -174.05 3.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -173.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -69.79 66.47 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.52 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 121.0 49.34 0.28 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.263 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.656 ' HB2' ' H ' ' A' ' 145' ' ' LYS . 5.8 tp10 -99.34 154.52 18.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.822 HG13 ' HB3' ' A' ' 181' ' ' LEU . 1.0 OUTLIER -112.32 134.2 55.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.69 -173.108 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.719 HD22 HD21 ' A' ' 142' ' ' LEU . 21.0 mt -143.14 155.8 44.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.899 0.857 . . . . 0.0 110.913 -170.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.856 HG22 ' O ' ' A' ' 182' ' ' VAL . 39.3 t -126.32 126.41 69.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.614 173.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.793 HD13 ' HB2' ' A' ' 163' ' ' ALA . 36.2 mm -74.53 86.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 122.156 0.979 . . . . 0.0 110.412 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.852 HG21 HG22 ' A' ' 170' ' ' VAL . 9.1 tt -82.51 -28.28 8.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.726 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.958 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 28.0 mt-10 -130.73 141.66 50.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -136.23 77.43 48.33 Favored Pre-proline 0 C--O 1.24 0.566 0 O-C-N 121.472 -0.768 . . . . 0.0 111.566 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 16.6 Cg_exo -66.16 -54.62 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.256 1.971 . . . . 0.0 111.342 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -106.82 175.06 5.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.62 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -98.89 -23.33 15.39 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.33 -27.64 21.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.273 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.404 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 44.2 m95 -124.41 122.47 37.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.642 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.756 ' HB3' HD12 ' A' ' 152' ' ' ILE . 45.7 m0 -112.18 137.72 49.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.53 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.958 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.7 m -94.82 109.54 21.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.793 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -116.79 159.32 22.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -173.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.691 ' HE ' HG21 ' A' ' 151' ' ' VAL . 9.7 ptt180 -94.0 118.86 32.09 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.996 173.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.752 ' HB3' HD11 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -69.16 179.11 2.03 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.664 0.269 . . . . 0.0 111.452 -178.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -61.41 -30.37 70.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.987 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -93.65 4.1 54.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.636 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.41 ' H ' HD22 ' A' ' 165' ' ' ASN . . . 84.23 74.82 1.22 Allowed Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.785 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -150.92 138.41 19.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 177.022 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 210' ' ' PRO . 95.1 t -103.78 126.03 58.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.201 0.524 . . . . 0.0 111.973 -175.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . -157.42 167.45 34.01 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 171.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 22.7 mtp -79.96 139.44 37.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.178 0.489 . . . . 0.0 110.7 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.766 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -138.24 148.3 59.14 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.75 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 5.7 Cg_exo -78.24 131.77 10.98 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.65 2.233 . . . . 0.0 112.435 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.547 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 61.1 t -59.34 -45.07 99.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 31.9 Cg_endo -65.29 -1.62 4.8 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.22 1.947 . . . . 0.0 113.452 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 2.6 m-85 -99.7 -7.94 24.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.783 0.325 . . . . 0.0 111.066 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.952 HG12 HG22 ' A' ' 130' ' ' THR . 2.9 m -144.2 176.56 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.662 -166.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.695 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 6.6 pt-20 -153.64 -55.65 0.11 Allowed 'General case' 0 C--O 1.2 -1.533 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 144.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -147.04 133.97 20.23 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 122.538 2.426 . . . . 0.0 115.686 -171.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.822 ' HB3' HG13 ' A' ' 149' ' ' ILE . 0.1 OUTLIER 161.66 133.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 164.234 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.856 ' O ' HG22 ' A' ' 151' ' ' VAL . 69.7 t 67.51 134.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 124.823 1.249 . . . . 0.0 113.044 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.994 ' HE ' ' HB2' ' A' ' 126' ' ' GLU . 2.6 ttm180 169.54 -23.34 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.93 1.292 . . . . 0.0 109.356 -165.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.0 m -45.12 134.18 6.27 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.91 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.576 ' OG ' HD13 ' A' ' 118' ' ' LEU . 94.5 p -133.91 163.15 53.21 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.704 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.74 ' HD3' ' HB3' ' A' ' 206' ' ' ALA . 31.6 Cg_exo -59.7 135.95 67.41 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.806 2.337 . . . . 0.0 112.091 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -141.07 175.62 9.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.412 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.39 97.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.99 173.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -126.22 113.93 17.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.843 0.354 . . . . 0.0 110.384 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -166.55 -41.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.049 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 90.17 149.48 22.12 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.431 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -102.58 123.53 46.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.764 0.316 . . . . 0.0 110.616 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -138.27 -43.2 0.51 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.273 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 63.94 -98.83 0.07 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.551 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.0 t 179.42 150.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -85.63 164.22 17.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.9 t 64.43 -159.76 0.29 Allowed 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.546 0.528 . . . . 0.0 109.811 -177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 69.27 120.92 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.443 0.64 . . . . 0.0 111.379 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.24 67.1 3.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.972 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 29.6 pt -130.08 152.52 80.18 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.289 . . . . 0.0 111.11 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.44 ' O ' ' HD3' ' A' ' 203' ' ' PRO . 95.0 Cg_endo -85.21 -169.3 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.047 2.498 . . . . 0.0 111.794 173.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -110.41 96.28 26.3 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.858 0.361 . . . . 0.0 110.43 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 201' ' ' PRO . 11.7 Cg_exo -70.98 -47.01 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.838 2.359 . . . . 0.0 112.197 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.33 -71.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.567 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.49 ' HB3' ' HG3' ' A' ' 186' ' ' PRO . 52.1 t60 179.88 -60.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.737 173.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.74 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . . . -169.13 121.71 0.77 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.036 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.753 ' O1P' ' HB ' ' A' ' 43' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.647 ' HB1' HD11 ' A' ' 153' ' ' ILE . . . -84.65 96.25 9.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.246 0.546 . . . . 0.0 109.918 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.474 ' HG3' ' CA ' ' A' ' 74' ' ' GLY . 60.8 tt0 -101.6 107.11 50.04 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.818 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.966 ' HA ' HG23 ' A' ' 170' ' ' VAL . 1.7 Cg_endo -88.45 -179.09 2.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.868 3.045 . . . . 0.0 112.783 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.477 ' OE1' ' HB2' ' A' ' 169' ' ' ARG . 31.2 tt0 -175.75 127.41 0.24 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.876 0.37 . . . . 0.0 110.913 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.676 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 82.7 m -125.3 143.08 51.13 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.448 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.569 ' H ' ' HB2' ' A' ' 139' ' ' ALA . 13.1 m -50.79 106.92 0.14 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 120.958 0.409 . . . . 0.0 110.706 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.659 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 16.7 m -70.44 -53.35 10.18 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.745 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 14.5 Cg_exo -69.57 107.0 1.73 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.091 1.861 . . . . 0.0 112.096 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 216' ' ' LEU . 1.1 tm? -121.63 102.68 41.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.535 ' HG3' HD22 ' A' ' 230' ' ' LEU . 71.7 Cg_endo -82.09 108.54 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.777 2.318 . . . . 0.0 112.309 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -85.89 -59.52 2.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.852 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 76.9 t -122.76 -42.58 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.703 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 29.9 m -86.21 134.39 33.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.414 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.12 -79.26 0.27 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.6 t -158.75 104.36 1.61 Allowed Pre-proline 0 C--N 1.323 -0.587 0 CA-C-O 120.793 0.33 . . . . 0.0 110.42 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -81.77 21.49 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.055 2.503 . . . . 0.0 111.141 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -158.81 -154.23 7.12 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.16 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 67.88 -73.75 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.152 0.581 . . . . 0.0 111.407 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 69.14 -58.99 0.49 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.663 0.785 . . . . 0.0 111.94 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -38.93 64.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.853 0.359 . . . . 0.0 110.252 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.1 m -79.97 128.46 73.79 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.572 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.59 153.66 73.68 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.789 2.326 . . . . 0.0 112.224 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.535 HD22 ' HG3' ' A' ' 217' ' ' PRO . 7.7 mp -91.23 135.46 28.27 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.791 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 4.6 Cg_exo -73.75 107.07 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.707 2.271 . . . . 0.0 111.384 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 16.2 m -87.45 -32.3 19.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.594 0.712 . . . . 0.0 109.246 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 17.0 p -135.6 148.0 48.88 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.424 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -70.24 -37.74 75.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.626 ' HB2' ' HB2' ' A' ' 269' ' ' MET . 2.2 p30 -94.51 174.39 7.15 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.95 164.04 37.44 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.091 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.655 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 4.7 Cg_exo -74.0 102.0 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.082 2.521 . . . . 0.0 111.357 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.405 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 28.3 t -116.51 146.08 21.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.704 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.472 ' CE1' ' HE2' ' A' ' 265' ' ' LYS . 54.1 m-85 -81.28 126.64 31.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.17 0.509 . . . . 0.0 111.272 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.685 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -135.32 130.9 35.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.097 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -97.47 126.66 42.87 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -73.48 111.69 8.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.434 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.455 HD12 ' HG3' ' A' ' 244' ' ' GLN . 1.9 pp -87.81 -10.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.691 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.455 ' HG3' HD12 ' A' ' 243' ' ' ILE . 79.0 mt-30 -120.23 167.19 12.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 258' ' ' LEU . 21.2 pttp -118.79 137.48 53.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.302 0.573 . . . . 0.0 111.058 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.539 ' NH1' ' HD2' ' A' ' 287' ' ' PRO . 40.8 ttp-105 -139.41 117.55 11.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.845 -176.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.84 131.58 24.31 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.973 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.84 127.7 11.76 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.611 2.207 . . . . 0.0 111.861 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 5.7 p -84.24 -178.96 7.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.977 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -67.24 -16.28 64.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.903 0.383 . . . . 0.0 111.683 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -121.43 29.62 7.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.431 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.558 ' HB2' ' HB3' ' A' ' 255' ' ' ALA . 1.8 p-10 -64.31 126.58 28.24 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.668 0.747 . . . . 0.0 110.526 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 253' ' ' LYS . 73.5 mmtt -98.03 86.68 3.77 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.339 177.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 44.4 p 60.95 38.15 17.73 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.069 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . . . -91.35 103.95 16.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.695 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 257' ' ' ALA . 1.5 tt -67.23 131.38 45.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.632 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.437 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -75.21 120.38 20.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.618 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 245' ' ' LYS . 81.7 mt -138.0 113.02 9.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.593 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.63 172.45 7.7 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 43.9 t -69.56 106.91 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.02 0.438 . . . . 0.0 110.443 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 123.4 -8.56 8.92 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.415 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.03 130.9 44.35 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.836 0.35 . . . . 0.0 110.867 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 45.9 mm -89.02 108.73 19.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.378 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.416 HG21 HG11 ' A' ' 291' ' ' VAL . 36.1 t -85.81 106.54 15.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.27 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.472 ' HE2' ' CE1' ' A' ' 239' ' ' PHE . 28.5 mmtt -84.24 92.74 8.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 237' ' ' PRO . 7.6 p -87.31 125.66 41.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.972 0.415 . . . . 0.0 110.044 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 4.9 p -100.34 -32.86 10.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.59 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 24.8 tpp180 -125.88 99.36 5.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.976 0.417 . . . . 0.0 110.165 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' MET . . . . . 0.626 ' HB2' ' HB2' ' A' ' 235' ' ' ASN . 25.2 mtt -85.32 107.65 17.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.511 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -63.63 125.28 23.78 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.4 mt -75.79 68.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.899 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -177.26 -69.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.147 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.576 ' O ' ' HG2' ' A' ' 274' ' ' GLN . . . 179.11 143.26 5.28 Favored Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -166.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.576 ' HG2' ' O ' ' A' ' 273' ' ' GLY . 9.3 pt20 64.31 119.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 125.418 1.487 . . . . 0.0 110.189 -172.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 286' ' ' PHE . 15.2 m0 -114.02 167.73 10.42 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.985 -174.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -122.67 115.02 21.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.364 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -141.03 158.01 26.17 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 1.07 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 16.5 mt-10 -103.17 108.98 20.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.34 0.57 . . . . 0.0 110.275 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 41.1 t -133.09 139.45 49.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.828 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 26.6 p30 43.52 32.38 0.52 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.757 1.223 . . . . 0.0 113.695 172.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.61 -59.86 0.43 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.858 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.54 176.11 12.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.654 -0.321 . . . . 0.0 111.681 -174.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 1.07 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 13.1 pttm -87.14 141.1 28.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.123 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.87 173.93 32.46 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.76 127.83 37.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.078 0.466 . . . . 0.0 110.258 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 275' ' ' TRP . 43.4 p90 -126.13 131.16 23.87 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.688 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.539 ' HD2' ' NH1' ' A' ' 246' ' ' ARG . 48.2 Cg_exo -58.0 138.69 87.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.615 2.21 . . . . 0.0 111.593 172.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -72.22 -18.39 61.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.401 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 13.8 p -79.43 -0.54 33.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.3 0.572 . . . . 0.0 111.081 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -95.59 -18.69 20.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.586 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.416 HG11 HG21 ' A' ' 264' ' ' VAL . 31.7 m -127.83 164.17 29.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.456 -175.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.426 ' HG2' HG12 ' A' ' 243' ' ' ILE . 30.9 mmmt -127.42 122.54 33.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.728 0.299 . . . . 0.0 110.393 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.685 HD13 ' HB2' ' A' ' 240' ' ' ALA . 48.8 mm -71.0 122.09 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.152 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -135.54 147.64 48.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.826 0.346 . . . . 0.0 110.272 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.487 ' HB2' ' OD1' ' A' ' 298' ' ' ASN . 6.9 m-20 -72.52 129.43 87.17 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.06 -18.99 31.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.335 2.69 . . . . 0.0 113.324 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -85.79 15.34 4.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.719 0.295 . . . . 0.0 111.322 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.487 ' OD1' ' HB2' ' A' ' 295' ' ' ASP . 15.2 m120 -115.16 96.59 45.81 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.91 0.386 . . . . 0.0 111.675 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 301' ' ' GLU . 96.3 Cg_endo -96.4 19.99 0.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.307 2.672 . . . . 0.0 110.916 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 301' ' ' GLU . 15.7 m-20 73.5 -39.03 0.43 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.484 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 300' ' ' ASP . 41.9 tt0 165.91 -43.06 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 301' ' ' GLU . 7.1 t30 163.02 -52.58 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 113.265 -1.789 . . . . 0.0 108.638 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--O 1.246 0.908 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.372 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.01 0.433 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -111.76 84.29 1.93 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.099 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -74.89 -37.01 62.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.902 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.43 127.83 40.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.542 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -142.06 91.51 2.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.331 0.586 . . . . 0.0 111.079 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -147.17 148.38 31.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.496 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -79.82 96.88 6.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.991 0.424 . . . . 0.0 110.259 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 m -69.78 74.48 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.133 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 t -176.53 -43.33 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.915 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.85 107.49 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.183 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -32.54 67.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.17 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.0 t -69.78 -9.22 53.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.278 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.26 -46.76 7.56 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.761 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -118.4 -19.93 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -170.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -82.03 123.42 28.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.798 0.333 . . . . 0.0 110.649 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.562 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 16.6 mmt -101.72 -9.55 20.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.557 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.4 -113.23 2.18 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.49 -177.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 16.9 Cg_exo -67.17 91.06 0.32 Allowed 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.063 2.509 . . . . 0.0 113.38 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.994 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 14.3 t -137.43 -157.12 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.891 ' H ' HG12 ' A' ' 19' ' ' VAL . 12.5 t 178.93 174.96 0.66 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.8 1.182 . . . . 0.0 108.661 -169.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.541 HH11 ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -44.49 -66.84 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.885 0.741 . . . . 0.0 112.046 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -63.79 -54.34 36.63 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.443 0.464 . . . . 0.0 111.991 -173.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -54.7 -46.82 74.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.41 -42.9 83.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.459 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -80.39 -33.39 37.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.663 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 t -74.19 -18.77 60.72 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.886 -0.325 . . . . 0.0 111.429 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -97.8 -10.38 24.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 110.727 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.68 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 73.2 mt -111.45 0.86 16.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.657 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.14 108.88 3.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.878 0.847 . . . . 0.0 110.679 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.78 -76.69 0.92 Allowed Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.915 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.535 ' N ' ' HA ' ' A' ' 117' ' ' ASN . 17.2 mm-40 45.28 -159.38 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.169 0.57 . . . . 0.0 111.737 -175.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.565 HH21 ' HB2' ' A' ' 100' ' ' GLU . 33.0 ptt180 -101.13 5.94 43.0 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.521 176.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 53' ' ' SER . 27.3 m170 68.29 123.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.478 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.75 16.53 21.63 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.416 ' HG3' ' HB3' ' A' ' 31' ' ' GLN . 73.2 mmm -106.0 134.94 48.33 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.472 ' CB ' HG22 ' A' ' 52' ' ' VAL . 43.3 p90 -139.58 162.93 33.88 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.621 -174.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.562 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -155.73 141.9 18.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.56 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.31 129.19 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.994 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 32.0 ptt-85 -129.43 173.2 10.77 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.59 133.77 34.04 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 170.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.462 ' HB2' HG22 ' A' ' 43' ' ' THR . 93.9 p -80.45 147.97 30.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.212 0.529 . . . . 0.0 111.162 -173.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.0 t -99.28 34.42 2.17 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 41' ' ' SER . 9.0 t -135.47 -27.55 1.18 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.206 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 91.2 m -147.36 118.25 4.53 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.786 0.327 . . . . 0.0 110.622 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.21 117.98 4.81 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.776 2.317 . . . . 0.0 112.144 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.66 -22.81 34.55 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.713 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 20.0 m-20 -89.84 152.03 21.48 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -119.85 174.97 6.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.557 0.218 . . . . 0.0 111.3 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.628 HG11 ' HE2' ' A' ' 207' ' ' PTR . 24.1 t -142.63 109.83 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.31 . . . . 0.0 110.861 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 36' ' ' PHE . 32.1 tp -85.29 100.63 11.92 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.972 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.7 m -96.54 127.41 42.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.97 177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.835 HG21 HD13 ' A' ' 93' ' ' LEU . 48.4 t -123.61 137.17 57.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.453 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.68 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 90.1 p -97.28 123.8 41.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.647 0.26 . . . . 0.0 111.367 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.696 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 26.7 mt-10 -145.14 175.95 9.88 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.653 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 2.6 p30 -37.04 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -163.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.5 m 37.55 56.87 1.44 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.109 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.876 HH21 ' HB2' ' A' ' 94' ' ' ASP . 7.0 ttp85 -167.67 53.72 0.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.79 -159.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.2 t -77.18 98.52 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.909 0.861 . . . . 0.0 109.193 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -87.47 121.17 29.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.839 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -94.71 99.4 11.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.19 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.608 ' CE2' HD22 ' A' ' 93' ' ' LEU . 58.6 m-85 -96.07 116.15 28.52 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.367 0.267 . . . . 0.0 111.529 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 64.5 mt -80.31 134.2 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.739 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.0 mp -109.45 119.5 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 123.16 0.584 . . . . 0.0 110.347 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.51 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 91.6 m-20 -84.98 137.68 32.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.789 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.7 t -87.41 102.0 14.12 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.68 HD11 ' HB2' ' A' ' 72' ' ' LYS . 91.4 mt -83.44 140.27 41.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.993 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.75 -23.07 69.48 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.221 2.614 . . . . 0.0 112.958 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -85.23 17.71 2.93 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.014 0.435 . . . . 0.0 110.287 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.893 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.8 OUTLIER 61.97 57.84 2.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.957 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.773 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 62.0 mtt180 -138.59 171.41 14.4 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.124 175.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.513 ' HB3' HG23 ' A' ' 63' ' ' ILE . 53.8 m-85 -130.63 114.99 16.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.404 0.621 . . . . 0.0 110.493 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.68 ' HB2' HD11 ' A' ' 66' ' ' LEU . 87.5 tttt -105.62 99.79 9.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.981 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.739 ' HB ' HG13 ' A' ' 63' ' ' ILE . 8.6 tt -83.63 78.63 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 122.024 0.916 . . . . 0.0 111.063 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.976 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 85.07 -15.99 40.64 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.119 -0.946 . . . . 0.0 114.645 171.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.564 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 19.1 t70 176.92 -63.3 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.809 0.804 . . . . 0.0 111.275 -176.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -66.42 129.14 38.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.59 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -87.47 108.41 19.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.378 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.471 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 67.0 m-85 -105.51 149.46 26.21 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.773 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 22.6 m-20 -73.55 -25.05 60.21 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -173.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 6.1 p80 -160.04 168.73 24.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.707 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.59 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.1 mt -56.27 -56.27 33.22 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.612 ' HA ' HD12 ' A' ' 85' ' ' LEU . 32.4 Cg_exo -63.15 -3.0 4.32 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.261 1.974 . . . . 0.0 113.681 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.86 -33.72 17.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.019 0.438 . . . . 0.0 110.284 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.4 pp -79.38 -26.73 41.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.289 0.566 . . . . 0.0 109.6 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.612 HD12 ' HA ' ' A' ' 82' ' ' PRO . 79.3 mt -67.89 -29.52 68.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.616 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 82' ' ' PRO . 16.6 mm-40 -83.52 -14.66 51.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.995 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -84.23 -39.02 19.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.267 0.556 . . . . 0.0 109.831 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -81.59 0.81 36.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.36 0.6 . . . . 0.0 110.572 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -74.12 -22.43 59.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.827 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.4 pt -122.72 -19.64 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.597 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -84.29 -19.95 32.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.343 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 72.41 162.24 0.25 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.832 0.707 . . . . 0.0 109.54 -170.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.835 HD13 HG21 ' A' ' 52' ' ' VAL . 11.5 mt -114.55 -11.01 12.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.174 0.511 . . . . 0.0 110.087 168.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.876 ' HB2' HH21 ' A' ' 57' ' ' ARG . 9.6 t70 -157.57 -80.28 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.636 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 7.0 t -132.49 -16.0 2.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.073 0.463 . . . . 0.0 110.077 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.472 HG22 ' OE1' ' A' ' 54' ' ' GLU . 4.6 t -121.76 -177.83 3.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.5 p -114.88 178.77 4.16 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.155 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.449 HD22 ' CD1' ' A' ' 36' ' ' PHE . 87.7 mt -64.37 97.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.1 mm -85.56 -64.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.673 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.565 ' HB2' HH21 ' A' ' 32' ' ' ARG . 43.2 mt-10 -150.27 153.36 34.86 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.889 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.69 154.65 72.72 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.793 2.329 . . . . 0.0 112.444 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.46 157.6 82.34 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.227 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.28 135.68 20.9 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.366 2.044 . . . . 0.0 111.819 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.507 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 88.9 mtm180 -71.48 123.63 22.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.719 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 32.0 p90 50.43 178.96 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.987 0 O-C-N 124.489 1.118 . . . . 0.0 111.852 -176.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.719 ' HD2' ' HB2' ' A' ' 105' ' ' TYR . 88.7 Cg_exo -50.72 109.42 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.983 1.789 . . . . 0.0 111.71 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.629 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 0.8 OUTLIER -57.89 141.5 80.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.382 -174.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.93 148.17 58.84 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.54 2.16 . . . . 0.0 111.723 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.37 33.17 0.28 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.127 2.552 . . . . 0.0 113.098 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 70.4 mtm -97.7 -20.52 17.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 160.12 90.21 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.26 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.629 ' HB2' ' HB2' ' A' ' 107' ' ' SER . 40.2 t -112.49 -21.8 11.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.9 t 64.92 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.886 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.3 m -86.1 87.25 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.361 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -143.16 -47.62 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.984 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 115' ' ' ALA . 8.3 Cg_exo -74.48 -137.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.461 2.107 . . . . 0.0 111.551 174.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.535 ' HA ' ' N ' ' A' ' 31' ' ' GLN . 88.0 m-20 63.75 43.07 5.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.14 0.495 . . . . 0.0 110.034 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 87.1 mt -105.97 102.83 41.48 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.137 -174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 117' ' ' ASN . 10.5 Cg_endo -91.03 144.44 3.42 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.272 2.648 . . . . 0.0 111.657 175.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.8 m -126.05 68.9 1.2 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 63.81 98.9 0.04 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.548 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.6 54.03 0.92 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.544 0.687 . . . . 0.0 111.758 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -100.63 94.81 6.3 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 126' ' ' GLU . 4.3 p-10 -87.57 149.29 24.43 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -160.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.899 HD12 HG13 ' A' ' 152' ' ' ILE . 1.3 mm? -52.36 123.56 11.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.591 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.687 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 32.6 tt0 -155.94 -72.74 0.11 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.003 -177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -93.1 109.19 20.67 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.156 -168.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.919 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 90.6 t -134.25 129.17 53.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.011 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.976 ' HG2' ' HB3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -109.79 154.71 22.58 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 118.584 -1.247 . . . . 0.0 108.54 172.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 178' ' ' VAL . 18.9 p -112.21 141.34 46.03 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.755 HD21 ' HG3' ' A' ' 179' ' ' GLU . 58.3 mt -111.82 -41.4 4.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.222 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 51.5 t80 -72.22 -27.88 62.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -168.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.646 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 30.1 t70 69.51 96.36 0.07 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.626 0.727 . . . . 0.0 110.994 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -122.72 96.32 45.54 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.839 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.72 88.92 0.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.44 2.093 . . . . 0.0 112.139 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -87.65 -23.76 38.22 Favored Glycine 0 C--O 1.228 -0.227 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.324 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 47.02 80.33 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.593 0.757 . . . . 0.0 112.57 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -162.64 173.39 13.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.19 -3.29 58.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.155 0.502 . . . . 0.0 110.588 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.26 -11.29 10.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.378 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -129.78 105.43 8.02 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.021 HD11 ' HB2' ' A' ' 165' ' ' ASN . 36.5 tp -76.52 117.57 65.42 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.674 0.273 . . . . 0.0 110.62 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.467 ' HD2' HD12 ' A' ' 142' ' ' LEU . 45.8 Cg_endo -71.16 106.27 1.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.109 1.873 . . . . 0.0 111.244 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -113.64 164.45 13.66 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.216 -177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.646 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -106.13 -169.56 1.59 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.105 -168.541 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.557 ' HD2' ' HB2' ' A' ' 133' ' ' ASP . 13.7 mptt -78.37 -5.15 51.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.176 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.72 56.53 0.16 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.361 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.462 ' HB2' ' HD3' ' A' ' 145' ' ' LYS . 7.8 tp10 -105.54 150.74 25.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.615 HD13 ' HB3' ' A' ' 129' ' ' ARG . 45.9 mm -96.66 129.72 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' A' ' 165' ' ' ASN . 44.0 mt -123.03 160.48 26.24 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.315 0.579 . . . . 0.0 109.5 -178.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 87.2 t -124.77 128.03 73.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.899 HG13 HD12 ' A' ' 125' ' ' LEU . 36.7 mm -74.33 87.84 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 122.244 1.021 . . . . 0.0 109.529 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.656 HG23 ' HG3' ' A' ' 154' ' ' GLU . 18.0 tt -78.49 -26.38 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.32 -174.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.961 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 15.5 mt-10 -142.04 143.99 33.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.697 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 48.4 tttm -137.05 90.52 15.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 O-C-N 121.237 -0.915 . . . . 0.0 111.399 171.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 52.8 Cg_endo -81.0 -44.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.064 1.843 . . . . 0.0 112.497 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -109.43 178.52 4.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.331 -172.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -98.77 -33.09 11.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.353 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.484 ' OE1' ' HA ' ' A' ' 159' ' ' GLN . 14.2 mm-40 -100.0 -11.36 20.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.927 0.394 . . . . 0.0 110.762 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.436 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 71.9 m95 -126.38 118.57 25.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.719 ' CZ3' HD11 ' A' ' 125' ' ' LEU . 48.5 m0 -112.28 136.71 51.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.961 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 10.6 t -92.05 92.97 8.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.346 0.593 . . . . 0.0 109.418 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -103.26 158.09 16.57 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 122.022 -0.424 . . . . 0.0 111.477 -174.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.858 HH12 ' HA ' ' A' ' 208' ' ' ALA . 12.7 ptt180 -98.22 128.71 44.83 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.812 176.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.021 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.5 t30 -70.75 164.64 24.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.556 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -71.96 -10.6 60.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.49 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 165' ' ' ASN . 2.4 p-10 -87.0 -10.58 52.79 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 210' ' ' PRO . . . 93.64 57.14 1.36 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.926 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.739 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 19.1 ttm-85 -136.21 141.9 44.04 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 122.85 -0.206 . . . . 0.0 110.968 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.538 HG22 HG21 ' A' ' 153' ' ' ILE . 49.6 t -103.28 118.46 50.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.609 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -151.15 158.31 27.63 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.411 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 22.5 mtp -79.18 140.03 37.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.894 0.378 . . . . 0.0 110.431 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -135.54 145.57 53.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.342 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.455 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 4.3 Cg_exo -76.53 133.06 13.98 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.32 2.68 . . . . 0.0 113.111 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.648 ' O ' HG22 ' A' ' 178' ' ' VAL . 88.3 t -60.4 -44.58 96.24 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 23.9 Cg_exo -65.27 3.92 0.89 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.219 1.946 . . . . 0.0 113.345 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.5 m-85 -107.89 -4.81 17.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.282 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.8 m -106.89 -169.07 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -165.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.976 ' HB3' ' HG2' ' A' ' 129' ' ' ARG . 0.4 OUTLIER -160.13 41.51 0.19 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.82 -161.164 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.919 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 25.2 pttm -73.28 140.42 46.81 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 120.456 -1.403 . . . . 0.0 109.58 -162.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 17.4 tp -75.18 54.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.699 -168.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.4 m 52.34 10.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.785 1.634 . . . . 0.0 113.752 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 57.33 88.64 0.05 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.269 0.557 . . . . 0.0 110.65 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.7 t 61.8 -137.52 0.51 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.211 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.482 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 60.6 p -175.16 167.33 1.89 Allowed Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 40.4 Cg_endo -68.16 -7.32 19.59 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.428 2.085 . . . . 0.0 111.711 172.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 190' ' ' HIS . 51.6 m80 66.25 -161.03 0.25 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.163 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.431 ' H ' ' HB3' ' A' ' 187' ' ' HIS . . . 84.67 -66.74 3.82 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.93 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -101.61 -2.66 29.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.028 0.442 . . . . 0.0 110.77 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 187' ' ' HIS . 50.5 t60 -87.36 105.45 17.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.66 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -103.79 -141.02 10.96 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.222 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -149.62 168.68 22.88 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 53.5 ttp180 -147.15 -84.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.74 0.305 . . . . 0.0 110.626 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 193' ' ' ARG . 27.8 t-20 165.92 150.55 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -173.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.7 m -77.07 -74.24 0.25 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -164.75 30.02 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.217 0.532 . . . . 0.0 110.279 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 24.4 t -137.29 86.91 2.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -76.47 156.39 33.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.885 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 119.06 -32.46 5.1 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -174.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.753 HG22 ' H ' ' A' ' 202' ' ' GLU . 71.2 mt -126.6 132.0 24.14 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 27.4 Cg_exo -63.6 -16.61 55.7 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.691 2.261 . . . . 0.0 112.566 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.753 ' H ' HG22 ' A' ' 200' ' ' ILE . 11.6 pt-20 34.08 80.89 0.25 Allowed Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.376 1.07 . . . . 0.0 112.903 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 205' ' ' HIS . 55.8 Cg_endo -70.87 -11.31 29.2 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.237 1.958 . . . . 0.0 112.421 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 69.02 -28.24 0.16 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.859 0.864 . . . . 0.0 112.861 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -78.27 39.04 0.31 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.997 0.519 . . . . 0.0 111.538 -177.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -88.68 84.15 6.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.862 0.363 . . . . 0.0 110.912 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.953 ' O3P' ' HE1' ' A' ' 207' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.858 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -122.59 23.57 9.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.949 -175.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -74.79 149.3 85.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.976 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 50.5 Cg_exo -54.45 -51.54 10.26 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.989 2.459 . . . . 0.0 113.456 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 29.9 tp60 -74.76 123.82 25.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.214 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.7 t -60.07 142.95 53.21 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 170.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 9.2 m -95.77 113.82 25.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.81 0.338 . . . . 0.0 111.778 -173.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 9.2 m -111.69 87.69 8.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -92.27 170.08 2.7 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.04 2.494 . . . . 0.0 112.393 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.2 mp -112.76 103.1 55.47 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.329 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -83.59 -7.21 10.68 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.908 2.406 . . . . 0.0 112.018 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -101.1 116.89 33.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.061 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.06 -19.82 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.232 0.539 . . . . 0.0 110.876 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 21.2 p -92.07 -4.93 53.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 76.05 -85.27 0.9 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.542 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 20.4 m 50.54 67.83 3.98 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.49 -34.61 85.42 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.725 2.283 . . . . 0.0 112.133 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -122.19 51.32 0.8 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 174.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 65.2 -166.96 0.22 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.785 0.434 . . . . 0.0 110.8 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -125.13 -177.94 4.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.38 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 40.5 pt -100.37 -167.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 123.217 0.323 . . . . 0.0 110.384 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.3 p -62.39 131.48 93.86 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.073 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.09 96.06 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.713 2.275 . . . . 0.0 112.276 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.681 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 6.3 tt -101.81 -55.25 0.13 Allowed Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.319 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 75.3 Cg_exo -51.69 -57.77 1.98 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.258 1.972 . . . . 0.0 112.835 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 50.6 m -158.91 133.78 8.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.971 0.415 . . . . 0.0 111.377 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.5 157.27 19.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 170.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -122.64 -74.91 0.6 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.023 -174.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 63.83 81.27 0.21 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.78 0.675 . . . . 0.0 110.954 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -132.2 -88.63 0.41 Allowed Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.77 101.76 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.259 1.973 . . . . 0.0 110.148 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.458 HG11 HD12 ' A' ' 293' ' ' ILE . 21.6 t -92.96 145.98 6.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.885 -173.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.1 116.9 32.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.685 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.51 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.29 128.16 53.04 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.46 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.601 ' HG3' ' CE1' ' A' ' 294' ' ' PHE . 28.5 mtpp -78.75 125.25 29.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.567 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -75.59 91.42 2.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.888 0.375 . . . . 0.0 110.136 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 24.6 pt -73.24 9.59 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.847 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -148.91 152.87 37.17 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -95.85 144.96 25.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.542 ' HE ' ' HB3' ' A' ' 249' ' ' CYS . 0.5 OUTLIER -171.02 125.69 0.67 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.638 0.256 . . . . 0.0 110.756 178.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.706 ' HB ' ' HD3' ' A' ' 248' ' ' PRO . 60.3 t -102.18 -55.0 0.13 Allowed Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.812 172.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.706 ' HD3' ' HB ' ' A' ' 247' ' ' VAL . 61.5 Cg_endo -90.0 167.85 4.6 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.427 2.085 . . . . 0.0 113.782 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.542 ' HB3' ' HE ' ' A' ' 246' ' ' ARG . 24.3 p -173.32 89.77 0.08 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.623 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 64.92 -72.68 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.216 1.006 . . . . 0.0 112.971 172.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.589 ' HD1' ' H ' ' A' ' 253' ' ' LYS . 18.3 p90 -91.67 -31.0 16.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.919 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 64.98 -1.33 0.87 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.589 ' H ' ' HD1' ' A' ' 251' ' ' TYR . 57.7 tttp -62.11 -65.31 0.71 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.195 0.521 . . . . 0.0 110.827 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 9.3 p -106.9 40.1 1.72 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.663 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -79.56 107.42 12.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.931 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.55 HD23 HH11 ' A' ' 282' ' ' ARG . 1.0 OUTLIER -76.34 101.67 5.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.381 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -68.66 124.2 22.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.912 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 82.3 mt -128.7 143.68 50.99 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.605 0.566 . . . . 0.0 111.275 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.83 170.93 9.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.359 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.3 p -89.34 113.25 25.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.485 0.66 . . . . 0.0 110.485 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 110.3 -6.49 30.33 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.999 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -76.88 161.2 28.61 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.662 0.268 . . . . 0.0 110.646 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 35.0 mm -104.02 111.17 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.296 0.57 . . . . 0.0 111.13 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.44 ' HA ' HG22 ' A' ' 279' ' ' VAL . 38.8 t -88.55 109.19 19.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.532 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -85.16 88.13 7.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.766 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.88 131.86 35.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.553 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -114.79 -22.5 9.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.817 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.71 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 26.4 mmm180 -125.25 123.69 40.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.245 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 51.4 mtt -112.46 102.73 10.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.226 0.536 . . . . 0.0 110.41 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -81.25 139.42 35.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.034 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.0 pt -67.92 -8.99 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.261 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -63.07 -38.65 92.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.529 176.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 121.47 -9.97 9.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.71 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -114.28 119.31 36.56 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.463 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 47.2 m0 -93.63 159.77 15.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.829 0.347 . . . . 0.0 111.073 -174.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 41.5 mt-10 -107.27 117.77 34.95 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.089 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -142.31 154.01 24.78 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 283' ' ' LYS . 37.7 tt0 -111.73 109.82 19.88 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.567 HG12 HD22 ' A' ' 280' ' ' ASN . 57.6 t -112.55 122.15 66.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.033 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.567 HD22 HG12 ' A' ' 279' ' ' VAL . 31.5 m-80 65.48 -70.21 0.1 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.049 0.843 . . . . 0.0 111.793 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -159.65 26.99 0.35 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.588 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.55 HH11 HD23 ' A' ' 256' ' ' LEU . 17.2 ttm180 -150.82 128.66 11.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.711 0.255 . . . . 0.0 110.444 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 278' ' ' GLU . 53.4 pttt -102.57 139.33 38.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.969 0.414 . . . . 0.0 110.338 174.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -167.38 -169.96 31.59 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.713 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 93.6 mt -100.13 146.3 26.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.934 0.397 . . . . 0.0 110.692 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.463 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 41.1 p90 -148.82 145.54 19.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.609 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 11.8 Cg_exo -72.37 149.22 50.27 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.628 2.218 . . . . 0.0 111.99 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -76.38 -17.68 59.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.837 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.0 t -82.08 3.82 25.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.727 0.775 . . . . 0.0 109.934 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.422 ' NE2' ' HB3' ' A' ' 246' ' ' ARG . 49.6 t-80 -96.27 -24.17 16.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.557 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 242' ' ' ALA . 29.1 m -125.02 175.41 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.798 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -138.57 125.36 20.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.557 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.51 HD13 ' HB2' ' A' ' 240' ' ' ALA . 49.8 mm -73.95 102.7 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.601 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 21.4 p90 -100.19 167.61 10.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.433 -174.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -107.98 145.43 31.39 Favored Pre-proline 0 CA--C 1.504 -0.814 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.425 ' O ' ' HB3' ' A' ' 297' ' ' GLN . 77.3 Cg_exo -21.73 76.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 1 C-N-CA 125.877 4.385 . . . . 0.0 115.008 -168.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.425 ' HB3' ' O ' ' A' ' 296' ' ' PRO . 22.9 tm0? 83.09 -48.35 0.15 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.218 175.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.3 t30 64.08 95.85 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.156 0 O-C-N 123.864 0.728 . . . . 0.0 112.248 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.29 -16.37 17.49 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.567 2.178 . . . . 0.0 111.807 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 301' ' ' GLU . 27.1 t70 -72.34 120.02 17.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.557 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 300' ' ' ASP . 42.4 tt0 77.14 -9.97 1.43 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.122 0.889 . . . . 0.0 110.704 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -80.62 -36.8 32.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.644 178.065 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 tmm? . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m -87.7 88.15 7.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.849 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.1 t -74.32 -13.34 60.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.58 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -48.05 119.44 2.9 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.133 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -140.63 88.44 2.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.625 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -168.96 165.82 11.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.932 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -99.63 115.58 29.76 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -69.25 -11.46 60.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.001 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 p -101.65 -23.38 14.26 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.82 102.19 1.2 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.899 -0.501 . . . . 0.0 110.778 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 11' ' ' ARG . 11.4 mmt180 -58.51 -42.3 87.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.239 -176.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.7 m -74.6 10.75 1.23 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.916 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.22 -47.5 4.5 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.828 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -118.02 -21.54 8.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -173.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -85.6 115.15 23.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.862 0.363 . . . . 0.0 110.356 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.461 ' HG2' ' HB2' ' A' ' 37' ' ' LEU . 18.0 mmt -102.09 -1.92 30.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 -174.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.7 -114.32 3.01 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.057 -0.974 . . . . 0.0 114.19 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 14.4 Cg_exo -70.6 82.68 0.9 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.961 2.44 . . . . 0.0 113.676 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.931 HG12 ' H ' ' A' ' 20' ' ' SER . 16.4 t -121.02 -160.6 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.931 ' H ' HG12 ' A' ' 19' ' ' VAL . 50.8 p -165.84 172.96 11.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 119.751 1.16 . . . . 0.0 109.706 -168.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -52.73 -59.54 4.36 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.158 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -64.32 -52.63 57.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.081 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.6 -44.5 96.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.987 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.58 69.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 110.988 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.624 ' HG3' ' HA ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -65.63 -46.04 80.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.934 0.397 . . . . 0.0 110.471 175.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.404 ' N ' HE21 ' A' ' 25' ' ' GLN . 28.0 m -61.91 -27.45 68.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.177 -174.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.531 ' HG2' ' HA ' ' A' ' 106' ' ' PRO . 39.7 mtp180 -91.99 -14.26 29.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.952 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.027 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 67.1 mt -114.96 -17.11 11.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.574 -0.45 . . . . 0.0 112.082 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 11.65 -97.29 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.284 1.433 . . . . 0.0 114.565 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.29 33.22 1.82 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.516 ' HB3' ' CE ' ' A' ' 35' ' ' MET . 2.7 tt0 -73.41 -154.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.361 -0.92 . . . . 0.0 109.43 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.484 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -53.65 110.21 0.55 Allowed 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.117 179.13 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -73.04 104.33 4.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.72 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' A' ' 99' ' ' ILE . . . 141.93 -3.5 2.01 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.303 -171.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.667 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 38.4 mtm -83.36 144.91 29.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.95 157.26 45.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.585 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.461 ' HB2' ' HG2' ' A' ' 16' ' ' MET . 4.6 pp -150.11 137.47 19.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.575 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.8 t -105.77 128.71 59.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.244 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.877 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 34.9 ptt-85 -129.94 161.6 30.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.828 -175.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.97 133.1 46.91 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 48.9 m -64.48 131.93 48.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.148 0.499 . . . . 0.0 111.441 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.593 ' HB3' ' O2P' ' A' ' 207' ' ' PTR . 34.0 t -76.98 43.68 0.36 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.987 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 t -165.87 -37.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.033 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 41' ' ' SER . 65.4 m -134.77 121.6 14.99 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 14.5 Cg_exo -69.36 -19.0 38.63 Favored 'Trans proline' 0 CA--C 1.527 0.163 0 C-N-CA 122.723 2.282 . . . . 0.0 112.724 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.15 -52.82 3.31 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.792 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.604 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 5.7 m-20 -77.38 157.84 30.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.594 0.235 . . . . 0.0 110.987 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -123.73 177.42 5.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.932 0.396 . . . . 0.0 111.328 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.635 HG22 HD13 ' A' ' 62' ' ' ILE . 22.8 t -139.27 112.58 6.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.8 tp -83.05 100.07 10.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.952 0.406 . . . . 0.0 109.933 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 59' ' ' SER . 59.5 m -97.4 118.02 32.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.114 0.483 . . . . 0.0 111.202 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.737 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 41.1 t -111.18 157.28 12.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.377 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 1.027 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 88.1 p -123.65 135.04 53.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.302 0.955 . . . . 0.0 112.7 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.69 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 1.7 pm0 -146.05 176.24 9.86 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.513 175.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -25.51 80.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 -173.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.7 m 39.61 65.32 0.72 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.781 0.8 . . . . 0.0 110.121 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.69 ' HG3' ' HG2' ' A' ' 54' ' ' GLU . 28.5 tpt85 -168.11 52.58 0.06 Allowed 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.689 -149.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 52' ' ' VAL . 2.2 p -76.65 114.19 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.024 -1.047 . . . . 0.0 111.834 -170.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.774 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 53.5 m -73.62 90.4 1.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.002 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.475 ' CD2' HG22 ' A' ' 58' ' ' VAL . 58.6 m-70 -87.05 87.9 7.57 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.208 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.774 ' CE2' ' HB3' ' A' ' 59' ' ' SER . 71.2 m-85 -92.52 117.76 30.28 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.635 HD13 HG22 ' A' ' 49' ' ' VAL . 30.7 mm -69.95 139.69 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.792 0.33 . . . . 0.0 111.188 176.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 2.7 mp -125.08 118.2 52.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.288 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.604 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 7.8 m120 -73.42 128.89 36.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.943 0.402 . . . . 0.0 110.964 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.6 t -86.85 113.66 22.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.304 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.0 mt -93.72 135.62 24.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.757 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.2 -16.21 32.66 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.144 2.562 . . . . 0.0 113.053 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -85.5 15.57 4.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.0 110.537 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 68.6 22.91 7.41 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.18 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -113.38 162.95 15.47 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.544 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 91.9 m-85 -135.55 116.31 14.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.457 0.646 . . . . 0.0 112.169 -172.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 31.3 ttpt -98.17 98.83 10.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.587 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 12.0 tt -80.72 77.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 122.077 0.942 . . . . 0.0 111.469 -175.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.652 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 79.07 -30.17 2.1 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.737 172.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.65 ' OD1' ' HB2' ' A' ' 210' ' ' PRO . 0.1 OUTLIER -143.15 -77.01 0.24 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.256 0.55 . . . . 0.0 111.434 -169.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.434 ' H ' ' HG2' ' A' ' 76' ' ' GLN . 12.9 pt20 -95.05 148.53 22.25 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.437 -169.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -82.14 124.88 30.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.682 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.408 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 77.5 m-85 -112.4 144.4 41.91 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 169.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.02 -25.37 63.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.788 -170.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -164.8 168.5 17.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.238 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.458 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 8.4 mt -55.21 -55.81 35.4 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.0 Cg_exo -59.27 -8.98 7.45 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.548 2.165 . . . . 0.0 114.002 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.04 -33.51 18.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.792 0.329 . . . . 0.0 111.139 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -79.55 -27.41 41.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.286 0.565 . . . . 0.0 109.675 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 82' ' ' PRO . 79.4 mt -67.87 -33.94 75.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.616 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.66 ' HA ' ' HE3' ' A' ' 89' ' ' LYS . 11.1 pt-20 -90.9 -3.71 57.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.329 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -91.01 -37.06 13.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.377 0.608 . . . . 0.0 110.01 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -83.39 1.5 41.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.884 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.66 ' HE3' ' HA ' ' A' ' 86' ' ' GLU . 17.8 ptpt -86.36 14.97 5.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 91' ' ' HIS . 1.7 pp -165.33 -30.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.787 0.804 . . . . 0.0 108.845 -170.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.45 ' N ' HD12 ' A' ' 90' ' ' ILE . 9.0 t60 -65.73 -28.2 68.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.414 172.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.649 ' CD1' HG23 ' A' ' 97' ' ' THR . 70.3 m-85 64.0 110.81 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 124.569 1.168 . . . . 0.0 109.538 -168.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.503 HD11 HD21 ' A' ' 98' ' ' LEU . 20.0 mt -56.2 -42.34 77.04 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 1.034 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 0.1 OUTLIER -138.59 -80.67 0.33 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.378 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.768 HG21 ' HB3' ' A' ' 156' ' ' PRO . 11.0 m -136.94 -6.17 1.88 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.493 1.14 . . . . 0.0 108.546 166.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -106.53 138.69 42.25 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.931 172.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.649 HG23 ' CD1' ' A' ' 92' ' ' TYR . 11.9 p -98.55 -175.46 3.09 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.949 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.503 HD21 HD11 ' A' ' 93' ' ' LEU . 87.6 mt -88.77 88.76 7.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.621 HD13 ' HA3' ' A' ' 34' ' ' GLY . 3.6 mp -75.1 -54.96 13.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.725 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 35' ' ' MET . 15.2 pt-20 -154.07 161.34 29.5 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.725 -176.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.94 155.78 61.43 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.536 2.157 . . . . 0.0 112.341 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -77.95 168.22 29.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.527 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 21.8 Cg_endo -62.08 148.01 93.99 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.328 2.019 . . . . 0.0 112.116 175.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 81.4 mtp180 -94.21 11.9 28.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.113 0.483 . . . . 0.0 110.218 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 71.8 t80 -120.46 135.53 24.62 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.409 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.531 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 31.6 Cg_exo -60.18 108.24 0.49 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.602 2.201 . . . . 0.0 111.935 175.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.0 m -65.93 154.17 89.89 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.785 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 25.9 Cg_exo -63.16 136.13 54.44 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.545 2.163 . . . . 0.0 111.587 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 42.8 Cg_exo -56.97 -39.75 89.17 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.85 2.367 . . . . 0.0 112.112 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 84.9 mtp 70.03 -47.22 0.61 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.914 0.886 . . . . 0.0 112.16 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.05 -15.84 33.24 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.771 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.0 m -58.69 -34.69 71.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 110.904 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.17 139.53 36.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.876 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.5 t -140.25 27.61 2.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.135 0.493 . . . . 0.0 110.019 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.497 ' CB ' ' HA ' ' A' ' 119' ' ' PRO . . . -139.66 109.5 7.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.246 -175.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.624 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 58.6 Cg_endo -73.1 77.66 2.36 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.74 2.293 . . . . 0.0 112.06 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.692 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.9 t-20 69.47 161.48 0.21 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.928 0.767 . . . . 0.0 109.08 -173.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.698 ' HA ' ' HG3' ' A' ' 126' ' ' GLU . 0.6 OUTLIER 42.4 81.23 0.25 Allowed Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 121.567 0.699 . . . . 0.0 110.874 -173.413 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.497 ' HA ' ' CB ' ' A' ' 115' ' ' ALA . 28.0 Cg_exo -60.46 142.27 97.6 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 123.069 2.513 . . . . 0.0 113.557 -169.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.46 ' HA ' ' HG2' ' A' ' 186' ' ' PRO . 3.2 p -79.76 -0.11 32.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.603 175.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 122' ' ' GLU . . . -132.89 102.22 5.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.971 173.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 45.6 mt-10 73.89 136.17 0.05 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.231 0.957 . . . . 0.0 111.473 -173.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.65 -44.85 92.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 66.6 t30 62.53 -106.92 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.289 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.85 HD12 HG21 ' A' ' 152' ' ' ILE . 1.3 mm? -119.11 89.46 3.13 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.722 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 3.9 mm-40 -159.82 -68.67 0.08 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.908 -173.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.62 110.86 23.17 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.328 1.061 . . . . 0.0 111.791 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.991 HG22 ' HB3' ' A' ' 180' ' ' LYS . 70.1 t -115.08 150.1 17.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.918 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.96 ' HG2' ' HG3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -124.58 153.24 42.45 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.72 165.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.975 HG22 HG12 ' A' ' 178' ' ' VAL . 21.7 p -112.81 141.18 46.91 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -99.13 -45.05 6.05 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.946 0.403 . . . . 0.0 111.368 -177.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 35.1 t80 -70.62 -38.63 73.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -163.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 13.5 t70 75.63 100.71 0.07 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -172.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 77.2 t80 -139.14 107.54 7.38 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.112 -175.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 27.1 Cg_endo -92.31 85.73 0.23 Allowed 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.783 2.322 . . . . 0.0 112.356 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.751 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -71.74 -11.88 73.75 Favored Glycine 0 CA--C 1.506 -0.499 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 172.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 138' ' ' ASP . 17.7 m120 51.46 59.53 4.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.603 -1.299 . . . . 0.0 113.312 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.471 ' H ' ' HD3' ' A' ' 143' ' ' PRO . 21.0 t70 81.36 163.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 155.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 88.79 -47.52 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.638 1.575 . . . . 0.0 111.704 169.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -160.35 6.08 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.324 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.751 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 39.0 m-20 -139.64 97.14 3.2 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.075 HD11 ' HB2' ' A' ' 165' ' ' ASN . 21.9 tp -70.13 128.02 91.86 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 120.832 0.348 . . . . 0.0 110.792 -174.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 56.4 Cg_endo -79.28 101.62 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.212 1.941 . . . . 0.0 111.736 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 15.1 p90 -109.94 157.09 19.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.366 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.549 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 35.4 mtmm -112.02 175.62 5.35 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.056 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.786 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -76.58 71.89 3.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.621 0.724 . . . . 0.0 110.443 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 131.21 30.39 0.57 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.244 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -95.32 155.13 16.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.84 HD13 ' HB3' ' A' ' 129' ' ' ARG . 47.1 mm -105.34 132.55 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.521 HD22 ' HA ' ' A' ' 165' ' ' ASN . 29.9 mt -122.03 156.97 32.38 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.722 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 39.0 t -114.47 127.87 71.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 171.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.85 HG21 HD12 ' A' ' 125' ' ' LEU . 23.4 mm -75.03 114.04 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.481 1.134 . . . . 0.0 110.491 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.885 HG21 HG13 ' A' ' 170' ' ' VAL . 2.5 tp -92.89 -24.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.37 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.034 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 6.8 tp10 -155.51 147.58 23.52 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 121.553 -0.717 . . . . 0.0 111.774 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -129.83 84.13 61.9 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.094 168.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.768 ' HB3' HG21 ' A' ' 95' ' ' THR . 57.2 Cg_endo -91.61 -58.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.092 1.861 . . . . 0.0 111.334 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.451 ' OE1' ' HG2' ' A' ' 156' ' ' PRO . 1.3 mp0 -82.63 175.02 10.49 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.476 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -112.86 -5.64 13.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.493 ' HA ' ' OE1' ' A' ' 159' ' ' GLN . 6.3 tp60 -104.44 -24.23 13.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.675 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.774 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 34.9 m95 -129.0 138.23 51.82 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.811 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.649 ' O ' HG13 ' A' ' 173' ' ' ILE . 36.1 m0 -123.74 137.63 54.66 Favored 'General case' 0 C--O 1.213 -0.818 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.868 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 12.9 m -88.34 123.66 33.13 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.794 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -130.76 155.11 47.22 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.361 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 26.9 ptt-85 -97.75 136.89 37.45 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 171.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.075 ' HB2' HD11 ' A' ' 142' ' ' LEU . 65.5 t30 -71.33 168.22 17.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.24 -173.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.519 ' HE3' ' H ' ' A' ' 149' ' ' ILE . 10.2 ttpp -66.01 -17.55 64.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' A' ' 211' ' ' GLN . 0.0 OUTLIER -74.4 -33.81 63.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.61 172.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 137.82 -36.37 1.94 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.215 -0.993 . . . . 0.0 115.4 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.565 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -90.8 160.82 15.56 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.492 1.146 . . . . 0.0 113.463 -163.182 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.885 HG13 HG21 ' A' ' 153' ' ' ILE . 78.1 t -89.65 136.27 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.363 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.91 156.42 28.15 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.565 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.774 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -72.85 136.15 45.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.649 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -135.44 147.92 63.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.771 0.319 . . . . 0.0 110.859 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 1.03 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 16.2 Cg_exo -70.71 139.13 36.29 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.943 2.429 . . . . 0.0 113.128 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.54 ' O ' HG22 ' A' ' 178' ' ' VAL . 21.9 t -78.31 -44.95 2.15 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.4 Cg_endo -66.92 0.51 3.64 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.888 1.725 . . . . 0.0 111.684 173.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 1.03 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 0.9 OUTLIER -100.92 -4.99 26.62 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.139 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.975 HG12 HG22 ' A' ' 130' ' ' THR . 26.8 m -123.5 170.89 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 122.543 1.163 . . . . 0.0 113.645 -171.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.96 ' HG3' ' HG2' ' A' ' 129' ' ' ARG . 8.2 pt-20 -133.6 48.57 2.36 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.677 -2.056 . . . . 0.0 110.232 -170.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.991 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -71.1 142.47 50.79 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 -166.105 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.531 HD13 ' NH1' ' A' ' 129' ' ' ARG . 9.7 tp -59.58 -37.22 77.91 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.756 HG13 ' HD2' ' A' ' 183' ' ' ARG . 2.3 p 66.8 -48.48 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.729 1.612 . . . . 0.0 115.015 160.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.756 ' HD2' HG13 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -124.74 -86.77 0.63 Allowed 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.213 -0.929 . . . . 0.0 110.271 178.305 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.4 t 49.59 -148.25 0.28 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.828 0.346 . . . . 0.0 110.843 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.512 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 12.8 m -155.56 151.94 23.37 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.46 ' HG2' ' HA ' ' A' ' 120' ' ' THR . 22.6 Cg_exo -66.19 114.33 2.98 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.392 2.061 . . . . 0.0 111.262 173.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 185' ' ' SER . 42.0 m80 -125.3 166.13 17.09 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -59.79 -48.06 87.89 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.956 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -91.12 -7.42 51.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 109.834 173.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.479 ' CA ' ' HB2' ' A' ' 187' ' ' HIS . 2.2 t-160 69.3 -51.9 0.6 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.262 1.025 . . . . 0.0 111.494 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 142.66 20.07 0.24 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.427 HD22 ' C ' ' A' ' 192' ' ' ASN . 0.3 OUTLIER -157.02 154.18 29.17 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.974 0.11 . . . . 0.0 110.794 -177.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -126.94 1.76 6.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.522 0.201 . . . . 0.0 110.964 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.446 ' CG ' ' H ' ' A' ' 195' ' ' SER . 63.9 t30 68.36 -169.59 0.19 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.883 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.446 ' H ' ' CG ' ' A' ' 194' ' ' ASN . 7.4 m -54.18 -45.22 72.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.879 0.371 . . . . 0.0 111.032 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -177.66 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.425 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 36.5 m 66.42 -174.39 0.19 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.782 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -111.11 119.06 37.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.067 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 71.23 -159.72 53.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.097 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.925 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 4.1 mp -110.99 -58.81 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 176.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.925 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 5.2 Cg_exo -78.34 129.45 9.49 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.339 2.026 . . . . 0.0 111.016 173.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 0.3 OUTLIER -96.75 126.57 42.5 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.255 0.55 . . . . 0.0 111.094 -177.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 7.5 Cg_exo -73.86 67.31 4.87 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.631 2.221 . . . . 0.0 110.601 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.22 115.43 3.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.881 -174.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.45 ' O ' ' HD1' ' A' ' 207' ' ' PTR . 19.1 p80 -99.03 -17.13 18.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.693 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 207' ' ' PTR . . . 59.46 -148.82 0.46 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.681 175.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.593 ' O2P' ' HB3' ' A' ' 42' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -113.57 18.63 17.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.89 -176.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.49 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 10.1 tt0 -58.97 134.08 87.26 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.541 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.652 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 32.1 Cg_exo -58.04 -103.39 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.113 2.542 . . . . 0.0 113.703 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' A' ' 167' ' ' ASP . 76.7 mt-30 -78.42 -21.45 49.2 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.469 -0.77 . . . . 0.0 111.194 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 211' ' ' GLN . 92.1 m 73.88 -49.53 0.68 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.565 0.541 . . . . 0.0 110.624 -176.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.2 m 64.54 -103.64 0.11 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.007 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 57.8 m -164.75 135.99 3.32 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -176.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 3.0 Cg_exo -77.92 -164.48 0.27 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.05 2.5 . . . . 0.0 111.275 171.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 57.2 mt -135.31 110.5 10.64 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.824 0.345 . . . . 0.0 111.478 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.76 -51.51 0.66 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.58 2.187 . . . . 0.0 111.22 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 55.67 -99.57 0.1 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.501 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.1 t -94.25 -58.27 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.536 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.9 m 65.91 19.38 11.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.017 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 112.02 -160.53 13.13 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.039 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.463 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 3.1 p -81.57 123.52 80.75 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.93 0.395 . . . . 0.0 110.786 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 3.0 Cg_exo -76.37 45.15 1.51 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.308 2.672 . . . . 0.0 112.383 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -81.98 57.38 4.96 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.571 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -165.49 129.91 2.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -69.63 -31.37 69.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.201 0.524 . . . . 0.0 110.715 177.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.712 HG12 HG22 ' A' ' 228' ' ' THR . 5.7 tt -117.73 111.13 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.595 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.712 HG22 HG12 ' A' ' 227' ' ' ILE . 6.4 t 39.72 87.66 0.11 Allowed Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 124.371 1.069 . . . . 0.0 113.462 177.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.46 105.32 0.41 Allowed 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 122.636 2.224 . . . . 0.0 111.216 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 48.4 tp -115.39 95.77 43.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.033 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -89.82 -1.33 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.799 2.333 . . . . 0.0 111.447 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 18.2 t -90.96 100.67 13.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.98 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 34.2 p -105.86 -41.71 5.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.164 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.425 ' O ' ' HD2' ' A' ' 237' ' ' PRO . 6.8 tp60 56.37 79.83 0.17 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.899 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -75.23 97.83 3.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.044 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -174.4 -58.9 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.788 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 234' ' ' GLN . 45.4 Cg_exo -58.49 169.59 3.02 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.722 2.282 . . . . 0.0 112.594 174.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 1.003 HG13 HG13 ' A' ' 266' ' ' VAL . 0.2 OUTLIER -87.18 144.67 8.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.107 -176.04 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -114.23 126.26 54.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.527 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.647 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -133.56 129.23 36.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.077 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -94.81 129.4 41.78 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.619 -0.432 . . . . 0.0 109.979 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.653 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -74.71 115.56 14.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.288 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.844 HD12 ' HG2' ' A' ' 292' ' ' LYS . 0.2 OUTLIER -102.14 -16.06 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.268 0.556 . . . . 0.0 110.387 179.01 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.29 120.45 23.2 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -58.65 155.58 12.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.175 0.988 . . . . 0.0 112.812 -168.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 25.6 tpt180 -131.0 97.71 4.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.637 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.4 m -104.32 155.56 37.09 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.256 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.99 -171.07 0.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.064 2.509 . . . . 0.0 111.583 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.447 ' N ' ' HB3' ' A' ' 252' ' ' ASP . 53.5 t -163.65 166.86 21.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.63 -26.19 61.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.878 0.37 . . . . 0.0 111.22 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -125.08 33.99 5.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.228 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.447 ' HB3' ' N ' ' A' ' 249' ' ' CYS . 0.5 OUTLIER -72.27 135.43 46.0 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.225 0.536 . . . . 0.0 110.16 178.493 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -100.18 85.99 3.13 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.491 174.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 201' ' ' PRO . 41.0 p 59.87 53.84 4.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.365 -1.288 . . . . 0.0 111.213 174.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -86.85 142.23 28.21 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.452 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.443 ' HB2' ' HA3' ' A' ' 284' ' ' GLY . 1.3 tt -98.72 115.84 29.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.99 115.38 7.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.2 0.524 . . . . 0.0 110.929 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.55 HD21 HG21 ' A' ' 279' ' ' VAL . 72.8 mt -129.7 153.6 48.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.912 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -133.93 172.13 13.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 170.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 2.1 p -67.94 114.11 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.575 0.703 . . . . 0.0 111.071 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 121.44 -0.16 11.29 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.628 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -96.55 142.06 29.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.904 0.383 . . . . 0.0 110.939 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.7 mm -94.76 114.36 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.741 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.495 ' HA ' HG22 ' A' ' 279' ' ' VAL . 20.1 t -94.96 115.81 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.064 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -98.3 98.84 10.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 1.003 HG13 HG13 ' A' ' 238' ' ' VAL . 7.2 p -88.74 132.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.107 0.48 . . . . 0.0 110.878 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 2.5 p -108.57 -30.99 7.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.561 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 40.7 ttm180 -127.68 112.29 14.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.131 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' MET . . . . . 0.559 ' HE3' HG11 ' A' ' 238' ' ' VAL . 31.8 mtt -92.86 106.16 18.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.36 0.6 . . . . 0.0 111.216 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 92.9 m-20 -80.08 117.93 21.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.637 176.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.39 -17.26 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.715 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.416 ' OD1' ' HB3' ' A' ' 270' ' ' ASN . 3.4 p-10 -75.27 -7.58 54.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 134.41 -66.46 0.57 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.806 -1.188 . . . . 0.0 113.628 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 24.3 mp0 -81.72 120.58 25.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.841 0.32 . . . . 0.0 110.571 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.472 ' CZ3' ' HE2' ' A' ' 269' ' ' MET . 28.8 m0 -93.76 164.54 13.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.659 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 46.7 mt-10 -102.93 102.97 13.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.358 175.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -126.38 168.21 18.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 282' ' ' ARG . 0.9 OUTLIER -122.64 144.05 49.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.451 . . . . 0.0 109.844 178.045 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.55 HG21 HD21 ' A' ' 258' ' ' LEU . 95.6 t -135.42 100.76 2.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.204 174.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 68.66 28.82 5.58 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.6 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 101.11 14.02 32.1 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.988 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 20.2 mtp-105 -125.71 120.02 29.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.89 0.345 . . . . 0.0 110.823 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 283' ' ' LYS . 30.4 mtpt -96.07 141.83 28.99 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 256' ' ' LEU . . . -165.6 164.17 37.13 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.262 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.727 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 85.5 mt -86.85 110.57 20.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.464 0.649 . . . . 0.0 110.87 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 24.2 p90 -115.94 128.53 25.91 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.174 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 10.7 Cg_exo -72.98 143.78 37.04 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.646 2.231 . . . . 0.0 111.076 173.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -66.01 -7.63 18.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.16 -11.96 60.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.041 0.448 . . . . 0.0 111.462 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -103.63 -11.94 17.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 111.029 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.417 HG21 ' HE2' ' A' ' 286' ' ' PHE . 27.3 m -127.9 163.76 30.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.031 -175.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.844 ' HG2' HD12 ' A' ' 243' ' ' ILE . 32.5 mmmt -124.9 122.3 36.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.569 176.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.647 HD13 ' HB2' ' A' ' 240' ' ' ALA . 45.1 mm -71.06 102.84 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.89 170.9 8.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.248 0.547 . . . . 0.0 111.698 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' A' ' 298' ' ' ASN . 6.7 p-10 -97.56 127.55 37.41 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.755 175.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 295' ' ' ASP . 24.3 Cg_exo -64.64 -48.4 4.26 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.289 1.993 . . . . 0.0 111.652 176.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -149.3 -5.93 0.37 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.203 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 295' ' ' ASP . 79.6 m-20 -62.26 122.97 76.42 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.392 -174.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.4 -42.53 40.54 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 121.686 1.591 . . . . 0.0 109.749 170.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.6 t70 65.43 -69.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.874 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 58.63 51.31 7.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.493 0.663 . . . . 0.0 110.985 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -75.83 -27.42 57.88 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 167.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 C--O 1.248 1.01 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.313 174.168 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 p -129.29 103.01 6.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.109 0.48 . . . . 0.0 112.137 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.0 t -92.95 -38.25 11.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.698 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 54.49 84.25 0.07 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.837 0.711 . . . . 0.0 111.312 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -109.15 20.03 18.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.696 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 50.7 p90 -91.34 156.27 17.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.08 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.36 135.27 36.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 m -110.84 10.9 22.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.414 ' OG ' ' HD2' ' A' ' 229' ' ' PRO . 8.2 t -121.52 -37.82 2.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.511 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -72.25 116.34 12.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.219 0.533 . . . . 0.0 110.715 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HG2' ' H ' ' A' ' 11' ' ' ARG . 16.5 mmt180 -56.87 -30.17 63.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.995 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.5 t -80.88 -2.71 48.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -175.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.76 -46.9 6.4 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.815 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 31.7 p-90 -120.4 -21.38 6.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -172.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -78.94 118.27 20.79 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.944 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.692 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 7.8 tpp -97.38 -4.48 38.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.201 0.524 . . . . 0.0 110.455 -172.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.66 -115.81 3.72 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.951 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.43 103.49 1.75 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.455 2.103 . . . . 0.0 112.338 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.861 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 80.8 t -132.66 -83.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.255 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.691 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 66.9 m 87.73 152.38 0.06 Allowed 'General case' 0 C--N 1.348 0.543 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -59.06 -35.67 73.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -164.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -25.94 66.97 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.019 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' HG22 ' A' ' 26' ' ' THR . 23.7 tp10 -87.29 -45.24 10.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.7 -44.24 77.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.838 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -76.92 -32.74 57.59 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 23' ' ' GLU . 6.9 t -72.54 -22.07 61.07 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.591 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -88.42 -24.64 22.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.399 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.813 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 95.2 mt -107.86 20.35 18.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.532 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -66.58 90.99 0.17 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.527 0.68 . . . . 0.0 109.217 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.41 -70.1 2.68 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.576 ' HG3' ' H ' ' A' ' 32' ' ' ARG . 4.6 tp-100 48.74 -167.39 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.795 0.838 . . . . 0.0 110.894 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.576 ' H ' ' HG3' ' A' ' 31' ' ' GLN . 74.1 mtm-85 -80.04 112.09 17.01 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 170.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.478 ' NE2' ' HA ' ' A' ' 55' ' ' ASN . 32.8 m170 -57.88 117.75 4.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.115 0.483 . . . . 0.0 110.053 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.05 14.36 7.22 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -168.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -95.82 145.95 24.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.557 ' HB2' HG22 ' A' ' 52' ' ' VAL . 31.1 p90 -150.34 166.97 28.42 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.45 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.1 pp -156.45 135.57 12.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.511 173.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.52 HG22 HD13 ' A' ' 50' ' ' LEU . 51.4 t -101.74 111.28 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.861 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 13.4 ptt-85 -110.7 173.95 6.09 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.868 0.366 . . . . 0.0 110.791 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -82.22 137.37 34.92 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.6 p -59.44 -28.58 67.09 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.582 -174.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.2 t 61.29 19.98 10.63 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.942 0.877 . . . . 0.0 108.787 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.5 m -116.41 -49.86 2.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.045 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 44.7 t -145.83 124.45 6.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.614 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.511 ' HD2' HG23 ' A' ' 219' ' ' VAL . 28.0 Cg_exo -62.62 87.11 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.411 2.074 . . . . 0.0 111.344 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.43 -11.27 0.13 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.774 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -126.34 145.88 50.26 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.36 -0.494 . . . . 0.0 109.763 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.43 164.42 13.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.363 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.515 HG11 ' HE2' ' A' ' 207' ' ' PTR . 38.6 t -129.29 99.42 4.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.213 0.53 . . . . 0.0 110.619 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.52 HD13 HG22 ' A' ' 38' ' ' VAL . 41.9 tp -78.67 99.53 6.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.894 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.4 m -96.3 121.51 38.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.135 0.493 . . . . 0.0 109.992 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.863 HG21 HD13 ' A' ' 93' ' ' LEU . 84.2 t -116.5 134.3 60.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.955 -177.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.813 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 95.5 p -105.78 134.54 48.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.563 0.697 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.515 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 7.2 mt-10 -144.56 175.81 9.87 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.478 ' HA ' ' NE2' ' A' ' 33' ' ' HIS . 0.3 OUTLIER -38.45 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -173.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m 50.57 59.79 4.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.444 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 55' ' ' ASN . 21.0 mmm180 -160.33 49.46 0.27 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.177 -157.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 36.4 t -80.96 90.9 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.967 0.889 . . . . 0.0 109.351 -175.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 51.1 m -80.4 120.81 24.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.172 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.56 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 88.9 m-70 -97.81 99.02 10.33 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.366 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.647 ' CE2' HD22 ' A' ' 93' ' ' LEU . 64.0 m-85 -103.17 116.03 31.71 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.445 ' H ' ' HB3' ' A' ' 209' ' ' GLN . 63.6 mt -81.69 139.27 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.524 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.8 mp -127.05 118.04 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 122.877 0.471 . . . . 0.0 110.422 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -84.35 139.41 32.29 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.464 -0.148 . . . . 0.0 110.822 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.9 t -84.52 107.77 16.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -83.84 149.66 57.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.007 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.71 -23.9 73.49 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.129 2.553 . . . . 0.0 112.911 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -79.66 6.13 11.49 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.013 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 66.11 36.07 5.87 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.676 0.751 . . . . 0.0 110.234 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 92.7 mtt180 -113.97 172.99 6.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.604 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.524 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 60.0 m-85 -135.92 115.72 13.04 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.12 0.486 . . . . 0.0 111.291 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -98.39 108.4 21.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.745 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.548 HD13 ' HE2' ' A' ' 88' ' ' TYR . 9.5 tt -97.8 78.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.842 0.829 . . . . 0.0 110.043 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.622 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 69.74 95.62 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.283 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.684 ' HB2' ' HB2' ' A' ' 211' ' ' GLN . 10.6 t0 71.81 -56.96 0.63 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.033 0.533 . . . . 0.0 111.736 173.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -78.61 140.53 38.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.738 0.304 . . . . 0.0 110.665 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -112.7 128.64 56.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.627 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.485 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 74.6 m-85 -116.77 164.6 14.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.273 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' ARG . 3.6 m-20 -72.97 -29.66 63.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -176.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.623 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -164.06 167.06 20.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.974 -178.291 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.659 HD23 HD21 ' A' ' 84' ' ' LEU . 10.6 mt -53.58 -51.79 72.96 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.623 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 32.2 Cg_exo -59.96 -11.92 17.01 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.956 1.77 . . . . 0.0 112.955 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . . . -91.73 -32.21 15.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.111 -175.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.659 HD21 HD23 ' A' ' 81' ' ' LEU . 3.9 pp -77.46 -31.95 54.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.67 -38.3 90.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.354 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.645 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 13.9 pt-20 -78.25 -18.17 55.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.196 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -79.07 -39.01 34.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.191 0.519 . . . . 0.0 109.961 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.548 ' HE2' HD13 ' A' ' 73' ' ' ILE . 32.4 m-85 -77.85 -15.95 58.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.599 -177.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 22.0 pttm -67.48 -20.27 65.44 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.316 -0.254 . . . . 0.0 110.316 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.441 HG23 ' HG3' ' A' ' 89' ' ' LYS . 18.9 pt -121.91 22.48 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.991 -0.443 . . . . 0.0 111.529 174.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 22.3 t-160 -113.56 -32.47 6.18 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.078 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.584 ' HA ' HG22 ' A' ' 97' ' ' THR . 76.1 m-85 73.32 107.75 0.07 Allowed 'General case' 0 C--O 1.22 -0.452 0 O-C-N 124.072 0.858 . . . . 0.0 109.966 -172.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.863 HD13 HG21 ' A' ' 52' ' ' VAL . 12.2 mt -79.87 -12.2 59.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.76 0.79 . . . . 0.0 109.173 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.515 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 24.9 t70 -149.04 -71.83 0.19 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.238 160.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.607 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.7 t -149.22 2.33 0.56 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.433 HG22 ' CD ' ' A' ' 54' ' ' GLU . 1.9 t -132.08 -12.54 3.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.409 -0.807 . . . . 0.0 112.795 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 92' ' ' TYR . 8.4 p 74.08 -166.06 0.1 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.301 1.041 . . . . 0.0 111.696 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.414 HD22 ' CD1' ' A' ' 36' ' ' PHE . 63.5 mt -81.72 108.56 15.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.311 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.7 mm -98.45 -48.57 12.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.556 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 9.8 pt-20 -167.56 158.14 9.67 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.916 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 1.5 Cg_endo -83.28 162.82 15.15 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.801 2.334 . . . . 0.0 112.726 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.18 154.08 63.26 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.096 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.725 ' HB2' ' HG3' ' A' ' 106' ' ' PRO . 22.8 Cg_exo -64.71 139.31 62.6 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.629 2.22 . . . . 0.0 112.119 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.692 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 68.1 mtm180 -77.03 -42.56 38.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.049 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -139.61 80.67 21.39 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.562 0.696 . . . . 0.0 110.155 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.725 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 1.4 Cg_endo -82.81 -19.54 5.94 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.671 2.248 . . . . 0.0 112.254 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.8 t 56.18 86.67 0.16 Allowed Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.865 -172.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 33.6 Cg_exo -56.86 126.59 22.72 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.746 2.298 . . . . 0.0 112.193 -176.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 8.5 Cg_exo -74.54 41.35 0.69 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.383 2.722 . . . . 0.0 112.316 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 92.4 mmm 56.51 45.96 21.49 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.178 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.84 -72.97 0.43 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.049 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m -70.08 96.84 1.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.959 0.409 . . . . 0.0 111.257 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.607 HG23 ' HD2' ' A' ' 116' ' ' PRO . 11.1 m -100.82 -22.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.794 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.3 m 58.76 24.83 12.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.345 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.807 ' H ' ' HD2' ' A' ' 116' ' ' PRO . . . -108.42 -50.4 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.807 ' HD2' ' H ' ' A' ' 115' ' ' ALA . 10.2 Cg_endo -53.84 133.68 55.61 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 122.651 2.234 . . . . 0.0 113.21 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -70.06 -46.31 65.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.448 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 91.1 mt -151.77 124.78 4.13 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.239 -174.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 118' ' ' LEU . 4.3 Cg_endo -87.04 26.91 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.388 2.725 . . . . 0.0 111.21 174.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.6 t -69.71 145.14 52.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.563 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.59 26.87 6.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.276 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.39 -57.39 8.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.795 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -81.71 132.1 35.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.332 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -97.37 -74.57 0.57 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.552 174.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.661 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? 61.89 101.49 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.912 0.758 . . . . 0.0 111.586 176.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 47.9 tp10 -161.14 -78.72 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.092 -175.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.89 116.49 32.04 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.9 0.857 . . . . 0.0 112.039 -171.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.826 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 86.6 t -134.36 125.89 48.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.573 -173.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.672 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 7.2 ptp85 -111.49 135.01 52.65 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 118.127 -1.429 . . . . 0.0 110.817 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.413 HG22 HG12 ' A' ' 178' ' ' VAL . 7.4 p -97.48 140.66 31.59 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.094 0.473 . . . . 0.0 112.081 -174.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.054 HD21 ' HB2' ' A' ' 179' ' ' GLU . 0.1 OUTLIER -117.44 -38.33 3.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.448 -171.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 29.9 t80 -64.32 -32.56 74.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.886 -170.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 12.5 t70 72.44 105.84 0.07 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.737 0.648 . . . . 0.0 110.04 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 71.3 t80 -144.08 108.72 5.0 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.095 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 66.1 Cg_endo -87.92 99.6 0.44 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.325 2.017 . . . . 0.0 112.661 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -81.65 -3.71 90.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.99 175.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 57.92 24.66 11.2 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.133 0.573 . . . . 0.0 111.777 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.704 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 2.0 p30 50.45 -176.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.038 1.335 . . . . 0.0 114.457 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 71.89 9.17 6.14 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.432 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -175.38 -46.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.069 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.411 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 17.5 m-20 -137.07 124.26 21.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.828 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.936 HD11 ' HB2' ' A' ' 165' ' ' ASN . 46.7 tp -69.86 132.28 88.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-O 120.693 0.282 . . . . 0.0 110.662 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 6.4 Cg_endo -85.25 89.23 0.83 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.374 2.049 . . . . 0.0 110.636 176.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 14.2 p90 -99.5 158.02 16.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.472 -177.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.58 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 82.9 mttt -112.15 -172.44 2.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.469 -172.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.22 18.46 1.4 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.742 -175.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.94 36.06 0.08 OUTLIER Glycine 0 C--N 1.33 0.218 0 C-N-CA 119.813 -1.185 . . . . 0.0 113.916 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.58 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 21.9 mm-40 -98.84 157.41 16.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.4 tp -103.52 138.83 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.563 HD22 ' HA ' ' A' ' 165' ' ' ASN . 26.5 mt -120.61 155.7 33.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 19.2 t -119.74 130.89 73.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 163' ' ' ALA . 39.6 mm -74.3 96.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.557 HG23 ' HG2' ' A' ' 154' ' ' GLU . 16.3 tt -79.02 -31.2 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.77 -175.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.557 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -146.9 141.0 26.09 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.934 171.172 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.623 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 1.6 ttpm? -119.06 87.13 33.54 Favored Pre-proline 0 C--N 1.328 -0.367 0 O-C-N 121.331 -0.856 . . . . 0.0 110.877 173.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.607 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 11.4 Cg_exo -72.92 -58.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.584 2.19 . . . . 0.0 112.35 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -107.83 177.44 4.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.23 -20.18 14.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.757 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -85.47 -34.76 21.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.15 0.5 . . . . 0.0 110.122 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -128.3 129.73 46.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.206 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -108.97 156.17 20.02 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 22.7 t -111.58 101.96 10.33 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.351 0.596 . . . . 0.0 110.056 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -113.71 163.19 15.34 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.169 -176.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' A' ' 210' ' ' PRO . 29.8 ptt-85 -108.23 140.55 41.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.328 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.936 ' HB2' HD11 ' A' ' 142' ' ' LEU . 57.1 t30 -70.56 178.61 2.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.587 -175.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -58.67 -32.02 68.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 211' ' ' GLN . 17.9 m-20 -60.6 -42.14 96.15 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.105 170.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.883 ' HA3' ' H ' ' A' ' 211' ' ' GLN . . . 115.86 -9.33 18.81 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.689 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.704 ' HD3' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -76.73 152.69 35.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.541 0.671 . . . . 0.0 110.811 -176.363 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.464 ' CG2' HD13 ' A' ' 153' ' ' ILE . 26.2 t -99.73 143.59 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.287 0.565 . . . . 0.0 112.413 -168.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -171.98 162.98 35.29 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.757 169.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.421 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 22.9 mtp -81.7 147.31 29.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.3 0.55 . . . . 0.0 110.822 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.8 pp -141.32 145.83 39.9 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.386 -174.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 7.8 Cg_exo -73.29 133.17 18.88 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.185 2.59 . . . . 0.0 112.699 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.62 ' O ' HG22 ' A' ' 178' ' ' VAL . 58.0 t -61.7 -47.3 92.69 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 23.3 Cg_endo -61.4 -13.44 29.0 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.169 1.913 . . . . 0.0 113.294 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -86.35 -4.21 59.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.888 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 175' ' ' VAL . 4.1 m -110.61 159.04 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -166.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 1.054 ' HB2' HD21 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -117.75 45.19 2.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 111.493 -2.594 . . . . 0.0 109.242 -178.725 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.826 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -74.27 137.77 43.18 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 120.963 -1.085 . . . . 0.0 109.398 -168.274 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.548 HD13 HH22 ' A' ' 129' ' ' ARG . 27.2 tp -60.54 -53.15 60.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.715 -164.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.64 115.91 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.683 0.754 . . . . 0.0 111.565 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -155.11 86.58 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.6 m -74.6 163.27 27.92 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.411 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 1.6 p -78.2 168.18 29.55 Favored Pre-proline 0 C--N 1.318 -0.761 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.77 90.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.852 2.368 . . . . 0.0 114.211 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 1.9 p80 174.22 -176.11 0.08 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.723 1.209 . . . . 0.0 108.566 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -84.3 -162.54 34.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.403 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -74.58 -13.11 60.62 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.146 0.179 . . . . 0.0 110.863 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 43.04 98.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.742 1.217 . . . . 0.0 113.917 175.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -133.39 156.98 22.51 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.206 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -62.97 -44.64 95.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.812 0.339 . . . . 0.0 110.389 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -137.56 88.23 2.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 110.149 176.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -93.92 98.87 11.34 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 12.3 p -148.88 -74.28 0.18 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.75 -176.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.41 45.66 1.26 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.544 0.688 . . . . 0.0 109.497 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 24.8 m -103.86 94.66 5.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.399 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.79 169.46 12.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.188 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 91.73 52.12 2.35 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -171.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.697 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 63.7 mt -95.51 -53.6 0.23 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.234 -0.483 . . . . 0.0 111.496 -176.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.697 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 50.6 Cg_exo -55.24 139.26 80.89 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.319 2.012 . . . . 0.0 112.319 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.35 126.46 86.44 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.721 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.61 0.9 9.55 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.476 2.117 . . . . 0.0 111.628 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -159.26 -145.83 0.14 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.467 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 68.84 24.84 6.36 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.469 0.652 . . . . 0.0 110.37 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.1 -60.86 2.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.687 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.56 ' HD2' ' HB3' ' A' ' 60' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -107.07 12.24 28.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.097 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.445 ' HB3' ' H ' ' A' ' 62' ' ' ILE . 28.9 pt20 -57.45 136.06 81.86 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.357 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.622 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 26.4 Cg_exo -63.36 145.85 93.01 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.82 1.68 . . . . 0.0 110.167 170.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.883 ' H ' ' HA3' ' A' ' 168' ' ' GLY . 7.4 tp-100 70.62 168.35 0.31 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.974 0.416 . . . . 0.0 109.952 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 4.7 t -114.83 106.7 14.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.588 0.708 . . . . 0.0 110.37 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 27.0 p -87.66 167.09 14.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.004 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 8.7 t -128.95 125.36 22.85 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.894 0.378 . . . . 0.0 110.359 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 8.2 Cg_exo -71.64 110.23 2.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.741 2.294 . . . . 0.0 111.339 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.76 ' H ' HD23 ' A' ' 216' ' ' LEU . 2.4 pt? -86.24 142.9 36.13 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.064 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 7.9 Cg_exo -73.62 -4.15 14.94 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.864 2.376 . . . . 0.0 112.447 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -98.19 115.29 28.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.427 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.511 HG23 ' HD2' ' A' ' 45' ' ' PRO . 3.4 p -71.06 103.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.575 0.702 . . . . 0.0 110.959 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 55.4 m -148.26 127.01 12.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.704 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 146.53 39.14 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.29 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 48.7 m -75.52 118.7 72.8 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 15.0 Cg_exo -68.98 -32.46 21.84 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.935 2.423 . . . . 0.0 112.653 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 79.37 -78.86 1.69 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.746 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -148.64 145.58 27.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.3 116.21 27.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.33 . . . . 0.0 110.605 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.76 127.97 31.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.857 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.4 t -83.02 124.61 76.43 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.537 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.414 ' HD2' ' OG ' ' A' ' 9' ' ' SER . 88.9 Cg_endo -87.04 -161.39 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.67 2.247 . . . . 0.0 112.238 178.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.493 ' HG ' ' H ' ' A' ' 232' ' ' SER . 2.5 pt? -142.44 174.03 4.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 230' ' ' LEU . 50.6 Cg_exo -55.61 -24.19 43.98 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.6 2.2 . . . . 0.0 113.167 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.493 ' H ' ' HG ' ' A' ' 230' ' ' LEU . 8.4 m -79.1 141.25 37.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.342 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 35.3 p -69.86 162.5 27.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.242 0.544 . . . . 0.0 111.606 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -77.4 80.91 3.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.145 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -134.54 2.01 3.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.844 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -130.63 110.03 0.97 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.588 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.66 163.92 18.64 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.313 2.675 . . . . 0.0 111.409 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.704 HG12 HD11 ' A' ' 293' ' ' ILE . 45.8 t -94.9 131.14 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -115.14 135.12 54.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.851 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -122.29 142.56 50.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.2 174.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.741 ' HA ' ' O ' ' A' ' 262' ' ' ASP . 56.3 mttm -84.52 119.6 25.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.088 0.47 . . . . 0.0 110.233 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 1.091 ' HB1' ' HA ' ' A' ' 259' ' ' GLU . . . -89.39 114.91 26.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.217 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -130.7 -10.26 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -165.718 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.667 ' HB3' ' OE2' ' A' ' 259' ' ' GLU . 57.7 tt0 -113.57 -89.05 0.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.059 -0.657 . . . . 0.0 112.752 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.445 ' N ' ' HB3' ' A' ' 259' ' ' GLU . 85.8 tttt -173.81 118.74 0.27 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -173.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.954 ' HG2' ' HG3' ' A' ' 259' ' ' GLU . 19.8 mmm180 -131.34 98.74 4.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.61 167.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.68 132.75 21.75 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.106 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 73.3 Cg_endo -81.97 107.69 1.75 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.587 2.192 . . . . 0.0 112.631 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 6.0 t -63.86 161.68 15.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.37 -9.45 3.57 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -67.66 -33.98 76.02 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 46.07 86.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.853 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -121.07 72.83 1.0 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.755 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.9 m 60.18 36.82 20.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.057 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -94.37 118.43 31.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.507 . . . . 0.0 111.183 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 tt -91.17 126.28 36.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.367 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.467 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -81.82 110.66 17.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.188 0.518 . . . . 0.0 110.931 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.59 HD22 HG22 ' A' ' 264' ' ' VAL . 1.3 pp -164.86 -141.82 0.05 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.115 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 1.091 ' HA ' ' HB1' ' A' ' 242' ' ' ALA . 0.0 OUTLIER 80.82 1.18 1.78 Allowed 'General case' 0 C--O 1.222 -0.367 0 O-C-N 123.899 0.75 . . . . 0.0 111.566 177.432 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.32 90.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -178.8 -83.35 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.823 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.741 ' O ' ' HA ' ' A' ' 241' ' ' LYS . 29.2 t0 179.04 -79.06 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 121.056 0.455 . . . . 0.0 111.68 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 36.9 mm -100.65 119.81 49.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -170.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.59 HG22 HD22 ' A' ' 258' ' ' LEU . 99.2 t -107.11 121.79 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.472 168.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -94.09 116.25 28.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.163 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 275' ' ' TRP . 2.7 p -111.68 117.27 54.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.306 0.574 . . . . 0.0 110.692 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.2 p -107.57 -15.44 14.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.753 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.499 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 38.2 mmt-85 -124.01 100.38 6.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.043 0.449 . . . . 0.0 111.211 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 46.8 mtt -101.85 140.31 36.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.332 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.632 ' OD1' ' HB3' ' A' ' 272' ' ' ASN . 9.0 p30 -135.49 176.66 8.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.461 -176.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 271' ' ' ILE . 13.7 pt -87.1 4.58 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -172.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.632 ' HB3' ' OD1' ' A' ' 270' ' ' ASN . 7.4 t-20 -74.77 -44.59 48.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.26 0.552 . . . . 0.0 109.578 175.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.73 -39.21 2.55 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 44.3 mt-30 -79.35 116.54 19.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.578 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 13.6 m0 -93.04 155.85 17.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.977 -173.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 40.2 mt-10 -101.26 107.62 19.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.994 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.99 148.74 17.89 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 282' ' ' ARG . 0.0 OUTLIER -110.09 109.63 20.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.372 0.606 . . . . 0.0 110.33 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.487 HG21 HG13 ' A' ' 264' ' ' VAL . 21.6 t -127.6 -79.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.755 -176.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -82.26 67.04 8.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.268 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.07 16.92 60.49 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.85 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 40.5 ttm180 -155.32 146.63 22.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.139 0.469 . . . . 0.0 111.095 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 278' ' ' GLU . 39.4 tttm -102.48 113.98 27.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.118 170.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -146.67 178.21 24.48 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.074 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 96.5 mt -84.86 140.43 31.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 0.0 111.681 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.412 ' HE2' HG21 ' A' ' 291' ' ' VAL . 34.8 p90 -142.86 129.5 10.69 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.22 170.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.28 137.08 25.31 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.58 2.187 . . . . 0.0 112.536 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -71.51 -10.74 60.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.844 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.7 m -84.65 -2.57 57.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.451 0.643 . . . . 0.0 110.411 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.455 ' HB3' ' OE2' ' A' ' 259' ' ' GLU . 3.1 m-70 -101.12 -54.65 2.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.395 174.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.412 HG21 ' HE2' ' A' ' 286' ' ' PHE . 35.0 m -85.03 159.61 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.798 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.42 107.16 16.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.229 0.538 . . . . 0.0 110.3 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' A' ' 240' ' ' ALA . 5.0 tp -70.1 131.66 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.472 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 18.3 p90 -134.63 160.64 37.48 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.624 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -99.31 111.6 61.5 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.178 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.07 39.35 0.83 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.144 2.563 . . . . 0.0 111.603 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 58.85 52.01 6.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.227 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 0.5 OUTLIER -83.3 145.59 48.97 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.444 176.893 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 75.8 Cg_endo -94.52 24.88 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.053 2.502 . . . . 0.0 113.617 -175.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -131.3 177.13 7.71 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.419 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 302' ' ' ASN . 7.3 pt-20 59.18 -55.05 0.06 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.033 1.733 . . . . 0.0 114.208 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.47 ' N ' ' HG3' ' A' ' 301' ' ' GLU . 8.6 t30 -78.42 133.32 37.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.193 0.521 . . . . 0.0 111.581 -174.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.236 175.397 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.745 0.307 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.8 m -77.59 141.99 39.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.712 0.291 . . . . 0.0 110.652 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.546 ' HB3' HD12 ' A' ' 99' ' ' ILE . 15.0 m -76.96 -39.74 49.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.034 0.445 . . . . 0.0 109.92 178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.55 94.61 1.32 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.993 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.657 ' HA ' ' NE ' ' A' ' 5' ' ' ARG . 5.0 mmp_? -113.71 15.14 18.84 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -86.59 171.13 11.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.456 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 24.4 t70 -82.52 -133.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.444 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 9.6 t -173.71 43.19 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.406 ' H ' ' H ' ' A' ' 10' ' ' ASP . 9.9 t -164.51 -11.02 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.968 174.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.456 ' OD1' ' HB3' ' A' ' 7' ' ' ASP . 7.9 p-10 -75.44 81.0 2.49 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.809 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 48.0 mtt-85 -70.5 -16.85 62.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.479 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 t -75.77 -7.96 55.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.659 174.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.3 -47.08 3.59 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.8 p-90 -107.63 -20.46 13.22 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -172.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 22.8 t80 -81.92 122.71 28.11 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 122.027 -0.421 . . . . 0.0 110.672 -174.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.694 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 24.7 mmt -103.36 -13.55 16.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.479 -176.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.05 -113.42 2.18 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.658 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.6 84.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.199 2.599 . . . . 0.0 113.327 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.523 HG21 ' HB3' ' A' ' 16' ' ' MET . 84.1 t -137.03 172.8 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 19' ' ' VAL . 43.8 p -145.41 172.28 13.42 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -168.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.645 ' HD2' ' O2P' ' A' ' 207' ' ' PTR . 37.4 ttt85 -63.02 -37.15 86.04 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.873 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -56.74 11.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.688 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -61.55 -50.25 73.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.25 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.73 -37.23 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.353 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -64.33 -43.94 93.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.128 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.2 t -78.92 -21.27 47.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.871 0.367 . . . . 0.0 111.409 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.415 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 51.1 mtp180 -82.43 -10.43 59.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.892 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.611 HD22 ' HB2' ' A' ' 53' ' ' SER . 26.9 mt -126.97 12.06 7.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.097 0.475 . . . . 0.0 111.018 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.49 98.25 2.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.377 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 117' ' ' ASN . . . 78.69 -1.92 70.52 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.344 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.793 ' HA ' ' H ' ' A' ' 117' ' ' ASN . 37.4 mm-40 -60.37 168.15 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.853 0.461 . . . . 0.0 111.689 -175.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.471 ' HD3' ' HB1' ' A' ' 115' ' ' ALA . 20.8 ttp180 -47.63 118.98 2.49 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.551 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.601 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 36.3 m170 -63.6 117.16 6.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.337 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.8 -13.55 6.1 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.997 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.691 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 64.3 mtt -69.19 153.58 43.46 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.511 0.196 . . . . 0.0 110.518 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.418 ' CB ' HG22 ' A' ' 52' ' ' VAL . 28.7 p90 -155.62 159.23 39.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.694 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.6 pp -153.52 140.41 19.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.001 0.429 . . . . 0.0 110.851 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.3 t -110.39 116.47 52.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.861 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.499 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 25.4 ptt-85 -117.77 176.05 5.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.97 -177.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.41 134.46 40.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.133 0.492 . . . . 0.0 110.645 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 t -87.36 107.97 18.77 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.5 t -73.96 8.09 2.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.563 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.5 p -94.6 -25.56 16.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.803 0.335 . . . . 0.0 110.659 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 76.7 m -152.36 115.23 2.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.879 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 28.0 Cg_endo -62.45 103.05 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.799 2.333 . . . . 0.0 112.436 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.54 -24.73 4.1 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.659 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -88.37 165.87 14.66 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.422 ' CD2' HD11 ' A' ' 81' ' ' LEU . 58.0 m-85 -134.52 -177.87 4.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.758 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.556 HG22 HG12 ' A' ' 62' ' ' ILE . 6.2 t -143.96 113.85 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.62 177.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.452 ' HB2' HD11 ' A' ' 63' ' ' ILE . 62.8 tp -80.83 97.09 7.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.1 m -94.05 118.12 31.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.329 0.585 . . . . 0.0 109.666 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 58.7 t -110.68 142.66 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.639 -174.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 40.7 t -91.68 103.89 16.41 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.601 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 7.0 tp10 -167.11 166.43 15.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.898 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.574 HD22 ' CG ' ' A' ' 94' ' ' ASP . 0.7 OUTLIER 76.82 -64.5 0.33 Allowed 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 123.58 1.657 . . . . 0.0 108.546 -168.41 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.42 ' HB3' ' OE1' ' A' ' 122' ' ' GLU . 75.5 m -160.86 -27.64 0.06 Allowed 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 111.314 -2.675 . . . . 0.0 106.133 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.82 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.363 0.0 OUTLIER -163.08 -48.34 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.084 1 N-CA-C 123.333 4.568 . . . . 0.0 123.333 179.624 . . . . . . . . 5 4 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.82 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -147.98 107.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 121.785 2.084 . . . . 0.0 114.096 -166.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.522 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -98.03 112.6 24.49 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 171.135 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -101.53 86.48 2.97 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -169.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.759 ' CE1' HD11 ' A' ' 153' ' ' ILE . 55.5 m-85 -102.01 110.27 22.2 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 118.626 0.648 . . . . 0.0 112.248 -174.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.556 HG12 HG22 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -75.38 139.49 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.295 0.569 . . . . 0.0 112.39 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.616 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.3 mp -110.33 108.8 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.587 175.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -82.82 141.93 31.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.177 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.7 t -85.75 118.46 25.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.104 0.478 . . . . 0.0 110.352 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.512 HD21 ' HE2' ' A' ' 72' ' ' LYS . 95.3 mt -95.15 142.54 24.74 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.058 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 19.9 Cg_exo -66.54 -8.66 21.61 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.864 2.376 . . . . 0.0 112.386 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.48 10.12 5.1 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.658 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 67.32 25.9 8.64 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.087 -179.497 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 71.0 mtt180 -115.2 -176.1 2.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.199 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.516 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 61.5 m-85 -138.85 124.69 19.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.718 0.294 . . . . 0.0 110.934 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.801 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 25.7 ttpt -113.62 109.65 18.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 111.466 -177.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.616 ' HB ' HG13 ' A' ' 63' ' ' ILE . 14.0 tt -95.91 81.29 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.723 0.773 . . . . 0.0 110.052 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.56 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 71.76 82.59 0.27 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.79 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.778 ' HB2' ' CB ' ' A' ' 211' ' ' GLN . 20.2 t0 71.46 -47.09 0.65 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.963 0.905 . . . . 0.0 111.48 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -74.75 101.34 4.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.889 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.801 ' HB3' ' HD3' ' A' ' 72' ' ' LYS . 8.2 pt-20 -95.55 118.26 31.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.662 0.744 . . . . 0.0 110.934 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.583 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 76.3 m-85 -100.22 174.71 6.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.83 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 31.9 t70 -73.06 -25.14 60.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.317 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.649 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 1.7 p80 -172.01 172.17 4.79 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.662 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.6 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.5 mt -51.4 -54.41 39.05 Favored Pre-proline 0 N--CA 1.472 0.633 0 O-C-N 123.301 0.376 . . . . 0.0 111.95 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.649 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 59.6 Cg_endo -70.4 16.99 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.284 1.99 . . . . 0.0 113.292 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.5 -35.4 6.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 174.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.8 pp -76.88 -31.74 56.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.175 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.68 -30.35 71.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.619 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 89' ' ' LYS . 3.6 tt0 -91.36 -12.61 34.41 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.104 0.478 . . . . 0.0 111.107 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.403 ' CE2' ' ND1' ' A' ' 91' ' ' HIS . 72.4 t80 -86.01 -30.62 22.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.98 0.895 . . . . 0.0 108.957 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.791 ' CD1' HD23 ' A' ' 93' ' ' LEU . 40.7 m-85 -82.71 2.38 33.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.252 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.552 ' HD2' ' HG3' ' A' ' 86' ' ' GLU . 98.3 mttt -76.39 -3.96 39.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.875 173.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.34 -2.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.032 0.444 . . . . 0.0 110.726 177.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.403 ' ND1' ' CE2' ' A' ' 87' ' ' PHE . 5.0 t60 -81.36 -31.83 33.2 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.383 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 96' ' ' THR . 75.7 m-85 62.77 67.0 0.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.125 -173.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.791 HD23 ' CD1' ' A' ' 88' ' ' TYR . 2.0 pp -71.62 117.58 13.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.79 174.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.82 ' CA ' ' HB3' ' A' ' 154' ' ' GLU . 7.6 t70 97.81 -48.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.973 1.709 . . . . 0.0 108.278 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.704 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 6.0 t 167.23 22.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.615 -1.629 . . . . 0.0 106.652 168.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.535 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 2.2 t -149.2 150.64 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.445 -173.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.7 p -91.44 157.55 17.0 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.51 99.66 0.22 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.883 0.373 . . . . 0.0 110.18 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.546 HD12 ' HB3' ' A' ' 3' ' ' SER . 32.4 mm -80.83 -57.81 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.765 -176.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.691 ' O ' ' HA ' ' A' ' 35' ' ' MET . 29.8 tt0 -165.16 136.93 3.32 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 -174.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.31 155.68 44.99 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.652 2.235 . . . . 0.0 112.956 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.75 157.84 85.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.697 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.31 122.5 11.91 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.34 2.027 . . . . 0.0 111.823 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -69.53 -31.83 70.29 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.591 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -108.62 108.74 61.14 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 174.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.48 -21.11 22.95 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.352 2.034 . . . . 0.0 112.459 -177.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.7 m 69.25 149.59 0.12 Allowed Pre-proline 0 CA--C 1.534 0.349 0 O-C-N 123.837 0.71 . . . . 0.0 110.647 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.709 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 51.5 Cg_exo -53.3 -56.0 3.12 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.435 2.09 . . . . 0.0 113.318 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.709 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 88.8 Cg_endo -93.24 149.65 2.47 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.028 1.818 . . . . 0.0 112.723 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 87.9 mtp -106.1 119.71 39.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.239 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.73 -52.85 3.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.25 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.932 ' HA ' ' HG2' ' A' ' 116' ' ' PRO . 71.7 p 50.76 -153.2 0.17 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.315 0.646 . . . . 0.0 111.871 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 113' ' ' VAL . 11.5 t 64.12 30.67 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.806 0.813 . . . . 0.0 110.508 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.6 m -151.87 -88.9 0.06 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.432 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.693 ' H ' ' HD2' ' A' ' 116' ' ' PRO . . . -101.65 -47.07 0.19 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.33 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.932 ' HG2' ' HA ' ' A' ' 112' ' ' SER . 33.3 Cg_endo -67.01 121.75 8.98 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.454 1.436 . . . . 0.0 112.304 174.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.793 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 56.2 t30 74.86 108.0 0.07 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.0 0.812 . . . . 0.0 111.89 175.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.754 ' HB2' ' HD3' ' A' ' 119' ' ' PRO . 2.3 mm? -119.59 -60.72 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.301 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.754 ' HD3' ' HB2' ' A' ' 118' ' ' LEU . 19.4 Cg_exo -65.66 141.69 67.41 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.602 2.201 . . . . 0.0 112.884 -173.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.5 m -103.31 114.27 28.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.876 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 71.87 128.84 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.95 0.781 . . . . 0.0 111.734 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.42 ' OE1' ' HB3' ' A' ' 56' ' ' SER . 3.6 mm-40 -83.17 143.29 30.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.868 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.39 -98.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 171.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.533 ' ND2' ' HG3' ' A' ' 183' ' ' ARG . 34.0 m-80 -154.91 -95.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.962 HD12 HG21 ' A' ' 152' ' ' ILE . 3.8 mm? 48.7 90.77 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.006 0.816 . . . . 0.0 111.625 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 11.1 tp10 -165.1 -61.4 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.13 -173.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -113.49 112.34 23.43 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.271 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 1.034 HG22 ' HG3' ' A' ' 180' ' ' LYS . 2.4 t -117.19 153.39 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.669 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.4 ptp180 -129.15 148.35 51.08 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 117.947 -1.501 . . . . 0.0 108.059 157.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.529 HG22 HG12 ' A' ' 178' ' ' VAL . 43.6 p -100.58 133.54 44.87 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.695 0.759 . . . . 0.0 110.874 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.498 HD21 ' HG2' ' A' ' 179' ' ' GLU . 8.0 mt -107.56 2.25 23.91 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.555 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.48 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 16.3 t80 -102.41 -45.02 5.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.039 -173.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.622 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.9 t70 78.74 103.74 0.07 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.166 0.508 . . . . 0.0 110.679 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 68.9 t80 -132.93 91.08 29.99 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 98.3 Cg_endo -87.45 70.33 3.43 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.219 1.946 . . . . 0.0 112.763 -175.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.62 -33.88 82.22 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.737 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.469 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 26.5 m-80 61.97 66.49 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.133 -0.533 . . . . 0.0 111.825 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -143.66 172.63 12.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.271 176.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.46 -9.55 49.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.051 0.929 . . . . 0.0 108.795 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' A' ' 172' ' ' MET . 28.5 mt-10 -106.63 -15.58 14.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.807 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -137.89 106.82 5.97 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.331 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.973 HD11 ' HB2' ' A' ' 165' ' ' ASN . 20.1 tp -75.53 126.91 86.93 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.767 0.317 . . . . 0.0 110.989 -175.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 73.9 Cg_endo -78.12 97.18 1.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.845 1.697 . . . . 0.0 111.687 173.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.617 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 15.3 p90 -105.95 156.71 18.1 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.622 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 62.5 mttp -113.07 173.34 6.44 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -173.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.529 ' N ' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -71.72 57.88 0.3 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.209 178.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 134.41 38.25 0.21 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.784 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.667 ' CD ' ' HG ' ' A' ' 150' ' ' LEU . 1.7 pp20? -91.04 169.06 11.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.17 127.66 73.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.803 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 78.1 mt -117.21 156.33 27.89 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -173.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 89.4 t -120.45 122.13 67.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 171.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.074 HD13 ' HB2' ' A' ' 163' ' ' ALA . 46.4 mm -78.0 78.82 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 122.793 1.282 . . . . 0.0 108.325 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.759 HD11 ' CE1' ' A' ' 61' ' ' TYR . 5.4 tt -70.89 -28.91 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 112.577 -2.101 . . . . 0.0 109.478 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.82 ' HB3' ' CA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -134.89 143.14 46.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.165 176.077 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.523 ' H ' HD21 ' A' ' 55' ' ' ASN . 67.0 tttt -141.61 83.76 12.87 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.704 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 21.8 Cg_exo -68.14 -49.69 0.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.432 2.088 . . . . 0.0 112.199 174.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -119.35 175.73 5.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.658 -171.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -101.96 -4.93 25.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.276 0.56 . . . . 0.0 110.164 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -93.64 -36.55 12.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.516 0.674 . . . . 0.0 109.853 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.47 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 41.0 m95 -129.8 145.04 51.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.925 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.758 ' O ' HG13 ' A' ' 173' ' ' ILE . 48.5 m0 -124.31 138.88 54.34 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 122.761 0.424 . . . . 0.0 110.184 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.678 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 2.9 m -98.55 98.36 9.54 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -174.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.074 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -114.77 155.83 25.99 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -170.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.922 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 31.7 ptt-85 -94.86 128.11 41.38 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.858 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.973 ' HB2' HD11 ' A' ' 142' ' ' LEU . 65.8 t30 -59.21 178.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.106 -1.406 . . . . 0.0 112.21 -169.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -51.01 -28.34 9.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.182 164.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -70.57 -44.33 67.63 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.492 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.587 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 113.87 9.58 15.99 Favored Glycine 0 C--O 1.223 -0.533 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.966 -169.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.922 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 16.4 ttm-85 -76.09 136.54 39.87 Favored 'General case' 0 C--O 1.212 -0.892 0 C-N-CA 123.409 0.683 . . . . 0.0 112.319 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.953 HG23 ' HA ' ' A' ' 210' ' ' PRO . 56.2 t -84.07 120.2 34.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.15 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.402 ' CA ' ' HB2' ' A' ' 142' ' ' LEU . . . -156.12 155.89 26.65 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.476 -0.649 . . . . 0.0 111.476 172.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.657 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -76.02 138.8 41.12 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 117.354 0.577 . . . . 0.0 111.277 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.758 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -139.16 141.48 29.77 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.187 -176.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 21.4 Cg_exo -65.58 131.77 28.86 Favored 'Trans proline' 0 CA--C 1.527 0.146 0 C-N-CA 122.464 2.109 . . . . 0.0 112.936 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.519 ' O ' HG22 ' A' ' 178' ' ' VAL . 66.6 t -61.42 -44.54 92.86 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.438 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 22.7 Cg_exo -64.61 2.17 1.38 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.188 1.925 . . . . 0.0 113.162 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.7 m-30 -100.99 -11.65 19.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.231 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.73 ' HB ' HG13 ' A' ' 128' ' ' VAL . 3.6 m -105.63 -177.03 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -164.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.669 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.8 tp10 -151.82 51.59 0.81 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 111.947 -2.388 . . . . 0.0 112.332 -155.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 1.034 ' HG3' HG22 ' A' ' 128' ' ' VAL . 1.8 mppt? -68.22 135.83 52.62 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 120.056 -1.652 . . . . 0.0 109.96 -161.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.9 tp -84.11 -74.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.872 -165.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 19.0 m -88.04 25.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.23 -175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.926 ' HD3' ' HE3' ' A' ' 180' ' ' LYS . 28.0 ttt180 -103.12 118.18 36.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.026 0.441 . . . . 0.0 111.525 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 68.7 p -116.21 144.35 44.3 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 9.0 p -57.52 145.11 70.12 Favored Pre-proline 0 C--O 1.238 0.453 0 CA-C-O 120.453 0.168 . . . . 0.0 110.725 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 25.7 Cg_exo -61.67 100.3 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.682 2.255 . . . . 0.0 112.305 -177.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -96.51 177.71 5.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.111 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -83.34 88.24 1.5 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.396 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp 59.85 89.23 0.07 Allowed 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.03 0.532 . . . . 0.0 111.29 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -97.79 -46.79 5.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.831 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 94.44 77.86 1.39 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.142 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -122.2 18.22 10.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.189 0.519 . . . . 0.0 109.761 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.411 ' HA ' ' NE ' ' A' ' 193' ' ' ARG . 4.5 mmp_? -88.52 101.42 13.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.013 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 58.8 t30 69.21 99.0 0.06 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.536 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.7 p -111.32 160.99 16.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.922 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -91.62 -174.01 3.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.79 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 22.9 t 72.47 -68.81 0.21 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.248 0.619 . . . . 0.0 110.367 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -87.35 92.77 9.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.162 0.506 . . . . 0.0 110.749 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.73 135.54 6.38 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.553 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 62.6 mt -116.96 109.32 43.02 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.776 0.322 . . . . 0.0 110.339 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.49 124.62 11.81 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.747 2.298 . . . . 0.0 112.316 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 70.31 112.64 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.249 0 O-C-N 123.935 0.772 . . . . 0.0 111.245 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 1.227 ' HG2' ' O1P' ' A' ' 207' ' ' PTR . 37.9 Cg_endo -67.15 120.14 7.2 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.781 2.32 . . . . 0.0 111.998 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.38 173.57 3.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.576 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -70.34 2.53 3.73 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.503 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.405 ' HA ' HG23 ' A' ' 212' ' ' THR . . . -59.52 -65.01 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.27 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 1.227 ' O1P' ' HG2' ' A' ' 203' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -102.05 51.6 0.82 Allowed 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.322 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.405 ' CG ' ' HB ' ' A' ' 62' ' ' ILE . 50.2 mt-30 -65.7 151.25 95.09 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.427 174.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.953 ' HA ' HG23 ' A' ' 170' ' ' VAL . 44.1 Cg_exo -60.76 -9.05 10.6 Favored 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 122.952 2.435 . . . . 0.0 111.848 170.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.778 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 20.7 tp60 -164.52 100.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.67 173.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 206' ' ' ALA . 88.4 m -53.09 125.5 17.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.187 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 35.5 p -88.61 160.49 17.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.786 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 216' ' ' LEU . 14.2 m -63.48 118.64 46.15 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.792 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 1.2 Cg_endo -83.74 7.53 5.14 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.103 2.535 . . . . 0.0 112.795 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.474 ' H ' HG22 ' A' ' 214' ' ' THR . 4.1 mm? -75.86 -50.1 3.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.762 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 216' ' ' LEU . 73.3 Cg_endo -75.67 37.29 0.51 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.16 1.907 . . . . 0.0 112.939 176.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -140.21 158.93 43.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.012 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.08 -22.38 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.399 0.619 . . . . 0.0 110.589 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.8 t -115.89 103.88 11.07 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.807 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -138.07 -178.51 16.18 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.84 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.717 ' HB2' ' HD3' ' A' ' 223' ' ' PRO . 4.6 m -61.76 -54.53 50.51 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.717 ' HD3' ' HB2' ' A' ' 222' ' ' SER . 3.0 Cg_exo -76.67 -32.51 3.55 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.947 1.765 . . . . 0.0 112.122 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 100.6 73.45 1.04 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.48 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -76.61 99.63 5.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.028 0.442 . . . . 0.0 110.993 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -107.21 -40.9 5.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.526 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 9.3 tp -153.93 147.48 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.028 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.2 t -104.04 132.08 21.35 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.791 0.329 . . . . 0.0 110.414 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.35 102.38 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.515 2.144 . . . . 0.0 112.455 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.608 ' H ' ' HD2' ' A' ' 231' ' ' PRO . 57.6 tp -95.83 -45.28 0.26 Allowed Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.889 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.608 ' HD2' ' H ' ' A' ' 230' ' ' LEU . 34.9 Cg_endo -66.1 135.31 40.03 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.509 1.473 . . . . 0.0 112.941 177.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 57.2 m 67.47 18.37 10.06 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.638 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 53.5 p -123.43 143.94 49.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.083 0.468 . . . . 0.0 111.404 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 234' ' ' GLN . 0.8 OUTLIER -89.62 -13.13 37.8 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 170.155 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 2.3 p30 46.09 -81.3 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.082 1.353 . . . . 0.0 113.478 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -58.43 125.86 40.78 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.122 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.8 155.63 69.14 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.619 2.212 . . . . 0.0 112.313 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.505 ' HB ' HG13 ' A' ' 266' ' ' VAL . 17.8 t -73.07 130.25 35.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.784 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.668 ' HB2' ' HG2' ' A' ' 296' ' ' PRO . 79.4 m-85 -105.44 129.0 53.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.55 137.19 53.99 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.421 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 44.6 tptt -81.19 118.58 22.69 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -72.84 108.92 6.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 28.1 pt -102.36 12.88 6.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.016 0.436 . . . . 0.0 111.099 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -157.83 149.0 21.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.07 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.645 ' HG2' ' HG3' ' A' ' 259' ' ' GLU . 26.4 mtpp -68.27 101.56 1.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.064 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -89.73 83.52 6.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.04 142.46 28.79 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.313 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.03 154.46 33.14 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.518 2.146 . . . . 0.0 112.023 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.45 ' HB2' ' CB ' ' A' ' 252' ' ' ASP . 1.3 m -108.07 165.14 11.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.625 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.04 -30.22 71.17 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -105.34 15.91 26.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.972 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.45 ' CB ' ' HB2' ' A' ' 249' ' ' CYS . 15.1 t0 -135.83 81.07 1.86 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 175.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -91.96 -15.69 27.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.617 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 47.9 p -85.27 5.78 28.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.306 0.574 . . . . 0.0 109.705 175.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.06 119.71 25.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.513 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 246' ' ' ARG . 1.2 tt -78.4 134.67 37.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.425 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -82.54 110.27 17.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.075 0.464 . . . . 0.0 110.961 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 77.5 mt -122.09 172.76 8.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.383 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.645 ' HG3' ' HG2' ' A' ' 245' ' ' LYS . 31.6 tt0 -147.7 149.86 33.24 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 2.4 p -60.35 122.14 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 110.61 8.19 24.96 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.195 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -105.02 149.92 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.4 mm -103.9 109.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.358 0.599 . . . . 0.0 110.453 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 43.7 t -89.38 109.65 20.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.855 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 265' ' ' LYS . 13.2 ptmm? -88.48 99.88 12.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.417 0.627 . . . . 0.0 109.944 174.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.505 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.4 p -89.2 119.55 36.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.349 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 m -96.84 -18.9 19.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.947 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.561 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 48.3 ttt180 -132.18 122.35 25.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.762 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 29.9 mtt -118.53 141.05 48.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.286 0.565 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -125.25 178.95 5.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.004 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.0 tp -96.61 -5.81 9.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.47 . . . . 0.0 111.329 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -94.14 14.81 18.87 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.94 -0.475 . . . . 0.0 111.99 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 98.59 -61.53 0.85 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.705 -0.759 . . . . 0.0 114.218 169.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 28.8 mp0 -77.15 110.82 12.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.899 0.349 . . . . 0.0 110.724 -176.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.54 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 11.2 m0 -93.34 168.05 11.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.741 -176.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 27.7 tt0 -108.9 108.22 18.91 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.31 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -124.16 154.99 17.9 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.127 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -108.32 108.48 19.5 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 15.5 t -130.53 -91.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.102 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -88.27 77.96 8.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.746 -170.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 67.67 -0.74 9.0 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.227 175.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 282' ' ' ARG . 46.4 mtp180 -147.92 153.61 39.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -174.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 55.0 pttt -120.06 134.57 55.21 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -161.26 -170.16 25.53 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.263 -175.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 71.4 mt -94.22 117.5 30.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.351 0.595 . . . . 0.0 110.966 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -115.62 138.26 23.72 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.525 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.9 133.43 12.51 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.734 2.289 . . . . 0.0 111.169 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -61.05 -14.21 22.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.816 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.5 p -75.56 -14.33 60.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.799 0.333 . . . . 0.0 111.578 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -98.83 -9.03 24.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.854 0.359 . . . . 0.0 110.675 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.4 m -128.58 179.11 4.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.343 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.437 ' NZ ' ' HB2' ' A' ' 292' ' ' LYS . 2.4 ttmp? -141.11 131.24 24.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.53 174.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 293' ' ' ILE . 28.5 mm -79.91 124.42 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.523 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.506 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 1.1 p90 -149.49 -174.72 4.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.886 -174.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -96.98 101.08 8.61 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.668 ' HG2' ' HB2' ' A' ' 239' ' ' PHE . 1.8 Cg_endo -82.36 -51.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.705 2.27 . . . . 0.0 112.071 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -102.04 82.76 2.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -72.1 127.44 90.45 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.614 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -89.08 -5.5 5.78 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.872 2.381 . . . . 0.0 109.593 161.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.04 -38.62 70.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 113.864 -1.516 . . . . 0.0 112.293 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.68 13.17 18.58 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.03 0.443 . . . . 0.0 111.115 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -101.48 -31.12 11.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.532 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.441 -178.977 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.767 0.318 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 99' ' ' ILE . 28.6 t -168.77 171.15 8.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -64.44 84.39 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.721 0.638 . . . . 0.0 111.874 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 68.59 38.77 2.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.727 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 5' ' ' ARG . 4.5 ptp180 -79.79 -2.03 41.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.019 0.438 . . . . 0.0 110.764 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -74.76 161.58 29.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.047 0.451 . . . . 0.0 111.017 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -98.65 117.32 32.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.78 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -83.69 1.81 40.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.39 -173.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.4 m -105.11 -31.23 9.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.774 0.321 . . . . 0.0 111.137 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.86 106.09 3.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.077 0.465 . . . . 0.0 110.727 -176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -58.76 -38.24 78.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.141 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.9 m -74.35 -0.94 18.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.693 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.47 -34.86 13.93 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.408 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -130.42 -24.66 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -173.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -79.16 123.56 27.5 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.026 -0.421 . . . . 0.0 110.692 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.496 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.1 mmt -109.06 -4.62 16.48 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.208 -175.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.82 -113.74 2.67 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.67 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.19 106.54 1.39 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.606 2.204 . . . . 0.0 112.635 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.75 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 79.7 t -137.81 -78.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.532 -177.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.837 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 8.1 t 89.79 156.99 0.05 OUTLIER 'General case' 0 C--N 1.349 0.557 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.738 ' CG ' ' O3P' ' A' ' 207' ' ' PTR . 9.3 ptm85 -62.58 -31.73 72.6 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.589 -169.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -55.04 -45.92 75.28 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.389 0.431 . . . . 0.0 111.153 175.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -84.03 -44.64 13.92 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.126 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.46 -34.9 51.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.286 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.576 ' HA ' HG21 ' A' ' 58' ' ' VAL . 46.6 tt0 -67.36 -47.23 71.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -76.85 -11.5 59.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -173.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -98.79 -14.98 19.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.651 0.263 . . . . 0.0 111.134 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 58.8 mt -127.29 23.78 6.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.254 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -84.7 63.48 7.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.264 0.554 . . . . 0.0 112.027 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 117' ' ' ASN . . . 87.54 4.38 80.11 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.865 -0.683 . . . . 0.0 114.164 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.46 -51.23 70.74 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 117.187 0.494 . . . . 0.0 111.478 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 35' ' ' MET . 30.8 ttm180 -142.1 148.15 37.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -92.87 112.36 24.29 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.76 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . 116.99 -7.61 16.84 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.213 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.802 ' HG3' ' HB3' ' A' ' 53' ' ' SER . 6.5 ptp -79.69 134.24 36.4 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.036 177.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.502 ' H ' ' HA ' ' A' ' 101' ' ' PRO . 47.1 p90 -142.32 167.79 21.26 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.861 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.551 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.2 pp -155.76 137.21 14.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.185 0.517 . . . . 0.0 110.933 175.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.1 t -102.26 124.05 55.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.837 ' HD2' ' H ' ' A' ' 20' ' ' SER . 14.7 ptt-85 -123.52 167.17 14.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.019 -173.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.56 115.95 18.61 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 28.5 t -63.75 122.49 16.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.494 -173.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 p -74.69 -29.69 61.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.331 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.956 HG23 ' O1P' ' A' ' 207' ' ' PTR . 6.4 p -85.63 -18.57 32.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.061 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' SER . 34.4 m -137.25 85.63 21.5 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.98 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.95 107.12 0.42 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.896 2.397 . . . . 0.0 112.518 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.04 -6.84 23.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.206 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -111.04 179.28 4.09 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -126.83 158.92 35.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.921 0.391 . . . . 0.0 111.301 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 62' ' ' ILE . 46.1 t -131.21 113.04 22.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.338 174.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.1 tp -85.15 100.45 11.74 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.884 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 59' ' ' SER . 73.5 m -96.12 132.46 41.49 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.731 174.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.598 HG21 HD13 ' A' ' 93' ' ' LEU . 95.1 t -127.76 137.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.912 -172.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.802 ' HB3' ' HG3' ' A' ' 35' ' ' MET . 29.5 t -93.57 97.57 10.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.48 0.657 . . . . 0.0 109.484 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -135.97 136.26 40.23 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.332 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 55.5 16.98 2.03 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.24 0.337 . . . . 0.0 111.361 -169.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.56 ' HB2' ' OG1' ' A' ' 120' ' ' THR . 20.2 m 69.21 25.78 5.61 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.371 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 1.9 ppt_? -124.93 144.24 50.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 25' ' ' GLN . 14.6 t -85.51 96.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.27 0.557 . . . . 0.0 110.962 -173.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 51' ' ' SER . 2.4 m -67.7 113.17 5.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.993 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.856 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 96.3 m-70 -101.65 88.41 3.4 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.241 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.694 ' CE2' HD22 ' A' ' 93' ' ' LEU . 40.6 m-85 -102.77 114.71 29.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.49 0.186 . . . . 0.0 111.015 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.664 HG12 HG22 ' A' ' 49' ' ' VAL . 51.7 mt -81.28 126.52 39.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.818 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.4 mp -106.55 119.0 55.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 170.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' A' ' 72' ' ' LYS . 35.3 p-10 -105.26 151.69 23.81 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.249 -174.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t -86.56 91.96 8.73 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.677 -176.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.529 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 97.4 mt -63.82 128.62 93.08 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -48.03 -64.4 0.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.118 2.546 . . . . 0.0 114.629 -172.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -113.92 34.12 4.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.8 -164.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.529 ' HG3' ' HB3' ' A' ' 66' ' ' LEU . 8.7 ptt180 -154.28 -85.02 0.06 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.524 ' HG2' HD12 ' A' ' 66' ' ' LEU . 4.3 ptm180 -156.36 -171.44 3.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -161.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.545 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 56.9 m-85 -107.41 121.96 45.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.641 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 17.9 ttmm -109.17 114.0 27.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.735 0.302 . . . . 0.0 110.703 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.818 ' HB ' HG13 ' A' ' 63' ' ' ILE . 8.9 tt -93.43 77.61 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 110.002 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.547 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 61.93 96.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.165 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t70 72.89 -61.46 0.5 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.378 0.271 . . . . 0.0 111.168 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -75.62 111.08 10.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 10.0 pt-20 -94.59 130.05 41.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.198 0.523 . . . . 0.0 110.563 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.52 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 89.4 m-85 -116.36 168.24 10.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.128 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.68 -46.16 86.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.806 0.336 . . . . 0.0 111.399 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -154.54 176.16 12.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.38 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.632 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.5 mt -57.59 -56.41 34.51 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 40.0 Cg_exo -59.68 -8.25 7.08 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.202 1.935 . . . . 0.0 113.504 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.56 -29.4 20.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.786 0.327 . . . . 0.0 110.525 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.7 pp -83.64 -30.4 26.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 82' ' ' PRO . 89.2 mt -65.17 -40.98 95.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.501 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -79.68 -4.39 51.55 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.46 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -91.39 -39.32 12.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.343 0.592 . . . . 0.0 109.559 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.551 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 50.9 m-85 -74.28 -10.59 59.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.25 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -57.16 -37.94 72.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.118 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 pp -111.32 7.79 8.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 O-C-N 121.65 -0.657 . . . . 0.0 111.784 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.551 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 8.3 t-160 -94.41 -35.71 12.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -177.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.785 ' HA ' HG22 ' A' ' 97' ' ' THR . 79.2 m-85 70.86 99.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 124.066 0.854 . . . . 0.0 109.96 -170.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.694 HD22 ' CE2' ' A' ' 61' ' ' TYR . 25.2 mt -64.79 -21.24 66.73 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.693 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 1.5 m-20 -145.63 -74.65 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.791 165.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.5 t -144.14 -11.17 0.65 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.531 HG22 ' CD ' ' A' ' 54' ' ' GLU . 5.8 t -124.7 -12.74 7.11 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.752 -0.592 . . . . 0.0 112.034 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 92' ' ' TYR . 6.6 p 74.18 -169.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.34 1.056 . . . . 0.0 111.599 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.476 HD22 ' CD1' ' A' ' 36' ' ' PHE . 81.0 mt -75.88 106.47 7.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.791 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.76 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 31.2 mm -99.78 -56.4 5.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.105 -172.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.705 ' O ' ' HA ' ' A' ' 35' ' ' MET . 28.3 tt0 -166.62 124.79 1.05 Allowed Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -174.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.502 ' HA ' ' H ' ' A' ' 36' ' ' PHE . 18.0 Cg_endo -58.03 162.31 11.65 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.551 2.834 . . . . 0.0 113.719 -171.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.29 151.02 94.38 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.054 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.3 141.81 36.23 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.301 2.001 . . . . 0.0 113.402 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.607 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 17.3 mtp180 -89.04 165.2 14.69 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -109.15 95.82 19.22 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.573 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 104' ' ' ARG . 69.6 Cg_endo -100.06 26.33 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.707 2.938 . . . . 0.0 111.934 177.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.2 m 63.48 77.5 0.32 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.01 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.512 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 4.4 Cg_endo -85.9 148.81 9.56 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.197 2.598 . . . . 0.0 112.157 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 2.7 Cg_exo -76.51 -80.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.742 2.295 . . . . 0.0 111.565 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 109' ' ' PRO . 26.3 mmm -168.53 -170.0 1.15 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.22 0.608 . . . . 0.0 109.426 176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.33 -101.24 2.77 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.564 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.7 m 65.45 -175.96 0.18 Allowed 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 122.835 0.454 . . . . 0.0 110.947 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.5 t -68.4 -72.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.996 0.427 . . . . 0.0 109.913 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 p -171.85 171.27 5.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.471 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -122.42 107.38 34.55 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -59.95 -70.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.541 2.161 . . . . 0.0 111.032 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 58.9 t30 49.46 88.46 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.083 0.865 . . . . 0.0 112.355 172.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -129.27 97.2 26.22 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.689 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.91 134.27 27.26 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.916 2.411 . . . . 0.0 111.981 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.56 ' OG1' ' HB2' ' A' ' 56' ' ' SER . 1.0 OUTLIER -71.05 -32.84 69.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.74 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 64.13 -86.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.969 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -85.88 91.04 8.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.863 0.363 . . . . 0.0 110.377 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -143.78 134.76 25.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.957 0.408 . . . . 0.0 110.595 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.554 ' OD1' ' HG3' ' A' ' 183' ' ' ARG . 15.1 m120 -130.5 26.01 5.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.599 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.725 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? -77.45 96.89 4.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.545 0.688 . . . . 0.0 111.555 -175.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.621 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 36.6 tt0 -171.25 -56.76 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.261 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.644 ' HB3' HH12 ' A' ' 129' ' ' ARG . 36.3 m-85 -105.2 107.97 19.24 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.33 -175.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 93.8 t -132.9 147.42 31.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.171 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.644 HH12 ' HB3' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -129.49 145.11 51.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.814 0.34 . . . . 0.0 110.346 176.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.97 HG22 HG12 ' A' ' 178' ' ' VAL . 16.5 p -100.56 139.44 36.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.591 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.493 ' CD1' ' HG3' ' A' ' 179' ' ' GLU . 3.8 mp -119.25 -4.96 10.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.308 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -98.59 -39.76 8.55 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.558 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.444 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 74.21 120.81 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.865 0.84 . . . . 0.0 110.747 -175.255 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.477 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 62.1 t80 -153.78 116.53 2.65 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.91 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 4.0 Cg_endo -87.27 102.53 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.726 2.284 . . . . 0.0 112.347 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -82.37 -9.42 84.97 Favored Glycine 0 CA--C 1.511 -0.208 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.174 176.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 51.5 24.52 2.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.229 0.612 . . . . 0.0 112.618 -173.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.531 ' HB2' ' HD3' ' A' ' 169' ' ' ARG . 19.0 t0 73.1 157.89 0.2 Allowed 'General case' 0 C--O 1.232 0.14 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 165.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 70.63 18.46 6.39 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.091 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.9 tp10 -168.23 -50.53 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.528 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 49.6 m-20 -142.39 148.03 37.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.055 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' A' ' 165' ' ' ASN . 34.1 tp -90.44 125.37 60.0 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.258 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 7.9 Cg_exo -70.16 108.34 2.13 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.284 1.989 . . . . 0.0 111.231 170.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.478 ' CG ' HG21 ' A' ' 130' ' ' THR . 6.6 p90 -126.06 163.52 22.88 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.494 ' H ' ' HB2' ' A' ' 148' ' ' GLU . 42.0 mttp -100.18 -175.2 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 110.41 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.842 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -90.88 8.47 34.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.441 179.158 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.8 34.55 0.8 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.494 ' HB2' ' H ' ' A' ' 145' ' ' LYS . 4.5 tp10 -93.52 144.42 25.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.745 -0.227 . . . . 0.0 110.62 -175.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.9 mm -98.3 135.6 32.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 165' ' ' ASN . 49.2 mt -128.56 158.5 38.26 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -175.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 43.3 t -119.47 129.25 75.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.725 HG21 HD12 ' A' ' 125' ' ' LEU . 37.5 mm -75.05 87.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.645 HG21 HG22 ' A' ' 170' ' ' VAL . 16.0 tt -74.45 -32.74 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.313 -173.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.692 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 29.2 mt-10 -144.7 140.76 28.81 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.428 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 32.4 tttp -127.67 91.43 45.51 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 121.664 -0.648 . . . . 0.0 111.948 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.45 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 15.6 Cg_exo -72.39 -52.2 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.248 1.966 . . . . 0.0 112.865 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -113.5 -172.85 2.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -170.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -99.1 -42.91 6.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.914 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -93.09 -10.09 37.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.392 . . . . 0.0 111.212 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.659 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 58.0 m95 -128.89 125.78 38.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.905 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.656 ' O ' HG13 ' A' ' 173' ' ' ILE . 54.9 m0 -121.73 144.87 48.54 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.097 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 20.2 m -95.64 94.82 7.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.3 0.572 . . . . 0.0 110.279 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -101.29 161.81 13.35 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.172 -0.33 . . . . 0.0 110.549 -177.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.736 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 20.6 ptt-85 -104.98 133.95 48.9 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.861 ' ND2' ' HE ' ' A' ' 169' ' ' ARG . 44.7 p30 -78.31 -176.69 4.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.685 -175.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -49.48 -31.64 10.45 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.204 0.94 . . . . 0.0 111.926 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.637 ' HA ' ' HG3' ' A' ' 215' ' ' PRO . 8.0 m-20 -72.33 -58.93 3.01 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 172.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 139.84 3.28 1.54 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.407 -172.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.861 ' HE ' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -73.66 152.69 40.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.584 0.692 . . . . 0.0 110.866 -177.27 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.645 HG22 HG21 ' A' ' 153' ' ' ILE . 26.0 t -103.65 121.37 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.133 0.492 . . . . 0.0 111.077 -176.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.64 157.78 27.38 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.659 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.3 OUTLIER -73.8 140.06 45.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.001 0.429 . . . . 0.0 111.165 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.675 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -137.95 143.68 40.78 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.153 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.472 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 5.6 Cg_exo -80.87 135.73 10.18 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 123.226 2.617 . . . . 0.0 112.923 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.551 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 99.8 t -58.33 -44.83 99.57 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.6 Cg_endo -64.48 -0.95 3.35 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.036 1.824 . . . . 0.0 113.502 177.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.88 -6.36 21.42 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.746 0.308 . . . . 0.0 111.185 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.97 HG12 HG22 ' A' ' 130' ' ' THR . 17.3 m -128.58 156.07 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -168.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.493 ' HG3' ' CD1' ' A' ' 131' ' ' LEU . 21.8 mt-10 -119.7 125.64 49.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.008 166.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.538 ' HD2' ' HD2' ' A' ' 183' ' ' ARG . 28.2 mttp -72.55 158.17 36.2 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.563 ' HG ' ' CZ ' ' A' ' 129' ' ' ARG . 1.7 mt -65.2 -177.66 0.4 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.532 174.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.3 p -52.63 99.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 121.955 0.883 . . . . 0.0 112.191 -171.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.554 ' HG3' ' OD1' ' A' ' 124' ' ' ASN . 48.3 ttt180 -101.92 112.31 24.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.426 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.42 ' HB3' ' CD2' ' A' ' 190' ' ' HIS . 22.9 t -178.49 168.45 1.81 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.547 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 37.8 p -74.44 165.86 49.96 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.86 94.11 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.992 2.461 . . . . 0.0 113.012 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -108.6 10.18 27.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.752 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 68.34 -122.11 14.53 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.327 -172.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -71.36 101.29 2.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.337 0.589 . . . . 0.0 110.845 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 184' ' ' SER . 18.4 p-80 -146.57 123.17 11.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.309 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 135.72 175.82 14.03 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -175.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -107.25 177.63 4.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.086 0.443 . . . . 0.0 110.857 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -75.67 116.27 16.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.223 0.535 . . . . 0.0 111.393 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -110.9 137.76 48.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.888 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 10.8 t 62.73 28.11 16.39 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.211 0.529 . . . . 0.0 109.975 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 58.41 -90.84 0.03 OUTLIER 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.024 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.8 p -147.8 8.57 0.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.262 0.553 . . . . 0.0 110.449 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -99.13 142.39 30.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.04 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -138.59 85.26 0.23 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.684 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 13.0 tt -105.0 130.93 22.29 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.891 0.376 . . . . 0.0 110.8 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.73 92.35 0.61 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.908 2.405 . . . . 0.0 111.973 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.711 ' H ' ' HD2' ' A' ' 203' ' ' PRO . 5.4 tp10 -113.49 -56.58 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.597 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' A' ' 202' ' ' GLU . 56.4 Cg_endo -70.01 146.05 57.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.908 1.739 . . . . 0.0 112.633 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 214' ' ' THR . . . -78.77 139.29 38.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.246 177.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -122.78 27.33 7.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.289 0.566 . . . . 0.0 110.582 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.06 92.75 3.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.115 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.956 ' O1P' HG23 ' A' ' 43' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.491 ' H ' ' HB2' ' A' ' 207' ' ' PTR . . . -110.35 18.28 20.01 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.209 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.464 ' HB3' ' H ' ' A' ' 62' ' ' ILE . 18.6 pt20 -70.46 164.03 57.74 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.768 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.547 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 19.0 Cg_exo -66.82 81.77 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.468 1.446 . . . . 0.0 109.221 165.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.423 ' H ' ' HG2' ' A' ' 211' ' ' GLN . 3.2 pt20 -82.88 65.64 8.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.123 -164.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 167' ' ' ASP . 12.7 m -77.09 65.9 2.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.931 0.872 . . . . 0.0 110.919 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 5.6 m -138.92 7.65 2.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.429 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.571 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 9.4 t -107.35 -27.92 0.18 Allowed Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.54 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.637 ' HG3' ' HA ' ' A' ' 167' ' ' ASP . 51.5 Cg_endo -70.08 122.55 9.14 Favored 'Trans proline' 0 C--N 1.362 1.277 0 CA-C-N 121.25 1.482 . . . . 0.0 111.944 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.3 mp -88.82 113.13 54.63 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.25 -25.49 9.92 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.643 2.228 . . . . 0.0 112.905 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 63.69 -86.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.722 0.639 . . . . 0.0 111.113 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.6 160.33 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.5 m -80.75 68.87 7.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.251 0.548 . . . . 0.0 110.572 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.84 -39.36 9.54 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.991 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.8 m -120.9 82.45 35.73 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.491 0.186 . . . . 0.0 111.08 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.77 121.65 8.55 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.672 2.248 . . . . 0.0 111.918 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -152.48 71.05 0.29 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 69.1 -178.59 0.22 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.171 0.588 . . . . 0.0 110.309 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -144.51 114.04 7.12 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.283 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 69.6 mt 68.27 -77.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 124.089 0.868 . . . . 0.0 111.957 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 34.3 p -80.15 155.08 74.92 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.56 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.81 169.55 14.45 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.785 2.323 . . . . 0.0 112.11 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.745 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 59.3 tp -86.28 -55.35 0.38 Allowed Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.294 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.745 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 2.7 Cg_exo -76.52 88.03 1.4 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.987 1.792 . . . . 0.0 111.887 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 40.5 t -90.68 121.86 32.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.523 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.1 m -88.18 -13.7 40.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 65.72 91.73 0.08 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.356 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -81.9 94.12 7.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.419 0.628 . . . . 0.0 110.983 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -179.17 63.81 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 83.9 Cg_endo -88.91 137.23 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.724 2.282 . . . . 0.0 113.866 -171.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.47 ' HB ' HG13 ' A' ' 266' ' ' VAL . 20.3 t -98.93 145.5 10.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -100.08 112.88 25.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.907 0.384 . . . . 0.0 111.348 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -120.68 122.01 39.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.124 175.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.98 122.3 28.12 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -72.04 112.88 8.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.21 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.533 HG13 ' HG3' ' A' ' 244' ' ' GLN . 33.2 pt -89.28 -9.04 10.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.229 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 75.5 mt-30 -134.86 149.16 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -79.08 141.96 36.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.429 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.611 ' HD2' ' NE2' ' A' ' 290' ' ' HIS . 58.1 ttt85 -135.8 138.82 42.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.347 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 17.7 m -132.7 151.34 77.93 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.433 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.536 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 4.5 Cg_exo -77.96 125.75 7.5 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.958 2.439 . . . . 0.0 111.645 176.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 51.0 t -72.55 175.37 6.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.439 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -63.04 -24.43 67.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.908 0.385 . . . . 0.0 111.452 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -85.37 -6.81 59.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.967 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 30.8 t70 69.91 -72.34 0.11 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.011 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt 61.56 29.32 18.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.234 174.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 285' ' ' LEU . 2.6 m 63.71 19.11 11.56 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.9 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -76.85 115.54 16.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.749 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.615 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.6 tt -84.67 129.43 34.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.035 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.536 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -72.09 121.83 19.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.863 0.363 . . . . 0.0 110.597 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.538 HD22 HG22 ' A' ' 264' ' ' VAL . 96.0 mt -129.89 145.04 51.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 262' ' ' ASP . 8.7 mm-40 -101.0 161.4 13.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.141 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.26 119.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.3 64.26 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.511 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.739 ' HB2' ' HB2' ' A' ' 259' ' ' GLU . 24.7 t70 -85.81 146.18 26.88 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.673 0.273 . . . . 0.0 110.436 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.4 mm -92.69 106.51 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.758 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.538 HG22 HD22 ' A' ' 258' ' ' LEU . 16.3 t -83.97 107.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.501 177.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -87.96 92.43 9.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.45 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.63 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 3.8 p -88.29 134.35 28.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.889 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 58.9 p -103.79 -45.11 4.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -111.47 116.98 31.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 32.9 mtt -106.72 116.65 32.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.915 0.388 . . . . 0.0 111.121 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -82.92 152.13 25.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.25 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 8.6 mm -95.61 29.39 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.559 0.695 . . . . 0.0 110.259 -172.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.47 HD21 ' HG2' ' A' ' 274' ' ' GLN . 30.4 p-10 -113.35 -25.43 8.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.146 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 136.3 -23.6 3.3 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.142 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.47 ' HG2' HD21 ' A' ' 272' ' ' ASN . 14.3 pt20 -107.25 130.24 54.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.038 0.419 . . . . 0.0 110.263 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.443 ' HE3' ' CE2' ' A' ' 286' ' ' PHE . 5.8 m0 -118.75 169.64 9.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.245 -174.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -111.28 110.66 21.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.337 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -116.31 155.88 15.97 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 176.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.465 ' HB2' ' HE2' ' A' ' 283' ' ' LYS . 35.3 tt0 -108.0 109.46 20.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.384 0.592 . . . . 0.0 110.539 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.615 ' HB ' HD21 ' A' ' 256' ' ' LEU . 71.7 t -131.34 129.36 62.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 65.83 30.4 10.03 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.43 0.456 . . . . 0.0 110.982 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.53 9.29 86.12 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.825 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -118.71 123.02 43.86 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.705 -0.291 . . . . 0.0 110.779 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 83.4 mttt -94.13 111.64 23.39 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -132.81 168.72 22.74 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.817 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.43 ' H ' HG22 ' A' ' 254' ' ' THR . 87.8 mt -86.62 132.2 33.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.245 0.545 . . . . 0.0 110.82 -178.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.944 ' HB2' ' HE1' ' A' ' 290' ' ' HIS . 36.1 p90 -132.5 126.57 20.22 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.595 175.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.527 ' HD2' ' CE1' ' A' ' 290' ' ' HIS . 31.6 Cg_exo -61.21 161.29 23.54 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 123.04 2.493 . . . . 0.0 113.185 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -68.18 -33.73 74.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.183 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.3 p -81.7 17.88 1.37 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.944 ' HE1' ' HB2' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -143.45 8.35 1.56 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.071 -0.651 . . . . 0.0 112.097 176.271 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.32 161.09 37.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -139.9 119.93 13.63 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.752 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 240' ' ' ALA . 1.4 mp -72.64 117.89 16.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -115.35 143.73 44.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.424 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 296' ' ' PRO . 8.8 t70 -78.76 121.8 83.95 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 295' ' ' ASP . 31.7 Cg_exo -59.8 -14.93 29.37 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.131 2.554 . . . . 0.0 113.234 -176.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -84.14 42.76 0.89 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.49 0.662 . . . . 0.0 110.549 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -126.0 94.62 41.27 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.466 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.19 75.77 4.55 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.991 2.461 . . . . 0.0 111.765 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.5 135.55 48.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.662 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -110.54 -12.56 14.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.856 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -113.29 142.02 46.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.957 -176.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.46 176.895 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.66 0.266 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 m -89.97 -178.14 5.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.648 0.261 . . . . 0.0 111.115 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.509 ' HB2' HD12 ' A' ' 99' ' ' ILE . 5.6 p -82.64 -50.97 8.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.023 0.439 . . . . 0.0 110.133 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -68.66 117.47 10.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.67 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -138.31 89.16 2.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.03 0.443 . . . . 0.0 110.959 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -161.93 163.06 29.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 9' ' ' SER . 32.7 m-20 -82.3 -17.87 44.32 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.382 -173.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 70.28 -32.88 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.547 0.739 . . . . 0.0 111.48 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 7' ' ' ASP . 17.6 m -93.06 -23.27 18.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.95 100.74 4.22 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.431 -173.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.63 -26.36 68.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 104' ' ' ARG . 68.5 m -70.81 -4.78 25.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.488 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.22 -47.3 4.77 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 40.0 p-90 -111.54 -20.19 12.27 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -76.41 116.71 17.36 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.971 -0.455 . . . . 0.0 110.894 -173.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.612 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.5 mmt -98.14 -12.08 22.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.396 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.58 ' HA3' HD12 ' A' ' 227' ' ' ILE . . . 50.94 -113.0 1.89 Allowed Glycine 0 CA--C 1.521 0.45 0 O-C-N 123.852 0.72 . . . . 0.0 113.828 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.4 Cg_exo -69.92 84.33 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.041 2.494 . . . . 0.0 113.281 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.013 HG12 ' H ' ' A' ' 20' ' ' SER . 61.0 t -135.92 -162.16 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.013 ' H ' HG12 ' A' ' 19' ' ' VAL . 87.2 p -170.88 165.12 7.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -168.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.623 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 8.1 ptm85 -68.01 -31.71 71.59 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 118.872 -1.131 . . . . 0.0 110.851 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -59.16 -58.57 8.07 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.092 0.472 . . . . 0.0 110.387 176.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.63 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 35.7 mt-10 -64.95 -46.22 82.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.353 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.08 -43.75 78.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.833 -177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 67.8 mt-30 -69.5 -34.45 74.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.79 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 23' ' ' GLU . 11.5 t -78.65 -7.97 58.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.947 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.63 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 41.6 mtp180 -97.12 -10.54 25.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.048 0.452 . . . . 0.0 109.828 176.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 45.7 mt -114.27 -11.64 12.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.414 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 113' ' ' VAL . 55.3 tp60 -70.88 125.97 28.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.441 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.93 15.07 71.32 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.197 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HB3' ' CE ' ' A' ' 35' ' ' MET . 27.5 mm-40 -101.29 164.6 11.7 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 32' ' ' ARG . 19.4 ptt85 -61.21 130.87 48.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.212 0.529 . . . . 0.0 110.642 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.409 ' HA ' ' O ' ' A' ' 53' ' ' SER . 32.2 m170 -67.79 132.59 47.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.953 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.54 -20.29 7.4 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.682 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.738 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.9 mtm -75.01 136.85 41.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.412 ' CB ' HG22 ' A' ' 52' ' ' VAL . 50.0 p90 -139.16 168.21 20.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.294 -176.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.612 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -156.07 141.3 17.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.921 0.391 . . . . 0.0 110.755 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.436 ' HB ' ' CE3' ' A' ' 14' ' ' TRP . 61.6 t -114.07 124.93 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.617 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 19.2 ptt-85 -125.46 167.91 14.35 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.909 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.87 129.98 38.62 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.429 ' HB3' ' OG1' ' A' ' 43' ' ' THR . 61.8 m -68.78 147.22 52.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.559 0.695 . . . . 0.0 112.5 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.818 ' HB3' ' O1P' ' A' ' 207' ' ' PTR . 37.2 t -76.71 -14.29 59.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.426 175.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.871 ' N ' ' O1P' ' A' ' 207' ' ' PTR . 0.2 OUTLIER -76.3 -62.1 1.73 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.646 176.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 73.2 m -149.75 141.41 14.92 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.391 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.435 ' HG3' ' HD3' ' A' ' 223' ' ' PRO . 40.4 Cg_exo -59.35 -23.04 68.4 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.963 2.442 . . . . 0.0 112.258 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.25 37.38 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.647 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -156.86 148.32 22.33 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.419 ' CD2' HD11 ' A' ' 81' ' ' LEU . 29.0 m-85 -129.5 171.65 12.35 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.453 HG21 ' HE2' ' A' ' 207' ' ' PTR . 3.6 t -137.05 112.9 11.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.543 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.414 ' HB2' HD11 ' A' ' 63' ' ' ILE . 63.6 tp -82.22 92.44 6.91 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.79 171.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.2 m -95.59 120.59 36.11 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.627 HG12 ' HG3' ' A' ' 54' ' ' GLU . 88.2 t -112.76 141.78 27.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.552 -174.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 29.5 t -82.02 100.26 9.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.627 ' HG3' HG12 ' A' ' 52' ' ' VAL . 29.6 mt-10 -155.58 149.99 25.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.457 . . . . 0.0 112.142 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.598 ' HB2' ' OD2' ' A' ' 94' ' ' ASP . 0.1 OUTLIER 60.13 59.37 2.39 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.416 179.734 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 55' ' ' ASN . 32.8 t 70.98 -24.52 0.17 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.751 -174.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.854 ' HD3' ' H ' ' A' ' 118' ' ' LEU 0.405 0.0 OUTLIER -160.0 -53.39 0.06 Allowed 'General case' 0 C--N 1.363 1.156 1 N-CA-C 124.47 4.989 . . . . 0.0 124.47 -178.551 . . . . . . . . 5 4 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.711 ' H ' ' CD ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -154.24 116.84 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 121.671 2.032 . . . . 0.0 113.3 -171.741 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.576 ' OG ' ' HB2' ' A' ' 54' ' ' GLU . 6.0 m -97.8 110.54 23.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 164.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.818 ' O ' ' HB3' ' A' ' 208' ' ' ALA . 91.3 m-70 -94.01 110.13 21.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.946 ' HB3' HD11 ' A' ' 73' ' ' ILE . 69.1 m-85 -120.1 102.5 8.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.019 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.94 HG13 ' HB2' ' A' ' 209' ' ' GLN . 0.1 OUTLIER -77.82 148.67 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.6 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.8 mp -129.67 86.47 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.07 131.94 47.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.881 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.8 t -77.45 125.26 29.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.265 0.555 . . . . 0.0 110.799 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.999 HD13 ' HB2' ' A' ' 69' ' ' ARG . 94.1 mt -76.0 147.57 80.56 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.12 169.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.505 ' HD2' HH21 ' A' ' 69' ' ' ARG . 35.8 Cg_exo -64.25 61.99 0.25 Allowed 'Trans proline' 0 C--O 1.218 -0.479 0 C-N-CA 122.762 2.308 . . . . 0.0 110.458 165.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.484 ' OD1' ' N ' ' A' ' 69' ' ' ARG 0.268 30.1 p30 103.66 -50.88 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 128.67 2.788 . . . . 0.0 109.467 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.999 ' HB2' HD13 ' A' ' 66' ' ' LEU . 73.1 mtm180 -34.45 -53.94 0.52 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 125.093 1.496 . . . . 0.0 112.137 -149.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.841 ' H ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -169.85 -167.11 0.62 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.184 1.794 . . . . 0.0 106.572 167.015 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.15 114.18 26.31 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.378 166.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 23.2 ttmm -102.51 104.78 15.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 111.339 -171.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.946 HD11 ' HB3' ' A' ' 61' ' ' TYR . 6.5 tt -92.49 77.53 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.773 0.797 . . . . 0.0 109.463 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.51 ' HA3' ' HG2' ' A' ' 209' ' ' GLN . . . 66.98 89.1 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.947 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.757 ' HB2' ' HB2' ' A' ' 211' ' ' GLN . 44.4 t0 75.48 -52.03 0.65 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.705 0.402 . . . . 0.0 110.877 173.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -83.16 114.84 21.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.643 0.258 . . . . 0.0 110.472 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.5 pm0 -93.38 133.03 37.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.386 0.612 . . . . 0.0 110.613 174.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.755 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 64.1 m-85 -121.0 158.23 28.22 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.837 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 4.3 m-20 -44.15 -41.23 5.54 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.514 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 3.4 p80 -170.46 -173.13 1.37 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 11.6 mt -57.83 -55.23 47.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 123.047 0.217 . . . . 0.0 111.339 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 32.1 Cg_exo -63.56 5.68 0.32 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.774 2.316 . . . . 0.0 114.005 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -107.54 -32.19 7.8 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.26 -0.275 . . . . 0.0 110.952 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.57 HD21 HD23 ' A' ' 81' ' ' LEU . 4.4 pp -76.15 -30.14 58.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.211 0.529 . . . . 0.0 109.739 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 53.5 mt -63.02 -32.41 73.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.943 176.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.639 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 24.3 tp10 -72.07 -26.8 62.31 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.544 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 91' ' ' HIS . 14.1 t80 -73.3 -29.3 62.61 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.053 0.93 . . . . 0.0 108.932 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.533 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 42.0 m-85 -92.39 2.67 56.52 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.338 -175.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.639 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 52.0 mtpt -85.65 -15.52 42.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.639 172.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.2 pt -122.74 -1.85 7.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 121.309 0.576 . . . . 0.0 110.091 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.4 t-160 -86.88 -43.78 12.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.841 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.459 ' CD2' HG23 ' A' ' 97' ' ' THR . 66.1 m-85 63.74 94.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -162.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.728 HD22 ' CE2' ' A' ' 61' ' ' TYR . 16.5 mt -51.53 -97.21 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 123.712 0.633 . . . . 0.0 110.564 176.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.598 ' OD2' ' HB2' ' A' ' 55' ' ' ASN . 3.2 t0 -68.04 -65.26 0.72 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.546 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 9.8 t -157.31 13.06 0.23 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.915 0.864 . . . . 0.0 110.228 175.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.49 HG22 ' OE1' ' A' ' 54' ' ' GLU . 6.5 t -140.65 171.72 13.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 169.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.459 HG23 ' CD2' ' A' ' 92' ' ' TYR . 17.8 p -98.02 171.55 8.19 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.042 -0.411 . . . . 0.0 110.619 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.4 94.26 0.72 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.1 mm -76.17 -53.78 14.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.802 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.738 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.9 pt-20 -167.92 154.57 7.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.632 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 42.3 Cg_endo -66.88 154.56 74.16 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.297 1.998 . . . . 0.0 112.737 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -72.61 161.05 81.15 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.323 175.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 9.6 Cg_endo -51.64 126.43 19.63 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.154 1.902 . . . . 0.0 110.971 176.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.52 ' HG2' ' H ' ' A' ' 105' ' ' TYR . 40.7 ttt180 -63.75 175.97 1.01 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.295 -176.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.52 ' H ' ' HG2' ' A' ' 104' ' ' ARG . 4.9 t80 -52.25 -44.52 93.37 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -174.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.6 90.07 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.697 1.598 . . . . 0.0 112.511 173.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.4 t -173.54 132.92 0.6 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.556 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.15 134.49 16.01 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.554 2.169 . . . . 0.0 112.248 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.14 127.02 10.26 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.548 2.165 . . . . 0.0 112.18 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 88.5 mtp -84.91 -45.76 11.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.262 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.98 109.03 0.76 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.2 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.8 t -137.74 152.66 49.44 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 11.9 p -66.8 142.72 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.992 0.425 . . . . 0.0 110.305 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.3 t -92.96 86.29 5.39 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -107.79 108.4 61.42 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.455 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 5.1 Cg_endo -84.7 97.55 0.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.104 2.536 . . . . 0.0 112.229 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.897 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . 63.5 t30 69.2 110.99 0.05 OUTLIER 'General case' 0 C--N 1.342 0.281 0 O-C-N 123.752 0.657 . . . . 0.0 111.048 177.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.854 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 3.2 mm? 72.73 160.36 0.16 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.922 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 18.2 Cg_endo -60.67 130.54 33.72 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.555 2.17 . . . . 0.0 112.528 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.2 m 73.9 -62.5 0.46 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.321 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.34 175.52 9.95 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.897 ' HG2' ' HB3' ' A' ' 117' ' ' ASN . 26.6 mt-10 -68.17 96.25 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.123 0.487 . . . . 0.0 110.301 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -104.57 -60.74 1.55 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.75 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.656 ' CB ' ' HG3' ' A' ' 183' ' ' ARG . 8.5 p30 -149.2 178.93 8.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.344 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.538 HD12 HG21 ' A' ' 152' ' ' ILE . 3.6 mm? 61.03 84.94 0.12 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.523 0.678 . . . . 0.0 110.281 -174.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.0 tp10 -177.57 -68.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.648 -172.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -112.92 106.96 15.36 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.332 0.587 . . . . 0.0 110.293 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.74 HG22 ' CG ' ' A' ' 180' ' ' LYS . 99.4 t -120.49 133.88 65.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.287 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.714 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 7.4 ptp180 -110.35 144.42 39.13 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.855 -1.938 . . . . 0.0 108.724 170.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.541 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -101.28 132.15 46.95 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.514 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.554 HD21 ' HG2' ' A' ' 179' ' ' GLU . 14.9 mt -107.4 -15.13 14.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.973 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.405 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 19.1 t80 -82.06 -40.97 21.23 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -173.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.635 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 11.3 t70 71.52 96.43 0.07 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.459 0.647 . . . . 0.0 110.603 -175.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -127.81 88.25 53.77 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 91.3 Cg_endo -84.85 79.02 2.51 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.075 1.85 . . . . 0.0 113.158 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.29 -23.94 77.51 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.381 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.856 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 4.3 m-20 67.38 50.8 0.92 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.452 0.701 . . . . 0.0 111.639 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.419 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 19.7 m-20 -144.5 178.96 7.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.387 . . . . 0.0 110.969 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.519 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -99.96 -9.41 22.78 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 171.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 172' ' ' MET . 4.8 mm-40 -80.87 -38.25 28.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.432 174.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 172' ' ' MET . 24.1 m-20 -133.88 108.67 8.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.945 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.054 HD11 ' HB2' ' A' ' 165' ' ' ASN . 35.4 tp -63.95 129.78 94.1 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.856 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 10.2 Cg_endo -81.21 87.53 1.47 Allowed 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 121.627 1.551 . . . . 0.0 111.088 175.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.49 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 10.2 p90 -100.63 159.83 14.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.527 -173.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.635 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 40.5 mttp -104.22 -172.44 2.11 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -174.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.954 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -85.23 8.55 17.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.334 -172.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.95 41.19 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.405 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -105.1 148.25 27.04 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.706 -177.431 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.64 132.84 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.331 0.586 . . . . 0.0 109.817 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.752 HD22 ' CD2' ' A' ' 142' ' ' LEU . 24.4 mt -125.85 162.31 25.43 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -176.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.631 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 99.0 t -125.44 122.08 61.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 175.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.073 HD13 ' HB2' ' A' ' 163' ' ' ALA . 34.0 mm -77.01 78.68 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.445 HG21 HG22 ' A' ' 170' ' ' VAL . 10.5 tt -78.34 -39.26 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.727 -176.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.654 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 63.1 mt-10 -116.54 140.27 49.57 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 171.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.531 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 78.4 tttt -136.71 86.93 21.18 Favored Pre-proline 0 C--N 1.316 -0.863 0 O-C-N 121.49 -0.756 . . . . 0.0 110.149 175.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.693 ' HG2' ' SD ' ' A' ' 172' ' ' MET . 4.3 Cg_exo -67.32 -55.53 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.614 2.209 . . . . 0.0 111.592 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 160' ' ' TRP . 17.4 mm-40 -107.17 167.94 9.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.814 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.431 ' O ' HG21 ' A' ' 175' ' ' VAL . 1.6 mm-40 -94.47 -16.35 23.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.153 0.502 . . . . 0.0 109.714 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.419 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 11.7 pt20 -94.21 -21.23 19.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.547 173.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.721 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 52.4 m95 -131.22 127.71 38.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.555 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.852 ' HB3' HD12 ' A' ' 152' ' ' ILE . 47.2 m0 -117.88 136.85 53.19 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.357 -176.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.683 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 74.5 m -100.46 90.38 4.28 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.073 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -102.44 149.4 24.41 Favored 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.48 -171.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.825 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 23.5 ptt-85 -86.75 119.35 26.89 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.054 ' HB2' HD11 ' A' ' 142' ' ' LEU . 6.0 t30 -46.59 166.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 112.374 -2.194 . . . . 0.0 111.213 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -68.57 10.71 0.23 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.64 0.733 . . . . 0.0 110.505 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 165' ' ' ASN . 18.5 m-20 -114.38 -6.68 12.91 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.798 172.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.688 ' HA3' ' HA ' ' A' ' 211' ' ' GLN . . . 79.37 67.87 1.54 Allowed Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.257 -172.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.825 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 8.7 ttm-85 -139.48 126.31 20.81 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.494 HG11 ' CD ' ' A' ' 154' ' ' GLU . 12.1 t -86.65 116.27 28.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.073 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -144.09 149.16 21.18 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.721 ' HE2' ' HB3' ' A' ' 160' ' ' TRP . 7.4 mtp -74.93 134.89 41.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.223 0.511 . . . . 0.0 110.583 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.779 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.5 pp -137.11 142.74 39.23 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.341 -176.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.602 ' HG2' ' CG ' ' A' ' 177' ' ' TYR . 9.7 Cg_endo -62.85 130.4 29.23 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.989 2.459 . . . . 0.0 113.152 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 178' ' ' VAL . 99.2 t -64.67 -44.91 75.35 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.167 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.524 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 48.6 Cg_exo -58.25 1.44 0.25 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.429 2.086 . . . . 0.0 114.104 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.602 ' CG ' ' HG2' ' A' ' 174' ' ' PRO . 3.2 m-85 -104.77 -10.53 17.36 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.34 0.256 . . . . 0.0 111.589 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.642 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.4 m -106.39 -171.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -165.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.714 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.1 tp10 -159.34 47.51 0.3 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.327 -1.761 . . . . 0.0 111.497 -154.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.74 ' CG ' HG22 ' A' ' 128' ' ' VAL . 1.9 mptt -72.35 138.21 47.13 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 119.297 -2.127 . . . . 0.0 110.469 -162.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.1 tp -78.3 -71.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.956 -170.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.18 109.44 17.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.509 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.656 ' HG3' ' CB ' ' A' ' 124' ' ' ASN . 35.1 ttt180 -168.27 119.63 0.81 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.9 -177.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.1 m -98.17 68.66 1.96 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.462 0.649 . . . . 0.0 109.844 173.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.454 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 3.1 p -70.78 170.39 11.19 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.38 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 86.7 Cg_exo -49.28 101.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.805 2.337 . . . . 0.0 113.189 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -129.68 -37.77 1.54 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.044 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 190' ' ' HIS . . . 156.54 52.65 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.029 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm 69.47 -14.32 0.34 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.04 0.936 . . . . 0.0 112.421 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 188' ' ' GLY . 37.5 t-80 70.36 -48.0 0.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.494 0.717 . . . . 0.0 110.898 -175.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 176.22 -131.46 1.88 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -155.27 -167.06 2.43 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -66.35 101.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 0.0 110.655 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -121.66 -37.74 2.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.149 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.0 m -138.08 111.46 8.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.119 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -100.38 -2.48 33.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.552 0.691 . . . . 0.0 109.3 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.5 p -137.54 110.2 7.55 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.271 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 62.91 84.06 0.15 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.72 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -90.94 -33.21 8.4 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.799 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.717 ' HB ' ' HD2' ' A' ' 203' ' ' PRO . 13.9 pt -116.23 91.79 33.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.236 0.541 . . . . 0.0 111.149 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.35 -14.61 11.73 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.949 2.433 . . . . 0.0 112.473 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.789 ' HB3' ' HD3' ' A' ' 203' ' ' PRO . 25.8 tp10 -83.34 -57.51 0.43 Allowed Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.342 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' A' ' 202' ' ' GLU . 1.1 Cg_endo -83.69 101.46 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.356 2.038 . . . . 0.0 111.836 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.54 125.45 26.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.416 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -110.22 108.32 18.41 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.071 0.462 . . . . 0.0 110.659 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -103.97 -130.43 0.27 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.62 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.871 ' O1P' ' N ' ' A' ' 43' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 60' ' ' HIS . . . -92.42 -75.46 0.49 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.94 ' HB2' HG13 ' A' ' 62' ' ' ILE . 36.7 tt0 67.77 137.64 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.335 0 O-C-N 124.216 0.948 . . . . 0.0 109.547 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.15 -35.26 72.42 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 121.813 1.676 . . . . 0.0 111.547 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.757 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 30.2 tt0 -97.26 148.23 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 171.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.478 ' H ' ' HA3' ' A' ' 168' ' ' GLY . 15.2 t -74.98 142.03 43.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 0.0 110.931 -175.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 18.5 m -64.19 140.69 58.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.648 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.3 p -68.5 148.69 98.14 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.89 -34.4 91.56 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.804 2.336 . . . . 0.0 111.71 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.841 HD23 ' H ' ' A' ' 216' ' ' LEU . 1.6 pt? -87.57 117.15 68.16 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.681 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -93.15 -159.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.237 2.625 . . . . 0.0 112.592 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -139.39 150.39 45.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.227 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.85 161.24 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.72 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.1 m -86.1 160.71 19.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.079 0.466 . . . . 0.0 111.562 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 167.2 78.53 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.638 ' OG ' ' HA ' ' A' ' 42' ' ' SER . 1.4 m -105.09 119.23 53.85 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.435 ' HD3' ' HG3' ' A' ' 45' ' ' PRO . 5.5 Cg_exo -79.69 159.67 24.98 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.068 2.512 . . . . 0.0 111.222 174.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -158.82 -173.3 27.05 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.766 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 65.1 14.24 9.24 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.073 0.549 . . . . 0.0 112.068 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.16 11.17 37.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.889 0.376 . . . . 0.0 111.056 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.58 HD12 ' HA3' ' A' ' 17' ' ' GLY . 61.6 mt -131.26 128.81 62.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.612 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.1 t -83.35 145.42 48.44 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.135 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.07 -76.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.482 2.121 . . . . 0.0 112.844 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 231' ' ' PRO . 2.4 pt? -176.92 170.12 1.08 Allowed Pre-proline 0 C--O 1.235 0.327 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -177.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.41 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 50.3 Cg_exo -55.95 150.82 44.58 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.453 2.102 . . . . 0.0 111.944 172.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 20.3 p -71.93 105.55 3.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.28 0.562 . . . . 0.0 111.591 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 13.7 p -115.67 136.29 53.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.134 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -102.55 -52.04 3.19 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.903 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 66.7 -177.97 0.2 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.784 0.677 . . . . 0.0 111.84 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 82.35 173.3 48.84 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.622 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.92 163.94 23.57 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.898 2.399 . . . . 0.0 111.592 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.56 ' CG1' HD12 ' A' ' 293' ' ' ILE . 7.6 t -97.62 136.08 29.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.052 0.453 . . . . 0.0 110.691 -175.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.68 125.98 52.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.172 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.484 ' HB1' ' HB ' ' A' ' 291' ' ' VAL . . . -124.57 139.07 54.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.708 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.96 130.72 46.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.107 176.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -75.41 104.56 6.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.896 0.379 . . . . 0.0 110.18 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 21.0 pt -75.24 -13.0 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -146.94 157.82 43.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.308 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -73.27 158.71 34.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.429 0.633 . . . . 0.0 111.082 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.645 ' HD3' HD12 ' A' ' 258' ' ' LEU . 58.9 mtp85 -132.21 115.66 15.97 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.84 175.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 29.5 m -111.71 126.48 28.45 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 172.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 3.0 Cg_exo -80.06 144.08 16.54 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.983 2.455 . . . . 0.0 112.268 -176.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 35.6 t -77.63 171.34 15.07 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.76 87.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.497 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -90.09 6.27 43.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.764 0.316 . . . . 0.0 111.524 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -116.92 64.09 0.72 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.955 0.407 . . . . 0.0 110.234 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -78.44 -13.66 59.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.07 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.0 p -95.39 -1.69 50.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.336 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.0 116.83 23.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.48 133.64 49.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.938 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -95.77 135.48 37.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.675 177.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.645 HD12 ' HD3' ' A' ' 246' ' ' ARG . 96.7 mt -134.75 151.91 51.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 0.0 111.851 -169.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -97.67 172.98 7.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.392 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.69 122.53 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.893 0.378 . . . . 0.0 110.669 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.48 22.22 62.83 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.373 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -89.63 169.12 11.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.6 mm -106.58 116.0 49.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.325 0.584 . . . . 0.0 110.635 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.531 ' HA ' HG22 ' A' ' 279' ' ' VAL . 21.9 t -102.4 109.86 27.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.268 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.481 ' HB2' ' HE3' ' A' ' 265' ' ' LYS . 33.3 mtmt -87.2 99.73 12.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.013 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 5.8 p -90.15 116.48 31.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.593 0.711 . . . . 0.0 109.833 175.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 19.6 p -93.43 -36.31 12.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.321 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.563 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 56.5 ttt180 -121.56 96.9 5.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.832 175.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' MET . . . . . 0.45 ' HG3' ' NE1' ' A' ' 275' ' ' TRP . 45.7 ttm -81.81 111.54 18.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.059 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 91.6 m-20 -86.74 144.95 26.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.996 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 16.3 tt -79.46 -12.95 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.109 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -75.81 -25.47 56.36 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.725 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.19 -40.05 1.89 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.608 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 34.6 mt-30 -75.7 108.85 8.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.45 ' NE1' ' HG3' ' A' ' 269' ' ' MET . 52.8 m0 -93.39 145.43 24.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.857 0.361 . . . . 0.0 111.315 -176.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 9.0 tp10 -91.99 107.35 19.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.183 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -140.03 157.11 25.29 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.534 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -124.13 123.99 41.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.232 0.539 . . . . 0.0 110.043 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 264' ' ' VAL . 28.7 t -124.81 160.96 29.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.078 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -54.82 85.64 0.0 OUTLIER 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.559 0.695 . . . . 0.0 110.889 174.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 156.3 -39.69 0.58 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.375 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 282' ' ' ARG . 34.5 ttm180 179.69 152.89 0.45 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.1 0.476 . . . . 0.0 111.233 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -101.25 127.64 47.75 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.5 -169.41 35.84 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.68 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 97.4 mt -93.87 145.8 24.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.706 0.288 . . . . 0.0 110.376 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -141.73 127.48 10.91 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 121.083 0.468 . . . . 0.0 111.092 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.508 ' HD2' ' CZ ' ' A' ' 246' ' ' ARG . 72.4 Cg_exo -55.39 126.37 22.29 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 123.269 2.646 . . . . 0.0 112.449 169.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -64.75 -14.76 60.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.454 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 13.8 p -71.8 -2.43 17.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -113.79 0.19 14.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.175 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.484 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 28.5 m -128.28 168.99 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.011 0.434 . . . . 0.0 111.164 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -129.33 129.38 44.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.37 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.56 HD12 ' CG1' ' A' ' 238' ' ' VAL . 32.9 mm -81.16 126.25 39.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.259 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.23 157.05 40.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.947 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -104.96 99.2 17.99 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 121.431 0.634 . . . . 0.0 110.008 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.33 -25.21 30.83 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.815 2.343 . . . . 0.0 112.805 -175.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 165.47 -34.56 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -171.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 57.68 89.24 0.11 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.694 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.62 5.75 4.98 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.968 2.445 . . . . 0.0 111.098 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -96.35 129.07 43.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.306 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 67.84 0.25 2.25 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.763 0.664 . . . . 0.0 111.037 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -140.0 155.22 47.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.448 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.606 178.801 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 3' ' ' SER . 22.5 t -123.24 13.88 9.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.297 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.446 ' O ' HG23 ' A' ' 99' ' ' ILE . 28.9 t 68.0 -71.34 0.11 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.119 0.568 . . . . 0.0 110.095 -173.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.78 120.61 20.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.04 0.448 . . . . 0.0 110.598 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -148.93 -53.02 0.17 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.686 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 p90 37.46 -162.35 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.632 1.208 . . . . 0.0 113.09 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.99 -44.91 19.37 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.046 -0.409 . . . . 0.0 110.861 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 t 72.5 -53.7 0.69 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.971 0.795 . . . . 0.0 111.87 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 m -84.47 -25.38 28.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.109 0.481 . . . . 0.0 110.946 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -86.74 116.91 25.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.063 0.459 . . . . 0.0 111.119 -171.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -63.54 -31.74 72.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.521 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.8 t -69.28 -8.28 44.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.23 -47.69 7.09 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.913 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -117.78 -23.38 7.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -170.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -73.65 116.01 13.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.619 ' HB3' HG21 ' A' ' 19' ' ' VAL . 12.4 tpp -100.71 -1.66 34.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.347 -172.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.96 -115.9 3.95 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.252 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.1 Cg_exo -72.4 103.28 1.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.9 2.4 . . . . 0.0 112.036 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.853 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 64.4 t -136.17 -83.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -176.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.796 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 11.7 t 83.6 176.47 0.06 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 168.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 7.8 tpt180 -42.16 -62.68 0.88 Allowed 'General case' 0 C--N 1.314 -0.944 0 O-C-N 124.112 0.883 . . . . 0.0 112.276 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -62.12 -28.53 69.7 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.05 -168.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -95.75 -45.55 6.95 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.561 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -55.54 32.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.504 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 12.3 pt20 -68.69 -31.26 70.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.829 -174.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.2 m -65.48 -42.95 91.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.42 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -71.22 -28.83 64.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.962 0.411 . . . . 0.0 111.239 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.079 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 17.4 mt -107.24 25.88 10.87 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.233 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -75.56 76.22 2.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.54 0.686 . . . . 0.0 109.9 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.41 -64.47 3.98 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.258 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 11.99 -108.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.208 1.403 . . . . 0.0 113.796 -172.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.415 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 18.7 ttp180 -111.06 143.88 41.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 53' ' ' SER . 36.5 m170 -94.6 140.99 29.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.73 23.21 12.26 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -173.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.569 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 41.7 mtm -115.58 143.34 45.47 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.758 0.313 . . . . 0.0 110.373 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.536 ' CG ' HD22 ' A' ' 98' ' ' LEU . 29.6 p90 -144.79 161.13 40.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.472 -176.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.1 pp -150.92 133.99 15.99 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.051 0.453 . . . . 0.0 110.415 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.51 113.78 38.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.853 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 12.1 ptt180 -114.29 168.83 9.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.08 128.21 33.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.3 t -85.0 163.1 19.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.27 0.557 . . . . 0.0 111.573 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.42 ' OG ' ' O1P' ' A' ' 207' ' ' PTR . 3.8 p -105.84 13.57 29.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.659 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.7 p -78.34 -52.71 8.2 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.128 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 47' ' ' ASP . 24.3 p -165.22 139.31 3.97 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.563 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.57 113.41 1.36 Allowed 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.918 2.412 . . . . 0.0 112.437 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 65' ' ' SER . . . 121.26 -20.34 8.46 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.528 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.5 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 32.4 t70 -86.37 152.14 22.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.411 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 35.7 m-85 -131.04 162.06 30.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.705 0.288 . . . . 0.0 110.991 -176.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.613 HG11 ' HE2' ' A' ' 207' ' ' PTR . 56.6 t -137.67 112.02 9.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.017 0.436 . . . . 0.0 111.227 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 36' ' ' PHE . 30.9 tp -85.85 100.67 12.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.189 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 59' ' ' SER . 61.2 m -96.72 134.23 40.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.053 0.454 . . . . 0.0 110.44 175.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.734 HG21 HD13 ' A' ' 93' ' ' LEU . 96.4 t -123.59 149.5 27.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.102 -174.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 1.079 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 33.5 t -123.0 98.21 5.79 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.681 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 0.9 OUTLIER -133.9 139.93 46.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.025 172.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 55.39 29.32 12.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.695 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.4 m 64.94 31.46 11.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.702 0.763 . . . . 0.0 111.1 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -124.18 120.71 33.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.668 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 25' ' ' GLN . 19.2 t -88.31 93.98 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.199 0.523 . . . . 0.0 110.215 -178.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 38.6 m -74.39 118.24 17.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.787 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 82.6 m-70 -102.16 94.38 5.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.467 -175.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.698 ' CE2' HD22 ' A' ' 93' ' ' LEU . 27.6 m-85 -101.97 115.27 30.18 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.566 0.222 . . . . 0.0 111.355 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 69.0 mt -80.55 133.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.73 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.4 mp -108.23 120.97 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 5.4 t-20 -107.29 133.17 52.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -165.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 25.7 t -77.64 97.32 5.07 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.06 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.5 mt -66.82 151.55 96.66 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 17.2 Cg_exo -66.91 73.57 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.298 1.999 . . . . 0.0 112.339 177.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 67' ' ' PRO . 28.6 t-20 85.71 1.39 0.67 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.985 165.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -80.65 -85.17 0.09 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.737 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.546 ' HD2' ' HG3' ' A' ' 77' ' ' GLU . 8.4 ptp85 -158.41 -168.32 2.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.169 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.417 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 47.8 m-85 -104.3 115.51 30.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.151 0.501 . . . . 0.0 110.56 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' A' ' 75' ' ' ASP . 87.6 tttt -103.65 107.95 19.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.769 -176.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.73 ' HB ' HG13 ' A' ' 63' ' ' ILE . 5.8 tt -96.69 88.68 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.603 0.716 . . . . 0.0 110.627 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.636 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 60.99 79.28 0.13 Allowed Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.346 177.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 211' ' ' GLN . 32.2 t70 73.36 -44.37 0.58 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.93 0.492 . . . . 0.0 112.016 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -66.39 148.49 51.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.059 0.457 . . . . 0.0 111.234 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.546 ' HG3' ' HD2' ' A' ' 70' ' ' ARG . 3.4 tp10 -110.42 116.81 32.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.166 -171.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 93.0 m-85 -131.73 141.99 49.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -76.46 -16.95 59.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.902 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 15.6 p80 -167.63 167.97 13.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.94 -0.118 . . . . 0.0 110.738 173.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.539 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 9.8 mt -52.46 -57.78 14.28 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 23.5 Cg_exo -67.53 13.66 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.35 2.033 . . . . 0.0 113.838 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -36.95 8.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.144 0.497 . . . . 0.0 109.981 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.5 pp -76.74 -27.84 55.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.657 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.73 -30.15 70.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.106 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.498 ' CD ' ' HZ2' ' A' ' 89' ' ' LYS . 29.8 mm-40 -83.1 -31.26 27.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.564 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -69.07 -39.52 79.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.939 0.4 . . . . 0.0 110.705 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.425 ' HE2' HD13 ' A' ' 73' ' ' ILE . 43.9 m-85 -77.7 -15.37 59.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.205 0.526 . . . . 0.0 110.598 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.498 ' HZ2' ' CD ' ' A' ' 86' ' ' GLU . 40.0 ttmt -66.81 -21.58 66.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.932 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.1 pt -116.42 18.43 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.937 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -111.24 -37.54 5.28 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.606 ' CD1' HG23 ' A' ' 97' ' ' THR . 54.7 m-85 71.11 102.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.786 0.679 . . . . 0.0 110.183 -173.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.734 HD13 HG21 ' A' ' 52' ' ' VAL . 2.9 mt -78.67 -19.32 52.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 110.728 -177.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.681 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 23.2 t70 -167.55 75.38 0.14 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.723 170.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 68.18 -22.69 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.133 0.973 . . . . 0.0 112.018 -176.545 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.563 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 18.9 m -117.39 154.29 31.59 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.606 HG23 ' CD1' ' A' ' 92' ' ' TYR . 14.1 p -95.21 -178.73 4.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.173 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.536 HD22 ' CG ' ' A' ' 36' ' ' PHE . 97.7 mt -69.98 88.54 0.58 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.468 HG22 ' HG3' ' A' ' 100' ' ' GLU . 33.2 mm -74.07 -65.04 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.237 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 35' ' ' MET . 46.1 mt-10 -144.32 153.79 56.33 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.202 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.3 151.87 80.09 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.18 1.92 . . . . 0.0 111.358 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -69.36 147.79 97.14 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.362 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 38.9 Cg_exo -61.32 116.92 3.71 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.628 2.219 . . . . 0.0 112.154 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.2 ttm180 -66.71 -33.05 74.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.107 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.487 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 28.8 p90 -109.97 125.92 30.11 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.213 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 13.2 Cg_exo -70.8 99.39 0.85 Allowed 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.825 2.35 . . . . 0.0 112.263 178.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 t -93.45 153.77 41.35 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.445 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.54 159.63 4.46 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.828 2.352 . . . . 0.0 112.441 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.07 68.27 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.529 2.82 . . . . 0.0 113.583 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 60.5 mtm -114.74 118.82 34.67 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.51 -51.5 3.98 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.246 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 56.5 m -78.43 5.87 9.72 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.692 -0.299 . . . . 0.0 111.567 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.4 p -84.81 -10.83 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.262 0.553 . . . . 0.0 109.834 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.9 m -66.59 129.77 40.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.814 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.56 111.4 53.83 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.994 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -88.7 -151.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.183 2.589 . . . . 0.0 112.094 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -57.38 106.8 0.36 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.669 ' H ' ' HD2' ' A' ' 119' ' ' PRO . 0.9 OUTLIER -122.68 -52.98 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.496 -176.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.669 ' HD2' ' H ' ' A' ' 118' ' ' LEU . 67.9 Cg_exo -40.51 106.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 123.328 2.686 . . . . 0.0 114.315 -175.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.3 m -140.09 118.25 11.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.675 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.03 -164.23 1.15 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.639 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.407 ' CD ' ' HE2' ' A' ' 190' ' ' HIS . 36.3 mt-10 -83.92 81.55 8.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.937 0.399 . . . . 0.0 112.034 -176.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.458 ' C ' ' HE ' ' A' ' 183' ' ' ARG . 0.0 OUTLIER -102.52 153.53 19.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 167.504 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -61.89 -76.13 0.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -170.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.638 HD12 HG21 ' A' ' 152' ' ' ILE . 3.2 mm? 62.32 -175.37 0.14 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.742 0.651 . . . . 0.0 111.98 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 7.3 tp10 62.45 -87.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.59 176.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -103.22 106.93 17.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.3 1.048 . . . . 0.0 112.253 -175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.581 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 55.9 t -119.6 162.25 18.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.779 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.576 HH11 ' HG2' ' A' ' 129' ' ' ARG . 0.8 OUTLIER -149.82 126.18 10.8 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.072 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.904 HG22 HG12 ' A' ' 178' ' ' VAL . 3.0 p -87.42 140.45 29.52 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -169.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 90.7 mt -110.63 -29.69 7.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.022 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 40.5 t80 -78.64 -30.48 46.42 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -170.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.543 ' HB2' ' HD3' ' A' ' 146' ' ' LYS . 14.1 t70 68.82 103.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.246 0.546 . . . . 0.0 110.185 -174.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 66.9 t80 -140.6 96.88 7.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.819 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 10.3 Cg_endo -92.29 100.79 0.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.048 2.499 . . . . 0.0 113.18 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 137' ' ' ASN . . . -96.41 2.59 63.07 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.855 174.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.61 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 3.7 m-20 73.81 -7.91 1.5 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.815 0.846 . . . . 0.0 111.552 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.917 ' HB2' ' HD3' ' A' ' 143' ' ' PRO . 32.5 t0 62.85 162.88 0.1 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 158.87 -34.44 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 111.625 -2.534 . . . . 0.0 104.382 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.33 31.24 0.06 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.629 -2.078 . . . . 0.0 107.694 166.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 172' ' ' MET . 9.4 p-10 -163.1 85.59 0.52 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.79 -175.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.066 HD11 ' HB2' ' A' ' 165' ' ' ASN . 33.7 tp -64.96 132.85 95.6 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.931 -168.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 1.013 ' HD2' HD12 ' A' ' 142' ' ' LEU . 68.1 Cg_endo -80.6 86.71 1.6 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.487 2.791 . . . . 0.0 111.906 175.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.526 ' CG ' HG21 ' A' ' 130' ' ' THR . 10.0 p90 -97.3 156.78 16.29 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.786 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.729 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 2.8 mptp? -105.89 -171.0 1.82 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.001 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.543 ' HD3' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -88.42 9.03 24.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.542 -177.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.99 27.12 0.63 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.312 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.729 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 5.9 mm-40 -98.5 150.78 21.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.83 0.315 . . . . 0.0 110.231 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.71 134.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.644 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 52.7 mt -119.68 155.8 31.7 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 42.5 t -122.0 126.48 74.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.84 HD13 ' HB2' ' A' ' 163' ' ' ALA . 32.9 mm -74.99 81.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.695 HG23 ' HG2' ' A' ' 154' ' ' GLU . 8.2 tt -69.01 -34.11 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.607 -173.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.695 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -131.49 139.66 49.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.214 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.546 ' HD2' HD11 ' A' ' 125' ' ' LEU . 74.3 tttt -119.7 86.0 34.34 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.021 0.438 . . . . 0.0 110.453 172.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 3.1 Cg_exo -77.26 -54.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.674 2.25 . . . . 0.0 111.682 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -109.17 -178.53 3.59 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -109.98 -22.58 11.77 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.115 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.561 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 24.3 pt20 -88.6 -21.72 23.88 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.101 0.476 . . . . 0.0 110.251 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.561 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 48.7 m95 -129.09 123.57 32.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.785 178.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.652 ' O ' HG13 ' A' ' 173' ' ' ILE . 38.2 m0 -112.53 133.58 54.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.319 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 54.0 m -86.26 99.71 11.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.26 0.553 . . . . 0.0 110.311 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.84 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.29 158.62 17.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 1.06 ' HD2' ' HA ' ' A' ' 210' ' ' PRO . 16.0 ptt-85 -104.61 135.42 46.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.039 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.066 ' HB2' HD11 ' A' ' 142' ' ' LEU . 55.5 t30 -73.87 -173.96 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.998 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -68.89 -13.88 62.7 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 170.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -81.99 -13.76 56.96 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.071 170.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.6 1.54 90.19 Favored Glycine 0 C--O 1.229 -0.182 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.502 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.718 ' HG2' ' OD2' ' A' ' 138' ' ' ASP . 38.5 ttm-85 -66.0 132.58 48.91 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.371 0.668 . . . . 0.0 110.069 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.48 HG21 HD13 ' A' ' 153' ' ' ILE . 59.5 t -104.62 106.4 20.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -173.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.627 ' HA3' ' OD1' ' A' ' 138' ' ' ASP . . . -140.98 168.34 25.35 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.266 175.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 26.0 mtp -81.35 136.85 35.76 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -132.68 149.96 74.46 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 2.9 Cg_exo -76.15 132.3 13.8 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.106 2.537 . . . . 0.0 112.577 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.679 ' O ' HG22 ' A' ' 178' ' ' VAL . 41.0 t -61.12 -45.59 95.97 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 30.8 Cg_endo -64.47 -1.09 3.49 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.027 1.818 . . . . 0.0 113.774 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.02 -4.48 29.87 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.744 0.307 . . . . 0.0 111.287 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.904 HG12 HG22 ' A' ' 130' ' ' THR . 6.1 m -120.57 163.46 18.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -167.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 160.73 21.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.521 172.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -118.52 159.36 23.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.679 0.276 . . . . 0.0 110.582 -173.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.541 ' HG ' HG23 ' A' ' 182' ' ' VAL . 32.1 tp -75.18 -83.27 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.661 175.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.541 HG23 ' HG ' ' A' ' 181' ' ' LEU . 42.9 t -139.56 -82.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.645 0.259 . . . . 0.0 110.951 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.458 ' HE ' ' C ' ' A' ' 123' ' ' ASP . 2.9 tmm_? 70.07 -30.49 0.2 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.951 0.9 . . . . 0.0 111.841 -177.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 182' ' ' VAL . 16.2 t -61.53 128.71 37.6 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.628 ' HB3' ' HD2' ' A' ' 186' ' ' PRO . 11.2 m -152.84 177.51 1.91 Allowed Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 185' ' ' SER . 86.5 Cg_exo -47.49 -39.92 29.18 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.862 2.375 . . . . 0.0 113.036 172.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.421 ' CD2' ' HB2' ' A' ' 185' ' ' SER . 9.5 p80 -57.6 136.56 56.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.7 -3.17 80.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.407 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.409 ' HB3' ' HE2' ' A' ' 189' ' ' LYS . 52.8 mtpt 56.44 73.52 0.44 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.001 0.521 . . . . 0.0 111.491 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.407 ' HE2' ' CD ' ' A' ' 122' ' ' GLU . 57.1 m-70 -98.3 -46.99 5.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.367 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.19 -169.9 38.46 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.26 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 59.96 70.84 0.61 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.072 0.549 . . . . 0.0 110.978 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -115.18 97.85 6.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -117.0 -63.09 1.49 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 10.6 t -166.73 99.92 0.57 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.168 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -131.12 115.81 16.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.079 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.8 m -100.31 -23.32 14.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.826 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -148.97 141.1 23.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.398 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.22 110.35 2.26 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 34.5 pt -74.81 131.16 79.83 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.031 0.443 . . . . 0.0 111.51 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 7.2 Cg_exo -73.42 139.45 28.77 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.109 2.54 . . . . 0.0 111.749 176.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.611 ' HB3' ' HD3' ' A' ' 203' ' ' PRO . 6.2 tp10 -65.72 -51.63 48.02 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.663 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 202' ' ' GLU . 7.0 Cg_exo -74.82 30.04 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.5 2.134 . . . . 0.0 112.861 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -99.54 -34.03 10.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.031 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -87.22 -31.27 20.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.695 0.283 . . . . 0.0 111.377 -176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -116.17 159.83 21.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.509 . . . . 0.0 111.572 -173.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.613 ' HE2' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -113.89 33.42 5.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.433 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -64.35 133.33 95.62 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 1.06 ' HA ' ' HD2' ' A' ' 164' ' ' ARG . 94.9 Cg_exo -45.8 -51.71 7.9 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.162 2.575 . . . . 0.0 113.168 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.491 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -114.11 172.92 6.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.966 0.412 . . . . 0.0 111.017 179.47 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 8.9 t -128.12 155.14 44.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.401 176.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 27.9 m -69.39 117.6 11.22 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 41.3 m 68.97 94.01 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.755 -174.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.38 23.46 0.79 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 123.581 2.854 . . . . 0.0 112.588 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.638 ' HB3' ' HD3' ' A' ' 217' ' ' PRO . 64.2 tp -78.4 -53.22 1.33 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.014 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 216' ' ' LEU . 11.3 Cg_exo -72.36 16.5 0.38 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 122.717 2.278 . . . . 0.0 113.573 -176.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -89.09 90.35 8.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.861 0.363 . . . . 0.0 110.113 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.3 m -128.22 160.45 38.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.702 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.8 m -151.38 -158.39 0.9 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.93 -20.38 59.95 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.522 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.6 t 60.06 74.1 0.59 Allowed Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 123.049 0.54 . . . . 0.0 111.697 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.76 126.16 12.37 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.389 2.059 . . . . 0.0 111.495 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 159.83 -151.33 22.03 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -79.97 90.35 5.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.09 0.472 . . . . 0.0 110.65 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -98.85 2.56 46.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.903 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 67.4 mt 72.11 -62.18 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 O-C-N 123.661 0.601 . . . . 0.0 111.062 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.409 ' CG2' ' HD2' ' A' ' 229' ' ' PRO . 5.8 m -118.51 147.02 41.06 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.135 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.409 ' HD2' ' CG2' ' A' ' 228' ' ' THR . 25.6 Cg_endo -64.27 67.55 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.33 2.02 . . . . 0.0 112.136 172.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.687 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 57.3 tp -84.18 -50.15 0.63 Allowed Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.026 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 19.3 Cg_exo -66.92 89.63 0.3 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.909 1.739 . . . . 0.0 110.948 174.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 9.2 p -80.47 -75.42 0.27 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.234 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 43.0 p -132.65 132.28 42.26 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.81 0.338 . . . . 0.0 110.969 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -82.57 -43.54 16.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.931 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 63.7 -166.46 0.23 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.355 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.425 ' HA2' ' HD2' ' A' ' 237' ' ' PRO . . . -102.74 111.92 4.13 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 172.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.425 ' HD2' ' HA2' ' A' ' 236' ' ' GLY . 9.4 Cg_endo -52.16 120.79 7.8 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.247 2.631 . . . . 0.0 112.702 -176.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.532 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 35.3 t -78.51 133.38 30.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.597 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.86 115.26 27.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.165 0.507 . . . . 0.0 111.162 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.627 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.89 129.69 54.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.058 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -89.06 119.3 29.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.039 0.447 . . . . 0.0 110.498 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.917 ' HB1' ' HG2' ' A' ' 259' ' ' GLU . . . -78.42 119.56 21.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.675 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.635 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -109.5 -26.61 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -170.028 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.685 ' HG2' ' HG2' ' A' ' 245' ' ' LYS . 13.9 tt0 -93.92 -98.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.278 0.49 . . . . 0.0 111.339 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.685 ' HG2' ' HG2' ' A' ' 244' ' ' GLN . 24.4 pttm -175.45 107.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -177.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.567 ' H ' ' HB2' ' A' ' 259' ' ' GLU . 15.3 tpt180 -110.55 101.81 10.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.882 0.372 . . . . 0.0 111.491 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.9 m -124.0 117.75 27.05 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.879 173.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.763 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 30.0 Cg_endo -63.11 134.67 46.97 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.03 2.487 . . . . 0.0 113.212 -175.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 48.5 t -102.52 175.67 5.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.489 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.12 -26.43 62.64 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -70.93 -45.2 64.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 255' ' ' ALA . 0.9 OUTLIER -109.28 81.85 1.5 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.691 -174.219 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -83.06 -18.99 37.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.412 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.6 p -92.23 13.83 18.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.812 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.763 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -88.46 127.94 35.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.038 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -81.01 120.8 25.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.899 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.35 117.24 5.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.113 0.482 . . . . 0.0 110.45 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.438 ' H ' ' HB3' ' A' ' 246' ' ' ARG . 86.5 mt -143.46 -169.67 3.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.714 0.768 . . . . 0.0 111.333 -172.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.917 ' HG2' ' HB1' ' A' ' 242' ' ' ALA . 26.4 mt-10 79.62 -179.36 0.09 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 113.683 -1.599 . . . . 0.0 114.265 164.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 t 67.12 32.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.91 -172.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.05 38.89 2.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.126 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.72 137.6 44.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.298 . . . . 0.0 110.94 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.2 mm -89.64 106.95 17.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.143 0.497 . . . . 0.0 109.93 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.425 HG22 HD22 ' A' ' 258' ' ' LEU . 40.0 t -88.47 118.29 33.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.699 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -90.06 97.44 11.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.516 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 7.5 p -91.66 129.19 42.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 110.5 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.1 p -106.11 -38.17 6.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.536 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.587 ' NE ' ' HA ' ' A' ' 268' ' ' ARG . 2.2 mmp_? -124.46 114.09 19.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 111.084 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 50.1 mtt -95.41 113.88 25.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.196 0.522 . . . . 0.0 110.312 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -85.21 164.25 18.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.431 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.4 pt -88.72 7.37 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.185 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -88.25 -4.72 58.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.533 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 94.64 -47.02 2.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.554 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.513 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 43.3 mt-30 -81.05 124.93 29.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.247 0.546 . . . . 0.0 110.207 173.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -94.18 158.49 15.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.349 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 268' ' ' ARG . 9.4 pt-20 -115.27 125.34 53.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.59 0.709 . . . . 0.0 110.486 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -134.1 170.6 22.48 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.925 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.3 108.49 11.76 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 26.9 t -126.41 138.38 54.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.122 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 23.2 m120 71.82 -55.37 0.66 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.829 0.851 . . . . 0.0 110.669 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 164.75 30.69 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -141.86 147.65 37.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -105.24 126.91 52.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.35 167.65 32.98 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.731 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 87.1 mt -95.38 142.04 28.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.687 0.279 . . . . 0.0 110.722 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 53.8 p90 -138.3 136.87 19.7 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.973 176.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 12.1 Cg_exo -71.9 141.7 37.5 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.737 2.292 . . . . 0.0 111.941 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -61.67 -15.82 43.39 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.284 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.2 t -86.22 -3.33 58.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 111.563 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -104.44 -11.15 17.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.774 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.488 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 26.9 m -128.04 158.44 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.956 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -121.09 120.15 34.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.607 178.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.627 HD13 ' HB2' ' A' ' 240' ' ' ALA . 47.3 mm -76.91 111.86 14.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.587 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -121.11 163.88 17.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.491 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.33 121.7 75.28 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.19 -13.07 36.99 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.708 2.272 . . . . 0.0 113.245 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.565 ' C ' ' HD3' ' A' ' 299' ' ' PRO . 30.4 mm-40 -84.39 93.92 8.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.275 0.56 . . . . 0.0 110.647 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.599 ' N ' ' HD3' ' A' ' 299' ' ' PRO . 1.3 t-20 -125.49 49.42 3.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.915 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 298' ' ' ASN . 76.9 Cg_endo -99.66 40.55 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.235 2.624 . . . . 0.0 110.974 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -64.08 -26.82 68.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.233 -173.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -81.42 81.54 7.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.589 0.709 . . . . 0.0 110.017 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -166.81 130.75 1.96 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.066 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.684 -179.577 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.52 0.2 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 p -92.65 129.64 38.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -67.55 -37.33 82.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.914 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.83 104.48 5.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.419 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.475 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 22.5 mmt180 -105.9 6.81 31.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.528 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.772 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 51.9 p90 -79.35 148.59 31.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 175.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -88.79 101.75 14.33 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.567 0.699 . . . . 0.0 110.635 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 50.6 m -63.82 169.9 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.567 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 8' ' ' SER . 43.0 t 76.73 -50.84 0.57 Allowed 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.593 0.558 . . . . 0.0 111.397 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.79 101.45 1.71 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.467 0.651 . . . . 0.0 110.342 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 75.6 mtt-85 -72.45 -17.28 61.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.568 -171.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -76.36 0.52 19.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.799 0.333 . . . . 0.0 110.836 173.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.58 -46.45 5.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.4 p-90 -115.39 -20.94 10.07 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -171.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 84.1 t80 -86.4 128.94 35.0 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.023 -0.423 . . . . 0.0 110.61 -176.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.541 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 20.1 mmt -109.43 -9.3 14.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 110.909 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.48 -116.6 4.87 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.629 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.86 105.44 0.55 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.558 2.172 . . . . 0.0 112.508 -175.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.696 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 79.2 t -139.02 -77.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.606 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.841 ' OG ' ' O3P' ' A' ' 207' ' ' PTR . 17.2 t 86.2 170.34 0.06 Allowed 'General case' 0 C--N 1.347 0.469 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -59.63 -39.4 84.19 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.512 -171.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.36 -38.62 91.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.559 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.618 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -85.72 -47.31 9.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.175 0.512 . . . . 0.0 110.775 -177.331 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.92 -40.56 76.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.656 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 52.0 tp60 -70.27 -39.61 74.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.0 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -78.87 -15.13 58.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.641 0.258 . . . . 0.0 111.43 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 90.8 mtt180 -83.57 -50.8 7.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.674 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.51 ' HA ' ' CG ' ' A' ' 31' ' ' GLN . 39.9 mt -94.22 13.36 23.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.052 -173.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 36.6 tt0 -71.08 87.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.103 0.478 . . . . 0.0 110.615 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.33 36.43 8.16 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.334 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.51 ' CG ' ' HA ' ' A' ' 28' ' ' LEU . 71.4 mm-40 -91.4 170.66 9.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 111.59 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -52.81 139.14 27.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.722 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.475 ' HB3' HG21 ' A' ' 96' ' ' THR . 39.1 m170 -70.03 116.41 10.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.949 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.45 -11.99 7.52 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.256 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 57.6 mtt -74.17 149.18 41.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.853 0.327 . . . . 0.0 110.562 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.611 ' HB2' HG22 ' A' ' 52' ' ' VAL . 23.2 p90 -157.16 166.48 33.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.319 177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.541 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -158.04 138.91 13.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.73 175.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.96 125.96 57.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.696 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 12.8 ptt-85 -123.12 162.16 23.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.77 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.29 127.58 32.88 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 172.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.659 ' HB2' HG23 ' A' ' 49' ' ' VAL . 18.8 t -101.34 154.27 18.94 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.188 0.518 . . . . 0.0 110.779 -174.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 p -91.69 -5.36 53.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.807 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -44.77 94.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.595 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.784 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 69.4 m -152.05 150.67 26.31 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.806 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.36 109.13 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.525 2.15 . . . . 0.0 111.658 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.96 0.26 55.02 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.455 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.784 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 13.4 t70 -85.92 151.38 23.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.813 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 35.0 m-85 -132.6 171.59 13.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.635 0.255 . . . . 0.0 110.964 -176.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 41' ' ' SER . 78.1 t -145.24 112.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.107 0.48 . . . . 0.0 110.515 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.417 ' HB2' HD11 ' A' ' 63' ' ' ILE . 42.6 tp -83.42 102.26 11.93 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.044 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 59' ' ' SER . 69.5 m -96.95 125.77 41.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.078 0.466 . . . . 0.0 110.391 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.611 HG22 ' HB2' ' A' ' 36' ' ' PHE . 70.2 t -125.25 138.59 53.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.675 -172.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 28' ' ' LEU . 33.3 t -102.89 98.51 8.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.207 0.527 . . . . 0.0 110.947 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.726 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 35.5 mt-10 -138.32 148.48 44.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.532 ' HB2' ' CG ' ' A' ' 94' ' ' ASP . 1.8 t-20 63.94 11.16 5.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.666 0.387 . . . . 0.0 111.111 -176.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.2 m 70.2 26.41 4.4 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.523 0.678 . . . . 0.0 110.367 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.846 ' NH2' ' HA ' ' A' ' 154' ' ' GLU . 43.8 ptt85 -124.34 151.58 44.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.9 t -93.37 97.49 7.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.037 0.446 . . . . 0.0 110.102 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 51' ' ' SER . 19.3 m -73.18 118.13 15.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.317 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.644 ' HB2' ' HB3' ' A' ' 208' ' ' ALA . 92.0 m-70 -101.19 115.02 29.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.406 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.756 ' CE2' HD22 ' A' ' 93' ' ' LEU . 52.5 m-85 -121.93 108.01 12.93 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.433 HG12 HG22 ' A' ' 49' ' ' VAL . 58.8 mt -70.21 132.0 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.813 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.2 mp -104.72 123.86 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.352 1.061 . . . . 0.0 109.848 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -106.59 142.59 36.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -78.72 108.95 12.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.153 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 96.3 mt -85.82 170.91 11.63 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 26.2 Cg_exo -63.76 62.34 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.972 2.448 . . . . 0.0 114.263 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 13.2 m120 93.13 -43.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.986 0.914 . . . . 0.0 112.718 161.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.644 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.53 -29.4 33.56 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -169.413 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 1.052 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 81.6 mtt180 -148.07 177.65 9.2 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -169.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -129.7 120.69 25.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.522 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HB2' HD11 ' A' ' 66' ' ' LEU . 24.9 ttpp -98.31 112.59 24.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 61' ' ' TYR . 19.6 tt -77.48 78.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 122.158 0.98 . . . . 0.0 109.723 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.696 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 79.95 -55.8 4.54 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.085 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.442 ' CB ' ' HB2' ' A' ' 210' ' ' PRO . 31.8 t70 -146.8 -48.02 0.19 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.91 0.385 . . . . 0.0 110.581 -170.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -77.22 129.15 35.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.008 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.491 ' HG2' ' HD3' ' A' ' 70' ' ' ARG . 38.1 tt0 -99.45 130.15 45.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.026 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -128.53 160.79 31.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 1.052 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 36.5 m-20 -64.78 -45.47 86.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.455 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 6.0 p80 -153.27 177.12 11.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.504 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.645 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.2 mt -57.79 -57.87 22.5 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.645 ' HA ' HD12 ' A' ' 85' ' ' LEU . 30.5 Cg_exo -63.88 -6.71 11.51 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.012 1.808 . . . . 0.0 112.82 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.455 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -89.12 -31.73 17.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.645 0.26 . . . . 0.0 110.797 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.61 -30.32 56.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 82' ' ' PRO . 48.8 mt -68.04 -28.79 67.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.03 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.16 -23.94 63.07 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.049 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -86.67 -38.64 16.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.318 0.58 . . . . 0.0 110.435 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.502 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 45.1 m-85 -75.95 -7.75 55.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.878 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.466 ' HB3' ' HE2' ' A' ' 89' ' ' LYS . 30.7 ttpt -63.96 -33.1 74.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.573 173.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mt -110.32 -17.74 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.994 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 19.6 t-160 -69.79 -35.95 75.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.512 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.849 ' HA ' HG22 ' A' ' 97' ' ' THR . 97.2 m-85 71.61 101.61 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 124.083 0.865 . . . . 0.0 109.752 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.756 HD22 ' CE2' ' A' ' 61' ' ' TYR . 13.0 mt -70.83 -13.96 62.23 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.311 0.577 . . . . 0.0 109.649 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.726 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 21.5 t70 -152.56 -64.01 0.16 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.873 169.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.588 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 11.9 t -165.9 3.43 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 33' ' ' HIS . 13.0 t -133.38 -13.57 2.66 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.567 -0.708 . . . . 0.0 112.162 176.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.849 HG22 ' HA ' ' A' ' 92' ' ' TYR . 16.7 p 71.13 -179.49 0.23 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.379 1.072 . . . . 0.0 112.131 178.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.42 HD22 ' CD2' ' A' ' 36' ' ' PHE . 65.8 mt -71.34 109.26 5.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.267 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.3 mm -101.19 -52.39 8.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.059 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.772 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 17.1 pt-20 -154.84 164.16 21.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.619 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.591 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 98.4 Cg_endo -82.81 151.13 14.48 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.919 1.746 . . . . 0.0 112.119 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.425 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -75.15 153.16 86.35 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.91 175.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.63 120.36 7.72 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.5 2.133 . . . . 0.0 111.349 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.27 4.75 33.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 110.989 -175.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -78.08 150.17 77.39 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.629 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.47 -13.81 36.01 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.202 1.934 . . . . 0.0 111.714 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 16.7 m -144.14 135.08 12.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.692 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 107' ' ' SER . 39.7 Cg_exo -60.57 147.42 94.58 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.641 2.228 . . . . 0.0 111.742 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.41 -69.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.691 2.261 . . . . 0.0 111.712 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 87.0 mtp -120.93 -51.08 2.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.166 0.508 . . . . 0.0 109.706 173.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.59 150.81 19.86 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.017 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.9 m -104.21 -7.36 20.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.067 0.461 . . . . 0.0 110.306 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -60.93 115.37 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.658 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.6 m -103.13 -173.94 2.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.29 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.498 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -75.78 -54.79 2.12 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.883 177.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 115' ' ' ALA . 74.1 Cg_endo -75.54 -169.1 0.61 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.841 1.694 . . . . 0.0 111.753 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.7 t30 67.66 80.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.675 0.75 . . . . 0.0 111.567 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 48.6 tp -142.7 103.0 5.36 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.23 125.54 13.73 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.307 2.671 . . . . 0.0 112.894 -175.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.0 m -66.33 -43.42 86.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.15 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -166.17 143.81 5.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.622 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.95 97.98 0.26 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.373 0.42 . . . . 0.0 110.203 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.779 ' HB2' HD23 ' A' ' 125' ' ' LEU . 9.2 p-10 -90.56 137.66 32.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.536 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.514 ' HB2' ' HG3' ' A' ' 183' ' ' ARG . 20.4 m120 -91.98 50.21 1.64 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.362 0.601 . . . . 0.0 110.269 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.946 HD12 HG21 ' A' ' 152' ' ' ILE . 4.3 mm? -79.29 107.97 12.46 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.506 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 30.1 tt0 -165.65 -66.72 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.511 ' HB3' HD13 ' A' ' 181' ' ' LEU . 58.1 m-85 -110.94 118.04 35.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.616 0.722 . . . . 0.0 112.006 -177.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.487 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 55.5 t -130.92 159.57 42.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.701 -175.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 129' ' ' ARG . 19.6 mtt180 -131.6 145.29 51.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.866 HG22 HG12 ' A' ' 178' ' ' VAL . 12.3 p -102.51 136.4 42.4 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.724 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 179' ' ' GLU . 5.3 mt -107.68 -27.67 10.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.901 -174.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.479 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 44.6 t80 -86.4 -37.27 18.55 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -170.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.527 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 14.4 t70 70.8 108.04 0.06 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.529 0.681 . . . . 0.0 109.844 -170.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 70.3 t80 -147.06 113.19 4.17 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.401 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.734 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 30.2 Cg_endo -92.16 100.41 0.19 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.711 2.274 . . . . 0.0 112.422 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -85.31 14.4 50.47 Favored Glycine 0 CA--C 1.516 0.095 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.174 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 50.23 24.16 1.39 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.116 0.566 . . . . 0.0 112.447 -172.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.563 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 2.3 p30 46.86 -170.07 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.909 1.284 . . . . 0.0 114.157 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 75.76 -26.72 0.19 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.856 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.5 pt-20 -142.1 -30.56 0.57 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.07 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.488 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 5.6 m-20 -141.36 117.65 10.73 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.837 HD11 ' HB3' ' A' ' 165' ' ' ASN . 36.3 tp -67.81 136.25 92.38 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-O 120.718 0.294 . . . . 0.0 111.487 -173.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.734 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 1.0 OUTLIER -84.94 102.46 0.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.835 2.357 . . . . 0.0 110.661 172.646 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.673 ' CG ' HG21 ' A' ' 130' ' ' THR . 6.6 p90 -111.76 158.91 18.79 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.186 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.527 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -99.23 -179.43 4.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.756 -172.463 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -4.71 39.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -171.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.93 42.71 0.2 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.643 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -98.83 165.74 11.63 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.408 HD12 ' HE ' ' A' ' 129' ' ' ARG . 34.9 mm -99.9 138.38 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.521 HD22 ' HA ' ' A' ' 165' ' ' ASN . 29.4 mt -120.26 155.62 32.86 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 25.9 t -118.81 125.15 74.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.946 HG21 HD12 ' A' ' 125' ' ' LEU . 41.7 mm -75.13 95.84 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.265 1.031 . . . . 0.0 108.62 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.849 HG23 ' HG3' ' A' ' 154' ' ' GLU . 19.8 tt -89.71 -27.21 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.003 -171.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.919 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 27.0 mt-10 -142.75 144.47 32.65 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.945 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 7.1 ttpm? -135.62 81.01 42.83 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 121.424 -0.798 . . . . 0.0 111.26 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.588 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 19.9 Cg_exo -68.23 -46.07 2.4 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.787 2.325 . . . . 0.0 112.298 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -117.99 -175.22 2.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.541 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.56 -28.53 9.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.041 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.515 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 30.0 pt20 -93.84 -13.2 27.53 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.197 0.522 . . . . 0.0 110.515 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.76 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 51.6 m95 -129.28 127.81 41.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.733 175.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.687 ' O ' HG13 ' A' ' 173' ' ' ILE . 48.9 m0 -118.16 140.62 49.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.43 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.919 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 7.6 t -96.15 99.38 11.12 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.77 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -114.05 156.33 24.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.869 0.366 . . . . 0.0 111.464 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.486 ' HD3' HD12 ' A' ' 153' ' ' ILE . 26.7 ptt-85 -100.41 131.56 46.26 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.837 ' HB3' HD11 ' A' ' 142' ' ' LEU . 11.3 p-10 -79.58 171.38 15.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.871 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -72.37 -12.21 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.161 0.505 . . . . 0.0 110.314 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.533 ' HB3' HD22 ' A' ' 165' ' ' ASN . 5.6 t70 -80.13 -19.34 47.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.931 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.753 ' HA2' ' HB2' ' A' ' 211' ' ' GLN . . . 117.14 7.2 12.83 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 116.696 1.438 . . . . 0.0 116.696 169.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.645 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -123.52 155.79 36.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.511 1.655 . . . . 0.0 111.903 -177.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.92 143.8 11.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.106 -175.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -166.23 161.43 35.07 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.76 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.2 OUTLIER -74.23 137.95 43.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.845 0.355 . . . . 0.0 110.968 179.263 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -135.24 143.73 46.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.371 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 3.9 Cg_exo -77.01 134.04 14.21 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.7 2.267 . . . . 0.0 112.096 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.564 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 17.8 t -62.85 -43.45 82.84 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.078 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 34.5 Cg_endo -65.9 7.44 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 122.283 1.989 . . . . 0.0 113.651 175.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.0 m-85 -109.09 -6.56 15.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.697 0.284 . . . . 0.0 111.097 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.866 HG12 HG22 ' A' ' 130' ' ' THR . 26.3 m -127.62 166.46 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -168.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.681 ' HB2' HD21 ' A' ' 131' ' ' LEU . 4.1 mm-40 -125.41 163.75 21.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.577 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -111.21 144.13 40.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.511 HD13 ' HB3' ' A' ' 127' ' ' TYR . 4.3 mp -62.81 -75.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 110.439 172.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.1 m -138.78 129.92 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.716 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.514 ' HG3' ' HB2' ' A' ' 124' ' ' ASN . 18.1 ttt-85 -124.03 84.45 2.28 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.0 m -153.16 157.26 40.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.564 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.48 143.88 34.79 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.64 102.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.839 2.36 . . . . 0.0 112.503 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -126.34 -24.96 3.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.147 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.23 -66.02 3.91 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.565 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -86.48 61.84 7.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.241 0.543 . . . . 0.0 110.975 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -86.6 -9.88 55.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.506 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 94.38 25.0 17.21 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.045 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -133.53 163.82 28.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 195' ' ' SER . 0.3 OUTLIER -121.89 154.04 37.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -71.63 -24.96 61.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -173.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 193' ' ' ARG . 78.9 p 54.76 -87.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.917 0.887 . . . . 0.0 111.756 -175.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -68.13 115.82 8.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.606 0.717 . . . . 0.0 109.089 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 6.1 m -97.77 165.21 12.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.27 -172.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -84.95 92.79 8.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -144.79 87.78 0.17 Allowed Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 13.8 pt -117.3 148.78 43.33 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.485 0.183 . . . . 0.0 110.606 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.34 -41.1 52.72 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.054 2.503 . . . . 0.0 112.635 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 8.9 pt-20 -132.63 132.19 22.55 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 6.7 Cg_exo -72.77 81.17 1.64 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.109 2.54 . . . . 0.0 113.369 -173.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -81.21 -12.41 59.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.14 0.495 . . . . 0.0 110.05 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 39.1 m80 69.98 -88.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.662 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 178.24 -62.82 0.01 OUTLIER 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.793 0.683 . . . . 0.0 110.175 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.841 ' O3P' ' OG ' ' A' ' 20' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.644 ' HB3' ' HB2' ' A' ' 60' ' ' HIS . . . -139.53 131.15 27.24 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.4 172.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -165.28 147.0 6.36 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.696 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 88.4 Cg_exo -48.12 -46.92 20.93 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 121.903 1.735 . . . . 0.0 111.404 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.763 ' HG3' ' H ' ' A' ' 212' ' ' THR . 7.0 tp60 -178.39 -155.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 172.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.763 ' H ' ' HG3' ' A' ' 211' ' ' GLN . 6.3 p -129.07 -173.15 2.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.9 p -60.11 -62.57 1.77 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.821 0.343 . . . . 0.0 111.351 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.947 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 36.5 m -143.77 -58.89 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.967 176.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.947 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 78.2 Cg_endo -98.8 -176.9 0.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.707 2.271 . . . . 0.0 111.13 171.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.867 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 6.5 mp -94.47 -57.23 0.22 Allowed Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.867 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 4.6 Cg_endo -88.79 158.43 6.15 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.448 2.099 . . . . 0.0 111.402 172.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -69.94 152.12 44.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.079 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' ' 219' ' ' VAL . 12.4 t 63.9 13.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.534 0.683 . . . . 0.0 111.616 176.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 19.4 m -96.22 10.84 36.54 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.813 -0.554 . . . . 0.0 111.043 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -135.22 104.56 0.51 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.772 ' HB3' ' HD3' ' A' ' 223' ' ' PRO . 22.9 t -96.28 -61.39 0.14 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 222' ' ' SER . 53.0 Cg_exo -53.48 118.66 5.11 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.445 2.097 . . . . 0.0 112.909 -174.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 113.06 -66.79 0.25 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.84 -39.18 69.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.194 0.521 . . . . 0.0 110.52 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -111.12 112.87 24.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.92 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 9.1 tt -55.29 -39.77 53.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.726 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 17.5 m 58.05 89.76 0.1 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.231 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.87 -6.16 16.27 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.964 2.443 . . . . 0.0 112.94 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.561 ' N ' ' HD3' ' A' ' 231' ' ' PRO . 95.2 mt 61.07 55.41 3.31 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.207 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 230' ' ' LEU . 4.9 Cg_exo -75.76 -57.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.331 2.021 . . . . 0.0 111.215 176.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 48.8 m -102.44 102.19 12.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.656 175.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 13.0 p -76.22 97.32 4.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.905 -176.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -101.57 81.04 2.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.457 0.646 . . . . 0.0 110.028 174.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -151.37 171.41 17.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.362 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 139.44 94.02 0.27 Allowed Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.47 86.79 0.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.431 2.087 . . . . 0.0 111.979 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.7 t -93.24 142.83 12.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.612 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.05 125.71 53.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.139 0.495 . . . . 0.0 110.804 -174.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.748 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -127.59 131.78 49.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.883 176.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -86.99 125.43 34.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.574 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -78.2 104.1 8.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.228 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.606 HG13 ' HG3' ' A' ' 244' ' ' GLN . 29.1 pt -83.14 -11.89 12.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.072 0.463 . . . . 0.0 111.229 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.606 ' HG3' HG13 ' A' ' 243' ' ' ILE . 70.9 mt-30 -124.68 165.27 18.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.463 ' HB3' HG13 ' A' ' 260' ' ' VAL . 24.4 pttm -128.72 144.4 51.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.129 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.86 150.51 4.69 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.744 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.492 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 29.4 m -101.67 166.53 12.08 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.822 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.614 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 44.0 Cg_endo -95.31 174.99 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.68 2.92 . . . . 0.0 113.793 -176.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.708 ' HB3' ' HD3' ' A' ' 253' ' ' LYS . 50.6 t -171.04 136.15 1.07 Allowed 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.129 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -44.67 -45.28 9.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.688 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -91.74 58.99 3.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.0 t70 89.72 31.85 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.425 1.583 . . . . 0.0 111.687 162.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.708 ' HD3' ' HB3' ' A' ' 249' ' ' CYS . 2.8 mptp? -114.2 45.63 1.48 Allowed 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 104.354 -2.461 . . . . 0.0 104.354 147.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 7.0 p -53.65 -21.74 7.44 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 122.819 1.295 . . . . 0.0 107.943 169.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 285' ' ' LEU . . . -8.62 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 111.311 -2.677 . . . . 0.0 113.262 152.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.58 ' O ' ' HG ' ' A' ' 258' ' ' LEU . 1.7 tt -75.12 118.79 18.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.614 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -55.97 121.42 9.28 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 123.477 0.485 . . . . 0.0 110.527 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 256' ' ' LEU . 96.2 mt -136.18 136.54 40.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.785 -175.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -98.89 -176.68 3.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.316 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' A' ' 245' ' ' LYS . 17.5 m -86.79 132.64 31.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.956 0.408 . . . . 0.0 110.683 176.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 86.06 0.7 87.06 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.518 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.55 152.99 25.75 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.738 0.304 . . . . 0.0 110.724 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.7 mm -97.79 114.7 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.461 HG22 HD22 ' A' ' 258' ' ' LEU . 21.2 t -97.15 107.63 20.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.626 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -93.56 114.53 26.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 11.6 p -88.37 143.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.969 0.414 . . . . 0.0 110.677 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 30.0 m -98.74 -49.02 4.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.89 0.376 . . . . 0.0 110.266 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.515 ' HG3' ' HB3' ' A' ' 276' ' ' GLU . 3.3 ptp180 -132.45 118.84 19.83 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.096 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 47.1 mtt -89.62 110.8 21.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.128 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -131.62 139.7 49.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.415 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 52.3 mt 56.81 84.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.84 168.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 60.37 -29.14 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 166.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.626 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 165.24 -7.55 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.624 -1.274 . . . . 0.0 114.038 -177.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -85.78 77.05 9.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.558 0.679 . . . . 0.0 109.634 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.458 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 23.3 m0 -93.25 158.77 15.58 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.273 -170.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.515 ' HB3' ' HG3' ' A' ' 268' ' ' ARG . 40.9 tt0 -113.87 116.09 28.75 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.45 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.05 170.96 16.29 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.491 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.02 109.17 13.19 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.48 -86.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.531 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.12 66.98 8.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.188 0.518 . . . . 0.0 111.771 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 72.8 -2.49 32.51 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.456 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.53 ' NH1' ' H ' ' A' ' 257' ' ' ALA . 2.5 ptm180 -142.44 153.71 43.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.874 0.368 . . . . 0.0 110.983 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 20.3 pttp -104.48 142.01 35.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.766 173.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -160.19 -178.9 34.6 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.56 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.661 ' O ' ' HA ' ' A' ' 255' ' ' ALA . 91.3 mt -95.98 140.31 30.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.615 0.245 . . . . 0.0 110.961 -177.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 40.1 p90 -140.38 140.33 22.74 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 4.1 Cg_exo -79.85 142.79 16.02 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.702 2.268 . . . . 0.0 111.505 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.626 ' CD1' ' HA3' ' A' ' 273' ' ' GLY . 21.1 p90 -65.97 -15.43 62.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.9 m -77.54 -16.15 58.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.391 0.615 . . . . 0.0 110.541 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -86.81 -24.09 25.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.379 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 242' ' ' ALA . 30.4 m -127.7 178.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.663 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -140.56 119.42 12.58 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.748 HD13 ' HB2' ' A' ' 240' ' ' ALA . 39.3 mm -60.43 122.36 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.812 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.733 ' HD2' ' HD2' ' A' ' 296' ' ' PRO . 2.3 p90 -145.83 179.71 7.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.843 -173.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.512 ' HB3' ' HD3' ' A' ' 296' ' ' PRO . 28.5 t70 -110.9 -46.06 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.733 ' HD2' ' HD2' ' A' ' 294' ' ' PHE . 94.0 Cg_exo -49.58 39.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 124.821 3.681 . . . . 0.0 118.735 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -97.83 -27.11 14.45 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.579 ' HB2' ' HD3' ' A' ' 299' ' ' PRO . 1.8 m-20 -65.38 -58.22 12.69 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.964 -174.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 298' ' ' ASN . 85.6 Cg_endo -82.27 16.25 1.82 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.13 1.887 . . . . 0.0 113.638 -171.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.22 -21.17 62.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.233 0.54 . . . . 0.0 110.05 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -73.96 -13.06 60.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.646 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -121.44 -179.28 4.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.864 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.354 -0.832 . . . . 0.0 109.814 177.29 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 p -84.94 -10.84 56.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.471 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 m 69.13 -56.25 0.54 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.869 0.73 . . . . 0.0 111.197 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.646 ' HB3' ' HE3' ' A' ' 89' ' ' LYS . . . -77.76 96.47 4.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.179 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -123.66 94.7 4.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.998 -177.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -156.56 154.08 29.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.235 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -75.44 91.88 2.8 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.987 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 14.4 t -74.86 68.71 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.204 0.526 . . . . 0.0 110.068 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 t -179.62 -44.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.445 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -59.34 105.64 0.37 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.007 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 7.6 tpp180 -60.29 -32.35 71.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.549 -174.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.4 m -82.57 -1.36 50.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.644 0.259 . . . . 0.0 111.57 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.49 -45.61 8.05 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.326 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -117.94 -29.4 5.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.458 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 65.0 t80 -79.62 113.04 17.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.133 0.492 . . . . 0.0 110.696 -176.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.514 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 23.1 mmt -94.66 -2.86 50.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.051 -175.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.07 -114.21 3.09 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.663 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.63 96.75 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.015 2.477 . . . . 0.0 113.042 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.921 HG12 ' H ' ' A' ' 20' ' ' SER . 7.4 t -142.62 -161.15 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.921 ' H ' HG12 ' A' ' 19' ' ' VAL . 23.2 t 178.32 177.46 0.43 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -170.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.504 ' HG3' ' O2P' ' A' ' 207' ' ' PTR . 36.0 mtp85 -54.58 -61.6 2.2 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.75 -44.54 95.93 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.279 0.362 . . . . 0.0 111.336 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.465 ' HA ' HG22 ' A' ' 26' ' ' THR . 40.3 mt-10 -62.17 -47.51 84.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.345 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.85 -34.45 69.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 0.0 111.281 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.679 ' HG3' HG21 ' A' ' 58' ' ' VAL . 5.4 tt0 -81.88 -34.66 29.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.051 -175.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 23' ' ' GLU . 11.3 t -82.46 -14.7 54.63 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -104.39 -18.6 14.36 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.773 0.797 . . . . 0.0 110.878 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.788 HD13 ' HB2' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -132.54 33.01 3.83 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 123.647 1.689 . . . . 0.0 108.095 -174.281 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -58.18 177.52 0.12 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.229 173.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.454 ' HA2' ' OG ' ' A' ' 53' ' ' SER . . . -73.58 53.02 1.96 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.813 -176.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -78.31 -38.17 42.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.415 0.626 . . . . 0.0 109.893 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 22.7 ttp180 -144.67 128.46 17.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.57 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 3.7 m-70 -83.84 132.54 34.8 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.903 0.382 . . . . 0.0 110.607 -176.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.34 10.93 22.9 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.695 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.681 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.0 mtm -97.96 147.36 24.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' CD2' HD22 ' A' ' 98' ' ' LEU . 41.7 p90 -143.53 163.04 34.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.025 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.575 HD23 ' CB ' ' A' ' 28' ' ' LEU . 4.1 pp -150.36 134.3 16.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.968 0.413 . . . . 0.0 110.175 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.6 t -102.27 123.33 55.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.879 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 22.6 ptt-85 -126.57 153.42 45.27 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.571 -172.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 38.2 t70 -75.89 107.95 8.43 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 170.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.519 ' HB2' HG23 ' A' ' 49' ' ' VAL . 13.3 t -79.42 178.22 8.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.679 -168.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.8 m -125.12 17.55 8.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.951 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.478 HG23 ' O1P' ' A' ' 207' ' ' PTR . 0.3 OUTLIER -79.46 -47.94 14.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.25 0.547 . . . . 0.0 109.584 177.564 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.3 m -144.18 152.93 55.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.296 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.69 87.19 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.139 1.893 . . . . 0.0 111.674 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.52 15.57 2.97 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.967 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.98 155.09 19.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.289 0.544 . . . . 0.0 109.802 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.419 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 44.8 m-85 -127.2 159.91 32.86 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 62' ' ' ILE . 40.6 t -135.03 108.69 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.117 175.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.63 103.15 7.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.478 173.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 59' ' ' SER . 70.9 m -95.67 135.37 37.45 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.136 177.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 93' ' ' LEU . 92.8 t -127.73 134.38 65.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.579 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.454 ' OG ' ' HA2' ' A' ' 30' ' ' GLY . 29.2 t -100.28 112.42 24.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.744 0.307 . . . . 0.0 111.327 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.57 ' OE1' ' HB3' ' A' ' 33' ' ' HIS . 10.6 tp10 -157.34 140.76 15.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.176 175.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 117' ' ' ASN . 9.1 m120 48.3 39.38 12.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.469 0.707 . . . . 0.0 112.899 -176.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.9 m 66.98 18.44 10.58 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.1 173.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 57' ' ' ARG . 14.6 ptt180 -124.51 133.19 53.4 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.679 HG21 ' HG3' ' A' ' 25' ' ' GLN . 46.0 t -93.69 97.23 6.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.747 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 25.3 m -68.99 117.66 10.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.328 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 80.1 m-70 -101.26 92.56 5.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.95 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.695 ' CE2' HD22 ' A' ' 93' ' ' LEU . 37.4 m-85 -97.15 114.85 26.59 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.951 0.157 . . . . 0.0 111.056 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.779 HG12 HG22 ' A' ' 49' ' ' VAL . 28.8 mt -81.99 135.98 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -175.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.764 HG13 ' HB ' ' A' ' 73' ' ' ILE . 5.3 mp -117.38 123.81 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.292 1.037 . . . . 0.0 109.692 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -106.25 135.49 47.63 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.06 -0.4 . . . . 0.0 110.263 -173.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.0 t -80.29 108.63 14.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.006 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.6 mt -80.62 142.91 53.9 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.22 -17.97 49.27 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.728 2.286 . . . . 0.0 112.014 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -82.52 10.36 7.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.06 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 67.96 29.55 6.45 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.609 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -116.95 159.68 22.08 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.409 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 46.7 m-85 -118.84 115.55 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.188 0.518 . . . . 0.0 111.612 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 21.5 ttmm -104.15 109.02 20.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.027 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.764 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.6 tt -96.47 87.52 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.75 0.786 . . . . 0.0 110.557 177.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.98 75.74 0.43 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.901 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' N ' ' HB ' ' A' ' 212' ' ' THR . 25.7 t0 76.25 -52.69 0.61 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.111 0.564 . . . . 0.0 111.507 175.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -70.56 111.8 6.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.45 0.643 . . . . 0.0 110.41 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 8.6 pt-20 -95.68 128.91 42.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.938 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.547 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 89.3 m-85 -119.19 175.08 5.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.683 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.28 -51.05 63.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.18 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -156.2 -177.57 6.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.486 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.6 mt -56.62 -54.56 52.4 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.546 ' HA ' HD12 ' A' ' 85' ' ' LEU . 52.9 Cg_exo -58.77 -10.38 9.4 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.132 1.888 . . . . 0.0 113.614 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.21 -34.93 16.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.677 0.275 . . . . 0.0 110.919 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.8 pp -76.24 -27.03 56.61 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 82' ' ' PRO . 61.3 mt -67.89 -24.23 65.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.821 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 48.8 mt-10 -91.02 -9.41 46.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.762 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.682 ' HE1' ' CZ ' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -97.8 -29.66 13.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 176.025 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.682 ' CZ ' ' HE1' ' A' ' 87' ' ' PHE . 26.7 m-85 -78.03 -13.28 59.93 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.787 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.646 ' HE3' ' HB3' ' A' ' 4' ' ' ALA . 21.7 ptmt -74.01 -16.68 61.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.588 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.503 HD13 ' H ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -116.77 25.35 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.937 169.385 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -114.06 -41.62 3.5 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.248 -0.282 . . . . 0.0 111.662 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.599 ' CD1' HG23 ' A' ' 97' ' ' THR . 93.4 m-85 73.16 96.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.96 0.788 . . . . 0.0 110.624 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.695 HD22 ' CE2' ' A' ' 61' ' ' TYR . 2.2 mt -74.57 -13.89 60.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.062 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 95' ' ' THR . 20.0 t70 -172.45 63.02 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.609 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER 74.05 -25.15 0.2 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.114 -175.198 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 94' ' ' ASP . 41.7 m -114.52 146.18 41.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.599 HG23 ' CD1' ' A' ' 92' ' ' TYR . 16.7 p -90.97 -176.03 4.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.408 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.45 HD22 ' CD2' ' A' ' 36' ' ' PHE . 82.2 mt -69.61 96.39 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 38.5 mm -84.39 -55.08 7.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.031 0.443 . . . . 0.0 110.525 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.681 ' O ' ' HA ' ' A' ' 35' ' ' MET . 45.6 tt0 -162.32 141.75 7.24 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.454 -177.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.415 ' HD2' ' HG3' ' A' ' 100' ' ' GLU . 12.1 Cg_endo -56.66 153.23 37.17 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.738 2.292 . . . . 0.0 112.914 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.788 ' HB2' HD13 ' A' ' 28' ' ' LEU . . . -73.58 153.84 89.64 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.598 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.24 115.22 2.42 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.448 2.098 . . . . 0.0 112.22 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -58.1 -32.66 68.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.206 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 83.2 t80 -137.88 126.23 14.35 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 171.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 19.8 Cg_exo -65.75 86.08 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.66 2.24 . . . . 0.0 112.008 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.718 ' HB2' ' HD3' ' A' ' 108' ' ' PRO . 49.4 m -71.49 -53.67 7.42 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.446 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.718 ' HD3' ' HB2' ' A' ' 107' ' ' SER . 59.5 Cg_endo -90.73 155.09 4.16 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.094 1.862 . . . . 0.0 112.212 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.1 174.05 11.23 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.638 2.226 . . . . 0.0 112.036 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -73.31 112.97 9.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.072 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -91.29 175.46 39.45 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.705 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.0 t -111.78 165.38 12.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.781 0.324 . . . . 0.0 110.808 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 t 51.84 50.56 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.962 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.0 t -124.28 18.05 9.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 33' ' ' HIS . . . -162.82 112.66 1.07 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.204 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HD2' ' CD2' ' A' ' 33' ' ' HIS . 31.9 Cg_exo -62.3 -81.0 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.719 2.28 . . . . 0.0 112.818 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.44 ' HA ' ' ND2' ' A' ' 55' ' ' ASN . 64.0 t30 60.71 -179.46 0.1 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.147 0.498 . . . . 0.0 111.05 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mp -128.8 80.13 73.24 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 172.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.444 ' HA ' ' OE2' ' A' ' 122' ' ' GLU . 74.4 Cg_endo -75.59 50.78 2.79 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.007 2.471 . . . . 0.0 111.901 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.8 t -133.79 16.15 3.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.941 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.18 -44.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.876 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.444 ' OE2' ' HA ' ' A' ' 119' ' ' PRO . 7.0 mm-40 53.86 37.3 26.19 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.503 0.668 . . . . 0.0 109.506 -173.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -70.17 147.22 50.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.941 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -80.16 83.04 6.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.899 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.803 HD12 HG21 ' A' ' 152' ' ' ILE . 3.4 mm? -81.42 91.73 6.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.693 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 12.7 pt-20 -170.09 -59.14 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.073 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.562 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 15.1 m-85 -102.01 108.76 20.29 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.704 0.764 . . . . 0.0 111.666 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 65.0 t -130.18 154.98 41.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.057 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.581 ' NH2' HD13 ' A' ' 181' ' ' LEU . 14.1 ptp180 -135.74 137.6 41.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.848 0.356 . . . . 0.0 110.108 175.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.956 HG22 HG12 ' A' ' 178' ' ' VAL . 31.4 p -90.28 137.32 32.45 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.236 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.9 mt -113.19 -24.59 9.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.519 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 44.4 t80 -89.3 -34.77 16.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 27.1 t70 76.62 122.35 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.89 0.744 . . . . 0.0 111.171 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 80.9 t80 -156.98 107.59 1.93 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.781 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.748 ' HB3' ' HB3' ' A' ' 222' ' ' SER . 57.5 Cg_endo -87.52 97.55 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.594 2.196 . . . . 0.0 112.651 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.581 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -87.57 -6.51 77.03 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.077 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.84 22.76 12.8 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.998 0.519 . . . . 0.0 111.932 -175.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.674 ' CB ' ' HD3' ' A' ' 169' ' ' ARG . 2.4 p30 54.94 -173.37 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 168.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 77.48 -34.93 0.21 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 113.341 -1.754 . . . . 0.0 109.785 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 172' ' ' MET . 33.9 tt0 -133.69 -29.47 1.33 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.139 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.581 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 22.4 m-20 -138.26 111.39 7.89 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.049 HD11 ' HB2' ' A' ' 165' ' ' ASN . 25.9 tp -66.22 119.6 63.26 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 120.562 0.22 . . . . 0.0 110.612 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.561 ' HD2' ' HD2' ' A' ' 169' ' ' ARG . 29.2 Cg_endo -71.98 105.03 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.895 1.73 . . . . 0.0 111.335 174.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.629 ' CG ' HG21 ' A' ' 130' ' ' THR . 7.8 p90 -115.23 163.85 15.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 -177.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -97.2 -170.51 2.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.14 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.72 11.18 29.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.193 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.71 39.84 0.2 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.476 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -105.23 155.11 19.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.747 0.273 . . . . 0.0 110.453 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.39 137.43 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 165' ' ' ASN . 43.4 mt -125.42 160.71 28.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 22.0 t -122.83 131.67 72.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.803 HG21 HD12 ' A' ' 125' ' ' LEU . 32.7 mm -74.02 91.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.984 0.897 . . . . 0.0 109.433 -175.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.778 HG23 ' HG2' ' A' ' 154' ' ' GLU . 0.6 OUTLIER -74.61 -45.39 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.891 -176.256 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.778 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -129.81 139.94 51.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 174.11 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.712 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 0.7 OUTLIER -126.86 86.81 57.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.989 174.766 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.609 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 7.3 Cg_exo -77.4 -61.61 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.063 2.509 . . . . 0.0 113.64 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -97.05 -175.36 3.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 0.0 111.867 -169.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -90.32 -52.53 4.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.67 -178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -96.1 0.18 51.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.966 0.412 . . . . 0.0 110.915 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.664 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 57.0 m95 -129.53 124.71 34.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.159 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.687 ' O ' HG13 ' A' ' 173' ' ' ILE . 51.5 m0 -121.91 145.47 48.06 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.5 m -100.24 99.72 10.44 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.144 0.497 . . . . 0.0 109.742 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.618 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -105.45 160.9 14.79 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.131 -176.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.751 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 22.3 ptt-85 -101.32 128.95 47.25 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.501 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.049 ' HB2' HD11 ' A' ' 142' ' ' LEU . 66.7 t30 -65.52 164.14 14.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.097 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 15.3 tptp -67.86 -11.47 58.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.454 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.99 -4.53 46.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.939 0.4 . . . . 0.0 110.448 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.28 75.28 1.28 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.393 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.751 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 5.4 ttm-85 -155.36 135.07 12.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.359 0.123 . . . . 0.0 111.117 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.55 HG22 HG21 ' A' ' 153' ' ' ILE . 66.5 t -103.3 117.82 49.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.792 0.33 . . . . 0.0 111.361 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.44 166.92 30.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.866 173.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.664 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -79.72 138.35 37.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.702 0.287 . . . . 0.0 110.829 179.498 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -137.71 145.44 48.7 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.461 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 6.3 Cg_exo -80.28 136.81 11.56 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.95 2.433 . . . . 0.0 112.873 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.54 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 98.8 t -64.08 -42.62 70.22 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.436 177.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 37.4 Cg_endo -67.49 10.75 0.25 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.015 1.81 . . . . 0.0 113.06 175.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' A' ' 175' ' ' VAL . 3.3 m-85 -113.65 -5.93 13.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.716 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.956 HG12 HG22 ' A' ' 130' ' ' THR . 20.2 m -132.18 163.84 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.425 0.631 . . . . 0.0 112.614 -167.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -128.47 161.35 29.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.815 172.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 180' ' ' LYS . 3.2 mppt? -100.87 137.72 38.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.266 -175.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.581 HD13 ' NH2' ' A' ' 129' ' ' ARG . 65.5 tp -82.06 -41.81 20.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.774 -178.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.42 103.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.841 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.441 ' HB3' ' H ' ' A' ' 184' ' ' SER . 3.7 ttt180 -167.36 -92.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.051 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.441 ' H ' ' HB3' ' A' ' 183' ' ' ARG . 41.9 t 173.24 106.66 0.01 OUTLIER 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.006 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 11.0 p -71.23 167.74 27.11 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.72 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.78 97.94 0.1 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.079 1.853 . . . . 0.0 112.177 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -105.67 -44.5 4.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.91 -53.94 4.78 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.209 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -86.26 15.47 5.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.938 0.399 . . . . 0.0 110.539 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -86.96 81.3 8.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.131 0.491 . . . . 0.0 110.202 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -160.02 63.64 0.29 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.398 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 195' ' ' SER . 12.5 p30 -66.74 165.72 14.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.38 109.16 4.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.255 -175.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 56.0 t30 72.89 -60.74 0.53 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.846 0.716 . . . . 0.0 112.339 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.408 ' HB3' ' OD1' ' A' ' 192' ' ' ASN . 79.5 p 52.68 -162.45 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.783 0.833 . . . . 0.0 111.255 -173.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.56 160.77 26.33 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 19.9 m -75.33 134.67 40.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.679 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -119.56 158.64 25.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.21 -20.89 1.22 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.96 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 10.7 tt -62.4 120.91 63.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.537 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.32 115.63 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.363 2.042 . . . . 0.0 112.403 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.404 ' O ' ' HD2' ' A' ' 205' ' ' HIS . 1.8 pm0 -79.34 167.02 37.64 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.198 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -62.0 -7.64 10.16 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.245 2.63 . . . . 0.0 113.126 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.6 -27.87 68.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.21 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.404 ' HD2' ' O ' ' A' ' 202' ' ' GLU . 49.3 m-70 -79.52 74.65 6.17 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -76.56 89.27 3.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.649 -174.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.504 ' O2P' ' HG3' ' A' ' 21' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.416 ' HB3' ' H ' ' A' ' 60' ' ' HIS . . . -143.37 23.75 1.8 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.119 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 18.2 pt20 -66.63 145.57 98.96 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.867 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 209' ' ' GLN . 24.2 Cg_exo -64.47 -18.98 64.79 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.482 2.121 . . . . 0.0 112.193 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.555 ' HG2' ' H ' ' A' ' 212' ' ' THR . 46.3 tt0 69.06 174.34 0.29 Allowed 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.732 0.645 . . . . 0.0 110.011 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.555 ' H ' ' HG2' ' A' ' 211' ' ' GLN . 8.1 t -169.93 128.18 0.9 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.86 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.2 m 42.98 77.96 0.06 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.394 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.867 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 26.3 m -137.37 -60.75 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.235 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.867 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 7.1 Cg_exo -74.39 -175.79 2.41 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.018 1.812 . . . . 0.0 111.417 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 11.2 mp -69.98 130.22 90.12 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 52.0 Cg_exo -56.24 151.65 42.64 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.033 2.488 . . . . 0.0 112.342 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -75.95 81.59 2.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.15 0.5 . . . . 0.0 110.982 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 47.7 t -86.74 -46.42 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.593 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 2.7 p -103.68 137.83 41.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.109 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 139.07 -132.99 5.95 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.748 ' HB3' ' HB3' ' A' ' 135' ' ' PRO . 39.7 m -125.88 84.12 61.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.937 0.399 . . . . 0.0 110.968 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 224' ' ' GLY . 97.2 Cg_endo -96.97 -148.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.74 2.96 . . . . 0.0 112.277 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 223' ' ' PRO . . . -137.5 172.94 22.54 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 177.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.16 -31.36 64.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.755 0.277 . . . . 0.0 110.715 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 71.69 -53.51 0.68 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.623 0.769 . . . . 0.0 111.922 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 34.5 pt -63.86 146.64 12.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.821 0.343 . . . . 0.0 110.477 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.825 HG22 ' HD2' ' A' ' 231' ' ' PRO . 1.8 m -140.38 63.58 22.61 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 121.091 0.472 . . . . 0.0 110.278 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.19 38.07 0.67 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.21 2.606 . . . . 0.0 113.139 -171.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.92 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 57.5 tp -133.75 -60.88 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.663 178.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.92 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 3.1 Cg_endo -87.93 11.94 3.0 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.522 2.148 . . . . 0.0 111.739 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 8.8 t -149.9 -169.3 3.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -65.21 132.61 49.56 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 123.44 0.462 . . . . 0.0 111.17 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -74.9 -31.72 61.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.771 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 64.36 86.77 0.12 Allowed 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.637 0.585 . . . . 0.0 110.597 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -74.84 151.41 42.66 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.103 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.49 162.07 38.32 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.587 2.191 . . . . 0.0 112.193 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.411 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 21.6 t -89.08 134.03 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.775 ' HE2' ' HB3' ' A' ' 296' ' ' PRO . 0.1 OUTLIER -118.29 123.04 44.41 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.087 -171.127 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.585 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -124.62 158.69 32.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.098 0.475 . . . . 0.0 112.082 -170.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.735 ' HE3' ' HA2' ' A' ' 261' ' ' GLY . 54.4 tttp -102.23 130.85 49.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.498 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -75.44 104.68 6.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.551 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.864 HD12 ' HG3' ' A' ' 244' ' ' GLN . 2.7 pp -82.45 -15.44 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.226 0.536 . . . . 0.0 110.833 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.864 ' HG3' HD12 ' A' ' 243' ' ' ILE . 73.4 mt-30 -123.98 -172.05 2.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.229 172.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -124.5 169.42 11.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.521 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 57.6 mtp85 -148.78 125.85 11.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.342 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.443 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 29.3 m -118.33 157.22 49.76 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.487 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 247' ' ' VAL . 28.8 Cg_endo -63.55 108.08 0.81 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.465 2.11 . . . . 0.0 112.932 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.738 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 42.1 t -84.92 171.45 12.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.75 -40.24 75.42 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -104.0 3.78 33.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.162 0.506 . . . . 0.0 110.577 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.738 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.0 OUTLIER -104.0 51.08 0.78 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.259 178.61 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.62 -23.6 64.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.321 0.581 . . . . 0.0 109.787 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 13.9 p -95.65 16.3 17.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.913 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.723 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -81.2 128.4 33.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.654 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.58 127.28 31.96 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 172.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -83.33 117.84 23.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.083 0.468 . . . . 0.0 109.96 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.594 HD21 HG21 ' A' ' 279' ' ' VAL . 58.2 mt -131.81 160.18 36.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.915 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 262' ' ' ASP . 48.6 mt-10 -132.8 167.88 19.38 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.01 131.11 31.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.331 0.586 . . . . 0.0 111.291 -175.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.735 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 92.17 3.88 67.17 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.205 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 0.7 OUTLIER -85.38 160.01 19.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.943 0.401 . . . . 0.0 110.722 -175.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.739 HG23 ' HE1' ' A' ' 239' ' ' PHE . 18.5 mm -95.61 123.36 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.494 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.51 96.72 4.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.131 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -79.71 87.28 5.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 275' ' ' TRP . 2.4 p -87.01 118.12 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.871 0.843 . . . . 0.0 111.133 -175.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.5 m -103.09 -18.44 14.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.761 -171.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.779 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 36.2 ttm-85 -129.97 103.52 6.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.772 0.32 . . . . 0.0 110.915 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' MET . . . . . 0.411 ' HE3' ' HB ' ' A' ' 238' ' ' VAL . 58.5 mtt -102.98 118.68 37.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.875 0.369 . . . . 0.0 110.412 178.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -86.51 1.57 51.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 75.1 mt 74.51 -39.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.398 0.679 . . . . 0.0 112.581 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -63.16 -16.3 59.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 129.96 -27.4 4.08 Favored Glycine 0 CA--C 1.506 -0.501 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.647 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -85.02 113.45 21.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.04 0.447 . . . . 0.0 109.959 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.571 ' HB3' HG21 ' A' ' 266' ' ' VAL . 51.2 m0 -109.42 145.07 36.76 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.084 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.779 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 41.9 tt0 -100.97 114.92 29.26 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.96 149.58 18.16 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.297 -176.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -121.52 108.99 14.27 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.594 HG21 HD21 ' A' ' 258' ' ' LEU . 42.1 t -115.82 -98.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.245 -175.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -99.81 82.89 2.66 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.655 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.7 5.81 32.9 Favored Glycine 0 CA--C 1.517 0.167 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.202 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.404 ' NH1' ' H ' ' A' ' 257' ' ' ALA . 56.4 mtp180 -128.06 129.08 46.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.852 0.358 . . . . 0.0 110.977 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 28.6 ttpp -115.32 111.2 20.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.223 174.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -143.48 -174.66 15.93 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.052 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.14 144.59 27.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.144 0.497 . . . . 0.0 111.5 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.558 ' HE2' HG21 ' A' ' 291' ' ' VAL . 44.3 p90 -148.64 142.57 16.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.683 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 3.2 Cg_exo -77.2 145.21 24.12 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.539 2.16 . . . . 0.0 111.632 176.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -62.96 -14.73 50.89 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.577 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.3 p -72.24 -8.66 56.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -107.56 -8.36 16.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.482 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.558 HG21 ' HE2' ' A' ' 286' ' ' PHE . 34.9 m -128.62 164.29 31.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.832 ' HG2' HG12 ' A' ' 243' ' ' ILE . 31.4 mmtp -137.29 139.68 41.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 174.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 240' ' ' ALA . 47.1 mm -78.81 118.19 25.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 13.3 p90 -121.06 163.83 17.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.84 0.352 . . . . 0.0 110.324 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.909 ' HB3' ' HB2' ' A' ' 298' ' ' ASN . 4.2 m-20 -93.66 106.75 22.71 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.987 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.775 ' HB3' ' HE2' ' A' ' 239' ' ' PHE . 54.4 Cg_endo -72.56 -50.08 0.24 Allowed 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.422 2.081 . . . . 0.0 113.097 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -141.82 38.08 1.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 122.183 0.992 . . . . 0.0 108.529 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.909 ' HB2' ' HB3' ' A' ' 295' ' ' ASP . 2.6 m-20 -97.18 -54.01 0.21 Allowed Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.554 -172.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 298' ' ' ASN . 2.8 Cg_exo -77.04 -5.12 15.59 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.389 2.059 . . . . 0.0 112.763 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -137.68 172.76 12.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -133.49 16.29 4.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.27 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -113.48 112.85 24.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.103 0.478 . . . . 0.0 111.852 -169.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.433 -0.794 . . . . 0.0 109.089 171.453 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.582 ' SD ' ' HB2' ' A' ' 100' ' ' GLU . 58.6 mtt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.907 0.384 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -98.15 -78.78 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.9 t -99.88 80.26 2.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.722 0.296 . . . . 0.0 111.171 -175.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 51.81 46.99 25.67 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.046 174.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 5' ' ' ARG . 48.1 mtm105 -121.9 81.44 1.82 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.749 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.491 ' CE1' ' HD3' ' A' ' 89' ' ' LYS . 31.3 p90 -113.55 161.18 17.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.433 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.44 -45.31 94.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.631 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 63.1 m 67.72 157.61 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.762 0.664 . . . . 0.0 109.999 -169.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.6 t 72.64 -49.94 0.7 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.989 0.516 . . . . 0.0 111.491 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -50.98 101.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.34 0.59 . . . . 0.0 111.591 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -40.22 73.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.249 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -78.62 8.97 4.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.667 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.91 -47.62 4.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.708 0.29 . . . . 0.0 111.022 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -121.03 -25.87 5.25 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -86.46 115.46 23.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.93 0.395 . . . . 0.0 110.692 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.1 mtt -113.13 6.59 17.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.107 0.48 . . . . 0.0 110.779 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.0 -115.23 3.36 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.006 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 25.5 Cg_exo -63.95 103.75 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.697 2.265 . . . . 0.0 111.914 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.605 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 54.4 t -135.58 -75.26 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.732 -176.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.745 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 55.9 m 84.99 176.02 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 122.743 0.417 . . . . 0.0 110.141 166.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.725 ' HD3' ' O3P' ' A' ' 207' ' ' PTR . 26.6 mmm180 -40.65 -61.76 0.89 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.054 0.846 . . . . 0.0 111.782 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -55.17 -56.84 15.41 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.941 0.776 . . . . 0.0 112.007 -173.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.6 -42.92 60.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.253 -169.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.26 -52.8 63.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.197 -176.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.581 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 12.9 pt20 -70.89 -32.81 69.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.151 -176.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.598 ' HA ' ' OE1' ' A' ' 29' ' ' GLN . 39.5 m -66.73 -34.3 77.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 111.354 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.514 ' HD2' ' O ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -63.22 -35.39 80.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.82 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.052 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 23.6 mt -99.61 13.0 35.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.045 -173.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.598 ' OE1' ' HA ' ' A' ' 26' ' ' THR . 27.3 mt-30 -73.65 96.71 2.52 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.88 5.07 89.7 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.738 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -82.43 -162.26 0.55 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.946 0.373 . . . . 0.0 110.15 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.491 HH21 ' CD ' ' A' ' 100' ' ' GLU . 14.5 mtm180 -62.78 131.51 49.1 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.185 0.517 . . . . 0.0 111.352 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -73.72 114.66 12.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.474 173.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.08 -16.86 4.4 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.124 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.608 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 62.2 mtt -67.7 142.71 56.24 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.711 0.291 . . . . 0.0 111.544 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.498 ' CB ' HG22 ' A' ' 52' ' ' VAL . 40.2 p90 -140.24 160.04 40.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.016 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -151.1 141.74 22.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.967 0.413 . . . . 0.0 110.627 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.51 124.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.461 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.745 ' HD2' ' H ' ' A' ' 20' ' ' SER . 9.2 ptt180 -122.17 161.7 22.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.189 -173.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.3 113.17 18.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.449 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.1 t -73.51 140.5 46.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.703 -171.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 t -78.96 -13.46 59.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.351 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.0 p -68.03 -48.5 65.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.107 0.479 . . . . 0.0 109.983 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.4 m -146.95 103.45 3.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.163 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.7 116.58 3.09 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.59 2.193 . . . . 0.0 111.216 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.38 -30.89 5.26 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -172.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 3.2 m-20 -86.18 168.87 13.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 171.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.768 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 32.0 m-85 -135.52 174.02 11.07 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.684 -171.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.449 HG23 ' HB2' ' A' ' 41' ' ' SER . 58.5 t -143.27 112.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.175 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.509 ' HB2' HD11 ' A' ' 63' ' ' ILE . 46.0 tp -83.54 99.84 10.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.254 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' SER . 68.4 m -97.11 135.14 39.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.528 177.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 93' ' ' LEU . 81.9 t -132.09 142.39 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.553 -173.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 1.052 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 42.3 t -102.01 113.86 27.46 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.882 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.692 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 18.0 pt-20 -156.86 145.99 20.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.0 p30 43.3 31.39 0.38 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.732 0.813 . . . . 0.0 112.714 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.8 m 63.71 63.82 0.82 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.534 0.683 . . . . 0.0 111.234 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 29.3 ptt180 -160.3 166.34 29.66 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.638 HG23 ' HA ' ' A' ' 117' ' ' ASN . 34.3 t -119.45 90.85 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.081 0.467 . . . . 0.0 109.941 175.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.581 ' O ' ' HA ' ' A' ' 51' ' ' SER . 3.6 m -63.14 116.28 5.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.597 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.611 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 99.1 m-70 -102.86 97.04 7.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.683 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.628 ' HB3' HD11 ' A' ' 73' ' ' ILE . 82.7 m-85 -105.38 113.06 26.42 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.904 -0.134 . . . . 0.0 111.097 177.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.714 ' HB ' ' CB ' ' A' ' 207' ' ' PTR . 19.0 tt -77.53 139.34 18.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.768 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.5 mp -109.4 122.74 64.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.789 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.549 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 11.2 m120 -110.16 126.31 53.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.911 0.386 . . . . 0.0 110.211 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 p -80.67 100.89 8.91 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.02 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.848 HD12 ' HG2' ' A' ' 70' ' ' ARG . 96.3 mt -66.34 130.06 94.2 Favored Pre-proline 0 CA--C 1.51 -0.595 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -40.26 -68.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.166 2.577 . . . . 0.0 113.658 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -123.25 31.77 5.87 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.001 0.905 . . . . 0.0 108.605 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.775 HH21 HD22 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -131.24 -91.33 0.43 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.596 -173.457 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.848 ' HG2' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -157.81 -170.4 3.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.051 -167.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -97.62 130.22 44.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.339 0.59 . . . . 0.0 110.323 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.624 ' HD3' HD21 ' A' ' 66' ' ' LEU . 44.9 tttm -123.48 103.33 8.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.309 -173.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.628 HD11 ' HB3' ' A' ' 61' ' ' TYR . 15.0 tt -74.13 86.23 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.842 0.829 . . . . 0.0 111.049 -173.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 1.021 ' HA3' ' HA ' ' A' ' 209' ' ' GLN . . . 77.04 -34.73 1.47 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.784 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -168.08 -51.29 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.648 0.261 . . . . 0.0 110.46 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -80.87 121.28 25.78 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.436 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.8 pt-20 -94.86 143.28 26.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.289 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.515 ' HE1' ' CG2' ' A' ' 73' ' ' ILE . 91.2 m-85 -115.4 -77.37 0.57 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.688 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD2' ' HD2' ' A' ' 80' ' ' HIS . 11.7 t70 -177.11 -54.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.458 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.482 ' HD2' ' OD2' ' A' ' 79' ' ' ASP . 10.8 p80 -147.77 177.64 9.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.486 176.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 11.6 mt -58.84 -59.11 14.8 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.631 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 44.6 Cg_exo -60.05 -7.38 6.26 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.279 1.986 . . . . 0.0 113.427 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.414 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -87.88 -23.01 24.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.94 0.4 . . . . 0.0 110.963 -177.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -88.09 -28.76 21.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 82' ' ' PRO . 77.7 mt -68.21 -25.76 65.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.849 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.663 ' HA ' ' HE2' ' A' ' 89' ' ' LYS . 10.1 pt-20 -85.78 -15.58 41.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -79.8 -37.69 34.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.512 0.672 . . . . 0.0 110.116 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.463 ' HE2' HD13 ' A' ' 73' ' ' ILE . 60.3 m-85 -78.88 2.79 18.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.082 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.663 ' HE2' ' HA ' ' A' ' 86' ' ' GLU . 52.2 mtmt -86.37 -5.79 59.09 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.793 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 -27.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.087 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -79.39 -19.59 49.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.235 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.615 ' CD2' HG23 ' A' ' 97' ' ' THR . 54.5 m-85 67.28 174.32 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -168.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 52' ' ' VAL . 4.2 mt -114.27 2.04 14.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 165.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.418 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 15.7 t70 -178.07 -121.76 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.502 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.539 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.1 t -94.01 -3.96 50.46 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.1 m -120.3 141.68 49.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.52 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.615 HG23 ' CD2' ' A' ' 92' ' ' TYR . 18.6 p -94.8 178.92 5.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 174.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.512 ' CD2' HD11 ' A' ' 93' ' ' LEU . 83.0 mt -69.48 101.85 1.67 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 51.1 mm -86.02 -65.07 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.79 -176.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 35' ' ' MET . 5.7 pm0 -150.37 155.96 36.88 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.221 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.71 145.79 70.69 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.43 2.087 . . . . 0.0 111.726 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -69.62 147.4 96.56 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.426 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.514 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 25.0 Cg_exo -63.66 127.76 20.55 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.356 2.037 . . . . 0.0 111.184 175.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -74.83 78.33 2.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.431 0.634 . . . . 0.0 109.79 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -139.74 115.35 8.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.267 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.81 138.3 37.34 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.854 2.369 . . . . 0.0 111.701 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.5 m 60.55 86.76 0.15 Allowed Pre-proline 0 C--O 1.234 0.249 0 O-C-N 123.713 0.633 . . . . 0.0 111.343 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.99 156.5 54.21 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.067 2.511 . . . . 0.0 112.508 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.54 -25.94 54.86 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.506 2.138 . . . . 0.0 112.369 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 70.6 mtm -130.28 -178.8 4.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.381 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.57 -74.13 2.13 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.386 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.4 m 65.56 -62.3 0.23 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.642 0.777 . . . . 0.0 111.715 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.523 HG23 ' H ' ' A' ' 114' ' ' SER . 0.1 OUTLIER -145.11 -88.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.271 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.523 ' H ' HG23 ' A' ' 113' ' ' VAL . 32.2 m 64.26 -166.34 0.23 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.23 0.538 . . . . 0.0 111.924 171.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.608 ' N ' ' HD2' ' A' ' 116' ' ' PRO . . . -87.2 -44.31 0.52 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.379 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 115' ' ' ALA . 9.2 Cg_endo -51.32 95.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.522 2.148 . . . . 0.0 113.303 177.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.638 ' HA ' HG23 ' A' ' 58' ' ' VAL . 8.6 t-20 -179.37 172.94 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.505 ' HB2' ' H ' ' A' ' 58' ' ' VAL . 34.9 tp -163.18 81.74 1.54 Allowed Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 175.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.676 ' HA ' HH21 ' A' ' 21' ' ' ARG . 3.1 Cg_endo -86.35 -37.67 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.757 2.305 . . . . 0.0 109.501 165.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.505 ' H ' ' HD2' ' A' ' 119' ' ' PRO . 38.1 m -156.52 159.84 38.95 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.731 ' CB ' ' HB2' ' A' ' 126' ' ' GLU . . . -64.94 0.18 1.31 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 121' ' ' ALA . 7.9 tp10 72.24 -64.8 0.38 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.915 0.388 . . . . 0.0 110.754 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -143.41 -43.31 0.29 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.638 -173.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.463 ' O ' ' HB1' ' A' ' 121' ' ' ALA . 59.8 t30 -141.85 165.96 26.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.733 -174.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.592 HD12 HG21 ' A' ' 152' ' ' ILE . 4.1 mm? 70.38 73.97 0.21 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.504 0.722 . . . . 0.0 111.397 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.731 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . 4.9 tp10 -164.72 -81.31 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.38 -173.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -104.97 114.63 28.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.339 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.563 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 53.7 t -128.73 133.47 66.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.128 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.413 HH21 HD11 ' A' ' 149' ' ' ILE . 1.1 ptp180 -111.29 141.28 45.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.132 0.491 . . . . 0.0 110.922 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.829 HG22 HG12 ' A' ' 178' ' ' VAL . 7.3 p -93.49 139.61 30.53 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.426 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.429 HD11 ' CG ' ' A' ' 179' ' ' GLU . 16.7 mt -110.32 -27.46 9.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.464 -173.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 53.3 t80 -83.09 -37.47 23.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -171.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.676 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 17.7 t70 75.13 107.92 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.697 0.623 . . . . 0.0 110.33 -174.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 83.6 t80 -139.82 100.7 7.29 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 8.2 Cg_endo -89.03 78.37 1.09 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.018 2.478 . . . . 0.0 112.502 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -78.64 -22.41 66.93 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.162 176.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 49.53 55.01 10.02 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.47 -0.865 . . . . 0.0 112.815 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -153.48 171.39 18.77 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.687 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -79.86 -16.07 56.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.147 0.498 . . . . 0.0 110.929 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.43 -10.19 17.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.604 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.419 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 66.9 m-20 -135.73 92.14 2.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.847 HD11 ' HB2' ' A' ' 165' ' ' ASN . 46.8 tp -67.91 122.66 84.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.807 0.337 . . . . 0.0 110.793 -175.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.682 ' HD2' HD12 ' A' ' 142' ' ' LEU . 66.2 Cg_endo -71.62 99.68 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.403 2.069 . . . . 0.0 111.066 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.585 ' CG ' HG21 ' A' ' 130' ' ' THR . 6.3 p90 -116.49 155.67 28.22 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.85 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.676 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 52.8 mttp -101.7 176.17 5.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.15 -174.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.945 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -83.65 69.5 10.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.956 0.884 . . . . 0.0 109.421 176.137 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.5 23.43 0.73 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.591 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 145' ' ' LYS . 8.1 tp10 -92.93 153.53 18.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.722 HD12 HD21 ' A' ' 181' ' ' LEU . 43.1 mm -104.61 128.21 58.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.487 HD13 HD23 ' A' ' 142' ' ' LEU . 18.2 mt -122.65 159.02 28.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 42.1 t -117.01 129.02 74.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.728 HD13 ' HB2' ' A' ' 163' ' ' ALA . 38.3 mm -75.81 93.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.815 0.817 . . . . 0.0 109.641 -175.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.705 HG21 HG22 ' A' ' 170' ' ' VAL . 8.6 tp -91.04 -33.56 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.001 -172.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.061 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 19.3 mt-10 -132.02 143.63 50.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -145.32 75.06 13.91 Favored Pre-proline 0 C--N 1.323 -0.585 0 O-C-N 121.66 -0.65 . . . . 0.0 111.093 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.539 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 14.0 Cg_exo -68.28 -40.11 8.97 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.716 2.277 . . . . 0.0 111.678 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -112.26 -178.51 3.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.098 -175.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -110.27 -18.19 13.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.31 0.576 . . . . 0.0 109.599 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -88.88 -30.35 18.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.96 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.741 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 36.8 m95 -128.97 134.53 48.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.473 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.762 ' O ' HG13 ' A' ' 173' ' ' ILE . 41.5 m0 -124.82 135.21 52.73 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.906 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . 1.061 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.6 m -85.62 101.74 12.97 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.728 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -106.59 161.74 14.36 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 122.058 -0.401 . . . . 0.0 110.404 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.568 ' HG2' ' HB ' ' A' ' 151' ' ' VAL . 15.2 ptt180 -105.32 133.57 49.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.82 0.343 . . . . 0.0 110.317 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.847 ' HB2' HD11 ' A' ' 142' ' ' LEU . 60.2 t30 -64.71 170.41 4.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.905 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.408 ' HG3' ' OE1' ' A' ' 148' ' ' GLU . 8.9 mtmm -61.79 -16.34 48.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.11 0.481 . . . . 0.0 110.515 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.55 -1.8 58.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.283 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.42 -8.37 79.92 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.343 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.765 ' HA ' ' HB3' ' A' ' 211' ' ' GLN . 7.0 ttp-105 -68.59 129.24 39.36 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.803 -0.234 . . . . 0.0 111.103 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.705 HG22 HG21 ' A' ' 153' ' ' ILE . 73.5 t -89.73 128.53 41.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -153.17 149.02 20.51 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.025 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.741 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -69.5 130.62 42.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.755 0.312 . . . . 0.0 110.432 178.396 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.762 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -133.29 146.78 62.32 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.364 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 4.0 Cg_exo -77.39 134.54 14.11 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.724 2.283 . . . . 0.0 112.28 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 66.9 t -65.47 -40.83 45.54 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 27.4 Cg_endo -63.61 -4.56 7.16 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.824 1.683 . . . . 0.0 112.973 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-85 -96.69 -6.05 37.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.407 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.829 HG12 HG22 ' A' ' 130' ' ' THR . 15.5 m -126.6 163.92 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -168.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.429 ' CG ' HD11 ' A' ' 131' ' ' LEU . 4.7 mm-40 -139.87 163.94 31.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.587 170.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.525 ' N ' ' HD3' ' A' ' 180' ' ' LYS . 2.8 mppt? -98.97 137.86 36.91 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.573 0.225 . . . . 0.0 110.908 -172.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -53.85 -80.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.569 HG23 ' H ' ' A' ' 184' ' ' SER . 10.7 m -111.08 -30.6 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -171.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.52 ' O ' ' HB2' ' A' ' 184' ' ' SER . 3.8 tpt180 66.56 20.05 10.83 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.442 0.464 . . . . 0.0 110.532 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.569 ' H ' HG23 ' A' ' 182' ' ' VAL . 12.1 t 169.87 124.28 0.01 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.07 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.46 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 2.6 p -78.37 140.85 60.82 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 43.8 Cg_exo -56.89 108.71 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.146 2.564 . . . . 0.0 112.968 -178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -123.85 -5.98 7.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.308 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.69 -50.96 2.93 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -171.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -84.12 -28.93 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.527 . . . . 0.0 109.789 172.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.457 ' HB3' ' OG ' ' A' ' 184' ' ' SER . 90.4 m-70 -115.88 153.54 31.35 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.566 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 86.38 -100.83 2.56 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -139.53 140.14 37.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -83.52 159.97 21.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.223 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 74.78 -30.65 0.2 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.375 0.67 . . . . 0.0 111.979 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 12.6 p -76.0 74.28 2.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.569 0.7 . . . . 0.0 109.613 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -84.44 -5.81 59.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.927 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 19.2 t -138.39 143.38 39.77 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -160.66 -58.16 0.06 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.99 0.424 . . . . 0.0 110.391 -176.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -153.16 172.57 32.1 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.952 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.916 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 68.3 mt -128.75 -63.44 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.618 -0.141 . . . . 0.0 110.618 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.916 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 5.3 Cg_exo -78.15 127.7 8.56 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.389 2.059 . . . . 0.0 112.398 -177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -122.49 99.7 42.28 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.417 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.83 48.19 2.76 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 123.473 2.782 . . . . 0.0 112.371 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -161.69 -164.06 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.189 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 73.2 t60 61.75 29.93 18.21 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.566 0.698 . . . . 0.0 110.202 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.64 -175.34 5.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.0 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.737 ' O1P' ' HE1' ' A' ' 207' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.491 ' HA ' ' NH1' ' A' ' 164' ' ' ARG . . . 70.51 -71.53 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.335 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 1.021 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 51.9 mt-30 58.67 63.99 3.68 Favored Pre-proline 0 C--N 1.326 -0.428 0 O-C-N 123.601 0.563 . . . . 0.0 110.374 -171.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 73' ' ' ILE . 8.2 Cg_exo -72.66 145.45 41.59 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.061 2.508 . . . . 0.0 113.013 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.765 ' HB3' ' HA ' ' A' ' 169' ' ' ARG . 31.6 tt0 -133.69 125.9 29.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.05 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 213' ' ' THR . 11.8 m -100.9 176.82 5.15 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.565 ' H ' HG22 ' A' ' 212' ' ' THR . 17.2 m -64.33 92.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.003 0.43 . . . . 0.0 110.836 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 90.7 m -93.61 113.87 61.45 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.308 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.52 115.96 3.5 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.864 2.376 . . . . 0.0 111.979 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 47.9 tp -80.85 112.82 35.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.181 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 12.2 Cg_endo -90.62 21.19 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.385 2.724 . . . . 0.0 112.49 -177.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -144.55 168.3 20.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.025 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 10.8 p -100.98 -32.28 3.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 12.9 t 67.24 -70.05 0.12 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 117.45 152.2 9.47 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.733 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.2 m -151.02 72.83 8.63 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 120.649 0.261 . . . . 0.0 110.869 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.85 -17.1 15.87 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.383 2.055 . . . . 0.0 112.166 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 96.0 -174.64 31.64 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.59 140.15 46.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.748 0.274 . . . . 0.0 110.579 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.05 -44.75 53.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.403 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 20.3 pt -79.24 124.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.54 174.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.9 m -104.9 104.64 47.55 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 227' ' ' ILE . 5.2 Cg_exo -79.77 127.81 7.3 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.252 2.635 . . . . 0.0 112.042 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.542 HD11 HG23 ' A' ' 233' ' ' THR . 1.9 tm? -69.2 119.99 73.83 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 232' ' ' SER . 23.3 Cg_exo -64.05 -82.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.611 2.208 . . . . 0.0 112.382 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.454 ' H ' ' HB2' ' A' ' 231' ' ' PRO . 41.3 m -165.73 118.45 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.125 176.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.542 HG23 HD11 ' A' ' 230' ' ' LEU . 12.1 p -80.32 145.95 31.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.531 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.442 ' H ' ' HG3' ' A' ' 234' ' ' GLN . 3.7 pp0? -81.52 16.04 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.432 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.476 ' OD1' ' HB ' ' A' ' 233' ' ' THR . 2.2 m-20 -57.08 -45.95 82.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.764 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 166.14 89.13 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.122 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -89.49 97.61 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.825 2.35 . . . . 0.0 112.209 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.588 ' HB ' HG13 ' A' ' 266' ' ' VAL . 21.7 t -82.71 142.28 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.47 134.95 52.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.02 0.438 . . . . 0.0 110.922 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.581 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -138.93 131.87 29.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.372 175.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.417 ' HG3' ' CE1' ' A' ' 294' ' ' PHE . 92.3 mttt -84.46 124.02 30.89 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.613 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -76.94 100.42 5.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.018 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 36.0 pt -88.79 -15.69 8.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.266 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -140.3 135.69 32.49 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.43 ' HG3' HG23 ' A' ' 260' ' ' VAL . 27.4 mtpp -50.68 137.19 20.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 112.547 -175.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.728 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -111.86 91.64 3.73 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.589 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.9 m -86.28 156.16 57.09 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.781 0.324 . . . . 0.0 111.306 -175.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.41 ' HA ' ' HB1' ' A' ' 255' ' ' ALA . 17.1 Cg_exo -67.37 111.59 2.34 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.881 2.387 . . . . 0.0 111.88 176.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 42.7 t -68.56 165.17 19.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.18 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.93 -27.78 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -171.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -73.84 -21.61 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.536 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 41.82 68.66 0.43 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.601 0.76 . . . . 0.0 112.217 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -148.31 -62.04 0.25 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.056 0.455 . . . . 0.0 110.837 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.7 p -99.34 11.31 39.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.14 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' A' ' 248' ' ' PRO . . . -95.03 107.04 19.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.312 -174.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.49 120.0 27.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.728 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -75.98 111.25 11.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.143 0.497 . . . . 0.0 110.586 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.0 mt -114.52 144.14 43.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.315 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.99 167.41 9.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.371 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.43 HG23 ' HG3' ' A' ' 245' ' ' LYS . 58.3 t -77.41 121.31 29.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.976 0.417 . . . . 0.0 110.489 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 100.32 9.95 46.25 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.87 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -92.1 148.77 21.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 16.4 mm -99.35 111.65 29.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 0.0 110.186 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.502 HG21 HG11 ' A' ' 291' ' ' VAL . 35.7 t -87.51 115.21 27.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.179 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.5 ttpp -96.91 98.95 10.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.588 HG13 ' HB ' ' A' ' 238' ' ' VAL . 6.5 p -94.85 124.72 47.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.264 0.554 . . . . 0.0 110.585 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 88.2 m -116.75 -35.19 4.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.052 176.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -91.36 92.29 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.224 0.535 . . . . 0.0 110.07 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' MET . . . . . 0.789 ' HA ' ' HB3' ' A' ' 275' ' ' TRP . 29.9 mtt -97.58 139.61 33.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.879 0.371 . . . . 0.0 110.886 177.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -93.57 -175.01 3.65 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.3 tt -73.52 71.87 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.796 0.808 . . . . 0.0 110.976 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 41.3 t30 73.65 -37.99 0.39 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.903 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 274' ' ' GLN . . . -91.43 78.59 1.34 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.159 -1.019 . . . . 0.0 113.02 -169.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 287' ' ' PRO . 46.5 mt-30 75.67 128.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.894 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.789 ' HB3' ' HA ' ' A' ' 269' ' ' MET . 0.6 OUTLIER -124.62 169.57 11.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.36 -169.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 38.8 mt-10 -107.54 108.45 19.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.607 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.31 133.3 11.58 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.168 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 283' ' ' LYS . 1.4 pm0 -95.04 108.81 20.9 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.291 0.567 . . . . 0.0 109.489 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 27.1 t -115.74 -87.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.143 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -92.04 72.67 5.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.08 0.467 . . . . 0.0 111.059 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.89 4.89 78.41 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.729 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 282' ' ' ARG . 14.3 ptt180 -159.97 162.6 34.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.207 0.503 . . . . 0.0 111.426 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.59 ' HB3' ' HB3' ' A' ' 278' ' ' GLU . 10.1 ptmm? -116.88 138.79 51.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -154.35 175.8 32.4 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.146 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.49 127.17 34.84 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.094 0.473 . . . . 0.0 110.792 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -127.43 125.76 23.97 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.023 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 17.0 Cg_exo -68.31 139.61 46.21 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.636 2.224 . . . . 0.0 111.409 176.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -75.66 26.26 0.11 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.7 t -115.48 -9.82 12.03 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.961 0.41 . . . . 0.0 109.953 171.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -90.34 -30.34 17.51 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.613 HG12 ' HA ' ' A' ' 242' ' ' ALA . 18.0 m -124.25 161.53 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.51 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -130.75 133.16 45.78 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.02 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 240' ' ' ALA . 43.6 mm -70.76 111.98 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.723 178.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.417 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 34.8 p90 -111.12 142.08 43.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.901 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.718 ' HB3' ' HB2' ' A' ' 298' ' ' ASN . 38.8 t70 -72.11 124.11 90.39 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.473 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 295' ' ' ASP . 39.6 Cg_exo -57.81 -32.41 94.84 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.168 2.579 . . . . 0.0 113.179 -176.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.453 ' HG3' ' OD2' ' A' ' 295' ' ' ASP . 8.3 pt20 -98.07 9.05 43.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.802 0.334 . . . . 0.0 111.205 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.718 ' HB2' ' HB3' ' A' ' 295' ' ' ASP . 64.7 m-20 -129.56 81.86 68.75 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.905 175.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.56 88.03 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.077 2.518 . . . . 0.0 111.677 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 76.64 16.95 1.9 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.872 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' GLU . . . . . 0.653 ' HB3' ' HB3' ' A' ' 298' ' ' ASN . 10.5 tp10 -85.77 83.31 7.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 170.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -115.19 -75.15 0.59 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.493 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.648 -0.692 . . . . 0.0 110.182 -177.643 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mmt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -112.92 -55.44 2.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 172.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.484 ' HB3' HD12 ' A' ' 99' ' ' ILE . 70.2 m 67.23 -59.37 0.4 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.913 0.758 . . . . 0.0 111.071 -176.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.427 ' HB1' ' HE3' ' A' ' 89' ' ' LYS . . . -75.37 111.97 11.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.902 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -134.38 84.96 2.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.847 0.355 . . . . 0.0 111.0 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.418 ' HE1' ' O ' ' A' ' 98' ' ' LEU . 41.7 p90 -161.22 164.22 30.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.863 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 12.8 t70 -90.02 120.24 31.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 40.5 m -70.13 -16.53 63.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.856 -172.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -103.46 -11.79 17.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.89 0.376 . . . . 0.0 111.505 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 11.1 t0 -75.62 94.47 3.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.174 0.512 . . . . 0.0 110.879 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.3 mtm-85 -65.84 -25.19 67.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.311 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -73.88 1.83 9.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.849 0.357 . . . . 0.0 110.781 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.84 -47.43 3.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.718 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -114.05 -20.34 11.03 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -76.21 120.32 21.33 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.104 -0.372 . . . . 0.0 110.999 -172.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.642 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.6 mmt -102.12 -16.18 16.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.963 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.473 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.88 -112.57 1.71 Allowed Glycine 0 CA--C 1.525 0.667 0 O-C-N 123.431 0.457 . . . . 0.0 113.543 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.473 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 16.8 Cg_exo -66.55 83.06 0.3 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.217 2.611 . . . . 0.0 113.518 -176.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.966 HG12 ' H ' ' A' ' 20' ' ' SER . 57.5 t -135.33 -164.66 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.966 ' H ' HG12 ' A' ' 19' ' ' VAL . 45.7 p -172.68 174.32 3.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -168.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -53.07 60.9 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.092 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -57.12 -61.9 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.495 0.497 . . . . 0.0 111.532 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -57.72 -47.16 83.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.654 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.87 74.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.055 0.455 . . . . 0.0 111.641 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -61.56 -44.34 97.22 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.801 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m -57.85 -38.33 75.47 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -81.31 -9.52 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 80.1 mt -122.41 -12.98 8.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -74.36 117.26 15.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.971 0.415 . . . . 0.0 111.272 -174.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.97 3.05 63.19 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.75 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -80.75 -171.42 3.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.654 0.264 . . . . 0.0 110.453 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.462 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 17.2 mtm180 -60.79 152.71 26.3 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.652 ' HE1' ' HB2' ' A' ' 118' ' ' LEU . 62.3 m170 -98.54 142.08 30.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.11 -9.04 54.3 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -172.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.64 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 73.8 mtp -76.75 138.25 39.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.38 -0.41 . . . . 0.0 109.895 176.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' HB2' HG22 ' A' ' 52' ' ' VAL . 27.3 p90 -144.02 167.47 22.29 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.642 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -158.94 146.93 17.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.5 116.11 50.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.677 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.493 ' NH2' ' HE2' ' A' ' 207' ' ' PTR . 36.1 ptt-85 -114.17 -179.31 3.6 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.601 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -86.46 138.04 32.07 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -89.23 177.77 6.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.398 0.618 . . . . 0.0 111.433 -174.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 m -110.4 -4.94 15.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.21 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 p -73.98 -65.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.822 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 26.6 m -133.37 143.29 47.49 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.639 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.93 88.64 0.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.239 1.959 . . . . 0.0 111.334 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 145.72 -21.63 1.82 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -77.52 150.99 34.76 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -130.43 173.78 10.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG22 HG12 ' A' ' 62' ' ' ILE . 9.5 t -138.93 109.67 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.122 0.487 . . . . 0.0 111.722 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.404 ' HB2' HD11 ' A' ' 63' ' ' ILE . 51.6 tp -83.29 97.61 8.99 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.322 175.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.9 m -95.75 117.09 29.86 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.685 0.278 . . . . 0.0 110.254 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.651 HG21 HD13 ' A' ' 93' ' ' LEU . 60.4 t -113.23 133.62 58.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.405 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 48.1 t -102.05 118.05 36.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.712 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 10.7 tp10 -151.18 153.22 34.55 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.465 ' HB2' ' CG ' ' A' ' 57' ' ' ARG . 30.3 m120 57.41 21.85 7.31 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.323 0.389 . . . . 0.0 111.822 -177.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 m 57.6 51.51 9.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.253 1.025 . . . . 0.0 108.996 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.022 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.29 0.0 OUTLIER -166.81 70.03 0.11 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.376 -155.784 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 22.5 t -71.93 110.86 5.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.883 -168.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.3 m -76.64 120.46 21.86 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.282 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.689 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 91.3 m-70 -97.71 89.9 4.79 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -173.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.875 ' HE1' HD11 ' A' ' 153' ' ' ILE . 75.5 m-85 -89.05 106.76 18.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -80.51 136.41 23.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.209 0.528 . . . . 0.0 111.97 -178.652 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.6 mp -117.88 106.57 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.534 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -83.58 148.67 27.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.735 0.302 . . . . 0.0 110.548 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.9 t -85.49 109.32 18.4 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 72' ' ' LYS . 98.2 mt -79.41 147.43 68.28 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.544 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.8 -13.47 37.22 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.695 2.263 . . . . 0.0 110.547 170.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -75.39 -0.72 20.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.366 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 3.1 mmp_? 64.71 28.51 13.04 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.972 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 70' ' ' ARG . 59.1 mtt85 -124.8 157.37 35.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.537 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.526 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 25.7 m-85 -105.6 114.93 29.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.888 0.375 . . . . 0.0 110.519 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.63 ' HB2' HD11 ' A' ' 66' ' ' LEU . 38.6 ttpt -103.53 111.96 24.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.546 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.714 HD11 ' HB3' ' A' ' 61' ' ' TYR . 7.9 tt -93.23 75.26 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 122.179 0.99 . . . . 0.0 109.124 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.442 ' HA3' ' HG2' ' A' ' 209' ' ' GLN . . . 66.07 97.78 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.979 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.749 ' HA ' HG23 ' A' ' 212' ' ' THR . 42.4 t0 75.49 -51.5 0.64 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.649 0.379 . . . . 0.0 111.381 168.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -94.05 119.27 32.69 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.8 pt-20 -100.24 135.77 41.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.319 0.58 . . . . 0.0 110.796 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 94.2 m-85 -115.86 177.12 4.79 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.473 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.43 -49.68 74.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.903 0.382 . . . . 0.0 111.167 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -164.52 -175.43 3.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 15.2 mt -53.22 -58.82 10.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' A' ' 8' ' ' SER . 30.6 Cg_endo -64.89 -4.75 9.31 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.206 1.937 . . . . 0.0 113.433 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.87 -36.63 15.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.813 0.339 . . . . 0.0 110.425 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -77.11 -37.03 55.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.16 -38.8 84.27 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.832 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.599 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 1.9 tp10 -66.26 -43.84 85.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.725 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -64.91 -28.3 69.44 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.432 0.634 . . . . 0.0 110.968 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.494 ' CG ' HD21 ' A' ' 93' ' ' LEU . 20.6 m-85 -92.03 1.73 57.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.324 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.599 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 56.8 mtpt -85.02 3.54 38.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 175.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.3 pt -140.53 -8.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-O 121.252 0.549 . . . . 0.0 109.706 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 4.4 t60 -86.17 -36.68 19.36 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.973 -174.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 93.8 m-85 70.13 91.69 0.09 Allowed 'General case' 0 C--O 1.225 -0.205 0 O-C-N 124.277 0.986 . . . . 0.0 109.033 -166.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.651 HD13 HG21 ' A' ' 52' ' ' VAL . 25.1 mt -58.67 -44.76 90.27 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.351 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.964 ' HA ' ' HG2' ' A' ' 154' ' ' GLU . 28.3 p-10 -150.51 48.82 0.88 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.627 -166.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.8 OUTLIER 70.63 -5.73 1.37 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.413 1.885 . . . . 0.0 111.635 -169.744 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.58 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -126.13 151.64 46.99 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.0 p -96.72 167.05 11.35 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.418 ' O ' ' HE1' ' A' ' 6' ' ' PHE . 72.6 mt -65.38 99.66 0.42 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 3' ' ' SER . 48.0 mm -87.4 -64.06 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.343 -172.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 35' ' ' MET . 42.0 tt0 -156.86 126.01 3.09 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.201 -174.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.68 153.71 47.66 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.023 2.482 . . . . 0.0 113.127 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.439 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -69.62 154.23 94.98 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.514 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.61 115.78 2.76 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 121.904 1.736 . . . . 0.0 111.672 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.498 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 54.3 ttp180 -63.19 -27.16 69.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.439 0.638 . . . . 0.0 109.7 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -78.66 155.67 78.26 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.793 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.422 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 38.2 Cg_endo -66.0 161.7 38.59 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.567 2.178 . . . . 0.0 112.434 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.2 p -112.32 87.31 9.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 42.0 Cg_exo -57.84 -46.86 23.66 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.935 2.423 . . . . 0.0 113.423 175.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 3.7 Cg_exo -79.05 -153.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.98 1.787 . . . . 0.0 111.636 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -64.77 -30.94 71.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.926 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.81 45.57 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.481 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 m 55.35 47.89 20.33 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.687 0.395 . . . . 0.0 111.397 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.7 t 66.44 97.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.686 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.509 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 3.8 m -86.63 92.47 8.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.274 -178.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.62 93.48 14.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.931 0.396 . . . . 0.0 111.062 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 114' ' ' SER . 84.1 Cg_endo -98.71 118.23 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 123.426 2.751 . . . . 0.0 112.831 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -71.76 90.09 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.652 ' HB2' ' HE1' ' A' ' 33' ' ' HIS . 1.3 tm? -177.85 131.32 0.32 Allowed Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -175.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 118' ' ' LEU . 24.0 Cg_exo -64.45 79.45 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.71 2.274 . . . . 0.0 112.402 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.9 m 63.07 -86.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.231 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 177.19 -73.54 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 123.073 0.549 . . . . 0.0 109.787 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 64.81 22.81 12.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.875 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 124' ' ' ASN . 17.4 m-20 59.73 -145.56 0.51 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.918 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 123' ' ' ASP . 0.9 OUTLIER 78.04 161.42 0.21 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.749 0.656 . . . . 0.0 111.759 177.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.881 HD12 HG21 ' A' ' 152' ' ' ILE . 3.3 mm? 65.03 99.21 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.504 175.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 44.3 tt0 -175.59 -54.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.207 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.756 ' HB2' HG22 ' A' ' 182' ' ' VAL . 55.0 m-85 -118.5 107.5 13.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.909 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.67 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 4.2 t -116.26 140.02 40.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.719 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 4.9 ptp180 -115.24 138.61 50.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 116.71 -1.996 . . . . 0.0 108.682 164.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.634 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -100.67 125.5 47.1 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.738 -178.036 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.462 HD21 ' HG2' ' A' ' 179' ' ' GLU . 17.2 mt -99.22 -26.32 14.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.243 -173.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 34.7 t80 -73.48 -41.98 62.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -172.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.548 ' HB2' ' N ' ' A' ' 146' ' ' LYS . 6.0 t70 75.24 100.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.699 0.761 . . . . 0.0 110.832 -174.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 53.5 t80 -128.7 86.78 56.66 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.594 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 89.6 Cg_endo -83.6 86.72 1.33 Allowed 'Trans proline' 0 N--CA 1.441 -1.611 0 C-N-CA 121.147 1.231 . . . . 0.0 112.368 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.67 -24.47 60.35 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.541 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.6 m120 61.6 50.83 4.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.709 -1.246 . . . . 0.0 112.22 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.422 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 4.8 m-20 -136.67 176.25 8.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.273 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.82 -13.83 35.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 122.11 0.957 . . . . 0.0 108.496 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 172' ' ' MET . 19.6 mm-40 -88.02 -31.4 19.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.244 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -135.2 105.76 6.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.939 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.037 HD11 ' HB2' ' A' ' 165' ' ' ASN . 26.5 tp -66.94 128.79 94.0 Favored Pre-proline 0 CA--C 1.51 -0.563 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.989 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.621 ' HD2' HD12 ' A' ' 142' ' ' LEU . 92.4 Cg_endo -79.34 98.08 1.14 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 121.384 1.389 . . . . 0.0 111.306 173.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.562 ' CD2' ' HB ' ' A' ' 130' ' ' THR . 0.5 OUTLIER -89.32 -165.1 1.26 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.574 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.54 ' C ' ' HB2' ' A' ' 133' ' ' ASP . 56.2 mtpt -139.49 -176.02 4.39 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.408 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.946 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -82.99 50.41 1.72 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.665 0.745 . . . . 0.0 110.665 -174.653 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.99 35.28 0.17 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.663 ' OE1' ' HB2' ' A' ' 166' ' ' LYS . 5.1 tp10 -84.34 151.8 24.5 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.983 -173.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.3 122.82 64.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.549 0.69 . . . . 0.0 109.157 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.734 HD22 ' CD2' ' A' ' 142' ' ' LEU . 65.4 mt -123.67 157.57 33.53 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.008 -171.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 66.1 t -117.3 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.075 HD13 ' HB2' ' A' ' 163' ' ' ALA . 45.6 mm -76.86 95.48 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-O 122.177 0.989 . . . . 0.0 109.508 -175.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.875 HD11 ' HE1' ' A' ' 61' ' ' TYR . 19.3 tt -81.64 -28.07 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.602 -175.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.022 ' HA ' HH21 ' A' ' 57' ' ' ARG . 4.0 mt-10 -136.37 144.39 44.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.144 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.642 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 86.8 tttt -124.31 76.53 61.28 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 164.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.563 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 23.2 Cg_exo -67.2 -51.17 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.768 2.312 . . . . 0.0 111.778 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -113.8 177.54 4.6 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.619 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -100.18 -16.98 17.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.976 0.417 . . . . 0.0 110.3 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -99.8 -19.79 16.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.593 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 39.7 m95 -129.74 141.95 50.79 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.752 ' O ' HG13 ' A' ' 173' ' ' ILE . 46.5 m0 -124.92 137.86 54.26 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 6.1 m -97.7 109.88 22.55 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.075 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -121.29 152.1 39.3 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.244 -176.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.775 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 27.1 ptt-85 -87.65 127.69 35.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 173.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.037 ' HB2' HD11 ' A' ' 142' ' ' LEU . 56.3 t30 -61.75 178.01 0.37 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.133 -172.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.684 ' HG2' HG22 ' A' ' 214' ' ' THR . 3.6 ttmp? -54.19 -26.03 25.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.303 166.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 211' ' ' GLN . 24.7 m-20 -74.98 -38.45 61.66 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.03 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.479 ' HA3' ' HB2' ' A' ' 211' ' ' GLN . . . 115.32 -11.85 19.37 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.458 -175.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.775 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -59.12 138.18 57.66 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.26 0.624 . . . . 0.0 112.051 177.434 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 74.0 t -88.76 121.07 38.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.542 177.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -153.73 156.2 26.64 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.438 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.593 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -77.55 143.68 38.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.805 0.303 . . . . 0.0 111.295 178.714 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -142.07 142.0 23.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.526 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 20.4 Cg_exo -65.95 129.46 22.02 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.715 2.277 . . . . 0.0 112.879 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.614 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 44.9 t -62.72 -40.1 60.68 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 17.5 Cg_endo -59.39 -11.28 13.11 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.023 1.815 . . . . 0.0 112.627 175.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -93.29 -10.53 35.16 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.604 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.634 HG12 HG22 ' A' ' 130' ' ' THR . 2.1 m -105.98 -177.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -166.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.719 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 3.4 tp10 -159.43 44.82 0.25 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 112.467 -2.151 . . . . 0.0 110.833 -154.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.77 ' H ' ' HD2' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -74.02 138.7 44.25 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 119.174 -2.204 . . . . 0.0 112.87 -162.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 22.8 tp -75.77 -70.55 0.43 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 110.773 -2.921 . . . . 0.0 111.386 -168.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.756 HG22 ' HB2' ' A' ' 127' ' ' TYR . 16.5 m -78.2 70.33 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 122.151 0.977 . . . . 0.0 110.329 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.76 -52.75 0.09 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.056 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.3 m 48.63 73.78 0.21 Allowed 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 124.292 0.995 . . . . 0.0 111.02 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 3.7 m -53.56 147.6 20.63 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.108 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.82 104.57 0.1 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.57 2.18 . . . . 0.0 112.589 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.896 ' HB2' ' HB3' ' A' ' 190' ' ' HIS . 40.5 m80 -124.01 -14.91 7.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.35 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.06 -98.96 1.76 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -174.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -71.44 90.91 1.0 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 170.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.896 ' HB3' ' HB2' ' A' ' 187' ' ' HIS . 22.6 p-80 -136.16 136.48 40.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.985 -175.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 80.1 -45.86 3.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.149 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 63.83 14.46 8.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.855 0.462 . . . . 0.0 111.198 176.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.541 ' HD2' ' N ' ' A' ' 193' ' ' ARG . 3.4 mpt_? 55.48 39.06 31.03 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.733 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -67.71 -29.45 68.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.562 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.1 p -147.92 114.23 5.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.644 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -90.11 -75.03 0.47 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 54.4 p -179.54 148.7 0.35 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.834 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -74.44 -22.45 59.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.532 0.682 . . . . 0.0 109.314 174.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.5 ' O ' ' HB ' ' A' ' 200' ' ' ILE . . . 161.45 69.9 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.29 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.5 ' HB ' ' O ' ' A' ' 199' ' ' GLY . 2.0 mp 74.06 118.26 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.31 0 CA-C-O 121.113 0.482 . . . . 0.0 110.504 -174.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 7.6 Cg_exo -73.01 144.72 38.54 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.099 2.533 . . . . 0.0 112.085 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -116.57 95.76 46.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.528 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -91.04 -7.64 3.64 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.698 2.265 . . . . 0.0 112.087 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 59.78 81.13 0.18 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.234 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -81.76 87.69 6.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.03 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -88.86 -166.68 1.66 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.243 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' PTR . . . . . 0.689 ' HD2' ' HB3' ' A' ' 60' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.514 ' HB3' ' N ' ' A' ' 60' ' ' HIS . . . -90.32 3.83 52.52 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.307 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.543 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 49.8 tt0 -47.24 129.73 9.7 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.635 173.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 209' ' ' GLN . 15.8 Cg_exo -64.08 102.76 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.809 1.673 . . . . 0.0 109.756 177.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.479 ' HB2' ' HA3' ' A' ' 168' ' ' GLY . 78.6 mm-40 -46.96 141.15 4.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.143 0.497 . . . . 0.0 112.131 -171.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.749 HG23 ' HA ' ' A' ' 75' ' ' ASP . 18.0 m -88.14 88.26 7.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.378 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 10.2 m 72.02 157.48 0.18 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.804 0.69 . . . . 0.0 110.24 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.684 HG22 ' HG2' ' A' ' 166' ' ' LYS . 9.6 p -54.37 118.76 17.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.26 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.97 90.3 0.25 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.028 2.485 . . . . 0.0 112.001 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.45 ' N ' ' HD2' ' A' ' 217' ' ' PRO . 91.6 mt -72.84 -53.89 5.05 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.987 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 216' ' ' LEU . 18.6 Cg_endo -61.34 -54.56 1.67 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.802 1.668 . . . . 0.0 112.134 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -167.08 164.34 15.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.621 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.57 -41.11 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.262 0.553 . . . . 0.0 110.248 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 28.6 m -147.49 101.61 3.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.706 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 178.81 -167.94 38.57 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.798 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 23.1 t -147.59 139.18 13.66 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 26.0 Cg_exo -63.96 147.62 91.86 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.865 2.377 . . . . 0.0 112.235 177.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -166.4 150.09 16.83 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.041 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.583 ' HB1' ' HG3' ' A' ' 229' ' ' PRO . . . 59.24 64.37 1.38 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 122.83 0.452 . . . . 0.0 111.745 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -84.73 117.85 24.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.123 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.6 mt 70.55 -64.91 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.714 0.634 . . . . 0.0 110.994 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 83.6 m -151.27 126.75 4.87 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 177.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.583 ' HG3' ' HB1' ' A' ' 225' ' ' ALA . 10.7 Cg_exo -69.28 -92.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.52 2.147 . . . . 0.0 111.735 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.487 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 86.5 mt -151.77 127.37 4.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.902 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 23.9 Cg_exo -65.06 171.82 8.3 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.854 2.369 . . . . 0.0 111.674 174.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 24.2 m -61.53 97.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.812 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 234' ' ' GLN . 3.3 p -92.59 -28.86 16.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.794 -175.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 233' ' ' THR . 59.0 mm-40 67.88 85.1 0.15 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.76 0.662 . . . . 0.0 111.251 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.78 3.25 39.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.532 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 107.02 88.89 2.06 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.25 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 7.5 Cg_exo -73.51 89.1 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.61 2.206 . . . . 0.0 110.831 171.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.617 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 27.7 t -93.43 145.22 8.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.037 -174.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -93.77 123.45 37.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.173 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.81 143.34 47.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.175 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 45.0 tttp -90.89 119.08 30.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.15 0.5 . . . . 0.0 109.752 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.94 ' HB1' ' HG2' ' A' ' 259' ' ' GLU . . . -84.23 127.22 33.81 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.781 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 46.2 pt -128.12 -30.1 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -168.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 19.7 tm0? -82.62 -75.9 0.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.298 -169.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.692 ' HA ' ' CB ' ' A' ' 259' ' ' GLU . 1.0 OUTLIER 153.85 131.25 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.391 1.476 . . . . 0.0 108.183 168.495 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 19.2 mmm180 -124.2 100.61 6.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.917 0.389 . . . . 0.0 110.968 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.5 m -117.42 127.0 26.96 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.453 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.558 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 88.9 Cg_endo -87.8 160.86 7.63 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.029 2.486 . . . . 0.0 112.266 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 11.7 t -94.25 -177.1 4.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.41 -21.88 66.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.918 0.39 . . . . 0.0 111.18 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.09 -22.27 36.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.4 -178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 248' ' ' PRO . 37.7 m-20 -93.48 102.81 15.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.191 -172.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -94.9 -33.9 12.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.171 0.51 . . . . 0.0 109.734 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 19.5 p -93.25 8.18 41.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.737 -176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -93.0 126.76 38.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.532 HD13 HD21 ' A' ' 258' ' ' LEU . 0.6 OUTLIER -85.08 122.12 28.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.952 0.406 . . . . 0.0 110.524 -176.252 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -84.06 109.89 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.779 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.571 HD23 ' HB ' ' A' ' 279' ' ' VAL . 0.4 OUTLIER -157.05 -156.25 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.166 176.269 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.94 ' HG2' ' HB1' ' A' ' 242' ' ' ALA . 3.7 mt-10 88.12 139.92 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 24.9 t 82.56 83.16 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 112.695 -2.048 . . . . 0.0 111.114 -172.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 89.98 14.38 59.33 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.417 -0.81 . . . . 0.0 113.48 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -105.36 145.99 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.974 0.416 . . . . 0.0 111.163 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 32.2 mm -98.45 111.4 28.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.534 HG22 HD22 ' A' ' 258' ' ' LEU . 43.5 t -92.83 117.25 35.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 -175.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -96.39 105.67 17.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.102 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 237' ' ' PRO . 2.4 p -94.67 118.01 39.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.999 0.428 . . . . 0.0 110.304 176.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -93.8 -24.37 17.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.173 0.511 . . . . 0.0 110.763 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 88.8 mtt180 -121.56 98.27 5.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.801 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' MET . . . . . 0.617 ' HE3' ' HB ' ' A' ' 238' ' ' VAL . 1.2 mtt -91.39 112.93 25.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.321 0.581 . . . . 0.0 111.373 -176.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -92.13 158.79 15.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.173 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.5 tt -91.28 -14.98 8.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.347 0.594 . . . . 0.0 109.851 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.99 23.02 1.57 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.8 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 91.04 -55.63 3.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.136 -0.554 . . . . 0.0 114.077 168.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.458 ' H ' ' HG2' ' A' ' 274' ' ' GLN . 6.1 pt20 -77.81 114.84 17.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.346 0.593 . . . . 0.0 110.526 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.52 ' HB3' HG21 ' A' ' 266' ' ' VAL . 42.9 m0 -94.74 155.65 16.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.457 -175.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 0.2 OUTLIER -107.58 113.29 26.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.425 -179.844 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -141.73 168.35 25.61 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.288 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -118.25 110.16 17.21 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.571 ' HB ' HD23 ' A' ' 258' ' ' LEU . 43.9 t -139.93 146.72 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 63.61 24.51 14.0 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.094 0.473 . . . . 0.0 111.02 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 82.16 3.37 90.58 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.238 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -134.24 149.58 50.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.943 0.402 . . . . 0.0 110.767 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -103.6 143.26 32.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.274 178.508 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -172.18 170.74 43.72 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.477 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 95.3 mt -90.34 133.5 34.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.119 0.485 . . . . 0.0 111.122 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -134.62 147.85 64.93 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.184 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -87.77 139.29 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.685 2.257 . . . . 0.0 112.752 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -70.53 -11.52 60.98 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.063 0.459 . . . . 0.0 111.016 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.5 p -78.23 4.84 11.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.236 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -116.94 -49.11 2.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.657 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 242' ' ' ALA . 27.5 m -85.98 152.52 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.216 -175.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -109.29 124.34 50.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.797 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 240' ' ' ALA . 20.8 mm -79.77 127.62 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.473 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.468 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 2.6 p90 -146.08 173.19 12.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.166 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.614 ' HB2' ' HG2' ' A' ' 297' ' ' GLN . 14.7 p-10 -107.66 98.7 25.6 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-O 121.373 0.606 . . . . 0.0 111.049 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 3.9 Cg_exo -76.69 14.53 1.22 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.759 2.973 . . . . 0.0 111.97 -178.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.614 ' HG2' ' HB2' ' A' ' 295' ' ' ASP . 13.7 pt20 -78.66 -11.39 59.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.877 175.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 45.1 m-80 -93.07 150.53 39.38 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.447 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 5.3 Cg_exo -79.2 12.33 2.34 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 123.175 2.583 . . . . 0.0 112.889 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.26 -46.54 88.34 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -113.52 79.46 1.25 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.493 0.663 . . . . 0.0 110.152 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -144.42 93.64 2.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.119 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.575 -177.358 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 98' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -114.73 25.32 11.06 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.361 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.552 ' CE1' ' HB1' ' A' ' 4' ' ' ALA . 46.2 p90 -69.47 140.49 54.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 165.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.45 118.69 18.59 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.582 -178.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.668 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 17.0 m -90.52 78.73 6.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.85 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -176.39 -53.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.068 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 12' ' ' SER . 34.8 t70 -78.18 127.75 32.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.311 0.577 . . . . 0.0 111.562 -170.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -51.82 -37.68 52.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.674 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.464 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 3.2 m -73.87 23.97 0.08 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.875 0.369 . . . . 0.0 111.929 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.428 ' HB3' ' HD1' ' A' ' 14' ' ' TRP . . . -118.59 -47.19 2.54 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.883 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.428 ' HD1' ' HB3' ' A' ' 13' ' ' ALA . 28.3 p-90 -132.21 -22.39 2.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -166.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -86.86 119.71 27.38 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.942 -171.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 55.6 mtt -117.09 5.78 12.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.908 0.385 . . . . 0.0 111.143 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 49.91 -114.4 2.4 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.247 -0.888 . . . . 0.0 114.73 174.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 15.3 Cg_exo -69.01 95.96 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.916 2.411 . . . . 0.0 112.608 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.859 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 95.3 t -128.88 -71.53 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.117 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.888 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 54.1 m 78.52 170.01 0.2 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.196 0.598 . . . . 0.0 110.439 172.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -49.05 -43.61 40.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 1.5 pt20 -46.57 -58.57 3.69 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.956 0.785 . . . . 0.0 112.81 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.54 ' HB2' HG13 ' A' ' 19' ' ' VAL . 23.5 mm-40 -85.65 -43.46 13.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.118 0.485 . . . . 0.0 110.467 -172.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.76 -37.41 63.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.765 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -72.25 -35.97 68.95 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.554 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 23' ' ' GLU . 10.8 t -79.8 -32.62 40.79 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.192 -174.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -84.65 -15.06 46.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.082 0.468 . . . . 0.0 111.173 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.475 HD11 ' HG ' ' A' ' 37' ' ' LEU . 78.3 mt -117.11 30.44 7.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.298 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -113.73 139.69 48.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.238 0.542 . . . . 0.0 111.671 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.09 -47.85 3.93 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.653 ' O ' ' HG3' ' A' ' 32' ' ' ARG . 77.9 mt-30 -131.91 80.47 1.92 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 118.875 1.338 . . . . 0.0 111.801 -168.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.981 ' HA ' ' HE2' ' A' ' 35' ' ' MET . 0.0 OUTLIER -169.22 146.07 3.49 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.523 -176.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.98 104.91 1.93 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 166.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.44 -3.67 69.09 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.566 -173.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.981 ' HE2' ' HA ' ' A' ' 32' ' ' ARG . 57.7 mtm -85.61 138.07 32.42 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.932 0.396 . . . . 0.0 110.511 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -144.27 174.33 10.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.743 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.2 pp -160.45 143.37 13.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.747 172.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.05 135.88 45.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.888 ' HD2' ' H ' ' A' ' 20' ' ' SER . 22.5 ptt-85 -139.64 155.26 47.52 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.397 -173.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.432 ' OD1' ' HA2' ' A' ' 17' ' ' GLY . 2.2 m-20 -66.18 118.25 9.63 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 168.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.525 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.4 t -84.44 170.06 13.91 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.993 0.425 . . . . 0.0 110.263 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t -112.23 7.13 19.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.484 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -53.68 27.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 47.4 t -170.62 121.74 0.55 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.414 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -40.41 104.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.464 2.776 . . . . 0.0 112.465 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.11 -21.73 2.62 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.209 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -103.25 145.36 30.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.076 0.465 . . . . 0.0 109.773 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.565 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 24.8 m-85 -126.42 160.19 31.18 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 41' ' ' SER . 44.0 t -128.16 103.46 10.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.471 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 tp -79.66 98.38 6.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.399 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 m -96.0 120.1 35.68 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.279 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.635 HG21 HD13 ' A' ' 93' ' ' LEU . 54.5 t -116.83 134.24 61.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.28 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 31.8 t -103.58 111.63 24.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.209 0.528 . . . . 0.0 111.78 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.557 ' HG3' ' HB ' ' A' ' 96' ' ' THR . 3.2 mm-40 -150.01 152.71 35.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.071 173.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 56.74 28.12 13.79 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.501 0.501 . . . . 0.0 110.877 -171.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.9 m 60.31 28.38 17.99 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.281 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 53' ' ' SER . 12.0 ptt-85 -124.53 158.29 33.29 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 t -110.56 95.21 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 t -81.22 118.8 22.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -100.63 99.91 10.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.675 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.793 ' HE1' HD11 ' A' ' 153' ' ' ILE . 63.1 m-85 -98.09 113.7 25.66 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.74 0.305 . . . . 0.0 111.205 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 68.5 mt -82.3 131.52 33.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.427 0.632 . . . . 0.0 112.448 -174.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 4.3 mp -98.25 122.55 50.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.176 174.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -111.4 132.53 54.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -77.78 110.35 12.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.449 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.726 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 93.1 mt -77.93 170.85 14.32 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.726 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 23.5 Cg_endo -61.69 56.37 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.007 2.472 . . . . 0.0 114.412 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 t30 79.92 4.99 1.94 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.34 0.656 . . . . 0.0 111.964 161.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -97.6 -51.26 4.18 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.836 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.684 ' HB3' ' HA ' ' A' ' 79' ' ' ASP . 5.8 ptp180 -156.32 -171.69 3.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.865 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.401 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 45.6 m-85 -109.72 157.92 18.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.595 0.236 . . . . 0.0 110.476 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.76 ' HE3' ' HA ' ' A' ' 75' ' ' ASP . 55.9 tttp -129.27 96.54 4.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.675 0.274 . . . . 0.0 110.278 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.547 HD13 ' HE2' ' A' ' 88' ' ' TYR . 3.1 tt -97.1 94.12 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.496 0.665 . . . . 0.0 109.869 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.94 57.38 7.84 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.277 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.76 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 25.1 t0 76.74 -50.21 0.57 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.16 0.584 . . . . 0.0 111.487 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -61.5 123.2 17.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.888 0.375 . . . . 0.0 110.057 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -107.2 130.33 54.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.723 0.773 . . . . 0.0 111.809 -176.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.542 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 7.8 m-85 -127.74 150.28 49.86 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.684 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 9.9 m-20 -62.43 -26.05 68.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -170.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 4.7 p80 -161.95 172.78 15.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.029 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.61 HD23 HD21 ' A' ' 84' ' ' LEU . 11.6 mt -56.55 -51.45 81.1 Favored Pre-proline 0 CA--C 1.537 0.455 0 O-C-N 123.373 0.42 . . . . 0.0 111.868 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.668 ' HB3' ' O ' ' A' ' 8' ' ' SER . 60.3 Cg_exo -57.35 -11.34 8.15 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.661 2.24 . . . . 0.0 114.095 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.95 -36.11 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.236 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.61 HD21 HD23 ' A' ' 81' ' ' LEU . 3.9 pp -76.33 -26.97 56.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.071 0.462 . . . . 0.0 110.557 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.81 -15.68 62.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.784 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -86.16 -37.46 18.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.886 0.374 . . . . 0.0 110.566 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -63.84 -37.7 88.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.28 0.562 . . . . 0.0 110.49 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.547 ' HE2' HD13 ' A' ' 73' ' ' ILE . 38.8 m-85 -81.77 -1.16 46.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.545 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.439 ' O ' HG21 ' A' ' 97' ' ' THR . 7.7 tmtm? -76.26 -24.89 54.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.106 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -115.57 -12.67 11.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.478 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.516 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 12.3 t-160 -72.44 -41.56 66.01 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.995 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.567 ' HA ' HG22 ' A' ' 97' ' ' THR . 83.6 m-85 72.8 108.9 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.379 1.049 . . . . 0.0 109.548 -167.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.736 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 4.9 mt -82.53 14.14 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 95' ' ' THR . 27.2 t70 172.55 -140.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 156' ' ' PRO . 12.8 t -78.12 -7.12 56.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.305 0.574 . . . . 0.0 109.685 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.557 ' HB ' ' HG3' ' A' ' 54' ' ' GLU . 20.7 m -136.44 158.73 43.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.692 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 92' ' ' TYR . 56.7 p -96.63 -169.12 1.83 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.574 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 74.3 mt -67.53 125.76 27.18 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 167.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.56 -68.67 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.896 0.379 . . . . 0.0 110.415 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.642 ' O ' ' HA ' ' A' ' 35' ' ' MET . 61.8 mm-40 -144.02 149.4 45.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.053 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.38 162.86 37.51 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.754 2.302 . . . . 0.0 113.718 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -78.62 171.59 12.1 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.488 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 74.1 Cg_exo -55.8 177.58 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.581 2.854 . . . . 0.0 114.524 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.699 -178.765 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 1.056 HD23 HG21 ' A' ' 152' ' ' ILE . 10.6 mp . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 122.246 1.022 . . . . 0.0 113.007 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 17.0 tp10 -167.59 -74.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.715 -175.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -107.1 110.39 22.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.187 0.517 . . . . 0.0 111.11 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.526 HG22 ' HG2' ' A' ' 180' ' ' LYS . 70.3 t -127.84 132.04 69.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.687 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.467 ' HB3' HD13 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -112.57 145.0 41.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.87 0.367 . . . . 0.0 110.66 -178.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.882 HG22 HG12 ' A' ' 178' ' ' VAL . 42.1 p -93.29 129.07 39.5 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.332 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 21.2 mt -104.14 -32.98 8.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.717 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.613 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 34.1 t80 -86.12 -36.08 19.8 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -170.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.673 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 2.0 t70 79.65 129.3 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.557 0.535 . . . . 0.0 110.728 -175.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 91.5 t80 -151.39 100.64 2.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -89.1 65.88 2.6 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.595 2.197 . . . . 0.0 113.006 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.95 -29.82 73.81 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.774 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.517 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 47.3 m-80 50.22 73.32 0.27 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.87 0.868 . . . . 0.0 113.313 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -171.14 -176.28 1.89 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.09 -10.13 51.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.535 0.684 . . . . 0.0 109.168 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -94.09 -32.75 13.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.304 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.79 104.78 9.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.733 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.088 HD11 ' HB2' ' A' ' 165' ' ' ASN . 46.2 tp -71.9 117.81 61.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.566 ' HD2' HD12 ' A' ' 142' ' ' LEU . 55.2 Cg_endo -76.59 111.38 3.24 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.062 1.842 . . . . 0.0 111.728 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.627 ' CG ' HG21 ' A' ' 130' ' ' THR . 12.5 p90 -125.91 163.69 22.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.143 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.673 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 20.8 pttm -122.15 -168.51 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.739 -173.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.542 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.4 OUTLIER -80.94 67.15 6.74 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -178.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.9 42.95 0.11 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.413 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.631 ' HG2' ' HG2' ' A' ' 145' ' ' LYS . 5.3 mm-40 -99.2 145.09 27.6 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.535 -0.391 . . . . 0.0 110.073 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.467 HD13 ' HB3' ' A' ' 129' ' ' ARG . 46.5 mm -98.41 124.35 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 175.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.55 HD22 ' HA ' ' A' ' 165' ' ' ASN . 34.2 mt -120.43 158.7 26.64 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 90.4 t -119.0 126.05 75.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.056 HG21 HD23 ' A' ' 125' ' ' LEU . 48.6 mm -75.76 87.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 122.355 1.074 . . . . 0.0 108.913 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.793 HD11 ' HE1' ' A' ' 61' ' ' TYR . 6.7 tt -82.77 -37.36 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.832 -170.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.804 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 20.7 mt-10 -136.0 143.44 44.79 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -131.8 90.54 35.94 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 121.593 -0.692 . . . . 0.0 111.41 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.649 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 6.7 Cg_exo -74.05 -52.14 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.401 2.067 . . . . 0.0 111.957 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -115.19 -179.12 3.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.436 ' O ' HG21 ' A' ' 175' ' ' VAL . 42.1 mt-10 -102.48 -25.48 13.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.831 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 175' ' ' VAL . 7.6 tt0 -85.45 -27.78 25.48 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.237 0.541 . . . . 0.0 110.404 175.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.479 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 45.4 m95 -128.86 124.19 34.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.634 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.563 ' O ' HG13 ' A' ' 173' ' ' ILE . 52.6 m0 -111.3 148.32 33.18 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.804 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 33.3 m -95.63 101.01 12.67 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.756 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.93 153.96 22.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.573 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.9 ptt180 -96.2 133.4 40.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.088 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.2 t30 -74.27 -177.5 3.04 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.777 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 166' ' ' LYS . 38.6 ttmt -62.44 -26.21 68.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.04 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.649 ' OD1' ' HB3' ' A' ' 165' ' ' ASN . 54.0 p-10 -90.56 3.7 53.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.335 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.04 -1.08 87.8 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.804 -0.635 . . . . 0.0 113.131 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 25.7 ttm-85 -64.67 129.22 38.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.698 0.285 . . . . 0.0 111.021 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.409 HG21 HD13 ' A' ' 153' ' ' ILE . 40.4 t -98.97 111.68 29.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.038 178.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.39 165.65 26.32 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 175.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.649 ' HE3' ' HG2' ' A' ' 156' ' ' PRO . 21.0 mtp -79.92 138.47 37.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.13 0.465 . . . . 0.0 110.229 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.592 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -133.7 145.61 56.87 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.023 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.479 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 4.6 Cg_exo -77.3 131.97 12.13 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.809 2.339 . . . . 0.0 112.371 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.569 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 57.2 t -62.05 -43.27 85.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 18.3 Cg_endo -61.37 -11.6 20.23 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.899 1.732 . . . . 0.0 112.903 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -92.17 -12.34 33.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.53 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.882 HG12 HG22 ' A' ' 130' ' ' THR . 32.7 m -126.6 162.17 31.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.228 0.537 . . . . 0.0 112.376 -169.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -133.98 134.77 42.89 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.931 176.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.526 ' HG2' HG22 ' A' ' 128' ' ' VAL . 45.9 mtmt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.753 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.539 ' HB ' HG13 ' A' ' 266' ' ' VAL . 22.0 t . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -114.73 115.27 26.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.275 0.559 . . . . 0.0 110.941 -175.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -136.55 127.6 27.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.889 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.789 ' HB3' HD13 ' A' ' 263' ' ' ILE . 22.3 pttm -93.06 140.51 29.41 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.271 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.4 110.52 6.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.613 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.477 HG13 ' HG3' ' A' ' 244' ' ' GLN . 26.6 pt -69.1 -32.69 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 111.04 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.477 ' HG3' HG13 ' A' ' 243' ' ' ILE . 23.6 mt-30 -118.41 166.2 12.95 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.478 ' HB3' HG13 ' A' ' 260' ' ' VAL . 9.3 ptpp? -94.81 146.16 24.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.42 0.628 . . . . 0.0 111.099 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.709 HH11 ' HB2' ' A' ' 246' ' ' ARG . 0.0 OUTLIER -128.28 110.85 12.77 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.35 173.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--N 1.316 -0.853 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.689 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -84.55 113.39 21.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.687 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.638 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.3 tt -88.86 117.3 27.76 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.68 120.74 14.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.586 HD22 HG22 ' A' ' 264' ' ' VAL . 95.0 mt -128.12 116.26 19.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.174 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -86.55 158.37 19.54 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.053 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 245' ' ' LYS . 9.6 m -62.1 110.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.509 0.671 . . . . 0.0 111.864 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.99 -1.44 57.79 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.96 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -79.32 138.55 37.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.841 0.321 . . . . 0.0 110.665 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.789 HD13 ' HB3' ' A' ' 241' ' ' LYS . 46.2 mm -84.1 116.64 28.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.04 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.586 HG22 HD22 ' A' ' 258' ' ' LEU . 40.4 t -89.31 114.09 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.307 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -86.26 88.7 7.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.539 HG13 ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -91.85 117.34 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.515 0.674 . . . . 0.0 110.714 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.06 -22.85 13.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.504 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.621 ' HB2' ' HG2' ' A' ' 276' ' ' GLU . 55.6 mtp180 -123.32 126.09 46.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.412 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 53.1 mtt -122.95 127.2 48.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.448 ' HB2' ' HG3' ' A' ' 274' ' ' GLN . 40.3 m-80 -91.68 139.79 30.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 25.9 pt -70.66 -8.29 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.903 0.383 . . . . 0.0 111.858 -173.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -69.1 -30.46 68.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.952 0.406 . . . . 0.0 110.774 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.3 -5.06 13.43 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.572 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.448 ' HG3' ' HB2' ' A' ' 270' ' ' ASN . 7.8 pt20 -94.69 115.0 27.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 175.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.483 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 36.5 m0 -110.42 145.58 37.35 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.146 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.621 ' HG2' ' HB2' ' A' ' 268' ' ' ARG . 1.4 pm0 -112.61 115.38 28.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.556 0.694 . . . . 0.0 110.383 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -118.22 164.21 12.87 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.112 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -102.02 110.79 22.84 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.638 ' HB ' HD21 ' A' ' 256' ' ' LEU . 98.7 t -122.76 117.87 53.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.204 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.422 HD22 ' N ' ' A' ' 280' ' ' ASN . 0.9 OUTLIER 64.36 -81.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.369 -175.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -147.32 3.63 0.9 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.364 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.8 mtp-105 -108.31 144.54 35.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.845 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -120.44 121.57 38.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.847 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.512 ' H ' HD12 ' A' ' 256' ' ' LEU . . . -144.95 169.24 26.75 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.404 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 95.5 mt -93.56 113.99 26.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.975 0.417 . . . . 0.0 110.225 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -115.51 143.17 30.0 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.565 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.64 149.89 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.256 1.97 . . . . 0.0 112.205 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -65.17 -16.64 63.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.274 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -5.65 56.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.023 0.44 . . . . 0.0 111.597 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 246' ' ' ARG . 63.4 t60 -96.73 -18.76 19.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.01 0.433 . . . . 0.0 110.662 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 242' ' ' ALA . 31.3 m -128.03 170.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.419 -176.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -131.1 126.4 35.69 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 240' ' ' ALA . 41.5 mm -70.83 130.72 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -133.24 161.26 34.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.033 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 28.2 t0 . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.69 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.27 0.557 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -150.38 92.93 1.92 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.773 0.797 . . . . 0.0 110.652 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -138.88 162.8 33.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.18 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -78.24 93.19 4.58 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.634 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 4.5 p -77.26 65.15 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.304 0.573 . . . . 0.0 110.434 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.4 t -175.48 -41.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.079 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.36 104.46 0.5 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.489 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 9.1 mtm-85 -70.51 -14.39 62.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.554 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -85.31 -1.94 57.52 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.1 -47.79 5.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.722 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 30.2 p-90 -114.95 -29.99 6.53 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 47.9 t80 -75.42 111.21 10.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.631 ' HB3' HG21 ' A' ' 19' ' ' VAL . 10.7 tpp -100.58 1.53 40.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.367 -172.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.6 -114.71 3.23 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.013 -0.994 . . . . 0.0 114.225 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.58 104.3 1.85 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.429 2.086 . . . . 0.0 112.383 -176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.858 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 93.2 t -132.88 -76.35 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 119.256 -0.402 . . . . 0.0 112.037 -174.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.708 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 73.3 m 74.47 167.99 0.29 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -53.36 -32.79 50.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -44.46 -54.72 5.68 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.884 0.74 . . . . 0.0 112.111 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.617 ' HB2' HG13 ' A' ' 19' ' ' VAL . 47.3 mt-10 -95.6 -45.21 7.14 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.262 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.55 -46.65 28.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.28 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.666 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 20.7 mt-30 -64.71 -56.4 13.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.668 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -66.2 -23.44 66.44 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -171.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -86.24 -15.75 39.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.898 0.38 . . . . 0.0 110.692 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.601 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 68.7 mt -121.63 17.89 11.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.593 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 54.8 mm-40 -76.3 70.02 2.87 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.08 -20.04 52.38 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.677 171.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -61.79 123.11 17.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.244 0.522 . . . . 0.0 111.477 -175.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 34.8 mtm180 55.58 -51.56 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.111 1.764 . . . . 0.0 115.19 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 32.0 m170 74.19 134.01 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.571 0.748 . . . . 0.0 109.143 -170.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.15 -3.24 44.13 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -172.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.759 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 76.1 mtm -96.62 147.72 23.6 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.438 ' CD1' HD22 ' A' ' 98' ' ' LEU . 45.8 p90 -146.68 165.94 28.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.613 0.244 . . . . 0.0 110.935 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.3 pp -152.8 136.04 15.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.94 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.8 t -103.86 122.8 57.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.49 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.858 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 9.6 ptt180 -121.63 165.63 15.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.507 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.423 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 3.9 p30 -85.57 138.8 31.93 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.52 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 8.5 t -74.45 135.73 42.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.212 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.1 t -78.13 -10.32 59.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.639 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -78.39 -48.34 15.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.581 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 41' ' ' SER . 48.4 t -159.03 135.98 6.79 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.37 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.42 5.08 2.1 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.303 2.002 . . . . 0.0 112.728 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.34 8.26 58.69 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.523 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -144.7 160.84 40.55 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.423 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 22.1 m-85 -124.78 164.05 20.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.955 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 62' ' ' ILE . 18.6 t -127.56 99.13 5.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 0.0 110.569 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.41 ' CB ' HD11 ' A' ' 63' ' ' ILE . 22.2 tp -78.17 101.31 6.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.134 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 59' ' ' SER . 58.4 m -96.75 131.98 42.91 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.385 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.617 HG21 HD13 ' A' ' 93' ' ' LEU . 47.2 t -119.36 151.82 21.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.835 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.601 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 14.1 t -102.59 119.02 38.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.999 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 1.101 ' HG2' ' HB3' ' A' ' 57' ' ' ARG . 7.1 pm0 -145.61 175.25 10.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 169.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 6.0 p30 -36.2 89.51 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.391 1.076 . . . . 0.0 113.865 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m 39.8 62.55 1.2 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.912 0.863 . . . . 0.0 110.023 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 1.101 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -162.14 50.57 0.2 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.027 -154.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 38.2 t -76.62 95.63 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.566 ' OG ' ' HB ' ' A' ' 52' ' ' VAL . 12.5 p -77.88 119.35 21.22 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.281 -172.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -101.11 88.13 3.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.081 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.733 ' HB3' HD11 ' A' ' 73' ' ' ILE . 71.4 m-85 -93.12 112.12 23.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.516 0.327 . . . . 0.0 111.713 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.515 HG12 HG22 ' A' ' 49' ' ' VAL . 43.9 mt -82.17 140.56 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.1 mp -124.2 121.04 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.629 0.771 . . . . 0.0 110.603 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -85.39 135.57 33.82 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.7 t -80.86 103.23 10.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 72' ' ' LYS . 83.3 mt -85.6 132.13 45.5 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.877 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.46 -5.84 12.3 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.019 2.48 . . . . 0.0 112.28 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -87.85 14.76 8.12 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.81 31.29 14.2 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.518 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -121.14 176.04 5.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.881 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.446 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 58.9 m-85 -139.13 129.24 25.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.105 0.478 . . . . 0.0 110.692 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HB2' HD11 ' A' ' 66' ' ' LEU . 39.7 ttmt -115.94 108.01 15.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.73 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.733 HD11 ' HB3' ' A' ' 61' ' ' TYR . 15.9 tt -87.5 78.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.642 0.734 . . . . 0.0 110.17 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.68 81.37 0.09 OUTLIER Glycine 0 C--O 1.226 -0.4 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.89 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.8 t70 75.94 -48.09 0.58 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.962 0.505 . . . . 0.0 112.158 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -66.93 125.01 24.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.632 0.73 . . . . 0.0 111.744 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -84.47 131.79 34.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.129 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -139.53 173.77 11.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.998 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -77.04 -42.95 36.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.974 0.416 . . . . 0.0 110.454 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.486 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 6.8 p80 -172.49 -174.48 1.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.159 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 13.0 mt -54.4 -60.74 6.88 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.634 ' HB3' ' O ' ' A' ' 8' ' ' SER . 51.5 Cg_exo -58.43 -9.69 7.36 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.411 2.074 . . . . 0.0 113.795 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.469 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -94.48 -35.62 12.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.759 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.19 -29.7 57.75 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.323 0.582 . . . . 0.0 109.431 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.17 -30.64 70.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.794 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.422 ' HA ' ' CD ' ' A' ' 89' ' ' LYS . 33.9 tt0 -76.43 -7.98 56.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.37 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -97.23 -37.17 10.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.499 0.666 . . . . 0.0 109.445 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.573 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 38.8 m-85 -81.0 -10.32 59.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.466 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.422 ' CD ' ' HA ' ' A' ' 86' ' ' GLU . 22.4 ptmt -81.31 -7.34 59.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.225 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.6 pt -123.74 3.67 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 121.262 0.553 . . . . 0.0 110.619 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.573 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 4.5 t-160 -97.13 -40.27 8.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.435 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.719 ' CD2' HG23 ' A' ' 97' ' ' THR . 95.7 m-85 75.17 88.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.416 1.073 . . . . 0.0 110.472 -172.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.732 HD22 ' CE2' ' A' ' 61' ' ' TYR . 2.0 mt -66.51 97.88 0.46 Allowed 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.743 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 9.4 t70 56.33 73.13 0.46 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.021 -175.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 27.2 m 75.32 -39.32 0.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -107.75 139.9 41.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.176 0.512 . . . . 0.0 111.047 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.719 HG23 ' CD2' ' A' ' 92' ' ' TYR . 2.9 p -83.62 177.14 8.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.789 0.328 . . . . 0.0 110.527 176.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.438 HD22 ' CD1' ' A' ' 36' ' ' PHE . 81.5 mt -70.05 98.44 1.31 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 172.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 50.8 mm -84.47 -55.73 6.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.808 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 35' ' ' MET . 36.7 tt0 -167.02 141.59 3.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.061 -175.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.12 157.74 28.59 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.556 2.171 . . . . 0.0 112.734 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.43 144.49 57.5 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.818 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HD3' ' SD ' ' A' ' 35' ' ' MET . 33.5 Cg_exo -60.42 131.68 39.65 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.569 2.179 . . . . 0.0 111.594 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.471 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 26.3 ptt180 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.748 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.842 HD12 HG21 ' A' ' 152' ' ' ILE . 2.2 mm? . . . . . 0 N--CA 1.467 0.41 0 CA-C-O 121.293 0.568 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 5.2 tp10 -165.86 -76.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.413 -171.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.487 ' O ' ' HB2' ' A' ' 180' ' ' LYS . 28.5 m-85 -106.01 124.4 49.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.753 -171.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 22.3 t -133.22 151.36 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.112 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.727 ' HG2' ' HB3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -131.02 142.11 50.29 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.681 162.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.472 HG22 HG12 ' A' ' 178' ' ' VAL . 1.8 p -97.94 140.22 32.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.914 0.387 . . . . 0.0 111.949 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 61.8 mt -108.55 -22.63 12.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.14 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 57.0 t80 -92.33 -35.04 13.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -167.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 7.0 t70 76.01 113.19 0.07 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.337 0.589 . . . . 0.0 110.395 -174.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 71.4 t80 -147.19 109.51 3.96 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.068 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 20.9 Cg_endo -92.91 102.28 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.53 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.737 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -95.12 4.27 67.47 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.365 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.7 m120 57.54 20.63 6.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.331 0.653 . . . . 0.0 112.547 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 169' ' ' ARG . 1.9 p30 52.2 -175.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 173.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 69.09 7.2 6.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.494 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -169.39 -45.7 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.241 -1.345 . . . . 0.0 108.361 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.737 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 24.2 m-20 -140.85 116.04 9.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.759 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.048 HD11 ' HB2' ' A' ' 165' ' ' ASN . 25.2 tp -67.53 120.57 74.03 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.617 0.246 . . . . 0.0 110.937 -174.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 43.6 Cg_endo -75.13 95.59 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.031 1.821 . . . . 0.0 111.346 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 10.0 p90 -104.6 172.58 6.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.567 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.468 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 8.7 ttmm -122.52 -178.14 3.82 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.941 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.637 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -84.02 75.18 10.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.458 0.647 . . . . 0.0 109.604 177.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.9 33.83 0.54 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.171 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 6.7 mm-40 -94.62 154.95 17.1 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 129' ' ' ARG . 40.0 mm -103.85 125.84 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.559 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 32.9 mt -118.82 156.77 28.85 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 59.8 t -124.83 129.79 73.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.842 HG21 HD12 ' A' ' 125' ' ' LEU . 30.6 mm -74.55 86.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.384 1.088 . . . . 0.0 109.073 -176.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.485 HG12 ' HE1' ' A' ' 61' ' ' TYR . 10.4 tt -75.18 -26.42 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.341 -174.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.785 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 44.5 mt-10 -146.69 143.91 29.08 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.437 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 44.4 tttm -125.34 87.44 55.64 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 121.46 -0.775 . . . . 0.0 111.026 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.597 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 16.8 Cg_exo -70.62 -62.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.387 2.058 . . . . 0.0 112.542 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -109.63 -174.8 2.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.845 0.355 . . . . 0.0 111.748 -171.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -95.81 -29.15 14.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.324 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -96.18 -22.53 17.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.155 0.502 . . . . 0.0 110.82 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.49 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 42.5 m95 -128.93 124.55 35.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.67 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -107.42 164.87 11.83 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.785 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 29.3 m -113.13 106.66 14.92 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.926 -0.484 . . . . 0.0 109.748 174.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.772 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -115.95 158.92 22.3 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.388 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.2 ptt180 -95.48 132.43 40.58 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.355 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.048 ' HB2' HD11 ' A' ' 142' ' ' LEU . 63.0 t30 -72.0 171.35 12.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.522 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -59.31 -29.79 67.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.45 -43.43 94.28 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.02 67.43 0.7 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.866 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.665 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -143.73 160.01 41.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.438 HG22 HD13 ' A' ' 153' ' ' ILE . 37.5 t -101.75 125.57 55.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.307 0.575 . . . . 0.0 111.986 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.6 161.9 30.44 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.597 ' HE3' ' HG2' ' A' ' 156' ' ' PRO . 25.6 mtp -81.07 144.25 31.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.179 0.489 . . . . 0.0 110.271 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.504 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.7 pp -139.66 143.4 35.02 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.875 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.49 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 3.0 Cg_exo -76.3 132.65 13.94 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.897 2.398 . . . . 0.0 112.561 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 178' ' ' VAL . 60.3 t -62.8 -43.03 81.87 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 23.2 Cg_endo -62.57 -4.39 5.56 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.953 1.769 . . . . 0.0 113.302 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -99.64 -8.57 24.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.592 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 175' ' ' VAL . 10.5 m -107.24 -178.33 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 122.265 1.031 . . . . 0.0 113.576 -168.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.727 ' HB3' ' HG2' ' A' ' 129' ' ' ARG . 23.6 tt0 -154.46 42.13 0.49 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.098 -1.865 . . . . 0.0 109.221 -165.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.834 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.626 0 O-C-N 120.432 -1.418 . . . . 0.0 108.817 -167.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.877 ' N ' HG13 ' A' ' 266' ' ' VAL . 88.8 t . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 1.01 ' HB2' ' HA ' ' A' ' 265' ' ' LYS . 0.0 OUTLIER -69.21 130.61 43.12 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.333 1.063 . . . . 0.0 111.996 -160.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.535 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -148.63 159.41 44.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.802 -168.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -91.3 135.78 33.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.579 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -77.56 126.5 30.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 31.9 pt -101.75 -6.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.439 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.32 155.63 43.25 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.578 ' HB3' HG23 ' A' ' 260' ' ' VAL . 18.4 pttp -113.88 137.02 52.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.749 0.309 . . . . 0.0 110.777 174.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.549 ' HG3' ' CE1' ' A' ' 290' ' ' HIS . 0.0 OUTLIER -174.72 137.61 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 257' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.629 0 CA-C-O 119.248 -0.406 . . . . 0.0 112.041 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 121.405 0.621 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -89.64 147.77 23.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.577 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.39 110.15 22.29 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 247' ' ' VAL . . . -56.75 105.48 0.22 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.514 0.509 . . . . 0.0 110.588 177.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 279' ' ' VAL . 90.8 mt -118.38 130.59 56.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.018 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -111.79 173.7 6.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.038 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.578 HG23 ' HB3' ' A' ' 245' ' ' LYS . 57.7 t -75.58 124.57 33.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 112.109 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 88.25 25.31 31.52 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.383 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.28 150.84 36.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.135 0.468 . . . . 0.0 110.389 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 30.7 mm -86.52 123.19 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.317 0.579 . . . . 0.0 111.639 -175.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.73 ' HA ' HG22 ' A' ' 279' ' ' VAL . 44.7 t -101.07 103.2 14.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.772 177.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 1.01 ' HA ' ' HB2' ' A' ' 239' ' ' PHE . 18.0 ttpp -86.03 86.5 7.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.006 0.432 . . . . 0.0 110.667 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.877 HG13 ' N ' ' A' ' 238' ' ' VAL . 13.7 p -105.29 136.46 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 15.3 t -124.55 -14.41 6.85 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -167.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -135.78 98.64 3.96 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 120.921 1.691 . . . . 0.0 111.744 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . 0.732 ' HE3' HG23 ' A' ' 238' ' ' VAL . 34.1 ttm -79.1 140.29 37.88 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -162.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -98.3 137.0 37.67 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.734 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.6 tt -75.93 -8.35 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.267 0.556 . . . . 0.0 110.623 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -69.21 -28.51 66.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.945 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 109.48 -17.79 30.68 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.696 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.1 118.82 29.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.445 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 47.3 m0 -98.85 145.03 27.4 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.051 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.592 ' O ' HG23 ' A' ' 266' ' ' VAL . 38.7 tt0 -117.93 97.41 5.81 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.275 0.56 . . . . 0.0 109.741 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -107.61 150.73 16.9 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.153 -168.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -104.65 109.83 21.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.73 HG22 ' HA ' ' A' ' 264' ' ' VAL . 60.4 t -114.39 91.27 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.083 0.468 . . . . 0.0 110.453 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 54.37 55.89 7.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.814 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 97.71 -28.33 14.86 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.512 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.1 mtm105 -104.39 118.48 36.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.945 0.373 . . . . 0.0 110.377 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 47.9 pttt -121.31 142.44 49.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.084 0.468 . . . . 0.0 111.882 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -171.07 -174.48 38.91 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.484 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 87.0 mt -93.38 144.75 25.04 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.583 0.706 . . . . 0.0 111.905 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.464 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 36.1 p90 -149.77 151.41 32.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.999 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 290' ' ' HIS . 60.8 Cg_endo -74.34 151.71 43.39 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.261 1.974 . . . . 0.0 112.26 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -64.25 -21.34 66.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.636 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.2 m -77.22 -8.53 57.73 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.229 0.538 . . . . 0.0 110.992 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.549 ' CE1' ' HG3' ' A' ' 246' ' ' ARG . 16.5 t60 -86.03 -22.01 27.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.157 0.503 . . . . 0.0 110.631 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.0 m -128.31 178.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.501 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -141.29 136.91 32.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.524 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.535 HD13 ' HB2' ' A' ' 240' ' ' ALA . 47.2 mm -81.68 102.82 7.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -100.23 14.44 30.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.825 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.348 177.351 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.34 0 CA-C-O 120.777 0.323 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 6' ' ' PHE . 4.4 tmt_? -113.9 -68.07 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 5.4 m-85 62.96 165.28 0.11 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -109.53 -39.35 5.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.818 161.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.2 m 64.68 147.56 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.037 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.0 p 61.15 -49.65 0.12 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.988 1.315 . . . . 0.0 113.875 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -57.31 107.01 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 111.586 -172.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.601 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -61.97 -22.81 65.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.479 -178.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.2 t -79.32 -15.96 57.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.641 0.258 . . . . 0.0 110.862 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.93 -49.03 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.168 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -110.83 -22.81 11.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.601 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 56.2 t80 -85.57 113.13 21.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.713 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 9.6 tpp -97.42 -1.16 44.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.555 -172.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.444 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.44 -115.43 3.75 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.159 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.1 Cg_exo -74.75 103.61 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.842 2.361 . . . . 0.0 112.187 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.636 ' HB ' ' CB ' ' A' ' 39' ' ' ARG . 88.3 t -137.36 -74.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 60.0 m 76.02 172.12 0.25 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.493 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -51.95 -43.69 63.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -174.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -60.37 -38.04 82.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -92.35 -44.79 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.385 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.56 68.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.882 0.372 . . . . 0.0 111.121 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.57 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 64.9 tt0 -67.37 -52.83 35.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.908 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -72.71 -14.25 61.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 0.0 111.425 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -78.65 -44.07 24.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.565 0.697 . . . . 0.0 110.055 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 16.1 mt -104.25 12.07 34.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.491 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 20.8 tt0 -76.87 104.45 7.37 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.618 0.723 . . . . 0.0 110.573 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.499 ' H ' ' NE2' ' A' ' 31' ' ' GLN . . . 118.02 -20.82 10.53 Favored Glycine 0 CA--C 1.499 -0.917 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.922 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER 40.11 111.02 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 112.592 -1.804 . . . . 0.0 115.185 172.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 39.6 ttp180 -68.84 -10.22 55.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.959 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 32.3 m170 74.26 122.5 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.113 176.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.54 19.99 49.83 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.059 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.456 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 35.8 mtm -115.49 147.58 40.48 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' ' 50' ' ' LEU . 40.0 p90 -147.44 158.85 44.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.129 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 pp -150.95 135.35 16.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.218 0.533 . . . . 0.0 110.507 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.11 115.58 44.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.113 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.636 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.68 -173.44 2.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.05 0.452 . . . . 0.0 112.048 -176.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.464 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 7.3 p-10 -71.23 138.06 49.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.874 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -100.42 89.14 3.86 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 168.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 p -71.75 11.82 0.46 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.449 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 t -100.19 -8.51 23.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 50.3 t -164.76 110.0 0.84 Allowed Pre-proline 0 CA--C 1.528 0.121 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.079 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.04 115.83 2.83 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.966 2.444 . . . . 0.0 112.466 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.48 -41.94 1.78 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.049 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.646 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 3.3 m-20 -74.3 158.66 33.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.723 0.297 . . . . 0.0 110.483 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.404 ' CD2' HD11 ' A' ' 81' ' ' LEU . 46.2 m-85 -134.68 173.91 11.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.695 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.634 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 58.4 t -137.94 109.38 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 111.007 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 36' ' ' PHE . 26.2 tp -81.03 104.55 11.6 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.536 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 m -95.46 120.95 36.6 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.856 0.36 . . . . 0.0 110.34 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 22.1 t -120.4 142.55 35.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.922 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 89.2 p -121.99 133.56 54.82 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.531 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.505 ' CB ' ' HB3' ' A' ' 94' ' ' ASP . 1.9 tm-20 -147.94 178.15 8.75 Favored 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -16.94 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.452 ' HA ' ' CD ' ' A' ' 31' ' ' GLN . 36.3 m 35.91 72.13 0.11 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.706 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.906 ' HD2' ' HB3' ' A' ' 155' ' ' LYS . 9.8 ttp85 -168.51 52.93 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.743 -158.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 25.3 t -77.68 101.62 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 122.07 0.938 . . . . 0.0 109.651 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 m -93.21 121.22 34.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.323 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -94.25 89.45 5.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.283 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.772 ' HB3' HD11 ' A' ' 73' ' ' ILE . 88.0 m-85 -84.81 115.07 22.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.725 0.41 . . . . 0.0 110.786 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.1 mt -81.3 140.0 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -174.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.663 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.6 mp -115.75 121.19 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.597 0.759 . . . . 0.0 110.568 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.646 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 8.3 m120 -85.74 146.28 26.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.916 0.487 . . . . 0.0 111.566 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.0 t -93.18 99.18 11.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.924 174.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.4 mt -84.22 142.91 41.44 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.48 -28.78 46.31 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.617 2.878 . . . . 0.0 114.115 -172.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -91.63 20.15 5.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.412 -0.18 . . . . 0.0 111.383 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.538 ' HD2' ' HB3' ' A' ' 280' ' ' ASN . 0.0 OUTLIER 67.43 40.21 2.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.139 0.495 . . . . 0.0 111.045 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -113.61 148.24 36.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.489 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 58.7 m-85 -114.71 115.77 27.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.936 0.398 . . . . 0.0 111.297 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 39.5 ttpt -110.77 105.94 14.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.538 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.772 HD11 ' HB3' ' A' ' 61' ' ' TYR . 10.2 tt -81.74 76.99 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.842 0.83 . . . . 0.0 110.175 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 60.73 95.15 0.01 OUTLIER Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.547 178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 15.9 t70 74.93 -49.51 0.66 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.849 0.357 . . . . 0.0 111.498 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -85.15 113.25 21.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 11.6 pt-20 -101.7 134.96 44.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.317 0.579 . . . . 0.0 110.816 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 80.1 m-85 -121.73 174.14 7.02 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.956 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.27 -46.89 85.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.026 0.441 . . . . 0.0 110.885 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -166.47 -178.07 4.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.427 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.519 HD23 HD21 ' A' ' 84' ' ' LEU . 16.4 mt -55.19 -57.49 19.78 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.51 25.46 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.062 1.841 . . . . 0.0 112.831 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 81' ' ' LEU . . . -119.81 -34.86 3.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.951 175.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.519 HD21 HD23 ' A' ' 81' ' ' LEU . 3.7 pp -76.68 -30.82 56.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.214 0.531 . . . . 0.0 109.968 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 6' ' ' PHE . 48.6 mt -64.57 -41.48 96.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.403 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.641 ' HA ' ' HD2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -69.5 -4.08 17.31 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.562 178.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -96.21 -37.69 10.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.812 0.815 . . . . 0.0 109.637 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.813 ' CD1' HD23 ' A' ' 93' ' ' LEU . 46.7 m-85 -77.37 -2.92 37.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.506 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.641 ' HD2' ' HA ' ' A' ' 86' ' ' GLU . 16.5 ptmt -78.86 -11.11 59.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.607 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.99 -12.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 120.936 0.398 . . . . 0.0 110.88 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -75.46 -29.68 59.71 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.867 ' HA ' HG22 ' A' ' 97' ' ' THR . 23.0 m-85 59.14 55.21 4.48 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.7 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.813 HD23 ' CD1' ' A' ' 88' ' ' TYR . 3.4 pp -60.9 123.27 17.08 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 118.463 -1.295 . . . . 0.0 107.518 169.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 1.9 m-20 81.6 -2.5 1.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.28 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.798 ' OG1' ' HB3' ' A' ' 156' ' ' PRO . 33.6 m 55.99 75.55 0.33 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 122.054 0.93 . . . . 0.0 110.665 -172.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m 179.06 -34.32 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.211 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.867 HG22 ' HA ' ' A' ' 92' ' ' TYR . 4.8 p 73.38 -172.17 0.13 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.641 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 35.0 mt -85.65 94.13 9.0 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.478 173.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.79 -56.87 10.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.557 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 11.2 pt-20 -157.5 163.56 24.42 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.497 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 100' ' ' GLU . 40.4 Cg_endo -67.32 153.09 78.06 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.129 1.886 . . . . 0.0 113.026 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -71.98 143.34 86.36 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.467 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 24.0 Cg_exo -64.57 155.94 63.74 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.548 2.165 . . . . 0.0 112.066 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.713 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 14.1 mtm180 . . . . . 0 C--N 1.324 -0.508 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 1.05 HD12 HG21 ' A' ' 152' ' ' ILE . 3.5 mm? . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -170.14 -81.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.878 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -104.66 124.63 49.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.207 0.527 . . . . 0.0 110.655 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.697 HG22 ' CB ' ' A' ' 180' ' ' LYS . 61.4 t -133.53 137.15 53.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.407 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.613 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 2.3 ptp180 -114.31 146.67 40.19 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.066 167.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.58 HG22 HG12 ' A' ' 178' ' ' VAL . 2.1 p -103.58 135.28 45.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.017 0.436 . . . . 0.0 111.577 -176.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.586 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 78.3 mt -101.46 -40.1 7.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.421 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 23.1 t80 -74.28 -35.12 63.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -168.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.571 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.1 t70 73.47 107.34 0.07 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.247 0.546 . . . . 0.0 110.095 -177.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 77.3 t80 -140.92 103.25 6.26 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.78 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 33.7 Cg_endo -90.08 93.06 0.3 Allowed 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.378 2.052 . . . . 0.0 112.11 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -83.31 -21.16 59.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.014 174.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.9 m120 48.22 47.58 19.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.492 -0.854 . . . . 0.0 111.967 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 141' ' ' ASP . 20.1 t70 -141.14 161.04 38.8 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.55 -7.12 53.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.271 0.558 . . . . 0.0 110.98 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 172' ' ' MET . 1.4 mp0 -125.62 15.51 8.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.695 172.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.67 ' HB2' ' HB3' ' A' ' 138' ' ' ASP . 20.4 m-20 -146.61 87.75 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.788 HD11 ' HB2' ' A' ' 165' ' ' ASN . 27.1 tp -69.76 119.96 74.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.49 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.78 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 59.2 Cg_endo -73.99 90.97 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.221 1.948 . . . . 0.0 111.434 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 11.4 p90 -99.6 158.74 15.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.571 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 72.9 mmtt -98.94 178.75 4.85 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.278 0.561 . . . . 0.0 111.322 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.76 18.21 2.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.596 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.64 29.87 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.35 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 145' ' ' LYS . 24.0 tt0 -99.81 156.64 17.0 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.48 HD13 ' HB3' ' A' ' 129' ' ' ARG . 50.4 mm -99.02 133.52 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.63 HD22 HD21 ' A' ' 142' ' ' LEU . 57.4 mt -120.54 157.04 30.32 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.14 132.47 70.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.05 HG21 HD12 ' A' ' 125' ' ' LEU . 35.5 mm -75.09 88.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 122.184 0.992 . . . . 0.0 109.633 -176.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.468 HG21 HG22 ' A' ' 170' ' ' VAL . 21.5 tt -76.96 -31.32 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.189 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.997 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 65.5 mt-10 -132.63 141.46 48.66 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 171.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.906 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 1.9 tptm -129.8 84.14 61.95 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 122.305 1.05 . . . . 0.0 109.357 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.798 ' HB3' ' OG1' ' A' ' 95' ' ' THR . 19.3 Cg_exo -77.73 -66.78 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.413 2.742 . . . . 0.0 113.308 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -94.55 175.93 6.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.956 -172.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.78 -10.26 20.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -123.46 -3.34 8.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.272 0.558 . . . . 0.0 110.602 173.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.667 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 58.4 m95 -129.75 125.74 36.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.395 173.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.762 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.4 m0 -122.22 135.68 54.79 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.31 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.997 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.6 m -90.28 92.8 9.08 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.192 0.52 . . . . 0.0 109.632 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.69 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -94.22 163.27 13.51 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.939 0.4 . . . . 0.0 110.657 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.3 ptt180 -100.78 132.3 46.25 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.44 0.638 . . . . 0.0 110.583 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.788 ' HB2' HD11 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -50.3 139.06 15.65 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.467 172.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 12.4 tmtt? -56.85 -27.0 59.7 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -99.93 9.6 42.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.583 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.5 83.11 1.63 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.21 -0.995 . . . . 0.0 115.279 166.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 169' ' ' ARG . 2.5 ptp180 -173.04 157.63 3.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.508 0.194 . . . . 0.0 110.488 162.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 153' ' ' ILE . 48.0 t -98.32 129.91 47.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 142' ' ' LEU . . . -154.44 152.79 24.31 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.102 172.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.69 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -73.45 138.44 45.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.652 0.263 . . . . 0.0 110.461 177.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.762 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -136.71 144.65 47.84 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.74 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.898 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 23.7 Cg_exo -68.22 139.12 45.19 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.28 2.653 . . . . 0.0 112.989 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 178' ' ' VAL . 88.0 t -76.34 -47.61 3.35 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.7 Cg_endo -66.08 6.43 0.49 Allowed 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.994 1.796 . . . . 0.0 111.909 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.898 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 1.2 m-85 -105.76 -1.64 24.16 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.439 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 175' ' ' VAL . 12.9 m -116.75 -167.04 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -169.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.613 ' HB3' ' HG3' ' A' ' 129' ' ' ARG . 7.7 tp10 -157.97 41.31 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.705 -1.588 . . . . 0.0 108.791 -163.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.697 ' CB ' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 O-C-N 120.987 -1.07 . . . . 0.0 111.466 -167.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.537 ' HB ' HG13 ' A' ' 266' ' ' VAL . 26.1 t . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.695 0.283 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.48 118.92 37.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.579 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.467 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.28 128.07 52.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.093 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -82.75 126.18 32.09 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -78.72 92.29 4.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.593 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -82.97 -15.99 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.133 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -130.18 129.87 43.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -69.77 172.92 6.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.397 0.618 . . . . 0.0 111.64 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 25.3 tpt180 -147.0 103.26 3.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.158 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 54.2 t . . . . . 0 C--N 1.32 -0.703 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.553 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.002 0.429 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -66.01 125.68 26.2 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.159 0.504 . . . . 0.0 110.622 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.492 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.9 OUTLIER -79.08 115.68 18.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.869 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -70.11 115.15 8.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.917 0.389 . . . . 0.0 110.44 177.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 279' ' ' VAL . 93.0 mt -118.62 154.82 32.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.617 -176.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.75 159.15 38.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.954 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.44 122.96 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.557 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.61 3.3 30.62 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.668 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.421 ' CG ' HH11 ' A' ' 69' ' ' ARG . 41.7 t0 -107.51 161.97 14.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.519 0.659 . . . . 0.0 110.204 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 27.2 mm -102.91 121.91 54.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.243 0.545 . . . . 0.0 111.362 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.424 ' HA ' HG22 ' A' ' 279' ' ' VAL . 21.5 t -91.01 112.1 24.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.589 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -88.98 94.36 9.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.537 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.9 p -86.07 123.68 39.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.428 0.632 . . . . 0.0 110.69 -173.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.9 t -110.81 -17.83 13.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.514 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.82 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 24.9 ttm-85 -131.87 97.35 4.16 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.02 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 54.9 mtt -94.83 134.01 37.91 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.593 ' OD1' ' HB3' ' A' ' 272' ' ' ASN . 7.5 p30 -131.26 167.74 18.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.976 -172.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.432 ' H ' HG13 ' A' ' 271' ' ' ILE . 2.4 pp -83.58 6.8 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.312 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.593 ' HB3' ' OD1' ' A' ' 270' ' ' ASN . 3.7 t30 -87.39 -30.68 20.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.869 0.366 . . . . 0.0 110.93 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 125.42 -64.43 0.57 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.304 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -73.71 124.54 26.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.547 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 11.1 m0 -93.65 168.29 11.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.56 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.82 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 35.8 tt0 -104.38 113.29 26.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.681 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.21 162.95 18.16 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.811 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.52 116.81 30.15 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.857 HG12 ' H ' ' A' ' 280' ' ' ASN . 15.2 t -125.82 -172.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.857 ' H ' HG12 ' A' ' 279' ' ' VAL . 9.2 p30 -55.06 -32.08 61.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.026 0.376 . . . . 0.0 111.874 -176.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.28 -68.39 1.6 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.071 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.492 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -179.71 -169.87 0.14 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 60.7 mttm -85.2 129.11 34.87 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -161.54 176.88 38.01 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 80.0 mt -84.32 134.52 34.51 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.985 0.421 . . . . 0.0 111.103 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.412 ' HE2' HG21 ' A' ' 291' ' ' VAL . 46.4 p90 -137.45 140.93 31.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.211 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.22 139.03 16.5 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.478 2.118 . . . . 0.0 112.239 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -73.72 6.79 2.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.87 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.2 p -95.67 -15.97 22.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.764 0.316 . . . . 0.0 111.35 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -98.74 -13.12 20.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.234 0.54 . . . . 0.0 110.059 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.412 HG21 ' HE2' ' A' ' 286' ' ' PHE . 34.3 m -120.1 160.89 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.287 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -127.78 120.21 27.38 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.076 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 240' ' ' ALA . 36.4 mm -70.71 109.05 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.172 171.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -103.92 11.58 35.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.21 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.464 0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.353 -178.237 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 121.118 0.485 . . . . 0.0 112.145 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -137.69 105.29 5.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.049 0.452 . . . . 0.0 110.496 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -155.89 157.86 37.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.545 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.36 111.79 14.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.908 0.385 . . . . 0.0 110.21 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 t -87.93 64.91 8.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.169 0.509 . . . . 0.0 110.397 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.0 t -173.47 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.915 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.46 111.44 1.39 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.742 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -56.0 -33.16 64.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.097 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 m -79.89 3.15 20.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.891 0.377 . . . . 0.0 111.595 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.85 -47.87 5.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.174 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -124.39 -22.67 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -87.68 117.33 26.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.745 0.307 . . . . 0.0 110.633 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.754 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 2.0 mpp? -109.57 7.23 24.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.722 0.296 . . . . 0.0 111.445 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.85 -114.6 3.27 Favored Glycine 0 C--O 1.225 -0.457 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.875 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 13.6 Cg_exo -69.73 101.08 0.86 Allowed 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.448 2.099 . . . . 0.0 112.137 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' A' ' 39' ' ' ARG . 86.0 t -129.11 -76.48 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.597 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.467 ' HA ' ' HE ' ' A' ' 39' ' ' ARG . 2.2 p 88.4 170.87 0.04 OUTLIER 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 169.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.7 mtp85 -53.35 -35.83 60.69 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.793 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -61.37 -51.91 66.81 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.458 0.474 . . . . 0.0 111.801 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.78 -43.6 12.4 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.16 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.57 -41.12 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.825 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.535 ' HA ' HG11 ' A' ' 58' ' ' VAL . 11.1 tt0 -81.88 -33.48 30.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.984 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.2 t -79.8 -18.33 51.19 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.02 0.438 . . . . 0.0 111.339 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 27' ' ' ARG . 39.1 ttm180 -88.86 -27.93 20.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.017 0.436 . . . . 0.0 110.792 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' A' ' 102' ' ' ALA . 78.0 mt -111.22 25.69 11.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.38 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.59 29.76 0.07 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -172.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.65 -1.45 39.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.908 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -50.24 -59.24 4.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.951 0.405 . . . . 0.0 110.936 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -132.09 111.46 11.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -68.98 114.87 7.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.46 -18.46 6.42 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.781 -173.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.756 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.6 mtm -74.65 144.71 43.71 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 120.674 0.273 . . . . 0.0 110.327 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.451 ' CG ' HD22 ' A' ' 98' ' ' LEU . 33.4 p90 -144.34 164.59 30.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.139 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.6 pp -153.85 138.79 17.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.043 0.449 . . . . 0.0 110.464 174.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.5 121.49 54.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.599 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -124.82 168.97 12.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -178.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.55 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 2.1 m-20 -72.23 134.13 45.45 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 168.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.532 ' HA ' HG23 ' A' ' 49' ' ' VAL . 24.3 t -37.01 -86.69 0.0 OUTLIER 'General case' 0 C--O 1.236 0.376 0 O-C-N 124.585 1.178 . . . . 0.0 112.875 -168.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.9 m -172.58 -61.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.4 t -98.3 -26.96 14.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.671 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.2 m -102.43 108.62 58.1 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.158 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.03 107.84 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.231 2.621 . . . . 0.0 111.686 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.99 -47.97 0.89 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 11.4 m-20 -78.24 151.75 32.94 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 168.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -124.3 172.9 8.74 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 121.387 -0.125 . . . . 0.0 110.731 -172.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.687 HG22 HG13 ' A' ' 62' ' ' ILE . 42.8 t -145.48 104.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 175.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.31 105.37 4.04 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.329 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.7 m -96.63 139.26 32.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.977 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.681 HG21 HD13 ' A' ' 93' ' ' LEU . 40.6 t -129.09 150.45 34.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.876 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.63 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 31.1 t -98.73 121.1 40.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.322 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.725 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 1.3 mt-10 -143.11 173.96 11.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 56.7 m-80 -40.24 87.39 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.857 0.863 . . . . 0.0 112.917 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m 42.13 58.35 2.97 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.278 1.037 . . . . 0.0 109.25 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.725 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -161.01 53.87 0.29 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.239 -153.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 25' ' ' GLN . 8.9 t -75.94 94.33 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 t -87.03 121.27 29.25 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.332 -172.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -100.77 98.55 9.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.383 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.59 ' CE2' HD22 ' A' ' 93' ' ' LEU . 50.2 m-85 -97.83 115.74 28.65 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.486 0.315 . . . . 0.0 111.371 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.687 HG13 HG22 ' A' ' 49' ' ' VAL . 7.1 tt -72.44 150.02 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.615 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.2 mp -128.37 117.74 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.184 0.594 . . . . 0.0 109.549 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.415 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 9.6 m120 -87.41 138.39 31.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.37 -173.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.3 t -83.23 100.28 10.5 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 171.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -78.17 157.87 77.79 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.8 62.48 2.36 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.586 2.191 . . . . 0.0 112.426 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 84.3 0.72 0.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.806 0.842 . . . . 0.0 110.61 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -72.32 -78.64 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.244 173.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.725 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 3.2 mpt_? -153.95 -171.01 3.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.358 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.438 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 27.4 m-85 -112.98 115.18 27.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -101.53 109.61 21.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.564 -171.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.615 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.3 tt -97.46 85.22 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.658 0.742 . . . . 0.0 110.72 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.02 81.38 0.09 OUTLIER Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.635 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.4 t70 72.6 -43.99 0.58 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.062 0.545 . . . . 0.0 111.315 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -74.81 126.16 30.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.826 0.346 . . . . 0.0 110.184 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.401 ' OE1' ' HD3' ' A' ' 70' ' ' ARG . 39.5 tt0 -108.01 124.77 50.66 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.562 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.725 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 81.7 m-85 -124.19 148.6 47.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.582 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 10.7 m-20 -62.7 -29.82 70.94 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -170.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 6.5 p80 -160.35 171.63 18.76 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.254 -0.179 . . . . 0.0 110.871 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.9 mt -55.91 -56.62 28.45 Favored Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.34 0.4 . . . . 0.0 111.84 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 32.3 Cg_exo -61.6 -9.2 12.82 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.215 1.943 . . . . 0.0 113.538 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.34 -36.19 16.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.515 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -76.17 -30.03 57.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 82' ' ' PRO . 92.2 mt -65.17 -38.74 91.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.495 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.817 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 40.3 mt-10 -75.86 -20.94 57.7 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -74.49 -38.8 62.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.295 0.569 . . . . 0.0 110.128 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HE2' HD13 ' A' ' 73' ' ' ILE . 47.8 m-85 -79.28 -6.77 57.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.104 0.478 . . . . 0.0 110.703 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.817 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 25.5 mtpp -71.78 -17.21 62.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.496 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.77 7.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 121.042 0.448 . . . . 0.0 111.162 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 20.2 t-160 -102.07 -32.29 10.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.299 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CD1' HG23 ' A' ' 97' ' ' THR . 98.8 m-85 70.43 101.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.741 0.651 . . . . 0.0 110.513 -175.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.681 HD13 HG21 ' A' ' 52' ' ' VAL . 9.4 mt -70.98 -20.61 62.41 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.856 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.592 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 30.9 t70 -172.75 82.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.715 171.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 66.7 -24.39 0.11 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.57 0.748 . . . . 0.0 111.874 -178.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 94' ' ' ASP . 13.9 t -124.3 157.94 33.76 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.539 HG23 ' CD1' ' A' ' 92' ' ' TYR . 19.1 p -100.04 -172.84 2.3 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.655 0.264 . . . . 0.0 111.088 -177.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.451 HD22 ' CG ' ' A' ' 36' ' ' PHE . 86.5 mt -70.96 93.54 1.0 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 35.9 mm -85.03 -59.32 2.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.138 -173.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.756 ' O ' ' HA ' ' A' ' 35' ' ' MET . 4.9 pt-20 -149.33 147.55 23.76 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.652 -174.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.43 149.54 27.58 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.5 2.134 . . . . 0.0 112.471 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -70.58 146.49 93.86 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.999 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.97 140.83 92.22 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.879 2.386 . . . . 0.0 112.16 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.754 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 52.4 mtm180 . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.984 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.969 HD12 HG13 ' A' ' 152' ' ' ILE . 4.3 mm? . . . . . 0 N--CA 1.461 0.119 0 CA-C-O 121.83 0.824 . . . . 0.0 112.721 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -151.53 -88.45 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.533 -172.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.522 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 79.0 m-85 -109.95 119.9 40.78 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.921 0.867 . . . . 0.0 112.035 -175.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.743 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 68.5 t -132.99 130.97 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.367 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.896 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 8.4 ptp85 -110.58 155.94 21.63 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 118.415 -1.314 . . . . 0.0 109.431 172.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.435 HG22 HG12 ' A' ' 178' ' ' VAL . 3.9 p -111.72 141.03 45.85 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.5 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 76.4 mt -103.44 -39.35 6.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.211 -175.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.3 t80 -73.82 -31.68 63.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -167.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.653 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 17.3 t70 67.82 91.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.443 0.639 . . . . 0.0 109.892 -172.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 88.1 t80 -124.85 113.24 26.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.349 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 58.0 Cg_endo -87.88 95.1 0.42 Allowed 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.15 1.9 . . . . 0.0 112.573 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.89 -10.27 84.28 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.586 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 137' ' ' ASN . 10.8 m120 62.96 25.62 15.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.033 0.533 . . . . 0.0 111.524 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.78 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 3.8 p30 46.83 -168.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 73.66 1.27 3.89 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.155 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -178.59 -35.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.125 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -134.41 110.38 9.39 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.492 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.686 HD12 ' HD2' ' A' ' 143' ' ' PRO . 31.4 tp -68.04 127.47 93.31 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 120.829 0.347 . . . . 0.0 111.72 -172.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.686 ' HD2' HD12 ' A' ' 142' ' ' LEU . 60.0 Cg_endo -78.8 105.28 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.292 1.995 . . . . 0.0 110.943 171.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 9.0 p90 -112.7 157.87 20.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.647 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.653 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 3.4 mptp? -102.91 178.79 4.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.817 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -66.45 -9.3 32.82 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.862 -177.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.512 ' N ' ' HD2' ' A' ' 146' ' ' LYS . . . -164.16 45.8 0.31 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.678 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -102.3 147.18 27.0 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 129' ' ' ARG . 33.8 mm -93.23 132.52 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.542 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 18.7 mt -118.8 154.85 32.18 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.66 129.86 74.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 172.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.969 HG13 HD12 ' A' ' 125' ' ' LEU . 46.3 mm -75.67 86.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.798 HG23 ' HG2' ' A' ' 154' ' ' GLU . 17.0 tt -67.95 -26.8 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.128 -176.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.798 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.5 OUTLIER -155.85 140.95 17.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.934 0.397 . . . . 0.0 111.2 173.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.475 ' HD2' ' CD2' ' A' ' 125' ' ' LEU . 32.2 tttm -120.89 95.84 48.82 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-O 121.249 0.547 . . . . 0.0 110.482 172.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.16 -59.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.81 2.34 . . . . 0.0 112.062 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -104.87 -170.37 1.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.052 -174.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -100.27 -42.72 6.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.897 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -80.31 -25.3 39.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.768 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.518 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 39.1 m95 -129.01 128.17 43.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.005 0.431 . . . . 0.0 110.759 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.647 ' O ' HG13 ' A' ' 173' ' ' ILE . 53.6 m0 -114.18 135.68 53.78 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.059 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.703 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 17.6 m -87.58 103.14 15.28 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.257 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.711 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -112.35 173.68 6.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.987 0.422 . . . . 0.0 111.13 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.4 ptt180 -119.88 137.56 53.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.0 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.58 HD22 ' H ' ' A' ' 168' ' ' GLY . 0.1 OUTLIER -78.59 -168.1 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.505 -177.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -60.45 -34.8 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.799 0.333 . . . . 0.0 110.422 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.503 ' HB2' HD21 ' A' ' 165' ' ' ASN . 44.8 m-20 -70.63 -21.27 62.65 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.042 0.449 . . . . 0.0 110.655 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.58 ' H ' HD22 ' A' ' 165' ' ' ASN . . . 97.62 5.26 57.82 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.701 -0.761 . . . . 0.0 114.449 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.78 ' HD3' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -86.77 151.15 23.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.998 0.899 . . . . 0.0 111.45 -177.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 153' ' ' ILE . 39.5 t -98.91 140.74 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.567 -166.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -168.1 158.14 30.75 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 169.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.526 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 31.5 mtp -76.12 139.48 41.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.366 0.583 . . . . 0.0 110.089 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.647 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -133.77 148.69 69.45 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.678 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.518 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 3.5 Cg_exo -77.48 132.6 12.39 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.168 2.579 . . . . 0.0 112.674 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.647 ' O ' HG22 ' A' ' 178' ' ' VAL . 24.1 t -58.62 -46.33 99.59 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.363 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.48 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.0 Cg_exo -63.27 -2.1 3.62 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.375 2.05 . . . . 0.0 113.786 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.58 -5.66 26.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.415 -0.178 . . . . 0.0 111.327 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.0 m -107.41 -172.19 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -166.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.896 ' HB3' ' HG3' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -159.66 42.21 0.21 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.609 -163.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.743 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.754 0 O-C-N 121.219 -0.926 . . . . 0.0 109.25 -168.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 266' ' ' VAL . 20.7 t . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.928 0.394 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.11 132.56 56.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.382 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.567 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -121.17 155.27 34.9 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.669 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -119.5 119.08 32.8 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.45 119.06 14.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.686 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 22.9 pt -91.01 -4.25 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.053 -172.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -142.48 160.87 39.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.587 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.895 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 20.9 ttmm -93.51 123.05 36.55 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.871 ' HB3' HH11 ' A' ' 246' ' ' ARG . 0.7 OUTLIER -139.44 114.31 9.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--N 1.32 -0.689 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.323 -179.418 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 68.6 p . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -98.95 107.03 19.36 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.072 0.463 . . . . 0.0 110.964 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -73.18 113.62 10.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -58.71 108.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.538 0.524 . . . . 0.0 110.811 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.689 HD21 HG21 ' A' ' 279' ' ' VAL . 95.8 mt -130.25 127.03 38.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.264 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.895 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 11.7 pt-20 -119.61 -177.12 3.31 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.538 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 30.7 m -61.36 135.31 26.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.22 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 68.12 28.86 73.21 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.984 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -108.2 140.02 42.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.972 0.386 . . . . 0.0 110.146 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.0 mm -88.28 123.23 40.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.34 0.591 . . . . 0.0 111.523 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 240' ' ' ALA . 23.2 t -104.71 107.89 23.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.078 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -82.44 87.68 6.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.717 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' A' ' 238' ' ' VAL . 4.9 p -88.55 116.92 31.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.622 0.725 . . . . 0.0 110.584 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.421 ' O ' ' HD2' ' A' ' 268' ' ' ARG . 3.1 m -110.6 -19.15 12.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.694 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.466 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 13.8 mmm180 -122.34 109.96 15.07 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.5 mtt -107.6 118.3 36.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.154 0.502 . . . . 0.0 111.572 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -90.76 158.92 16.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.023 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.57 -14.7 9.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.455 0.645 . . . . 0.0 110.493 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -80.81 -1.8 44.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.893 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.82 -61.65 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.918 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.596 ' HG3' HD13 ' A' ' 285' ' ' LEU . 0.0 OUTLIER -77.71 131.21 37.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.93 0.395 . . . . 0.0 110.628 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 15.8 m0 -107.08 168.64 9.07 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.237 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 14.0 mt-10 -110.51 122.53 47.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.096 0.474 . . . . 0.0 110.299 174.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -130.26 145.14 16.41 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.511 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -94.41 109.11 20.99 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.689 HG21 HD21 ' A' ' 258' ' ' LEU . 20.8 t -113.43 167.76 6.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.437 ' N ' HG12 ' A' ' 279' ' ' VAL . 16.2 m120 -60.13 -16.66 34.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -81.28 -45.08 7.66 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.863 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.64 ' HG2' HH11 ' A' ' 282' ' ' ARG . 1.0 OUTLIER 173.16 178.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 16.5 pttp -103.75 139.43 39.0 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 166.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -172.33 -170.24 35.95 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.7 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.596 HD13 ' HG3' ' A' ' 274' ' ' GLN . 97.9 mt -91.1 143.42 26.71 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.242 0.544 . . . . 0.0 110.803 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 41.6 p90 -147.97 137.16 11.9 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.561 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 7.3 Cg_exo -72.89 136.34 24.97 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.43 2.086 . . . . 0.0 111.309 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -63.51 -20.64 65.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.926 0.393 . . . . 0.0 110.956 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 m -69.81 -13.11 62.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.315 0.579 . . . . 0.0 110.828 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -97.39 -14.35 21.28 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.079 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.525 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 27.6 m -124.61 165.82 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.527 0.68 . . . . 0.0 112.14 -173.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -114.43 116.33 28.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.517 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' ' 240' ' ' ALA . 21.3 mm -89.02 117.12 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.13 0.49 . . . . 0.0 110.643 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -141.52 148.32 39.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.699 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 35.1 t0 . . . . . 0 C--N 1.316 -0.855 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.02 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -119.1 -8.01 10.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.837 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.741 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 27.6 p90 -94.11 162.37 13.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.58 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.28 123.84 48.9 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 m -79.96 21.83 0.54 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.723 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -111.41 -37.16 5.33 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.651 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' ' 12' ' ' SER . 34.4 t70 -87.94 108.35 19.15 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.055 -174.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -65.49 -20.04 66.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.426 -179.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.409 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 23.9 m -74.03 -5.41 41.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.803 0.335 . . . . 0.0 110.669 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.76 -47.88 5.42 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 38.3 p-90 -115.62 -21.26 9.79 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -171.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.439 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 49.3 t80 -81.52 118.55 22.83 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.202 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.794 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 6.9 tpp -95.14 -7.94 37.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.359 -172.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.08 -115.45 3.6 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.254 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 6.4 Cg_exo -73.65 95.02 0.86 Allowed 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.974 2.449 . . . . 0.0 112.529 -174.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.914 HG12 ' H ' ' A' ' 20' ' ' SER . 14.1 t -136.86 -152.97 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.914 ' H ' HG12 ' A' ' 19' ' ' VAL . 82.4 p 176.32 178.56 0.21 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -166.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -69.31 -39.89 78.0 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.121 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -63.34 -59.54 4.57 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.395 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.61 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 8.3 tp10 -59.9 -47.23 86.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.124 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.31 -35.87 70.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.51 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.447 HE21 ' HB3' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -64.65 -40.95 96.33 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.647 -179.372 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -80.17 -6.51 57.9 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.126 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.61 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 20.6 mmt85 -87.57 -35.32 18.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.714 0.769 . . . . 0.0 109.03 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.93 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 39.2 mt -100.08 27.4 5.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.331 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -51.35 97.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.478 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.2 -4.63 31.62 Favored Glycine 0 CA--C 1.49 -1.503 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 167.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 1.051 HE21 ' HA ' ' A' ' 56' ' ' SER . 1.6 mp0 57.14 85.59 0.08 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 113.814 -1.193 . . . . 0.0 110.768 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -70.33 -19.95 63.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.653 ' NE2' ' HA ' ' A' ' 55' ' ' ASN . 41.2 m170 78.63 118.93 0.06 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.297 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.95 9.08 59.95 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.972 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.646 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 29.3 mtm -106.75 137.07 45.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.498 -0.413 . . . . 0.0 110.176 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.569 ' HB2' HD11 ' A' ' 50' ' ' LEU . 43.3 p90 -133.98 162.34 32.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.247 -175.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 pp -151.0 135.03 16.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.52 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.0 t -102.49 108.31 23.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.766 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 23.6 ptt-85 -110.82 168.62 9.34 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.134 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.445 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 27.2 t70 -85.81 92.99 8.78 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.505 ' HA ' HG23 ' A' ' 49' ' ' VAL . 37.7 m 33.81 -149.22 0.0 OUTLIER 'General case' 0 C--O 1.238 0.5 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.501 ' H ' ' HB3' ' A' ' 41' ' ' SER . 63.8 m -157.29 -15.67 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.105 171.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 m -121.37 -44.87 2.35 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.038 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 40.9 t -115.65 99.87 52.96 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.11 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 22.6 Cg_endo -61.87 129.26 26.89 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.716 2.277 . . . . 0.0 111.84 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.32 -33.36 4.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.37 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.42 166.45 12.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.445 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 25.4 m-85 -125.73 166.22 17.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.778 0.323 . . . . 0.0 111.123 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.505 HG23 ' HA ' ' A' ' 41' ' ' SER . 45.0 t -144.13 106.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.846 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.72 ' HB2' HD11 ' A' ' 63' ' ' ILE . 63.8 tp -70.09 101.34 1.81 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.408 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.9 m -94.82 118.85 32.44 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.08 0.467 . . . . 0.0 109.99 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG21 HD13 ' A' ' 93' ' ' LEU . 46.5 t -119.2 134.19 63.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.192 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.93 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 84.1 p -93.39 132.85 37.25 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.776 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.664 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 5.1 mm-40 -143.95 176.24 9.43 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.653 ' HA ' ' NE2' ' A' ' 33' ' ' HIS . 55.5 m-80 -31.34 82.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -168.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 1.051 ' HA ' HE21 ' A' ' 31' ' ' GLN . 3.9 m 44.89 57.18 4.79 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.948 0.88 . . . . 0.0 109.765 -177.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.989 HH21 ' HB2' ' A' ' 94' ' ' ASP . 35.8 ttp85 -167.17 55.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.366 -151.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 61.8 t -74.93 102.49 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.245 -0.91 . . . . 0.0 109.598 -173.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 t -86.4 121.3 28.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.724 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -93.3 88.2 5.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.624 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.446 ' CE2' HD22 ' A' ' 93' ' ' LEU . 77.8 m-85 -78.86 116.01 18.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 18.5 tt -79.64 145.55 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -171.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.72 HD11 ' HB2' ' A' ' 50' ' ' LEU . 14.9 mt -138.31 116.35 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.602 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 9.3 m120 -87.21 142.34 27.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 122.314 0.246 . . . . 0.0 110.735 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.6 t -87.53 100.68 12.95 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 72' ' ' LYS . 87.9 mt -90.01 142.77 29.08 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.385 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 17.2 Cg_exo -67.49 -8.15 21.34 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.244 2.629 . . . . 0.0 113.071 -176.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.731 ' HB2' ' HG2' ' A' ' 70' ' ' ARG . 9.4 m120 -83.69 9.49 11.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.745 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 2.3 tpm_? 63.46 26.45 14.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.611 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.731 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 5.9 ptp180 -112.78 172.4 6.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.989 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.472 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 96.0 m-85 -131.66 127.2 36.47 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.204 0.526 . . . . 0.0 110.948 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.602 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 18.5 ttmm -97.16 100.06 11.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.926 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 10.9 tt -93.44 86.38 2.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.838 0.828 . . . . 0.0 110.227 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.32 60.34 4.46 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.087 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t0 74.44 -16.27 0.55 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.935 0.494 . . . . 0.0 111.38 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.461 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -78.83 126.86 31.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.876 0.369 . . . . 0.0 111.109 177.112 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -98.45 100.1 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.457 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.461 ' CE2' ' HB3' ' A' ' 76' ' ' GLN . 97.6 m-85 -103.46 168.85 8.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.839 0.352 . . . . 0.0 110.59 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.17 -53.56 53.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.461 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.449 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 1.2 p80 -164.81 -174.11 3.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.264 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.1 mt -55.23 -57.84 18.08 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.55 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 39.1 Cg_exo -59.8 -10.74 12.69 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.327 2.018 . . . . 0.0 113.214 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.447 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -95.22 -30.74 13.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.389 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.19 -26.27 56.02 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.5 mt -70.56 -25.85 63.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.913 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 52.1 mt-10 -73.5 -20.64 60.62 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.768 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -84.84 -35.59 22.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.054 0.454 . . . . 0.0 110.77 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.523 ' HE2' HD13 ' A' ' 73' ' ' ILE . 49.6 m-85 -86.59 1.07 53.05 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.999 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 13.0 ptmt -74.02 -21.99 59.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 171.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.448 HG23 ' HG3' ' A' ' 89' ' ' LYS . 23.6 pt -120.85 9.14 6.2 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -96.55 -38.78 9.84 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.206 -0.309 . . . . 0.0 111.233 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.543 ' CD1' HG23 ' A' ' 97' ' ' THR . 76.9 m-85 70.39 102.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.894 0.746 . . . . 0.0 109.716 -171.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.729 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 6.4 mt -74.23 -19.76 60.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.53 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.989 ' HB2' HH21 ' A' ' 57' ' ' ARG . 33.6 t70 -173.78 70.96 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 170.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 76.91 -29.81 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.22 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.408 HG22 HD13 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -107.43 157.58 17.88 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.543 HG23 ' CD1' ' A' ' 92' ' ' TYR . 18.1 p -105.26 -169.25 1.57 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.761 0.315 . . . . 0.0 110.178 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.464 HD22 ' CD1' ' A' ' 36' ' ' PHE . 97.6 mt -77.47 99.97 5.85 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 1.8 mp -96.91 -55.37 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.646 ' O ' ' HA ' ' A' ' 35' ' ' MET . 8.1 mm-40 -143.96 151.61 53.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.735 0.302 . . . . 0.0 111.293 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 24.7 Cg_endo -88.83 156.58 6.05 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.807 2.338 . . . . 0.0 111.893 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.48 139.63 55.4 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.947 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.43 135.57 46.74 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.479 2.119 . . . . 0.0 112.16 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.794 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 39.9 ptt180 . . . . . 0 C--N 1.327 -0.393 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 1.017 HD23 HG21 ' A' ' 152' ' ' ILE . 7.9 mp . . . . . 0 CA--C 1.508 -0.668 0 CA-C-O 121.527 0.679 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 16.8 pt-20 -165.77 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.193 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.46 130.92 54.51 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.908 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.976 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 72.8 t -142.41 157.57 19.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 179' ' ' GLU . 0.7 OUTLIER -136.05 150.8 49.32 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.092 161.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.483 HG22 HG12 ' A' ' 178' ' ' VAL . 6.0 p -105.67 140.46 38.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.052 0.453 . . . . 0.0 111.994 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.518 HD11 ' HG2' ' A' ' 179' ' ' GLU . 67.2 mt -110.83 -25.58 9.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.726 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.528 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 41.5 t80 -86.38 -32.6 20.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -168.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.67 ' HB2' ' HD3' ' A' ' 146' ' ' LYS . 6.6 t70 73.38 111.59 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.133 0.492 . . . . 0.0 110.617 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -141.65 89.1 9.31 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 35.4 Cg_endo -94.87 84.16 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 122.799 2.333 . . . . 0.0 112.871 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.508 ' HA3' ' OD2' ' A' ' 141' ' ' ASP . . . -94.1 -24.34 19.91 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.206 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.428 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 52.0 m-80 68.05 83.22 0.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.484 0.714 . . . . 0.0 112.715 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -173.42 -171.96 0.74 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 173.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.28 -16.89 28.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.314 1.054 . . . . 0.0 108.334 171.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 172' ' ' MET . 41.4 tt0 -73.57 -28.88 62.09 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.978 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.6 ' HA ' ' O ' ' A' ' 172' ' ' MET . 8.0 p-10 -157.17 117.04 3.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.369 174.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 165' ' ' ASN . 13.6 tp -69.62 121.39 82.27 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.964 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 41.6 Cg_endo -67.87 98.16 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.293 1.996 . . . . 0.0 111.324 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -112.73 162.25 15.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.522 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 1.6 mptm? -112.6 -167.79 1.23 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.291 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.67 ' HD3' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -91.25 19.6 5.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.921 176.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.4 30.86 0.52 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.606 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 23.2 mm-40 -104.71 144.14 32.13 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.887 -0.184 . . . . 0.0 110.73 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.502 HD13 ' HB3' ' A' ' 129' ' ' ARG . 46.7 mm -98.65 135.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.555 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 18.5 mt -118.95 155.24 31.68 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 93.4 t -120.32 125.42 74.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 174.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.017 HG21 HD23 ' A' ' 125' ' ' LEU . 47.1 mm -76.05 83.8 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 122.761 1.267 . . . . 0.0 108.674 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.759 HG21 HG22 ' A' ' 170' ' ' VAL . 15.1 tt -79.3 -26.97 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.195 -174.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 14.9 mt-10 -144.41 142.23 30.19 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.505 0.503 . . . . 0.0 109.975 173.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.601 ' HD3' HD22 ' A' ' 125' ' ' LEU . 3.8 ttpm? -134.58 89.74 25.55 Favored Pre-proline 0 C--O 1.236 0.371 0 O-C-N 121.842 -0.536 . . . . 0.0 111.172 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.465 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 16.9 Cg_exo -71.94 -55.31 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.549 2.166 . . . . 0.0 112.76 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -106.52 172.51 6.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.521 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 2.7 mm-40 -113.76 70.15 0.72 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.551 0.691 . . . . 0.0 110.505 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.503 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 13.9 pt20 175.58 -34.37 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.601 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.503 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 53.1 m95 -122.96 129.34 51.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.767 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.661 ' O ' HG13 ' A' ' 173' ' ' ILE . 51.0 m0 -120.21 137.26 54.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.35 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.868 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.5 m -88.29 92.72 9.27 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.439 0.638 . . . . 0.0 109.899 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.72 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.62 161.24 15.26 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.822 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.8 ptt180 -104.27 136.76 43.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.809 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 142' ' ' LEU . 16.3 p-10 -81.63 -173.1 4.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 110.993 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -59.13 -27.5 65.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.773 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.81 -18.93 38.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.734 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.16 29.06 7.77 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.134 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.822 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 19.6 ttm-85 -104.02 136.07 44.35 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.568 -0.372 . . . . 0.0 110.857 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.759 HG22 HG21 ' A' ' 153' ' ' ILE . 59.0 t -99.88 119.81 48.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.99 0.424 . . . . 0.0 111.167 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.2 160.22 28.22 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.6 ' O ' ' HA ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -68.81 131.37 45.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.027 0.441 . . . . 0.0 111.023 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.661 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -130.22 145.45 57.38 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.261 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.46 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 4.5 Cg_exo -78.71 131.66 10.4 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.062 2.508 . . . . 0.0 112.633 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.62 ' O ' HG22 ' A' ' 178' ' ' VAL . 41.4 t -59.68 -44.19 96.92 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.401 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 27.2 Cg_exo -65.13 5.49 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.225 1.95 . . . . 0.0 113.6 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -108.43 -6.14 16.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.093 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.1 m -107.52 -171.08 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -165.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 0.2 OUTLIER -156.09 41.21 0.38 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 112.821 -1.991 . . . . 0.0 106.91 -163.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.976 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 16.3 pttm . . . . . 0 N--CA 1.446 -0.637 0 CA-C-O 121.891 0.853 . . . . 0.0 110.435 -162.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.497 ' HB ' HG13 ' A' ' 266' ' ' VAL . 22.8 t . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.502 ' HD1' HG21 ' A' ' 263' ' ' ILE . 96.2 m-85 -109.6 123.91 50.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.0 111.001 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.692 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -142.02 122.04 13.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.033 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.476 ' H ' ' CD ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -80.96 144.68 31.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.068 0.461 . . . . 0.0 110.505 -178.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -88.78 94.67 10.0 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.049 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.447 ' H ' HG13 ' A' ' 243' ' ' ILE . 2.4 pp -94.48 19.45 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.687 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.61 173.39 11.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.331 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.435 ' H ' ' HG2' ' A' ' 245' ' ' LYS . 20.8 pttm -95.34 133.67 38.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.553 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -147.77 113.55 5.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.096 0.474 . . . . 0.0 111.382 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.755 174.674 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 121.049 0.452 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -104.58 99.61 9.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.119 0.485 . . . . 0.0 110.442 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.507 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.7 OUTLIER -78.37 121.5 24.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.919 -177.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -83.45 136.92 34.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.056 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.74 119.5 20.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.998 0.427 . . . . 0.0 110.313 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -100.01 149.83 23.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.514 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 15.6 t -58.02 123.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.839 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 157.46 -68.1 0.28 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.815 -1.183 . . . . 0.0 114.952 174.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 263' ' ' ILE . 5.0 t70 -116.96 -169.33 1.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.473 0.637 . . . . 0.0 112.496 -159.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.502 HG21 ' HD1' ' A' ' 239' ' ' PHE . 40.6 mm -91.72 135.6 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.238 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.47 110.16 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.735 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -80.58 87.81 5.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 110.862 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.497 HG13 ' HB ' ' A' ' 238' ' ' VAL . 6.8 p -90.21 130.62 39.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.038 0.447 . . . . 0.0 110.911 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.426 HG23 ' HG3' ' A' ' 268' ' ' ARG . 9.0 t -113.07 -20.83 11.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.426 ' HG3' HG23 ' A' ' 267' ' ' THR . 98.2 mtt180 -117.92 98.92 6.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 0.0 110.107 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 34.8 ttm -101.18 109.68 21.59 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.168 0.509 . . . . 0.0 110.804 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -83.31 162.31 21.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.932 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.1 tt -97.38 -13.72 7.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.129 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -67.24 -53.7 27.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.227 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 164.77 -37.81 0.29 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.791 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.421 ' HG3' HD13 ' A' ' 285' ' ' LEU . 0.5 OUTLIER -101.89 134.92 44.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.057 0.456 . . . . 0.0 110.24 178.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.519 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 20.9 m0 -107.89 165.1 11.7 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.167 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 43.7 tt0 -121.53 116.85 25.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.136 0.494 . . . . 0.0 110.253 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -129.56 169.98 20.59 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.54 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 74.8 mt-10 -108.39 108.35 19.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.906 0.384 . . . . 0.0 110.767 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.507 ' HB ' HD21 ' A' ' 256' ' ' LEU . 47.2 t -128.28 139.08 52.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 279' ' ' VAL . 15.4 m120 70.96 8.02 6.39 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.631 0.373 . . . . 0.0 110.76 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 86.46 13.46 67.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.975 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 282' ' ' ARG . 1.7 ptm180 -132.03 137.98 48.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.86 0.362 . . . . 0.0 110.525 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 3.3 ptpp? -97.79 134.3 41.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.693 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -152.39 173.94 31.39 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.566 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 91.7 mt -90.14 140.59 29.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.015 0.436 . . . . 0.0 111.504 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 33.5 p90 -145.64 134.73 11.21 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.521 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 5.0 Cg_exo -74.54 148.82 38.11 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.857 2.371 . . . . 0.0 112.811 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.406 ' C ' ' H ' ' A' ' 290' ' ' HIS . 36.7 p90 -64.32 -25.27 67.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.286 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.8 m -76.0 37.45 0.15 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.45 0.643 . . . . 0.0 110.928 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.406 ' H ' ' C ' ' A' ' 288' ' ' PHE . 8.5 m-70 -141.6 -61.02 0.47 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.384 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.461 HG21 ' HE2' ' A' ' 286' ' ' PHE . 23.2 m -90.92 150.38 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.797 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -109.35 117.04 33.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.86 0.362 . . . . 0.0 110.785 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.692 HD13 ' HB2' ' A' ' 240' ' ' ALA . 36.8 mm -69.94 125.49 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.837 175.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -122.3 -179.31 4.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.465 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.133 0.492 . . . . 0.0 110.017 178.319 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 98' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 5' ' ' ARG . 17.4 ttp180 -163.11 105.15 1.01 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.114 0.483 . . . . 0.0 110.319 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.477 ' CB ' ' HD3' ' A' ' 101' ' ' PRO . 25.4 p90 -132.28 -180.0 5.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.985 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -89.36 91.03 8.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.122 0.487 . . . . 0.0 110.699 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.766 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 40.8 m -67.65 150.56 48.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.894 177.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m 78.28 -39.35 0.26 Allowed 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.799 0.687 . . . . 0.0 112.31 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.96 101.85 0.17 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.049 0.452 . . . . 0.0 110.295 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -56.96 -46.2 82.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.033 -170.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m -77.27 7.87 4.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.34 -40.27 11.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.572 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.3 p-90 -127.76 -27.81 2.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.0 t80 -79.77 123.67 27.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.896 0.317 . . . . 0.0 110.355 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.441 ' HB2' HG21 ' A' ' 19' ' ' VAL . 22.3 mmt -110.52 -1.33 17.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.844 -173.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.46 -114.27 2.88 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.007 -0.542 . . . . 0.0 113.709 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 10.3 Cg_exo -70.33 103.59 1.28 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.008 2.472 . . . . 0.0 112.175 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.816 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 85.9 t -136.57 -70.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.794 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 30.1 t 81.36 165.59 0.15 Allowed 'General case' 0 C--N 1.347 0.477 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -55.83 -38.96 70.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.746 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -59.63 -40.99 89.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.069 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -91.98 -44.97 8.58 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.235 -175.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.92 -41.31 67.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.811 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 47.8 tt0 -72.3 -46.27 56.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.413 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.3 t -68.39 -23.42 64.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.988 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -83.39 -29.31 28.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.2 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.713 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 38.4 mt -103.43 -0.05 30.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.027 0.441 . . . . 0.0 110.757 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 25.7 tt0 -70.15 113.53 7.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.6 -174.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.89 33.82 84.96 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.573 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -102.47 -168.48 1.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.678 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 17.8 ttp180 -62.85 113.19 2.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.627 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.66 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 42.7 m170 -62.26 118.5 7.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.929 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.91 -8.33 6.81 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.569 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.678 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 20.1 mtp -87.17 140.11 29.88 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 122.52 0.328 . . . . 0.0 110.442 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.778 ' HB2' HG22 ' A' ' 52' ' ' VAL . 28.8 p90 -142.52 164.52 29.89 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.643 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.402 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.2 pp -154.98 136.67 14.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.221 0.534 . . . . 0.0 111.056 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 15' ' ' TYR . 93.2 t -101.42 112.7 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.816 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 20.9 ptt-85 -107.59 176.47 5.14 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.685 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -81.5 138.97 35.41 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.415 ' HA ' HG23 ' A' ' 49' ' ' VAL . 83.3 p -55.6 -19.87 11.75 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.086 0.241 . . . . 0.0 111.596 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m 69.41 17.63 8.07 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.507 0.67 . . . . 0.0 109.794 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 p -140.42 -45.05 0.41 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.733 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 66.3 m -134.27 127.13 18.79 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.765 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 24.2 Cg_exo -64.48 -14.37 43.95 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.863 2.375 . . . . 0.0 112.578 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.57 29.2 13.03 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.862 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.31 134.74 18.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -124.76 162.34 24.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.512 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.715 HG22 HG12 ' A' ' 62' ' ' ILE . 21.2 t -131.51 99.88 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.125 0.488 . . . . 0.0 111.189 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.2 tp -76.28 96.34 3.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.141 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.9 m -97.35 135.41 39.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.971 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.778 HG22 ' HB2' ' A' ' 36' ' ' PHE . 86.7 t -128.87 137.18 57.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.114 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.713 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 31.3 t -83.5 99.38 10.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.704 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.66 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 15.8 pt-20 -172.81 173.87 3.74 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.995 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.748 ' HB3' HH21 ' A' ' 57' ' ' ARG . 27.7 t-20 71.67 -56.3 0.64 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.734 1.254 . . . . 0.0 109.499 -164.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.401 ' C ' ' HG3' ' A' ' 57' ' ' ARG . 29.8 t -162.32 -40.63 0.04 OUTLIER 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.068 -1.878 . . . . 0.0 106.88 -176.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.748 HH21 ' HB3' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -165.35 -39.51 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.705 ' CG2' ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -144.2 110.97 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 120.822 1.646 . . . . 0.0 114.899 -173.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.652 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 16.0 m -95.85 108.29 20.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 163.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -100.34 99.0 9.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -170.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.729 ' CE2' HD22 ' A' ' 93' ' ' LEU . 44.0 m-85 -116.97 114.31 23.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.715 HG12 HG22 ' A' ' 49' ' ' VAL . 19.9 mt -81.07 138.59 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.787 HG13 ' HB ' ' A' ' 73' ' ' ILE . 5.3 mp -114.2 115.25 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.205 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -85.0 143.15 29.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.692 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.7 t -93.56 98.69 11.33 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' A' ' 72' ' ' LYS . 23.0 mt -78.58 124.94 85.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 14.1 Cg_exo -68.12 -33.58 24.73 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.313 2.009 . . . . 0.0 113.44 -174.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -67.53 -18.85 65.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -172.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.641 ' HG2' ' N ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -176.65 -53.55 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.641 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 2.3 ptm180 -136.85 -172.18 3.11 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -160.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -102.36 157.81 16.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.539 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.659 ' HB2' HD11 ' A' ' 66' ' ' LEU . 24.7 ttmm -138.82 104.67 5.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.787 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.7 tt -90.88 78.78 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.785 0.802 . . . . 0.0 110.006 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 65.52 86.49 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.742 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 10.8 t70 75.1 -61.68 0.48 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.475 0.31 . . . . 0.0 111.472 176.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.28 124.04 23.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.023 0.44 . . . . 0.0 109.987 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 11.1 pt-20 -107.3 138.5 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.282 0.563 . . . . 0.0 110.489 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.495 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 44.5 m-85 -127.18 166.59 17.42 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.54 -50.42 71.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -149.38 175.78 11.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.452 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.653 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 15.4 mt -54.85 -55.22 40.97 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.766 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 41.4 Cg_exo -59.96 -10.42 12.31 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.277 1.985 . . . . 0.0 113.797 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.74 -34.92 16.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.348 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -76.32 -28.75 57.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.394 0.616 . . . . 0.0 109.385 176.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 82' ' ' PRO . 74.0 mt -66.35 -23.4 66.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.009 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' A' ' 89' ' ' LYS . 38.0 tt0 -85.46 -29.27 24.45 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.237 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -69.37 -38.7 78.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.238 0.542 . . . . 0.0 110.063 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HE2' HD13 ' A' ' 73' ' ' ILE . 59.2 m-85 -80.83 -2.61 47.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.54 0.686 . . . . 0.0 110.467 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 47.5 tttm -78.77 -14.82 59.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.035 174.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -128.73 -1.77 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 111.474 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 22.6 t-160 -98.75 -28.51 13.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.127 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 70.1 132.23 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 O-C-N 124.079 0.862 . . . . 0.0 109.376 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 61' ' ' TYR . 9.2 mt -92.31 -26.63 18.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.734 ' CG ' ' HB2' ' A' ' 55' ' ' ASN . 10.3 t0 -173.83 83.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.777 168.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 71.66 -19.18 0.27 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.925 0.89 . . . . 0.0 112.064 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.7 m -120.43 158.0 28.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.0 p -106.16 172.57 6.73 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.458 ' O ' ' HB1' ' A' ' 4' ' ' ALA . 95.5 mt -64.71 93.69 0.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.032 0.444 . . . . 0.0 110.104 175.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.598 HG22 ' HG3' ' A' ' 100' ' ' GLU . 47.1 mm -81.34 -62.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.254 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.598 ' HG3' HG22 ' A' ' 99' ' ' ILE . 43.5 mt-10 -147.65 157.16 44.8 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.562 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 11.9 Cg_exo -70.46 156.98 60.36 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.097 1.865 . . . . 0.0 111.19 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.24 138.74 71.83 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -52.14 126.19 19.59 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.232 1.954 . . . . 0.0 111.808 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.057 179.87 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.597 HD12 HG21 ' A' ' 152' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.517 -0.297 0 CA-C-O 122.04 0.924 . . . . 0.0 111.488 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -172.07 -33.75 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.895 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -123.7 109.77 14.13 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.655 0.741 . . . . 0.0 111.352 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 179' ' ' GLU . 25.4 t -124.38 153.05 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.372 -175.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.732 ' HG2' ' O ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -135.06 150.37 50.25 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.066 174.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.649 HG22 ' CG1' ' A' ' 178' ' ' VAL . 51.4 p -95.46 133.95 38.85 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.823 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 178' ' ' VAL . 6.4 mt -106.96 -37.52 6.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.664 -173.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.599 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 47.5 t80 -90.45 -31.62 16.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -168.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.599 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 6.5 t70 77.67 123.91 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.214 0.53 . . . . 0.0 111.113 -172.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 84.8 t80 -156.77 106.3 1.96 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.733 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -91.98 95.22 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.879 2.386 . . . . 0.0 113.123 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -97.41 0.6 59.97 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.794 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.557 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 66.96 5.33 4.0 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.301 0.641 . . . . 0.0 112.223 -178.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.883 ' HB2' ' HD3' ' A' ' 143' ' ' PRO . 18.5 t0 52.47 -146.51 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.869 0.867 . . . . 0.0 112.94 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 140' ' ' GLU . . . 69.51 11.83 8.08 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.499 1.12 . . . . 0.0 108.828 -165.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 139' ' ' ALA . 23.2 tt0 171.81 -39.67 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.139 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.506 ' C ' ' HA ' ' A' ' 138' ' ' ASP . 21.8 m-20 -133.33 97.73 4.05 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.78 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.819 HD12 ' HD2' ' A' ' 143' ' ' PRO . 23.7 tp -54.67 129.86 63.91 Favored Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 122.971 0.509 . . . . 0.0 111.931 -174.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.883 ' HD3' ' HB2' ' A' ' 138' ' ' ASP . 73.1 Cg_endo -81.54 117.5 3.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.513 2.142 . . . . 0.0 111.355 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.615 ' CB ' HG21 ' A' ' 130' ' ' THR . 21.3 p90 -123.04 165.51 16.66 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.986 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.521 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 42.4 mttp -115.05 -165.88 1.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.272 0.558 . . . . 0.0 111.904 -174.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.531 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -93.98 26.98 2.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.089 179.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.43 25.92 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 119.625 -1.274 . . . . 0.0 114.388 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.541 ' OE1' ' HB2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -108.12 161.6 14.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.93 0.865 . . . . 0.0 109.331 174.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.0 mm -119.36 146.9 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.757 -167.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 165' ' ' ASN . 15.9 mt -122.77 166.38 15.05 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -173.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.44 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 97.6 t -123.53 125.76 72.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.712 HD13 ' HB2' ' A' ' 163' ' ' ALA . 21.6 mm -77.0 97.54 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 CA-C-O 122.475 1.131 . . . . 0.0 108.747 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.615 ' CD1' ' HE1' ' A' ' 61' ' ' TYR . 1.7 tt -97.52 -49.01 12.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 112.472 -2.149 . . . . 0.0 109.024 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.044 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 15.7 mt-10 -116.16 142.85 46.27 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.573 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 15.8 ttpp -140.23 72.04 32.96 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 121.466 -0.771 . . . . 0.0 109.901 170.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.474 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 24.5 Cg_exo -62.12 -43.89 22.13 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.453 2.102 . . . . 0.0 111.885 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -113.73 -174.07 2.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.05 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 4.2 tp10 -107.14 -40.0 5.55 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.525 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -84.08 -11.55 56.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.174 0.512 . . . . 0.0 110.324 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.427 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 68.0 m95 -129.2 118.58 22.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.407 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.604 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.7 m0 -108.76 139.08 44.07 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 1.044 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 11.3 t -101.72 91.08 4.25 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.39 0.614 . . . . 0.0 109.639 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.712 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.52 161.53 15.25 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.197 -172.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.699 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 19.5 ptt-85 -97.54 136.21 38.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.9 HD21 ' HB3' ' A' ' 167' ' ' ASP . 12.9 p-10 -85.76 175.57 8.62 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.619 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -79.9 4.28 17.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.37 0.605 . . . . 0.0 110.975 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.9 ' HB3' HD21 ' A' ' 165' ' ' ASN . 33.6 t70 -104.03 -1.28 27.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.245 0.545 . . . . 0.0 109.535 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 85.47 72.09 1.3 Allowed Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.81 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 38.4 ttm-85 -164.46 129.04 2.65 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.78 -0.247 . . . . 0.0 110.364 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.689 HG22 ' HB3' ' A' ' 164' ' ' ARG . 39.0 t -105.48 109.56 28.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.373 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.505 ' HA3' ' OD1' ' A' ' 138' ' ' ASP . . . -146.23 170.09 27.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.095 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.587 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 22.5 mtp -82.49 137.11 34.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.038 0.447 . . . . 0.0 111.211 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.613 HG23 ' HB3' ' A' ' 142' ' ' LEU . 2.7 pp -133.9 146.04 58.4 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.699 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.461 ' HD2' ' CE2' ' A' ' 144' ' ' PHE . 7.3 Cg_exo -72.23 128.35 13.72 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.064 2.509 . . . . 0.0 112.41 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 47.8 t -67.4 -36.67 10.86 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.278 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 26.8 Cg_endo -63.49 10.4 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.646 1.564 . . . . 0.0 113.177 173.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 175' ' ' VAL . 4.6 m-85 -118.38 -19.83 8.73 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.554 0.342 . . . . 0.0 111.322 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.649 ' CG1' HG22 ' A' ' 130' ' ' THR . 3.8 m -146.2 155.97 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.674 -166.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.5 ' C ' ' HD3' ' A' ' 180' ' ' LYS . 11.7 mt-10 -150.46 -56.35 0.17 Allowed 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 115.939 -2.305 . . . . 0.0 115.652 155.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.732 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.349 0 C-N-CA 115.619 -2.432 . . . . 0.0 116.04 -160.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.442 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 38.4 t . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.19 122.01 46.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.88 0.371 . . . . 0.0 110.818 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.492 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.28 142.91 48.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.25 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -95.37 123.75 39.06 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -75.81 111.24 10.96 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.121 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.417 HG21 ' HE3' ' A' ' 292' ' ' LYS . 35.6 pt -94.58 -9.98 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.431 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 9.2 tt0 -138.92 144.04 38.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.607 ' HG2' ' HA ' ' A' ' 259' ' ' GLU . 84.1 mttt -82.3 121.94 27.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.932 0.396 . . . . 0.0 111.093 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.703 ' HD2' ' CE1' ' A' ' 290' ' ' HIS . 54.1 ttt85 -93.16 102.47 14.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 C--N 1.318 -0.765 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.196 -179.246 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.267 0.556 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -92.59 111.01 22.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.929 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.475 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.4 tt -90.11 113.3 25.01 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -64.68 123.82 20.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.016 0.436 . . . . 0.0 110.909 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.3 mt -128.03 165.18 20.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.848 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.607 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 14.3 pt-20 -146.36 166.27 26.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.535 177.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 42.9 t -70.56 124.01 25.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.022 0.439 . . . . 0.0 111.071 -174.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.35 4.43 50.08 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.805 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -100.3 155.08 17.98 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.977 0.389 . . . . 0.0 109.992 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.8 mm -94.74 113.04 28.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.169 0.509 . . . . 0.0 110.99 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 t -87.05 95.4 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.285 0.565 . . . . 0.0 109.592 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -81.52 98.58 8.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.057 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 275' ' ' TRP . 4.0 p -89.11 120.96 38.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.392 0.615 . . . . 0.0 111.27 -176.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 26.4 m -93.99 -30.91 14.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.506 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 1.001 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 13.0 tpt180 -115.54 97.34 6.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.441 -177.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 2.2 tpt -81.53 106.16 13.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.167 0.508 . . . . 0.0 109.659 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -86.39 166.17 15.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.192 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 40.1 mm -76.91 83.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.418 -175.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.6 t30 83.65 82.42 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.752 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.407 ' HA2' ' HD1' ' A' ' 288' ' ' PHE . . . 114.35 -77.16 0.25 Allowed Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 119.69 -1.243 . . . . 0.0 114.066 154.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -72.52 88.57 1.24 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.825 0.345 . . . . 0.0 110.718 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.514 ' HB3' HG21 ' A' ' 266' ' ' VAL . 9.9 m0 -92.88 161.47 14.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.033 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 1.001 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 27.5 tt0 -109.98 116.09 30.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.086 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.36 155.71 18.24 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.368 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.3 108.37 19.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.475 ' HB ' HD21 ' A' ' 256' ' ' LEU . 61.0 t -128.98 140.12 50.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 13.7 m120 66.68 -71.05 0.1 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.831 0.707 . . . . 0.0 110.882 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -173.98 31.51 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -151.17 143.59 24.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.733 -0.233 . . . . 0.0 110.577 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 98.3 mttt -96.52 131.39 43.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 171.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.71 171.23 30.52 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.98 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 37.2 mt -92.83 145.09 24.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.093 0.473 . . . . 0.0 110.668 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.437 ' HZ ' ' HB ' ' A' ' 266' ' ' VAL . 31.5 p90 -148.22 124.93 5.46 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.16 177.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.416 ' HB2' HG22 ' A' ' 289' ' ' THR . 44.4 Cg_endo -71.6 157.48 55.84 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.271 1.981 . . . . 0.0 111.772 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.407 ' HD1' ' HA2' ' A' ' 273' ' ' GLY . 22.8 p90 -81.55 15.21 2.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.1 0.476 . . . . 0.0 111.5 -176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.416 HG22 ' HB2' ' A' ' 287' ' ' PRO . 8.8 t -89.81 1.56 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.576 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.703 ' CE1' ' HD2' ' A' ' 246' ' ' ARG . 1.2 p-80 -137.39 3.77 2.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 176.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.661 HG13 ' HD2' ' A' ' 290' ' ' HIS . 18.4 m -129.54 157.35 42.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.417 ' HE3' HG21 ' A' ' 243' ' ' ILE . 16.8 ptpt -129.9 135.66 48.62 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.516 176.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.492 HD13 ' HB2' ' A' ' 240' ' ' ALA . 46.5 mm -83.47 103.4 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.252 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -93.69 167.56 11.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.194 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--N 1.321 -0.651 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.859 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.629 ' HB3' ' HG2' ' A' ' 89' ' ' LYS . . . . . . . . 0 C--O 1.234 0.271 0 N-CA-C 110.637 -0.134 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.96 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.619 0.575 . . . . 0.0 109.487 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.684 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 3.5 p90 38.4 -122.56 0.28 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 124.288 0.992 . . . . 0.0 111.14 -174.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -139.99 81.59 1.83 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 172.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -71.84 62.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.943 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -179.19 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.12 100.07 4.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.576 -174.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -64.41 -24.62 67.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.761 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.6 m -67.41 -7.6 26.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.353 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.49 -47.99 4.49 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -112.15 -20.6 11.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -82.08 110.34 17.22 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.811 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 11.3 tpp -96.34 0.6 50.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.168 -171.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.433 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.49 -113.36 2.29 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.181 -0.918 . . . . 0.0 114.152 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 3.0 Cg_exo -79.33 100.24 1.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.823 2.348 . . . . 0.0 112.127 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.598 ' HB ' ' HG2' ' A' ' 39' ' ' ARG . 85.1 t -130.34 -76.63 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 48.8 m 82.65 162.92 0.13 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -51.65 -42.3 61.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -55.86 -39.46 71.52 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.423 0.452 . . . . 0.0 112.104 -177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 34.2 mt-10 -95.75 -44.91 7.22 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.254 -177.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.86 51.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.336 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -81.67 -32.88 31.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.759 -173.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.493 ' HA ' ' HB2' ' A' ' 29' ' ' GLN . 10.6 t -78.0 -27.74 49.05 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 110.682 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 21.2 mmt85 -64.62 -33.9 77.01 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.855 0.836 . . . . 0.0 109.755 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.987 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 80.7 mt -113.89 23.29 13.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.077 -176.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.493 ' HB2' ' HA ' ' A' ' 26' ' ' THR . 24.4 tt0 -72.71 72.13 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.227 0.537 . . . . 0.0 110.536 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.14 15.96 59.32 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.296 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -62.98 -28.37 70.04 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 20.0 ttm180 -156.24 -36.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.476 172.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.623 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 28.9 m170 77.08 132.0 0.05 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.129 0.893 . . . . 0.0 109.52 -173.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.31 -10.86 67.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.567 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 55.4 mtm -87.36 153.75 21.21 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 50' ' ' LEU . 39.0 p90 -141.63 162.16 36.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.331 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.5 pp -150.81 135.98 17.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.024 0.44 . . . . 0.0 110.337 172.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.7 t -105.54 116.26 48.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.425 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.618 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -119.85 163.72 17.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.893 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.2 131.81 45.51 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.527 ' OG ' HG22 ' A' ' 43' ' ' THR . 26.8 t -79.4 158.62 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.57 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.0 t -117.92 4.4 12.15 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.176 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.527 HG22 ' OG ' ' A' ' 41' ' ' SER . 14.7 t -93.52 -26.2 17.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.893 0.378 . . . . 0.0 110.345 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.696 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 62.8 m -141.98 144.67 33.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.07 -48.92 15.9 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.819 2.346 . . . . 0.0 112.568 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.92 71.59 0.21 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.577 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.696 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 34.3 t70 -151.3 150.98 31.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -173.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -130.35 172.1 12.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.647 HG22 HG12 ' A' ' 62' ' ' ILE . 54.2 t -144.47 108.29 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 111.543 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' A' ' 36' ' ' PHE . 42.9 tp -81.37 105.36 12.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.214 173.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -96.96 128.56 44.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.304 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.596 HG21 HD13 ' A' ' 93' ' ' LEU . 86.9 t -125.7 134.62 66.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.04 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.987 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 65.6 p -106.93 124.65 49.92 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.623 ' HG2' ' HB3' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -154.84 153.64 31.48 Favored 'General case' 0 C--O 1.212 -0.888 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 163.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 57.72 19.98 6.02 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.0 m 54.46 61.27 3.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 123.018 1.39 . . . . 0.0 108.259 -170.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 39.6 ttp85 -162.3 57.75 0.23 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.121 -2.309 . . . . 0.0 107.286 -159.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.2 t -76.97 100.24 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.723 -172.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 p -79.69 120.99 24.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.924 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -95.41 98.7 10.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.105 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.678 ' CE2' HD22 ' A' ' 93' ' ' LEU . 26.0 m-85 -93.9 115.83 28.23 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.647 HG12 HG22 ' A' ' 49' ' ' VAL . 7.1 mt -76.43 139.63 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.585 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 2.7 mp -124.81 118.41 53.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.696 0.798 . . . . 0.0 109.895 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 11.0 m120 -84.99 131.66 34.44 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 -172.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -79.77 99.45 7.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 72' ' ' LYS . 61.2 mt -90.63 132.48 34.95 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.429 -176.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 25.1 Cg_exo -64.07 -3.81 6.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.902 2.402 . . . . 0.0 112.699 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -93.82 22.18 5.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.152 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.655 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 2.8 mmp_? 63.36 26.83 15.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.394 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.7 164.41 15.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.663 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.585 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 62.5 m-85 -133.69 114.9 13.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.72 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.47 ' NZ ' ' HG3' ' A' ' 77' ' ' GLU . 21.8 ttmm -100.73 107.18 18.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.817 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.0 tt -94.7 78.42 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.858 0.837 . . . . 0.0 109.742 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.42 89.31 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.226 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.93 -57.69 0.63 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.464 0.706 . . . . 0.0 111.193 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -69.19 121.53 16.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.995 0.426 . . . . 0.0 110.965 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.47 ' HG3' ' NZ ' ' A' ' 72' ' ' LYS . 20.4 mt-10 -97.59 125.56 42.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.966 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 74.3 m-85 -115.38 152.45 32.82 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.84 -11.19 60.81 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -175.17 176.32 2.09 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.628 0.195 . . . . 0.0 110.757 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.5 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 5.9 mt -56.44 -55.56 41.27 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 123.278 0.361 . . . . 0.0 111.833 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.418 ' HA ' HD12 ' A' ' 85' ' ' LEU . 37.8 Cg_exo -63.38 -3.86 5.82 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.123 1.882 . . . . 0.0 113.638 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.13 -35.04 16.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.76 0.314 . . . . 0.0 110.55 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -76.15 -31.92 58.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 82' ' ' PRO . 55.5 mt -68.24 -24.35 64.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.713 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.18 -19.12 40.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.828 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -88.38 -39.14 14.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.177 0.513 . . . . 0.0 110.199 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.519 ' HE2' HD13 ' A' ' 73' ' ' ILE . 52.8 m-85 -78.28 -3.5 43.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.518 0.675 . . . . 0.0 109.78 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.629 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 1.4 tmtp? -64.71 -35.09 79.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.869 170.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.7 pt -113.69 -6.39 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.629 -0.428 . . . . 0.0 112.072 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 6.2 t-160 -73.18 -43.21 61.77 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.806 -0.179 . . . . 0.0 110.886 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.62 ' CD1' HG23 ' A' ' 97' ' ' THR . 94.5 m-85 68.03 100.04 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.257 0.973 . . . . 0.0 108.867 -165.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.717 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 4.2 mt -69.64 -98.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.527 ' OD2' ' HB3' ' A' ' 54' ' ' GLU . 17.5 t0 -89.84 76.86 7.09 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 121.368 -0.832 . . . . 0.0 109.325 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 68.15 -34.07 0.24 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.538 1.135 . . . . 0.0 112.409 -177.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.404 ' H ' ' C ' ' A' ' 94' ' ' ASP . 39.5 m -107.87 146.06 32.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.62 HG23 ' CD1' ' A' ' 92' ' ' TYR . 3.1 p -81.76 -178.5 7.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 0.0 110.704 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.401 HD22 ' CD2' ' A' ' 36' ' ' PHE . 95.1 mt -77.18 91.76 3.76 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.1 mm -74.93 -60.83 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.424 -175.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.684 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 9.4 pt-20 -162.35 156.09 17.9 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.407 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.2 158.15 49.32 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.621 2.214 . . . . 0.0 113.36 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -72.49 154.38 91.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.842 176.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.25 124.4 15.55 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.054 2.503 . . . . 0.0 112.673 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.811 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 75.8 ttt180 . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.072 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.969 HD12 HG21 ' A' ' 152' ' ' ILE . 1.3 mm? . . . . . 0 C--O 1.234 0.289 0 CA-C-O 121.77 0.795 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -154.77 -76.73 0.1 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.608 -171.112 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.578 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 48.9 m-85 -104.98 108.52 20.07 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.612 0.72 . . . . 0.0 111.392 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.944 HG22 ' HB3' ' A' ' 180' ' ' LYS . 74.3 t -122.81 132.25 71.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.516 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.975 ' HB2' ' HB3' ' A' ' 179' ' ' GLU . 26.1 mtt180 -107.7 160.29 15.82 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.548 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.452 HG21 ' CG ' ' A' ' 144' ' ' PHE . 12.5 p -117.08 134.43 54.77 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.547 176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.634 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 81.0 mt -104.42 -32.22 9.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.692 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.54 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 47.6 t80 -78.13 -36.85 47.32 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -169.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.601 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 7.4 t70 74.5 105.22 0.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.336 0.589 . . . . 0.0 109.813 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -141.1 100.15 6.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 51.9 Cg_endo -88.52 87.7 0.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.273 1.982 . . . . 0.0 112.492 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.682 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -83.3 -12.83 78.04 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.931 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 1.026 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 4.6 p30 35.71 66.74 0.33 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.431 1.092 . . . . 0.0 113.888 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -159.39 -178.88 7.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.57 -7.33 57.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.577 0.703 . . . . 0.0 109.763 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.4 pt-20 -116.85 4.07 12.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.451 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.682 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 10.3 m-20 -146.79 97.3 2.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.378 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.099 HD11 ' HB2' ' A' ' 165' ' ' ASN . 49.1 tp -75.16 120.55 82.17 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 1.026 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 12.1 Cg_endo -80.84 92.94 1.04 Allowed 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.106 1.871 . . . . 0.0 111.178 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.452 ' CG ' HG21 ' A' ' 130' ' ' THR . 10.3 p90 -100.9 164.61 11.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.685 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.601 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 9.2 mtpt -119.46 -178.83 3.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.654 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -77.28 63.56 2.51 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.089 0.947 . . . . 0.0 111.544 -175.259 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.97 35.54 0.27 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.722 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.486 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 5.3 mm-40 -96.7 141.0 30.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.982 0.42 . . . . 0.0 110.224 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.06 128.37 43.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 165' ' ' ASN . 40.1 mt -121.03 157.23 30.46 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 58.0 t -116.08 128.41 73.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.969 HG21 HD12 ' A' ' 125' ' ' LEU . 42.5 mm -75.16 97.38 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.809 0.814 . . . . 0.0 109.204 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.735 HG23 ' HG2' ' A' ' 154' ' ' GLU . 8.7 tt -85.11 -42.81 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.868 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.984 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 0.8 OUTLIER -122.23 140.23 52.85 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.567 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 45.6 tttt -131.24 88.72 43.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 O-C-N 121.673 -0.642 . . . . 0.0 110.915 171.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.478 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 16.2 Cg_exo -74.3 -51.83 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.66 2.24 . . . . 0.0 113.083 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -110.91 -171.38 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.233 -0.292 . . . . 0.0 110.82 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.42 ' HA ' ' HE1' ' A' ' 161' ' ' TRP . 0.2 OUTLIER -110.65 -25.7 9.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.774 0.321 . . . . 0.0 110.411 174.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -84.72 -28.0 26.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.277 0.56 . . . . 0.0 110.416 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.682 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 43.3 m95 -128.36 130.39 47.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.122 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.704 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.7 m0 -122.52 142.83 50.17 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.064 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.984 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.2 m -98.82 94.59 6.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.438 0.637 . . . . 0.0 110.391 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.71 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -100.1 164.23 12.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.217 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.703 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.2 ptt180 -104.35 134.52 47.43 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.775 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.099 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.7 t30 -75.12 -179.32 4.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.568 -177.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -58.78 -21.12 55.17 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 172.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.5 -36.78 81.73 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.469 0.652 . . . . 0.0 109.36 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.25 -6.78 42.94 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.808 -168.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.703 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 13.0 ttm-85 -69.72 140.08 53.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.463 -0.868 . . . . 0.0 111.606 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.644 HG22 HG21 ' A' ' 153' ' ' ILE . 44.4 t -98.89 125.42 52.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.953 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.418 ' CA ' ' HB2' ' A' ' 142' ' ' LEU . . . -150.1 163.2 29.41 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.59 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.682 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -79.65 136.18 36.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.622 0.249 . . . . 0.0 110.609 179.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.704 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -136.09 145.39 52.14 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.378 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.488 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 6.1 Cg_exo -80.45 133.65 9.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.037 2.491 . . . . 0.0 112.903 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.677 ' O ' HG22 ' A' ' 178' ' ' VAL . 92.6 t -62.84 -41.74 73.61 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.1 Cg_endo -63.42 0.73 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.012 1.808 . . . . 0.0 113.304 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -106.74 -3.48 20.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.645 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 175' ' ' VAL . 11.4 m -107.2 -178.85 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -165.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.975 ' HB3' ' HB2' ' A' ' 129' ' ' ARG . 1.0 OUTLIER -149.25 39.98 0.85 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 112.702 -2.045 . . . . 0.0 108.498 -165.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.944 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.686 0 O-C-N 121.109 -0.995 . . . . 0.0 110.913 -169.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 1.054 ' N ' HG22 ' A' ' 266' ' ' VAL . 21.4 t . . . . . 0 N--CA 1.524 3.226 0 CA-C-O 117.968 -1.015 . . . . 0.0 108.342 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.448 ' HA ' HG13 ' A' ' 266' ' ' VAL . 60.1 m-85 -65.26 119.59 11.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.621 1.101 . . . . 0.0 111.315 -163.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -132.96 156.98 46.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.583 -168.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -96.65 122.59 39.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.336 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.465 ' HB2' HG23 ' A' ' 264' ' ' VAL . . . -73.39 115.09 12.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.12 -0.22 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -172.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 245' ' ' LYS . 7.2 tt0 -140.94 147.89 39.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.869 0.366 . . . . 0.0 110.507 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.822 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 51.6 mtmt -79.24 140.23 37.69 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.297 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -140.39 104.91 4.88 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.998 0.428 . . . . 0.0 110.462 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.692 -179.369 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 121.049 0.452 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.95 103.5 14.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.064 0.459 . . . . 0.0 111.444 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.455 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.0 OUTLIER -74.27 114.06 12.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.817 177.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -70.95 132.44 45.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.524 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.429 HD21 HG21 ' A' ' 279' ' ' VAL . 96.7 mt -136.35 -177.96 4.95 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.337 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.822 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 7.5 pt-20 -154.55 -165.66 2.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.181 176.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.76 HG23 ' HG3' ' A' ' 245' ' ' LYS . 39.2 t -108.23 130.43 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 111.802 -173.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.21 15.87 12.05 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.586 -0.816 . . . . 0.0 114.497 168.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.3 179.78 6.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.87 0.835 . . . . 0.0 111.212 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.9 mm -105.82 119.43 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.816 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 266' ' ' VAL . 65.7 t -76.38 125.15 35.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.488 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 89.5 mttt -68.34 88.63 0.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.808 0.813 . . . . 0.0 109.5 173.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 1.054 HG22 ' N ' ' A' ' 238' ' ' VAL . 2.1 p -127.56 126.19 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.556 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.404 ' N ' ' N ' ' A' ' 238' ' ' VAL . 5.1 m -137.87 -26.18 0.96 Allowed 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.64 HH12 ' HB3' ' A' ' 276' ' ' GLU . 5.9 tmm_? -136.05 93.07 2.87 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.115 0.966 . . . . 0.0 110.46 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . 0.551 ' CE ' ' HB ' ' A' ' 238' ' ' VAL . 4.0 ptp -87.37 141.36 28.69 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.205 -0.934 . . . . 0.0 113.255 -174.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -75.03 157.4 34.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.372 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.2 tp -92.54 -3.47 10.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.531 0.681 . . . . 0.0 110.253 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -73.27 -10.01 59.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.104 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 100.18 -29.35 12.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.932 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.991 HE21 ' HA ' ' A' ' 274' ' ' GLN . 0.0 OUTLIER -89.5 113.38 24.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.181 0.515 . . . . 0.0 109.654 175.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.568 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 55.0 m0 -92.8 162.76 13.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.564 -173.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.64 ' HB3' HH12 ' A' ' 268' ' ' ARG . 2.8 tm-20 -128.6 89.63 2.92 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 120.209 -0.597 . . . . 0.0 109.814 -168.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -117.96 158.35 14.72 Favored Glycine 0 C--O 1.226 -0.389 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.995 -174.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 265' ' ' LYS . 18.0 tt0 -116.79 111.08 19.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.246 0.523 . . . . 0.0 110.572 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.455 ' HB ' HD21 ' A' ' 256' ' ' LEU . 97.9 t -109.93 122.22 64.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.682 0.277 . . . . 0.0 110.64 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 48.15 32.22 2.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.58 1.152 . . . . 0.0 112.41 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 97.3 -3.03 61.45 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.198 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -107.92 114.96 29.27 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.1 OUTLIER -106.61 141.56 37.68 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.875 178.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -171.18 -170.29 35.14 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.649 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 80.5 mt -99.56 135.01 41.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.064 0.459 . . . . 0.0 110.188 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 50.7 p90 -136.79 140.87 33.12 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.16 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 2.8 Cg_exo -76.65 152.37 33.22 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.989 2.459 . . . . 0.0 112.661 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.502 ' HB3' ' CH2' ' A' ' 275' ' ' TRP . 7.6 p90 -69.71 -2.51 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.399 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.7 p -90.45 4.33 51.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.058 0.456 . . . . 0.0 111.47 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -117.44 -15.37 10.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.778 0.323 . . . . 0.0 111.441 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.418 HG21 ' HE2' ' A' ' 286' ' ' PHE . 33.1 m -128.6 160.85 38.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.266 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -121.54 119.0 30.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.73 0.3 . . . . 0.0 110.535 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.653 HD13 ' HB2' ' A' ' 240' ' ' ALA . 49.5 mm -73.36 123.22 27.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.604 175.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -126.16 174.26 8.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.394 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 121.486 0.66 . . . . 0.0 112.438 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -122.59 -57.55 1.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.107 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 62.58 176.27 0.14 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 172.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.08 73.7 0.76 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.624 -2.08 . . . . 0.0 106.08 164.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.2 m -63.44 154.84 30.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.0 -167.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.474 ' H ' ' HB3' ' A' ' 82' ' ' PRO . 24.6 m 75.84 -45.9 0.54 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.321 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.38 110.21 0.92 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.525 0.679 . . . . 0.0 111.048 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -57.72 -32.14 67.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.941 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 t -81.38 -1.66 46.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.3 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.2 -46.94 7.49 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.367 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -117.76 -26.22 6.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -173.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -84.33 125.38 32.23 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.025 -0.422 . . . . 0.0 110.866 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.519 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.2 mmt -108.53 -3.47 18.04 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.189 -175.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 52.17 -112.18 1.88 Allowed Glycine 0 CA--C 1.522 0.53 0 O-C-N 123.66 0.6 . . . . 0.0 113.953 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.6 Cg_exo -66.63 88.35 0.28 Allowed 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.411 2.741 . . . . 0.0 113.499 -176.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.882 HG12 ' H ' ' A' ' 20' ' ' SER . 16.4 t -131.96 -162.88 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.882 ' H ' HG12 ' A' ' 19' ' ' VAL . 47.5 p -173.77 178.27 2.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.701 1.137 . . . . 0.0 109.167 -169.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 20.1 tpt180 -55.43 -54.45 43.62 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.288 0.367 . . . . 0.0 110.034 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -58.28 -59.6 5.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.717 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 56.5 mm-40 -61.05 -46.53 90.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.02 -174.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.85 77.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 18.3 pt20 -70.06 -33.32 71.79 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.954 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.6 m -64.5 -34.41 78.15 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.43 0.633 . . . . 0.0 111.082 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 22.8 mmt85 -64.23 -41.41 97.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.843 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 14.5 mt -112.19 6.97 19.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -168.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 4.1 pt20 -74.65 100.41 3.94 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.454 0.645 . . . . 0.0 111.721 -176.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.67 4.96 90.23 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.313 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -88.19 -171.69 3.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.574 0.226 . . . . 0.0 110.691 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.538 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 6.0 mtp180 -48.78 126.47 12.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.934 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.439 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 30.5 m170 -85.59 155.17 21.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.929 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.7 -2.06 79.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.322 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 39.5 mtm -93.1 153.25 18.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.0 110.335 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.634 ' CD1' HD22 ' A' ' 98' ' ' LEU . 49.3 p90 -150.13 166.53 29.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.434 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.519 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -155.27 138.33 15.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.641 174.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t -105.41 125.12 60.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.605 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.793 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 32.7 ptt-85 -124.44 174.37 7.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.291 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -72.55 131.76 42.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.634 ' HA ' HG23 ' A' ' 49' ' ' VAL . 15.4 t -56.05 146.64 22.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.633 0.73 . . . . 0.0 112.443 -170.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -92.22 -7.93 46.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.213 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.6 m -110.34 -47.87 3.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.335 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 41' ' ' SER . 56.2 m -125.09 119.0 25.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.714 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.9 112.79 1.75 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.527 2.151 . . . . 0.0 111.572 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.04 -21.88 11.85 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.459 ' C ' ' HB2' ' A' ' 41' ' ' SER . 26.4 t70 -82.85 171.94 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 27.1 m-85 -130.37 160.91 32.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.458 0.572 . . . . 0.0 111.205 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 41' ' ' SER . 39.5 t -136.77 105.4 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.213 0.53 . . . . 0.0 111.218 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.485 ' CB ' HD11 ' A' ' 63' ' ' ILE . 33.6 tp -82.27 102.7 11.34 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.226 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.7 m -95.36 119.43 33.86 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.55 HG21 HD13 ' A' ' 93' ' ' LEU . 48.9 t -117.89 136.33 55.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.113 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 1.079 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 89.6 p -104.89 135.12 46.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.694 0.759 . . . . 0.0 111.806 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.554 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 18.9 mt-10 -144.79 176.29 9.55 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 170.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.49 ' N ' HD22 ' A' ' 55' ' ' ASN . 0.0 OUTLIER -29.23 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 m 34.14 70.95 0.11 Allowed 'General case' 0 C--N 1.349 0.582 0 CA-C-O 121.983 0.897 . . . . 0.0 110.882 -171.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.933 HH12 ' HA ' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -162.31 45.46 0.15 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.088 -157.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.6 t -81.83 90.6 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.561 0.696 . . . . 0.0 109.667 -177.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.5 m -86.1 122.13 29.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.477 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -93.72 95.89 9.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.685 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.608 ' CE2' HD22 ' A' ' 93' ' ' LEU . 78.4 m-85 -87.51 117.31 26.22 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 123.15 0.58 . . . . 0.0 111.657 -175.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 49' ' ' VAL . 5.6 mt -80.49 133.38 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.7 mp -115.49 118.63 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.197 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -83.77 134.53 34.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.813 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -87.77 105.77 17.62 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 82.9 mt -88.26 145.79 36.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.415 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 34.6 Cg_exo -62.19 -23.11 75.17 Favored 'Trans proline' 0 N--CA 1.473 0.315 0 C-N-CA 123.363 2.708 . . . . 0.0 112.962 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -89.03 18.1 5.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.186 0.517 . . . . 0.0 110.183 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.837 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 1.2 mmp_? 64.41 31.95 12.3 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.275 173.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -113.18 165.41 12.42 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.487 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 60.1 m-85 -127.22 117.45 22.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.441 0.639 . . . . 0.0 111.509 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -106.57 98.76 8.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.511 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.593 HD11 ' HB3' ' A' ' 61' ' ' TYR . 8.7 tt -79.6 85.16 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.545 0.688 . . . . 0.0 110.476 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.69 73.2 0.52 Allowed Glycine 0 C--O 1.227 -0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.117 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.6 t0 75.7 -38.39 0.35 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.101 0.56 . . . . 0.0 111.023 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.54 HE21 ' HA ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -59.26 114.66 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.46 0.304 . . . . 0.0 110.902 174.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.82 115.43 27.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.794 0.33 . . . . 0.0 111.345 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 76' ' ' GLN . 84.4 m-85 -126.05 168.02 14.54 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -86.22 -34.71 20.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.708 0.29 . . . . 0.0 111.524 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 2.6 p80 -152.63 168.54 25.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.677 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.659 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 12.4 mt -57.04 -55.26 45.84 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.601 ' HA ' HD12 ' A' ' 85' ' ' LEU . 32.8 Cg_endo -65.29 -3.8 8.13 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.789 1.659 . . . . 0.0 113.014 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.81 -32.62 17.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.736 0.303 . . . . 0.0 110.558 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.2 pp -76.74 -32.35 57.72 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.601 HD12 ' HA ' ' A' ' 82' ' ' PRO . 51.1 mt -66.03 -26.98 67.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.731 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -74.57 -35.11 63.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.823 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -75.36 -38.02 60.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 111.301 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.463 ' HE2' HD13 ' A' ' 73' ' ' ILE . 44.5 m-85 -72.79 1.94 7.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.954 0.407 . . . . 0.0 111.34 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -64.91 -36.66 85.1 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.322 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 mt -104.13 -7.39 9.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.177 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -82.69 -37.09 25.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.875 -171.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.755 ' HA ' HG22 ' A' ' 97' ' ' THR . 81.2 m-85 66.27 95.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.993 0.808 . . . . 0.0 110.203 -169.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.712 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 23.6 mt -62.71 -23.52 67.2 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.404 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.554 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 23.7 t70 -139.11 -77.89 0.34 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 164.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.686 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 5.8 t -146.95 10.44 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.585 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 99' ' ' ILE . 4.3 m -124.19 -39.23 2.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.755 HG22 ' HA ' ' A' ' 92' ' ' TYR . 17.6 p 82.9 -173.3 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.422 1.489 . . . . 0.0 111.011 -174.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.634 HD22 ' CD1' ' A' ' 36' ' ' PHE . 93.7 mt -88.25 106.11 17.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.857 176.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 1.9 mp -89.08 -53.82 8.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.574 ' HG2' HG22 ' A' ' 99' ' ' ILE . 9.9 pt-20 -163.54 149.39 9.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.74 159.56 47.9 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.328 2.019 . . . . 0.0 112.413 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.57 124.48 89.33 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.89 76.48 0.61 Allowed 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.908 2.405 . . . . 0.0 113.678 -171.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.469 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 3.7 tpm_? . . . . . 0 N--CA 1.469 0.504 0 C-N-CA 124.142 0.977 . . . . 0.0 111.772 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 1.045 ' HG ' ' HD3' ' A' ' 155' ' ' LYS . 4.3 mm? . . . . . 0 N--CA 1.461 0.092 0 CA-C-O 121.687 0.756 . . . . 0.0 112.339 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 45.0 tt0 -144.93 -66.09 0.33 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.647 -172.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -117.39 118.37 32.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.806 0.812 . . . . 0.0 111.457 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.763 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 71.8 t -133.3 135.31 56.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.746 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 1.032 ' HB2' ' HB3' ' A' ' 179' ' ' GLU . 23.0 mtt180 -107.7 158.25 17.43 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.055 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.449 HG21 ' CD2' ' A' ' 144' ' ' PHE . 6.3 p -116.22 138.8 50.98 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.801 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.547 HD21 ' CG ' ' A' ' 179' ' ' GLU . 12.3 mt -112.87 -37.03 4.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.636 -172.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -69.79 -35.98 75.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.994 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.8 t70 70.69 92.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.456 0.646 . . . . 0.0 109.262 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 79.1 t80 -127.59 116.89 21.14 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.917 -176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.627 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 48.8 Cg_endo -92.47 96.38 0.18 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 122.37 2.047 . . . . 0.0 113.067 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.84 -17.49 80.13 Favored Glycine 0 CA--C 1.507 -0.466 0 CA-C-O 121.795 0.664 . . . . 0.0 111.483 173.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.526 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 17.4 m120 55.57 29.99 14.48 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.024 -1.088 . . . . 0.0 112.804 -171.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.545 ' HB2' ' HD3' ' A' ' 169' ' ' ARG . 34.4 t0 82.63 168.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 157.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 89.06 -35.39 0.02 OUTLIER 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.832 1.653 . . . . 0.0 112.409 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -143.76 -14.61 0.64 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.945 0.403 . . . . 0.0 110.253 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -147.53 120.48 8.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.446 0.641 . . . . 0.0 110.511 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.04 HD11 ' HB2' ' A' ' 165' ' ' ASN . 41.7 tp -75.71 124.32 88.7 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.019 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.627 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 55.5 Cg_endo -77.61 96.2 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.42 2.08 . . . . 0.0 110.808 172.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 6.9 p90 -105.23 163.4 12.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.716 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.879 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 8.4 mmpt? -103.75 -176.39 3.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.303 0.573 . . . . 0.0 111.233 -175.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 13.73 2.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.52 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.75 39.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.719 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.879 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 29.9 mm-40 -98.54 155.74 17.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.744 HD12 ' HG2' ' A' ' 129' ' ' ARG . 15.7 mm -97.27 134.57 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 165' ' ' ASN . 22.5 mt -117.32 156.61 27.53 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.589 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 62.1 t -116.87 127.01 74.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.668 HD13 ' HB2' ' A' ' 163' ' ' ALA . 45.9 mm -76.06 82.52 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.221 1.01 . . . . 0.0 108.889 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.759 HG21 HG22 ' A' ' 170' ' ' VAL . 14.7 tt -77.44 -27.43 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.913 -175.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.933 ' HA ' HH12 ' A' ' 57' ' ' ARG . 4.4 mt-10 -139.97 139.74 36.14 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 173.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 1.045 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 5.7 ttpm? -133.86 86.47 38.18 Favored Pre-proline 0 C--O 1.237 0.412 0 O-C-N 121.755 -0.59 . . . . 0.0 111.036 174.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.686 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 53.6 Cg_endo -79.01 -46.07 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.285 1.99 . . . . 0.0 112.786 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -109.11 179.88 4.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.252 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -103.37 -29.43 11.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.842 0.353 . . . . 0.0 110.962 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -93.44 -21.44 19.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.618 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.625 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 35.9 m95 -129.06 126.02 38.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.1 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.648 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.1 m0 -116.1 137.79 51.81 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.09 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.863 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.5 m -89.33 89.72 8.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.129 0.49 . . . . 0.0 110.071 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.668 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -101.22 154.84 18.42 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.962 -0.461 . . . . 0.0 111.354 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.2 ptt180 -98.54 128.9 45.05 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.533 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.04 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.5 t30 -63.58 160.73 16.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.12 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -59.46 -25.01 64.04 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.48 ' HB3' HD22 ' A' ' 165' ' ' ASN . 11.1 t70 -75.69 -24.33 56.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.797 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.9 74.84 1.11 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.293 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.735 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -159.07 133.12 7.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.819 -0.191 . . . . 0.0 110.979 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.759 HG22 HG21 ' A' ' 153' ' ' ILE . 83.9 t -103.35 120.39 53.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.192 0.52 . . . . 0.0 111.892 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.97 159.89 28.29 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 170.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.625 ' HE2' ' HB3' ' A' ' 160' ' ' TRP . 21.6 mtp -71.21 138.95 49.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.254 0.527 . . . . 0.0 110.0 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.648 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -134.96 145.85 56.21 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.291 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 5.5 Cg_exo -75.94 129.04 11.19 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 123.299 2.666 . . . . 0.0 112.702 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.671 ' O ' HG22 ' A' ' 178' ' ' VAL . 92.3 t -58.77 -45.66 99.61 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 47.4 Cg_exo -59.5 -6.92 4.72 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.329 2.019 . . . . 0.0 113.86 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -98.15 -1.29 42.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 175' ' ' VAL . 5.9 m -109.41 178.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -164.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 1.032 ' HB3' ' HB2' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -138.9 40.38 2.15 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 111.267 -2.697 . . . . 0.0 107.983 -168.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.763 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 20.0 pttm . . . . . 0 C--N 1.322 -0.625 0 O-C-N 121.669 -0.644 . . . . 0.0 110.038 -165.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -91.94 118.47 30.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.412 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.94 150.67 40.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.027 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -111.13 130.79 55.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.897 0.379 . . . . 0.0 110.244 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.581 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -74.31 122.36 22.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.414 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 290' ' ' HIS . 27.1 pt -104.03 6.15 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -169.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.12 149.11 24.22 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.581 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 11.2 tptm -79.45 116.44 19.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.427 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.644 ' HB3' ' CE1' ' A' ' 290' ' ' HIS . 6.4 ttt-85 -151.32 107.64 3.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.143 0.497 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.891 178.495 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.452 -0.375 0 CA-C-O 120.647 0.261 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -89.06 116.74 27.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.867 0.365 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.544 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 1.1 tt -77.96 125.0 28.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -70.83 108.11 4.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.907 0.384 . . . . 0.0 110.581 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.6 mt -136.15 123.26 21.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.294 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 7.5 pt-20 -100.08 -134.87 0.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.782 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.86 130.2 68.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.53 . . . . 0.0 111.736 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 85.66 21.92 52.04 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.666 173.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -109.71 159.41 17.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.429 0.614 . . . . 0.0 110.019 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.47 127.09 56.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 110.94 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.638 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 39.9 t -107.03 122.03 60.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.496 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.495 ' HB2' ' HE3' ' A' ' 265' ' ' LYS . 34.7 ttmt -90.94 101.23 14.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.636 HG11 ' CZ3' ' A' ' 275' ' ' TRP . 4.8 p -126.34 147.83 31.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.424 -170.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -112.64 -54.22 2.64 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 275' ' ' TRP . 45.4 mtt180 -90.48 128.22 36.46 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 122.365 -0.21 . . . . 0.0 110.633 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . 0.882 ' C ' ' HA3' ' A' ' 273' ' ' GLY . 0.2 OUTLIER -117.25 113.48 22.25 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.921 ' HB2' ' HD2' ' A' ' 288' ' ' PHE . 0.9 OUTLIER -20.67 176.59 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 129.849 3.26 . . . . 0.0 117.643 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.428 HG13 ' CE2' ' A' ' 288' ' ' PHE . 43.6 mt 63.8 70.41 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 113.315 -1.766 . . . . 0.0 107.14 -160.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.6 13.42 9.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.048 -164.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.882 ' HA3' ' C ' ' A' ' 269' ' ' MET . . . -91.59 -35.47 6.89 Favored Glycine 0 N--CA 1.427 -1.924 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.558 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.898 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 8.9 pt20 23.44 121.71 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 125.638 1.434 . . . . 0.0 113.716 -161.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.845 ' CE2' ' HB3' ' A' ' 288' ' ' PHE . 7.6 m0 -83.81 132.57 34.81 Favored 'General case' 0 CA--C 1.48 -1.726 0 C-N-CA 118.015 -1.474 . . . . 0.0 111.18 -161.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.5 94.53 4.83 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 111.593 -2.549 . . . . 0.0 110.281 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.95 137.7 10.6 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.419 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.675 ' HG3' ' HB3' ' A' ' 283' ' ' LYS . 23.8 mp0 -101.88 109.52 21.29 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 256' ' ' LEU . 58.7 t -123.17 121.74 63.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.743 0.306 . . . . 0.0 111.438 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 5.9 t30 66.24 -72.68 0.08 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.541 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -113.56 -43.47 0.82 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.244 -174.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.544 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 5.5 ppt_? -158.11 174.26 15.47 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.675 ' HB3' ' HG3' ' A' ' 278' ' ' GLU . 60.0 pttt -95.77 143.83 26.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.873 -175.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.39 161.44 29.75 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.514 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 275' ' ' TRP . 21.1 mt -87.53 137.48 32.3 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.718 0.771 . . . . 0.0 111.558 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.638 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 21.4 p90 -149.54 142.9 16.28 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.096 174.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.611 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 13.8 Cg_exo -69.64 144.69 55.48 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.005 1.803 . . . . 0.0 110.76 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.921 ' HD2' ' HB2' ' A' ' 270' ' ' ASN . 26.5 p90 -69.1 6.02 1.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.5 m -88.14 -12.48 43.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.358 0.599 . . . . 0.0 109.685 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.644 ' CE1' ' HB3' ' A' ' 246' ' ' ARG . 69.1 t60 -83.41 -20.92 33.27 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.135 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.581 HG12 ' HA ' ' A' ' 242' ' ' ALA . 23.6 m -127.02 176.99 6.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.694 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -136.87 134.89 37.37 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.133 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 240' ' ' ALA . 44.5 mm -82.75 102.96 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -93.43 176.2 6.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.878 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--N 1.332 -0.189 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.662 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.644 0.259 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -154.85 93.42 1.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.207 0.527 . . . . 0.0 110.622 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.587 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 45.7 p90 -145.02 154.88 42.99 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.58 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -71.99 97.77 1.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.63 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.7 m -77.17 59.0 1.67 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.191 0.52 . . . . 0.0 110.51 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 t 179.42 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.603 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -69.66 102.02 1.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.34 0.59 . . . . 0.0 110.759 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.498 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 11.6 mmt180 -61.73 -29.25 69.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.525 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.3 m -79.09 0.38 28.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.607 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.12 -47.34 5.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -116.42 -21.32 9.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.498 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 44.4 t80 -85.7 118.5 25.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.809 0.338 . . . . 0.0 111.28 -173.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.602 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 19.1 mmt -104.15 -2.11 26.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 110.963 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.07 -115.86 4.47 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.485 -0.779 . . . . 0.0 114.022 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.1 94.61 0.73 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.265 1.977 . . . . 0.0 113.534 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.86 HG12 ' H ' ' A' ' 20' ' ' SER . 19.0 t -139.93 -175.56 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.86 ' H ' HG12 ' A' ' 19' ' ' VAL . 93.9 p -151.45 176.64 11.09 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.254 0.934 . . . . 0.0 108.554 -170.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -53.79 -66.03 0.46 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.39 -43.24 91.25 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.21 -45.8 90.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.471 0.176 . . . . 0.0 111.369 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.37 76.83 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.063 0.459 . . . . 0.0 111.27 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -73.53 -30.04 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.004 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.69 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 95.7 m -62.1 -34.78 76.96 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.272 0.558 . . . . 0.0 110.466 174.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -75.43 -14.29 60.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.121 0.486 . . . . 0.0 110.417 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.552 ' O ' ' HB3' ' A' ' 31' ' ' GLN . 20.4 mt -115.75 17.7 16.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.406 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 26' ' ' THR . 12.5 pt20 -88.08 116.0 25.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.399 0.619 . . . . 0.0 110.675 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.74 26.55 24.46 Favored Glycine 0 CA--C 1.499 -0.916 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.606 ' HG2' ' HD2' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -50.59 177.7 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 111.187 -2.506 . . . . 0.0 115.141 -175.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -86.19 -9.31 56.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.558 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.606 ' HD2' ' HG2' ' A' ' 31' ' ' GLN . 61.7 m170 66.03 92.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.445 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.41 28.89 3.61 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -170.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 52.4 ttp -124.19 134.19 53.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.56 ' CD1' HD22 ' A' ' 98' ' ' LEU . 43.8 p90 -135.6 164.13 28.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -173.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.48 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -150.62 144.02 24.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.364 171.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.403 HG22 HD13 ' A' ' 50' ' ' LEU . 61.2 t -109.24 119.17 58.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.545 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -123.01 168.47 12.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.708 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.455 ' OD2' ' HA ' ' A' ' 45' ' ' PRO . 34.6 t70 -66.11 125.93 27.05 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.02 -0.734 . . . . 0.0 109.02 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.624 ' HA ' HG23 ' A' ' 49' ' ' VAL . 31.9 p -53.63 120.02 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.518 0.675 . . . . 0.0 112.104 -172.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.719 ' HB3' ' HA ' ' A' ' 20' ' ' SER . 3.4 p -74.58 73.62 1.97 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.922 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.0 t 174.72 -36.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.327 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 66.5 m -147.43 93.85 4.57 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.253 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.455 ' HA ' ' OD2' ' A' ' 40' ' ' ASP . 54.5 Cg_exo -52.21 116.18 2.65 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.524 2.149 . . . . 0.0 112.253 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.57 -47.83 0.9 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.529 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 1.2 m-20 -78.62 -172.05 2.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.46 ' CE1' ' HE1' ' A' ' 15' ' ' TYR . 25.9 m-85 -138.46 169.4 17.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.255 0.55 . . . . 0.0 112.132 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 41' ' ' SER . 44.1 t -146.94 111.42 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.525 175.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.482 ' HG ' HG23 ' A' ' 52' ' ' VAL . 62.5 tp -82.04 104.27 12.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.133 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.9 m -94.99 109.32 21.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.271 0.558 . . . . 0.0 109.829 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.556 HG12 ' OE2' ' A' ' 54' ' ' GLU . 29.0 t -111.2 138.16 40.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.126 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 81.8 p -118.22 137.37 53.06 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.724 ' HB2' ' HE ' ' A' ' 57' ' ' ARG . 13.9 mp0 -143.58 179.44 7.12 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.434 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 23.6 m-20 -21.15 81.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 124.846 1.341 . . . . 0.0 114.194 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m 42.68 62.8 1.63 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.671 0.788 . . . . 0.0 111.787 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.724 ' HE ' ' HB2' ' A' ' 54' ' ' GLU . 1.4 ptm85 -167.52 57.45 0.07 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -163.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 19.2 t -76.58 103.79 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.34 -0.85 . . . . 0.0 109.54 -176.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.8 m -92.1 121.47 33.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.185 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -92.58 88.26 6.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.768 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.531 ' CE2' HD22 ' A' ' 93' ' ' LEU . 90.3 m-85 -78.89 117.25 19.81 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.077 0.551 . . . . 0.0 110.924 -176.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 8.4 tp -71.4 135.96 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.561 HG23 ' HB3' ' A' ' 71' ' ' PHE . 4.0 mp -122.23 117.76 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.964 0.411 . . . . 0.0 110.769 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.529 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 5.5 m120 -85.61 136.07 33.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.936 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 47' ' ' ASP . 10.8 t -92.73 98.43 11.41 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 174.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.572 HD11 ' HG3' ' A' ' 72' ' ' LYS . 55.0 mt -72.89 168.36 25.23 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.107 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 36.6 Cg_exo -63.17 68.3 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.998 2.465 . . . . 0.0 112.803 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 70.79 14.89 6.99 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.369 1.468 . . . . 0.0 112.176 164.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 66.4 mtt180 -93.75 -72.75 0.6 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.707 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.711 ' HB2' ' O ' ' A' ' 78' ' ' PHE . 3.2 ptp180 -156.79 -169.62 3.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.596 -172.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.561 ' HB3' HG23 ' A' ' 63' ' ' ILE . 97.4 m-85 -118.31 127.92 54.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.959 0.409 . . . . 0.0 111.053 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.693 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 52.9 mttm -98.22 101.09 12.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.842 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.675 HD13 ' HE2' ' A' ' 88' ' ' TYR . 10.7 tt -87.41 81.94 2.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 122.127 0.965 . . . . 0.0 110.202 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.27 81.63 0.38 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.161 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.5 t0 72.59 -58.0 0.61 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.778 0.431 . . . . 0.0 111.376 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -79.03 140.02 38.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.406 0.622 . . . . 0.0 110.726 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.693 ' HB3' ' HG2' ' A' ' 72' ' ' LYS . 10.5 pt-20 -110.8 141.72 43.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.321 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.711 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 71.9 m-85 -122.68 151.08 41.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -58.94 -24.89 62.99 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -169.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -163.75 172.32 14.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.332 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.574 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.7 mt -55.09 -56.49 27.61 Favored Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 34.6 Cg_exo -61.15 -9.48 12.62 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.125 1.884 . . . . 0.0 113.23 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . . . -88.7 -25.58 22.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.66 0.267 . . . . 0.0 110.991 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -79.49 -31.52 42.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.26 -35.48 79.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.756 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.502 ' HG2' ' HA ' ' A' ' 83' ' ' ALA . 7.6 pt-20 -80.56 -6.16 57.83 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -87.65 -37.58 16.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.372 0.606 . . . . 0.0 109.592 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.675 ' HE2' HD13 ' A' ' 73' ' ' ILE . 41.9 m-85 -81.85 -6.88 59.47 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.565 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.538 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 14.2 ptmm? -83.62 -3.73 57.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.527 171.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.4 pt -123.21 -22.16 2.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 121.021 0.439 . . . . 0.0 110.522 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 10.6 t-160 -68.9 -41.96 77.55 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.946 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.567 ' CD2' HG23 ' A' ' 97' ' ' THR . 91.3 m-85 71.81 108.39 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 O-C-N 124.554 1.159 . . . . 0.0 108.93 -165.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.659 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 4.8 mt -78.86 1.38 23.66 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.687 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 28.4 t70 -168.53 -134.19 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.467 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 10.6 t -83.07 -8.05 59.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.516 0.674 . . . . 0.0 109.372 172.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.9 t -125.92 169.46 12.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.912 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.567 HG23 ' CD2' ' A' ' 92' ' ' TYR . 9.1 p -109.14 -176.66 3.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.555 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.56 HD22 ' CD1' ' A' ' 36' ' ' PHE . 92.6 mt -69.13 98.8 1.04 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.697 HG22 ' HG3' ' A' ' 100' ' ' GLU . 51.3 mm -90.68 -58.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.929 -176.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.697 ' HG3' HG22 ' A' ' 99' ' ' ILE . 45.3 mt-10 -141.01 158.12 65.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.712 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 93.6 Cg_endo -83.27 157.37 14.83 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.611 2.208 . . . . 0.0 112.04 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.45 158.33 83.59 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.386 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.74 129.43 27.67 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.258 1.972 . . . . 0.0 111.812 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.602 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 35.3 ttt180 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.371 0.605 . . . . 0.0 110.266 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.492 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 0.5 OUTLIER . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.625 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 8.5 mt-10 169.08 -54.42 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 O-C-N 125.703 1.877 . . . . 0.0 109.988 171.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.651 ' O ' ' HA ' ' A' ' 180' ' ' LYS . 12.9 m-85 -61.28 107.42 0.76 Allowed 'General case' 0 C--O 1.208 -1.12 0 CA-C-N 119.18 0.9 . . . . 0.0 110.805 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.787 HG21 HD11 ' A' ' 152' ' ' ILE . 2.0 t -131.23 132.66 63.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.807 172.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.811 HH21 HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -126.31 135.43 51.5 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.601 173.29 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.952 HG22 HG12 ' A' ' 178' ' ' VAL . 70.9 p -94.06 132.86 38.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -173.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -112.38 -0.32 15.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.801 -175.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -105.93 -44.36 4.63 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -168.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.3 t70 81.16 102.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.273 0.629 . . . . 0.0 110.35 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 87.3 t80 -142.61 110.82 5.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 57.6 Cg_endo -91.89 90.42 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.619 2.213 . . . . 0.0 112.615 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.605 ' HA3' ' OD1' ' A' ' 141' ' ' ASP . . . -79.93 -2.42 88.56 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.257 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.44 HD22 ' HA ' ' A' ' 137' ' ' ASN . 7.4 m120 56.95 25.84 11.08 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.642 0.377 . . . . 0.0 111.974 -174.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.794 ' HA ' ' O ' ' A' ' 141' ' ' ASP . 3.0 p30 53.35 -166.61 0.07 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 168.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 138' ' ' ASP . . . 90.6 -47.49 0.02 OUTLIER 'General case' 0 C--N 1.347 0.46 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.875 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -142.37 14.01 1.99 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.794 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 11.5 t70 -153.53 173.55 15.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 112.756 -2.02 . . . . 0.0 105.824 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.752 HD11 ' HB3' ' A' ' 165' ' ' ASN . 54.8 tp -134.61 128.81 19.19 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 119.16 0.891 . . . . 0.0 110.477 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.651 ' HD2' HD12 ' A' ' 142' ' ' LEU . 12.6 Cg_endo -85.09 98.77 0.67 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.449 2.099 . . . . 0.0 111.194 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.666 ' CG ' HG21 ' A' ' 130' ' ' THR . 10.9 p90 -111.77 167.96 9.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.556 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.656 ' H ' ' HB2' ' A' ' 148' ' ' GLU . 24.5 mtpp -126.1 -174.05 3.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -173.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -69.79 66.47 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.52 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 121.0 49.34 0.28 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.263 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.656 ' HB2' ' H ' ' A' ' 145' ' ' LYS . 5.8 tp10 -99.34 154.52 18.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.811 HD11 HH21 ' A' ' 129' ' ' ARG . 1.0 OUTLIER -112.32 134.2 55.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.69 -173.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.719 HD22 HD21 ' A' ' 142' ' ' LEU . 21.0 mt -143.14 155.8 44.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.899 0.857 . . . . 0.0 110.913 -170.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.691 HG21 ' HE ' ' A' ' 164' ' ' ARG . 39.3 t -126.32 126.41 69.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.614 173.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.793 HD13 ' HB2' ' A' ' 163' ' ' ALA . 36.2 mm -74.53 86.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 122.156 0.979 . . . . 0.0 110.412 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.852 HG21 HG22 ' A' ' 170' ' ' VAL . 9.1 tt -82.51 -28.28 8.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.726 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.958 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 28.0 mt-10 -130.73 141.66 50.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -136.23 77.43 48.33 Favored Pre-proline 0 C--O 1.24 0.566 0 O-C-N 121.472 -0.768 . . . . 0.0 111.566 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 16.6 Cg_exo -66.16 -54.62 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.256 1.971 . . . . 0.0 111.342 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -106.82 175.06 5.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.62 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -98.89 -23.33 15.39 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.33 -27.64 21.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.273 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.404 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 44.2 m95 -124.41 122.47 37.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.642 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.756 ' HB3' HD12 ' A' ' 152' ' ' ILE . 45.7 m0 -112.18 137.72 49.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.53 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.958 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.7 m -94.82 109.54 21.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.793 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -116.79 159.32 22.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -173.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.691 ' HE ' HG21 ' A' ' 151' ' ' VAL . 9.7 ptt180 -94.0 118.86 32.09 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.996 173.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.752 ' HB3' HD11 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -69.16 179.11 2.03 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.664 0.269 . . . . 0.0 111.452 -178.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -61.41 -30.37 70.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.987 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -93.65 4.1 54.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.636 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.41 ' H ' HD22 ' A' ' 165' ' ' ASN . . . 84.23 74.82 1.22 Allowed Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.785 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -150.92 138.41 19.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 177.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.852 HG22 HG21 ' A' ' 153' ' ' ILE . 95.1 t -103.78 126.03 58.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.201 0.524 . . . . 0.0 111.973 -175.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . -157.42 167.45 34.01 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 171.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 22.7 mtp -79.96 139.44 37.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.178 0.489 . . . . 0.0 110.7 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.766 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -138.24 148.3 59.14 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.75 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 5.7 Cg_exo -78.24 131.77 10.98 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.65 2.233 . . . . 0.0 112.435 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.547 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 61.1 t -59.34 -45.07 99.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 31.9 Cg_endo -65.29 -1.62 4.8 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.22 1.947 . . . . 0.0 113.452 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 2.6 m-85 -99.7 -7.94 24.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.783 0.325 . . . . 0.0 111.066 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.952 HG12 HG22 ' A' ' 130' ' ' THR . 2.9 m -144.2 176.56 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.662 -166.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.695 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 6.6 pt-20 -153.64 -55.65 0.11 Allowed 'General case' 0 C--O 1.2 -1.533 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 144.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-N 122.538 2.426 . . . . 0.0 115.686 -171.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.405 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 28.3 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.592 0.234 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.472 ' CE1' ' HE2' ' A' ' 265' ' ' LYS . 54.1 m-85 -81.28 126.64 31.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.17 0.509 . . . . 0.0 111.272 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.685 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -135.32 130.9 35.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.097 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -97.47 126.66 42.87 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -73.48 111.69 8.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.434 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.455 HD12 ' HG3' ' A' ' 244' ' ' GLN . 1.9 pp -87.81 -10.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.691 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.455 ' HG3' HD12 ' A' ' 243' ' ' ILE . 28.8 mt-30 -120.23 167.19 12.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 258' ' ' LEU . 21.2 pttp -118.79 137.48 53.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.302 0.573 . . . . 0.0 111.058 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.539 ' NH1' ' HD2' ' A' ' 287' ' ' PRO . 40.8 ttp-105 -139.41 117.55 11.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.845 -176.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.973 179.725 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 N--CA 1.468 0.452 0 CA-C-O 121.28 0.562 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -91.35 103.95 16.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.695 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 257' ' ' ALA . 1.5 tt -67.23 131.38 45.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.632 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.437 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -75.21 120.38 20.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.618 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 245' ' ' LYS . 81.7 mt -138.0 113.02 9.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.593 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.63 172.45 7.7 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 43.9 t -69.56 106.91 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.02 0.438 . . . . 0.0 110.443 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 123.4 -8.56 8.92 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.415 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.03 130.9 44.35 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.836 0.35 . . . . 0.0 110.867 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 45.9 mm -89.02 108.73 19.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.378 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.416 HG21 HG11 ' A' ' 291' ' ' VAL . 36.1 t -85.81 106.54 15.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.27 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.472 ' HE2' ' CE1' ' A' ' 239' ' ' PHE . 28.5 mmtt -84.24 92.74 8.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.567 ' HA ' ' HA3' ' A' ' 277' ' ' GLY . 7.6 p -87.31 125.66 41.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.972 0.415 . . . . 0.0 110.044 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 4.9 p -100.34 -32.86 10.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.59 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 24.8 tpp180 -125.88 99.36 5.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.976 0.417 . . . . 0.0 110.165 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . 0.405 ' HE3' ' HB ' ' A' ' 238' ' ' VAL . 25.2 mtt -85.32 107.65 17.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.511 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -63.63 125.28 23.78 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.4 mt -75.79 68.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.899 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.409 HD22 ' N ' ' A' ' 273' ' ' GLY . 3.1 t30 -177.26 -69.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.147 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.576 ' O ' ' HG2' ' A' ' 274' ' ' GLN . . . 179.11 143.26 5.28 Favored Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -166.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.576 ' HG2' ' O ' ' A' ' 273' ' ' GLY . 0.6 OUTLIER 64.31 119.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 125.418 1.487 . . . . 0.0 110.189 -172.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 286' ' ' PHE . 15.2 m0 -114.02 167.73 10.42 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.985 -174.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -122.67 115.02 21.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.364 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -141.03 158.01 26.17 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 1.07 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 16.5 mt-10 -103.17 108.98 20.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.34 0.57 . . . . 0.0 110.275 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 41.1 t -133.09 139.45 49.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.828 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 26.6 p30 43.52 32.38 0.52 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.757 1.223 . . . . 0.0 113.695 172.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.61 -59.86 0.43 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.858 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.54 176.11 12.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.654 -0.321 . . . . 0.0 111.681 -174.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 1.07 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 13.1 pttm -87.14 141.1 28.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.123 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.87 173.93 32.46 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.76 127.83 37.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.078 0.466 . . . . 0.0 110.258 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 275' ' ' TRP . 43.4 p90 -126.13 131.16 23.87 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.688 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.539 ' HD2' ' NH1' ' A' ' 246' ' ' ARG . 48.2 Cg_exo -58.0 138.69 87.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.615 2.21 . . . . 0.0 111.593 172.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -72.22 -18.39 61.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.401 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 13.8 p -79.43 -0.54 33.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.3 0.572 . . . . 0.0 111.081 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -95.59 -18.69 20.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.586 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.416 HG11 HG21 ' A' ' 264' ' ' VAL . 31.7 m -127.83 164.17 29.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.456 -175.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.426 ' HG2' HG12 ' A' ' 243' ' ' ILE . 30.9 mmmt -127.42 122.54 33.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.728 0.299 . . . . 0.0 110.393 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.685 HD13 ' HB2' ' A' ' 240' ' ' ALA . 48.8 mm -71.0 122.09 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.152 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -135.54 147.64 48.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.826 0.346 . . . . 0.0 110.272 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.307 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -142.06 91.51 2.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.331 0.586 . . . . 0.0 111.079 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -147.17 148.38 31.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.496 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -79.82 96.88 6.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.991 0.424 . . . . 0.0 110.259 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 m -69.78 74.48 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.133 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 t -176.53 -43.33 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.915 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.85 107.49 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.183 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -32.54 67.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.17 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.0 t -69.78 -9.22 53.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.278 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.26 -46.76 7.56 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.761 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -118.4 -19.93 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -170.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -82.03 123.42 28.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.798 0.333 . . . . 0.0 110.649 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.562 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 16.6 mmt -101.72 -9.55 20.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.557 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.4 -113.23 2.18 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.49 -177.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 16.9 Cg_exo -67.17 91.06 0.32 Allowed 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.063 2.509 . . . . 0.0 113.38 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.994 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 14.3 t -137.43 -157.12 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.891 ' H ' HG12 ' A' ' 19' ' ' VAL . 12.5 t 178.93 174.96 0.66 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.8 1.182 . . . . 0.0 108.661 -169.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' HG2' HH11 ' A' ' 21' ' ' ARG . 0.0 OUTLIER -44.49 -66.84 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.885 0.741 . . . . 0.0 112.046 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -63.79 -54.34 36.63 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.443 0.464 . . . . 0.0 111.991 -173.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -54.7 -46.82 74.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.41 -42.9 83.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.459 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -80.39 -33.39 37.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.663 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 t -74.19 -18.77 60.72 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.886 -0.325 . . . . 0.0 111.429 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -97.8 -10.38 24.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 110.727 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.68 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 73.2 mt -111.45 0.86 16.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.657 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.14 108.88 3.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.878 0.847 . . . . 0.0 110.679 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.78 -76.69 0.92 Allowed Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.915 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.417 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 17.2 mm-40 45.28 -159.38 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.169 0.57 . . . . 0.0 111.737 -175.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.565 HH21 ' HB2' ' A' ' 100' ' ' GLU . 33.0 ptt180 -101.13 5.94 43.0 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.521 176.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 53' ' ' SER . 27.3 m170 68.29 123.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.478 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.75 16.53 21.63 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.416 ' HG3' ' HB3' ' A' ' 31' ' ' GLN . 73.2 mmm -106.0 134.94 48.33 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.472 ' CB ' HG22 ' A' ' 52' ' ' VAL . 43.3 p90 -139.58 162.93 33.88 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.621 -174.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.562 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -155.73 141.9 18.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.56 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.31 129.19 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.994 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 32.0 ptt-85 -129.43 173.2 10.77 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.59 133.77 34.04 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 170.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.462 ' HB2' HG22 ' A' ' 43' ' ' THR . 93.9 p -80.45 147.97 30.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.212 0.529 . . . . 0.0 111.162 -173.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.0 t -99.28 34.42 2.17 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 41' ' ' SER . 9.0 t -135.47 -27.55 1.18 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.206 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 91.2 m -147.36 118.25 4.53 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.786 0.327 . . . . 0.0 110.622 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.21 117.98 4.81 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.776 2.317 . . . . 0.0 112.144 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.66 -22.81 34.55 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.713 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 20.0 m-20 -89.84 152.03 21.48 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -119.85 174.97 6.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.557 0.218 . . . . 0.0 111.3 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.436 HG23 ' HB3' ' A' ' 41' ' ' SER . 24.1 t -142.63 109.83 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.31 . . . . 0.0 110.861 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 36' ' ' PHE . 32.1 tp -85.29 100.63 11.92 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.972 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.7 m -96.54 127.41 42.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.97 177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.835 HG21 HD13 ' A' ' 93' ' ' LEU . 48.4 t -123.61 137.17 57.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.453 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.68 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 90.1 p -97.28 123.8 41.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.647 0.26 . . . . 0.0 111.367 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.696 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 26.7 mt-10 -145.14 175.95 9.88 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.653 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 2.6 p30 -37.04 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -163.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.5 m 37.55 56.87 1.44 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.109 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.876 HH21 ' HB2' ' A' ' 94' ' ' ASP . 7.0 ttp85 -167.67 53.72 0.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.79 -159.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.2 t -77.18 98.52 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.909 0.861 . . . . 0.0 109.193 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -87.47 121.17 29.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.839 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -94.71 99.4 11.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.19 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.608 ' CE2' HD22 ' A' ' 93' ' ' LEU . 58.6 m-85 -96.07 116.15 28.52 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.367 0.267 . . . . 0.0 111.529 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 64.5 mt -80.31 134.2 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.739 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.0 mp -109.45 119.5 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 123.16 0.584 . . . . 0.0 110.347 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.51 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 13.2 m120 -84.98 137.68 32.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.789 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.7 t -87.41 102.0 14.12 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.68 HD11 ' HB2' ' A' ' 72' ' ' LYS . 91.4 mt -83.44 140.27 41.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.993 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.75 -23.07 69.48 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.221 2.614 . . . . 0.0 112.958 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -85.23 17.71 2.93 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.014 0.435 . . . . 0.0 110.287 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.893 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.8 OUTLIER 61.97 57.84 2.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.957 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.773 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 62.0 mtt180 -138.59 171.41 14.4 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.124 175.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.513 ' HB3' HG23 ' A' ' 63' ' ' ILE . 53.8 m-85 -130.63 114.99 16.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.404 0.621 . . . . 0.0 110.493 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.68 ' HB2' HD11 ' A' ' 66' ' ' LEU . 87.5 tttt -105.62 99.79 9.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.981 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.739 ' HB ' HG13 ' A' ' 63' ' ' ILE . 8.6 tt -83.63 78.63 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 122.024 0.916 . . . . 0.0 111.063 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.07 -15.99 40.64 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.119 -0.946 . . . . 0.0 114.645 171.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.564 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 19.1 t70 176.92 -63.3 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.809 0.804 . . . . 0.0 111.275 -176.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -66.42 129.14 38.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.59 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -87.47 108.41 19.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.378 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.471 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 67.0 m-85 -105.51 149.46 26.21 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.773 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 22.6 m-20 -73.55 -25.05 60.21 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -173.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 6.1 p80 -160.04 168.73 24.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.707 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.59 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.1 mt -56.27 -56.27 33.22 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.612 ' HA ' HD12 ' A' ' 85' ' ' LEU . 32.4 Cg_exo -63.15 -3.0 4.32 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.261 1.974 . . . . 0.0 113.681 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.86 -33.72 17.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.019 0.438 . . . . 0.0 110.284 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.4 pp -79.38 -26.73 41.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.289 0.566 . . . . 0.0 109.6 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.612 HD12 ' HA ' ' A' ' 82' ' ' PRO . 79.3 mt -67.89 -29.52 68.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.616 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 82' ' ' PRO . 16.6 mm-40 -83.52 -14.66 51.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.995 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -84.23 -39.02 19.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.267 0.556 . . . . 0.0 109.831 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -81.59 0.81 36.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.36 0.6 . . . . 0.0 110.572 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -74.12 -22.43 59.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.827 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.4 pt -122.72 -19.64 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.597 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -84.29 -19.95 32.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.343 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 72.41 162.24 0.25 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.832 0.707 . . . . 0.0 109.54 -170.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.835 HD13 HG21 ' A' ' 52' ' ' VAL . 11.5 mt -114.55 -11.01 12.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.174 0.511 . . . . 0.0 110.087 168.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.876 ' HB2' HH21 ' A' ' 57' ' ' ARG . 9.6 t70 -157.57 -80.28 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.636 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 7.0 t -132.49 -16.0 2.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.073 0.463 . . . . 0.0 110.077 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.472 HG22 ' OE1' ' A' ' 54' ' ' GLU . 4.6 t -121.76 -177.83 3.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.5 p -114.88 178.77 4.16 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.155 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.449 HD22 ' CD1' ' A' ' 36' ' ' PHE . 87.7 mt -64.37 97.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.1 mm -85.56 -64.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.673 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.565 ' HB2' HH21 ' A' ' 32' ' ' ARG . 43.2 mt-10 -150.27 153.36 34.86 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.889 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.69 154.65 72.72 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.793 2.329 . . . . 0.0 112.444 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.46 157.6 82.34 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.227 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.28 135.68 20.9 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.366 2.044 . . . . 0.0 111.819 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.507 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 88.9 mtm180 . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.899 HD12 HG13 ' A' ' 152' ' ' ILE . 1.3 mm? . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.687 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 32.6 tt0 -155.94 -72.74 0.11 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.003 -177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -93.1 109.19 20.67 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.156 -168.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.919 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 90.6 t -134.25 129.17 53.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.011 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.976 ' HG2' ' HB3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -109.79 154.71 22.58 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 118.584 -1.247 . . . . 0.0 108.54 172.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 178' ' ' VAL . 18.9 p -112.21 141.34 46.03 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.755 HD21 ' HG3' ' A' ' 179' ' ' GLU . 58.3 mt -111.82 -41.4 4.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.222 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 51.5 t80 -72.22 -27.88 62.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -168.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.646 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 30.1 t70 69.51 96.36 0.07 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.626 0.727 . . . . 0.0 110.994 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -122.72 96.32 45.54 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.839 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.72 88.92 0.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.44 2.093 . . . . 0.0 112.139 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -87.65 -23.76 38.22 Favored Glycine 0 C--O 1.228 -0.227 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.324 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 47.02 80.33 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.593 0.757 . . . . 0.0 112.57 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -162.64 173.39 13.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.19 -3.29 58.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.155 0.502 . . . . 0.0 110.588 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.26 -11.29 10.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.378 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -129.78 105.43 8.02 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.021 HD11 ' HB2' ' A' ' 165' ' ' ASN . 36.5 tp -76.52 117.57 65.42 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.674 0.273 . . . . 0.0 110.62 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.467 ' HD2' HD12 ' A' ' 142' ' ' LEU . 45.8 Cg_endo -71.16 106.27 1.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.109 1.873 . . . . 0.0 111.244 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -113.64 164.45 13.66 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.216 -177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.646 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -106.13 -169.56 1.59 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.105 -168.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.557 ' HD2' ' HB2' ' A' ' 133' ' ' ASP . 13.7 mptt -78.37 -5.15 51.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.176 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.72 56.53 0.16 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.361 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.462 ' HB2' ' HD3' ' A' ' 145' ' ' LYS . 7.8 tp10 -105.54 150.74 25.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.615 HD13 ' HB3' ' A' ' 129' ' ' ARG . 45.9 mm -96.66 129.72 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' A' ' 165' ' ' ASN . 44.0 mt -123.03 160.48 26.24 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.315 0.579 . . . . 0.0 109.5 -178.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 87.2 t -124.77 128.03 73.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.899 HG13 HD12 ' A' ' 125' ' ' LEU . 36.7 mm -74.33 87.84 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 122.244 1.021 . . . . 0.0 109.529 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.656 HG23 ' HG3' ' A' ' 154' ' ' GLU . 18.0 tt -78.49 -26.38 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.32 -174.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.961 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 15.5 mt-10 -142.04 143.99 33.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.697 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 48.4 tttm -137.05 90.52 15.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 O-C-N 121.237 -0.915 . . . . 0.0 111.399 171.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 52.8 Cg_endo -81.0 -44.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.064 1.843 . . . . 0.0 112.497 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -109.43 178.52 4.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.331 -172.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -98.77 -33.09 11.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.353 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.484 ' HA ' ' OE1' ' A' ' 159' ' ' GLN . 14.2 mm-40 -100.0 -11.36 20.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.927 0.394 . . . . 0.0 110.762 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.436 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 71.9 m95 -126.38 118.57 25.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.719 ' CZ3' HD11 ' A' ' 125' ' ' LEU . 48.5 m0 -112.28 136.71 51.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.961 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 10.6 t -92.05 92.97 8.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.346 0.593 . . . . 0.0 109.418 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -103.26 158.09 16.57 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 122.022 -0.424 . . . . 0.0 111.477 -174.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.739 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.7 ptt180 -98.22 128.71 44.83 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.812 176.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.021 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.5 t30 -70.75 164.64 24.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.556 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -71.96 -10.6 60.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.49 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 165' ' ' ASN . 2.4 p-10 -87.0 -10.58 52.79 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.64 57.14 1.36 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.926 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.739 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 19.1 ttm-85 -136.21 141.9 44.04 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 122.85 -0.206 . . . . 0.0 110.968 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.538 HG22 HG21 ' A' ' 153' ' ' ILE . 49.6 t -103.28 118.46 50.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.609 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -151.15 158.31 27.63 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.411 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 22.5 mtp -79.18 140.03 37.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.894 0.378 . . . . 0.0 110.431 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -135.54 145.57 53.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.342 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.455 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 4.3 Cg_exo -76.53 133.06 13.98 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.32 2.68 . . . . 0.0 113.111 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.648 ' O ' HG22 ' A' ' 178' ' ' VAL . 88.3 t -60.4 -44.58 96.24 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 23.9 Cg_exo -65.27 3.92 0.89 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.219 1.946 . . . . 0.0 113.345 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.5 m-85 -107.89 -4.81 17.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.282 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.8 m -106.89 -169.07 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -165.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.976 ' HB3' ' HG2' ' A' ' 129' ' ' ARG . 0.4 OUTLIER -160.13 41.51 0.19 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.82 -161.164 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.919 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 25.2 pttm . . . . . 0 C--N 1.321 -0.64 0 O-C-N 120.456 -1.403 . . . . 0.0 109.58 -162.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.458 HG11 HD12 ' A' ' 293' ' ' ILE . 21.6 t . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 121.026 0.441 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.1 116.9 32.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.685 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.51 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.29 128.16 53.04 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.46 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.601 ' HG3' ' CE1' ' A' ' 294' ' ' PHE . 28.5 mtpp -78.75 125.25 29.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.567 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -75.59 91.42 2.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.888 0.375 . . . . 0.0 110.136 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 24.6 pt -73.24 9.59 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.847 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -148.91 152.87 37.17 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -95.85 144.96 25.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.637 ' HB3' ' CE1' ' A' ' 290' ' ' HIS . 0.5 OUTLIER -171.02 125.69 0.67 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.638 0.256 . . . . 0.0 110.756 178.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.812 172.86 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.104 0.478 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -79.56 107.42 12.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.931 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.55 HD23 HH11 ' A' ' 282' ' ' ARG . 1.0 OUTLIER -76.34 101.67 5.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -68.66 124.2 22.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.912 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 82.3 mt -128.7 143.68 50.99 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.605 0.566 . . . . 0.0 111.275 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.83 170.93 9.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.359 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.3 p -89.34 113.25 25.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.485 0.66 . . . . 0.0 110.485 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 110.3 -6.49 30.33 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.999 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -76.88 161.2 28.61 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.662 0.268 . . . . 0.0 110.646 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 35.0 mm -104.02 111.17 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.296 0.57 . . . . 0.0 111.13 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.44 ' HA ' HG22 ' A' ' 279' ' ' VAL . 38.8 t -88.55 109.19 19.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.532 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -85.16 88.13 7.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.766 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.88 131.86 35.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.553 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -114.79 -22.5 9.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.817 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.71 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 26.4 mmm180 -125.25 123.69 40.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.245 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 51.4 mtt -112.46 102.73 10.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.226 0.536 . . . . 0.0 110.41 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -81.25 139.42 35.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.034 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.0 pt -67.92 -8.99 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.261 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -63.07 -38.65 92.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.529 176.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 121.47 -9.97 9.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.71 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -114.28 119.31 36.56 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.463 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 47.2 m0 -93.63 159.77 15.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.829 0.347 . . . . 0.0 111.073 -174.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 41.5 mt-10 -107.27 117.77 34.95 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.089 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -142.31 154.01 24.78 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 283' ' ' LYS . 37.7 tt0 -111.73 109.82 19.88 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.567 HG12 HD22 ' A' ' 280' ' ' ASN . 57.6 t -112.55 122.15 66.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.033 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.567 HD22 HG12 ' A' ' 279' ' ' VAL . 31.5 m-80 65.48 -70.21 0.1 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.049 0.843 . . . . 0.0 111.793 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -159.65 26.99 0.35 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.588 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.55 HH11 HD23 ' A' ' 256' ' ' LEU . 17.2 ttm180 -150.82 128.66 11.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.711 0.255 . . . . 0.0 110.444 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 278' ' ' GLU . 53.4 pttt -102.57 139.33 38.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.969 0.414 . . . . 0.0 110.338 174.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -167.38 -169.96 31.59 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.713 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 93.6 mt -100.13 146.3 26.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.934 0.397 . . . . 0.0 110.692 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.463 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 41.1 p90 -148.82 145.54 19.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.609 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 11.8 Cg_exo -72.37 149.22 50.27 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.628 2.218 . . . . 0.0 111.99 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -76.38 -17.68 59.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.837 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.0 t -82.08 3.82 25.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.727 0.775 . . . . 0.0 109.934 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.637 ' CE1' ' HB3' ' A' ' 246' ' ' ARG . 52.8 t60 -96.27 -24.17 16.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.557 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 242' ' ' ALA . 29.1 m -125.02 175.41 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.798 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -138.57 125.36 20.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.557 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.51 HD13 ' HB2' ' A' ' 240' ' ' ALA . 49.8 mm -73.95 102.7 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.601 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 21.4 p90 -100.19 167.61 10.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.433 -174.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.498 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.234 0.272 0 CA-C-O 121.071 0.462 . . . . 0.0 112.133 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -140.63 88.44 2.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.625 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -168.96 165.82 11.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.932 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -99.63 115.58 29.76 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -69.25 -11.46 60.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.001 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 p -101.65 -23.38 14.26 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.82 102.19 1.2 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.899 -0.501 . . . . 0.0 110.778 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 11' ' ' ARG . 11.4 mmt180 -58.51 -42.3 87.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.239 -176.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.7 m -74.6 10.75 1.23 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.916 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.22 -47.5 4.5 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.828 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -118.02 -21.54 8.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -173.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -85.6 115.15 23.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.862 0.363 . . . . 0.0 110.356 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.461 ' HG2' ' HB2' ' A' ' 37' ' ' LEU . 18.0 mmt -102.09 -1.92 30.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 -174.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.7 -114.32 3.01 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.057 -0.974 . . . . 0.0 114.19 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 14.4 Cg_exo -70.6 82.68 0.9 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.961 2.44 . . . . 0.0 113.676 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.931 HG12 ' H ' ' A' ' 20' ' ' SER . 16.4 t -121.02 -160.6 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.931 ' H ' HG12 ' A' ' 19' ' ' VAL . 50.8 p -165.84 172.96 11.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 119.751 1.16 . . . . 0.0 109.706 -168.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -52.73 -59.54 4.36 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.158 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -64.32 -52.63 57.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.081 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.6 -44.5 96.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.987 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.58 69.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 110.988 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.404 HE21 ' N ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -65.63 -46.04 80.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.934 0.397 . . . . 0.0 110.471 175.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.404 ' N ' HE21 ' A' ' 25' ' ' GLN . 28.0 m -61.91 -27.45 68.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.177 -174.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -91.99 -14.26 29.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.952 -176.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.027 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 67.1 mt -114.96 -17.11 11.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.574 -0.45 . . . . 0.0 112.082 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 11.65 -97.29 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.284 1.433 . . . . 0.0 114.565 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.29 33.22 1.82 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.516 ' HB3' ' CE ' ' A' ' 35' ' ' MET . 9.4 tt0 -73.41 -154.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.361 -0.92 . . . . 0.0 109.43 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.484 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -53.65 110.21 0.55 Allowed 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.117 179.13 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -73.04 104.33 4.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.72 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' A' ' 99' ' ' ILE . . . 141.93 -3.5 2.01 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.303 -171.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.667 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 38.4 mtm -83.36 144.91 29.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.95 157.26 45.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.585 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.461 ' HB2' ' HG2' ' A' ' 16' ' ' MET . 4.6 pp -150.11 137.47 19.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.575 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.8 t -105.77 128.71 59.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.244 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.877 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 34.9 ptt-85 -129.94 161.6 30.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.828 -175.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.97 133.1 46.91 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 48.9 m -64.48 131.93 48.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.148 0.499 . . . . 0.0 111.441 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.0 t -76.98 43.68 0.36 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.987 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 t -165.87 -37.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.033 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 41' ' ' SER . 65.4 m -134.77 121.6 14.99 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 14.5 Cg_exo -69.36 -19.0 38.63 Favored 'Trans proline' 0 CA--C 1.527 0.163 0 C-N-CA 122.723 2.282 . . . . 0.0 112.724 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.15 -52.82 3.31 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.792 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.604 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 5.7 m-20 -77.38 157.84 30.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.594 0.235 . . . . 0.0 110.987 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -123.73 177.42 5.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.932 0.396 . . . . 0.0 111.328 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.635 HG22 HD13 ' A' ' 62' ' ' ILE . 22.8 t -139.27 112.58 6.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.8 tp -83.05 100.07 10.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.952 0.406 . . . . 0.0 109.933 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 59' ' ' SER . 59.5 m -97.4 118.02 32.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.114 0.483 . . . . 0.0 111.202 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.737 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 41.1 t -111.18 157.28 12.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.377 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 1.027 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 88.1 p -123.65 135.04 53.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.302 0.955 . . . . 0.0 112.7 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.69 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 1.7 pm0 -146.05 176.24 9.86 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.513 175.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -25.51 80.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 -173.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.7 m 39.61 65.32 0.72 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.781 0.8 . . . . 0.0 110.121 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.69 ' HG3' ' HG2' ' A' ' 54' ' ' GLU . 28.5 tpt85 -168.11 52.58 0.06 Allowed 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.689 -149.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 52' ' ' VAL . 2.2 p -76.65 114.19 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.024 -1.047 . . . . 0.0 111.834 -170.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.774 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 53.5 m -73.62 90.4 1.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.002 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.475 ' CD2' HG22 ' A' ' 58' ' ' VAL . 58.6 m-70 -87.05 87.9 7.57 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.208 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.774 ' CE2' ' HB3' ' A' ' 59' ' ' SER . 71.2 m-85 -92.52 117.76 30.28 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.635 HD13 HG22 ' A' ' 49' ' ' VAL . 30.7 mm -69.95 139.69 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.792 0.33 . . . . 0.0 111.188 176.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 2.7 mp -125.08 118.2 52.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.288 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.604 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 7.8 m120 -73.42 128.89 36.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.943 0.402 . . . . 0.0 110.964 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.6 t -86.85 113.66 22.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.304 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.0 mt -93.72 135.62 24.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.757 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.2 -16.21 32.66 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.144 2.562 . . . . 0.0 113.053 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -85.5 15.57 4.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.0 110.537 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 68.6 22.91 7.41 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.18 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -113.38 162.95 15.47 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.544 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 91.9 m-85 -135.55 116.31 14.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.457 0.646 . . . . 0.0 112.169 -172.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 31.3 ttpt -98.17 98.83 10.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.587 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 12.0 tt -80.72 77.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 122.077 0.942 . . . . 0.0 111.469 -175.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.07 -30.17 2.1 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.737 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.15 -77.01 0.24 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.256 0.55 . . . . 0.0 111.434 -169.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.434 ' H ' ' HG2' ' A' ' 76' ' ' GLN . 12.9 pt20 -95.05 148.53 22.25 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.437 -169.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -82.14 124.88 30.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.682 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.408 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 77.5 m-85 -112.4 144.4 41.91 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 169.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.02 -25.37 63.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.788 -170.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -164.8 168.5 17.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.238 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.458 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 8.4 mt -55.21 -55.81 35.4 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.0 Cg_exo -59.27 -8.98 7.45 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.548 2.165 . . . . 0.0 114.002 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.04 -33.51 18.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.792 0.329 . . . . 0.0 111.139 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -79.55 -27.41 41.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.286 0.565 . . . . 0.0 109.675 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 82' ' ' PRO . 79.4 mt -67.87 -33.94 75.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.616 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.66 ' HA ' ' HE3' ' A' ' 89' ' ' LYS . 11.1 pt-20 -90.9 -3.71 57.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.329 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -91.01 -37.06 13.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.377 0.608 . . . . 0.0 110.01 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -83.39 1.5 41.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.884 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.66 ' HE3' ' HA ' ' A' ' 86' ' ' GLU . 17.8 ptpt -86.36 14.97 5.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 91' ' ' HIS . 1.7 pp -165.33 -30.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.787 0.804 . . . . 0.0 108.845 -170.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.45 ' N ' HD12 ' A' ' 90' ' ' ILE . 9.0 t60 -65.73 -28.2 68.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.414 172.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.649 ' CD1' HG23 ' A' ' 97' ' ' THR . 70.3 m-85 64.0 110.81 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 124.569 1.168 . . . . 0.0 109.538 -168.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.503 HD11 HD21 ' A' ' 98' ' ' LEU . 20.0 mt -56.2 -42.34 77.04 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 1.034 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 0.1 OUTLIER -138.59 -80.67 0.33 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.378 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.768 HG21 ' HB3' ' A' ' 156' ' ' PRO . 11.0 m -136.94 -6.17 1.88 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.493 1.14 . . . . 0.0 108.546 166.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -106.53 138.69 42.25 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.931 172.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.649 HG23 ' CD1' ' A' ' 92' ' ' TYR . 11.9 p -98.55 -175.46 3.09 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.949 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.503 HD21 HD11 ' A' ' 93' ' ' LEU . 87.6 mt -88.77 88.76 7.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.621 HD13 ' HA3' ' A' ' 34' ' ' GLY . 3.6 mp -75.1 -54.96 13.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.725 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 35' ' ' MET . 15.2 pt-20 -154.07 161.34 29.5 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.725 -176.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.94 155.78 61.43 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.536 2.157 . . . . 0.0 112.341 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -77.95 168.22 29.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.527 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 21.8 Cg_endo -62.08 148.01 93.99 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.328 2.019 . . . . 0.0 112.116 175.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 81.4 mtp180 . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.113 0.483 . . . . 0.0 110.218 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.85 HD12 HG21 ' A' ' 152' ' ' ILE . 1.3 mm? . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.722 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 3.9 mm-40 -159.82 -68.67 0.08 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.908 -173.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.62 110.86 23.17 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.328 1.061 . . . . 0.0 111.791 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.991 HG22 ' HB3' ' A' ' 180' ' ' LYS . 70.1 t -115.08 150.1 17.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.918 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.96 ' HG2' ' HG3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -124.58 153.24 42.45 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.72 165.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.975 HG22 HG12 ' A' ' 178' ' ' VAL . 21.7 p -112.81 141.18 46.91 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -99.13 -45.05 6.05 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.946 0.403 . . . . 0.0 111.368 -177.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 35.1 t80 -70.62 -38.63 73.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -163.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 13.5 t70 75.63 100.71 0.07 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -172.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 77.2 t80 -139.14 107.54 7.38 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.112 -175.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 27.1 Cg_endo -92.31 85.73 0.23 Allowed 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.783 2.322 . . . . 0.0 112.356 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.751 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -71.74 -11.88 73.75 Favored Glycine 0 CA--C 1.506 -0.499 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 172.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 138' ' ' ASP . 17.7 m120 51.46 59.53 4.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.603 -1.299 . . . . 0.0 113.312 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.471 ' H ' ' HD3' ' A' ' 143' ' ' PRO . 21.0 t70 81.36 163.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 155.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 88.79 -47.52 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.638 1.575 . . . . 0.0 111.704 169.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -160.35 6.08 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.324 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.751 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 39.0 m-20 -139.64 97.14 3.2 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.075 HD11 ' HB2' ' A' ' 165' ' ' ASN . 21.9 tp -70.13 128.02 91.86 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 120.832 0.348 . . . . 0.0 110.792 -174.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 56.4 Cg_endo -79.28 101.62 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.212 1.941 . . . . 0.0 111.736 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 15.1 p90 -109.94 157.09 19.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.366 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.549 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 35.4 mtmm -112.02 175.62 5.35 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.056 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.786 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -76.58 71.89 3.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.621 0.724 . . . . 0.0 110.443 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 131.21 30.39 0.57 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.244 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -95.32 155.13 16.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.84 HD13 ' HB3' ' A' ' 129' ' ' ARG . 47.1 mm -105.34 132.55 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.521 HD22 ' HA ' ' A' ' 165' ' ' ASN . 29.9 mt -122.03 156.97 32.38 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.722 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 39.0 t -114.47 127.87 71.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 171.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.85 HG21 HD12 ' A' ' 125' ' ' LEU . 23.4 mm -75.03 114.04 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.481 1.134 . . . . 0.0 110.491 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.885 HG21 HG13 ' A' ' 170' ' ' VAL . 2.5 tp -92.89 -24.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.37 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.034 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 6.8 tp10 -155.51 147.58 23.52 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 121.553 -0.717 . . . . 0.0 111.774 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -129.83 84.13 61.9 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.094 168.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.768 ' HB3' HG21 ' A' ' 95' ' ' THR . 57.2 Cg_endo -91.61 -58.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.092 1.861 . . . . 0.0 111.334 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.451 ' OE1' ' HG2' ' A' ' 156' ' ' PRO . 1.3 mp0 -82.63 175.02 10.49 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.476 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -112.86 -5.64 13.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.493 ' HA ' ' OE1' ' A' ' 159' ' ' GLN . 6.3 tp60 -104.44 -24.23 13.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.675 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.774 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 34.9 m95 -129.0 138.23 51.82 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.811 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.649 ' O ' HG13 ' A' ' 173' ' ' ILE . 36.1 m0 -123.74 137.63 54.66 Favored 'General case' 0 C--O 1.213 -0.818 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.868 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 12.9 m -88.34 123.66 33.13 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.794 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -130.76 155.11 47.22 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.361 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 26.9 ptt-85 -97.75 136.89 37.45 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 171.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.075 ' HB2' HD11 ' A' ' 142' ' ' LEU . 65.5 t30 -71.33 168.22 17.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.24 -173.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.519 ' HE3' ' H ' ' A' ' 149' ' ' ILE . 10.2 ttpp -66.01 -17.55 64.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.545 ' HB3' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -74.4 -33.81 63.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.61 172.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 137.82 -36.37 1.94 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.215 -0.993 . . . . 0.0 115.4 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.565 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -90.8 160.82 15.56 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.492 1.146 . . . . 0.0 113.463 -163.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.885 HG13 HG21 ' A' ' 153' ' ' ILE . 78.1 t -89.65 136.27 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.363 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.91 156.42 28.15 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.565 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.774 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -72.85 136.15 45.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.649 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -135.44 147.92 63.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.771 0.319 . . . . 0.0 110.859 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 1.03 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 16.2 Cg_exo -70.71 139.13 36.29 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.943 2.429 . . . . 0.0 113.128 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.54 ' O ' HG22 ' A' ' 178' ' ' VAL . 21.9 t -78.31 -44.95 2.15 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.4 Cg_endo -66.92 0.51 3.64 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.888 1.725 . . . . 0.0 111.684 173.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 1.03 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 0.9 OUTLIER -100.92 -4.99 26.62 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.139 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.975 HG12 HG22 ' A' ' 130' ' ' THR . 26.8 m -123.5 170.89 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 122.543 1.163 . . . . 0.0 113.645 -171.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.96 ' HG3' ' HG2' ' A' ' 129' ' ' ARG . 8.2 pt-20 -133.6 48.57 2.36 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.677 -2.056 . . . . 0.0 110.232 -170.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.991 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 -166.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 1.003 HG13 HG13 ' A' ' 266' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 120.996 0.427 . . . . 0.0 111.107 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -114.23 126.26 54.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.527 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.647 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -133.56 129.23 36.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.077 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -94.81 129.4 41.78 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.619 -0.432 . . . . 0.0 109.979 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.653 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -74.71 115.56 14.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.288 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.844 HD12 ' HG2' ' A' ' 292' ' ' LYS . 0.2 OUTLIER -102.14 -16.06 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.268 0.556 . . . . 0.0 110.387 179.01 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.29 120.45 23.2 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -58.65 155.58 12.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.175 0.988 . . . . 0.0 112.812 -168.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 25.6 tpt180 -131.0 97.71 4.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.637 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.315 -0.915 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.256 -174.57 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 121.602 0.715 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -86.85 142.23 28.21 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.452 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.443 ' HB2' ' HA3' ' A' ' 284' ' ' GLY . 1.3 tt -98.72 115.84 29.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.99 115.38 7.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.2 0.524 . . . . 0.0 110.929 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.55 HD21 HG21 ' A' ' 279' ' ' VAL . 72.8 mt -129.7 153.6 48.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.912 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -133.93 172.13 13.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 170.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 2.1 p -67.94 114.11 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.575 0.703 . . . . 0.0 111.071 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 121.44 -0.16 11.29 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.628 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -96.55 142.06 29.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.904 0.383 . . . . 0.0 110.939 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.7 mm -94.76 114.36 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.741 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.495 ' HA ' HG22 ' A' ' 279' ' ' VAL . 20.1 t -94.96 115.81 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.064 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -98.3 98.84 10.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 1.003 HG13 HG13 ' A' ' 238' ' ' VAL . 7.2 p -88.74 132.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.107 0.48 . . . . 0.0 110.878 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 2.5 p -108.57 -30.99 7.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.561 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 40.7 ttm180 -127.68 112.29 14.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.131 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . 0.559 ' HE3' HG11 ' A' ' 238' ' ' VAL . 31.8 mtt -92.86 106.16 18.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.36 0.6 . . . . 0.0 111.216 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 92.9 m-20 -80.08 117.93 21.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.637 176.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.39 -17.26 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.715 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.416 ' OD1' ' HB3' ' A' ' 270' ' ' ASN . 3.4 p-10 -75.27 -7.58 54.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 134.41 -66.46 0.57 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.806 -1.188 . . . . 0.0 113.628 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp0 -81.72 120.58 25.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.841 0.32 . . . . 0.0 110.571 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.472 ' CZ3' ' HE2' ' A' ' 269' ' ' MET . 28.8 m0 -93.76 164.54 13.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.659 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 46.7 mt-10 -102.93 102.97 13.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.358 175.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -126.38 168.21 18.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 282' ' ' ARG . 0.9 OUTLIER -122.64 144.05 49.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.451 . . . . 0.0 109.844 178.045 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.55 HG21 HD21 ' A' ' 258' ' ' LEU . 95.6 t -135.42 100.76 2.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.204 174.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 68.66 28.82 5.58 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.6 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 101.11 14.02 32.1 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.988 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 20.2 mtp-105 -125.71 120.02 29.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.89 0.345 . . . . 0.0 110.823 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 283' ' ' LYS . 30.4 mtpt -96.07 141.83 28.99 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 256' ' ' LEU . . . -165.6 164.17 37.13 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.262 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.727 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 85.5 mt -86.85 110.57 20.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.464 0.649 . . . . 0.0 110.87 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 24.2 p90 -115.94 128.53 25.91 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.174 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 10.7 Cg_exo -72.98 143.78 37.04 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.646 2.231 . . . . 0.0 111.076 173.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -66.01 -7.63 18.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.16 -11.96 60.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.041 0.448 . . . . 0.0 111.462 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -103.63 -11.94 17.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 111.029 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.417 HG21 ' HE2' ' A' ' 286' ' ' PHE . 27.3 m -127.9 163.76 30.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.031 -175.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.844 ' HG2' HD12 ' A' ' 243' ' ' ILE . 32.5 mmmt -124.9 122.3 36.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.569 176.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.647 HD13 ' HB2' ' A' ' 240' ' ' ALA . 45.1 mm -71.06 102.84 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.89 170.9 8.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.248 0.547 . . . . 0.0 111.698 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.755 175.357 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 121.13 0.49 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -109.15 20.03 18.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.696 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.499 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 50.7 p90 -91.34 156.27 17.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.08 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.36 135.27 36.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 m -110.84 10.9 22.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -121.52 -37.82 2.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.511 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -72.25 116.34 12.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.219 0.533 . . . . 0.0 110.715 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HG2' ' H ' ' A' ' 11' ' ' ARG . 16.5 mmt180 -56.87 -30.17 63.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.995 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.5 t -80.88 -2.71 48.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -175.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.76 -46.9 6.4 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.815 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 31.7 p-90 -120.4 -21.38 6.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -172.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -78.94 118.27 20.79 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.944 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.692 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 7.8 tpp -97.38 -4.48 38.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.201 0.524 . . . . 0.0 110.455 -172.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.66 -115.81 3.72 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.951 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.43 103.49 1.75 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.455 2.103 . . . . 0.0 112.338 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.861 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 80.8 t -132.66 -83.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.255 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.691 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 66.9 m 87.73 152.38 0.06 Allowed 'General case' 0 C--N 1.348 0.543 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -59.06 -35.67 73.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -164.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -25.94 66.97 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.019 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' HG22 ' A' ' 26' ' ' THR . 23.7 tp10 -87.29 -45.24 10.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.7 -44.24 77.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.838 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -76.92 -32.74 57.59 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 23' ' ' GLU . 6.9 t -72.54 -22.07 61.07 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.591 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -88.42 -24.64 22.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.399 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.813 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 95.2 mt -107.86 20.35 18.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.532 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -66.58 90.99 0.17 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.527 0.68 . . . . 0.0 109.217 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.41 -70.1 2.68 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.576 ' HG3' ' H ' ' A' ' 32' ' ' ARG . 4.6 tp-100 48.74 -167.39 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.795 0.838 . . . . 0.0 110.894 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.576 ' H ' ' HG3' ' A' ' 31' ' ' GLN . 74.1 mtm-85 -80.04 112.09 17.01 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 170.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.478 ' NE2' ' HA ' ' A' ' 55' ' ' ASN . 32.8 m170 -57.88 117.75 4.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.115 0.483 . . . . 0.0 110.053 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.05 14.36 7.22 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -168.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -95.82 145.95 24.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.557 ' HB2' HG22 ' A' ' 52' ' ' VAL . 31.1 p90 -150.34 166.97 28.42 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.45 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.1 pp -156.45 135.57 12.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.511 173.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.52 HG22 HD13 ' A' ' 50' ' ' LEU . 51.4 t -101.74 111.28 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.861 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 13.4 ptt-85 -110.7 173.95 6.09 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.868 0.366 . . . . 0.0 110.791 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -82.22 137.37 34.92 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.6 p -59.44 -28.58 67.09 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.582 -174.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.2 t 61.29 19.98 10.63 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.942 0.877 . . . . 0.0 108.787 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.5 m -116.41 -49.86 2.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.045 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 44.7 t -145.83 124.45 6.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.614 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.62 87.11 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.411 2.074 . . . . 0.0 111.344 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.43 -11.27 0.13 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.774 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -126.34 145.88 50.26 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.36 -0.494 . . . . 0.0 109.763 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.43 164.42 13.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.363 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.29 99.42 4.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.213 0.53 . . . . 0.0 110.619 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.52 HD13 HG22 ' A' ' 38' ' ' VAL . 41.9 tp -78.67 99.53 6.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.894 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.4 m -96.3 121.51 38.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.135 0.493 . . . . 0.0 109.992 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.863 HG21 HD13 ' A' ' 93' ' ' LEU . 84.2 t -116.5 134.3 60.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.955 -177.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.813 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 95.5 p -105.78 134.54 48.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.563 0.697 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.515 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 7.2 mt-10 -144.56 175.81 9.87 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.478 ' HA ' ' NE2' ' A' ' 33' ' ' HIS . 0.3 OUTLIER -38.45 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -173.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m 50.57 59.79 4.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.444 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 55' ' ' ASN . 21.0 mmm180 -160.33 49.46 0.27 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.177 -157.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 36.4 t -80.96 90.9 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.967 0.889 . . . . 0.0 109.351 -175.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 51.1 m -80.4 120.81 24.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.172 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -97.81 99.02 10.33 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.366 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.647 ' CE2' HD22 ' A' ' 93' ' ' LEU . 64.0 m-85 -103.17 116.03 31.71 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.6 mt -81.69 139.27 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.524 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.8 mp -127.05 118.04 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 122.877 0.471 . . . . 0.0 110.422 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -84.35 139.41 32.29 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.464 -0.148 . . . . 0.0 110.822 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.9 t -84.52 107.77 16.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -83.84 149.66 57.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.007 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.71 -23.9 73.49 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.129 2.553 . . . . 0.0 112.911 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -79.66 6.13 11.49 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.013 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 66.11 36.07 5.87 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.676 0.751 . . . . 0.0 110.234 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 92.7 mtt180 -113.97 172.99 6.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.604 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.524 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 60.0 m-85 -135.92 115.72 13.04 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.12 0.486 . . . . 0.0 111.291 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -98.39 108.4 21.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.745 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.548 HD13 ' HE2' ' A' ' 88' ' ' TYR . 9.5 tt -97.8 78.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.842 0.829 . . . . 0.0 110.043 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.74 95.62 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.283 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 t0 71.81 -56.96 0.63 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.033 0.533 . . . . 0.0 111.736 173.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -78.61 140.53 38.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.738 0.304 . . . . 0.0 110.665 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -112.7 128.64 56.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.627 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.485 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 74.6 m-85 -116.77 164.6 14.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.273 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' ARG . 3.6 m-20 -72.97 -29.66 63.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -176.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.623 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -164.06 167.06 20.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.974 -178.291 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.659 HD23 HD21 ' A' ' 84' ' ' LEU . 10.6 mt -53.58 -51.79 72.96 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.623 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 32.2 Cg_exo -59.96 -11.92 17.01 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.956 1.77 . . . . 0.0 112.955 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . . . -91.73 -32.21 15.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.111 -175.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.659 HD21 HD23 ' A' ' 81' ' ' LEU . 3.9 pp -77.46 -31.95 54.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.67 -38.3 90.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.354 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.645 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 13.9 pt-20 -78.25 -18.17 55.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.196 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -79.07 -39.01 34.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.191 0.519 . . . . 0.0 109.961 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.548 ' HE2' HD13 ' A' ' 73' ' ' ILE . 32.4 m-85 -77.85 -15.95 58.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.599 -177.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 22.0 pttm -67.48 -20.27 65.44 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.316 -0.254 . . . . 0.0 110.316 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.441 HG23 ' HG3' ' A' ' 89' ' ' LYS . 18.9 pt -121.91 22.48 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.991 -0.443 . . . . 0.0 111.529 174.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 22.3 t-160 -113.56 -32.47 6.18 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.078 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.584 ' HA ' HG22 ' A' ' 97' ' ' THR . 76.1 m-85 73.32 107.75 0.07 Allowed 'General case' 0 C--O 1.22 -0.452 0 O-C-N 124.072 0.858 . . . . 0.0 109.966 -172.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.863 HD13 HG21 ' A' ' 52' ' ' VAL . 12.2 mt -79.87 -12.2 59.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.76 0.79 . . . . 0.0 109.173 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.515 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 24.9 t70 -149.04 -71.83 0.19 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.238 160.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.607 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.7 t -149.22 2.33 0.56 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.433 HG22 ' CD ' ' A' ' 54' ' ' GLU . 1.9 t -132.08 -12.54 3.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.409 -0.807 . . . . 0.0 112.795 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 92' ' ' TYR . 8.4 p 74.08 -166.06 0.1 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.301 1.041 . . . . 0.0 111.696 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.414 HD22 ' CD1' ' A' ' 36' ' ' PHE . 63.5 mt -81.72 108.56 15.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.311 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.7 mm -98.45 -48.57 12.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.556 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 9.8 pt-20 -167.56 158.14 9.67 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.916 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 1.5 Cg_endo -83.28 162.82 15.15 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.801 2.334 . . . . 0.0 112.726 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.18 154.08 63.26 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.096 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.71 139.31 62.6 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.629 2.22 . . . . 0.0 112.119 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.692 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 68.1 mtm180 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.049 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.661 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.586 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 47.9 tp10 -161.14 -78.72 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.092 -175.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.89 116.49 32.04 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.9 0.857 . . . . 0.0 112.039 -171.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.826 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 86.6 t -134.36 125.89 48.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.573 -173.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.672 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 7.2 ptp85 -111.49 135.01 52.65 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 118.127 -1.429 . . . . 0.0 110.817 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.413 HG22 HG12 ' A' ' 178' ' ' VAL . 7.4 p -97.48 140.66 31.59 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.094 0.473 . . . . 0.0 112.081 -174.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.054 HD21 ' HB2' ' A' ' 179' ' ' GLU . 0.1 OUTLIER -117.44 -38.33 3.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.448 -171.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 29.9 t80 -64.32 -32.56 74.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.886 -170.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 12.5 t70 72.44 105.84 0.07 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.737 0.648 . . . . 0.0 110.04 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 71.3 t80 -144.08 108.72 5.0 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.095 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 66.1 Cg_endo -87.92 99.6 0.44 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.325 2.017 . . . . 0.0 112.661 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -81.65 -3.71 90.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.99 175.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.428 HD22 ' HA ' ' A' ' 137' ' ' ASN . 11.1 m120 57.92 24.66 11.2 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.133 0.573 . . . . 0.0 111.777 -176.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.704 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 2.0 p30 50.45 -176.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.038 1.335 . . . . 0.0 114.457 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 71.89 9.17 6.14 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.432 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -175.38 -46.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.069 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.411 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 17.5 m-20 -137.07 124.26 21.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.828 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.936 HD11 ' HB2' ' A' ' 165' ' ' ASN . 46.7 tp -69.86 132.28 88.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-O 120.693 0.282 . . . . 0.0 110.662 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 6.4 Cg_endo -85.25 89.23 0.83 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.374 2.049 . . . . 0.0 110.636 176.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 14.2 p90 -99.5 158.02 16.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.472 -177.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.58 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 82.9 mttt -112.15 -172.44 2.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.469 -172.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.22 18.46 1.4 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.742 -175.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.94 36.06 0.08 OUTLIER Glycine 0 C--N 1.33 0.218 0 C-N-CA 119.813 -1.185 . . . . 0.0 113.916 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.58 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 21.9 mm-40 -98.84 157.41 16.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.4 tp -103.52 138.83 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.563 HD22 ' HA ' ' A' ' 165' ' ' ASN . 26.5 mt -120.61 155.7 33.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 19.2 t -119.74 130.89 73.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 163' ' ' ALA . 39.6 mm -74.3 96.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.557 HG23 ' HG2' ' A' ' 154' ' ' GLU . 16.3 tt -79.02 -31.2 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.77 -175.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.557 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -146.9 141.0 26.09 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.934 171.172 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.623 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 1.6 ttpm? -119.06 87.13 33.54 Favored Pre-proline 0 C--N 1.328 -0.367 0 O-C-N 121.331 -0.856 . . . . 0.0 110.877 173.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.607 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 11.4 Cg_exo -72.92 -58.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.584 2.19 . . . . 0.0 112.35 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -107.83 177.44 4.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.23 -20.18 14.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.757 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -85.47 -34.76 21.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.15 0.5 . . . . 0.0 110.122 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -128.3 129.73 46.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.206 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -108.97 156.17 20.02 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 22.7 t -111.58 101.96 10.33 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.351 0.596 . . . . 0.0 110.056 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -113.71 163.19 15.34 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.169 -176.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 168' ' ' GLY . 29.8 ptt-85 -108.23 140.55 41.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.328 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.936 ' HB2' HD11 ' A' ' 142' ' ' LEU . 57.1 t30 -70.56 178.61 2.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.587 -175.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -58.67 -32.02 68.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -60.6 -42.14 96.15 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.105 170.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 164' ' ' ARG . . . 115.86 -9.33 18.81 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.689 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.704 ' HD3' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -76.73 152.69 35.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.541 0.671 . . . . 0.0 110.811 -176.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.464 ' CG2' HD13 ' A' ' 153' ' ' ILE . 26.2 t -99.73 143.59 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.287 0.565 . . . . 0.0 112.413 -168.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -171.98 162.98 35.29 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.757 169.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.421 ' HE3' ' HG2' ' A' ' 156' ' ' PRO . 22.9 mtp -81.7 147.31 29.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.3 0.55 . . . . 0.0 110.822 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.8 pp -141.32 145.83 39.9 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.386 -174.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 7.8 Cg_exo -73.29 133.17 18.88 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.185 2.59 . . . . 0.0 112.699 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.62 ' O ' HG22 ' A' ' 178' ' ' VAL . 58.0 t -61.7 -47.3 92.69 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 23.3 Cg_endo -61.4 -13.44 29.0 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.169 1.913 . . . . 0.0 113.294 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -86.35 -4.21 59.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.888 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 175' ' ' VAL . 4.1 m -110.61 159.04 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -166.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 1.054 ' HB2' HD21 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -117.75 45.19 2.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 111.493 -2.594 . . . . 0.0 109.242 -178.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.826 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.586 0 O-C-N 120.963 -1.085 . . . . 0.0 109.398 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.704 HG12 HD11 ' A' ' 293' ' ' ILE . 45.8 t . . . . . 0 C--O 1.234 0.26 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -115.14 135.12 54.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.851 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -122.29 142.56 50.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.2 174.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.741 ' HA ' ' O ' ' A' ' 262' ' ' ASP . 56.3 mttm -84.52 119.6 25.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.088 0.47 . . . . 0.0 110.233 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 1.091 ' HB1' ' HA ' ' A' ' 259' ' ' GLU . . . -89.39 114.91 26.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.217 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -130.7 -10.26 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -165.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.667 ' HB3' ' OE2' ' A' ' 259' ' ' GLU . 7.7 tt0 -113.57 -89.05 0.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.059 -0.657 . . . . 0.0 112.752 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.445 ' N ' ' HB3' ' A' ' 259' ' ' GLU . 85.8 tttt -173.81 118.74 0.27 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -173.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.954 ' HG2' ' HG3' ' A' ' 259' ' ' GLU . 19.8 mmm180 -131.34 98.74 4.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.61 167.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.106 179.168 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 121.384 0.612 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -94.37 118.43 31.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.507 . . . . 0.0 111.183 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 tt -91.17 126.28 36.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.367 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -81.82 110.66 17.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.188 0.518 . . . . 0.0 110.931 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.59 HD22 HG22 ' A' ' 264' ' ' VAL . 1.3 pp -164.86 -141.82 0.05 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.115 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 1.091 ' HA ' ' HB1' ' A' ' 242' ' ' ALA . 0.0 OUTLIER 80.82 1.18 1.78 Allowed 'General case' 0 C--O 1.222 -0.367 0 O-C-N 123.899 0.75 . . . . 0.0 111.566 177.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.32 90.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -178.8 -83.35 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.823 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.741 ' O ' ' HA ' ' A' ' 241' ' ' LYS . 29.2 t0 179.04 -79.06 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 121.056 0.455 . . . . 0.0 111.68 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 36.9 mm -100.65 119.81 49.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -170.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.59 HG22 HD22 ' A' ' 258' ' ' LEU . 99.2 t -107.11 121.79 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.472 168.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -94.09 116.25 28.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.163 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 275' ' ' TRP . 2.7 p -111.68 117.27 54.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.306 0.574 . . . . 0.0 110.692 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.2 p -107.57 -15.44 14.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.753 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.499 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 38.2 mmt-85 -124.01 100.38 6.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.043 0.449 . . . . 0.0 111.211 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 46.8 mtt -101.85 140.31 36.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.332 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.632 ' OD1' ' HB3' ' A' ' 272' ' ' ASN . 9.0 p30 -135.49 176.66 8.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.461 -176.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 271' ' ' ILE . 13.7 pt -87.1 4.58 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -172.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.632 ' HB3' ' OD1' ' A' ' 270' ' ' ASN . 7.4 t-20 -74.77 -44.59 48.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.26 0.552 . . . . 0.0 109.578 175.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.73 -39.21 2.55 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 44.3 mt-30 -79.35 116.54 19.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.578 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 13.6 m0 -93.04 155.85 17.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.977 -173.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 40.2 mt-10 -101.26 107.62 19.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.994 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.99 148.74 17.89 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 282' ' ' ARG . 0.0 OUTLIER -110.09 109.63 20.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.372 0.606 . . . . 0.0 110.33 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.487 HG21 HG13 ' A' ' 264' ' ' VAL . 21.6 t -127.6 -79.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.755 -176.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -82.26 67.04 8.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.268 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.07 16.92 60.49 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.85 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 40.5 ttm180 -155.32 146.63 22.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.139 0.469 . . . . 0.0 111.095 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 278' ' ' GLU . 39.4 tttm -102.48 113.98 27.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.118 170.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -146.67 178.21 24.48 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.074 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 96.5 mt -84.86 140.43 31.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 0.0 111.681 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.412 ' HE2' HG21 ' A' ' 291' ' ' VAL . 34.8 p90 -142.86 129.5 10.69 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.22 170.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.28 137.08 25.31 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.58 2.187 . . . . 0.0 112.536 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -71.51 -10.74 60.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.844 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.7 m -84.65 -2.57 57.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.451 0.643 . . . . 0.0 110.411 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.455 ' HB3' ' OE2' ' A' ' 259' ' ' GLU . 3.1 m-70 -101.12 -54.65 2.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.395 174.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.412 HG21 ' HE2' ' A' ' 286' ' ' PHE . 35.0 m -85.03 159.61 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.798 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.42 107.16 16.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.229 0.538 . . . . 0.0 110.3 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' A' ' 240' ' ' ALA . 5.0 tp -70.1 131.66 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.472 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 18.3 p90 -134.63 160.64 37.48 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.624 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.1 t0 . . . . . 0 C--N 1.316 -0.888 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.178 177.277 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.657 ' NE ' ' HA ' ' A' ' 5' ' ' ARG . 5.0 mmp_? -113.71 15.14 18.84 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -86.59 171.13 11.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.456 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 24.4 t70 -82.52 -133.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.444 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 9.6 t -173.71 43.19 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.406 ' H ' ' H ' ' A' ' 10' ' ' ASP . 9.9 t -164.51 -11.02 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.968 174.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.456 ' OD1' ' HB3' ' A' ' 7' ' ' ASP . 7.9 p-10 -75.44 81.0 2.49 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.809 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 48.0 mtt-85 -70.5 -16.85 62.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.479 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 t -75.77 -7.96 55.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.659 174.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.3 -47.08 3.59 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.8 p-90 -107.63 -20.46 13.22 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -172.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 22.8 t80 -81.92 122.71 28.11 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 122.027 -0.421 . . . . 0.0 110.672 -174.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.694 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 24.7 mmt -103.36 -13.55 16.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.479 -176.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.05 -113.42 2.18 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.658 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.6 84.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.199 2.599 . . . . 0.0 113.327 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.523 HG21 ' HB3' ' A' ' 16' ' ' MET . 84.1 t -137.03 172.8 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 19' ' ' VAL . 43.8 p -145.41 172.28 13.42 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -168.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -63.02 -37.15 86.04 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.873 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -56.74 11.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.688 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -61.55 -50.25 73.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.25 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.73 -37.23 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.353 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -64.33 -43.94 93.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.128 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.2 t -78.92 -21.27 47.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.871 0.367 . . . . 0.0 111.409 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.415 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 51.1 mtp180 -82.43 -10.43 59.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.892 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.611 HD22 ' HB2' ' A' ' 53' ' ' SER . 26.9 mt -126.97 12.06 7.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.097 0.475 . . . . 0.0 111.018 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.49 98.25 2.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.377 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.69 -1.92 70.52 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.344 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 4.7 mm100 -60.37 168.15 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.853 0.461 . . . . 0.0 111.689 -175.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -47.63 118.98 2.49 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.551 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.601 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 36.3 m170 -63.6 117.16 6.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.337 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.8 -13.55 6.1 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.997 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.691 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 64.3 mtt -69.19 153.58 43.46 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.511 0.196 . . . . 0.0 110.518 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.418 ' CB ' HG22 ' A' ' 52' ' ' VAL . 28.7 p90 -155.62 159.23 39.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.694 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.6 pp -153.52 140.41 19.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.001 0.429 . . . . 0.0 110.851 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.3 t -110.39 116.47 52.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.861 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.499 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 25.4 ptt-85 -117.77 176.05 5.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.97 -177.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.41 134.46 40.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.133 0.492 . . . . 0.0 110.645 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 t -87.36 107.97 18.77 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.5 t -73.96 8.09 2.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.563 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.5 p -94.6 -25.56 16.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.803 0.335 . . . . 0.0 110.659 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 76.7 m -152.36 115.23 2.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.879 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 28.0 Cg_endo -62.45 103.05 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.799 2.333 . . . . 0.0 112.436 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.54 -24.73 4.1 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.659 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -88.37 165.87 14.66 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.422 ' CD2' HD11 ' A' ' 81' ' ' LEU . 58.0 m-85 -134.52 -177.87 4.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.758 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.556 HG22 HG12 ' A' ' 62' ' ' ILE . 6.2 t -143.96 113.85 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.62 177.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.452 ' HB2' HD11 ' A' ' 63' ' ' ILE . 62.8 tp -80.83 97.09 7.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.1 m -94.05 118.12 31.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.329 0.585 . . . . 0.0 109.666 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 58.7 t -110.68 142.66 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.639 -174.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 40.7 t -91.68 103.89 16.41 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.601 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 7.0 tp10 -167.11 166.43 15.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.898 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.574 HD22 ' CG ' ' A' ' 94' ' ' ASP . 0.7 OUTLIER 76.82 -64.5 0.33 Allowed 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 123.58 1.657 . . . . 0.0 108.546 -168.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.5 m -160.86 -27.64 0.06 Allowed 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 111.314 -2.675 . . . . 0.0 106.133 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.82 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.363 0.0 OUTLIER -163.08 -48.34 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.084 1 N-CA-C 123.333 4.568 . . . . 0.0 123.333 179.624 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.82 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -147.98 107.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 121.785 2.084 . . . . 0.0 114.096 -166.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.522 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -98.03 112.6 24.49 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 171.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -101.53 86.48 2.97 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -169.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.759 ' CE1' HD11 ' A' ' 153' ' ' ILE . 55.5 m-85 -102.01 110.27 22.2 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 118.626 0.648 . . . . 0.0 112.248 -174.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.556 HG12 HG22 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -75.38 139.49 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.295 0.569 . . . . 0.0 112.39 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.616 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.3 mp -110.33 108.8 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.587 175.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -82.82 141.93 31.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.177 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.7 t -85.75 118.46 25.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.104 0.478 . . . . 0.0 110.352 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.512 HD21 ' HE2' ' A' ' 72' ' ' LYS . 95.3 mt -95.15 142.54 24.74 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.058 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 19.9 Cg_exo -66.54 -8.66 21.61 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.864 2.376 . . . . 0.0 112.386 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.48 10.12 5.1 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.658 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 67.32 25.9 8.64 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.087 -179.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 71.0 mtt180 -115.2 -176.1 2.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.199 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.516 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 61.5 m-85 -138.85 124.69 19.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.718 0.294 . . . . 0.0 110.934 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.801 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 25.7 ttpt -113.62 109.65 18.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 111.466 -177.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.616 ' HB ' HG13 ' A' ' 63' ' ' ILE . 14.0 tt -95.91 81.29 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.723 0.773 . . . . 0.0 110.052 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.76 82.59 0.27 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.79 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.2 t0 71.46 -47.09 0.65 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.963 0.905 . . . . 0.0 111.48 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -74.75 101.34 4.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.889 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.801 ' HB3' ' HD3' ' A' ' 72' ' ' LYS . 8.2 pt-20 -95.55 118.26 31.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.662 0.744 . . . . 0.0 110.934 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.583 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 76.3 m-85 -100.22 174.71 6.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.83 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 31.9 t70 -73.06 -25.14 60.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.317 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.649 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 1.7 p80 -172.01 172.17 4.79 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.662 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.6 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.5 mt -51.4 -54.41 39.05 Favored Pre-proline 0 N--CA 1.472 0.633 0 O-C-N 123.301 0.376 . . . . 0.0 111.95 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.649 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 59.6 Cg_endo -70.4 16.99 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.284 1.99 . . . . 0.0 113.292 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.5 -35.4 6.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 174.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.8 pp -76.88 -31.74 56.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.175 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.68 -30.35 71.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.619 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 89' ' ' LYS . 3.6 tt0 -91.36 -12.61 34.41 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.104 0.478 . . . . 0.0 111.107 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.403 ' CE2' ' ND1' ' A' ' 91' ' ' HIS . 72.4 t80 -86.01 -30.62 22.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.98 0.895 . . . . 0.0 108.957 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.791 ' CD1' HD23 ' A' ' 93' ' ' LEU . 40.7 m-85 -82.71 2.38 33.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.252 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.552 ' HD2' ' HG3' ' A' ' 86' ' ' GLU . 98.3 mttt -76.39 -3.96 39.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.875 173.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.34 -2.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.032 0.444 . . . . 0.0 110.726 177.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.403 ' ND1' ' CE2' ' A' ' 87' ' ' PHE . 5.0 t60 -81.36 -31.83 33.2 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.383 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 96' ' ' THR . 75.7 m-85 62.77 67.0 0.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.125 -173.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.791 HD23 ' CD1' ' A' ' 88' ' ' TYR . 2.0 pp -71.62 117.58 13.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.79 174.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.82 ' CA ' ' HB3' ' A' ' 154' ' ' GLU . 7.6 t70 97.81 -48.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.973 1.709 . . . . 0.0 108.278 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.704 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 6.0 t 167.23 22.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.615 -1.629 . . . . 0.0 106.652 168.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.535 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 2.2 t -149.2 150.64 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.445 -173.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.7 p -91.44 157.55 17.0 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.51 99.66 0.22 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.883 0.373 . . . . 0.0 110.18 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.4 mm -80.83 -57.81 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.765 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.691 ' O ' ' HA ' ' A' ' 35' ' ' MET . 29.8 tt0 -165.16 136.93 3.32 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 -174.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.31 155.68 44.99 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.652 2.235 . . . . 0.0 112.956 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.75 157.84 85.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.697 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.31 122.5 11.91 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.34 2.027 . . . . 0.0 111.823 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 . . . . . 0 CA--C 1.519 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.591 -179.333 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.962 HD12 HG21 ' A' ' 152' ' ' ILE . 3.8 mm? . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.512 0.672 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 11.1 tp10 -165.1 -61.4 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.13 -173.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -113.49 112.34 23.43 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.271 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 1.034 HG22 ' HG3' ' A' ' 180' ' ' LYS . 2.4 t -117.19 153.39 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.669 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.4 ptp180 -129.15 148.35 51.08 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 117.947 -1.501 . . . . 0.0 108.059 157.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.529 HG22 HG12 ' A' ' 178' ' ' VAL . 43.6 p -100.58 133.54 44.87 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.695 0.759 . . . . 0.0 110.874 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.498 HD21 ' HG2' ' A' ' 179' ' ' GLU . 8.0 mt -107.56 2.25 23.91 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.555 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.48 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 16.3 t80 -102.41 -45.02 5.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.039 -173.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.622 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.9 t70 78.74 103.74 0.07 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.166 0.508 . . . . 0.0 110.679 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 68.9 t80 -132.93 91.08 29.99 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 98.3 Cg_endo -87.45 70.33 3.43 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.219 1.946 . . . . 0.0 112.763 -175.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.62 -33.88 82.22 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.737 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.469 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 26.5 m-80 61.97 66.49 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.133 -0.533 . . . . 0.0 111.825 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -143.66 172.63 12.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.271 176.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.46 -9.55 49.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.051 0.929 . . . . 0.0 108.795 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' A' ' 172' ' ' MET . 28.5 mt-10 -106.63 -15.58 14.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.807 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -137.89 106.82 5.97 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.331 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.973 HD11 ' HB2' ' A' ' 165' ' ' ASN . 20.1 tp -75.53 126.91 86.93 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.767 0.317 . . . . 0.0 110.989 -175.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 73.9 Cg_endo -78.12 97.18 1.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.845 1.697 . . . . 0.0 111.687 173.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.617 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 15.3 p90 -105.95 156.71 18.1 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.622 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 62.5 mttp -113.07 173.34 6.44 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -173.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.529 ' N ' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -71.72 57.88 0.3 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.209 178.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 134.41 38.25 0.21 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.784 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.667 ' CD ' ' HG ' ' A' ' 150' ' ' LEU . 1.7 pp20? -91.04 169.06 11.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.17 127.66 73.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.803 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 78.1 mt -117.21 156.33 27.89 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -173.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 89.4 t -120.45 122.13 67.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 171.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.074 HD13 ' HB2' ' A' ' 163' ' ' ALA . 46.4 mm -78.0 78.82 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 122.793 1.282 . . . . 0.0 108.325 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.759 HD11 ' CE1' ' A' ' 61' ' ' TYR . 5.4 tt -70.89 -28.91 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 112.577 -2.101 . . . . 0.0 109.478 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.82 ' HB3' ' CA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -134.89 143.14 46.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.165 176.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.523 ' H ' HD21 ' A' ' 55' ' ' ASN . 67.0 tttt -141.61 83.76 12.87 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.704 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 21.8 Cg_exo -68.14 -49.69 0.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.432 2.088 . . . . 0.0 112.199 174.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -119.35 175.73 5.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.658 -171.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -101.96 -4.93 25.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.276 0.56 . . . . 0.0 110.164 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -93.64 -36.55 12.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.516 0.674 . . . . 0.0 109.853 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.47 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 41.0 m95 -129.8 145.04 51.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.925 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.758 ' O ' HG13 ' A' ' 173' ' ' ILE . 48.5 m0 -124.31 138.88 54.34 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 122.761 0.424 . . . . 0.0 110.184 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.678 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 2.9 m -98.55 98.36 9.54 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -174.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.074 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -114.77 155.83 25.99 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -170.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.922 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 31.7 ptt-85 -94.86 128.11 41.38 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.858 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.973 ' HB2' HD11 ' A' ' 142' ' ' LEU . 65.8 t30 -59.21 178.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.106 -1.406 . . . . 0.0 112.21 -169.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -51.01 -28.34 9.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.182 164.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -70.57 -44.33 67.63 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.492 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.587 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 113.87 9.58 15.99 Favored Glycine 0 C--O 1.223 -0.533 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.966 -169.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.922 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 16.4 ttm-85 -76.09 136.54 39.87 Favored 'General case' 0 C--O 1.212 -0.892 0 C-N-CA 123.409 0.683 . . . . 0.0 112.319 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.57 HG22 HG21 ' A' ' 153' ' ' ILE . 56.2 t -84.07 120.2 34.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.15 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.402 ' CA ' ' HB2' ' A' ' 142' ' ' LEU . . . -156.12 155.89 26.65 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.476 -0.649 . . . . 0.0 111.476 172.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.657 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -76.02 138.8 41.12 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 117.354 0.577 . . . . 0.0 111.277 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.758 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -139.16 141.48 29.77 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.187 -176.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 21.4 Cg_exo -65.58 131.77 28.86 Favored 'Trans proline' 0 CA--C 1.527 0.146 0 C-N-CA 122.464 2.109 . . . . 0.0 112.936 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.519 ' O ' HG22 ' A' ' 178' ' ' VAL . 66.6 t -61.42 -44.54 92.86 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.438 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 22.7 Cg_exo -64.61 2.17 1.38 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.188 1.925 . . . . 0.0 113.162 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.7 m-30 -100.99 -11.65 19.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.231 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.73 ' HB ' HG13 ' A' ' 128' ' ' VAL . 3.6 m -105.63 -177.03 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -164.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.669 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.8 tp10 -151.82 51.59 0.81 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 111.947 -2.388 . . . . 0.0 112.332 -155.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 1.034 ' HG3' HG22 ' A' ' 128' ' ' VAL . 1.8 mppt? . . . . . 0 N--CA 1.463 0.221 0 O-C-N 120.056 -1.652 . . . . 0.0 109.96 -161.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.505 ' HB ' HG13 ' A' ' 266' ' ' VAL . 17.8 t . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -105.44 129.0 53.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.55 137.19 53.99 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.421 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 44.6 tptt -81.19 118.58 22.69 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -72.84 108.92 6.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 28.1 pt -102.36 12.88 6.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.016 0.436 . . . . 0.0 111.099 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -157.83 149.0 21.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.07 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.645 ' HG2' ' HG3' ' A' ' 259' ' ' GLU . 26.4 mtpp -68.27 101.56 1.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.064 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -89.73 83.52 6.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.313 178.859 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 47.9 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.306 0.574 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.06 119.71 25.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.513 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 246' ' ' ARG . 1.2 tt -78.4 134.67 37.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.425 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -82.54 110.27 17.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.075 0.464 . . . . 0.0 110.961 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 77.5 mt -122.09 172.76 8.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.383 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.645 ' HG3' ' HG2' ' A' ' 245' ' ' LYS . 31.6 tt0 -147.7 149.86 33.24 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 2.4 p -60.35 122.14 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 110.61 8.19 24.96 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.195 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -105.02 149.92 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.4 mm -103.9 109.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.358 0.599 . . . . 0.0 110.453 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 43.7 t -89.38 109.65 20.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.855 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 265' ' ' LYS . 13.2 ptmm? -88.48 99.88 12.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.417 0.627 . . . . 0.0 109.944 174.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.505 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.4 p -89.2 119.55 36.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.349 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 m -96.84 -18.9 19.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.947 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.561 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 48.3 ttt180 -132.18 122.35 25.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.762 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 29.9 mtt -118.53 141.05 48.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.286 0.565 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -125.25 178.95 5.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.004 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.0 tp -96.61 -5.81 9.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.47 . . . . 0.0 111.329 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -94.14 14.81 18.87 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.94 -0.475 . . . . 0.0 111.99 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 98.59 -61.53 0.85 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.705 -0.759 . . . . 0.0 114.218 169.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 2.2 mp0 -77.15 110.82 12.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.899 0.349 . . . . 0.0 110.724 -176.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.54 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 11.2 m0 -93.34 168.05 11.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.741 -176.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 27.7 tt0 -108.9 108.22 18.91 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.31 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -124.16 154.99 17.9 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.127 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -108.32 108.48 19.5 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 15.5 t -130.53 -91.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.102 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -88.27 77.96 8.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.746 -170.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 67.67 -0.74 9.0 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.227 175.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 282' ' ' ARG . 46.4 mtp180 -147.92 153.61 39.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -174.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 55.0 pttt -120.06 134.57 55.21 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -161.26 -170.16 25.53 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.263 -175.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 71.4 mt -94.22 117.5 30.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.351 0.595 . . . . 0.0 110.966 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -115.62 138.26 23.72 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.525 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.9 133.43 12.51 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.734 2.289 . . . . 0.0 111.169 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -61.05 -14.21 22.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.816 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.5 p -75.56 -14.33 60.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.799 0.333 . . . . 0.0 111.578 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -98.83 -9.03 24.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.854 0.359 . . . . 0.0 110.675 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.4 m -128.58 179.11 4.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.343 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.437 ' HB2' ' NZ ' ' A' ' 292' ' ' LYS . 2.4 ttmp? -141.11 131.24 24.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.53 174.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 293' ' ' ILE . 28.5 mm -79.91 124.42 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.523 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.433 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.1 p90 -149.49 -174.72 4.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.886 -174.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 C--N 1.323 -0.581 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.763 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 120.819 0.343 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 5' ' ' ARG . 4.5 ptp180 -79.79 -2.03 41.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.019 0.438 . . . . 0.0 110.764 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -74.76 161.58 29.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.047 0.451 . . . . 0.0 111.017 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -98.65 117.32 32.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.78 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -83.69 1.81 40.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.39 -173.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.4 m -105.11 -31.23 9.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.774 0.321 . . . . 0.0 111.137 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.86 106.09 3.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.077 0.465 . . . . 0.0 110.727 -176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -58.76 -38.24 78.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.141 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.9 m -74.35 -0.94 18.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.693 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.47 -34.86 13.93 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.408 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -130.42 -24.66 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -173.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -79.16 123.56 27.5 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.026 -0.421 . . . . 0.0 110.692 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.496 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.1 mmt -109.06 -4.62 16.48 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.208 -175.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.82 -113.74 2.67 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.67 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.19 106.54 1.39 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.606 2.204 . . . . 0.0 112.635 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.75 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 79.7 t -137.81 -78.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.532 -177.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.837 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 8.1 t 89.79 156.99 0.05 OUTLIER 'General case' 0 C--N 1.349 0.557 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -62.58 -31.73 72.6 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.589 -169.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -55.04 -45.92 75.28 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.389 0.431 . . . . 0.0 111.153 175.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -84.03 -44.64 13.92 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.126 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.46 -34.9 51.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.286 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.576 ' HA ' HG21 ' A' ' 58' ' ' VAL . 7.9 tt0 -67.36 -47.23 71.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -76.85 -11.5 59.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -173.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -98.79 -14.98 19.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.651 0.263 . . . . 0.0 111.134 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 58.8 mt -127.29 23.78 6.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.254 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -84.7 63.48 7.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.264 0.554 . . . . 0.0 112.027 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.54 4.38 80.11 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.865 -0.683 . . . . 0.0 114.164 171.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.46 -51.23 70.74 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 117.187 0.494 . . . . 0.0 111.478 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 35' ' ' MET . 30.8 ttm180 -142.1 148.15 37.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -92.87 112.36 24.29 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.76 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . 116.99 -7.61 16.84 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.213 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.802 ' HG3' ' HB3' ' A' ' 53' ' ' SER . 6.5 ptp -79.69 134.24 36.4 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.036 177.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.502 ' H ' ' HA ' ' A' ' 101' ' ' PRO . 47.1 p90 -142.32 167.79 21.26 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.861 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.551 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.2 pp -155.76 137.21 14.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.185 0.517 . . . . 0.0 110.933 175.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.1 t -102.26 124.05 55.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.837 ' HD2' ' H ' ' A' ' 20' ' ' SER . 14.7 ptt-85 -123.52 167.17 14.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.019 -173.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.56 115.95 18.61 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 28.5 t -63.75 122.49 16.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.494 -173.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 p -74.69 -29.69 61.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.331 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 p -85.63 -18.57 32.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.061 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' SER . 34.4 m -137.25 85.63 21.5 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.98 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.95 107.12 0.42 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.896 2.397 . . . . 0.0 112.518 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.04 -6.84 23.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.206 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -111.04 179.28 4.09 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -126.83 158.92 35.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.921 0.391 . . . . 0.0 111.301 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 62' ' ' ILE . 46.1 t -131.21 113.04 22.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.338 174.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.1 tp -85.15 100.45 11.74 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.884 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 59' ' ' SER . 73.5 m -96.12 132.46 41.49 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.731 174.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.598 HG21 HD13 ' A' ' 93' ' ' LEU . 95.1 t -127.76 137.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.912 -172.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.802 ' HB3' ' HG3' ' A' ' 35' ' ' MET . 29.5 t -93.57 97.57 10.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.48 0.657 . . . . 0.0 109.484 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -135.97 136.26 40.23 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.332 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 55.5 16.98 2.03 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.24 0.337 . . . . 0.0 111.361 -169.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m 69.21 25.78 5.61 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.371 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 1.9 ppt_? -124.93 144.24 50.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 25' ' ' GLN . 14.6 t -85.51 96.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.27 0.557 . . . . 0.0 110.962 -173.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 51' ' ' SER . 2.4 m -67.7 113.17 5.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.993 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -101.65 88.41 3.4 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.241 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.694 ' CE2' HD22 ' A' ' 93' ' ' LEU . 40.6 m-85 -102.77 114.71 29.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.49 0.186 . . . . 0.0 111.015 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.664 HG12 HG22 ' A' ' 49' ' ' VAL . 51.7 mt -81.28 126.52 39.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.818 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.4 mp -106.55 119.0 55.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 170.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' A' ' 72' ' ' LYS . 35.3 p-10 -105.26 151.69 23.81 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.249 -174.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t -86.56 91.96 8.73 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.677 -176.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.529 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 97.4 mt -63.82 128.62 93.08 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -48.03 -64.4 0.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.118 2.546 . . . . 0.0 114.629 -172.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -113.92 34.12 4.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.8 -164.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.529 ' HG3' ' HB3' ' A' ' 66' ' ' LEU . 8.7 ptt180 -154.28 -85.02 0.06 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.524 ' HG2' HD12 ' A' ' 66' ' ' LEU . 4.3 ptm180 -156.36 -171.44 3.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -161.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.545 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 56.9 m-85 -107.41 121.96 45.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.641 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 17.9 ttmm -109.17 114.0 27.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.735 0.302 . . . . 0.0 110.703 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.818 ' HB ' HG13 ' A' ' 63' ' ' ILE . 8.9 tt -93.43 77.61 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 110.002 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.93 96.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.165 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t70 72.89 -61.46 0.5 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.378 0.271 . . . . 0.0 111.168 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.781 HE21 ' HA ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -75.62 111.08 10.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -175.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 10.0 pt-20 -94.59 130.05 41.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.198 0.523 . . . . 0.0 110.563 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.52 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 89.4 m-85 -116.36 168.24 10.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.128 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.68 -46.16 86.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.806 0.336 . . . . 0.0 111.399 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -154.54 176.16 12.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.38 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.632 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.5 mt -57.59 -56.41 34.51 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 40.0 Cg_exo -59.68 -8.25 7.08 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.202 1.935 . . . . 0.0 113.504 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.56 -29.4 20.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.786 0.327 . . . . 0.0 110.525 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.7 pp -83.64 -30.4 26.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 82' ' ' PRO . 89.2 mt -65.17 -40.98 95.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.501 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -79.68 -4.39 51.55 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.46 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -91.39 -39.32 12.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.343 0.592 . . . . 0.0 109.559 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.551 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 50.9 m-85 -74.28 -10.59 59.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.25 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -57.16 -37.94 72.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.118 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 pp -111.32 7.79 8.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 O-C-N 121.65 -0.657 . . . . 0.0 111.784 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.551 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 8.3 t-160 -94.41 -35.71 12.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -177.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.785 ' HA ' HG22 ' A' ' 97' ' ' THR . 79.2 m-85 70.86 99.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 124.066 0.854 . . . . 0.0 109.96 -170.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.694 HD22 ' CE2' ' A' ' 61' ' ' TYR . 25.2 mt -64.79 -21.24 66.73 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.693 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 1.5 m-20 -145.63 -74.65 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.791 165.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.5 t -144.14 -11.17 0.65 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.531 HG22 ' CD ' ' A' ' 54' ' ' GLU . 5.8 t -124.7 -12.74 7.11 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.752 -0.592 . . . . 0.0 112.034 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 92' ' ' TYR . 6.6 p 74.18 -169.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.34 1.056 . . . . 0.0 111.599 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.476 HD22 ' CD1' ' A' ' 36' ' ' PHE . 81.0 mt -75.88 106.47 7.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.791 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.76 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 31.2 mm -99.78 -56.4 5.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.105 -172.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.705 ' O ' ' HA ' ' A' ' 35' ' ' MET . 28.3 tt0 -166.62 124.79 1.05 Allowed Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -174.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.502 ' HA ' ' H ' ' A' ' 36' ' ' PHE . 18.0 Cg_endo -58.03 162.31 11.65 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.551 2.834 . . . . 0.0 113.719 -171.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.29 151.02 94.38 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.054 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.3 141.81 36.23 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.301 2.001 . . . . 0.0 113.402 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.238 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.725 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 121.545 0.688 . . . . 0.0 111.555 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.621 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 36.6 tt0 -171.25 -56.76 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.261 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.644 ' HB3' HH12 ' A' ' 129' ' ' ARG . 36.3 m-85 -105.2 107.97 19.24 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.33 -175.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 93.8 t -132.9 147.42 31.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.171 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.644 HH12 ' HB3' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -129.49 145.11 51.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.814 0.34 . . . . 0.0 110.346 176.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.97 HG22 HG12 ' A' ' 178' ' ' VAL . 16.5 p -100.56 139.44 36.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.591 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.493 ' CD1' ' HG3' ' A' ' 179' ' ' GLU . 3.8 mp -119.25 -4.96 10.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.308 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -98.59 -39.76 8.55 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.558 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.444 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 74.21 120.81 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.865 0.84 . . . . 0.0 110.747 -175.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.477 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 62.1 t80 -153.78 116.53 2.65 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.91 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 4.0 Cg_endo -87.27 102.53 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.726 2.284 . . . . 0.0 112.347 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -82.37 -9.42 84.97 Favored Glycine 0 CA--C 1.511 -0.208 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.174 176.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.2 m120 51.5 24.52 2.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.229 0.612 . . . . 0.0 112.618 -173.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.531 ' HB2' ' HD3' ' A' ' 169' ' ' ARG . 19.0 t0 73.1 157.89 0.2 Allowed 'General case' 0 C--O 1.232 0.14 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 165.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 70.63 18.46 6.39 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.091 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.9 tp10 -168.23 -50.53 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.528 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 49.6 m-20 -142.39 148.03 37.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.055 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' A' ' 165' ' ' ASN . 34.1 tp -90.44 125.37 60.0 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.258 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 7.9 Cg_exo -70.16 108.34 2.13 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.284 1.989 . . . . 0.0 111.231 170.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.478 ' CG ' HG21 ' A' ' 130' ' ' THR . 6.6 p90 -126.06 163.52 22.88 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.494 ' H ' ' HB2' ' A' ' 148' ' ' GLU . 42.0 mttp -100.18 -175.2 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 110.41 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.842 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -90.88 8.47 34.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.441 179.158 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.8 34.55 0.8 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.494 ' HB2' ' H ' ' A' ' 145' ' ' LYS . 4.5 tp10 -93.52 144.42 25.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.745 -0.227 . . . . 0.0 110.62 -175.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.9 mm -98.3 135.6 32.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 165' ' ' ASN . 49.2 mt -128.56 158.5 38.26 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -175.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 43.3 t -119.47 129.25 75.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.725 HG21 HD12 ' A' ' 125' ' ' LEU . 37.5 mm -75.05 87.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.645 HG21 HG22 ' A' ' 170' ' ' VAL . 16.0 tt -74.45 -32.74 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.313 -173.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.692 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 29.2 mt-10 -144.7 140.76 28.81 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.428 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 32.4 tttp -127.67 91.43 45.51 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 121.664 -0.648 . . . . 0.0 111.948 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.45 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 15.6 Cg_exo -72.39 -52.2 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.248 1.966 . . . . 0.0 112.865 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -113.5 -172.85 2.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -170.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -99.1 -42.91 6.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.914 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -93.09 -10.09 37.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.392 . . . . 0.0 111.212 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.659 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 58.0 m95 -128.89 125.78 38.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.905 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.656 ' O ' HG13 ' A' ' 173' ' ' ILE . 54.9 m0 -121.73 144.87 48.54 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.097 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 20.2 m -95.64 94.82 7.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.3 0.572 . . . . 0.0 110.279 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -101.29 161.81 13.35 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.172 -0.33 . . . . 0.0 110.549 -177.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.736 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 20.6 ptt-85 -104.98 133.95 48.9 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.836 ' HB3' HD11 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -78.31 -176.69 4.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.685 -175.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -49.48 -31.64 10.45 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.204 0.94 . . . . 0.0 111.926 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.545 ' HB2' HD21 ' A' ' 165' ' ' ASN . 8.0 m-20 -72.33 -58.93 3.01 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 172.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.588 ' H ' ' ND2' ' A' ' 165' ' ' ASN . . . 139.84 3.28 1.54 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.407 -172.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.736 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -73.66 152.69 40.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.584 0.692 . . . . 0.0 110.866 -177.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.645 HG22 HG21 ' A' ' 153' ' ' ILE . 26.0 t -103.65 121.37 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.133 0.492 . . . . 0.0 111.077 -176.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.64 157.78 27.38 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.659 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.3 OUTLIER -73.8 140.06 45.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.001 0.429 . . . . 0.0 111.165 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.675 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -137.95 143.68 40.78 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.153 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.472 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 5.6 Cg_exo -80.87 135.73 10.18 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 123.226 2.617 . . . . 0.0 112.923 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.551 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 99.8 t -58.33 -44.83 99.57 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.6 Cg_endo -64.48 -0.95 3.35 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.036 1.824 . . . . 0.0 113.502 177.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.88 -6.36 21.42 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.746 0.308 . . . . 0.0 111.185 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.97 HG12 HG22 ' A' ' 130' ' ' THR . 17.3 m -128.58 156.07 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -168.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.493 ' HG3' ' CD1' ' A' ' 131' ' ' LEU . 21.8 mt-10 -119.7 125.64 49.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.008 166.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.411 ' HE3' ' HH2' ' A' ' 161' ' ' TRP . 28.2 mttp . . . . . 0 C--N 1.313 -1.017 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.47 ' HB ' HG13 ' A' ' 266' ' ' VAL . 20.3 t . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -100.08 112.88 25.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.907 0.384 . . . . 0.0 111.348 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -120.68 122.01 39.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.124 175.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.98 122.3 28.12 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -72.04 112.88 8.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.21 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.533 HG13 ' HG3' ' A' ' 244' ' ' GLN . 33.2 pt -89.28 -9.04 10.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.229 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 19.4 mt-30 -134.86 149.16 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -79.08 141.96 36.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.429 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 1.028 ' HD2' ' HE1' ' A' ' 290' ' ' HIS . 58.1 ttt85 -135.8 138.82 42.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.347 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.433 177.767 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 285' ' ' LEU . 2.6 m . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 121.377 0.608 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -76.85 115.54 16.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.749 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.615 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.6 tt -84.67 129.43 34.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.035 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -72.09 121.83 19.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.863 0.363 . . . . 0.0 110.597 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.538 HD22 HG22 ' A' ' 264' ' ' VAL . 96.0 mt -129.89 145.04 51.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 262' ' ' ASP . 8.7 mm-40 -101.0 161.4 13.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.141 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.26 119.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.3 64.26 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.511 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.739 ' HB2' ' HB2' ' A' ' 259' ' ' GLU . 24.7 t70 -85.81 146.18 26.88 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.673 0.273 . . . . 0.0 110.436 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.4 mm -92.69 106.51 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.758 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.538 HG22 HD22 ' A' ' 258' ' ' LEU . 16.3 t -83.97 107.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.501 177.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -87.96 92.43 9.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.45 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.63 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 3.8 p -88.29 134.35 28.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.889 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 58.9 p -103.79 -45.11 4.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -111.47 116.98 31.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 32.9 mtt -106.72 116.65 32.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.915 0.388 . . . . 0.0 111.121 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -82.92 152.13 25.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.25 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 8.6 mm -95.61 29.39 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.559 0.695 . . . . 0.0 110.259 -172.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.47 HD21 ' HG2' ' A' ' 274' ' ' GLN . 30.4 p-10 -113.35 -25.43 8.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.146 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 136.3 -23.6 3.3 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.142 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.47 ' HG2' HD21 ' A' ' 272' ' ' ASN . 14.3 pt20 -107.25 130.24 54.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.038 0.419 . . . . 0.0 110.263 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.443 ' HE3' ' CE2' ' A' ' 286' ' ' PHE . 5.8 m0 -118.75 169.64 9.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.245 -174.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -111.28 110.66 21.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.337 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -116.31 155.88 15.97 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 176.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.465 ' HB2' ' HE2' ' A' ' 283' ' ' LYS . 35.3 tt0 -108.0 109.46 20.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.384 0.592 . . . . 0.0 110.539 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.615 ' HB ' HD21 ' A' ' 256' ' ' LEU . 71.7 t -131.34 129.36 62.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 14.2 m120 65.83 30.4 10.03 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.43 0.456 . . . . 0.0 110.982 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.53 9.29 86.12 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.825 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -118.71 123.02 43.86 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.705 -0.291 . . . . 0.0 110.779 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 83.4 mttt -94.13 111.64 23.39 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -132.81 168.72 22.74 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.817 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.43 ' H ' HG22 ' A' ' 254' ' ' THR . 87.8 mt -86.62 132.2 33.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.245 0.545 . . . . 0.0 110.82 -178.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.479 ' HB2' ' NE2' ' A' ' 290' ' ' HIS . 36.1 p90 -132.5 126.57 20.22 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.595 175.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.21 161.29 23.54 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 123.04 2.493 . . . . 0.0 113.185 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -68.18 -33.73 74.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.183 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.3 p -81.7 17.88 1.37 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 1.028 ' HE1' ' HD2' ' A' ' 246' ' ' ARG . 0.6 OUTLIER -143.45 8.35 1.56 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.071 -0.651 . . . . 0.0 112.097 176.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.32 161.09 37.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -139.9 119.93 13.63 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.752 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 240' ' ' ALA . 1.4 mp -72.64 117.89 16.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -115.35 143.73 44.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.424 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 C--N 1.32 -0.705 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.234 0.263 0 CA-C-O 120.745 0.307 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -138.31 89.16 2.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.03 0.443 . . . . 0.0 110.959 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -161.93 163.06 29.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 9' ' ' SER . 32.7 m-20 -82.3 -17.87 44.32 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.382 -173.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 70.28 -32.88 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.547 0.739 . . . . 0.0 111.48 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 7' ' ' ASP . 17.6 m -93.06 -23.27 18.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.95 100.74 4.22 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.431 -173.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.63 -26.36 68.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 104' ' ' ARG . 68.5 m -70.81 -4.78 25.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.488 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.22 -47.3 4.77 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 40.0 p-90 -111.54 -20.19 12.27 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -76.41 116.71 17.36 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.971 -0.455 . . . . 0.0 110.894 -173.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.612 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.5 mmt -98.14 -12.08 22.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.396 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.94 -113.0 1.89 Allowed Glycine 0 CA--C 1.521 0.45 0 O-C-N 123.852 0.72 . . . . 0.0 113.828 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.4 Cg_exo -69.92 84.33 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.041 2.494 . . . . 0.0 113.281 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.013 HG12 ' H ' ' A' ' 20' ' ' SER . 61.0 t -135.92 -162.16 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.013 ' H ' HG12 ' A' ' 19' ' ' VAL . 87.2 p -170.88 165.12 7.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -168.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.623 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 8.1 ptm85 -68.01 -31.71 71.59 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 118.872 -1.131 . . . . 0.0 110.851 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -59.16 -58.57 8.07 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.092 0.472 . . . . 0.0 110.387 176.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.63 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 35.7 mt-10 -64.95 -46.22 82.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.353 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.08 -43.75 78.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.833 -177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 18.2 mt-30 -69.5 -34.45 74.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.79 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 23' ' ' GLU . 11.5 t -78.65 -7.97 58.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.947 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.63 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 41.6 mtp180 -97.12 -10.54 25.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.048 0.452 . . . . 0.0 109.828 176.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 45.7 mt -114.27 -11.64 12.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.414 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.635 HE22 ' HB3' ' A' ' 57' ' ' ARG . 7.0 tp-100 -70.88 125.97 28.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.441 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.93 15.07 71.32 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.197 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.583 HE21 ' HA ' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -101.29 164.6 11.7 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -178.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 32' ' ' ARG . 19.4 ptt85 -61.21 130.87 48.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.212 0.529 . . . . 0.0 110.642 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.409 ' HA ' ' O ' ' A' ' 53' ' ' SER . 32.2 m170 -67.79 132.59 47.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.953 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.54 -20.29 7.4 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.682 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.738 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.9 mtm -75.01 136.85 41.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.412 ' CB ' HG22 ' A' ' 52' ' ' VAL . 50.0 p90 -139.16 168.21 20.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.294 -176.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.612 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -156.07 141.3 17.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.921 0.391 . . . . 0.0 110.755 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.436 ' HB ' ' CE3' ' A' ' 14' ' ' TRP . 61.6 t -114.07 124.93 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.617 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 19.2 ptt-85 -125.46 167.91 14.35 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.909 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.87 129.98 38.62 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.429 ' HB3' ' OG1' ' A' ' 43' ' ' THR . 61.8 m -68.78 147.22 52.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.559 0.695 . . . . 0.0 112.5 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.2 t -76.71 -14.29 59.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.426 175.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.429 ' OG1' ' HB3' ' A' ' 41' ' ' SER . 0.2 OUTLIER -76.3 -62.1 1.73 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.646 176.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 73.2 m -149.75 141.41 14.92 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.391 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 40.4 Cg_exo -59.35 -23.04 68.4 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.963 2.442 . . . . 0.0 112.258 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.25 37.38 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.647 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -156.86 148.32 22.33 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.419 ' CD2' HD11 ' A' ' 81' ' ' LEU . 29.0 m-85 -129.5 171.65 12.35 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 t -137.05 112.9 11.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.543 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.414 ' HB2' HD11 ' A' ' 63' ' ' ILE . 63.6 tp -82.22 92.44 6.91 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.79 171.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.2 m -95.59 120.59 36.11 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.627 HG12 ' HG3' ' A' ' 54' ' ' GLU . 88.2 t -112.76 141.78 27.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.552 -174.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 29.5 t -82.02 100.26 9.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.627 ' HG3' HG12 ' A' ' 52' ' ' VAL . 29.6 mt-10 -155.58 149.99 25.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.457 . . . . 0.0 112.142 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.721 HD21 ' HB3' ' A' ' 155' ' ' LYS . 1.7 m-20 60.13 59.37 2.39 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.416 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 55' ' ' ASN . 32.8 t 70.98 -24.52 0.17 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.751 -174.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.711 ' CD ' ' H ' ' A' ' 58' ' ' VAL 0.405 0.0 OUTLIER -160.0 -53.39 0.06 Allowed 'General case' 0 C--N 1.363 1.156 1 N-CA-C 124.47 4.989 . . . . 0.0 124.47 -178.551 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.711 ' H ' ' CD ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -154.24 116.84 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 121.671 2.032 . . . . 0.0 113.3 -171.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.576 ' OG ' ' HB2' ' A' ' 54' ' ' GLU . 6.0 m -97.8 110.54 23.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 164.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -94.01 110.13 21.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.946 ' HB3' HD11 ' A' ' 73' ' ' ILE . 69.1 m-85 -120.1 102.5 8.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.019 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.82 148.67 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.6 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.8 mp -129.67 86.47 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.07 131.94 47.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.881 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.8 t -77.45 125.26 29.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.265 0.555 . . . . 0.0 110.799 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.999 HD13 ' HB2' ' A' ' 69' ' ' ARG . 94.1 mt -76.0 147.57 80.56 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.12 169.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.505 ' HD2' HH21 ' A' ' 69' ' ' ARG . 35.8 Cg_exo -64.25 61.99 0.25 Allowed 'Trans proline' 0 C--O 1.218 -0.479 0 C-N-CA 122.762 2.308 . . . . 0.0 110.458 165.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 1.027 HD22 ' N ' ' A' ' 69' ' ' ARG 0.268 0.2 OUTLIER 103.66 -50.88 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 128.67 2.788 . . . . 0.0 109.467 -179.688 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 1.027 ' N ' HD22 ' A' ' 68' ' ' ASN . 73.1 mtm180 -34.45 -53.94 0.52 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 125.093 1.496 . . . . 0.0 112.137 -149.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.841 ' H ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -169.85 -167.11 0.62 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.184 1.794 . . . . 0.0 106.572 167.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.15 114.18 26.31 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.378 166.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 23.2 ttmm -102.51 104.78 15.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 111.339 -171.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.946 HD11 ' HB3' ' A' ' 61' ' ' TYR . 6.5 tt -92.49 77.53 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.773 0.797 . . . . 0.0 109.463 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.98 89.1 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.947 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.4 t0 75.48 -52.03 0.65 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.705 0.402 . . . . 0.0 110.877 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -83.16 114.84 21.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.643 0.258 . . . . 0.0 110.472 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.5 pm0 -93.38 133.03 37.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.386 0.612 . . . . 0.0 110.613 174.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.755 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 64.1 m-85 -121.0 158.23 28.22 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.837 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 4.3 m-20 -44.15 -41.23 5.54 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.514 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 3.4 p80 -170.46 -173.13 1.37 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 11.6 mt -57.83 -55.23 47.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 123.047 0.217 . . . . 0.0 111.339 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 32.1 Cg_exo -63.56 5.68 0.32 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.774 2.316 . . . . 0.0 114.005 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -107.54 -32.19 7.8 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.26 -0.275 . . . . 0.0 110.952 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.57 HD21 HD23 ' A' ' 81' ' ' LEU . 4.4 pp -76.15 -30.14 58.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.211 0.529 . . . . 0.0 109.739 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 53.5 mt -63.02 -32.41 73.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.943 176.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.639 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 24.3 tp10 -72.07 -26.8 62.31 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.544 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 91' ' ' HIS . 14.1 t80 -73.3 -29.3 62.61 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.053 0.93 . . . . 0.0 108.932 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.533 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 42.0 m-85 -92.39 2.67 56.52 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.338 -175.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.639 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 52.0 mtpt -85.65 -15.52 42.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.639 172.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.2 pt -122.74 -1.85 7.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 121.309 0.576 . . . . 0.0 110.091 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.4 t-160 -86.88 -43.78 12.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.841 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.459 ' CD2' HG23 ' A' ' 97' ' ' THR . 66.1 m-85 63.74 94.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -162.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.728 HD22 ' CE2' ' A' ' 61' ' ' TYR . 16.5 mt -51.53 -97.21 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 123.712 0.633 . . . . 0.0 110.564 176.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.598 ' OD2' ' HB2' ' A' ' 55' ' ' ASN . 3.2 t0 -68.04 -65.26 0.72 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.546 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 9.8 t -157.31 13.06 0.23 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.915 0.864 . . . . 0.0 110.228 175.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.49 HG22 ' OE1' ' A' ' 54' ' ' GLU . 6.5 t -140.65 171.72 13.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 169.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.459 HG23 ' CD2' ' A' ' 92' ' ' TYR . 17.8 p -98.02 171.55 8.19 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.042 -0.411 . . . . 0.0 110.619 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.4 94.26 0.72 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.1 mm -76.17 -53.78 14.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.802 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.738 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.9 pt-20 -167.92 154.57 7.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.632 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 42.3 Cg_endo -66.88 154.56 74.16 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.297 1.998 . . . . 0.0 112.737 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -72.61 161.05 81.15 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.323 175.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 9.6 Cg_endo -51.64 126.43 19.63 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.154 1.902 . . . . 0.0 110.971 176.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 12' ' ' SER . 40.7 ttt180 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.295 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.538 HD12 HG21 ' A' ' 152' ' ' ILE . 3.6 mm? . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 121.523 0.678 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.0 tp10 -177.57 -68.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.648 -172.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -112.92 106.96 15.36 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.332 0.587 . . . . 0.0 110.293 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.74 HG22 ' CG ' ' A' ' 180' ' ' LYS . 99.4 t -120.49 133.88 65.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.287 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.714 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 7.4 ptp180 -110.35 144.42 39.13 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.855 -1.938 . . . . 0.0 108.724 170.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.541 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -101.28 132.15 46.95 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.514 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.554 HD21 ' HG2' ' A' ' 179' ' ' GLU . 14.9 mt -107.4 -15.13 14.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.973 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.405 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 19.1 t80 -82.06 -40.97 21.23 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -173.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.635 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 11.3 t70 71.52 96.43 0.07 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.459 0.647 . . . . 0.0 110.603 -175.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -127.81 88.25 53.77 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 91.3 Cg_endo -84.85 79.02 2.51 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.075 1.85 . . . . 0.0 113.158 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.29 -23.94 77.51 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.381 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.856 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 67.38 50.8 0.92 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.452 0.701 . . . . 0.0 111.639 177.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.419 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 19.7 m-20 -144.5 178.96 7.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.387 . . . . 0.0 110.969 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.519 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -99.96 -9.41 22.78 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 171.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 172' ' ' MET . 4.8 mm-40 -80.87 -38.25 28.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.432 174.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 172' ' ' MET . 24.1 m-20 -133.88 108.67 8.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.945 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.054 HD11 ' HB2' ' A' ' 165' ' ' ASN . 35.4 tp -63.95 129.78 94.1 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.856 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 10.2 Cg_endo -81.21 87.53 1.47 Allowed 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 121.627 1.551 . . . . 0.0 111.088 175.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.49 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 10.2 p90 -100.63 159.83 14.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.527 -173.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.635 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 40.5 mttp -104.22 -172.44 2.11 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -174.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.954 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -85.23 8.55 17.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.334 -172.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.95 41.19 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.405 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -105.1 148.25 27.04 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.706 -177.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.64 132.84 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.331 0.586 . . . . 0.0 109.817 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.752 HD22 ' CD2' ' A' ' 142' ' ' LEU . 24.4 mt -125.85 162.31 25.43 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -176.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.631 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 99.0 t -125.44 122.08 61.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 175.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.073 HD13 ' HB2' ' A' ' 163' ' ' ALA . 34.0 mm -77.01 78.68 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.445 HG21 HG22 ' A' ' 170' ' ' VAL . 10.5 tt -78.34 -39.26 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.727 -176.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.654 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 63.1 mt-10 -116.54 140.27 49.57 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 171.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.721 ' HB3' HD21 ' A' ' 55' ' ' ASN . 78.4 tttt -136.71 86.93 21.18 Favored Pre-proline 0 C--N 1.316 -0.863 0 O-C-N 121.49 -0.756 . . . . 0.0 110.149 175.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.693 ' HG2' ' SD ' ' A' ' 172' ' ' MET . 4.3 Cg_exo -67.32 -55.53 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.614 2.209 . . . . 0.0 111.592 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 160' ' ' TRP . 17.4 mm-40 -107.17 167.94 9.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.814 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.431 ' O ' HG21 ' A' ' 175' ' ' VAL . 1.6 mm-40 -94.47 -16.35 23.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.153 0.502 . . . . 0.0 109.714 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.419 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 2.0 pt20 -94.21 -21.23 19.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.547 173.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.721 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 52.4 m95 -131.22 127.71 38.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.555 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.852 ' HB3' HD12 ' A' ' 152' ' ' ILE . 47.2 m0 -117.88 136.85 53.19 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.357 -176.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.683 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 74.5 m -100.46 90.38 4.28 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.073 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -102.44 149.4 24.41 Favored 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.48 -171.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.825 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 23.5 ptt-85 -86.75 119.35 26.89 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.054 ' HB2' HD11 ' A' ' 142' ' ' LEU . 6.0 t30 -46.59 166.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 112.374 -2.194 . . . . 0.0 111.213 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -68.57 10.71 0.23 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.64 0.733 . . . . 0.0 110.505 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 165' ' ' ASN . 18.5 m-20 -114.38 -6.68 12.91 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.798 172.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.37 67.87 1.54 Allowed Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.257 -172.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.825 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 8.7 ttm-85 -139.48 126.31 20.81 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.494 HG11 ' CD ' ' A' ' 154' ' ' GLU . 12.1 t -86.65 116.27 28.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.073 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -144.09 149.16 21.18 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.721 ' HE2' ' HB3' ' A' ' 160' ' ' TRP . 7.4 mtp -74.93 134.89 41.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.223 0.511 . . . . 0.0 110.583 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.779 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.5 pp -137.11 142.74 39.23 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.341 -176.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.602 ' HG2' ' CG ' ' A' ' 177' ' ' TYR . 9.7 Cg_endo -62.85 130.4 29.23 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.989 2.459 . . . . 0.0 113.152 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 178' ' ' VAL . 99.2 t -64.67 -44.91 75.35 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.167 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.524 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 48.6 Cg_exo -58.25 1.44 0.25 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.429 2.086 . . . . 0.0 114.104 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.602 ' CG ' ' HG2' ' A' ' 174' ' ' PRO . 3.2 m-85 -104.77 -10.53 17.36 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.34 0.256 . . . . 0.0 111.589 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.642 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.4 m -106.39 -171.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -165.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.714 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.1 tp10 -159.34 47.51 0.3 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.327 -1.761 . . . . 0.0 111.497 -154.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.74 ' CG ' HG22 ' A' ' 128' ' ' VAL . 1.9 mptt . . . . . 0 C--N 1.33 -0.24 0 O-C-N 119.297 -2.127 . . . . 0.0 110.469 -162.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.56 ' CG1' HD12 ' A' ' 293' ' ' ILE . 7.6 t . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 121.052 0.453 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.68 125.98 52.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.172 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.484 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -124.57 139.07 54.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.708 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.96 130.72 46.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.107 176.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -75.41 104.56 6.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.896 0.379 . . . . 0.0 110.18 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 21.0 pt -75.24 -13.0 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.416 HE21 ' HB2' ' A' ' 244' ' ' GLN . 0.7 OUTLIER -146.94 157.82 43.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.308 178.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -73.27 158.71 34.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.429 0.633 . . . . 0.0 111.082 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.645 ' HD3' HD12 ' A' ' 258' ' ' LEU . 58.9 mtp85 -132.21 115.66 15.97 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.84 175.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.317 -0.829 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 172.204 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 120.784 0.325 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.0 116.83 23.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.48 133.64 49.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.938 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -95.77 135.48 37.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.675 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.645 HD12 ' HD3' ' A' ' 246' ' ' ARG . 96.7 mt -134.75 151.91 51.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 0.0 111.851 -169.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -97.67 172.98 7.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.392 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.69 122.53 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.893 0.378 . . . . 0.0 110.669 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.48 22.22 62.83 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.373 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -89.63 169.12 11.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.6 mm -106.58 116.0 49.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.325 0.584 . . . . 0.0 110.635 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.531 ' HA ' HG22 ' A' ' 279' ' ' VAL . 21.9 t -102.4 109.86 27.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.268 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.481 ' HB2' ' HE3' ' A' ' 265' ' ' LYS . 33.3 mtmt -87.2 99.73 12.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.013 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 5.8 p -90.15 116.48 31.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.593 0.711 . . . . 0.0 109.833 175.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 19.6 p -93.43 -36.31 12.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.321 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.563 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 56.5 ttt180 -121.56 96.9 5.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.832 175.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . 0.45 ' HG3' ' NE1' ' A' ' 275' ' ' TRP . 45.7 ttm -81.81 111.54 18.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.059 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 91.6 m-20 -86.74 144.95 26.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.996 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 16.3 tt -79.46 -12.95 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.109 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -75.81 -25.47 56.36 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.725 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.19 -40.05 1.89 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.608 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 34.6 mt-30 -75.7 108.85 8.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.45 ' NE1' ' HG3' ' A' ' 269' ' ' MET . 52.8 m0 -93.39 145.43 24.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.857 0.361 . . . . 0.0 111.315 -176.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 9.0 tp10 -91.99 107.35 19.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.183 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -140.03 157.11 25.29 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.534 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -124.13 123.99 41.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.232 0.539 . . . . 0.0 110.043 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 264' ' ' VAL . 28.7 t -124.81 160.96 29.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.078 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -54.82 85.64 0.0 OUTLIER 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.559 0.695 . . . . 0.0 110.889 174.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 156.3 -39.69 0.58 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.375 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 282' ' ' ARG . 34.5 ttm180 179.69 152.89 0.45 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.1 0.476 . . . . 0.0 111.233 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -101.25 127.64 47.75 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.5 -169.41 35.84 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.68 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 97.4 mt -93.87 145.8 24.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.706 0.288 . . . . 0.0 110.376 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -141.73 127.48 10.91 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 121.083 0.468 . . . . 0.0 111.092 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.508 ' HD2' ' CZ ' ' A' ' 246' ' ' ARG . 72.4 Cg_exo -55.39 126.37 22.29 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 123.269 2.646 . . . . 0.0 112.449 169.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -64.75 -14.76 60.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.454 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 13.8 p -71.8 -2.43 17.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -113.79 0.19 14.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.175 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.484 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 28.5 m -128.28 168.99 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.011 0.434 . . . . 0.0 111.164 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -129.33 129.38 44.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.37 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.56 HD12 ' CG1' ' A' ' 238' ' ' VAL . 32.9 mm -81.16 126.25 39.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.259 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.23 157.05 40.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.947 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 121.431 0.634 . . . . 0.0 110.008 175.142 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 121.04 0.448 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -148.93 -53.02 0.17 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.686 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 p90 37.46 -162.35 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.632 1.208 . . . . 0.0 113.09 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.99 -44.91 19.37 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.046 -0.409 . . . . 0.0 110.861 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 t 72.5 -53.7 0.69 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.971 0.795 . . . . 0.0 111.87 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 m -84.47 -25.38 28.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.109 0.481 . . . . 0.0 110.946 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -86.74 116.91 25.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.063 0.459 . . . . 0.0 111.119 -171.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -63.54 -31.74 72.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.521 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.8 t -69.28 -8.28 44.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.23 -47.69 7.09 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.913 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -117.78 -23.38 7.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -170.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -73.65 116.01 13.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.619 ' HB3' HG21 ' A' ' 19' ' ' VAL . 12.4 tpp -100.71 -1.66 34.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.347 -172.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.96 -115.9 3.95 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.252 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.1 Cg_exo -72.4 103.28 1.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.9 2.4 . . . . 0.0 112.036 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.853 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 64.4 t -136.17 -83.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -176.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.796 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 11.7 t 83.6 176.47 0.06 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 168.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 7.8 tpt180 -42.16 -62.68 0.88 Allowed 'General case' 0 C--N 1.314 -0.944 0 O-C-N 124.112 0.883 . . . . 0.0 112.276 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -62.12 -28.53 69.7 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.05 -168.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -95.75 -45.55 6.95 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.561 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -55.54 32.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.504 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 12.3 pt20 -68.69 -31.26 70.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.829 -174.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.2 m -65.48 -42.95 91.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.42 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -71.22 -28.83 64.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.962 0.411 . . . . 0.0 111.239 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.079 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 17.4 mt -107.24 25.88 10.87 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.233 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -75.56 76.22 2.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.54 0.686 . . . . 0.0 109.9 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.41 -64.47 3.98 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.258 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 11.99 -108.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.208 1.403 . . . . 0.0 113.796 -172.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.415 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 18.7 ttp180 -111.06 143.88 41.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 53' ' ' SER . 36.5 m170 -94.6 140.99 29.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.73 23.21 12.26 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -173.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.569 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 41.7 mtm -115.58 143.34 45.47 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.758 0.313 . . . . 0.0 110.373 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.536 ' CG ' HD22 ' A' ' 98' ' ' LEU . 29.6 p90 -144.79 161.13 40.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.472 -176.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.1 pp -150.92 133.99 15.99 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.051 0.453 . . . . 0.0 110.415 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.51 113.78 38.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.853 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 12.1 ptt180 -114.29 168.83 9.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.08 128.21 33.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.3 t -85.0 163.1 19.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.27 0.557 . . . . 0.0 111.573 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 p -105.84 13.57 29.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.659 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.7 p -78.34 -52.71 8.2 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.128 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 47' ' ' ASP . 24.3 p -165.22 139.31 3.97 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.563 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.57 113.41 1.36 Allowed 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.918 2.412 . . . . 0.0 112.437 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 65' ' ' SER . . . 121.26 -20.34 8.46 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.528 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.5 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 32.4 t70 -86.37 152.14 22.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.411 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 35.7 m-85 -131.04 162.06 30.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.705 0.288 . . . . 0.0 110.991 -176.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.49 HG23 ' HB2' ' A' ' 41' ' ' SER . 56.6 t -137.67 112.02 9.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.017 0.436 . . . . 0.0 111.227 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 36' ' ' PHE . 30.9 tp -85.85 100.67 12.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.189 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 59' ' ' SER . 61.2 m -96.72 134.23 40.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.053 0.454 . . . . 0.0 110.44 175.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.734 HG21 HD13 ' A' ' 93' ' ' LEU . 96.4 t -123.59 149.5 27.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.102 -174.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 1.079 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 33.5 t -123.0 98.21 5.79 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.681 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 0.9 OUTLIER -133.9 139.93 46.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.025 172.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 55.39 29.32 12.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.695 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.4 m 64.94 31.46 11.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.702 0.763 . . . . 0.0 111.1 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -124.18 120.71 33.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.668 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 25' ' ' GLN . 19.2 t -88.31 93.98 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.199 0.523 . . . . 0.0 110.215 -178.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 38.6 m -74.39 118.24 17.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.787 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -102.16 94.38 5.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.467 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.698 ' CE2' HD22 ' A' ' 93' ' ' LEU . 27.6 m-85 -101.97 115.27 30.18 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.566 0.222 . . . . 0.0 111.355 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 69.0 mt -80.55 133.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.73 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.4 mp -108.23 120.97 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 5.4 t-20 -107.29 133.17 52.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -165.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 25.7 t -77.64 97.32 5.07 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.06 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.5 mt -66.82 151.55 96.66 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 17.2 Cg_exo -66.91 73.57 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.298 1.999 . . . . 0.0 112.339 177.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 67' ' ' PRO . 28.6 t-20 85.71 1.39 0.67 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.985 165.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -80.65 -85.17 0.09 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.737 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.546 ' HD2' ' HG3' ' A' ' 77' ' ' GLU . 8.4 ptp85 -158.41 -168.32 2.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.169 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.417 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 47.8 m-85 -104.3 115.51 30.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.151 0.501 . . . . 0.0 110.56 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' A' ' 75' ' ' ASP . 87.6 tttt -103.65 107.95 19.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.769 -176.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.73 ' HB ' HG13 ' A' ' 63' ' ' ILE . 5.8 tt -96.69 88.68 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.603 0.716 . . . . 0.0 110.627 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.99 79.28 0.13 Allowed Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.346 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.406 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 32.2 t70 73.36 -44.37 0.58 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.93 0.492 . . . . 0.0 112.016 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -66.39 148.49 51.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.059 0.457 . . . . 0.0 111.234 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.546 ' HG3' ' HD2' ' A' ' 70' ' ' ARG . 3.4 tp10 -110.42 116.81 32.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.166 -171.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 93.0 m-85 -131.73 141.99 49.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -76.46 -16.95 59.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.902 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 15.6 p80 -167.63 167.97 13.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.94 -0.118 . . . . 0.0 110.738 173.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.539 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 9.8 mt -52.46 -57.78 14.28 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 23.5 Cg_exo -67.53 13.66 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.35 2.033 . . . . 0.0 113.838 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -36.95 8.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.144 0.497 . . . . 0.0 109.981 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.5 pp -76.74 -27.84 55.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.657 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.73 -30.15 70.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.106 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.498 ' CD ' ' HZ2' ' A' ' 89' ' ' LYS . 29.8 mm-40 -83.1 -31.26 27.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.564 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -69.07 -39.52 79.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.939 0.4 . . . . 0.0 110.705 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.425 ' HE2' HD13 ' A' ' 73' ' ' ILE . 43.9 m-85 -77.7 -15.37 59.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.205 0.526 . . . . 0.0 110.598 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.498 ' HZ2' ' CD ' ' A' ' 86' ' ' GLU . 40.0 ttmt -66.81 -21.58 66.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.932 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.1 pt -116.42 18.43 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.937 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -111.24 -37.54 5.28 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.606 ' CD1' HG23 ' A' ' 97' ' ' THR . 54.7 m-85 71.11 102.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.786 0.679 . . . . 0.0 110.183 -173.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.734 HD13 HG21 ' A' ' 52' ' ' VAL . 2.9 mt -78.67 -19.32 52.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 110.728 -177.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.681 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 23.2 t70 -167.55 75.38 0.14 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.723 170.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 68.18 -22.69 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.133 0.973 . . . . 0.0 112.018 -176.545 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.563 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 18.9 m -117.39 154.29 31.59 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.606 HG23 ' CD1' ' A' ' 92' ' ' TYR . 14.1 p -95.21 -178.73 4.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.173 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.536 HD22 ' CG ' ' A' ' 36' ' ' PHE . 97.7 mt -69.98 88.54 0.58 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.468 HG22 ' HG3' ' A' ' 100' ' ' GLU . 33.2 mm -74.07 -65.04 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.237 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 35' ' ' MET . 46.1 mt-10 -144.32 153.79 56.33 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.202 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.3 151.87 80.09 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.18 1.92 . . . . 0.0 111.358 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -69.36 147.79 97.14 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.362 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 38.9 Cg_exo -61.32 116.92 3.71 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.628 2.219 . . . . 0.0 112.154 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.2 ttm180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.107 178.179 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.638 HD12 HG21 ' A' ' 152' ' ' ILE . 3.2 mm? . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.272 0.558 . . . . 0.0 111.98 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 7.3 tp10 62.45 -87.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.59 176.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -103.22 106.93 17.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.3 1.048 . . . . 0.0 112.253 -175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.581 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 55.9 t -119.6 162.25 18.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.779 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.576 ' HG2' HH11 ' A' ' 129' ' ' ARG . 0.8 OUTLIER -149.82 126.18 10.8 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.072 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.904 HG22 HG12 ' A' ' 178' ' ' VAL . 3.0 p -87.42 140.45 29.52 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -169.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 90.7 mt -110.63 -29.69 7.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.022 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 40.5 t80 -78.64 -30.48 46.42 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -170.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.543 ' HB2' ' HD3' ' A' ' 146' ' ' LYS . 14.1 t70 68.82 103.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.246 0.546 . . . . 0.0 110.185 -174.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 66.9 t80 -140.6 96.88 7.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.819 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 10.3 Cg_endo -92.29 100.79 0.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.048 2.499 . . . . 0.0 113.18 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 137' ' ' ASN . . . -96.41 2.59 63.07 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.855 174.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.61 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 73.81 -7.91 1.5 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.815 0.846 . . . . 0.0 111.552 -178.105 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.917 ' HB2' ' HD3' ' A' ' 143' ' ' PRO . 32.5 t0 62.85 162.88 0.1 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 158.87 -34.44 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 111.625 -2.534 . . . . 0.0 104.382 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.33 31.24 0.06 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.629 -2.078 . . . . 0.0 107.694 166.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 172' ' ' MET . 9.4 p-10 -163.1 85.59 0.52 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.79 -175.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.066 HD11 ' HB2' ' A' ' 165' ' ' ASN . 33.7 tp -64.96 132.85 95.6 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.931 -168.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 1.013 ' HD2' HD12 ' A' ' 142' ' ' LEU . 68.1 Cg_endo -80.6 86.71 1.6 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.487 2.791 . . . . 0.0 111.906 175.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.526 ' CG ' HG21 ' A' ' 130' ' ' THR . 10.0 p90 -97.3 156.78 16.29 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.786 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.729 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 2.8 mptp? -105.89 -171.0 1.82 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.001 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.543 ' HD3' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -88.42 9.03 24.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.542 -177.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.99 27.12 0.63 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.312 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.729 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 5.9 mm-40 -98.5 150.78 21.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.83 0.315 . . . . 0.0 110.231 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.71 134.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.644 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 52.7 mt -119.68 155.8 31.7 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 42.5 t -122.0 126.48 74.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.84 HD13 ' HB2' ' A' ' 163' ' ' ALA . 32.9 mm -74.99 81.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.695 HG23 ' HG2' ' A' ' 154' ' ' GLU . 8.2 tt -69.01 -34.11 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.607 -173.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.695 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -131.49 139.66 49.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.546 ' HD2' HD11 ' A' ' 125' ' ' LEU . 74.3 tttt -119.7 86.0 34.34 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.021 0.438 . . . . 0.0 110.453 172.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 3.1 Cg_exo -77.26 -54.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.674 2.25 . . . . 0.0 111.682 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -109.17 -178.53 3.59 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -109.98 -22.58 11.77 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.115 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.561 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 24.3 pt20 -88.6 -21.72 23.88 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.101 0.476 . . . . 0.0 110.251 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.561 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 48.7 m95 -129.09 123.57 32.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.785 178.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.652 ' O ' HG13 ' A' ' 173' ' ' ILE . 38.2 m0 -112.53 133.58 54.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.319 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 54.0 m -86.26 99.71 11.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.26 0.553 . . . . 0.0 110.311 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.84 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.29 158.62 17.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.716 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 16.0 ptt-85 -104.61 135.42 46.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.039 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.066 ' HB2' HD11 ' A' ' 142' ' ' LEU . 55.5 t30 -73.87 -173.96 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.998 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -68.89 -13.88 62.7 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 170.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -81.99 -13.76 56.96 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.071 170.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.6 1.54 90.19 Favored Glycine 0 C--O 1.229 -0.182 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.502 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.718 ' HG2' ' OD2' ' A' ' 138' ' ' ASP . 38.5 ttm-85 -66.0 132.58 48.91 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.371 0.668 . . . . 0.0 110.069 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.48 HG21 HD13 ' A' ' 153' ' ' ILE . 59.5 t -104.62 106.4 20.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -173.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.627 ' HA3' ' OD1' ' A' ' 138' ' ' ASP . . . -140.98 168.34 25.35 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.266 175.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 26.0 mtp -81.35 136.85 35.76 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -132.68 149.96 74.46 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 2.9 Cg_exo -76.15 132.3 13.8 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.106 2.537 . . . . 0.0 112.577 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.679 ' O ' HG22 ' A' ' 178' ' ' VAL . 41.0 t -61.12 -45.59 95.97 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 30.8 Cg_endo -64.47 -1.09 3.49 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.027 1.818 . . . . 0.0 113.774 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.02 -4.48 29.87 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.744 0.307 . . . . 0.0 111.287 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.904 HG12 HG22 ' A' ' 130' ' ' THR . 6.1 m -120.57 163.46 18.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -167.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 160.73 21.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.521 172.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp . . . . . 0 C--N 1.321 -0.66 0 CA-C-O 120.679 0.276 . . . . 0.0 110.582 -173.302 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.532 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 35.3 t . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.86 115.26 27.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.165 0.507 . . . . 0.0 111.162 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.627 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.89 129.69 54.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.058 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -89.06 119.3 29.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.039 0.447 . . . . 0.0 110.498 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.917 ' HB1' ' HG2' ' A' ' 259' ' ' GLU . . . -78.42 119.56 21.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.675 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.635 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -109.5 -26.61 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -170.028 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.685 ' HG2' ' HG2' ' A' ' 245' ' ' LYS . 13.9 tt0 -93.92 -98.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.278 0.49 . . . . 0.0 111.339 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.685 ' HG2' ' HG2' ' A' ' 244' ' ' GLN . 24.4 pttm -175.45 107.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -177.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.567 ' H ' ' HB2' ' A' ' 259' ' ' GLU . 15.3 tpt180 -110.55 101.81 10.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.882 0.372 . . . . 0.0 111.491 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.879 173.634 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 121.125 0.488 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -88.46 127.94 35.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.038 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -81.01 120.8 25.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.899 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.35 117.24 5.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.113 0.482 . . . . 0.0 110.45 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.438 ' H ' ' HB3' ' A' ' 246' ' ' ARG . 86.5 mt -143.46 -169.67 3.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.714 0.768 . . . . 0.0 111.333 -172.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.917 ' HG2' ' HB1' ' A' ' 242' ' ' ALA . 26.4 mt-10 79.62 -179.36 0.09 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 113.683 -1.599 . . . . 0.0 114.265 164.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 t 67.12 32.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.91 -172.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.05 38.89 2.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.126 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.72 137.6 44.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.298 . . . . 0.0 110.94 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.2 mm -89.64 106.95 17.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.143 0.497 . . . . 0.0 109.93 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.425 HG22 HD22 ' A' ' 258' ' ' LEU . 40.0 t -88.47 118.29 33.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.699 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -90.06 97.44 11.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.516 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 7.5 p -91.66 129.19 42.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 110.5 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.1 p -106.11 -38.17 6.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.536 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.587 ' NE ' ' HA ' ' A' ' 268' ' ' ARG . 2.2 mmp_? -124.46 114.09 19.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 111.084 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 50.1 mtt -95.41 113.88 25.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.196 0.522 . . . . 0.0 110.312 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -85.21 164.25 18.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.431 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.4 pt -88.72 7.37 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.185 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -88.25 -4.72 58.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.533 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 94.64 -47.02 2.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.554 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.513 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 43.3 mt-30 -81.05 124.93 29.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.247 0.546 . . . . 0.0 110.207 173.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -94.18 158.49 15.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.349 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 268' ' ' ARG . 9.4 pt-20 -115.27 125.34 53.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.59 0.709 . . . . 0.0 110.486 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -134.1 170.6 22.48 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.925 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.3 108.49 11.76 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.462 HG12 ' ND2' ' A' ' 280' ' ' ASN . 26.9 t -126.41 138.38 54.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.122 -175.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.462 ' ND2' HG12 ' A' ' 279' ' ' VAL . 52.8 m-80 71.82 -55.37 0.66 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.829 0.851 . . . . 0.0 110.669 -177.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 164.75 30.69 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -141.86 147.65 37.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -105.24 126.91 52.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.35 167.65 32.98 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.731 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 87.1 mt -95.38 142.04 28.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.687 0.279 . . . . 0.0 110.722 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 53.8 p90 -138.3 136.87 19.7 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.973 176.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 12.1 Cg_exo -71.9 141.7 37.5 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.737 2.292 . . . . 0.0 111.941 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -61.67 -15.82 43.39 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.284 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.2 t -86.22 -3.33 58.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 111.563 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -104.44 -11.15 17.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.774 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.488 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 26.9 m -128.04 158.44 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.956 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -121.09 120.15 34.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.607 178.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.627 HD13 ' HB2' ' A' ' 240' ' ' ALA . 47.3 mm -76.91 111.86 14.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.587 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -121.11 163.88 17.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.491 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 11.6 t0 . . . . . 0 C--N 1.325 -0.48 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.286 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.888 0.375 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.475 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 22.5 mmt180 -105.9 6.81 31.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.528 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.772 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 51.9 p90 -79.35 148.59 31.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 175.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -88.79 101.75 14.33 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.567 0.699 . . . . 0.0 110.635 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 50.6 m -63.82 169.9 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.567 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 8' ' ' SER . 43.0 t 76.73 -50.84 0.57 Allowed 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.593 0.558 . . . . 0.0 111.397 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.79 101.45 1.71 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.467 0.651 . . . . 0.0 110.342 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 75.6 mtt-85 -72.45 -17.28 61.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.568 -171.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -76.36 0.52 19.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.799 0.333 . . . . 0.0 110.836 173.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.58 -46.45 5.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.4 p-90 -115.39 -20.94 10.07 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -171.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 84.1 t80 -86.4 128.94 35.0 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.023 -0.423 . . . . 0.0 110.61 -176.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.541 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 20.1 mmt -109.43 -9.3 14.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 110.909 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.48 -116.6 4.87 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.629 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.86 105.44 0.55 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.558 2.172 . . . . 0.0 112.508 -175.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.696 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 79.2 t -139.02 -77.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.606 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.66 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 17.2 t 86.2 170.34 0.06 Allowed 'General case' 0 C--N 1.347 0.469 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -59.63 -39.4 84.19 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.512 -171.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.36 -38.62 91.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.559 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.618 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -85.72 -47.31 9.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.175 0.512 . . . . 0.0 110.775 -177.331 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.92 -40.56 76.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.656 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 52.0 tp60 -70.27 -39.61 74.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.0 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -78.87 -15.13 58.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.641 0.258 . . . . 0.0 111.43 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 90.8 mtt180 -83.57 -50.8 7.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.674 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.51 ' HA ' ' CG ' ' A' ' 31' ' ' GLN . 39.9 mt -94.22 13.36 23.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.052 -173.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 36.6 tt0 -71.08 87.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.103 0.478 . . . . 0.0 110.615 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.33 36.43 8.16 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.334 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.51 ' CG ' ' HA ' ' A' ' 28' ' ' LEU . 71.4 mm-40 -91.4 170.66 9.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 111.59 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -52.81 139.14 27.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.722 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.475 ' HB3' HG21 ' A' ' 96' ' ' THR . 39.1 m170 -70.03 116.41 10.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.949 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.45 -11.99 7.52 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.256 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 57.6 mtt -74.17 149.18 41.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.853 0.327 . . . . 0.0 110.562 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.611 ' HB2' HG22 ' A' ' 52' ' ' VAL . 23.2 p90 -157.16 166.48 33.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.319 177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.541 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -158.04 138.91 13.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.73 175.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.96 125.96 57.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.696 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 12.8 ptt-85 -123.12 162.16 23.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.77 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.29 127.58 32.88 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 172.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.659 ' HB2' HG23 ' A' ' 49' ' ' VAL . 18.8 t -101.34 154.27 18.94 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.188 0.518 . . . . 0.0 110.779 -174.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 p -91.69 -5.36 53.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.807 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -44.77 94.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.595 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.784 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 69.4 m -152.05 150.67 26.31 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.806 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.36 109.13 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.525 2.15 . . . . 0.0 111.658 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.96 0.26 55.02 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.455 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.784 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 13.4 t70 -85.92 151.38 23.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.813 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 35.0 m-85 -132.6 171.59 13.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.635 0.255 . . . . 0.0 110.964 -176.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 41' ' ' SER . 78.1 t -145.24 112.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.107 0.48 . . . . 0.0 110.515 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.417 ' HB2' HD11 ' A' ' 63' ' ' ILE . 42.6 tp -83.42 102.26 11.93 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.044 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 59' ' ' SER . 69.5 m -96.95 125.77 41.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.078 0.466 . . . . 0.0 110.391 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.611 HG22 ' HB2' ' A' ' 36' ' ' PHE . 70.2 t -125.25 138.59 53.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.675 -172.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 28' ' ' LEU . 33.3 t -102.89 98.51 8.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.207 0.527 . . . . 0.0 110.947 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.726 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 35.5 mt-10 -138.32 148.48 44.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.532 ' HB2' ' CG ' ' A' ' 94' ' ' ASP . 1.8 t-20 63.94 11.16 5.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.666 0.387 . . . . 0.0 111.111 -176.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.2 m 70.2 26.41 4.4 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.523 0.678 . . . . 0.0 110.367 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.846 ' NH2' ' HA ' ' A' ' 154' ' ' GLU . 43.8 ptt85 -124.34 151.58 44.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.9 t -93.37 97.49 7.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.037 0.446 . . . . 0.0 110.102 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 51' ' ' SER . 19.3 m -73.18 118.13 15.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.317 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -101.19 115.02 29.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.406 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.756 ' CE2' HD22 ' A' ' 93' ' ' LEU . 52.5 m-85 -121.93 108.01 12.93 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.433 HG12 HG22 ' A' ' 49' ' ' VAL . 58.8 mt -70.21 132.0 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.813 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.2 mp -104.72 123.86 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.352 1.061 . . . . 0.0 109.848 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -106.59 142.59 36.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -78.72 108.95 12.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.153 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 96.3 mt -85.82 170.91 11.63 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 26.2 Cg_exo -63.76 62.34 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.972 2.448 . . . . 0.0 114.263 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 13.2 m120 93.13 -43.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.986 0.914 . . . . 0.0 112.718 161.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.644 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.53 -29.4 33.56 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -169.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 1.052 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 81.6 mtt180 -148.07 177.65 9.2 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -169.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -129.7 120.69 25.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.522 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HB2' HD11 ' A' ' 66' ' ' LEU . 24.9 ttpp -98.31 112.59 24.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 61' ' ' TYR . 19.6 tt -77.48 78.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 122.158 0.98 . . . . 0.0 109.723 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.95 -55.8 4.54 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.085 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -146.8 -48.02 0.19 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.91 0.385 . . . . 0.0 110.581 -170.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -77.22 129.15 35.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.008 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.491 ' HG2' ' HD3' ' A' ' 70' ' ' ARG . 38.1 tt0 -99.45 130.15 45.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.026 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -128.53 160.79 31.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 1.052 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 36.5 m-20 -64.78 -45.47 86.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.455 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 6.0 p80 -153.27 177.12 11.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.504 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.645 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.2 mt -57.79 -57.87 22.5 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.645 ' HA ' HD12 ' A' ' 85' ' ' LEU . 30.5 Cg_exo -63.88 -6.71 11.51 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.012 1.808 . . . . 0.0 112.82 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.455 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -89.12 -31.73 17.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.645 0.26 . . . . 0.0 110.797 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.61 -30.32 56.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 82' ' ' PRO . 48.8 mt -68.04 -28.79 67.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.03 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.16 -23.94 63.07 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.049 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -86.67 -38.64 16.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.318 0.58 . . . . 0.0 110.435 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.502 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 45.1 m-85 -75.95 -7.75 55.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.878 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.466 ' HB3' ' HE2' ' A' ' 89' ' ' LYS . 30.7 ttpt -63.96 -33.1 74.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.573 173.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mt -110.32 -17.74 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.994 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 19.6 t-160 -69.79 -35.95 75.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.512 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.849 ' HA ' HG22 ' A' ' 97' ' ' THR . 97.2 m-85 71.61 101.61 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 124.083 0.865 . . . . 0.0 109.752 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.756 HD22 ' CE2' ' A' ' 61' ' ' TYR . 13.0 mt -70.83 -13.96 62.23 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.311 0.577 . . . . 0.0 109.649 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.726 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 21.5 t70 -152.56 -64.01 0.16 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.873 169.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.588 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 11.9 t -165.9 3.43 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 33' ' ' HIS . 13.0 t -133.38 -13.57 2.66 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.567 -0.708 . . . . 0.0 112.162 176.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.849 HG22 ' HA ' ' A' ' 92' ' ' TYR . 16.7 p 71.13 -179.49 0.23 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.379 1.072 . . . . 0.0 112.131 178.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.42 HD22 ' CD2' ' A' ' 36' ' ' PHE . 65.8 mt -71.34 109.26 5.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.267 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.3 mm -101.19 -52.39 8.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.059 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.772 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 17.1 pt-20 -154.84 164.16 21.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.619 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.591 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 98.4 Cg_endo -82.81 151.13 14.48 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.919 1.746 . . . . 0.0 112.119 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.425 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -75.15 153.16 86.35 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.91 175.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.63 120.36 7.72 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.5 2.133 . . . . 0.0 111.349 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 110.989 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.946 HD12 HG21 ' A' ' 152' ' ' ILE . 4.3 mm? . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 30.1 tt0 -165.65 -66.72 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -110.94 118.04 35.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.616 0.722 . . . . 0.0 112.006 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.487 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 55.5 t -130.92 159.57 42.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.701 -175.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 129' ' ' ARG . 19.6 mtt180 -131.6 145.29 51.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.866 HG22 HG12 ' A' ' 178' ' ' VAL . 12.3 p -102.51 136.4 42.4 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.724 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 179' ' ' GLU . 5.3 mt -107.68 -27.67 10.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.901 -174.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.479 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 44.6 t80 -86.4 -37.27 18.55 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -170.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.527 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 14.4 t70 70.8 108.04 0.06 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.529 0.681 . . . . 0.0 109.844 -170.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 70.3 t80 -147.06 113.19 4.17 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.401 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.734 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 30.2 Cg_endo -92.16 100.41 0.19 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.711 2.274 . . . . 0.0 112.422 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -85.31 14.4 50.47 Favored Glycine 0 CA--C 1.516 0.095 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.174 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.2 m120 50.23 24.16 1.39 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.116 0.566 . . . . 0.0 112.447 -172.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.563 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 2.3 p30 46.86 -170.07 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.909 1.284 . . . . 0.0 114.157 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 75.76 -26.72 0.19 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.856 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.5 pt-20 -142.1 -30.56 0.57 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.07 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.488 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 5.6 m-20 -141.36 117.65 10.73 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.837 HD11 ' HB3' ' A' ' 165' ' ' ASN . 36.3 tp -67.81 136.25 92.38 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-O 120.718 0.294 . . . . 0.0 111.487 -173.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.734 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 1.0 OUTLIER -84.94 102.46 0.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.835 2.357 . . . . 0.0 110.661 172.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.673 ' CG ' HG21 ' A' ' 130' ' ' THR . 6.6 p90 -111.76 158.91 18.79 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.186 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.527 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -99.23 -179.43 4.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.756 -172.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -4.71 39.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -171.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.93 42.71 0.2 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.643 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -98.83 165.74 11.63 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.408 HD12 ' HE ' ' A' ' 129' ' ' ARG . 34.9 mm -99.9 138.38 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.521 HD22 ' HA ' ' A' ' 165' ' ' ASN . 29.4 mt -120.26 155.62 32.86 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 25.9 t -118.81 125.15 74.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.946 HG21 HD12 ' A' ' 125' ' ' LEU . 41.7 mm -75.13 95.84 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.265 1.031 . . . . 0.0 108.62 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.849 HG23 ' HG3' ' A' ' 154' ' ' GLU . 19.8 tt -89.71 -27.21 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.003 -171.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.919 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 27.0 mt-10 -142.75 144.47 32.65 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.945 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 7.1 ttpm? -135.62 81.01 42.83 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 121.424 -0.798 . . . . 0.0 111.26 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.588 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 19.9 Cg_exo -68.23 -46.07 2.4 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.787 2.325 . . . . 0.0 112.298 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -117.99 -175.22 2.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.541 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.56 -28.53 9.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.041 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.515 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 4.2 pt20 -93.84 -13.2 27.53 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.197 0.522 . . . . 0.0 110.515 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.76 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 51.6 m95 -129.28 127.81 41.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.733 175.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.687 ' O ' HG13 ' A' ' 173' ' ' ILE . 48.9 m0 -118.16 140.62 49.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.43 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.919 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 7.6 t -96.15 99.38 11.12 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.77 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -114.05 156.33 24.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.869 0.366 . . . . 0.0 111.464 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.486 ' HD3' HD12 ' A' ' 153' ' ' ILE . 26.7 ptt-85 -100.41 131.56 46.26 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.837 ' HB3' HD11 ' A' ' 142' ' ' LEU . 0.1 OUTLIER -79.58 171.38 15.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.871 -179.017 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -72.37 -12.21 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.161 0.505 . . . . 0.0 110.314 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -80.13 -19.34 47.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.931 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.419 ' H ' ' ND2' ' A' ' 165' ' ' ASN . . . 117.14 7.2 12.83 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 116.696 1.438 . . . . 0.0 116.696 169.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.645 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -123.52 155.79 36.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.511 1.655 . . . . 0.0 111.903 -177.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.92 143.8 11.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.106 -175.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -166.23 161.43 35.07 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.76 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.2 OUTLIER -74.23 137.95 43.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.845 0.355 . . . . 0.0 110.968 179.263 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -135.24 143.73 46.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.371 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 3.9 Cg_exo -77.01 134.04 14.21 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.7 2.267 . . . . 0.0 112.096 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.564 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 17.8 t -62.85 -43.45 82.84 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.078 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 34.5 Cg_endo -65.9 7.44 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 122.283 1.989 . . . . 0.0 113.651 175.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.0 m-85 -109.09 -6.56 15.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.697 0.284 . . . . 0.0 111.097 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.866 HG12 HG22 ' A' ' 130' ' ' THR . 26.3 m -127.62 166.46 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -168.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.681 ' HB2' HD21 ' A' ' 131' ' ' LEU . 4.1 mm-40 -125.41 163.75 21.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.577 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.62 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.05 125.71 53.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.139 0.495 . . . . 0.0 110.804 -174.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.748 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -127.59 131.78 49.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.883 176.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -86.99 125.43 34.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.574 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -78.2 104.1 8.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.228 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.606 HG13 ' HG3' ' A' ' 244' ' ' GLN . 29.1 pt -83.14 -11.89 12.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.072 0.463 . . . . 0.0 111.229 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.606 ' HG3' HG13 ' A' ' 243' ' ' ILE . 24.7 mt-30 -124.68 165.27 18.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.463 ' HB3' HG13 ' A' ' 260' ' ' VAL . 24.4 pttm -128.72 144.4 51.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.129 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.86 150.51 4.69 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.744 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 CA--C 1.535 0.383 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.822 -172.122 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 122.819 1.295 . . . . 0.0 107.943 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 285' ' ' LEU . . . -8.62 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 111.311 -2.677 . . . . 0.0 113.262 152.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.58 ' O ' ' HG ' ' A' ' 258' ' ' LEU . 1.7 tt -75.12 118.79 18.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.53 ' H ' ' NH1' ' A' ' 282' ' ' ARG . . . -55.97 121.42 9.28 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 123.477 0.485 . . . . 0.0 110.527 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 256' ' ' LEU . 96.2 mt -136.18 136.54 40.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.785 -175.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -98.89 -176.68 3.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.316 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' A' ' 245' ' ' LYS . 17.5 m -86.79 132.64 31.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.956 0.408 . . . . 0.0 110.683 176.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 86.06 0.7 87.06 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.518 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.55 152.99 25.75 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.738 0.304 . . . . 0.0 110.724 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.7 mm -97.79 114.7 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.461 HG22 HD22 ' A' ' 258' ' ' LEU . 21.2 t -97.15 107.63 20.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.626 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -93.56 114.53 26.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 11.6 p -88.37 143.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.969 0.414 . . . . 0.0 110.677 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 30.0 m -98.74 -49.02 4.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.89 0.376 . . . . 0.0 110.266 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.515 ' HG3' ' HB3' ' A' ' 276' ' ' GLU . 3.3 ptp180 -132.45 118.84 19.83 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.096 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 47.1 mtt -89.62 110.8 21.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.128 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -131.62 139.7 49.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.415 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 52.3 mt 56.81 84.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.84 168.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 60.37 -29.14 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 166.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.626 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 165.24 -7.55 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.624 -1.274 . . . . 0.0 114.038 -177.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -85.78 77.05 9.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.558 0.679 . . . . 0.0 109.634 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.458 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 23.3 m0 -93.25 158.77 15.58 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.273 -170.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.515 ' HB3' ' HG3' ' A' ' 268' ' ' ARG . 40.9 tt0 -113.87 116.09 28.75 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.45 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.05 170.96 16.29 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.491 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.02 109.17 13.19 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.48 -86.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.531 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.12 66.98 8.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.188 0.518 . . . . 0.0 111.771 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 72.8 -2.49 32.51 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.456 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.53 ' NH1' ' H ' ' A' ' 257' ' ' ALA . 2.5 ptm180 -142.44 153.71 43.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.874 0.368 . . . . 0.0 110.983 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 20.3 pttp -104.48 142.01 35.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.766 173.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -160.19 -178.9 34.6 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.56 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.661 ' O ' ' HA ' ' A' ' 255' ' ' ALA . 91.3 mt -95.98 140.31 30.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.615 0.245 . . . . 0.0 110.961 -177.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 40.1 p90 -140.38 140.33 22.74 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 4.1 Cg_exo -79.85 142.79 16.02 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.702 2.268 . . . . 0.0 111.505 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.626 ' CD1' ' HA3' ' A' ' 273' ' ' GLY . 21.1 p90 -65.97 -15.43 62.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.9 m -77.54 -16.15 58.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.391 0.615 . . . . 0.0 110.541 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -86.81 -24.09 25.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.379 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 242' ' ' ALA . 30.4 m -127.7 178.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.663 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -140.56 119.42 12.58 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.748 HD13 ' HB2' ' A' ' 240' ' ' ALA . 39.3 mm -60.43 122.36 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.812 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -145.83 179.71 7.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.843 -173.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.35 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.646 ' HB3' ' HE3' ' A' ' 89' ' ' LYS . . . . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.772 0.32 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -123.66 94.7 4.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.998 -177.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -156.56 154.08 29.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.235 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -75.44 91.88 2.8 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.987 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 14.4 t -74.86 68.71 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.204 0.526 . . . . 0.0 110.068 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 t -179.62 -44.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.445 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -59.34 105.64 0.37 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.007 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 7.6 tpp180 -60.29 -32.35 71.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.549 -174.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.4 m -82.57 -1.36 50.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.644 0.259 . . . . 0.0 111.57 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.49 -45.61 8.05 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.326 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -117.94 -29.4 5.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.458 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 65.0 t80 -79.62 113.04 17.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.133 0.492 . . . . 0.0 110.696 -176.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.514 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 23.1 mmt -94.66 -2.86 50.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.051 -175.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.07 -114.21 3.09 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.663 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.63 96.75 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.015 2.477 . . . . 0.0 113.042 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.921 HG12 ' H ' ' A' ' 20' ' ' SER . 7.4 t -142.62 -161.15 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.921 ' H ' HG12 ' A' ' 19' ' ' VAL . 23.2 t 178.32 177.46 0.43 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -170.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.0 mtp85 -54.58 -61.6 2.2 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.75 -44.54 95.93 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.279 0.362 . . . . 0.0 111.336 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.465 ' HA ' HG22 ' A' ' 26' ' ' THR . 40.3 mt-10 -62.17 -47.51 84.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.345 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.85 -34.45 69.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 0.0 111.281 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.679 ' HG3' HG21 ' A' ' 58' ' ' VAL . 5.4 tt0 -81.88 -34.66 29.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.051 -175.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 23' ' ' GLU . 11.3 t -82.46 -14.7 54.63 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -104.39 -18.6 14.36 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.773 0.797 . . . . 0.0 110.878 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.788 HD13 ' HB2' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -132.54 33.01 3.83 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 123.647 1.689 . . . . 0.0 108.095 -174.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -58.18 177.52 0.12 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.229 173.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.454 ' HA2' ' OG ' ' A' ' 53' ' ' SER . . . -73.58 53.02 1.96 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.813 -176.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -78.31 -38.17 42.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.415 0.626 . . . . 0.0 109.893 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 22.7 ttp180 -144.67 128.46 17.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.57 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 63.9 m170 -83.84 132.54 34.8 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.903 0.382 . . . . 0.0 110.607 -176.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.34 10.93 22.9 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.695 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.681 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.0 mtm -97.96 147.36 24.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.45 ' CD2' HD22 ' A' ' 98' ' ' LEU . 41.7 p90 -143.53 163.04 34.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.025 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.575 HD23 ' CB ' ' A' ' 28' ' ' LEU . 4.1 pp -150.36 134.3 16.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.968 0.413 . . . . 0.0 110.175 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.6 t -102.27 123.33 55.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.879 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 22.6 ptt-85 -126.57 153.42 45.27 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.571 -172.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 38.2 t70 -75.89 107.95 8.43 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 170.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.519 ' HB2' HG23 ' A' ' 49' ' ' VAL . 13.3 t -79.42 178.22 8.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.679 -168.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.8 m -125.12 17.55 8.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.951 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.46 -47.94 14.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.25 0.547 . . . . 0.0 109.584 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.3 m -144.18 152.93 55.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.296 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.69 87.19 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.139 1.893 . . . . 0.0 111.674 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.52 15.57 2.97 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.967 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.98 155.09 19.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.289 0.544 . . . . 0.0 109.802 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.419 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 44.8 m-85 -127.2 159.91 32.86 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 62' ' ' ILE . 40.6 t -135.03 108.69 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.117 175.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.63 103.15 7.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.478 173.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 59' ' ' SER . 70.9 m -95.67 135.37 37.45 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.136 177.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 93' ' ' LEU . 92.8 t -127.73 134.38 65.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.579 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.454 ' OG ' ' HA2' ' A' ' 30' ' ' GLY . 29.2 t -100.28 112.42 24.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.744 0.307 . . . . 0.0 111.327 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.57 ' OE1' ' HB3' ' A' ' 33' ' ' HIS . 10.6 tp10 -157.34 140.76 15.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.176 175.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.465 ' ND2' ' HZ1' ' A' ' 155' ' ' LYS . 30.2 m-80 48.3 39.38 12.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.469 0.707 . . . . 0.0 112.899 -176.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.9 m 66.98 18.44 10.58 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.1 173.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 57' ' ' ARG . 14.6 ptt180 -124.51 133.19 53.4 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.679 HG21 ' HG3' ' A' ' 25' ' ' GLN . 46.0 t -93.69 97.23 6.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.747 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 25.3 m -68.99 117.66 10.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.328 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -101.26 92.56 5.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.95 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.695 ' CE2' HD22 ' A' ' 93' ' ' LEU . 37.4 m-85 -97.15 114.85 26.59 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.951 0.157 . . . . 0.0 111.056 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.779 HG12 HG22 ' A' ' 49' ' ' VAL . 28.8 mt -81.99 135.98 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -175.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.764 HG13 ' HB ' ' A' ' 73' ' ' ILE . 5.3 mp -117.38 123.81 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.292 1.037 . . . . 0.0 109.692 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -106.25 135.49 47.63 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.06 -0.4 . . . . 0.0 110.263 -173.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.0 t -80.29 108.63 14.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.006 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.6 mt -80.62 142.91 53.9 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.22 -17.97 49.27 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.728 2.286 . . . . 0.0 112.014 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.52 10.36 7.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.06 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 67.96 29.55 6.45 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.609 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -116.95 159.68 22.08 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.409 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 46.7 m-85 -118.84 115.55 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.188 0.518 . . . . 0.0 111.612 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 21.5 ttmm -104.15 109.02 20.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.027 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.764 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.6 tt -96.47 87.52 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.75 0.786 . . . . 0.0 110.557 177.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.98 75.74 0.43 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.901 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 t0 76.25 -52.69 0.61 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.111 0.564 . . . . 0.0 111.507 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -70.56 111.8 6.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.45 0.643 . . . . 0.0 110.41 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 8.6 pt-20 -95.68 128.91 42.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.938 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.547 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 89.3 m-85 -119.19 175.08 5.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.683 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.28 -51.05 63.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.18 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -156.2 -177.57 6.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.486 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.6 mt -56.62 -54.56 52.4 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.546 ' HA ' HD12 ' A' ' 85' ' ' LEU . 52.9 Cg_exo -58.77 -10.38 9.4 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.132 1.888 . . . . 0.0 113.614 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.21 -34.93 16.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.677 0.275 . . . . 0.0 110.919 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.8 pp -76.24 -27.03 56.61 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 82' ' ' PRO . 61.3 mt -67.89 -24.23 65.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.821 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 48.8 mt-10 -91.02 -9.41 46.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.762 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.682 ' HE1' ' CZ ' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -97.8 -29.66 13.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 176.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.682 ' CZ ' ' HE1' ' A' ' 87' ' ' PHE . 26.7 m-85 -78.03 -13.28 59.93 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.787 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.646 ' HE3' ' HB3' ' A' ' 4' ' ' ALA . 21.7 ptmt -74.01 -16.68 61.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.588 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.503 ' H ' HD13 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -116.77 25.35 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.937 169.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -114.06 -41.62 3.5 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.248 -0.282 . . . . 0.0 111.662 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.599 ' CD1' HG23 ' A' ' 97' ' ' THR . 93.4 m-85 73.16 96.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.96 0.788 . . . . 0.0 110.624 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.695 HD22 ' CE2' ' A' ' 61' ' ' TYR . 2.2 mt -74.57 -13.89 60.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.062 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 95' ' ' THR . 20.0 t70 -172.45 63.02 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.609 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER 74.05 -25.15 0.2 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.114 -175.198 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 94' ' ' ASP . 41.7 m -114.52 146.18 41.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.599 HG23 ' CD1' ' A' ' 92' ' ' TYR . 16.7 p -90.97 -176.03 4.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.408 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.45 HD22 ' CD2' ' A' ' 36' ' ' PHE . 82.2 mt -69.61 96.39 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 38.5 mm -84.39 -55.08 7.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.031 0.443 . . . . 0.0 110.525 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.681 ' O ' ' HA ' ' A' ' 35' ' ' MET . 45.6 tt0 -162.32 141.75 7.24 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.454 -177.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.415 ' HD2' ' HG3' ' A' ' 100' ' ' GLU . 12.1 Cg_endo -56.66 153.23 37.17 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.738 2.292 . . . . 0.0 112.914 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.788 ' HB2' HD13 ' A' ' 28' ' ' LEU . . . -73.58 153.84 89.64 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.598 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.24 115.22 2.42 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.448 2.098 . . . . 0.0 112.22 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.206 177.646 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.803 HD12 HG21 ' A' ' 152' ' ' ILE . 3.4 mm? . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 12.7 pt-20 -170.09 -59.14 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.073 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.482 ' H ' ' HG3' ' A' ' 126' ' ' GLU . 15.1 m-85 -102.01 108.76 20.29 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.704 0.764 . . . . 0.0 111.666 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 65.0 t -130.18 154.98 41.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.057 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -135.74 137.6 41.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.848 0.356 . . . . 0.0 110.108 175.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.956 HG22 HG12 ' A' ' 178' ' ' VAL . 31.4 p -90.28 137.32 32.45 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.236 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.9 mt -113.19 -24.59 9.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.519 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 44.4 t80 -89.3 -34.77 16.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 27.1 t70 76.62 122.35 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.89 0.744 . . . . 0.0 111.171 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 80.9 t80 -156.98 107.59 1.93 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.781 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 57.5 Cg_endo -87.52 97.55 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.594 2.196 . . . . 0.0 112.651 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.581 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -87.57 -6.51 77.03 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.077 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.84 22.76 12.8 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.998 0.519 . . . . 0.0 111.932 -175.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.674 ' CB ' ' HD3' ' A' ' 169' ' ' ARG . 2.4 p30 54.94 -173.37 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 168.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 77.48 -34.93 0.21 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 113.341 -1.754 . . . . 0.0 109.785 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 172' ' ' MET . 33.9 tt0 -133.69 -29.47 1.33 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.139 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.581 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 22.4 m-20 -138.26 111.39 7.89 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.049 HD11 ' HB2' ' A' ' 165' ' ' ASN . 25.9 tp -66.22 119.6 63.26 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 120.562 0.22 . . . . 0.0 110.612 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.561 ' HD2' ' HD2' ' A' ' 169' ' ' ARG . 29.2 Cg_endo -71.98 105.03 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.895 1.73 . . . . 0.0 111.335 174.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.629 ' CG ' HG21 ' A' ' 130' ' ' THR . 7.8 p90 -115.23 163.85 15.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 -177.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -97.2 -170.51 2.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.14 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.72 11.18 29.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.193 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.71 39.84 0.2 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.476 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -105.23 155.11 19.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.747 0.273 . . . . 0.0 110.453 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.39 137.43 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 165' ' ' ASN . 43.4 mt -125.42 160.71 28.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 22.0 t -122.83 131.67 72.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.803 HG21 HD12 ' A' ' 125' ' ' LEU . 32.7 mm -74.02 91.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.984 0.897 . . . . 0.0 109.433 -175.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.778 HG23 ' HG2' ' A' ' 154' ' ' GLU . 0.6 OUTLIER -74.61 -45.39 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.891 -176.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.778 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -129.81 139.94 51.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 174.11 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.712 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 0.7 OUTLIER -126.86 86.81 57.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.989 174.766 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.609 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 7.3 Cg_exo -77.4 -61.61 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.063 2.509 . . . . 0.0 113.64 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -97.05 -175.36 3.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 0.0 111.867 -169.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -90.32 -52.53 4.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.67 -178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.1 0.18 51.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.966 0.412 . . . . 0.0 110.915 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.664 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 57.0 m95 -129.53 124.71 34.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.159 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.687 ' O ' HG13 ' A' ' 173' ' ' ILE . 51.5 m0 -121.91 145.47 48.06 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.5 m -100.24 99.72 10.44 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.144 0.497 . . . . 0.0 109.742 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.618 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -105.45 160.9 14.79 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.131 -176.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.751 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 22.3 ptt-85 -101.32 128.95 47.25 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.501 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.049 ' HB2' HD11 ' A' ' 142' ' ' LEU . 66.7 t30 -65.52 164.14 14.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.097 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 15.3 tptp -67.86 -11.47 58.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.454 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.99 -4.53 46.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.939 0.4 . . . . 0.0 110.448 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.28 75.28 1.28 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.393 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.751 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 5.4 ttm-85 -155.36 135.07 12.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.359 0.123 . . . . 0.0 111.117 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.55 HG22 HG21 ' A' ' 153' ' ' ILE . 66.5 t -103.3 117.82 49.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.792 0.33 . . . . 0.0 111.361 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.44 166.92 30.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.866 173.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.664 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -79.72 138.35 37.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.702 0.287 . . . . 0.0 110.829 179.498 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -137.71 145.44 48.7 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.461 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 6.3 Cg_exo -80.28 136.81 11.56 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.95 2.433 . . . . 0.0 112.873 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.54 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 98.8 t -64.08 -42.62 70.22 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.436 177.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 37.4 Cg_endo -67.49 10.75 0.25 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.015 1.81 . . . . 0.0 113.06 175.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' A' ' 175' ' ' VAL . 3.3 m-85 -113.65 -5.93 13.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.716 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.956 HG12 HG22 ' A' ' 130' ' ' THR . 20.2 m -132.18 163.84 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.425 0.631 . . . . 0.0 112.614 -167.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -128.47 161.35 29.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.815 172.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 180' ' ' LYS . 3.2 mppt? . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.266 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.411 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 21.6 t . . . . . 0 CA--C 1.512 -0.511 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.739 ' HE1' HG23 ' A' ' 263' ' ' ILE . 0.1 OUTLIER -118.29 123.04 44.41 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.087 -171.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.585 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -124.62 158.69 32.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.098 0.475 . . . . 0.0 112.082 -170.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.735 ' HE3' ' HA2' ' A' ' 261' ' ' GLY . 54.4 tttp -102.23 130.85 49.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.498 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -75.44 104.68 6.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.551 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.864 HD12 ' HG3' ' A' ' 244' ' ' GLN . 2.7 pp -82.45 -15.44 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.226 0.536 . . . . 0.0 110.833 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.864 ' HG3' HD12 ' A' ' 243' ' ' ILE . 23.5 mt-30 -123.98 -172.05 2.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.229 172.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -124.5 169.42 11.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.521 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 57.6 mtp85 -148.78 125.85 11.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.342 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.487 173.432 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -81.2 128.4 33.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.654 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.58 127.28 31.96 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 172.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -83.33 117.84 23.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.083 0.468 . . . . 0.0 109.96 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.594 HD21 HG21 ' A' ' 279' ' ' VAL . 58.2 mt -131.81 160.18 36.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.915 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 262' ' ' ASP . 48.6 mt-10 -132.8 167.88 19.38 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.01 131.11 31.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.331 0.586 . . . . 0.0 111.291 -175.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.735 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 92.17 3.88 67.17 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.205 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 0.7 OUTLIER -85.38 160.01 19.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.943 0.401 . . . . 0.0 110.722 -175.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.739 HG23 ' HE1' ' A' ' 239' ' ' PHE . 18.5 mm -95.61 123.36 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.494 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.51 96.72 4.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.131 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -79.71 87.28 5.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 275' ' ' TRP . 2.4 p -87.01 118.12 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.871 0.843 . . . . 0.0 111.133 -175.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.5 m -103.09 -18.44 14.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.761 -171.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.779 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 36.2 ttm-85 -129.97 103.52 6.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.772 0.32 . . . . 0.0 110.915 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . 0.411 ' HE3' ' HB ' ' A' ' 238' ' ' VAL . 58.5 mtt -102.98 118.68 37.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.875 0.369 . . . . 0.0 110.412 178.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -86.51 1.57 51.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 75.1 mt 74.51 -39.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.398 0.679 . . . . 0.0 112.581 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -63.16 -16.3 59.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 129.96 -27.4 4.08 Favored Glycine 0 CA--C 1.506 -0.501 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.647 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -85.02 113.45 21.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.04 0.447 . . . . 0.0 109.959 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.571 ' HB3' HG21 ' A' ' 266' ' ' VAL . 51.2 m0 -109.42 145.07 36.76 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.084 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.779 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 41.9 tt0 -100.97 114.92 29.26 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.96 149.58 18.16 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.297 -176.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -121.52 108.99 14.27 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.594 HG21 HD21 ' A' ' 258' ' ' LEU . 42.1 t -115.82 -98.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.245 -175.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -99.81 82.89 2.66 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.655 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.7 5.81 32.9 Favored Glycine 0 CA--C 1.517 0.167 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.202 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.404 ' NH1' ' H ' ' A' ' 257' ' ' ALA . 56.4 mtp180 -128.06 129.08 46.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.852 0.358 . . . . 0.0 110.977 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 28.6 ttpp -115.32 111.2 20.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.223 174.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -143.48 -174.66 15.93 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.052 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.14 144.59 27.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.144 0.497 . . . . 0.0 111.5 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.558 ' HE2' HG21 ' A' ' 291' ' ' VAL . 44.3 p90 -148.64 142.57 16.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.683 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 3.2 Cg_exo -77.2 145.21 24.12 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.539 2.16 . . . . 0.0 111.632 176.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -62.96 -14.73 50.89 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.577 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.3 p -72.24 -8.66 56.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -107.56 -8.36 16.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.482 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.558 HG21 ' HE2' ' A' ' 286' ' ' PHE . 34.9 m -128.62 164.29 31.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.832 ' HG2' HG12 ' A' ' 243' ' ' ILE . 31.4 mmtp -137.29 139.68 41.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 174.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 240' ' ' ALA . 47.1 mm -78.81 118.19 25.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 13.3 p90 -121.06 163.83 17.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.84 0.352 . . . . 0.0 110.324 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.987 -178.928 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.012 0.434 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 5' ' ' ARG . 48.1 mtm105 -121.9 81.44 1.82 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.749 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.491 ' CE1' ' HD3' ' A' ' 89' ' ' LYS . 31.3 p90 -113.55 161.18 17.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.433 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.44 -45.31 94.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.631 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 63.1 m 67.72 157.61 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.762 0.664 . . . . 0.0 109.999 -169.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.6 t 72.64 -49.94 0.7 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.989 0.516 . . . . 0.0 111.491 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -50.98 101.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.34 0.59 . . . . 0.0 111.591 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -40.22 73.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.249 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -78.62 8.97 4.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.667 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.91 -47.62 4.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.708 0.29 . . . . 0.0 111.022 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -121.03 -25.87 5.25 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -86.46 115.46 23.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.93 0.395 . . . . 0.0 110.692 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.1 mtt -113.13 6.59 17.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.107 0.48 . . . . 0.0 110.779 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.0 -115.23 3.36 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.006 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 25.5 Cg_exo -63.95 103.75 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.697 2.265 . . . . 0.0 111.914 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.605 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 54.4 t -135.58 -75.26 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.732 -176.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.745 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 55.9 m 84.99 176.02 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 122.743 0.417 . . . . 0.0 110.141 166.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 26.6 mmm180 -40.65 -61.76 0.89 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.054 0.846 . . . . 0.0 111.782 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -55.17 -56.84 15.41 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.941 0.776 . . . . 0.0 112.007 -173.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.6 -42.92 60.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.253 -169.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.26 -52.8 63.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.197 -176.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.581 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 12.9 pt20 -70.89 -32.81 69.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.151 -176.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.598 ' HA ' ' OE1' ' A' ' 29' ' ' GLN . 39.5 m -66.73 -34.3 77.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 111.354 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.514 ' HD2' ' O ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -63.22 -35.39 80.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.82 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.052 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 23.6 mt -99.61 13.0 35.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.045 -173.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.598 ' OE1' ' HA ' ' A' ' 26' ' ' THR . 27.3 mt-30 -73.65 96.71 2.52 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.88 5.07 89.7 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.738 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -82.43 -162.26 0.55 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.946 0.373 . . . . 0.0 110.15 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.491 HH21 ' CD ' ' A' ' 100' ' ' GLU . 14.5 mtm180 -62.78 131.51 49.1 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.185 0.517 . . . . 0.0 111.352 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -73.72 114.66 12.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.474 173.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.08 -16.86 4.4 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.124 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.608 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 62.2 mtt -67.7 142.71 56.24 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.711 0.291 . . . . 0.0 111.544 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.498 ' CB ' HG22 ' A' ' 52' ' ' VAL . 40.2 p90 -140.24 160.04 40.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.016 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -151.1 141.74 22.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.967 0.413 . . . . 0.0 110.627 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.51 124.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.461 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.745 ' HD2' ' H ' ' A' ' 20' ' ' SER . 9.2 ptt180 -122.17 161.7 22.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.189 -173.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.3 113.17 18.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.449 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.1 t -73.51 140.5 46.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.703 -171.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 t -78.96 -13.46 59.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.351 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.0 p -68.03 -48.5 65.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.107 0.479 . . . . 0.0 109.983 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.4 m -146.95 103.45 3.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.163 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.7 116.58 3.09 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.59 2.193 . . . . 0.0 111.216 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.38 -30.89 5.26 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -172.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 3.2 m-20 -86.18 168.87 13.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 171.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.768 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 32.0 m-85 -135.52 174.02 11.07 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.684 -171.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.449 HG23 ' HB2' ' A' ' 41' ' ' SER . 58.5 t -143.27 112.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.175 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.509 ' HB2' HD11 ' A' ' 63' ' ' ILE . 46.0 tp -83.54 99.84 10.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.254 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' SER . 68.4 m -97.11 135.14 39.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.528 177.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 93' ' ' LEU . 81.9 t -132.09 142.39 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.553 -173.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 1.052 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 42.3 t -102.01 113.86 27.46 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.882 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.692 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 18.0 pt-20 -156.86 145.99 20.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.0 p30 43.3 31.39 0.38 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.732 0.813 . . . . 0.0 112.714 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.8 m 63.71 63.82 0.82 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.534 0.683 . . . . 0.0 111.234 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 29.3 ptt180 -160.3 166.34 29.66 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 34.3 t -119.45 90.85 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.081 0.467 . . . . 0.0 109.941 175.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.581 ' O ' ' HA ' ' A' ' 51' ' ' SER . 3.6 m -63.14 116.28 5.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.597 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -102.86 97.04 7.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.683 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.628 ' HB3' HD11 ' A' ' 73' ' ' ILE . 82.7 m-85 -105.38 113.06 26.42 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.904 -0.134 . . . . 0.0 111.097 177.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.578 ' O ' HG13 ' A' ' 73' ' ' ILE . 19.0 tt -77.53 139.34 18.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.768 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.5 mp -109.4 122.74 64.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.789 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.549 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 11.2 m120 -110.16 126.31 53.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.911 0.386 . . . . 0.0 110.211 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 p -80.67 100.89 8.91 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.02 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.848 HD12 ' HG2' ' A' ' 70' ' ' ARG . 96.3 mt -66.34 130.06 94.2 Favored Pre-proline 0 CA--C 1.51 -0.595 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -40.26 -68.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.166 2.577 . . . . 0.0 113.658 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -123.25 31.77 5.87 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.001 0.905 . . . . 0.0 108.605 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.775 HH21 HD22 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -131.24 -91.33 0.43 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.596 -173.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.848 ' HG2' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -157.81 -170.4 3.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.051 -167.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -97.62 130.22 44.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.339 0.59 . . . . 0.0 110.323 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.624 ' HD3' HD21 ' A' ' 66' ' ' LEU . 44.9 tttm -123.48 103.33 8.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.309 -173.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.628 HD11 ' HB3' ' A' ' 61' ' ' TYR . 15.0 tt -74.13 86.23 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.842 0.829 . . . . 0.0 111.049 -173.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.04 -34.73 1.47 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.784 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -168.08 -51.29 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.648 0.261 . . . . 0.0 110.46 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -80.87 121.28 25.78 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.436 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.8 pt-20 -94.86 143.28 26.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.289 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.515 ' HE1' ' CG2' ' A' ' 73' ' ' ILE . 91.2 m-85 -115.4 -77.37 0.57 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.688 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD2' ' HD2' ' A' ' 80' ' ' HIS . 11.7 t70 -177.11 -54.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.458 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.482 ' HD2' ' OD2' ' A' ' 79' ' ' ASP . 10.8 p80 -147.77 177.64 9.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.486 176.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 11.6 mt -58.84 -59.11 14.8 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.631 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 44.6 Cg_exo -60.05 -7.38 6.26 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.279 1.986 . . . . 0.0 113.427 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.414 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -87.88 -23.01 24.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.94 0.4 . . . . 0.0 110.963 -177.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -88.09 -28.76 21.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 82' ' ' PRO . 77.7 mt -68.21 -25.76 65.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.849 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.663 ' HA ' ' HE2' ' A' ' 89' ' ' LYS . 10.1 pt-20 -85.78 -15.58 41.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -79.8 -37.69 34.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.512 0.672 . . . . 0.0 110.116 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.463 ' HE2' HD13 ' A' ' 73' ' ' ILE . 60.3 m-85 -78.88 2.79 18.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.082 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.663 ' HE2' ' HA ' ' A' ' 86' ' ' GLU . 52.2 mtmt -86.37 -5.79 59.09 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.793 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 -27.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.087 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -79.39 -19.59 49.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.235 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.615 ' CD2' HG23 ' A' ' 97' ' ' THR . 54.5 m-85 67.28 174.32 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -168.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 52' ' ' VAL . 4.2 mt -114.27 2.04 14.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 165.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.418 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 15.7 t70 -178.07 -121.76 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.502 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.539 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.1 t -94.01 -3.96 50.46 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.1 m -120.3 141.68 49.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.52 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.615 HG23 ' CD2' ' A' ' 92' ' ' TYR . 18.6 p -94.8 178.92 5.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 174.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.512 ' CD2' HD11 ' A' ' 93' ' ' LEU . 83.0 mt -69.48 101.85 1.67 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 51.1 mm -86.02 -65.07 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.79 -176.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 35' ' ' MET . 5.7 pm0 -150.37 155.96 36.88 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.221 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.71 145.79 70.69 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.43 2.087 . . . . 0.0 111.726 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -69.62 147.4 96.56 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.426 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.514 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 25.0 Cg_exo -63.66 127.76 20.55 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.356 2.037 . . . . 0.0 111.184 175.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.431 0.634 . . . . 0.0 109.79 178.897 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.592 HD12 HG21 ' A' ' 152' ' ' ILE . 4.1 mm? . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 121.415 0.626 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 -164.72 -81.31 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.38 -173.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -104.97 114.63 28.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.339 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.563 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 53.7 t -128.73 133.47 66.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.128 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.413 HH21 HD11 ' A' ' 149' ' ' ILE . 1.1 ptp180 -111.29 141.28 45.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.132 0.491 . . . . 0.0 110.922 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.829 HG22 HG12 ' A' ' 178' ' ' VAL . 7.3 p -93.49 139.61 30.53 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.426 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.429 HD11 ' CG ' ' A' ' 179' ' ' GLU . 16.7 mt -110.32 -27.46 9.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.464 -173.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 53.3 t80 -83.09 -37.47 23.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -171.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.676 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 17.7 t70 75.13 107.92 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.697 0.623 . . . . 0.0 110.33 -174.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 83.6 t80 -139.82 100.7 7.29 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 8.2 Cg_endo -89.03 78.37 1.09 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.018 2.478 . . . . 0.0 112.502 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -78.64 -22.41 66.93 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.162 176.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 49.53 55.01 10.02 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.47 -0.865 . . . . 0.0 112.815 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -153.48 171.39 18.77 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.687 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -79.86 -16.07 56.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.147 0.498 . . . . 0.0 110.929 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.43 -10.19 17.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.604 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.419 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 66.9 m-20 -135.73 92.14 2.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.847 HD11 ' HB2' ' A' ' 165' ' ' ASN . 46.8 tp -67.91 122.66 84.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.807 0.337 . . . . 0.0 110.793 -175.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.682 ' HD2' HD12 ' A' ' 142' ' ' LEU . 66.2 Cg_endo -71.62 99.68 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.403 2.069 . . . . 0.0 111.066 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.585 ' CG ' HG21 ' A' ' 130' ' ' THR . 6.3 p90 -116.49 155.67 28.22 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.85 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.676 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 52.8 mttp -101.7 176.17 5.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.15 -174.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.945 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -83.65 69.5 10.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.956 0.884 . . . . 0.0 109.421 176.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.5 23.43 0.73 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.591 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 145' ' ' LYS . 8.1 tp10 -92.93 153.53 18.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.413 HD11 HH21 ' A' ' 129' ' ' ARG . 43.1 mm -104.61 128.21 58.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.487 HD13 HD23 ' A' ' 142' ' ' LEU . 18.2 mt -122.65 159.02 28.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 42.1 t -117.01 129.02 74.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.728 HD13 ' HB2' ' A' ' 163' ' ' ALA . 38.3 mm -75.81 93.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.815 0.817 . . . . 0.0 109.641 -175.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.705 HG21 HG22 ' A' ' 170' ' ' VAL . 8.6 tp -91.04 -33.56 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.001 -172.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.061 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 19.3 mt-10 -132.02 143.63 50.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -145.32 75.06 13.91 Favored Pre-proline 0 C--N 1.323 -0.585 0 O-C-N 121.66 -0.65 . . . . 0.0 111.093 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.539 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 14.0 Cg_exo -68.28 -40.11 8.97 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.716 2.277 . . . . 0.0 111.678 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -112.26 -178.51 3.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.098 -175.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -110.27 -18.19 13.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.31 0.576 . . . . 0.0 109.599 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -88.88 -30.35 18.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.96 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.741 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 36.8 m95 -128.97 134.53 48.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.473 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.762 ' O ' HG13 ' A' ' 173' ' ' ILE . 41.5 m0 -124.82 135.21 52.73 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.906 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 1.061 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.6 m -85.62 101.74 12.97 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.728 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -106.59 161.74 14.36 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 122.058 -0.401 . . . . 0.0 110.404 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.568 ' HG2' ' HB ' ' A' ' 151' ' ' VAL . 15.2 ptt180 -105.32 133.57 49.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.82 0.343 . . . . 0.0 110.317 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.847 ' HB2' HD11 ' A' ' 142' ' ' LEU . 60.2 t30 -64.71 170.41 4.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.905 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.408 ' HG3' ' OE1' ' A' ' 148' ' ' GLU . 8.9 mtmm -61.79 -16.34 48.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.11 0.481 . . . . 0.0 110.515 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.55 -1.8 58.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.283 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.42 -8.37 79.92 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.343 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 7.0 ttp-105 -68.59 129.24 39.36 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.803 -0.234 . . . . 0.0 111.103 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.705 HG22 HG21 ' A' ' 153' ' ' ILE . 73.5 t -89.73 128.53 41.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -153.17 149.02 20.51 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.025 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.741 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -69.5 130.62 42.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.755 0.312 . . . . 0.0 110.432 178.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.762 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -133.29 146.78 62.32 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.364 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 4.0 Cg_exo -77.39 134.54 14.11 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.724 2.283 . . . . 0.0 112.28 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 66.9 t -65.47 -40.83 45.54 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 27.4 Cg_endo -63.61 -4.56 7.16 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.824 1.683 . . . . 0.0 112.973 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-85 -96.69 -6.05 37.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.407 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.829 HG12 HG22 ' A' ' 130' ' ' THR . 15.5 m -126.6 163.92 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -168.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.429 ' CG ' HD11 ' A' ' 131' ' ' LEU . 4.7 mm-40 -139.87 163.94 31.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.587 170.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.525 ' HD3' ' N ' ' A' ' 180' ' ' LYS . 2.8 mppt? . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 120.573 0.225 . . . . 0.0 110.908 -172.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.588 ' HB ' HG13 ' A' ' 266' ' ' VAL . 21.7 t . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.47 134.95 52.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.02 0.438 . . . . 0.0 110.922 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.581 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -138.93 131.87 29.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.372 175.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.417 ' HG3' ' CE1' ' A' ' 294' ' ' PHE . 92.3 mttt -84.46 124.02 30.89 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.613 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -76.94 100.42 5.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.018 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 36.0 pt -88.79 -15.69 8.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.266 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 244' ' ' GLN . 0.7 OUTLIER -140.3 135.69 32.49 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.43 ' HG3' HG23 ' A' ' 260' ' ' VAL . 27.4 mtpp -50.68 137.19 20.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 112.547 -175.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.728 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -111.86 91.64 3.73 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 120.781 0.324 . . . . 0.0 111.306 -175.593 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.851 0.358 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -95.03 107.04 19.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.312 -174.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.49 120.0 27.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.728 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -75.98 111.25 11.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.143 0.497 . . . . 0.0 110.586 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.0 mt -114.52 144.14 43.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.315 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.99 167.41 9.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.371 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.43 HG23 ' HG3' ' A' ' 245' ' ' LYS . 58.3 t -77.41 121.31 29.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.976 0.417 . . . . 0.0 110.489 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 100.32 9.95 46.25 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.87 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -92.1 148.77 21.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 16.4 mm -99.35 111.65 29.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 0.0 110.186 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.502 HG21 HG11 ' A' ' 291' ' ' VAL . 35.7 t -87.51 115.21 27.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.179 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.5 ttpp -96.91 98.95 10.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.588 HG13 ' HB ' ' A' ' 238' ' ' VAL . 6.5 p -94.85 124.72 47.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.264 0.554 . . . . 0.0 110.585 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 88.2 m -116.75 -35.19 4.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.052 176.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -91.36 92.29 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.224 0.535 . . . . 0.0 110.07 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . 0.789 ' HA ' ' HB3' ' A' ' 275' ' ' TRP . 29.9 mtt -97.58 139.61 33.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.879 0.371 . . . . 0.0 110.886 177.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -93.57 -175.01 3.65 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.3 tt -73.52 71.87 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.796 0.808 . . . . 0.0 110.976 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 73.65 -37.99 0.39 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.903 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 274' ' ' GLN . . . -91.43 78.59 1.34 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.159 -1.019 . . . . 0.0 113.02 -169.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 287' ' ' PRO . 46.5 mt-30 75.67 128.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.894 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.789 ' HB3' ' HA ' ' A' ' 269' ' ' MET . 0.6 OUTLIER -124.62 169.57 11.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.36 -169.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 38.8 mt-10 -107.54 108.45 19.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.607 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.31 133.3 11.58 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.168 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 283' ' ' LYS . 1.4 pm0 -95.04 108.81 20.9 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.291 0.567 . . . . 0.0 109.489 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 27.1 t -115.74 -87.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.143 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -92.04 72.67 5.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.08 0.467 . . . . 0.0 111.059 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.89 4.89 78.41 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.729 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 282' ' ' ARG . 14.3 ptt180 -159.97 162.6 34.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.207 0.503 . . . . 0.0 111.426 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.59 ' HB3' ' HB3' ' A' ' 278' ' ' GLU . 10.1 ptmm? -116.88 138.79 51.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -154.35 175.8 32.4 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.146 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.49 127.17 34.84 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.094 0.473 . . . . 0.0 110.792 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -127.43 125.76 23.97 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.023 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 17.0 Cg_exo -68.31 139.61 46.21 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.636 2.224 . . . . 0.0 111.409 176.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -75.66 26.26 0.11 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.7 t -115.48 -9.82 12.03 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.961 0.41 . . . . 0.0 109.953 171.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -90.34 -30.34 17.51 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.613 HG12 ' HA ' ' A' ' 242' ' ' ALA . 18.0 m -124.25 161.53 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.51 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -130.75 133.16 45.78 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.02 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 240' ' ' ALA . 43.6 mm -70.76 111.98 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.723 178.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.417 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 34.8 p90 -111.12 142.08 43.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.901 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.473 -179.049 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.427 ' HB1' ' HE3' ' A' ' 89' ' ' LYS . . . . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.6 0.238 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -134.38 84.96 2.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.847 0.355 . . . . 0.0 111.0 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.418 ' HE1' ' O ' ' A' ' 98' ' ' LEU . 41.7 p90 -161.22 164.22 30.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.863 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 12.8 t70 -90.02 120.24 31.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 40.5 m -70.13 -16.53 63.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.856 -172.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -103.46 -11.79 17.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.89 0.376 . . . . 0.0 111.505 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 11.1 t0 -75.62 94.47 3.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.174 0.512 . . . . 0.0 110.879 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.3 mtm-85 -65.84 -25.19 67.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.311 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -73.88 1.83 9.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.849 0.357 . . . . 0.0 110.781 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.84 -47.43 3.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.718 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -114.05 -20.34 11.03 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -76.21 120.32 21.33 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.104 -0.372 . . . . 0.0 110.999 -172.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.642 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.6 mmt -102.12 -16.18 16.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.963 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.473 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.88 -112.57 1.71 Allowed Glycine 0 CA--C 1.525 0.667 0 O-C-N 123.431 0.457 . . . . 0.0 113.543 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.473 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 16.8 Cg_exo -66.55 83.06 0.3 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.217 2.611 . . . . 0.0 113.518 -176.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.966 HG12 ' H ' ' A' ' 20' ' ' SER . 57.5 t -135.33 -164.66 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.966 ' H ' HG12 ' A' ' 19' ' ' VAL . 45.7 p -172.68 174.32 3.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -168.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -53.07 60.9 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.092 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -57.12 -61.9 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.495 0.497 . . . . 0.0 111.532 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -57.72 -47.16 83.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.654 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.87 74.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.055 0.455 . . . . 0.0 111.641 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -61.56 -44.34 97.22 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.801 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m -57.85 -38.33 75.47 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -81.31 -9.52 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 80.1 mt -122.41 -12.98 8.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.934 HE21 ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -74.36 117.26 15.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.971 0.415 . . . . 0.0 111.272 -174.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.97 3.05 63.19 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.75 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -80.75 -171.42 3.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.654 0.264 . . . . 0.0 110.453 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.462 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 17.2 mtm180 -60.79 152.71 26.3 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.434 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 62.3 m170 -98.54 142.08 30.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.11 -9.04 54.3 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -172.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.64 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 73.8 mtp -76.75 138.25 39.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.38 -0.41 . . . . 0.0 109.895 176.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' HB2' HG22 ' A' ' 52' ' ' VAL . 27.3 p90 -144.02 167.47 22.29 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.642 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -158.94 146.93 17.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.5 116.11 50.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.677 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.463 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 36.1 ptt-85 -114.17 -179.31 3.6 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.601 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -86.46 138.04 32.07 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -89.23 177.77 6.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.398 0.618 . . . . 0.0 111.433 -174.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 m -110.4 -4.94 15.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.21 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 p -73.98 -65.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.822 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 26.6 m -133.37 143.29 47.49 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.639 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.93 88.64 0.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.239 1.959 . . . . 0.0 111.334 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 145.72 -21.63 1.82 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -77.52 150.99 34.76 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -130.43 173.78 10.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG22 HG12 ' A' ' 62' ' ' ILE . 9.5 t -138.93 109.67 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.122 0.487 . . . . 0.0 111.722 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.404 ' HB2' HD11 ' A' ' 63' ' ' ILE . 51.6 tp -83.29 97.61 8.99 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.322 175.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.9 m -95.75 117.09 29.86 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.685 0.278 . . . . 0.0 110.254 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.651 HG21 HD13 ' A' ' 93' ' ' LEU . 60.4 t -113.23 133.62 58.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.405 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 48.1 t -102.05 118.05 36.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.712 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 10.7 tp10 -151.18 153.22 34.55 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.518 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 63.4 m-80 57.41 21.85 7.31 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.323 0.389 . . . . 0.0 111.822 -177.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 m 57.6 51.51 9.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.253 1.025 . . . . 0.0 108.996 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 1.022 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.29 0.0 OUTLIER -166.81 70.03 0.11 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.376 -155.784 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 22.5 t -71.93 110.86 5.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.883 -168.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.3 m -76.64 120.46 21.86 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.282 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -97.71 89.9 4.79 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.875 ' HE1' HD11 ' A' ' 153' ' ' ILE . 75.5 m-85 -89.05 106.76 18.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -80.51 136.41 23.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.209 0.528 . . . . 0.0 111.97 -178.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.6 mp -117.88 106.57 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.534 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -83.58 148.67 27.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.735 0.302 . . . . 0.0 110.548 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.9 t -85.49 109.32 18.4 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 72' ' ' LYS . 98.2 mt -79.41 147.43 68.28 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.544 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.8 -13.47 37.22 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.695 2.263 . . . . 0.0 110.547 170.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -75.39 -0.72 20.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.366 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 3.1 mmp_? 64.71 28.51 13.04 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.972 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 70' ' ' ARG . 59.1 mtt85 -124.8 157.37 35.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.537 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.526 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 25.7 m-85 -105.6 114.93 29.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.888 0.375 . . . . 0.0 110.519 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.63 ' HB2' HD11 ' A' ' 66' ' ' LEU . 38.6 ttpt -103.53 111.96 24.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.546 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.714 HD11 ' HB3' ' A' ' 61' ' ' TYR . 7.9 tt -93.23 75.26 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 122.179 0.99 . . . . 0.0 109.124 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.07 97.78 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.979 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.4 t0 75.49 -51.5 0.64 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.649 0.379 . . . . 0.0 111.381 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -94.05 119.27 32.69 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.8 pt-20 -100.24 135.77 41.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.319 0.58 . . . . 0.0 110.796 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 94.2 m-85 -115.86 177.12 4.79 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.473 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.43 -49.68 74.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.903 0.382 . . . . 0.0 111.167 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -164.52 -175.43 3.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 15.2 mt -53.22 -58.82 10.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' A' ' 8' ' ' SER . 30.6 Cg_endo -64.89 -4.75 9.31 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.206 1.937 . . . . 0.0 113.433 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.87 -36.63 15.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.813 0.339 . . . . 0.0 110.425 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -77.11 -37.03 55.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.16 -38.8 84.27 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.832 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.599 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 1.9 tp10 -66.26 -43.84 85.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.725 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -64.91 -28.3 69.44 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.432 0.634 . . . . 0.0 110.968 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.494 ' CG ' HD21 ' A' ' 93' ' ' LEU . 20.6 m-85 -92.03 1.73 57.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.324 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.599 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 56.8 mtpt -85.02 3.54 38.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 175.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.3 pt -140.53 -8.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-O 121.252 0.549 . . . . 0.0 109.706 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 4.4 t60 -86.17 -36.68 19.36 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.973 -174.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 93.8 m-85 70.13 91.69 0.09 Allowed 'General case' 0 C--O 1.225 -0.205 0 O-C-N 124.277 0.986 . . . . 0.0 109.033 -166.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.651 HD13 HG21 ' A' ' 52' ' ' VAL . 25.1 mt -58.67 -44.76 90.27 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.351 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.964 ' HA ' ' HG2' ' A' ' 154' ' ' GLU . 28.3 p-10 -150.51 48.82 0.88 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.627 -166.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.8 OUTLIER 70.63 -5.73 1.37 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.413 1.885 . . . . 0.0 111.635 -169.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.58 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -126.13 151.64 46.99 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.0 p -96.72 167.05 11.35 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.418 ' O ' ' HE1' ' A' ' 6' ' ' PHE . 72.6 mt -65.38 99.66 0.42 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 97' ' ' THR . 48.0 mm -87.4 -64.06 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.343 -172.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 35' ' ' MET . 42.0 tt0 -156.86 126.01 3.09 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.201 -174.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.68 153.71 47.66 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.023 2.482 . . . . 0.0 113.127 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.439 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -69.62 154.23 94.98 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.514 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.61 115.78 2.76 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 121.904 1.736 . . . . 0.0 111.672 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.498 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 54.3 ttp180 . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.439 0.638 . . . . 0.0 109.7 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.881 HD12 HG21 ' A' ' 152' ' ' ILE . 3.3 mm? . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 121.66 0.743 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 44.3 tt0 -175.59 -54.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.207 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -118.5 107.5 13.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.909 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.67 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 4.2 t -116.26 140.02 40.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.719 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 4.9 ptp180 -115.24 138.61 50.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 116.71 -1.996 . . . . 0.0 108.682 164.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.634 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -100.67 125.5 47.1 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.738 -178.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' A' ' 179' ' ' GLU . 17.2 mt -99.22 -26.32 14.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.243 -173.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 34.7 t80 -73.48 -41.98 62.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -172.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.548 ' HB2' ' N ' ' A' ' 146' ' ' LYS . 6.0 t70 75.24 100.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.699 0.761 . . . . 0.0 110.832 -174.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 53.5 t80 -128.7 86.78 56.66 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.594 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 89.6 Cg_endo -83.6 86.72 1.33 Allowed 'Trans proline' 0 N--CA 1.441 -1.611 0 C-N-CA 121.147 1.231 . . . . 0.0 112.368 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.67 -24.47 60.35 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.541 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.6 m120 61.6 50.83 4.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.709 -1.246 . . . . 0.0 112.22 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.422 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 4.8 m-20 -136.67 176.25 8.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.273 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.82 -13.83 35.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 122.11 0.957 . . . . 0.0 108.496 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 172' ' ' MET . 19.6 mm-40 -88.02 -31.4 19.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.244 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -135.2 105.76 6.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.939 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.037 HD11 ' HB2' ' A' ' 165' ' ' ASN . 26.5 tp -66.94 128.79 94.0 Favored Pre-proline 0 CA--C 1.51 -0.563 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.989 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.621 ' HD2' HD12 ' A' ' 142' ' ' LEU . 92.4 Cg_endo -79.34 98.08 1.14 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 121.384 1.389 . . . . 0.0 111.306 173.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.562 ' CD2' ' HB ' ' A' ' 130' ' ' THR . 0.5 OUTLIER -89.32 -165.1 1.26 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.54 ' C ' ' HB2' ' A' ' 133' ' ' ASP . 56.2 mtpt -139.49 -176.02 4.39 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.408 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.946 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -82.99 50.41 1.72 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.665 0.745 . . . . 0.0 110.665 -174.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.99 35.28 0.17 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.663 ' OE1' ' HB2' ' A' ' 166' ' ' LYS . 5.1 tp10 -84.34 151.8 24.5 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.983 -173.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.3 122.82 64.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.549 0.69 . . . . 0.0 109.157 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.734 HD22 ' CD2' ' A' ' 142' ' ' LEU . 65.4 mt -123.67 157.57 33.53 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.008 -171.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 66.1 t -117.3 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.075 HD13 ' HB2' ' A' ' 163' ' ' ALA . 45.6 mm -76.86 95.48 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-O 122.177 0.989 . . . . 0.0 109.508 -175.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.875 HD11 ' HE1' ' A' ' 61' ' ' TYR . 19.3 tt -81.64 -28.07 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.602 -175.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.022 ' HA ' HH21 ' A' ' 57' ' ' ARG . 4.0 mt-10 -136.37 144.39 44.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.144 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.642 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 86.8 tttt -124.31 76.53 61.28 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 164.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.563 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 23.2 Cg_exo -67.2 -51.17 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.768 2.312 . . . . 0.0 111.778 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -113.8 177.54 4.6 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.619 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -100.18 -16.98 17.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.976 0.417 . . . . 0.0 110.3 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -99.8 -19.79 16.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.593 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 39.7 m95 -129.74 141.95 50.79 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.752 ' O ' HG13 ' A' ' 173' ' ' ILE . 46.5 m0 -124.92 137.86 54.26 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 6.1 m -97.7 109.88 22.55 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.075 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -121.29 152.1 39.3 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.244 -176.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.775 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 27.1 ptt-85 -87.65 127.69 35.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 173.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.037 ' HB2' HD11 ' A' ' 142' ' ' LEU . 56.3 t30 -61.75 178.01 0.37 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.133 -172.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.663 ' HB2' ' OE1' ' A' ' 148' ' ' GLU . 3.6 ttmp? -54.19 -26.03 25.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.303 166.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -74.98 -38.45 61.66 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.03 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 164' ' ' ARG . . . 115.32 -11.85 19.37 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.458 -175.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.775 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -59.12 138.18 57.66 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.26 0.624 . . . . 0.0 112.051 177.434 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 74.0 t -88.76 121.07 38.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.542 177.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -153.73 156.2 26.64 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.438 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.593 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -77.55 143.68 38.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.805 0.303 . . . . 0.0 111.295 178.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -142.07 142.0 23.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.526 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 20.4 Cg_exo -65.95 129.46 22.02 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.715 2.277 . . . . 0.0 112.879 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.614 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 44.9 t -62.72 -40.1 60.68 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 17.5 Cg_endo -59.39 -11.28 13.11 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.023 1.815 . . . . 0.0 112.627 175.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -93.29 -10.53 35.16 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.604 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.634 HG12 HG22 ' A' ' 130' ' ' THR . 2.1 m -105.98 -177.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -166.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.719 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 3.4 tp10 -159.43 44.82 0.25 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 112.467 -2.151 . . . . 0.0 110.833 -154.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.77 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.449 0 O-C-N 119.174 -2.204 . . . . 0.0 112.87 -162.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.617 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 27.7 t . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 121.043 0.449 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -93.77 123.45 37.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.173 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.81 143.34 47.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.175 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 45.0 tttp -90.89 119.08 30.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.15 0.5 . . . . 0.0 109.752 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.94 ' HB1' ' HG2' ' A' ' 259' ' ' GLU . . . -84.23 127.22 33.81 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.781 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 46.2 pt -128.12 -30.1 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -168.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -82.62 -75.9 0.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.298 -169.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.692 ' HA ' ' CB ' ' A' ' 259' ' ' GLU . 1.0 OUTLIER 153.85 131.25 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.391 1.476 . . . . 0.0 108.183 168.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 19.2 mmm180 -124.2 100.61 6.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.917 0.389 . . . . 0.0 110.968 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.453 178.165 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -93.0 126.76 38.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.532 HD13 HD21 ' A' ' 258' ' ' LEU . 0.6 OUTLIER -85.08 122.12 28.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.952 0.406 . . . . 0.0 110.524 -176.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -84.06 109.89 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.779 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.571 HD23 ' HB ' ' A' ' 279' ' ' VAL . 0.4 OUTLIER -157.05 -156.25 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.166 176.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.94 ' HG2' ' HB1' ' A' ' 242' ' ' ALA . 3.7 mt-10 88.12 139.92 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 24.9 t 82.56 83.16 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 112.695 -2.048 . . . . 0.0 111.114 -172.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 89.98 14.38 59.33 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.417 -0.81 . . . . 0.0 113.48 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -105.36 145.99 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.974 0.416 . . . . 0.0 111.163 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 32.2 mm -98.45 111.4 28.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.534 HG22 HD22 ' A' ' 258' ' ' LEU . 43.5 t -92.83 117.25 35.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 -175.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -96.39 105.67 17.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.102 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.52 HG21 ' HB3' ' A' ' 275' ' ' TRP . 2.4 p -94.67 118.01 39.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.999 0.428 . . . . 0.0 110.304 176.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -93.8 -24.37 17.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.173 0.511 . . . . 0.0 110.763 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 88.8 mtt180 -121.56 98.27 5.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.801 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . 0.617 ' HE3' ' HB ' ' A' ' 238' ' ' VAL . 1.2 mtt -91.39 112.93 25.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.321 0.581 . . . . 0.0 111.373 -176.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -92.13 158.79 15.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.173 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.5 tt -91.28 -14.98 8.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.347 0.594 . . . . 0.0 109.851 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.99 23.02 1.57 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.8 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 91.04 -55.63 3.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.136 -0.554 . . . . 0.0 114.077 168.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.458 ' H ' ' HG2' ' A' ' 274' ' ' GLN . 6.1 pt20 -77.81 114.84 17.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.346 0.593 . . . . 0.0 110.526 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.52 ' HB3' HG21 ' A' ' 266' ' ' VAL . 42.9 m0 -94.74 155.65 16.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.457 -175.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 0.2 OUTLIER -107.58 113.29 26.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.425 -179.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -141.73 168.35 25.61 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.288 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -118.25 110.16 17.21 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.571 ' HB ' HD23 ' A' ' 258' ' ' LEU . 43.9 t -139.93 146.72 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 63.61 24.51 14.0 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.094 0.473 . . . . 0.0 111.02 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 82.16 3.37 90.58 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.238 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -134.24 149.58 50.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.943 0.402 . . . . 0.0 110.767 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -103.6 143.26 32.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.274 178.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -172.18 170.74 43.72 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.477 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 95.3 mt -90.34 133.5 34.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.119 0.485 . . . . 0.0 111.122 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -134.62 147.85 64.93 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.184 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -87.77 139.29 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.685 2.257 . . . . 0.0 112.752 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -70.53 -11.52 60.98 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.063 0.459 . . . . 0.0 111.016 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.5 p -78.23 4.84 11.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.236 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -116.94 -49.11 2.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.657 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 242' ' ' ALA . 27.5 m -85.98 152.52 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.216 -175.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -109.29 124.34 50.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.797 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 240' ' ' ALA . 20.8 mm -79.77 127.62 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.473 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 2.6 p90 -146.08 173.19 12.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.166 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 . . . . . 0 C--N 1.315 -0.91 0 CA-C-O 121.373 0.606 . . . . 0.0 111.049 179.147 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtt . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.451 ' CB ' ' HE ' ' A' ' 5' ' ' ARG . 12.7 m 61.72 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.646 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.3 m 66.49 -51.14 0.44 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.326 0.65 . . . . 0.0 110.331 -168.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 98' ' ' LEU . . . -130.98 92.69 3.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.244 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.451 ' HE ' ' CB ' ' A' ' 2' ' ' SER . 5.3 ptp180 -114.73 25.32 11.06 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.361 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.552 ' CE1' ' HB1' ' A' ' 4' ' ' ALA . 46.2 p90 -69.47 140.49 54.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 165.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.45 118.69 18.59 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.582 -178.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.668 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 17.0 m -90.52 78.73 6.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.85 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -176.39 -53.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.068 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 12' ' ' SER . 34.8 t70 -78.18 127.75 32.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.311 0.577 . . . . 0.0 111.562 -170.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -51.82 -37.68 52.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.674 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 108' ' ' PRO . 3.2 m -73.87 23.97 0.08 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.875 0.369 . . . . 0.0 111.929 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.428 ' HB3' ' HD1' ' A' ' 14' ' ' TRP . . . -118.59 -47.19 2.54 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.883 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.428 ' HD1' ' HB3' ' A' ' 13' ' ' ALA . 28.3 p-90 -132.21 -22.39 2.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -166.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -86.86 119.71 27.38 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.942 -171.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.835 ' HG2' ' HG3' ' A' ' 109' ' ' PRO . 55.6 mtt -117.09 5.78 12.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.908 0.385 . . . . 0.0 111.143 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 49.91 -114.4 2.4 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.247 -0.888 . . . . 0.0 114.73 174.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 15.3 Cg_exo -69.01 95.96 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.916 2.411 . . . . 0.0 112.608 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.859 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 95.3 t -128.88 -71.53 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.117 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.888 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 54.1 m 78.52 170.01 0.2 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.196 0.598 . . . . 0.0 110.439 172.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -49.05 -43.61 40.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 1.5 pt20 -46.57 -58.57 3.69 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.956 0.785 . . . . 0.0 112.81 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.54 ' HB2' HG13 ' A' ' 19' ' ' VAL . 23.5 mm-40 -85.65 -43.46 13.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.118 0.485 . . . . 0.0 110.467 -172.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.76 -37.41 63.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.765 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -72.25 -35.97 68.95 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.554 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 23' ' ' GLU . 10.8 t -79.8 -32.62 40.79 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.192 -174.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -84.65 -15.06 46.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.082 0.468 . . . . 0.0 111.173 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.475 HD11 ' HG ' ' A' ' 37' ' ' LEU . 78.3 mt -117.11 30.44 7.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.298 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -113.73 139.69 48.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.238 0.542 . . . . 0.0 111.671 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.09 -47.85 3.93 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.653 ' O ' ' HG3' ' A' ' 32' ' ' ARG . 77.9 mt-30 -131.91 80.47 1.92 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 118.875 1.338 . . . . 0.0 111.801 -168.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.981 ' HA ' ' HE2' ' A' ' 35' ' ' MET . 0.0 OUTLIER -169.22 146.07 3.49 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.523 -176.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.4 ' CD2' ' HB3' ' A' ' 119' ' ' PRO . 0.1 OUTLIER -157.98 104.91 1.93 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 166.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.44 -3.67 69.09 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.566 -173.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.981 ' HE2' ' HA ' ' A' ' 32' ' ' ARG . 57.7 mtm -85.61 138.07 32.42 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.932 0.396 . . . . 0.0 110.511 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -144.27 174.33 10.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.743 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.2 pp -160.45 143.37 13.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.747 172.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.05 135.88 45.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.888 ' HD2' ' H ' ' A' ' 20' ' ' SER . 22.5 ptt-85 -139.64 155.26 47.52 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.397 -173.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' OD1' ' HA2' ' A' ' 17' ' ' GLY . 2.2 m-20 -66.18 118.25 9.63 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 168.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.525 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.4 t -84.44 170.06 13.91 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.993 0.425 . . . . 0.0 110.263 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t -112.23 7.13 19.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.484 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -53.68 27.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 47.4 t -170.62 121.74 0.55 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.414 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -40.41 104.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.464 2.776 . . . . 0.0 112.465 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.11 -21.73 2.62 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.209 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -103.25 145.36 30.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.076 0.465 . . . . 0.0 109.773 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.565 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 24.8 m-85 -126.42 160.19 31.18 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 41' ' ' SER . 44.0 t -128.16 103.46 10.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.471 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 tp -79.66 98.38 6.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.399 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 m -96.0 120.1 35.68 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.279 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.635 HG21 HD13 ' A' ' 93' ' ' LEU . 54.5 t -116.83 134.24 61.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.28 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 31.8 t -103.58 111.63 24.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.209 0.528 . . . . 0.0 111.78 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.557 ' HG3' ' HB ' ' A' ' 96' ' ' THR . 3.2 mm-40 -150.01 152.71 35.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.071 173.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 56.74 28.12 13.79 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.501 0.501 . . . . 0.0 110.877 -171.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.9 m 60.31 28.38 17.99 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.281 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 53' ' ' SER . 12.0 ptt-85 -124.53 158.29 33.29 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 t -110.56 95.21 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 t -81.22 118.8 22.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -100.63 99.91 10.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.675 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.793 ' HE1' HD11 ' A' ' 153' ' ' ILE . 63.1 m-85 -98.09 113.7 25.66 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.74 0.305 . . . . 0.0 111.205 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.477 ' HB ' ' CD ' ' A' ' 209' ' ' GLN . 68.5 mt -82.3 131.52 33.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.427 0.632 . . . . 0.0 112.448 -174.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 4.3 mp -98.25 122.55 50.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.176 174.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -111.4 132.53 54.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -77.78 110.35 12.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.449 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.726 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 93.1 mt -77.93 170.85 14.32 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.726 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 23.5 Cg_endo -61.69 56.37 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.007 2.472 . . . . 0.0 114.412 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 t30 79.92 4.99 1.94 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.34 0.656 . . . . 0.0 111.964 161.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -97.6 -51.26 4.18 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.836 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.684 ' HB3' ' HA ' ' A' ' 79' ' ' ASP . 5.8 ptp180 -156.32 -171.69 3.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.865 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.401 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 45.6 m-85 -109.72 157.92 18.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.595 0.236 . . . . 0.0 110.476 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.76 ' HE3' ' HA ' ' A' ' 75' ' ' ASP . 55.9 tttp -129.27 96.54 4.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.675 0.274 . . . . 0.0 110.278 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.547 HD13 ' HE2' ' A' ' 88' ' ' TYR . 3.1 tt -97.1 94.12 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.496 0.665 . . . . 0.0 109.869 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.94 57.38 7.84 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.277 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.76 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 25.1 t0 76.74 -50.21 0.57 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.16 0.584 . . . . 0.0 111.487 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -61.5 123.2 17.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.888 0.375 . . . . 0.0 110.057 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -107.2 130.33 54.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.723 0.773 . . . . 0.0 111.809 -176.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.542 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 7.8 m-85 -127.74 150.28 49.86 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.684 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 9.9 m-20 -62.43 -26.05 68.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -170.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 4.7 p80 -161.95 172.78 15.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.029 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.61 HD23 HD21 ' A' ' 84' ' ' LEU . 11.6 mt -56.55 -51.45 81.1 Favored Pre-proline 0 CA--C 1.537 0.455 0 O-C-N 123.373 0.42 . . . . 0.0 111.868 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.668 ' HB3' ' O ' ' A' ' 8' ' ' SER . 60.3 Cg_exo -57.35 -11.34 8.15 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.661 2.24 . . . . 0.0 114.095 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.95 -36.11 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.236 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.61 HD21 HD23 ' A' ' 81' ' ' LEU . 3.9 pp -76.33 -26.97 56.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.071 0.462 . . . . 0.0 110.557 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.81 -15.68 62.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.784 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -86.16 -37.46 18.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.886 0.374 . . . . 0.0 110.566 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -63.84 -37.7 88.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.28 0.562 . . . . 0.0 110.49 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.547 ' HE2' HD13 ' A' ' 73' ' ' ILE . 38.8 m-85 -81.77 -1.16 46.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.545 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.439 ' O ' HG21 ' A' ' 97' ' ' THR . 7.7 tmtm? -76.26 -24.89 54.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.106 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -115.57 -12.67 11.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.478 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.516 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 12.3 t-160 -72.44 -41.56 66.01 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.995 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.567 ' HA ' HG22 ' A' ' 97' ' ' THR . 83.6 m-85 72.8 108.9 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.379 1.049 . . . . 0.0 109.548 -167.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.736 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 4.9 mt -82.53 14.14 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 95' ' ' THR . 27.2 t70 172.55 -140.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 156' ' ' PRO . 12.8 t -78.12 -7.12 56.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.305 0.574 . . . . 0.0 109.685 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.557 ' HB ' ' HG3' ' A' ' 54' ' ' GLU . 20.7 m -136.44 158.73 43.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.692 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 92' ' ' TYR . 56.7 p -96.63 -169.12 1.83 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.574 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 74.3 mt -67.53 125.76 27.18 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 167.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.56 -68.67 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.896 0.379 . . . . 0.0 110.415 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.642 ' O ' ' HA ' ' A' ' 35' ' ' MET . 61.8 mm-40 -144.02 149.4 45.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.053 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.38 162.86 37.51 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.754 2.302 . . . . 0.0 113.718 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -78.62 171.59 12.1 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.488 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 74.1 Cg_exo -55.8 177.58 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.581 2.854 . . . . 0.0 114.524 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.702 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 2.8 ttp180 -98.75 156.14 16.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.699 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 1.014 ' HB3' ' HD3' ' A' ' 106' ' ' PRO . 45.8 t80 -159.19 -69.3 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.366 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 1.014 ' HD3' ' HB3' ' A' ' 105' ' ' TYR . 9.2 Cg_endo -94.36 -87.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.789 2.326 . . . . 0.0 112.464 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.631 ' O ' ' HD3' ' A' ' 109' ' ' PRO . 13.1 t -76.65 141.53 69.08 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.507 ' O ' ' HA ' ' A' ' 12' ' ' SER . 43.3 Cg_endo -68.8 108.06 1.81 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.051 2.5 . . . . 0.0 114.754 -172.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.835 ' HG3' ' HG2' ' A' ' 16' ' ' MET . 90.7 Cg_endo -102.16 -150.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 124.079 3.186 . . . . 0.0 111.149 170.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -60.4 3.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.05 0.453 . . . . 0.0 110.636 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.23 80.28 1.36 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.879 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.453 ' H ' ' HA ' ' A' ' 103' ' ' PRO . 39.3 m -114.42 149.18 36.61 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.0 t -82.23 -38.05 15.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.069 0.462 . . . . 0.0 110.256 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.3 m -149.81 159.45 44.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.727 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -118.41 138.43 25.72 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.813 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 14.6 Cg_exo -70.28 -19.69 33.33 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.291 2.661 . . . . 0.0 112.976 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -83.32 87.2 6.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.938 0.399 . . . . 0.0 111.96 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.586 HD12 ' HD2' ' A' ' 119' ' ' PRO . 50.3 tp -80.96 118.54 72.84 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 170.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.586 ' HD2' HD12 ' A' ' 118' ' ' LEU . 72.2 Cg_endo -76.87 -179.38 5.34 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.462 2.108 . . . . 0.0 113.237 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.8 t -144.53 137.26 26.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.243 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 66.9 166.95 0.22 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.796 0.685 . . . . 0.0 112.707 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.41 176.6 11.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.268 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -157.64 177.26 11.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.34 -96.06 0.21 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 1.056 HD23 HG21 ' A' ' 152' ' ' ILE . 10.6 mp 62.93 123.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.246 1.022 . . . . 0.0 113.007 174.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 17.0 tp10 -167.59 -74.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.715 -175.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -107.1 110.39 22.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.187 0.517 . . . . 0.0 111.11 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.526 HG22 ' HG2' ' A' ' 180' ' ' LYS . 70.3 t -127.84 132.04 69.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.687 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.526 HH22 ' HB2' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -112.57 145.0 41.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.87 0.367 . . . . 0.0 110.66 -178.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.882 HG22 HG12 ' A' ' 178' ' ' VAL . 42.1 p -93.29 129.07 39.5 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.332 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 21.2 mt -104.14 -32.98 8.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.717 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.613 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 34.1 t80 -86.12 -36.08 19.8 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -170.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.673 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 2.0 t70 79.65 129.3 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.557 0.535 . . . . 0.0 110.728 -175.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 91.5 t80 -151.39 100.64 2.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -89.1 65.88 2.6 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.595 2.197 . . . . 0.0 113.006 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.95 -29.82 73.81 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.774 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.517 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 47.3 m-80 50.22 73.32 0.27 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.87 0.868 . . . . 0.0 113.313 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -171.14 -176.28 1.89 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.09 -10.13 51.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.535 0.684 . . . . 0.0 109.168 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -94.09 -32.75 13.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.304 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.79 104.78 9.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.733 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.088 HD11 ' HB2' ' A' ' 165' ' ' ASN . 46.2 tp -71.9 117.81 61.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.566 ' HD2' HD12 ' A' ' 142' ' ' LEU . 55.2 Cg_endo -76.59 111.38 3.24 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.062 1.842 . . . . 0.0 111.728 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.627 ' CG ' HG21 ' A' ' 130' ' ' THR . 12.5 p90 -125.91 163.69 22.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.143 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.673 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 20.8 pttm -122.15 -168.51 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.739 -173.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.542 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.4 OUTLIER -80.94 67.15 6.74 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -178.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.9 42.95 0.11 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.413 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.631 ' HG2' ' HG2' ' A' ' 145' ' ' LYS . 5.3 mm-40 -99.2 145.09 27.6 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.535 -0.391 . . . . 0.0 110.073 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.467 HD13 ' HB3' ' A' ' 129' ' ' ARG . 46.5 mm -98.41 124.35 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 175.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.55 HD22 ' HA ' ' A' ' 165' ' ' ASN . 34.2 mt -120.43 158.7 26.64 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 90.4 t -119.0 126.05 75.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.056 HG21 HD23 ' A' ' 125' ' ' LEU . 48.6 mm -75.76 87.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 122.355 1.074 . . . . 0.0 108.913 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.793 HD11 ' HE1' ' A' ' 61' ' ' TYR . 6.7 tt -82.77 -37.36 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.832 -170.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.804 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 20.7 mt-10 -136.0 143.44 44.79 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -131.8 90.54 35.94 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 121.593 -0.692 . . . . 0.0 111.41 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.649 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 6.7 Cg_exo -74.05 -52.14 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.401 2.067 . . . . 0.0 111.957 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -115.19 -179.12 3.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.436 ' O ' HG21 ' A' ' 175' ' ' VAL . 42.1 mt-10 -102.48 -25.48 13.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.831 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 175' ' ' VAL . 7.6 tt0 -85.45 -27.78 25.48 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.237 0.541 . . . . 0.0 110.404 175.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.479 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 45.4 m95 -128.86 124.19 34.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.634 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.563 ' O ' HG13 ' A' ' 173' ' ' ILE . 52.6 m0 -111.3 148.32 33.18 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.804 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 33.3 m -95.63 101.01 12.67 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.756 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.93 153.96 22.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.573 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.9 ptt180 -96.2 133.4 40.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.088 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.2 t30 -74.27 -177.5 3.04 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.777 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 166' ' ' LYS . 38.6 ttmt -62.44 -26.21 68.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.04 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.649 ' OD1' ' HB3' ' A' ' 165' ' ' ASN . 54.0 p-10 -90.56 3.7 53.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.335 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 210' ' ' PRO . . . 86.04 -1.08 87.8 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.804 -0.635 . . . . 0.0 113.131 172.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 25.7 ttm-85 -64.67 129.22 38.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.698 0.285 . . . . 0.0 111.021 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.409 HG21 HD13 ' A' ' 153' ' ' ILE . 40.4 t -98.97 111.68 29.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.038 178.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.39 165.65 26.32 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 175.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.649 ' HE3' ' HG2' ' A' ' 156' ' ' PRO . 21.0 mtp -79.92 138.47 37.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.13 0.465 . . . . 0.0 110.229 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.592 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -133.7 145.61 56.87 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.023 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.479 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 4.6 Cg_exo -77.3 131.97 12.13 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.809 2.339 . . . . 0.0 112.371 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.569 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 57.2 t -62.05 -43.27 85.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 18.3 Cg_endo -61.37 -11.6 20.23 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.899 1.732 . . . . 0.0 112.903 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -92.17 -12.34 33.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.53 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.882 HG12 HG22 ' A' ' 130' ' ' THR . 32.7 m -126.6 162.17 31.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.228 0.537 . . . . 0.0 112.376 -169.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -133.98 134.77 42.89 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.931 176.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.526 ' HG2' HG22 ' A' ' 128' ' ' VAL . 45.9 mtmt -81.93 148.56 28.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.753 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.526 ' HB2' HH22 ' A' ' 129' ' ' ARG . 26.2 tp -76.92 -32.28 57.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 171.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 19.6 t -85.93 69.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.662 171.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.51 ' HE ' ' HE2' ' A' ' 180' ' ' LYS . 15.9 ttm180 -177.95 32.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.993 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.1 t -66.28 102.34 0.84 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.035 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.2 p -156.92 161.9 28.65 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.313 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.84 105.99 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.895 2.397 . . . . 0.0 112.731 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -103.82 -74.82 0.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -121.72 51.54 0.78 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 67.95 97.79 0.06 Allowed 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.586 0.754 . . . . 0.0 110.58 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -92.97 7.03 45.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.291 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.48 -24.16 63.51 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.452 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -75.33 -9.8 58.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.94 0.37 . . . . 0.0 110.198 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 64.78 -93.36 0.04 OUTLIER 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.793 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 60.1 t30 56.02 29.78 15.02 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.766 0.666 . . . . 0.0 111.129 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.5 m -74.01 -30.2 62.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.872 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -71.66 -42.05 67.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.887 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 56.1 p 50.37 -94.98 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.093 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -153.33 123.81 7.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 159.02 166.13 17.4 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.382 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 30.1 pt -92.5 139.57 23.84 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.852 0.358 . . . . 0.0 110.501 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 6.3 Cg_exo -74.43 85.11 1.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.773 2.315 . . . . 0.0 112.432 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -127.93 96.39 32.08 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.822 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.97 82.05 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.893 2.395 . . . . 0.0 112.022 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -103.62 158.07 16.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.613 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -92.76 95.11 9.35 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.24 3.94 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.531 -170.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.422 ' CD1' HD11 ' A' ' 62' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.479 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -100.38 2.37 42.31 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.477 ' CD ' ' HB ' ' A' ' 62' ' ' ILE . 7.1 tp60 -53.11 121.53 24.65 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.076 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.521 ' HA ' ' HD2' ' A' ' 164' ' ' ARG . 52.3 Cg_exo -55.58 100.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.219 1.946 . . . . 0.0 110.788 171.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -71.05 92.93 0.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.698 -173.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 16.8 m -49.87 -47.27 51.99 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.709 0.631 . . . . 0.0 111.544 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 19.6 m 57.36 76.0 0.34 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.421 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 12.7 m -64.93 112.92 9.16 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.864 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 1.7 Cg_endo -83.12 35.65 0.58 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.546 2.83 . . . . 0.0 112.204 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 94.4 mt 64.96 105.09 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.287 0 O-C-N 123.819 0.7 . . . . 0.0 111.066 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 220' ' ' SER . 55.4 Cg_endo -72.9 111.23 3.22 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.324 2.016 . . . . 0.0 112.049 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -80.61 -34.6 35.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.156 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.34 91.83 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.739 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 217' ' ' PRO . 28.9 t -128.14 91.76 3.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.54 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -129.85 144.9 16.06 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.311 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.9 p -67.74 138.57 93.25 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 122.398 0.279 . . . . 0.0 110.852 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.3 106.95 0.9 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.498 2.132 . . . . 0.0 112.098 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -91.89 120.34 6.03 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.283 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 73.24 -43.85 0.57 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.653 0.781 . . . . 0.0 112.705 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 60.24 42.5 15.09 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.228 0.537 . . . . 0.0 110.53 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.466 ' H ' HG13 ' A' ' 227' ' ' ILE . 2.4 pp -80.21 -5.94 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.645 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 26.2 m -76.27 130.51 77.33 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.27 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.27 -41.56 65.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.012 2.475 . . . . 0.0 112.945 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 48.8 tp -120.75 88.34 43.65 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.792 0.33 . . . . 0.0 110.401 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -95.02 10.37 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.389 2.726 . . . . 0.0 112.457 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 20.6 m -123.83 169.52 11.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.063 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 41.1 p -87.43 156.76 19.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.687 0.279 . . . . 0.0 110.796 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -66.17 98.16 0.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.832 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -98.11 -33.79 11.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.415 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.9 -135.18 1.9 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.761 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.25 160.26 39.54 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.749 2.3 . . . . 0.0 112.023 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.539 ' HB ' HG13 ' A' ' 266' ' ' VAL . 22.0 t -99.65 145.12 11.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -114.73 115.27 26.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.275 0.559 . . . . 0.0 110.941 -175.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -136.55 127.6 27.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.889 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.789 ' HB3' HD13 ' A' ' 263' ' ' ILE . 22.3 pttm -93.06 140.51 29.41 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.271 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.4 110.52 6.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.613 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.477 HG13 ' HG3' ' A' ' 244' ' ' GLN . 26.6 pt -69.1 -32.69 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 111.04 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.477 ' HG3' HG13 ' A' ' 243' ' ' ILE . 23.6 mt-30 -118.41 166.2 12.95 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.478 ' HB3' HG13 ' A' ' 260' ' ' VAL . 9.3 ptpp? -94.81 146.16 24.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.42 0.628 . . . . 0.0 111.099 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.709 HH11 ' HB2' ' A' ' 246' ' ' ARG . 0.0 OUTLIER -128.28 110.85 12.77 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.35 173.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.839 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 33.7 m -82.21 173.3 7.82 Favored Pre-proline 0 C--N 1.316 -0.853 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.839 ' HD2' ' HB ' ' A' ' 247' ' ' VAL . 46.2 Cg_endo -69.1 52.88 0.81 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.615 2.21 . . . . 0.0 112.864 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 15.8 t -100.28 -146.71 0.34 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 61.11 19.06 9.63 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.306 0.575 . . . . 0.0 109.995 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 60.33 31.32 20.37 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.32 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 69.65 14.83 8.18 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.141 168.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -81.41 89.42 6.12 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.554 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.7 p 50.84 31.85 6.56 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.489 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -84.55 113.39 21.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.687 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.638 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.3 tt -88.86 117.3 27.76 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.68 120.74 14.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.586 HD22 HG22 ' A' ' 264' ' ' VAL . 95.0 mt -128.12 116.26 19.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.174 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -86.55 158.37 19.54 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.053 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 245' ' ' LYS . 9.6 m -62.1 110.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.509 0.671 . . . . 0.0 111.864 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.99 -1.44 57.79 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.96 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -79.32 138.55 37.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.841 0.321 . . . . 0.0 110.665 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.789 HD13 ' HB3' ' A' ' 241' ' ' LYS . 46.2 mm -84.1 116.64 28.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.04 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.586 HG22 HD22 ' A' ' 258' ' ' LEU . 40.4 t -89.31 114.09 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.307 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -86.26 88.7 7.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.539 HG13 ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -91.85 117.34 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.515 0.674 . . . . 0.0 110.714 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.06 -22.85 13.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.504 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.621 ' HB2' ' HG2' ' A' ' 276' ' ' GLU . 55.6 mtp180 -123.32 126.09 46.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.412 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 53.1 mtt -122.95 127.2 48.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.448 ' HB2' ' HG3' ' A' ' 274' ' ' GLN . 40.3 m-80 -91.68 139.79 30.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 25.9 pt -70.66 -8.29 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.903 0.383 . . . . 0.0 111.858 -173.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -69.1 -30.46 68.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.952 0.406 . . . . 0.0 110.774 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.3 -5.06 13.43 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.572 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.448 ' HG3' ' HB2' ' A' ' 270' ' ' ASN . 7.8 pt20 -94.69 115.0 27.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 175.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.483 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 36.5 m0 -110.42 145.58 37.35 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.146 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.621 ' HG2' ' HB2' ' A' ' 268' ' ' ARG . 1.4 pm0 -112.61 115.38 28.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.556 0.694 . . . . 0.0 110.383 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -118.22 164.21 12.87 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.112 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -102.02 110.79 22.84 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.638 ' HB ' HD21 ' A' ' 256' ' ' LEU . 98.7 t -122.76 117.87 53.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.204 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.422 HD22 ' N ' ' A' ' 280' ' ' ASN . 0.9 OUTLIER 64.36 -81.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.369 -175.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -147.32 3.63 0.9 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.364 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.8 mtp-105 -108.31 144.54 35.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.845 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -120.44 121.57 38.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.847 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.512 ' H ' HD12 ' A' ' 256' ' ' LEU . . . -144.95 169.24 26.75 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.404 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 95.5 mt -93.56 113.99 26.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.975 0.417 . . . . 0.0 110.225 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -115.51 143.17 30.0 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.565 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.64 149.89 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.256 1.97 . . . . 0.0 112.205 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -65.17 -16.64 63.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.274 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -5.65 56.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.023 0.44 . . . . 0.0 111.597 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 246' ' ' ARG . 63.4 t60 -96.73 -18.76 19.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.01 0.433 . . . . 0.0 110.662 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 242' ' ' ALA . 31.3 m -128.03 170.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.419 -176.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -131.1 126.4 35.69 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 240' ' ' ALA . 41.5 mm -70.83 130.72 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -133.24 161.26 34.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.033 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -67.76 115.41 27.35 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.27 -25.25 64.66 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.754 2.303 . . . . 0.0 111.991 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -101.87 86.95 3.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.077 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -90.46 113.32 57.19 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.04 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.67 -13.24 22.24 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.359 2.04 . . . . 0.0 111.781 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.22 146.27 26.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.541 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 71.51 -75.4 0.08 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.996 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 303' ' ' GLU . 6.3 t30 -109.19 91.95 3.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -172.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 302' ' ' ASN . 10.7 tp10 . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.523 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.644 0.259 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.8 m -78.45 110.1 13.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.244 0.545 . . . . 0.0 110.667 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 t -142.94 147.86 35.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.258 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -73.6 85.3 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.27 0.557 . . . . 0.0 110.67 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -150.38 92.93 1.92 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.773 0.797 . . . . 0.0 110.652 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -138.88 162.8 33.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.18 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -78.24 93.19 4.58 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.634 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 4.5 p -77.26 65.15 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.304 0.573 . . . . 0.0 110.434 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.4 t -175.48 -41.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.079 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.36 104.46 0.5 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.489 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 9.1 mtm-85 -70.51 -14.39 62.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.554 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -85.31 -1.94 57.52 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.1 -47.79 5.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.722 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 30.2 p-90 -114.95 -29.99 6.53 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 47.9 t80 -75.42 111.21 10.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.631 ' HB3' HG21 ' A' ' 19' ' ' VAL . 10.7 tpp -100.58 1.53 40.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.367 -172.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.6 -114.71 3.23 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.013 -0.994 . . . . 0.0 114.225 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.58 104.3 1.85 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.429 2.086 . . . . 0.0 112.383 -176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.858 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 93.2 t -132.88 -76.35 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 119.256 -0.402 . . . . 0.0 112.037 -174.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.708 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 73.3 m 74.47 167.99 0.29 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -53.36 -32.79 50.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -44.46 -54.72 5.68 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.884 0.74 . . . . 0.0 112.111 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.617 ' HB2' HG13 ' A' ' 19' ' ' VAL . 47.3 mt-10 -95.6 -45.21 7.14 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.262 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.55 -46.65 28.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.28 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.666 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 20.7 mt-30 -64.71 -56.4 13.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.668 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -66.2 -23.44 66.44 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -171.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -86.24 -15.75 39.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.898 0.38 . . . . 0.0 110.692 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.601 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 68.7 mt -121.63 17.89 11.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.593 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 54.8 mm-40 -76.3 70.02 2.87 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.08 -20.04 52.38 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.677 171.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.788 ' HG2' ' HB3' ' A' ' 108' ' ' PRO . 26.1 mp0 -61.79 123.11 17.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.244 0.522 . . . . 0.0 111.477 -175.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 34.8 mtm180 55.58 -51.56 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.111 1.764 . . . . 0.0 115.19 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 32.0 m170 74.19 134.01 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.571 0.748 . . . . 0.0 109.143 -170.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.15 -3.24 44.13 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -172.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.759 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 76.1 mtm -96.62 147.72 23.6 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.438 ' CD1' HD22 ' A' ' 98' ' ' LEU . 45.8 p90 -146.68 165.94 28.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.613 0.244 . . . . 0.0 110.935 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.3 pp -152.8 136.04 15.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.94 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.8 t -103.86 122.8 57.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.49 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.858 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 9.6 ptt180 -121.63 165.63 15.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.507 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.423 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 3.9 p30 -85.57 138.8 31.93 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.52 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 8.5 t -74.45 135.73 42.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.212 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.1 t -78.13 -10.32 59.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.639 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -78.39 -48.34 15.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.581 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 41' ' ' SER . 48.4 t -159.03 135.98 6.79 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.37 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.42 5.08 2.1 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.303 2.002 . . . . 0.0 112.728 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.34 8.26 58.69 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.523 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -144.7 160.84 40.55 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.423 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 22.1 m-85 -124.78 164.05 20.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.955 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 62' ' ' ILE . 18.6 t -127.56 99.13 5.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 0.0 110.569 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.41 ' CB ' HD11 ' A' ' 63' ' ' ILE . 22.2 tp -78.17 101.31 6.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.134 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 59' ' ' SER . 58.4 m -96.75 131.98 42.91 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.385 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.617 HG21 HD13 ' A' ' 93' ' ' LEU . 47.2 t -119.36 151.82 21.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.835 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.601 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 14.1 t -102.59 119.02 38.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.999 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 1.101 ' HG2' ' HB3' ' A' ' 57' ' ' ARG . 7.1 pm0 -145.61 175.25 10.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 169.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.475 ' HB2' ' C ' ' A' ' 117' ' ' ASN . 6.0 p30 -36.2 89.51 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.391 1.076 . . . . 0.0 113.865 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.671 ' CB ' ' HA ' ' A' ' 116' ' ' PRO . 1.4 m 39.8 62.55 1.2 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.912 0.863 . . . . 0.0 110.023 -173.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.101 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -162.14 50.57 0.2 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.027 -154.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 38.2 t -76.62 95.63 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.566 ' OG ' ' HB ' ' A' ' 52' ' ' VAL . 12.5 p -77.88 119.35 21.22 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.281 -172.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 84.4 m-70 -101.11 88.13 3.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.081 -176.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.733 ' HB3' HD11 ' A' ' 73' ' ' ILE . 71.4 m-85 -93.12 112.12 23.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.516 0.327 . . . . 0.0 111.713 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.515 HG12 HG22 ' A' ' 49' ' ' VAL . 43.9 mt -82.17 140.56 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.1 mp -124.2 121.04 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.629 0.771 . . . . 0.0 110.603 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -85.39 135.57 33.82 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.7 t -80.86 103.23 10.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 72' ' ' LYS . 83.3 mt -85.6 132.13 45.5 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.877 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.46 -5.84 12.3 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.019 2.48 . . . . 0.0 112.28 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -87.85 14.76 8.12 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.81 31.29 14.2 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.518 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -121.14 176.04 5.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.881 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.446 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 58.9 m-85 -139.13 129.24 25.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.105 0.478 . . . . 0.0 110.692 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HB2' HD11 ' A' ' 66' ' ' LEU . 39.7 ttmt -115.94 108.01 15.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.73 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.733 HD11 ' HB3' ' A' ' 61' ' ' TYR . 15.9 tt -87.5 78.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.642 0.734 . . . . 0.0 110.17 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.545 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 61.68 81.37 0.09 OUTLIER Glycine 0 C--O 1.226 -0.4 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.89 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.847 ' HB2' ' HB2' ' A' ' 211' ' ' GLN . 37.8 t70 75.94 -48.09 0.58 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.962 0.505 . . . . 0.0 112.158 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -66.93 125.01 24.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.632 0.73 . . . . 0.0 111.744 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -84.47 131.79 34.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.129 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -139.53 173.77 11.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.998 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -77.04 -42.95 36.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.974 0.416 . . . . 0.0 110.454 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.486 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 6.8 p80 -172.49 -174.48 1.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.159 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 13.0 mt -54.4 -60.74 6.88 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.634 ' HB3' ' O ' ' A' ' 8' ' ' SER . 51.5 Cg_exo -58.43 -9.69 7.36 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.411 2.074 . . . . 0.0 113.795 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.469 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -94.48 -35.62 12.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.759 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.19 -29.7 57.75 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.323 0.582 . . . . 0.0 109.431 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.17 -30.64 70.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.794 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.422 ' HA ' ' CD ' ' A' ' 89' ' ' LYS . 33.9 tt0 -76.43 -7.98 56.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.37 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -97.23 -37.17 10.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.499 0.666 . . . . 0.0 109.445 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.573 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 38.8 m-85 -81.0 -10.32 59.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.466 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.422 ' CD ' ' HA ' ' A' ' 86' ' ' GLU . 22.4 ptmt -81.31 -7.34 59.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.225 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.6 pt -123.74 3.67 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 121.262 0.553 . . . . 0.0 110.619 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.573 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 4.5 t-160 -97.13 -40.27 8.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.435 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.719 ' CD2' HG23 ' A' ' 97' ' ' THR . 95.7 m-85 75.17 88.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.416 1.073 . . . . 0.0 110.472 -172.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.732 HD22 ' CE2' ' A' ' 61' ' ' TYR . 2.0 mt -66.51 97.88 0.46 Allowed 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.743 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 9.4 t70 56.33 73.13 0.46 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.021 -175.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 27.2 m 75.32 -39.32 0.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -107.75 139.9 41.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.176 0.512 . . . . 0.0 111.047 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.719 HG23 ' CD2' ' A' ' 92' ' ' TYR . 2.9 p -83.62 177.14 8.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.789 0.328 . . . . 0.0 110.527 176.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.438 HD22 ' CD1' ' A' ' 36' ' ' PHE . 81.5 mt -70.05 98.44 1.31 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 172.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 50.8 mm -84.47 -55.73 6.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.808 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 35' ' ' MET . 36.7 tt0 -167.02 141.59 3.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.061 -175.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.12 157.74 28.59 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.556 2.171 . . . . 0.0 112.734 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.43 144.49 57.5 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.818 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HD3' ' SD ' ' A' ' 35' ' ' MET . 33.5 Cg_exo -60.42 131.68 39.65 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.569 2.179 . . . . 0.0 111.594 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.471 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 26.3 ptt180 -80.51 30.95 0.29 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.748 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -131.36 135.19 26.66 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.44 53.92 3.22 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.175 2.584 . . . . 0.0 113.131 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.653 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 11.2 t -84.61 -43.94 0.71 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.788 ' HB3' ' HG2' ' A' ' 31' ' ' GLN . 10.1 Cg_endo -52.76 134.88 55.73 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.468 2.112 . . . . 0.0 112.955 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.87 155.78 23.59 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.676 2.251 . . . . 0.0 112.413 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 50.8 ttm -83.99 106.69 15.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.602 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.01 111.77 4.47 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.895 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m -83.84 75.13 10.12 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.834 -0.215 . . . . 0.0 111.477 -176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.58 ' HA ' ' HB2' ' A' ' 121' ' ' ALA . 7.1 p 35.53 84.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.454 1.102 . . . . 0.0 113.966 173.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 m -97.03 -57.52 2.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.292 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.628 ' HB3' ' HG2' ' A' ' 119' ' ' PRO . . . -172.54 144.8 1.35 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.762 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.671 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 6.3 Cg_exo -79.81 168.08 19.69 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.964 2.442 . . . . 0.0 112.512 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.549 ' H ' ' HB2' ' A' ' 56' ' ' SER . 10.6 m120 73.03 8.5 5.4 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 173.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.903 ' HB3' ' HD3' ' A' ' 119' ' ' PRO . 1.0 OUTLIER -169.64 -68.35 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.167 169.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.903 ' HD3' ' HB3' ' A' ' 118' ' ' LEU . 37.3 Cg_exo -61.74 -76.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 122.478 2.119 . . . . 0.0 114.034 -173.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.5 t -172.19 169.22 5.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.528 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.58 ' HB2' ' HA ' ' A' ' 113' ' ' VAL . . . 80.84 144.99 0.08 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.486 1.114 . . . . 0.0 112.917 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.436 ' OE2' ' HB ' ' A' ' 58' ' ' VAL . 54.9 mt-10 -94.9 119.19 33.04 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.312 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.435 ' HB3' ' HG3' ' A' ' 116' ' ' PRO . 26.4 t70 -152.78 -77.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.454 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 1.9 t-20 -82.65 168.66 17.06 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.842 HD12 HG21 ' A' ' 152' ' ' ILE . 2.2 mm? 65.88 94.05 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.635 0.584 . . . . 0.0 109.887 -175.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 5.2 tp10 -165.86 -76.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.413 -171.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.487 ' O ' ' HB2' ' A' ' 180' ' ' LYS . 28.5 m-85 -106.01 124.4 49.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.753 -171.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 22.3 t -133.22 151.36 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.112 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.727 ' HG2' ' HB3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -131.02 142.11 50.29 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.681 162.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.472 HG22 HG12 ' A' ' 178' ' ' VAL . 1.8 p -97.94 140.22 32.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.914 0.387 . . . . 0.0 111.949 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 61.8 mt -108.55 -22.63 12.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.14 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 57.0 t80 -92.33 -35.04 13.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -167.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 7.0 t70 76.01 113.19 0.07 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.337 0.589 . . . . 0.0 110.395 -174.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 71.4 t80 -147.19 109.51 3.96 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.068 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 20.9 Cg_endo -92.91 102.28 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.53 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.737 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -95.12 4.27 67.47 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.365 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.7 m120 57.54 20.63 6.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.331 0.653 . . . . 0.0 112.547 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 169' ' ' ARG . 1.9 p30 52.2 -175.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 173.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 69.09 7.2 6.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.494 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -169.39 -45.7 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.241 -1.345 . . . . 0.0 108.361 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.737 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 24.2 m-20 -140.85 116.04 9.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.759 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.048 HD11 ' HB2' ' A' ' 165' ' ' ASN . 25.2 tp -67.53 120.57 74.03 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.617 0.246 . . . . 0.0 110.937 -174.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 43.6 Cg_endo -75.13 95.59 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.031 1.821 . . . . 0.0 111.346 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 10.0 p90 -104.6 172.58 6.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.567 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.468 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 8.7 ttmm -122.52 -178.14 3.82 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.941 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.637 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -84.02 75.18 10.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.458 0.647 . . . . 0.0 109.604 177.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.9 33.83 0.54 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.171 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 6.7 mm-40 -94.62 154.95 17.1 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 129' ' ' ARG . 40.0 mm -103.85 125.84 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.559 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 32.9 mt -118.82 156.77 28.85 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 59.8 t -124.83 129.79 73.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.842 HG21 HD12 ' A' ' 125' ' ' LEU . 30.6 mm -74.55 86.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.384 1.088 . . . . 0.0 109.073 -176.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 210' ' ' PRO . 10.4 tt -75.18 -26.42 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.341 -174.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.785 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 44.5 mt-10 -146.69 143.91 29.08 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.437 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 44.4 tttm -125.34 87.44 55.64 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 121.46 -0.775 . . . . 0.0 111.026 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.597 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 16.8 Cg_exo -70.62 -62.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.387 2.058 . . . . 0.0 112.542 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -109.63 -174.8 2.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.845 0.355 . . . . 0.0 111.748 -171.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -95.81 -29.15 14.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.324 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -96.18 -22.53 17.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.155 0.502 . . . . 0.0 110.82 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.49 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 42.5 m95 -128.93 124.55 35.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.67 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -107.42 164.87 11.83 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.785 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 29.3 m -113.13 106.66 14.92 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.926 -0.484 . . . . 0.0 109.748 174.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.772 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -115.95 158.92 22.3 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.388 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.708 HH12 ' HA ' ' A' ' 208' ' ' ALA . 13.2 ptt180 -95.48 132.43 40.58 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.355 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.048 ' HB2' HD11 ' A' ' 142' ' ' LEU . 63.0 t30 -72.0 171.35 12.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.522 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -59.31 -29.79 67.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.45 -43.43 94.28 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.783 ' HA3' ' HA ' ' A' ' 211' ' ' GLN . . . 105.02 67.43 0.7 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.866 -176.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.665 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -143.73 160.01 41.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.438 HG22 HD13 ' A' ' 153' ' ' ILE . 37.5 t -101.75 125.57 55.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.307 0.575 . . . . 0.0 111.986 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.6 161.9 30.44 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.597 ' HE3' ' HG2' ' A' ' 156' ' ' PRO . 25.6 mtp -81.07 144.25 31.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.179 0.489 . . . . 0.0 110.271 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.504 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.7 pp -139.66 143.4 35.02 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.875 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.49 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 3.0 Cg_exo -76.3 132.65 13.94 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.897 2.398 . . . . 0.0 112.561 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 178' ' ' VAL . 60.3 t -62.8 -43.03 81.87 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 23.2 Cg_endo -62.57 -4.39 5.56 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.953 1.769 . . . . 0.0 113.302 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -99.64 -8.57 24.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.592 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 175' ' ' VAL . 10.5 m -107.24 -178.33 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 122.265 1.031 . . . . 0.0 113.576 -168.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.727 ' HB3' ' HG2' ' A' ' 129' ' ' ARG . 23.6 tt0 -154.46 42.13 0.49 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.098 -1.865 . . . . 0.0 109.221 -165.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.955 ' HE3' ' HB2' ' A' ' 183' ' ' ARG . 0.1 OUTLIER -77.69 137.74 38.68 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 120.432 -1.418 . . . . 0.0 108.817 -167.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.421 HD23 ' HB3' ' A' ' 127' ' ' TYR . 4.6 mm? -30.51 -76.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 113.303 -1.771 . . . . 0.0 114.085 -157.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.8 t -118.88 110.49 30.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.415 -175.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.955 ' HB2' ' HE3' ' A' ' 180' ' ' LYS . 18.2 ttt180 -170.07 99.53 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 173.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.5 t -134.83 97.72 3.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.262 0.553 . . . . 0.0 110.194 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.425 ' HB3' ' HE1' ' A' ' 187' ' ' HIS . 8.3 t -88.53 136.43 31.37 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.65 127.28 22.13 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.589 2.193 . . . . 0.0 112.363 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 190' ' ' HIS . 80.3 m80 -139.35 170.62 15.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -58.92 -59.19 11.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.457 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -125.79 59.2 1.3 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.96 0.409 . . . . 0.0 110.434 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 187' ' ' HIS . 51.0 t60 -161.5 118.25 2.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.697 173.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -172.45 -158.64 17.17 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.886 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -142.98 143.49 31.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.726 0.298 . . . . 0.0 110.327 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -84.76 -40.43 17.26 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -156.46 140.76 16.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.98 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 51.8 m -143.4 114.74 7.96 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -143.75 113.63 7.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.365 0.602 . . . . 0.0 110.779 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.498 ' HB3' HD13 ' A' ' 200' ' ' ILE . 38.8 m -149.19 83.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.847 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -94.73 -36.49 11.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.795 -174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -88.94 32.68 4.5 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.538 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.642 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 2.6 mp -114.1 -54.14 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 119.751 -0.166 . . . . 0.0 111.225 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 16.2 Cg_exo -68.59 106.94 1.53 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.155 1.903 . . . . 0.0 112.711 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -118.27 109.38 40.68 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.457 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.46 94.8 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.688 2.259 . . . . 0.0 111.838 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -96.2 -51.11 4.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.488 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -152.61 93.2 1.75 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.789 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -76.85 90.23 3.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.233 0.539 . . . . 0.0 111.658 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.411 ' HD2' ' HB3' ' A' ' 60' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.708 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -91.39 39.38 1.0 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.399 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.481 ' HG2' ' HB ' ' A' ' 62' ' ' ILE . 39.5 mt-30 -61.29 146.01 89.51 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.545 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 52.8 Cg_exo -57.15 -51.44 8.69 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 121.936 1.757 . . . . 0.0 110.76 172.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.847 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 50.2 tt0 -85.09 111.06 19.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.523 ' HB ' ' HE ' ' A' ' 164' ' ' ARG . 15.2 t -62.08 -39.92 94.06 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.185 -0.206 . . . . 0.0 110.715 -176.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 25.2 m 68.83 -63.01 0.37 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.929 0.492 . . . . 0.0 111.774 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 4.7 m 62.63 78.18 0.31 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.78 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.74 128.81 5.37 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.885 2.39 . . . . 0.0 111.262 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.75 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 6.3 mp -103.78 -58.24 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.618 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.75 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 27.9 Cg_exo -63.28 -19.83 69.25 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.286 1.991 . . . . 0.0 112.539 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -86.0 21.12 2.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.661 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.623 HG22 ' H ' ' A' ' 221' ' ' GLY . 11.5 p -89.25 132.48 33.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.056 0.455 . . . . 0.0 110.276 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 11.0 p -91.72 -12.91 32.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.959 0.409 . . . . 0.0 110.923 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.623 ' H ' HG22 ' A' ' 219' ' ' VAL . . . 88.53 -116.32 4.59 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 9.5 t 69.37 100.71 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.059 0.544 . . . . 0.0 111.615 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.93 167.75 25.52 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.505 2.137 . . . . 0.0 111.919 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -81.43 70.27 3.13 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.379 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.53 -35.09 17.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.628 0.251 . . . . 0.0 110.666 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 57.14 -171.58 0.09 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.863 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.2 tt -89.32 -38.48 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.215 0.531 . . . . 0.0 109.575 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 229' ' ' PRO . 4.7 p -134.31 112.63 12.07 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.992 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 228' ' ' THR . 17.8 Cg_endo -60.94 -32.05 92.11 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.712 2.275 . . . . 0.0 112.178 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -146.46 108.82 4.17 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.02 116.96 3.67 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 111.987 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 12.3 t -84.18 124.83 31.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.003 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 12.5 p -102.43 154.93 18.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.127 0.489 . . . . 0.0 111.44 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -130.38 27.3 5.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.554 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.674 ' N ' HD22 ' A' ' 235' ' ' ASN . 0.0 OUTLIER -171.49 119.44 0.46 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.118 -164.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.836 ' HA3' ' HB3' ' A' ' 276' ' ' GLU . . . -133.64 -175.92 14.15 Favored Glycine 0 C--O 1.19 -2.639 0 CA-C-O 118.474 -1.181 . . . . 0.0 111.498 177.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.944 ' HD2' ' H ' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -14.42 -134.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.519 3.017 2 C-N-CA 130.787 7.658 . . . . 0.0 124.952 -168.747 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.877 ' N ' HG13 ' A' ' 266' ' ' VAL . 88.8 t -131.52 131.84 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.965 -1.085 . . . . 0.0 111.988 -165.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 1.01 ' HB2' ' HA ' ' A' ' 265' ' ' LYS . 0.0 OUTLIER -69.21 130.61 43.12 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.333 1.063 . . . . 0.0 111.996 -160.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.535 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -148.63 159.41 44.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.802 -168.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -91.3 135.78 33.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.579 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -77.56 126.5 30.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 31.9 pt -101.75 -6.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.439 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.32 155.63 43.25 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.578 ' HB3' HG23 ' A' ' 260' ' ' VAL . 18.4 pttp -113.88 137.02 52.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.749 0.309 . . . . 0.0 110.777 174.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.549 ' HG3' ' CE1' ' A' ' 290' ' ' HIS . 0.0 OUTLIER -174.72 137.61 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 1.058 HG13 ' HD3' ' A' ' 248' ' ' PRO . 0.2 OUTLIER -95.61 -52.33 0.23 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 119.248 -0.406 . . . . 0.0 112.041 178.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 1.058 ' HD3' HG13 ' A' ' 247' ' ' VAL . 33.6 Cg_endo -95.53 143.8 1.22 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.119 1.88 . . . . 0.0 111.997 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 45.7 t -84.76 58.94 5.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 65.9 -66.21 0.16 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.798 0.839 . . . . 0.0 111.453 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -102.53 -11.01 18.84 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.199 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 31.4 t70 67.32 106.76 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.917 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -135.68 86.39 2.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.765 174.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.7 p 51.4 57.6 6.42 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.987 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -89.64 147.77 23.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.577 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.39 110.15 22.29 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 247' ' ' VAL . . . -56.75 105.48 0.22 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.514 0.509 . . . . 0.0 110.588 177.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 279' ' ' VAL . 90.8 mt -118.38 130.59 56.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.018 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -111.79 173.7 6.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.038 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.578 HG23 ' HB3' ' A' ' 245' ' ' LYS . 57.7 t -75.58 124.57 33.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 112.109 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 88.25 25.31 31.52 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.383 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.28 150.84 36.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.135 0.468 . . . . 0.0 110.389 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 30.7 mm -86.52 123.19 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.317 0.579 . . . . 0.0 111.639 -175.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.73 ' HA ' HG22 ' A' ' 279' ' ' VAL . 44.7 t -101.07 103.2 14.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.772 177.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 1.01 ' HA ' ' HB2' ' A' ' 239' ' ' PHE . 18.0 ttpp -86.03 86.5 7.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.006 0.432 . . . . 0.0 110.667 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.877 HG13 ' N ' ' A' ' 238' ' ' VAL . 13.7 p -105.29 136.46 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 236' ' ' GLY . 15.3 t -124.55 -14.41 6.85 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -167.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 236' ' ' GLY . 35.1 ttt180 -135.78 98.64 3.96 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 120.921 1.691 . . . . 0.0 111.744 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . 0.891 ' CA ' ' HA ' ' A' ' 237' ' ' PRO . 34.1 ttm -79.1 140.29 37.88 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -162.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.561 ' H ' ' HG3' ' A' ' 237' ' ' PRO . 83.2 m-20 -98.3 137.0 37.67 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.734 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.6 tt -75.93 -8.35 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.267 0.556 . . . . 0.0 110.623 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -69.21 -28.51 66.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.945 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 109.48 -17.79 30.68 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.696 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.1 118.82 29.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.879 ' HA ' ' HG2' ' A' ' 237' ' ' PRO . 47.3 m0 -98.85 145.03 27.4 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.051 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.944 ' H ' ' HD2' ' A' ' 237' ' ' PRO . 38.7 tt0 -117.93 97.41 5.81 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.275 0.56 . . . . 0.0 109.741 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -107.61 150.73 16.9 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.153 -168.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -104.65 109.83 21.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.73 HG22 ' HA ' ' A' ' 264' ' ' VAL . 60.4 t -114.39 91.27 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.083 0.468 . . . . 0.0 110.453 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 54.37 55.89 7.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.814 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 97.71 -28.33 14.86 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.512 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.1 mtm105 -104.39 118.48 36.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.945 0.373 . . . . 0.0 110.377 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 47.9 pttt -121.31 142.44 49.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.084 0.468 . . . . 0.0 111.882 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -171.07 -174.48 38.91 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.484 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 87.0 mt -93.38 144.75 25.04 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.583 0.706 . . . . 0.0 111.905 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.464 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 36.1 p90 -149.77 151.41 32.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.999 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 290' ' ' HIS . 60.8 Cg_endo -74.34 151.71 43.39 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.261 1.974 . . . . 0.0 112.26 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -64.25 -21.34 66.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.636 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.2 m -77.22 -8.53 57.73 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.229 0.538 . . . . 0.0 110.992 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.549 ' CE1' ' HG3' ' A' ' 246' ' ' ARG . 16.5 t60 -86.03 -22.01 27.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.157 0.503 . . . . 0.0 110.631 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.0 m -128.31 178.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.501 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -141.29 136.91 32.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.524 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.535 HD13 ' HB2' ' A' ' 240' ' ' ALA . 47.2 mm -81.68 102.82 7.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -100.23 14.44 30.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.825 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 53.58 70.72 1.64 Allowed Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.348 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.76 -22.34 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.119 2.546 . . . . 0.0 113.634 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -140.63 19.84 2.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.03 0.443 . . . . 0.0 110.864 -176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -140.14 115.56 7.82 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.339 0.59 . . . . 0.0 110.625 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -86.69 41.61 0.8 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.161 2.574 . . . . 0.0 111.881 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -114.42 127.31 55.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.503 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -87.52 -0.9 57.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.999 170.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.586 ' ND2' ' HG2' ' A' ' 303' ' ' GLU . 0.2 OUTLIER 64.45 -95.56 0.04 OUTLIER 'General case' 0 C--O 1.23 0.067 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.839 -178.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . 0.586 ' HG2' ' ND2' ' A' ' 302' ' ' ASN . 6.0 pt-20 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 117.622 -1.18 . . . . 0.0 109.573 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.713 ' HG3' ' HE2' ' A' ' 89' ' ' LYS . 25.8 mmt . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.859 0.362 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.8 p -87.39 -57.43 2.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.99 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -128.74 100.61 5.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.977 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -179.65 135.72 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.445 0.466 . . . . 0.0 111.054 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 6' ' ' PHE . 4.4 tmt_? -113.9 -68.07 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 5.4 m-85 62.96 165.28 0.11 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -109.53 -39.35 5.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.818 161.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.2 m 64.68 147.56 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.037 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.0 p 61.15 -49.65 0.12 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.988 1.315 . . . . 0.0 113.875 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -57.31 107.01 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 111.586 -172.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.601 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -61.97 -22.81 65.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.479 -178.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.2 t -79.32 -15.96 57.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.641 0.258 . . . . 0.0 110.862 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.93 -49.03 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.168 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -110.83 -22.81 11.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.601 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 56.2 t80 -85.57 113.13 21.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.713 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 9.6 tpp -97.42 -1.16 44.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.555 -172.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.444 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.44 -115.43 3.75 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.159 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.1 Cg_exo -74.75 103.61 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.842 2.361 . . . . 0.0 112.187 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.636 ' HB ' ' CB ' ' A' ' 39' ' ' ARG . 88.3 t -137.36 -74.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 60.0 m 76.02 172.12 0.25 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.493 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -51.95 -43.69 63.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -174.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -60.37 -38.04 82.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -92.35 -44.79 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.385 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.56 68.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.882 0.372 . . . . 0.0 111.121 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.57 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 64.9 tt0 -67.37 -52.83 35.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.908 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -72.71 -14.25 61.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 0.0 111.425 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -78.65 -44.07 24.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.565 0.697 . . . . 0.0 110.055 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 16.1 mt -104.25 12.07 34.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.491 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 20.8 tt0 -76.87 104.45 7.37 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.618 0.723 . . . . 0.0 110.573 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.499 ' H ' ' NE2' ' A' ' 31' ' ' GLN . . . 118.02 -20.82 10.53 Favored Glycine 0 CA--C 1.499 -0.917 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.922 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER 40.11 111.02 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 112.592 -1.804 . . . . 0.0 115.185 172.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.734 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 39.6 ttp180 -68.84 -10.22 55.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.959 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.567 ' HE1' ' HG3' ' A' ' 119' ' ' PRO . 32.3 m170 74.26 122.5 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.113 176.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.54 19.99 49.83 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.059 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.456 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 35.8 mtm -115.49 147.58 40.48 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' ' 50' ' ' LEU . 40.0 p90 -147.44 158.85 44.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.129 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 pp -150.95 135.35 16.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.218 0.533 . . . . 0.0 110.507 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.11 115.58 44.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.113 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.636 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.68 -173.44 2.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.05 0.452 . . . . 0.0 112.048 -176.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 7.3 p-10 -71.23 138.06 49.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.874 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -100.42 89.14 3.86 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 168.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 p -71.75 11.82 0.46 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.449 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 t -100.19 -8.51 23.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 50.3 t -164.76 110.0 0.84 Allowed Pre-proline 0 CA--C 1.528 0.121 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.079 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.04 115.83 2.83 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.966 2.444 . . . . 0.0 112.466 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.48 -41.94 1.78 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.049 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.646 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 3.3 m-20 -74.3 158.66 33.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.723 0.297 . . . . 0.0 110.483 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.404 ' CD2' HD11 ' A' ' 81' ' ' LEU . 46.2 m-85 -134.68 173.91 11.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.695 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.634 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 58.4 t -137.94 109.38 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 111.007 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 36' ' ' PHE . 26.2 tp -81.03 104.55 11.6 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.536 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 m -95.46 120.95 36.6 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.856 0.36 . . . . 0.0 110.34 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 22.1 t -120.4 142.55 35.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.922 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 89.2 p -121.99 133.56 54.82 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.531 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.505 ' CB ' ' HB3' ' A' ' 94' ' ' ASP . 1.9 tm-20 -147.94 178.15 8.75 Favored 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -16.94 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.455 ' HB2' ' H ' ' A' ' 122' ' ' GLU . 36.3 m 35.91 72.13 0.11 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.706 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.906 ' HD2' ' HB3' ' A' ' 155' ' ' LYS . 9.8 ttp85 -168.51 52.93 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.743 -158.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 25.3 t -77.68 101.62 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 122.07 0.938 . . . . 0.0 109.651 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 m -93.21 121.22 34.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.323 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -94.25 89.45 5.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.283 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.772 ' HB3' HD11 ' A' ' 73' ' ' ILE . 88.0 m-85 -84.81 115.07 22.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.725 0.41 . . . . 0.0 110.786 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.632 HD12 ' HG2' ' A' ' 209' ' ' GLN . 63.1 mt -81.3 140.0 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -174.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.663 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.6 mp -115.75 121.19 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.597 0.759 . . . . 0.0 110.568 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.646 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 8.3 m120 -85.74 146.28 26.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.916 0.487 . . . . 0.0 111.566 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.0 t -93.18 99.18 11.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.924 174.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.4 mt -84.22 142.91 41.44 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.48 -28.78 46.31 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.617 2.878 . . . . 0.0 114.115 -172.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -91.63 20.15 5.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.412 -0.18 . . . . 0.0 111.383 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.538 ' HD2' ' HB3' ' A' ' 280' ' ' ASN . 0.0 OUTLIER 67.43 40.21 2.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.139 0.495 . . . . 0.0 111.045 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -113.61 148.24 36.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.489 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 58.7 m-85 -114.71 115.77 27.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.936 0.398 . . . . 0.0 111.297 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 39.5 ttpt -110.77 105.94 14.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.538 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.772 HD11 ' HB3' ' A' ' 61' ' ' TYR . 10.2 tt -81.74 76.99 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.842 0.83 . . . . 0.0 110.175 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.845 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 60.73 95.15 0.01 OUTLIER Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.547 178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 15.9 t70 74.93 -49.51 0.66 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.849 0.357 . . . . 0.0 111.498 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -85.15 113.25 21.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 11.6 pt-20 -101.7 134.96 44.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.317 0.579 . . . . 0.0 110.816 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 80.1 m-85 -121.73 174.14 7.02 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.956 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.27 -46.89 85.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.026 0.441 . . . . 0.0 110.885 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -166.47 -178.07 4.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.427 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.519 HD23 HD21 ' A' ' 84' ' ' LEU . 16.4 mt -55.19 -57.49 19.78 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.51 25.46 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.062 1.841 . . . . 0.0 112.831 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 81' ' ' LEU . . . -119.81 -34.86 3.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.951 175.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.519 HD21 HD23 ' A' ' 81' ' ' LEU . 3.7 pp -76.68 -30.82 56.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.214 0.531 . . . . 0.0 109.968 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 6' ' ' PHE . 48.6 mt -64.57 -41.48 96.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.403 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.641 ' HA ' ' HD2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -69.5 -4.08 17.31 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.562 178.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -96.21 -37.69 10.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.812 0.815 . . . . 0.0 109.637 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.813 ' CD1' HD23 ' A' ' 93' ' ' LEU . 46.7 m-85 -77.37 -2.92 37.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.506 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.713 ' HE2' ' HG3' ' A' ' 1' ' ' MET . 16.5 ptmt -78.86 -11.11 59.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.607 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.99 -12.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 120.936 0.398 . . . . 0.0 110.88 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -75.46 -29.68 59.71 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.867 ' HA ' HG22 ' A' ' 97' ' ' THR . 23.0 m-85 59.14 55.21 4.48 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.7 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.813 HD23 ' CD1' ' A' ' 88' ' ' TYR . 3.4 pp -60.9 123.27 17.08 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 118.463 -1.295 . . . . 0.0 107.518 169.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 1.9 m-20 81.6 -2.5 1.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.28 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.798 ' OG1' ' HB3' ' A' ' 156' ' ' PRO . 33.6 m 55.99 75.55 0.33 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 122.054 0.93 . . . . 0.0 110.665 -172.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m 179.06 -34.32 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.211 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.867 HG22 ' HA ' ' A' ' 92' ' ' TYR . 4.8 p 73.38 -172.17 0.13 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.641 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 35.0 mt -85.65 94.13 9.0 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.478 173.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.79 -56.87 10.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.557 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 11.2 pt-20 -157.5 163.56 24.42 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.497 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 100' ' ' GLU . 40.4 Cg_endo -67.32 153.09 78.06 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.129 1.886 . . . . 0.0 113.026 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -71.98 143.34 86.36 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.467 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 24.0 Cg_exo -64.57 155.94 63.74 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.548 2.165 . . . . 0.0 112.066 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.713 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 14.1 mtm180 -93.94 -79.93 0.4 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 65.0 120.6 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 124.043 0.839 . . . . 0.0 112.881 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.67 -11.6 22.14 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.516 2.144 . . . . 0.0 111.385 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.486 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 47.7 t -140.25 129.17 13.23 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.023 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 107' ' ' SER . 16.7 Cg_exo -66.88 111.98 2.34 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.828 2.352 . . . . 0.0 111.91 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.58 -31.09 1.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.45 2.1 . . . . 0.0 112.763 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 97.1 mmm 62.4 175.28 0.14 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.781 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.17 118.73 1.05 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.742 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.3 m -155.25 85.2 1.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.93 -27.06 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.722 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 p -103.32 87.49 2.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.117 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.486 ' CB ' ' HG3' ' A' ' 32' ' ' ARG . . . -169.49 143.54 2.3 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.428 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 32' ' ' ARG . 1.3 Cg_endo -86.03 30.81 0.48 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 123.849 3.032 . . . . 0.0 111.999 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.734 ' OD1' ' HA ' ' A' ' 32' ' ' ARG . 5.0 m-20 -50.52 142.37 10.82 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.697 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.1 mt 49.2 74.21 0.85 Allowed Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.807 174.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.567 ' HG3' ' HE1' ' A' ' 33' ' ' HIS . 72.8 Cg_endo -93.41 -36.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.571 2.18 . . . . 0.0 111.859 168.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 90.5 m -160.85 145.86 14.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.32 103.97 16.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.455 ' H ' ' HB2' ' A' ' 56' ' ' SER . 4.3 tp10 -93.96 118.37 31.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.229 -172.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -136.12 -11.94 1.93 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.582 0.706 . . . . 0.0 109.818 176.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.716 ' HA ' HG11 ' A' ' 182' ' ' VAL . 0.9 OUTLIER -79.47 -12.2 59.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.028 -178.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 1.05 HD12 HG21 ' A' ' 152' ' ' ILE . 3.5 mm? -100.49 107.07 18.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.244 -173.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -170.14 -81.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.878 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -104.66 124.63 49.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.207 0.527 . . . . 0.0 110.655 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.697 HG22 ' CB ' ' A' ' 180' ' ' LYS . 61.4 t -133.53 137.15 53.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.407 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.613 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 2.3 ptp180 -114.31 146.67 40.19 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.066 167.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.58 HG22 HG12 ' A' ' 178' ' ' VAL . 2.1 p -103.58 135.28 45.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.017 0.436 . . . . 0.0 111.577 -176.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.586 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 78.3 mt -101.46 -40.1 7.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.421 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 23.1 t80 -74.28 -35.12 63.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -168.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.571 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.1 t70 73.47 107.34 0.07 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.247 0.546 . . . . 0.0 110.095 -177.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 77.3 t80 -140.92 103.25 6.26 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.78 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 33.7 Cg_endo -90.08 93.06 0.3 Allowed 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.378 2.052 . . . . 0.0 112.11 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -83.31 -21.16 59.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.014 174.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.9 m120 48.22 47.58 19.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.492 -0.854 . . . . 0.0 111.967 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 141' ' ' ASP . 20.1 t70 -141.14 161.04 38.8 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.55 -7.12 53.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.271 0.558 . . . . 0.0 110.98 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 172' ' ' MET . 1.4 mp0 -125.62 15.51 8.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.695 172.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.67 ' HB2' ' HB3' ' A' ' 138' ' ' ASP . 20.4 m-20 -146.61 87.75 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.788 HD11 ' HB2' ' A' ' 165' ' ' ASN . 27.1 tp -69.76 119.96 74.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.49 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.78 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 59.2 Cg_endo -73.99 90.97 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.221 1.948 . . . . 0.0 111.434 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 11.4 p90 -99.6 158.74 15.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.571 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 72.9 mmtt -98.94 178.75 4.85 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.278 0.561 . . . . 0.0 111.322 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.76 18.21 2.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.596 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.64 29.87 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.35 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 145' ' ' LYS . 24.0 tt0 -99.81 156.64 17.0 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.48 HD13 ' HB3' ' A' ' 129' ' ' ARG . 50.4 mm -99.02 133.52 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.63 HD22 HD21 ' A' ' 142' ' ' LEU . 57.4 mt -120.54 157.04 30.32 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.14 132.47 70.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.05 HG21 HD12 ' A' ' 125' ' ' LEU . 35.5 mm -75.09 88.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 122.184 0.992 . . . . 0.0 109.633 -176.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.468 HG21 HG22 ' A' ' 170' ' ' VAL . 21.5 tt -76.96 -31.32 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.189 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.997 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 65.5 mt-10 -132.63 141.46 48.66 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 171.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.906 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 1.9 tptm -129.8 84.14 61.95 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 122.305 1.05 . . . . 0.0 109.357 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.798 ' HB3' ' OG1' ' A' ' 95' ' ' THR . 19.3 Cg_exo -77.73 -66.78 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.413 2.742 . . . . 0.0 113.308 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -94.55 175.93 6.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.956 -172.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.78 -10.26 20.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -123.46 -3.34 8.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.272 0.558 . . . . 0.0 110.602 173.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.667 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 58.4 m95 -129.75 125.74 36.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.395 173.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.762 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.4 m0 -122.22 135.68 54.79 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.31 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.997 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.6 m -90.28 92.8 9.08 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.192 0.52 . . . . 0.0 109.632 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.69 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -94.22 163.27 13.51 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.939 0.4 . . . . 0.0 110.657 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.609 HH12 ' HA ' ' A' ' 208' ' ' ALA . 13.3 ptt180 -100.78 132.3 46.25 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.44 0.638 . . . . 0.0 110.583 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.788 ' HB2' HD11 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -50.3 139.06 15.65 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.467 172.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 12.4 tmtt? -56.85 -27.0 59.7 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.453 ' OD1' ' HA ' ' A' ' 215' ' ' PRO . 67.1 m-20 -99.93 9.6 42.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.583 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.64 ' HA3' HG23 ' A' ' 212' ' ' THR . . . 95.5 83.11 1.63 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.21 -0.995 . . . . 0.0 115.279 166.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 169' ' ' ARG . 2.5 ptp180 -173.04 157.63 3.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.508 0.194 . . . . 0.0 110.488 162.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 153' ' ' ILE . 48.0 t -98.32 129.91 47.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 142' ' ' LEU . . . -154.44 152.79 24.31 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.102 172.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.69 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -73.45 138.44 45.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.652 0.263 . . . . 0.0 110.461 177.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.762 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -136.71 144.65 47.84 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.74 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.898 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 23.7 Cg_exo -68.22 139.12 45.19 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.28 2.653 . . . . 0.0 112.989 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 178' ' ' VAL . 88.0 t -76.34 -47.61 3.35 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.7 Cg_endo -66.08 6.43 0.49 Allowed 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.994 1.796 . . . . 0.0 111.909 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.898 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 1.2 m-85 -105.76 -1.64 24.16 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.439 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 175' ' ' VAL . 12.9 m -116.75 -167.04 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -169.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.613 ' HB3' ' HG3' ' A' ' 129' ' ' ARG . 7.7 tp10 -157.97 41.31 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.705 -1.588 . . . . 0.0 108.791 -163.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.697 ' CB ' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -79.61 137.98 37.29 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.987 -1.07 . . . . 0.0 111.466 -167.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.4 mt -55.32 -44.56 75.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.782 -1.554 . . . . 0.0 114.05 -165.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.716 HG11 ' HA ' ' A' ' 124' ' ' ASN . 35.8 t -56.77 -37.86 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -168.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.457 ' HD2' ' HE2' ' A' ' 180' ' ' LYS . 79.2 mtt180 -92.03 18.87 7.36 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.89 -0.506 . . . . 0.0 111.337 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.6 t -152.6 58.91 0.81 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.254 0.549 . . . . 0.0 109.819 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.498 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 67.6 m -140.24 148.65 55.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.108 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 190' ' ' HIS . 9.3 Cg_endo -53.08 -59.08 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.079 2.519 . . . . 0.0 112.791 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 185' ' ' SER . 42.1 m80 67.95 -70.05 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.069 0.548 . . . . 0.0 111.356 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.49 -68.75 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.236 -0.507 . . . . 0.0 111.909 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.23 -30.38 38.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.72 0.295 . . . . 0.0 111.125 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.535 ' O ' ' HA ' ' A' ' 186' ' ' PRO . 83.1 t60 -79.94 60.34 3.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.486 0.66 . . . . 0.0 110.791 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 93.87 40.85 4.53 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.783 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.452 ' HA ' HH21 ' A' ' 193' ' ' ARG . 84.6 m-20 62.15 -163.28 0.27 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.797 0.332 . . . . 0.0 110.725 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.452 HH21 ' HA ' ' A' ' 192' ' ' ASN . 0.1 OUTLIER -99.74 -74.86 0.58 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 63.2 -76.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.028 0.83 . . . . 0.0 112.102 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.2 t -75.02 104.78 5.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.96 0.41 . . . . 0.0 110.051 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -146.63 69.25 1.18 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.625 0.726 . . . . 0.0 109.663 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 21.5 t -115.63 110.57 19.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.005 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -87.13 -45.58 10.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.947 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 59.06 -119.53 18.44 Favored Glycine 0 N--CA 1.453 -0.187 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.364 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 9.4 tt -140.03 92.75 9.58 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 121.64 0.733 . . . . 0.0 110.359 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.71 ' HB2' ' HB2' ' A' ' 204' ' ' ALA . 71.6 Cg_endo -81.57 112.83 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.703 2.269 . . . . 0.0 112.205 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.567 ' HB2' ' HD3' ' A' ' 203' ' ' PRO . 33.4 mt-10 -71.77 -53.55 7.07 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.24 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 202' ' ' GLU . 3.3 Cg_exo -81.38 19.42 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.416 2.078 . . . . 0.0 112.899 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 201' ' ' PRO . . . -80.85 8.05 9.12 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -64.41 113.4 3.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.951 0.405 . . . . 0.0 110.202 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.66 80.04 7.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 111.855 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.526 ' HE2' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.609 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -103.32 25.58 9.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.191 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.632 ' HG2' HD12 ' A' ' 62' ' ' ILE . 4.0 pp0? -71.89 142.43 85.51 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.845 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 73.0 Cg_exo -53.45 -14.33 4.58 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 C-N-CA 123.724 2.95 . . . . 0.0 114.807 -172.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 75.01 86.88 0.09 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.646 0.591 . . . . 0.0 112.374 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.64 HG23 ' HA3' ' A' ' 168' ' ' GLY . 0.7 OUTLIER -134.05 86.67 2.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.855 174.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 11.8 m -112.41 -58.05 2.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.038 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.2 m -148.01 100.55 3.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.018 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.453 ' HA ' ' OD1' ' A' ' 167' ' ' ASP . 8.2 Cg_exo -73.57 150.08 45.06 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 123.037 2.491 . . . . 0.0 112.294 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 217' ' ' PRO . 10.1 mp -66.71 -49.06 51.59 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.821 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 216' ' ' LEU . 64.1 Cg_endo -72.45 13.54 0.55 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.251 1.967 . . . . 0.0 112.954 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -113.67 112.62 23.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.086 0.469 . . . . 0.0 110.657 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.7 m -105.34 -13.86 9.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.228 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.4 m 65.23 169.66 0.2 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.61 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -90.15 175.08 41.04 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.4 t 64.44 84.22 0.18 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.036 0.446 . . . . 0.0 110.116 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.64 -5.69 17.59 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.201 2.601 . . . . 0.0 112.33 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -84.39 140.24 18.84 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.123 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.44 -8.49 47.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.205 0.526 . . . . 0.0 110.372 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -101.82 88.58 3.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.119 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 69.5 mt -99.13 108.17 21.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 13.6 m -59.49 117.86 26.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.016 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 228' ' ' THR . 6.3 Cg_exo -79.2 64.69 8.87 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.263 2.642 . . . . 0.0 111.149 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.696 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 46.5 tp -78.11 -53.54 1.38 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.863 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 16.4 Cg_exo -68.69 -22.22 37.84 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.915 1.743 . . . . 0.0 111.733 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 16.6 m -74.35 105.76 5.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.492 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 6.2 p -126.91 120.92 30.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.622 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -87.49 76.33 9.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.748 0.785 . . . . 0.0 109.663 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -108.78 -21.98 12.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.564 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 82.75 82.26 0.91 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.157 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.51 134.25 43.72 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.373 2.049 . . . . 0.0 111.372 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.537 ' HB ' HG13 ' A' ' 266' ' ' VAL . 26.1 t -72.09 137.34 23.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.242 -177.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.48 118.92 37.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.579 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.467 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.28 128.07 52.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.093 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -82.75 126.18 32.09 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -78.72 92.29 4.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.593 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -82.97 -15.99 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.133 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -130.18 129.87 43.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -69.77 172.92 6.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.397 0.618 . . . . 0.0 111.64 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 25.3 tpt180 -147.0 103.26 3.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.158 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.99 126.82 54.08 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 32.1 Cg_endo -63.52 146.43 92.86 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.683 2.255 . . . . 0.0 112.456 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.87 160.06 18.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.1 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.99 -34.0 71.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.703 0.287 . . . . 0.0 111.138 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.39 9.85 27.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.013 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.4 t70 74.65 -69.18 0.19 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.262 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 62.76 21.76 12.96 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.543 0.527 . . . . 0.0 112.387 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.1 m 66.02 14.28 9.52 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.002 0.429 . . . . 0.0 110.984 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -66.01 125.68 26.2 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.159 0.504 . . . . 0.0 110.622 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.492 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.9 OUTLIER -79.08 115.68 18.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.869 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -70.11 115.15 8.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.917 0.389 . . . . 0.0 110.44 177.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 279' ' ' VAL . 93.0 mt -118.62 154.82 32.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.617 -176.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.75 159.15 38.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.954 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.44 122.96 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.557 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.61 3.3 30.62 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.668 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.421 ' CG ' HH11 ' A' ' 69' ' ' ARG . 41.7 t0 -107.51 161.97 14.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.519 0.659 . . . . 0.0 110.204 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 27.2 mm -102.91 121.91 54.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.243 0.545 . . . . 0.0 111.362 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.424 ' HA ' HG22 ' A' ' 279' ' ' VAL . 21.5 t -91.01 112.1 24.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.589 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -88.98 94.36 9.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.537 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.9 p -86.07 123.68 39.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.428 0.632 . . . . 0.0 110.69 -173.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.9 t -110.81 -17.83 13.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.514 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.82 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 24.9 ttm-85 -131.87 97.35 4.16 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.02 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 54.9 mtt -94.83 134.01 37.91 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.593 ' OD1' ' HB3' ' A' ' 272' ' ' ASN . 7.5 p30 -131.26 167.74 18.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.976 -172.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.432 ' H ' HG13 ' A' ' 271' ' ' ILE . 2.4 pp -83.58 6.8 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.312 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.593 ' HB3' ' OD1' ' A' ' 270' ' ' ASN . 3.7 t30 -87.39 -30.68 20.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.869 0.366 . . . . 0.0 110.93 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 125.42 -64.43 0.57 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.304 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -73.71 124.54 26.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.547 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 11.1 m0 -93.65 168.29 11.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.56 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.82 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 35.8 tt0 -104.38 113.29 26.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.681 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.21 162.95 18.16 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.811 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.52 116.81 30.15 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.857 HG12 ' H ' ' A' ' 280' ' ' ASN . 15.2 t -125.82 -172.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.857 ' H ' HG12 ' A' ' 279' ' ' VAL . 9.2 p30 -55.06 -32.08 61.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.026 0.376 . . . . 0.0 111.874 -176.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.28 -68.39 1.6 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.071 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.492 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -179.71 -169.87 0.14 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 60.7 mttm -85.2 129.11 34.87 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -161.54 176.88 38.01 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 80.0 mt -84.32 134.52 34.51 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.985 0.421 . . . . 0.0 111.103 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.412 ' HE2' HG21 ' A' ' 291' ' ' VAL . 46.4 p90 -137.45 140.93 31.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.211 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.22 139.03 16.5 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.478 2.118 . . . . 0.0 112.239 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -73.72 6.79 2.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.87 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.2 p -95.67 -15.97 22.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.764 0.316 . . . . 0.0 111.35 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -98.74 -13.12 20.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.234 0.54 . . . . 0.0 110.059 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.412 HG21 ' HE2' ' A' ' 286' ' ' PHE . 34.3 m -120.1 160.89 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.287 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -127.78 120.21 27.38 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.076 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 240' ' ' ALA . 36.4 mm -70.71 109.05 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.172 171.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -103.92 11.58 35.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.21 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 54.37 80.1 0.31 Allowed Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.353 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.07 -53.24 6.67 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.401 2.734 . . . . 0.0 113.091 -173.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -145.32 18.95 1.55 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.622 0.725 . . . . 0.0 109.599 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -153.81 92.05 3.16 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.193 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.05 58.82 5.68 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.731 2.287 . . . . 0.0 110.996 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.02 143.2 50.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.968 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.22 54.15 2.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.842 0.829 . . . . 0.0 109.71 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -79.48 120.76 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.227 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.742 -0.647 . . . . 0.0 109.982 177.916 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtm . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.428 0.156 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m 59.98 47.98 9.23 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.643 0.59 . . . . 0.0 111.405 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 t -156.02 104.67 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.587 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 62.29 95.0 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.743 0.652 . . . . 0.0 112.145 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -137.69 105.29 5.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.049 0.452 . . . . 0.0 110.496 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -155.89 157.86 37.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.545 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.36 111.79 14.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.908 0.385 . . . . 0.0 110.21 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 t -87.93 64.91 8.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.169 0.509 . . . . 0.0 110.397 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.0 t -173.47 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.915 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.46 111.44 1.39 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.742 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -56.0 -33.16 64.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.097 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 m -79.89 3.15 20.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.891 0.377 . . . . 0.0 111.595 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.85 -47.87 5.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.174 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -124.39 -22.67 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -87.68 117.33 26.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.745 0.307 . . . . 0.0 110.633 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.754 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 2.0 mpp? -109.57 7.23 24.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.722 0.296 . . . . 0.0 111.445 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.85 -114.6 3.27 Favored Glycine 0 C--O 1.225 -0.457 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.875 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 13.6 Cg_exo -69.73 101.08 0.86 Allowed 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.448 2.099 . . . . 0.0 112.137 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' A' ' 39' ' ' ARG . 86.0 t -129.11 -76.48 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.597 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.467 ' HA ' ' HE ' ' A' ' 39' ' ' ARG . 2.2 p 88.4 170.87 0.04 OUTLIER 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 169.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.7 mtp85 -53.35 -35.83 60.69 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.793 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -61.37 -51.91 66.81 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.458 0.474 . . . . 0.0 111.801 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.78 -43.6 12.4 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.16 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.57 -41.12 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.825 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.535 ' HA ' HG11 ' A' ' 58' ' ' VAL . 11.1 tt0 -81.88 -33.48 30.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.984 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.2 t -79.8 -18.33 51.19 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.02 0.438 . . . . 0.0 111.339 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 27' ' ' ARG . 39.1 ttm180 -88.86 -27.93 20.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.017 0.436 . . . . 0.0 110.792 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' A' ' 102' ' ' ALA . 78.0 mt -111.22 25.69 11.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.38 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.59 29.76 0.07 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -172.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.65 -1.45 39.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.908 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -50.24 -59.24 4.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.951 0.405 . . . . 0.0 110.936 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -132.09 111.46 11.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -68.98 114.87 7.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.46 -18.46 6.42 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.781 -173.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.756 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.6 mtm -74.65 144.71 43.71 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 120.674 0.273 . . . . 0.0 110.327 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.451 ' CG ' HD22 ' A' ' 98' ' ' LEU . 33.4 p90 -144.34 164.59 30.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.139 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.6 pp -153.85 138.79 17.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.043 0.449 . . . . 0.0 110.464 174.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.5 121.49 54.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.599 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -124.82 168.97 12.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -178.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.55 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 2.1 m-20 -72.23 134.13 45.45 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 168.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.532 ' HA ' HG23 ' A' ' 49' ' ' VAL . 24.3 t -37.01 -86.69 0.0 OUTLIER 'General case' 0 C--O 1.236 0.376 0 O-C-N 124.585 1.178 . . . . 0.0 112.875 -168.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.9 m -172.58 -61.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.4 t -98.3 -26.96 14.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.671 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.2 m -102.43 108.62 58.1 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.158 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.03 107.84 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.231 2.621 . . . . 0.0 111.686 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.99 -47.97 0.89 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 11.4 m-20 -78.24 151.75 32.94 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 168.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -124.3 172.9 8.74 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 121.387 -0.125 . . . . 0.0 110.731 -172.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.687 HG22 HG13 ' A' ' 62' ' ' ILE . 42.8 t -145.48 104.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 175.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.31 105.37 4.04 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.329 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.7 m -96.63 139.26 32.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.977 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.681 HG21 HD13 ' A' ' 93' ' ' LEU . 40.6 t -129.09 150.45 34.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.876 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.63 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 31.1 t -98.73 121.1 40.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.322 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.725 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 1.3 mt-10 -143.11 173.96 11.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 56.7 m-80 -40.24 87.39 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.857 0.863 . . . . 0.0 112.917 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m 42.13 58.35 2.97 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.278 1.037 . . . . 0.0 109.25 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.725 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -161.01 53.87 0.29 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.239 -153.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 25' ' ' GLN . 8.9 t -75.94 94.33 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 t -87.03 121.27 29.25 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.332 -172.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -100.77 98.55 9.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.383 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.59 ' CE2' HD22 ' A' ' 93' ' ' LEU . 50.2 m-85 -97.83 115.74 28.65 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.486 0.315 . . . . 0.0 111.371 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.687 HG13 HG22 ' A' ' 49' ' ' VAL . 7.1 tt -72.44 150.02 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.615 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.2 mp -128.37 117.74 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.184 0.594 . . . . 0.0 109.549 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.415 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 9.6 m120 -87.41 138.39 31.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.37 -173.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.3 t -83.23 100.28 10.5 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 171.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -78.17 157.87 77.79 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.8 62.48 2.36 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.586 2.191 . . . . 0.0 112.426 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 84.3 0.72 0.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.806 0.842 . . . . 0.0 110.61 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -72.32 -78.64 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.244 173.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.725 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 3.2 mpt_? -153.95 -171.01 3.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.358 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.438 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 27.4 m-85 -112.98 115.18 27.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -101.53 109.61 21.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.564 -171.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.615 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.3 tt -97.46 85.22 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.658 0.742 . . . . 0.0 110.72 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 210' ' ' PRO . . . 62.02 81.38 0.09 OUTLIER Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.635 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.4 t70 72.6 -43.99 0.58 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.062 0.545 . . . . 0.0 111.315 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -74.81 126.16 30.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.826 0.346 . . . . 0.0 110.184 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.401 ' OE1' ' HD3' ' A' ' 70' ' ' ARG . 39.5 tt0 -108.01 124.77 50.66 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.562 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.725 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 81.7 m-85 -124.19 148.6 47.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.582 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 10.7 m-20 -62.7 -29.82 70.94 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -170.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 6.5 p80 -160.35 171.63 18.76 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.254 -0.179 . . . . 0.0 110.871 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.9 mt -55.91 -56.62 28.45 Favored Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.34 0.4 . . . . 0.0 111.84 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 32.3 Cg_exo -61.6 -9.2 12.82 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.215 1.943 . . . . 0.0 113.538 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.34 -36.19 16.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.515 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -76.17 -30.03 57.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 82' ' ' PRO . 92.2 mt -65.17 -38.74 91.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.495 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.817 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 40.3 mt-10 -75.86 -20.94 57.7 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -74.49 -38.8 62.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.295 0.569 . . . . 0.0 110.128 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HE2' HD13 ' A' ' 73' ' ' ILE . 47.8 m-85 -79.28 -6.77 57.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.104 0.478 . . . . 0.0 110.703 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.817 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 25.5 mtpp -71.78 -17.21 62.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.496 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.77 7.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 121.042 0.448 . . . . 0.0 111.162 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 20.2 t-160 -102.07 -32.29 10.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.299 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CD1' HG23 ' A' ' 97' ' ' THR . 98.8 m-85 70.43 101.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.741 0.651 . . . . 0.0 110.513 -175.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.681 HD13 HG21 ' A' ' 52' ' ' VAL . 9.4 mt -70.98 -20.61 62.41 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.856 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.592 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 30.9 t70 -172.75 82.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.715 171.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 66.7 -24.39 0.11 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.57 0.748 . . . . 0.0 111.874 -178.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 94' ' ' ASP . 13.9 t -124.3 157.94 33.76 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.539 HG23 ' CD1' ' A' ' 92' ' ' TYR . 19.1 p -100.04 -172.84 2.3 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.655 0.264 . . . . 0.0 111.088 -177.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.451 HD22 ' CG ' ' A' ' 36' ' ' PHE . 86.5 mt -70.96 93.54 1.0 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 35.9 mm -85.03 -59.32 2.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.138 -173.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.756 ' O ' ' HA ' ' A' ' 35' ' ' MET . 4.9 pt-20 -149.33 147.55 23.76 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.652 -174.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.43 149.54 27.58 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.5 2.134 . . . . 0.0 112.471 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -70.58 146.49 93.86 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.999 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.97 140.83 92.22 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.879 2.386 . . . . 0.0 112.16 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.754 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 52.4 mtm180 -81.07 -179.52 7.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.984 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.4 t80 72.42 133.43 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.411 0 O-C-N 123.961 0.788 . . . . 0.0 110.449 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.28 116.21 2.14 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.193 2.595 . . . . 0.0 112.427 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 11.2 p -91.9 147.23 34.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.519 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 107' ' ' SER . 31.2 Cg_exo -59.41 118.2 5.05 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.593 2.195 . . . . 0.0 111.498 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.8 106.47 1.12 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.697 2.265 . . . . 0.0 112.324 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 55.9 ttp -103.83 -65.21 1.03 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.48 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.68 65.98 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.04 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.1 m -109.34 109.17 19.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.828 0.347 . . . . 0.0 110.819 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.57 HG13 ' H ' ' A' ' 114' ' ' SER . 2.7 p -96.55 -59.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.487 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.57 ' H ' HG13 ' A' ' 113' ' ' VAL . 61.0 m -165.91 -174.37 3.0 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.484 ' N ' ' HD2' ' A' ' 116' ' ' PRO . . . -67.49 -52.01 29.73 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 115' ' ' ALA . 20.7 Cg_endo -61.25 152.2 73.79 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.995 1.797 . . . . 0.0 112.158 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.633 HD22 ' HG ' ' A' ' 118' ' ' LEU . 1.1 p-10 -79.46 -177.96 6.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.891 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.633 ' HG ' HD22 ' A' ' 117' ' ' ASN . 87.9 mt 68.51 88.51 0.1 Allowed Pre-proline 0 N--CA 1.464 0.275 0 O-C-N 123.966 0.791 . . . . 0.0 110.797 -175.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.66 160.25 31.48 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.933 2.422 . . . . 0.0 111.505 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.4 m -79.29 63.36 3.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.63 0.729 . . . . 0.0 110.545 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -176.62 105.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.236 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 60.73 77.71 0.31 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.653 0.596 . . . . 0.0 111.553 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.6 ' HB2' ' HB3' ' A' ' 183' ' ' ARG . 4.4 m-20 -75.35 87.15 2.54 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -87.16 83.89 7.36 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.006 -173.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.969 HD12 HG13 ' A' ' 152' ' ' ILE . 4.3 mm? 72.71 120.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.721 169.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -151.53 -88.45 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.533 -172.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.522 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 79.0 m-85 -109.95 119.9 40.78 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.921 0.867 . . . . 0.0 112.035 -175.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.743 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 68.5 t -132.99 130.97 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.367 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.896 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 8.4 ptp85 -110.58 155.94 21.63 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 118.415 -1.314 . . . . 0.0 109.431 172.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.435 HG22 HG12 ' A' ' 178' ' ' VAL . 3.9 p -111.72 141.03 45.85 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.5 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 76.4 mt -103.44 -39.35 6.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.211 -175.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.3 t80 -73.82 -31.68 63.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -167.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.653 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 17.3 t70 67.82 91.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.443 0.639 . . . . 0.0 109.892 -172.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 88.1 t80 -124.85 113.24 26.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.349 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 58.0 Cg_endo -87.88 95.1 0.42 Allowed 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.15 1.9 . . . . 0.0 112.573 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.89 -10.27 84.28 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.586 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 137' ' ' ASN . 10.8 m120 62.96 25.62 15.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.033 0.533 . . . . 0.0 111.524 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.78 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 3.8 p30 46.83 -168.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 73.66 1.27 3.89 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.155 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -178.59 -35.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.125 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -134.41 110.38 9.39 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.492 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.686 HD12 ' HD2' ' A' ' 143' ' ' PRO . 31.4 tp -68.04 127.47 93.31 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 120.829 0.347 . . . . 0.0 111.72 -172.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.686 ' HD2' HD12 ' A' ' 142' ' ' LEU . 60.0 Cg_endo -78.8 105.28 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.292 1.995 . . . . 0.0 110.943 171.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 9.0 p90 -112.7 157.87 20.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.647 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.653 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 3.4 mptp? -102.91 178.79 4.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.817 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -66.45 -9.3 32.82 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.862 -177.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.512 ' N ' ' HD2' ' A' ' 146' ' ' LYS . . . -164.16 45.8 0.31 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.678 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -102.3 147.18 27.0 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 129' ' ' ARG . 33.8 mm -93.23 132.52 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.542 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 18.7 mt -118.8 154.85 32.18 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.66 129.86 74.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 172.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.969 HG13 HD12 ' A' ' 125' ' ' LEU . 46.3 mm -75.67 86.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.798 HG23 ' HG2' ' A' ' 154' ' ' GLU . 17.0 tt -67.95 -26.8 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.128 -176.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.798 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.5 OUTLIER -155.85 140.95 17.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.934 0.397 . . . . 0.0 111.2 173.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.475 ' HD2' ' CD2' ' A' ' 125' ' ' LEU . 32.2 tttm -120.89 95.84 48.82 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-O 121.249 0.547 . . . . 0.0 110.482 172.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.16 -59.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.81 2.34 . . . . 0.0 112.062 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -104.87 -170.37 1.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.052 -174.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -100.27 -42.72 6.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.897 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -80.31 -25.3 39.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.768 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.518 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 39.1 m95 -129.01 128.17 43.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.005 0.431 . . . . 0.0 110.759 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.647 ' O ' HG13 ' A' ' 173' ' ' ILE . 53.6 m0 -114.18 135.68 53.78 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.059 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.703 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 17.6 m -87.58 103.14 15.28 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.257 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.711 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -112.35 173.68 6.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.987 0.422 . . . . 0.0 111.13 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.4 ptt180 -119.88 137.56 53.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.0 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.58 HD22 ' H ' ' A' ' 168' ' ' GLY . 0.1 OUTLIER -78.59 -168.1 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.505 -177.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -60.45 -34.8 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.799 0.333 . . . . 0.0 110.422 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.503 ' HB2' HD21 ' A' ' 165' ' ' ASN . 44.8 m-20 -70.63 -21.27 62.65 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.042 0.449 . . . . 0.0 110.655 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.58 ' H ' HD22 ' A' ' 165' ' ' ASN . . . 97.62 5.26 57.82 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.701 -0.761 . . . . 0.0 114.449 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.78 ' HD3' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -86.77 151.15 23.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.998 0.899 . . . . 0.0 111.45 -177.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 153' ' ' ILE . 39.5 t -98.91 140.74 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.567 -166.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -168.1 158.14 30.75 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 169.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.526 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 31.5 mtp -76.12 139.48 41.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.366 0.583 . . . . 0.0 110.089 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.647 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -133.77 148.69 69.45 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.678 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.518 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 3.5 Cg_exo -77.48 132.6 12.39 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.168 2.579 . . . . 0.0 112.674 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.647 ' O ' HG22 ' A' ' 178' ' ' VAL . 24.1 t -58.62 -46.33 99.59 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.363 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.48 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.0 Cg_exo -63.27 -2.1 3.62 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.375 2.05 . . . . 0.0 113.786 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.58 -5.66 26.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.415 -0.178 . . . . 0.0 111.327 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.0 m -107.41 -172.19 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -166.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.896 ' HB3' ' HG3' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -159.66 42.21 0.21 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.609 -163.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.743 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -75.32 139.08 42.23 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 121.219 -0.926 . . . . 0.0 109.25 -168.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.61 ' O ' ' HB ' ' A' ' 182' ' ' VAL . 4.2 mm? -37.5 -60.9 0.65 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 124.802 1.314 . . . . 0.0 112.438 -170.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 181' ' ' LEU . 8.9 p 160.74 -9.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 123.921 0.763 . . . . 0.0 111.11 -175.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.6 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 95.7 mtt180 69.88 -80.46 0.04 OUTLIER 'General case' 0 C--N 1.343 0.318 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -169.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.1 t 177.48 121.59 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.699 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 15.3 m -60.92 128.93 89.78 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 77.3 Cg_exo -53.61 -9.08 0.93 Allowed 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.96 3.107 . . . . 0.0 115.132 -172.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.699 ' CE1' ' HB2' ' A' ' 185' ' ' SER . 0.0 OUTLIER -65.96 127.77 33.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.949 0.404 . . . . 0.0 110.525 175.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -65.5 -25.05 71.28 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.195 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 189' ' ' LYS . 12.3 mptt -91.45 104.27 16.8 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.423 0.63 . . . . 0.0 110.078 177.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -144.21 114.93 7.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.544 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -141.35 104.99 0.4 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.457 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -69.11 112.68 5.87 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 66.7 mtm180 -73.01 102.2 3.44 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.9 m120 70.44 165.73 0.28 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.887 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.6 p -79.31 18.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.695 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -71.64 -55.34 7.92 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 109.739 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.7 m -88.27 78.94 7.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.005 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -95.52 105.07 17.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.681 0.753 . . . . 0.0 111.399 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -100.97 13.68 58.89 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.7 tt -140.72 119.6 8.36 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.568 -176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -93.38 -161.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.111 2.54 . . . . 0.0 111.164 174.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 202' ' ' GLU . 1.5 pm0 -80.39 112.08 27.98 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.948 0.404 . . . . 0.0 109.913 174.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 16.8 Cg_exo -67.78 -24.96 40.02 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.194 2.596 . . . . 0.0 112.58 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 73.05 -50.84 0.71 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.554 0.742 . . . . 0.0 111.761 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -117.85 110.22 17.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.778 0.323 . . . . 0.0 110.173 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -83.47 66.52 8.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.483 . . . . 0.0 110.96 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -103.7 18.76 21.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -62.8 146.22 95.09 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.684 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.492 ' HB2' ' HA3' ' A' ' 74' ' ' GLY . 36.6 Cg_exo -59.49 145.28 98.45 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.751 1.634 . . . . 0.0 110.402 172.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -81.54 -174.09 4.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.302 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 21.1 m -108.07 123.84 49.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.351 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 167' ' ' ASP . 73.1 m -57.67 130.83 48.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.089 172.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 3.7 t -125.99 99.89 31.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.638 0.732 . . . . 0.0 111.256 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.36 116.1 3.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.954 2.436 . . . . 0.0 111.037 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.1 tt -141.94 95.56 6.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -93.21 -76.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.211 2.607 . . . . 0.0 112.047 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -159.49 131.48 6.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.508 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.57 111.74 26.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.676 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 24.3 m 68.55 113.89 0.04 OUTLIER 'General case' 0 C--O 1.234 0.262 0 O-C-N 123.825 0.703 . . . . 0.0 111.746 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -129.28 -125.66 2.76 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.018 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.464 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 10.3 m -126.82 143.85 48.05 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 11.7 Cg_exo -71.66 146.48 49.02 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.803 2.336 . . . . 0.0 111.214 172.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.88 ' HA3' ' HD3' ' A' ' 229' ' ' PRO . . . -84.82 54.01 4.88 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.732 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 61.83 -85.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.3 0.64 . . . . 0.0 111.006 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.37 104.03 14.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.631 HG12 ' H ' ' A' ' 228' ' ' THR . 0.1 OUTLIER 40.43 -92.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 124.276 0.985 . . . . 0.0 112.662 -171.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.631 ' H ' HG12 ' A' ' 227' ' ' ILE . 8.8 t -133.25 149.73 73.36 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.88 ' HD3' ' HA3' ' A' ' 224' ' ' GLY . 13.8 Cg_endo -58.57 99.63 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.158 1.906 . . . . 0.0 111.099 174.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 96.8 mt -75.21 118.43 70.59 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.182 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 5.8 Cg_exo -79.69 66.63 8.77 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.142 2.562 . . . . 0.0 111.255 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 8.6 p -73.17 -71.18 0.32 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.502 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 12.5 p -95.34 -27.48 15.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.724 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 72.64 0.95 3.82 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.928 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 13.3 m120 68.29 -67.43 0.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.62 0.768 . . . . 0.0 111.582 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 111.32 -137.94 14.63 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.59 114.14 3.9 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.796 2.331 . . . . 0.0 111.384 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 266' ' ' VAL . 20.7 t -94.21 145.06 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.928 0.394 . . . . 0.0 110.229 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.11 132.56 56.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.382 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.567 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -121.17 155.27 34.9 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.669 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -119.5 119.08 32.8 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.45 119.06 14.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.686 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 22.9 pt -91.01 -4.25 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.053 -172.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -142.48 160.87 39.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.587 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.895 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 20.9 ttmm -93.51 123.05 36.55 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.871 ' HB3' HH11 ' A' ' 246' ' ' ARG . 0.7 OUTLIER -139.44 114.31 9.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.519 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 35.9 m -97.16 159.87 30.32 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.323 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.845 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 85.6 Cg_endo -79.04 178.6 7.33 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.607 2.205 . . . . 0.0 112.273 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.578 ' HB3' ' HG3' ' A' ' 253' ' ' LYS . 47.2 t -103.39 96.37 6.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.307 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 66.06 -74.29 0.06 Allowed 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 124.245 0.965 . . . . 0.0 112.589 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 252' ' ' ASP . 0.0 OUTLIER -88.08 -46.74 9.06 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -177.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.554 ' HA ' ' HB2' ' A' ' 248' ' ' PRO . 7.5 p-10 167.84 -57.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.617 -174.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.578 ' HG3' ' HB3' ' A' ' 249' ' ' CYS . 13.7 mmmm 55.87 41.8 29.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.749 0.309 . . . . 0.0 110.278 -173.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 68.6 p 57.74 15.04 2.72 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.426 1.091 . . . . 0.0 112.251 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 248' ' ' PRO . . . -98.95 107.03 19.36 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.072 0.463 . . . . 0.0 110.964 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -73.18 113.62 10.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.845 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -58.71 108.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.538 0.524 . . . . 0.0 110.811 177.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.689 HD21 HG21 ' A' ' 279' ' ' VAL . 95.8 mt -130.25 127.03 38.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.264 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.895 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 11.7 pt-20 -119.61 -177.12 3.31 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.538 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 30.7 m -61.36 135.31 26.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.22 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 68.12 28.86 73.21 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.984 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -108.2 140.02 42.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.972 0.386 . . . . 0.0 110.146 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.0 mm -88.28 123.23 40.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.34 0.591 . . . . 0.0 111.523 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 240' ' ' ALA . 23.2 t -104.71 107.89 23.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.078 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -82.44 87.68 6.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.717 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' A' ' 238' ' ' VAL . 4.9 p -88.55 116.92 31.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.622 0.725 . . . . 0.0 110.584 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.421 ' O ' ' HD2' ' A' ' 268' ' ' ARG . 3.1 m -110.6 -19.15 12.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.694 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.466 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 13.8 mmm180 -122.34 109.96 15.07 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.5 mtt -107.6 118.3 36.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.154 0.502 . . . . 0.0 111.572 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -90.76 158.92 16.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.023 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.57 -14.7 9.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.455 0.645 . . . . 0.0 110.493 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -80.81 -1.8 44.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.893 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.82 -61.65 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.918 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.596 ' HG3' HD13 ' A' ' 285' ' ' LEU . 0.0 OUTLIER -77.71 131.21 37.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.93 0.395 . . . . 0.0 110.628 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 15.8 m0 -107.08 168.64 9.07 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.237 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 14.0 mt-10 -110.51 122.53 47.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.096 0.474 . . . . 0.0 110.299 174.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -130.26 145.14 16.41 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.511 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -94.41 109.11 20.99 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.689 HG21 HD21 ' A' ' 258' ' ' LEU . 20.8 t -113.43 167.76 6.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.437 ' N ' HG12 ' A' ' 279' ' ' VAL . 16.2 m120 -60.13 -16.66 34.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -81.28 -45.08 7.66 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.863 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.64 ' HG2' HH11 ' A' ' 282' ' ' ARG . 1.0 OUTLIER 173.16 178.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 16.5 pttp -103.75 139.43 39.0 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 166.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -172.33 -170.24 35.95 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.7 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.596 HD13 ' HG3' ' A' ' 274' ' ' GLN . 97.9 mt -91.1 143.42 26.71 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.242 0.544 . . . . 0.0 110.803 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 41.6 p90 -147.97 137.16 11.9 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.561 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 7.3 Cg_exo -72.89 136.34 24.97 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.43 2.086 . . . . 0.0 111.309 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -63.51 -20.64 65.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.926 0.393 . . . . 0.0 110.956 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 m -69.81 -13.11 62.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.315 0.579 . . . . 0.0 110.828 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -97.39 -14.35 21.28 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.079 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.525 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 27.6 m -124.61 165.82 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.527 0.68 . . . . 0.0 112.14 -173.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -114.43 116.33 28.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.517 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' ' 240' ' ' ALA . 21.3 mm -89.02 117.12 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.13 0.49 . . . . 0.0 110.643 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.417 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 25.3 p90 -141.52 148.32 39.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.699 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.603 ' OD2' ' HA ' ' A' ' 298' ' ' ASN . 35.1 t0 -92.97 105.89 16.89 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 26.8 Cg_exo -61.88 -50.43 5.19 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.033 2.489 . . . . 0.0 112.675 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -111.94 -15.49 13.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.008 -172.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.603 ' HA ' ' OD2' ' A' ' 295' ' ' ASP . 3.6 t-20 55.23 72.8 0.98 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 123.656 0.782 . . . . 0.0 112.446 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -90.08 0.47 5.5 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.751 2.301 . . . . 0.0 111.012 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.12 82.23 1.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.797 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -172.96 -65.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.833 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -100.23 90.45 4.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.628 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.36 -0.828 . . . . 0.0 109.782 178.135 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 m -103.55 17.29 24.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.126 0.489 . . . . 0.0 110.168 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 m -79.25 93.12 5.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.458 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 73.48 130.41 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.072 0.858 . . . . 0.0 112.659 173.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -119.1 -8.01 10.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.837 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.741 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 27.6 p90 -94.11 162.37 13.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.58 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.28 123.84 48.9 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 m -79.96 21.83 0.54 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.723 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -111.41 -37.16 5.33 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.651 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' ' 12' ' ' SER . 34.4 t70 -87.94 108.35 19.15 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.055 -174.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -65.49 -20.04 66.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.426 -179.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.409 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 23.9 m -74.03 -5.41 41.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.803 0.335 . . . . 0.0 110.669 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.76 -47.88 5.42 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 38.3 p-90 -115.62 -21.26 9.79 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -171.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.439 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 49.3 t80 -81.52 118.55 22.83 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.202 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.794 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 6.9 tpp -95.14 -7.94 37.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.359 -172.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.08 -115.45 3.6 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.254 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 6.4 Cg_exo -73.65 95.02 0.86 Allowed 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.974 2.449 . . . . 0.0 112.529 -174.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.914 HG12 ' H ' ' A' ' 20' ' ' SER . 14.1 t -136.86 -152.97 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.914 ' H ' HG12 ' A' ' 19' ' ' VAL . 82.4 p 176.32 178.56 0.21 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -166.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -69.31 -39.89 78.0 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.121 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -63.34 -59.54 4.57 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.395 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.61 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 8.3 tp10 -59.9 -47.23 86.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.124 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.31 -35.87 70.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.51 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.447 HE21 ' HB3' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -64.65 -40.95 96.33 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.647 -179.372 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -80.17 -6.51 57.9 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.126 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.61 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 20.6 mmt85 -87.57 -35.32 18.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.714 0.769 . . . . 0.0 109.03 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.93 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 39.2 mt -100.08 27.4 5.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.331 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -51.35 97.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.478 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.2 -4.63 31.62 Favored Glycine 0 CA--C 1.49 -1.503 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 167.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 1.051 HE21 ' HA ' ' A' ' 56' ' ' SER . 1.6 mp0 57.14 85.59 0.08 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 113.814 -1.193 . . . . 0.0 110.768 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.735 ' HA ' ' HB3' ' A' ' 116' ' ' PRO . 14.7 ttm180 -70.33 -19.95 63.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.653 ' NE2' ' HA ' ' A' ' 55' ' ' ASN . 41.2 m170 78.63 118.93 0.06 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.297 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.95 9.08 59.95 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.972 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.646 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 29.3 mtm -106.75 137.07 45.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.498 -0.413 . . . . 0.0 110.176 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.569 ' HB2' HD11 ' A' ' 50' ' ' LEU . 43.3 p90 -133.98 162.34 32.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.247 -175.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 pp -151.0 135.03 16.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.52 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.0 t -102.49 108.31 23.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.766 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 23.6 ptt-85 -110.82 168.62 9.34 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.134 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.445 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 27.2 t70 -85.81 92.99 8.78 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.505 ' HA ' HG23 ' A' ' 49' ' ' VAL . 37.7 m 33.81 -149.22 0.0 OUTLIER 'General case' 0 C--O 1.238 0.5 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.944 ' HB2' ' O1P' ' A' ' 207' ' ' PTR . 63.8 m -157.29 -15.67 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.105 171.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.601 ' OG1' ' O3P' ' A' ' 207' ' ' PTR . 19.5 m -121.37 -44.87 2.35 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.038 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 40.9 t -115.65 99.87 52.96 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.11 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 22.6 Cg_endo -61.87 129.26 26.89 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.716 2.277 . . . . 0.0 111.84 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.32 -33.36 4.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.37 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.42 166.45 12.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.445 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 25.4 m-85 -125.73 166.22 17.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.778 0.323 . . . . 0.0 111.123 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.505 HG23 ' HA ' ' A' ' 41' ' ' SER . 45.0 t -144.13 106.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.846 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.72 ' HB2' HD11 ' A' ' 63' ' ' ILE . 63.8 tp -70.09 101.34 1.81 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.408 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.9 m -94.82 118.85 32.44 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.08 0.467 . . . . 0.0 109.99 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG21 HD13 ' A' ' 93' ' ' LEU . 46.5 t -119.2 134.19 63.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.192 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.93 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 84.1 p -93.39 132.85 37.25 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.776 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.664 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 5.1 mm-40 -143.95 176.24 9.43 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.653 ' HA ' ' NE2' ' A' ' 33' ' ' HIS . 55.5 m-80 -31.34 82.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -168.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 1.051 ' HA ' HE21 ' A' ' 31' ' ' GLN . 3.9 m 44.89 57.18 4.79 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.948 0.88 . . . . 0.0 109.765 -177.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.989 HH21 ' HB2' ' A' ' 94' ' ' ASP . 35.8 ttp85 -167.17 55.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.366 -151.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 61.8 t -74.93 102.49 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.245 -0.91 . . . . 0.0 109.598 -173.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 t -86.4 121.3 28.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.724 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -93.3 88.2 5.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.624 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.446 ' CE2' HD22 ' A' ' 93' ' ' LEU . 77.8 m-85 -78.86 116.01 18.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 18.5 tt -79.64 145.55 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -171.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.72 HD11 ' HB2' ' A' ' 50' ' ' LEU . 14.9 mt -138.31 116.35 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.602 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 9.3 m120 -87.21 142.34 27.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 122.314 0.246 . . . . 0.0 110.735 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.6 t -87.53 100.68 12.95 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 72' ' ' LYS . 87.9 mt -90.01 142.77 29.08 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.385 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 17.2 Cg_exo -67.49 -8.15 21.34 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.244 2.629 . . . . 0.0 113.071 -176.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.731 ' HB2' ' HG2' ' A' ' 70' ' ' ARG . 9.4 m120 -83.69 9.49 11.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.745 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 2.3 tpm_? 63.46 26.45 14.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.611 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.731 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 5.9 ptp180 -112.78 172.4 6.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.989 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.472 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 96.0 m-85 -131.66 127.2 36.47 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.204 0.526 . . . . 0.0 110.948 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.602 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 18.5 ttmm -97.16 100.06 11.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.926 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 10.9 tt -93.44 86.38 2.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.838 0.828 . . . . 0.0 110.227 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' A' ' 209' ' ' GLN . . . 71.32 60.34 4.46 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.087 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t0 74.44 -16.27 0.55 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.935 0.494 . . . . 0.0 111.38 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 211' ' ' GLN . 0.1 OUTLIER -78.83 126.86 31.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.876 0.369 . . . . 0.0 111.109 177.112 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -98.45 100.1 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.457 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.461 ' CE2' ' HB3' ' A' ' 76' ' ' GLN . 97.6 m-85 -103.46 168.85 8.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.839 0.352 . . . . 0.0 110.59 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.17 -53.56 53.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.461 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.449 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 1.2 p80 -164.81 -174.11 3.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.264 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.1 mt -55.23 -57.84 18.08 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.55 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 39.1 Cg_exo -59.8 -10.74 12.69 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.327 2.018 . . . . 0.0 113.214 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.447 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -95.22 -30.74 13.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.389 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.19 -26.27 56.02 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.5 mt -70.56 -25.85 63.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.913 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 52.1 mt-10 -73.5 -20.64 60.62 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.768 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.751 ' HZ ' HG21 ' A' ' 212' ' ' THR . 34.7 t80 -84.84 -35.59 22.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.054 0.454 . . . . 0.0 110.77 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.523 ' HE2' HD13 ' A' ' 73' ' ' ILE . 49.6 m-85 -86.59 1.07 53.05 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.999 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 13.0 ptmt -74.02 -21.99 59.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 171.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.448 HG23 ' HG3' ' A' ' 89' ' ' LYS . 23.6 pt -120.85 9.14 6.2 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -96.55 -38.78 9.84 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.206 -0.309 . . . . 0.0 111.233 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.543 ' CD1' HG23 ' A' ' 97' ' ' THR . 76.9 m-85 70.39 102.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.894 0.746 . . . . 0.0 109.716 -171.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.729 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 6.4 mt -74.23 -19.76 60.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.53 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.989 ' HB2' HH21 ' A' ' 57' ' ' ARG . 33.6 t70 -173.78 70.96 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 170.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 76.91 -29.81 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.22 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.408 HG22 HD13 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -107.43 157.58 17.88 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.543 HG23 ' CD1' ' A' ' 92' ' ' TYR . 18.1 p -105.26 -169.25 1.57 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.761 0.315 . . . . 0.0 110.178 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.464 HD22 ' CD1' ' A' ' 36' ' ' PHE . 97.6 mt -77.47 99.97 5.85 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 1.8 mp -96.91 -55.37 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.646 ' O ' ' HA ' ' A' ' 35' ' ' MET . 8.1 mm-40 -143.96 151.61 53.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.735 0.302 . . . . 0.0 111.293 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 24.7 Cg_endo -88.83 156.58 6.05 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.807 2.338 . . . . 0.0 111.893 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.48 139.63 55.4 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.947 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.529 ' CG ' ' HA ' ' A' ' 107' ' ' SER . 27.7 Cg_endo -64.43 135.57 46.74 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.479 2.119 . . . . 0.0 112.16 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.794 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 39.9 ptt180 -78.8 -23.52 45.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.681 ' HB3' ' HD3' ' A' ' 106' ' ' PRO . 26.1 t80 -135.59 -58.09 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 120.651 -0.42 . . . . 0.0 112.084 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 105' ' ' TYR . 47.0 Cg_exo -55.92 -72.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.134 1.89 . . . . 0.0 112.435 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.529 ' HA ' ' CG ' ' A' ' 103' ' ' PRO . 23.4 m 70.54 135.9 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 123.761 0.663 . . . . 0.0 112.056 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.446 ' HD3' ' HG3' ' A' ' 103' ' ' PRO . 14.0 Cg_exo -69.54 112.95 3.18 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.686 2.257 . . . . 0.0 111.274 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.94 113.71 2.12 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.818 2.346 . . . . 0.0 112.18 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.3 mmt 55.82 40.28 30.68 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.456 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.89 66.82 2.75 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.78 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 p -133.96 -171.73 2.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.593 0.235 . . . . 0.0 110.931 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t 67.61 -94.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.408 0.683 . . . . 0.0 111.327 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 p -103.73 9.18 37.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.085 0.469 . . . . 0.0 111.342 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.447 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -75.48 -47.75 4.17 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.689 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.735 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 98.8 Cg_endo -81.76 -158.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.835 1.69 . . . . 0.0 111.596 172.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -79.77 -5.59 55.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 51.0 tp 56.68 85.66 0.18 Allowed Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.49 -174.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.554 ' HB3' ' HE1' ' A' ' 33' ' ' HIS . 36.8 Cg_endo -67.27 128.96 19.34 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.506 2.137 . . . . 0.0 112.933 -176.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 p -91.52 -26.79 18.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.999 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.66 74.38 9.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.647 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.65 90.91 8.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.51 ' HB2' HD13 ' A' ' 125' ' ' LEU . 2.9 p30 -98.08 179.26 4.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.391 0.615 . . . . 0.0 111.35 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.402 HD22 ' C ' ' A' ' 124' ' ' ASN . 0.2 OUTLIER -131.38 45.73 2.76 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 1.017 HD23 HG21 ' A' ' 152' ' ' ILE . 7.9 mp -76.89 123.44 26.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.158 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 16.8 pt-20 -165.77 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.193 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.46 130.92 54.51 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.908 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.976 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 72.8 t -142.41 157.57 19.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 179' ' ' GLU . 0.7 OUTLIER -136.05 150.8 49.32 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.092 161.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.483 HG22 HG12 ' A' ' 178' ' ' VAL . 6.0 p -105.67 140.46 38.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.052 0.453 . . . . 0.0 111.994 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.518 HD11 ' HG2' ' A' ' 179' ' ' GLU . 67.2 mt -110.83 -25.58 9.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.726 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.528 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 41.5 t80 -86.38 -32.6 20.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -168.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.67 ' HB2' ' HD3' ' A' ' 146' ' ' LYS . 6.6 t70 73.38 111.59 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.133 0.492 . . . . 0.0 110.617 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -141.65 89.1 9.31 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 35.4 Cg_endo -94.87 84.16 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 122.799 2.333 . . . . 0.0 112.871 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.508 ' HA3' ' OD2' ' A' ' 141' ' ' ASP . . . -94.1 -24.34 19.91 Favored Glycine 0 N--CA 1.454 -0.123 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.206 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.428 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 52.0 m-80 68.05 83.22 0.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.484 0.714 . . . . 0.0 112.715 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -173.42 -171.96 0.74 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 173.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.28 -16.89 28.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.314 1.054 . . . . 0.0 108.334 171.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 172' ' ' MET . 41.4 tt0 -73.57 -28.88 62.09 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.978 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.6 ' HA ' ' O ' ' A' ' 172' ' ' MET . 8.0 p-10 -157.17 117.04 3.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.369 174.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 165' ' ' ASN . 13.6 tp -69.62 121.39 82.27 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.964 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 41.6 Cg_endo -67.87 98.16 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.293 1.996 . . . . 0.0 111.324 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -112.73 162.25 15.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.522 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 1.6 mptm? -112.6 -167.79 1.23 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.291 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.67 ' HD3' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -91.25 19.6 5.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.921 176.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.4 30.86 0.52 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.606 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 23.2 mm-40 -104.71 144.14 32.13 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.887 -0.184 . . . . 0.0 110.73 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.502 HD13 ' HB3' ' A' ' 129' ' ' ARG . 46.7 mm -98.65 135.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.555 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 18.5 mt -118.95 155.24 31.68 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 93.4 t -120.32 125.42 74.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 174.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.017 HG21 HD23 ' A' ' 125' ' ' LEU . 47.1 mm -76.05 83.8 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 122.761 1.267 . . . . 0.0 108.674 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.759 HG21 HG22 ' A' ' 170' ' ' VAL . 15.1 tt -79.3 -26.97 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.195 -174.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 14.9 mt-10 -144.41 142.23 30.19 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.505 0.503 . . . . 0.0 109.975 173.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.601 ' HD3' HD22 ' A' ' 125' ' ' LEU . 3.8 ttpm? -134.58 89.74 25.55 Favored Pre-proline 0 C--O 1.236 0.371 0 O-C-N 121.842 -0.536 . . . . 0.0 111.172 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.465 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 16.9 Cg_exo -71.94 -55.31 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.549 2.166 . . . . 0.0 112.76 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -106.52 172.51 6.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.521 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 2.7 mm-40 -113.76 70.15 0.72 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.551 0.691 . . . . 0.0 110.505 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.503 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 13.9 pt20 175.58 -34.37 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.601 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.503 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 53.1 m95 -122.96 129.34 51.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.767 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.661 ' O ' HG13 ' A' ' 173' ' ' ILE . 51.0 m0 -120.21 137.26 54.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.35 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.868 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.5 m -88.29 92.72 9.27 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.439 0.638 . . . . 0.0 109.899 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.72 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.62 161.24 15.26 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.822 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.8 ptt180 -104.27 136.76 43.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.809 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 142' ' ' LEU . 16.3 p-10 -81.63 -173.1 4.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 110.993 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -59.13 -27.5 65.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.773 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.81 -18.93 38.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.734 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.16 29.06 7.77 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.134 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.822 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 19.6 ttm-85 -104.02 136.07 44.35 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.568 -0.372 . . . . 0.0 110.857 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.759 HG22 HG21 ' A' ' 153' ' ' ILE . 59.0 t -99.88 119.81 48.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.99 0.424 . . . . 0.0 111.167 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.2 160.22 28.22 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.6 ' O ' ' HA ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -68.81 131.37 45.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.027 0.441 . . . . 0.0 111.023 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.661 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -130.22 145.45 57.38 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.261 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.46 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 4.5 Cg_exo -78.71 131.66 10.4 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.062 2.508 . . . . 0.0 112.633 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.62 ' O ' HG22 ' A' ' 178' ' ' VAL . 41.4 t -59.68 -44.19 96.92 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.401 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 27.2 Cg_exo -65.13 5.49 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.225 1.95 . . . . 0.0 113.6 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -108.43 -6.14 16.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.093 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.1 m -107.52 -171.08 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -165.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 0.2 OUTLIER -156.09 41.21 0.38 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 112.821 -1.991 . . . . 0.0 106.91 -163.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.976 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 16.3 pttm -77.45 150.94 34.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.891 0.853 . . . . 0.0 110.435 -162.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 181' ' ' LEU . 4.1 tp -68.65 150.66 47.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.469 -173.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.611 HG23 ' H ' ' A' ' 183' ' ' ARG . 3.1 m -66.76 -69.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -169.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.611 ' H ' HG23 ' A' ' 182' ' ' VAL . 0.1 OUTLIER -161.92 164.6 28.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.151 -0.343 . . . . 0.0 110.46 -173.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.6 t -102.32 158.66 16.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 5.4 p -69.0 144.02 95.14 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-O 120.546 0.212 . . . . 0.0 110.772 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.17 -58.83 1.39 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.645 2.897 . . . . 0.0 113.852 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 56.4 m80 64.37 -78.01 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.525 0.515 . . . . 0.0 110.814 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -166.82 -61.45 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -90.2 76.0 6.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.994 0.426 . . . . 0.0 110.065 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.37 -46.06 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.615 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -169.0 60.04 0.2 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.495 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 67.56 -171.93 0.19 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.815 0.446 . . . . 0.0 111.057 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.402 ' HB2' ' OD1' ' A' ' 196' ' ' ASN . 14.3 ptm180 -131.87 139.81 48.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.558 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -139.92 -40.25 0.44 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.807 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 55.3 m -115.6 -17.94 11.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.791 0.329 . . . . 0.0 110.602 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 193' ' ' ARG . 62.7 m-20 66.94 -89.22 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.382 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 4.5 p -96.84 132.25 42.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.267 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -101.16 -21.08 15.04 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.685 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 113.8 25.02 4.39 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.341 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 30.3 pt -129.32 162.38 52.94 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.42 107.16 2.34 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.376 2.051 . . . . 0.0 112.083 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.491 ' N ' ' HD2' ' A' ' 203' ' ' PRO . 2.8 mp0 -63.29 -47.64 84.21 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.388 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 202' ' ' GLU . 56.5 Cg_endo -71.2 64.18 2.69 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.187 1.925 . . . . 0.0 111.758 172.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.34 179.22 4.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.423 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -82.58 31.63 0.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.582 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.19 79.46 3.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.332 0.587 . . . . 0.0 110.806 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.944 ' O1P' ' HB2' ' A' ' 42' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.758 ' HA ' ' NH1' ' A' ' 164' ' ' ARG . . . -124.97 113.45 17.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.651 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 3.8 pt20 -107.38 101.49 39.26 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.241 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.723 ' HA ' HG23 ' A' ' 170' ' ' VAL . 15.0 Cg_endo -99.11 83.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.648 2.899 . . . . 0.0 114.215 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.65 ' HB3' ' HA ' ' A' ' 169' ' ' ARG . 4.2 tp-100 -57.58 -49.64 75.73 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.751 HG21 ' HZ ' ' A' ' 87' ' ' PHE . 51.6 m 73.89 -45.15 0.59 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 172.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.43 ' OG1' ' HD3' ' A' ' 169' ' ' ARG . 3.2 m 81.13 83.89 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.581 0.753 . . . . 0.0 109.475 -172.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 7.2 p -88.86 126.18 60.26 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.229 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.04 -15.07 11.91 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.52 2.147 . . . . 0.0 112.444 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.3 tt 59.01 82.52 0.23 Allowed Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.091 -177.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.45 109.0 2.7 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.857 2.372 . . . . 0.0 112.408 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -94.13 93.4 7.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.746 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.25 135.9 24.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.968 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 41.2 m -87.36 135.35 33.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.561 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -108.29 109.02 2.79 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.758 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 32.5 p -81.36 122.29 80.96 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 24.6 Cg_exo -63.12 134.7 47.13 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.6 2.2 . . . . 0.0 112.218 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -69.65 156.65 53.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.794 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -74.87 137.32 41.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.849 0.356 . . . . 0.0 111.012 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -82.67 95.0 7.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.053 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 228' ' ' THR . 16.3 pt -62.94 -48.05 89.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.974 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.468 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 11.6 t -166.43 134.8 2.3 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 228' ' ' THR . 36.7 Cg_endo -89.22 96.22 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.808 2.339 . . . . 0.0 112.522 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.724 HD23 ' H ' ' A' ' 230' ' ' LEU . 1.7 pt? -99.93 100.09 10.56 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.75 109.44 2.86 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.568 2.179 . . . . 0.0 112.407 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 48.8 m -73.82 149.54 41.57 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 12.0 p -71.84 90.54 1.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.712 0.768 . . . . 0.0 111.176 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.417 ' HG2' ' HB ' ' A' ' 267' ' ' THR . 67.5 mt-30 -75.9 75.74 2.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.445 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -68.22 -36.88 80.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.719 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -142.85 78.01 0.28 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.858 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.69 133.13 21.48 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.414 2.076 . . . . 0.0 112.295 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.497 ' HB ' HG13 ' A' ' 266' ' ' VAL . 22.8 t -94.43 144.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.502 ' HD1' HG21 ' A' ' 263' ' ' ILE . 96.2 m-85 -109.6 123.91 50.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.0 111.001 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.692 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -142.02 122.04 13.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.033 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.476 ' CD ' ' H ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -80.96 144.68 31.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.068 0.461 . . . . 0.0 110.505 -178.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -88.78 94.67 10.0 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.049 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.447 ' H ' HG13 ' A' ' 243' ' ' ILE . 2.4 pp -94.48 19.45 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.687 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.61 173.39 11.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.331 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.435 ' H ' ' HG2' ' A' ' 245' ' ' LYS . 20.8 pttm -95.34 133.67 38.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.553 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -147.77 113.55 5.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.096 0.474 . . . . 0.0 111.382 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.62 158.62 33.36 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.755 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -94.57 -172.31 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.946 2.431 . . . . 0.0 112.68 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 252' ' ' ASP . 42.4 t -80.01 149.62 30.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.25 -48.04 74.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.706 0.289 . . . . 0.0 111.672 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.53 ' HE1' ' HB2' ' A' ' 253' ' ' LYS . 19.2 p90 -92.1 -7.22 49.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.85 0.357 . . . . 0.0 110.651 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' ' 249' ' ' CYS . 15.1 t70 63.9 106.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.751 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.53 ' HB2' ' HE1' ' A' ' 251' ' ' TYR . 1.7 tmtp? -113.04 84.5 2.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 34.7 p 48.25 36.25 6.57 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.665 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -104.58 99.61 9.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.119 0.485 . . . . 0.0 110.442 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.507 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.7 OUTLIER -78.37 121.5 24.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.919 -177.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -83.45 136.92 34.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.056 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.74 119.5 20.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.998 0.427 . . . . 0.0 110.313 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -100.01 149.83 23.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.514 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 15.6 t -58.02 123.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.839 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 157.46 -68.1 0.28 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.815 -1.183 . . . . 0.0 114.952 174.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 263' ' ' ILE . 5.0 t70 -116.96 -169.33 1.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.473 0.637 . . . . 0.0 112.496 -159.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.502 HG21 ' HD1' ' A' ' 239' ' ' PHE . 40.6 mm -91.72 135.6 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.238 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.47 110.16 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.735 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -80.58 87.81 5.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 110.862 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.497 HG13 ' HB ' ' A' ' 238' ' ' VAL . 6.8 p -90.21 130.62 39.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.038 0.447 . . . . 0.0 110.911 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.426 HG23 ' HG3' ' A' ' 268' ' ' ARG . 9.0 t -113.07 -20.83 11.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.426 ' HG3' HG23 ' A' ' 267' ' ' THR . 98.2 mtt180 -117.92 98.92 6.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 0.0 110.107 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 34.8 ttm -101.18 109.68 21.59 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.168 0.509 . . . . 0.0 110.804 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -83.31 162.31 21.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.932 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.1 tt -97.38 -13.72 7.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.129 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -67.24 -53.7 27.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.227 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 164.77 -37.81 0.29 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.791 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.421 ' HG3' HD13 ' A' ' 285' ' ' LEU . 0.5 OUTLIER -101.89 134.92 44.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.057 0.456 . . . . 0.0 110.24 178.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.519 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 20.9 m0 -107.89 165.1 11.7 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.167 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 43.7 tt0 -121.53 116.85 25.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.136 0.494 . . . . 0.0 110.253 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -129.56 169.98 20.59 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.54 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 74.8 mt-10 -108.39 108.35 19.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.906 0.384 . . . . 0.0 110.767 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.507 ' HB ' HD21 ' A' ' 256' ' ' LEU . 47.2 t -128.28 139.08 52.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 279' ' ' VAL . 15.4 m120 70.96 8.02 6.39 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.631 0.373 . . . . 0.0 110.76 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 86.46 13.46 67.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.975 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 282' ' ' ARG . 1.7 ptm180 -132.03 137.98 48.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.86 0.362 . . . . 0.0 110.525 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 3.3 ptpp? -97.79 134.3 41.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.693 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -152.39 173.94 31.39 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.566 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 91.7 mt -90.14 140.59 29.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.015 0.436 . . . . 0.0 111.504 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 33.5 p90 -145.64 134.73 11.21 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.521 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 5.0 Cg_exo -74.54 148.82 38.11 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.857 2.371 . . . . 0.0 112.811 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.406 ' C ' ' H ' ' A' ' 290' ' ' HIS . 36.7 p90 -64.32 -25.27 67.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.286 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.8 m -76.0 37.45 0.15 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.45 0.643 . . . . 0.0 110.928 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.406 ' H ' ' C ' ' A' ' 288' ' ' PHE . 8.5 m-70 -141.6 -61.02 0.47 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.384 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.461 HG21 ' HE2' ' A' ' 286' ' ' PHE . 23.2 m -90.92 150.38 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.797 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -109.35 117.04 33.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.86 0.362 . . . . 0.0 110.785 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.692 HD13 ' HB2' ' A' ' 240' ' ' ALA . 36.8 mm -69.94 125.49 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.837 175.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -122.3 -179.31 4.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.465 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 296' ' ' PRO . 14.7 m-20 -78.82 114.86 47.55 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.133 0.492 . . . . 0.0 110.017 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 295' ' ' ASP . 21.5 Cg_endo -94.5 43.55 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.513 2.809 . . . . 0.0 113.126 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.534 ' NE2' HD22 ' A' ' 298' ' ' ASN . 5.6 pm0 -73.29 -14.88 61.39 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.534 HD22 ' NE2' ' A' ' 297' ' ' GLN . 4.3 p30 -96.07 98.73 4.27 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.779 171.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 297' ' ' GLN . 74.3 Cg_endo -95.24 21.14 0.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.946 2.431 . . . . 0.0 113.285 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 44.3 t0 65.08 97.08 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.703 0.627 . . . . 0.0 110.402 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.45 -49.67 70.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.738 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -76.52 101.73 5.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.165 0.507 . . . . 0.0 111.493 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.396 -0.812 . . . . 0.0 109.543 177.117 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.677 0.275 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 p -111.5 28.51 8.67 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 m -65.88 -44.39 85.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.599 0.714 . . . . 0.0 109.315 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 98' ' ' LEU . . . -91.94 117.3 29.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.144 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 5' ' ' ARG . 17.4 ttp180 -163.11 105.15 1.01 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.114 0.483 . . . . 0.0 110.319 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.477 ' CB ' ' HD3' ' A' ' 101' ' ' PRO . 25.4 p90 -132.28 -180.0 5.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.985 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -89.36 91.03 8.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.122 0.487 . . . . 0.0 110.699 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.766 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 40.8 m -67.65 150.56 48.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.894 177.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m 78.28 -39.35 0.26 Allowed 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.799 0.687 . . . . 0.0 112.31 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.96 101.85 0.17 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.049 0.452 . . . . 0.0 110.295 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -56.96 -46.2 82.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.033 -170.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m -77.27 7.87 4.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.34 -40.27 11.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.572 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.3 p-90 -127.76 -27.81 2.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.0 t80 -79.77 123.67 27.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.896 0.317 . . . . 0.0 110.355 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.441 ' HB2' HG21 ' A' ' 19' ' ' VAL . 22.3 mmt -110.52 -1.33 17.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.844 -173.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.46 -114.27 2.88 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.007 -0.542 . . . . 0.0 113.709 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 10.3 Cg_exo -70.33 103.59 1.28 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.008 2.472 . . . . 0.0 112.175 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.816 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 85.9 t -136.57 -70.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.794 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 30.1 t 81.36 165.59 0.15 Allowed 'General case' 0 C--N 1.347 0.477 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -55.83 -38.96 70.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.746 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -59.63 -40.99 89.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.069 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -91.98 -44.97 8.58 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.235 -175.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.92 -41.31 67.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.811 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 47.8 tt0 -72.3 -46.27 56.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.413 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.3 t -68.39 -23.42 64.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.988 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -83.39 -29.31 28.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.2 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.713 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 38.4 mt -103.43 -0.05 30.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.027 0.441 . . . . 0.0 110.757 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 25.7 tt0 -70.15 113.53 7.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.6 -174.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.89 33.82 84.96 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.573 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -102.47 -168.48 1.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.678 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 17.8 ttp180 -62.85 113.19 2.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.627 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.66 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 42.7 m170 -62.26 118.5 7.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.929 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.91 -8.33 6.81 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.569 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.678 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 20.1 mtp -87.17 140.11 29.88 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 122.52 0.328 . . . . 0.0 110.442 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.778 ' HB2' HG22 ' A' ' 52' ' ' VAL . 28.8 p90 -142.52 164.52 29.89 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.643 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.402 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.2 pp -154.98 136.67 14.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.221 0.534 . . . . 0.0 111.056 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 15' ' ' TYR . 93.2 t -101.42 112.7 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.816 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 20.9 ptt-85 -107.59 176.47 5.14 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.685 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -81.5 138.97 35.41 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.415 ' HA ' HG23 ' A' ' 49' ' ' VAL . 83.3 p -55.6 -19.87 11.75 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.086 0.241 . . . . 0.0 111.596 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m 69.41 17.63 8.07 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.507 0.67 . . . . 0.0 109.794 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 p -140.42 -45.05 0.41 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.733 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 66.3 m -134.27 127.13 18.79 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.765 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 24.2 Cg_exo -64.48 -14.37 43.95 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.863 2.375 . . . . 0.0 112.578 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.57 29.2 13.03 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.862 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.31 134.74 18.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -124.76 162.34 24.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.512 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.72 HG11 ' HE2' ' A' ' 207' ' ' PTR . 21.2 t -131.51 99.88 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.125 0.488 . . . . 0.0 111.189 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.2 tp -76.28 96.34 3.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.141 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.9 m -97.35 135.41 39.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.971 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.778 HG22 ' HB2' ' A' ' 36' ' ' PHE . 86.7 t -128.87 137.18 57.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.114 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.713 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 31.3 t -83.5 99.38 10.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.704 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.66 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 15.8 pt-20 -172.81 173.87 3.74 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.995 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.748 ' HB3' HH21 ' A' ' 57' ' ' ARG . 27.7 t-20 71.67 -56.3 0.64 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.734 1.254 . . . . 0.0 109.499 -164.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.401 ' C ' ' HG3' ' A' ' 57' ' ' ARG . 29.8 t -162.32 -40.63 0.04 OUTLIER 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.068 -1.878 . . . . 0.0 106.88 -176.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.748 HH21 ' HB3' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -165.35 -39.51 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.705 ' CG2' ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -144.2 110.97 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 120.822 1.646 . . . . 0.0 114.899 -173.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.652 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 16.0 m -95.85 108.29 20.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 163.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -100.34 99.0 9.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -170.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.729 ' CE2' HD22 ' A' ' 93' ' ' LEU . 44.0 m-85 -116.97 114.31 23.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.715 HG12 HG22 ' A' ' 49' ' ' VAL . 19.9 mt -81.07 138.59 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.787 HG13 ' HB ' ' A' ' 73' ' ' ILE . 5.3 mp -114.2 115.25 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.205 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -85.0 143.15 29.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.692 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.7 t -93.56 98.69 11.33 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' A' ' 72' ' ' LYS . 23.0 mt -78.58 124.94 85.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 14.1 Cg_exo -68.12 -33.58 24.73 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.313 2.009 . . . . 0.0 113.44 -174.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -67.53 -18.85 65.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -172.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.641 ' HG2' ' N ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -176.65 -53.55 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.641 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 2.3 ptm180 -136.85 -172.18 3.11 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -160.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -102.36 157.81 16.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.539 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.659 ' HB2' HD11 ' A' ' 66' ' ' LEU . 24.7 ttmm -138.82 104.67 5.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.787 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.7 tt -90.88 78.78 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.785 0.802 . . . . 0.0 110.006 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.749 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 65.52 86.49 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.742 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 10.8 t70 75.1 -61.68 0.48 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.475 0.31 . . . . 0.0 111.472 176.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.28 124.04 23.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.023 0.44 . . . . 0.0 109.987 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 11.1 pt-20 -107.3 138.5 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.282 0.563 . . . . 0.0 110.489 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.495 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 44.5 m-85 -127.18 166.59 17.42 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.54 -50.42 71.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -149.38 175.78 11.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.452 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.653 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 15.4 mt -54.85 -55.22 40.97 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.766 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 41.4 Cg_exo -59.96 -10.42 12.31 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.277 1.985 . . . . 0.0 113.797 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.74 -34.92 16.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.348 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -76.32 -28.75 57.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.394 0.616 . . . . 0.0 109.385 176.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 82' ' ' PRO . 74.0 mt -66.35 -23.4 66.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.009 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' A' ' 89' ' ' LYS . 38.0 tt0 -85.46 -29.27 24.45 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.237 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -69.37 -38.7 78.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.238 0.542 . . . . 0.0 110.063 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HE2' HD13 ' A' ' 73' ' ' ILE . 59.2 m-85 -80.83 -2.61 47.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.54 0.686 . . . . 0.0 110.467 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 47.5 tttm -78.77 -14.82 59.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.035 174.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -128.73 -1.77 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 111.474 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 22.6 t-160 -98.75 -28.51 13.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.127 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 70.1 132.23 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 O-C-N 124.079 0.862 . . . . 0.0 109.376 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 61' ' ' TYR . 9.2 mt -92.31 -26.63 18.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.734 ' CG ' ' HB2' ' A' ' 55' ' ' ASN . 10.3 t0 -173.83 83.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.777 168.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 71.66 -19.18 0.27 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.925 0.89 . . . . 0.0 112.064 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.7 m -120.43 158.0 28.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.0 p -106.16 172.57 6.73 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.458 ' O ' ' HB1' ' A' ' 4' ' ' ALA . 95.5 mt -64.71 93.69 0.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.032 0.444 . . . . 0.0 110.104 175.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.598 HG22 ' HG3' ' A' ' 100' ' ' GLU . 47.1 mm -81.34 -62.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.254 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.598 ' HG3' HG22 ' A' ' 99' ' ' ILE . 43.5 mt-10 -147.65 157.16 44.8 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.562 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 11.9 Cg_exo -70.46 156.98 60.36 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.097 1.865 . . . . 0.0 111.19 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.24 138.74 71.83 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.584 ' HG2' ' HB2' ' A' ' 107' ' ' SER . 69.4 Cg_exo -52.14 126.19 19.59 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.232 1.954 . . . . 0.0 111.808 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -60.62 -31.48 70.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.057 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -108.45 138.17 20.15 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.214 174.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -44.97 119.29 2.33 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.549 2.833 . . . . 0.0 113.496 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.603 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 23.3 t -72.47 -49.74 8.61 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.756 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 107' ' ' SER . 8.0 Cg_exo -34.6 -54.88 0.55 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 124.025 3.15 . . . . 0.0 115.604 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.47 -0.81 7.2 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 122.006 1.804 . . . . 0.0 113.701 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 22.4 ptm -147.84 25.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.22 165.23 24.74 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.195 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.3 m -107.57 106.95 17.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.846 0.355 . . . . 0.0 110.402 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.4 t -81.85 82.31 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.585 0.707 . . . . 0.0 110.124 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.414 ' H ' ' HD2' ' A' ' 116' ' ' PRO . 70.1 m -151.54 -42.93 0.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.338 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.478 ' N ' ' HD2' ' A' ' 116' ' ' PRO . . . -62.42 -48.78 86.17 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.355 174.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HB3' ' HB2' ' A' ' 32' ' ' ARG . 38.1 Cg_endo -67.59 104.34 0.93 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.5 1.467 . . . . 0.0 111.715 172.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -76.18 140.37 41.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.799 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 53.3 tp -120.82 83.65 36.81 Favored Pre-proline 0 C--N 1.32 -0.686 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.766 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -88.97 115.82 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.305 2.67 . . . . 0.0 110.188 167.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 t -116.83 157.32 25.79 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.668 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.08 -153.9 0.5 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.221 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.77 -178.63 1.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.326 0.584 . . . . 0.0 110.724 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -86.35 -7.96 58.06 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -86.83 -151.83 0.17 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.152 -1.386 . . . . 0.0 109.386 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.597 HD12 HG21 ' A' ' 152' ' ' ILE . 1.0 OUTLIER 63.19 86.08 0.12 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 122.04 0.924 . . . . 0.0 111.488 177.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -172.07 -33.75 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.895 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.678 ' HB3' HH21 ' A' ' 183' ' ' ARG . 19.2 m-85 -123.7 109.77 14.13 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.655 0.741 . . . . 0.0 111.352 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 179' ' ' GLU . 25.4 t -124.38 153.05 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.372 -175.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.732 ' HG2' ' O ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -135.06 150.37 50.25 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.066 174.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.649 HG22 ' CG1' ' A' ' 178' ' ' VAL . 51.4 p -95.46 133.95 38.85 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.823 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 178' ' ' VAL . 6.4 mt -106.96 -37.52 6.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.664 -173.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.599 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 47.5 t80 -90.45 -31.62 16.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -168.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.599 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 6.5 t70 77.67 123.91 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.214 0.53 . . . . 0.0 111.113 -172.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 84.8 t80 -156.77 106.3 1.96 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.733 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -91.98 95.22 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.879 2.386 . . . . 0.0 113.123 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -97.41 0.6 59.97 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.794 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.557 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 66.96 5.33 4.0 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.301 0.641 . . . . 0.0 112.223 -178.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.883 ' HB2' ' HD3' ' A' ' 143' ' ' PRO . 18.5 t0 52.47 -146.51 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.869 0.867 . . . . 0.0 112.94 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 140' ' ' GLU . . . 69.51 11.83 8.08 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.499 1.12 . . . . 0.0 108.828 -165.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 139' ' ' ALA . 23.2 tt0 171.81 -39.67 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.139 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.506 ' C ' ' HA ' ' A' ' 138' ' ' ASP . 21.8 m-20 -133.33 97.73 4.05 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.78 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.819 HD12 ' HD2' ' A' ' 143' ' ' PRO . 23.7 tp -54.67 129.86 63.91 Favored Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 122.971 0.509 . . . . 0.0 111.931 -174.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.883 ' HD3' ' HB2' ' A' ' 138' ' ' ASP . 73.1 Cg_endo -81.54 117.5 3.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.513 2.142 . . . . 0.0 111.355 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.615 ' CB ' HG21 ' A' ' 130' ' ' THR . 21.3 p90 -123.04 165.51 16.66 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.986 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.521 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 42.4 mttp -115.05 -165.88 1.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.272 0.558 . . . . 0.0 111.904 -174.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.531 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -93.98 26.98 2.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.089 179.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.43 25.92 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 119.625 -1.274 . . . . 0.0 114.388 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.541 ' OE1' ' HB2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -108.12 161.6 14.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.93 0.865 . . . . 0.0 109.331 174.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.602 HG21 HD23 ' A' ' 181' ' ' LEU . 7.0 mm -119.36 146.9 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.757 -167.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 165' ' ' ASN . 15.9 mt -122.77 166.38 15.05 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -173.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.44 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 97.6 t -123.53 125.76 72.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.712 HD13 ' HB2' ' A' ' 163' ' ' ALA . 21.6 mm -77.0 97.54 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 CA-C-O 122.475 1.131 . . . . 0.0 108.747 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.615 ' CD1' ' HE1' ' A' ' 61' ' ' TYR . 1.7 tt -97.52 -49.01 12.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 112.472 -2.149 . . . . 0.0 109.024 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.044 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 15.7 mt-10 -116.16 142.85 46.27 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.573 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 15.8 ttpp -140.23 72.04 32.96 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 121.466 -0.771 . . . . 0.0 109.901 170.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.474 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 24.5 Cg_exo -62.12 -43.89 22.13 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.453 2.102 . . . . 0.0 111.885 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -113.73 -174.07 2.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.05 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 4.2 tp10 -107.14 -40.0 5.55 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.525 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -84.08 -11.55 56.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.174 0.512 . . . . 0.0 110.324 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.427 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 68.0 m95 -129.2 118.58 22.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.407 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.604 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.7 m0 -108.76 139.08 44.07 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 1.044 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 11.3 t -101.72 91.08 4.25 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.39 0.614 . . . . 0.0 109.639 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.712 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.52 161.53 15.25 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.197 -172.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.837 HH12 ' HA ' ' A' ' 208' ' ' ALA . 19.5 ptt-85 -97.54 136.21 38.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.9 HD21 ' HB3' ' A' ' 167' ' ' ASP . 12.9 p-10 -85.76 175.57 8.62 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.619 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -79.9 4.28 17.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.37 0.605 . . . . 0.0 110.975 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.9 ' HB3' HD21 ' A' ' 165' ' ' ASN . 33.6 t70 -104.03 -1.28 27.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.245 0.545 . . . . 0.0 109.535 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.798 ' HA3' ' HA ' ' A' ' 212' ' ' THR . . . 85.47 72.09 1.3 Allowed Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.81 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 38.4 ttm-85 -164.46 129.04 2.65 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.78 -0.247 . . . . 0.0 110.364 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.689 HG22 ' HB3' ' A' ' 164' ' ' ARG . 39.0 t -105.48 109.56 28.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.373 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.505 ' HA3' ' OD1' ' A' ' 138' ' ' ASP . . . -146.23 170.09 27.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.095 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.587 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 22.5 mtp -82.49 137.11 34.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.038 0.447 . . . . 0.0 111.211 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.613 HG23 ' HB3' ' A' ' 142' ' ' LEU . 2.7 pp -133.9 146.04 58.4 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.699 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.461 ' HD2' ' CE2' ' A' ' 144' ' ' PHE . 7.3 Cg_exo -72.23 128.35 13.72 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.064 2.509 . . . . 0.0 112.41 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 47.8 t -67.4 -36.67 10.86 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.278 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 26.8 Cg_endo -63.49 10.4 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.646 1.564 . . . . 0.0 113.177 173.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 175' ' ' VAL . 4.6 m-85 -118.38 -19.83 8.73 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.554 0.342 . . . . 0.0 111.322 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.649 ' CG1' HG22 ' A' ' 130' ' ' THR . 3.8 m -146.2 155.97 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.674 -166.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.5 ' C ' ' HD3' ' A' ' 180' ' ' LYS . 11.7 mt-10 -150.46 -56.35 0.17 Allowed 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 115.939 -2.305 . . . . 0.0 115.652 155.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.732 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -144.35 150.0 37.07 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 115.619 -2.432 . . . . 0.0 116.04 -160.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.602 HD23 HG21 ' A' ' 149' ' ' ILE . 37.0 tp -147.08 110.42 4.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.242 163.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.74 -26.98 21.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 O-C-N 123.837 0.71 . . . . 0.0 111.241 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.678 HH21 ' HB3' ' A' ' 127' ' ' TYR . 0.2 OUTLIER 83.15 -42.11 0.1 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.64 169.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.2 t -67.98 91.79 0.35 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.377 0.608 . . . . 0.0 110.451 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 4.4 p -144.6 139.1 15.14 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.182 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 52.7 Cg_exo -55.81 -41.92 72.44 Favored 'Trans proline' 0 N--CA 1.471 0.191 0 C-N-CA 123.287 2.658 . . . . 0.0 113.479 -174.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 71.4 m80 60.61 -155.52 0.36 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -76.42 -52.55 6.01 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.227 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -138.51 18.45 2.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 110.27 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 66.13 10.08 6.78 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.59 0.71 . . . . 0.0 110.51 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -149.88 -138.35 2.89 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -157.74 161.9 38.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -128.73 132.27 47.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.129 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 195' ' ' SER . 10.8 t30 -136.91 -81.67 0.37 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.145 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 194' ' ' ASN . 15.7 t 174.33 116.69 0.02 OUTLIER 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 60.17 -165.57 0.2 Allowed 'General case' 0 C--O 1.235 0.316 0 O-C-N 123.803 0.689 . . . . 0.0 110.311 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 32.2 t 66.03 19.37 11.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.673 0.389 . . . . 0.0 111.15 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -79.91 105.73 11.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.262 0.554 . . . . 0.0 110.693 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -169.88 63.27 0.18 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.579 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 203' ' ' PRO . 14.2 pt -98.08 116.2 65.65 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 121.283 0.564 . . . . 0.0 111.335 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -87.57 101.11 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.891 2.394 . . . . 0.0 112.086 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 60.85 81.65 0.24 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.665 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.545 ' HB3' HD12 ' A' ' 200' ' ' ILE . 74.4 Cg_endo -76.73 19.93 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.877 2.385 . . . . 0.0 113.249 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -78.75 -58.76 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.343 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -120.93 -21.6 6.49 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.419 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 59.79 -156.07 0.35 Allowed 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.498 0.498 . . . . 0.0 111.098 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.72 ' HE2' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.837 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -92.57 5.65 50.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.64 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.406 ' HB3' ' H ' ' A' ' 62' ' ' ILE . 19.4 pt20 -59.91 145.82 83.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.676 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.749 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 21.4 Cg_exo -65.81 85.82 0.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.221 1.948 . . . . 0.0 111.465 175.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.829 HE21 ' HA ' ' A' ' 211' ' ' GLN . 0.0 OUTLIER -72.98 112.05 8.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 -178.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.798 ' HA ' ' HA3' ' A' ' 168' ' ' GLY . 2.9 m -67.13 -38.83 86.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.449 -176.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 25.3 m 72.87 -68.1 0.24 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.953 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 212' ' ' THR . 11.3 p -105.96 150.45 39.27 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.826 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.49 147.32 86.75 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.531 2.154 . . . . 0.0 112.152 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.691 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 98.7 mt -57.81 -53.47 65.4 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 13.6 Cg_exo -70.77 132.86 22.52 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.071 1.847 . . . . 0.0 111.926 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -67.6 -29.24 68.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.208 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 47.2 t -67.22 106.6 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.322 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 32.7 t -127.91 97.74 4.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.295 0.569 . . . . 0.0 110.696 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -132.92 -49.78 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 66.4 m -157.94 110.11 1.76 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -51.74 -48.78 19.77 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.764 2.309 . . . . 0.0 112.166 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 179.47 100.69 0.14 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.867 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.35 -32.13 72.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.236 0.541 . . . . 0.0 109.571 176.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -106.79 142.02 37.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.295 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 60.8 mt -95.0 100.58 11.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.042 0.449 . . . . 0.0 110.902 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.473 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 63.8 m -106.59 112.39 63.67 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.797 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 228' ' ' THR . 17.1 Cg_exo -66.32 -78.79 0.01 OUTLIER 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.866 2.377 . . . . 0.0 112.889 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 229' ' ' PRO . 2.7 pt? -168.31 151.67 5.58 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.94 129.46 8.01 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.381 2.054 . . . . 0.0 111.718 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 39.6 p -99.75 2.22 43.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.118 0.485 . . . . 0.0 110.391 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 43.7 p -105.0 -172.75 2.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.866 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -94.26 9.93 36.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.215 0.531 . . . . 0.0 110.131 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -82.36 113.67 20.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.501 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -177.3 -139.76 3.42 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.037 -0.601 . . . . 0.0 111.632 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.92 160.4 33.82 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.548 2.165 . . . . 0.0 111.948 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.442 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 38.4 t -103.21 145.16 12.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.19 122.01 46.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.88 0.371 . . . . 0.0 110.818 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.492 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.28 142.91 48.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.25 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -95.37 123.75 39.06 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -75.81 111.24 10.96 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.121 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.417 HG21 ' HE3' ' A' ' 292' ' ' LYS . 35.6 pt -94.58 -9.98 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.431 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 9.2 tt0 -138.92 144.04 38.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.607 ' HG2' ' HA ' ' A' ' 259' ' ' GLU . 84.1 mttt -82.3 121.94 27.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.932 0.396 . . . . 0.0 111.093 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.703 ' HD2' ' CE1' ' A' ' 290' ' ' HIS . 54.1 ttt85 -93.16 102.47 14.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 45.7 t -80.59 136.97 51.52 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.196 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 11.6 Cg_endo -55.02 141.48 79.02 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.994 2.463 . . . . 0.0 112.75 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.93 165.5 25.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.234 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.75 -23.66 67.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.949 0.404 . . . . 0.0 111.108 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -125.33 30.32 5.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.945 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.487 ' HB2' ' HB3' ' A' ' 255' ' ' ALA . 9.9 p-10 -43.63 103.84 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.971 0.891 . . . . 0.0 112.277 -169.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -111.97 -33.8 6.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.904 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 7.4 p -129.96 16.18 5.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.307 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . . . -92.59 111.01 22.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.929 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.475 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.4 tt -90.11 113.3 25.01 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -64.68 123.82 20.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.016 0.436 . . . . 0.0 110.909 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.3 mt -128.03 165.18 20.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.848 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.607 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 14.3 pt-20 -146.36 166.27 26.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.535 177.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 42.9 t -70.56 124.01 25.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.022 0.439 . . . . 0.0 111.071 -174.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.35 4.43 50.08 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.805 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -100.3 155.08 17.98 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.977 0.389 . . . . 0.0 109.992 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.447 HD11 ' OD1' ' A' ' 302' ' ' ASN . 22.8 mm -94.74 113.04 28.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.169 0.509 . . . . 0.0 110.99 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 t -87.05 95.4 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.285 0.565 . . . . 0.0 109.592 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -81.52 98.58 8.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.057 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 275' ' ' TRP . 4.0 p -89.11 120.96 38.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.392 0.615 . . . . 0.0 111.27 -176.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 26.4 m -93.99 -30.91 14.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.506 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 1.001 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 13.0 tpt180 -115.54 97.34 6.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.441 -177.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 2.2 tpt -81.53 106.16 13.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.167 0.508 . . . . 0.0 109.659 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -86.39 166.17 15.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.192 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 40.1 mm -76.91 83.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.418 -175.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.6 t30 83.65 82.42 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.752 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.407 ' HA2' ' HD1' ' A' ' 288' ' ' PHE . . . 114.35 -77.16 0.25 Allowed Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 119.69 -1.243 . . . . 0.0 114.066 154.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -72.52 88.57 1.24 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.825 0.345 . . . . 0.0 110.718 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.514 ' HB3' HG21 ' A' ' 266' ' ' VAL . 9.9 m0 -92.88 161.47 14.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.033 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 1.001 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 27.5 tt0 -109.98 116.09 30.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.086 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.36 155.71 18.24 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.368 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.3 108.37 19.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.475 ' HB ' HD21 ' A' ' 256' ' ' LEU . 61.0 t -128.98 140.12 50.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 13.7 m120 66.68 -71.05 0.1 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.831 0.707 . . . . 0.0 110.882 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -173.98 31.51 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -151.17 143.59 24.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.733 -0.233 . . . . 0.0 110.577 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 98.3 mttt -96.52 131.39 43.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 171.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.71 171.23 30.52 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.98 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 37.2 mt -92.83 145.09 24.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.093 0.473 . . . . 0.0 110.668 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.437 ' HZ ' ' HB ' ' A' ' 266' ' ' VAL . 31.5 p90 -148.22 124.93 5.46 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.16 177.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.416 ' HB2' HG22 ' A' ' 289' ' ' THR . 44.4 Cg_endo -71.6 157.48 55.84 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.271 1.981 . . . . 0.0 111.772 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.407 ' HD1' ' HA2' ' A' ' 273' ' ' GLY . 22.8 p90 -81.55 15.21 2.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.1 0.476 . . . . 0.0 111.5 -176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.416 HG22 ' HB2' ' A' ' 287' ' ' PRO . 8.8 t -89.81 1.56 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.576 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.703 ' CE1' ' HD2' ' A' ' 246' ' ' ARG . 1.2 p-80 -137.39 3.77 2.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 176.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.661 HG13 ' HD2' ' A' ' 290' ' ' HIS . 18.4 m -129.54 157.35 42.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.417 ' HE3' HG21 ' A' ' 243' ' ' ILE . 16.8 ptpt -129.9 135.66 48.62 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.516 176.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.492 HD13 ' HB2' ' A' ' 240' ' ' ALA . 46.5 mm -83.47 103.4 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.252 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -93.69 167.56 11.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.194 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.1 134.72 59.16 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.89 -20.06 27.89 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.158 2.572 . . . . 0.0 113.359 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -86.58 86.28 7.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.182 0.515 . . . . 0.0 110.005 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 17.0 m120 -83.06 135.93 44.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.962 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 16.5 Cg_exo -69.24 -32.69 20.2 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.698 2.265 . . . . 0.0 110.518 171.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -96.86 -173.37 2.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.222 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -121.2 14.9 11.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.027 0.441 . . . . 0.0 110.154 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.447 ' OD1' HD11 ' A' ' 263' ' ' ILE . 0.7 OUTLIER 66.26 3.32 2.7 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.632 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 . . . . . 0 C--O 1.244 0.771 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.294 173.162 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 ttp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -117.07 88.39 2.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.178 0.513 . . . . 0.0 110.226 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -95.27 -37.48 10.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.709 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.629 ' HB3' ' HG2' ' A' ' 89' ' ' LYS . . . -179.5 143.24 0.19 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.637 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.96 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.619 0.575 . . . . 0.0 109.487 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.684 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 3.5 p90 38.4 -122.56 0.28 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 124.288 0.992 . . . . 0.0 111.14 -174.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -139.99 81.59 1.83 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 172.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -71.84 62.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.943 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -179.19 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.12 100.07 4.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.576 -174.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -64.41 -24.62 67.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.761 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.6 m -67.41 -7.6 26.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.353 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.49 -47.99 4.49 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -112.15 -20.6 11.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -82.08 110.34 17.22 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.811 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 11.3 tpp -96.34 0.6 50.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.168 -171.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.433 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.49 -113.36 2.29 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.181 -0.918 . . . . 0.0 114.152 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 3.0 Cg_exo -79.33 100.24 1.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.823 2.348 . . . . 0.0 112.127 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.598 ' HB ' ' HG2' ' A' ' 39' ' ' ARG . 85.1 t -130.34 -76.63 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 48.8 m 82.65 162.92 0.13 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.803 ' HG3' ' O2P' ' A' ' 207' ' ' PTR . 44.4 mtp85 -51.65 -42.3 61.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -55.86 -39.46 71.52 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.423 0.452 . . . . 0.0 112.104 -177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 34.2 mt-10 -95.75 -44.91 7.22 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.254 -177.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.86 51.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.336 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -81.67 -32.88 31.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.759 -173.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.493 ' HA ' ' HB2' ' A' ' 29' ' ' GLN . 10.6 t -78.0 -27.74 49.05 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 110.682 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 21.2 mmt85 -64.62 -33.9 77.01 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.855 0.836 . . . . 0.0 109.755 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.987 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 80.7 mt -113.89 23.29 13.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.077 -176.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.493 ' HB2' ' HA ' ' A' ' 26' ' ' THR . 24.4 tt0 -72.71 72.13 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.227 0.537 . . . . 0.0 110.536 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.14 15.96 59.32 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.296 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -62.98 -28.37 70.04 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 20.0 ttm180 -156.24 -36.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.476 172.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.623 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 28.9 m170 77.08 132.0 0.05 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.129 0.893 . . . . 0.0 109.52 -173.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.31 -10.86 67.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.567 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 55.4 mtm -87.36 153.75 21.21 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 50' ' ' LEU . 39.0 p90 -141.63 162.16 36.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.331 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.5 pp -150.81 135.98 17.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.024 0.44 . . . . 0.0 110.337 172.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.7 t -105.54 116.26 48.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.425 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.618 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -119.85 163.72 17.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.893 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.2 131.81 45.51 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.527 ' OG ' HG22 ' A' ' 43' ' ' THR . 26.8 t -79.4 158.62 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.57 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.656 ' HB3' ' O1P' ' A' ' 207' ' ' PTR . 40.0 t -117.92 4.4 12.15 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.176 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.527 HG22 ' OG ' ' A' ' 41' ' ' SER . 14.7 t -93.52 -26.2 17.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.893 0.378 . . . . 0.0 110.345 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.696 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 62.8 m -141.98 144.67 33.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.07 -48.92 15.9 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.819 2.346 . . . . 0.0 112.568 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.92 71.59 0.21 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.577 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.696 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 34.3 t70 -151.3 150.98 31.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -173.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -130.35 172.1 12.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.647 HG22 HG12 ' A' ' 62' ' ' ILE . 54.2 t -144.47 108.29 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 111.543 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' A' ' 36' ' ' PHE . 42.9 tp -81.37 105.36 12.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.214 173.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -96.96 128.56 44.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.304 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.596 HG21 HD13 ' A' ' 93' ' ' LEU . 86.9 t -125.7 134.62 66.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.04 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.987 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 65.6 p -106.93 124.65 49.92 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.623 ' HG2' ' HB3' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -154.84 153.64 31.48 Favored 'General case' 0 C--O 1.212 -0.888 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 163.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 57.72 19.98 6.02 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.0 m 54.46 61.27 3.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 123.018 1.39 . . . . 0.0 108.259 -170.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 39.6 ttp85 -162.3 57.75 0.23 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.121 -2.309 . . . . 0.0 107.286 -159.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.2 t -76.97 100.24 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.723 -172.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 p -79.69 120.99 24.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.924 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -95.41 98.7 10.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.105 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.678 ' CE2' HD22 ' A' ' 93' ' ' LEU . 26.0 m-85 -93.9 115.83 28.23 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.864 ' HB ' ' HB3' ' A' ' 209' ' ' GLN . 7.1 mt -76.43 139.63 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.585 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 2.7 mp -124.81 118.41 53.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.696 0.798 . . . . 0.0 109.895 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 11.0 m120 -84.99 131.66 34.44 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 -172.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -79.77 99.45 7.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 72' ' ' LYS . 61.2 mt -90.63 132.48 34.95 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.429 -176.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 25.1 Cg_exo -64.07 -3.81 6.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.902 2.402 . . . . 0.0 112.699 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -93.82 22.18 5.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.152 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.655 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.8 mmp_? 63.36 26.83 15.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.394 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.7 164.41 15.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.663 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.585 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 62.5 m-85 -133.69 114.9 13.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.72 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.47 ' NZ ' ' HG3' ' A' ' 77' ' ' GLU . 21.8 ttmm -100.73 107.18 18.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.817 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.0 tt -94.7 78.42 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.858 0.837 . . . . 0.0 109.742 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.406 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 67.42 89.31 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.226 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.93 -57.69 0.63 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.464 0.706 . . . . 0.0 111.193 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -69.19 121.53 16.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.995 0.426 . . . . 0.0 110.965 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.47 ' HG3' ' NZ ' ' A' ' 72' ' ' LYS . 20.4 mt-10 -97.59 125.56 42.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.966 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 74.3 m-85 -115.38 152.45 32.82 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.84 -11.19 60.81 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -175.17 176.32 2.09 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.628 0.195 . . . . 0.0 110.757 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.5 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 5.9 mt -56.44 -55.56 41.27 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 123.278 0.361 . . . . 0.0 111.833 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.418 ' HA ' HD12 ' A' ' 85' ' ' LEU . 37.8 Cg_exo -63.38 -3.86 5.82 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.123 1.882 . . . . 0.0 113.638 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.13 -35.04 16.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.76 0.314 . . . . 0.0 110.55 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -76.15 -31.92 58.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 82' ' ' PRO . 55.5 mt -68.24 -24.35 64.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.713 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.18 -19.12 40.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.828 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -88.38 -39.14 14.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.177 0.513 . . . . 0.0 110.199 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.519 ' HE2' HD13 ' A' ' 73' ' ' ILE . 52.8 m-85 -78.28 -3.5 43.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.518 0.675 . . . . 0.0 109.78 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.629 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 1.4 tmtp? -64.71 -35.09 79.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.869 170.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.7 pt -113.69 -6.39 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.629 -0.428 . . . . 0.0 112.072 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 6.2 t-160 -73.18 -43.21 61.77 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.806 -0.179 . . . . 0.0 110.886 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.62 ' CD1' HG23 ' A' ' 97' ' ' THR . 94.5 m-85 68.03 100.04 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.257 0.973 . . . . 0.0 108.867 -165.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.717 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 4.2 mt -69.64 -98.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.527 ' OD2' ' HB3' ' A' ' 54' ' ' GLU . 17.5 t0 -89.84 76.86 7.09 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 121.368 -0.832 . . . . 0.0 109.325 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 68.15 -34.07 0.24 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.538 1.135 . . . . 0.0 112.409 -177.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.404 ' H ' ' C ' ' A' ' 94' ' ' ASP . 39.5 m -107.87 146.06 32.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.62 HG23 ' CD1' ' A' ' 92' ' ' TYR . 3.1 p -81.76 -178.5 7.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 0.0 110.704 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.401 HD22 ' CD2' ' A' ' 36' ' ' PHE . 95.1 mt -77.18 91.76 3.76 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.1 mm -74.93 -60.83 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.424 -175.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.684 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 9.4 pt-20 -162.35 156.09 17.9 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.407 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.2 158.15 49.32 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.621 2.214 . . . . 0.0 113.36 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -72.49 154.38 91.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.842 176.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.25 124.4 15.55 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.054 2.503 . . . . 0.0 112.673 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.811 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 75.8 ttt180 -67.58 -46.96 71.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.072 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 78.5 t80 -129.78 118.97 18.89 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.045 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 12.7 Cg_exo -70.82 98.08 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.714 2.276 . . . . 0.0 111.262 175.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.0 m -70.94 125.45 92.01 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.511 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.437 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 79.8 Cg_exo -48.75 -46.52 24.15 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.099 2.532 . . . . 0.0 113.253 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 108' ' ' PRO . 18.3 Cg_endo -62.21 105.07 0.38 Allowed 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 121.455 1.437 . . . . 0.0 110.936 169.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -76.14 120.07 20.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.281 0.562 . . . . 0.0 111.437 -174.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.99 0.11 27.08 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.752 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.8 t -162.88 114.27 1.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 110.457 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.8 m -121.07 -19.51 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.803 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.8 m -96.5 112.39 24.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.892 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.705 ' H ' ' HD2' ' A' ' 116' ' ' PRO . . . -165.58 -49.48 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.809 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.705 ' HD2' ' H ' ' A' ' 115' ' ' ALA . 40.8 Cg_endo -68.51 126.04 13.62 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 121.994 1.796 . . . . 0.0 112.78 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -81.76 -28.42 33.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.504 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.6 mt -145.86 95.99 4.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.391 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -82.2 -6.26 12.03 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.013 2.475 . . . . 0.0 111.567 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.7 p -70.54 129.33 38.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.685 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.59 133.77 55.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.009 0.433 . . . . 0.0 111.823 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -151.44 109.7 3.75 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.1 106.07 0.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.49 0.493 . . . . 0.0 111.87 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.454 ' HA ' ' CD ' ' A' ' 183' ' ' ARG . 45.1 m-80 -143.89 171.93 13.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.434 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.969 HD12 HG21 ' A' ' 152' ' ' ILE . 1.3 mm? 66.51 85.94 0.14 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.77 0.795 . . . . 0.0 111.147 174.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -154.77 -76.73 0.1 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.608 -171.112 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.578 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 48.9 m-85 -104.98 108.52 20.07 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.612 0.72 . . . . 0.0 111.392 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.944 HG22 ' HB3' ' A' ' 180' ' ' LYS . 74.3 t -122.81 132.25 71.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.516 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.975 ' HB2' ' HB3' ' A' ' 179' ' ' GLU . 26.1 mtt180 -107.7 160.29 15.82 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.548 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.452 HG21 ' CG ' ' A' ' 144' ' ' PHE . 12.5 p -117.08 134.43 54.77 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.547 176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.634 ' HG ' ' HB2' ' A' ' 179' ' ' GLU . 81.0 mt -104.42 -32.22 9.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.692 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.54 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 47.6 t80 -78.13 -36.85 47.32 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -169.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.601 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 7.4 t70 74.5 105.22 0.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.336 0.589 . . . . 0.0 109.813 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -141.1 100.15 6.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 51.9 Cg_endo -88.52 87.7 0.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.273 1.982 . . . . 0.0 112.492 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.682 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -83.3 -12.83 78.04 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.931 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 1.026 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 4.6 p30 35.71 66.74 0.33 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.431 1.092 . . . . 0.0 113.888 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -159.39 -178.88 7.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.57 -7.33 57.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.577 0.703 . . . . 0.0 109.763 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.4 pt-20 -116.85 4.07 12.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.451 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.682 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 10.3 m-20 -146.79 97.3 2.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.378 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.099 HD11 ' HB2' ' A' ' 165' ' ' ASN . 49.1 tp -75.16 120.55 82.17 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 1.026 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 12.1 Cg_endo -80.84 92.94 1.04 Allowed 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.106 1.871 . . . . 0.0 111.178 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.452 ' CG ' HG21 ' A' ' 130' ' ' THR . 10.3 p90 -100.9 164.61 11.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.685 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.601 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 9.2 mtpt -119.46 -178.83 3.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.654 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -77.28 63.56 2.51 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.089 0.947 . . . . 0.0 111.544 -175.259 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.97 35.54 0.27 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.722 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.486 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 5.3 mm-40 -96.7 141.0 30.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.982 0.42 . . . . 0.0 110.224 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.06 128.37 43.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 165' ' ' ASN . 40.1 mt -121.03 157.23 30.46 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 58.0 t -116.08 128.41 73.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.969 HG21 HD12 ' A' ' 125' ' ' LEU . 42.5 mm -75.16 97.38 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.809 0.814 . . . . 0.0 109.204 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.735 HG23 ' HG2' ' A' ' 154' ' ' GLU . 8.7 tt -85.11 -42.81 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.868 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.984 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 0.8 OUTLIER -122.23 140.23 52.85 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.567 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 45.6 tttt -131.24 88.72 43.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 O-C-N 121.673 -0.642 . . . . 0.0 110.915 171.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.478 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 16.2 Cg_exo -74.3 -51.83 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.66 2.24 . . . . 0.0 113.083 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -110.91 -171.38 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.233 -0.292 . . . . 0.0 110.82 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.42 ' HA ' ' HE1' ' A' ' 161' ' ' TRP . 0.2 OUTLIER -110.65 -25.7 9.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.774 0.321 . . . . 0.0 110.411 174.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -84.72 -28.0 26.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.277 0.56 . . . . 0.0 110.416 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.682 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 43.3 m95 -128.36 130.39 47.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.122 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.704 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.7 m0 -122.52 142.83 50.17 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.064 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.984 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.2 m -98.82 94.59 6.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.438 0.637 . . . . 0.0 110.391 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.71 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -100.1 164.23 12.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.217 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.703 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.2 ptt180 -104.35 134.52 47.43 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.775 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.099 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.7 t30 -75.12 -179.32 4.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.568 -177.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.604 ' O ' ' HB ' ' A' ' 213' ' ' THR . 4.4 tppp? -58.78 -21.12 55.17 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.5 -36.78 81.73 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.469 0.652 . . . . 0.0 109.36 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.25 -6.78 42.94 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.808 -168.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.703 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 13.0 ttm-85 -69.72 140.08 53.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.463 -0.868 . . . . 0.0 111.606 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.644 HG22 HG21 ' A' ' 153' ' ' ILE . 44.4 t -98.89 125.42 52.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.953 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.418 ' CA ' ' HB2' ' A' ' 142' ' ' LEU . . . -150.1 163.2 29.41 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.59 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.682 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -79.65 136.18 36.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.622 0.249 . . . . 0.0 110.609 179.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.704 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -136.09 145.39 52.14 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.378 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.488 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 6.1 Cg_exo -80.45 133.65 9.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.037 2.491 . . . . 0.0 112.903 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.677 ' O ' HG22 ' A' ' 178' ' ' VAL . 92.6 t -62.84 -41.74 73.61 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.1 Cg_endo -63.42 0.73 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.012 1.808 . . . . 0.0 113.304 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -106.74 -3.48 20.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.645 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 175' ' ' VAL . 11.4 m -107.2 -178.85 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -165.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.975 ' HB3' ' HB2' ' A' ' 129' ' ' ARG . 1.0 OUTLIER -149.25 39.98 0.85 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 112.702 -2.045 . . . . 0.0 108.498 -165.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.944 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -77.41 150.77 35.0 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.109 -0.995 . . . . 0.0 110.913 -169.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.586 HD21 ' NH2' ' A' ' 129' ' ' ARG . 48.7 mt -63.66 179.7 0.46 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.35 -170.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.95 -22.23 4.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.78 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.454 ' CD ' ' HA ' ' A' ' 124' ' ' ASN . 22.4 mtm-85 63.31 84.68 0.14 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.57 0.7 . . . . 0.0 110.698 -175.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.3 p -84.41 -178.34 6.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.921 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.477 ' H ' ' HD2' ' A' ' 186' ' ' PRO . 69.1 m -147.72 -44.53 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.477 ' HD2' ' H ' ' A' ' 185' ' ' SER . 25.3 Cg_exo -64.4 93.06 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.214 1.276 . . . . 0.0 110.288 168.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.423 ' HB3' ' HA3' ' A' ' 191' ' ' GLY . 32.8 m-70 -101.37 -56.18 2.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.265 -172.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 65.07 -112.92 5.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.33 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -86.25 -3.21 58.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.19 0.519 . . . . 0.0 110.583 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -103.99 48.53 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.373 0.606 . . . . 0.0 109.482 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' A' ' 187' ' ' HIS . . . -171.85 -149.57 6.7 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.626 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -134.92 145.8 48.54 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -71.05 135.54 47.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.953 0.406 . . . . 0.0 110.407 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.416 ' HB2' ' CD ' ' A' ' 202' ' ' GLU . 4.3 p-10 -73.91 170.55 15.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.543 -176.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 4.8 m -74.58 139.22 43.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.323 -175.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 62.95 -88.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.043 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 14.1 p -159.88 -62.88 0.07 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.784 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -85.57 96.07 9.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.956 0.407 . . . . 0.0 110.462 -178.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.48 ' HA3' ' OE2' ' A' ' 202' ' ' GLU . . . -157.43 107.11 0.31 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.792 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 42.5 mm -102.88 -59.57 0.08 OUTLIER Pre-proline 0 C--N 1.322 -0.601 0 O-C-N 122.859 -0.201 . . . . 0.0 111.186 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.792 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 69.2 Cg_endo -89.45 40.19 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.168 1.912 . . . . 0.0 113.086 -177.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.48 ' OE2' ' HA3' ' A' ' 199' ' ' GLY . 8.7 pt-20 -111.13 111.4 55.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.198 0.523 . . . . 0.0 110.836 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.18 -24.87 14.23 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.293 1.995 . . . . 0.0 111.322 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 55.49 -97.8 0.08 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.584 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 64.16 162.85 0.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.995 0.809 . . . . 0.0 111.764 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.0 174.26 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.556 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.803 ' O2P' ' HG3' ' A' ' 21' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -87.68 39.89 0.91 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.541 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.864 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 8.0 pt20 -67.07 146.2 98.99 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.406 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 47.1 Cg_exo -57.43 -27.11 74.54 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.471 2.114 . . . . 0.0 112.045 176.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 68.53 -173.46 0.19 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.332 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 26.1 m -146.43 97.24 2.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.833 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' A' ' 166' ' ' LYS . 24.2 m -120.05 92.81 3.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.219 0.533 . . . . 0.0 110.956 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.9 t -132.65 104.63 13.09 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.034 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.483 ' HB2' HD22 ' A' ' 216' ' ' LEU . 37.8 Cg_endo -67.03 -41.01 10.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.795 2.33 . . . . 0.0 112.733 -176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' A' ' 215' ' ' PRO . 3.0 mm? -129.77 138.79 33.88 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.23 106.91 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.452 2.101 . . . . 0.0 110.951 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -66.52 108.07 2.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.201 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.83 110.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.557 0.694 . . . . 0.0 110.899 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.6 p -166.22 170.71 12.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.67 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 85.34 -102.53 2.63 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.832 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.759 ' HB2' ' HD3' ' A' ' 223' ' ' PRO . 16.0 m -68.6 -53.16 17.22 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 116.501 0.15 . . . . 0.0 111.134 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.759 ' HD3' ' HB2' ' A' ' 222' ' ' SER . 56.6 Cg_endo -93.76 115.66 0.26 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.209 1.939 . . . . 0.0 112.056 174.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 131.35 -0.43 5.16 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.689 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 72.87 -42.62 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.609 0.764 . . . . 0.0 112.435 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -70.23 99.53 1.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.958 0.408 . . . . 0.0 110.538 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 37.5 pt -91.33 156.66 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.498 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.5 p -132.46 164.14 45.6 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.344 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.14 -61.26 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.659 2.239 . . . . 0.0 112.143 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 37.2 tp -173.42 101.45 0.32 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.452 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.81 33.97 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.795 2.33 . . . . 0.0 111.333 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 24.4 m 70.46 170.59 0.31 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.991 -171.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 18.6 p -87.23 -76.43 0.37 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.153 -0.219 . . . . 0.0 110.413 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.523 ' HA ' ' HB ' ' A' ' 267' ' ' THR . 7.6 tt0 51.22 50.25 19.38 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.284 0.564 . . . . 0.0 110.503 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.793 ' HB3' ' HB3' ' A' ' 265' ' ' LYS . 52.1 m-80 -66.69 -18.11 65.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.562 -174.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.891 ' C ' ' H ' ' A' ' 267' ' ' THR . . . -172.77 -132.58 1.53 Allowed Glycine 0 C--O 1.211 -1.287 0 CA-C-O 118.877 -0.957 . . . . 0.0 112.362 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.964 ' CD ' HG23 ' A' ' 266' ' ' VAL . 4.5 Cg_exo -87.0 -36.99 0.09 OUTLIER 'Trans proline' 1 CA--C 1.622 4.915 2 N-CA-C 126.178 5.415 . . . . 0.0 126.178 167.597 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 1.054 ' N ' HG22 ' A' ' 266' ' ' VAL . 21.4 t 169.21 127.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 C-N-CA 127.902 2.481 . . . . 0.0 108.342 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.448 ' HA ' HG13 ' A' ' 266' ' ' VAL . 60.1 m-85 -65.26 119.59 11.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.621 1.101 . . . . 0.0 111.315 -163.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -132.96 156.98 46.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.583 -168.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -96.65 122.59 39.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.336 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.465 ' HB2' HG23 ' A' ' 264' ' ' VAL . . . -73.39 115.09 12.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.12 -0.22 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -172.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 245' ' ' LYS . 7.2 tt0 -140.94 147.89 39.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.869 0.366 . . . . 0.0 110.507 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.822 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 51.6 mtmt -79.24 140.23 37.69 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.297 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -140.39 104.91 4.88 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.998 0.428 . . . . 0.0 110.462 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.4 m -105.57 140.95 21.68 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.692 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 51.7 Cg_endo -70.54 126.57 12.94 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.429 2.086 . . . . 0.0 111.838 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.421 ' C ' ' H ' ' A' ' 251' ' ' TYR . 23.8 t -88.54 178.69 6.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.533 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -71.24 10.17 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.139 0.495 . . . . 0.0 111.557 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 249' ' ' CYS . 27.5 m-85 -121.44 19.86 11.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.748 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.68 132.18 51.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.259 0.552 . . . . 0.0 111.376 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -130.27 -49.47 1.09 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.121 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.9 p -138.98 30.07 2.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.988 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.95 103.5 14.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.064 0.459 . . . . 0.0 111.444 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.455 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.0 OUTLIER -74.27 114.06 12.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.817 177.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.642 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -70.95 132.44 45.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.524 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.429 HD21 HG21 ' A' ' 279' ' ' VAL . 96.7 mt -136.35 -177.96 4.95 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.337 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.822 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 7.5 pt-20 -154.55 -165.66 2.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.181 176.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.76 HG23 ' HG3' ' A' ' 245' ' ' LYS . 39.2 t -108.23 130.43 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 111.802 -173.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.21 15.87 12.05 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.586 -0.816 . . . . 0.0 114.497 168.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.3 179.78 6.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.87 0.835 . . . . 0.0 111.212 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.9 mm -105.82 119.43 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.816 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 266' ' ' VAL . 65.7 t -76.38 125.15 35.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.488 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.793 ' HB3' ' HB3' ' A' ' 235' ' ' ASN . 89.5 mttt -68.34 88.63 0.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.808 0.813 . . . . 0.0 109.5 173.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 1.054 HG22 ' N ' ' A' ' 238' ' ' VAL . 2.1 p -127.56 126.19 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.556 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.891 ' H ' ' C ' ' A' ' 236' ' ' GLY . 5.1 m -137.87 -26.18 0.96 Allowed 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.929 ' C ' ' HA ' ' A' ' 237' ' ' PRO . 5.9 tmm_? -136.05 93.07 2.87 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.115 0.966 . . . . 0.0 110.46 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . 0.778 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 4.0 ptp -87.37 141.36 28.69 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.205 -0.934 . . . . 0.0 113.255 -174.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -75.03 157.4 34.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.372 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.2 tp -92.54 -3.47 10.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.531 0.681 . . . . 0.0 110.253 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -73.27 -10.01 59.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.104 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 100.18 -29.35 12.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.932 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.991 HE21 ' HA ' ' A' ' 274' ' ' GLN . 0.0 OUTLIER -89.5 113.38 24.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.181 0.515 . . . . 0.0 109.654 175.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.872 ' HB3' ' CG ' ' A' ' 237' ' ' PRO . 55.0 m0 -92.8 162.76 13.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.564 -173.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.952 ' H ' ' HG3' ' A' ' 237' ' ' PRO . 2.8 tm-20 -128.6 89.63 2.92 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 120.209 -0.597 . . . . 0.0 109.814 -168.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.575 ' CA ' ' HD3' ' A' ' 237' ' ' PRO . . . -117.96 158.35 14.72 Favored Glycine 0 C--O 1.226 -0.389 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.995 -174.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 265' ' ' LYS . 18.0 tt0 -116.79 111.08 19.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.246 0.523 . . . . 0.0 110.572 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.455 ' HB ' HD21 ' A' ' 256' ' ' LEU . 97.9 t -109.93 122.22 64.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.682 0.277 . . . . 0.0 110.64 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 48.15 32.22 2.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.58 1.152 . . . . 0.0 112.41 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 97.3 -3.03 61.45 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.198 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -107.92 114.96 29.27 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.1 OUTLIER -106.61 141.56 37.68 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.875 178.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -171.18 -170.29 35.14 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.649 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 80.5 mt -99.56 135.01 41.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.064 0.459 . . . . 0.0 110.188 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 50.7 p90 -136.79 140.87 33.12 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.16 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 2.8 Cg_exo -76.65 152.37 33.22 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.989 2.459 . . . . 0.0 112.661 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.502 ' HB3' ' CH2' ' A' ' 275' ' ' TRP . 7.6 p90 -69.71 -2.51 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.399 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.7 p -90.45 4.33 51.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.058 0.456 . . . . 0.0 111.47 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -117.44 -15.37 10.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.778 0.323 . . . . 0.0 111.441 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.418 HG21 ' HE2' ' A' ' 286' ' ' PHE . 33.1 m -128.6 160.85 38.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.266 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -121.54 119.0 30.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.73 0.3 . . . . 0.0 110.535 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.653 HD13 ' HB2' ' A' ' 240' ' ' ALA . 49.5 mm -73.36 123.22 27.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.604 175.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.471 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 8.8 p90 -126.16 174.26 8.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.394 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -102.64 90.15 2.11 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 57.6 Cg_endo -71.54 -32.87 11.52 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.359 2.039 . . . . 0.0 112.68 -173.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -137.36 68.75 1.41 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.206 0.527 . . . . 0.0 110.116 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 5.5 p30 -76.33 115.35 46.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.362 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 8.9 Cg_exo -72.29 -35.12 6.99 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.802 2.335 . . . . 0.0 111.361 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -136.0 -167.52 2.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.432 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 62.29 33.16 16.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.4 0.619 . . . . 0.0 110.335 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -80.57 1.21 30.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.552 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.021 -179.325 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.757 0.313 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -148.42 154.04 39.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.314 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.2 m -126.63 26.97 6.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.862 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 75.58 147.39 0.09 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.438 175.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -122.59 -57.55 1.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.107 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 62.58 176.27 0.14 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 172.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.08 73.7 0.76 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.624 -2.08 . . . . 0.0 106.08 164.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.2 m -63.44 154.84 30.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.0 -167.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.474 ' H ' ' HB3' ' A' ' 82' ' ' PRO . 24.6 m 75.84 -45.9 0.54 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.321 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.38 110.21 0.92 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.525 0.679 . . . . 0.0 111.048 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -57.72 -32.14 67.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.941 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 t -81.38 -1.66 46.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.3 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.2 -46.94 7.49 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.367 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -117.76 -26.22 6.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -173.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -84.33 125.38 32.23 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.025 -0.422 . . . . 0.0 110.866 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.519 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.2 mmt -108.53 -3.47 18.04 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.189 -175.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 52.17 -112.18 1.88 Allowed Glycine 0 CA--C 1.522 0.53 0 O-C-N 123.66 0.6 . . . . 0.0 113.953 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.6 Cg_exo -66.63 88.35 0.28 Allowed 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.411 2.741 . . . . 0.0 113.499 -176.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.882 HG12 ' H ' ' A' ' 20' ' ' SER . 16.4 t -131.96 -162.88 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.882 ' H ' HG12 ' A' ' 19' ' ' VAL . 47.5 p -173.77 178.27 2.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.701 1.137 . . . . 0.0 109.167 -169.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 20.1 tpt180 -55.43 -54.45 43.62 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.288 0.367 . . . . 0.0 110.034 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -58.28 -59.6 5.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.717 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 56.5 mm-40 -61.05 -46.53 90.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.02 -174.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.85 77.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 18.3 pt20 -70.06 -33.32 71.79 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.954 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.6 m -64.5 -34.41 78.15 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.43 0.633 . . . . 0.0 111.082 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 22.8 mmt85 -64.23 -41.41 97.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.843 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 14.5 mt -112.19 6.97 19.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -168.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 4.1 pt20 -74.65 100.41 3.94 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.454 0.645 . . . . 0.0 111.721 -176.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.67 4.96 90.23 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.313 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -88.19 -171.69 3.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.574 0.226 . . . . 0.0 110.691 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.538 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 6.0 mtp180 -48.78 126.47 12.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.934 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.439 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 30.5 m170 -85.59 155.17 21.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.929 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.7 -2.06 79.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.322 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 39.5 mtm -93.1 153.25 18.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.0 110.335 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.634 ' CD1' HD22 ' A' ' 98' ' ' LEU . 49.3 p90 -150.13 166.53 29.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.434 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.519 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -155.27 138.33 15.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.641 174.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t -105.41 125.12 60.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.605 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.793 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 32.7 ptt-85 -124.44 174.37 7.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.291 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -72.55 131.76 42.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.634 ' HA ' HG23 ' A' ' 49' ' ' VAL . 15.4 t -56.05 146.64 22.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.633 0.73 . . . . 0.0 112.443 -170.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.407 ' HB2' ' OH ' ' A' ' 207' ' ' PTR . 12.8 m -92.22 -7.93 46.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.213 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.6 m -110.34 -47.87 3.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.335 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 41' ' ' SER . 56.2 m -125.09 119.0 25.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.714 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.9 112.79 1.75 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.527 2.151 . . . . 0.0 111.572 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.04 -21.88 11.85 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.459 ' C ' ' HB2' ' A' ' 41' ' ' SER . 26.4 t70 -82.85 171.94 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 27.1 m-85 -130.37 160.91 32.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.458 0.572 . . . . 0.0 111.205 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 41' ' ' SER . 39.5 t -136.77 105.4 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.213 0.53 . . . . 0.0 111.218 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.485 ' CB ' HD11 ' A' ' 63' ' ' ILE . 33.6 tp -82.27 102.7 11.34 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.226 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.7 m -95.36 119.43 33.86 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.55 HG21 HD13 ' A' ' 93' ' ' LEU . 48.9 t -117.89 136.33 55.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.113 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 1.079 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 89.6 p -104.89 135.12 46.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.694 0.759 . . . . 0.0 111.806 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.554 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 18.9 mt-10 -144.79 176.29 9.55 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 170.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.49 ' N ' HD22 ' A' ' 55' ' ' ASN . 0.0 OUTLIER -29.23 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 m 34.14 70.95 0.11 Allowed 'General case' 0 C--N 1.349 0.582 0 CA-C-O 121.983 0.897 . . . . 0.0 110.882 -171.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.933 HH12 ' HA ' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -162.31 45.46 0.15 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.088 -157.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.6 t -81.83 90.6 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.561 0.696 . . . . 0.0 109.667 -177.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.5 m -86.1 122.13 29.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.477 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.501 ' O ' ' HB2' ' A' ' 207' ' ' PTR . 14.3 m-70 -93.72 95.89 9.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.685 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.922 ' HA ' ' HB3' ' A' ' 208' ' ' ALA . 78.4 m-85 -87.51 117.31 26.22 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 123.15 0.58 . . . . 0.0 111.657 -175.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 49' ' ' VAL . 5.6 mt -80.49 133.38 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.7 mp -115.49 118.63 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.197 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -83.77 134.53 34.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.813 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -87.77 105.77 17.62 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 82.9 mt -88.26 145.79 36.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.415 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 34.6 Cg_exo -62.19 -23.11 75.17 Favored 'Trans proline' 0 N--CA 1.473 0.315 0 C-N-CA 123.363 2.708 . . . . 0.0 112.962 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -89.03 18.1 5.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.186 0.517 . . . . 0.0 110.183 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.837 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 1.2 mmp_? 64.41 31.95 12.3 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.275 173.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -113.18 165.41 12.42 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.487 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 60.1 m-85 -127.22 117.45 22.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.441 0.639 . . . . 0.0 111.509 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -106.57 98.76 8.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.511 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.593 HD11 ' HB3' ' A' ' 61' ' ' TYR . 8.7 tt -79.6 85.16 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.545 0.688 . . . . 0.0 110.476 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.493 ' O ' ' HD2' ' A' ' 210' ' ' PRO . . . 60.69 73.2 0.52 Allowed Glycine 0 C--O 1.227 -0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.117 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' OD2' HG22 ' A' ' 212' ' ' THR . 45.6 t0 75.7 -38.39 0.35 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.101 0.56 . . . . 0.0 111.023 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.54 HE21 ' HA ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -59.26 114.66 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.46 0.304 . . . . 0.0 110.902 174.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.82 115.43 27.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.794 0.33 . . . . 0.0 111.345 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 76' ' ' GLN . 84.4 m-85 -126.05 168.02 14.54 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -86.22 -34.71 20.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.708 0.29 . . . . 0.0 111.524 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 2.6 p80 -152.63 168.54 25.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.677 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.659 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 12.4 mt -57.04 -55.26 45.84 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.601 ' HA ' HD12 ' A' ' 85' ' ' LEU . 32.8 Cg_endo -65.29 -3.8 8.13 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.789 1.659 . . . . 0.0 113.014 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.81 -32.62 17.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.736 0.303 . . . . 0.0 110.558 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.2 pp -76.74 -32.35 57.72 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.601 HD12 ' HA ' ' A' ' 82' ' ' PRO . 51.1 mt -66.03 -26.98 67.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.731 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -74.57 -35.11 63.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.823 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -75.36 -38.02 60.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 111.301 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.493 ' OH ' ' HG2' ' A' ' 210' ' ' PRO . 44.5 m-85 -72.79 1.94 7.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.954 0.407 . . . . 0.0 111.34 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -64.91 -36.66 85.1 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.322 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 mt -104.13 -7.39 9.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.177 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -82.69 -37.09 25.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.875 -171.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.755 ' HA ' HG22 ' A' ' 97' ' ' THR . 81.2 m-85 66.27 95.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.993 0.808 . . . . 0.0 110.203 -169.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.712 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 23.6 mt -62.71 -23.52 67.2 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.404 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.554 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 23.7 t70 -139.11 -77.89 0.34 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 164.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.686 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 5.8 t -146.95 10.44 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.585 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 99' ' ' ILE . 4.3 m -124.19 -39.23 2.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.755 HG22 ' HA ' ' A' ' 92' ' ' TYR . 17.6 p 82.9 -173.3 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.422 1.489 . . . . 0.0 111.011 -174.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.634 HD22 ' CD1' ' A' ' 36' ' ' PHE . 93.7 mt -88.25 106.11 17.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.857 176.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 1.9 mp -89.08 -53.82 8.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.574 ' HG2' HG22 ' A' ' 99' ' ' ILE . 9.9 pt-20 -163.54 149.39 9.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.74 159.56 47.9 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.328 2.019 . . . . 0.0 112.413 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.57 124.48 89.33 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.89 76.48 0.61 Allowed 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.908 2.405 . . . . 0.0 113.678 -171.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.469 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 3.7 tpm_? 70.33 -58.52 0.54 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.142 0.977 . . . . 0.0 111.772 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.657 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 3.3 p90 -124.05 167.22 15.96 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' A' ' 105' ' ' TYR . 73.3 Cg_endo -73.53 25.67 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.906 2.404 . . . . 0.0 114.326 -172.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.6 p 49.36 94.86 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.802 0.841 . . . . 0.0 112.538 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.59 ' HD3' ' HD2' ' A' ' 105' ' ' TYR . 21.2 Cg_exo -65.63 162.9 32.31 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.177 2.585 . . . . 0.0 111.888 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.66 93.66 0.17 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.688 2.259 . . . . 0.0 112.23 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.1 ttt -108.2 -31.02 8.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.791 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.1 -25.4 3.51 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.831 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.6 m -81.33 112.66 18.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -92.25 -17.69 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.831 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 m 68.89 176.7 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.685 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.547 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -71.65 -52.69 8.05 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.4 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 115' ' ' ALA . 2.8 Cg_exo -76.64 41.86 0.97 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.698 2.266 . . . . 0.0 112.935 -176.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.49 ' O ' HD22 ' A' ' 118' ' ' LEU . 46.0 t30 -78.06 110.82 13.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.702 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.49 HD22 ' O ' ' A' ' 117' ' ' ASN . 1.3 mm? -155.48 82.97 3.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.02 -71.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.782 2.322 . . . . 0.0 113.419 -172.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.0 p -90.92 104.05 16.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.374 0.607 . . . . 0.0 112.449 -172.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.56 110.43 12.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.618 ' HG2' ' HA2' ' A' ' 188' ' ' GLY . 3.8 mp0 -62.78 -75.29 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.863 ' HA ' ' HA ' ' A' ' 185' ' ' SER . 3.3 t70 48.14 -151.48 0.12 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.006 0.816 . . . . 0.0 111.539 174.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 173.87 -80.41 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 1.045 ' HG ' ' HD3' ' A' ' 155' ' ' LYS . 4.3 mm? 46.99 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.092 0 O-C-N 124.251 0.969 . . . . 0.0 112.339 173.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 45.0 tt0 -144.93 -66.09 0.33 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.647 -172.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -117.39 118.37 32.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.806 0.812 . . . . 0.0 111.457 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.763 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 71.8 t -133.3 135.31 56.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.746 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 1.032 ' HB2' ' HB3' ' A' ' 179' ' ' GLU . 23.0 mtt180 -107.7 158.25 17.43 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.055 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.449 HG21 ' CD2' ' A' ' 144' ' ' PHE . 6.3 p -116.22 138.8 50.98 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.801 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.547 HD21 ' CG ' ' A' ' 179' ' ' GLU . 12.3 mt -112.87 -37.03 4.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.636 -172.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -69.79 -35.98 75.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.994 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.8 t70 70.69 92.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.456 0.646 . . . . 0.0 109.262 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 79.1 t80 -127.59 116.89 21.14 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.917 -176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.627 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 48.8 Cg_endo -92.47 96.38 0.18 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 122.37 2.047 . . . . 0.0 113.067 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.84 -17.49 80.13 Favored Glycine 0 CA--C 1.507 -0.466 0 CA-C-O 121.795 0.664 . . . . 0.0 111.483 173.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.526 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 17.4 m120 55.57 29.99 14.48 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.024 -1.088 . . . . 0.0 112.804 -171.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.545 ' HB2' ' HD3' ' A' ' 169' ' ' ARG . 34.4 t0 82.63 168.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 157.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.805 ' HA ' ' NE2' ' A' ' 211' ' ' GLN . . . 89.06 -35.39 0.02 OUTLIER 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.832 1.653 . . . . 0.0 112.409 173.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -143.76 -14.61 0.64 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.945 0.403 . . . . 0.0 110.253 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -147.53 120.48 8.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.446 0.641 . . . . 0.0 110.511 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.04 HD11 ' HB2' ' A' ' 165' ' ' ASN . 41.7 tp -75.71 124.32 88.7 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.019 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.627 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 55.5 Cg_endo -77.61 96.2 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.42 2.08 . . . . 0.0 110.808 172.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 6.9 p90 -105.23 163.4 12.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.716 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.879 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 8.4 mmpt? -103.75 -176.39 3.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.303 0.573 . . . . 0.0 111.233 -175.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 13.73 2.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.52 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.75 39.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.719 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.879 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 29.9 mm-40 -98.54 155.74 17.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.744 HD12 ' HG2' ' A' ' 129' ' ' ARG . 15.7 mm -97.27 134.57 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 165' ' ' ASN . 22.5 mt -117.32 156.61 27.53 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.589 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 62.1 t -116.87 127.01 74.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.668 HD13 ' HB2' ' A' ' 163' ' ' ALA . 45.9 mm -76.06 82.52 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.221 1.01 . . . . 0.0 108.889 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.759 HG21 HG22 ' A' ' 170' ' ' VAL . 14.7 tt -77.44 -27.43 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.913 -175.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.933 ' HA ' HH12 ' A' ' 57' ' ' ARG . 4.4 mt-10 -139.97 139.74 36.14 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 173.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 1.045 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 5.7 ttpm? -133.86 86.47 38.18 Favored Pre-proline 0 C--O 1.237 0.412 0 O-C-N 121.755 -0.59 . . . . 0.0 111.036 174.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.686 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 53.6 Cg_endo -79.01 -46.07 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.285 1.99 . . . . 0.0 112.786 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -109.11 179.88 4.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.252 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -103.37 -29.43 11.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.842 0.353 . . . . 0.0 110.962 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -93.44 -21.44 19.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.618 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.625 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 35.9 m95 -129.06 126.02 38.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.1 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.648 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.1 m0 -116.1 137.79 51.81 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.09 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.863 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.5 m -89.33 89.72 8.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.129 0.49 . . . . 0.0 110.071 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.668 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -101.22 154.84 18.42 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.962 -0.461 . . . . 0.0 111.354 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.2 ptt180 -98.54 128.9 45.05 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.533 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.04 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.5 t30 -63.58 160.73 16.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.12 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -59.46 -25.01 64.04 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.48 ' HB3' HD22 ' A' ' 165' ' ' ASN . 11.1 t70 -75.69 -24.33 56.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.797 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.9 74.84 1.11 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.293 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.735 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -159.07 133.12 7.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.819 -0.191 . . . . 0.0 110.979 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.759 HG22 HG21 ' A' ' 153' ' ' ILE . 83.9 t -103.35 120.39 53.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.192 0.52 . . . . 0.0 111.892 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.97 159.89 28.29 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 170.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.625 ' HE2' ' HB3' ' A' ' 160' ' ' TRP . 21.6 mtp -71.21 138.95 49.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.254 0.527 . . . . 0.0 110.0 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.648 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -134.96 145.85 56.21 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.291 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 5.5 Cg_exo -75.94 129.04 11.19 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 123.299 2.666 . . . . 0.0 112.702 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.671 ' O ' HG22 ' A' ' 178' ' ' VAL . 92.3 t -58.77 -45.66 99.61 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 47.4 Cg_exo -59.5 -6.92 4.72 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.329 2.019 . . . . 0.0 113.86 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -98.15 -1.29 42.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 175' ' ' VAL . 5.9 m -109.41 178.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -164.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 1.032 ' HB3' ' HB2' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -138.9 40.38 2.15 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 111.267 -2.697 . . . . 0.0 107.983 -168.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.763 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 20.0 pttm -77.75 144.14 37.44 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.669 -0.644 . . . . 0.0 110.038 -165.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 181' ' ' LEU . 4.0 mt -69.36 -58.36 4.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.24 -169.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.11 147.59 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.024 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.437 ' HD3' ' HH2' ' A' ' 161' ' ' TRP . 15.6 tpt180 -153.02 116.27 4.64 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.029 177.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.4 t -160.5 77.93 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.863 ' HA ' ' HA ' ' A' ' 123' ' ' ASP . 0.3 OUTLIER -64.84 -57.85 14.88 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.283 -176.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 32.4 Cg_endo -97.05 -135.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.602 2.201 . . . . 0.0 110.57 169.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.605 ' CE1' ' HD2' ' A' ' 186' ' ' PRO . 0.0 OUTLIER 43.38 65.33 1.0 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.34 0.656 . . . . 0.0 111.481 -177.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.618 ' HA2' ' HG2' ' A' ' 122' ' ' GLU . . . -60.04 -24.18 60.36 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.919 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -69.1 -19.08 64.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -99.47 -3.03 34.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.33 0.586 . . . . 0.0 110.177 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -93.1 95.41 1.99 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.466 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 193' ' ' ARG . 88.0 m-20 -71.53 -25.47 62.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.421 ' HB3' ' O ' ' A' ' 192' ' ' ASN . 55.0 ttt180 72.65 136.16 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.755 0.659 . . . . 0.0 111.581 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 34.6 m-80 -108.95 141.19 41.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.963 177.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 30.7 p -107.8 -18.01 13.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.979 0.419 . . . . 0.0 110.048 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -109.09 24.57 12.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.469 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.53 ' O ' HG12 ' A' ' 200' ' ' ILE . 5.6 p -66.16 -26.93 67.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.315 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -82.8 4.81 23.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.167 0.508 . . . . 0.0 110.546 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -93.12 -6.39 63.19 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.589 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 197' ' ' SER . 38.1 pt -80.31 130.37 65.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.402 . . . . 0.0 110.583 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 1.2 Cg_endo -83.89 135.86 6.84 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.162 2.575 . . . . 0.0 112.609 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . 14.7 tp10 -132.16 112.41 14.46 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.35 117.05 3.64 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.101 2.534 . . . . 0.0 112.22 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 59.56 40.8 19.91 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.737 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.715 ' HB3' ' HB3' ' A' ' 202' ' ' GLU . 1.4 p80 -62.77 103.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.562 0.696 . . . . 0.0 110.9 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.0 147.33 36.88 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.978 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.501 ' HB2' ' O ' ' A' ' 60' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.922 ' HB3' ' HA ' ' A' ' 61' ' ' TYR . . . -161.28 173.37 15.11 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.638 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.435 HE21 ' HB2' ' A' ' 209' ' ' GLN . 6.5 tt0 174.89 101.84 0.08 OUTLIER Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.754 ' HA ' HG23 ' A' ' 170' ' ' VAL . 7.6 Cg_exo -75.66 -126.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 123.905 3.07 . . . . 0.0 113.549 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.805 ' NE2' ' HA ' ' A' ' 139' ' ' ALA . 27.6 mt-30 -98.5 -172.95 2.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.432 0.634 . . . . 0.0 112.21 -172.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.405 HG22 ' OD2' ' A' ' 75' ' ' ASP . 82.5 p -93.0 -176.3 4.14 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.248 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 215' ' ' PRO . 4.5 m -72.87 92.2 1.59 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.687 HG21 ' HB2' ' A' ' 139' ' ' ALA . 3.4 m -111.38 100.17 46.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.431 -174.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 213' ' ' THR . 6.9 Cg_endo -87.61 93.47 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.9 2.4 . . . . 0.0 111.54 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 62.4 tp -114.9 106.27 52.0 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.972 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.571 ' HA ' HD11 ' A' ' 230' ' ' LEU . 59.6 Cg_endo -75.15 67.4 6.06 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.8 2.333 . . . . 0.0 112.071 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -148.29 -42.98 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.32 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 14.6 m -80.48 49.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.172 0.51 . . . . 0.0 112.313 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 13.8 p -164.65 -77.46 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.456 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 156.37 34.3 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.736 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 22.7 m -135.68 112.44 10.71 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.07 -23.73 39.69 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.921 2.414 . . . . 0.0 111.966 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 92.15 36.87 6.14 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.734 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.22 66.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.922 0.392 . . . . 0.0 110.901 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -165.26 -61.29 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.805 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.6 mt -90.79 136.64 23.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.625 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.1 t -162.88 135.35 4.16 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-O 120.761 0.315 . . . . 0.0 110.664 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.49 -9.32 21.41 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.768 2.312 . . . . 0.0 112.409 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' A' ' 217' ' ' PRO . 2.9 pp -139.25 146.78 50.37 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.514 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 14.3 Cg_exo -69.83 170.94 15.49 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.677 2.251 . . . . 0.0 112.08 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.6 m -98.16 158.82 15.33 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.405 ' HA ' ' HG2' ' A' ' 215' ' ' PRO . 10.7 t -60.22 142.17 54.89 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.046 0.451 . . . . 0.0 111.022 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -139.96 -44.32 0.43 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.65 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.3 p30 46.03 -91.73 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.075 0.95 . . . . 0.0 112.868 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -164.88 179.91 39.26 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.022 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.61 116.62 4.35 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.853 2.368 . . . . 0.0 111.852 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 21.1 t -87.72 145.98 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.509 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -91.94 118.47 30.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.412 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.94 150.67 40.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.027 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -111.13 130.79 55.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.897 0.379 . . . . 0.0 110.244 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.581 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -74.31 122.36 22.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.414 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 290' ' ' HIS . 27.1 pt -104.03 6.15 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -169.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.12 149.11 24.22 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.581 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 11.2 tptm -79.45 116.44 19.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.427 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.644 ' HB3' ' CE1' ' A' ' 290' ' ' HIS . 6.4 ttt-85 -151.32 107.64 3.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.143 0.497 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.554 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 34.6 m -92.6 174.48 4.04 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.891 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 247' ' ' VAL . 39.3 Cg_exo -60.87 122.38 11.13 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.417 2.078 . . . . 0.0 112.119 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.876 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 52.7 t -71.19 159.03 35.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.374 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.07 -42.93 66.33 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -105.45 11.18 32.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.811 0.339 . . . . 0.0 111.197 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.876 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.5 m-20 -111.3 92.42 4.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.174 0.512 . . . . 0.0 111.21 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -77.53 -27.76 51.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.689 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.5 p -89.2 15.03 9.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.608 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -89.06 116.74 27.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.867 0.365 . . . . 0.0 110.924 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.544 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 1.1 tt -77.96 125.0 28.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.465 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -70.83 108.11 4.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.907 0.384 . . . . 0.0 110.581 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.6 mt -136.15 123.26 21.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.294 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 7.5 pt-20 -100.08 -134.87 0.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.782 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.86 130.2 68.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.53 . . . . 0.0 111.736 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 85.66 21.92 52.04 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.666 173.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -109.71 159.41 17.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.429 0.614 . . . . 0.0 110.019 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.47 127.09 56.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 110.94 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.638 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 39.9 t -107.03 122.03 60.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.496 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.495 ' HB2' ' HE3' ' A' ' 265' ' ' LYS . 34.7 ttmt -90.94 101.23 14.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.636 HG11 ' CZ3' ' A' ' 275' ' ' TRP . 4.8 p -126.34 147.83 31.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.424 -170.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -112.64 -54.22 2.64 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 275' ' ' TRP . 45.4 mtt180 -90.48 128.22 36.46 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 122.365 -0.21 . . . . 0.0 110.633 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . 0.882 ' C ' ' HA3' ' A' ' 273' ' ' GLY . 0.2 OUTLIER -117.25 113.48 22.25 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.921 ' HB2' ' HD2' ' A' ' 288' ' ' PHE . 0.9 OUTLIER -20.67 176.59 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 129.849 3.26 . . . . 0.0 117.643 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.428 HG13 ' CE2' ' A' ' 288' ' ' PHE . 43.6 mt 63.8 70.41 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 113.315 -1.766 . . . . 0.0 107.14 -160.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.6 13.42 9.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.048 -164.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.882 ' HA3' ' C ' ' A' ' 269' ' ' MET . . . -91.59 -35.47 6.89 Favored Glycine 0 N--CA 1.427 -1.924 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.558 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.898 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 8.9 pt20 23.44 121.71 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 125.638 1.434 . . . . 0.0 113.716 -161.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.845 ' CE2' ' HB3' ' A' ' 288' ' ' PHE . 7.6 m0 -83.81 132.57 34.81 Favored 'General case' 0 CA--C 1.48 -1.726 0 C-N-CA 118.015 -1.474 . . . . 0.0 111.18 -161.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.5 94.53 4.83 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 111.593 -2.549 . . . . 0.0 110.281 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.95 137.7 10.6 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.419 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.675 ' HG3' ' HB3' ' A' ' 283' ' ' LYS . 23.8 mp0 -101.88 109.52 21.29 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 256' ' ' LEU . 58.7 t -123.17 121.74 63.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.743 0.306 . . . . 0.0 111.438 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 5.9 t30 66.24 -72.68 0.08 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.541 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -113.56 -43.47 0.82 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.244 -174.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.544 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 5.5 ppt_? -158.11 174.26 15.47 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.675 ' HB3' ' HG3' ' A' ' 278' ' ' GLU . 60.0 pttt -95.77 143.83 26.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.873 -175.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.39 161.44 29.75 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.514 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 275' ' ' TRP . 21.1 mt -87.53 137.48 32.3 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.718 0.771 . . . . 0.0 111.558 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.638 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 21.4 p90 -149.54 142.9 16.28 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.096 174.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.611 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 13.8 Cg_exo -69.64 144.69 55.48 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.005 1.803 . . . . 0.0 110.76 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.921 ' HD2' ' HB2' ' A' ' 270' ' ' ASN . 26.5 p90 -69.1 6.02 1.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.5 m -88.14 -12.48 43.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.358 0.599 . . . . 0.0 109.685 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.644 ' CE1' ' HB3' ' A' ' 246' ' ' ARG . 69.1 t60 -83.41 -20.92 33.27 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.135 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.581 HG12 ' HA ' ' A' ' 242' ' ' ALA . 23.6 m -127.02 176.99 6.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.694 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -136.87 134.89 37.37 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.133 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 240' ' ' ALA . 44.5 mm -82.75 102.96 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -93.43 176.2 6.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.878 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 296' ' ' PRO . 10.1 m-20 -59.92 109.58 2.1 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 295' ' ' ASP . 7.1 Cg_exo -73.29 -25.04 16.05 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.904 2.403 . . . . 0.0 112.711 -173.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -85.31 93.55 8.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.167 0.508 . . . . 0.0 110.836 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.45 ' N ' HD22 ' A' ' 298' ' ' ASN . 0.9 OUTLIER -106.26 102.9 42.86 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.23 73.84 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.074 2.516 . . . . 0.0 113.257 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -111.12 -44.41 3.58 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.698 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 301' ' ' GLU . 0.1 OUTLIER -96.17 -14.0 23.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.044 178.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -71.69 126.28 29.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.399 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.891 -0.576 . . . . 0.0 110.5 -179.637 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 t -76.94 97.55 4.65 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 p -79.64 162.94 24.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.259 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.93 127.88 34.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.37 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -154.85 93.42 1.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.207 0.527 . . . . 0.0 110.622 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.587 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 45.7 p90 -145.02 154.88 42.99 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.58 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -71.99 97.77 1.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.63 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.7 m -77.17 59.0 1.67 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.191 0.52 . . . . 0.0 110.51 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 t 179.42 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.603 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -69.66 102.02 1.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.34 0.59 . . . . 0.0 110.759 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.498 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 11.6 mmt180 -61.73 -29.25 69.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.525 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.3 m -79.09 0.38 28.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.607 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.12 -47.34 5.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -116.42 -21.32 9.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.498 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 44.4 t80 -85.7 118.5 25.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.809 0.338 . . . . 0.0 111.28 -173.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.602 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 19.1 mmt -104.15 -2.11 26.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 110.963 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.07 -115.86 4.47 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.485 -0.779 . . . . 0.0 114.022 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.1 94.61 0.73 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.265 1.977 . . . . 0.0 113.534 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.86 HG12 ' H ' ' A' ' 20' ' ' SER . 19.0 t -139.93 -175.56 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.86 ' H ' HG12 ' A' ' 19' ' ' VAL . 93.9 p -151.45 176.64 11.09 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.254 0.934 . . . . 0.0 108.554 -170.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.678 ' HG3' ' O3P' ' A' ' 207' ' ' PTR . 46.0 mtp85 -53.79 -66.03 0.46 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.39 -43.24 91.25 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.21 -45.8 90.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.471 0.176 . . . . 0.0 111.369 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.37 76.83 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.063 0.459 . . . . 0.0 111.27 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -73.53 -30.04 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.004 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.69 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 95.7 m -62.1 -34.78 76.96 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.272 0.558 . . . . 0.0 110.466 174.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -75.43 -14.29 60.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.121 0.486 . . . . 0.0 110.417 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.552 ' O ' ' HB3' ' A' ' 31' ' ' GLN . 20.4 mt -115.75 17.7 16.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.406 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 26' ' ' THR . 12.5 pt20 -88.08 116.0 25.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.399 0.619 . . . . 0.0 110.675 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.74 26.55 24.46 Favored Glycine 0 CA--C 1.499 -0.916 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.606 ' HG2' ' HD2' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -50.59 177.7 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 111.187 -2.506 . . . . 0.0 115.141 -175.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -86.19 -9.31 56.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.558 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.606 ' HD2' ' HG2' ' A' ' 31' ' ' GLN . 61.7 m170 66.03 92.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.445 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.41 28.89 3.61 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -170.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 52.4 ttp -124.19 134.19 53.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.56 ' CD1' HD22 ' A' ' 98' ' ' LEU . 43.8 p90 -135.6 164.13 28.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -173.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.48 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -150.62 144.02 24.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.364 171.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.403 HG22 HD13 ' A' ' 50' ' ' LEU . 61.2 t -109.24 119.17 58.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.545 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -123.01 168.47 12.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.708 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.455 ' OD2' ' HA ' ' A' ' 45' ' ' PRO . 34.6 t70 -66.11 125.93 27.05 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.02 -0.734 . . . . 0.0 109.02 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.624 ' HA ' HG23 ' A' ' 49' ' ' VAL . 31.9 p -53.63 120.02 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.518 0.675 . . . . 0.0 112.104 -172.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.719 ' HB3' ' HA ' ' A' ' 20' ' ' SER . 3.4 p -74.58 73.62 1.97 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.922 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.753 ' HB ' ' O1P' ' A' ' 207' ' ' PTR . 10.0 t 174.72 -36.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.327 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 66.5 m -147.43 93.85 4.57 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.253 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.455 ' HA ' ' OD2' ' A' ' 40' ' ' ASP . 54.5 Cg_exo -52.21 116.18 2.65 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.524 2.149 . . . . 0.0 112.253 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.57 -47.83 0.9 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.529 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 1.2 m-20 -78.62 -172.05 2.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.46 ' CE1' ' HE1' ' A' ' 15' ' ' TYR . 25.9 m-85 -138.46 169.4 17.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.255 0.55 . . . . 0.0 112.132 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 41' ' ' SER . 44.1 t -146.94 111.42 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.525 175.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.482 ' HG ' HG23 ' A' ' 52' ' ' VAL . 62.5 tp -82.04 104.27 12.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.133 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.9 m -94.99 109.32 21.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.271 0.558 . . . . 0.0 109.829 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.556 HG12 ' OE2' ' A' ' 54' ' ' GLU . 29.0 t -111.2 138.16 40.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.126 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 81.8 p -118.22 137.37 53.06 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.724 ' HB2' ' HE ' ' A' ' 57' ' ' ARG . 13.9 mp0 -143.58 179.44 7.12 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.434 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 23.6 m-20 -21.15 81.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 124.846 1.341 . . . . 0.0 114.194 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m 42.68 62.8 1.63 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.671 0.788 . . . . 0.0 111.787 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.724 ' HE ' ' HB2' ' A' ' 54' ' ' GLU . 1.4 ptm85 -167.52 57.45 0.07 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -163.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 19.2 t -76.58 103.79 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.34 -0.85 . . . . 0.0 109.54 -176.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.8 m -92.1 121.47 33.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.185 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -92.58 88.26 6.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.768 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.531 ' CE2' HD22 ' A' ' 93' ' ' LEU . 90.3 m-85 -78.89 117.25 19.81 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.077 0.551 . . . . 0.0 110.924 -176.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 8.4 tp -71.4 135.96 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.561 HG23 ' HB3' ' A' ' 71' ' ' PHE . 4.0 mp -122.23 117.76 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.964 0.411 . . . . 0.0 110.769 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.529 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 5.5 m120 -85.61 136.07 33.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.936 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 47' ' ' ASP . 10.8 t -92.73 98.43 11.41 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 174.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.572 HD11 ' HG3' ' A' ' 72' ' ' LYS . 55.0 mt -72.89 168.36 25.23 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.107 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 36.6 Cg_exo -63.17 68.3 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.998 2.465 . . . . 0.0 112.803 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 70.79 14.89 6.99 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.369 1.468 . . . . 0.0 112.176 164.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 66.4 mtt180 -93.75 -72.75 0.6 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.707 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.711 ' HB2' ' O ' ' A' ' 78' ' ' PHE . 3.2 ptp180 -156.79 -169.62 3.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.596 -172.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.561 ' HB3' HG23 ' A' ' 63' ' ' ILE . 97.4 m-85 -118.31 127.92 54.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.959 0.409 . . . . 0.0 111.053 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.693 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 52.9 mttm -98.22 101.09 12.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.842 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.675 HD13 ' HE2' ' A' ' 88' ' ' TYR . 10.7 tt -87.41 81.94 2.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 122.127 0.965 . . . . 0.0 110.202 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.474 ' CA ' ' HG3' ' A' ' 209' ' ' GLN . . . 73.27 81.63 0.38 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.161 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.5 t0 72.59 -58.0 0.61 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.778 0.431 . . . . 0.0 111.376 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -79.03 140.02 38.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.406 0.622 . . . . 0.0 110.726 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.693 ' HB3' ' HG2' ' A' ' 72' ' ' LYS . 10.5 pt-20 -110.8 141.72 43.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.321 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.711 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 71.9 m-85 -122.68 151.08 41.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -58.94 -24.89 62.99 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -169.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -163.75 172.32 14.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.332 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.574 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.7 mt -55.09 -56.49 27.61 Favored Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 34.6 Cg_exo -61.15 -9.48 12.62 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.125 1.884 . . . . 0.0 113.23 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . . . -88.7 -25.58 22.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.66 0.267 . . . . 0.0 110.991 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -79.49 -31.52 42.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.26 -35.48 79.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.756 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.502 ' HG2' ' HA ' ' A' ' 83' ' ' ALA . 7.6 pt-20 -80.56 -6.16 57.83 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -87.65 -37.58 16.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.372 0.606 . . . . 0.0 109.592 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.675 ' HE2' HD13 ' A' ' 73' ' ' ILE . 41.9 m-85 -81.85 -6.88 59.47 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.565 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.538 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 14.2 ptmm? -83.62 -3.73 57.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.527 171.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.4 pt -123.21 -22.16 2.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 121.021 0.439 . . . . 0.0 110.522 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 10.6 t-160 -68.9 -41.96 77.55 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.946 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.567 ' CD2' HG23 ' A' ' 97' ' ' THR . 91.3 m-85 71.81 108.39 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 O-C-N 124.554 1.159 . . . . 0.0 108.93 -165.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.659 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 4.8 mt -78.86 1.38 23.66 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.687 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 28.4 t70 -168.53 -134.19 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.467 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 10.6 t -83.07 -8.05 59.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.516 0.674 . . . . 0.0 109.372 172.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.9 t -125.92 169.46 12.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.912 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.567 HG23 ' CD2' ' A' ' 92' ' ' TYR . 9.1 p -109.14 -176.66 3.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.555 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.56 HD22 ' CD1' ' A' ' 36' ' ' PHE . 92.6 mt -69.13 98.8 1.04 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.697 HG22 ' HG3' ' A' ' 100' ' ' GLU . 51.3 mm -90.68 -58.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.929 -176.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.697 ' HG3' HG22 ' A' ' 99' ' ' ILE . 45.3 mt-10 -141.01 158.12 65.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.712 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 93.6 Cg_endo -83.27 157.37 14.83 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.611 2.208 . . . . 0.0 112.04 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.45 158.33 83.59 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.386 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.74 129.43 27.67 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.258 1.972 . . . . 0.0 111.812 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.602 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 35.3 ttt180 -73.33 -2.69 23.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.371 0.605 . . . . 0.0 110.266 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 6.1 m-85 -91.32 130.27 40.31 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.15 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 12.3 Cg_exo -70.72 86.41 0.71 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.642 2.228 . . . . 0.0 112.363 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.0 m -151.63 98.42 3.03 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.165 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 3.0 Cg_exo -76.56 147.05 27.9 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.014 2.476 . . . . 0.0 112.46 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 22.6 Cg_exo -65.88 147.97 85.66 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.798 2.332 . . . . 0.0 111.7 175.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.8 mmt -115.33 144.72 43.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.06 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.4 179.9 16.4 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.644 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 64.9 m -71.35 -21.39 62.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.722 0.296 . . . . 0.0 111.154 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.58 -19.3 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.061 0.457 . . . . 0.0 110.638 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.3 m -67.76 97.47 0.64 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.69 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -145.28 128.28 8.3 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.911 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.528 ' HA ' HG23 ' A' ' 58' ' ' VAL . 96.6 Cg_endo -92.28 -162.6 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.312 2.675 . . . . 0.0 110.93 171.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.566 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 61.3 t30 -102.37 152.61 20.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.596 ' N ' ' HD3' ' A' ' 119' ' ' PRO . 19.9 mt 53.07 52.94 11.19 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.8 0.688 . . . . 0.0 112.819 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 118' ' ' LEU . 3.1 Cg_exo -81.21 -34.16 0.62 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.361 2.041 . . . . 0.0 111.207 176.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 66.2 p -119.71 -176.93 3.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.056 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.55 13.68 33.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.165 0.507 . . . . 0.0 110.217 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.58 148.34 37.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.613 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.671 ' HA ' HH12 ' A' ' 183' ' ' ARG . 21.7 t0 -80.04 102.66 9.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -118.35 -98.09 0.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.315 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.492 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 0.5 OUTLIER -127.11 103.44 7.44 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -173.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.994 ' HB2' ' HE ' ' A' ' 183' ' ' ARG . 8.5 mt-10 169.08 -54.42 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 O-C-N 125.703 1.877 . . . . 0.0 109.988 171.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.977 ' CE1' ' HB3' ' A' ' 183' ' ' ARG . 12.9 m-85 -61.28 107.42 0.76 Allowed 'General case' 0 C--O 1.208 -1.12 0 CA-C-N 119.18 0.9 . . . . 0.0 110.805 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.787 HG21 HD11 ' A' ' 152' ' ' ILE . 2.0 t -131.23 132.66 63.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.807 172.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.811 HH21 HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -126.31 135.43 51.5 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.601 173.29 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.952 HG22 HG12 ' A' ' 178' ' ' VAL . 70.9 p -94.06 132.86 38.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -173.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -112.38 -0.32 15.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.801 -175.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -105.93 -44.36 4.63 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -168.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.3 t70 81.16 102.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.273 0.629 . . . . 0.0 110.35 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 87.3 t80 -142.61 110.82 5.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 57.6 Cg_endo -91.89 90.42 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.619 2.213 . . . . 0.0 112.615 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.605 ' HA3' ' OD1' ' A' ' 141' ' ' ASP . . . -79.93 -2.42 88.56 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.257 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.44 HD22 ' HA ' ' A' ' 137' ' ' ASN . 7.4 m120 56.95 25.84 11.08 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.642 0.377 . . . . 0.0 111.974 -174.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.794 ' HA ' ' O ' ' A' ' 141' ' ' ASP . 3.0 p30 53.35 -166.61 0.07 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 168.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . 90.6 -47.49 0.02 OUTLIER 'General case' 0 C--N 1.347 0.46 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.875 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -142.37 14.01 1.99 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.794 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 11.5 t70 -153.53 173.55 15.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 112.756 -2.02 . . . . 0.0 105.824 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.752 HD11 ' HB3' ' A' ' 165' ' ' ASN . 54.8 tp -134.61 128.81 19.19 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 119.16 0.891 . . . . 0.0 110.477 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.651 ' HD2' HD12 ' A' ' 142' ' ' LEU . 12.6 Cg_endo -85.09 98.77 0.67 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.449 2.099 . . . . 0.0 111.194 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.666 ' CG ' HG21 ' A' ' 130' ' ' THR . 10.9 p90 -111.77 167.96 9.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.556 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.656 ' H ' ' HB2' ' A' ' 148' ' ' GLU . 24.5 mtpp -126.1 -174.05 3.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -173.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -69.79 66.47 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.52 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 121.0 49.34 0.28 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.263 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.656 ' HB2' ' H ' ' A' ' 145' ' ' LYS . 5.8 tp10 -99.34 154.52 18.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.822 HG13 ' HB3' ' A' ' 181' ' ' LEU . 1.0 OUTLIER -112.32 134.2 55.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.69 -173.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.719 HD22 HD21 ' A' ' 142' ' ' LEU . 21.0 mt -143.14 155.8 44.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.899 0.857 . . . . 0.0 110.913 -170.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.856 HG22 ' O ' ' A' ' 182' ' ' VAL . 39.3 t -126.32 126.41 69.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.614 173.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.793 HD13 ' HB2' ' A' ' 163' ' ' ALA . 36.2 mm -74.53 86.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 122.156 0.979 . . . . 0.0 110.412 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.852 HG21 HG22 ' A' ' 170' ' ' VAL . 9.1 tt -82.51 -28.28 8.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.726 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.958 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 28.0 mt-10 -130.73 141.66 50.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -136.23 77.43 48.33 Favored Pre-proline 0 C--O 1.24 0.566 0 O-C-N 121.472 -0.768 . . . . 0.0 111.566 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 16.6 Cg_exo -66.16 -54.62 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.256 1.971 . . . . 0.0 111.342 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -106.82 175.06 5.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.62 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -98.89 -23.33 15.39 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.33 -27.64 21.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.273 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.404 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 44.2 m95 -124.41 122.47 37.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.642 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.756 ' HB3' HD12 ' A' ' 152' ' ' ILE . 45.7 m0 -112.18 137.72 49.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.53 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.958 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.7 m -94.82 109.54 21.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.793 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -116.79 159.32 22.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -173.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.691 ' HE ' HG21 ' A' ' 151' ' ' VAL . 9.7 ptt180 -94.0 118.86 32.09 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.996 173.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.752 ' HB3' HD11 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -69.16 179.11 2.03 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.664 0.269 . . . . 0.0 111.452 -178.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -61.41 -30.37 70.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.987 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -93.65 4.1 54.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.636 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.41 ' H ' HD22 ' A' ' 165' ' ' ASN . . . 84.23 74.82 1.22 Allowed Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.785 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -150.92 138.41 19.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 177.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 210' ' ' PRO . 95.1 t -103.78 126.03 58.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.201 0.524 . . . . 0.0 111.973 -175.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . -157.42 167.45 34.01 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 171.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 22.7 mtp -79.96 139.44 37.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.178 0.489 . . . . 0.0 110.7 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.766 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -138.24 148.3 59.14 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.75 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 5.7 Cg_exo -78.24 131.77 10.98 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.65 2.233 . . . . 0.0 112.435 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.547 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 61.1 t -59.34 -45.07 99.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 31.9 Cg_endo -65.29 -1.62 4.8 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.22 1.947 . . . . 0.0 113.452 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 2.6 m-85 -99.7 -7.94 24.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.783 0.325 . . . . 0.0 111.066 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.952 HG12 HG22 ' A' ' 130' ' ' THR . 2.9 m -144.2 176.56 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.662 -166.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.695 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 6.6 pt-20 -153.64 -55.65 0.11 Allowed 'General case' 0 C--O 1.2 -1.533 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 144.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -147.04 133.97 20.23 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 122.538 2.426 . . . . 0.0 115.686 -171.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.822 ' HB3' HG13 ' A' ' 149' ' ' ILE . 0.1 OUTLIER 161.66 133.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 164.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.856 ' O ' HG22 ' A' ' 151' ' ' VAL . 69.7 t 67.51 134.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 124.823 1.249 . . . . 0.0 113.044 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.994 ' HE ' ' HB2' ' A' ' 126' ' ' GLU . 2.6 ttm180 169.54 -23.34 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.93 1.292 . . . . 0.0 109.356 -165.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.0 m -45.12 134.18 6.27 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.91 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.576 ' OG ' HD13 ' A' ' 118' ' ' LEU . 94.5 p -133.91 163.15 53.21 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.704 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.74 ' HD3' ' HB3' ' A' ' 206' ' ' ALA . 31.6 Cg_exo -59.7 135.95 67.41 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.806 2.337 . . . . 0.0 112.091 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -141.07 175.62 9.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.412 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.39 97.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.99 173.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -126.22 113.93 17.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.843 0.354 . . . . 0.0 110.384 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -166.55 -41.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.049 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 90.17 149.48 22.12 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.431 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -102.58 123.53 46.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.764 0.316 . . . . 0.0 110.616 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -138.27 -43.2 0.51 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.273 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 63.94 -98.83 0.07 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.551 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.0 t 179.42 150.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.63 164.22 17.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.9 t 64.43 -159.76 0.29 Allowed 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.546 0.528 . . . . 0.0 109.811 -177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 69.27 120.92 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.443 0.64 . . . . 0.0 111.379 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.24 67.1 3.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.972 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 29.6 pt -130.08 152.52 80.18 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.289 . . . . 0.0 111.11 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.44 ' O ' ' HD3' ' A' ' 203' ' ' PRO . 95.0 Cg_endo -85.21 -169.3 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.047 2.498 . . . . 0.0 111.794 173.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -110.41 96.28 26.3 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.858 0.361 . . . . 0.0 110.43 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 201' ' ' PRO . 11.7 Cg_exo -70.98 -47.01 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.838 2.359 . . . . 0.0 112.197 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.33 -71.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.567 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.49 ' HB3' ' HG3' ' A' ' 186' ' ' PRO . 52.1 t60 179.88 -60.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.737 173.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.74 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . . . -169.13 121.71 0.77 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.036 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.753 ' O1P' ' HB ' ' A' ' 43' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.647 ' HB1' HD11 ' A' ' 153' ' ' ILE . . . -84.65 96.25 9.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.246 0.546 . . . . 0.0 109.918 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.474 ' HG3' ' CA ' ' A' ' 74' ' ' GLY . 60.8 tt0 -101.6 107.11 50.04 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.818 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.966 ' HA ' HG23 ' A' ' 170' ' ' VAL . 1.7 Cg_endo -88.45 -179.09 2.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.868 3.045 . . . . 0.0 112.783 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.477 ' OE1' ' HB2' ' A' ' 169' ' ' ARG . 31.2 tt0 -175.75 127.41 0.24 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.876 0.37 . . . . 0.0 110.913 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.676 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 82.7 m -125.3 143.08 51.13 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.448 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.569 ' H ' ' HB2' ' A' ' 139' ' ' ALA . 13.1 m -50.79 106.92 0.14 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 120.958 0.409 . . . . 0.0 110.706 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.659 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 16.7 m -70.44 -53.35 10.18 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.745 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 14.5 Cg_exo -69.57 107.0 1.73 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.091 1.861 . . . . 0.0 112.096 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 216' ' ' LEU . 1.1 tm? -121.63 102.68 41.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.535 ' HG3' HD22 ' A' ' 230' ' ' LEU . 71.7 Cg_endo -82.09 108.54 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.777 2.318 . . . . 0.0 112.309 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -85.89 -59.52 2.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.852 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 76.9 t -122.76 -42.58 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.703 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 29.9 m -86.21 134.39 33.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.414 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.12 -79.26 0.27 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.6 t -158.75 104.36 1.61 Allowed Pre-proline 0 C--N 1.323 -0.587 0 CA-C-O 120.793 0.33 . . . . 0.0 110.42 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -81.77 21.49 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.055 2.503 . . . . 0.0 111.141 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -158.81 -154.23 7.12 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.16 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 67.88 -73.75 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.152 0.581 . . . . 0.0 111.407 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 69.14 -58.99 0.49 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.663 0.785 . . . . 0.0 111.94 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -38.93 64.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.853 0.359 . . . . 0.0 110.252 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.1 m -79.97 128.46 73.79 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.572 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.59 153.66 73.68 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.789 2.326 . . . . 0.0 112.224 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.535 HD22 ' HG3' ' A' ' 217' ' ' PRO . 7.7 mp -91.23 135.46 28.27 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.791 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 4.6 Cg_exo -73.75 107.07 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.707 2.271 . . . . 0.0 111.384 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 16.2 m -87.45 -32.3 19.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.594 0.712 . . . . 0.0 109.246 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 17.0 p -135.6 148.0 48.88 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.424 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -70.24 -37.74 75.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.626 ' HB2' ' HB2' ' A' ' 269' ' ' MET . 2.2 p30 -94.51 174.39 7.15 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.95 164.04 37.44 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.091 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.655 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 4.7 Cg_exo -74.0 102.0 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.082 2.521 . . . . 0.0 111.357 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.405 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 28.3 t -116.51 146.08 21.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.704 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.472 ' CE1' ' HE2' ' A' ' 265' ' ' LYS . 54.1 m-85 -81.28 126.64 31.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.17 0.509 . . . . 0.0 111.272 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.685 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -135.32 130.9 35.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.097 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -97.47 126.66 42.87 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -73.48 111.69 8.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.434 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.455 HD12 ' HG3' ' A' ' 244' ' ' GLN . 1.9 pp -87.81 -10.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.691 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.455 ' HG3' HD12 ' A' ' 243' ' ' ILE . 28.8 mt-30 -120.23 167.19 12.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 258' ' ' LEU . 21.2 pttp -118.79 137.48 53.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.302 0.573 . . . . 0.0 111.058 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.539 ' NH1' ' HD2' ' A' ' 287' ' ' PRO . 40.8 ttp-105 -139.41 117.55 11.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.845 -176.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.84 131.58 24.31 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.973 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.84 127.7 11.76 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.611 2.207 . . . . 0.0 111.861 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 5.7 p -84.24 -178.96 7.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.977 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -67.24 -16.28 64.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.903 0.383 . . . . 0.0 111.683 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -121.43 29.62 7.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.431 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.558 ' HB2' ' HB3' ' A' ' 255' ' ' ALA . 1.8 p-10 -64.31 126.58 28.24 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.668 0.747 . . . . 0.0 110.526 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 253' ' ' LYS . 73.5 mmtt -98.03 86.68 3.77 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.339 177.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 44.4 p 60.95 38.15 17.73 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.069 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . . . -91.35 103.95 16.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.695 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 257' ' ' ALA . 1.5 tt -67.23 131.38 45.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.632 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.437 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -75.21 120.38 20.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.618 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 245' ' ' LYS . 81.7 mt -138.0 113.02 9.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.593 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.63 172.45 7.7 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 43.9 t -69.56 106.91 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.02 0.438 . . . . 0.0 110.443 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 123.4 -8.56 8.92 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.415 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.03 130.9 44.35 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.836 0.35 . . . . 0.0 110.867 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 45.9 mm -89.02 108.73 19.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.378 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.416 HG21 HG11 ' A' ' 291' ' ' VAL . 36.1 t -85.81 106.54 15.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.27 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.472 ' HE2' ' CE1' ' A' ' 239' ' ' PHE . 28.5 mmtt -84.24 92.74 8.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 237' ' ' PRO . 7.6 p -87.31 125.66 41.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.972 0.415 . . . . 0.0 110.044 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 4.9 p -100.34 -32.86 10.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.59 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 24.8 tpp180 -125.88 99.36 5.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.976 0.417 . . . . 0.0 110.165 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . 0.626 ' HB2' ' HB2' ' A' ' 235' ' ' ASN . 25.2 mtt -85.32 107.65 17.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.511 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -63.63 125.28 23.78 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.4 mt -75.79 68.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.899 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.409 HD22 ' N ' ' A' ' 273' ' ' GLY . 3.1 t30 -177.26 -69.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.147 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.576 ' O ' ' HG2' ' A' ' 274' ' ' GLN . . . 179.11 143.26 5.28 Favored Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -166.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.576 ' HG2' ' O ' ' A' ' 273' ' ' GLY . 0.6 OUTLIER 64.31 119.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 125.418 1.487 . . . . 0.0 110.189 -172.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 286' ' ' PHE . 15.2 m0 -114.02 167.73 10.42 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.985 -174.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -122.67 115.02 21.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.364 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -141.03 158.01 26.17 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 1.07 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 16.5 mt-10 -103.17 108.98 20.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.34 0.57 . . . . 0.0 110.275 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 41.1 t -133.09 139.45 49.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.828 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 26.6 p30 43.52 32.38 0.52 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.757 1.223 . . . . 0.0 113.695 172.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.61 -59.86 0.43 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.858 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.54 176.11 12.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.654 -0.321 . . . . 0.0 111.681 -174.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 1.07 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 13.1 pttm -87.14 141.1 28.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.123 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.87 173.93 32.46 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.76 127.83 37.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.078 0.466 . . . . 0.0 110.258 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 275' ' ' TRP . 43.4 p90 -126.13 131.16 23.87 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.688 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.539 ' HD2' ' NH1' ' A' ' 246' ' ' ARG . 48.2 Cg_exo -58.0 138.69 87.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.615 2.21 . . . . 0.0 111.593 172.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -72.22 -18.39 61.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.401 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 13.8 p -79.43 -0.54 33.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.3 0.572 . . . . 0.0 111.081 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -95.59 -18.69 20.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.586 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.416 HG11 HG21 ' A' ' 264' ' ' VAL . 31.7 m -127.83 164.17 29.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.456 -175.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.426 ' HG2' HG12 ' A' ' 243' ' ' ILE . 30.9 mmmt -127.42 122.54 33.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.728 0.299 . . . . 0.0 110.393 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.685 HD13 ' HB2' ' A' ' 240' ' ' ALA . 48.8 mm -71.0 122.09 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.152 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -135.54 147.64 48.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.826 0.346 . . . . 0.0 110.272 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.677 ' HB2' HD22 ' A' ' 298' ' ' ASN . 6.9 m-20 -72.52 129.43 87.17 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.06 -18.99 31.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.335 2.69 . . . . 0.0 113.324 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -85.79 15.34 4.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.719 0.295 . . . . 0.0 111.322 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.677 HD22 ' HB2' ' A' ' 295' ' ' ASP . 41.7 m-80 -115.16 96.59 45.81 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.91 0.386 . . . . 0.0 111.675 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 301' ' ' GLU . 96.3 Cg_endo -96.4 19.99 0.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.307 2.672 . . . . 0.0 110.916 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 301' ' ' GLU . 15.7 m-20 73.5 -39.03 0.43 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.484 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 300' ' ' ASP . 41.9 tt0 165.91 -43.06 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 301' ' ' GLU . 7.1 t30 163.02 -52.58 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 113.265 -1.789 . . . . 0.0 108.638 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--O 1.246 0.908 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.372 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.01 0.433 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -111.76 84.29 1.93 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.099 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -74.89 -37.01 62.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.902 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.43 127.83 40.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.542 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -142.06 91.51 2.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.331 0.586 . . . . 0.0 111.079 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -147.17 148.38 31.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.496 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -79.82 96.88 6.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.991 0.424 . . . . 0.0 110.259 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 m -69.78 74.48 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.133 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 t -176.53 -43.33 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.915 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.85 107.49 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.183 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -32.54 67.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.17 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.0 t -69.78 -9.22 53.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.278 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.26 -46.76 7.56 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.761 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -118.4 -19.93 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -170.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -82.03 123.42 28.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.798 0.333 . . . . 0.0 110.649 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.562 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 16.6 mmt -101.72 -9.55 20.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.557 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.4 -113.23 2.18 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.49 -177.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 16.9 Cg_exo -67.17 91.06 0.32 Allowed 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.063 2.509 . . . . 0.0 113.38 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.994 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 14.3 t -137.43 -157.12 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.891 ' H ' HG12 ' A' ' 19' ' ' VAL . 12.5 t 178.93 174.96 0.66 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.8 1.182 . . . . 0.0 108.661 -169.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' HG2' HH11 ' A' ' 21' ' ' ARG . 0.0 OUTLIER -44.49 -66.84 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.885 0.741 . . . . 0.0 112.046 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -63.79 -54.34 36.63 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.443 0.464 . . . . 0.0 111.991 -173.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -54.7 -46.82 74.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.41 -42.9 83.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.459 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -80.39 -33.39 37.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.663 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 t -74.19 -18.77 60.72 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.886 -0.325 . . . . 0.0 111.429 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -97.8 -10.38 24.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 110.727 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.68 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 73.2 mt -111.45 0.86 16.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.657 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.14 108.88 3.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.878 0.847 . . . . 0.0 110.679 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.78 -76.69 0.92 Allowed Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.915 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.535 ' N ' ' HA ' ' A' ' 117' ' ' ASN . 17.2 mm-40 45.28 -159.38 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.169 0.57 . . . . 0.0 111.737 -175.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.565 HH21 ' HB2' ' A' ' 100' ' ' GLU . 33.0 ptt180 -101.13 5.94 43.0 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.521 176.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 53' ' ' SER . 27.3 m170 68.29 123.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.478 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.75 16.53 21.63 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.416 ' HG3' ' HB3' ' A' ' 31' ' ' GLN . 73.2 mmm -106.0 134.94 48.33 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.472 ' CB ' HG22 ' A' ' 52' ' ' VAL . 43.3 p90 -139.58 162.93 33.88 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.621 -174.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.562 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -155.73 141.9 18.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.56 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.31 129.19 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.994 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 32.0 ptt-85 -129.43 173.2 10.77 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.59 133.77 34.04 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 170.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.462 ' HB2' HG22 ' A' ' 43' ' ' THR . 93.9 p -80.45 147.97 30.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.212 0.529 . . . . 0.0 111.162 -173.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.0 t -99.28 34.42 2.17 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 41' ' ' SER . 9.0 t -135.47 -27.55 1.18 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.206 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 91.2 m -147.36 118.25 4.53 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.786 0.327 . . . . 0.0 110.622 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.21 117.98 4.81 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.776 2.317 . . . . 0.0 112.144 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.66 -22.81 34.55 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.713 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 20.0 m-20 -89.84 152.03 21.48 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -119.85 174.97 6.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.557 0.218 . . . . 0.0 111.3 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.628 HG11 ' HE2' ' A' ' 207' ' ' PTR . 24.1 t -142.63 109.83 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.31 . . . . 0.0 110.861 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 36' ' ' PHE . 32.1 tp -85.29 100.63 11.92 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.972 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.7 m -96.54 127.41 42.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.97 177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.835 HG21 HD13 ' A' ' 93' ' ' LEU . 48.4 t -123.61 137.17 57.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.453 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.68 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 90.1 p -97.28 123.8 41.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.647 0.26 . . . . 0.0 111.367 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.696 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 26.7 mt-10 -145.14 175.95 9.88 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.653 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 2.6 p30 -37.04 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -163.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.5 m 37.55 56.87 1.44 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.109 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.876 HH21 ' HB2' ' A' ' 94' ' ' ASP . 7.0 ttp85 -167.67 53.72 0.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.79 -159.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.2 t -77.18 98.52 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.909 0.861 . . . . 0.0 109.193 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -87.47 121.17 29.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.839 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -94.71 99.4 11.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.19 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.608 ' CE2' HD22 ' A' ' 93' ' ' LEU . 58.6 m-85 -96.07 116.15 28.52 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.367 0.267 . . . . 0.0 111.529 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 64.5 mt -80.31 134.2 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.739 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.0 mp -109.45 119.5 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 123.16 0.584 . . . . 0.0 110.347 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.51 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 13.2 m120 -84.98 137.68 32.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.789 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.7 t -87.41 102.0 14.12 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.68 HD11 ' HB2' ' A' ' 72' ' ' LYS . 91.4 mt -83.44 140.27 41.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.993 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.75 -23.07 69.48 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.221 2.614 . . . . 0.0 112.958 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -85.23 17.71 2.93 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.014 0.435 . . . . 0.0 110.287 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.893 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.8 OUTLIER 61.97 57.84 2.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.957 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.773 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 62.0 mtt180 -138.59 171.41 14.4 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.124 175.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.513 ' HB3' HG23 ' A' ' 63' ' ' ILE . 53.8 m-85 -130.63 114.99 16.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.404 0.621 . . . . 0.0 110.493 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.68 ' HB2' HD11 ' A' ' 66' ' ' LEU . 87.5 tttt -105.62 99.79 9.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.981 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.739 ' HB ' HG13 ' A' ' 63' ' ' ILE . 8.6 tt -83.63 78.63 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 122.024 0.916 . . . . 0.0 111.063 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.976 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 85.07 -15.99 40.64 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.119 -0.946 . . . . 0.0 114.645 171.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.564 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 19.1 t70 176.92 -63.3 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.809 0.804 . . . . 0.0 111.275 -176.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -66.42 129.14 38.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.59 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -87.47 108.41 19.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.378 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.471 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 67.0 m-85 -105.51 149.46 26.21 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.773 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 22.6 m-20 -73.55 -25.05 60.21 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -173.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 6.1 p80 -160.04 168.73 24.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.707 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.59 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.1 mt -56.27 -56.27 33.22 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.612 ' HA ' HD12 ' A' ' 85' ' ' LEU . 32.4 Cg_exo -63.15 -3.0 4.32 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.261 1.974 . . . . 0.0 113.681 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.86 -33.72 17.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.019 0.438 . . . . 0.0 110.284 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.4 pp -79.38 -26.73 41.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.289 0.566 . . . . 0.0 109.6 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.612 HD12 ' HA ' ' A' ' 82' ' ' PRO . 79.3 mt -67.89 -29.52 68.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.616 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 82' ' ' PRO . 16.6 mm-40 -83.52 -14.66 51.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.995 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -84.23 -39.02 19.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.267 0.556 . . . . 0.0 109.831 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -81.59 0.81 36.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.36 0.6 . . . . 0.0 110.572 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -74.12 -22.43 59.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.827 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.4 pt -122.72 -19.64 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.597 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -84.29 -19.95 32.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.343 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 72.41 162.24 0.25 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.832 0.707 . . . . 0.0 109.54 -170.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.835 HD13 HG21 ' A' ' 52' ' ' VAL . 11.5 mt -114.55 -11.01 12.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.174 0.511 . . . . 0.0 110.087 168.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.876 ' HB2' HH21 ' A' ' 57' ' ' ARG . 9.6 t70 -157.57 -80.28 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.636 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 7.0 t -132.49 -16.0 2.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.073 0.463 . . . . 0.0 110.077 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.472 HG22 ' OE1' ' A' ' 54' ' ' GLU . 4.6 t -121.76 -177.83 3.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.5 p -114.88 178.77 4.16 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.155 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.449 HD22 ' CD1' ' A' ' 36' ' ' PHE . 87.7 mt -64.37 97.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.1 mm -85.56 -64.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.673 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.565 ' HB2' HH21 ' A' ' 32' ' ' ARG . 43.2 mt-10 -150.27 153.36 34.86 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.889 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.69 154.65 72.72 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.793 2.329 . . . . 0.0 112.444 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.46 157.6 82.34 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.227 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.28 135.68 20.9 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.366 2.044 . . . . 0.0 111.819 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.507 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 88.9 mtm180 -71.48 123.63 22.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.719 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 32.0 p90 50.43 178.96 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.987 0 O-C-N 124.489 1.118 . . . . 0.0 111.852 -176.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.719 ' HD2' ' HB2' ' A' ' 105' ' ' TYR . 88.7 Cg_exo -50.72 109.42 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.983 1.789 . . . . 0.0 111.71 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.629 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 0.8 OUTLIER -57.89 141.5 80.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.382 -174.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.93 148.17 58.84 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.54 2.16 . . . . 0.0 111.723 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.37 33.17 0.28 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.127 2.552 . . . . 0.0 113.098 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 70.4 mtm -97.7 -20.52 17.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 160.12 90.21 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.26 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.629 ' HB2' ' HB2' ' A' ' 107' ' ' SER . 40.2 t -112.49 -21.8 11.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.9 t 64.92 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.886 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.3 m -86.1 87.25 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.361 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -143.16 -47.62 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.984 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 115' ' ' ALA . 8.3 Cg_exo -74.48 -137.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.461 2.107 . . . . 0.0 111.551 174.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.535 ' HA ' ' N ' ' A' ' 31' ' ' GLN . 88.0 m-20 63.75 43.07 5.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.14 0.495 . . . . 0.0 110.034 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 87.1 mt -105.97 102.83 41.48 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.137 -174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 117' ' ' ASN . 10.5 Cg_endo -91.03 144.44 3.42 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.272 2.648 . . . . 0.0 111.657 175.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.8 m -126.05 68.9 1.2 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 63.81 98.9 0.04 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.548 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.6 54.03 0.92 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.544 0.687 . . . . 0.0 111.758 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -100.63 94.81 6.3 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 126' ' ' GLU . 4.3 p-10 -87.57 149.29 24.43 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -160.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.899 HD12 HG13 ' A' ' 152' ' ' ILE . 1.3 mm? -52.36 123.56 11.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.591 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.687 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 32.6 tt0 -155.94 -72.74 0.11 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.003 -177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -93.1 109.19 20.67 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.156 -168.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.919 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 90.6 t -134.25 129.17 53.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.011 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.976 ' HG2' ' HB3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -109.79 154.71 22.58 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 118.584 -1.247 . . . . 0.0 108.54 172.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 178' ' ' VAL . 18.9 p -112.21 141.34 46.03 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.755 HD21 ' HG3' ' A' ' 179' ' ' GLU . 58.3 mt -111.82 -41.4 4.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.222 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 51.5 t80 -72.22 -27.88 62.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -168.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.646 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 30.1 t70 69.51 96.36 0.07 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.626 0.727 . . . . 0.0 110.994 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -122.72 96.32 45.54 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.839 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.72 88.92 0.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.44 2.093 . . . . 0.0 112.139 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -87.65 -23.76 38.22 Favored Glycine 0 C--O 1.228 -0.227 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.324 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 47.02 80.33 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.593 0.757 . . . . 0.0 112.57 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -162.64 173.39 13.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.19 -3.29 58.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.155 0.502 . . . . 0.0 110.588 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.26 -11.29 10.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.378 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -129.78 105.43 8.02 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.021 HD11 ' HB2' ' A' ' 165' ' ' ASN . 36.5 tp -76.52 117.57 65.42 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.674 0.273 . . . . 0.0 110.62 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.467 ' HD2' HD12 ' A' ' 142' ' ' LEU . 45.8 Cg_endo -71.16 106.27 1.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.109 1.873 . . . . 0.0 111.244 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -113.64 164.45 13.66 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.216 -177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.646 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -106.13 -169.56 1.59 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.105 -168.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.557 ' HD2' ' HB2' ' A' ' 133' ' ' ASP . 13.7 mptt -78.37 -5.15 51.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.176 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.72 56.53 0.16 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.361 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.462 ' HB2' ' HD3' ' A' ' 145' ' ' LYS . 7.8 tp10 -105.54 150.74 25.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.615 HD13 ' HB3' ' A' ' 129' ' ' ARG . 45.9 mm -96.66 129.72 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' A' ' 165' ' ' ASN . 44.0 mt -123.03 160.48 26.24 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.315 0.579 . . . . 0.0 109.5 -178.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 87.2 t -124.77 128.03 73.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.899 HG13 HD12 ' A' ' 125' ' ' LEU . 36.7 mm -74.33 87.84 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 122.244 1.021 . . . . 0.0 109.529 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.656 HG23 ' HG3' ' A' ' 154' ' ' GLU . 18.0 tt -78.49 -26.38 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.32 -174.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.961 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 15.5 mt-10 -142.04 143.99 33.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.697 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 48.4 tttm -137.05 90.52 15.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 O-C-N 121.237 -0.915 . . . . 0.0 111.399 171.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 52.8 Cg_endo -81.0 -44.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.064 1.843 . . . . 0.0 112.497 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -109.43 178.52 4.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.331 -172.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -98.77 -33.09 11.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.353 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.484 ' HA ' ' OE1' ' A' ' 159' ' ' GLN . 14.2 mm-40 -100.0 -11.36 20.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.927 0.394 . . . . 0.0 110.762 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.436 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 71.9 m95 -126.38 118.57 25.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.719 ' CZ3' HD11 ' A' ' 125' ' ' LEU . 48.5 m0 -112.28 136.71 51.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.961 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 10.6 t -92.05 92.97 8.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.346 0.593 . . . . 0.0 109.418 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -103.26 158.09 16.57 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 122.022 -0.424 . . . . 0.0 111.477 -174.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.858 HH12 ' HA ' ' A' ' 208' ' ' ALA . 12.7 ptt180 -98.22 128.71 44.83 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.812 176.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.021 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.5 t30 -70.75 164.64 24.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.556 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -71.96 -10.6 60.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.49 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 165' ' ' ASN . 2.4 p-10 -87.0 -10.58 52.79 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 210' ' ' PRO . . . 93.64 57.14 1.36 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.926 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.739 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 19.1 ttm-85 -136.21 141.9 44.04 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 122.85 -0.206 . . . . 0.0 110.968 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.538 HG22 HG21 ' A' ' 153' ' ' ILE . 49.6 t -103.28 118.46 50.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.609 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -151.15 158.31 27.63 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.411 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 22.5 mtp -79.18 140.03 37.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.894 0.378 . . . . 0.0 110.431 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -135.54 145.57 53.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.342 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.455 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 4.3 Cg_exo -76.53 133.06 13.98 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.32 2.68 . . . . 0.0 113.111 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.648 ' O ' HG22 ' A' ' 178' ' ' VAL . 88.3 t -60.4 -44.58 96.24 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 23.9 Cg_exo -65.27 3.92 0.89 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.219 1.946 . . . . 0.0 113.345 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.5 m-85 -107.89 -4.81 17.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.282 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.8 m -106.89 -169.07 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -165.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.976 ' HB3' ' HG2' ' A' ' 129' ' ' ARG . 0.4 OUTLIER -160.13 41.51 0.19 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.82 -161.164 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.919 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 25.2 pttm -73.28 140.42 46.81 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 120.456 -1.403 . . . . 0.0 109.58 -162.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 17.4 tp -75.18 54.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.699 -168.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.4 m 52.34 10.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.785 1.634 . . . . 0.0 113.752 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 57.33 88.64 0.05 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.269 0.557 . . . . 0.0 110.65 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.7 t 61.8 -137.52 0.51 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.211 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.482 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 60.6 p -175.16 167.33 1.89 Allowed Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 40.4 Cg_endo -68.16 -7.32 19.59 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.428 2.085 . . . . 0.0 111.711 172.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 190' ' ' HIS . 51.6 m80 66.25 -161.03 0.25 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.163 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.431 ' H ' ' HB3' ' A' ' 187' ' ' HIS . . . 84.67 -66.74 3.82 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.93 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -101.61 -2.66 29.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.028 0.442 . . . . 0.0 110.77 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 187' ' ' HIS . 50.5 t60 -87.36 105.45 17.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.66 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -103.79 -141.02 10.96 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.222 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -149.62 168.68 22.88 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 53.5 ttp180 -147.15 -84.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.74 0.305 . . . . 0.0 110.626 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 193' ' ' ARG . 27.8 t-20 165.92 150.55 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -173.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.7 m -77.07 -74.24 0.25 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.458 HD22 ' HA ' ' A' ' 196' ' ' ASN . 0.3 OUTLIER -164.75 30.02 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.217 0.532 . . . . 0.0 110.279 177.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 24.4 t -137.29 86.91 2.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -76.47 156.39 33.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.885 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 119.06 -32.46 5.1 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -174.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.753 HG22 ' H ' ' A' ' 202' ' ' GLU . 71.2 mt -126.6 132.0 24.14 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 27.4 Cg_exo -63.6 -16.61 55.7 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.691 2.261 . . . . 0.0 112.566 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.753 ' H ' HG22 ' A' ' 200' ' ' ILE . 11.6 pt-20 34.08 80.89 0.25 Allowed Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.376 1.07 . . . . 0.0 112.903 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 205' ' ' HIS . 55.8 Cg_endo -70.87 -11.31 29.2 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.237 1.958 . . . . 0.0 112.421 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 69.02 -28.24 0.16 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.859 0.864 . . . . 0.0 112.861 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -78.27 39.04 0.31 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.997 0.519 . . . . 0.0 111.538 -177.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -88.68 84.15 6.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.862 0.363 . . . . 0.0 110.912 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.953 ' O3P' ' HE1' ' A' ' 207' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.858 ' HA ' HH12 ' A' ' 164' ' ' ARG . . . -122.59 23.57 9.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.949 -175.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -74.79 149.3 85.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.976 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 50.5 Cg_exo -54.45 -51.54 10.26 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.989 2.459 . . . . 0.0 113.456 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 29.9 tp60 -74.76 123.82 25.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.214 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.7 t -60.07 142.95 53.21 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 170.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 9.2 m -95.77 113.82 25.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.81 0.338 . . . . 0.0 111.778 -173.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 9.2 m -111.69 87.69 8.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -92.27 170.08 2.7 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.04 2.494 . . . . 0.0 112.393 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.2 mp -112.76 103.1 55.47 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.329 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -83.59 -7.21 10.68 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.908 2.406 . . . . 0.0 112.018 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -101.1 116.89 33.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.061 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.06 -19.82 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.232 0.539 . . . . 0.0 110.876 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 21.2 p -92.07 -4.93 53.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 76.05 -85.27 0.9 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.542 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 20.4 m 50.54 67.83 3.98 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 177.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.49 -34.61 85.42 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.725 2.283 . . . . 0.0 112.133 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -122.19 51.32 0.8 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 174.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 65.2 -166.96 0.22 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.785 0.434 . . . . 0.0 110.8 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -125.13 -177.94 4.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.38 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 40.5 pt -100.37 -167.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 123.217 0.323 . . . . 0.0 110.384 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.3 p -62.39 131.48 93.86 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.073 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.09 96.06 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.713 2.275 . . . . 0.0 112.276 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.681 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 6.3 tt -101.81 -55.25 0.13 Allowed Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.319 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 75.3 Cg_exo -51.69 -57.77 1.98 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.258 1.972 . . . . 0.0 112.835 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 50.6 m -158.91 133.78 8.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.971 0.415 . . . . 0.0 111.377 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.5 157.27 19.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 170.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.424 ' N ' HE21 ' A' ' 234' ' ' GLN . 0.0 OUTLIER -122.64 -74.91 0.6 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.023 -174.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 63.83 81.27 0.21 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.78 0.675 . . . . 0.0 110.954 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -132.2 -88.63 0.41 Allowed Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.77 101.76 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.259 1.973 . . . . 0.0 110.148 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.458 HG11 HD12 ' A' ' 293' ' ' ILE . 21.6 t -92.96 145.98 6.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.885 -173.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.1 116.9 32.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.685 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.51 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.29 128.16 53.04 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.46 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.601 ' HG3' ' CE1' ' A' ' 294' ' ' PHE . 28.5 mtpp -78.75 125.25 29.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.567 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -75.59 91.42 2.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.888 0.375 . . . . 0.0 110.136 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 24.6 pt -73.24 9.59 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.847 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -148.91 152.87 37.17 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -95.85 144.96 25.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.637 ' HB3' ' CE1' ' A' ' 290' ' ' HIS . 0.5 OUTLIER -171.02 125.69 0.67 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.638 0.256 . . . . 0.0 110.756 178.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.706 ' HB ' ' HD3' ' A' ' 248' ' ' PRO . 60.3 t -102.18 -55.0 0.13 Allowed Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.812 172.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.706 ' HD3' ' HB ' ' A' ' 247' ' ' VAL . 61.5 Cg_endo -90.0 167.85 4.6 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.427 2.085 . . . . 0.0 113.782 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.542 ' HB3' ' HE ' ' A' ' 246' ' ' ARG . 24.3 p -173.32 89.77 0.08 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.623 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 64.92 -72.68 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.216 1.006 . . . . 0.0 112.971 172.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.589 ' HD1' ' H ' ' A' ' 253' ' ' LYS . 18.3 p90 -91.67 -31.0 16.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.919 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 64.98 -1.33 0.87 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.589 ' H ' ' HD1' ' A' ' 251' ' ' TYR . 57.7 tttp -62.11 -65.31 0.71 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.195 0.521 . . . . 0.0 110.827 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 9.3 p -106.9 40.1 1.72 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.663 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -79.56 107.42 12.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.931 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.55 HD23 HH11 ' A' ' 282' ' ' ARG . 1.0 OUTLIER -76.34 101.67 5.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -68.66 124.2 22.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.912 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 82.3 mt -128.7 143.68 50.99 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.605 0.566 . . . . 0.0 111.275 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.83 170.93 9.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.359 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.3 p -89.34 113.25 25.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.485 0.66 . . . . 0.0 110.485 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 110.3 -6.49 30.33 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.999 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -76.88 161.2 28.61 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.662 0.268 . . . . 0.0 110.646 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 35.0 mm -104.02 111.17 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.296 0.57 . . . . 0.0 111.13 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.44 ' HA ' HG22 ' A' ' 279' ' ' VAL . 38.8 t -88.55 109.19 19.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.532 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -85.16 88.13 7.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.766 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.88 131.86 35.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.553 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -114.79 -22.5 9.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.817 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.71 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 26.4 mmm180 -125.25 123.69 40.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.245 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 51.4 mtt -112.46 102.73 10.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.226 0.536 . . . . 0.0 110.41 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -81.25 139.42 35.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.034 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.0 pt -67.92 -8.99 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.261 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -63.07 -38.65 92.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.529 176.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 121.47 -9.97 9.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.71 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -114.28 119.31 36.56 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.463 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 47.2 m0 -93.63 159.77 15.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.829 0.347 . . . . 0.0 111.073 -174.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 41.5 mt-10 -107.27 117.77 34.95 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.089 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -142.31 154.01 24.78 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 283' ' ' LYS . 37.7 tt0 -111.73 109.82 19.88 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.567 HG12 HD22 ' A' ' 280' ' ' ASN . 57.6 t -112.55 122.15 66.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.033 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.567 HD22 HG12 ' A' ' 279' ' ' VAL . 31.5 m-80 65.48 -70.21 0.1 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.049 0.843 . . . . 0.0 111.793 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -159.65 26.99 0.35 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.588 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.55 HH11 HD23 ' A' ' 256' ' ' LEU . 17.2 ttm180 -150.82 128.66 11.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.711 0.255 . . . . 0.0 110.444 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 278' ' ' GLU . 53.4 pttt -102.57 139.33 38.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.969 0.414 . . . . 0.0 110.338 174.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -167.38 -169.96 31.59 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.713 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 93.6 mt -100.13 146.3 26.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.934 0.397 . . . . 0.0 110.692 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.463 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 41.1 p90 -148.82 145.54 19.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.609 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 11.8 Cg_exo -72.37 149.22 50.27 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.628 2.218 . . . . 0.0 111.99 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -76.38 -17.68 59.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.837 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.0 t -82.08 3.82 25.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.727 0.775 . . . . 0.0 109.934 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.637 ' CE1' ' HB3' ' A' ' 246' ' ' ARG . 52.8 t60 -96.27 -24.17 16.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.557 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 242' ' ' ALA . 29.1 m -125.02 175.41 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.798 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -138.57 125.36 20.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.557 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.51 HD13 ' HB2' ' A' ' 240' ' ' ALA . 49.8 mm -73.95 102.7 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.601 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 21.4 p90 -100.19 167.61 10.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.433 -174.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -107.98 145.43 31.39 Favored Pre-proline 0 CA--C 1.504 -0.814 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.425 ' O ' ' HB3' ' A' ' 297' ' ' GLN . 77.3 Cg_exo -21.73 76.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 1 C-N-CA 125.877 4.385 . . . . 0.0 115.008 -168.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.425 ' HB3' ' O ' ' A' ' 296' ' ' PRO . 22.9 tm0? 83.09 -48.35 0.15 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.218 175.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.3 t30 64.08 95.85 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.156 0 O-C-N 123.864 0.728 . . . . 0.0 112.248 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.29 -16.37 17.49 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.567 2.178 . . . . 0.0 111.807 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 301' ' ' GLU . 27.1 t70 -72.34 120.02 17.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.557 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 300' ' ' ASP . 42.4 tt0 77.14 -9.97 1.43 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.122 0.889 . . . . 0.0 110.704 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -80.62 -36.8 32.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.644 178.065 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 tmm? . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m -87.7 88.15 7.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.849 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.1 t -74.32 -13.34 60.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.58 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -48.05 119.44 2.9 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.133 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -140.63 88.44 2.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.625 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -168.96 165.82 11.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.932 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -99.63 115.58 29.76 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -69.25 -11.46 60.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.001 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 p -101.65 -23.38 14.26 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.82 102.19 1.2 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.899 -0.501 . . . . 0.0 110.778 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 11' ' ' ARG . 11.4 mmt180 -58.51 -42.3 87.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.239 -176.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.7 m -74.6 10.75 1.23 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.916 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.22 -47.5 4.5 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.828 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -118.02 -21.54 8.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -173.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -85.6 115.15 23.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.862 0.363 . . . . 0.0 110.356 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.461 ' HG2' ' HB2' ' A' ' 37' ' ' LEU . 18.0 mmt -102.09 -1.92 30.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 -174.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.7 -114.32 3.01 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.057 -0.974 . . . . 0.0 114.19 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 14.4 Cg_exo -70.6 82.68 0.9 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.961 2.44 . . . . 0.0 113.676 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.931 HG12 ' H ' ' A' ' 20' ' ' SER . 16.4 t -121.02 -160.6 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.931 ' H ' HG12 ' A' ' 19' ' ' VAL . 50.8 p -165.84 172.96 11.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 119.751 1.16 . . . . 0.0 109.706 -168.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -52.73 -59.54 4.36 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.158 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -64.32 -52.63 57.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.081 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.6 -44.5 96.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.987 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.58 69.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 110.988 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.624 ' HG3' ' HA ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -65.63 -46.04 80.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.934 0.397 . . . . 0.0 110.471 175.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.404 ' N ' HE21 ' A' ' 25' ' ' GLN . 28.0 m -61.91 -27.45 68.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.177 -174.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.531 ' HG2' ' HA ' ' A' ' 106' ' ' PRO . 39.7 mtp180 -91.99 -14.26 29.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.952 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.027 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 67.1 mt -114.96 -17.11 11.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.574 -0.45 . . . . 0.0 112.082 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 11.65 -97.29 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.284 1.433 . . . . 0.0 114.565 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.29 33.22 1.82 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.516 ' HB3' ' CE ' ' A' ' 35' ' ' MET . 9.4 tt0 -73.41 -154.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.361 -0.92 . . . . 0.0 109.43 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.484 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -53.65 110.21 0.55 Allowed 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.117 179.13 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -73.04 104.33 4.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.72 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' A' ' 99' ' ' ILE . . . 141.93 -3.5 2.01 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.303 -171.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.667 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 38.4 mtm -83.36 144.91 29.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.95 157.26 45.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.585 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.461 ' HB2' ' HG2' ' A' ' 16' ' ' MET . 4.6 pp -150.11 137.47 19.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.575 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.8 t -105.77 128.71 59.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.244 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.877 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 34.9 ptt-85 -129.94 161.6 30.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.828 -175.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.97 133.1 46.91 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 48.9 m -64.48 131.93 48.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.148 0.499 . . . . 0.0 111.441 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.593 ' HB3' ' O2P' ' A' ' 207' ' ' PTR . 34.0 t -76.98 43.68 0.36 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.987 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 t -165.87 -37.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.033 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 41' ' ' SER . 65.4 m -134.77 121.6 14.99 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 14.5 Cg_exo -69.36 -19.0 38.63 Favored 'Trans proline' 0 CA--C 1.527 0.163 0 C-N-CA 122.723 2.282 . . . . 0.0 112.724 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.15 -52.82 3.31 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.792 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.604 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 5.7 m-20 -77.38 157.84 30.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.594 0.235 . . . . 0.0 110.987 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -123.73 177.42 5.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.932 0.396 . . . . 0.0 111.328 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.635 HG22 HD13 ' A' ' 62' ' ' ILE . 22.8 t -139.27 112.58 6.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.8 tp -83.05 100.07 10.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.952 0.406 . . . . 0.0 109.933 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 59' ' ' SER . 59.5 m -97.4 118.02 32.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.114 0.483 . . . . 0.0 111.202 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.737 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 41.1 t -111.18 157.28 12.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.377 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 1.027 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 88.1 p -123.65 135.04 53.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.302 0.955 . . . . 0.0 112.7 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.69 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 1.7 pm0 -146.05 176.24 9.86 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.513 175.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -25.51 80.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 -173.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.7 m 39.61 65.32 0.72 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.781 0.8 . . . . 0.0 110.121 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.69 ' HG3' ' HG2' ' A' ' 54' ' ' GLU . 28.5 tpt85 -168.11 52.58 0.06 Allowed 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.689 -149.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 52' ' ' VAL . 2.2 p -76.65 114.19 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.024 -1.047 . . . . 0.0 111.834 -170.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.774 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 53.5 m -73.62 90.4 1.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.002 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.475 ' CD2' HG22 ' A' ' 58' ' ' VAL . 58.6 m-70 -87.05 87.9 7.57 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.208 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.774 ' CE2' ' HB3' ' A' ' 59' ' ' SER . 71.2 m-85 -92.52 117.76 30.28 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.635 HD13 HG22 ' A' ' 49' ' ' VAL . 30.7 mm -69.95 139.69 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.792 0.33 . . . . 0.0 111.188 176.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 2.7 mp -125.08 118.2 52.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.288 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.604 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 7.8 m120 -73.42 128.89 36.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.943 0.402 . . . . 0.0 110.964 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.6 t -86.85 113.66 22.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.304 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.0 mt -93.72 135.62 24.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.757 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.2 -16.21 32.66 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.144 2.562 . . . . 0.0 113.053 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -85.5 15.57 4.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.0 110.537 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 68.6 22.91 7.41 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.18 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -113.38 162.95 15.47 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.544 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 91.9 m-85 -135.55 116.31 14.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.457 0.646 . . . . 0.0 112.169 -172.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.452 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 31.3 ttpt -98.17 98.83 10.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.587 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 12.0 tt -80.72 77.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 122.077 0.942 . . . . 0.0 111.469 -175.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.652 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 79.07 -30.17 2.1 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.737 172.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.65 ' OD1' ' HB2' ' A' ' 210' ' ' PRO . 0.1 OUTLIER -143.15 -77.01 0.24 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.256 0.55 . . . . 0.0 111.434 -169.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.434 ' H ' ' HG2' ' A' ' 76' ' ' GLN . 12.9 pt20 -95.05 148.53 22.25 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.437 -169.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -82.14 124.88 30.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.682 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.408 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 77.5 m-85 -112.4 144.4 41.91 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 169.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.02 -25.37 63.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.788 -170.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -164.8 168.5 17.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.238 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.458 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 8.4 mt -55.21 -55.81 35.4 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.0 Cg_exo -59.27 -8.98 7.45 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.548 2.165 . . . . 0.0 114.002 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.04 -33.51 18.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.792 0.329 . . . . 0.0 111.139 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -79.55 -27.41 41.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.286 0.565 . . . . 0.0 109.675 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 82' ' ' PRO . 79.4 mt -67.87 -33.94 75.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.616 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.66 ' HA ' ' HE3' ' A' ' 89' ' ' LYS . 11.1 pt-20 -90.9 -3.71 57.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.329 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -91.01 -37.06 13.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.377 0.608 . . . . 0.0 110.01 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -83.39 1.5 41.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.884 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.66 ' HE3' ' HA ' ' A' ' 86' ' ' GLU . 17.8 ptpt -86.36 14.97 5.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 91' ' ' HIS . 1.7 pp -165.33 -30.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.787 0.804 . . . . 0.0 108.845 -170.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.45 ' N ' HD12 ' A' ' 90' ' ' ILE . 9.0 t60 -65.73 -28.2 68.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.414 172.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.649 ' CD1' HG23 ' A' ' 97' ' ' THR . 70.3 m-85 64.0 110.81 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 124.569 1.168 . . . . 0.0 109.538 -168.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.503 HD11 HD21 ' A' ' 98' ' ' LEU . 20.0 mt -56.2 -42.34 77.04 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 1.034 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 0.1 OUTLIER -138.59 -80.67 0.33 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.378 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.768 HG21 ' HB3' ' A' ' 156' ' ' PRO . 11.0 m -136.94 -6.17 1.88 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.493 1.14 . . . . 0.0 108.546 166.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -106.53 138.69 42.25 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.931 172.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.649 HG23 ' CD1' ' A' ' 92' ' ' TYR . 11.9 p -98.55 -175.46 3.09 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.949 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.503 HD21 HD11 ' A' ' 93' ' ' LEU . 87.6 mt -88.77 88.76 7.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.621 HD13 ' HA3' ' A' ' 34' ' ' GLY . 3.6 mp -75.1 -54.96 13.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.725 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 35' ' ' MET . 15.2 pt-20 -154.07 161.34 29.5 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.725 -176.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.94 155.78 61.43 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.536 2.157 . . . . 0.0 112.341 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -77.95 168.22 29.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.527 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 21.8 Cg_endo -62.08 148.01 93.99 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.328 2.019 . . . . 0.0 112.116 175.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 81.4 mtp180 -94.21 11.9 28.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.113 0.483 . . . . 0.0 110.218 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 71.8 t80 -120.46 135.53 24.62 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.409 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.531 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 31.6 Cg_exo -60.18 108.24 0.49 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.602 2.201 . . . . 0.0 111.935 175.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.0 m -65.93 154.17 89.89 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.785 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 25.9 Cg_exo -63.16 136.13 54.44 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.545 2.163 . . . . 0.0 111.587 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 42.8 Cg_exo -56.97 -39.75 89.17 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.85 2.367 . . . . 0.0 112.112 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 84.9 mtp 70.03 -47.22 0.61 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.914 0.886 . . . . 0.0 112.16 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.05 -15.84 33.24 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.771 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.0 m -58.69 -34.69 71.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 110.904 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.17 139.53 36.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.876 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.5 t -140.25 27.61 2.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.135 0.493 . . . . 0.0 110.019 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.497 ' CB ' ' HA ' ' A' ' 119' ' ' PRO . . . -139.66 109.5 7.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.246 -175.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.624 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 58.6 Cg_endo -73.1 77.66 2.36 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.74 2.293 . . . . 0.0 112.06 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.692 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.4 t30 69.47 161.48 0.21 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.928 0.767 . . . . 0.0 109.08 -173.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.698 ' HA ' ' HG3' ' A' ' 126' ' ' GLU . 0.6 OUTLIER 42.4 81.23 0.25 Allowed Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 121.567 0.699 . . . . 0.0 110.874 -173.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.497 ' HA ' ' CB ' ' A' ' 115' ' ' ALA . 28.0 Cg_exo -60.46 142.27 97.6 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 123.069 2.513 . . . . 0.0 113.557 -169.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.46 ' HA ' ' HG2' ' A' ' 186' ' ' PRO . 3.2 p -79.76 -0.11 32.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.603 175.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 122' ' ' GLU . . . -132.89 102.22 5.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.971 173.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 45.6 mt-10 73.89 136.17 0.05 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.231 0.957 . . . . 0.0 111.473 -173.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.65 -44.85 92.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 66.6 t30 62.53 -106.92 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.289 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.85 HD12 HG21 ' A' ' 152' ' ' ILE . 1.3 mm? -119.11 89.46 3.13 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.722 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 3.9 mm-40 -159.82 -68.67 0.08 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.908 -173.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.62 110.86 23.17 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.328 1.061 . . . . 0.0 111.791 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.991 HG22 ' HB3' ' A' ' 180' ' ' LYS . 70.1 t -115.08 150.1 17.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.918 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.96 ' HG2' ' HG3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -124.58 153.24 42.45 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.72 165.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.975 HG22 HG12 ' A' ' 178' ' ' VAL . 21.7 p -112.81 141.18 46.91 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -99.13 -45.05 6.05 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.946 0.403 . . . . 0.0 111.368 -177.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 35.1 t80 -70.62 -38.63 73.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -163.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 13.5 t70 75.63 100.71 0.07 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -172.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 77.2 t80 -139.14 107.54 7.38 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.112 -175.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 27.1 Cg_endo -92.31 85.73 0.23 Allowed 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.783 2.322 . . . . 0.0 112.356 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.751 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -71.74 -11.88 73.75 Favored Glycine 0 CA--C 1.506 -0.499 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 172.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 138' ' ' ASP . 17.7 m120 51.46 59.53 4.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.603 -1.299 . . . . 0.0 113.312 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.471 ' H ' ' HD3' ' A' ' 143' ' ' PRO . 21.0 t70 81.36 163.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 155.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 88.79 -47.52 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.638 1.575 . . . . 0.0 111.704 169.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -160.35 6.08 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.324 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.751 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 39.0 m-20 -139.64 97.14 3.2 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.075 HD11 ' HB2' ' A' ' 165' ' ' ASN . 21.9 tp -70.13 128.02 91.86 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 120.832 0.348 . . . . 0.0 110.792 -174.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 56.4 Cg_endo -79.28 101.62 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.212 1.941 . . . . 0.0 111.736 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 15.1 p90 -109.94 157.09 19.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.366 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.549 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 35.4 mtmm -112.02 175.62 5.35 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.056 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.786 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -76.58 71.89 3.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.621 0.724 . . . . 0.0 110.443 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 131.21 30.39 0.57 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.244 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -95.32 155.13 16.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.84 HD13 ' HB3' ' A' ' 129' ' ' ARG . 47.1 mm -105.34 132.55 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.521 HD22 ' HA ' ' A' ' 165' ' ' ASN . 29.9 mt -122.03 156.97 32.38 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.722 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 39.0 t -114.47 127.87 71.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 171.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.85 HG21 HD12 ' A' ' 125' ' ' LEU . 23.4 mm -75.03 114.04 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.481 1.134 . . . . 0.0 110.491 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.885 HG21 HG13 ' A' ' 170' ' ' VAL . 2.5 tp -92.89 -24.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.37 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.034 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 6.8 tp10 -155.51 147.58 23.52 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 121.553 -0.717 . . . . 0.0 111.774 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -129.83 84.13 61.9 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.094 168.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.768 ' HB3' HG21 ' A' ' 95' ' ' THR . 57.2 Cg_endo -91.61 -58.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.092 1.861 . . . . 0.0 111.334 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.451 ' OE1' ' HG2' ' A' ' 156' ' ' PRO . 1.3 mp0 -82.63 175.02 10.49 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.476 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -112.86 -5.64 13.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.493 ' HA ' ' OE1' ' A' ' 159' ' ' GLN . 6.3 tp60 -104.44 -24.23 13.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.675 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.774 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 34.9 m95 -129.0 138.23 51.82 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.811 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.649 ' O ' HG13 ' A' ' 173' ' ' ILE . 36.1 m0 -123.74 137.63 54.66 Favored 'General case' 0 C--O 1.213 -0.818 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.868 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 12.9 m -88.34 123.66 33.13 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.794 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -130.76 155.11 47.22 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.361 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 26.9 ptt-85 -97.75 136.89 37.45 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 171.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.075 ' HB2' HD11 ' A' ' 142' ' ' LEU . 65.5 t30 -71.33 168.22 17.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.24 -173.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.519 ' HE3' ' H ' ' A' ' 149' ' ' ILE . 10.2 ttpp -66.01 -17.55 64.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' A' ' 211' ' ' GLN . 0.0 OUTLIER -74.4 -33.81 63.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.61 172.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 137.82 -36.37 1.94 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.215 -0.993 . . . . 0.0 115.4 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.565 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -90.8 160.82 15.56 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.492 1.146 . . . . 0.0 113.463 -163.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.885 HG13 HG21 ' A' ' 153' ' ' ILE . 78.1 t -89.65 136.27 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.363 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.91 156.42 28.15 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.565 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.774 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -72.85 136.15 45.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.649 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -135.44 147.92 63.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.771 0.319 . . . . 0.0 110.859 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 1.03 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 16.2 Cg_exo -70.71 139.13 36.29 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.943 2.429 . . . . 0.0 113.128 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.54 ' O ' HG22 ' A' ' 178' ' ' VAL . 21.9 t -78.31 -44.95 2.15 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.4 Cg_endo -66.92 0.51 3.64 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.888 1.725 . . . . 0.0 111.684 173.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 1.03 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 0.9 OUTLIER -100.92 -4.99 26.62 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.139 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.975 HG12 HG22 ' A' ' 130' ' ' THR . 26.8 m -123.5 170.89 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 122.543 1.163 . . . . 0.0 113.645 -171.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.96 ' HG3' ' HG2' ' A' ' 129' ' ' ARG . 8.2 pt-20 -133.6 48.57 2.36 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.677 -2.056 . . . . 0.0 110.232 -170.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.991 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -71.1 142.47 50.79 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 -166.105 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.531 HD13 ' NH1' ' A' ' 129' ' ' ARG . 9.7 tp -59.58 -37.22 77.91 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.756 HG13 ' HD2' ' A' ' 183' ' ' ARG . 2.3 p 66.8 -48.48 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.729 1.612 . . . . 0.0 115.015 160.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.756 ' HD2' HG13 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -124.74 -86.77 0.63 Allowed 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.213 -0.929 . . . . 0.0 110.271 178.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.4 t 49.59 -148.25 0.28 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.828 0.346 . . . . 0.0 110.843 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.512 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 12.8 m -155.56 151.94 23.37 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.46 ' HG2' ' HA ' ' A' ' 120' ' ' THR . 22.6 Cg_exo -66.19 114.33 2.98 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.392 2.061 . . . . 0.0 111.262 173.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 185' ' ' SER . 42.0 m80 -125.3 166.13 17.09 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -59.79 -48.06 87.89 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.956 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -91.12 -7.42 51.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 109.834 173.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.479 ' CA ' ' HB2' ' A' ' 187' ' ' HIS . 2.2 t-160 69.3 -51.9 0.6 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.262 1.025 . . . . 0.0 111.494 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 142.66 20.07 0.24 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.427 ' C ' HD22 ' A' ' 192' ' ' ASN . 0.3 OUTLIER -157.02 154.18 29.17 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.974 0.11 . . . . 0.0 110.794 -177.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -126.94 1.76 6.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.522 0.201 . . . . 0.0 110.964 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.446 ' CG ' ' H ' ' A' ' 195' ' ' SER . 63.9 t30 68.36 -169.59 0.19 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.883 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.446 ' H ' ' CG ' ' A' ' 194' ' ' ASN . 7.4 m -54.18 -45.22 72.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.879 0.371 . . . . 0.0 111.032 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -177.66 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.425 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 36.5 m 66.42 -174.39 0.19 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.782 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -111.11 119.06 37.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.067 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 71.23 -159.72 53.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.097 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.925 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 4.1 mp -110.99 -58.81 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 176.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.925 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 5.2 Cg_exo -78.34 129.45 9.49 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.339 2.026 . . . . 0.0 111.016 173.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 0.3 OUTLIER -96.75 126.57 42.5 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.255 0.55 . . . . 0.0 111.094 -177.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 7.5 Cg_exo -73.86 67.31 4.87 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.631 2.221 . . . . 0.0 110.601 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.22 115.43 3.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.881 -174.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.45 ' O ' ' HD1' ' A' ' 207' ' ' PTR . 19.1 p80 -99.03 -17.13 18.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.693 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 207' ' ' PTR . . . 59.46 -148.82 0.46 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.681 175.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.593 ' O2P' ' HB3' ' A' ' 42' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -113.57 18.63 17.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.89 -176.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.49 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 10.1 tt0 -58.97 134.08 87.26 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.541 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.652 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 32.1 Cg_exo -58.04 -103.39 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.113 2.542 . . . . 0.0 113.703 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' A' ' 167' ' ' ASP . 76.7 mt-30 -78.42 -21.45 49.2 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.469 -0.77 . . . . 0.0 111.194 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 211' ' ' GLN . 92.1 m 73.88 -49.53 0.68 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.565 0.541 . . . . 0.0 110.624 -176.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.2 m 64.54 -103.64 0.11 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.007 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 57.8 m -164.75 135.99 3.32 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -176.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 3.0 Cg_exo -77.92 -164.48 0.27 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.05 2.5 . . . . 0.0 111.275 171.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 57.2 mt -135.31 110.5 10.64 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.824 0.345 . . . . 0.0 111.478 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.76 -51.51 0.66 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.58 2.187 . . . . 0.0 111.22 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 55.67 -99.57 0.1 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.501 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.1 t -94.25 -58.27 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.536 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.9 m 65.91 19.38 11.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.017 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 112.02 -160.53 13.13 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.039 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.463 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 3.1 p -81.57 123.52 80.75 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.93 0.395 . . . . 0.0 110.786 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 3.0 Cg_exo -76.37 45.15 1.51 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.308 2.672 . . . . 0.0 112.383 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -81.98 57.38 4.96 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.571 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -165.49 129.91 2.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -69.63 -31.37 69.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.201 0.524 . . . . 0.0 110.715 177.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.712 HG12 HG22 ' A' ' 228' ' ' THR . 5.7 tt -117.73 111.13 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.595 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.712 HG22 HG12 ' A' ' 227' ' ' ILE . 6.4 t 39.72 87.66 0.11 Allowed Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 124.371 1.069 . . . . 0.0 113.462 177.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.46 105.32 0.41 Allowed 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 122.636 2.224 . . . . 0.0 111.216 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 48.4 tp -115.39 95.77 43.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.033 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -89.82 -1.33 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.799 2.333 . . . . 0.0 111.447 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 18.2 t -90.96 100.67 13.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.98 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 34.2 p -105.86 -41.71 5.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.164 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.425 ' O ' ' HD2' ' A' ' 237' ' ' PRO . 6.8 tp60 56.37 79.83 0.17 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.899 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -75.23 97.83 3.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.044 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -174.4 -58.9 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.788 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 234' ' ' GLN . 45.4 Cg_exo -58.49 169.59 3.02 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.722 2.282 . . . . 0.0 112.594 174.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 1.003 HG13 HG13 ' A' ' 266' ' ' VAL . 0.2 OUTLIER -87.18 144.67 8.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.107 -176.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -114.23 126.26 54.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.527 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.647 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -133.56 129.23 36.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.077 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -94.81 129.4 41.78 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.619 -0.432 . . . . 0.0 109.979 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.653 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -74.71 115.56 14.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.288 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.844 HD12 ' HG2' ' A' ' 292' ' ' LYS . 0.2 OUTLIER -102.14 -16.06 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.268 0.556 . . . . 0.0 110.387 179.01 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.29 120.45 23.2 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -58.65 155.58 12.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.175 0.988 . . . . 0.0 112.812 -168.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 25.6 tpt180 -131.0 97.71 4.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.637 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 30.4 m -104.32 155.56 37.09 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.256 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.99 -171.07 0.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.064 2.509 . . . . 0.0 111.583 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.447 ' N ' ' HB3' ' A' ' 252' ' ' ASP . 53.5 t -163.65 166.86 21.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.63 -26.19 61.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.878 0.37 . . . . 0.0 111.22 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -125.08 33.99 5.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.228 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.447 ' HB3' ' N ' ' A' ' 249' ' ' CYS . 0.5 OUTLIER -72.27 135.43 46.0 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.225 0.536 . . . . 0.0 110.16 178.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -100.18 85.99 3.13 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.491 174.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 201' ' ' PRO . 41.0 p 59.87 53.84 4.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.365 -1.288 . . . . 0.0 111.213 174.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -86.85 142.23 28.21 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.452 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.443 ' HB2' ' HA3' ' A' ' 284' ' ' GLY . 1.3 tt -98.72 115.84 29.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.99 115.38 7.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.2 0.524 . . . . 0.0 110.929 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.55 HD21 HG21 ' A' ' 279' ' ' VAL . 72.8 mt -129.7 153.6 48.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.912 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -133.93 172.13 13.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 170.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 2.1 p -67.94 114.11 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.575 0.703 . . . . 0.0 111.071 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 121.44 -0.16 11.29 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.628 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -96.55 142.06 29.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.904 0.383 . . . . 0.0 110.939 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.7 mm -94.76 114.36 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.741 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.495 ' HA ' HG22 ' A' ' 279' ' ' VAL . 20.1 t -94.96 115.81 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.064 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -98.3 98.84 10.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 1.003 HG13 HG13 ' A' ' 238' ' ' VAL . 7.2 p -88.74 132.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.107 0.48 . . . . 0.0 110.878 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 2.5 p -108.57 -30.99 7.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.561 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 40.7 ttm180 -127.68 112.29 14.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.131 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . 0.559 ' HE3' HG11 ' A' ' 238' ' ' VAL . 31.8 mtt -92.86 106.16 18.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.36 0.6 . . . . 0.0 111.216 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 92.9 m-20 -80.08 117.93 21.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.637 176.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.39 -17.26 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.715 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.416 ' OD1' ' HB3' ' A' ' 270' ' ' ASN . 3.4 p-10 -75.27 -7.58 54.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 134.41 -66.46 0.57 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.806 -1.188 . . . . 0.0 113.628 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp0 -81.72 120.58 25.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.841 0.32 . . . . 0.0 110.571 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.472 ' CZ3' ' HE2' ' A' ' 269' ' ' MET . 28.8 m0 -93.76 164.54 13.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.659 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 46.7 mt-10 -102.93 102.97 13.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.358 175.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -126.38 168.21 18.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 282' ' ' ARG . 0.9 OUTLIER -122.64 144.05 49.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.451 . . . . 0.0 109.844 178.045 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.55 HG21 HD21 ' A' ' 258' ' ' LEU . 95.6 t -135.42 100.76 2.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.204 174.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 68.66 28.82 5.58 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.6 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 101.11 14.02 32.1 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.988 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 20.2 mtp-105 -125.71 120.02 29.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.89 0.345 . . . . 0.0 110.823 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 283' ' ' LYS . 30.4 mtpt -96.07 141.83 28.99 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 256' ' ' LEU . . . -165.6 164.17 37.13 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.262 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.727 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 85.5 mt -86.85 110.57 20.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.464 0.649 . . . . 0.0 110.87 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 24.2 p90 -115.94 128.53 25.91 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.174 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 10.7 Cg_exo -72.98 143.78 37.04 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.646 2.231 . . . . 0.0 111.076 173.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -66.01 -7.63 18.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.16 -11.96 60.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.041 0.448 . . . . 0.0 111.462 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -103.63 -11.94 17.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 111.029 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.417 HG21 ' HE2' ' A' ' 286' ' ' PHE . 27.3 m -127.9 163.76 30.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.031 -175.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.844 ' HG2' HD12 ' A' ' 243' ' ' ILE . 32.5 mmmt -124.9 122.3 36.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.569 176.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.647 HD13 ' HB2' ' A' ' 240' ' ' ALA . 45.1 mm -71.06 102.84 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.89 170.9 8.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.248 0.547 . . . . 0.0 111.698 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' A' ' 298' ' ' ASN . 6.7 p-10 -97.56 127.55 37.41 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.755 175.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 295' ' ' ASP . 24.3 Cg_exo -64.64 -48.4 4.26 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.289 1.993 . . . . 0.0 111.652 176.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -149.3 -5.93 0.37 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.203 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 295' ' ' ASP . 79.6 m-20 -62.26 122.97 76.42 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.392 -174.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.4 -42.53 40.54 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 121.686 1.591 . . . . 0.0 109.749 170.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.6 t70 65.43 -69.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.874 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 58.63 51.31 7.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.493 0.663 . . . . 0.0 110.985 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -75.83 -27.42 57.88 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 167.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 C--O 1.248 1.01 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.313 174.168 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 p -129.29 103.01 6.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.109 0.48 . . . . 0.0 112.137 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.0 t -92.95 -38.25 11.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.698 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 54.49 84.25 0.07 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.837 0.711 . . . . 0.0 111.312 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -109.15 20.03 18.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.696 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 50.7 p90 -91.34 156.27 17.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.08 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.36 135.27 36.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 m -110.84 10.9 22.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.414 ' OG ' ' HD2' ' A' ' 229' ' ' PRO . 8.2 t -121.52 -37.82 2.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.511 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -72.25 116.34 12.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.219 0.533 . . . . 0.0 110.715 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HG2' ' H ' ' A' ' 11' ' ' ARG . 16.5 mmt180 -56.87 -30.17 63.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.995 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.5 t -80.88 -2.71 48.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -175.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.76 -46.9 6.4 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.815 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 31.7 p-90 -120.4 -21.38 6.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -172.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -78.94 118.27 20.79 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.944 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.692 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 7.8 tpp -97.38 -4.48 38.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.201 0.524 . . . . 0.0 110.455 -172.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.66 -115.81 3.72 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.951 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.43 103.49 1.75 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.455 2.103 . . . . 0.0 112.338 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.861 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 80.8 t -132.66 -83.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.255 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.691 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 66.9 m 87.73 152.38 0.06 Allowed 'General case' 0 C--N 1.348 0.543 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -59.06 -35.67 73.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -164.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -25.94 66.97 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.019 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' HG22 ' A' ' 26' ' ' THR . 23.7 tp10 -87.29 -45.24 10.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.7 -44.24 77.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.838 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -76.92 -32.74 57.59 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 23' ' ' GLU . 6.9 t -72.54 -22.07 61.07 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.591 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -88.42 -24.64 22.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.399 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.813 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 95.2 mt -107.86 20.35 18.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.532 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -66.58 90.99 0.17 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.527 0.68 . . . . 0.0 109.217 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.41 -70.1 2.68 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.576 ' HG3' ' H ' ' A' ' 32' ' ' ARG . 4.6 tp-100 48.74 -167.39 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.795 0.838 . . . . 0.0 110.894 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.576 ' H ' ' HG3' ' A' ' 31' ' ' GLN . 74.1 mtm-85 -80.04 112.09 17.01 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 170.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.478 ' NE2' ' HA ' ' A' ' 55' ' ' ASN . 32.8 m170 -57.88 117.75 4.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.115 0.483 . . . . 0.0 110.053 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.05 14.36 7.22 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -168.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -95.82 145.95 24.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.557 ' HB2' HG22 ' A' ' 52' ' ' VAL . 31.1 p90 -150.34 166.97 28.42 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.45 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.1 pp -156.45 135.57 12.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.511 173.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.52 HG22 HD13 ' A' ' 50' ' ' LEU . 51.4 t -101.74 111.28 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.861 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 13.4 ptt-85 -110.7 173.95 6.09 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.868 0.366 . . . . 0.0 110.791 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -82.22 137.37 34.92 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.6 p -59.44 -28.58 67.09 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.582 -174.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.2 t 61.29 19.98 10.63 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.942 0.877 . . . . 0.0 108.787 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.5 m -116.41 -49.86 2.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.045 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 44.7 t -145.83 124.45 6.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.614 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.511 ' HD2' HG23 ' A' ' 219' ' ' VAL . 28.0 Cg_exo -62.62 87.11 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.411 2.074 . . . . 0.0 111.344 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.43 -11.27 0.13 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.774 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -126.34 145.88 50.26 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.36 -0.494 . . . . 0.0 109.763 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.43 164.42 13.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.363 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.515 HG11 ' HE2' ' A' ' 207' ' ' PTR . 38.6 t -129.29 99.42 4.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.213 0.53 . . . . 0.0 110.619 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.52 HD13 HG22 ' A' ' 38' ' ' VAL . 41.9 tp -78.67 99.53 6.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.894 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.4 m -96.3 121.51 38.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.135 0.493 . . . . 0.0 109.992 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.863 HG21 HD13 ' A' ' 93' ' ' LEU . 84.2 t -116.5 134.3 60.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.955 -177.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.813 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 95.5 p -105.78 134.54 48.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.563 0.697 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.515 ' CD ' ' HB3' ' A' ' 94' ' ' ASP . 7.2 mt-10 -144.56 175.81 9.87 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.478 ' HA ' ' NE2' ' A' ' 33' ' ' HIS . 0.3 OUTLIER -38.45 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -173.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m 50.57 59.79 4.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.444 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 55' ' ' ASN . 21.0 mmm180 -160.33 49.46 0.27 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.177 -157.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 36.4 t -80.96 90.9 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.967 0.889 . . . . 0.0 109.351 -175.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 51.1 m -80.4 120.81 24.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.172 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.56 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 88.9 m-70 -97.81 99.02 10.33 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.366 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.647 ' CE2' HD22 ' A' ' 93' ' ' LEU . 64.0 m-85 -103.17 116.03 31.71 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.445 ' H ' ' HB3' ' A' ' 209' ' ' GLN . 63.6 mt -81.69 139.27 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.524 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.8 mp -127.05 118.04 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 122.877 0.471 . . . . 0.0 110.422 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -84.35 139.41 32.29 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.464 -0.148 . . . . 0.0 110.822 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.9 t -84.52 107.77 16.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -83.84 149.66 57.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.007 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.71 -23.9 73.49 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.129 2.553 . . . . 0.0 112.911 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -79.66 6.13 11.49 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.013 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 66.11 36.07 5.87 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.676 0.751 . . . . 0.0 110.234 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 92.7 mtt180 -113.97 172.99 6.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.604 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.524 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 60.0 m-85 -135.92 115.72 13.04 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.12 0.486 . . . . 0.0 111.291 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -98.39 108.4 21.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.745 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.548 HD13 ' HE2' ' A' ' 88' ' ' TYR . 9.5 tt -97.8 78.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.842 0.829 . . . . 0.0 110.043 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.622 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 69.74 95.62 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.283 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.684 ' HB2' ' HB2' ' A' ' 211' ' ' GLN . 10.6 t0 71.81 -56.96 0.63 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.033 0.533 . . . . 0.0 111.736 173.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -78.61 140.53 38.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.738 0.304 . . . . 0.0 110.665 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -112.7 128.64 56.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.627 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.485 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 74.6 m-85 -116.77 164.6 14.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.273 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' ARG . 3.6 m-20 -72.97 -29.66 63.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -176.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.623 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -164.06 167.06 20.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.974 -178.291 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.659 HD23 HD21 ' A' ' 84' ' ' LEU . 10.6 mt -53.58 -51.79 72.96 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.623 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 32.2 Cg_exo -59.96 -11.92 17.01 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.956 1.77 . . . . 0.0 112.955 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . . . -91.73 -32.21 15.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.111 -175.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.659 HD21 HD23 ' A' ' 81' ' ' LEU . 3.9 pp -77.46 -31.95 54.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.67 -38.3 90.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.354 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.645 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 13.9 pt-20 -78.25 -18.17 55.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.196 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -79.07 -39.01 34.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.191 0.519 . . . . 0.0 109.961 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.548 ' HE2' HD13 ' A' ' 73' ' ' ILE . 32.4 m-85 -77.85 -15.95 58.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.599 -177.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 22.0 pttm -67.48 -20.27 65.44 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.316 -0.254 . . . . 0.0 110.316 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.441 HG23 ' HG3' ' A' ' 89' ' ' LYS . 18.9 pt -121.91 22.48 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.991 -0.443 . . . . 0.0 111.529 174.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 22.3 t-160 -113.56 -32.47 6.18 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.078 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.584 ' HA ' HG22 ' A' ' 97' ' ' THR . 76.1 m-85 73.32 107.75 0.07 Allowed 'General case' 0 C--O 1.22 -0.452 0 O-C-N 124.072 0.858 . . . . 0.0 109.966 -172.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.863 HD13 HG21 ' A' ' 52' ' ' VAL . 12.2 mt -79.87 -12.2 59.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.76 0.79 . . . . 0.0 109.173 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.515 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 24.9 t70 -149.04 -71.83 0.19 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.238 160.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.607 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.7 t -149.22 2.33 0.56 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.433 HG22 ' CD ' ' A' ' 54' ' ' GLU . 1.9 t -132.08 -12.54 3.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.409 -0.807 . . . . 0.0 112.795 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 92' ' ' TYR . 8.4 p 74.08 -166.06 0.1 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.301 1.041 . . . . 0.0 111.696 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.414 HD22 ' CD1' ' A' ' 36' ' ' PHE . 63.5 mt -81.72 108.56 15.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.311 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.7 mm -98.45 -48.57 12.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.556 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 9.8 pt-20 -167.56 158.14 9.67 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.916 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 1.5 Cg_endo -83.28 162.82 15.15 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.801 2.334 . . . . 0.0 112.726 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.18 154.08 63.26 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.096 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.725 ' HB2' ' HG3' ' A' ' 106' ' ' PRO . 22.8 Cg_exo -64.71 139.31 62.6 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.629 2.22 . . . . 0.0 112.119 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.692 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 68.1 mtm180 -77.03 -42.56 38.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.049 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -139.61 80.67 21.39 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.562 0.696 . . . . 0.0 110.155 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.725 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 1.4 Cg_endo -82.81 -19.54 5.94 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.671 2.248 . . . . 0.0 112.254 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.8 t 56.18 86.67 0.16 Allowed Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.865 -172.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 33.6 Cg_exo -56.86 126.59 22.72 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.746 2.298 . . . . 0.0 112.193 -176.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 8.5 Cg_exo -74.54 41.35 0.69 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.383 2.722 . . . . 0.0 112.316 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 92.4 mmm 56.51 45.96 21.49 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.178 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.84 -72.97 0.43 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.049 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m -70.08 96.84 1.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.959 0.409 . . . . 0.0 111.257 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.607 HG23 ' HD2' ' A' ' 116' ' ' PRO . 11.1 m -100.82 -22.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.794 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.3 m 58.76 24.83 12.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.345 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.807 ' H ' ' HD2' ' A' ' 116' ' ' PRO . . . -108.42 -50.4 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.807 ' HD2' ' H ' ' A' ' 115' ' ' ALA . 10.2 Cg_endo -53.84 133.68 55.61 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 122.651 2.234 . . . . 0.0 113.21 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -70.06 -46.31 65.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.448 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 91.1 mt -151.77 124.78 4.13 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.239 -174.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 118' ' ' LEU . 4.3 Cg_endo -87.04 26.91 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.388 2.725 . . . . 0.0 111.21 174.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.6 t -69.71 145.14 52.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.563 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.59 26.87 6.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.276 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.39 -57.39 8.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.795 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -81.71 132.1 35.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.332 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -97.37 -74.57 0.57 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.552 174.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.661 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? 61.89 101.49 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.912 0.758 . . . . 0.0 111.586 176.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 47.9 tp10 -161.14 -78.72 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.092 -175.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.89 116.49 32.04 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.9 0.857 . . . . 0.0 112.039 -171.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.826 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 86.6 t -134.36 125.89 48.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.573 -173.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.672 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 7.2 ptp85 -111.49 135.01 52.65 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 118.127 -1.429 . . . . 0.0 110.817 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.413 HG22 HG12 ' A' ' 178' ' ' VAL . 7.4 p -97.48 140.66 31.59 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.094 0.473 . . . . 0.0 112.081 -174.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.054 HD21 ' HB2' ' A' ' 179' ' ' GLU . 0.1 OUTLIER -117.44 -38.33 3.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.448 -171.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 29.9 t80 -64.32 -32.56 74.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.886 -170.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 12.5 t70 72.44 105.84 0.07 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.737 0.648 . . . . 0.0 110.04 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 71.3 t80 -144.08 108.72 5.0 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.095 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 66.1 Cg_endo -87.92 99.6 0.44 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.325 2.017 . . . . 0.0 112.661 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -81.65 -3.71 90.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.99 175.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.428 HD22 ' HA ' ' A' ' 137' ' ' ASN . 11.1 m120 57.92 24.66 11.2 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.133 0.573 . . . . 0.0 111.777 -176.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.704 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 2.0 p30 50.45 -176.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.038 1.335 . . . . 0.0 114.457 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 71.89 9.17 6.14 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.432 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -175.38 -46.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.069 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.411 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 17.5 m-20 -137.07 124.26 21.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.828 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.936 HD11 ' HB2' ' A' ' 165' ' ' ASN . 46.7 tp -69.86 132.28 88.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-O 120.693 0.282 . . . . 0.0 110.662 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 6.4 Cg_endo -85.25 89.23 0.83 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.374 2.049 . . . . 0.0 110.636 176.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 14.2 p90 -99.5 158.02 16.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.472 -177.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.58 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 82.9 mttt -112.15 -172.44 2.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.469 -172.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.22 18.46 1.4 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.742 -175.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.94 36.06 0.08 OUTLIER Glycine 0 C--N 1.33 0.218 0 C-N-CA 119.813 -1.185 . . . . 0.0 113.916 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.58 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 21.9 mm-40 -98.84 157.41 16.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.4 tp -103.52 138.83 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.563 HD22 ' HA ' ' A' ' 165' ' ' ASN . 26.5 mt -120.61 155.7 33.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 19.2 t -119.74 130.89 73.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 163' ' ' ALA . 39.6 mm -74.3 96.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.557 HG23 ' HG2' ' A' ' 154' ' ' GLU . 16.3 tt -79.02 -31.2 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.77 -175.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.557 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -146.9 141.0 26.09 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.934 171.172 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.623 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 1.6 ttpm? -119.06 87.13 33.54 Favored Pre-proline 0 C--N 1.328 -0.367 0 O-C-N 121.331 -0.856 . . . . 0.0 110.877 173.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.607 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 11.4 Cg_exo -72.92 -58.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.584 2.19 . . . . 0.0 112.35 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -107.83 177.44 4.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.23 -20.18 14.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.757 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -85.47 -34.76 21.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.15 0.5 . . . . 0.0 110.122 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -128.3 129.73 46.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.206 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -108.97 156.17 20.02 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 22.7 t -111.58 101.96 10.33 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.351 0.596 . . . . 0.0 110.056 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -113.71 163.19 15.34 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.169 -176.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' A' ' 210' ' ' PRO . 29.8 ptt-85 -108.23 140.55 41.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.328 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.936 ' HB2' HD11 ' A' ' 142' ' ' LEU . 57.1 t30 -70.56 178.61 2.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.587 -175.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -58.67 -32.02 68.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 211' ' ' GLN . 17.9 m-20 -60.6 -42.14 96.15 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.105 170.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.883 ' HA3' ' H ' ' A' ' 211' ' ' GLN . . . 115.86 -9.33 18.81 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.689 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.704 ' HD3' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -76.73 152.69 35.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.541 0.671 . . . . 0.0 110.811 -176.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.464 ' CG2' HD13 ' A' ' 153' ' ' ILE . 26.2 t -99.73 143.59 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.287 0.565 . . . . 0.0 112.413 -168.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -171.98 162.98 35.29 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.757 169.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.421 ' HE3' ' HG2' ' A' ' 156' ' ' PRO . 22.9 mtp -81.7 147.31 29.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.3 0.55 . . . . 0.0 110.822 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.8 pp -141.32 145.83 39.9 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.386 -174.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 7.8 Cg_exo -73.29 133.17 18.88 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.185 2.59 . . . . 0.0 112.699 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.62 ' O ' HG22 ' A' ' 178' ' ' VAL . 58.0 t -61.7 -47.3 92.69 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 23.3 Cg_endo -61.4 -13.44 29.0 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.169 1.913 . . . . 0.0 113.294 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -86.35 -4.21 59.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.888 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 175' ' ' VAL . 4.1 m -110.61 159.04 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -166.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 1.054 ' HB2' HD21 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -117.75 45.19 2.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 111.493 -2.594 . . . . 0.0 109.242 -178.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.826 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -74.27 137.77 43.18 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 120.963 -1.085 . . . . 0.0 109.398 -168.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.548 HD13 HH22 ' A' ' 129' ' ' ARG . 27.2 tp -60.54 -53.15 60.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.715 -164.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.64 115.91 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.683 0.754 . . . . 0.0 111.565 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -155.11 86.58 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.6 m -74.6 163.27 27.92 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.411 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 1.6 p -78.2 168.18 29.55 Favored Pre-proline 0 C--N 1.318 -0.761 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.77 90.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.852 2.368 . . . . 0.0 114.211 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 1.9 p80 174.22 -176.11 0.08 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.723 1.209 . . . . 0.0 108.566 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -84.3 -162.54 34.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.403 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -74.58 -13.11 60.62 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.146 0.179 . . . . 0.0 110.863 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 14.5 p80 43.04 98.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.742 1.217 . . . . 0.0 113.917 175.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -133.39 156.98 22.51 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.206 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.433 ' N ' HD22 ' A' ' 192' ' ' ASN . 0.9 OUTLIER -62.97 -44.64 95.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.812 0.339 . . . . 0.0 110.389 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -137.56 88.23 2.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 110.149 176.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -93.92 98.87 11.34 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 12.3 p -148.88 -74.28 0.18 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.75 -176.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.41 45.66 1.26 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.544 0.688 . . . . 0.0 109.497 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 24.8 m -103.86 94.66 5.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.399 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.79 169.46 12.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.188 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 91.73 52.12 2.35 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -171.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.697 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 63.7 mt -95.51 -53.6 0.23 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.234 -0.483 . . . . 0.0 111.496 -176.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.697 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 50.6 Cg_exo -55.24 139.26 80.89 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.319 2.012 . . . . 0.0 112.319 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.35 126.46 86.44 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.721 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.61 0.9 9.55 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.476 2.117 . . . . 0.0 111.628 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -159.26 -145.83 0.14 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.467 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 68.84 24.84 6.36 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.469 0.652 . . . . 0.0 110.37 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.1 -60.86 2.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.687 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.56 ' HD2' ' HB3' ' A' ' 60' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -107.07 12.24 28.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.097 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.445 ' HB3' ' H ' ' A' ' 62' ' ' ILE . 28.9 pt20 -57.45 136.06 81.86 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.357 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.622 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 26.4 Cg_exo -63.36 145.85 93.01 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.82 1.68 . . . . 0.0 110.167 170.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.883 ' H ' ' HA3' ' A' ' 168' ' ' GLY . 7.4 tp-100 70.62 168.35 0.31 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.974 0.416 . . . . 0.0 109.952 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 4.7 t -114.83 106.7 14.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.588 0.708 . . . . 0.0 110.37 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 27.0 p -87.66 167.09 14.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.004 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 8.7 t -128.95 125.36 22.85 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.894 0.378 . . . . 0.0 110.359 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 8.2 Cg_exo -71.64 110.23 2.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.741 2.294 . . . . 0.0 111.339 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.76 HD23 ' H ' ' A' ' 216' ' ' LEU . 2.4 pt? -86.24 142.9 36.13 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.064 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 7.9 Cg_exo -73.62 -4.15 14.94 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.864 2.376 . . . . 0.0 112.447 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -98.19 115.29 28.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.427 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.511 HG23 ' HD2' ' A' ' 45' ' ' PRO . 3.4 p -71.06 103.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.575 0.702 . . . . 0.0 110.959 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 55.4 m -148.26 127.01 12.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.704 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 146.53 39.14 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.29 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 48.7 m -75.52 118.7 72.8 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 15.0 Cg_exo -68.98 -32.46 21.84 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.935 2.423 . . . . 0.0 112.653 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 79.37 -78.86 1.69 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.746 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -148.64 145.58 27.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.3 116.21 27.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.33 . . . . 0.0 110.605 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.76 127.97 31.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.857 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.4 t -83.02 124.61 76.43 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.537 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.414 ' HD2' ' OG ' ' A' ' 9' ' ' SER . 88.9 Cg_endo -87.04 -161.39 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.67 2.247 . . . . 0.0 112.238 178.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.493 ' HG ' ' H ' ' A' ' 232' ' ' SER . 2.5 pt? -142.44 174.03 4.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 230' ' ' LEU . 50.6 Cg_exo -55.61 -24.19 43.98 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.6 2.2 . . . . 0.0 113.167 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.493 ' H ' ' HG ' ' A' ' 230' ' ' LEU . 8.4 m -79.1 141.25 37.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.342 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 35.3 p -69.86 162.5 27.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.242 0.544 . . . . 0.0 111.606 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -77.4 80.91 3.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.145 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -134.54 2.01 3.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.844 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -130.63 110.03 0.97 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.588 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.66 163.92 18.64 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.313 2.675 . . . . 0.0 111.409 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.704 HG12 HD11 ' A' ' 293' ' ' ILE . 45.8 t -94.9 131.14 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -115.14 135.12 54.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.851 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -122.29 142.56 50.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.2 174.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.741 ' HA ' ' O ' ' A' ' 262' ' ' ASP . 56.3 mttm -84.52 119.6 25.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.088 0.47 . . . . 0.0 110.233 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 1.091 ' HB1' ' HA ' ' A' ' 259' ' ' GLU . . . -89.39 114.91 26.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.217 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -130.7 -10.26 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -165.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.667 ' HB3' ' OE2' ' A' ' 259' ' ' GLU . 7.7 tt0 -113.57 -89.05 0.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.059 -0.657 . . . . 0.0 112.752 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.445 ' N ' ' HB3' ' A' ' 259' ' ' GLU . 85.8 tttt -173.81 118.74 0.27 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -173.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.954 ' HG2' ' HG3' ' A' ' 259' ' ' GLU . 19.8 mmm180 -131.34 98.74 4.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.61 167.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.68 132.75 21.75 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.106 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 73.3 Cg_endo -81.97 107.69 1.75 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.587 2.192 . . . . 0.0 112.631 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 6.0 t -63.86 161.68 15.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.37 -9.45 3.57 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -67.66 -33.98 76.02 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 46.07 86.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.853 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -121.07 72.83 1.0 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.755 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.9 m 60.18 36.82 20.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.057 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -94.37 118.43 31.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.507 . . . . 0.0 111.183 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 tt -91.17 126.28 36.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.367 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.467 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -81.82 110.66 17.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.188 0.518 . . . . 0.0 110.931 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.59 HD22 HG22 ' A' ' 264' ' ' VAL . 1.3 pp -164.86 -141.82 0.05 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.115 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 1.091 ' HA ' ' HB1' ' A' ' 242' ' ' ALA . 0.0 OUTLIER 80.82 1.18 1.78 Allowed 'General case' 0 C--O 1.222 -0.367 0 O-C-N 123.899 0.75 . . . . 0.0 111.566 177.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.32 90.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -178.8 -83.35 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.823 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.741 ' O ' ' HA ' ' A' ' 241' ' ' LYS . 29.2 t0 179.04 -79.06 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 121.056 0.455 . . . . 0.0 111.68 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 36.9 mm -100.65 119.81 49.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -170.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.59 HG22 HD22 ' A' ' 258' ' ' LEU . 99.2 t -107.11 121.79 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.472 168.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -94.09 116.25 28.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.163 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 275' ' ' TRP . 2.7 p -111.68 117.27 54.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.306 0.574 . . . . 0.0 110.692 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.2 p -107.57 -15.44 14.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.753 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.499 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 38.2 mmt-85 -124.01 100.38 6.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.043 0.449 . . . . 0.0 111.211 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 46.8 mtt -101.85 140.31 36.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.332 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.632 ' OD1' ' HB3' ' A' ' 272' ' ' ASN . 9.0 p30 -135.49 176.66 8.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.461 -176.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 271' ' ' ILE . 13.7 pt -87.1 4.58 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -172.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.632 ' HB3' ' OD1' ' A' ' 270' ' ' ASN . 7.4 t-20 -74.77 -44.59 48.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.26 0.552 . . . . 0.0 109.578 175.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.73 -39.21 2.55 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 44.3 mt-30 -79.35 116.54 19.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.578 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 13.6 m0 -93.04 155.85 17.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.977 -173.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 40.2 mt-10 -101.26 107.62 19.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.994 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.99 148.74 17.89 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 282' ' ' ARG . 0.0 OUTLIER -110.09 109.63 20.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.372 0.606 . . . . 0.0 110.33 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.487 HG21 HG13 ' A' ' 264' ' ' VAL . 21.6 t -127.6 -79.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.755 -176.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -82.26 67.04 8.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.268 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.07 16.92 60.49 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.85 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 40.5 ttm180 -155.32 146.63 22.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.139 0.469 . . . . 0.0 111.095 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 278' ' ' GLU . 39.4 tttm -102.48 113.98 27.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.118 170.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -146.67 178.21 24.48 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.074 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 96.5 mt -84.86 140.43 31.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 0.0 111.681 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.412 ' HE2' HG21 ' A' ' 291' ' ' VAL . 34.8 p90 -142.86 129.5 10.69 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.22 170.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.28 137.08 25.31 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.58 2.187 . . . . 0.0 112.536 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -71.51 -10.74 60.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.844 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.7 m -84.65 -2.57 57.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.451 0.643 . . . . 0.0 110.411 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.455 ' HB3' ' OE2' ' A' ' 259' ' ' GLU . 3.1 m-70 -101.12 -54.65 2.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.395 174.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.412 HG21 ' HE2' ' A' ' 286' ' ' PHE . 35.0 m -85.03 159.61 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.798 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.42 107.16 16.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.229 0.538 . . . . 0.0 110.3 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' A' ' 240' ' ' ALA . 5.0 tp -70.1 131.66 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.472 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 18.3 p90 -134.63 160.64 37.48 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.624 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -99.31 111.6 61.5 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.178 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.07 39.35 0.83 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.144 2.563 . . . . 0.0 111.603 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 58.85 52.01 6.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.227 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 0.5 OUTLIER -83.3 145.59 48.97 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.444 176.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 75.8 Cg_endo -94.52 24.88 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.053 2.502 . . . . 0.0 113.617 -175.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -131.3 177.13 7.71 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.419 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 302' ' ' ASN . 7.3 pt-20 59.18 -55.05 0.06 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.033 1.733 . . . . 0.0 114.208 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.47 ' N ' ' HG3' ' A' ' 301' ' ' GLU . 8.6 t30 -78.42 133.32 37.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.193 0.521 . . . . 0.0 111.581 -174.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.236 175.397 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.745 0.307 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.8 m -77.59 141.99 39.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.712 0.291 . . . . 0.0 110.652 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.546 ' HB3' HD12 ' A' ' 99' ' ' ILE . 15.0 m -76.96 -39.74 49.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.034 0.445 . . . . 0.0 109.92 178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.55 94.61 1.32 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.993 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.657 ' NE ' ' HA ' ' A' ' 5' ' ' ARG . 5.0 mmp_? -113.71 15.14 18.84 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -86.59 171.13 11.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.456 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 24.4 t70 -82.52 -133.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.444 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 9.6 t -173.71 43.19 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.406 ' H ' ' H ' ' A' ' 10' ' ' ASP . 9.9 t -164.51 -11.02 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.968 174.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.456 ' OD1' ' HB3' ' A' ' 7' ' ' ASP . 7.9 p-10 -75.44 81.0 2.49 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.809 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 48.0 mtt-85 -70.5 -16.85 62.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.479 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 t -75.77 -7.96 55.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.659 174.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.3 -47.08 3.59 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.8 p-90 -107.63 -20.46 13.22 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -172.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 22.8 t80 -81.92 122.71 28.11 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 122.027 -0.421 . . . . 0.0 110.672 -174.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.694 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 24.7 mmt -103.36 -13.55 16.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.479 -176.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.05 -113.42 2.18 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.658 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.6 84.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.199 2.599 . . . . 0.0 113.327 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.523 HG21 ' HB3' ' A' ' 16' ' ' MET . 84.1 t -137.03 172.8 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 19' ' ' VAL . 43.8 p -145.41 172.28 13.42 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -168.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.645 ' HD2' ' O2P' ' A' ' 207' ' ' PTR . 37.4 ttt85 -63.02 -37.15 86.04 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.873 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -56.74 11.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.688 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -61.55 -50.25 73.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.25 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.73 -37.23 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.353 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -64.33 -43.94 93.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.128 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.2 t -78.92 -21.27 47.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.871 0.367 . . . . 0.0 111.409 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.415 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 51.1 mtp180 -82.43 -10.43 59.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.892 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.611 HD22 ' HB2' ' A' ' 53' ' ' SER . 26.9 mt -126.97 12.06 7.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.097 0.475 . . . . 0.0 111.018 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.49 98.25 2.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.377 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 117' ' ' ASN . . . 78.69 -1.92 70.52 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.344 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.793 ' HA ' ' H ' ' A' ' 117' ' ' ASN . 4.7 mm100 -60.37 168.15 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.853 0.461 . . . . 0.0 111.689 -175.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.471 ' HD3' ' HB1' ' A' ' 115' ' ' ALA . 20.8 ttp180 -47.63 118.98 2.49 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.551 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.601 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 36.3 m170 -63.6 117.16 6.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.337 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.8 -13.55 6.1 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.997 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.691 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 64.3 mtt -69.19 153.58 43.46 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.511 0.196 . . . . 0.0 110.518 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.418 ' CB ' HG22 ' A' ' 52' ' ' VAL . 28.7 p90 -155.62 159.23 39.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.694 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.6 pp -153.52 140.41 19.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.001 0.429 . . . . 0.0 110.851 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.3 t -110.39 116.47 52.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.861 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.499 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 25.4 ptt-85 -117.77 176.05 5.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.97 -177.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.41 134.46 40.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.133 0.492 . . . . 0.0 110.645 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 t -87.36 107.97 18.77 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.5 t -73.96 8.09 2.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.563 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.5 p -94.6 -25.56 16.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.803 0.335 . . . . 0.0 110.659 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 76.7 m -152.36 115.23 2.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.879 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 28.0 Cg_endo -62.45 103.05 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.799 2.333 . . . . 0.0 112.436 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.54 -24.73 4.1 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.659 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -88.37 165.87 14.66 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.422 ' CD2' HD11 ' A' ' 81' ' ' LEU . 58.0 m-85 -134.52 -177.87 4.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.758 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.556 HG22 HG12 ' A' ' 62' ' ' ILE . 6.2 t -143.96 113.85 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.62 177.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.452 ' HB2' HD11 ' A' ' 63' ' ' ILE . 62.8 tp -80.83 97.09 7.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.1 m -94.05 118.12 31.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.329 0.585 . . . . 0.0 109.666 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 58.7 t -110.68 142.66 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.639 -174.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 40.7 t -91.68 103.89 16.41 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.601 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 7.0 tp10 -167.11 166.43 15.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.898 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.574 HD22 ' CG ' ' A' ' 94' ' ' ASP . 0.7 OUTLIER 76.82 -64.5 0.33 Allowed 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 123.58 1.657 . . . . 0.0 108.546 -168.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.42 ' HB3' ' OE1' ' A' ' 122' ' ' GLU . 75.5 m -160.86 -27.64 0.06 Allowed 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 111.314 -2.675 . . . . 0.0 106.133 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.82 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.363 0.0 OUTLIER -163.08 -48.34 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.084 1 N-CA-C 123.333 4.568 . . . . 0.0 123.333 179.624 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.82 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -147.98 107.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 121.785 2.084 . . . . 0.0 114.096 -166.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.522 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -98.03 112.6 24.49 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 171.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -101.53 86.48 2.97 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -169.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.759 ' CE1' HD11 ' A' ' 153' ' ' ILE . 55.5 m-85 -102.01 110.27 22.2 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 118.626 0.648 . . . . 0.0 112.248 -174.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.556 HG12 HG22 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -75.38 139.49 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.295 0.569 . . . . 0.0 112.39 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.616 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.3 mp -110.33 108.8 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.587 175.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -82.82 141.93 31.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.177 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.7 t -85.75 118.46 25.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.104 0.478 . . . . 0.0 110.352 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.512 HD21 ' HE2' ' A' ' 72' ' ' LYS . 95.3 mt -95.15 142.54 24.74 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.058 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 19.9 Cg_exo -66.54 -8.66 21.61 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.864 2.376 . . . . 0.0 112.386 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.48 10.12 5.1 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.658 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 67.32 25.9 8.64 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.087 -179.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 71.0 mtt180 -115.2 -176.1 2.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.199 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.516 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 61.5 m-85 -138.85 124.69 19.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.718 0.294 . . . . 0.0 110.934 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.801 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 25.7 ttpt -113.62 109.65 18.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 111.466 -177.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.616 ' HB ' HG13 ' A' ' 63' ' ' ILE . 14.0 tt -95.91 81.29 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.723 0.773 . . . . 0.0 110.052 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.56 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 71.76 82.59 0.27 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.79 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.778 ' HB2' ' CB ' ' A' ' 211' ' ' GLN . 20.2 t0 71.46 -47.09 0.65 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.963 0.905 . . . . 0.0 111.48 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -74.75 101.34 4.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.889 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.801 ' HB3' ' HD3' ' A' ' 72' ' ' LYS . 8.2 pt-20 -95.55 118.26 31.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.662 0.744 . . . . 0.0 110.934 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.583 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 76.3 m-85 -100.22 174.71 6.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.83 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 31.9 t70 -73.06 -25.14 60.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.317 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.649 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 1.7 p80 -172.01 172.17 4.79 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.662 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.6 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.5 mt -51.4 -54.41 39.05 Favored Pre-proline 0 N--CA 1.472 0.633 0 O-C-N 123.301 0.376 . . . . 0.0 111.95 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.649 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 59.6 Cg_endo -70.4 16.99 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.284 1.99 . . . . 0.0 113.292 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.5 -35.4 6.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 174.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.8 pp -76.88 -31.74 56.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.175 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.68 -30.35 71.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.619 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 89' ' ' LYS . 3.6 tt0 -91.36 -12.61 34.41 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.104 0.478 . . . . 0.0 111.107 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.403 ' CE2' ' ND1' ' A' ' 91' ' ' HIS . 72.4 t80 -86.01 -30.62 22.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.98 0.895 . . . . 0.0 108.957 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.791 ' CD1' HD23 ' A' ' 93' ' ' LEU . 40.7 m-85 -82.71 2.38 33.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.252 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.552 ' HD2' ' HG3' ' A' ' 86' ' ' GLU . 98.3 mttt -76.39 -3.96 39.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.875 173.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.34 -2.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.032 0.444 . . . . 0.0 110.726 177.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.403 ' ND1' ' CE2' ' A' ' 87' ' ' PHE . 5.0 t60 -81.36 -31.83 33.2 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.383 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 96' ' ' THR . 75.7 m-85 62.77 67.0 0.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.125 -173.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.791 HD23 ' CD1' ' A' ' 88' ' ' TYR . 2.0 pp -71.62 117.58 13.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.79 174.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.82 ' CA ' ' HB3' ' A' ' 154' ' ' GLU . 7.6 t70 97.81 -48.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.973 1.709 . . . . 0.0 108.278 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.704 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 6.0 t 167.23 22.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.615 -1.629 . . . . 0.0 106.652 168.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.535 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 2.2 t -149.2 150.64 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.445 -173.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.7 p -91.44 157.55 17.0 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.51 99.66 0.22 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.883 0.373 . . . . 0.0 110.18 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.546 HD12 ' HB3' ' A' ' 3' ' ' SER . 32.4 mm -80.83 -57.81 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.765 -176.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.691 ' O ' ' HA ' ' A' ' 35' ' ' MET . 29.8 tt0 -165.16 136.93 3.32 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 -174.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.31 155.68 44.99 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.652 2.235 . . . . 0.0 112.956 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.75 157.84 85.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.697 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.31 122.5 11.91 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.34 2.027 . . . . 0.0 111.823 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -69.53 -31.83 70.29 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.591 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -108.62 108.74 61.14 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 174.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.48 -21.11 22.95 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.352 2.034 . . . . 0.0 112.459 -177.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.7 m 69.25 149.59 0.12 Allowed Pre-proline 0 CA--C 1.534 0.349 0 O-C-N 123.837 0.71 . . . . 0.0 110.647 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.709 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 51.5 Cg_exo -53.3 -56.0 3.12 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.435 2.09 . . . . 0.0 113.318 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.709 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 88.8 Cg_endo -93.24 149.65 2.47 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.028 1.818 . . . . 0.0 112.723 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 87.9 mtp -106.1 119.71 39.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.239 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.73 -52.85 3.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.25 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.932 ' HA ' ' HG2' ' A' ' 116' ' ' PRO . 71.7 p 50.76 -153.2 0.17 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.315 0.646 . . . . 0.0 111.871 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 113' ' ' VAL . 11.5 t 64.12 30.67 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.806 0.813 . . . . 0.0 110.508 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.6 m -151.87 -88.9 0.06 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.432 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.693 ' H ' ' HD2' ' A' ' 116' ' ' PRO . . . -101.65 -47.07 0.19 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.33 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.932 ' HG2' ' HA ' ' A' ' 112' ' ' SER . 33.3 Cg_endo -67.01 121.75 8.98 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.454 1.436 . . . . 0.0 112.304 174.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.793 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 56.2 t30 74.86 108.0 0.07 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.0 0.812 . . . . 0.0 111.89 175.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.754 ' HB2' ' HD3' ' A' ' 119' ' ' PRO . 2.3 mm? -119.59 -60.72 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.301 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.754 ' HD3' ' HB2' ' A' ' 118' ' ' LEU . 19.4 Cg_exo -65.66 141.69 67.41 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.602 2.201 . . . . 0.0 112.884 -173.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.5 m -103.31 114.27 28.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.876 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 71.87 128.84 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.95 0.781 . . . . 0.0 111.734 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.42 ' OE1' ' HB3' ' A' ' 56' ' ' SER . 3.6 mm-40 -83.17 143.29 30.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.868 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.39 -98.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 171.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.533 ' ND2' ' HG3' ' A' ' 183' ' ' ARG . 34.0 m-80 -154.91 -95.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.962 HD12 HG21 ' A' ' 152' ' ' ILE . 3.8 mm? 48.7 90.77 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.006 0.816 . . . . 0.0 111.625 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 11.1 tp10 -165.1 -61.4 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.13 -173.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -113.49 112.34 23.43 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.271 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 1.034 HG22 ' HG3' ' A' ' 180' ' ' LYS . 2.4 t -117.19 153.39 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.669 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.4 ptp180 -129.15 148.35 51.08 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 117.947 -1.501 . . . . 0.0 108.059 157.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.529 HG22 HG12 ' A' ' 178' ' ' VAL . 43.6 p -100.58 133.54 44.87 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.695 0.759 . . . . 0.0 110.874 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.498 HD21 ' HG2' ' A' ' 179' ' ' GLU . 8.0 mt -107.56 2.25 23.91 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.555 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.48 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 16.3 t80 -102.41 -45.02 5.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.039 -173.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.622 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.9 t70 78.74 103.74 0.07 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.166 0.508 . . . . 0.0 110.679 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 68.9 t80 -132.93 91.08 29.99 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 98.3 Cg_endo -87.45 70.33 3.43 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.219 1.946 . . . . 0.0 112.763 -175.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.62 -33.88 82.22 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.737 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.469 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 26.5 m-80 61.97 66.49 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.133 -0.533 . . . . 0.0 111.825 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -143.66 172.63 12.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.271 176.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.46 -9.55 49.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.051 0.929 . . . . 0.0 108.795 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' A' ' 172' ' ' MET . 28.5 mt-10 -106.63 -15.58 14.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.807 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -137.89 106.82 5.97 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.331 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.973 HD11 ' HB2' ' A' ' 165' ' ' ASN . 20.1 tp -75.53 126.91 86.93 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.767 0.317 . . . . 0.0 110.989 -175.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 73.9 Cg_endo -78.12 97.18 1.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.845 1.697 . . . . 0.0 111.687 173.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.617 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 15.3 p90 -105.95 156.71 18.1 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.622 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 62.5 mttp -113.07 173.34 6.44 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -173.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.529 ' N ' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -71.72 57.88 0.3 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.209 178.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 134.41 38.25 0.21 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.784 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.667 ' CD ' ' HG ' ' A' ' 150' ' ' LEU . 1.7 pp20? -91.04 169.06 11.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.17 127.66 73.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.803 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 78.1 mt -117.21 156.33 27.89 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -173.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 89.4 t -120.45 122.13 67.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 171.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.074 HD13 ' HB2' ' A' ' 163' ' ' ALA . 46.4 mm -78.0 78.82 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 122.793 1.282 . . . . 0.0 108.325 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.759 HD11 ' CE1' ' A' ' 61' ' ' TYR . 5.4 tt -70.89 -28.91 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 112.577 -2.101 . . . . 0.0 109.478 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.82 ' HB3' ' CA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -134.89 143.14 46.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.165 176.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.523 ' H ' HD21 ' A' ' 55' ' ' ASN . 67.0 tttt -141.61 83.76 12.87 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.704 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 21.8 Cg_exo -68.14 -49.69 0.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.432 2.088 . . . . 0.0 112.199 174.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -119.35 175.73 5.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.658 -171.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -101.96 -4.93 25.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.276 0.56 . . . . 0.0 110.164 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -93.64 -36.55 12.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.516 0.674 . . . . 0.0 109.853 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.47 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 41.0 m95 -129.8 145.04 51.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.925 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.758 ' O ' HG13 ' A' ' 173' ' ' ILE . 48.5 m0 -124.31 138.88 54.34 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 122.761 0.424 . . . . 0.0 110.184 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.678 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 2.9 m -98.55 98.36 9.54 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -174.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.074 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -114.77 155.83 25.99 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -170.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.922 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 31.7 ptt-85 -94.86 128.11 41.38 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.858 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.973 ' HB2' HD11 ' A' ' 142' ' ' LEU . 65.8 t30 -59.21 178.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.106 -1.406 . . . . 0.0 112.21 -169.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -51.01 -28.34 9.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.182 164.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -70.57 -44.33 67.63 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.492 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.587 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 113.87 9.58 15.99 Favored Glycine 0 C--O 1.223 -0.533 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.966 -169.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.922 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 16.4 ttm-85 -76.09 136.54 39.87 Favored 'General case' 0 C--O 1.212 -0.892 0 C-N-CA 123.409 0.683 . . . . 0.0 112.319 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.953 HG23 ' HA ' ' A' ' 210' ' ' PRO . 56.2 t -84.07 120.2 34.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.15 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.402 ' CA ' ' HB2' ' A' ' 142' ' ' LEU . . . -156.12 155.89 26.65 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.476 -0.649 . . . . 0.0 111.476 172.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.657 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -76.02 138.8 41.12 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 117.354 0.577 . . . . 0.0 111.277 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.758 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -139.16 141.48 29.77 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.187 -176.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 21.4 Cg_exo -65.58 131.77 28.86 Favored 'Trans proline' 0 CA--C 1.527 0.146 0 C-N-CA 122.464 2.109 . . . . 0.0 112.936 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.519 ' O ' HG22 ' A' ' 178' ' ' VAL . 66.6 t -61.42 -44.54 92.86 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.438 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 22.7 Cg_exo -64.61 2.17 1.38 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.188 1.925 . . . . 0.0 113.162 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.7 m-30 -100.99 -11.65 19.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.231 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.73 ' HB ' HG13 ' A' ' 128' ' ' VAL . 3.6 m -105.63 -177.03 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -164.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.669 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.8 tp10 -151.82 51.59 0.81 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 111.947 -2.388 . . . . 0.0 112.332 -155.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 1.034 ' HG3' HG22 ' A' ' 128' ' ' VAL . 1.8 mppt? -68.22 135.83 52.62 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 120.056 -1.652 . . . . 0.0 109.96 -161.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.9 tp -84.11 -74.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.872 -165.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 19.0 m -88.04 25.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.23 -175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.926 ' HD3' ' HE3' ' A' ' 180' ' ' LYS . 28.0 ttt180 -103.12 118.18 36.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.026 0.441 . . . . 0.0 111.525 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 68.7 p -116.21 144.35 44.3 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 9.0 p -57.52 145.11 70.12 Favored Pre-proline 0 C--O 1.238 0.453 0 CA-C-O 120.453 0.168 . . . . 0.0 110.725 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 25.7 Cg_exo -61.67 100.3 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.682 2.255 . . . . 0.0 112.305 -177.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -96.51 177.71 5.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.111 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -83.34 88.24 1.5 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.396 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp 59.85 89.23 0.07 Allowed 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.03 0.532 . . . . 0.0 111.29 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -97.79 -46.79 5.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.831 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 94.44 77.86 1.39 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.142 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -122.2 18.22 10.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.189 0.519 . . . . 0.0 109.761 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.411 ' HA ' ' NE ' ' A' ' 193' ' ' ARG . 4.5 mmp_? -88.52 101.42 13.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.013 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 58.8 t30 69.21 99.0 0.06 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.536 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.7 p -111.32 160.99 16.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.922 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -91.62 -174.01 3.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.79 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 22.9 t 72.47 -68.81 0.21 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.248 0.619 . . . . 0.0 110.367 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -87.35 92.77 9.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.162 0.506 . . . . 0.0 110.749 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.73 135.54 6.38 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.553 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 62.6 mt -116.96 109.32 43.02 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.776 0.322 . . . . 0.0 110.339 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.49 124.62 11.81 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.747 2.298 . . . . 0.0 112.316 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 70.31 112.64 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.249 0 O-C-N 123.935 0.772 . . . . 0.0 111.245 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 1.227 ' HG2' ' O1P' ' A' ' 207' ' ' PTR . 37.9 Cg_endo -67.15 120.14 7.2 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.781 2.32 . . . . 0.0 111.998 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.38 173.57 3.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.576 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -70.34 2.53 3.73 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.503 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.405 ' HA ' HG23 ' A' ' 212' ' ' THR . . . -59.52 -65.01 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.27 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 1.227 ' O1P' ' HG2' ' A' ' 203' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -102.05 51.6 0.82 Allowed 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.322 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.405 ' CG ' ' HB ' ' A' ' 62' ' ' ILE . 50.2 mt-30 -65.7 151.25 95.09 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.427 174.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.953 ' HA ' HG23 ' A' ' 170' ' ' VAL . 44.1 Cg_exo -60.76 -9.05 10.6 Favored 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 122.952 2.435 . . . . 0.0 111.848 170.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.778 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 20.7 tp60 -164.52 100.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.67 173.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 206' ' ' ALA . 88.4 m -53.09 125.5 17.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.187 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 35.5 p -88.61 160.49 17.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.786 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 216' ' ' LEU . 14.2 m -63.48 118.64 46.15 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.792 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 1.2 Cg_endo -83.74 7.53 5.14 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.103 2.535 . . . . 0.0 112.795 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.474 ' H ' HG22 ' A' ' 214' ' ' THR . 4.1 mm? -75.86 -50.1 3.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.762 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 216' ' ' LEU . 73.3 Cg_endo -75.67 37.29 0.51 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.16 1.907 . . . . 0.0 112.939 176.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -140.21 158.93 43.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.012 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.08 -22.38 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.399 0.619 . . . . 0.0 110.589 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.8 t -115.89 103.88 11.07 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.807 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -138.07 -178.51 16.18 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.84 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.717 ' HB2' ' HD3' ' A' ' 223' ' ' PRO . 4.6 m -61.76 -54.53 50.51 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.717 ' HD3' ' HB2' ' A' ' 222' ' ' SER . 3.0 Cg_exo -76.67 -32.51 3.55 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.947 1.765 . . . . 0.0 112.122 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 100.6 73.45 1.04 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.48 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -76.61 99.63 5.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.028 0.442 . . . . 0.0 110.993 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -107.21 -40.9 5.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.526 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 9.3 tp -153.93 147.48 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.028 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.2 t -104.04 132.08 21.35 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.791 0.329 . . . . 0.0 110.414 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.35 102.38 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.515 2.144 . . . . 0.0 112.455 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.608 ' H ' ' HD2' ' A' ' 231' ' ' PRO . 57.6 tp -95.83 -45.28 0.26 Allowed Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.889 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.608 ' HD2' ' H ' ' A' ' 230' ' ' LEU . 34.9 Cg_endo -66.1 135.31 40.03 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.509 1.473 . . . . 0.0 112.941 177.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 57.2 m 67.47 18.37 10.06 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.638 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 53.5 p -123.43 143.94 49.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.083 0.468 . . . . 0.0 111.404 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 234' ' ' GLN . 0.8 OUTLIER -89.62 -13.13 37.8 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 170.155 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 2.3 p30 46.09 -81.3 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.082 1.353 . . . . 0.0 113.478 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -58.43 125.86 40.78 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.122 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.8 155.63 69.14 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.619 2.212 . . . . 0.0 112.313 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.505 ' HB ' HG13 ' A' ' 266' ' ' VAL . 17.8 t -73.07 130.25 35.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.784 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.668 ' HB2' ' HG2' ' A' ' 296' ' ' PRO . 79.4 m-85 -105.44 129.0 53.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.55 137.19 53.99 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.421 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 44.6 tptt -81.19 118.58 22.69 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -72.84 108.92 6.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 28.1 pt -102.36 12.88 6.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.016 0.436 . . . . 0.0 111.099 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -157.83 149.0 21.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.07 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.645 ' HG2' ' HG3' ' A' ' 259' ' ' GLU . 26.4 mtpp -68.27 101.56 1.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.064 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -89.73 83.52 6.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.04 142.46 28.79 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.313 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.03 154.46 33.14 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.518 2.146 . . . . 0.0 112.023 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.45 ' HB2' ' CB ' ' A' ' 252' ' ' ASP . 1.3 m -108.07 165.14 11.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.625 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.04 -30.22 71.17 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -105.34 15.91 26.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.972 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.45 ' CB ' ' HB2' ' A' ' 249' ' ' CYS . 15.1 t0 -135.83 81.07 1.86 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 175.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -91.96 -15.69 27.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.617 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 47.9 p -85.27 5.78 28.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.306 0.574 . . . . 0.0 109.705 175.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.06 119.71 25.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.513 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 246' ' ' ARG . 1.2 tt -78.4 134.67 37.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.425 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -82.54 110.27 17.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.075 0.464 . . . . 0.0 110.961 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 77.5 mt -122.09 172.76 8.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.383 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.645 ' HG3' ' HG2' ' A' ' 245' ' ' LYS . 31.6 tt0 -147.7 149.86 33.24 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 2.4 p -60.35 122.14 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 110.61 8.19 24.96 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.195 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -105.02 149.92 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.4 mm -103.9 109.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.358 0.599 . . . . 0.0 110.453 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 43.7 t -89.38 109.65 20.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.855 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 265' ' ' LYS . 13.2 ptmm? -88.48 99.88 12.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.417 0.627 . . . . 0.0 109.944 174.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.505 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.4 p -89.2 119.55 36.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.349 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 m -96.84 -18.9 19.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.947 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.561 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 48.3 ttt180 -132.18 122.35 25.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.762 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 29.9 mtt -118.53 141.05 48.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.286 0.565 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -125.25 178.95 5.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.004 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.0 tp -96.61 -5.81 9.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.47 . . . . 0.0 111.329 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -94.14 14.81 18.87 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.94 -0.475 . . . . 0.0 111.99 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 98.59 -61.53 0.85 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.705 -0.759 . . . . 0.0 114.218 169.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 2.2 mp0 -77.15 110.82 12.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.899 0.349 . . . . 0.0 110.724 -176.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.54 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 11.2 m0 -93.34 168.05 11.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.741 -176.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 27.7 tt0 -108.9 108.22 18.91 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.31 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -124.16 154.99 17.9 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.127 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -108.32 108.48 19.5 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 15.5 t -130.53 -91.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.102 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -88.27 77.96 8.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.746 -170.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 67.67 -0.74 9.0 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.227 175.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 282' ' ' ARG . 46.4 mtp180 -147.92 153.61 39.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -174.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 55.0 pttt -120.06 134.57 55.21 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -161.26 -170.16 25.53 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.263 -175.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 71.4 mt -94.22 117.5 30.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.351 0.595 . . . . 0.0 110.966 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -115.62 138.26 23.72 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.525 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.9 133.43 12.51 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.734 2.289 . . . . 0.0 111.169 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -61.05 -14.21 22.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.816 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.5 p -75.56 -14.33 60.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.799 0.333 . . . . 0.0 111.578 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -98.83 -9.03 24.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.854 0.359 . . . . 0.0 110.675 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.4 m -128.58 179.11 4.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.343 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.437 ' HB2' ' NZ ' ' A' ' 292' ' ' LYS . 2.4 ttmp? -141.11 131.24 24.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.53 174.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 293' ' ' ILE . 28.5 mm -79.91 124.42 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.523 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.506 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 1.1 p90 -149.49 -174.72 4.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.886 -174.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -96.98 101.08 8.61 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.668 ' HG2' ' HB2' ' A' ' 239' ' ' PHE . 1.8 Cg_endo -82.36 -51.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.705 2.27 . . . . 0.0 112.071 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -102.04 82.76 2.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -72.1 127.44 90.45 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.614 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -89.08 -5.5 5.78 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.872 2.381 . . . . 0.0 109.593 161.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.04 -38.62 70.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 113.864 -1.516 . . . . 0.0 112.293 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.68 13.17 18.58 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.03 0.443 . . . . 0.0 111.115 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -101.48 -31.12 11.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.532 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.441 -178.977 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.767 0.318 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 99' ' ' ILE . 28.6 t -168.77 171.15 8.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -64.44 84.39 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.721 0.638 . . . . 0.0 111.874 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 68.59 38.77 2.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.727 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 5' ' ' ARG . 4.5 ptp180 -79.79 -2.03 41.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.019 0.438 . . . . 0.0 110.764 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -74.76 161.58 29.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.047 0.451 . . . . 0.0 111.017 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -98.65 117.32 32.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.78 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -83.69 1.81 40.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.39 -173.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.4 m -105.11 -31.23 9.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.774 0.321 . . . . 0.0 111.137 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.86 106.09 3.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.077 0.465 . . . . 0.0 110.727 -176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -58.76 -38.24 78.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.141 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.9 m -74.35 -0.94 18.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.693 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.47 -34.86 13.93 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.408 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -130.42 -24.66 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -173.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -79.16 123.56 27.5 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.026 -0.421 . . . . 0.0 110.692 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.496 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.1 mmt -109.06 -4.62 16.48 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.208 -175.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.82 -113.74 2.67 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.67 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.19 106.54 1.39 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.606 2.204 . . . . 0.0 112.635 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.75 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 79.7 t -137.81 -78.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.532 -177.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.837 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 8.1 t 89.79 156.99 0.05 OUTLIER 'General case' 0 C--N 1.349 0.557 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.738 ' CG ' ' O3P' ' A' ' 207' ' ' PTR . 9.3 ptm85 -62.58 -31.73 72.6 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.589 -169.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -55.04 -45.92 75.28 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.389 0.431 . . . . 0.0 111.153 175.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -84.03 -44.64 13.92 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.126 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.46 -34.9 51.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.286 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.576 ' HA ' HG21 ' A' ' 58' ' ' VAL . 7.9 tt0 -67.36 -47.23 71.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -76.85 -11.5 59.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -173.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -98.79 -14.98 19.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.651 0.263 . . . . 0.0 111.134 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 58.8 mt -127.29 23.78 6.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.254 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -84.7 63.48 7.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.264 0.554 . . . . 0.0 112.027 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 117' ' ' ASN . . . 87.54 4.38 80.11 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.865 -0.683 . . . . 0.0 114.164 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.46 -51.23 70.74 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 117.187 0.494 . . . . 0.0 111.478 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 35' ' ' MET . 30.8 ttm180 -142.1 148.15 37.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -92.87 112.36 24.29 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.76 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . 116.99 -7.61 16.84 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.213 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.802 ' HG3' ' HB3' ' A' ' 53' ' ' SER . 6.5 ptp -79.69 134.24 36.4 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.036 177.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.502 ' H ' ' HA ' ' A' ' 101' ' ' PRO . 47.1 p90 -142.32 167.79 21.26 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.861 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.551 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.2 pp -155.76 137.21 14.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.185 0.517 . . . . 0.0 110.933 175.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.1 t -102.26 124.05 55.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.837 ' HD2' ' H ' ' A' ' 20' ' ' SER . 14.7 ptt-85 -123.52 167.17 14.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.019 -173.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.56 115.95 18.61 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 28.5 t -63.75 122.49 16.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.494 -173.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 p -74.69 -29.69 61.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.331 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.956 HG23 ' O1P' ' A' ' 207' ' ' PTR . 6.4 p -85.63 -18.57 32.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.061 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' SER . 34.4 m -137.25 85.63 21.5 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.98 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.95 107.12 0.42 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.896 2.397 . . . . 0.0 112.518 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.04 -6.84 23.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.206 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -111.04 179.28 4.09 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -126.83 158.92 35.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.921 0.391 . . . . 0.0 111.301 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 62' ' ' ILE . 46.1 t -131.21 113.04 22.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.338 174.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.1 tp -85.15 100.45 11.74 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.884 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 59' ' ' SER . 73.5 m -96.12 132.46 41.49 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.731 174.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.598 HG21 HD13 ' A' ' 93' ' ' LEU . 95.1 t -127.76 137.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.912 -172.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.802 ' HB3' ' HG3' ' A' ' 35' ' ' MET . 29.5 t -93.57 97.57 10.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.48 0.657 . . . . 0.0 109.484 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -135.97 136.26 40.23 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.332 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 55.5 16.98 2.03 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.24 0.337 . . . . 0.0 111.361 -169.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.56 ' HB2' ' OG1' ' A' ' 120' ' ' THR . 20.2 m 69.21 25.78 5.61 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.371 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 1.9 ppt_? -124.93 144.24 50.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 25' ' ' GLN . 14.6 t -85.51 96.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.27 0.557 . . . . 0.0 110.962 -173.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 51' ' ' SER . 2.4 m -67.7 113.17 5.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.993 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.856 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 96.3 m-70 -101.65 88.41 3.4 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.241 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.694 ' CE2' HD22 ' A' ' 93' ' ' LEU . 40.6 m-85 -102.77 114.71 29.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.49 0.186 . . . . 0.0 111.015 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.664 HG12 HG22 ' A' ' 49' ' ' VAL . 51.7 mt -81.28 126.52 39.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.818 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.4 mp -106.55 119.0 55.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 170.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' A' ' 72' ' ' LYS . 35.3 p-10 -105.26 151.69 23.81 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.249 -174.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t -86.56 91.96 8.73 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.677 -176.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.529 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 97.4 mt -63.82 128.62 93.08 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -48.03 -64.4 0.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.118 2.546 . . . . 0.0 114.629 -172.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -113.92 34.12 4.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.8 -164.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.529 ' HG3' ' HB3' ' A' ' 66' ' ' LEU . 8.7 ptt180 -154.28 -85.02 0.06 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.524 ' HG2' HD12 ' A' ' 66' ' ' LEU . 4.3 ptm180 -156.36 -171.44 3.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -161.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.545 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 56.9 m-85 -107.41 121.96 45.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.641 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 17.9 ttmm -109.17 114.0 27.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.735 0.302 . . . . 0.0 110.703 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.818 ' HB ' HG13 ' A' ' 63' ' ' ILE . 8.9 tt -93.43 77.61 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 110.002 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.547 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 61.93 96.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.165 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t70 72.89 -61.46 0.5 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.378 0.271 . . . . 0.0 111.168 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.781 HE21 ' HA ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -75.62 111.08 10.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -175.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 10.0 pt-20 -94.59 130.05 41.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.198 0.523 . . . . 0.0 110.563 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.52 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 89.4 m-85 -116.36 168.24 10.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.128 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.68 -46.16 86.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.806 0.336 . . . . 0.0 111.399 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -154.54 176.16 12.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.38 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.632 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.5 mt -57.59 -56.41 34.51 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 40.0 Cg_exo -59.68 -8.25 7.08 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.202 1.935 . . . . 0.0 113.504 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.56 -29.4 20.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.786 0.327 . . . . 0.0 110.525 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.7 pp -83.64 -30.4 26.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 82' ' ' PRO . 89.2 mt -65.17 -40.98 95.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.501 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -79.68 -4.39 51.55 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.46 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -91.39 -39.32 12.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.343 0.592 . . . . 0.0 109.559 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.551 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 50.9 m-85 -74.28 -10.59 59.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.25 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -57.16 -37.94 72.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.118 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 pp -111.32 7.79 8.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 O-C-N 121.65 -0.657 . . . . 0.0 111.784 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.551 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 8.3 t-160 -94.41 -35.71 12.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -177.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.785 ' HA ' HG22 ' A' ' 97' ' ' THR . 79.2 m-85 70.86 99.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 124.066 0.854 . . . . 0.0 109.96 -170.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.694 HD22 ' CE2' ' A' ' 61' ' ' TYR . 25.2 mt -64.79 -21.24 66.73 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.693 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 1.5 m-20 -145.63 -74.65 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.791 165.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.5 t -144.14 -11.17 0.65 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.531 HG22 ' CD ' ' A' ' 54' ' ' GLU . 5.8 t -124.7 -12.74 7.11 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.752 -0.592 . . . . 0.0 112.034 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 92' ' ' TYR . 6.6 p 74.18 -169.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.34 1.056 . . . . 0.0 111.599 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.476 HD22 ' CD1' ' A' ' 36' ' ' PHE . 81.0 mt -75.88 106.47 7.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.791 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.76 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 31.2 mm -99.78 -56.4 5.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.105 -172.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.705 ' O ' ' HA ' ' A' ' 35' ' ' MET . 28.3 tt0 -166.62 124.79 1.05 Allowed Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -174.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.502 ' HA ' ' H ' ' A' ' 36' ' ' PHE . 18.0 Cg_endo -58.03 162.31 11.65 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.551 2.834 . . . . 0.0 113.719 -171.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.29 151.02 94.38 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.054 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.3 141.81 36.23 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.301 2.001 . . . . 0.0 113.402 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.607 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 17.3 mtp180 -89.04 165.2 14.69 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -109.15 95.82 19.22 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.573 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 104' ' ' ARG . 69.6 Cg_endo -100.06 26.33 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.707 2.938 . . . . 0.0 111.934 177.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.2 m 63.48 77.5 0.32 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.01 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.512 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 4.4 Cg_endo -85.9 148.81 9.56 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.197 2.598 . . . . 0.0 112.157 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 2.7 Cg_exo -76.51 -80.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.742 2.295 . . . . 0.0 111.565 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 109' ' ' PRO . 26.3 mmm -168.53 -170.0 1.15 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.22 0.608 . . . . 0.0 109.426 176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.33 -101.24 2.77 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.564 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.7 m 65.45 -175.96 0.18 Allowed 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 122.835 0.454 . . . . 0.0 110.947 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.5 t -68.4 -72.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.996 0.427 . . . . 0.0 109.913 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 p -171.85 171.27 5.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.471 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -122.42 107.38 34.55 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -59.95 -70.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.541 2.161 . . . . 0.0 111.032 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 58.9 t30 49.46 88.46 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.083 0.865 . . . . 0.0 112.355 172.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -129.27 97.2 26.22 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.689 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.91 134.27 27.26 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.916 2.411 . . . . 0.0 111.981 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.56 ' OG1' ' HB2' ' A' ' 56' ' ' SER . 1.0 OUTLIER -71.05 -32.84 69.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.74 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 64.13 -86.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.969 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -85.88 91.04 8.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.863 0.363 . . . . 0.0 110.377 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -143.78 134.76 25.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.957 0.408 . . . . 0.0 110.595 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.554 ' OD1' ' HG3' ' A' ' 183' ' ' ARG . 15.1 m120 -130.5 26.01 5.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.599 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.725 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? -77.45 96.89 4.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.545 0.688 . . . . 0.0 111.555 -175.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.621 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 36.6 tt0 -171.25 -56.76 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.261 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.644 ' HB3' HH12 ' A' ' 129' ' ' ARG . 36.3 m-85 -105.2 107.97 19.24 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.33 -175.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 93.8 t -132.9 147.42 31.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.171 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.644 HH12 ' HB3' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -129.49 145.11 51.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.814 0.34 . . . . 0.0 110.346 176.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.97 HG22 HG12 ' A' ' 178' ' ' VAL . 16.5 p -100.56 139.44 36.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.591 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.493 ' CD1' ' HG3' ' A' ' 179' ' ' GLU . 3.8 mp -119.25 -4.96 10.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.308 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -98.59 -39.76 8.55 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.558 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.444 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 74.21 120.81 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.865 0.84 . . . . 0.0 110.747 -175.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.477 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 62.1 t80 -153.78 116.53 2.65 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.91 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 4.0 Cg_endo -87.27 102.53 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.726 2.284 . . . . 0.0 112.347 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -82.37 -9.42 84.97 Favored Glycine 0 CA--C 1.511 -0.208 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.174 176.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.2 m120 51.5 24.52 2.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.229 0.612 . . . . 0.0 112.618 -173.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.531 ' HB2' ' HD3' ' A' ' 169' ' ' ARG . 19.0 t0 73.1 157.89 0.2 Allowed 'General case' 0 C--O 1.232 0.14 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 165.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 70.63 18.46 6.39 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.091 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.9 tp10 -168.23 -50.53 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.528 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 49.6 m-20 -142.39 148.03 37.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.055 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' A' ' 165' ' ' ASN . 34.1 tp -90.44 125.37 60.0 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.258 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 7.9 Cg_exo -70.16 108.34 2.13 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.284 1.989 . . . . 0.0 111.231 170.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.478 ' CG ' HG21 ' A' ' 130' ' ' THR . 6.6 p90 -126.06 163.52 22.88 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.494 ' H ' ' HB2' ' A' ' 148' ' ' GLU . 42.0 mttp -100.18 -175.2 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 110.41 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.842 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -90.88 8.47 34.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.441 179.158 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.8 34.55 0.8 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.494 ' HB2' ' H ' ' A' ' 145' ' ' LYS . 4.5 tp10 -93.52 144.42 25.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.745 -0.227 . . . . 0.0 110.62 -175.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.9 mm -98.3 135.6 32.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 165' ' ' ASN . 49.2 mt -128.56 158.5 38.26 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -175.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 43.3 t -119.47 129.25 75.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.725 HG21 HD12 ' A' ' 125' ' ' LEU . 37.5 mm -75.05 87.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.645 HG21 HG22 ' A' ' 170' ' ' VAL . 16.0 tt -74.45 -32.74 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.313 -173.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.692 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 29.2 mt-10 -144.7 140.76 28.81 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.428 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 32.4 tttp -127.67 91.43 45.51 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 121.664 -0.648 . . . . 0.0 111.948 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.45 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 15.6 Cg_exo -72.39 -52.2 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.248 1.966 . . . . 0.0 112.865 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -113.5 -172.85 2.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -170.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -99.1 -42.91 6.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.914 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -93.09 -10.09 37.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.392 . . . . 0.0 111.212 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.659 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 58.0 m95 -128.89 125.78 38.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.905 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.656 ' O ' HG13 ' A' ' 173' ' ' ILE . 54.9 m0 -121.73 144.87 48.54 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.097 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 20.2 m -95.64 94.82 7.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.3 0.572 . . . . 0.0 110.279 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -101.29 161.81 13.35 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.172 -0.33 . . . . 0.0 110.549 -177.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.736 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 20.6 ptt-85 -104.98 133.95 48.9 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.836 ' HB3' HD11 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -78.31 -176.69 4.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.685 -175.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -49.48 -31.64 10.45 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.204 0.94 . . . . 0.0 111.926 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.637 ' HA ' ' HG3' ' A' ' 215' ' ' PRO . 8.0 m-20 -72.33 -58.93 3.01 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 172.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.588 ' H ' ' ND2' ' A' ' 165' ' ' ASN . . . 139.84 3.28 1.54 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.407 -172.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.736 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -73.66 152.69 40.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.584 0.692 . . . . 0.0 110.866 -177.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.645 HG22 HG21 ' A' ' 153' ' ' ILE . 26.0 t -103.65 121.37 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.133 0.492 . . . . 0.0 111.077 -176.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.64 157.78 27.38 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.659 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.3 OUTLIER -73.8 140.06 45.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.001 0.429 . . . . 0.0 111.165 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.675 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -137.95 143.68 40.78 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.153 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.472 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 5.6 Cg_exo -80.87 135.73 10.18 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 123.226 2.617 . . . . 0.0 112.923 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.551 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 99.8 t -58.33 -44.83 99.57 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.6 Cg_endo -64.48 -0.95 3.35 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.036 1.824 . . . . 0.0 113.502 177.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.88 -6.36 21.42 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.746 0.308 . . . . 0.0 111.185 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.97 HG12 HG22 ' A' ' 130' ' ' THR . 17.3 m -128.58 156.07 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -168.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.493 ' HG3' ' CD1' ' A' ' 131' ' ' LEU . 21.8 mt-10 -119.7 125.64 49.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.008 166.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.538 ' HD2' ' HD2' ' A' ' 183' ' ' ARG . 28.2 mttp -72.55 158.17 36.2 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.563 ' HG ' ' CZ ' ' A' ' 129' ' ' ARG . 1.7 mt -65.2 -177.66 0.4 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.532 174.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.3 p -52.63 99.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 121.955 0.883 . . . . 0.0 112.191 -171.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.554 ' HG3' ' OD1' ' A' ' 124' ' ' ASN . 48.3 ttt180 -101.92 112.31 24.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.426 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.42 ' HB3' ' CD2' ' A' ' 190' ' ' HIS . 22.9 t -178.49 168.45 1.81 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.547 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 37.8 p -74.44 165.86 49.96 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.86 94.11 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.992 2.461 . . . . 0.0 113.012 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -108.6 10.18 27.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.752 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 68.34 -122.11 14.53 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.327 -172.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -71.36 101.29 2.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.337 0.589 . . . . 0.0 110.845 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 184' ' ' SER . 18.4 p-80 -146.57 123.17 11.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.309 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 135.72 175.82 14.03 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -175.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -107.25 177.63 4.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.086 0.443 . . . . 0.0 110.857 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -75.67 116.27 16.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.223 0.535 . . . . 0.0 111.393 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -110.9 137.76 48.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.888 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 10.8 t 62.73 28.11 16.39 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.211 0.529 . . . . 0.0 109.975 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 58.41 -90.84 0.03 OUTLIER 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.024 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.8 p -147.8 8.57 0.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.262 0.553 . . . . 0.0 110.449 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -99.13 142.39 30.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.04 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -138.59 85.26 0.23 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.684 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 13.0 tt -105.0 130.93 22.29 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.891 0.376 . . . . 0.0 110.8 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.73 92.35 0.61 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.908 2.405 . . . . 0.0 111.973 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.711 ' H ' ' HD2' ' A' ' 203' ' ' PRO . 5.4 tp10 -113.49 -56.58 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.597 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' A' ' 202' ' ' GLU . 56.4 Cg_endo -70.01 146.05 57.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.908 1.739 . . . . 0.0 112.633 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 214' ' ' THR . . . -78.77 139.29 38.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.246 177.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -122.78 27.33 7.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.289 0.566 . . . . 0.0 110.582 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.06 92.75 3.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.115 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.956 ' O1P' HG23 ' A' ' 43' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.491 ' H ' ' HB2' ' A' ' 207' ' ' PTR . . . -110.35 18.28 20.01 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.209 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.477 ' NE2' HD12 ' A' ' 62' ' ' ILE . 11.0 pt20 -70.46 164.03 57.74 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.768 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.547 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 19.0 Cg_exo -66.82 81.77 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.468 1.446 . . . . 0.0 109.221 165.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.423 ' H ' ' HG2' ' A' ' 211' ' ' GLN . 3.2 pt20 -82.88 65.64 8.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.123 -164.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 167' ' ' ASP . 12.7 m -77.09 65.9 2.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.931 0.872 . . . . 0.0 110.919 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 5.6 m -138.92 7.65 2.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.429 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.571 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 9.4 t -107.35 -27.92 0.18 Allowed Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.54 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.637 ' HG3' ' HA ' ' A' ' 167' ' ' ASP . 51.5 Cg_endo -70.08 122.55 9.14 Favored 'Trans proline' 0 C--N 1.362 1.277 0 CA-C-N 121.25 1.482 . . . . 0.0 111.944 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.3 mp -88.82 113.13 54.63 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.25 -25.49 9.92 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.643 2.228 . . . . 0.0 112.905 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 63.69 -86.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.722 0.639 . . . . 0.0 111.113 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.6 160.33 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.5 m -80.75 68.87 7.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.251 0.548 . . . . 0.0 110.572 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.84 -39.36 9.54 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.991 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.8 m -120.9 82.45 35.73 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.491 0.186 . . . . 0.0 111.08 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.77 121.65 8.55 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.672 2.248 . . . . 0.0 111.918 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -152.48 71.05 0.29 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 69.1 -178.59 0.22 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.171 0.588 . . . . 0.0 110.309 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -144.51 114.04 7.12 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.283 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 69.6 mt 68.27 -77.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 124.089 0.868 . . . . 0.0 111.957 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 34.3 p -80.15 155.08 74.92 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.56 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.81 169.55 14.45 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.785 2.323 . . . . 0.0 112.11 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.745 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 59.3 tp -86.28 -55.35 0.38 Allowed Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.294 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.745 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 2.7 Cg_exo -76.52 88.03 1.4 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.987 1.792 . . . . 0.0 111.887 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 40.5 t -90.68 121.86 32.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.523 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.1 m -88.18 -13.7 40.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 65.72 91.73 0.08 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.356 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.9 94.12 7.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.419 0.628 . . . . 0.0 110.983 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -179.17 63.81 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 83.9 Cg_endo -88.91 137.23 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.724 2.282 . . . . 0.0 113.866 -171.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.47 ' HB ' HG13 ' A' ' 266' ' ' VAL . 20.3 t -98.93 145.5 10.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -100.08 112.88 25.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.907 0.384 . . . . 0.0 111.348 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -120.68 122.01 39.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.124 175.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.98 122.3 28.12 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -72.04 112.88 8.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.21 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.533 HG13 ' HG3' ' A' ' 244' ' ' GLN . 33.2 pt -89.28 -9.04 10.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.229 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 19.4 mt-30 -134.86 149.16 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -79.08 141.96 36.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.429 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 1.028 ' HD2' ' HE1' ' A' ' 290' ' ' HIS . 58.1 ttt85 -135.8 138.82 42.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.347 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 17.7 m -132.7 151.34 77.93 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.433 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.536 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 4.5 Cg_exo -77.96 125.75 7.5 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.958 2.439 . . . . 0.0 111.645 176.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 51.0 t -72.55 175.37 6.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.439 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -63.04 -24.43 67.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.908 0.385 . . . . 0.0 111.452 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -85.37 -6.81 59.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.967 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 30.8 t70 69.91 -72.34 0.11 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.011 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt 61.56 29.32 18.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.234 174.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 285' ' ' LEU . 2.6 m 63.71 19.11 11.56 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.9 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -76.85 115.54 16.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.749 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.615 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.6 tt -84.67 129.43 34.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.035 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.536 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -72.09 121.83 19.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.863 0.363 . . . . 0.0 110.597 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.538 HD22 HG22 ' A' ' 264' ' ' VAL . 96.0 mt -129.89 145.04 51.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 262' ' ' ASP . 8.7 mm-40 -101.0 161.4 13.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.141 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.26 119.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.3 64.26 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.511 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.739 ' HB2' ' HB2' ' A' ' 259' ' ' GLU . 24.7 t70 -85.81 146.18 26.88 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.673 0.273 . . . . 0.0 110.436 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.4 mm -92.69 106.51 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.758 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.538 HG22 HD22 ' A' ' 258' ' ' LEU . 16.3 t -83.97 107.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.501 177.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -87.96 92.43 9.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.45 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.63 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 3.8 p -88.29 134.35 28.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.889 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 58.9 p -103.79 -45.11 4.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -111.47 116.98 31.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 32.9 mtt -106.72 116.65 32.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.915 0.388 . . . . 0.0 111.121 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -82.92 152.13 25.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.25 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 8.6 mm -95.61 29.39 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.559 0.695 . . . . 0.0 110.259 -172.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.47 HD21 ' HG2' ' A' ' 274' ' ' GLN . 30.4 p-10 -113.35 -25.43 8.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.146 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 136.3 -23.6 3.3 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.142 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.47 ' HG2' HD21 ' A' ' 272' ' ' ASN . 14.3 pt20 -107.25 130.24 54.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.038 0.419 . . . . 0.0 110.263 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.443 ' HE3' ' CE2' ' A' ' 286' ' ' PHE . 5.8 m0 -118.75 169.64 9.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.245 -174.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -111.28 110.66 21.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.337 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -116.31 155.88 15.97 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 176.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.465 ' HB2' ' HE2' ' A' ' 283' ' ' LYS . 35.3 tt0 -108.0 109.46 20.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.384 0.592 . . . . 0.0 110.539 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.615 ' HB ' HD21 ' A' ' 256' ' ' LEU . 71.7 t -131.34 129.36 62.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 14.2 m120 65.83 30.4 10.03 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.43 0.456 . . . . 0.0 110.982 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.53 9.29 86.12 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.825 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -118.71 123.02 43.86 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.705 -0.291 . . . . 0.0 110.779 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 83.4 mttt -94.13 111.64 23.39 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -132.81 168.72 22.74 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.817 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.43 ' H ' HG22 ' A' ' 254' ' ' THR . 87.8 mt -86.62 132.2 33.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.245 0.545 . . . . 0.0 110.82 -178.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.479 ' HB2' ' NE2' ' A' ' 290' ' ' HIS . 36.1 p90 -132.5 126.57 20.22 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.595 175.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.21 161.29 23.54 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 123.04 2.493 . . . . 0.0 113.185 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -68.18 -33.73 74.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.183 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.3 p -81.7 17.88 1.37 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 1.028 ' HE1' ' HD2' ' A' ' 246' ' ' ARG . 0.6 OUTLIER -143.45 8.35 1.56 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.071 -0.651 . . . . 0.0 112.097 176.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.32 161.09 37.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -139.9 119.93 13.63 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.752 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 240' ' ' ALA . 1.4 mp -72.64 117.89 16.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -115.35 143.73 44.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.424 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 296' ' ' PRO . 8.8 t70 -78.76 121.8 83.95 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 295' ' ' ASP . 31.7 Cg_exo -59.8 -14.93 29.37 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.131 2.554 . . . . 0.0 113.234 -176.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -84.14 42.76 0.89 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.49 0.662 . . . . 0.0 110.549 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -126.0 94.62 41.27 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.466 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.19 75.77 4.55 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.991 2.461 . . . . 0.0 111.765 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.5 135.55 48.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.662 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -110.54 -12.56 14.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.856 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -113.29 142.02 46.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.957 -176.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.46 176.895 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.66 0.266 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 m -89.97 -178.14 5.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.648 0.261 . . . . 0.0 111.115 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.509 ' HB2' HD12 ' A' ' 99' ' ' ILE . 5.6 p -82.64 -50.97 8.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.023 0.439 . . . . 0.0 110.133 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -68.66 117.47 10.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.67 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -138.31 89.16 2.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.03 0.443 . . . . 0.0 110.959 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -161.93 163.06 29.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 9' ' ' SER . 32.7 m-20 -82.3 -17.87 44.32 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.382 -173.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 70.28 -32.88 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.547 0.739 . . . . 0.0 111.48 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 7' ' ' ASP . 17.6 m -93.06 -23.27 18.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.95 100.74 4.22 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.431 -173.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.63 -26.36 68.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 104' ' ' ARG . 68.5 m -70.81 -4.78 25.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.488 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.22 -47.3 4.77 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 40.0 p-90 -111.54 -20.19 12.27 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -76.41 116.71 17.36 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.971 -0.455 . . . . 0.0 110.894 -173.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.612 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.5 mmt -98.14 -12.08 22.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.396 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.58 ' HA3' HD12 ' A' ' 227' ' ' ILE . . . 50.94 -113.0 1.89 Allowed Glycine 0 CA--C 1.521 0.45 0 O-C-N 123.852 0.72 . . . . 0.0 113.828 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.4 Cg_exo -69.92 84.33 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.041 2.494 . . . . 0.0 113.281 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.013 HG12 ' H ' ' A' ' 20' ' ' SER . 61.0 t -135.92 -162.16 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.013 ' H ' HG12 ' A' ' 19' ' ' VAL . 87.2 p -170.88 165.12 7.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -168.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.623 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 8.1 ptm85 -68.01 -31.71 71.59 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 118.872 -1.131 . . . . 0.0 110.851 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -59.16 -58.57 8.07 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.092 0.472 . . . . 0.0 110.387 176.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.63 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 35.7 mt-10 -64.95 -46.22 82.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.353 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.08 -43.75 78.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.833 -177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 18.2 mt-30 -69.5 -34.45 74.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.79 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 23' ' ' GLU . 11.5 t -78.65 -7.97 58.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.947 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.63 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 41.6 mtp180 -97.12 -10.54 25.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.048 0.452 . . . . 0.0 109.828 176.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 45.7 mt -114.27 -11.64 12.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.414 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.635 HE22 ' HB3' ' A' ' 57' ' ' ARG . 7.0 tp-100 -70.88 125.97 28.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.441 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.93 15.07 71.32 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.197 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.583 HE21 ' HA ' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -101.29 164.6 11.7 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -178.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 32' ' ' ARG . 19.4 ptt85 -61.21 130.87 48.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.212 0.529 . . . . 0.0 110.642 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.409 ' HA ' ' O ' ' A' ' 53' ' ' SER . 32.2 m170 -67.79 132.59 47.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.953 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.54 -20.29 7.4 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.682 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.738 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.9 mtm -75.01 136.85 41.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.412 ' CB ' HG22 ' A' ' 52' ' ' VAL . 50.0 p90 -139.16 168.21 20.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.294 -176.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.612 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -156.07 141.3 17.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.921 0.391 . . . . 0.0 110.755 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.436 ' HB ' ' CE3' ' A' ' 14' ' ' TRP . 61.6 t -114.07 124.93 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.617 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 19.2 ptt-85 -125.46 167.91 14.35 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.909 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.87 129.98 38.62 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.429 ' HB3' ' OG1' ' A' ' 43' ' ' THR . 61.8 m -68.78 147.22 52.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.559 0.695 . . . . 0.0 112.5 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.818 ' HB3' ' O1P' ' A' ' 207' ' ' PTR . 37.2 t -76.71 -14.29 59.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.426 175.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.871 ' N ' ' O1P' ' A' ' 207' ' ' PTR . 0.2 OUTLIER -76.3 -62.1 1.73 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.646 176.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 73.2 m -149.75 141.41 14.92 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.391 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.435 ' HG3' ' HD3' ' A' ' 223' ' ' PRO . 40.4 Cg_exo -59.35 -23.04 68.4 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.963 2.442 . . . . 0.0 112.258 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.25 37.38 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.647 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -156.86 148.32 22.33 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.419 ' CD2' HD11 ' A' ' 81' ' ' LEU . 29.0 m-85 -129.5 171.65 12.35 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.453 HG21 ' HE2' ' A' ' 207' ' ' PTR . 3.6 t -137.05 112.9 11.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.543 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.414 ' HB2' HD11 ' A' ' 63' ' ' ILE . 63.6 tp -82.22 92.44 6.91 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.79 171.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.2 m -95.59 120.59 36.11 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.627 HG12 ' HG3' ' A' ' 54' ' ' GLU . 88.2 t -112.76 141.78 27.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.552 -174.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 29.5 t -82.02 100.26 9.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.627 ' HG3' HG12 ' A' ' 52' ' ' VAL . 29.6 mt-10 -155.58 149.99 25.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.457 . . . . 0.0 112.142 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.721 HD21 ' HB3' ' A' ' 155' ' ' LYS . 1.7 m-20 60.13 59.37 2.39 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.416 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 55' ' ' ASN . 32.8 t 70.98 -24.52 0.17 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.751 -174.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.854 ' HD3' ' H ' ' A' ' 118' ' ' LEU 0.405 0.0 OUTLIER -160.0 -53.39 0.06 Allowed 'General case' 0 C--N 1.363 1.156 1 N-CA-C 124.47 4.989 . . . . 0.0 124.47 -178.551 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.711 ' H ' ' CD ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -154.24 116.84 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 121.671 2.032 . . . . 0.0 113.3 -171.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.576 ' OG ' ' HB2' ' A' ' 54' ' ' GLU . 6.0 m -97.8 110.54 23.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 164.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.818 ' O ' ' HB3' ' A' ' 208' ' ' ALA . 91.3 m-70 -94.01 110.13 21.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.946 ' HB3' HD11 ' A' ' 73' ' ' ILE . 69.1 m-85 -120.1 102.5 8.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.019 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.94 HG13 ' HB2' ' A' ' 209' ' ' GLN . 0.1 OUTLIER -77.82 148.67 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.6 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.8 mp -129.67 86.47 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.07 131.94 47.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.881 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.8 t -77.45 125.26 29.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.265 0.555 . . . . 0.0 110.799 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.999 HD13 ' HB2' ' A' ' 69' ' ' ARG . 94.1 mt -76.0 147.57 80.56 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.12 169.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.505 ' HD2' HH21 ' A' ' 69' ' ' ARG . 35.8 Cg_exo -64.25 61.99 0.25 Allowed 'Trans proline' 0 C--O 1.218 -0.479 0 C-N-CA 122.762 2.308 . . . . 0.0 110.458 165.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 1.027 HD22 ' N ' ' A' ' 69' ' ' ARG 0.268 0.2 OUTLIER 103.66 -50.88 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 128.67 2.788 . . . . 0.0 109.467 -179.688 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 1.027 ' N ' HD22 ' A' ' 68' ' ' ASN . 73.1 mtm180 -34.45 -53.94 0.52 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 125.093 1.496 . . . . 0.0 112.137 -149.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.841 ' H ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -169.85 -167.11 0.62 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.184 1.794 . . . . 0.0 106.572 167.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.15 114.18 26.31 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.378 166.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 23.2 ttmm -102.51 104.78 15.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 111.339 -171.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.946 HD11 ' HB3' ' A' ' 61' ' ' TYR . 6.5 tt -92.49 77.53 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.773 0.797 . . . . 0.0 109.463 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.51 ' HA3' ' HG2' ' A' ' 209' ' ' GLN . . . 66.98 89.1 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.947 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.757 ' HB2' ' HB2' ' A' ' 211' ' ' GLN . 44.4 t0 75.48 -52.03 0.65 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.705 0.402 . . . . 0.0 110.877 173.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -83.16 114.84 21.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.643 0.258 . . . . 0.0 110.472 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.5 pm0 -93.38 133.03 37.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.386 0.612 . . . . 0.0 110.613 174.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.755 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 64.1 m-85 -121.0 158.23 28.22 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.837 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 4.3 m-20 -44.15 -41.23 5.54 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.514 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 3.4 p80 -170.46 -173.13 1.37 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 11.6 mt -57.83 -55.23 47.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 123.047 0.217 . . . . 0.0 111.339 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 32.1 Cg_exo -63.56 5.68 0.32 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.774 2.316 . . . . 0.0 114.005 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -107.54 -32.19 7.8 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.26 -0.275 . . . . 0.0 110.952 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.57 HD21 HD23 ' A' ' 81' ' ' LEU . 4.4 pp -76.15 -30.14 58.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.211 0.529 . . . . 0.0 109.739 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 53.5 mt -63.02 -32.41 73.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.943 176.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.639 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 24.3 tp10 -72.07 -26.8 62.31 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.544 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 91' ' ' HIS . 14.1 t80 -73.3 -29.3 62.61 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.053 0.93 . . . . 0.0 108.932 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.533 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 42.0 m-85 -92.39 2.67 56.52 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.338 -175.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.639 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 52.0 mtpt -85.65 -15.52 42.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.639 172.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.2 pt -122.74 -1.85 7.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 121.309 0.576 . . . . 0.0 110.091 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.4 t-160 -86.88 -43.78 12.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.841 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.459 ' CD2' HG23 ' A' ' 97' ' ' THR . 66.1 m-85 63.74 94.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -162.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.728 HD22 ' CE2' ' A' ' 61' ' ' TYR . 16.5 mt -51.53 -97.21 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 123.712 0.633 . . . . 0.0 110.564 176.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.598 ' OD2' ' HB2' ' A' ' 55' ' ' ASN . 3.2 t0 -68.04 -65.26 0.72 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.546 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 9.8 t -157.31 13.06 0.23 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.915 0.864 . . . . 0.0 110.228 175.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.49 HG22 ' OE1' ' A' ' 54' ' ' GLU . 6.5 t -140.65 171.72 13.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 169.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.459 HG23 ' CD2' ' A' ' 92' ' ' TYR . 17.8 p -98.02 171.55 8.19 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.042 -0.411 . . . . 0.0 110.619 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.4 94.26 0.72 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.1 mm -76.17 -53.78 14.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.802 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.738 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.9 pt-20 -167.92 154.57 7.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.632 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 42.3 Cg_endo -66.88 154.56 74.16 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.297 1.998 . . . . 0.0 112.737 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -72.61 161.05 81.15 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.323 175.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 9.6 Cg_endo -51.64 126.43 19.63 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.154 1.902 . . . . 0.0 110.971 176.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.52 ' HG2' ' H ' ' A' ' 105' ' ' TYR . 40.7 ttt180 -63.75 175.97 1.01 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.295 -176.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.52 ' H ' ' HG2' ' A' ' 104' ' ' ARG . 4.9 t80 -52.25 -44.52 93.37 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -174.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.6 90.07 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.697 1.598 . . . . 0.0 112.511 173.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.4 t -173.54 132.92 0.6 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.556 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.15 134.49 16.01 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.554 2.169 . . . . 0.0 112.248 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.14 127.02 10.26 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.548 2.165 . . . . 0.0 112.18 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 88.5 mtp -84.91 -45.76 11.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.262 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.98 109.03 0.76 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.2 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.8 t -137.74 152.66 49.44 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 11.9 p -66.8 142.72 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.992 0.425 . . . . 0.0 110.305 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.3 t -92.96 86.29 5.39 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -107.79 108.4 61.42 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.455 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HA ' ' NE2' ' A' ' 25' ' ' GLN . 5.1 Cg_endo -84.7 97.55 0.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.104 2.536 . . . . 0.0 112.229 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.897 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . 63.5 t30 69.2 110.99 0.05 OUTLIER 'General case' 0 C--N 1.342 0.281 0 O-C-N 123.752 0.657 . . . . 0.0 111.048 177.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.854 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 3.2 mm? 72.73 160.36 0.16 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.922 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 18.2 Cg_endo -60.67 130.54 33.72 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.555 2.17 . . . . 0.0 112.528 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.2 m 73.9 -62.5 0.46 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.321 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.34 175.52 9.95 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.897 ' HG2' ' HB3' ' A' ' 117' ' ' ASN . 26.6 mt-10 -68.17 96.25 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.123 0.487 . . . . 0.0 110.301 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -104.57 -60.74 1.55 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.75 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.656 ' CB ' ' HG3' ' A' ' 183' ' ' ARG . 8.5 p30 -149.2 178.93 8.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.344 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.538 HD12 HG21 ' A' ' 152' ' ' ILE . 3.6 mm? 61.03 84.94 0.12 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.523 0.678 . . . . 0.0 110.281 -174.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 13.0 tp10 -177.57 -68.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.648 -172.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -112.92 106.96 15.36 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.332 0.587 . . . . 0.0 110.293 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.74 HG22 ' CG ' ' A' ' 180' ' ' LYS . 99.4 t -120.49 133.88 65.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.287 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.714 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 7.4 ptp180 -110.35 144.42 39.13 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.855 -1.938 . . . . 0.0 108.724 170.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.541 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -101.28 132.15 46.95 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.514 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.554 HD21 ' HG2' ' A' ' 179' ' ' GLU . 14.9 mt -107.4 -15.13 14.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.973 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.405 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 19.1 t80 -82.06 -40.97 21.23 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -173.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.635 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 11.3 t70 71.52 96.43 0.07 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.459 0.647 . . . . 0.0 110.603 -175.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -127.81 88.25 53.77 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 91.3 Cg_endo -84.85 79.02 2.51 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.075 1.85 . . . . 0.0 113.158 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.29 -23.94 77.51 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.381 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.856 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 67.38 50.8 0.92 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.452 0.701 . . . . 0.0 111.639 177.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.419 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 19.7 m-20 -144.5 178.96 7.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.387 . . . . 0.0 110.969 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.519 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -99.96 -9.41 22.78 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 171.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 172' ' ' MET . 4.8 mm-40 -80.87 -38.25 28.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.432 174.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 172' ' ' MET . 24.1 m-20 -133.88 108.67 8.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.945 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.054 HD11 ' HB2' ' A' ' 165' ' ' ASN . 35.4 tp -63.95 129.78 94.1 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.856 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 10.2 Cg_endo -81.21 87.53 1.47 Allowed 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 121.627 1.551 . . . . 0.0 111.088 175.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.49 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 10.2 p90 -100.63 159.83 14.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.527 -173.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.635 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 40.5 mttp -104.22 -172.44 2.11 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -174.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.954 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -85.23 8.55 17.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.334 -172.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.95 41.19 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.405 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -105.1 148.25 27.04 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.706 -177.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.64 132.84 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.331 0.586 . . . . 0.0 109.817 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.752 HD22 ' CD2' ' A' ' 142' ' ' LEU . 24.4 mt -125.85 162.31 25.43 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -176.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.631 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 99.0 t -125.44 122.08 61.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 175.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.073 HD13 ' HB2' ' A' ' 163' ' ' ALA . 34.0 mm -77.01 78.68 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.445 HG21 HG22 ' A' ' 170' ' ' VAL . 10.5 tt -78.34 -39.26 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.727 -176.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.654 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 63.1 mt-10 -116.54 140.27 49.57 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 171.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.721 ' HB3' HD21 ' A' ' 55' ' ' ASN . 78.4 tttt -136.71 86.93 21.18 Favored Pre-proline 0 C--N 1.316 -0.863 0 O-C-N 121.49 -0.756 . . . . 0.0 110.149 175.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.693 ' HG2' ' SD ' ' A' ' 172' ' ' MET . 4.3 Cg_exo -67.32 -55.53 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.614 2.209 . . . . 0.0 111.592 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 160' ' ' TRP . 17.4 mm-40 -107.17 167.94 9.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.814 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.431 ' O ' HG21 ' A' ' 175' ' ' VAL . 1.6 mm-40 -94.47 -16.35 23.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.153 0.502 . . . . 0.0 109.714 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.419 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 2.0 pt20 -94.21 -21.23 19.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.547 173.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.721 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 52.4 m95 -131.22 127.71 38.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.555 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.852 ' HB3' HD12 ' A' ' 152' ' ' ILE . 47.2 m0 -117.88 136.85 53.19 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.357 -176.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.683 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 74.5 m -100.46 90.38 4.28 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.073 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -102.44 149.4 24.41 Favored 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.48 -171.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.825 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 23.5 ptt-85 -86.75 119.35 26.89 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.054 ' HB2' HD11 ' A' ' 142' ' ' LEU . 6.0 t30 -46.59 166.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 112.374 -2.194 . . . . 0.0 111.213 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -68.57 10.71 0.23 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.64 0.733 . . . . 0.0 110.505 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 165' ' ' ASN . 18.5 m-20 -114.38 -6.68 12.91 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.798 172.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.688 ' HA3' ' HA ' ' A' ' 211' ' ' GLN . . . 79.37 67.87 1.54 Allowed Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.257 -172.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.825 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 8.7 ttm-85 -139.48 126.31 20.81 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.494 HG11 ' CD ' ' A' ' 154' ' ' GLU . 12.1 t -86.65 116.27 28.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.073 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -144.09 149.16 21.18 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.721 ' HE2' ' HB3' ' A' ' 160' ' ' TRP . 7.4 mtp -74.93 134.89 41.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.223 0.511 . . . . 0.0 110.583 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.779 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.5 pp -137.11 142.74 39.23 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.341 -176.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.602 ' HG2' ' CG ' ' A' ' 177' ' ' TYR . 9.7 Cg_endo -62.85 130.4 29.23 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.989 2.459 . . . . 0.0 113.152 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 178' ' ' VAL . 99.2 t -64.67 -44.91 75.35 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.167 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.524 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 48.6 Cg_exo -58.25 1.44 0.25 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.429 2.086 . . . . 0.0 114.104 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.602 ' CG ' ' HG2' ' A' ' 174' ' ' PRO . 3.2 m-85 -104.77 -10.53 17.36 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.34 0.256 . . . . 0.0 111.589 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.642 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.4 m -106.39 -171.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -165.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.714 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.1 tp10 -159.34 47.51 0.3 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.327 -1.761 . . . . 0.0 111.497 -154.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.74 ' CG ' HG22 ' A' ' 128' ' ' VAL . 1.9 mptt -72.35 138.21 47.13 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 119.297 -2.127 . . . . 0.0 110.469 -162.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.1 tp -78.3 -71.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.956 -170.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.18 109.44 17.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.509 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.656 ' HG3' ' CB ' ' A' ' 124' ' ' ASN . 35.1 ttt180 -168.27 119.63 0.81 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.9 -177.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.1 m -98.17 68.66 1.96 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.462 0.649 . . . . 0.0 109.844 173.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.454 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 3.1 p -70.78 170.39 11.19 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.38 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 86.7 Cg_exo -49.28 101.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.805 2.337 . . . . 0.0 113.189 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -129.68 -37.77 1.54 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.044 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 190' ' ' HIS . . . 156.54 52.65 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.029 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm 69.47 -14.32 0.34 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.04 0.936 . . . . 0.0 112.421 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 188' ' ' GLY . 37.5 t-80 70.36 -48.0 0.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.494 0.717 . . . . 0.0 110.898 -175.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 176.22 -131.46 1.88 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -155.27 -167.06 2.43 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -66.35 101.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 0.0 110.655 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -121.66 -37.74 2.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.149 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.0 m -138.08 111.46 8.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.119 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -100.38 -2.48 33.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.552 0.691 . . . . 0.0 109.3 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.5 p -137.54 110.2 7.55 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.271 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 62.91 84.06 0.15 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.72 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -90.94 -33.21 8.4 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.799 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.717 ' HB ' ' HD2' ' A' ' 203' ' ' PRO . 13.9 pt -116.23 91.79 33.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.236 0.541 . . . . 0.0 111.149 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.35 -14.61 11.73 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.949 2.433 . . . . 0.0 112.473 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.789 ' HB3' ' HD3' ' A' ' 203' ' ' PRO . 25.8 tp10 -83.34 -57.51 0.43 Allowed Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.342 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' A' ' 202' ' ' GLU . 1.1 Cg_endo -83.69 101.46 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.356 2.038 . . . . 0.0 111.836 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.54 125.45 26.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.416 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -110.22 108.32 18.41 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.071 0.462 . . . . 0.0 110.659 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -103.97 -130.43 0.27 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.62 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.871 ' O1P' ' N ' ' A' ' 43' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 60' ' ' HIS . . . -92.42 -75.46 0.49 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.94 ' HB2' HG13 ' A' ' 62' ' ' ILE . 36.7 tt0 67.77 137.64 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.335 0 O-C-N 124.216 0.948 . . . . 0.0 109.547 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.15 -35.26 72.42 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 121.813 1.676 . . . . 0.0 111.547 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.757 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 30.2 tt0 -97.26 148.23 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 171.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.478 ' H ' ' HA3' ' A' ' 168' ' ' GLY . 15.2 t -74.98 142.03 43.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 0.0 110.931 -175.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 18.5 m -64.19 140.69 58.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.648 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.3 p -68.5 148.69 98.14 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.89 -34.4 91.56 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.804 2.336 . . . . 0.0 111.71 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.841 HD23 ' H ' ' A' ' 216' ' ' LEU . 1.6 pt? -87.57 117.15 68.16 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.681 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -93.15 -159.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.237 2.625 . . . . 0.0 112.592 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -139.39 150.39 45.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.227 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.85 161.24 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.72 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.1 m -86.1 160.71 19.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.079 0.466 . . . . 0.0 111.562 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 167.2 78.53 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.638 ' OG ' ' HA ' ' A' ' 42' ' ' SER . 1.4 m -105.09 119.23 53.85 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.435 ' HD3' ' HG3' ' A' ' 45' ' ' PRO . 5.5 Cg_exo -79.69 159.67 24.98 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.068 2.512 . . . . 0.0 111.222 174.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -158.82 -173.3 27.05 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.766 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 65.1 14.24 9.24 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.073 0.549 . . . . 0.0 112.068 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.16 11.17 37.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.889 0.376 . . . . 0.0 111.056 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.58 HD12 ' HA3' ' A' ' 17' ' ' GLY . 61.6 mt -131.26 128.81 62.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.612 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.1 t -83.35 145.42 48.44 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.135 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.07 -76.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.482 2.121 . . . . 0.0 112.844 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 231' ' ' PRO . 2.4 pt? -176.92 170.12 1.08 Allowed Pre-proline 0 C--O 1.235 0.327 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -177.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.41 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 50.3 Cg_exo -55.95 150.82 44.58 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.453 2.102 . . . . 0.0 111.944 172.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 20.3 p -71.93 105.55 3.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.28 0.562 . . . . 0.0 111.591 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 13.7 p -115.67 136.29 53.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.134 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -102.55 -52.04 3.19 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.903 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 66.7 -177.97 0.2 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.784 0.677 . . . . 0.0 111.84 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 82.35 173.3 48.84 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.622 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.92 163.94 23.57 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.898 2.399 . . . . 0.0 111.592 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.56 ' CG1' HD12 ' A' ' 293' ' ' ILE . 7.6 t -97.62 136.08 29.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.052 0.453 . . . . 0.0 110.691 -175.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.68 125.98 52.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.172 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.484 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -124.57 139.07 54.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.708 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.96 130.72 46.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.107 176.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -75.41 104.56 6.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.896 0.379 . . . . 0.0 110.18 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 21.0 pt -75.24 -13.0 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.416 HE21 ' HB2' ' A' ' 244' ' ' GLN . 0.7 OUTLIER -146.94 157.82 43.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.308 178.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -73.27 158.71 34.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.429 0.633 . . . . 0.0 111.082 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.645 ' HD3' HD12 ' A' ' 258' ' ' LEU . 58.9 mtp85 -132.21 115.66 15.97 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.84 175.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 29.5 m -111.71 126.48 28.45 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 172.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 3.0 Cg_exo -80.06 144.08 16.54 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.983 2.455 . . . . 0.0 112.268 -176.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 35.6 t -77.63 171.34 15.07 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.76 87.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.497 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -90.09 6.27 43.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.764 0.316 . . . . 0.0 111.524 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -116.92 64.09 0.72 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.955 0.407 . . . . 0.0 110.234 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -78.44 -13.66 59.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.07 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.0 p -95.39 -1.69 50.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.336 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -85.0 116.83 23.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.48 133.64 49.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.938 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -95.77 135.48 37.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.675 177.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.645 HD12 ' HD3' ' A' ' 246' ' ' ARG . 96.7 mt -134.75 151.91 51.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 0.0 111.851 -169.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -97.67 172.98 7.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.392 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.69 122.53 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.893 0.378 . . . . 0.0 110.669 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.48 22.22 62.83 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.373 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -89.63 169.12 11.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.6 mm -106.58 116.0 49.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.325 0.584 . . . . 0.0 110.635 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.531 ' HA ' HG22 ' A' ' 279' ' ' VAL . 21.9 t -102.4 109.86 27.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.268 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.481 ' HB2' ' HE3' ' A' ' 265' ' ' LYS . 33.3 mtmt -87.2 99.73 12.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.013 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 5.8 p -90.15 116.48 31.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.593 0.711 . . . . 0.0 109.833 175.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 19.6 p -93.43 -36.31 12.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.321 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.563 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 56.5 ttt180 -121.56 96.9 5.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.832 175.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . 0.45 ' HG3' ' NE1' ' A' ' 275' ' ' TRP . 45.7 ttm -81.81 111.54 18.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.059 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 91.6 m-20 -86.74 144.95 26.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.996 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 16.3 tt -79.46 -12.95 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.109 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -75.81 -25.47 56.36 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.725 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.19 -40.05 1.89 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.608 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 34.6 mt-30 -75.7 108.85 8.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.45 ' NE1' ' HG3' ' A' ' 269' ' ' MET . 52.8 m0 -93.39 145.43 24.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.857 0.361 . . . . 0.0 111.315 -176.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 9.0 tp10 -91.99 107.35 19.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.183 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -140.03 157.11 25.29 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.534 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -124.13 123.99 41.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.232 0.539 . . . . 0.0 110.043 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 264' ' ' VAL . 28.7 t -124.81 160.96 29.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.078 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -54.82 85.64 0.0 OUTLIER 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.559 0.695 . . . . 0.0 110.889 174.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 156.3 -39.69 0.58 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.375 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 282' ' ' ARG . 34.5 ttm180 179.69 152.89 0.45 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.1 0.476 . . . . 0.0 111.233 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -101.25 127.64 47.75 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.5 -169.41 35.84 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.68 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 97.4 mt -93.87 145.8 24.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.706 0.288 . . . . 0.0 110.376 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -141.73 127.48 10.91 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 121.083 0.468 . . . . 0.0 111.092 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.508 ' HD2' ' CZ ' ' A' ' 246' ' ' ARG . 72.4 Cg_exo -55.39 126.37 22.29 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 123.269 2.646 . . . . 0.0 112.449 169.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -64.75 -14.76 60.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.454 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 13.8 p -71.8 -2.43 17.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -113.79 0.19 14.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.175 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.484 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 28.5 m -128.28 168.99 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.011 0.434 . . . . 0.0 111.164 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -129.33 129.38 44.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.37 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.56 HD12 ' CG1' ' A' ' 238' ' ' VAL . 32.9 mm -81.16 126.25 39.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.259 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.23 157.05 40.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.947 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -104.96 99.2 17.99 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 121.431 0.634 . . . . 0.0 110.008 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.33 -25.21 30.83 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.815 2.343 . . . . 0.0 112.805 -175.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 165.47 -34.56 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -171.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 57.68 89.24 0.11 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.694 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.62 5.75 4.98 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.968 2.445 . . . . 0.0 111.098 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -96.35 129.07 43.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.306 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 67.84 0.25 2.25 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.763 0.664 . . . . 0.0 111.037 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -140.0 155.22 47.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.448 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.606 178.801 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 3' ' ' SER . 22.5 t -123.24 13.88 9.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.297 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.446 ' O ' HG23 ' A' ' 99' ' ' ILE . 28.9 t 68.0 -71.34 0.11 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.119 0.568 . . . . 0.0 110.095 -173.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.78 120.61 20.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.04 0.448 . . . . 0.0 110.598 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -148.93 -53.02 0.17 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.686 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 p90 37.46 -162.35 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.632 1.208 . . . . 0.0 113.09 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.99 -44.91 19.37 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.046 -0.409 . . . . 0.0 110.861 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 t 72.5 -53.7 0.69 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.971 0.795 . . . . 0.0 111.87 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 m -84.47 -25.38 28.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.109 0.481 . . . . 0.0 110.946 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -86.74 116.91 25.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.063 0.459 . . . . 0.0 111.119 -171.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -63.54 -31.74 72.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.521 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.8 t -69.28 -8.28 44.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.23 -47.69 7.09 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.913 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -117.78 -23.38 7.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -170.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -73.65 116.01 13.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.619 ' HB3' HG21 ' A' ' 19' ' ' VAL . 12.4 tpp -100.71 -1.66 34.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.347 -172.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.96 -115.9 3.95 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.252 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.1 Cg_exo -72.4 103.28 1.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.9 2.4 . . . . 0.0 112.036 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.853 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 64.4 t -136.17 -83.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -176.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.796 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 11.7 t 83.6 176.47 0.06 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 168.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 7.8 tpt180 -42.16 -62.68 0.88 Allowed 'General case' 0 C--N 1.314 -0.944 0 O-C-N 124.112 0.883 . . . . 0.0 112.276 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -62.12 -28.53 69.7 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.05 -168.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -95.75 -45.55 6.95 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.561 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -55.54 32.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.504 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 12.3 pt20 -68.69 -31.26 70.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.829 -174.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.2 m -65.48 -42.95 91.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.42 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -71.22 -28.83 64.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.962 0.411 . . . . 0.0 111.239 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.079 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 17.4 mt -107.24 25.88 10.87 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.233 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -75.56 76.22 2.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.54 0.686 . . . . 0.0 109.9 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.41 -64.47 3.98 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.258 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 11.99 -108.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.208 1.403 . . . . 0.0 113.796 -172.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.415 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 18.7 ttp180 -111.06 143.88 41.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 53' ' ' SER . 36.5 m170 -94.6 140.99 29.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.73 23.21 12.26 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -173.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.569 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 41.7 mtm -115.58 143.34 45.47 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.758 0.313 . . . . 0.0 110.373 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.536 ' CG ' HD22 ' A' ' 98' ' ' LEU . 29.6 p90 -144.79 161.13 40.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.472 -176.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.1 pp -150.92 133.99 15.99 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.051 0.453 . . . . 0.0 110.415 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.51 113.78 38.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.853 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 12.1 ptt180 -114.29 168.83 9.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.08 128.21 33.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.3 t -85.0 163.1 19.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.27 0.557 . . . . 0.0 111.573 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.42 ' OG ' ' O1P' ' A' ' 207' ' ' PTR . 3.8 p -105.84 13.57 29.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.659 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.7 p -78.34 -52.71 8.2 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.128 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 47' ' ' ASP . 24.3 p -165.22 139.31 3.97 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.563 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.57 113.41 1.36 Allowed 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.918 2.412 . . . . 0.0 112.437 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 65' ' ' SER . . . 121.26 -20.34 8.46 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.528 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.5 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 32.4 t70 -86.37 152.14 22.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.411 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 35.7 m-85 -131.04 162.06 30.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.705 0.288 . . . . 0.0 110.991 -176.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.613 HG11 ' HE2' ' A' ' 207' ' ' PTR . 56.6 t -137.67 112.02 9.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.017 0.436 . . . . 0.0 111.227 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 36' ' ' PHE . 30.9 tp -85.85 100.67 12.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.189 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 59' ' ' SER . 61.2 m -96.72 134.23 40.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.053 0.454 . . . . 0.0 110.44 175.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.734 HG21 HD13 ' A' ' 93' ' ' LEU . 96.4 t -123.59 149.5 27.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.102 -174.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 1.079 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 33.5 t -123.0 98.21 5.79 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.681 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 0.9 OUTLIER -133.9 139.93 46.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.025 172.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 55.39 29.32 12.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.695 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.4 m 64.94 31.46 11.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.702 0.763 . . . . 0.0 111.1 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -124.18 120.71 33.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.668 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 25' ' ' GLN . 19.2 t -88.31 93.98 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.199 0.523 . . . . 0.0 110.215 -178.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 38.6 m -74.39 118.24 17.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.787 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 82.6 m-70 -102.16 94.38 5.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.467 -175.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.698 ' CE2' HD22 ' A' ' 93' ' ' LEU . 27.6 m-85 -101.97 115.27 30.18 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.566 0.222 . . . . 0.0 111.355 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 69.0 mt -80.55 133.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.73 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.4 mp -108.23 120.97 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 5.4 t-20 -107.29 133.17 52.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -165.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 25.7 t -77.64 97.32 5.07 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.06 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.5 mt -66.82 151.55 96.66 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 17.2 Cg_exo -66.91 73.57 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.298 1.999 . . . . 0.0 112.339 177.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 67' ' ' PRO . 28.6 t-20 85.71 1.39 0.67 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.985 165.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -80.65 -85.17 0.09 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.737 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.546 ' HD2' ' HG3' ' A' ' 77' ' ' GLU . 8.4 ptp85 -158.41 -168.32 2.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.169 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.417 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 47.8 m-85 -104.3 115.51 30.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.151 0.501 . . . . 0.0 110.56 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' A' ' 75' ' ' ASP . 87.6 tttt -103.65 107.95 19.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.769 -176.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.73 ' HB ' HG13 ' A' ' 63' ' ' ILE . 5.8 tt -96.69 88.68 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.603 0.716 . . . . 0.0 110.627 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.636 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 60.99 79.28 0.13 Allowed Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.346 177.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 211' ' ' GLN . 32.2 t70 73.36 -44.37 0.58 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.93 0.492 . . . . 0.0 112.016 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -66.39 148.49 51.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.059 0.457 . . . . 0.0 111.234 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.546 ' HG3' ' HD2' ' A' ' 70' ' ' ARG . 3.4 tp10 -110.42 116.81 32.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.166 -171.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 93.0 m-85 -131.73 141.99 49.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -76.46 -16.95 59.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.902 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 15.6 p80 -167.63 167.97 13.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.94 -0.118 . . . . 0.0 110.738 173.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.539 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 9.8 mt -52.46 -57.78 14.28 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 23.5 Cg_exo -67.53 13.66 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.35 2.033 . . . . 0.0 113.838 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -36.95 8.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.144 0.497 . . . . 0.0 109.981 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.5 pp -76.74 -27.84 55.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.657 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.73 -30.15 70.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.106 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.498 ' CD ' ' HZ2' ' A' ' 89' ' ' LYS . 29.8 mm-40 -83.1 -31.26 27.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.564 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -69.07 -39.52 79.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.939 0.4 . . . . 0.0 110.705 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.425 ' HE2' HD13 ' A' ' 73' ' ' ILE . 43.9 m-85 -77.7 -15.37 59.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.205 0.526 . . . . 0.0 110.598 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.498 ' HZ2' ' CD ' ' A' ' 86' ' ' GLU . 40.0 ttmt -66.81 -21.58 66.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.932 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.1 pt -116.42 18.43 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.937 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -111.24 -37.54 5.28 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.606 ' CD1' HG23 ' A' ' 97' ' ' THR . 54.7 m-85 71.11 102.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.786 0.679 . . . . 0.0 110.183 -173.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.734 HD13 HG21 ' A' ' 52' ' ' VAL . 2.9 mt -78.67 -19.32 52.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 110.728 -177.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.681 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 23.2 t70 -167.55 75.38 0.14 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.723 170.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 68.18 -22.69 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.133 0.973 . . . . 0.0 112.018 -176.545 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.563 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 18.9 m -117.39 154.29 31.59 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.606 HG23 ' CD1' ' A' ' 92' ' ' TYR . 14.1 p -95.21 -178.73 4.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.173 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.536 HD22 ' CG ' ' A' ' 36' ' ' PHE . 97.7 mt -69.98 88.54 0.58 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.468 HG22 ' HG3' ' A' ' 100' ' ' GLU . 33.2 mm -74.07 -65.04 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.237 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 35' ' ' MET . 46.1 mt-10 -144.32 153.79 56.33 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.202 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.3 151.87 80.09 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.18 1.92 . . . . 0.0 111.358 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -69.36 147.79 97.14 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.362 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 38.9 Cg_exo -61.32 116.92 3.71 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.628 2.219 . . . . 0.0 112.154 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.2 ttm180 -66.71 -33.05 74.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.107 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.487 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 28.8 p90 -109.97 125.92 30.11 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.213 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 13.2 Cg_exo -70.8 99.39 0.85 Allowed 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.825 2.35 . . . . 0.0 112.263 178.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 t -93.45 153.77 41.35 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.445 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.54 159.63 4.46 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.828 2.352 . . . . 0.0 112.441 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.07 68.27 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.529 2.82 . . . . 0.0 113.583 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 60.5 mtm -114.74 118.82 34.67 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.51 -51.5 3.98 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.246 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 56.5 m -78.43 5.87 9.72 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.692 -0.299 . . . . 0.0 111.567 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.4 p -84.81 -10.83 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.262 0.553 . . . . 0.0 109.834 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.9 m -66.59 129.77 40.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.814 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.56 111.4 53.83 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.994 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -88.7 -151.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.183 2.589 . . . . 0.0 112.094 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -57.38 106.8 0.36 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.669 ' H ' ' HD2' ' A' ' 119' ' ' PRO . 0.9 OUTLIER -122.68 -52.98 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.496 -176.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.669 ' HD2' ' H ' ' A' ' 118' ' ' LEU . 67.9 Cg_exo -40.51 106.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 123.328 2.686 . . . . 0.0 114.315 -175.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.3 m -140.09 118.25 11.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.675 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.03 -164.23 1.15 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.639 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.407 ' CD ' ' HE2' ' A' ' 190' ' ' HIS . 36.3 mt-10 -83.92 81.55 8.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.937 0.399 . . . . 0.0 112.034 -176.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.458 ' C ' ' HE ' ' A' ' 183' ' ' ARG . 0.0 OUTLIER -102.52 153.53 19.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 167.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -61.89 -76.13 0.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -170.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.638 HD12 HG21 ' A' ' 152' ' ' ILE . 3.2 mm? 62.32 -175.37 0.14 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.742 0.651 . . . . 0.0 111.98 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 7.3 tp10 62.45 -87.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.59 176.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -103.22 106.93 17.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.3 1.048 . . . . 0.0 112.253 -175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.581 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 55.9 t -119.6 162.25 18.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.779 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.576 ' HG2' HH11 ' A' ' 129' ' ' ARG . 0.8 OUTLIER -149.82 126.18 10.8 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.072 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.904 HG22 HG12 ' A' ' 178' ' ' VAL . 3.0 p -87.42 140.45 29.52 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -169.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 90.7 mt -110.63 -29.69 7.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.022 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 40.5 t80 -78.64 -30.48 46.42 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -170.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.543 ' HB2' ' HD3' ' A' ' 146' ' ' LYS . 14.1 t70 68.82 103.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.246 0.546 . . . . 0.0 110.185 -174.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 66.9 t80 -140.6 96.88 7.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.819 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 10.3 Cg_endo -92.29 100.79 0.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.048 2.499 . . . . 0.0 113.18 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 137' ' ' ASN . . . -96.41 2.59 63.07 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.855 174.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.61 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 73.81 -7.91 1.5 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.815 0.846 . . . . 0.0 111.552 -178.105 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.917 ' HB2' ' HD3' ' A' ' 143' ' ' PRO . 32.5 t0 62.85 162.88 0.1 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 158.87 -34.44 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 111.625 -2.534 . . . . 0.0 104.382 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.33 31.24 0.06 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.629 -2.078 . . . . 0.0 107.694 166.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 172' ' ' MET . 9.4 p-10 -163.1 85.59 0.52 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.79 -175.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.066 HD11 ' HB2' ' A' ' 165' ' ' ASN . 33.7 tp -64.96 132.85 95.6 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.931 -168.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 1.013 ' HD2' HD12 ' A' ' 142' ' ' LEU . 68.1 Cg_endo -80.6 86.71 1.6 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.487 2.791 . . . . 0.0 111.906 175.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.526 ' CG ' HG21 ' A' ' 130' ' ' THR . 10.0 p90 -97.3 156.78 16.29 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.786 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.729 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 2.8 mptp? -105.89 -171.0 1.82 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.001 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.543 ' HD3' ' HB2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -88.42 9.03 24.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.542 -177.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.99 27.12 0.63 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.312 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.729 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 5.9 mm-40 -98.5 150.78 21.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.83 0.315 . . . . 0.0 110.231 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.71 134.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.644 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 52.7 mt -119.68 155.8 31.7 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 42.5 t -122.0 126.48 74.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.84 HD13 ' HB2' ' A' ' 163' ' ' ALA . 32.9 mm -74.99 81.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.695 HG23 ' HG2' ' A' ' 154' ' ' GLU . 8.2 tt -69.01 -34.11 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.607 -173.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.695 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -131.49 139.66 49.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.546 ' HD2' HD11 ' A' ' 125' ' ' LEU . 74.3 tttt -119.7 86.0 34.34 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.021 0.438 . . . . 0.0 110.453 172.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 3.1 Cg_exo -77.26 -54.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.674 2.25 . . . . 0.0 111.682 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -109.17 -178.53 3.59 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -109.98 -22.58 11.77 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.115 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.561 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 24.3 pt20 -88.6 -21.72 23.88 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.101 0.476 . . . . 0.0 110.251 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.561 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 48.7 m95 -129.09 123.57 32.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.785 178.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.652 ' O ' HG13 ' A' ' 173' ' ' ILE . 38.2 m0 -112.53 133.58 54.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.319 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 54.0 m -86.26 99.71 11.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.26 0.553 . . . . 0.0 110.311 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.84 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.29 158.62 17.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 1.06 ' HD2' ' HA ' ' A' ' 210' ' ' PRO . 16.0 ptt-85 -104.61 135.42 46.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.039 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.066 ' HB2' HD11 ' A' ' 142' ' ' LEU . 55.5 t30 -73.87 -173.96 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.998 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -68.89 -13.88 62.7 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 170.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -81.99 -13.76 56.96 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.071 170.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.6 1.54 90.19 Favored Glycine 0 C--O 1.229 -0.182 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.502 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.718 ' HG2' ' OD2' ' A' ' 138' ' ' ASP . 38.5 ttm-85 -66.0 132.58 48.91 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.371 0.668 . . . . 0.0 110.069 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.48 HG21 HD13 ' A' ' 153' ' ' ILE . 59.5 t -104.62 106.4 20.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -173.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.627 ' HA3' ' OD1' ' A' ' 138' ' ' ASP . . . -140.98 168.34 25.35 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.266 175.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 26.0 mtp -81.35 136.85 35.76 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.9 pp -132.68 149.96 74.46 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 2.9 Cg_exo -76.15 132.3 13.8 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.106 2.537 . . . . 0.0 112.577 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.679 ' O ' HG22 ' A' ' 178' ' ' VAL . 41.0 t -61.12 -45.59 95.97 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 30.8 Cg_endo -64.47 -1.09 3.49 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.027 1.818 . . . . 0.0 113.774 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.02 -4.48 29.87 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.744 0.307 . . . . 0.0 111.287 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.904 HG12 HG22 ' A' ' 130' ' ' THR . 6.1 m -120.57 163.46 18.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -167.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 160.73 21.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.521 172.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -118.52 159.36 23.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.679 0.276 . . . . 0.0 110.582 -173.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.541 ' HG ' HG23 ' A' ' 182' ' ' VAL . 32.1 tp -75.18 -83.27 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.661 175.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.541 HG23 ' HG ' ' A' ' 181' ' ' LEU . 42.9 t -139.56 -82.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.645 0.259 . . . . 0.0 110.951 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.458 ' HE ' ' C ' ' A' ' 123' ' ' ASP . 2.9 tmm_? 70.07 -30.49 0.2 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.951 0.9 . . . . 0.0 111.841 -177.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 182' ' ' VAL . 16.2 t -61.53 128.71 37.6 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.628 ' HB3' ' HD2' ' A' ' 186' ' ' PRO . 11.2 m -152.84 177.51 1.91 Allowed Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 185' ' ' SER . 86.5 Cg_exo -47.49 -39.92 29.18 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.862 2.375 . . . . 0.0 113.036 172.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.421 ' CD2' ' HB2' ' A' ' 185' ' ' SER . 9.5 p80 -57.6 136.56 56.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.7 -3.17 80.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.407 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.409 ' HB3' ' HE2' ' A' ' 189' ' ' LYS . 52.8 mtpt 56.44 73.52 0.44 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.001 0.521 . . . . 0.0 111.491 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.407 ' HE2' ' CD ' ' A' ' 122' ' ' GLU . 57.1 m-70 -98.3 -46.99 5.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.367 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.19 -169.9 38.46 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.26 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 59.96 70.84 0.61 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.072 0.549 . . . . 0.0 110.978 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -115.18 97.85 6.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -117.0 -63.09 1.49 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 10.6 t -166.73 99.92 0.57 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.168 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -131.12 115.81 16.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.079 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.8 m -100.31 -23.32 14.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.826 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -148.97 141.1 23.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.398 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.22 110.35 2.26 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 34.5 pt -74.81 131.16 79.83 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.031 0.443 . . . . 0.0 111.51 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 7.2 Cg_exo -73.42 139.45 28.77 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.109 2.54 . . . . 0.0 111.749 176.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.611 ' HB3' ' HD3' ' A' ' 203' ' ' PRO . 6.2 tp10 -65.72 -51.63 48.02 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.663 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 202' ' ' GLU . 7.0 Cg_exo -74.82 30.04 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.5 2.134 . . . . 0.0 112.861 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -99.54 -34.03 10.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.031 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -87.22 -31.27 20.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.695 0.283 . . . . 0.0 111.377 -176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -116.17 159.83 21.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.509 . . . . 0.0 111.572 -173.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.613 ' HE2' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -113.89 33.42 5.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.433 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -64.35 133.33 95.62 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 1.06 ' HA ' ' HD2' ' A' ' 164' ' ' ARG . 94.9 Cg_exo -45.8 -51.71 7.9 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.162 2.575 . . . . 0.0 113.168 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.491 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -114.11 172.92 6.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.966 0.412 . . . . 0.0 111.017 179.47 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 8.9 t -128.12 155.14 44.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.401 176.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 27.9 m -69.39 117.6 11.22 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 41.3 m 68.97 94.01 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.755 -174.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.38 23.46 0.79 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 123.581 2.854 . . . . 0.0 112.588 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.638 ' HB3' ' HD3' ' A' ' 217' ' ' PRO . 64.2 tp -78.4 -53.22 1.33 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.014 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 216' ' ' LEU . 11.3 Cg_exo -72.36 16.5 0.38 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 122.717 2.278 . . . . 0.0 113.573 -176.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -89.09 90.35 8.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.861 0.363 . . . . 0.0 110.113 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.3 m -128.22 160.45 38.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.702 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.8 m -151.38 -158.39 0.9 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.93 -20.38 59.95 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.522 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.6 t 60.06 74.1 0.59 Allowed Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 123.049 0.54 . . . . 0.0 111.697 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.76 126.16 12.37 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.389 2.059 . . . . 0.0 111.495 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 159.83 -151.33 22.03 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -79.97 90.35 5.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.09 0.472 . . . . 0.0 110.65 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -98.85 2.56 46.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.903 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 67.4 mt 72.11 -62.18 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 O-C-N 123.661 0.601 . . . . 0.0 111.062 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.409 ' CG2' ' HD2' ' A' ' 229' ' ' PRO . 5.8 m -118.51 147.02 41.06 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.135 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.409 ' HD2' ' CG2' ' A' ' 228' ' ' THR . 25.6 Cg_endo -64.27 67.55 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.33 2.02 . . . . 0.0 112.136 172.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.687 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 57.3 tp -84.18 -50.15 0.63 Allowed Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.026 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 19.3 Cg_exo -66.92 89.63 0.3 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.909 1.739 . . . . 0.0 110.948 174.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 9.2 p -80.47 -75.42 0.27 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.234 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 43.0 p -132.65 132.28 42.26 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.81 0.338 . . . . 0.0 110.969 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -82.57 -43.54 16.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.931 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 63.7 -166.46 0.23 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.355 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.425 ' HA2' ' HD2' ' A' ' 237' ' ' PRO . . . -102.74 111.92 4.13 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 172.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.425 ' HD2' ' HA2' ' A' ' 236' ' ' GLY . 9.4 Cg_endo -52.16 120.79 7.8 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.247 2.631 . . . . 0.0 112.702 -176.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.532 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 35.3 t -78.51 133.38 30.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.597 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.86 115.26 27.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.165 0.507 . . . . 0.0 111.162 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.627 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.89 129.69 54.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.058 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -89.06 119.3 29.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.039 0.447 . . . . 0.0 110.498 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.917 ' HB1' ' HG2' ' A' ' 259' ' ' GLU . . . -78.42 119.56 21.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.675 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.635 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -109.5 -26.61 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -170.028 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.685 ' HG2' ' HG2' ' A' ' 245' ' ' LYS . 13.9 tt0 -93.92 -98.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.278 0.49 . . . . 0.0 111.339 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.685 ' HG2' ' HG2' ' A' ' 244' ' ' GLN . 24.4 pttm -175.45 107.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -177.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.567 ' H ' ' HB2' ' A' ' 259' ' ' GLU . 15.3 tpt180 -110.55 101.81 10.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.882 0.372 . . . . 0.0 111.491 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.9 m -124.0 117.75 27.05 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.879 173.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.763 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 30.0 Cg_endo -63.11 134.67 46.97 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.03 2.487 . . . . 0.0 113.212 -175.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 48.5 t -102.52 175.67 5.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.489 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.12 -26.43 62.64 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -70.93 -45.2 64.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 255' ' ' ALA . 0.9 OUTLIER -109.28 81.85 1.5 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.691 -174.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -83.06 -18.99 37.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.412 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.6 p -92.23 13.83 18.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.812 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.763 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -88.46 127.94 35.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.038 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -81.01 120.8 25.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.899 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.35 117.24 5.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.113 0.482 . . . . 0.0 110.45 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.438 ' H ' ' HB3' ' A' ' 246' ' ' ARG . 86.5 mt -143.46 -169.67 3.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.714 0.768 . . . . 0.0 111.333 -172.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.917 ' HG2' ' HB1' ' A' ' 242' ' ' ALA . 26.4 mt-10 79.62 -179.36 0.09 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 113.683 -1.599 . . . . 0.0 114.265 164.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 t 67.12 32.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.91 -172.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.05 38.89 2.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.126 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.72 137.6 44.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.298 . . . . 0.0 110.94 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.2 mm -89.64 106.95 17.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.143 0.497 . . . . 0.0 109.93 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.425 HG22 HD22 ' A' ' 258' ' ' LEU . 40.0 t -88.47 118.29 33.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.699 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -90.06 97.44 11.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.516 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 7.5 p -91.66 129.19 42.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 110.5 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.1 p -106.11 -38.17 6.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.536 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.587 ' NE ' ' HA ' ' A' ' 268' ' ' ARG . 2.2 mmp_? -124.46 114.09 19.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 111.084 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 50.1 mtt -95.41 113.88 25.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.196 0.522 . . . . 0.0 110.312 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -85.21 164.25 18.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.431 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.4 pt -88.72 7.37 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.185 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -88.25 -4.72 58.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.533 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 94.64 -47.02 2.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.554 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.513 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 43.3 mt-30 -81.05 124.93 29.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.247 0.546 . . . . 0.0 110.207 173.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -94.18 158.49 15.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.349 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 268' ' ' ARG . 9.4 pt-20 -115.27 125.34 53.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.59 0.709 . . . . 0.0 110.486 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -134.1 170.6 22.48 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.925 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.3 108.49 11.76 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.462 HG12 ' ND2' ' A' ' 280' ' ' ASN . 26.9 t -126.41 138.38 54.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.122 -175.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.462 ' ND2' HG12 ' A' ' 279' ' ' VAL . 52.8 m-80 71.82 -55.37 0.66 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.829 0.851 . . . . 0.0 110.669 -177.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 164.75 30.69 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -141.86 147.65 37.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -105.24 126.91 52.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.35 167.65 32.98 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.731 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 87.1 mt -95.38 142.04 28.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.687 0.279 . . . . 0.0 110.722 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 53.8 p90 -138.3 136.87 19.7 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.973 176.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 12.1 Cg_exo -71.9 141.7 37.5 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.737 2.292 . . . . 0.0 111.941 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -61.67 -15.82 43.39 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.284 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.2 t -86.22 -3.33 58.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 111.563 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -104.44 -11.15 17.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.774 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.488 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 26.9 m -128.04 158.44 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.956 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -121.09 120.15 34.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.607 178.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.627 HD13 ' HB2' ' A' ' 240' ' ' ALA . 47.3 mm -76.91 111.86 14.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.587 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -121.11 163.88 17.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.491 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.33 121.7 75.28 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.19 -13.07 36.99 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.708 2.272 . . . . 0.0 113.245 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.565 ' C ' ' HD3' ' A' ' 299' ' ' PRO . 30.4 mm-40 -84.39 93.92 8.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.275 0.56 . . . . 0.0 110.647 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.599 ' N ' ' HD3' ' A' ' 299' ' ' PRO . 1.3 t-20 -125.49 49.42 3.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.915 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 298' ' ' ASN . 76.9 Cg_endo -99.66 40.55 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.235 2.624 . . . . 0.0 110.974 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -64.08 -26.82 68.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.233 -173.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -81.42 81.54 7.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.589 0.709 . . . . 0.0 110.017 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -166.81 130.75 1.96 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.066 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.684 -179.577 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.52 0.2 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 p -92.65 129.64 38.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -67.55 -37.33 82.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.914 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.83 104.48 5.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.419 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.475 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 22.5 mmt180 -105.9 6.81 31.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.528 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.772 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 51.9 p90 -79.35 148.59 31.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 175.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -88.79 101.75 14.33 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.567 0.699 . . . . 0.0 110.635 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 50.6 m -63.82 169.9 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.567 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 8' ' ' SER . 43.0 t 76.73 -50.84 0.57 Allowed 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.593 0.558 . . . . 0.0 111.397 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.79 101.45 1.71 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.467 0.651 . . . . 0.0 110.342 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 75.6 mtt-85 -72.45 -17.28 61.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.568 -171.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -76.36 0.52 19.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.799 0.333 . . . . 0.0 110.836 173.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.58 -46.45 5.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.4 p-90 -115.39 -20.94 10.07 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -171.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 84.1 t80 -86.4 128.94 35.0 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.023 -0.423 . . . . 0.0 110.61 -176.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.541 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 20.1 mmt -109.43 -9.3 14.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 110.909 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.48 -116.6 4.87 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.629 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.86 105.44 0.55 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.558 2.172 . . . . 0.0 112.508 -175.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.696 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 79.2 t -139.02 -77.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.606 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.841 ' OG ' ' O3P' ' A' ' 207' ' ' PTR . 17.2 t 86.2 170.34 0.06 Allowed 'General case' 0 C--N 1.347 0.469 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -59.63 -39.4 84.19 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.512 -171.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.36 -38.62 91.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.559 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.618 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -85.72 -47.31 9.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.175 0.512 . . . . 0.0 110.775 -177.331 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.92 -40.56 76.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.656 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 52.0 tp60 -70.27 -39.61 74.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.0 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -78.87 -15.13 58.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.641 0.258 . . . . 0.0 111.43 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 90.8 mtt180 -83.57 -50.8 7.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.674 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.51 ' HA ' ' CG ' ' A' ' 31' ' ' GLN . 39.9 mt -94.22 13.36 23.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.052 -173.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 36.6 tt0 -71.08 87.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.103 0.478 . . . . 0.0 110.615 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.33 36.43 8.16 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.334 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.51 ' CG ' ' HA ' ' A' ' 28' ' ' LEU . 71.4 mm-40 -91.4 170.66 9.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 111.59 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -52.81 139.14 27.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.722 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.475 ' HB3' HG21 ' A' ' 96' ' ' THR . 39.1 m170 -70.03 116.41 10.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.949 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.45 -11.99 7.52 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.256 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 57.6 mtt -74.17 149.18 41.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.853 0.327 . . . . 0.0 110.562 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.611 ' HB2' HG22 ' A' ' 52' ' ' VAL . 23.2 p90 -157.16 166.48 33.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.319 177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.541 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -158.04 138.91 13.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.73 175.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.96 125.96 57.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.696 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 12.8 ptt-85 -123.12 162.16 23.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.77 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.29 127.58 32.88 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 172.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.659 ' HB2' HG23 ' A' ' 49' ' ' VAL . 18.8 t -101.34 154.27 18.94 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.188 0.518 . . . . 0.0 110.779 -174.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 p -91.69 -5.36 53.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.807 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -44.77 94.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.595 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.784 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 69.4 m -152.05 150.67 26.31 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.806 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.36 109.13 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.525 2.15 . . . . 0.0 111.658 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.96 0.26 55.02 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.455 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.784 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 13.4 t70 -85.92 151.38 23.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.813 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 35.0 m-85 -132.6 171.59 13.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.635 0.255 . . . . 0.0 110.964 -176.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 41' ' ' SER . 78.1 t -145.24 112.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.107 0.48 . . . . 0.0 110.515 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.417 ' HB2' HD11 ' A' ' 63' ' ' ILE . 42.6 tp -83.42 102.26 11.93 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.044 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 59' ' ' SER . 69.5 m -96.95 125.77 41.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.078 0.466 . . . . 0.0 110.391 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.611 HG22 ' HB2' ' A' ' 36' ' ' PHE . 70.2 t -125.25 138.59 53.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.675 -172.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 28' ' ' LEU . 33.3 t -102.89 98.51 8.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.207 0.527 . . . . 0.0 110.947 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.726 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 35.5 mt-10 -138.32 148.48 44.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.532 ' HB2' ' CG ' ' A' ' 94' ' ' ASP . 1.8 t-20 63.94 11.16 5.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.666 0.387 . . . . 0.0 111.111 -176.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.2 m 70.2 26.41 4.4 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.523 0.678 . . . . 0.0 110.367 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.846 ' NH2' ' HA ' ' A' ' 154' ' ' GLU . 43.8 ptt85 -124.34 151.58 44.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.9 t -93.37 97.49 7.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.037 0.446 . . . . 0.0 110.102 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 51' ' ' SER . 19.3 m -73.18 118.13 15.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.317 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.644 ' HB2' ' HB3' ' A' ' 208' ' ' ALA . 92.0 m-70 -101.19 115.02 29.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.406 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.756 ' CE2' HD22 ' A' ' 93' ' ' LEU . 52.5 m-85 -121.93 108.01 12.93 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.433 HG12 HG22 ' A' ' 49' ' ' VAL . 58.8 mt -70.21 132.0 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.813 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.2 mp -104.72 123.86 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.352 1.061 . . . . 0.0 109.848 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -106.59 142.59 36.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -78.72 108.95 12.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.153 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 96.3 mt -85.82 170.91 11.63 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 26.2 Cg_exo -63.76 62.34 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.972 2.448 . . . . 0.0 114.263 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 13.2 m120 93.13 -43.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.986 0.914 . . . . 0.0 112.718 161.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.644 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.53 -29.4 33.56 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -169.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 1.052 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 81.6 mtt180 -148.07 177.65 9.2 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -169.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -129.7 120.69 25.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.522 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HB2' HD11 ' A' ' 66' ' ' LEU . 24.9 ttpp -98.31 112.59 24.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 61' ' ' TYR . 19.6 tt -77.48 78.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 122.158 0.98 . . . . 0.0 109.723 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.696 ' HA3' ' HD2' ' A' ' 210' ' ' PRO . . . 79.95 -55.8 4.54 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.085 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.442 ' CB ' ' HB2' ' A' ' 210' ' ' PRO . 31.8 t70 -146.8 -48.02 0.19 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.91 0.385 . . . . 0.0 110.581 -170.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -77.22 129.15 35.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.008 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.491 ' HG2' ' HD3' ' A' ' 70' ' ' ARG . 38.1 tt0 -99.45 130.15 45.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.026 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -128.53 160.79 31.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 1.052 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 36.5 m-20 -64.78 -45.47 86.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.455 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 6.0 p80 -153.27 177.12 11.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.504 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.645 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.2 mt -57.79 -57.87 22.5 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.645 ' HA ' HD12 ' A' ' 85' ' ' LEU . 30.5 Cg_exo -63.88 -6.71 11.51 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.012 1.808 . . . . 0.0 112.82 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.455 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -89.12 -31.73 17.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.645 0.26 . . . . 0.0 110.797 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.61 -30.32 56.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 82' ' ' PRO . 48.8 mt -68.04 -28.79 67.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.03 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.16 -23.94 63.07 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.049 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -86.67 -38.64 16.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.318 0.58 . . . . 0.0 110.435 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.502 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 45.1 m-85 -75.95 -7.75 55.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.878 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.466 ' HB3' ' HE2' ' A' ' 89' ' ' LYS . 30.7 ttpt -63.96 -33.1 74.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.573 173.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mt -110.32 -17.74 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.994 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 19.6 t-160 -69.79 -35.95 75.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.512 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.849 ' HA ' HG22 ' A' ' 97' ' ' THR . 97.2 m-85 71.61 101.61 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 124.083 0.865 . . . . 0.0 109.752 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.756 HD22 ' CE2' ' A' ' 61' ' ' TYR . 13.0 mt -70.83 -13.96 62.23 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.311 0.577 . . . . 0.0 109.649 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.726 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 21.5 t70 -152.56 -64.01 0.16 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.873 169.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.588 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 11.9 t -165.9 3.43 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 33' ' ' HIS . 13.0 t -133.38 -13.57 2.66 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.567 -0.708 . . . . 0.0 112.162 176.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.849 HG22 ' HA ' ' A' ' 92' ' ' TYR . 16.7 p 71.13 -179.49 0.23 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.379 1.072 . . . . 0.0 112.131 178.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.42 HD22 ' CD2' ' A' ' 36' ' ' PHE . 65.8 mt -71.34 109.26 5.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.267 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.3 mm -101.19 -52.39 8.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.059 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.772 ' HA ' ' HB3' ' A' ' 6' ' ' PHE . 17.1 pt-20 -154.84 164.16 21.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.619 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.591 ' HD3' ' HB3' ' A' ' 6' ' ' PHE . 98.4 Cg_endo -82.81 151.13 14.48 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.919 1.746 . . . . 0.0 112.119 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.425 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -75.15 153.16 86.35 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.91 175.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.63 120.36 7.72 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.5 2.133 . . . . 0.0 111.349 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.27 4.75 33.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 110.989 -175.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -78.08 150.17 77.39 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.629 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.47 -13.81 36.01 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.202 1.934 . . . . 0.0 111.714 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 16.7 m -144.14 135.08 12.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.692 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 107' ' ' SER . 39.7 Cg_exo -60.57 147.42 94.58 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.641 2.228 . . . . 0.0 111.742 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.41 -69.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.691 2.261 . . . . 0.0 111.712 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 87.0 mtp -120.93 -51.08 2.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.166 0.508 . . . . 0.0 109.706 173.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.59 150.81 19.86 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.017 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.9 m -104.21 -7.36 20.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.067 0.461 . . . . 0.0 110.306 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -60.93 115.37 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.658 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.6 m -103.13 -173.94 2.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.29 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.498 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -75.78 -54.79 2.12 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.883 177.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 115' ' ' ALA . 74.1 Cg_endo -75.54 -169.1 0.61 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.841 1.694 . . . . 0.0 111.753 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.7 t30 67.66 80.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.675 0.75 . . . . 0.0 111.567 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 48.6 tp -142.7 103.0 5.36 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.23 125.54 13.73 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.307 2.671 . . . . 0.0 112.894 -175.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.0 m -66.33 -43.42 86.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.15 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -166.17 143.81 5.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.622 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.95 97.98 0.26 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.373 0.42 . . . . 0.0 110.203 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.779 ' HB2' HD23 ' A' ' 125' ' ' LEU . 9.2 p-10 -90.56 137.66 32.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.536 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.514 ' HB2' ' HG3' ' A' ' 183' ' ' ARG . 20.4 m120 -91.98 50.21 1.64 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.362 0.601 . . . . 0.0 110.269 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.946 HD12 HG21 ' A' ' 152' ' ' ILE . 4.3 mm? -79.29 107.97 12.46 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.506 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 30.1 tt0 -165.65 -66.72 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.511 ' HB3' HD13 ' A' ' 181' ' ' LEU . 58.1 m-85 -110.94 118.04 35.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.616 0.722 . . . . 0.0 112.006 -177.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.487 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 55.5 t -130.92 159.57 42.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.701 -175.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 129' ' ' ARG . 19.6 mtt180 -131.6 145.29 51.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.866 HG22 HG12 ' A' ' 178' ' ' VAL . 12.3 p -102.51 136.4 42.4 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.724 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 179' ' ' GLU . 5.3 mt -107.68 -27.67 10.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.901 -174.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.479 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 44.6 t80 -86.4 -37.27 18.55 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -170.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.527 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 14.4 t70 70.8 108.04 0.06 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.529 0.681 . . . . 0.0 109.844 -170.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 70.3 t80 -147.06 113.19 4.17 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.401 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.734 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 30.2 Cg_endo -92.16 100.41 0.19 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.711 2.274 . . . . 0.0 112.422 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -85.31 14.4 50.47 Favored Glycine 0 CA--C 1.516 0.095 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.174 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.2 m120 50.23 24.16 1.39 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.116 0.566 . . . . 0.0 112.447 -172.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.563 ' HB3' ' HD3' ' A' ' 169' ' ' ARG . 2.3 p30 46.86 -170.07 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.909 1.284 . . . . 0.0 114.157 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 75.76 -26.72 0.19 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.856 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.5 pt-20 -142.1 -30.56 0.57 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.07 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.488 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 5.6 m-20 -141.36 117.65 10.73 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.837 HD11 ' HB3' ' A' ' 165' ' ' ASN . 36.3 tp -67.81 136.25 92.38 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-O 120.718 0.294 . . . . 0.0 111.487 -173.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.734 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 1.0 OUTLIER -84.94 102.46 0.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.835 2.357 . . . . 0.0 110.661 172.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.673 ' CG ' HG21 ' A' ' 130' ' ' THR . 6.6 p90 -111.76 158.91 18.79 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.186 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.527 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -99.23 -179.43 4.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.756 -172.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -4.71 39.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -171.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.93 42.71 0.2 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.643 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -98.83 165.74 11.63 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.408 HD12 ' HE ' ' A' ' 129' ' ' ARG . 34.9 mm -99.9 138.38 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.521 HD22 ' HA ' ' A' ' 165' ' ' ASN . 29.4 mt -120.26 155.62 32.86 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 25.9 t -118.81 125.15 74.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.946 HG21 HD12 ' A' ' 125' ' ' LEU . 41.7 mm -75.13 95.84 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.265 1.031 . . . . 0.0 108.62 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.849 HG23 ' HG3' ' A' ' 154' ' ' GLU . 19.8 tt -89.71 -27.21 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.003 -171.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.919 ' HB2' ' HB3' ' A' ' 162' ' ' SER . 27.0 mt-10 -142.75 144.47 32.65 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.945 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 7.1 ttpm? -135.62 81.01 42.83 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 121.424 -0.798 . . . . 0.0 111.26 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.588 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 19.9 Cg_exo -68.23 -46.07 2.4 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.787 2.325 . . . . 0.0 112.298 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -117.99 -175.22 2.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.541 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.56 -28.53 9.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.041 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.515 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 4.2 pt20 -93.84 -13.2 27.53 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.197 0.522 . . . . 0.0 110.515 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.76 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 51.6 m95 -129.28 127.81 41.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.733 175.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.687 ' O ' HG13 ' A' ' 173' ' ' ILE . 48.9 m0 -118.16 140.62 49.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.43 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.919 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 7.6 t -96.15 99.38 11.12 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.77 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -114.05 156.33 24.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.869 0.366 . . . . 0.0 111.464 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.486 ' HD3' HD12 ' A' ' 153' ' ' ILE . 26.7 ptt-85 -100.41 131.56 46.26 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.837 ' HB3' HD11 ' A' ' 142' ' ' LEU . 0.1 OUTLIER -79.58 171.38 15.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.871 -179.017 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -72.37 -12.21 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.161 0.505 . . . . 0.0 110.314 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -80.13 -19.34 47.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.931 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.753 ' HA2' ' HB2' ' A' ' 211' ' ' GLN . . . 117.14 7.2 12.83 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 116.696 1.438 . . . . 0.0 116.696 169.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.645 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -123.52 155.79 36.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.511 1.655 . . . . 0.0 111.903 -177.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.92 143.8 11.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.106 -175.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -166.23 161.43 35.07 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.76 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.2 OUTLIER -74.23 137.95 43.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.845 0.355 . . . . 0.0 110.968 179.263 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -135.24 143.73 46.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.371 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 3.9 Cg_exo -77.01 134.04 14.21 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.7 2.267 . . . . 0.0 112.096 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.564 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 17.8 t -62.85 -43.45 82.84 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.078 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 34.5 Cg_endo -65.9 7.44 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 122.283 1.989 . . . . 0.0 113.651 175.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.0 m-85 -109.09 -6.56 15.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.697 0.284 . . . . 0.0 111.097 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.866 HG12 HG22 ' A' ' 130' ' ' THR . 26.3 m -127.62 166.46 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -168.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.681 ' HB2' HD21 ' A' ' 131' ' ' LEU . 4.1 mm-40 -125.41 163.75 21.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.577 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -111.21 144.13 40.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.511 HD13 ' HB3' ' A' ' 127' ' ' TYR . 4.3 mp -62.81 -75.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 110.439 172.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.1 m -138.78 129.92 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.716 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.514 ' HG3' ' HB2' ' A' ' 124' ' ' ASN . 18.1 ttt-85 -124.03 84.45 2.28 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.0 m -153.16 157.26 40.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.564 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.48 143.88 34.79 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.64 102.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.839 2.36 . . . . 0.0 112.503 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -126.34 -24.96 3.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.147 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.23 -66.02 3.91 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.565 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -86.48 61.84 7.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.241 0.543 . . . . 0.0 110.975 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -86.6 -9.88 55.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.506 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 94.38 25.0 17.21 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.045 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -133.53 163.82 28.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 195' ' ' SER . 0.3 OUTLIER -121.89 154.04 37.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -71.63 -24.96 61.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -173.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 193' ' ' ARG . 78.9 p 54.76 -87.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.917 0.887 . . . . 0.0 111.756 -175.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -68.13 115.82 8.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.606 0.717 . . . . 0.0 109.089 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 6.1 m -97.77 165.21 12.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.27 -172.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -84.95 92.79 8.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -144.79 87.78 0.17 Allowed Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 13.8 pt -117.3 148.78 43.33 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.485 0.183 . . . . 0.0 110.606 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.34 -41.1 52.72 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.054 2.503 . . . . 0.0 112.635 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 8.9 pt-20 -132.63 132.19 22.55 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 6.7 Cg_exo -72.77 81.17 1.64 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.109 2.54 . . . . 0.0 113.369 -173.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -81.21 -12.41 59.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.14 0.495 . . . . 0.0 110.05 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 39.1 m80 69.98 -88.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.662 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 178.24 -62.82 0.01 OUTLIER 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.793 0.683 . . . . 0.0 110.175 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.841 ' O3P' ' OG ' ' A' ' 20' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.644 ' HB3' ' HB2' ' A' ' 60' ' ' HIS . . . -139.53 131.15 27.24 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.4 172.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.421 HE21 HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -165.28 147.0 6.36 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.696 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 88.4 Cg_exo -48.12 -46.92 20.93 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 121.903 1.735 . . . . 0.0 111.404 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.763 ' HG3' ' H ' ' A' ' 212' ' ' THR . 7.0 tp60 -178.39 -155.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 172.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.763 ' H ' ' HG3' ' A' ' 211' ' ' GLN . 6.3 p -129.07 -173.15 2.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.9 p -60.11 -62.57 1.77 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.821 0.343 . . . . 0.0 111.351 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.947 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 36.5 m -143.77 -58.89 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.967 176.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.947 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 78.2 Cg_endo -98.8 -176.9 0.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.707 2.271 . . . . 0.0 111.13 171.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.867 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 6.5 mp -94.47 -57.23 0.22 Allowed Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.867 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 4.6 Cg_endo -88.79 158.43 6.15 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.448 2.099 . . . . 0.0 111.402 172.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -69.94 152.12 44.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.079 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' ' 219' ' ' VAL . 12.4 t 63.9 13.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.534 0.683 . . . . 0.0 111.616 176.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 19.4 m -96.22 10.84 36.54 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.813 -0.554 . . . . 0.0 111.043 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -135.22 104.56 0.51 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.772 ' HB3' ' HD3' ' A' ' 223' ' ' PRO . 22.9 t -96.28 -61.39 0.14 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 222' ' ' SER . 53.0 Cg_exo -53.48 118.66 5.11 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.445 2.097 . . . . 0.0 112.909 -174.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 113.06 -66.79 0.25 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.84 -39.18 69.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.194 0.521 . . . . 0.0 110.52 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -111.12 112.87 24.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.92 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 9.1 tt -55.29 -39.77 53.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.726 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 17.5 m 58.05 89.76 0.1 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.231 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.87 -6.16 16.27 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.964 2.443 . . . . 0.0 112.94 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.561 ' N ' ' HD3' ' A' ' 231' ' ' PRO . 95.2 mt 61.07 55.41 3.31 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.207 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 230' ' ' LEU . 4.9 Cg_exo -75.76 -57.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.331 2.021 . . . . 0.0 111.215 176.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 48.8 m -102.44 102.19 12.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.656 175.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 13.0 p -76.22 97.32 4.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.905 -176.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -101.57 81.04 2.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.457 0.646 . . . . 0.0 110.028 174.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -151.37 171.41 17.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.362 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 139.44 94.02 0.27 Allowed Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.47 86.79 0.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.431 2.087 . . . . 0.0 111.979 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.7 t -93.24 142.83 12.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.612 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.05 125.71 53.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.139 0.495 . . . . 0.0 110.804 -174.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.748 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -127.59 131.78 49.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.883 176.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -86.99 125.43 34.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.574 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -78.2 104.1 8.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.228 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.606 HG13 ' HG3' ' A' ' 244' ' ' GLN . 29.1 pt -83.14 -11.89 12.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.072 0.463 . . . . 0.0 111.229 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.606 ' HG3' HG13 ' A' ' 243' ' ' ILE . 24.7 mt-30 -124.68 165.27 18.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.463 ' HB3' HG13 ' A' ' 260' ' ' VAL . 24.4 pttm -128.72 144.4 51.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.129 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.86 150.51 4.69 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.744 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.492 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 29.4 m -101.67 166.53 12.08 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.822 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.614 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 44.0 Cg_endo -95.31 174.99 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.68 2.92 . . . . 0.0 113.793 -176.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.708 ' HB3' ' HD3' ' A' ' 253' ' ' LYS . 50.6 t -171.04 136.15 1.07 Allowed 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.129 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -44.67 -45.28 9.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.688 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -91.74 58.99 3.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.0 t70 89.72 31.85 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.425 1.583 . . . . 0.0 111.687 162.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.708 ' HD3' ' HB3' ' A' ' 249' ' ' CYS . 2.8 mptp? -114.2 45.63 1.48 Allowed 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 104.354 -2.461 . . . . 0.0 104.354 147.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 7.0 p -53.65 -21.74 7.44 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 122.819 1.295 . . . . 0.0 107.943 169.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 285' ' ' LEU . . . -8.62 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 111.311 -2.677 . . . . 0.0 113.262 152.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.58 ' O ' ' HG ' ' A' ' 258' ' ' LEU . 1.7 tt -75.12 118.79 18.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.614 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -55.97 121.42 9.28 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 123.477 0.485 . . . . 0.0 110.527 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 256' ' ' LEU . 96.2 mt -136.18 136.54 40.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.785 -175.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -98.89 -176.68 3.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.316 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' A' ' 245' ' ' LYS . 17.5 m -86.79 132.64 31.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.956 0.408 . . . . 0.0 110.683 176.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 86.06 0.7 87.06 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.518 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.55 152.99 25.75 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.738 0.304 . . . . 0.0 110.724 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.7 mm -97.79 114.7 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.461 HG22 HD22 ' A' ' 258' ' ' LEU . 21.2 t -97.15 107.63 20.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.626 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -93.56 114.53 26.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 11.6 p -88.37 143.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.969 0.414 . . . . 0.0 110.677 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 30.0 m -98.74 -49.02 4.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.89 0.376 . . . . 0.0 110.266 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.515 ' HG3' ' HB3' ' A' ' 276' ' ' GLU . 3.3 ptp180 -132.45 118.84 19.83 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.096 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 47.1 mtt -89.62 110.8 21.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.128 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -131.62 139.7 49.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.415 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 52.3 mt 56.81 84.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.84 168.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 60.37 -29.14 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 166.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.626 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 165.24 -7.55 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.624 -1.274 . . . . 0.0 114.038 -177.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -85.78 77.05 9.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.558 0.679 . . . . 0.0 109.634 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.458 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 23.3 m0 -93.25 158.77 15.58 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.273 -170.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.515 ' HB3' ' HG3' ' A' ' 268' ' ' ARG . 40.9 tt0 -113.87 116.09 28.75 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.45 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -124.05 170.96 16.29 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.491 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.02 109.17 13.19 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.48 -86.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.531 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.12 66.98 8.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.188 0.518 . . . . 0.0 111.771 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 72.8 -2.49 32.51 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.456 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.53 ' NH1' ' H ' ' A' ' 257' ' ' ALA . 2.5 ptm180 -142.44 153.71 43.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.874 0.368 . . . . 0.0 110.983 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 20.3 pttp -104.48 142.01 35.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.766 173.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -160.19 -178.9 34.6 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.56 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.661 ' O ' ' HA ' ' A' ' 255' ' ' ALA . 91.3 mt -95.98 140.31 30.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.615 0.245 . . . . 0.0 110.961 -177.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 40.1 p90 -140.38 140.33 22.74 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 4.1 Cg_exo -79.85 142.79 16.02 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.702 2.268 . . . . 0.0 111.505 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.626 ' CD1' ' HA3' ' A' ' 273' ' ' GLY . 21.1 p90 -65.97 -15.43 62.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.9 m -77.54 -16.15 58.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.391 0.615 . . . . 0.0 110.541 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -86.81 -24.09 25.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.379 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 242' ' ' ALA . 30.4 m -127.7 178.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.663 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -140.56 119.42 12.58 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.748 HD13 ' HB2' ' A' ' 240' ' ' ALA . 39.3 mm -60.43 122.36 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.812 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.733 ' HD2' ' HD2' ' A' ' 296' ' ' PRO . 2.3 p90 -145.83 179.71 7.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.843 -173.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.512 ' HB3' ' HD3' ' A' ' 296' ' ' PRO . 28.5 t70 -110.9 -46.06 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.733 ' HD2' ' HD2' ' A' ' 294' ' ' PHE . 94.0 Cg_exo -49.58 39.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 124.821 3.681 . . . . 0.0 118.735 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.424 HE21 ' HB3' ' A' ' 297' ' ' GLN . 0.9 OUTLIER -97.83 -27.11 14.45 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.579 ' HB2' ' HD3' ' A' ' 299' ' ' PRO . 1.8 m-20 -65.38 -58.22 12.69 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.964 -174.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 298' ' ' ASN . 85.6 Cg_endo -82.27 16.25 1.82 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.13 1.887 . . . . 0.0 113.638 -171.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.22 -21.17 62.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.233 0.54 . . . . 0.0 110.05 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -73.96 -13.06 60.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.646 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -121.44 -179.28 4.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.864 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.354 -0.832 . . . . 0.0 109.814 177.29 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 p -84.94 -10.84 56.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.471 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 m 69.13 -56.25 0.54 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.869 0.73 . . . . 0.0 111.197 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.646 ' HB3' ' HE3' ' A' ' 89' ' ' LYS . . . -77.76 96.47 4.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.179 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -123.66 94.7 4.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.998 -177.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -156.56 154.08 29.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.235 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -75.44 91.88 2.8 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.987 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 14.4 t -74.86 68.71 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.204 0.526 . . . . 0.0 110.068 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 t -179.62 -44.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.445 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -59.34 105.64 0.37 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.007 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 7.6 tpp180 -60.29 -32.35 71.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.549 -174.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.4 m -82.57 -1.36 50.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.644 0.259 . . . . 0.0 111.57 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.49 -45.61 8.05 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.326 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -117.94 -29.4 5.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.458 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 65.0 t80 -79.62 113.04 17.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.133 0.492 . . . . 0.0 110.696 -176.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.514 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 23.1 mmt -94.66 -2.86 50.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.051 -175.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.07 -114.21 3.09 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.663 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.63 96.75 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.015 2.477 . . . . 0.0 113.042 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.921 HG12 ' H ' ' A' ' 20' ' ' SER . 7.4 t -142.62 -161.15 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.921 ' H ' HG12 ' A' ' 19' ' ' VAL . 23.2 t 178.32 177.46 0.43 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -170.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.504 ' HG3' ' O2P' ' A' ' 207' ' ' PTR . 36.0 mtp85 -54.58 -61.6 2.2 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.75 -44.54 95.93 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.279 0.362 . . . . 0.0 111.336 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.465 ' HA ' HG22 ' A' ' 26' ' ' THR . 40.3 mt-10 -62.17 -47.51 84.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.345 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.85 -34.45 69.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 0.0 111.281 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.679 ' HG3' HG21 ' A' ' 58' ' ' VAL . 5.4 tt0 -81.88 -34.66 29.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.051 -175.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 23' ' ' GLU . 11.3 t -82.46 -14.7 54.63 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -104.39 -18.6 14.36 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.773 0.797 . . . . 0.0 110.878 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.788 HD13 ' HB2' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -132.54 33.01 3.83 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 123.647 1.689 . . . . 0.0 108.095 -174.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -58.18 177.52 0.12 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.229 173.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.454 ' HA2' ' OG ' ' A' ' 53' ' ' SER . . . -73.58 53.02 1.96 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.813 -176.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -78.31 -38.17 42.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.415 0.626 . . . . 0.0 109.893 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 22.7 ttp180 -144.67 128.46 17.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.773 ' HE1' ' HB2' ' A' ' 117' ' ' ASN . 63.9 m170 -83.84 132.54 34.8 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.903 0.382 . . . . 0.0 110.607 -176.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.34 10.93 22.9 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.695 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.681 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 56.0 mtm -97.96 147.36 24.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' CD2' HD22 ' A' ' 98' ' ' LEU . 41.7 p90 -143.53 163.04 34.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.025 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.575 HD23 ' CB ' ' A' ' 28' ' ' LEU . 4.1 pp -150.36 134.3 16.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.968 0.413 . . . . 0.0 110.175 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.6 t -102.27 123.33 55.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.879 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 22.6 ptt-85 -126.57 153.42 45.27 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.571 -172.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HA ' ' HD1' ' A' ' 48' ' ' TYR . 38.2 t70 -75.89 107.95 8.43 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 170.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.519 ' HB2' HG23 ' A' ' 49' ' ' VAL . 13.3 t -79.42 178.22 8.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.679 -168.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.8 m -125.12 17.55 8.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.951 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.478 HG23 ' O1P' ' A' ' 207' ' ' PTR . 0.3 OUTLIER -79.46 -47.94 14.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.25 0.547 . . . . 0.0 109.584 177.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.3 m -144.18 152.93 55.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.296 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.69 87.19 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.139 1.893 . . . . 0.0 111.674 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.52 15.57 2.97 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.967 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.98 155.09 19.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.289 0.544 . . . . 0.0 109.802 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.419 ' HD1' ' HA ' ' A' ' 40' ' ' ASP . 44.8 m-85 -127.2 159.91 32.86 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 62' ' ' ILE . 40.6 t -135.03 108.69 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.117 175.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.63 103.15 7.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.478 173.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 59' ' ' SER . 70.9 m -95.67 135.37 37.45 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.136 177.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 93' ' ' LEU . 92.8 t -127.73 134.38 65.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.579 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.454 ' OG ' ' HA2' ' A' ' 30' ' ' GLY . 29.2 t -100.28 112.42 24.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.744 0.307 . . . . 0.0 111.327 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.57 ' OE1' ' HB3' ' A' ' 33' ' ' HIS . 10.6 tp10 -157.34 140.76 15.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.176 175.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.465 ' ND2' ' HZ1' ' A' ' 155' ' ' LYS . 30.2 m-80 48.3 39.38 12.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.469 0.707 . . . . 0.0 112.899 -176.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.9 m 66.98 18.44 10.58 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.1 173.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 57' ' ' ARG . 14.6 ptt180 -124.51 133.19 53.4 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.679 HG21 ' HG3' ' A' ' 25' ' ' GLN . 46.0 t -93.69 97.23 6.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.747 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 25.3 m -68.99 117.66 10.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.328 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 80.1 m-70 -101.26 92.56 5.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.95 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.695 ' CE2' HD22 ' A' ' 93' ' ' LEU . 37.4 m-85 -97.15 114.85 26.59 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.951 0.157 . . . . 0.0 111.056 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.779 HG12 HG22 ' A' ' 49' ' ' VAL . 28.8 mt -81.99 135.98 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -175.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.764 HG13 ' HB ' ' A' ' 73' ' ' ILE . 5.3 mp -117.38 123.81 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.292 1.037 . . . . 0.0 109.692 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -106.25 135.49 47.63 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.06 -0.4 . . . . 0.0 110.263 -173.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.0 t -80.29 108.63 14.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.006 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.6 mt -80.62 142.91 53.9 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.22 -17.97 49.27 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.728 2.286 . . . . 0.0 112.014 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.52 10.36 7.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.06 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 67.96 29.55 6.45 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.609 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -116.95 159.68 22.08 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.409 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 46.7 m-85 -118.84 115.55 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.188 0.518 . . . . 0.0 111.612 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 21.5 ttmm -104.15 109.02 20.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.027 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.764 ' HB ' HG13 ' A' ' 63' ' ' ILE . 7.6 tt -96.47 87.52 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.75 0.786 . . . . 0.0 110.557 177.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.98 75.74 0.43 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.901 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' N ' ' HB ' ' A' ' 212' ' ' THR . 25.7 t0 76.25 -52.69 0.61 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.111 0.564 . . . . 0.0 111.507 175.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -70.56 111.8 6.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.45 0.643 . . . . 0.0 110.41 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 8.6 pt-20 -95.68 128.91 42.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.938 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.547 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 89.3 m-85 -119.19 175.08 5.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.683 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.28 -51.05 63.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.18 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -156.2 -177.57 6.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.486 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.6 mt -56.62 -54.56 52.4 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.546 ' HA ' HD12 ' A' ' 85' ' ' LEU . 52.9 Cg_exo -58.77 -10.38 9.4 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.132 1.888 . . . . 0.0 113.614 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.21 -34.93 16.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.677 0.275 . . . . 0.0 110.919 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.8 pp -76.24 -27.03 56.61 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 82' ' ' PRO . 61.3 mt -67.89 -24.23 65.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.821 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 48.8 mt-10 -91.02 -9.41 46.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.762 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.682 ' HE1' ' CZ ' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -97.8 -29.66 13.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 176.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.682 ' CZ ' ' HE1' ' A' ' 87' ' ' PHE . 26.7 m-85 -78.03 -13.28 59.93 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.787 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.646 ' HE3' ' HB3' ' A' ' 4' ' ' ALA . 21.7 ptmt -74.01 -16.68 61.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.588 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.503 ' H ' HD13 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -116.77 25.35 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.937 169.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -114.06 -41.62 3.5 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.248 -0.282 . . . . 0.0 111.662 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.599 ' CD1' HG23 ' A' ' 97' ' ' THR . 93.4 m-85 73.16 96.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.96 0.788 . . . . 0.0 110.624 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.695 HD22 ' CE2' ' A' ' 61' ' ' TYR . 2.2 mt -74.57 -13.89 60.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.062 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 95' ' ' THR . 20.0 t70 -172.45 63.02 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.609 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER 74.05 -25.15 0.2 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.114 -175.198 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 94' ' ' ASP . 41.7 m -114.52 146.18 41.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.599 HG23 ' CD1' ' A' ' 92' ' ' TYR . 16.7 p -90.97 -176.03 4.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.408 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.45 HD22 ' CD2' ' A' ' 36' ' ' PHE . 82.2 mt -69.61 96.39 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 38.5 mm -84.39 -55.08 7.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.031 0.443 . . . . 0.0 110.525 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.681 ' O ' ' HA ' ' A' ' 35' ' ' MET . 45.6 tt0 -162.32 141.75 7.24 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.454 -177.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.415 ' HD2' ' HG3' ' A' ' 100' ' ' GLU . 12.1 Cg_endo -56.66 153.23 37.17 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.738 2.292 . . . . 0.0 112.914 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.788 ' HB2' HD13 ' A' ' 28' ' ' LEU . . . -73.58 153.84 89.64 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.598 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.24 115.22 2.42 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.448 2.098 . . . . 0.0 112.22 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -58.1 -32.66 68.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.206 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 83.2 t80 -137.88 126.23 14.35 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 171.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 19.8 Cg_exo -65.75 86.08 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.66 2.24 . . . . 0.0 112.008 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.718 ' HB2' ' HD3' ' A' ' 108' ' ' PRO . 49.4 m -71.49 -53.67 7.42 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.446 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.718 ' HD3' ' HB2' ' A' ' 107' ' ' SER . 59.5 Cg_endo -90.73 155.09 4.16 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.094 1.862 . . . . 0.0 112.212 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.1 174.05 11.23 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.638 2.226 . . . . 0.0 112.036 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -73.31 112.97 9.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.072 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -91.29 175.46 39.45 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.705 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.0 t -111.78 165.38 12.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.781 0.324 . . . . 0.0 110.808 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 t 51.84 50.56 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.962 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.0 t -124.28 18.05 9.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.477 ' HB1' ' CE1' ' A' ' 33' ' ' HIS . . . -162.82 112.66 1.07 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.204 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.3 -81.0 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.719 2.28 . . . . 0.0 112.818 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.773 ' HB2' ' HE1' ' A' ' 33' ' ' HIS . 3.6 t-20 60.71 -179.46 0.1 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.147 0.498 . . . . 0.0 111.05 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.56 ' H ' ' ND2' ' A' ' 117' ' ' ASN . 5.9 mp -128.8 80.13 73.24 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 172.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.444 ' HA ' ' OE2' ' A' ' 122' ' ' GLU . 74.4 Cg_endo -75.59 50.78 2.79 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.007 2.471 . . . . 0.0 111.901 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.8 t -133.79 16.15 3.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.941 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.18 -44.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.876 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.444 ' OE2' ' HA ' ' A' ' 119' ' ' PRO . 7.0 mm-40 53.86 37.3 26.19 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.503 0.668 . . . . 0.0 109.506 -173.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -70.17 147.22 50.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.941 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -80.16 83.04 6.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.899 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.803 HD12 HG21 ' A' ' 152' ' ' ILE . 3.4 mm? -81.42 91.73 6.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.693 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 12.7 pt-20 -170.09 -59.14 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.073 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.562 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 15.1 m-85 -102.01 108.76 20.29 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.704 0.764 . . . . 0.0 111.666 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 65.0 t -130.18 154.98 41.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.057 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.581 ' NH2' HD13 ' A' ' 181' ' ' LEU . 14.1 ptp180 -135.74 137.6 41.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.848 0.356 . . . . 0.0 110.108 175.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.956 HG22 HG12 ' A' ' 178' ' ' VAL . 31.4 p -90.28 137.32 32.45 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.236 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.9 mt -113.19 -24.59 9.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.519 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 44.4 t80 -89.3 -34.77 16.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 27.1 t70 76.62 122.35 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.89 0.744 . . . . 0.0 111.171 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 80.9 t80 -156.98 107.59 1.93 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.781 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.748 ' HB3' ' HB3' ' A' ' 222' ' ' SER . 57.5 Cg_endo -87.52 97.55 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.594 2.196 . . . . 0.0 112.651 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.581 ' HA3' ' HB2' ' A' ' 141' ' ' ASP . . . -87.57 -6.51 77.03 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.077 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.84 22.76 12.8 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.998 0.519 . . . . 0.0 111.932 -175.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.674 ' CB ' ' HD3' ' A' ' 169' ' ' ARG . 2.4 p30 54.94 -173.37 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 168.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 77.48 -34.93 0.21 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 113.341 -1.754 . . . . 0.0 109.785 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 172' ' ' MET . 33.9 tt0 -133.69 -29.47 1.33 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.139 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.581 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 22.4 m-20 -138.26 111.39 7.89 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.049 HD11 ' HB2' ' A' ' 165' ' ' ASN . 25.9 tp -66.22 119.6 63.26 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 120.562 0.22 . . . . 0.0 110.612 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.561 ' HD2' ' HD2' ' A' ' 169' ' ' ARG . 29.2 Cg_endo -71.98 105.03 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.895 1.73 . . . . 0.0 111.335 174.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.629 ' CG ' HG21 ' A' ' 130' ' ' THR . 7.8 p90 -115.23 163.85 15.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 -177.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -97.2 -170.51 2.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.14 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.72 11.18 29.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.193 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.71 39.84 0.2 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.476 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -105.23 155.11 19.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.747 0.273 . . . . 0.0 110.453 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.39 137.43 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 165' ' ' ASN . 43.4 mt -125.42 160.71 28.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 22.0 t -122.83 131.67 72.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.803 HG21 HD12 ' A' ' 125' ' ' LEU . 32.7 mm -74.02 91.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.984 0.897 . . . . 0.0 109.433 -175.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.778 HG23 ' HG2' ' A' ' 154' ' ' GLU . 0.6 OUTLIER -74.61 -45.39 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.891 -176.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.778 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -129.81 139.94 51.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 174.11 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.712 ' HD3' ' HG ' ' A' ' 125' ' ' LEU . 0.7 OUTLIER -126.86 86.81 57.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.989 174.766 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.609 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 7.3 Cg_exo -77.4 -61.61 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.063 2.509 . . . . 0.0 113.64 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -97.05 -175.36 3.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 0.0 111.867 -169.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -90.32 -52.53 4.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.67 -178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.1 0.18 51.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.966 0.412 . . . . 0.0 110.915 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.664 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 57.0 m95 -129.53 124.71 34.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.159 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.687 ' O ' HG13 ' A' ' 173' ' ' ILE . 51.5 m0 -121.91 145.47 48.06 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.5 m -100.24 99.72 10.44 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.144 0.497 . . . . 0.0 109.742 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.618 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -105.45 160.9 14.79 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.131 -176.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.751 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 22.3 ptt-85 -101.32 128.95 47.25 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.501 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.049 ' HB2' HD11 ' A' ' 142' ' ' LEU . 66.7 t30 -65.52 164.14 14.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.097 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 15.3 tptp -67.86 -11.47 58.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.454 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.99 -4.53 46.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.939 0.4 . . . . 0.0 110.448 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.28 75.28 1.28 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.393 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.751 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 5.4 ttm-85 -155.36 135.07 12.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.359 0.123 . . . . 0.0 111.117 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.55 HG22 HG21 ' A' ' 153' ' ' ILE . 66.5 t -103.3 117.82 49.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.792 0.33 . . . . 0.0 111.361 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.44 166.92 30.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.866 173.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.664 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -79.72 138.35 37.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.702 0.287 . . . . 0.0 110.829 179.498 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -137.71 145.44 48.7 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.461 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 6.3 Cg_exo -80.28 136.81 11.56 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.95 2.433 . . . . 0.0 112.873 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.54 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 98.8 t -64.08 -42.62 70.22 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.436 177.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 37.4 Cg_endo -67.49 10.75 0.25 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.015 1.81 . . . . 0.0 113.06 175.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' A' ' 175' ' ' VAL . 3.3 m-85 -113.65 -5.93 13.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.716 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.956 HG12 HG22 ' A' ' 130' ' ' THR . 20.2 m -132.18 163.84 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.425 0.631 . . . . 0.0 112.614 -167.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -128.47 161.35 29.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.815 172.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 180' ' ' LYS . 3.2 mppt? -100.87 137.72 38.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.266 -175.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.581 HD13 ' NH2' ' A' ' 129' ' ' ARG . 65.5 tp -82.06 -41.81 20.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.774 -178.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.42 103.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.841 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.441 ' HB3' ' H ' ' A' ' 184' ' ' SER . 3.7 ttt180 -167.36 -92.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.051 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.441 ' H ' ' HB3' ' A' ' 183' ' ' ARG . 41.9 t 173.24 106.66 0.01 OUTLIER 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.006 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 11.0 p -71.23 167.74 27.11 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.72 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.78 97.94 0.1 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.079 1.853 . . . . 0.0 112.177 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -105.67 -44.5 4.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.91 -53.94 4.78 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.209 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -86.26 15.47 5.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.938 0.399 . . . . 0.0 110.539 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -86.96 81.3 8.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.131 0.491 . . . . 0.0 110.202 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -160.02 63.64 0.29 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.398 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.57 ' ND2' ' HB3' ' A' ' 195' ' ' SER . 0.2 OUTLIER -66.74 165.72 14.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.38 109.16 4.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.255 -175.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 72.89 -60.74 0.53 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.846 0.716 . . . . 0.0 112.339 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.57 ' HB3' ' ND2' ' A' ' 192' ' ' ASN . 79.5 p 52.68 -162.45 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.783 0.833 . . . . 0.0 111.255 -173.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.56 160.77 26.33 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 19.9 m -75.33 134.67 40.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.679 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -119.56 158.64 25.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.21 -20.89 1.22 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.96 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 10.7 tt -62.4 120.91 63.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.537 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.32 115.63 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.363 2.042 . . . . 0.0 112.403 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.404 ' O ' ' HD2' ' A' ' 205' ' ' HIS . 1.8 pm0 -79.34 167.02 37.64 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.198 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -62.0 -7.64 10.16 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.245 2.63 . . . . 0.0 113.126 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.6 -27.87 68.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.21 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.404 ' HD2' ' O ' ' A' ' 202' ' ' GLU . 49.3 m-70 -79.52 74.65 6.17 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -76.56 89.27 3.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.649 -174.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.504 ' O2P' ' HG3' ' A' ' 21' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.416 ' HB3' ' H ' ' A' ' 60' ' ' HIS . . . -143.37 23.75 1.8 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.119 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 18.2 pt20 -66.63 145.57 98.96 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.867 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 209' ' ' GLN . 24.2 Cg_exo -64.47 -18.98 64.79 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.482 2.121 . . . . 0.0 112.193 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.555 ' HG2' ' H ' ' A' ' 212' ' ' THR . 46.3 tt0 69.06 174.34 0.29 Allowed 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.732 0.645 . . . . 0.0 110.011 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.555 ' H ' ' HG2' ' A' ' 211' ' ' GLN . 8.1 t -169.93 128.18 0.9 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.86 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.2 m 42.98 77.96 0.06 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.394 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.867 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 26.3 m -137.37 -60.75 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.235 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.867 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 7.1 Cg_exo -74.39 -175.79 2.41 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.018 1.812 . . . . 0.0 111.417 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 11.2 mp -69.98 130.22 90.12 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 52.0 Cg_exo -56.24 151.65 42.64 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.033 2.488 . . . . 0.0 112.342 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -75.95 81.59 2.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.15 0.5 . . . . 0.0 110.982 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 47.7 t -86.74 -46.42 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.593 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 2.7 p -103.68 137.83 41.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.109 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 139.07 -132.99 5.95 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.748 ' HB3' ' HB3' ' A' ' 135' ' ' PRO . 39.7 m -125.88 84.12 61.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.937 0.399 . . . . 0.0 110.968 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 224' ' ' GLY . 97.2 Cg_endo -96.97 -148.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.74 2.96 . . . . 0.0 112.277 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 223' ' ' PRO . . . -137.5 172.94 22.54 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 177.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.16 -31.36 64.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.755 0.277 . . . . 0.0 110.715 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 71.69 -53.51 0.68 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.623 0.769 . . . . 0.0 111.922 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 34.5 pt -63.86 146.64 12.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.821 0.343 . . . . 0.0 110.477 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.825 HG22 ' HD2' ' A' ' 231' ' ' PRO . 1.8 m -140.38 63.58 22.61 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 121.091 0.472 . . . . 0.0 110.278 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.19 38.07 0.67 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.21 2.606 . . . . 0.0 113.139 -171.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.92 ' HB3' ' HD3' ' A' ' 231' ' ' PRO . 57.5 tp -133.75 -60.88 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.663 178.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.92 ' HD3' ' HB3' ' A' ' 230' ' ' LEU . 3.1 Cg_endo -87.93 11.94 3.0 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.522 2.148 . . . . 0.0 111.739 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 8.8 t -149.9 -169.3 3.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -65.21 132.61 49.56 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 123.44 0.462 . . . . 0.0 111.17 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.414 ' HB2' HE21 ' A' ' 234' ' ' GLN . 1.1 mp0 -74.9 -31.72 61.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.771 -175.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 64.36 86.77 0.12 Allowed 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.637 0.585 . . . . 0.0 110.597 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -74.84 151.41 42.66 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.103 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.49 162.07 38.32 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.587 2.191 . . . . 0.0 112.193 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.411 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 21.6 t -89.08 134.03 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.775 ' HE2' ' HB3' ' A' ' 296' ' ' PRO . 0.1 OUTLIER -118.29 123.04 44.41 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.087 -171.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.585 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -124.62 158.69 32.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.098 0.475 . . . . 0.0 112.082 -170.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.735 ' HE3' ' HA2' ' A' ' 261' ' ' GLY . 54.4 tttp -102.23 130.85 49.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.498 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -75.44 104.68 6.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.551 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.864 HD12 ' HG3' ' A' ' 244' ' ' GLN . 2.7 pp -82.45 -15.44 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.226 0.536 . . . . 0.0 110.833 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.864 ' HG3' HD12 ' A' ' 243' ' ' ILE . 23.5 mt-30 -123.98 -172.05 2.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.229 172.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -124.5 169.42 11.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.521 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 57.6 mtp85 -148.78 125.85 11.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.342 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.443 ' HB ' ' HD2' ' A' ' 248' ' ' PRO . 29.3 m -118.33 157.22 49.76 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.487 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 247' ' ' VAL . 28.8 Cg_endo -63.55 108.08 0.81 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.465 2.11 . . . . 0.0 112.932 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.738 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 42.1 t -84.92 171.45 12.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.75 -40.24 75.42 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -104.0 3.78 33.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.162 0.506 . . . . 0.0 110.577 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.738 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.0 OUTLIER -104.0 51.08 0.78 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.259 178.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.62 -23.6 64.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.321 0.581 . . . . 0.0 109.787 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 13.9 p -95.65 16.3 17.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.913 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.723 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -81.2 128.4 33.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.654 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.58 127.28 31.96 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 172.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -83.33 117.84 23.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.083 0.468 . . . . 0.0 109.96 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.594 HD21 HG21 ' A' ' 279' ' ' VAL . 58.2 mt -131.81 160.18 36.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.915 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 262' ' ' ASP . 48.6 mt-10 -132.8 167.88 19.38 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.01 131.11 31.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.331 0.586 . . . . 0.0 111.291 -175.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.735 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 92.17 3.88 67.17 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.205 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 0.7 OUTLIER -85.38 160.01 19.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.943 0.401 . . . . 0.0 110.722 -175.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.739 HG23 ' HE1' ' A' ' 239' ' ' PHE . 18.5 mm -95.61 123.36 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.494 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.51 96.72 4.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.131 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -79.71 87.28 5.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 275' ' ' TRP . 2.4 p -87.01 118.12 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.871 0.843 . . . . 0.0 111.133 -175.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.5 m -103.09 -18.44 14.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.761 -171.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.779 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 36.2 ttm-85 -129.97 103.52 6.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.772 0.32 . . . . 0.0 110.915 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . 0.411 ' HE3' ' HB ' ' A' ' 238' ' ' VAL . 58.5 mtt -102.98 118.68 37.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.875 0.369 . . . . 0.0 110.412 178.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -86.51 1.57 51.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 75.1 mt 74.51 -39.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.398 0.679 . . . . 0.0 112.581 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -63.16 -16.3 59.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 129.96 -27.4 4.08 Favored Glycine 0 CA--C 1.506 -0.501 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.647 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -85.02 113.45 21.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.04 0.447 . . . . 0.0 109.959 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.571 ' HB3' HG21 ' A' ' 266' ' ' VAL . 51.2 m0 -109.42 145.07 36.76 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.084 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.779 ' HB3' ' HB3' ' A' ' 268' ' ' ARG . 41.9 tt0 -100.97 114.92 29.26 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.96 149.58 18.16 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.297 -176.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -121.52 108.99 14.27 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.594 HG21 HD21 ' A' ' 258' ' ' LEU . 42.1 t -115.82 -98.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.245 -175.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -99.81 82.89 2.66 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.655 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.7 5.81 32.9 Favored Glycine 0 CA--C 1.517 0.167 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.202 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.404 ' NH1' ' H ' ' A' ' 257' ' ' ALA . 56.4 mtp180 -128.06 129.08 46.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.852 0.358 . . . . 0.0 110.977 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 28.6 ttpp -115.32 111.2 20.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.223 174.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -143.48 -174.66 15.93 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.052 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.14 144.59 27.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.144 0.497 . . . . 0.0 111.5 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.558 ' HE2' HG21 ' A' ' 291' ' ' VAL . 44.3 p90 -148.64 142.57 16.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.683 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 3.2 Cg_exo -77.2 145.21 24.12 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.539 2.16 . . . . 0.0 111.632 176.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -62.96 -14.73 50.89 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.577 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.3 p -72.24 -8.66 56.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -107.56 -8.36 16.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.482 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.558 HG21 ' HE2' ' A' ' 286' ' ' PHE . 34.9 m -128.62 164.29 31.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.832 ' HG2' HG12 ' A' ' 243' ' ' ILE . 31.4 mmtp -137.29 139.68 41.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 174.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 240' ' ' ALA . 47.1 mm -78.81 118.19 25.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 13.3 p90 -121.06 163.83 17.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.84 0.352 . . . . 0.0 110.324 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.909 ' HB3' ' HB2' ' A' ' 298' ' ' ASN . 4.2 m-20 -93.66 106.75 22.71 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.987 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.775 ' HB3' ' HE2' ' A' ' 239' ' ' PHE . 54.4 Cg_endo -72.56 -50.08 0.24 Allowed 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.422 2.081 . . . . 0.0 113.097 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -141.82 38.08 1.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 122.183 0.992 . . . . 0.0 108.529 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.909 ' HB2' ' HB3' ' A' ' 295' ' ' ASP . 2.6 m-20 -97.18 -54.01 0.21 Allowed Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.554 -172.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 298' ' ' ASN . 2.8 Cg_exo -77.04 -5.12 15.59 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.389 2.059 . . . . 0.0 112.763 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -137.68 172.76 12.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -133.49 16.29 4.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.27 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -113.48 112.85 24.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.103 0.478 . . . . 0.0 111.852 -169.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.433 -0.794 . . . . 0.0 109.089 171.453 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.582 ' SD ' ' HB2' ' A' ' 100' ' ' GLU . 58.6 mtt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.907 0.384 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -98.15 -78.78 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.9 t -99.88 80.26 2.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.722 0.296 . . . . 0.0 111.171 -175.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 51.81 46.99 25.67 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.046 174.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 5' ' ' ARG . 48.1 mtm105 -121.9 81.44 1.82 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.749 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.491 ' CE1' ' HD3' ' A' ' 89' ' ' LYS . 31.3 p90 -113.55 161.18 17.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.433 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.44 -45.31 94.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.631 ' HB3' ' HB3' ' A' ' 82' ' ' PRO . 63.1 m 67.72 157.61 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.762 0.664 . . . . 0.0 109.999 -169.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.6 t 72.64 -49.94 0.7 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.989 0.516 . . . . 0.0 111.491 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -50.98 101.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.34 0.59 . . . . 0.0 111.591 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -40.22 73.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.249 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -78.62 8.97 4.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.667 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.91 -47.62 4.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.708 0.29 . . . . 0.0 111.022 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -121.03 -25.87 5.25 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -86.46 115.46 23.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.93 0.395 . . . . 0.0 110.692 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.1 mtt -113.13 6.59 17.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.107 0.48 . . . . 0.0 110.779 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.0 -115.23 3.36 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.006 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 25.5 Cg_exo -63.95 103.75 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.697 2.265 . . . . 0.0 111.914 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.605 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 54.4 t -135.58 -75.26 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.732 -176.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.745 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 55.9 m 84.99 176.02 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 122.743 0.417 . . . . 0.0 110.141 166.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.725 ' HD3' ' O3P' ' A' ' 207' ' ' PTR . 26.6 mmm180 -40.65 -61.76 0.89 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.054 0.846 . . . . 0.0 111.782 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -55.17 -56.84 15.41 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.941 0.776 . . . . 0.0 112.007 -173.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.6 -42.92 60.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.253 -169.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.26 -52.8 63.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.197 -176.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.581 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 12.9 pt20 -70.89 -32.81 69.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.151 -176.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.598 ' HA ' ' OE1' ' A' ' 29' ' ' GLN . 39.5 m -66.73 -34.3 77.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 111.354 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.514 ' HD2' ' O ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -63.22 -35.39 80.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.82 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.052 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 23.6 mt -99.61 13.0 35.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.045 -173.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.598 ' OE1' ' HA ' ' A' ' 26' ' ' THR . 27.3 mt-30 -73.65 96.71 2.52 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.88 5.07 89.7 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.738 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -82.43 -162.26 0.55 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.946 0.373 . . . . 0.0 110.15 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.491 HH21 ' CD ' ' A' ' 100' ' ' GLU . 14.5 mtm180 -62.78 131.51 49.1 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.185 0.517 . . . . 0.0 111.352 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -73.72 114.66 12.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.474 173.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.08 -16.86 4.4 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.124 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.608 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 62.2 mtt -67.7 142.71 56.24 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.711 0.291 . . . . 0.0 111.544 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.498 ' CB ' HG22 ' A' ' 52' ' ' VAL . 40.2 p90 -140.24 160.04 40.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.016 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -151.1 141.74 22.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.967 0.413 . . . . 0.0 110.627 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.51 124.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.461 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.745 ' HD2' ' H ' ' A' ' 20' ' ' SER . 9.2 ptt180 -122.17 161.7 22.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.189 -173.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.3 113.17 18.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.449 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.1 t -73.51 140.5 46.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.703 -171.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 t -78.96 -13.46 59.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.351 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.0 p -68.03 -48.5 65.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.107 0.479 . . . . 0.0 109.983 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.4 m -146.95 103.45 3.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.163 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.7 116.58 3.09 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.59 2.193 . . . . 0.0 111.216 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.38 -30.89 5.26 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -172.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 3.2 m-20 -86.18 168.87 13.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 171.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.768 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 32.0 m-85 -135.52 174.02 11.07 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.684 -171.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.449 HG23 ' HB2' ' A' ' 41' ' ' SER . 58.5 t -143.27 112.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.175 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.509 ' HB2' HD11 ' A' ' 63' ' ' ILE . 46.0 tp -83.54 99.84 10.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.254 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' SER . 68.4 m -97.11 135.14 39.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.528 177.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 93' ' ' LEU . 81.9 t -132.09 142.39 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.553 -173.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 1.052 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 42.3 t -102.01 113.86 27.46 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.882 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.692 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 18.0 pt-20 -156.86 145.99 20.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.0 p30 43.3 31.39 0.38 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.732 0.813 . . . . 0.0 112.714 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.8 m 63.71 63.82 0.82 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.534 0.683 . . . . 0.0 111.234 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 29.3 ptt180 -160.3 166.34 29.66 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.638 HG23 ' HA ' ' A' ' 117' ' ' ASN . 34.3 t -119.45 90.85 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.081 0.467 . . . . 0.0 109.941 175.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.581 ' O ' ' HA ' ' A' ' 51' ' ' SER . 3.6 m -63.14 116.28 5.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.597 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.611 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 99.1 m-70 -102.86 97.04 7.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.683 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.628 ' HB3' HD11 ' A' ' 73' ' ' ILE . 82.7 m-85 -105.38 113.06 26.42 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.904 -0.134 . . . . 0.0 111.097 177.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.714 ' HB ' ' CB ' ' A' ' 207' ' ' PTR . 19.0 tt -77.53 139.34 18.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.768 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.5 mp -109.4 122.74 64.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.789 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.549 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 11.2 m120 -110.16 126.31 53.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.911 0.386 . . . . 0.0 110.211 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 p -80.67 100.89 8.91 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.02 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.848 HD12 ' HG2' ' A' ' 70' ' ' ARG . 96.3 mt -66.34 130.06 94.2 Favored Pre-proline 0 CA--C 1.51 -0.595 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -40.26 -68.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.166 2.577 . . . . 0.0 113.658 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -123.25 31.77 5.87 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.001 0.905 . . . . 0.0 108.605 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.775 HH21 HD22 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -131.24 -91.33 0.43 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.596 -173.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.848 ' HG2' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -157.81 -170.4 3.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.051 -167.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -97.62 130.22 44.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.339 0.59 . . . . 0.0 110.323 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.624 ' HD3' HD21 ' A' ' 66' ' ' LEU . 44.9 tttm -123.48 103.33 8.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.309 -173.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.628 HD11 ' HB3' ' A' ' 61' ' ' TYR . 15.0 tt -74.13 86.23 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.842 0.829 . . . . 0.0 111.049 -173.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 1.021 ' HA3' ' HA ' ' A' ' 209' ' ' GLN . . . 77.04 -34.73 1.47 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.784 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -168.08 -51.29 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.648 0.261 . . . . 0.0 110.46 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -80.87 121.28 25.78 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.436 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.8 pt-20 -94.86 143.28 26.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.289 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.515 ' HE1' ' CG2' ' A' ' 73' ' ' ILE . 91.2 m-85 -115.4 -77.37 0.57 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.688 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD2' ' HD2' ' A' ' 80' ' ' HIS . 11.7 t70 -177.11 -54.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.458 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.482 ' HD2' ' OD2' ' A' ' 79' ' ' ASP . 10.8 p80 -147.77 177.64 9.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.486 176.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 11.6 mt -58.84 -59.11 14.8 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.631 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 44.6 Cg_exo -60.05 -7.38 6.26 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.279 1.986 . . . . 0.0 113.427 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.414 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -87.88 -23.01 24.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.94 0.4 . . . . 0.0 110.963 -177.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -88.09 -28.76 21.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 82' ' ' PRO . 77.7 mt -68.21 -25.76 65.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.849 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.663 ' HA ' ' HE2' ' A' ' 89' ' ' LYS . 10.1 pt-20 -85.78 -15.58 41.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -79.8 -37.69 34.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.512 0.672 . . . . 0.0 110.116 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.463 ' HE2' HD13 ' A' ' 73' ' ' ILE . 60.3 m-85 -78.88 2.79 18.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.082 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.663 ' HE2' ' HA ' ' A' ' 86' ' ' GLU . 52.2 mtmt -86.37 -5.79 59.09 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.793 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 -27.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.087 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -79.39 -19.59 49.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.235 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.615 ' CD2' HG23 ' A' ' 97' ' ' THR . 54.5 m-85 67.28 174.32 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -168.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 52' ' ' VAL . 4.2 mt -114.27 2.04 14.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 165.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.418 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 15.7 t70 -178.07 -121.76 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.502 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.539 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.1 t -94.01 -3.96 50.46 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.1 m -120.3 141.68 49.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.52 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.615 HG23 ' CD2' ' A' ' 92' ' ' TYR . 18.6 p -94.8 178.92 5.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 174.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.512 ' CD2' HD11 ' A' ' 93' ' ' LEU . 83.0 mt -69.48 101.85 1.67 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 51.1 mm -86.02 -65.07 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.79 -176.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 35' ' ' MET . 5.7 pm0 -150.37 155.96 36.88 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.221 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.71 145.79 70.69 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.43 2.087 . . . . 0.0 111.726 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -69.62 147.4 96.56 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.426 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.514 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 25.0 Cg_exo -63.66 127.76 20.55 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.356 2.037 . . . . 0.0 111.184 175.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -74.83 78.33 2.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.431 0.634 . . . . 0.0 109.79 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -139.74 115.35 8.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.267 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.81 138.3 37.34 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.854 2.369 . . . . 0.0 111.701 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.5 m 60.55 86.76 0.15 Allowed Pre-proline 0 C--O 1.234 0.249 0 O-C-N 123.713 0.633 . . . . 0.0 111.343 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.99 156.5 54.21 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.067 2.511 . . . . 0.0 112.508 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.54 -25.94 54.86 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.506 2.138 . . . . 0.0 112.369 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 70.6 mtm -130.28 -178.8 4.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.381 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.57 -74.13 2.13 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.386 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.4 m 65.56 -62.3 0.23 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.642 0.777 . . . . 0.0 111.715 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.523 HG23 ' H ' ' A' ' 114' ' ' SER . 0.1 OUTLIER -145.11 -88.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.271 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.523 ' H ' HG23 ' A' ' 113' ' ' VAL . 32.2 m 64.26 -166.34 0.23 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.23 0.538 . . . . 0.0 111.924 171.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.608 ' N ' ' HD2' ' A' ' 116' ' ' PRO . . . -87.2 -44.31 0.52 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.379 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 115' ' ' ALA . 9.2 Cg_endo -51.32 95.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.522 2.148 . . . . 0.0 113.303 177.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.638 ' HA ' HG23 ' A' ' 58' ' ' VAL . 8.6 t-20 -179.37 172.94 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.505 ' HB2' ' H ' ' A' ' 58' ' ' VAL . 34.9 tp -163.18 81.74 1.54 Allowed Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 175.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.676 ' HA ' HH21 ' A' ' 21' ' ' ARG . 3.1 Cg_endo -86.35 -37.67 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.757 2.305 . . . . 0.0 109.501 165.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.505 ' H ' ' HD2' ' A' ' 119' ' ' PRO . 38.1 m -156.52 159.84 38.95 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.731 ' CB ' ' HB2' ' A' ' 126' ' ' GLU . . . -64.94 0.18 1.31 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 121' ' ' ALA . 7.9 tp10 72.24 -64.8 0.38 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.915 0.388 . . . . 0.0 110.754 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -143.41 -43.31 0.29 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.638 -173.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.463 ' O ' ' HB1' ' A' ' 121' ' ' ALA . 59.8 t30 -141.85 165.96 26.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.733 -174.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.592 HD12 HG21 ' A' ' 152' ' ' ILE . 4.1 mm? 70.38 73.97 0.21 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.504 0.722 . . . . 0.0 111.397 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.731 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . 4.9 tp10 -164.72 -81.31 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.38 -173.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -104.97 114.63 28.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.339 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.563 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 53.7 t -128.73 133.47 66.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.128 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.413 HH21 HD11 ' A' ' 149' ' ' ILE . 1.1 ptp180 -111.29 141.28 45.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.132 0.491 . . . . 0.0 110.922 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.829 HG22 HG12 ' A' ' 178' ' ' VAL . 7.3 p -93.49 139.61 30.53 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.426 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.429 HD11 ' CG ' ' A' ' 179' ' ' GLU . 16.7 mt -110.32 -27.46 9.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.464 -173.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 53.3 t80 -83.09 -37.47 23.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -171.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.676 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 17.7 t70 75.13 107.92 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.697 0.623 . . . . 0.0 110.33 -174.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 83.6 t80 -139.82 100.7 7.29 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 8.2 Cg_endo -89.03 78.37 1.09 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.018 2.478 . . . . 0.0 112.502 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -78.64 -22.41 66.93 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.162 176.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 49.53 55.01 10.02 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.47 -0.865 . . . . 0.0 112.815 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -153.48 171.39 18.77 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.687 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -79.86 -16.07 56.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.147 0.498 . . . . 0.0 110.929 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.43 -10.19 17.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.604 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.419 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 66.9 m-20 -135.73 92.14 2.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.847 HD11 ' HB2' ' A' ' 165' ' ' ASN . 46.8 tp -67.91 122.66 84.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.807 0.337 . . . . 0.0 110.793 -175.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.682 ' HD2' HD12 ' A' ' 142' ' ' LEU . 66.2 Cg_endo -71.62 99.68 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.403 2.069 . . . . 0.0 111.066 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.585 ' CG ' HG21 ' A' ' 130' ' ' THR . 6.3 p90 -116.49 155.67 28.22 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.85 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.676 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 52.8 mttp -101.7 176.17 5.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.15 -174.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.945 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -83.65 69.5 10.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.956 0.884 . . . . 0.0 109.421 176.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.5 23.43 0.73 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.591 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 145' ' ' LYS . 8.1 tp10 -92.93 153.53 18.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.722 HD12 HD21 ' A' ' 181' ' ' LEU . 43.1 mm -104.61 128.21 58.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.487 HD13 HD23 ' A' ' 142' ' ' LEU . 18.2 mt -122.65 159.02 28.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 42.1 t -117.01 129.02 74.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.728 HD13 ' HB2' ' A' ' 163' ' ' ALA . 38.3 mm -75.81 93.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.815 0.817 . . . . 0.0 109.641 -175.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.705 HG21 HG22 ' A' ' 170' ' ' VAL . 8.6 tp -91.04 -33.56 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.001 -172.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.061 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 19.3 mt-10 -132.02 143.63 50.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -145.32 75.06 13.91 Favored Pre-proline 0 C--N 1.323 -0.585 0 O-C-N 121.66 -0.65 . . . . 0.0 111.093 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.539 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 14.0 Cg_exo -68.28 -40.11 8.97 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.716 2.277 . . . . 0.0 111.678 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -112.26 -178.51 3.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.098 -175.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -110.27 -18.19 13.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.31 0.576 . . . . 0.0 109.599 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -88.88 -30.35 18.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.96 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.741 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 36.8 m95 -128.97 134.53 48.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.473 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.762 ' O ' HG13 ' A' ' 173' ' ' ILE . 41.5 m0 -124.82 135.21 52.73 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.906 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 1.061 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.6 m -85.62 101.74 12.97 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.728 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -106.59 161.74 14.36 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 122.058 -0.401 . . . . 0.0 110.404 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.568 ' HG2' ' HB ' ' A' ' 151' ' ' VAL . 15.2 ptt180 -105.32 133.57 49.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.82 0.343 . . . . 0.0 110.317 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.847 ' HB2' HD11 ' A' ' 142' ' ' LEU . 60.2 t30 -64.71 170.41 4.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.905 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.408 ' HG3' ' OE1' ' A' ' 148' ' ' GLU . 8.9 mtmm -61.79 -16.34 48.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.11 0.481 . . . . 0.0 110.515 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.55 -1.8 58.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.283 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.42 -8.37 79.92 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.343 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.765 ' HA ' ' HB3' ' A' ' 211' ' ' GLN . 7.0 ttp-105 -68.59 129.24 39.36 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.803 -0.234 . . . . 0.0 111.103 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.705 HG22 HG21 ' A' ' 153' ' ' ILE . 73.5 t -89.73 128.53 41.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -153.17 149.02 20.51 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.025 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.741 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -69.5 130.62 42.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.755 0.312 . . . . 0.0 110.432 178.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.762 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -133.29 146.78 62.32 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.364 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 4.0 Cg_exo -77.39 134.54 14.11 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.724 2.283 . . . . 0.0 112.28 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 66.9 t -65.47 -40.83 45.54 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 27.4 Cg_endo -63.61 -4.56 7.16 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.824 1.683 . . . . 0.0 112.973 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-85 -96.69 -6.05 37.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.407 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.829 HG12 HG22 ' A' ' 130' ' ' THR . 15.5 m -126.6 163.92 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -168.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.429 ' CG ' HD11 ' A' ' 131' ' ' LEU . 4.7 mm-40 -139.87 163.94 31.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.587 170.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.525 ' HD3' ' N ' ' A' ' 180' ' ' LYS . 2.8 mppt? -98.97 137.86 36.91 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.573 0.225 . . . . 0.0 110.908 -172.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -53.85 -80.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.569 HG23 ' H ' ' A' ' 184' ' ' SER . 10.7 m -111.08 -30.6 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -171.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.52 ' O ' ' HB2' ' A' ' 184' ' ' SER . 3.8 tpt180 66.56 20.05 10.83 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.442 0.464 . . . . 0.0 110.532 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.569 ' H ' HG23 ' A' ' 182' ' ' VAL . 12.1 t 169.87 124.28 0.01 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.07 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.46 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 2.6 p -78.37 140.85 60.82 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 43.8 Cg_exo -56.89 108.71 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.146 2.564 . . . . 0.0 112.968 -178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -123.85 -5.98 7.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.308 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.69 -50.96 2.93 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -171.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -84.12 -28.93 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.527 . . . . 0.0 109.789 172.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.457 ' HB3' ' OG ' ' A' ' 184' ' ' SER . 90.4 m-70 -115.88 153.54 31.35 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.566 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 86.38 -100.83 2.56 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -139.53 140.14 37.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -83.52 159.97 21.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.223 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.6 m120 74.78 -30.65 0.2 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.375 0.67 . . . . 0.0 111.979 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 12.6 p -76.0 74.28 2.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.569 0.7 . . . . 0.0 109.613 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -84.44 -5.81 59.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.927 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 19.2 t -138.39 143.38 39.77 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -160.66 -58.16 0.06 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.99 0.424 . . . . 0.0 110.391 -176.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -153.16 172.57 32.1 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.952 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.916 ' HB ' ' HD3' ' A' ' 201' ' ' PRO . 68.3 mt -128.75 -63.44 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.618 -0.141 . . . . 0.0 110.618 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.916 ' HD3' ' HB ' ' A' ' 200' ' ' ILE . 5.3 Cg_exo -78.15 127.7 8.56 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.389 2.059 . . . . 0.0 112.398 -177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -122.49 99.7 42.28 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.417 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.83 48.19 2.76 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 123.473 2.782 . . . . 0.0 112.371 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -161.69 -164.06 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.189 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 73.2 t60 61.75 29.93 18.21 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.566 0.698 . . . . 0.0 110.202 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.64 -175.34 5.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.0 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.737 ' O1P' ' HE1' ' A' ' 207' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.491 ' HA ' ' NH1' ' A' ' 164' ' ' ARG . . . 70.51 -71.53 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.335 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 1.021 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 51.9 mt-30 58.67 63.99 3.68 Favored Pre-proline 0 C--N 1.326 -0.428 0 O-C-N 123.601 0.563 . . . . 0.0 110.374 -171.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 73' ' ' ILE . 8.2 Cg_exo -72.66 145.45 41.59 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.061 2.508 . . . . 0.0 113.013 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.765 ' HB3' ' HA ' ' A' ' 169' ' ' ARG . 31.6 tt0 -133.69 125.9 29.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.05 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 213' ' ' THR . 11.8 m -100.9 176.82 5.15 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.565 ' H ' HG22 ' A' ' 212' ' ' THR . 17.2 m -64.33 92.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.003 0.43 . . . . 0.0 110.836 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 90.7 m -93.61 113.87 61.45 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.308 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.52 115.96 3.5 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.864 2.376 . . . . 0.0 111.979 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 47.9 tp -80.85 112.82 35.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.181 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 12.2 Cg_endo -90.62 21.19 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.385 2.724 . . . . 0.0 112.49 -177.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -144.55 168.3 20.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.025 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 10.8 p -100.98 -32.28 3.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 12.9 t 67.24 -70.05 0.12 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 117.45 152.2 9.47 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.733 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.2 m -151.02 72.83 8.63 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 120.649 0.261 . . . . 0.0 110.869 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.85 -17.1 15.87 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.383 2.055 . . . . 0.0 112.166 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 96.0 -174.64 31.64 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.59 140.15 46.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.748 0.274 . . . . 0.0 110.579 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.05 -44.75 53.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.403 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 20.3 pt -79.24 124.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.54 174.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.9 m -104.9 104.64 47.55 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 227' ' ' ILE . 5.2 Cg_exo -79.77 127.81 7.3 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.252 2.635 . . . . 0.0 112.042 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.542 HD11 HG23 ' A' ' 233' ' ' THR . 1.9 tm? -69.2 119.99 73.83 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 232' ' ' SER . 23.3 Cg_exo -64.05 -82.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.611 2.208 . . . . 0.0 112.382 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.454 ' H ' ' HB2' ' A' ' 231' ' ' PRO . 41.3 m -165.73 118.45 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.125 176.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.542 HG23 HD11 ' A' ' 230' ' ' LEU . 12.1 p -80.32 145.95 31.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.531 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.442 ' H ' ' HG3' ' A' ' 234' ' ' GLN . 0.0 OUTLIER -81.52 16.04 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.432 -178.032 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.476 ' OD1' ' HB ' ' A' ' 233' ' ' THR . 2.2 m-20 -57.08 -45.95 82.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.764 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 166.14 89.13 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.122 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -89.49 97.61 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.825 2.35 . . . . 0.0 112.209 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.588 ' HB ' HG13 ' A' ' 266' ' ' VAL . 21.7 t -82.71 142.28 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.47 134.95 52.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.02 0.438 . . . . 0.0 110.922 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.581 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -138.93 131.87 29.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.372 175.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.417 ' HG3' ' CE1' ' A' ' 294' ' ' PHE . 92.3 mttt -84.46 124.02 30.89 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.613 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -76.94 100.42 5.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.018 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 36.0 pt -88.79 -15.69 8.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.266 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 244' ' ' GLN . 0.7 OUTLIER -140.3 135.69 32.49 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.43 ' HG3' HG23 ' A' ' 260' ' ' VAL . 27.4 mtpp -50.68 137.19 20.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 112.547 -175.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.728 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -111.86 91.64 3.73 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.9 m -86.28 156.16 57.09 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.781 0.324 . . . . 0.0 111.306 -175.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.41 ' HA ' ' HB1' ' A' ' 255' ' ' ALA . 17.1 Cg_exo -67.37 111.59 2.34 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.881 2.387 . . . . 0.0 111.88 176.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 42.7 t -68.56 165.17 19.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.18 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.93 -27.78 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -171.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -73.84 -21.61 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.536 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 41.82 68.66 0.43 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.601 0.76 . . . . 0.0 112.217 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -148.31 -62.04 0.25 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.056 0.455 . . . . 0.0 110.837 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.7 p -99.34 11.31 39.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.14 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' A' ' 248' ' ' PRO . . . -95.03 107.04 19.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.312 -174.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.49 120.0 27.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.728 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -75.98 111.25 11.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.143 0.497 . . . . 0.0 110.586 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.0 mt -114.52 144.14 43.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.315 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.99 167.41 9.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.371 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.43 HG23 ' HG3' ' A' ' 245' ' ' LYS . 58.3 t -77.41 121.31 29.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.976 0.417 . . . . 0.0 110.489 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 100.32 9.95 46.25 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.87 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -92.1 148.77 21.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 16.4 mm -99.35 111.65 29.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 0.0 110.186 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.502 HG21 HG11 ' A' ' 291' ' ' VAL . 35.7 t -87.51 115.21 27.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.179 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.5 ttpp -96.91 98.95 10.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.588 HG13 ' HB ' ' A' ' 238' ' ' VAL . 6.5 p -94.85 124.72 47.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.264 0.554 . . . . 0.0 110.585 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 88.2 m -116.75 -35.19 4.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.052 176.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -91.36 92.29 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.224 0.535 . . . . 0.0 110.07 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . 0.789 ' HA ' ' HB3' ' A' ' 275' ' ' TRP . 29.9 mtt -97.58 139.61 33.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.879 0.371 . . . . 0.0 110.886 177.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -93.57 -175.01 3.65 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.3 tt -73.52 71.87 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.796 0.808 . . . . 0.0 110.976 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 73.65 -37.99 0.39 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.903 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 274' ' ' GLN . . . -91.43 78.59 1.34 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.159 -1.019 . . . . 0.0 113.02 -169.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 287' ' ' PRO . 46.5 mt-30 75.67 128.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.894 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.789 ' HB3' ' HA ' ' A' ' 269' ' ' MET . 0.6 OUTLIER -124.62 169.57 11.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.36 -169.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 38.8 mt-10 -107.54 108.45 19.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.607 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.31 133.3 11.58 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.168 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 283' ' ' LYS . 1.4 pm0 -95.04 108.81 20.9 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.291 0.567 . . . . 0.0 109.489 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 27.1 t -115.74 -87.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.143 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -92.04 72.67 5.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.08 0.467 . . . . 0.0 111.059 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.89 4.89 78.41 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.729 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 282' ' ' ARG . 14.3 ptt180 -159.97 162.6 34.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.207 0.503 . . . . 0.0 111.426 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.59 ' HB3' ' HB3' ' A' ' 278' ' ' GLU . 10.1 ptmm? -116.88 138.79 51.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -154.35 175.8 32.4 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.146 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.49 127.17 34.84 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.094 0.473 . . . . 0.0 110.792 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -127.43 125.76 23.97 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.023 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 17.0 Cg_exo -68.31 139.61 46.21 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.636 2.224 . . . . 0.0 111.409 176.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -75.66 26.26 0.11 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.7 t -115.48 -9.82 12.03 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.961 0.41 . . . . 0.0 109.953 171.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -90.34 -30.34 17.51 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.613 HG12 ' HA ' ' A' ' 242' ' ' ALA . 18.0 m -124.25 161.53 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.51 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -130.75 133.16 45.78 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.02 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 240' ' ' ALA . 43.6 mm -70.76 111.98 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.723 178.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.417 ' CE1' ' HG3' ' A' ' 241' ' ' LYS . 34.8 p90 -111.12 142.08 43.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.901 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.718 ' HB3' ' HB2' ' A' ' 298' ' ' ASN . 38.8 t70 -72.11 124.11 90.39 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.473 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 295' ' ' ASP . 39.6 Cg_exo -57.81 -32.41 94.84 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.168 2.579 . . . . 0.0 113.179 -176.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.453 ' HG3' ' OD2' ' A' ' 295' ' ' ASP . 8.3 pt20 -98.07 9.05 43.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.802 0.334 . . . . 0.0 111.205 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.718 ' HB2' ' HB3' ' A' ' 295' ' ' ASP . 64.7 m-20 -129.56 81.86 68.75 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.905 175.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.56 88.03 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.077 2.518 . . . . 0.0 111.677 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 76.64 16.95 1.9 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.872 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . 0.653 ' HB3' ' HB3' ' A' ' 298' ' ' ASN . 10.5 tp10 -85.77 83.31 7.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 170.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -115.19 -75.15 0.59 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.493 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.648 -0.692 . . . . 0.0 110.182 -177.643 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mmt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -112.92 -55.44 2.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 172.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.484 ' HB3' HD12 ' A' ' 99' ' ' ILE . 70.2 m 67.23 -59.37 0.4 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.913 0.758 . . . . 0.0 111.071 -176.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.427 ' HB1' ' HE3' ' A' ' 89' ' ' LYS . . . -75.37 111.97 11.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.902 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -134.38 84.96 2.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.847 0.355 . . . . 0.0 111.0 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.418 ' HE1' ' O ' ' A' ' 98' ' ' LEU . 41.7 p90 -161.22 164.22 30.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.863 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 12.8 t70 -90.02 120.24 31.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 40.5 m -70.13 -16.53 63.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.856 -172.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -103.46 -11.79 17.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.89 0.376 . . . . 0.0 111.505 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 11.1 t0 -75.62 94.47 3.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.174 0.512 . . . . 0.0 110.879 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.3 mtm-85 -65.84 -25.19 67.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.311 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -73.88 1.83 9.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.849 0.357 . . . . 0.0 110.781 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.84 -47.43 3.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.718 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -114.05 -20.34 11.03 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -76.21 120.32 21.33 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.104 -0.372 . . . . 0.0 110.999 -172.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.642 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.6 mmt -102.12 -16.18 16.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.963 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.473 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.88 -112.57 1.71 Allowed Glycine 0 CA--C 1.525 0.667 0 O-C-N 123.431 0.457 . . . . 0.0 113.543 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.473 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 16.8 Cg_exo -66.55 83.06 0.3 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.217 2.611 . . . . 0.0 113.518 -176.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.966 HG12 ' H ' ' A' ' 20' ' ' SER . 57.5 t -135.33 -164.66 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.966 ' H ' HG12 ' A' ' 19' ' ' VAL . 45.7 p -172.68 174.32 3.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -168.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -53.07 60.9 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.092 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -57.12 -61.9 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.495 0.497 . . . . 0.0 111.532 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -57.72 -47.16 83.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.654 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.87 74.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.055 0.455 . . . . 0.0 111.641 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -61.56 -44.34 97.22 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.801 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m -57.85 -38.33 75.47 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -81.31 -9.52 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 80.1 mt -122.41 -12.98 8.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.934 ' HA ' HE21 ' A' ' 29' ' ' GLN . 0.0 OUTLIER -74.36 117.26 15.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.971 0.415 . . . . 0.0 111.272 -174.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.97 3.05 63.19 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.75 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -80.75 -171.42 3.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.654 0.264 . . . . 0.0 110.453 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.462 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 17.2 mtm180 -60.79 152.71 26.3 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.652 ' HE1' ' HB2' ' A' ' 118' ' ' LEU . 62.3 m170 -98.54 142.08 30.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.11 -9.04 54.3 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -172.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.64 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 73.8 mtp -76.75 138.25 39.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.38 -0.41 . . . . 0.0 109.895 176.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' HB2' HG22 ' A' ' 52' ' ' VAL . 27.3 p90 -144.02 167.47 22.29 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.642 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -158.94 146.93 17.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.5 116.11 50.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.677 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.493 ' NH2' ' HE2' ' A' ' 207' ' ' PTR . 36.1 ptt-85 -114.17 -179.31 3.6 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.601 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -86.46 138.04 32.07 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -89.23 177.77 6.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.398 0.618 . . . . 0.0 111.433 -174.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 m -110.4 -4.94 15.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.21 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 p -73.98 -65.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.822 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 26.6 m -133.37 143.29 47.49 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.639 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.93 88.64 0.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.239 1.959 . . . . 0.0 111.334 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 145.72 -21.63 1.82 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -77.52 150.99 34.76 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -130.43 173.78 10.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG22 HG12 ' A' ' 62' ' ' ILE . 9.5 t -138.93 109.67 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.122 0.487 . . . . 0.0 111.722 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.404 ' HB2' HD11 ' A' ' 63' ' ' ILE . 51.6 tp -83.29 97.61 8.99 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.322 175.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.9 m -95.75 117.09 29.86 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.685 0.278 . . . . 0.0 110.254 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.651 HG21 HD13 ' A' ' 93' ' ' LEU . 60.4 t -113.23 133.62 58.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.405 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 48.1 t -102.05 118.05 36.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.712 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 10.7 tp10 -151.18 153.22 34.55 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.518 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 63.4 m-80 57.41 21.85 7.31 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.323 0.389 . . . . 0.0 111.822 -177.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 m 57.6 51.51 9.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.253 1.025 . . . . 0.0 108.996 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.022 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.29 0.0 OUTLIER -166.81 70.03 0.11 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.376 -155.784 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 22.5 t -71.93 110.86 5.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.883 -168.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.3 m -76.64 120.46 21.86 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.282 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.689 ' HB3' ' HD2' ' A' ' 207' ' ' PTR . 91.3 m-70 -97.71 89.9 4.79 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -173.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.875 ' HE1' HD11 ' A' ' 153' ' ' ILE . 75.5 m-85 -89.05 106.76 18.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -80.51 136.41 23.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.209 0.528 . . . . 0.0 111.97 -178.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.6 mp -117.88 106.57 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.534 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -83.58 148.67 27.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.735 0.302 . . . . 0.0 110.548 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.9 t -85.49 109.32 18.4 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 72' ' ' LYS . 98.2 mt -79.41 147.43 68.28 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.544 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.8 -13.47 37.22 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.695 2.263 . . . . 0.0 110.547 170.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -75.39 -0.72 20.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.366 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 3.1 mmp_? 64.71 28.51 13.04 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.972 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 70' ' ' ARG . 59.1 mtt85 -124.8 157.37 35.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.537 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.526 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 25.7 m-85 -105.6 114.93 29.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.888 0.375 . . . . 0.0 110.519 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.63 ' HB2' HD11 ' A' ' 66' ' ' LEU . 38.6 ttpt -103.53 111.96 24.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.546 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.714 HD11 ' HB3' ' A' ' 61' ' ' TYR . 7.9 tt -93.23 75.26 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 122.179 0.99 . . . . 0.0 109.124 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.442 ' HA3' ' HG2' ' A' ' 209' ' ' GLN . . . 66.07 97.78 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.979 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.749 ' HA ' HG23 ' A' ' 212' ' ' THR . 42.4 t0 75.49 -51.5 0.64 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.649 0.379 . . . . 0.0 111.381 168.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -94.05 119.27 32.69 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.8 pt-20 -100.24 135.77 41.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.319 0.58 . . . . 0.0 110.796 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 94.2 m-85 -115.86 177.12 4.79 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.473 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.43 -49.68 74.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.903 0.382 . . . . 0.0 111.167 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -164.52 -175.43 3.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 15.2 mt -53.22 -58.82 10.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' A' ' 8' ' ' SER . 30.6 Cg_endo -64.89 -4.75 9.31 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.206 1.937 . . . . 0.0 113.433 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.87 -36.63 15.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.813 0.339 . . . . 0.0 110.425 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -77.11 -37.03 55.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.16 -38.8 84.27 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.832 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.599 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 1.9 tp10 -66.26 -43.84 85.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.725 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -64.91 -28.3 69.44 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.432 0.634 . . . . 0.0 110.968 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.494 ' CG ' HD21 ' A' ' 93' ' ' LEU . 20.6 m-85 -92.03 1.73 57.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.324 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.599 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 56.8 mtpt -85.02 3.54 38.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 175.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.3 pt -140.53 -8.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-O 121.252 0.549 . . . . 0.0 109.706 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 4.4 t60 -86.17 -36.68 19.36 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.973 -174.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 93.8 m-85 70.13 91.69 0.09 Allowed 'General case' 0 C--O 1.225 -0.205 0 O-C-N 124.277 0.986 . . . . 0.0 109.033 -166.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.651 HD13 HG21 ' A' ' 52' ' ' VAL . 25.1 mt -58.67 -44.76 90.27 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.351 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.964 ' HA ' ' HG2' ' A' ' 154' ' ' GLU . 28.3 p-10 -150.51 48.82 0.88 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.627 -166.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.8 OUTLIER 70.63 -5.73 1.37 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.413 1.885 . . . . 0.0 111.635 -169.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.58 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -126.13 151.64 46.99 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.0 p -96.72 167.05 11.35 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.418 ' O ' ' HE1' ' A' ' 6' ' ' PHE . 72.6 mt -65.38 99.66 0.42 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 3' ' ' SER . 48.0 mm -87.4 -64.06 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.343 -172.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 35' ' ' MET . 42.0 tt0 -156.86 126.01 3.09 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.201 -174.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.68 153.71 47.66 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.023 2.482 . . . . 0.0 113.127 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.439 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -69.62 154.23 94.98 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.514 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.61 115.78 2.76 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 121.904 1.736 . . . . 0.0 111.672 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.498 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 54.3 ttp180 -63.19 -27.16 69.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.439 0.638 . . . . 0.0 109.7 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -78.66 155.67 78.26 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.793 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.422 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 38.2 Cg_endo -66.0 161.7 38.59 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.567 2.178 . . . . 0.0 112.434 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.2 p -112.32 87.31 9.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 42.0 Cg_exo -57.84 -46.86 23.66 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.935 2.423 . . . . 0.0 113.423 175.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 3.7 Cg_exo -79.05 -153.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.98 1.787 . . . . 0.0 111.636 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -64.77 -30.94 71.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.926 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.81 45.57 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.481 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 m 55.35 47.89 20.33 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.687 0.395 . . . . 0.0 111.397 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.7 t 66.44 97.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.686 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.509 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 3.8 m -86.63 92.47 8.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.274 -178.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.62 93.48 14.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.931 0.396 . . . . 0.0 111.062 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 114' ' ' SER . 84.1 Cg_endo -98.71 118.23 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 123.426 2.751 . . . . 0.0 112.831 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -71.76 90.09 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.652 ' HB2' ' HE1' ' A' ' 33' ' ' HIS . 1.3 tm? -177.85 131.32 0.32 Allowed Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -175.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 118' ' ' LEU . 24.0 Cg_exo -64.45 79.45 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.71 2.274 . . . . 0.0 112.402 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.9 m 63.07 -86.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.231 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 177.19 -73.54 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 123.073 0.549 . . . . 0.0 109.787 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 64.81 22.81 12.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.875 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 124' ' ' ASN . 17.4 m-20 59.73 -145.56 0.51 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.918 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 123' ' ' ASP . 0.9 OUTLIER 78.04 161.42 0.21 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.749 0.656 . . . . 0.0 111.759 177.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.881 HD12 HG21 ' A' ' 152' ' ' ILE . 3.3 mm? 65.03 99.21 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.504 175.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 44.3 tt0 -175.59 -54.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.207 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.756 ' HB2' HG22 ' A' ' 182' ' ' VAL . 55.0 m-85 -118.5 107.5 13.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.909 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.67 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 4.2 t -116.26 140.02 40.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.719 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 4.9 ptp180 -115.24 138.61 50.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 116.71 -1.996 . . . . 0.0 108.682 164.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.634 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -100.67 125.5 47.1 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.738 -178.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' A' ' 179' ' ' GLU . 17.2 mt -99.22 -26.32 14.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.243 -173.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 34.7 t80 -73.48 -41.98 62.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -172.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.548 ' HB2' ' N ' ' A' ' 146' ' ' LYS . 6.0 t70 75.24 100.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.699 0.761 . . . . 0.0 110.832 -174.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 53.5 t80 -128.7 86.78 56.66 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.594 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 89.6 Cg_endo -83.6 86.72 1.33 Allowed 'Trans proline' 0 N--CA 1.441 -1.611 0 C-N-CA 121.147 1.231 . . . . 0.0 112.368 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.67 -24.47 60.35 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.541 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.6 m120 61.6 50.83 4.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.709 -1.246 . . . . 0.0 112.22 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.422 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 4.8 m-20 -136.67 176.25 8.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.273 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.82 -13.83 35.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 122.11 0.957 . . . . 0.0 108.496 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 172' ' ' MET . 19.6 mm-40 -88.02 -31.4 19.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.244 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -135.2 105.76 6.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.939 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.037 HD11 ' HB2' ' A' ' 165' ' ' ASN . 26.5 tp -66.94 128.79 94.0 Favored Pre-proline 0 CA--C 1.51 -0.563 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.989 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.621 ' HD2' HD12 ' A' ' 142' ' ' LEU . 92.4 Cg_endo -79.34 98.08 1.14 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 121.384 1.389 . . . . 0.0 111.306 173.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.562 ' CD2' ' HB ' ' A' ' 130' ' ' THR . 0.5 OUTLIER -89.32 -165.1 1.26 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.54 ' C ' ' HB2' ' A' ' 133' ' ' ASP . 56.2 mtpt -139.49 -176.02 4.39 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.408 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.946 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -82.99 50.41 1.72 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.665 0.745 . . . . 0.0 110.665 -174.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.99 35.28 0.17 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.663 ' OE1' ' HB2' ' A' ' 166' ' ' LYS . 5.1 tp10 -84.34 151.8 24.5 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.983 -173.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.3 122.82 64.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.549 0.69 . . . . 0.0 109.157 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.734 HD22 ' CD2' ' A' ' 142' ' ' LEU . 65.4 mt -123.67 157.57 33.53 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.008 -171.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 66.1 t -117.3 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.075 HD13 ' HB2' ' A' ' 163' ' ' ALA . 45.6 mm -76.86 95.48 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-O 122.177 0.989 . . . . 0.0 109.508 -175.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.875 HD11 ' HE1' ' A' ' 61' ' ' TYR . 19.3 tt -81.64 -28.07 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.602 -175.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.022 ' HA ' HH21 ' A' ' 57' ' ' ARG . 4.0 mt-10 -136.37 144.39 44.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.144 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.642 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 86.8 tttt -124.31 76.53 61.28 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 164.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.563 ' HD2' ' HE1' ' A' ' 172' ' ' MET . 23.2 Cg_exo -67.2 -51.17 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.768 2.312 . . . . 0.0 111.778 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -113.8 177.54 4.6 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.619 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -100.18 -16.98 17.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.976 0.417 . . . . 0.0 110.3 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -99.8 -19.79 16.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.593 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 39.7 m95 -129.74 141.95 50.79 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.752 ' O ' HG13 ' A' ' 173' ' ' ILE . 46.5 m0 -124.92 137.86 54.26 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 6.1 m -97.7 109.88 22.55 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.075 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -121.29 152.1 39.3 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.244 -176.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.775 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 27.1 ptt-85 -87.65 127.69 35.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 173.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.037 ' HB2' HD11 ' A' ' 142' ' ' LEU . 56.3 t30 -61.75 178.01 0.37 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.133 -172.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.684 ' HG2' HG22 ' A' ' 214' ' ' THR . 3.6 ttmp? -54.19 -26.03 25.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.303 166.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 211' ' ' GLN . 24.7 m-20 -74.98 -38.45 61.66 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.03 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.479 ' HA3' ' HB2' ' A' ' 211' ' ' GLN . . . 115.32 -11.85 19.37 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.458 -175.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.775 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -59.12 138.18 57.66 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.26 0.624 . . . . 0.0 112.051 177.434 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 74.0 t -88.76 121.07 38.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.542 177.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -153.73 156.2 26.64 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.438 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.593 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -77.55 143.68 38.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.805 0.303 . . . . 0.0 111.295 178.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -142.07 142.0 23.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.526 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 20.4 Cg_exo -65.95 129.46 22.02 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.715 2.277 . . . . 0.0 112.879 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.614 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 44.9 t -62.72 -40.1 60.68 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 17.5 Cg_endo -59.39 -11.28 13.11 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.023 1.815 . . . . 0.0 112.627 175.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -93.29 -10.53 35.16 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.604 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.634 HG12 HG22 ' A' ' 130' ' ' THR . 2.1 m -105.98 -177.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -166.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.719 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 3.4 tp10 -159.43 44.82 0.25 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 112.467 -2.151 . . . . 0.0 110.833 -154.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.77 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -74.02 138.7 44.25 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 119.174 -2.204 . . . . 0.0 112.87 -162.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 22.8 tp -75.77 -70.55 0.43 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 110.773 -2.921 . . . . 0.0 111.386 -168.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.756 HG22 ' HB2' ' A' ' 127' ' ' TYR . 16.5 m -78.2 70.33 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 122.151 0.977 . . . . 0.0 110.329 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.76 -52.75 0.09 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.056 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.3 m 48.63 73.78 0.21 Allowed 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 124.292 0.995 . . . . 0.0 111.02 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 3.7 m -53.56 147.6 20.63 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.108 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.82 104.57 0.1 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.57 2.18 . . . . 0.0 112.589 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.896 ' HB2' ' HB3' ' A' ' 190' ' ' HIS . 40.5 m80 -124.01 -14.91 7.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.35 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.06 -98.96 1.76 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -174.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -71.44 90.91 1.0 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 170.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.896 ' HB3' ' HB2' ' A' ' 187' ' ' HIS . 22.6 p-80 -136.16 136.48 40.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.985 -175.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 80.1 -45.86 3.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.149 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 63.83 14.46 8.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.855 0.462 . . . . 0.0 111.198 176.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.541 ' HD2' ' N ' ' A' ' 193' ' ' ARG . 3.4 mpt_? 55.48 39.06 31.03 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.733 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -67.71 -29.45 68.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.562 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.1 p -147.92 114.23 5.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.644 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -90.11 -75.03 0.47 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 54.4 p -179.54 148.7 0.35 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.834 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -74.44 -22.45 59.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.532 0.682 . . . . 0.0 109.314 174.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.5 ' O ' ' HB ' ' A' ' 200' ' ' ILE . . . 161.45 69.9 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.29 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.5 ' HB ' ' O ' ' A' ' 199' ' ' GLY . 2.0 mp 74.06 118.26 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.31 0 CA-C-O 121.113 0.482 . . . . 0.0 110.504 -174.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 7.6 Cg_exo -73.01 144.72 38.54 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.099 2.533 . . . . 0.0 112.085 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -116.57 95.76 46.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.528 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -91.04 -7.64 3.64 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.698 2.265 . . . . 0.0 112.087 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 59.78 81.13 0.18 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.234 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -81.76 87.69 6.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.03 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -88.86 -166.68 1.66 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.243 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' PTR . . . . . 0.689 ' HD2' ' HB3' ' A' ' 60' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.514 ' HB3' ' N ' ' A' ' 60' ' ' HIS . . . -90.32 3.83 52.52 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.307 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.543 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 49.8 tt0 -47.24 129.73 9.7 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.635 173.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 209' ' ' GLN . 15.8 Cg_exo -64.08 102.76 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.809 1.673 . . . . 0.0 109.756 177.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.479 ' HB2' ' HA3' ' A' ' 168' ' ' GLY . 13.4 mm100 -46.96 141.15 4.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.143 0.497 . . . . 0.0 112.131 -171.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.749 HG23 ' HA ' ' A' ' 75' ' ' ASP . 18.0 m -88.14 88.26 7.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.378 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 10.2 m 72.02 157.48 0.18 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.804 0.69 . . . . 0.0 110.24 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.684 HG22 ' HG2' ' A' ' 166' ' ' LYS . 9.6 p -54.37 118.76 17.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.26 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.97 90.3 0.25 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.028 2.485 . . . . 0.0 112.001 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.45 ' N ' ' HD2' ' A' ' 217' ' ' PRO . 91.6 mt -72.84 -53.89 5.05 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.987 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 216' ' ' LEU . 18.6 Cg_endo -61.34 -54.56 1.67 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.802 1.668 . . . . 0.0 112.134 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -167.08 164.34 15.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.621 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.57 -41.11 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.262 0.553 . . . . 0.0 110.248 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 28.6 m -147.49 101.61 3.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.706 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 178.81 -167.94 38.57 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.798 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 23.1 t -147.59 139.18 13.66 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 26.0 Cg_exo -63.96 147.62 91.86 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.865 2.377 . . . . 0.0 112.235 177.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -166.4 150.09 16.83 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.041 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.583 ' HB1' ' HG3' ' A' ' 229' ' ' PRO . . . 59.24 64.37 1.38 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 122.83 0.452 . . . . 0.0 111.745 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -84.73 117.85 24.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.123 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.6 mt 70.55 -64.91 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.714 0.634 . . . . 0.0 110.994 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 83.6 m -151.27 126.75 4.87 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 177.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.583 ' HG3' ' HB1' ' A' ' 225' ' ' ALA . 10.7 Cg_exo -69.28 -92.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.52 2.147 . . . . 0.0 111.735 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.487 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 86.5 mt -151.77 127.37 4.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.902 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 23.9 Cg_exo -65.06 171.82 8.3 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.854 2.369 . . . . 0.0 111.674 174.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 24.2 m -61.53 97.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.812 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 234' ' ' GLN . 3.3 p -92.59 -28.86 16.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.794 -175.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 233' ' ' THR . 59.0 mm-40 67.88 85.1 0.15 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.76 0.662 . . . . 0.0 111.251 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.78 3.25 39.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.532 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 107.02 88.89 2.06 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.25 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 7.5 Cg_exo -73.51 89.1 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.61 2.206 . . . . 0.0 110.831 171.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.617 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 27.7 t -93.43 145.22 8.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.037 -174.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -93.77 123.45 37.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.173 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.81 143.34 47.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.175 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 45.0 tttp -90.89 119.08 30.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.15 0.5 . . . . 0.0 109.752 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.94 ' HB1' ' HG2' ' A' ' 259' ' ' GLU . . . -84.23 127.22 33.81 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.781 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 46.2 pt -128.12 -30.1 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -168.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -82.62 -75.9 0.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.298 -169.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.692 ' HA ' ' CB ' ' A' ' 259' ' ' GLU . 1.0 OUTLIER 153.85 131.25 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.391 1.476 . . . . 0.0 108.183 168.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 19.2 mmm180 -124.2 100.61 6.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.917 0.389 . . . . 0.0 110.968 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 18.5 m -117.42 127.0 26.96 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.453 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.558 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 88.9 Cg_endo -87.8 160.86 7.63 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.029 2.486 . . . . 0.0 112.266 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 11.7 t -94.25 -177.1 4.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.41 -21.88 66.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.918 0.39 . . . . 0.0 111.18 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.09 -22.27 36.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.4 -178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 248' ' ' PRO . 37.7 m-20 -93.48 102.81 15.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.191 -172.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -94.9 -33.9 12.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.171 0.51 . . . . 0.0 109.734 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 19.5 p -93.25 8.18 41.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.737 -176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -93.0 126.76 38.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.532 HD13 HD21 ' A' ' 258' ' ' LEU . 0.6 OUTLIER -85.08 122.12 28.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.952 0.406 . . . . 0.0 110.524 -176.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -84.06 109.89 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.779 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.571 HD23 ' HB ' ' A' ' 279' ' ' VAL . 0.4 OUTLIER -157.05 -156.25 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.166 176.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.94 ' HG2' ' HB1' ' A' ' 242' ' ' ALA . 3.7 mt-10 88.12 139.92 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 24.9 t 82.56 83.16 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 112.695 -2.048 . . . . 0.0 111.114 -172.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 89.98 14.38 59.33 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.417 -0.81 . . . . 0.0 113.48 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -105.36 145.99 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.974 0.416 . . . . 0.0 111.163 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 32.2 mm -98.45 111.4 28.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.534 HG22 HD22 ' A' ' 258' ' ' LEU . 43.5 t -92.83 117.25 35.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 -175.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -96.39 105.67 17.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.102 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 237' ' ' PRO . 2.4 p -94.67 118.01 39.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.999 0.428 . . . . 0.0 110.304 176.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.6 m -93.8 -24.37 17.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.173 0.511 . . . . 0.0 110.763 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 88.8 mtt180 -121.56 98.27 5.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.801 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . 0.617 ' HE3' ' HB ' ' A' ' 238' ' ' VAL . 1.2 mtt -91.39 112.93 25.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.321 0.581 . . . . 0.0 111.373 -176.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -92.13 158.79 15.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.173 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.5 tt -91.28 -14.98 8.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.347 0.594 . . . . 0.0 109.851 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.99 23.02 1.57 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.8 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 91.04 -55.63 3.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.136 -0.554 . . . . 0.0 114.077 168.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.458 ' H ' ' HG2' ' A' ' 274' ' ' GLN . 6.1 pt20 -77.81 114.84 17.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.346 0.593 . . . . 0.0 110.526 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.52 ' HB3' HG21 ' A' ' 266' ' ' VAL . 42.9 m0 -94.74 155.65 16.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.457 -175.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 0.2 OUTLIER -107.58 113.29 26.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.425 -179.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -141.73 168.35 25.61 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.288 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -118.25 110.16 17.21 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.571 ' HB ' HD23 ' A' ' 258' ' ' LEU . 43.9 t -139.93 146.72 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 63.61 24.51 14.0 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.094 0.473 . . . . 0.0 111.02 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 82.16 3.37 90.58 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.238 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -134.24 149.58 50.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.943 0.402 . . . . 0.0 110.767 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -103.6 143.26 32.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.274 178.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -172.18 170.74 43.72 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.477 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 95.3 mt -90.34 133.5 34.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.119 0.485 . . . . 0.0 111.122 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -134.62 147.85 64.93 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.184 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -87.77 139.29 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.685 2.257 . . . . 0.0 112.752 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -70.53 -11.52 60.98 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.063 0.459 . . . . 0.0 111.016 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.5 p -78.23 4.84 11.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.236 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -116.94 -49.11 2.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.657 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 242' ' ' ALA . 27.5 m -85.98 152.52 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.216 -175.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -109.29 124.34 50.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.797 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 240' ' ' ALA . 20.8 mm -79.77 127.62 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.473 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.468 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 2.6 p90 -146.08 173.19 12.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.166 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.614 ' HB2' ' HG2' ' A' ' 297' ' ' GLN . 14.7 p-10 -107.66 98.7 25.6 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-O 121.373 0.606 . . . . 0.0 111.049 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 3.9 Cg_exo -76.69 14.53 1.22 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.759 2.973 . . . . 0.0 111.97 -178.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.614 ' HG2' ' HB2' ' A' ' 295' ' ' ASP . 13.7 pt20 -78.66 -11.39 59.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.877 175.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 45.1 m-80 -93.07 150.53 39.38 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.447 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 5.3 Cg_exo -79.2 12.33 2.34 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 123.175 2.583 . . . . 0.0 112.889 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.26 -46.54 88.34 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -113.52 79.46 1.25 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.493 0.663 . . . . 0.0 110.152 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -144.42 93.64 2.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.119 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.575 -177.358 . . . . . . . . 0 0 . 1 stop_ save_